Citrus Sinensis ID: 001922
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 995 | 2.2.26 [Sep-21-2011] | |||||||
| O49545 | 1003 | Leucine-rich repeat recep | yes | no | 0.968 | 0.961 | 0.584 | 0.0 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.957 | 0.951 | 0.578 | 0.0 | |
| O65440 | 992 | Leucine-rich repeat recep | no | no | 0.963 | 0.966 | 0.569 | 0.0 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.931 | 0.945 | 0.521 | 0.0 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.914 | 0.874 | 0.426 | 0.0 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.967 | 0.950 | 0.402 | 0.0 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.906 | 0.905 | 0.409 | 0.0 | |
| Q9FRS6 | 1029 | Leucine-rich repeat recep | no | no | 0.954 | 0.923 | 0.387 | 1e-180 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.914 | 0.797 | 0.379 | 1e-177 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.950 | 0.841 | 0.390 | 1e-174 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1108 bits (2866), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 576/986 (58%), Positives = 715/986 (72%), Gaps = 22/986 (2%)
Query: 15 NIPNLSSAASLVNDFHVLVALKQGF----ENPEPALISWNSSNPSSVCSWAGICC--SRD 68
+I + +A+ +++F L++LK ++ L SW S +S C+W G+ C SR
Sbjct: 12 HISHTFTASRPISEFRALLSLKTSLTGAGDDKNSPLSSWKVS--TSFCTWIGVTCDVSRR 69
Query: 69 RVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQF 126
V SLDL+ LNL G++ + L L NLSLA N +G I EI +LS L+ LN+SNN F
Sbjct: 70 HVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVF 129
Query: 127 SGGL-DWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGEL 185
+G D S LVNL V D YNNN T LPV + L +L++L LGGNYF GKIP SYG
Sbjct: 130 NGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSW 189
Query: 186 QGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSC 245
+EYL+++GN+L GKIP E+GNLT LRE+Y+GYYN FE G+P E+G L LV D ++C
Sbjct: 190 PVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANC 249
Query: 246 ELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFIN 305
L G+IP EIG L+ LDT+FL +N+ SG + +LG L++L ++DLSNN TGEIP SF
Sbjct: 250 GLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAE 309
Query: 306 LRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSN 365
L+ L L NLF N+LHG IP+++ DLP LE L LW+NNFTG IP+ LG+NGKL ++DLSSN
Sbjct: 310 LKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSN 369
Query: 366 KLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIY 425
KLTGT+P ++CS N+L LI L NFLFG IP+ LG C SLTR+R+G+N+LNGSIP G
Sbjct: 370 KLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFG 429
Query: 426 LPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLL 485
LP L ELQ NYLSG LP G S N LGQ++LSNN LSGPLP ++ NF+ +Q LLL
Sbjct: 430 LPKLTQVELQDNYLSGELPVAGGVSVN---LGQISLSNNQLSGPLPPAIGNFTGVQKLLL 486
Query: 486 SGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPE 545
GN+F GPIP +G+L+Q+ K+D S N SG I P I C LT++D+S+N LSG IP E
Sbjct: 487 DGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNE 546
Query: 546 ISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFA 605
I+ ++ILNYLNLSRNHL +IP SI SM+SLT DFS+N+ SG +P +GQF+ FN +SF
Sbjct: 547 ITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFL 606
Query: 606 GNPQLCGTLLNNPCN--VAPITHQ---PGKAPGDFKLIFALGLLICSLIFATAAIIKAKS 660
GNP LCG L PC VA HQ G KL+ LGLL+CS+ FA AIIKA+S
Sbjct: 607 GNPDLCGPYLG-PCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARS 665
Query: 661 FKKTG-SDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLL 719
KK S +W++TAFQ+L+F+ D+L+ +K+ N+IG+GGAGIVY G MPNG +AVK+L
Sbjct: 666 LKKASESRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLA 725
Query: 720 GFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKK 778
SHDHGF AEIQTLG IRHR+IVRLL FCSN ETNLLVYEYM NGSLGE LHGKK
Sbjct: 726 AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK 785
Query: 779 GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838
G L W+ RYKIA+EAAKGLCYLHHDCSPLIVHRDVKSNNILL+S FEAHVADFGLAKFL
Sbjct: 786 GGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL 845
Query: 839 IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD 898
D G SECMSAIAGSYGYIAPEYAYTL+VDEKSDVYSFGVVLLEL+TGR+PVG+FGDGVD
Sbjct: 846 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVD 905
Query: 899 IVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQML 958
IVQW ++ T+ K+ L +LDPRLS +P E H+ +VAMLC++E ++ERP MREVVQ+L
Sbjct: 906 IVQWVRKMTDSNKDSVLKVLDPRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQIL 965
Query: 959 SEFPRHSSDFNQSSSSSLKNLEKDPK 984
+E P+ +Q + S E PK
Sbjct: 966 TEIPKLPPSKDQPMTESAPESELSPK 991
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1092 bits (2823), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 564/975 (57%), Positives = 710/975 (72%), Gaps = 22/975 (2%)
Query: 21 SAASLVNDFHVLVALKQGFENPE--PALISWNSSNPSSVCSWAGICC--SRDRVASLDLT 76
+ A + + H L++LK F E P L SWN S ++ CSW G+ C S V SLDL+
Sbjct: 20 TVAKPITELHALLSLKSSFTIDEHSPLLTSWNLS--TTFCSWTGVTCDVSLRHVTSLDLS 77
Query: 77 DLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGL-DWN 133
LNL G++ + + L L NLSLA N +G I +I NL L+ LN+SNN F+G D
Sbjct: 78 GLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDEL 137
Query: 134 YSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSL 193
S LVNL V D YNNN T LPV + L +L++L LGGNYF GKIP +YG LEYL++
Sbjct: 138 SSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAV 197
Query: 194 AGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPH 253
+GN+LTGKIP E+GNLT LRE+Y+GYYN FE G+P E+G L LV D ++C L G+IP
Sbjct: 198 SGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPP 257
Query: 254 EIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFN 313
EIG L+ LDT+FL +N +G+I ++LG +++L ++DLSNN TGEIP SF L+ L L N
Sbjct: 258 EIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLN 317
Query: 314 LFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPT 373
LF N+L+G+IP+++ ++P LE L LW+NNFTG IP+ LG+NG+L +LDLSSNKLTGT+P
Sbjct: 318 LFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPP 377
Query: 374 DLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAE 433
++CS N+L LI L NFLFG IP+ LG C SLTR+R+G+N+LNGSIP LP L+ E
Sbjct: 378 NMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVE 437
Query: 434 LQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGP 493
LQ NYL+G LP +G S LGQ++LSNN LSG LP ++ N S +Q LLL GN+FSG
Sbjct: 438 LQDNYLTGELPISGGGVSG--DLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGS 495
Query: 494 IPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILN 553
IPP IG L+Q+ KLD S N SG I P I C LT++D+S+N LSG IP E++ ++ILN
Sbjct: 496 IPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILN 555
Query: 554 YLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGT 613
YLNLSRNHL +IP +I SM+SLT DFS+N+ SG +P +GQF+ FN +SF GN LCG
Sbjct: 556 YLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGP 615
Query: 614 LLNNPCNVAPITHQPGKAP--GDFKLIFALGLLICSLIFATAAIIKAKSFKKTG-SDSWK 670
L PC THQ P KL+ LGLL CS++FA AIIKA+S + + +W+
Sbjct: 616 YLG-PCGKG--THQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWR 672
Query: 671 MTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKL--LGFGTHSHDH 728
+TAFQ+L+F+ D+L+ +K+ N+IG+GGAGIVY G MP G +AVK+L + G+ SHDH
Sbjct: 673 LTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGS-SHDH 731
Query: 729 GFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY 788
GF AEIQTLG IRHR+IVRLL FCSN ETNLLVYEYM NGSLGE LHGKKG L WN RY
Sbjct: 732 GFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRY 791
Query: 789 KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS 848
KIA+EAAKGLCYLHHDCSPLIVHRDVKSNNILL+S FEAHVADFGLAKFL D G SECMS
Sbjct: 792 KIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMS 851
Query: 849 AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN 908
AIAGSYGYIAPEYAYTL+VDEKSDVYSFGVVLLEL+TG++PVG+FGDGVDIVQW + T+
Sbjct: 852 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDIVQWVRSMTD 911
Query: 909 GRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDF 968
K+ L ++D RLS VP E H+ +VA+LC++E ++ERP MREVVQ+L+E P+
Sbjct: 912 SNKDCVLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEIPKIPLSK 971
Query: 969 NQSSSSSLKNLEKDP 983
Q++ S + EK P
Sbjct: 972 QQAAESDVT--EKAP 984
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 1062 bits (2747), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 559/981 (56%), Positives = 707/981 (72%), Gaps = 22/981 (2%)
Query: 1 MAFFIVVTLLFSLLNIPNLSSA-ASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCS 59
FF++++ + LL +S SL+ +VL++LKQ F++ +P+L SWN N +S+CS
Sbjct: 6 FTFFLILSSISPLLCSSLISPLNLSLIRQANVLISLKQSFDSYDPSLDSWNIPNFNSLCS 65
Query: 60 WAGICCSR--DRVASLDLTDLNLCGSVPAQILRLD-KLTNLSLAGNNFTGSI--EIGNLS 114
W G+ C + LDL++LN+ G++ +I RL L L ++ N+F+G + EI LS
Sbjct: 66 WTGVSCDNLNQSITRLDLSNLNISGTISPEISRLSPSLVFLDISSNSFSGELPKEIYELS 125
Query: 115 SLQFLNISNNQFSGGLDWN-YSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY 173
L+ LNIS+N F G L+ +S + L DAY+N+F LP+ + L +L++LDLGGNY
Sbjct: 126 GLEVLNISSNVFEGELETRGFSQMTQLVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNY 185
Query: 174 FFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGK 233
F G+IP SYG L++LSL+GNDL G+IP EL N+T L ++YLGYYN + GGIP + G+
Sbjct: 186 FDGEIPRSYGSFLSLKFLSLSGNDLRGRIPNELANITTLVQLYLGYYNDYRGGIPADFGR 245
Query: 234 LVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNN 293
L+NLVHLDL++C L G IP E+GNLK L+ +FL N L+GS+P++LGN+T+L LDLSNN
Sbjct: 246 LINLVHLDLANCSLKGSIPAELGNLKNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNN 305
Query: 294 ALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQ 353
L GEIP L++L+LFNLF NRLHG IP+++++LP+L+ L LW NNFTG IP LG
Sbjct: 306 FLEGEIPLELSGLQKLQLFNLFFNRLHGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGS 365
Query: 354 NGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQN 413
NG L +DLS+NKLTG IP LC +L+ILIL NFLFGP+PE LG C L R RLGQN
Sbjct: 366 NGNLIEIDLSTNKLTGLIPESLCFGRRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQN 425
Query: 414 YLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFS 473
+L +P G IYLP L+L ELQ+N+L+G +PE ++ L Q+NLSNN LSGP+P S
Sbjct: 426 FLTSKLPKGLIYLPNLSLLELQNNFLTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGS 485
Query: 474 LSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDM 533
+ N SLQILLL N+ SG IP IG L+ +LK+D+SRN+ SG+ PP G C LTYLD+
Sbjct: 486 IRNLRSLQILLLGANRLSGQIPGEIGSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDL 545
Query: 534 SQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPES 593
S N +SG IP +IS +RILNYLN+S N NQ++P +G MKSLT ADFS N+FSG +P S
Sbjct: 546 SHNQISGQIPVQISQIRILNYLNVSWNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTS 605
Query: 594 GQFTVFNASSFAGNPQLCGTLLNNPCNVAPITHQP-----------GKAPGDFKLIFALG 642
GQF+ FN +SF GNP LCG +NPCN + Q G+ FKL F LG
Sbjct: 606 GQFSYFNNTSFLGNPFLCG-FSSNPCNGSQNQSQSQLLNQNNARSRGEISAKFKLFFGLG 664
Query: 643 LLICSLIFATAAIIKAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIV 702
LL L+F A++K + +K + WK+ FQKL F ILECVK+ +VIG+GG GIV
Sbjct: 665 LLGFFLVFVVLAVVKNRRMRKNNPNLWKLIGFQKLGFRSEHILECVKENHVIGKGGRGIV 724
Query: 703 YHGKMPNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761
Y G MPNG E+AVKKLL SHD+G AEIQTLG IRHRNIVRLLAFCSNK+ NLLV
Sbjct: 725 YKGVMPNGEEVAVKKLLTITKGSSHDNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLV 784
Query: 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL 821
YEYM NGSLGE LHGK G FL W R +IA+EAAKGLCYLHHDCSPLI+HRDVKSNNILL
Sbjct: 785 YEYMPNGSLGEVLHGKAGVFLKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILL 844
Query: 822 NSAFEAHVADFGLAKFLI-DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVL 880
FEAHVADFGLAKF++ D GASECMS+IAGSYGYIAPEYAYTLR+DEKSDVYSFGVVL
Sbjct: 845 GPEFEAHVADFGLAKFMMQDNGASECMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVL 904
Query: 881 LELLTGRRPVGDFG-DGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML 939
LEL+TGR+PV +FG +G+DIVQWSK TN ++ + I+D RLS +P EAM L FVAML
Sbjct: 905 LELITGRKPVDNFGEEGIDIVQWSKIQTNCNRQGVVKIIDQRLSNIPLAEAMELFFVAML 964
Query: 940 CIQENSIERPRMREVVQMLSE 960
C+QE+S+ERP MREVVQM+S+
Sbjct: 965 CVQEHSVERPTMREVVQMISQ 985
|
Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 954 bits (2466), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/955 (52%), Positives = 652/955 (68%), Gaps = 28/955 (2%)
Query: 28 DFHVLVALKQGFENPE-PALISW-NSSNPSSVCSWAGICCSRD-RVASLDLTDLNLCGSV 84
D VL+ LK P+ L W +SS+P + CS++G+ C D RV SL+++ L G++
Sbjct: 27 DMEVLLNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLNVSFTPLFGTI 86
Query: 85 PAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNN-----QFSGGLDWNYSSL 137
+I L L NL+LA NNFTG + E+ +L+SL+ LNISNN F G + ++
Sbjct: 87 SPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEI---LKAM 143
Query: 138 VNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGND 197
V+LEV D YNNNF LP + +L+KLKYL GGN+F G+IP SYG++Q LEYL L G
Sbjct: 144 VDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGLNGAG 203
Query: 198 LTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGN 257
L+GK P L L NLRE+Y+GYYN + GG+P E G L L LD++SC L G+IP + N
Sbjct: 204 LSGKSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSN 263
Query: 258 LKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMN 317
LK L T+FLHIN L+G IP +L L +L +LDLS N LTGEIP SFINL + L NLF N
Sbjct: 264 LKHLHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRN 323
Query: 318 RLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCS 377
L+G IP+ + +LP LE +W+NNFT +P NLG+NG L LD+S N LTG IP DLC
Sbjct: 324 NLYGQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCR 383
Query: 378 SNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSN 437
+L +LIL NF FGPIPE LG C SLT++R+ +N LNG++P G LP + + EL N
Sbjct: 384 GEKLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDN 443
Query: 438 YLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPS 497
+ SG LP + + D L Q+ LSNN SG +P ++ NF +LQ L L N+F G IP
Sbjct: 444 FFSGELP----VTMSGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPRE 499
Query: 498 IGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNL 557
I EL+ + +++ S N+++G IP +I C+ L +D+S+N ++G IP I+NV+ L LN+
Sbjct: 500 IFELKHLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNI 559
Query: 558 SRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLC----GT 613
S N L +IP IG+M SLT D SFND SG++P GQF VFN +SFAGN LC +
Sbjct: 560 SGNQLTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVS 619
Query: 614 LLNNPCNVAPITHQPGKAPGDFKLIFALGLLICSLIFATAAIIKAKSFKKTGSDSWKMTA 673
P + H +P +++ + I LI + AI + K S +WK+TA
Sbjct: 620 CPTRPGQTSDHNHTALFSPS--RIVITVIAAITGLILISVAIRQMNKKKNQKSLAWKLTA 677
Query: 674 FQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAE 733
FQKL+F D+LEC+K+ N+IG+GGAGIVY G MPN V++A+K+L+G GT DHGF AE
Sbjct: 678 FQKLDFKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRSDHGFTAE 737
Query: 734 IQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIE 793
IQTLG IRHR+IVRLL + +NK+TNLL+YEYM NGSLGE LHG KG L W R+++A+E
Sbjct: 738 IQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVE 797
Query: 794 AAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGS 853
AAKGLCYLHHDCSPLI+HRDVKSNNILL+S FEAHVADFGLAKFL+DG ASECMS+IAGS
Sbjct: 798 AAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGS 857
Query: 854 YGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913
YGYIAPEYAYTL+VDEKSDVYSFGVVLLEL+ G++PVG+FG+GVDIV+W + +
Sbjct: 858 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGEGVDIVRWVRNTEEEITQP 917
Query: 914 -----FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963
++I+DPRL+ P +H+ +AM+C++E + RP MREVV ML+ P+
Sbjct: 918 SDAAIVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHMLTNPPK 972
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 690 bits (1780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/960 (42%), Positives = 554/960 (57%), Gaps = 50/960 (5%)
Query: 42 PEPALISW----NSSNPSSVCSWAGICCSR--DRVASLDLTDLNLCGSVPAQILRLDKLT 95
P A W N N + CSW+G+ C +V SLDL+ NL G +P QI L L
Sbjct: 49 PPSAFQDWKVPVNGQNDAVWCSWSGVVCDNVTAQVISLDLSHRNLSGRIPIQIRYLSSLL 108
Query: 96 NLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTAL 153
L+L+GN+ GS I +L+ L L+IS N F S L L+VF+A++NNF L
Sbjct: 109 YLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLKFLKVFNAFSNNFEGL 168
Query: 154 LPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLR 213
LP + +L L+ L+ GG+YF G+IP +YG LQ L+++ LAGN L GK+P LG LT L+
Sbjct: 169 LPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVLGGKLPPRLGLLTELQ 228
Query: 214 EIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSG 273
+ +GY N F G IP E L NL + D+S+C L G +P E+GNL L+T+FL N +G
Sbjct: 229 HMEIGY-NHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGFTG 287
Query: 274 SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNL 333
IP+ NL +L LD S+N L+G IP F L+ L +L N L G +P+ + +LP L
Sbjct: 288 EIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPEL 347
Query: 334 ETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFG 393
TL LW NNFTGV+P LG NGKL+ +D+S+N TGTIP+ LC N+L LIL N G
Sbjct: 348 TTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEG 407
Query: 394 PIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNP 453
+P+ L C SL R R N LNG+IP GF L L +L +N + +P + ++
Sbjct: 408 ELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAP-- 465
Query: 454 DRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNS 513
L LNLS N LP ++ +LQI S + G IP +G + +++L NS
Sbjct: 466 -VLQYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPNYVG-CKSFYRIELQGNS 523
Query: 514 LSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSM 573
L+G IP IG+C L L++SQN+L+G IP EIS + + ++LS N L IP GS
Sbjct: 524 LNGTIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSS 583
Query: 574 KSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNNPCNVAPIT-------- 625
K++T + S+N G +P SG F N S F+ N LCG L+ PCN
Sbjct: 584 KTITTFNVSYNQLIGPIP-SGSFAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADIDG 642
Query: 626 ----HQPGKAPGDFKLIFALGLLICSLIFATAAIIKAKSF---------KKTGSDSWKMT 672
+P K G I A + + + A KS+ WK+T
Sbjct: 643 HHKEERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWKLT 702
Query: 673 AFQKLEFSVSDILECV-KDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHS-----H 726
AFQ+L F+ D++EC+ K N++G G G VY +MPNG IAVKKL G +
Sbjct: 703 AFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENGKIRRR 762
Query: 727 DHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLG--- 783
G AE+ LGN+RHRNIVRLL C+N++ +L+YEYM NGSL + LHG
Sbjct: 763 KSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAE 822
Query: 784 WNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843
W Y+IAI A+G+CYLHHDC P+IVHRD+K +NILL++ FEA VADFG+AK +
Sbjct: 823 WTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLI---QT 879
Query: 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVG-DFGDGVDIVQW 902
E MS +AGSYGYIAPEYAYTL+VD+KSD+YS+GV+LLE++TG+R V +FG+G IV W
Sbjct: 880 DESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGNSIVDW 939
Query: 903 --SKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
SK T EE L R + +EE +L +A+LC + +RP MR+V+ +L E
Sbjct: 940 VRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQE 999
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 654 bits (1687), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/1004 (40%), Positives = 576/1004 (57%), Gaps = 41/1004 (4%)
Query: 1 MAFFIVVTLLFSLLNIPNLSSAASL--VNDFHVLVALKQGFENPEPALISWNSSNPSSVC 58
M I+V L+ S AS+ VN+ VL+++K +P L W S+ S C
Sbjct: 1 MKMKIIVLFLYYCYIGSTSSVLASIDNVNELSVLLSVKSTLVDPLNFLKDWKLSDTSDHC 60
Query: 59 SWAGICC-SRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQ 117
+W G+ C S V LDL +NL G + I +L L + +++ N F S+ ++ L+
Sbjct: 61 NWTGVRCNSNGNVEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFE-SLLPKSIPPLK 119
Query: 118 FLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGK 177
++IS N FSG L + + L +A NN + L + L L+ LDL GN+F G
Sbjct: 120 SIDISQNSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGS 179
Query: 178 IPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNL 237
+P+S+ LQ L +L L+GN+LTG++P LG L +L LGY N F+G IP E G + +L
Sbjct: 180 LPSSFKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGY-NEFKGPIPPEFGNINSL 238
Query: 238 VHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTG 297
+LDL+ +L G+IP E+G LK L+T+ L+ N +G+IP+++G++T L LD S+NALTG
Sbjct: 239 KYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTG 298
Query: 298 EIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKL 357
EIP L+ L+L NL N+L GSIP ++ L L+ L LW N +G +P +LG+N L
Sbjct: 299 EIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPL 358
Query: 358 QVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNG 417
Q LD+SSN +G IP+ LC+ L LIL N G IP L C SL RVR+ N LNG
Sbjct: 359 QWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNG 418
Query: 418 SIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNF 477
SIP GF L L EL N LSG +P + + S + L ++ S N + LP ++ +
Sbjct: 419 SIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVS---LSFIDFSRNQIRSSLPSTILSI 475
Query: 478 SSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNN 537
+LQ L++ N SG +P + + LDLS N+L+G IP +I C L L++ NN
Sbjct: 476 HNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNN 535
Query: 538 LSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFT 597
L+G IP +I+ + L L+LS N L +P+SIG+ +L + + S+N +G +P +G
Sbjct: 536 LTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLK 595
Query: 598 VFNASSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFALGLLICS-LIFATAAII 656
N GN LCG +L PC+ + +++ + I S L I+
Sbjct: 596 TINPDDLRGNSGLCGGVL-PPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIV 654
Query: 657 KAKSFKK-------------TGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVY 703
+KK G W++ AF +L F+ SDIL C+K+ N+IG G GIVY
Sbjct: 655 TRTLYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVY 714
Query: 704 HGKMPNGVEI-AVKKLLGFGTHSHD---HGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759
+M + AVKKL D F E+ LG +RHRNIVRLL F N + +
Sbjct: 715 KAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMM 774
Query: 760 LVYEYMRNGSLGEALHGKKGA---FLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKS 816
+VYE+M NG+LG+A+HGK A + W RY IA+ A GL YLHHDC P ++HRD+KS
Sbjct: 775 IVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKS 834
Query: 817 NNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSF 876
NNILL++ +A +ADFGLA+ + E +S +AGSYGYIAPEY YTL+VDEK D+YS+
Sbjct: 835 NNILLDANLDARIADFGLARMM--ARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSY 892
Query: 877 GVVLLELLTGRRPVG-DFGDGVDIVQWSKRAT--NGRKEEFLSILDPRLS--MVPKEEAM 931
GVVLLELLTGRRP+ +FG+ VDIV+W +R N EE LDP + +EE +
Sbjct: 893 GVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEE---ALDPNVGNCRYVQEEML 949
Query: 932 HLLFVAMLCIQENSIERPRMREVVQMLSEF-PRHSSDFNQSSSS 974
+L +A+LC + +RP MR+V+ ML E PR S+ N+ ++S
Sbjct: 950 LVLQIALLCTTKLPKDRPSMRDVISMLGEAKPRRKSNSNEENTS 993
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 646 bits (1666), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/984 (40%), Positives = 552/984 (56%), Gaps = 82/984 (8%)
Query: 24 SLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSRD--RVASLDLTDLNLC 81
SL D +L +K ++P+ L SWNS N +S C W+G+ C+ D V S+DL+ NL
Sbjct: 15 SLNQDGFILQQVKLSLDDPDSYLSSWNS-NDASPCRWSGVSCAGDFSSVTSVDLSSANLA 73
Query: 82 GSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLE 141
G P+ I RL L +LSL NN + L N ++ +L+
Sbjct: 74 GPFPSVICRLSNLAHLSLY----------------------NNSINSTLPLNIAACKSLQ 111
Query: 142 VFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGK 201
D N T LP + + L +LDL GN F G IP S+G+ + LE LSL N L G
Sbjct: 112 TLDLSQNLLTGELPQTLADIPTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGT 171
Query: 202 IPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLL 261
IP LGN++ L+ + L Y IP E G L NL + L+ C L GQIP +G L L
Sbjct: 172 IPPFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKL 231
Query: 262 DTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG 321
+ L +N L G IP LG LTN+V ++L NN+LTGEIP NL+ L+L + MN+L G
Sbjct: 232 VDLDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTG 291
Query: 322 SIPDYLADLPNLETLGLWQNN------------------------FTGVIPENLGQNGKL 357
IPD L +P LE+L L++NN TG +P++LG N L
Sbjct: 292 KIPDELCRVP-LESLNLYENNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPL 350
Query: 358 QVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNG 417
+ LD+S N+ +G +P DLC+ +L L+++ N G IPE L C SLTR+RL N +G
Sbjct: 351 RWLDVSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSG 410
Query: 418 SIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNF 477
S+P GF LP +NL EL +N SG + ++ +SN L L LSNN +G LP + +
Sbjct: 411 SVPTGFWGLPHVNLLELVNNSFSGEISKSIGGASN---LSLLILSNNEFTGSLPEEIGSL 467
Query: 478 SSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNN 537
+L L SGN+FSG +P S+ L ++ LDL N SGE+ I L L+++ N
Sbjct: 468 DNLNQLSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNE 527
Query: 538 LSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFT 597
+G IP EI ++ +LNYL+LS N + IP S+ S+K L + S+N SG LP S
Sbjct: 528 FTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSLK-LNQLNLSYNRLSGDLPPSLAKD 586
Query: 598 VFNASSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFALGLLICSLIFATAA--I 655
++ +SF GNP LCG + C + K G L+ ++ +L ++ A A
Sbjct: 587 MYK-NSFIGNPGLCGD-IKGLCG----SENEAKKRGYVWLLRSIFVLAAMVLLAGVAWFY 640
Query: 656 IKAKSFKKTGS---DSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVE 712
K ++FKK + W + +F KL FS +ILE + + NVIG G +G VY + NG
Sbjct: 641 FKYRTFKKARAMERSKWTLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKVVLTNGET 700
Query: 713 IAVKKLL--------------GFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758
+AVK+L G+ D F AE++TLG IRH+NIV+L CS ++
Sbjct: 701 VAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCK 760
Query: 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNN 818
LLVYEYM NGSLG+ LH KG LGW R+KI ++AA+GL YLHHD P IVHRD+KSNN
Sbjct: 761 LLVYEYMPNGSLGDLLHSSKGGMLGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNN 820
Query: 819 ILLNSAFEAHVADFGLAKFL-IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFG 877
IL++ + A VADFG+AK + + G A + MS IAGS GYIAPEYAYTLRV+EKSD+YSFG
Sbjct: 821 ILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFG 880
Query: 878 VVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVA 937
VV+LE++T +RPV D+V+W + + E ++DP+L KEE +L V
Sbjct: 881 VVILEIVTRKRPVDPELGEKDLVKWVCSTLDQKGIEH--VIDPKLDSCFKEEISKILNVG 938
Query: 938 MLCIQENSIERPRMREVVQMLSEF 961
+LC I RP MR VV+ML E
Sbjct: 939 LLCTSPLPINRPSMRRVVKMLQEI 962
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 634 bits (1635), Expect = e-180, Method: Compositional matrix adjust.
Identities = 394/1017 (38%), Positives = 566/1017 (55%), Gaps = 67/1017 (6%)
Query: 3 FFIVVTLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALISWNSSNPSSV----- 57
FF+ + F+L P +SS ++ +L+A K +P L W ++
Sbjct: 7 FFLFYYIGFALF--PFVSSETFQNSEQEILLAFKSDLFDPSNNLQDWKRPENATTFSELV 64
Query: 58 -CSWAGICCSRD-RVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNL 113
C W G+ C + VA L L+++NL G+V QI L L L+ N F S+ + NL
Sbjct: 65 HCHWTGVHCDANGYVAKLLLSNMNLSGNVSDQIQSFPSLQALDLSNNAFESSLPKSLSNL 124
Query: 114 SSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY 173
+SL+ +++S N F G + L +A +NNF+ LP + L+ LD G Y
Sbjct: 125 TSLKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGY 184
Query: 174 FFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGK 233
F G +P+S+ L+ L++L L+GN+ GK+P +G L++L I LGY N F G IP E GK
Sbjct: 185 FEGSVPSSFKNLKNLKFLGLSGNNFGGKVPKVIGELSSLETIILGY-NGFMGEIPEEFGK 243
Query: 234 LVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNN 293
L L +LDL+ L GQIP +G LK L TV+L+ N L+G +P++LG +T+LV LDLS+N
Sbjct: 244 LTRLQYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDN 303
Query: 294 ALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQ 353
+TGEIP L+ L+L NL N+L G IP +A+LPNLE L LWQN+ G +P +LG+
Sbjct: 304 QITGEIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLGK 363
Query: 354 NGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQN 413
N L+ LD+SSNKL+G IP+ LC S L LIL N G IPE + +C +L RVR+ +N
Sbjct: 364 NSPLKWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKN 423
Query: 414 YLNGSIPDGFIYLPGLNLAELQSNYLSGSLPEN---GNSSSNPDRLGQLNLSNNLLSGPL 470
+++GSIP G LP L EL N L+G +P++ S S D S +
Sbjct: 424 HISGSIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTSLSFIDISFNHLSSLSSSIFSS 483
Query: 471 PFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTY 530
P +LQ + S N F+G IP I + + LDLS N SG IP I L
Sbjct: 484 P-------NLQTFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFSGGIPERIASFEKLVS 536
Query: 531 LDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKL 590
L++ N L G IP ++ + +L L+LS N L NIP +G+ +L + + SFN G +
Sbjct: 537 LNLKSNQLVGEIPKALAGMHMLAVLDLSNNSLTGNIPADLGASPTLEMLNVSFNKLDGPI 596
Query: 591 PESGQFTVFNASSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFAL-GLLI-CSL 648
P + F + GN LCG +L PC+ + G+ PG + A+ G ++ S+
Sbjct: 597 PSNMLFAAIDPKDLVGNNGLCGGVL-PPCSKSLALSAKGRNPGRIHVNHAVFGFIVGTSV 655
Query: 649 IFATAAIIKAKSFKKTGSD-------------------SWKMTAFQKLEFSVSDILECVK 689
I A + A + T D W++ AFQ+L F+ DIL +K
Sbjct: 656 IVAMGMMFLAGRWIYTRWDLYSNFAREYIFCKKPREEWPWRLVAFQRLCFTAGDILSHIK 715
Query: 690 DGNVIGRGGAGIVYHGKMPNG--VEIAVKKLLGFGTHSHD-----------HGFRAEIQT 736
+ N+IG G GIVY ++ + +AVKKL + +D E+
Sbjct: 716 ESNIIGMGAIGIVYKAEVMRRPLLTVAVKKLWRSPSPQNDIEDHHQEEDEEDDILREVNL 775
Query: 737 LGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFL--GWNLRYKIAIEA 794
LG +RHRNIV++L + N+ ++VYEYM NG+LG ALH K FL W RY +A+
Sbjct: 776 LGGLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGV 835
Query: 795 AKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY 854
+GL YLH+DC P I+HRD+KSNNILL+S EA +ADFGLAK ++ +E +S +AGSY
Sbjct: 836 VQGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMMLH--KNETVSMVAGSY 893
Query: 855 GYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVG-DFGDGVDIVQWSKRATNGRKEE 913
GYIAPEY YTL++DEKSD+YS GVVLLEL+TG+ P+ F D +D+V+W +R + E
Sbjct: 894 GYIAPEYGYTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDSIDVVEWIRRKVK-KNES 952
Query: 914 FLSILDPRLSMVPK---EEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF-PRHSS 966
++D ++ K EE + L +A+LC + +RP +R+V+ ML+E PR S
Sbjct: 953 LEEVIDASIAGDCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITMLAEAKPRRKS 1009
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 621 bits (1602), Expect = e-177, Method: Compositional matrix adjust.
Identities = 388/1023 (37%), Positives = 536/1023 (52%), Gaps = 113/1023 (11%)
Query: 49 WNSSNPSSVCSWAGICCS-RDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGS 107
WNS + + +W I CS + + +D+ + L S+P + L L+++G N TG+
Sbjct: 61 WNSIDNTPCNNWTFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGT 120
Query: 108 I--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLK 165
+ +G+ L+ L++S+N G + W+ S L NLE +N T +P I K KLK
Sbjct: 121 LPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLK 180
Query: 166 YLDLGGNYFFGKIPNSYGELQGLEYLSLAGND---------------------------- 197
L L N G IP G+L GLE + + GN
Sbjct: 181 SLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSG 240
Query: 198 ---------------------LTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVN 236
++G+IP +LGN + L +++L Y N G IPRE+G+L
Sbjct: 241 NLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFL-YENSLSGSIPREIGQLTK 299
Query: 237 LVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALT 296
L L L L G IP EIGN L + L +NLLSGSIP +G L+ L +S+N +
Sbjct: 300 LEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFS 359
Query: 297 GEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGK 356
G IP + N L L N++ G IP L L L W N G IP L
Sbjct: 360 GSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTD 419
Query: 357 LQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLN 416
LQ LDLS N LTGTIP+ L L L+L+ N L G IP+ +G C SL R+RLG N +
Sbjct: 420 LQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRIT 479
Query: 417 GSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSN 476
G IP G L +N + SN L G +P+ S S L ++LSNN L G LP +S+
Sbjct: 480 GEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCS---ELQMIDLSNNSLEGSLPNPVSS 536
Query: 477 FSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQN 536
S LQ+L +S NQFSG IP S+G L + KL LS+N SG IP ++G C+ L LD+ N
Sbjct: 537 LSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSN 596
Query: 537 NLSGSIPPEISNVRILNY-LNLSRNHLNQNIPKSIGSMKSLTIADFS------------- 582
LSG IP E+ ++ L LNLS N L IP I S+ L+I D S
Sbjct: 597 ELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLAN 656
Query: 583 ----------FNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNNPCNVAPITHQPGKAP 632
+N FSG LP++ F + GN +LC + ++ +T++ G
Sbjct: 657 IENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDS----CFLTYRKGNGL 712
Query: 633 GD-----------FKLIFALGLLICSLIFATAAIIKAKSFKKTGSDS-------WKMTAF 674
GD L + L + +I A+I+A+ DS W+ T F
Sbjct: 713 GDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQFTPF 772
Query: 675 QKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLL-GFGTHSHDH----- 728
QKL FSV I+ C+ + NVIG+G +G+VY + NG IAVKKL HD
Sbjct: 773 QKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNV 832
Query: 729 --GFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNL 786
F AE++TLG IRH+NIVR L C N+ T LL+Y+YM NGSLG LH ++G+ L W+L
Sbjct: 833 RDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDL 892
Query: 787 RYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846
RY+I + AA+GL YLHHDC P IVHRD+K+NNIL+ FE ++ADFGLAK + +G C
Sbjct: 893 RYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRC 952
Query: 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVG-DFGDGVDIVQWSKR 905
+ +AGSYGYIAPEY Y++++ EKSDVYS+GVV+LE+LTG++P+ +G+ +V W R
Sbjct: 953 SNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWV-R 1011
Query: 906 ATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965
G E S L R + +E M +L A+LC+ + ERP M++V ML E +
Sbjct: 1012 QNRGSLEVLDSTLRSR-TEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEIKQER 1070
Query: 966 SDF 968
++
Sbjct: 1071 EEY 1073
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 612 bits (1578), Expect = e-174, Method: Compositional matrix adjust.
Identities = 430/1101 (39%), Positives = 582/1101 (52%), Gaps = 155/1101 (14%)
Query: 2 AFFIVVTLLFSLLNIPNLSSAASLVNDFHVLVALK-QGFENPEPALISWNSSNPSSVCSW 60
+ F+ V L +LL + ++ SL +D L+ LK +GF++ L +WN + + C+W
Sbjct: 14 SMFVGVLFLLTLL----VWTSESLNSDGQFLLELKNRGFQDSLNRLHNWNGID-ETPCNW 68
Query: 61 AGICCSRDR---------VASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--E 109
G+ CS V SLDL+ +NL G V I L L L+LA N TG I E
Sbjct: 69 IGVNCSSQGSSSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPRE 128
Query: 110 IGN------------------------LSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDA 145
IGN LS L+ NI NN+ SG L L NLE A
Sbjct: 129 IGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVA 188
Query: 146 YNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGE 205
Y NN T LP + L KL G N F G IP G+ L+ L LA N ++G++P E
Sbjct: 189 YTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKE 248
Query: 206 LGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVF 265
+G L L+E+ L + N F G IP+++G L +L L L L G IP EIGN+K L ++
Sbjct: 249 IGMLVKLQEVIL-WQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLY 307
Query: 266 LHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPD 325
L+ N L+G+IPK+LG L+ ++ +D S N L+GEIP + +L+L LF N+L G IP+
Sbjct: 308 LYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPN 367
Query: 326 YLADLPNL------------------------ETLGLWQNNFTGVIPENLGQNGKLQVLD 361
L+ L NL L L+ N+ +GVIP+ LG L V+D
Sbjct: 368 ELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVD 427
Query: 362 LSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPD 421
S N+L+G IP +C + L +L L N +FG IP + C SL ++R+ N L G P
Sbjct: 428 FSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPT 487
Query: 422 GFIYLPGLNLAELQSNYLSGSLP---------------ENGNSSSNPDRLGQL------N 460
L L+ EL N SG LP N SS+ P+ + +L N
Sbjct: 488 ELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFN 547
Query: 461 LSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPP 520
+S+N L+GP+P ++N LQ L LS N F G +PP +G L Q+ L LS N SG IP
Sbjct: 548 VSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPF 607
Query: 521 AIGYCNHLTYLDM-------------------------SQNNLSGSIPPEISNVRILNYL 555
IG HLT L M S N+ SG IPPEI N+ +L YL
Sbjct: 608 TIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYL 667
Query: 556 NLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLL 615
+L+ NHL+ IP + ++ SL +FS+N+ +G+LP + F +SF GN LCG L
Sbjct: 668 SLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHL 727
Query: 616 NNPCNVAPIT--HQPGKAPGDFK------------------LIFALGLLICSLIFATAAI 655
+ C+ + + H G + LI + + + + TA
Sbjct: 728 RS-CDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPY 786
Query: 656 IKAKSFKKTGSDSWKMTAFQKLEFSVSDILECVK---DGNVIGRGGAGIVYHGKMPNGVE 712
+ K SD + + K F+V DILE K D ++GRG G VY MP+G
Sbjct: 787 VHDKEPFFQESDIYFVP---KERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKT 843
Query: 713 IAVKKL------LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETNLLVYEY 764
IAVKKL +++ D+ FRAEI TLG IRHRNIVRL +FC ++ +NLL+YEY
Sbjct: 844 IAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEY 903
Query: 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA 824
M GSLGE LHG K + W R+ IA+ AA+GL YLHHDC P I+HRD+KSNNIL++
Sbjct: 904 MSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDEN 963
Query: 825 FEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELL 884
FEAHV DFGLAK +ID S+ +SA+AGSYGYIAPEYAYT++V EK D+YSFGVVLLELL
Sbjct: 964 FEAHVGDFGLAK-VIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELL 1022
Query: 885 TGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS-ILDPRLSMVPKEEAM-HLLFV---AML 939
TG+ PV G D+ W++ R S ILDP L+ V + + H++ V A+L
Sbjct: 1023 TGKAPVQPLEQGGDLATWTRNHI--RDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVL 1080
Query: 940 CIQENSIERPRMREVVQMLSE 960
C + + +RP MREVV ML E
Sbjct: 1081 CTKSSPSDRPTMREVVLMLIE 1101
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 995 | ||||||
| 255571000 | 996 | Receptor protein kinase CLAVATA1 precurs | 0.993 | 0.992 | 0.820 | 0.0 | |
| 224129688 | 1001 | predicted protein [Populus trichocarpa] | 0.966 | 0.961 | 0.819 | 0.0 | |
| 357445293 | 1007 | Receptor-like protein kinase [Medicago t | 0.941 | 0.930 | 0.793 | 0.0 | |
| 359486251 | 976 | PREDICTED: leucine-rich repeat receptor- | 0.978 | 0.997 | 0.782 | 0.0 | |
| 147770228 | 954 | hypothetical protein VITISV_023530 [Viti | 0.952 | 0.993 | 0.795 | 0.0 | |
| 449478131 | 998 | PREDICTED: leucine-rich repeat receptor- | 0.962 | 0.959 | 0.788 | 0.0 | |
| 449466448 | 999 | PREDICTED: leucine-rich repeat receptor- | 0.962 | 0.958 | 0.784 | 0.0 | |
| 140053517 | 989 | Protein kinase [Medicago truncatula] | 0.923 | 0.929 | 0.773 | 0.0 | |
| 297739522 | 895 | unnamed protein product [Vitis vinifera] | 0.897 | 0.997 | 0.714 | 0.0 | |
| 225424960 | 988 | PREDICTED: leucine-rich repeat receptor- | 0.930 | 0.937 | 0.662 | 0.0 |
| >gi|255571000|ref|XP_002526451.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223534231|gb|EEF35946.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1596 bits (4133), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 820/999 (82%), Positives = 890/999 (89%), Gaps = 10/999 (1%)
Query: 1 MAFFIVVTLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSW 60
+ FFIV +LL+I SS+ASLV+DF+VL++LK+GF+ P+P L +WNSSNPSSVCSW
Sbjct: 2 VPFFIV---FLTLLSILTNSSSASLVSDFNVLLSLKRGFQFPQPFLSTWNSSNPSSVCSW 58
Query: 61 AGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLN 120
G+ CSR RV SLDLTD NL GSV Q+ RLD+L NLSLAGNNFTG++EI LSSL+FLN
Sbjct: 59 VGVSCSRGRVVSLDLTDFNLYGSVSPQLSRLDRLVNLSLAGNNFTGTVEIIRLSSLRFLN 118
Query: 121 ISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPN 180
ISNNQFSGGLDWNYS + NLEVFDAYNNNFTA LP+GIL L+KL+YLDLGGN+F+G IP
Sbjct: 119 ISNNQFSGGLDWNYSEMANLEVFDAYNNNFTAFLPLGILSLKKLRYLDLGGNFFYGNIPP 178
Query: 181 SYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHL 240
SYG L GLEYLSLAGNDL G+IPGELGNL+NL+EI+LG+YNVFEGGIP E G L+NLV +
Sbjct: 179 SYGRLVGLEYLSLAGNDLRGRIPGELGNLSNLKEIFLGHYNVFEGGIPAEFGSLMNLVQM 238
Query: 241 DLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIP 300
DLSSC LDG IP E+GNLK+LDT+ L+IN LSGSIPK+LGNLTNL NLDLS NALTGEIP
Sbjct: 239 DLSSCGLDGPIPRELGNLKMLDTLHLYINHLSGSIPKELGNLTNLANLDLSYNALTGEIP 298
Query: 301 YSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVL 360
+ FI+L+QLKLFNLFMNRLHGSIPDY+ADLPNLETL LW NNFTG IP LGQNGKLQ L
Sbjct: 299 FEFISLKQLKLFNLFMNRLHGSIPDYVADLPNLETLELWMNNFTGEIPRKLGQNGKLQAL 358
Query: 361 DLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIP 420
DLSSNKLTGTIP LCSSNQL+ILIL+KNFLFGPIP+ LG CYSLTR+RLGQNYLNGSIP
Sbjct: 359 DLSSNKLTGTIPQGLCSSNQLKILILMKNFLFGPIPDGLGRCYSLTRLRLGQNYLNGSIP 418
Query: 421 DGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSL 480
DG IYLP LNLAELQ+N LSG+L EN NSSS P RLGQLNLSNNLLSGPLPFS+SNFSSL
Sbjct: 419 DGLIYLPELNLAELQNNVLSGTLSENCNSSSRPVRLGQLNLSNNLLSGPLPFSISNFSSL 478
Query: 481 QILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSG 540
QILLLSGNQFSGPIPPSIG LRQVLKLD+SRNSLSG IPP IG C HLT+LDMSQNNLSG
Sbjct: 479 QILLLSGNQFSGPIPPSIGVLRQVLKLDVSRNSLSGSIPPEIGSCFHLTFLDMSQNNLSG 538
Query: 541 SIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFN 600
IPPEIS++ ILNYLNLSRNHLNQ IPKSIGSMKSLTIADFSFNDFSGKLPESGQF+ FN
Sbjct: 539 LIPPEISDIHILNYLNLSRNHLNQTIPKSIGSMKSLTIADFSFNDFSGKLPESGQFSFFN 598
Query: 601 ASSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFALGLLICSLIFATAAIIKAKS 660
ASSFAGNPQLCG LLNNPCN IT+ PGKAP DFKLIFALGLLICSLIFA AAIIKAKS
Sbjct: 599 ASSFAGNPQLCGPLLNNPCNFTAITNTPGKAPNDFKLIFALGLLICSLIFAIAAIIKAKS 658
Query: 661 FKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLG 720
KK SDSWK+TAFQK+EF+V+DILECVKDGNVIGRGGAGIVYHGKMPNGVE+AVKKLLG
Sbjct: 659 SKKNSSDSWKLTAFQKIEFTVTDILECVKDGNVIGRGGAGIVYHGKMPNGVEVAVKKLLG 718
Query: 721 FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGA 780
FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGA
Sbjct: 719 FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGA 778
Query: 781 FLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840
FL WNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS+FEAHVADFGLAKFLID
Sbjct: 779 FLSWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSSFEAHVADFGLAKFLID 838
Query: 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIV 900
GGASECMSAIAGSYGYIAPEYAYTL+VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIV
Sbjct: 839 GGASECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIV 898
Query: 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
QWSKR TN RKE+ L+I+D RL+MVPK+E MHL F+A+LC QENSIERP MREVVQMLSE
Sbjct: 899 QWSKRVTNNRKEDVLNIIDSRLTMVPKDEVMHLFFIALLCSQENSIERPTMREVVQMLSE 958
Query: 961 FPRHSSDFNQSSS----SSLKNLEKDPKGCPNNKLKQDL 995
F RHS D++ SSS LKN E + K K K DL
Sbjct: 959 FHRHSLDYHSSSSSVIFQQLKNSETEKKYA---KFKSDL 994
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224129688|ref|XP_002328778.1| predicted protein [Populus trichocarpa] gi|222839076|gb|EEE77427.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1575 bits (4078), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 792/967 (81%), Positives = 876/967 (90%), Gaps = 5/967 (0%)
Query: 1 MAFFIVVTLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSW 60
M FIV+TL FSLL+ + +SLV DF VLV+LK+GFE PEP L +WN SNPSSVCSW
Sbjct: 1 MVPFIVLTL-FSLLST---TCHSSLVGDFRVLVSLKRGFEFPEPVLNTWNLSNPSSVCSW 56
Query: 61 AGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLN 120
GI CSR RV+SLDLTD NL GSV QI +LD+LT+LSLAGNNF+G+IE+ +S+L+FLN
Sbjct: 57 VGIHCSRGRVSSLDLTDFNLYGSVSPQISKLDQLTSLSLAGNNFSGAIELAGMSNLRFLN 116
Query: 121 ISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPN 180
ISNNQF+GGLDWNY+S+ +LEVFDA++NNFTA LP+GIL L+KL++L+LGGNYF+GKIP
Sbjct: 117 ISNNQFNGGLDWNYTSIADLEVFDAFDNNFTAFLPLGILNLKKLRHLELGGNYFYGKIPT 176
Query: 181 SYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHL 240
SYGEL GLEYLSL GN+L GKIPGELGNLTNLREIYL YNVFEG IP E+ LVNLVH+
Sbjct: 177 SYGELAGLEYLSLMGNNLQGKIPGELGNLTNLREIYLANYNVFEGEIPVELSNLVNLVHM 236
Query: 241 DLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIP 300
DLSSC LDG IP+E+GNLKLL T++LHIN LSGSIPK+LGNLTNLVNLDLS NALTGEIP
Sbjct: 237 DLSSCGLDGPIPNELGNLKLLHTLYLHINFLSGSIPKELGNLTNLVNLDLSYNALTGEIP 296
Query: 301 YSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVL 360
+ FINL+QL L NLF+NRLHGSIPDY+ADLPNLETL LW+NNFTG IP NLG+NGKLQ+L
Sbjct: 297 FEFINLKQLNLLNLFLNRLHGSIPDYVADLPNLETLQLWKNNFTGEIPPNLGRNGKLQLL 356
Query: 361 DLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIP 420
DLSSNKLTGT+P DLCSSNQLRILIL KNFLFGPIPE LGACYSLT+VRLGQNYLNGSIP
Sbjct: 357 DLSSNKLTGTVPQDLCSSNQLRILILFKNFLFGPIPEGLGACYSLTKVRLGQNYLNGSIP 416
Query: 421 DGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSL 480
GFIYLP L LAE QSNYLSG+L ENGNSS P +LGQL+LSNNL SGPLP SLSNFSSL
Sbjct: 417 IGFIYLPELILAEFQSNYLSGTLSENGNSSLKPVKLGQLDLSNNLFSGPLPSSLSNFSSL 476
Query: 481 QILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSG 540
Q LLLSGN+FSGPIPP IGEL QVLKLDLSRNS SG +PP IG C HLT+LDMSQNNLSG
Sbjct: 477 QTLLLSGNKFSGPIPPMIGELLQVLKLDLSRNSFSGPVPPEIGNCFHLTFLDMSQNNLSG 536
Query: 541 SIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFN 600
IP ++SN+R LNYLNLSRNHLNQ IPKS+GS+KSLT+ADFSFNDF+GKLPESGQF++FN
Sbjct: 537 PIPSDMSNIRNLNYLNLSRNHLNQTIPKSLGSLKSLTVADFSFNDFAGKLPESGQFSLFN 596
Query: 601 ASSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFALGLLICSLIFATAAIIKAKS 660
ASSFAGNP LCG LLNNPCN +T+ PGKAP +FKLIFALGLLICSLIFATAA+IKAK+
Sbjct: 597 ASSFAGNPLLCGPLLNNPCNFTTVTNTPGKAPSNFKLIFALGLLICSLIFATAALIKAKT 656
Query: 661 FKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLG 720
FKK+ SDSWK+T FQKLEF+V+DI+ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLG
Sbjct: 657 FKKSSSDSWKLTTFQKLEFTVTDIIECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLG 716
Query: 721 FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGA 780
FG +SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK+TNLLVYEYMRNGSLGEALHGKKGA
Sbjct: 717 FGNNSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKDTNLLVYEYMRNGSLGEALHGKKGA 776
Query: 781 -FLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839
FLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS+FEAHVADFGLAKFL+
Sbjct: 777 LFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSSFEAHVADFGLAKFLV 836
Query: 840 DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDI 899
DGGAS+CMSAIAGSYGYIAPEYAYTL+VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDI
Sbjct: 837 DGGASQCMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDI 896
Query: 900 VQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959
VQWSKRATN RKE+ + I+DPRL+MVPK+EAMHL F+AMLC QENSIERP MREVVQMLS
Sbjct: 897 VQWSKRATNSRKEDAMHIVDPRLTMVPKDEAMHLFFIAMLCSQENSIERPTMREVVQMLS 956
Query: 960 EFPRHSS 966
EFPRH+S
Sbjct: 957 EFPRHTS 963
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357445293|ref|XP_003592924.1| Receptor-like protein kinase [Medicago truncatula] gi|355481972|gb|AES63175.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1514 bits (3920), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 744/938 (79%), Positives = 843/938 (89%), Gaps = 1/938 (0%)
Query: 28 DFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSRDRVASLDLTDLNLCGSVPAQ 87
DFH LV L+QGF+ P P + +WN+SN SSVCSW GI C + RV SLDLTDLNL GSV
Sbjct: 27 DFHALVTLRQGFQFPNPVINTWNTSNFSSVCSWVGIQCHQGRVVSLDLTDLNLFGSVSPS 86
Query: 88 ILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYN 147
I LD+L++LSLAGNNFTG+I I NL++LQFLNISNNQFSG +DWNYS++ NL+V D YN
Sbjct: 87 ISSLDRLSHLSLAGNNFTGTIHITNLTNLQFLNISNNQFSGHMDWNYSTMENLQVVDVYN 146
Query: 148 NNFTALLPVGILKLE-KLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGEL 206
NNFT+LLP+GIL L+ KLK+LDLGGN+FFG+IP SYG+L LEYLSLAGND++GKIPGEL
Sbjct: 147 NNFTSLLPLGILSLKNKLKHLDLGGNFFFGEIPKSYGKLVSLEYLSLAGNDISGKIPGEL 206
Query: 207 GNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFL 266
GNL+NLREIYLGYYN +EGGIP E G+L LVH+D+SSC+LDG IP E+GNLK L+T++L
Sbjct: 207 GNLSNLREIYLGYYNTYEGGIPMEFGRLTKLVHMDISSCDLDGSIPRELGNLKELNTLYL 266
Query: 267 HINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDY 326
HIN LSGSIPKQLGNLTNL+ LDLS+NALTGEIP FINL +L L NLF+NRLHGSIPDY
Sbjct: 267 HINQLSGSIPKQLGNLTNLLYLDLSSNALTGEIPIEFINLNRLTLLNLFLNRLHGSIPDY 326
Query: 327 LADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILIL 386
+AD P+L+TLGLW NNFTG IP LG NGKLQ+LDLSSNKLTG IP LCSS+QL+ILIL
Sbjct: 327 IADFPDLDTLGLWMNNFTGEIPYKLGLNGKLQILDLSSNKLTGIIPPHLCSSSQLKILIL 386
Query: 387 LKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPEN 446
L NFLFGPIP+ LG CYSLTRVRLG+NYLNGSIP+GF+YLP LNLAEL++NYLSG+L EN
Sbjct: 387 LNNFLFGPIPQGLGTCYSLTRVRLGENYLNGSIPNGFLYLPKLNLAELKNNYLSGTLSEN 446
Query: 447 GNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLK 506
GNSSS P L QL+LSNN LSGPLP+SLSNF+SLQILLLSGNQFSGPIPPSIG L QVLK
Sbjct: 447 GNSSSKPVSLEQLDLSNNALSGPLPYSLSNFTSLQILLLSGNQFSGPIPPSIGGLNQVLK 506
Query: 507 LDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNI 566
LDL+RNSLSG+IPP IGYC HLTYLDMSQNNLSGSIPP ISN+RILNYLNLSRNHLNQ+I
Sbjct: 507 LDLTRNSLSGDIPPEIGYCVHLTYLDMSQNNLSGSIPPLISNIRILNYLNLSRNHLNQSI 566
Query: 567 PKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNNPCNVAPITH 626
P+SIG+MKSLT+ADFSFN+FSGKLPESGQF+ FNA+SFAGNP+LCG+LLNNPC + +
Sbjct: 567 PRSIGTMKSLTVADFSFNEFSGKLPESGQFSFFNATSFAGNPKLCGSLLNNPCKLTRMKS 626
Query: 627 QPGKAPGDFKLIFALGLLICSLIFATAAIIKAKSFKKTGSDSWKMTAFQKLEFSVSDILE 686
PGK DFKLIFALGLL+CSL+FA AAIIKAKSFKK G SWKMTAF+KLEF+VSDILE
Sbjct: 627 TPGKNNSDFKLIFALGLLMCSLVFAVAAIIKAKSFKKKGPGSWKMTAFKKLEFTVSDILE 686
Query: 687 CVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
CVKDGNVIGRGGAGIVYHGKMPNG+EIAVKKLLGFG ++HDHGFRAEIQTLGNIRHRNIV
Sbjct: 687 CVKDGNVIGRGGAGIVYHGKMPNGMEIAVKKLLGFGANNHDHGFRAEIQTLGNIRHRNIV 746
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
RLLAFCSNKETNLLVYEYMRNGSLGE LHGKKGAFL WN RYKI+I++AKGLCYLHHDCS
Sbjct: 747 RLLAFCSNKETNLLVYEYMRNGSLGETLHGKKGAFLSWNFRYKISIDSAKGLCYLHHDCS 806
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
PLI+HRDVKSNNILL+S FEAHVADFGLAKFL+DG A+ECMS+IAGSYGYIAPEYAYTLR
Sbjct: 807 PLILHRDVKSNNILLSSNFEAHVADFGLAKFLVDGAAAECMSSIAGSYGYIAPEYAYTLR 866
Query: 867 VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926
VDEKSDVYSFGVVLLELLTGR+PVGDFG+GVD+VQW K+ATNGR+EE ++I+D RL +VP
Sbjct: 867 VDEKSDVYSFGVVLLELLTGRKPVGDFGEGVDLVQWCKKATNGRREEVVNIIDSRLMVVP 926
Query: 927 KEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964
KEEAMH+ F+AMLC++ENS++RP MREVVQMLSEFPR
Sbjct: 927 KEEAMHMFFIAMLCLEENSVQRPTMREVVQMLSEFPRQ 964
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486251|ref|XP_002263291.2| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1496 bits (3872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 764/976 (78%), Positives = 856/976 (87%), Gaps = 2/976 (0%)
Query: 1 MAFFIVVTLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSW 60
MA FI + L+ L + S ++SL +DFH LVALK+GF +P L SWN S SSVC W
Sbjct: 1 MASFIALALVL-FLRLSTPSFSSSLSSDFHALVALKRGFAFSDPGLSSWNVSTLSSVCWW 59
Query: 61 AGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLN 120
GI C+ RV LDLTD+NLCGSV I RLD+L+N+S++GNNFTG IEI NLSSL++LN
Sbjct: 60 RGIQCAHGRVVGLDLTDMNLCGSVSPDISRLDQLSNISISGNNFTGPIEIQNLSSLRWLN 119
Query: 121 ISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPN 180
ISNNQFSG L+W++S++ +LEV DAYNNNFTALLP G+L L+KL+YLDLGGN+F+GKIP
Sbjct: 120 ISNNQFSGSLNWSFSTMEDLEVLDAYNNNFTALLPQGVLSLKKLRYLDLGGNFFYGKIPK 179
Query: 181 SYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHL 240
YG L LEYLSLAGNDL GKIP ELGNLT+L+EIYLGYYN F GIP E GKL+NLVH+
Sbjct: 180 IYGGLAALEYLSLAGNDLRGKIPIELGNLTSLKEIYLGYYNSFTDGIPSEFGKLINLVHM 239
Query: 241 DLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIP 300
DLSSCELDG IP E+GNLK L+T+FLHIN LSGSIP +LGNLT+LVNLDLSNNALTGEIP
Sbjct: 240 DLSSCELDGHIPEELGNLKSLNTLFLHINQLSGSIPNRLGNLTSLVNLDLSNNALTGEIP 299
Query: 301 YSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVL 360
NL QL L NLF+NRLHGSIPD++A+LPNL+TLGLW NNFTG+IPE LGQNG+LQ L
Sbjct: 300 LELSNLLQLSLLNLFLNRLHGSIPDFVAELPNLQTLGLWMNNFTGIIPERLGQNGRLQEL 359
Query: 361 DLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIP 420
DLSSNKLTG IP +LCSSNQLRILILLKNFLFGPIPE LG C SLTRVRLGQNYLNGSIP
Sbjct: 360 DLSSNKLTGAIPGNLCSSNQLRILILLKNFLFGPIPEGLGRCSSLTRVRLGQNYLNGSIP 419
Query: 421 DGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSL 480
GFIYLP LNL ELQ+NY+SG+LPEN NSS P++LG+LNLSNNLLSG LP SLSNF+SL
Sbjct: 420 GGFIYLPLLNLMELQNNYISGTLPENHNSSFIPEKLGELNLSNNLLSGRLPSSLSNFTSL 479
Query: 481 QILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSG 540
QILLL GNQFSGPIPPSIGEL+QVLKLDLSRNSLSGEIP IG C HLTYLD+SQNNLSG
Sbjct: 480 QILLLGGNQFSGPIPPSIGELKQVLKLDLSRNSLSGEIPLEIGACFHLTYLDISQNNLSG 539
Query: 541 SIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFN 600
IP E+SN++I+NYLNLSRNHL++ IPKSIGSMKSLTIADFSFN+ SGKLPESGQF FN
Sbjct: 540 PIPSEVSNIKIMNYLNLSRNHLSEAIPKSIGSMKSLTIADFSFNELSGKLPESGQFAFFN 599
Query: 601 ASSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFALGLLICSLIFATAAIIKAKS 660
ASS+AGNP LCG+LLNNPCN I PGK P DFKLIFALGLLICSL+FA AAIIKAKS
Sbjct: 600 ASSYAGNPHLCGSLLNNPCNFTAINGTPGKPPADFKLIFALGLLICSLVFAAAAIIKAKS 659
Query: 661 FKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLG 720
FKKT SDSW+MTAFQK+EF+V+D+LECVKDGNVIGRGGAGIVYHGKMP G E+AVKKLLG
Sbjct: 660 FKKTASDSWRMTAFQKVEFTVADVLECVKDGNVIGRGGAGIVYHGKMPTGAEVAVKKLLG 719
Query: 721 FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGA 780
FG +SHDHGFRAEIQTLGNIRHRNIVRL+AFCSNKETNLLVYEYM+NGSLGEALHGKKG
Sbjct: 720 FGPNSHDHGFRAEIQTLGNIRHRNIVRLIAFCSNKETNLLVYEYMKNGSLGEALHGKKGG 779
Query: 781 FLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840
FLGWNLRYKIA++AAKGLCYLHHDCSPLIVHRDVKSNNILLNS+FEAHVADFGLAKFLID
Sbjct: 780 FLGWNLRYKIAVDAAKGLCYLHHDCSPLIVHRDVKSNNILLNSSFEAHVADFGLAKFLID 839
Query: 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIV 900
GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLEL+TGRRPVGDFG+GVDIV
Sbjct: 840 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELITGRRPVGDFGEGVDIV 899
Query: 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
QW+KR TN KE + I+DPRL+ +P+ EA HL F+A+LCI+ENS+ERP MREVVQMLSE
Sbjct: 900 QWAKRTTNCCKENVIRIVDPRLATIPRNEATHLFFIALLCIEENSVERPTMREVVQMLSE 959
Query: 961 FPRHSSDFNQSSSSSL 976
R+S D N++SSSS+
Sbjct: 960 SHRNSPD-NKTSSSSI 974
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147770228|emb|CAN71863.1| hypothetical protein VITISV_023530 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1494 bits (3868), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 755/949 (79%), Positives = 842/949 (88%), Gaps = 1/949 (0%)
Query: 28 DFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSRDRVASLDLTDLNLCGSVPAQ 87
DFH LVALK+GF +P L SWN S SSVC W GI C+ RV LDLTD+NLCGSV
Sbjct: 5 DFHALVALKRGFAFSDPGLSSWNVSTLSSVCWWRGIQCAHGRVVGLDLTDMNLCGSVSPD 64
Query: 88 ILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYN 147
I RLD+L+N+S++GNNFTG IEI NLSSL++LNISNNQFSG L+W++S++ +LEV DAYN
Sbjct: 65 ISRLDQLSNISISGNNFTGPIEIQNLSSLRWLNISNNQFSGSLNWSFSTMEDLEVLDAYN 124
Query: 148 NNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELG 207
NNFTALLP G+L L+KL+YLDLGGN+F+GKIP YG L LEYLSLAGNDL GKIP ELG
Sbjct: 125 NNFTALLPQGVLSLKKLRYLDLGGNFFYGKIPKIYGGLAALEYLSLAGNDLRGKIPIELG 184
Query: 208 NLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLH 267
NLT+L+EIYLGYYN F GIP E GKL+NLVH+DLSSCEJDG IP E+GNLK L+T+FLH
Sbjct: 185 NLTSLKEIYLGYYNSFTDGIPSEFGKLINLVHMDLSSCEJDGHIPEELGNLKSLNTLFLH 244
Query: 268 INLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYL 327
IN LSGSIP +LGNLT+LVNLDLSNNALTGEIP NL QL L NLF+NRLHGSIPD++
Sbjct: 245 INQLSGSIPNRLGNLTSLVNLDLSNNALTGEIPLELSNLLQLSLLNLFLNRLHGSIPDFV 304
Query: 328 ADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILL 387
A+LPNL+TLGLW NNFTG+IPE LGQNG+LQ LDLSSNKLTG IP +LCSSNQLRILILL
Sbjct: 305 AELPNLQTLGLWMNNFTGIIPERLGQNGRLQELDLSSNKLTGAIPGNLCSSNQLRILILL 364
Query: 388 KNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENG 447
KNFLFGPIPE LG C SLTRVRLGQNYLNGSIP GFIYLP LNL ELQ+NY+SG+LPEN
Sbjct: 365 KNFLFGPIPEGLGRCSSLTRVRLGQNYLNGSIPGGFIYLPLLNLMELQNNYISGTLPENH 424
Query: 448 NSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKL 507
NSSS P++LG+LNLSNNLLSG LP SLSNF+SLQILLL GNQFSGPIPPSIGEL+QVLKL
Sbjct: 425 NSSSIPEKLGELNLSNNLLSGRLPSSLSNFTSLQILLLGGNQFSGPIPPSIGELKQVLKL 484
Query: 508 DLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIP 567
DLSRNSLSGEIP IG C HLTYLD+SQNNLSG IP E+SN++I+NYLNLSRNHL++ IP
Sbjct: 485 DLSRNSLSGEIPLEIGACFHLTYLDISQNNLSGPIPSEVSNIKIMNYLNLSRNHLSEAIP 544
Query: 568 KSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNNPCNVAPITHQ 627
KSIGSMKSLTIADFSFN+ SGKLPESGQF FNASS+AGNP LCG+LLNNPCN I
Sbjct: 545 KSIGSMKSLTIADFSFNELSGKLPESGQFAFFNASSYAGNPHLCGSLLNNPCNFTAINGT 604
Query: 628 PGKAPGDFKLIFALGLLICSLIFATAAIIKAKSFKKTGSDSWKMTAFQKLEFSVSDILEC 687
PGK P DFKLIFALGLLICSL+FA AAIIKAKSFKKT SDSW+MTAFQK+EF+V+D+LEC
Sbjct: 605 PGKPPADFKLIFALGLLICSLVFAAAAIIKAKSFKKTASDSWRMTAFQKVEFTVADVLEC 664
Query: 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
VKDGNVIGRGGAGIVYHGKMP G E+AVKKLLGFG +SHDHGFRAEIQTLGNIRHRNIVR
Sbjct: 665 VKDGNVIGRGGAGIVYHGKMPTGAEVAVKKLLGFGPNSHDHGFRAEIQTLGNIRHRNIVR 724
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
L+AFCSNKETNLLVYEYM+NGSLGEALHGKKG FLGWNLRYKIA++AAKGLCYLHHDCSP
Sbjct: 725 LIAFCSNKETNLLVYEYMKNGSLGEALHGKKGGFLGWNLRYKIAVDAAKGLCYLHHDCSP 784
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
LIVHRDVKSNNILLNS+FEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV
Sbjct: 785 LIVHRDVKSNNILLNSSFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 844
Query: 868 DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927
DEKSDVYSFGVVLLEL+TGRRPVGDFG+GVDIVQW+KR TN KE + I+DPRL+ +P+
Sbjct: 845 DEKSDVYSFGVVLLELITGRRPVGDFGEGVDIVQWAKRTTNCCKENVIXIVDPRLATIPR 904
Query: 928 EEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQSSSSSL 976
EA HL F+A+LCI+ENS+ERP MREVVQMLSE R+S D N++SSSS+
Sbjct: 905 NEATHLFFIALLCIEENSVERPTMREVVQMLSESHRNSPD-NKTSSSSI 952
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449478131|ref|XP_004155230.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1491 bits (3860), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 762/967 (78%), Positives = 842/967 (87%), Gaps = 9/967 (0%)
Query: 3 FFIVVTLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALIS-WNSSNPSSVCSWA 61
FF+V T FSLL SS+ SLV+DFHVL+ALKQGFE + + +S W +SN SSVCSW
Sbjct: 2 FFLVFTF-FSLLG---FSSSHSLVSDFHVLLALKQGFEFSDSSTLSTWTASNFSSVCSWV 57
Query: 62 GICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNI 121
GI CS RV S++LTDL+L G V I LD+LT LS+AGNNF+G IE+ NLS L+FLNI
Sbjct: 58 GIQCSHGRVVSVNLTDLSLGGFVSPLISNLDQLTELSVAGNNFSGGIEVMNLSYLRFLNI 117
Query: 122 SNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNS 181
SNNQF+G LDWN+SSL NLEV DAYNNNFTALLP IL L+ LKYLDLGGN+F GKIP S
Sbjct: 118 SNNQFTGTLDWNFSSLPNLEVLDAYNNNFTALLPTEILNLQNLKYLDLGGNFFHGKIPES 177
Query: 182 YGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLD 241
YG L+GL+YL LAGNDL GKIPG LGNLTNLREIYLG+YNVFEGG+P E+GKL NLV +D
Sbjct: 178 YGSLEGLQYLFLAGNDLVGKIPGALGNLTNLREIYLGHYNVFEGGLPPELGKLANLVLMD 237
Query: 242 LSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPY 301
++ C LDGQIPHE+GNLK L+T++LH NL SGSIPKQLGNLTNLVNLDLSNNALTGEIP
Sbjct: 238 IADCGLDGQIPHELGNLKALETLYLHTNLFSGSIPKQLGNLTNLVNLDLSNNALTGEIPS 297
Query: 302 SFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLD 361
F+ L+QL L+ LFMN+LHGSIPDY+ADLPNLETL LW NNFT IP+NLGQNG+LQ+LD
Sbjct: 298 EFVELKQLNLYKLFMNKLHGSIPDYIADLPNLETLELWMNNFTSTIPKNLGQNGRLQLLD 357
Query: 362 LSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPD 421
LS+NKLTGTIP LCSSNQLRILIL+ NFLFGPIP+ LG C SLT+VRLGQNYLNGSIP+
Sbjct: 358 LSTNKLTGTIPEGLCSSNQLRILILMNNFLFGPIPDGLGTCTSLTKVRLGQNYLNGSIPN 417
Query: 422 GFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQ 481
GFIYLP LNLAE Q NYLSG+L EN SSS P +LGQLNLSNNLLSG LP SLSN SSLQ
Sbjct: 418 GFIYLPQLNLAEFQDNYLSGTLSENWESSSIPIKLGQLNLSNNLLSGTLPSSLSNLSSLQ 477
Query: 482 ILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGS 541
ILLL+GNQFSG IPPSIGEL Q+LKLDLSRNSLSGEIPP IG C HLTYLD+S+NNLSG
Sbjct: 478 ILLLNGNQFSGTIPPSIGELNQLLKLDLSRNSLSGEIPPEIGNCIHLTYLDLSRNNLSGP 537
Query: 542 IPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNA 601
IPPEISN ILNYLNLSRNHLNQ++PKS+G+MKSLT+ADFSFNDFSGKLPESG FNA
Sbjct: 538 IPPEISNAHILNYLNLSRNHLNQSLPKSLGAMKSLTVADFSFNDFSGKLPESG-LAFFNA 596
Query: 602 SSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFALGLLICSLIFATAAIIKAKSF 661
SSFAGNPQLCG+LLNNPCN A T + GK P FKLIFALGLLICSL+FA AA++KAKSF
Sbjct: 597 SSFAGNPQLCGSLLNNPCNFATTTTKSGKTPTYFKLIFALGLLICSLVFAIAAVVKAKSF 656
Query: 662 KKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGF 721
K+ GS SWKMT+FQKLEF+V D+LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGF
Sbjct: 657 KRNGSSSWKMTSFQKLEFTVFDVLECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGF 716
Query: 722 GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAF 781
G +SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKK +F
Sbjct: 717 GPNSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKASF 776
Query: 782 LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841
LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS FEAHVADFGLAKF+ DG
Sbjct: 777 LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSNFEAHVADFGLAKFMFDG 836
Query: 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG-VDIV 900
GASECMS IAGSYGYIAPEYAYTL+VDEKSDVYSFGVVLLELLTGRRPVGDFGDG VDI
Sbjct: 837 GASECMSVIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVVDIA 896
Query: 901 QWSKRA-TNGRKE-EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQML 958
QW KRA T+G E + + ++D + M+PKEEA HL F+AMLC+QENS+ERP MREVVQML
Sbjct: 897 QWCKRALTDGENENDIICVVDKSVGMIPKEEAKHLFFIAMLCVQENSVERPTMREVVQML 956
Query: 959 SEFPRHS 965
+EFP S
Sbjct: 957 AEFPHQS 963
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449466448|ref|XP_004150938.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1475 bits (3818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 759/968 (78%), Positives = 837/968 (86%), Gaps = 10/968 (1%)
Query: 3 FFIVVTLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALIS-WNSSNPSSVCSWA 61
FF+V T FSLL SS+ SLV+DFHVL+ALKQGFE + + +S W +SN SSVCSW
Sbjct: 2 FFLVFTF-FSLLG---FSSSHSLVSDFHVLLALKQGFEFSDSSTLSTWTASNFSSVCSWV 57
Query: 62 GICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNI 121
GI CS RV S++LTDL+L G V I LD+LT LS+AGNNF+G IE+ NL L+FLNI
Sbjct: 58 GIQCSHGRVVSVNLTDLSLGGFVSPLISNLDQLTELSVAGNNFSGGIEVMNLRYLRFLNI 117
Query: 122 SNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNS 181
SNNQF+G LDWN+SSL NLEV DAYNNNFTALLP IL L+ LKYLDLGGN+F GKIP S
Sbjct: 118 SNNQFTGTLDWNFSSLPNLEVLDAYNNNFTALLPTEILNLQNLKYLDLGGNFFHGKIPES 177
Query: 182 YGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLD 241
YG L+GL+YL LAGNDL GKIPG LGNLTNLREIYLG+YNVFEGG+P E+GKL NLV +D
Sbjct: 178 YGSLEGLQYLFLAGNDLVGKIPGALGNLTNLREIYLGHYNVFEGGLPPELGKLANLVLMD 237
Query: 242 LSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPY 301
++ C LDGQIPHE+GNLK L+T+++H NL SGSIPKQLGNLTNLVNLDLSNNALTGEIP
Sbjct: 238 IADCGLDGQIPHELGNLKALETLYMHTNLFSGSIPKQLGNLTNLVNLDLSNNALTGEIPS 297
Query: 302 SFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLD 361
F+ L+QL L+ LFMN+LHGSIPDY+ADLPNLETL LW NNFT IP+NLGQNG+LQ+LD
Sbjct: 298 EFVELKQLNLYKLFMNKLHGSIPDYIADLPNLETLELWMNNFTSTIPKNLGQNGRLQLLD 357
Query: 362 LSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPD 421
LS+NKLTGTIP LCSSNQLRILIL+ NFLFGPIP+ LG C SLT+VRLGQNYLNGSIP+
Sbjct: 358 LSTNKLTGTIPEGLCSSNQLRILILMNNFLFGPIPDGLGTCTSLTKVRLGQNYLNGSIPN 417
Query: 422 GFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQ 481
GFIYLP LNLAE Q NYLSG+L EN SSS P +LGQLNLSNNLLSG LP SLSN SSLQ
Sbjct: 418 GFIYLPQLNLAEFQDNYLSGTLSENWESSSIPIKLGQLNLSNNLLSGTLPSSLSNLSSLQ 477
Query: 482 ILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGS 541
ILLL+GNQFSG IPPSIGEL Q+LKLDLSRNSLSGEIPP IG C HLTYLD+S+NNLSG
Sbjct: 478 ILLLNGNQFSGTIPPSIGELNQLLKLDLSRNSLSGEIPPEIGNCIHLTYLDLSRNNLSGP 537
Query: 542 IPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNA 601
IPPEISN ILNYLNLSRNHLNQ++PKS+G+MKSLTIADFSFNDFSGKLPESG FNA
Sbjct: 538 IPPEISNAHILNYLNLSRNHLNQSLPKSLGAMKSLTIADFSFNDFSGKLPESG-LAFFNA 596
Query: 602 SSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGD-FKLIFALGLLICSLIFATAAIIKAKS 660
SSFAGNPQLCG+LLNNPCN A T FKLIFALGLLICSL+FA AA++KAKS
Sbjct: 597 SSFAGNPQLCGSLLNNPCNFATTTTTKSGKTPTYFKLIFALGLLICSLVFAIAAVVKAKS 656
Query: 661 FKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLG 720
FK+ GS SWKMT+FQKLEF+V D+LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLG
Sbjct: 657 FKRNGSSSWKMTSFQKLEFTVFDVLECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLG 716
Query: 721 FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGA 780
FG +SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKK +
Sbjct: 717 FGPNSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKAS 776
Query: 781 FLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840
FLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS FEAHVADFGLAKF+ D
Sbjct: 777 FLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSNFEAHVADFGLAKFMFD 836
Query: 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG-VDI 899
GGASECMS IAGSYGYIAPEYAYTL+VDEKSDVYSFGVVLLELLTGRRPVGDFGDG VDI
Sbjct: 837 GGASECMSVIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVVDI 896
Query: 900 VQWSKRA-TNGRKE-EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957
QW KRA T+G E + + + D R+ M+PKEEA HL F+AMLC+QENS+ERP MREVVQM
Sbjct: 897 AQWCKRALTDGENENDIICVADKRVGMIPKEEAKHLFFIAMLCVQENSVERPTMREVVQM 956
Query: 958 LSEFPRHS 965
L+EFP S
Sbjct: 957 LAEFPHQS 964
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|140053517|gb|ABE79572.2| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1462 bits (3786), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 726/938 (77%), Positives = 825/938 (87%), Gaps = 19/938 (2%)
Query: 28 DFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSRDRVASLDLTDLNLCGSVPAQ 87
DFH LV L+QGF+ P P + +WN+SN SSVCSW GI C + RV SLDLTDLNL GSV
Sbjct: 27 DFHALVTLRQGFQFPNPVINTWNTSNFSSVCSWVGIQCHQGRVVSLDLTDLNLFGSVSPS 86
Query: 88 ILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYN 147
I LD+L++LSLAGNNFTG+I I NL++LQFLNISNNQFSG +DWNYS++ NL+V D YN
Sbjct: 87 ISSLDRLSHLSLAGNNFTGTIHITNLTNLQFLNISNNQFSGHMDWNYSTMENLQVVDVYN 146
Query: 148 NNFTALLPVGILKLE-KLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGEL 206
NNFT+LLP+GIL L+ KLK+LDLGGN+FFG+IP SYG+L LEYLSLAGND++GKIPGEL
Sbjct: 147 NNFTSLLPLGILSLKNKLKHLDLGGNFFFGEIPKSYGKLVSLEYLSLAGNDISGKIPGEL 206
Query: 207 GNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFL 266
GNL+NLREIYLGYYN +EGGIP E G+L LVH+D+SSC+LDG IP E+GNLK L+T++L
Sbjct: 207 GNLSNLREIYLGYYNTYEGGIPMEFGRLTKLVHMDISSCDLDGSIPRELGNLKELNTLYL 266
Query: 267 HINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDY 326
HIN LSGSIPKQLGNLTNL+ LDLS+NALTGEIP FINL +L L NLF+NRLHGSIPDY
Sbjct: 267 HINQLSGSIPKQLGNLTNLLYLDLSSNALTGEIPIEFINLNRLTLLNLFLNRLHGSIPDY 326
Query: 327 LADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILIL 386
+AD P+L+TLGLW NNFTG IP LG NGKLQ+LDLSSNKLTG IP LCSS+QL+ILIL
Sbjct: 327 IADFPDLDTLGLWMNNFTGEIPYKLGLNGKLQILDLSSNKLTGIIPPHLCSSSQLKILIL 386
Query: 387 LKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPEN 446
L NFLFGPIP+ LG CYSLTRVRLG+NYLNGSIP+GF+YLP LNLAEL++NYLSG+L EN
Sbjct: 387 LNNFLFGPIPQGLGTCYSLTRVRLGENYLNGSIPNGFLYLPKLNLAELKNNYLSGTLSEN 446
Query: 447 GNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLK 506
GNSSS P L QL+LSNN LSGPLP+SLSNF+SLQILLLSGNQFSGPIPPSIG L QVLK
Sbjct: 447 GNSSSKPVSLEQLDLSNNALSGPLPYSLSNFTSLQILLLSGNQFSGPIPPSIGGLNQVLK 506
Query: 507 LDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNI 566
LDL+RNSLSG+IPP IGYC HLTYLDMSQNNLSGSIPP ISN+RILNYLNLSRNHLNQ+I
Sbjct: 507 LDLTRNSLSGDIPPEIGYCVHLTYLDMSQNNLSGSIPPLISNIRILNYLNLSRNHLNQSI 566
Query: 567 PKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNNPCNVAPITH 626
P+SIG+MKSLT+ADFSFN+FSGKLPESGQF+ FNA+SFAGNP+LCG+LLNNPC + +
Sbjct: 567 PRSIGTMKSLTVADFSFNEFSGKLPESGQFSFFNATSFAGNPKLCGSLLNNPCKLTRMKS 626
Query: 627 QPGKAPGDFKLIFALGLLICSLIFATAAIIKAKSFKKTGSDSWKMTAFQKLEFSVSDILE 686
PGK DFKLIFALGLL+CSL+FA AAIIKAKSFKK G SWKMTAF+KLEF+VSDILE
Sbjct: 627 TPGKNNSDFKLIFALGLLMCSLVFAVAAIIKAKSFKKKGPGSWKMTAFKKLEFTVSDILE 686
Query: 687 CVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
CVKDGNVIGRGGAGIVYHGKMPNG+EIAVKKLLGFG ++HDHGFRAEIQTLGNIRHRNIV
Sbjct: 687 CVKDGNVIGRGGAGIVYHGKMPNGMEIAVKKLLGFGANNHDHGFRAEIQTLGNIRHRNIV 746
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
RLLAFCSNKETNLLVYEYMRNGSLGE LHGKKGAFL WN RYKI+I++AKGLCYLHHDCS
Sbjct: 747 RLLAFCSNKETNLLVYEYMRNGSLGETLHGKKGAFLSWNFRYKISIDSAKGLCYLHHDCS 806
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
PLI+HRDVKSNNILL+S FEAHVADFGLAKFL+DG A+ECMS+IAGSYGYIAP
Sbjct: 807 PLILHRDVKSNNILLSSNFEAHVADFGLAKFLVDGAAAECMSSIAGSYGYIAP------- 859
Query: 867 VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926
VVLLELLTGR+PVGDFG+GVD+VQW K+ATNGR+EE ++I+D RL +VP
Sbjct: 860 -----------VVLLELLTGRKPVGDFGEGVDLVQWCKKATNGRREEVVNIIDSRLMVVP 908
Query: 927 KEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964
KEEAMH+ F+AMLC++ENS++RP MREVVQMLSEFPR
Sbjct: 909 KEEAMHMFFIAMLCLEENSVQRPTMREVVQMLSEFPRQ 946
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297739522|emb|CBI29704.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1323 bits (3423), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 697/976 (71%), Positives = 777/976 (79%), Gaps = 83/976 (8%)
Query: 1 MAFFIVVTLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSW 60
MA FI + L+ L + S ++SL +DFH LVALK+GF +P L SWN S SSVC W
Sbjct: 1 MASFIALALVL-FLRLSTPSFSSSLSSDFHALVALKRGFAFSDPGLSSWNVSTLSSVCWW 59
Query: 61 AGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLN 120
GI C+ RV LDLTD+NLCGSV I RLD+L+N+S++GNNFTG IEI NLSSL++LN
Sbjct: 60 RGIQCAHGRVVGLDLTDMNLCGSVSPDISRLDQLSNISISGNNFTGPIEIQNLSSLRWLN 119
Query: 121 ISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPN 180
ISNNQFSG L+W++S++ +LEV DAYNNNFTALLP G+L L+KL+YLDLGGN+F+GKIP
Sbjct: 120 ISNNQFSGSLNWSFSTMEDLEVLDAYNNNFTALLPQGVLSLKKLRYLDLGGNFFYGKIPK 179
Query: 181 SYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHL 240
YG L LEYLSLAGNDL GKIP ELGNLT+L+EIYLGYYN F GIP E GKL+NLVH+
Sbjct: 180 IYGGLAALEYLSLAGNDLRGKIPIELGNLTSLKEIYLGYYNSFTDGIPSEFGKLINLVHM 239
Query: 241 DLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIP 300
DLSSCELDG IP E+GNLK L+T+FLHIN LSGSIP +LGNLT+LVNLDLSNNALTGEIP
Sbjct: 240 DLSSCELDGHIPEELGNLKSLNTLFLHINQLSGSIPNRLGNLTSLVNLDLSNNALTGEIP 299
Query: 301 YSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVL 360
NL QL L NLF+NRLHGSIPD++A+LPNL+TLGLW NNFTG+IPE LGQNG+LQ L
Sbjct: 300 LELSNLLQLSLLNLFLNRLHGSIPDFVAELPNLQTLGLWMNNFTGIIPERLGQNGRLQEL 359
Query: 361 DLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIP 420
DLSSNKLTG IP +LCSSNQLRILILLKNFLFGPIPE LG C SLTRVRLGQNYLNGSIP
Sbjct: 360 DLSSNKLTGAIPGNLCSSNQLRILILLKNFLFGPIPEGLGRCSSLTRVRLGQNYLNGSIP 419
Query: 421 DGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSL 480
GFIYLP LNL ELQ+NY+SG+LPEN NSS P++LG+LNLSNNLLSG LP SLSNF+SL
Sbjct: 420 GGFIYLPLLNLMELQNNYISGTLPENHNSSFIPEKLGELNLSNNLLSGRLPSSLSNFTSL 479
Query: 481 QILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSG 540
QILLL GNQFSGPIPPSIGEL+QVLKLDLSRNSLSGEIP IG C HLTYLD+SQNNLSG
Sbjct: 480 QILLLGGNQFSGPIPPSIGELKQVLKLDLSRNSLSGEIPLEIGACFHLTYLDISQNNLSG 539
Query: 541 SIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFN 600
IP E SIGSMKSLTIADFSFN+ SGKLPESGQF FN
Sbjct: 540 PIPSE-----------------------SIGSMKSLTIADFSFNELSGKLPESGQFAFFN 576
Query: 601 ASSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFALGLLICSLIFATAAIIKAKS 660
ASS+AGNP LCG+LLNNPCN I PGK P DFK LIFA
Sbjct: 577 ASSYAGNPHLCGSLLNNPCNFTAINGTPGKPPADFK-----------LIFAL-------- 617
Query: 661 FKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLG 720
GIVYHGKMP G E+AVKKLLG
Sbjct: 618 ---------------------------------------GIVYHGKMPTGAEVAVKKLLG 638
Query: 721 FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGA 780
FG +SHDHGFRAEIQTLGNIRHRNIVRL+AFCSNKETNLLVYEYM+NGSLGEALHGKKG
Sbjct: 639 FGPNSHDHGFRAEIQTLGNIRHRNIVRLIAFCSNKETNLLVYEYMKNGSLGEALHGKKGG 698
Query: 781 FLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840
FLGWNLRYKIA++AAKGLCYLHHDCSPLIVHRDVKSNNILLNS+FEAHVADFGLAKFLID
Sbjct: 699 FLGWNLRYKIAVDAAKGLCYLHHDCSPLIVHRDVKSNNILLNSSFEAHVADFGLAKFLID 758
Query: 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIV 900
GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLEL+TGRRPVGDFG+GVDIV
Sbjct: 759 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELITGRRPVGDFGEGVDIV 818
Query: 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
QW+KR TN KE + I+DPRL+ +P+ EA HL F+A+LCI+ENS+ERP MREVVQMLSE
Sbjct: 819 QWAKRTTNCCKENVIRIVDPRLATIPRNEATHLFFIALLCIEENSVERPTMREVVQMLSE 878
Query: 961 FPRHSSDFNQSSSSSL 976
R+S D N++SSSS+
Sbjct: 879 SHRNSPD-NKTSSSSI 893
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225424960|ref|XP_002264952.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1202 bits (3111), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 625/944 (66%), Positives = 731/944 (77%), Gaps = 18/944 (1%)
Query: 31 VLVALKQGFENPEPALISWNSSNPSSVCSWAGICC--SRDRVASLDLTDLNLCGSVPAQI 88
LVALKQ FE P P+L SW SN S+CSW G+ C + V SLD+++ N+ G++ I
Sbjct: 39 TLVALKQAFEAPHPSLNSWKVSNYRSLCSWTGVQCDDTSTWVVSLDISNSNISGALSPAI 98
Query: 89 LRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAY 146
+ L L NLS+ GNN GS EI LS LQ+LNISNNQF+G L+W + L L V DAY
Sbjct: 99 MELGSLRNLSVCGNNLAGSFPPEIHKLSRLQYLNISNNQFNGSLNWEFHQLKELAVLDAY 158
Query: 147 NNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGEL 206
+NNF LPVG+ +L KLK+LD GGNYF GKIP +YG + L YLSLAGNDL G IP EL
Sbjct: 159 DNNFLGSLPVGVTQLPKLKHLDFGGNYFSGKIPRNYGGMVQLTYLSLAGNDLGGYIPVEL 218
Query: 207 GNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFL 266
GNLTNL+ +YLGYYN F+GGIP E+GKLVNLVHLDLSSC L+G IP E+GNLK LDT+FL
Sbjct: 219 GNLTNLKRLYLGYYNEFDGGIPPELGKLVNLVHLDLSSCGLEGPIPPELGNLKHLDTLFL 278
Query: 267 HINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDY 326
N LSGSIP QLGNL++L +LDLSNN LTGEIP F L +L L LF+N+ HG IP +
Sbjct: 279 QTNQLSGSIPPQLGNLSSLKSLDLSNNGLTGEIPLEFSELTELTLLQLFINKFHGEIPHF 338
Query: 327 LADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILIL 386
+A+LP LE L LWQNNFTG IP LG+NGKL LDLS+NKLTG IP LC +L+ILIL
Sbjct: 339 IAELPKLEVLKLWQNNFTGTIPSKLGRNGKLSELDLSTNKLTGLIPKSLCFGRRLKILIL 398
Query: 387 LKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPEN 446
L NFLFGP+P+ LG C +L RVRLGQNYL+G IP+GF+YLP L+L ELQ+NYL+G PE
Sbjct: 399 LNNFLFGPLPDDLGRCETLQRVRLGQNYLSGFIPNGFLYLPQLSLMELQNNYLTGGFPE- 457
Query: 447 GNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLK 506
SS P ++GQLNLSNN LSG LP S+ NFSSLQILLL+GN+F+G IP IG+L +LK
Sbjct: 458 -ESSKVPSKVGQLNLSNNRLSGSLPTSIGNFSSLQILLLNGNRFTGNIPSEIGQLISILK 516
Query: 507 LDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNI 566
LD+ RN+ SG IPP IG+C LTYLD+SQN +SG IP +I+ + ILNYLNLS NH+NQN+
Sbjct: 517 LDMRRNNFSGIIPPEIGHCLSLTYLDLSQNQISGPIPVQIAQIHILNYLNLSWNHMNQNL 576
Query: 567 PKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNNPCNVAPITH 626
PK IG MKSLT DFS N+FSG +P+ GQ++ FN+SSF GNPQLCG+ LN CN + +
Sbjct: 577 PKEIGFMKSLTSVDFSHNNFSGWIPQIGQYSFFNSSSFVGNPQLCGSYLNQ-CNYSSASP 635
Query: 627 QPGK--------APGDFKLIFALGLLICSLIFATAAIIKAKSFKKTGSDSWKMTAFQKLE 678
K PG FKL+ AL LLICSLIFA AI+K + +KT S+SWK+TAFQKLE
Sbjct: 636 LESKNQHDTSSHVPGKFKLVLALSLLICSLIFAVLAIVKTRKVRKT-SNSWKLTAFQKLE 694
Query: 679 FSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGT-HSHDHGFRAEIQTL 737
F DILEC+KD NVIGRGGAGIVY G MPNG ++AVKKL G SHD+G AEIQTL
Sbjct: 695 FGSEDILECLKDNNVIGRGGAGIVYRGTMPNGEQVAVKKLQGISKGSSHDNGLSAEIQTL 754
Query: 738 GNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKG 797
G IRHRNIVRLLAFCSNKETNLLVYEYM NGSLGE LHGK+G L W+ R KIAIEAAKG
Sbjct: 755 GRIRHRNIVRLLAFCSNKETNLLVYEYMPNGSLGEVLHGKRGGHLKWDTRLKIAIEAAKG 814
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI 857
LCYLHHDCSPLI+HRDVKSNNILLNS +EAHVADFGLAKFL D G SECMSAIAGSYGYI
Sbjct: 815 LCYLHHDCSPLILHRDVKSNNILLNSDYEAHVADFGLAKFLQDNGTSECMSAIAGSYGYI 874
Query: 858 APEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFG-DGVDIVQWSKRATNGRKEEFLS 916
APEYAYTL+VDEKSDVYSFGVVLLEL+TGRRPVG FG +G+DIVQWSK TN KE +
Sbjct: 875 APEYAYTLKVDEKSDVYSFGVVLLELITGRRPVGGFGEEGLDIVQWSKIQTNWSKEGVVK 934
Query: 917 ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
ILD RL VP++EA+ FVAMLC+QE+S+ERP MREV+QML++
Sbjct: 935 ILDERLRNVPEDEAIQTFFVAMLCVQEHSVERPTMREVIQMLAQ 978
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 995 | ||||||
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.960 | 0.953 | 0.569 | 1.5e-287 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.957 | 0.951 | 0.558 | 1.4e-284 | |
| TAIR|locus:2120412 | 992 | BAM3 "BARELY ANY MERISTEM 3" [ | 0.961 | 0.964 | 0.545 | 1.7e-279 | |
| TAIR|locus:2204350 | 980 | CLV1 "AT1G75820" [Arabidopsis | 0.959 | 0.974 | 0.494 | 2.1e-242 | |
| UNIPROTKB|Q5Z9N5 | 994 | P0481E08.42 "Os06g0717200 prot | 0.896 | 0.897 | 0.52 | 6e-238 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.700 | 0.677 | 0.357 | 7.5e-174 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.641 | 0.559 | 0.351 | 6.5e-164 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.947 | 0.943 | 0.390 | 4e-161 | |
| TAIR|locus:2032553 | 996 | HSL1 "HAESA-like 1" [Arabidops | 0.937 | 0.936 | 0.390 | 9.6e-160 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.825 | 0.826 | 0.404 | 2.1e-154 |
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2762 (977.3 bits), Expect = 1.5e-287, P = 1.5e-287
Identities = 556/977 (56%), Positives = 687/977 (70%)
Query: 1 MAFFIVVTLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENP--EPALIXXXXXXXXXXX 58
M F++ LLF LL+I + +A+ +++F L++LK +
Sbjct: 1 MKLFLL--LLF-LLHISHTFTASRPISEFRALLSLKTSLTGAGDDKNSPLSSWKVSTSFC 57
Query: 59 XXAGICC--SRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLS 114
G+ C SR V SLDL+ LNL G++ + L L NLSLA N +G I EI +LS
Sbjct: 58 TWIGVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLS 117
Query: 115 SLQFLNISNNQFSGGLDWNYSS-LVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY 173
L+ LN+SNN F+G SS LVNL V D YNNN T LPV + L +L++L LGGNY
Sbjct: 118 GLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNY 177
Query: 174 FFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGK 233
F GKIP SYG +EYL+++GN+L GKIP E+GNLT LRE+Y+GYYN FE G+P E+G
Sbjct: 178 FAGKIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGN 237
Query: 234 LVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNN 293
L LV D ++C L G+IP EIG L+ LDT+FL +N+ SG + +LG L++L ++DLSNN
Sbjct: 238 LSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNN 297
Query: 294 ALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQ 353
TGEIP SF L+ L L NLF N+LHG IP+++ DLP LE L LW+NNFTG IP+ LG+
Sbjct: 298 MFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGE 357
Query: 354 NGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQN 413
NGKL ++DLSSNKLTGT+P ++CS N+L LI L NFLFG IP+ LG C SLTR+R+G+N
Sbjct: 358 NGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGEN 417
Query: 414 YLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRXXXXXXXXXXXXXXXXXX 473
+LNGSIP G LP L ELQ NYLSG LP G S N +
Sbjct: 418 FLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGN 477
Query: 474 XXXXXXXXILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDM 533
LLL GN+F GPIP +G+L+Q+ K+D S N SG I P I C LT++D+
Sbjct: 478 FTGVQK---LLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDL 534
Query: 534 SQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPES 593
S+N LSG IP EI+ ++ILNYLNLSRNHL +IP SI SM+SLT DFS+N+ SG +P +
Sbjct: 535 SRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGT 594
Query: 594 GQFTVFNASSFAGNPQLCGTLLNNPCN--VAPITHQP-GKAP--GDFKLIFALGLLICSL 648
GQF+ FN +SF GNP LCG L PC VA HQ K P KL+ LGLL+CS+
Sbjct: 595 GQFSYFNYTSFLGNPDLCGPYLG-PCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSI 653
Query: 649 IFATAAIIKAKSFKKTG-SDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKM 707
FA AIIKA+S KK S +W++TAFQ+L+F+ D+L+ +K+ N+IG+GGAGIVY G M
Sbjct: 654 AFAVVAIIKARSLKKASESRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVM 713
Query: 708 PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMR 766
PNG +AVK+L SHDHGF AEIQTLG IRHR+IVRLL FCSN ETNLLVYEYM
Sbjct: 714 PNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMP 773
Query: 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE 826
NGSLGE LHGKKG L W+ RYKIA+EAAKGLCYLHHDCSPLIVHRDVKSNNILL+S FE
Sbjct: 774 NGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFE 833
Query: 827 AHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTG 886
AHVADFGLAKFL D G SECMSAIAGSYGYIAPEYAYTL+VDEKSDVYSFGVVLLEL+TG
Sbjct: 834 AHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTG 893
Query: 887 RRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSI 946
R+PVG+FGDGVDIVQW ++ T+ K+ L +LDPRLS +P E H+ +VAMLC++E ++
Sbjct: 894 RKPVGEFGDGVDIVQWVRKMTDSNKDSVLKVLDPRLSSIPIHEVTHVFYVAMLCVEEQAV 953
Query: 947 ERPRMREVVQMLSEFPR 963
ERP MREVVQ+L+E P+
Sbjct: 954 ERPTMREVVQILTEIPK 970
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2734 (967.5 bits), Expect = 1.4e-284, P = 1.4e-284
Identities = 541/969 (55%), Positives = 684/969 (70%)
Query: 5 IVVTLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALIXXXXXXXXXXXXXAGIC 64
+++ LL LL+I + + A + + H L++LK F E + + G+
Sbjct: 4 LLLLLLLLLLHISHSFTVAKPITELHALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVT 63
Query: 65 C--SRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLN 120
C S V SLDL+ LNL G++ + + L L NLSLA N +G I +I NL L+ LN
Sbjct: 64 CDVSLRHVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLN 123
Query: 121 ISNNQFSGGLDWNYSS-LVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIP 179
+SNN F+G SS LVNL V D YNNN T LPV + L +L++L LGGNYF GKIP
Sbjct: 124 LSNNVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIP 183
Query: 180 NSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVH 239
+YG LEYL+++GN+LTGKIP E+GNLT LRE+Y+GYYN FE G+P E+G L LV
Sbjct: 184 ATYGTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVR 243
Query: 240 LDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEI 299
D ++C L G+IP EIG L+ LDT+FL +N +G+I ++LG +++L ++DLSNN TGEI
Sbjct: 244 FDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEI 303
Query: 300 PYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQV 359
P SF L+ L L NLF N+L+G+IP+++ ++P LE L LW+NNFTG IP+ LG+NG+L +
Sbjct: 304 PTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVI 363
Query: 360 LDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSI 419
LDLSSNKLTGT+P ++CS N+L LI L NFLFG IP+ LG C SLTR+R+G+N+LNGSI
Sbjct: 364 LDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSI 423
Query: 420 PDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRXXXXXXXXXXXXXXXXXXXXXXXX 479
P LP L+ ELQ NYL+G LP +G S D
Sbjct: 424 PKELFGLPKLSQVELQDNYLTGELPISGGGVSG-DLGQISLSNNQLSGSLPAAIGNLSGV 482
Query: 480 XXILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLS 539
LLL GN+FSG IPP IG L+Q+ KLD S N SG I P I C LT++D+S+N LS
Sbjct: 483 QK-LLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELS 541
Query: 540 GSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVF 599
G IP E++ ++ILNYLNLSRNHL +IP +I SM+SLT DFS+N+ SG +P +GQF+ F
Sbjct: 542 GDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYF 601
Query: 600 NASSFAGNPQLCGTLLNNPCNVAPITHQPGKAP--GDFKLIFALGLLICSLIFATAAIIK 657
N +SF GN LCG L PC THQ P KL+ LGLL CS++FA AIIK
Sbjct: 602 NYTSFVGNSHLCGPYLG-PCGKG--THQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIK 658
Query: 658 AKSFKKTG-SDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVK 716
A+S + + +W++TAFQ+L+F+ D+L+ +K+ N+IG+GGAGIVY G MP G +AVK
Sbjct: 659 ARSLRNASEAKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVK 718
Query: 717 KL--LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL 774
+L + G+ SHDHGF AEIQTLG IRHR+IVRLL FCSN ETNLLVYEYM NGSLGE L
Sbjct: 719 RLATMSHGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL 777
Query: 775 HGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834
HGKKG L WN RYKIA+EAAKGLCYLHHDCSPLIVHRDVKSNNILL+S FEAHVADFGL
Sbjct: 778 HGKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGL 837
Query: 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFG 894
AKFL D G SECMSAIAGSYGYIAPEYAYTL+VDEKSDVYSFGVVLLEL+TG++PVG+FG
Sbjct: 838 AKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFG 897
Query: 895 DGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREV 954
DGVDIVQW + T+ K+ L ++D RLS VP E H+ +VA+LC++E ++ERP MREV
Sbjct: 898 DGVDIVQWVRSMTDSNKDCVLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREV 957
Query: 955 VQMLSEFPR 963
VQ+L+E P+
Sbjct: 958 VQILTEIPK 966
|
|
| TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2686 (950.6 bits), Expect = 1.7e-279, P = 1.7e-279
Identities = 534/979 (54%), Positives = 677/979 (69%)
Query: 3 FFIVVTLLFSLLNIPNLSSA-ASLVNDFHVLVALKQGFENPEPALIXXXXXXXXXXXXXA 61
FF++++ + LL +S SL+ +VL++LKQ F++ +P+L
Sbjct: 8 FFLILSSISPLLCSSLISPLNLSLIRQANVLISLKQSFDSYDPSLDSWNIPNFNSLCSWT 67
Query: 62 GICCSR--DRVASLDLTDLNLCGSVPAQILRLD-KLTNLSLAGNNFTGSI--EIGNLSSL 116
G+ C + LDL++LN+ G++ +I RL L L ++ N+F+G + EI LS L
Sbjct: 68 GVSCDNLNQSITRLDLSNLNISGTISPEISRLSPSLVFLDISSNSFSGELPKEIYELSGL 127
Query: 117 QFLNISNNQFSGGLDWN-YSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFF 175
+ LNIS+N F G L+ +S + L DAY+N+F LP+ + L +L++LDLGGNYF
Sbjct: 128 EVLNISSNVFEGELETRGFSQMTQLVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFD 187
Query: 176 GKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLV 235
G+IP SYG L++LSL+GNDL G+IP EL N+T L ++YLGYYN + GGIP + G+L+
Sbjct: 188 GEIPRSYGSFLSLKFLSLSGNDLRGRIPNELANITTLVQLYLGYYNDYRGGIPADFGRLI 247
Query: 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNAL 295
NLVHLDL++C L G IP E+GNLK L+ +FL N L+GS+P++LGN+T+L LDLSNN L
Sbjct: 248 NLVHLDLANCSLKGSIPAELGNLKNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFL 307
Query: 296 TGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNG 355
GEIP L++L+LFNLF NRLHG IP+++++LP+L+ L LW NNFTG IP LG NG
Sbjct: 308 EGEIPLELSGLQKLQLFNLFFNRLHGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNG 367
Query: 356 KLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYL 415
L +DLS+NKLTG IP LC +L+ILIL NFLFGP+PE LG C L R RLGQN+L
Sbjct: 368 NLIEIDLSTNKLTGLIPESLCFGRRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFL 427
Query: 416 NGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRXXXXXXXXXXXXXXXXXXXX 475
+P G IYLP L+L ELQ+N+L+G +PE ++
Sbjct: 428 TSKLPKGLIYLPNLSLLELQNNFLTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIR 487
Query: 476 XXXXXXILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQ 535
ILLL N+ SG IP IG L+ +LK+D+SRN+ SG+ PP G C LTYLD+S
Sbjct: 488 NLRSLQILLLGANRLSGQIPGEIGSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSH 547
Query: 536 NNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQ 595
N +SG IP +IS +RILNYLN+S N NQ++P +G MKSLT ADFS N+FSG +P SGQ
Sbjct: 548 NQISGQIPVQISQIRILNYLNVSWNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQ 607
Query: 596 FTVFNASSFAGNPQLCGTLLNNPCNVAPITHQP-----------GKAPGDFKLIFALGLL 644
F+ FN +SF GNP LCG +NPCN + Q G+ FKL F LGLL
Sbjct: 608 FSYFNNTSFLGNPFLCG-FSSNPCNGSQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLL 666
Query: 645 ICSLIFATAAIIKAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYH 704
L+F A++K + +K + WK+ FQKL F ILECVK+ +VIG+GG GIVY
Sbjct: 667 GFFLVFVVLAVVKNRRMRKNNPNLWKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYK 726
Query: 705 GKMPNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763
G MPNG E+AVKKLL SHD+G AEIQTLG IRHRNIVRLLAFCSNK+ NLLVYE
Sbjct: 727 GVMPNGEEVAVKKLLTITKGSSHDNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYE 786
Query: 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS 823
YM NGSLGE LHGK G FL W R +IA+EAAKGLCYLHHDCSPLI+HRDVKSNNILL
Sbjct: 787 YMPNGSLGEVLHGKAGVFLKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGP 846
Query: 824 AFEAHVADFGLAKFLI-DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLE 882
FEAHVADFGLAKF++ D GASECMS+IAGSYGYIAPEYAYTLR+DEKSDVYSFGVVLLE
Sbjct: 847 EFEAHVADFGLAKFMMQDNGASECMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLE 906
Query: 883 LLTGRRPVGDFGD-GVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCI 941
L+TGR+PV +FG+ G+DIVQWSK TN ++ + I+D RLS +P EAM L FVAMLC+
Sbjct: 907 LITGRKPVDNFGEEGIDIVQWSKIQTNCNRQGVVKIIDQRLSNIPLAEAMELFFVAMLCV 966
Query: 942 QENSIERPRMREVVQMLSE 960
QE+S+ERP MREVVQM+S+
Sbjct: 967 QEHSVERPTMREVVQMISQ 985
|
|
| TAIR|locus:2204350 CLV1 "AT1G75820" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2336 (827.4 bits), Expect = 2.1e-242, P = 2.1e-242
Identities = 485/980 (49%), Positives = 635/980 (64%)
Query: 1 MAFFIVVT-LLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALIXXXXXXXXXXX- 58
MA ++ T LLF L++ S D VL+ LK P+ +
Sbjct: 1 MAMRLLKTHLLF--LHLYLFFSPCFAYTDMEVLLNLKSSMIGPKGHGLHDWIHSSSPDAH 58
Query: 59 -XXAGICCSRD-RVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLS 114
+G+ C D RV SL+++ L G++ +I L L NL+LA NNFTG + E+ +L+
Sbjct: 59 CSFSGVSCDDDARVISLNVSFTPLFGTISPEIGMLTHLVNLTLAANNFTGELPLEMKSLT 118
Query: 115 SLQFLNISNN-QFSGGLDWNY-SSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGN 172
SL+ LNISNN +G ++V+LEV D YNNNF LP + +L+KLKYL GGN
Sbjct: 119 SLKVLNISNNGNLTGTFPGEILKAMVDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGN 178
Query: 173 YFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVG 232
+F G+IP SYG++Q LEYL L G L+GK P L L NLRE+Y+GYYN + GG+P E G
Sbjct: 179 FFSGEIPESYGDIQSLEYLGLNGAGLSGKSPAFLSRLKNLREMYIGYYNSYTGGVPPEFG 238
Query: 233 KLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSN 292
L L LD++SC L G+IP + NLK L T+FLHIN L+G IP +L L +L +LDLS
Sbjct: 239 GLTKLEILDMASCTLTGEIPTSLSNLKHLHTLFLHINNLTGHIPPELSGLVSLKSLDLSI 298
Query: 293 NALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLG 352
N LTGEIP SFINL + L NLF N L+G IP+ + +LP LE +W+NNFT +P NLG
Sbjct: 299 NQLTGEIPQSFINLGNITLINLFRNNLYGQIPEAIGELPKLEVFEVWENNFTLQLPANLG 358
Query: 353 QNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQ 412
+NG L LD+S N LTG IP DLC +L +LIL NF FGPIPE LG C SLT++R+ +
Sbjct: 359 RNGNLIKLDVSDNHLTGLIPKDLCRGEKLEMLILSNNFFFGPIPEELGKCKSLTKIRIVK 418
Query: 413 NYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRXXXXXXXXXXXXXXXXX 472
N LNG++P G LP + + EL N+ SG LP + + D
Sbjct: 419 NLLNGTVPAGLFNLPLVTIIELTDNFFSGELPV----TMSGDVLDQIYLSNNWFSGEIPP 474
Query: 473 XXXXXXXXXILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLD 532
L L N+F G IP I EL+ + +++ S N+++G IP +I C+ L +D
Sbjct: 475 AIGNFPNLQTLFLDRNRFRGNIPREIFELKHLSRINTSANNITGGIPDSISRCSTLISVD 534
Query: 533 MSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPE 592
+S+N ++G IP I+NV+ L LN+S N L +IP IG+M SLT D SFND SG++P
Sbjct: 535 LSRNRINGEIPKGINNVKNLGTLNISGNQLTGSIPTGIGNMTSLTTLDLSFNDLSGRVPL 594
Query: 593 SGQFTVFNASSFAGNPQLC----GTLLNNPCNVAPITHQPGKAPGDFKLIFALGLLICSL 648
GQF VFN +SFAGN LC + P + H +P +++ + I L
Sbjct: 595 GGQFLVFNETSFAGNTYLCLPHRVSCPTRPGQTSDHNHTALFSPS--RIVITVIAAITGL 652
Query: 649 IFATAAIIKAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMP 708
I + AI + K S +WK+TAFQKL+F D+LEC+K+ N+IG+GGAGIVY G MP
Sbjct: 653 ILISVAIRQMNKKKNQKSLAWKLTAFQKLDFKSEDVLECLKEENIIGKGGAGIVYRGSMP 712
Query: 709 NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNG 768
N V++A+K+L+G GT DHGF AEIQTLG IRHR+IVRLL + +NK+TNLL+YEYM NG
Sbjct: 713 NNVDVAIKRLVGRGTGRSDHGFTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNG 772
Query: 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH 828
SLGE LHG KG L W R+++A+EAAKGLCYLHHDCSPLI+HRDVKSNNILL+S FEAH
Sbjct: 773 SLGELLHGSKGGHLQWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAH 832
Query: 829 VADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRR 888
VADFGLAKFL+DG ASECMS+IAGSYGYIAPEYAYTL+VDEKSDVYSFGVVLLEL+ G++
Sbjct: 833 VADFGLAKFLVDGAASECMSSIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKK 892
Query: 889 PVGDFGDGVDIVQWSKRATNGRKEE-----FLSILDPRLSMVPKEEAMHLLFVAMLCIQE 943
PVG+FG+GVDIV+W + + ++I+DPRL+ P +H+ +AM+C++E
Sbjct: 893 PVGEFGEGVDIVRWVRNTEEEITQPSDAAIVVAIVDPRLTGYPLTSVIHVFKIAMMCVEE 952
Query: 944 NSIERPRMREVVQMLSEFPR 963
+ RP MREVV ML+ P+
Sbjct: 953 EAAARPTMREVVHMLTNPPK 972
|
|
| UNIPROTKB|Q5Z9N5 P0481E08.42 "Os06g0717200 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2294 (812.6 bits), Expect = 6.0e-238, P = 6.0e-238
Identities = 481/925 (52%), Positives = 604/925 (65%)
Query: 61 AGICCS-RDRVASLDLTDLNL-CGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSL 116
+G+ C R RV +++LT L L G +P +I LD L NL++A G + E+ L SL
Sbjct: 61 SGVTCDGRSRVVAINLTALPLHSGYLPPEIALLDSLANLTIAACCLPGHVPLELPTLPSL 120
Query: 117 QFLNISNNQFSGGLDWNYSS------LVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLG 170
+ LN+SNN SG S +LE+ DAYNNN + LLP +L+YL LG
Sbjct: 121 RHLNLSNNNLSGHFPVPDSGGGASPYFPSLELIDAYNNNLSGLLPPFSASHARLRYLHLG 180
Query: 171 GNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPRE 230
GNYF G IP+SYG+L LEYL L GN L+G +P L LT LRE+Y+GYYN ++GG+P E
Sbjct: 181 GNYFTGAIPDSYGDLAALEYLGLNGNTLSGHVPVSLSRLTRLREMYIGYYNQYDGGVPPE 240
Query: 231 VGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDL 290
G L L+ LD+SSC L G +P E+G L+ LDT+FL N LSG IP QLG+L++L +LDL
Sbjct: 241 FGDLGALLRLDMSSCNLTGPVPPELGRLQRLDTLFLQWNRLSGEIPPQLGDLSSLASLDL 300
Query: 291 SNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPEN 350
S N L GEIP S NL LKL NLF N L GSIPD++A LE L LW NN TG IP
Sbjct: 301 SVNDLAGEIPPSLANLSNLKLLNLFRNHLRGSIPDFVAGFAQLEVLQLWDNNLTGNIPAG 360
Query: 351 LGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRL 410
LG+NG+L+ LDL++N LTG IP DLC+ +L +L+L++N LFGPIP+ LG C +LTRVRL
Sbjct: 361 LGKNGRLKTLDLATNHLTGPIPADLCAGRRLEMLVLMENGLFGPIPDSLGDCKTLTRVRL 420
Query: 411 GQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRXXXXXXXXXXXXXXX 470
+N+L G +P G LP N+ EL N L+G LP+ D+
Sbjct: 421 AKNFLTGPVPAGLFNLPQANMVELTDNLLTGELPD----VIGGDKIGMLLLGNNGIGGRI 476
Query: 471 XXXXXXXXXXXILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTY 530
L L N FSG +PP IG L+ + +L++S N+L+G IP + C L
Sbjct: 477 PPAIGNLPALQTLSLESNNFSGALPPEIGNLKNLSRLNVSGNALTGAIPDELIRCASLAA 536
Query: 531 LDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKL 590
+D+S+N SG IP I++++IL LN+SRN L +P + +M SLT D S+N SG +
Sbjct: 537 VDLSRNGFSGEIPESITSLKILCTLNVSRNRLTGELPPEMSNMTSLTTLDVSYNSLSGPV 596
Query: 591 PESGQFTVFNASSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFALGLLICSLIF 650
P GQF VFN SSF GNP LCG + + C + + G A +L + ++ +L+
Sbjct: 597 PMQGQFLVFNESSFVGNPGLCGGPVADACPPS-MAGGGGGAGSQLRLRWDSKKMLVALVA 655
Query: 651 ATAAIIKA-----------KSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGA 699
A AA+ A +S + S +WKMTAFQKLEFS D++ECVK+ N+IG+GGA
Sbjct: 656 AFAAVAVAFLGARKGCSAWRSAARRRSGAWKMTAFQKLEFSAEDVVECVKEDNIIGKGGA 715
Query: 700 GIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759
GIVYHG + G E+A+K+L+G G HD GF AE+ TLG IRHRNIVRLL F SN+ETNL
Sbjct: 716 GIVYHG-VTRGAELAIKRLVGRGGGEHDRGFSAEVTTLGRIRHRNIVRLLGFVSNRETNL 774
Query: 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819
L+YEYM NGSLGE LHG KG LGW R ++A EAA GLCYLHHDC+P I+HRDVKSNNI
Sbjct: 775 LLYEYMPNGSLGEMLHGGKGGHLGWEARARVAAEAACGLCYLHHDCAPRIIHRDVKSNNI 834
Query: 820 LLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVV 879
LL+SAFEAHVADFGLAKFL G SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVV
Sbjct: 835 LLDSAFEAHVADFGLAKFL-GGATSECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVV 893
Query: 880 LLELLTGRRPVGDFGDGVDIVQWSKRAT-----NGRKEEFLSILDPRLSMVPKEEAMHLL 934
LLEL+TGRRPVG FGDGVDIV W ++ T N L++ D RL+ P ++L
Sbjct: 894 LLELITGRRPVGGFGDGVDIVHWVRKVTAELPDNSDTAAVLAVADRRLTPEPVALMVNLY 953
Query: 935 FVAMLCIQENSIERPRMREVVQMLS 959
VAM C++E S RP MREVV MLS
Sbjct: 954 KVAMACVEEASTARPTMREVVHMLS 978
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1050 (374.7 bits), Expect = 7.5e-174, Sum P(2) = 7.5e-174
Identities = 263/735 (35%), Positives = 384/735 (52%)
Query: 3 FFIVVTLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALIXXXXXXXXXXXXX-- 60
FF+ + F+L P +SS ++ +L+A K +P L
Sbjct: 7 FFLFYYIGFALF--PFVSSETFQNSEQEILLAFKSDLFDPSNNLQDWKRPENATTFSELV 64
Query: 61 ----AGICCSRDR-VASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNL 113
G+ C + VA L L+++NL G+V QI L L L+ N F S+ + NL
Sbjct: 65 HCHWTGVHCDANGYVAKLLLSNMNLSGNVSDQIQSFPSLQALDLSNNAFESSLPKSLSNL 124
Query: 114 SSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY 173
+SL+ +++S N F G + L +A +NNF+ LP + L+ LD G Y
Sbjct: 125 TSLKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGY 184
Query: 174 FFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGK 233
F G +P+S+ L+ L++L L+GN+ GK+P +G L++L I LGY N F G IP E GK
Sbjct: 185 FEGSVPSSFKNLKNLKFLGLSGNNFGGKVPKVIGELSSLETIILGY-NGFMGEIPEEFGK 243
Query: 234 LVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNN 293
L L +LDL+ L GQIP +G LK L TV+L+ N L+G +P++LG +T+LV LDLS+N
Sbjct: 244 LTRLQYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDN 303
Query: 294 ALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQ 353
+TGEIP L+ L+L NL N+L G IP +A+LPNLE L LWQN+ G +P +LG+
Sbjct: 304 QITGEIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLGK 363
Query: 354 NGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQN 413
N L+ LD+SSNKL+G IP+ LC S L LIL N G IPE + +C +L RVR+ +N
Sbjct: 364 NSPLKWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKN 423
Query: 414 YLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRXXXXXXXXXXXXXXXXXX 473
+++GSIP G LP L EL N L+G +P++ S++
Sbjct: 424 HISGSIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTS----LSFIDISFNHLSSLSSS 479
Query: 474 XXXXXXXXILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDM 533
+ S N F+G IP I + + LDLS N SG IP I L L++
Sbjct: 480 IFSSPNLQTFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFSGGIPERIASFEKLVSLNL 539
Query: 534 SQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPES 593
N L G IP ++ + +L L+LS N L NIP +G+ +L + + SFN G +P +
Sbjct: 540 KSNQLVGEIPKALAGMHMLAVLDLSNNSLTGNIPADLGASPTLEMLNVSFNKLDGPIPSN 599
Query: 594 GQFTVFNASSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFAL-GLLI-CSLIFA 651
F + GN LCG +L PC+ + G+ PG + A+ G ++ S+I A
Sbjct: 600 MLFAAIDPKDLVGNNGLCGGVLP-PCSKSLALSAKGRNPGRIHVNHAVFGFIVGTSVIVA 658
Query: 652 TAAIIKA-----------KSF-------KKTGSD-SWKMTAFQKLEFSVSDILECVKDGN 692
+ A +F KK + W++ AFQ+L F+ DIL +K+ N
Sbjct: 659 MGMMFLAGRWIYTRWDLYSNFAREYIFCKKPREEWPWRLVAFQRLCFTAGDILSHIKESN 718
Query: 693 VIGRGGAGIVYHGKM 707
+IG G GIVY ++
Sbjct: 719 IIGMGAIGIVYKAEV 733
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 861 (308.1 bits), Expect = 6.5e-164, Sum P(2) = 6.5e-164
Identities = 235/669 (35%), Positives = 335/669 (50%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNN-QFSG 128
+L L L G +P I + KL +L L N TGSI E+G LS L+ + I N + SG
Sbjct: 157 TLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISG 216
Query: 129 GLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGL 188
+ NL V + + LP + KL+KL+ L + G+IP+ G L
Sbjct: 217 QIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSEL 276
Query: 189 EYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELD 248
L L N L+G IP E+G LT L +++L + N GGIP E+G NL +DLS L
Sbjct: 277 VDLFLYENSLSGSIPREIGQLTKLEQLFL-WQNSLVGGIPEEIGNCSNLKMIDLSLNLLS 335
Query: 249 GQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQ 308
G IP IG L L+ + N SGSIP + N ++LV L L N ++G IP L +
Sbjct: 336 GSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTK 395
Query: 309 LKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLT 368
L LF + N+L GSIP LAD +L+ L L +N+ TG IP L L L L SN L+
Sbjct: 396 LTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLS 455
Query: 369 GTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPG 428
G IP ++ + + L L L N + G IP +G+ + + N L+G +PD
Sbjct: 456 GFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSE 515
Query: 429 LNLAELQSNYLSGSLPENGNSSSNPDRXXXXXXXXXXXXXXXXXXXXXXXXXXILLLSGN 488
L + +L +N L GSLP N S+ L+LS N
Sbjct: 516 LQMIDLSNNSLEGSLP---NPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKN 572
Query: 489 QFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTY-LDMSQNNLSGSIPPEIS 547
FSG IP S+G + LDL N LSGEIP +G +L L++S N L+G IP +I+
Sbjct: 573 LFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIA 632
Query: 548 NVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGN 607
++ L+ L+LS N L ++ + ++++L + S+N FSG LP++ F + GN
Sbjct: 633 SLNKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGN 691
Query: 608 PQLCGTLLNNPCNVAPITHQPGKAPGDF-------KLIFALGLLICS----LIFATAAII 656
+LC + ++ C +T++ G GD KL L LLI +I A+I
Sbjct: 692 KKLCSSTQDS-CF---LTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVI 747
Query: 657 KAKSFKKTGSDS-------WKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPN 709
+A+ DS W+ T FQKL FSV I+ C+ + NVIG+G +G+VY + N
Sbjct: 748 RARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDN 807
Query: 710 GVEIAVKKL 718
G IAVKKL
Sbjct: 808 GEVIAVKKL 816
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1569 (557.4 bits), Expect = 4.0e-161, P = 4.0e-161
Identities = 384/983 (39%), Positives = 546/983 (55%)
Query: 1 MAFFIVVTLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALIXXXXXXXXXXXXX 60
M + +++ L S +P+LS L D +L K G +P +L
Sbjct: 1 MLYCLILLLCLSSTYLPSLS----LNQDATILRQAKLGLSDPAQSLSSWSDNNDVTPCKW 56
Query: 61 AGICC-SRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSS---L 116
G+ C + V S+DL+ L G P+ + L L +LSL N+ GS+ + + L
Sbjct: 57 LGVSCDATSNVVSVDLSSFMLVGPFPSILCHLPSLHSLSLYNNSINGSLSADDFDTCHNL 116
Query: 117 QFLNISNNQFSGGLDWNYS-SLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFF 175
L++S N G + + +L NL+ + NN + +P + KL+ L+L GN+
Sbjct: 117 ISLDLSENLLVGSIPKSLPFNLPNLKFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLS 176
Query: 176 GKIPNSYGELQGLEYLSLAGNDLT-GKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKL 234
G IP S G + L+ L LA N + +IP +LGNLT L+ ++L N+ G IP + +L
Sbjct: 177 GTIPASLGNVTTLKELKLAYNLFSPSQIPSQLGNLTELQVLWLAGCNLV-GPIPPSLSRL 235
Query: 235 VNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNA 294
+LV+LDL+ +L G IP I LK ++ + L N SG +P+ +GN+T L D S N
Sbjct: 236 TSLVNLDLTFNQLTGSIPSWITQLKTVEQIELFNNSFSGELPESMGNMTTLKRFDASMNK 295
Query: 295 LTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQN 354
LTG+IP + +NL L+ NLF N L G +P+ + L L L+ N TGV+P LG N
Sbjct: 296 LTGKIPDN-LNLLNLESLNLFENMLEGPLPESITRSKTLSELKLFNNRLTGVLPSQLGAN 354
Query: 355 GKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNY 414
LQ +DLS N+ +G IP ++C +L LIL+ N G I LG C SLTRVRL N
Sbjct: 355 SPLQYVDLSYNRFSGEIPANVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNK 414
Query: 415 LNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRXXXXXXXXXXXXXXXXXXX 474
L+G IP GF LP L+L EL N +GS+P+ + N
Sbjct: 415 LSGQIPHGFWGLPRLSLLELSDNSFTGSIPKTIIGAKN-----LSNLRISKNRFSGSIPN 469
Query: 475 XXXXXXXILLLSG--NQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLD 532
I+ +SG N FSG IP S+ +L+Q+ +LDLS+N LSGEIP + +L L+
Sbjct: 470 EIGSLNGIIEISGAENDFSGEIPESLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLNELN 529
Query: 533 MSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPE 592
++ N+LSG IP E+ + +LNYL+LS N + IP + ++K L + + S+N SGK+P
Sbjct: 530 LANNHLSGEIPKEVGILPVLNYLDLSSNQFSGEIPLELQNLK-LNVLNLSYNHLSGKIPP 588
Query: 593 SGQFTVFNASSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFALGLL-ICSLIFA 651
++ A F GNP LC L + C + G + GL+ + ++
Sbjct: 589 LYANKIY-AHDFIGNPGLCVDL-DGLCRKITRSKNIGYVWILLTIFLLAGLVFVVGIVMF 646
Query: 652 TAAIIKAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGV 711
A K ++ K + + K +F KL FS +I +C+ + NVIG G +G VY ++ G
Sbjct: 647 IAKCRKLRALKSSTLAASKWRSFHKLHFSEHEIADCLDEKNVIGFGSSGKVYKVELRGGE 706
Query: 712 EIAVKKLL-----GFGTHSHDH----GFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762
+AVKKL G +S D F AE++TLG IRH++IVRL CS+ + LLVY
Sbjct: 707 VVAVKKLNKSVKGGDDEYSSDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVY 766
Query: 763 EYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNIL 820
EYM NGSL + LHG K G LGW R +IA++AA+GL YLHHDC P IVHRDVKS+NIL
Sbjct: 767 EYMPNGSLADVLHGDRKGGVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNIL 826
Query: 821 LNSAFEAHVADFGLAKF-LIDGGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGV 878
L+S + A VADFG+AK + G + E MS IAGS GYIAPEY YTLRV+EKSD+YSFGV
Sbjct: 827 LDSDYGAKVADFGIAKVGQMSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGV 886
Query: 879 VLLELLTGRRPV-GDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVA 937
VLLEL+TG++P + GD D+ +W A + K ++DP+L + KEE ++ +
Sbjct: 887 VLLELVTGKQPTDSELGDK-DMAKWVCTALD--KCGLEPVIDPKLDLKFKEEISKVIHIG 943
Query: 938 MLCIQENSIERPRMREVVQMLSE 960
+LC + RP MR+VV ML E
Sbjct: 944 LLCTSPLPLNRPSMRKVVIMLQE 966
|
|
| TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1556 (552.8 bits), Expect = 9.6e-160, P = 9.6e-160
Identities = 382/978 (39%), Positives = 537/978 (54%)
Query: 9 LLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALIXXXXXXXXXXXXXAGICCSRD 68
LLF L P + S L D +L +K ++P+ + + +G+ C+ D
Sbjct: 3 LLFLFLLFPTVFS---LNQDGFILQQVKLSLDDPD-SYLSSWNSNDASPCRWSGVSCAGD 58
Query: 69 --RVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGN--NFTGSIEIGNLSSLQFLNISNN 124
V S+DL+ NL G P+ I RL L +LSL N N T + I SLQ L++S N
Sbjct: 59 FSSVTSVDLSSANLAGPFPSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQN 118
Query: 125 QFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGE 184
+G L + + L D NNF+ +P K E L+ L L N G IP G
Sbjct: 119 LLTGELPQTLADIPTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGN 178
Query: 185 LQGLEYLSLAGNDLT-GKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLS 243
+ L+ L+L+ N + +IP E GNLTNL ++L ++ G IP +G+L LV LDL+
Sbjct: 179 ISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVMWLTECHLV-GQIPDSLGQLSKLVDLDLA 237
Query: 244 SCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSF 303
+L G IP +G L + + L+ N L+G IP +LGNL +L LD S N LTG+IP
Sbjct: 238 LNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDEL 297
Query: 304 INLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLS 363
+ L+ NL+ N L G +P +A PNL + ++ N TG +P++LG N L+ LD+S
Sbjct: 298 CRV-PLESLNLYENNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVS 356
Query: 364 SNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGF 423
N+ +G +P DLC+ +L L+++ N G IPE L C SLTR+RL N +GS+P GF
Sbjct: 357 ENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGF 416
Query: 424 IYLPGLNLAELQSNYLSGSLPENGNSSSNPDRXXXXXXXXXXXXXXXXXXXXXXXXXXIL 483
LP +NL EL +N SG + ++ +SN L
Sbjct: 417 WGLPHVNLLELVNNSFSGEISKSIGGASN---LSLLILSNNEFTGSLPEEIGSLDNLNQL 473
Query: 484 LLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIP 543
SGN+FSG +P S+ L ++ LDL N SGE+ I L L+++ N +G IP
Sbjct: 474 SASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIP 533
Query: 544 PEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASS 603
EI ++ +LNYL+LS N + IP S+ S+K L + S+N SG LP S ++ +S
Sbjct: 534 DEIGSLSVLNYLDLSGNMFSGKIPVSLQSLK-LNQLNLSYNRLSGDLPPSLAKDMYK-NS 591
Query: 604 FAGNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFALGLLICS-----LIFATAAIIKA 658
F GNP LCG + C + G + IF L ++ F KA
Sbjct: 592 FIGNPGLCGDI-KGLCGSENEAKKRGYV-WLLRSIFVLAAMVLLAGVAWFYFKYRTFKKA 649
Query: 659 KSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKL 718
++ +++ W + +F KL FS +ILE + + NVIG G +G VY + NG +AVK+L
Sbjct: 650 RAMERS---KWTLMSFHKLGFSEHEILESLDEDNVIGAGASGKVYKVVLTNGETVAVKRL 706
Query: 719 L--------------GFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764
G+ D F AE++TLG IRH+NIV+L CS ++ LLVYEY
Sbjct: 707 WTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEY 766
Query: 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA 824
M NGSLG+ LH KG LGW R+KI ++AA+GL YLHHD P IVHRD+KSNNIL++
Sbjct: 767 MPNGSLGDLLHSSKGGMLGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGD 826
Query: 825 FEAHVADFGLAKFL-IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLEL 883
+ A VADFG+AK + + G A + MS IAGS GYIAPEYAYTLRV+EKSD+YSFGVV+LE+
Sbjct: 827 YGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEI 886
Query: 884 LTGRRPVG-DFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQ 942
+T +RPV + G+ D+V+W + + E ++DP+L KEE +L V +LC
Sbjct: 887 VTRKRPVDPELGEK-DLVKWVCSTLDQKGIEH--VIDPKLDSCFKEEISKILNVGLLCTS 943
Query: 943 ENSIERPRMREVVQMLSE 960
I RP MR VV+ML E
Sbjct: 944 PLPINRPSMRRVVKMLQE 961
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1440 (512.0 bits), Expect = 2.1e-154, Sum P(2) = 2.1e-154
Identities = 346/856 (40%), Positives = 481/856 (56%)
Query: 70 VASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLS---SLQFLNISNNQF 126
V ++DL+ N+ G P R+ L N++L+ NN G+I+ LS LQ L ++ N F
Sbjct: 76 VTTIDLSGYNISGGFPYGFCRIRTLINITLSQNNLNGTIDSAPLSLCSKLQNLILNQNNF 135
Query: 127 SGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQ 186
SG L L V + +N FT +P +L L+ L+L GN G +P G L
Sbjct: 136 SGKLPEFSPEFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLT 195
Query: 187 GLEYLSLAGNDLT-GKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSC 245
L L LA IP LGNL+NL ++ L + N+ G IP + LV L +LDL+
Sbjct: 196 ELTRLDLAYISFDPSPIPSTLGNLSNLTDLRLTHSNLV-GEIPDSIMNLVLLENLDLAMN 254
Query: 246 ELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFIN 305
L G+IP IG L+ + + L+ N LSG +P+ +GNLT L N D+S N LTGE+P
Sbjct: 255 SLTGEIPESIGRLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAA 314
Query: 306 LRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSN 365
L QL FNL N G +PD +A PNL ++ N+FTG +P NLG+ ++ D+S+N
Sbjct: 315 L-QLISFNLNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTN 373
Query: 366 KLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIY 425
+ +G +P LC +L+ +I N L G IPE G C+SL +R+ N L+G +P F
Sbjct: 374 RFSGELPPYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWE 433
Query: 426 LPGLNLAELQSNYLSGSLPENGNSSSNPDRXXXXXXXXXXXXXXXXXXXXXXXXXXILLL 485
LP L +N L GS+P S S ++ L
Sbjct: 434 LPLTRLELANNNQLQGSIPP---SISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDL 490
Query: 486 SGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPE 545
S N F G IP I +L+ + ++++ N L GEIP ++ C LT L++S N L G IPPE
Sbjct: 491 SRNSFLGSIPSCINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPE 550
Query: 546 ISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFA 605
+ ++ +LNYL+LS N L IP + +K L + S N GK+P Q +F S F
Sbjct: 551 LGDLPVLNYLDLSNNQLTGEIPAELLRLK-LNQFNVSDNKLYGKIPSGFQQDIFRPS-FL 608
Query: 606 GNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFALGLLICSLIFATAAI---IKAKS-F 661
GNP LC P N+ PI +P ++ + + I + +L C + A + IK K F
Sbjct: 609 GNPNLCA-----P-NLDPI--RPCRSKRETRYILPISIL-CIVALTGALVWLFIKTKPLF 659
Query: 662 KKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLG- 720
K+ + K+T FQ++ F+ DI + + N+IG GG+G+VY K+ +G +AVKKL G
Sbjct: 660 KRKPKRTNKITIFQRVGFTEEDIYPQLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGE 719
Query: 721 FGTHSHDHG-FRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKG 779
G + FR+E++TLG +RH NIV+LL C+ +E LVYE+M NGSLG+ LH +K
Sbjct: 720 TGQKTESESVFRSEVETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKE 779
Query: 780 ----AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA 835
+ L W R+ IA+ AA+GL YLHHD P IVHRDVKSNNILL+ + VADFGLA
Sbjct: 780 HRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLA 839
Query: 836 KFLI----DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPV- 890
K L DG + MS +AGSYGYIAPEY YT +V+EKSDVYSFGVVLLEL+TG+RP
Sbjct: 840 KPLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPND 899
Query: 891 GDFGDGVDIVQWSKRA 906
FG+ DIV+++ A
Sbjct: 900 SSFGENKDIVKFAMEA 915
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O49545 | BAME1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5841 | 0.9688 | 0.9611 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00860030 | hypothetical protein (1002 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 995 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.0 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-25 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 581 bits (1499), Expect = 0.0
Identities = 366/981 (37%), Positives = 529/981 (53%), Gaps = 53/981 (5%)
Query: 4 FIVVTLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGI 63
+++ L F LN + + +L++ K +P L +WNSS VC W GI
Sbjct: 11 YLIFMLFFLFLN-----FSMLHAEELELLLSFKSSINDPLKYLSNWNSSA--DVCLWQGI 63
Query: 64 CCSR-DRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLS-SLQFL 119
C+ RV S+DL+ N+ G + + I RL + ++L+ N +G I +I S SL++L
Sbjct: 64 TCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL 123
Query: 120 NISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIP 179
N+SNN F+G + S+ NLE D NN + +P I LK LDLGGN GKIP
Sbjct: 124 NLSNNNFTGSIP--RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
Query: 180 NSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVH 239
NS L LE+L+LA N L G+IP ELG + +L+ IYLGY N+ G IP E+G L +L H
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL-SGEIPYEIGGLTSLNH 240
Query: 240 LDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEI 299
LDL L G IP +GNLK L +FL+ N LSG IP + +L L++LDLS+N+L+GEI
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 300 PYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQV 359
P I L+ L++ +LF N G IP L LP L+ L LW N F+G IP+NLG++ L V
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360
Query: 360 LDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSI 419
LDLS+N LTG IP LCSS L LIL N L G IP+ LGAC SL RVRL N +G +
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 420 PDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSS 479
P F LP + ++ +N L G + N P L L+L+ N G LP
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRI--NSRKWDMP-SLQMLSLARNKFFGGLP-DSFGSKR 476
Query: 480 LQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLS 539
L+ L LS NQFSG +P +G L ++++L LS N LSGEIP + C L LD+S N LS
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536
Query: 540 GSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVF 599
G IP S + +L+ L+LS+N L+ IPK++G+++SL + S N G LP +G F
Sbjct: 537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAI 596
Query: 600 NASSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGD-FKLIFALGLLICSLIFATAAII-- 656
NAS+ AGN LCG + + P + K P F + LG + + A +
Sbjct: 597 NASAVAGNIDLCG---GDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIR 653
Query: 657 --KAKSFKKTGSD--SWKMTAFQK---LEFSVSDILECVKDGNVIGRGGAGIVYHGK-MP 708
K+ ++ +W++ F +++DIL +K+ NVI RG G Y GK +
Sbjct: 654 GRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIK 713
Query: 709 NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNG 768
NG++ VK+ + + +EI +G ++H NIV+L+ C +++ L++EY+
Sbjct: 714 NGMQFVVKE-----INDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768
Query: 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH 828
+L E L L W R KIAI AK L +LH CSP +V ++ I+++ E H
Sbjct: 769 NLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH 823
Query: 829 VADFGLAKFLIDGGASECMSAIAG-SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGR 887
+ L L C S Y+APE T + EKSD+Y FG++L+ELLTG+
Sbjct: 824 LR-LSLPGLL-------CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGK 875
Query: 888 RPV-GDFGDGVDIVQWSKRA-TNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENS 945
P +FG IV+W++ ++ + ++ V + E + ++ +A+ C +
Sbjct: 876 SPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDP 935
Query: 946 IERPRMREVVQMLSEFPRHSS 966
RP +V++ L R SS
Sbjct: 936 TARPCANDVLKTLESASRSSS 956
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 79/282 (28%), Positives = 124/282 (43%), Gaps = 35/282 (12%)
Query: 688 VKDGNVIGRGGAGIVYHGK-----MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH 742
+ G +G G G VY G VE+AVK L + F E + + + H
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
NIV+LL C+ +E ++V EYM G L + L + L + A++ A+G+ YL
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG---ASECMSAIAGSYGYIAP 859
+HRD+ + N L+ ++DFGL++ L D I ++AP
Sbjct: 121 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAP 173
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
E + KSDV+SFGV+L E+ T G P +++++ K G
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM-SNAEVLEYLK---KGY-------- 221
Query: 919 DPRLSMVPK-EEAMHLLFVAML-CIQENSIERPRMREVVQML 958
RL P ++ L ML C E+ +RP E+V++L
Sbjct: 222 --RLPKPPNCPPELYKL---MLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 80/285 (28%), Positives = 125/285 (43%), Gaps = 42/285 (14%)
Query: 688 VKDGNVIGRGGAGIVYHGK-----MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH 742
+ G +G G G VY GK VE+AVK L + F E + + + H
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
N+V+LL C+ +E +V EYM G L L + L + A++ A+G+ YL
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARGMEYLE 119
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG---ASECMSAIAGSYGYIAP 859
+HRD+ + N L+ ++DFGL++ L D I ++AP
Sbjct: 120 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAP 172
Query: 860 E----YAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEF 914
E +T KSDV+SFGV+L E+ T G +P +++++ K
Sbjct: 173 ESLKEGKFT----SKSDVWSFGVLLWEIFTLGEQPYPGM-SNEEVLEYLK------NGYR 221
Query: 915 LSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQML 958
L P+ P E L+ ML C E+ +RP E+V++L
Sbjct: 222 L----PQPPNCPPE-----LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 74/270 (27%), Positives = 115/270 (42%), Gaps = 21/270 (7%)
Query: 689 KDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
+ +G G G VY + G +A+K + EI+ L ++H NIVR
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
L +++ LV EY G L + L K+G R+ + L YLH
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARF-YLRQILSALEYLHSKG-- 117
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
IVHRD+K NILL+ +ADFGLA+ L G ++ G+ Y+APE
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGKGY 173
Query: 868 DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927
+ D++S GV+L ELLTG+ P F +++ K+ + P +
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP---FPGDDQLLELFKKIGKPKPP-----FPPPEWDIS- 224
Query: 928 EEAMHLLFVAMLCIQENSIERPRMREVVQM 957
EA L+ + ++ +R E +Q
Sbjct: 225 PEAKDLI---RKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 41/282 (14%)
Query: 691 GNVIGRGGAGIVYHGKM-----PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
G +G G G VY G + ++AVK L + F E + + H NI
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH-HD 804
VRLL C+ E +V EYM G L + L L ++A++ AKG+ YL +
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLESKN 122
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG----ASECMSAIAGSYGYIAPE 860
VHRD+ + N L+ ++DFGL++ + + I ++APE
Sbjct: 123 F----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPE 174
Query: 861 YAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919
+ KSDV+SFGV+L E+ T G +P G+ + + +G
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY----PGMSNEEVLELLEDGY--------- 221
Query: 920 PRLSMVPK---EEAMHLLFVAMLCIQENSIERPRMREVVQML 958
RL P+ +E L+ + C + +RP E+V+ L
Sbjct: 222 -RLPR-PENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 91/273 (33%), Positives = 127/273 (46%), Gaps = 31/273 (11%)
Query: 693 VIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDH-GFRAEIQTLGNIRHRNIVRLLA 750
+G G G VY K G +AVK L S R EI+ L + H NIVRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
+K+ LV EY G L + L L + KIA++ +GL YLH + I+
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSNG---II 120
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE-YAYTLRVDE 869
HRD+K NILL+ +ADFGLAK L+ +S ++ G+ Y+APE
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLL--KSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 870 KSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL-SMVPK- 927
K DV+S GV+L ELLTG+ P +S + + IL P L PK
Sbjct: 179 KVDVWSLGVILYELLTGKPP------------FSGENILDQLQLIRRILGPPLEFDEPKW 226
Query: 928 ----EEAMHLLFVAMLCIQENSIERPRMREVVQ 956
EEA L+ C+ ++ +RP E++Q
Sbjct: 227 SSGSEEAKDLIKK---CLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 67/193 (34%), Positives = 98/193 (50%), Gaps = 9/193 (4%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC 752
+G GG G VY + G ++A+K + + S EI+ L + H NIV+L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 753 SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHR 812
++ LV EY GSL + L + L + +I ++ +GL YLH S I+HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 813 DVKSNNILLNSA-FEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE-YAYTLRVDEK 870
D+K NILL+S + +ADFGL+K L + I G+ Y+APE EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 871 SDVYSFGVVLLEL 883
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 80/284 (28%), Positives = 117/284 (41%), Gaps = 40/284 (14%)
Query: 692 NVIGRGGAGIVYHGKM----PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
+G G G VY GK+ E+AVK L + F E + + + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAF-------LGWNLRYKIAIEAAKGLCY 800
LL C+ +E LV EYM G L + L + F L AI+ AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG----ASECMSAIAGSYGY 856
L S VHRD+ + N L+ ++DFGL++ + D + I +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915
+APE KSDV+SFGV+L E+ T G P G+ + + G +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP----GLSNEEVLEYLRKGYRLPKP 229
Query: 916 SILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQML 958
L + ML C Q + +RP E+V+ L
Sbjct: 230 EYCPDELYEL------------MLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 69/211 (32%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 687 CVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRN 744
+ IG+GG G VY + G E+A+K + L EIQ L +H N
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII--NEIQILKKCKHPN 58
Query: 745 IVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH 803
IV+ K+ L +V E+ GSL + L + Y + E KGL YLH
Sbjct: 59 IVKYYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-VCKELLKGLEYLH- 115
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAY 863
S I+HRD+K+ NILL S E + DFGL+ L D A M G+ ++APE
Sbjct: 116 --SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPEVIN 170
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRPVGDFG 894
D K+D++S G+ +EL G+ P +
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPYSELP 201
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 2e-35
Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 11/215 (5%)
Query: 691 GNVIGRGGAGIVYHGKMP-NGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRL 748
G ++GRG G VY G +AVK + L + EI+ L +++H NIVR
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 749 LAFCSNKETN-LLVY-EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH-HDC 805
++E N L ++ EY+ GSL L K G +R K + +GL YLH +
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIR-KYTRQILEGLAYLHSNG- 121
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
IVHRD+K NIL++S +ADFG AK L D E ++ G+ ++APE
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 866 RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIV 900
+D++S G ++E+ TG+ P + G+ + +
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 75/215 (34%), Positives = 111/215 (51%), Gaps = 28/215 (13%)
Query: 685 LECVKDGNVIGRGGAGIVY---HGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR 741
LE VK V+G+G +G+VY H P G A+KK+ G E++TL +
Sbjct: 3 LERVK---VLGQGSSGVVYKVRH--KPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57
Query: 742 HRNIVRLL-AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
+V+ AF E ++ V EYM GSL + L K G L Y IA + KGL Y
Sbjct: 58 SPYVVKCYGAFYKEGEISI-VLEYMDGGSLAD-LLKKVGKIPEPVLAY-IARQILKGLDY 114
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE 860
LH I+HRD+K +N+L+NS E +ADFG++K L + +C + + G+ Y++PE
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFV-GTVTYMSPE 170
Query: 861 ------YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y+Y +D++S G+ LLE G+ P
Sbjct: 171 RIQGESYSY------AADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (308), Expect = 4e-30
Identities = 84/303 (27%), Positives = 120/303 (39%), Gaps = 22/303 (7%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLL--GFGTHSHDHGFRAEIQTLGNIRH-RNIVR 747
+G G G VY + + +A+K L F EIQ L ++ H NIV+
Sbjct: 5 LRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEAL-HGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
L F ++ + LV EY+ GSL + L + L + I + L YLH S
Sbjct: 63 LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---S 119
Query: 807 PLIVHRDVKSNNILLNS-AFEAHVADFGLAKFLIDGGAS----ECMSAIAGSYGYIAPEY 861
I+HRD+K NILL+ + DFGLAK L D G++ S G+ GY+APE
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 862 AYTL---RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
L SD++S G+ L ELLTG P + Q K S L
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQSSSSSLKN 978
P + + A LL + ++ R + + H S LK
Sbjct: 240 SPSNPELISKAASDLL---KKLLAKDPKNRLSSSSD--LSHDLLAHLKLKESDLSDLLKP 294
Query: 979 LEK 981
+
Sbjct: 295 DDS 297
|
Length = 384 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 72/200 (36%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
+G G G V+ G ++AVK L GT S + F E Q + +RH +V+L A CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
+E +V EYM GSL + L +G L +A + A+G+ YL S +HRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRD 128
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA---IAGSYGYIAPEYAYTLRVDEK 870
+ + NIL+ +ADFGLA+ + D + A I + APE A R K
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK----WTAPEAANYGRFTIK 184
Query: 871 SDVYSFGVVLLELLT-GRRP 889
SDV+SFG++L E++T GR P
Sbjct: 185 SDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 63/195 (32%), Positives = 93/195 (47%), Gaps = 6/195 (3%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
+G G G V+ G N V +A+K L F+ E+Q L +RH++++ L A
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD-FQKEVQALKRLRHKHLISLFA 69
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
CS E ++ E M GSL L +G L +A + A+G+ YL +
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSI 126
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEK 870
HRD+ + NIL+ VADFGLA+ + + I Y + APE A K
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTK 184
Query: 871 SDVYSFGVVLLELLT 885
SDV+SFG++L E+ T
Sbjct: 185 SDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 70/197 (35%), Positives = 99/197 (50%), Gaps = 7/197 (3%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
+G G G V+ G N +AVK L GT F AE Q + +RH +++L A C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKD-FLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
+E +V E M+ GSL E L G G L +A + A G+ YL + +HRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDV 873
+ + N+L+ VADFGLA+ +I E + APE A R KSDV
Sbjct: 129 LAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 874 YSFGVVLLELLT-GRRP 889
+SFG++L E++T GR P
Sbjct: 188 WSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 691 GNVIGRGGAGIVYHG-KMPNGVEIAVKK--LLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
G++IGRG G+VY G + G +A+K+ L + EI L N++H NIV+
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALK-SIMQEIDLLKNLKHPNIVK 63
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
+ ++ ++ EY NGSL + + KK +L + +GL YLH
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHEQG-- 119
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
++HRD+K+ NIL +ADFG+A L D S+ +++ G+ ++APE
Sbjct: 120 -VIHRDIKAANILTTKDGVVKLADFGVATKLND--VSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 868 DEKSDVYSFGVVLLELLTGRRPVGD 892
SD++S G ++ELLTG P D
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 71/272 (26%), Positives = 122/272 (44%), Gaps = 35/272 (12%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
+G G G+V+ GK +++A+K ++ G S D F E + + + H N+V+L C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDD-FIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAF-LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHR 812
+ +V EYM NG L L +KG W L + + + + YL + +HR
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL--DMCSDVCEAMEYLESNG---FIHR 124
Query: 813 DVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY--GYIAPEYAYTLRVDEK 870
D+ + N L+ V+DFGLA++++D + S+ + + PE R K
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLD---DQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 871 SDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLS---ILDPRLSMVP 926
SDV+SFGV++ E+ + G+ P F +N E +S L P
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERF-------------SNSEVVESVSAGYRLYR-----P 223
Query: 927 KEEAMHLLFVAMLCIQENSIERPRMREVVQML 958
K + + C E +RP ++++ L
Sbjct: 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 86/285 (30%), Positives = 133/285 (46%), Gaps = 31/285 (10%)
Query: 687 CVKDGNVIGRGGAGIVYHG--KMPNGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNIRH 742
CVK VIG G G V G K+P EI A+K L T F +E +G H
Sbjct: 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
NI+ L + +++ E+M NG+L L G F L + A G+ YL
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-VGMLRGIAAGMKYLS 123
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC-MSAIAGSYG--YIAP 859
+ + VHRD+ + NIL+NS V+DFGL++FL D + S++ G + AP
Sbjct: 124 -EMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
E + SDV+S+G+V+ E+++ G RP D + D++ N ++++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVI-------NAIEQDY---- 228
Query: 919 DPRLSMVPK-EEAMHLLFVAML-CIQENSIERPRMREVVQMLSEF 961
RL A+H L ML C Q++ RP+ ++V L +
Sbjct: 229 --RLPPPMDCPTALHQL---MLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 40/288 (13%)
Query: 687 CVKDGNVIGRGGAGIVYHG--KMPNGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNIRH 742
V VIG G G V G K+P EI A+K L + F E +G H
Sbjct: 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH 64
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
NI+RL + +++ EYM NGSL + L G F L + A G+ YL
Sbjct: 65 PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL-VGMLRGIASGMKYLS 123
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG-GASECMSAIAGSYGYI---- 857
VHRD+ + NIL+NS V+DFGL++ L D G I
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG------GKIPIRW 174
Query: 858 -APEYAYTLRV-DEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEF 914
APE A R SDV+SFG+V+ E+++ G RP D S ++
Sbjct: 175 TAPE-AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD---------MS-------NQDV 217
Query: 915 LSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEF 961
+ ++ + P + L+ ML C Q++ ERP ++V L +
Sbjct: 218 IKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHG-----FRAEIQTLGNIRHRNI 745
G IG+G G V G G ++AVK L D F AE + +RH N+
Sbjct: 11 GATIGKGEFGDVMLGDY-RGQKVAVKCL-------KDDSTAAQAFLAEASVMTTLRHPNL 62
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
V+LL +V EYM GSL + L + A + + A++ +G+ YL
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--- 119
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY--GYIAPEYAY 863
VHRD+ + N+L++ A V+DFGLAK +G + APE
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALR 172
Query: 864 TLRVDEKSDVYSFGVVLLELLT-GRRP 889
+ KSDV+SFG++L E+ + GR P
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 71/286 (24%), Positives = 120/286 (41%), Gaps = 36/286 (12%)
Query: 689 KDGNVIGRGGAGIVYHG-----KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHR 743
+ V+G G G VY G + +A+K L + + E + ++ H
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHP 69
Query: 744 NIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL-- 801
++VRLL C + L+ + M G L + + K +G ++ AKG+ YL
Sbjct: 70 HVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKGMSYLEE 127
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY--GYIAP 859
+VHRD+ + N+L+ + + DFGLAK L+D E A G ++A
Sbjct: 128 KR-----LVHRDLAARNVLVKTPQHVKITDFGLAK-LLDVDEKE-YHAEGGKVPIKWMAL 180
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
E KSDV+S+GV + EL+T G +P +G+ V+ G + I
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPY----EGIPAVEIPDLLEKGERLPQPPIC 236
Query: 919 DPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPR 963
+ MV ++ C ++ RP +E++ S+ R
Sbjct: 237 TIDVYMV------------LVKCWMIDAESRPTFKELINEFSKMAR 270
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 83/281 (29%), Positives = 128/281 (45%), Gaps = 25/281 (8%)
Query: 687 CVKDGNVIGRGGAGIVYHG--KMPNGVE--IAVKKLLGFGTHSHDHGFRAEIQTLGNIRH 742
+ VIG G G V+ G KMP E +A+K L T F +E +G H
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
NI+RL + + +++ EYM NG+L + L G F + L + AA G+ YL
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAA-GMKYL- 123
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG-GASECMSAIAGSYGYIAPEY 861
D + VHRD+ + NIL+NS E V+DFGL++ L D + S + APE
Sbjct: 124 SDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 862 AYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920
+ SDV+SFG+V+ E+++ G RP D + E +I D
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---------------HEVMKAINDG 226
Query: 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961
P + + + + C Q++ RPR ++V +L +
Sbjct: 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
VIG G +VY +PN ++A+K++ L S D R E+Q + H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE-LRKEVQAMSQCNHPNVVK-- 63
Query: 750 AFCSNKETNLL--VYEYMRNGSLGEAL-HGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
+ S + L V Y+ GSL + + L + + E KGL YLH S
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---S 120
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS--AIAGSYGYIAPEYAYT 864
+HRD+K+ NILL +ADFG++ L DGG G+ ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 865 LR-VDEKSDVYSFGVVLLELLTGRRP 889
+ D K+D++SFG+ +EL TG P
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 85/276 (30%), Positives = 126/276 (45%), Gaps = 35/276 (12%)
Query: 692 NVIGRGGAGIVYHGKM---PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRL 748
+G G +G+V K+ P G +AVK + + E+ L IV
Sbjct: 7 GELGAGNSGVVS--KVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 749 L-AFCSNKETNLLVYEYMRNGSLGEALHGKKGAF----LGWNLRYKIAIEAAKGLCYLHH 803
AF +N + ++ + EYM GSL + L +G LG KIA+ KGL YLH
Sbjct: 65 YGAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE 118
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAY 863
I+HRDVK +NIL+NS + + DFG++ L++ A G+ Y+APE
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQ 172
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD-IVQWSKRATNGRKEEFLSILDPRL 922
KSD++S G+ L+EL TGR P D D I + + N PRL
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--------PRL 224
Query: 923 -SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957
S + FV LC+ ++ ERP +E+++
Sbjct: 225 PSGKFSPDFQD--FVN-LCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 71/197 (36%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
+G+G G V+ G +A+K L GT S + F E Q + +RH +V+L A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
+E +V EYM GSL + L G+ G +L +A + A G+ Y+ VHRD
Sbjct: 72 -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 127
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDV 873
+++ NIL+ VADFGLA+ LI+ + APE A R KSDV
Sbjct: 128 LRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 874 YSFGVVLLELLT-GRRP 889
+SFG++L EL T GR P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 67/211 (31%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 692 NVIGRGGAGIVYHGKMPN-----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
+G G G V + G ++AVK L G H F EI+ L + H NIV
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 747 RLLAFCSNKETN--LLVYEYMRNGSLGEALHGKKGAF-LGWNLRYKIAIEAAKGLCYLHH 803
+ C L+ EY+ +GSL + L + L L + I KG+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI--CKGMDYLG- 126
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG-----GASECMSAIAGSYGYIA 858
S +HRD+ + NIL+ S ++DFGLAK L + S I + A
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----WYA 180
Query: 859 PEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
PE T + SDV+SFGV L EL T P
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 70/215 (32%), Positives = 114/215 (53%), Gaps = 19/215 (8%)
Query: 691 GNVIGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHDH---------GFRAEIQTLGNI 740
G +IG+G G VY + G +AVK++ T + H R+EI+TL ++
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 741 RHRNIVRLLAFCSNKETNLLVY-EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLC 799
H NIV+ L F E L ++ EY+ GS+G L G F +R+ + +GL
Sbjct: 66 DHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLR-TYGRFEEQLVRF-FTEQVLEGLA 122
Query: 800 YLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAP 859
YLH S I+HRD+K++N+L+++ ++DFG++K D ++ ++ GS ++AP
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 860 EYAYTLR--VDEKSDVYSFGVVLLELLTGRRPVGD 892
E ++ K D++S G V+LE+ GRRP D
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 36/223 (16%)
Query: 693 VIGRGGAGIVYHGKMPNGVE------IAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
+G G G V+ G+ + +AVK L ++ F E + L N +H NIV
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEAL--HGKKGAFLGWNLR----------YKIAIEA 794
+ C+ + ++V+EYM +G L + L HG AFL +IA++
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 795 AKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK-------FLIDGGASECM 847
A G+ YL S VHRD+ + N L+ + DFG+++ + + G M
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT---M 185
Query: 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRP 889
I ++ PE + +SDV+SFGVVL E+ T G++P
Sbjct: 186 LPIR----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 70/279 (25%), Positives = 106/279 (37%), Gaps = 36/279 (12%)
Query: 694 IGRGGAGIVYHG--KMPNG--VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
+G G G+V G G + +AVK L F E + ++ H N++RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLI 809
++V E GSL + L + A++ A G+ YL S
Sbjct: 63 GVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRF 118
Query: 810 VHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA-----IAGSYGYIAPEYAYT 864
+HRD+ + NILL S + + DFGL + L M A + APE T
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA----WCAPESLRT 174
Query: 865 LRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923
SDV+ FGV L E+ T G P W+ +G + L +D
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP------------WAGL--SG--SQILKKIDKEGE 218
Query: 924 MVPKEEAMHLLFVAML--CIQENSIERPRMREVVQMLSE 960
+ + EA ++ C N +RP + + L E
Sbjct: 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 5e-21
Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 21/208 (10%)
Query: 692 NVIGRGGAGIVY---HGKMPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
IG+G G VY +G +K++ L + E++ L + H NI++
Sbjct: 6 KQIGKGSFGKVYLVRRKS--DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALH--GKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
K +V EY G L + + K+G ++ L YLH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--- 120
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE----Y 861
S I+HRD+K NI L S + DFG++K L + + G+ Y++PE
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLSPELCQNK 178
Query: 862 AYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y + KSD++S G VL EL T + P
Sbjct: 179 PY----NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 70/270 (25%), Positives = 109/270 (40%), Gaps = 28/270 (10%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
IG+G G VY G + E+AVK F E + L H NIV+L+ C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
K+ +V E + GSL L KK L +++++AA G+ YL +HRD
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL-LQMSLDAAAGMEYLESKNC---IHRD 118
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-----APEYAYTLRVD 868
+ + N L+ ++DFG+++ G + ++ I APE R
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGG-----IYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 869 EKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKE 928
+SDV+S+G++L E + GD S + T R E + P+L
Sbjct: 174 SESDVWSYGILLWETFS-------LGDT-PYPGMSNQQTRERIESGYRMPAPQLCPEEIY 225
Query: 929 EAMHLLFVAMLCIQENSIERPRMREVVQML 958
M + C + RP E+ L
Sbjct: 226 RLM------LQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 83/283 (29%), Positives = 126/283 (44%), Gaps = 35/283 (12%)
Query: 687 CVKDGNVIGRGGAGIVYHG--KMPNGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNIRH 742
C+K VIG G G V G K+P EI A+K L T F +E +G H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
NI+ L + + ++V EYM NGSL L G F L + A G+ YL
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-VGMLRGIASGMKYL- 122
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI----- 857
D VHRD+ + NIL+NS V+DFGL++ L D + +A G I
Sbjct: 123 SDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLED----DPEAAYTTRGGKIPIRWT 176
Query: 858 APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916
APE + SDV+S+G+V+ E+++ G RP + + ++ +
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----------------QDVIK 220
Query: 917 ILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQML 958
++ + + L ML C Q++ ERP+ ++V +L
Sbjct: 221 AIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 31/276 (11%)
Query: 689 KDGNVIGRGGAGIVYHG-KMPNGVEIAVKKL----LGFGTHSHDHGFRAEIQTLGNIRHR 743
+ G ++G+G G VY + G E+AVK++ T + EIQ L N++H
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 744 NIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH 803
IV+ + ET + EYM GS+ + L K L + K + +G+ YLH
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLH- 121
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL----IDGGASECMSAIAGSYGYIAP 859
S +IVHRD+K NIL +SA + DFG +K L G M ++ G+ +++P
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTG---MKSVTGTPYWMSP 176
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919
E K+DV+S G ++E+LT + P +F I + + + TN
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN----------- 225
Query: 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVV 955
P+L P + EN+ +RP E++
Sbjct: 226 PQL---PSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLL-----GFGTHSHDHGFRAEIQTLGNIRHRNI 745
G V+G+G G VY G G IAVK++ + E+ L +++H NI
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
V+ L C + T + E++ GS+ L+ + G K + G+ YLH++C
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFC-KYTKQILDGVAYLHNNC 122
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL----IDGGASECMSAIAGSYGYIAPEY 861
+VHRD+K NN++L + DFG A+ L + G S + ++ G+ ++APE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 862 AYTLRVDEKSDVYSFGVVLLELLTGRRP 889
KSD++S G + E+ TG+ P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 36/222 (16%)
Query: 683 DILECVKDGNVIGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR 741
DILE +G G G VY G +A+K + EI L
Sbjct: 6 DILEK------LGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCD 56
Query: 742 HRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAA----- 795
IV+ K T+L +V EY GS+ + + + K E
Sbjct: 57 SPYIVKYYG-SYFKNTDLWIVMEYCGAGSVSDIM----------KITNKTLTEEEIAAIL 105
Query: 796 ----KGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIA 851
KGL YLH S +HRD+K+ NILLN +A +ADFG++ L D A + +
Sbjct: 106 YQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVI 160
Query: 852 GSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDF 893
G+ ++APE + + K+D++S G+ +E+ G+ P D
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
IG G G+V+ G ++A+K + D F E Q + + H +V+L C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED--FIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
+ LV+E+M +G L + L ++G F L + ++ +G+ YL ++HRD
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-LGMCLDVCEGMAYLESSN---VIHRD 125
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY--GYIAPEYAYTLRVDEKS 871
+ + N L+ V+DFG+ +F++D + S+ + + +PE + KS
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLD---DQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 872 DVYSFGVVLLELLT-GRRP 889
DV+SFGV++ E+ + G+ P
Sbjct: 183 DVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 80/276 (28%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
+G G G V+ G ++A+K L G+ S + F AE + ++H +VRL A +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
+E ++ EYM NGSL + L +G L N +A + A+G+ ++ +HRD
Sbjct: 72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRD 127
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY--GYIAPEYAYTLRVDEKS 871
+++ NIL++ +ADFGLA+ + D +E + + + APE KS
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 872 DVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD-----PRLSMV 925
DV+SFG++L E++T GR P TN E + L+ PR
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGM-------------TN---PEVIQNLERGYRMPRPDNC 228
Query: 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961
P+E L + LC +E ERP + +L +F
Sbjct: 229 PEE----LYELMRLCWKEKPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 68/217 (31%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 689 KDGNVIGRGGAGIVYHG-KMPNGVEIAVKKLL----GFGTHSHDHGFRAEIQTLGNIRHR 743
+ G ++G G G VY G + +G AVK++ G EI L ++H
Sbjct: 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 744 NIVRLLAFCSNKETNLLVY-EYMRNGSLGEALHGKKGAFLGWNLR-YKIAIEAAKGLCYL 801
NIV+ L +E NL ++ E + GSL L K G+F +R Y I GL YL
Sbjct: 63 NIVQYLG-TEREEDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQI--LLGLEYL 118
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY 861
H VHRD+K NIL+++ +ADFG+AK ++ + GS ++APE
Sbjct: 119 H---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV---EFSFAKSFKGSPYWMAPEV 172
Query: 862 -----AYTLRVDEKSDVYSFGVVLLELLTGRRPVGDF 893
Y L D++S G +LE+ TG+ P
Sbjct: 173 IAQQGGYGLAA----DIWSLGCTVLEMATGKPPWSQL 205
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 67/269 (24%), Positives = 126/269 (46%), Gaps = 27/269 (10%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
+G G G+V+ GK +++A+K + G S + F E + + + H +V+L C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEED-FIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
++ +V E+M NG L L ++G ++ + + +G+ YL + +HRD
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKL-SKDMLLSMCQDVCEGMEYLERNS---FIHRD 125
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY--GYIAPEYAYTLRVDEKS 871
+ + N L++S V+DFG+ ++++D E S+ + + PE + KS
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLD---DEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 872 DVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEA 930
DV+SFGV++ E+ T G+ P + ++V+ R RL PK +
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSN-YEVVEMISRGF-------------RLYR-PKLAS 227
Query: 931 MHLLFVAMLCIQENSIERPRMREVVQMLS 959
M + V C E RP E+++ ++
Sbjct: 228 MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 692 NVIGRGGAGIVYHG-KMPNGVEIAVKK--LLGFGTHSHDHGFRAEIQTLGNIRHRNIVRL 748
N IG+G G+V+ + + A+K+ L + E + L + I+R
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSSYIIRY 64
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
+K +V EY NG L + L ++G L + ++ I+ GL +LH S
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKK 121
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVD 868
I+HRD+KS N+ L++ + D G+AK L + + I G+ Y++PE +
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 869 EKSDVYSFGVVLLELLTGRRP 889
EKSDV++ GVVL E TG+ P
Sbjct: 180 EKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 70/197 (35%), Positives = 99/197 (50%), Gaps = 8/197 (4%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
+G G G V+ G ++AVK L GT S + F E Q + +RH +V+L A S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPE-SFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
+E +V EYM GSL + L +G L +A + A G+ Y+ +HRD
Sbjct: 72 -EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDV 873
++S NIL+ +ADFGLA+ LI+ + APE A R KSDV
Sbjct: 128 LRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 874 YSFGVVLLELLT-GRRP 889
+SFG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 82/282 (29%), Positives = 120/282 (42%), Gaps = 39/282 (13%)
Query: 692 NVIGRGGAGIVYHGKM----PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
VIG+G G VYHG + + AVK L F E + + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 748 LLAFCSNKE-TNLLVYEYMRNGSLGEALHGKK-----GAFLGWNLRYKIAIEAAKGLCYL 801
LL C E + L+V YM++G L + + +G+ L + AKG+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL------QVAKGMEYL 114
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY--GYIAP 859
S VHRD+ + N +L+ +F VADFGLA+ + D + ++A
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
E T + KSDV+SFGV+L EL+T G P D D DI + + + E+
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVYLLQGRRLLQPEYCP-- 228
Query: 919 DPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLS 959
DP L+ ML C RP E+V +
Sbjct: 229 DP-------------LYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 691 GNVIGRGGAGIVYHG-KMPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRL 748
GN IG G G VY + G +AVK++ + E++ L ++H N+V+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
++E + EY G+L E L + Y ++ +GL YLH S
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY--TLQLLEGLAYLH---SHG 119
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS--ECMSAIAGSYGYIAPEYAYTLR 866
IVHRD+K NI L+ + DFG A L + + E + ++AG+ Y+APE +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 867 VDEK---SDVYSFGVVLLELLTGRRP 889
+D++S G V+LE+ TG+RP
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHS--HDHGFRAEIQTLGNIRHR 743
E + + + +G G G V ++ N I K + + R E++ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSP 59
Query: 744 NIVRLL-AFCSNKETNL-LVYEYMRNGSLGEALHG---KKGAFLGWNLRYKIAIEAAKGL 798
IV+ AF +++ + EY GSL ++++ K+G +G + KIA KGL
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 799 CYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIA 858
YLH S I+HRD+K +NILL + + DFG++ L++ A + S+ Y+A
Sbjct: 119 SYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFTGTSF-YMA 171
Query: 859 PEY----AYTLRVDEKSDVYSFGVVLLELLTGRRP 889
PE Y++ SDV+S G+ LLE+ R P
Sbjct: 172 PERIQGKPYSIT----SDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 74/277 (26%), Positives = 121/277 (43%), Gaps = 29/277 (10%)
Query: 694 IGRGGAGIVYHG--KMPNGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
+G G G V G M +G E+ AVK L + F E + + H IVRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLI 809
C E +LV E G L + L K+ +L+ ++A + A G+ YL S
Sbjct: 63 GVCKG-EPLMLVMELAPLGPLLKYLK-KRREIPVSDLK-ELAHQVAMGMAYLE---SKHF 116
Query: 810 VHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY--GYIAPEYAYTLRV 867
VHRD+ + N+LL + +A ++DFG+++ L G+ + AG + + APE +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRAL-GAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 868 DEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926
KSDV+S+GV L E + G +P G+ G +++ + R P
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIA--MLESGERLPR------------P 220
Query: 927 KEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963
+E + + + C + +RP E+ P
Sbjct: 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 6e-19
Identities = 52/141 (36%), Positives = 80/141 (56%), Gaps = 9/141 (6%)
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLI 809
AF S+ E ++ + E+M GSL + L KK + N+ KI+I +GL YL I
Sbjct: 67 AFYSDGEISICM-EHMDGGSLDQVL--KKAGRIPENILGKISIAVLRGLTYLREKHK--I 121
Query: 810 VHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDE 869
+HRDVK +NIL+NS E + DFG++ LID A ++ G+ Y++PE
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTV 177
Query: 870 KSDVYSFGVVLLELLTGRRPV 890
+SD++S G+ L+E+ GR P+
Sbjct: 178 QSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 689 KDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
K+ IG G +G VY G E+A+KK+ + + EI + + +H NIV
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIIN-EILIMKDCKHPNIVD 79
Query: 748 LL-AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
++ E +V EYM GSL + + + Y + E +GL YLH S
Sbjct: 80 YYDSYLVGDEL-WVVMEYMDGGSLTDIITQNFVRMNEPQIAY-VCREVLQGLEYLH---S 134
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
++HRD+KS+NILL+ +ADFG A L + +++ G+ ++APE
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPYWMAPEVIKRKD 192
Query: 867 VDEKSDVYSFGVVLLELLTGRRP 889
K D++S G++ +E+ G P
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 9e-19
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 29/221 (13%)
Query: 689 KDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD-HGFRAEIQTLGNIRHRNIV 746
+ V+G+G GIVY + + V IA+K++ S EI ++HRNIV
Sbjct: 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIV 68
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLG----WNLRYKIAIEAAKGLCYLH 802
+ L S + E + GSL L K G K +E GL YLH
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE---GLKYLH 125
Query: 803 HDCSPLIVHRDVKSNNILLNS-AFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY 861
+ IVHRD+K +N+L+N+ + ++DFG +K L G + C G+ Y+APE
Sbjct: 126 DN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTETFTGTLQYMAPEV 180
Query: 862 AYTLRVDE-------KSDVYSFGVVLLELLTGRRPVGDFGD 895
+D+ +D++S G ++E+ TG+ P + G+
Sbjct: 181 -----IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 64/199 (32%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC 752
IG+G G V G G ++AVK + T F AE + +RH N+V+LL
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 753 SNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVH 811
++ L +V EYM GSL + L + + LG + K +++ + + YL + VH
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 812 RDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKS 871
RD+ + N+L++ A V+DFGL K AS + APE + KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 872 DVYSFGVVLLELLT-GRRP 889
DV+SFG++L E+ + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 75/220 (34%), Positives = 106/220 (48%), Gaps = 33/220 (15%)
Query: 691 GNVIGRGGAGIVY---HGKMPNGVEIAVKKLLGFGTHSHDHGFR----AEIQTLGNIRHR 743
N IG G G VY H P G A+K + G +H+ R EI+ L ++ H
Sbjct: 79 VNRIGSGAGGTVYKVIH--RPTGRLYALKVIYG----NHEDTVRRQICREIEILRDVNHP 132
Query: 744 NIVRLL-AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
N+V+ F N E +L+ E+M GSL E H FL +A + G+ YLH
Sbjct: 133 NVVKCHDMFDHNGEIQVLL-EFMDGGSL-EGTHIADEQFLA-----DVARQILSGIAYLH 185
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYA 862
IVHRD+K +N+L+NSA +ADFG+++ L C S++ G+ Y++PE
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL-AQTMDPCNSSV-GTIAYMSPERI 240
Query: 863 YTLRVDEK-----SDVYSFGVVLLELLTGRRP--VGDFGD 895
T D++S GV +LE GR P VG GD
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280
|
Length = 353 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 72/274 (26%), Positives = 117/274 (42%), Gaps = 33/274 (12%)
Query: 692 NVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
+ +G G G VY G + +AVK L + F E + I+H N+V+LL
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLG 69
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
C+ + ++ E+M G+L + L + + +A + + + YL +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 126
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGS---YGYIAPEYAYTLRV 867
HRD+ + N L+ VADFGL++ + + +A AG+ + APE +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 868 DEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926
KSDV++FGV+L E+ T G P G+D+ Q + G + E R P
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPY----PGIDLSQVYELLEKGYRME-------RPEGCP 231
Query: 927 KE--EAMHLLFVAMLCIQENSIERPRMREVVQML 958
+ E M C Q N +RP E+ Q
Sbjct: 232 PKVYELMR------ACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
+G G G+V +GK ++A+K ++ G+ S D F E + + + H +V+L C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDE-FIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
+ +V EYM NG L L F L ++ + +G+ YL S +HRD
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLE---SKQFIHRD 125
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY--GYIAPEYAYTLRVDEKS 871
+ + N L++ V+DFGL+++++D E S++ + + PE + KS
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 872 DVYSFGVVLLELLT-GRRP 889
DV++FGV++ E+ + G+ P
Sbjct: 183 DVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 77/280 (27%), Positives = 129/280 (46%), Gaps = 28/280 (10%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
E +K +G G G V+ G N ++AVK L GT S F E + ++H +
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSV-QAFLEEANLMKTLQHDKL 63
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
VRL A + +E ++ EYM GSL + L +G + + + A+G+ Y+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGS---YGYIAPEYA 862
+HRD+++ N+L++ + +ADFGLA+ + D +A G+ + APE
Sbjct: 124 ---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAKFPIKWTAPEAI 176
Query: 863 YTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921
KSDV+SFG++L E++T G+ P + D++ +R PR
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DVMSALQRGYRM----------PR 225
Query: 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961
+ P E L + C +E + ERP + +L +F
Sbjct: 226 MENCPDE----LYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 66/197 (33%), Positives = 98/197 (49%), Gaps = 8/197 (4%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
+G+G G V+ G ++A+K L GT + F E Q + +RH +V L A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
+E +V E+M GSL + L G +L +A + A G+ Y+ +HRD
Sbjct: 72 -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDV 873
+++ NIL+ +ADFGLA+ LI+ + APE A R KSDV
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 874 YSFGVVLLELLT-GRRP 889
+SFG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 11/208 (5%)
Query: 688 VKDGNVIGRGGAGIVYHGK-MPNG----VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH 742
++ ++G G G V+ G +P G + +A+K + + +G++ H
Sbjct: 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH 68
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
IVRLL C L V + GSL + + + + L ++ AKG+ YL
Sbjct: 69 AYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKGMYYLE 126
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYA 862
+VHR++ + NILL S +ADFG+A L S ++A E
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 863 YTLRVDEKSDVYSFGVVLLELLT-GRRP 889
R +SDV+S+GV + E+++ G P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 684 ILECVKDGNVIGRGGAGIVYHGKM--PNGVE----IAVKKLLGFGTHSHDHGFRAEIQTL 737
L V+ +G G G VY G++ PN +A+K L FR E + +
Sbjct: 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELM 62
Query: 738 GNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL-----HGKKGAFLG--------W 784
+++H NIV LL C+ ++ +++EY+ +G L E L H GA G
Sbjct: 63 SDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122
Query: 785 NLRY-KIAIEAAKGLCYL--HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841
+ IAI+ A G+ YL HH VHRD+ + N L+ ++DFGL++ +
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRP 889
S ++ PE + +SD++SFGVVL E+ + G +P
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 71/292 (24%), Positives = 115/292 (39%), Gaps = 53/292 (18%)
Query: 694 IGRGGAGIVYHGKMPN------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
+G+G G+VY G +A+K + + F E + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 748 LLAFCSNKETNLLVYEYMRNGSLG--------EALHGKKGAFLGWNLRYKIAIEAAKGLC 799
LL S + L+V E M G L EA + ++A E A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 800 YLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK-------FLIDGGASECMSAIAG 852
YL + VHRD+ + N ++ + DFG+ + + G + +
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG---LLPVR- 186
Query: 853 SYGYIAPEYAYTLR---VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG 909
++APE +L+ KSDV+SFGVVL E+ T + Q + +N
Sbjct: 187 ---WMAPE---SLKDGVFTTKSDVWSFGVVLWEMAT-------LAE-----QPYQGLSN- 227
Query: 910 RKEEFLS-ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
EE L ++D +P+ LL + +C Q N RP E+V L +
Sbjct: 228 --EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 70/233 (30%), Positives = 116/233 (49%), Gaps = 23/233 (9%)
Query: 689 KDGNVIGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHD-----HGFRAEIQTLGNIRH 742
+ G ++G+G G VY + G E+A K++ F S + EIQ L N++H
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQV-QFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 743 RNIVRLLAFCSNK-ETNLLVY-EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
IV+ ++ E L ++ EYM GS+ + L K L ++ K + +G+ Y
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSY 121
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS-----AIAGSYG 855
LH S +IVHRD+K NIL +SA + DFG +K L + CMS ++ G+
Sbjct: 122 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICMSGTGIRSVTGTPY 174
Query: 856 YIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN 908
+++PE K+DV+S G ++E+LT + P ++ I + + + TN
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 71/269 (26%), Positives = 113/269 (42%), Gaps = 42/269 (15%)
Query: 713 IAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSL-- 770
+AVK L + + F E++ L + NI RLL C+ ++ EYM NG L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 771 ---------GEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL 821
K L Y +A + A G+ YL S VHRD+ + N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFS-TLLY-MATQIASGMRYLE---SLNFVHRDLATRNCLV 163
Query: 822 NSAFEAHVADFGLAKFL-------IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVY 874
+ +ADFG+++ L + G A I ++A E + KSDV+
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRA---PLPIR----WMAWESVLLGKFTTKSDVW 216
Query: 875 SFGVVLLELLT--GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMH 932
+FGV L E+LT +P D +++ A + +++ I PR PK+
Sbjct: 217 AFGVTLWEILTLCREQPYEHLTDQ-QVIE---NAGHFFRDDGRQIYLPRPPNCPKD---- 268
Query: 933 LLFVAML-CIQENSIERPRMREVVQMLSE 960
++ ML C + + +RP RE+ L
Sbjct: 269 -IYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 71/239 (29%), Positives = 114/239 (47%), Gaps = 23/239 (9%)
Query: 691 GNVIGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHD-----HGFRAEIQTLGNIRHRN 744
G ++GRG G VY G E+AVK++ F S + + EIQ L N+RH
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQV-PFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 745 IVRLLAFCSNKETNLL--VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
IV+ + E L EYM GS+ + L K L N+ + + +G+ YLH
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVSYLH 123
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS-----AIAGSYGYI 857
S +IVHRD+K NIL +SA + DFG +K + + CMS ++ G+ ++
Sbjct: 124 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI----QTICMSGTGIKSVTGTPYWM 176
Query: 858 APEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916
+PE K+DV+S ++E+LT + P ++ I + + + T + +S
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 62/204 (30%), Positives = 88/204 (43%), Gaps = 17/204 (8%)
Query: 692 NVIGRGGAGIVYH-GKMPNGVEIAVK---KLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
VIG+G G V K A+K K S + E + L + H +V
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN-ERRILQELNHPFLVN 64
Query: 748 L-LAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
L +F E N+ LV + + G L L +K F +++ I E L YLH
Sbjct: 65 LWYSFQD--EENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWIC-EIVLALEYLH--- 117
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
S I+HRD+K +NILL+ H+ DF +A + + S G+ GY+APE
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQ 174
Query: 866 RVDEKSDVYSFGVVLLELLTGRRP 889
D +S GV E L G+RP
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 60/164 (36%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 731 RAEIQTLGNIRHRNIVRLL-AFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRY 788
E L I H IV+L AF + E L LV EY G L L K+G F R+
Sbjct: 41 LTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGGELFSHLS-KEGRFSEERARF 97
Query: 789 KIAIEAAKGLCYLH-HDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASE 845
A E L YLH I++RD+K NILL++ + H+ DFGLAK L G+
Sbjct: 98 YAA-EIVLALEYLHSLG----IIYRDLKPENILLDA--DGHIKLTDFGLAKELSSEGSR- 149
Query: 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ G+ Y+APE + D +S GV+L E+LTG+ P
Sbjct: 150 -TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 69/231 (29%), Positives = 113/231 (48%), Gaps = 23/231 (9%)
Query: 691 GNVIGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHD-----HGFRAEIQTLGNIRHRN 744
G ++G+G G VY G E+AVK++ F S + + EIQ L N+ H
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQV-QFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 745 IVRLLAFCSN-KETNLLVY-EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
IV+ + E L ++ E+M GS+ + L K L N+ K + +G+ YLH
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYLH 123
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS-----AIAGSYGYI 857
S +IVHRD+K NIL +S + DFG +K L + C+S ++ G+ ++
Sbjct: 124 ---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL----QTICLSGTGMKSVTGTPYWM 176
Query: 858 APEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN 908
+PE K+D++S G ++E+LT + P +F I + + + TN
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 81/288 (28%), Positives = 122/288 (42%), Gaps = 43/288 (14%)
Query: 685 LECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHR 743
LE + D +G G G V K +P G +A K + S E+Q + R
Sbjct: 7 LETISD---LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSP 63
Query: 744 NIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL-- 801
IV N+ + E+M GSL KKG + + KIA+ +GL YL
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 802 -HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE 860
H I+HRD+K +NIL+NS + + DFG++ LI+ A G+ Y++PE
Sbjct: 122 VHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA----DTFVGTSTYMSPE 172
Query: 861 YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD- 919
+ KSDV+S G+ ++EL G+ P F + D Q + ILD
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGKFPF-AFSNIDDDGQDDP----------MGILDL 221
Query: 920 ---------PRLSMVPKEE-AMHLLFVAMLCIQENSIERPRMREVVQM 957
PRL P + L C+ ++ ERP +++ M
Sbjct: 222 LQQIVQEPPPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 66/187 (35%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 710 GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC-SNKETNL-LVYEYMRN 767
G +AVKKL T H F EI+ L +++H NIV+ C S NL LV EY+
Sbjct: 33 GEVVAVKKL-QHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPY 91
Query: 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEA 827
GSL + L + L A + KG+ YL S VHRD+ + NIL+ S
Sbjct: 92 GSLRDYLQKHRERLDHRKL-LLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRV 147
Query: 828 HVADFGLAKFL---------IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGV 878
+ DFGL K L + G S + APE + SDV+SFGV
Sbjct: 148 KIGDFGLTKVLPQDKEYYKVREPGESPIF--------WYAPESLTESKFSVASDVWSFGV 199
Query: 879 VLLELLT 885
VL EL T
Sbjct: 200 VLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 31/272 (11%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
G +IG G G V G+ G ++AVK + T F E + + H+N+VRLL
Sbjct: 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA---QAFLEETAVMTKLHHKNLVRLLG 66
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
+ + V E M G+L L + A + + +++ A+G+ YL S +V
Sbjct: 67 VILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLV 122
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEK 870
HRD+ + NIL++ A V+DFGLA+ G + + + APE + K
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKKFSSK 177
Query: 871 SDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEE 929
SDV+S+GV+L E+ + GR P + K + KE ++ M P E
Sbjct: 178 SDVWSYGVLLWEVFSYGRAP------------YPKMSLKEVKEC----VEKGYRMEPPEG 221
Query: 930 AMHLLFVAML-CIQENSIERPRMREVVQMLSE 960
++V M C + +RP ++ + L +
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 16/211 (7%)
Query: 689 KDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDH-----GFRAEIQTLGNIRH 742
G +G G Y + + G +AVK++ S + R EI+ + + H
Sbjct: 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 743 RNIVRLL-AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
+I+R+L A C + NL V E+M GS+ L K GAF + + +GL YL
Sbjct: 63 PHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLS-KYGAFKE-AVIINYTEQLLRGLSYL 119
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFE-AHVADFGLA-KFLIDG-GASECMSAIAGSYGYIA 858
H + I+HRDVK N+L++S + +ADFG A + G GA E + G+ ++A
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 859 PEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
PE + DV+S G V++E+ T + P
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 777 KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836
KG + ++ KIA+ K L YLH S ++HRDVK +N+L+N + + DFG++
Sbjct: 95 DKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISG 152
Query: 837 FLIDGGASECMSAIAGSYGYIAPEYAYTLRVDE---------KSDVYSFGVVLLELLTGR 887
+L+D A + AG Y+APE R++ KSDV+S G+ ++EL TGR
Sbjct: 153 YLVDSVAK---TIDAGCKPYMAPE-----RINPELNQKGYDVKSDVWSLGITMIELATGR 204
Query: 888 RPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIE 947
P + Q K+ P+L FV C+++N E
Sbjct: 205 FPYDSWK---TPFQQLKQVVEEPS--------PQLPAEKFSPEFQ-DFVNK-CLKKNYKE 251
Query: 948 RPRMREVVQMLSEFPRHSSDFNQSSSSSL 976
RP E++Q S + + +S SL
Sbjct: 252 RPNYPELLQHPFFELHLSKNTDVASFVSL 280
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 693 VIGRGGAGIVYHGKMPNGVEI-AVKKLLGFGTHSHDHGFRA---EIQTLGNIRHRNIVRL 748
V+G G G+V + EI A+KK + + + E++ L +RH NIV L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH-HDCSP 807
K LV+EY+ +L E L G L + + + + Y H H+
Sbjct: 66 KEAFRRKGRLYLVFEYVER-TLLELLEASPGG-LPPDAVRSYIWQLLQAIAYCHSHN--- 120
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
I+HRD+K NIL++ + + DFG A+ L AS +A + Y APE L V
Sbjct: 121 -IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW-YRAPE----LLV 174
Query: 868 DEKS-----DVYSFGVVLLELLTGR 887
+ + DV++ G ++ ELL G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAF 751
IG G GIV+ K G +A+KK+ L + EI+ L +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 752 CSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVH 811
+ +LV EYM L E L ++ ++ KG+ Y+H + I+H
Sbjct: 68 FPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMH---ANGIMH 122
Query: 812 RDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR-VDEK 870
RD+K N+L+++ +ADFGLA+ L S + Y APE Y R D
Sbjct: 123 RDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 871 SDVYSFGVVLLELLTGR 887
D+++ G + ELL G
Sbjct: 182 VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 69/216 (31%), Positives = 111/216 (51%), Gaps = 20/216 (9%)
Query: 691 GNVIGRGGAGIVYHG-KMPNGVEIAVKKL-LGFGTHSHDHGFRA-------EIQTLGNIR 741
G +IG G G VY G +G +AVK++ L + S R+ EI L ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 742 HRNIVRLLAFCSNKETNLLVY-EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
H NIV+ L S +L ++ EY+ GS+ AL GAF +R + + KGL Y
Sbjct: 65 HENIVQYLG-SSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVR-QILKGLNY 121
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL----IDGGASECMSAIAGSYGY 856
LH + I+HRD+K NIL+++ ++DFG++K L + + ++ GS +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGD 892
+APE K+D++S G +++E+LTG+ P D
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 81/288 (28%), Positives = 134/288 (46%), Gaps = 33/288 (11%)
Query: 688 VKDGNVIGRGGAGIVYHGK-MPNG----VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH 742
+K V+G G G VY G +P G + +A+K L + F E + ++ H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
++VRLL C + T LV + M +G L + +H K +G L ++ AKG+ YL
Sbjct: 69 PHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLE 126
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY--GYIAPE 860
+VHRD+ + N+L+ S + DFGLA+ L++G E +A G ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLAR-LLEGDEKE-YNADGGKMPIKWMALE 181
Query: 861 YAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919
+ + +SDV+S+GV + EL+T G +P DG+ + G
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPY----DGIPTREIPDLLEKGE--------- 228
Query: 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSD 967
RL P + + V + C ++ RP+ +E+ +EF R + D
Sbjct: 229 -RLPQ-PPICTIDVYMVMVKCWMIDADSRPKFKELA---AEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA--EIQTLGNIRHRNIVRLLA 750
IG G G+VY + G +A+KK+ S A EI+ L + H NI++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK-LRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
+K LV+E+M L + + ++ ++ + +GL + H S I+
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKS-YLYQLLQGLAFCH---SHGIL 120
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV-DE 869
HRD+K N+L+N+ +ADFGLA+ G + + Y APE +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKGYST 178
Query: 870 KSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSK 904
D++S G + ELL+ RRP+ F +I Q K
Sbjct: 179 PVDIWSVGCIFAELLS-RRPL--FPGKSEIDQLFK 210
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 5e-16
Identities = 63/229 (27%), Positives = 91/229 (39%), Gaps = 71/229 (31%)
Query: 694 IGRGGAGIVY------HGKMPNGVEIAVKKLLGFGTHSHDHGF-----RAEIQTLGNIRH 742
IG G G VY G++ +A+KK+ + GF R EI+ L +RH
Sbjct: 7 IGEGTYGQVYKARNKKTGEL-----VALKKIR---MENEKEGFPITAIR-EIKLLQKLRH 57
Query: 743 RNIVRLLAFCSNKETN--LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK---- 796
NIVRL ++K +V+EYM + G + K K
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPE----------VKFTESQIKCYMK 107
Query: 797 ----GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
GL YLH + I+HRD+K +NIL+N+ +ADFGLA+ +
Sbjct: 108 QLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPY--------TKRNSA 156
Query: 853 SYG-------YIAPE-------YAYTLRVDEKSDVYSFGVVLLELLTGR 887
Y Y PE Y + D++S G +L EL G+
Sbjct: 157 DYTNRVITLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 34/221 (15%)
Query: 694 IGRGGAGIVY----HGKMPNGVEIAVK-KLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRL 748
+G G G V+ H +P ++ V K L + S F+ E + L ++H++IVR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEAL--HGKKGAF-----------LGWNLRYKIAIEAA 795
C+ L+V+EYMR+G L L HG L IA + A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 796 KGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID------GGASECMSA 849
G+ YL S VHRD+ + N L+ + DFG+++ + GG + M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT--MLP 187
Query: 850 IAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRP 889
I ++ PE + +SD++SFGVVL E+ T G++P
Sbjct: 188 IR----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 7e-16
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 38/211 (18%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA----EIQTLGNIRHRNIVRL 748
+G G G+VY + G +A+KK+ + + G + EI L ++H NIV+L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRL---DNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
L + LV+EY L + L + G ++ I + +GL Y H S
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS-IMYQLLRGLAYCH---SHR 118
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYG-------YIAPE- 860
I+HRD+K NIL+N +ADFGLA+ + +Y Y APE
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARA--------FGIPLR-TYTHEVVTLWYRAPEI 169
Query: 861 ----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
Y+ V D++S G + E++TG+
Sbjct: 170 LLGSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 8e-16
Identities = 52/171 (30%), Positives = 76/171 (44%), Gaps = 31/171 (18%)
Query: 741 RHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLC 799
H I++L + E NL V EY NG L + + K G+ R+ A E L
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAA-EILLALE 116
Query: 800 YLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL--------IDGGASECMSAIA 851
YLH S I+HRD+K NILL+ + DFG AK L G A+ S I
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 852 GSYG----------YIAPEYAYTLR---VDEKSDVYSFGVVLLELLTGRRP 889
+ Y++PE L + SD+++ G ++ ++LTG+ P
Sbjct: 174 KNRRRFASFVGTAEYVSPE---LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 65/245 (26%), Positives = 111/245 (45%), Gaps = 35/245 (14%)
Query: 730 FRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL--HGKKGAF------ 781
F+ E + L N++H +IV+ C + + ++V+EYM++G L + L HG
Sbjct: 54 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 113
Query: 782 ------LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA 835
LG + IA + A G+ YL S VHRD+ + N L+ + + DFG++
Sbjct: 114 RQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
Query: 836 KFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFG 894
+ + ++ PE + +SDV+SFGV+L E+ T G++P
Sbjct: 171 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230
Query: 895 DGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMRE 953
+ I + T GR E R + PKE ++ ML C Q +R ++E
Sbjct: 231 NTEVI----ECITQGRVLE-------RPRVCPKE-----VYDIMLGCWQREPQQRLNIKE 274
Query: 954 VVQML 958
+ ++L
Sbjct: 275 IYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 15/202 (7%)
Query: 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLL- 749
V+GRG GIV+ + ++ + K + T + E Q L + H NI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWN--LRYKIAIEAAKGLCYLHHDCSP 807
F +K ++V EY G+L E + + + L + L + + I L LHH +
Sbjct: 67 NFLEDKAL-MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI-----LLALHHVHTK 120
Query: 808 LIVHRDVKSNNILLNS-AFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
LI+HRD+K+ NILL+ + DFG++K L + + G+ YI+PE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEGKP 177
Query: 867 VDEKSDVYSFGVVLLELLTGRR 888
++KSD+++ G VL EL + +R
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 76/290 (26%), Positives = 116/290 (40%), Gaps = 48/290 (16%)
Query: 693 VIGRGGAGIVYHGKMPNGVE------IAVKKLLGFGTHSHDHG----FRAEIQTLGNIRH 742
+GRG G V+ K E + VK L + D FR E+ + H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL----QKTKDENLQSEFRRELDMFRKLSH 67
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAF-------LGWNLRYKIAIEAA 795
+N+VRLL C E + ++ EY G L + L K L + + + A
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 796 KGLCYL--HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGS 853
G+ +L VHRD+ + N L++S E V+ L+K + + + +A+
Sbjct: 128 LGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-P 181
Query: 854 YGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKE 912
++APE KSDV+SFGV++ E+ T G P D E
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----------------E 225
Query: 913 EFLSILDP-RLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSE 960
E L+ L +L + E L+ M C N +RP E+V L E
Sbjct: 226 EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 61/180 (33%), Positives = 88/180 (48%), Gaps = 9/180 (5%)
Query: 710 GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN--LLVYEYMRN 767
G ++AVK L +H + EI+ L N+ H NIV+ C+ N L+ E++ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 768 GSLGEALHGKKGAF-LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE 826
GSL E L K L L+Y A++ KG+ YL S VHRD+ + N+L+ S +
Sbjct: 93 GSLKEYLPRNKNKINLKQQLKY--AVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQ 147
Query: 827 AHVADFGLAKFL-IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
+ DFGL K + D + + APE + SDV+SFGV L ELLT
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 694 IGRGGAGIVYH-GKMPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL-A 750
+G G G+V+ P+G+ +A K + L + R E+Q L IV A
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGA 71
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
F S+ E ++ + E+M GSL + L KK + + K++I KGL YL I+
Sbjct: 72 FYSDGEISICM-EHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 126
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEK 870
HRDVK +NIL+NS E + DFG++ LID A ++ G+ Y++PE +
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQ 182
Query: 871 SDVYSFGVVLLELLTGRRPV 890
SD++S G+ L+E+ GR P+
Sbjct: 183 SDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 77/285 (27%), Positives = 121/285 (42%), Gaps = 39/285 (13%)
Query: 688 VKDGNVIGRGGAGIVYHG--KMPNGVE--IAVKKLLGFGTHSHDHGFRAEIQTLGNIRHR 743
+K ++G G G + G K+P+ E +A+ L + GF AE TLG H
Sbjct: 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHS 66
Query: 744 NIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH 803
NIVRL + T ++V EYM NG+L L +G + L + A G+ YL
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-MGMLPGLASGMKYL-- 123
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYG------YI 857
VH+ + ++ +L+NS ++ F + AI + +
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFR-------RLQEDKSEAIYTTMSGKSPVLWA 175
Query: 858 APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916
APE SDV+SFG+V+ E+++ G RP D G D++ K +G
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS-GQDVI---KAVEDG------- 224
Query: 917 ILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSE 960
+ +LL ML C Q+ ERPR ++ +LS+
Sbjct: 225 -----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 65/225 (28%), Positives = 93/225 (41%), Gaps = 23/225 (10%)
Query: 682 SDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI- 740
+ I E V+ VIG G G VY + ++ K++ + + E L
Sbjct: 5 TGIFELVE---VIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYS 60
Query: 741 RHRNIVRLL-AFCSNKETNL-----LVYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAI 792
H NI AF LV E GS+ + + G KKG L I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
E +GL YLH ++HRD+K NILL E + DFG++ L D + I
Sbjct: 121 ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-DSTLGRRNTFIGT 176
Query: 853 SYGYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGD 892
Y ++APE D +SDV+S G+ +EL G+ P+ D
Sbjct: 177 PY-WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-15
Identities = 55/159 (34%), Positives = 85/159 (53%), Gaps = 10/159 (6%)
Query: 733 EIQTLGNIRHRNIVRLL-AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIA 791
E+Q L IV AF S+ E ++ + E+M GSL + L K+ + + K++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL--KEAKRIPEEILGKVS 109
Query: 792 IEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIA 851
I +GL YL I+HRDVK +NIL+NS E + DFG++ LID A ++
Sbjct: 110 IAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFV 163
Query: 852 GSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPV 890
G+ Y++PE +SD++S G+ L+EL GR P+
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 62/210 (29%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 692 NVIGRGGAGIVYHGKM-PNGVEIAVK--KLLGFGTHSHDHGF---RAEIQTLGNIRHRNI 745
IG G G VY + G +A+K KL F + EI L RH NI
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKL------EPGDDFEIIQQEISMLKECRHPNI 62
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
V ++ +V EY GSL + +G + Y + E KGL YLH
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-VCRETLKGLAYLHETG 121
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYA--- 862
+HRD+K NILL + +ADFG++ + ++ S I Y ++APE A
Sbjct: 122 ---KIHRDIKGANILLTEDGDVKLADFGVSA-QLTATIAKRKSFIGTPY-WMAPEVAAVE 176
Query: 863 YTLRVDEKSDVYSFGVVLLELLTGRRPVGD 892
D K D+++ G+ +EL + P+ D
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPMFD 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 691 GNVIGRGGAGIVYH------GKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHR 743
G +G G G V K +++AVK L S +E++ + ++ H
Sbjct: 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE 99
Query: 744 NIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH 803
NIV LL C+ L++ EY G L L K+ +FL + + AKG+ +L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL-- 157
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK-------FLIDGGASECMSAIAGSYGY 856
S +HRD+ + N+LL + DFGLA+ +++ G A + +
Sbjct: 158 -ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-------W 209
Query: 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
+APE + +SDV+S+G++L E+ +
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 43/190 (22%)
Query: 789 KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS 848
K+ + K L YL ++HRDVK +NILL+++ + DFG++ L+D S+ +
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKT 172
Query: 849 AIAGSYGYIAPEYAYTLRVDEK---------SDVYSFGVVLLELLTGRRPVGDFGDGVDI 899
AG Y+APE R+D +DV+S G+ L+EL TG+ P
Sbjct: 173 RSAGCAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFPY--------- 218
Query: 900 VQWSKRATNGRKEEF--LS-ILDPRLSMVPKEEAMHLLFVAML--CIQENSIERPRMREV 954
K EF L+ IL +P E F + + C+ ++ +RP+ RE+
Sbjct: 219 --------KNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270
Query: 955 VQMLSEFPRH 964
+Q F R
Sbjct: 271 LQ--HPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 71/263 (26%), Positives = 119/263 (45%), Gaps = 26/263 (9%)
Query: 711 VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSL 770
V +AVK L + + F EI+ + ++ NI+RLLA C + ++ EYM NG L
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 771 GEAL--HGKKGA-------FLGW-NLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNIL 820
+ L H + A + + L + +A + A G+ YL S VHRD+ + N L
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIF-MATQIASGMKYL---SSLNFVHRDLATRNCL 162
Query: 821 LNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVL 880
+ + +ADFG+++ L G +++ E + SDV++FGV L
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222
Query: 881 LELLT--GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAM 938
E+LT +P D I + + ++ +L P+ ++ P L+ M
Sbjct: 223 WEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYL----PKPALCPD-----SLYKLM 273
Query: 939 L-CIQENSIERPRMREVVQMLSE 960
L C + N+ ERP +E+ L E
Sbjct: 274 LSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 63/230 (27%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 672 TAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD-HG 729
+ +Q+LE +IGRG G VY GK +P G +A+K ++ T D
Sbjct: 1 SLYQRLE--------------LIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSD 45
Query: 730 FRAEIQTLGNIRH---RNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGA--FLG 783
+ E+ L +R NI + K L ++ EY GS+ + A ++
Sbjct: 46 IQREVALLSQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS 104
Query: 784 WNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843
+R E L Y+H ++HRD+K+ NIL+ + + DFG+A L
Sbjct: 105 VIIR-----EVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-- 154
Query: 844 SECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGD 892
S S G+ ++APE + D K+D++S G+ + E+ TG P D
Sbjct: 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 77/284 (27%), Positives = 117/284 (41%), Gaps = 61/284 (21%)
Query: 693 VIGRGGAGIVYHG-KMPNGVEIAVKKL-LGFGTHSHDHGF--RAEIQTLGNIRHRNIVRL 748
IG+G G VY +A+K + L + D + EIQ L R I +
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDL---EEAEDEIEDIQQEIQFLSQCRSPYITKY 64
Query: 749 LAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI---EAAKGLCYLHHD 804
K + L ++ EY GS + L K G + Y IA E GL YLH +
Sbjct: 65 YG-SFLKGSKLWIIMEYCGGGSCLDLL--KPGKL---DETY-IAFILREVLLGLEYLHEE 117
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT 864
+HRD+K+ NILL+ + +ADFG++ L + G+ ++APE
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVSGQLTS--TMSKRNTFVGTPFWMAPEVIKQ 172
Query: 865 LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR--L 922
DEK+D++S G+ +EL G P LS L P L
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPP-------------------------LSDLHPMRVL 207
Query: 923 SMVPKEEAMHLL----------FVAMLCIQENSIERPRMREVVQ 956
++PK L FV+ LC+ ++ ERP +E+++
Sbjct: 208 FLIPKNNPPSLEGNKFSKPFKDFVS-LCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 69/275 (25%), Positives = 109/275 (39%), Gaps = 42/275 (15%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAF 751
+G+G G VY K + + A+K++ LG + EI+ L ++ H NI+
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY--- 64
Query: 752 CSNKETNLL------VYEYMRNGSLGEAL--HGKKGAFLGWNLRYKIAIEAAKGLCYLHH 803
KE L V EY G L +A+ KK + ++I I+ +GL LH
Sbjct: 65 ---KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH- 120
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAY 863
I+HRD+KS NILL + + D G++K L A G+ Y+APE
Sbjct: 121 --EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA----KTQIGTPHYMAPEVWK 174
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS--ILDPR 921
KSD++S G +L E+ T P R + L + +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPF-----------------EARSMQDLRYKVQRGK 217
Query: 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
+P + L +Q RP +++
Sbjct: 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 68/208 (32%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 694 IGRGGAGIVYHGKM-PNGVEIA---VKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
+G GG G V K+ A VKK T +H F E + L H IV+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIA--IEAAKGLCYLHHDCSP 807
+K+ ++ EY G L L +G F + R+ IA + A YLH+
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIACVVLA---FEYLHNRG-- 113
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY----AY 863
I++RD+K N+LL+S + DFG AK L G + G+ Y+APE Y
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAPEIILNKGY 169
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRPVG 891
VD +S G++L ELLTGR P G
Sbjct: 170 DFSVD----YWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 40/281 (14%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA----EIQTLGNIRHRNIVRL 748
IG+G +VY + +G +A+KK+ F D R EI L + H N+++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIF--EMMDAKARQDCLKEIDLLKQLDHPNVIKY 67
Query: 749 LA-FCSNKETNLLVYEYMRNGSLGEAL-HGKKGAFL-----GWNLRYKIAIEAAKGLCYL 801
LA F N E N+ V E G L + H KK L W ++ L ++
Sbjct: 68 LASFIENNELNI-VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHM 122
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA--IAGSYGYIAP 859
H S I+HRD+K N+ + + + D GL +F +S+ +A + G+ Y++P
Sbjct: 123 H---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSP 175
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919
E + + KSD++S G +L E+ + P +GD +++ K+ ++ +
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEKC---DYPPLPA 230
Query: 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
S EE L V+ CI + +RP + V+Q+ E
Sbjct: 231 DHYS----EELRDL--VSR-CINPDPEKRPDISYVLQVAKE 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 694 IGRGGAGIVYHGKMPNGVE--IAVKKL------LGFGTHSHDHGFRAEIQTLGNI----R 741
+G G G VY + N + +A+K++ G D + + I R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 742 HRNIVRLL-AFCSNKETNLLVYEYMRNGSLGE---ALHGKKGAFLGWNLRYKIAIEAAKG 797
H NIVR F N +V + + LGE +L KK F + + I ++
Sbjct: 68 HPNIVRYYKTFLENDRL-YIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMVLA 125
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI 857
L YLH + IVHRD+ NNI+L + + DFGLAK ++++ G+ Y
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYS 180
Query: 858 APEYAYTLRVDEKSDVYSFGVVLLELLT 885
PE EK+DV++FG +L ++ T
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 7e-14
Identities = 58/179 (32%), Positives = 85/179 (47%), Gaps = 9/179 (5%)
Query: 710 GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETNLLVYEYMRN 767
G +AVK L + G++ EI L + H NIV+ CS + + L+ EY+
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEA 827
GSL + L K L A + +G+ YLH S +HRD+ + N+LL++
Sbjct: 93 GSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLV 146
Query: 828 HVADFGLAKFLIDGGASECMSAIAGS-YGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
+ DFGLAK + +G + S + A E + SDV+SFGV L ELLT
Sbjct: 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-14
Identities = 37/85 (43%), Positives = 53/85 (62%), Gaps = 3/85 (3%)
Query: 439 LSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI 498
L G +P N S L +NLS N + G +P SL + +SL++L LS N F+G IP S+
Sbjct: 430 LRGFIP---NDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 499 GELRQVLKLDLSRNSLSGEIPPAIG 523
G+L + L+L+ NSLSG +P A+G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 69/211 (32%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 691 GNVIGRGGAGIVYHGKMPN-GVEIAVKKL-LG-FGTHSHDHGFRA--EIQTLGNIRHRNI 745
G +G G +VY + G +A+KK+ LG F A EI+ L ++H NI
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 746 VRLL-AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYK-IAIEAAKGLCYLHH 803
+ LL F NL V+E+M L E + K L K + +GL YLH
Sbjct: 65 IGLLDVFGHKSNINL-VFEFME-TDL-EKVIKDKSIVLT-PADIKSYMLMTLRGLEYLH- 119
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY-- 861
S I+HRD+K NN+L+ S +ADFGLA+ G + M+ + Y APE
Sbjct: 120 --SNWILHRDLKPNNLLIASDGVLKLADFGLARSF--GSPNRKMTHQVVTRWYRAPELLF 175
Query: 862 ---AYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y + V D++S G + ELL R P
Sbjct: 176 GARHYGVGV----DMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 9/192 (4%)
Query: 694 IGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC 752
IGRG G V+ G++ + +AVK F E + L H NIVRL+ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 753 SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHR 812
+ K+ +V E ++ G L +G L ++ AA G+ YL +HR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAGMEYLESKHC---IHR 118
Query: 813 DVKSNNILLNSAFEAHVADFGLAKFLIDG--GASECMSAIAGSYGYIAPEYAYTLRVDEK 870
D+ + N L+ ++DFG+++ DG ++ M I + APE R +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYSSE 176
Query: 871 SDVYSFGVVLLE 882
SDV+SFG++L E
Sbjct: 177 SDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
+G G G V+ ++AVK + G+ S + F AE + ++H +V+L A +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
KE ++ E+M GSL + L +G+ + + A+G+ ++ +HRD
Sbjct: 72 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 127
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY--GYIAPEYAYTLRVDEKS 871
+++ NIL++++ +ADFGLA+ + D +E + + + APE KS
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 872 DVYSFGVVLLELLT-GRRP 889
DV+SFG++L+E++T GR P
Sbjct: 185 DVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-13
Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 507 LDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNI 566
L L L G IP I HL +++S N++ G+IPP + ++ L L+LS N N +I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 567 PKSIGSMKSLTIADFSFNDFSGKLPES-GQFTVFNAS-SFAGNPQLCGTLLNNPCNVAPI 624
P+S+G + SL I + + N SG++P + G + AS +F N LCG C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG---- 538
Query: 625 THQPGKAPGDFKLIFALGLLICSLIFATAAII 656
H A K+ A G+ + L A+
Sbjct: 539 PHLSVGA----KIGIAFGVSVAFLFLVICAMC 566
|
Length = 623 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 59/246 (23%), Positives = 95/246 (38%), Gaps = 22/246 (8%)
Query: 694 IGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHDH--GFRAEIQTLGNIRHR-NIVRLL 749
I +G G VY K G A+K L + + +AE + + +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLI 809
+K+ LV EY+ G + G W +Y E G+ LH I
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---I 118
Query: 810 VHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDE 869
+HRD+K N+L++ + DFGL++ G+ Y+APE + D+
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPETILGVGDDK 172
Query: 870 KSDVYSFGVVLLELLTGRRPV-GDFGDGV------DIVQWSKRATNGRKEEFLSILDPRL 922
SD +S G V+ E L G P + D V + W + E + +++ L
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232
Query: 923 SMVPKE 928
M P +
Sbjct: 233 CMDPAK 238
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 25/218 (11%)
Query: 692 NVIGRGGAGIVYHGKMPN-------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
N +G G G VY G + + +AVK L T F E + N H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKK-----GAFLGWNLRYKIAIEAAKGLC 799
IV+LL C E ++ E M G L L + L I ++ AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 800 YLH--HDCSPLIVHRDVKSNNILLNSAFEA-----HVADFGLAKFLIDGGASECMSAIAG 852
YL H +HRD+ + N L++ + DFGLA+ +
Sbjct: 121 YLEQMH-----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRP 889
++APE + +SDV+SFGV++ E+LT G++P
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 78/290 (26%), Positives = 119/290 (41%), Gaps = 42/290 (14%)
Query: 693 VIGRGGAGIVYHGK-MPNG----VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
V+G G G VY G +P+G + +A+K L + + E + + + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
LL C T LV + M G L + + K +G ++ AKG+ YL
Sbjct: 74 LLGICLT-STVQLVTQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQIAKGMSYLE---EV 128
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFL--------IDGGASECMSAIAGSYGYIAP 859
+VHRD+ + N+L+ S + DFGLA+ L DGG ++A
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--------PIKWMAL 180
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
E R +SDV+S+GV + EL+T G +P DG+ + G
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPY----DGIPAREIPDLLEKGE-------- 228
Query: 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDF 968
RL P + + + + C +S RPR RE+V S R S F
Sbjct: 229 --RLPQ-PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRF 275
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 10/206 (4%)
Query: 692 NVIGRGGAGIVYHGKMPNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLL 749
IG+G G V + + +I V K + +G T +E+ L ++H NIVR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 750 AFCSNKETNLL--VYEYMRNGSLGEAL-HGKK-GAFLGWNLRYKIAIEAAKGLCYLHH-- 803
++ L V EY G L + + KK ++ ++I + L H+
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAY 863
D ++HRD+K NI L++ + DFGLAK ++ +S + + Y Y++PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK-ILGHDSSFAKTYVGTPY-YMSPEQLN 183
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRP 889
+ DEKSD++S G ++ EL P
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 41/292 (14%)
Query: 685 LECVKDGNVIGRGGAGIVYHGK-----MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGN 739
L V+ +G G +Y G M + +A+K L F+ E +
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE 63
Query: 740 IRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL-----HGKKGAFLGWNLRYK----- 789
+ H NIV LL + ++ +++EY+ G L E L H G + K
Sbjct: 64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 790 -----IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844
IAI+ A G+ YL S VH+D+ + NIL+ ++D GL++ +
Sbjct: 124 GDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180
Query: 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWS 903
++ PE + SD++SFGVVL E+ + G +P F +
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------- 232
Query: 904 KRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREV 954
+E + ++ R + E+ ++ M C QE RPR +++
Sbjct: 233 --------QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-13
Identities = 38/88 (43%), Positives = 51/88 (57%)
Query: 288 LDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVI 347
L L N L G IP LR L+ NL N + G+IP L + +LE L L N+F G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 348 PENLGQNGKLQVLDLSSNKLTGTIPTDL 375
PE+LGQ L++L+L+ N L+G +P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-13
Identities = 51/180 (28%), Positives = 76/180 (42%), Gaps = 31/180 (17%)
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI 857
L +HH S ++HRD+KS NILL S + DFG +K + + G+ Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 858 APEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917
APE +K+D++S GV+L ELLT +RP DG ++ + + GR
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPF----DGENMEEVMHKTLAGR------- 261
Query: 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPR----------------MREVVQMLSEF 961
DP + E M + A+L RP + E+VQ F
Sbjct: 262 YDPLPPSISPE--MQEIVTALLSSDPK--RRPSSSKLLNMPICKLFISGLLEIVQTQPGF 317
|
Length = 496 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 7/194 (3%)
Query: 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC 752
++G+G G V+ G + + +AVK F +E + L H NIV+L+ C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 753 SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHR 812
+ ++ +V E + G L KK L K A++AA G+ YL S +HR
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-VKFALDAAAGMAYLE---SKNCIHR 117
Query: 813 DVKSNNILLNSAFEAHVADFGLAKFLIDG-GASECMSAIAGSYGYIAPEYAYTLRVDEKS 871
D+ + N L+ ++DFG+++ DG +S + I + APE R +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 872 DVYSFGVVLLELLT 885
DV+S+G++L E +
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 691 GNVIGRGGAGIVYHGKMPNG---VEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
G +G G G V G++ +++AVK + + T S F +E + H N++
Sbjct: 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 747 RLLAFCSNKETN------LLVYEYMRNGSLGEALH----GKKGAFLGWNLRYKIAIEAAK 796
RL+ C + +++ +M++G L L G +L + K + A
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 797 GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGY 856
G+ YL S +HRD+ + N +LN VADFGL+K + +G +
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRP 889
IA E KSDV+SFGV + E+ T G+ P
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD----HGFRAEIQTLGNIRHRNIV 746
N IG G GIVY + +G +A+KK+ + D R EI L N+RH NIV
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRM--DNERDGIPISSLR-EITLLLNLRHPNIV 69
Query: 747 RLLAFCSNKETN--LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
L K + LV EY L L F ++ + ++ +GL YLH +
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVK-CLMLQLLRGLQYLHEN 127
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT 864
I+HRD+K +N+LL +ADFGLA+ G ++ M+ + Y APE
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLG 182
Query: 865 LRVDEKS-DVYSFGVVLLELLTGR 887
+ D+++ G +L ELL +
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLLA 750
IG G G +Y K + E V K + + E+ L ++H NIV
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF-- 64
Query: 751 FCSNKETNLL--VYEYMRNGSLGEALHGKKGAF------LGWNLRYKIAIEAAKGLCYLH 802
F S +E L V EY G L + ++ ++G L W ++ + GL ++H
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIH 118
Query: 803 HDCSPLIVHRDVKSNNILLNS-AFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY 861
I+HRD+KS NI L+ A + DFG+A+ L D + E G+ Y++PE
Sbjct: 119 ---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPYYLSPEI 173
Query: 862 AYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ K+D++S G VL EL T + P
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 693 VIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDH------GFRAEIQTLGNIRHRNI 745
++G G G+V K G +A+KK L S D R EI+ L +RH N+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFL----ESEDDKMVKKIAMR-EIRMLKQLRHENL 62
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
V L+ K+ LV+E++ + L + G L + K + +G+ + H
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH--- 117
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
S I+HRD+K NIL++ + + DFG A+ L G +A + Y APE L
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRW-YRAPE----L 171
Query: 866 RVDEKS-----DVYSFGVVLLELLTG 886
V + D+++ G ++ E+LTG
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 694 IGRGGAGIVYHGKMPN------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
+G G G V+ + N + +AVK L ++ F E + L N++H +IV+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD-FHREAELLTNLQHEHIVK 71
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEAL--HGKKGAF---------LGWNLRYKIAIEAAK 796
C + ++V+EYM++G L + L HG L + IA + A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 797 GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGY 856
G+ YL S VHRD+ + N L+ + DFG+++ + +
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRP 889
+ PE + +SDV+S GVVL E+ T G++P
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 28/219 (12%)
Query: 683 DILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH 742
DI E + + +G G G VY + A K++ + F EI L +H
Sbjct: 5 DIWEIIGE---LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
NIV L + ++ E+ G+L + + +RY + + + L +LH
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLH 120
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGL-AKFLIDGGASECM--SAIAGSYGYIAP 859
S ++HRD+K+ NILL + +ADFG+ AK S G+ ++AP
Sbjct: 121 ---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAK-----NKSTLQKRDTFIGTPYWMAP 172
Query: 860 EY---------AYTLRVDEKSDVYSFGVVLLELLTGRRP 889
E Y D K+D++S G+ L+EL P
Sbjct: 173 EVVACETFKDNPY----DYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 679 FSVSDILECVKDGNVIGRGGAGIVYHGKM---PNGVEIAVKKLLGFGTHSHDHGFRAEIQ 735
F+ D+ KD IGRG G V KM P+G +AVK++ ++
Sbjct: 1 FTAEDL----KDLGEIGRGAFGTVN--KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD 54
Query: 736 TLGNIRHRN---IVRLLAFCSNKETNLLVYEYMRNG--SLGEALHGKKGAFLGWNLRYKI 790
+ +R + IV+ + + E M + ++ + + + KI
Sbjct: 55 VV--MRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKI 112
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850
A+ K L YL + I+HRDVK +NILL+ + DFG++ L+D A +
Sbjct: 113 AVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRD 167
Query: 851 AGSYGYIAPEYAYTLRV---DEKSDVYSFGVVLLELLTGRRP 889
AG Y+APE D +SDV+S G+ L E+ TG+ P
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 75/290 (25%), Positives = 125/290 (43%), Gaps = 34/290 (11%)
Query: 689 KDGNVIGRGGAGIVYHGK-MPNG----VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHR 743
K V+G G G VY G +P G + +A+K+L + + E + ++ +
Sbjct: 10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 69
Query: 744 NIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLG-WNLRYKIAIEAAKGLCYLH 802
++ RLL C T L+ + M G L + + K + L + + I AKG+ YL
Sbjct: 70 HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI--AKGMNYLE 126
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGS---YGYIAP 859
+VHRD+ + N+L+ + + DFGLAK L GA E G ++A
Sbjct: 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GADEKEYHAEGGKVPIKWMAL 180
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
E +SDV+S+GV + EL+T G +P DG+ + S G
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGIPASEISSILEKGE-------- 228
Query: 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDF 968
RL P + + + + C ++ RP+ RE++ S+ R +
Sbjct: 229 --RLPQ-PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 275
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 15/186 (8%)
Query: 711 VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSL 770
V +AVK L T + + F EI+ + +++ NI+RLL C + + ++ EYM NG L
Sbjct: 45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 771 GEALHGKK-----------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819
+ L ++ + NL Y +A++ A G+ YL S VHRD+ + N
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLY-MAVQIASGMKYL---ASLNFVHRDLATRNC 160
Query: 820 LLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVV 879
L+ + + +ADFG+++ L G ++A E + SDV++FGV
Sbjct: 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVT 220
Query: 880 LLELLT 885
L E+ T
Sbjct: 221 LWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 9/158 (5%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI 792
EI L ++H NI+ + T L+ EY G+L + + +KG +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID--GGASECMSAI 850
+ + Y+H I+HRD+K+ NI L A + DFG++K L A +
Sbjct: 109 QIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV--- 162
Query: 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRR 888
G+ Y++PE ++ + KSD+++ G VL ELLT +R
Sbjct: 163 -GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 36/85 (42%), Positives = 50/85 (58%)
Query: 459 LNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEI 518
L L N L G +P +S LQ + LSGN G IPPS+G + + LDLS NS +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 519 PPAIGYCNHLTYLDMSQNNLSGSIP 543
P ++G L L+++ N+LSG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 2e-12
Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 51/223 (22%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEIQTLGNIRHRNIVRL 748
IG G G+V G ++A+KK+ D R EI+ L ++RH NI+ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGL 64
Query: 749 L-AFCSNKETNL----LVYEYMR---------NGSLGEALHGKKGAFLGWNLRYKIAIEA 794
L + +V E M L + H + FL Y+I
Sbjct: 65 LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDD-HIQ--YFL-----YQIL--- 113
Query: 795 AKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL-IDGGASECMSAIAGS 853
+GL YLH S ++HRD+K +NIL+NS + + DFGLA+ + D ++
Sbjct: 114 -RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT----E 165
Query: 854 Y----GYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
Y Y APE YT + D++S G + ELLT +
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 688 VKDGNVIGRGGAGIVYHG--KMPNGV--EIAVK--KLLGFGTHSHDHGFRAEIQTLGNIR 741
+K G ++G G G V G +G ++AVK KL T+S F +E + +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFD 59
Query: 742 HRNIVRLLAFCSNKETN------LLVYEYMRNGSLGEALHGKKGAFLGWNLR----YKIA 791
H N+++L+ C + +++ +M++G L L + L L K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 792 IEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIA 851
++ A G+ YL + +HRD+ + N +L VADFGL+K + G
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 852 GSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRP 889
+IA E KSDV++FGV + E+ T G+ P
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 56/176 (31%), Positives = 76/176 (43%), Gaps = 29/176 (16%)
Query: 732 AEIQTLGNIRHRNIVRLL-AFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYK 789
E L + +V+L +F K NL LV EY+ G L L G+ R
Sbjct: 42 TERDILSQAQSPYVVKLYYSFQGKK--NLYLVMEYLPGGDLASLLE-NVGSLDEDVARIY 98
Query: 790 IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF-------LIDGG 842
IA E L YLH S I+HRD+K +NIL++S + DFGL+K ++
Sbjct: 99 IA-EIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154
Query: 843 ASECMSAIAGSYGYIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGD 892
E I G+ YIAPE ++ T D +S G +L E L G P
Sbjct: 155 EKED-KRIVGTPDYIAPEVILGQGHSKT------VDWWSLGCILYEFLVGIPPFHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-12
Identities = 71/219 (32%), Positives = 104/219 (47%), Gaps = 48/219 (21%)
Query: 694 IGRGGAGIVY------HGKMPNGVEIAVKKLLGFGTHSHD--HGFRAEI---QTLGNIRH 742
+G+G GIV+ ++ +A+KK+ ++ D FR EI Q LG+ H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEV-----VALKKIFDAFRNATDAQRTFR-EIMFLQELGD--H 66
Query: 743 RNIVRLLAF--CSNKETNLLVYEYMRNGSLGEA-LHG--KKGAFLGWNLRYKIAIEAAKG 797
NIV+LL N + LV+EYM E LH + + RY I + K
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYM------ETDLHAVIRANILEDVHKRY-IMYQLLKA 119
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA----IAGS 853
L Y+H S ++HRD+K +NILLNS +ADFGLA+ L + + +A
Sbjct: 120 LKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 854 YGYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
+ Y APE YT V D++S G +L E+L G+
Sbjct: 177 W-YRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 63/206 (30%), Positives = 93/206 (45%), Gaps = 30/206 (14%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDH------GFRAEIQTLGNIRHRNIV 746
IG G G+V+ + G +A+KK S D R EI+ L ++H N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF----VESEDDPVIKKIALR-EIRMLKQLKHPNLV 63
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH-HDC 805
L+ K LV+EY + L E +G + +L KI + + + + H H+C
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY---- 861
+HRDVK NIL+ + + DFG A+ L G + +A + Y APE
Sbjct: 122 ----IHRDVKPENILITKQGQIKLCDFGFARILT-GPGDDYTDYVATRW-YRAPELLVGD 175
Query: 862 -AYTLRVDEKSDVYSFGVVLLELLTG 886
Y V DV++ G V ELLTG
Sbjct: 176 TQYGPPV----DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 680 SVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLG-FGTHS-HDHGFRAEIQT 736
+V +I D +G G G+V + G +A+KK++ F T +R E++
Sbjct: 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKL 62
Query: 737 LGNIRHRNIVRLL-AFCSNKETNLLVYEYMRNGSLGEALHGK--KGAFLGWNLRYKIAIE 793
L ++RH NI+ L F S E V E + L L + + F+ + L Y+I
Sbjct: 63 LKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFL-YQIL-- 118
Query: 794 AAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGS 853
+GL Y+H S +VHRD+K +NIL+N + + DFGLA+ M+ +
Sbjct: 119 --RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVST 168
Query: 854 YGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGR 887
Y APE T + D + D++S G + E+L G+
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 11/162 (6%)
Query: 731 RAEIQTLGNIRHRNIVRLLAFCSNKETN---LLVYEYMRNGSLGEALHGKKGAFLGWNLR 787
R E L ++H NIV AF + E + +V EY G L + + ++G +
Sbjct: 46 RKEAVLLAKMKHPNIV---AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI 102
Query: 788 YKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847
+ ++ G+ ++H ++HRD+KS NI L + + DFG A+ L GA C
Sbjct: 103 LQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC- 158
Query: 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
G+ Y+ PE + + KSD++S G +L EL T + P
Sbjct: 159 -TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 31/223 (13%)
Query: 691 GNVIGRGGAGIVYHGK------MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
G +G G G V +AVK L + S +E L + H +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALH-------GKKGAFLGWNLRY--------- 788
+++L CS LL+ EY + GSL L G+ N Y
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 789 ------KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842
A + ++G+ YL +VHRD+ + N+L+ + ++DFGL++ + +
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
+ S ++A E + +SDV+SFGV+L E++T
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHD-HGFRAEIQTLGNIRHRNIVRLLAFC 752
IG+G G VY G E+ K++ + + EI L I R
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 753 SNKETNLLVYEYMRNGSLGEALHGKKG----AFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
++ EY+ GS + L K G ++ LR E KGL YLH S
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILR-----EILKGLDYLH---SER 121
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVD 868
+HRD+K+ N+LL+ + +ADFG+A L D + G+ ++APE D
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYD 179
Query: 869 EKSDVYSFGVVLLELLTGRRPVGDF 893
K+D++S G+ +EL G P D
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 694 IGRGGAGIVYHGKMPNGVEI-AVKKLLGFGTHSHD--HGFRAEIQTLGNIRHRNIVRLLA 750
IG G G VY + E+ AVKK+ G +++ E++ L ++H N +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
+ T LV EY GS + L K + I A +GL YLH ++
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHSHN---MI 143
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL---RV 867
HRD+K+ NILL + +ADFG A +S S + Y ++APE + +
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGTPY-WMAPEVILAMDEGQY 197
Query: 868 DEKSDVYSFGVVLLELLTGRRPV 890
D K DV+S G+ +EL + P+
Sbjct: 198 DGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 52/157 (33%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 751 FCS--NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
FC+ KE V EY+ G L + G F R+ A E GL +LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQ-SSGRFDEARARF-YAAEIICGLQFLH---KKG 116
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVD 868
I++RD+K +N+LL+ +ADFG+ K ++G S G+ YIAPE + +
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAPEILKGQKYN 174
Query: 869 EKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKR 905
E D +SFGV+L E+L G+ P G+ D + S
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPF--HGEDEDELFDSIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 30/207 (14%)
Query: 733 EIQTLGNIRHRNIVRL-LAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKI 790
E L + H IV+L AF E L L+ +++R G L L K+ F ++++ +
Sbjct: 48 ERDILAEVNHPFIVKLHYAF--QTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYL 104
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850
A E A L +LH S I++RD+K NILL+ + DFGL+K ID +
Sbjct: 105 A-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSF 158
Query: 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910
G+ Y+APE + +D +SFGV++ E+LTG P G D R
Sbjct: 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF----QGKD-----------R 203
Query: 911 KEEFLSILDPRLSMVPK---EEAMHLL 934
KE IL +L M P+ EA LL
Sbjct: 204 KETMTMILKAKLGM-PQFLSPEAQSLL 229
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 6e-12
Identities = 76/296 (25%), Positives = 117/296 (39%), Gaps = 73/296 (24%)
Query: 693 VIGRGGAGIVYHGKMPNGVEI-AVKKLLGFGTHSHDH--GFRAEIQTLGNIRHRNIVRLL 749
VIGRG G V+ + + ++ A+K L + RAE L + IV+L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 750 AFCSNKETNLL--VYEYMRNGSLGEALHGKKGAFLGWNLRYKI-----AIEAAKGLCYLH 802
+ S ++ L V EYM G L L +K F R+ I A+++ L +
Sbjct: 67 -YYSFQDEEHLYLVMEYMPGGDLMNLLI-RKDVFPEETARFYIAELVLALDSVHKLGF-- 122
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMS------------ 848
+HRD+K +NIL+++ + H+ ADFGL K + E
Sbjct: 123 -------IHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 849 ---------------AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDF 893
+ G+ YIAPE + D +S GV+L E+L G P +
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF--Y 231
Query: 894 GDGV-----DIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQEN 944
D + I+ W KE DP +S EA+ L+ +LC E+
Sbjct: 232 SDTLQETYNKIINW--------KESLRFPPDPPVS----PEAIDLI-CRLLCDPED 274
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 691 GNVIGRGGAGIVYHG--KMPNGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
G IG G G VY G P +I AVK + S F E + H +IV
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAF-LGWNLRYKIAIEAAKGLCYLHHDC 805
+L+ + +V E G L L K + L + Y + + + L YL
Sbjct: 71 KLIGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILY--SYQLSTALAYLE--- 124
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY--GYIAPEYAY 863
S VHRD+ + N+L++S + DFGL+++L D A G ++APE
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED---ESYYKASKGKLPIKWMAPESIN 181
Query: 864 TLRVDEKSDVYSFGVVLLELLT-GRRP 889
R SDV+ FGV + E+L G +P
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-12
Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 13/165 (7%)
Query: 731 RAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWN----- 785
R+E+ L H IV+ + + LL+ EY G L + + + L +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 786 -LRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844
L Y+I + L +H ++HRD+KS NI L + DFG +K D +
Sbjct: 173 LLFYQIVL----ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225
Query: 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ S+ G+ Y+APE R +K+D++S GV+L ELLT RP
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 72/229 (31%), Positives = 100/229 (43%), Gaps = 42/229 (18%)
Query: 679 FSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEIQ 735
FS D + D IG G G VY + + +A+KK+ G S++ E++
Sbjct: 8 FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 736 TLGNIRHRNIVRLLAFCSNKE-TNLLVYEYMRNGSLGEA-----LHGKKGAFLGWNLR-- 787
L +RH N + C +E T LV EY LG A +H KK L+
Sbjct: 68 FLQQLRHPNTIEYKG-CYLREHTAWLVMEY----CLGSASDILEVH-KKP------LQEV 115
Query: 788 --YKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845
I A +GL YLH +HRD+K+ NILL +ADFG A S
Sbjct: 116 EIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASL-----VSP 167
Query: 846 CMSAIAGSYGYIAPEYAYTLRVDE-----KSDVYSFGVVLLELLTGRRP 889
S + Y ++APE L +DE K DV+S G+ +E L R+P
Sbjct: 168 ANSFVGTPY-WMAPE--VILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 27/224 (12%)
Query: 684 ILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RH 742
I E V+ V+G G G VY G+ ++A K++ T + + EI L H
Sbjct: 17 IFELVE---VVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHH 72
Query: 743 RNIVRLL-AFCS-----NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK 796
RNI AF + + LV E+ GS+ + + KG L + I E +
Sbjct: 73 RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 797 GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGY 856
GL +LH + ++HRD+K N+LL E + DFG++ L D + I Y +
Sbjct: 133 GLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPY-W 187
Query: 857 IAPEYAYTLRVDE--------KSDVYSFGVVLLELLTGRRPVGD 892
+APE + DE +SD++S G+ +E+ G P+ D
Sbjct: 188 MAPE---VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 66/268 (24%), Positives = 110/268 (41%), Gaps = 32/268 (11%)
Query: 713 IAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSL-- 770
+AVK L + + F E++ L ++ NI+RLL C +++ ++ EYM NG L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 771 -----------GEALHGKKGAFLGWNLRYK----IAIEAAKGLCYLHHDCSPLIVHRDVK 815
A + Y +A++ A G+ YL S VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 816 SNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYS 875
+ N L+ +ADFG+++ L G ++A E + SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 876 FGVVLLELLT--GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHL 933
FGV L E+L +P G+ D I + + ++ +L R P+
Sbjct: 226 FGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLF----RPPPCPQG----- 276
Query: 934 LFVAML-CIQENSIERPRMREVVQMLSE 960
L+ ML C + ERP ++ L+E
Sbjct: 277 LYELMLQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 57/216 (26%), Positives = 85/216 (39%), Gaps = 17/216 (7%)
Query: 694 IGRGGAGIVYHGKMPNGVEIA---VKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
IG G G V G+ G+ A VK+L T F E+Q + H N+++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGW---NLRYKIAIEAAKGLCYLHHDCSP 807
C LLV E+ G L L +G ++ ++A E A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYA----- 862
+H D+ N L + + D+GLA A ++APE
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 863 --YTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGD 895
+KS+++S GV + EL T +P D D
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD 215
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 36/92 (39%), Positives = 51/92 (55%)
Query: 240 LDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEI 299
L L + L G IP++I L+ L ++ L N + G+IP LG++T+L LDLS N+ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 300 PYSFINLRQLKLFNLFMNRLHGSIPDYLADLP 331
P S L L++ NL N L G +P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-11
Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 40/196 (20%)
Query: 710 GVEIAVKKLL-GFGTHSHDHGFRA--EIQTLGNIRHRNIVRLL-AFCSNKETN-----LL 760
G ++A+KKL F S H R E++ L ++ H N++ LL F L
Sbjct: 40 GRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL 97
Query: 761 VYEYMRNGSLGEALHGKKGAFLGWN----LRYKIAIEAAKGLCYLHHDCSPLIVHRDVKS 816
V M L + +K L + L Y+I +GL Y+H S I+HRD+K
Sbjct: 98 VTHLM-GADLNNIVKCQK---LSDDHIQFLVYQIL----RGLKYIH---SAGIIHRDLKP 146
Query: 817 NNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE-----YAYTLRVDEKS 871
+NI +N E + DFGLA+ + M+ + Y APE Y V
Sbjct: 147 SNIAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLNWMHYNQTV---- 197
Query: 872 DVYSFGVVLLELLTGR 887
D++S G ++ ELLTG+
Sbjct: 198 DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-11
Identities = 66/220 (30%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 694 IGRGGAGIVYHG-KMPNGVEIAVKKLL-GFGTHSHDHGFRAEIQTLGNIRHRNIVRLL-A 750
IG G GIV G+ +AVKKL F +H E+ L + H+NI+ LL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 751 FCSNKETN-----LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
F K LV E M + +L + +H + L Y++ LC + H
Sbjct: 89 FTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQM-------LCGIKHLH 140
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
S I+HRD+K +NI++ S + DFGLA+ + M+ + Y APE +
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGM 197
Query: 866 RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD-IVQWSK 904
E D++S G ++ EL+ G G D I QW+K
Sbjct: 198 GYKENVDIWSVGCIMGELVKGSV----IFQGTDHIDQWNK 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 70/291 (24%), Positives = 117/291 (40%), Gaps = 42/291 (14%)
Query: 691 GNVIGRGGAGIVYHG------KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHR 743
G +G G G V +AVK L T +E++ + I +H+
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 744 NIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKK----------GAFLGWNLRYK---- 789
NI+ LL C+ + +V EY +G+L + L ++ L K
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 790 IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA 849
A + A+G+ +L S +HRD+ + N+L+ +ADFGLA+ + +
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 850 IAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATN 908
++APE + +SDV+SFGV+L E+ T G P G+ +
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY----PGIPV--------- 240
Query: 909 GRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQML 958
EE +L M + L+ M C E +RP +++V+ L
Sbjct: 241 ---EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 47/137 (34%), Positives = 69/137 (50%), Gaps = 21/137 (15%)
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850
A E A GL +LH S I++RD+K +N++L++ +ADFG+ K I GG +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR--TF 161
Query: 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910
G+ YIAPE + D ++FGV+L E+L G+ P DG D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF----DGED-----------E 206
Query: 911 KEEFLSILDPRLSMVPK 927
E F SI++ +S PK
Sbjct: 207 DELFQSIMEHNVSY-PK 222
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 692 NVIGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
++G G G VY + +AVK + T +E++ L I+
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 751 --FCSNKETNLLVYEYMRNGSLGEALHGK-KGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
F N+ + + E+M GSL ++ K LG +IA+ KGL YL S
Sbjct: 67 AFFVENRIS--ICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYL---WSL 114
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
I+HRDVK +N+L+N+ + + DFG++ L++ A G+ Y+APE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA----KTYVGTNAYMAPERISGEQY 170
Query: 868 DEKSDVYSFGVVLLELLTGRRP 889
SDV+S G+ +EL GR P
Sbjct: 171 GIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 65/262 (24%), Positives = 114/262 (43%), Gaps = 34/262 (12%)
Query: 711 VEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRNGS 769
V +AVK L T +E++ + I +H+NI+ LL C+ ++ EY G+
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104
Query: 770 LGEALHGKKGAFLGWN----------LRYK----IAIEAAKGLCYLHHDCSPLIVHRDVK 815
L E L ++ + ++ L +K A + A+G+ YL S +HRD+
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLA 161
Query: 816 SNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYS 875
+ N+L+ +ADFGLA+ + + + + ++APE + +SDV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 876 FGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLF 935
FGV+L E+ T G G+ + EE +L M H L+
Sbjct: 222 FGVLLWEIFT---LGGSPYPGIPV------------EELFKLLKEGHRMDKPANCTHELY 266
Query: 936 VAML-CIQENSIERPRMREVVQ 956
+ M C +RP +++V+
Sbjct: 267 MIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 22/192 (11%)
Query: 711 VEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRNGS 769
V +AVK L T +E++ + I +H+NI+ LL C+ ++ EY G+
Sbjct: 48 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 107
Query: 770 LGEALHGKKGAFLGWNLRYKIA----------------IEAAKGLCYLHHDCSPLIVHRD 813
L E L ++ G Y IA + A+G+ YL S +HRD
Sbjct: 108 LREYLRARRP--PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRD 162
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDV 873
+ + N+L+ +ADFGLA+ + + + + ++APE + +SDV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 874 YSFGVVLLELLT 885
+SFGV++ E+ T
Sbjct: 223 WSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 43/218 (19%)
Query: 692 NVIGRGGAGIV---YHGKMPNGVEIAVKKLLGFGTHSHDHGFRA-----EIQTLGNIRHR 743
+ IG G G+V H P GV++A+KK+ F +H EI+ L +H
Sbjct: 11 SYIGEGAYGMVCSATHK--PTGVKVAIKKISPF-----EHQTFCQRTLREIKILRRFKHE 63
Query: 744 NIVRLLA------FCSNKETNLLVYEYMRNGSLGEALHGKKGA------FLGWNLRYKIA 791
NI+ +L F S + +V E M L + + + + FL Y+I
Sbjct: 64 NIIGILDIIRPPSFESFNDV-YIVQELMET-DLYKLIKTQHLSNDHIQYFL-----YQIL 116
Query: 792 IEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI-DGGASECMSAI 850
+GL Y+H S ++HRD+K +N+LLN+ + + DFGLA+ + + ++
Sbjct: 117 ----RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 851 AGSYGYIAPEYAYTLRVDEKS-DVYSFGVVLLELLTGR 887
+ Y APE + K+ D++S G +L E+L+ R
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 32/226 (14%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGN 739
+ + +G G G VY G +++AVK L + + F E +
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 740 IRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL-----HGKKGAFLGWNLRYKIAIEA 794
H+NIVRL+ + ++ E M G L L ++ + L A +
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 795 AKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE---AHVADFGLAK-------FLIDGGAS 844
AKG YL +HRD+ + N LL A +ADFG+A+ + G A
Sbjct: 126 AKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA- 181
Query: 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRP 889
M I ++ PE K+DV+SFGV+L E+ + G P
Sbjct: 182 --MLPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 50/141 (35%), Positives = 70/141 (49%), Gaps = 9/141 (6%)
Query: 751 FCS--NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
+C+ KE V EY+ G L + L Y A E GL +LH S
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLH---SKG 116
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVD 868
IV+RD+K +NILL++ +ADFG+ K + G A C G+ YIAPE + +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC--TFCGTPDYIAPEILLGQKYN 174
Query: 869 EKSDVYSFGVVLLELLTGRRP 889
D +SFGV+L E+L G+ P
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 694 IGRGGAGIVYHGKMPNGVEI-AVKKLLGFGTHSHD--HGFRAEIQTLGNIRHRNIVRLLA 750
IG G G VY + E+ A+KK+ G S++ E++ L I+H N +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
+ T LV EY GS + L K + I A +GL YLH S ++
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLH---SHNMI 147
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL---RV 867
HRD+K+ NILL + +ADFG A AS S + Y ++APE + +
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSFVGTPY-WMAPEVILAMDEGQY 201
Query: 868 DEKSDVYSFGVVLLELLTGRRPV 890
D K DV+S G+ +EL + P+
Sbjct: 202 DGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 694 IGRGGAGIVYHGKMPN-GVEIAVKKL--LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
+G+GG G V ++ G A KKL + E + L + R IV L A
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 751 FCSNKETNL-LVYEYMRNGSLGEAL--HGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
+ + +L LV M G L + G+ G + Y A + GL +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFY--AAQIICGLEHLHQR--- 114
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
IV+RD+K N+LL+ ++D GLA L G + + AG+ GY+APE
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRAGTPGYMAPEVLQGEVY 171
Query: 868 DEKSDVYSFGVVLLELLTGRRPVGDFGDGVD 898
D D ++ G L E++ GR P + V+
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 41/280 (14%)
Query: 708 PNGV-EIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYM 765
PN V ++AVK L T +E++ + I +H+NI+ LL C+ ++ EY
Sbjct: 47 PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 106
Query: 766 RNGSLGEALHGKKGAFLGW----------NLRYK----IAIEAAKGLCYLHHDCSPLIVH 811
G+L E L ++ + + L +K A + A+G+ YL S +H
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIH 163
Query: 812 RDVKSNNILLNSAFEAHVADFGLAKFL--IDGGASECMSAIAGSYGYIAPEYAYTLRVDE 869
RD+ + N+L+ +ADFGLA+ + ID + ++APE +
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPEALFDRIYTH 221
Query: 870 KSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKE 928
+SDV+SFGV+L E+ T G P GV + EE +L M
Sbjct: 222 QSDVWSFGVLLWEIFTLGGSPY----PGVPV------------EELFKLLKEGHRMDKPS 265
Query: 929 EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSD 967
+ L++ M C +RP +++V+ L +S+
Sbjct: 266 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-11
Identities = 35/83 (42%), Positives = 47/83 (56%)
Query: 319 LHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSS 378
L G IP+ ++ L +L+++ L N+ G IP +LG L+VLDLS N G+IP L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 379 NQLRILILLKNFLFGPIPERLGA 401
LRIL L N L G +P LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 64/246 (26%), Positives = 108/246 (43%), Gaps = 22/246 (8%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEIQTLGNIRHRNIVRLLA 750
IG G G VY + + N +A+KK+ G S++ E++ L +RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
+ T LV EY GS + L K + + A +GL YLH S ++
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLH---SHNMI 137
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL---RV 867
HRDVK+ NILL+ + DFG A + + G+ ++APE + +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQY 191
Query: 868 DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKR-----ATNGRKEEFLSILDPRL 922
D K DV+S G+ +EL + P+ + + ++ + E F + +D L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 923 SMVPKE 928
+P++
Sbjct: 252 QKIPQD 257
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-11
Identities = 98/313 (31%), Positives = 139/313 (44%), Gaps = 26/313 (8%)
Query: 84 VPAQILRLDKLTNLSLAGNN-FTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVN--- 139
+P+ + RL L LS +G + GS + NL L L+++ N+ N S L+
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRS----NISELLELTN 117
Query: 140 LEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLT 199
L D NNN T + P+ L LK LDL N +P+ L L+ L L+ NDL+
Sbjct: 118 LTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNK-IESLPSPLRNLPNLKNLDLSFNDLS 176
Query: 200 GKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLK 259
+P L NL+NL + L + + +P E+ L L LDLS+ + ++ + NLK
Sbjct: 177 -DLPKLLSNLSNLNNLDLSGNKISD--LPPEIELLSALEELDLSNNSII-ELLSSLSNLK 232
Query: 260 LLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPY--SFINLRQLKL-FNLFM 316
L + L N L +P+ +GNL+NL LDLSNN ++ I S NLR+L L N
Sbjct: 233 NLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLS 290
Query: 317 NRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLC 376
N L L L L L N L ++ SN T + P L
Sbjct: 291 NALPLIALLLLLLELLLNLLLTL-------KALELKLNSILLNNNILSNGET-SSPEALS 342
Query: 377 SSNQLRILILLKN 389
L L L N
Sbjct: 343 ILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 32/227 (14%)
Query: 685 LECVKDGNVIGRGGAGIVYHGKMPNGVE------IAVKKLLGFGTHSHDHGFRAEIQTLG 738
+E V+D IG+G G V+ + P + +AVK L + F+ E +
Sbjct: 7 IEYVRD---IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 63
Query: 739 NIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL------------HGKKGAF----- 781
H NIV+LL C+ + L++EYM G L E L H A
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 782 ---LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838
L + IA + A G+ YL VHRD+ + N L+ +ADFGL++ +
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 839 IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
+ A ++ PE + R +SDV+++GVVL E+ +
Sbjct: 181 YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLL-A 750
++G G G VY G+ ++A K++ T + + EI L HRNI A
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 751 FCSNKETNL-----LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
F + LV E+ GS+ + + KG L I E +GL +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH- 130
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
++HRD+K N+LL E + DFG++ L D + I Y ++APE +
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPY-WMAPE---VI 183
Query: 866 RVDE--------KSDVYSFGVVLLELLTGRRPVGDF 893
DE KSD++S G+ +E+ G P+ D
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 694 IGRGGAGIVYHG--KM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHR----NIV 746
+G G G V G KM +++A+K L + ++ R E+ I H+ IV
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVL----KNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
R++ C E +LV E G L + L GKK N+ ++ + + G+ YL
Sbjct: 59 RMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNV-VELMHQVSMGMKYLEGKN- 115
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFL-IDGGASECMSAIAGSYGYIAPEYAYTL 865
VHRD+ + N+LL + A ++DFGL+K L D + SA + APE
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 866 RVDEKSDVYSFGVVLLELLT-GRRP 889
+ +SDV+S+G+ + E + G++P
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-11
Identities = 55/179 (30%), Positives = 80/179 (44%), Gaps = 32/179 (17%)
Query: 730 FRAEIQTLGNIRHRNIVRLLAFCSNK-ETNLL--VYEYMRNGSLGEALH-------GKKG 779
FR E + H NIV LL S + LL V+EY+ +L E L G+ G
Sbjct: 25 FRRETALCARLYHPNIVALLD--SGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETG 82
Query: 780 AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA---FEAHVADFGLAK 836
+ L+ A+ A H+ IVHRD+K NI+++ A V DFG+
Sbjct: 83 RLM---LQVLDALACA-------HNQG--IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT 130
Query: 837 FLIDGGASECMSAIA-----GSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPV 890
L ++ + G+ Y APE V SD+Y++G++ LE LTG+R V
Sbjct: 131 LLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 686 ECVKDGNVIGRGGAGIVYHG---KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-R 741
E +K +VIG G G V K + A+K L F + + F E++ L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL---------------HGKKGAFLGWNL 786
H NI+ LL C N+ + EY G+L + L HG L
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 787 RYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846
+ A + A G+ YL +HRD+ + N+L+ + +ADFGL++ G
Sbjct: 122 -LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVY 172
Query: 847 MSAIAGSYG--YIAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
+ G ++A E KSDV+SFGV+L E+++
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 71/275 (25%), Positives = 119/275 (43%), Gaps = 39/275 (14%)
Query: 693 VIGRGGAG---IVYHGKMPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRL 748
V+G+G G +V H +G + +KKL L + E Q L ++H NIV
Sbjct: 7 VVGKGSYGEVSLVRHRT--DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 749 LAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
++ L +V + G L L +KG L N + ++ A L YLH
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC--MSAIAGSYGYIAPEYAYTL 865
I+HRD+K+ N+ L V D G+A+ L ++C S + G+ Y++PE
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVL----ENQCDMASTLIGTPYYMSPELFSNK 177
Query: 866 RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL--SILDPRLS 923
+ KSDV++ G + E+ T K A N + L I++ +L
Sbjct: 178 PYNYKSDVWALGCCVYEMAT-----------------LKHAFNAKDMNSLVYRIIEGKLP 220
Query: 924 MVPKEEAMHL--LFVAMLCIQENSIERPRMREVVQ 956
+PK+ + L L ML + +RP ++ +++
Sbjct: 221 PMPKDYSPELGELIATMLSKRPE--KRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 39/102 (38%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 791 AIEAAKGLCYLH-HDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECM 847
A E GL +LH I++RD+K +N+LL+S E H+ ADFG+ K I GG +
Sbjct: 102 AAEIVLGLQFLHERG----IIYRDLKLDNVLLDS--EGHIKIADFGMCKEGILGGVT--T 153
Query: 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
S G+ YIAPE D ++ GV+L E+L G+ P
Sbjct: 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 32/164 (19%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLV--------YEY--MRNGSLGEALHGKKGAFL 782
E L N+ H +++R+ + +V Y Y R+ L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPL------------ 154
Query: 783 GWNLRYKIAIEAA--KGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840
+ + IE +GL YLH + I+HRDVK+ NI +N + + D G A+F +
Sbjct: 155 --PIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV- 208
Query: 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELL 884
+ +AG+ APE + + K+D++S G+VL E+L
Sbjct: 209 --VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 731 RAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAF------LGW 784
R E+ L N++H NIV+ +V +Y G L + ++ ++G L W
Sbjct: 47 RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106
Query: 785 NLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844
++ +A++ HD I+HRD+KS NI L + DFG+A+ L
Sbjct: 107 FVQICLALKHV-------HDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTV 155
Query: 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
E G+ Y++PE + KSD+++ G VL E+ T
Sbjct: 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 53/164 (32%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLL--VYEYMRNGSLGEALHGKKGAFLGWNLRYKI 790
E + L + H I+RL F + + L + EY+ G L L G F +
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLF-Y 106
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMS 848
A E L YLH S IV+RD+K NILL+ E H+ DFG AK L D + C
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDK--EGHIKLTDFGFAKKLRDRTWTLC-- 159
Query: 849 AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGD 892
G+ Y+APE + ++ D ++ G+++ E+L G P D
Sbjct: 160 ---GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 8e-11
Identities = 73/289 (25%), Positives = 121/289 (41%), Gaps = 44/289 (15%)
Query: 711 VEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRNGS 769
V +AVK L T +E++ + I +H+NI+ LL C+ + ++ EY G+
Sbjct: 45 VTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGN 104
Query: 770 LGEALHGKKG-----AF---------LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVK 815
L E L ++ F L + A + A+G+ YL S +HRD+
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLA 161
Query: 816 SNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYS 875
+ N+L+ +ADFGLA+ + D + S ++APE + +SDV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 876 FGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLL 934
FG+++ E+ T G P G+ + EE +L M H L
Sbjct: 222 FGILMWEIFTLGGSPY----PGIPV------------EELFKLLREGHRMDKPSNCTHEL 265
Query: 935 FVAML-CIQENSIERPRMREVVQML--------SEFPRHSSDFNQSSSS 974
++ M C +RP +++V+ L E+ S F Q S S
Sbjct: 266 YMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 65/218 (29%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA----EIQTLGNIRHRNIV 746
IG G G VY + G +A+KK+ + GF EI+ L + HRNIV
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 747 RL----------LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK 796
L L F +K LV+EYM + +G L F +++ + +
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG-LLESGLVHFSEDHIK-SFMKQLLE 127
Query: 797 GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGY 856
GL Y H +HRD+K +NILLN+ + +ADFGLA+ + + + + Y
Sbjct: 128 GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW-Y 183
Query: 857 IAPEYAYTLRVDEKS----DVYSFGVVLLELLTGRRPV 890
PE L +E+ DV+S G +L EL T ++P+
Sbjct: 184 RPPEL---LLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819
++ EY+ GS + L + G F + + + E KGL YLH S +HRD+K+ N+
Sbjct: 79 IIMEYLGGGSALDLL--RAGPFDEFQIATMLK-EILKGLDYLH---SEKKIHRDIKAANV 132
Query: 820 LLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVV 879
LL+ + +ADFG+A L D + G+ ++APE D K+D++S G+
Sbjct: 133 LLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYDSKADIWSLGIT 190
Query: 880 LLELLTGRRPVGD 892
+EL G P D
Sbjct: 191 AIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 66/203 (32%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 693 VIGRGGAGIVYHGKMP-NGVEIAVKKL-----LGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
VIG+G G V K +G AVK L L H R + L N++H +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVL--LKNVKHPFLV 59
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
L + V +Y+ G L L ++ +F R+ A E A L YLH S
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRER-SFPEPRARF-YAAEIASALGYLH---S 114
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
I++RD+K NILL+S + DFGL K I+ S+ S G+ Y+APE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCGTPEYLAPEVLRKQP 172
Query: 867 VDEKSDVYSFGVVLLELLTGRRP 889
D D + G VL E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 68/227 (29%), Positives = 100/227 (44%), Gaps = 26/227 (11%)
Query: 682 SDILECVKDGNVIGRGGAGIVY--HGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGN 739
SD E ++ IG+G G V+ K NG + AVK L H D AE L
Sbjct: 17 SDTWEIIE---TIGKGTYGKVFKVLNKK-NGSKAAVKIL--DPIHDIDEEIEAEYNILKA 70
Query: 740 IR-HRNIVRLLAFCSNKETN-----LLVYEYMRNGSLGEALHG--KKGAFLGWNLRYKIA 791
+ H N+V+ K+ LV E GS+ + + G K+G + + I
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130
Query: 792 IEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIA 851
EA GL +LH + + +HRDVK NNILL + + DFG++ L S
Sbjct: 131 HEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--V 185
Query: 852 GSYGYIAPEYAYTLR-----VDEKSDVYSFGVVLLELLTGRRPVGDF 893
G+ ++APE + D + DV+S G+ +EL G P+ D
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 10/158 (6%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL--HGKKGAFLGWNLRYKI 790
EI + ++H NIVRL + +LV+EYM + L + + HG +GA L N
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGA-LDPNTVKSF 105
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850
+ KG+ + H + ++HRD+K N+L+N E +ADFGLA+ G S
Sbjct: 106 TYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF--GIPVNTFSNE 160
Query: 851 AGSYGYIAPEYAYTLRVDEKS-DVYSFGVVLLELLTGR 887
+ Y AP+ R S D++S G ++ E++TGR
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 51/161 (31%), Positives = 76/161 (47%), Gaps = 16/161 (9%)
Query: 732 AEIQTLGNIRHRNIVRLL-AFCSNKETNL-LVYEYMRNGSLGEALHGKKGAF-LGWNLRY 788
E + L +IRH +V L +F + NL LV EY+ G L + K G F Y
Sbjct: 50 NEKRILQSIRHPFLVNLYGSFQDDS--NLYLVMEYVPGGELF-SHLRKSGRFPEPVARFY 106
Query: 789 KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS 848
A + L YLH IV+RD+K N+LL+S + DFG AK + + C
Sbjct: 107 --AAQVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-- 159
Query: 849 AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
G+ Y+APE + + D ++ G+++ E+L G P
Sbjct: 160 ---GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 63/254 (24%), Positives = 117/254 (46%), Gaps = 24/254 (9%)
Query: 675 QKLEFSVSDILECVKDGNVIGRGGAGIV-YHGKMPNGVEIAVKKLL-GFGTHSHDHGFRA 732
Q++ ++ ++ + +D +G G G V G ++A+KKL F +
Sbjct: 4 QEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNL-------LVYEYMRNGSLGEALHGKKGAFLGWN 785
E++ L +++H N++ LL + + +L LV +M LG+ + +K L +
Sbjct: 64 ELRLLKHMKHENVIGLLDVFT-PDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK---LSED 118
Query: 786 LRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845
+ + KGL Y+H + I+HRD+K N+ +N E + DFGLA+
Sbjct: 119 RIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDS 170
Query: 846 CMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSK 904
M+ + Y APE + + D++S G ++ E+LTG +P+ D +D +
Sbjct: 171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHDHLDQLMEIM 229
Query: 905 RATNGRKEEFLSIL 918
+ T +EF+ L
Sbjct: 230 KVTGTPSKEFVQKL 243
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAF 751
IG G G+VY + G +A+KK+ L T EI L + H NIV+LL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 752 CSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVH 811
+ LV+E++ + L + + + + L + +GL + H S ++H
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 123
Query: 812 RDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYA-----YTLR 866
RD+K N+L+N+ +ADFGLA+ G + + Y APE Y+
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 181
Query: 867 VDEKSDVYSFGVVLLELLTGR 887
V D++S G + E++T R
Sbjct: 182 V----DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGF-----RAEIQTLGNIRHRNI 745
N I G G+VY + G +A+KKL GF R EI L ++H NI
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKL---KMEKEKEGFPITSLR-EINILLKLQHPNI 66
Query: 746 VRL--LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH 803
V + + SN + +V EY+ + L + K FL ++ + ++ G+ +LH
Sbjct: 67 VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC-LMLQLLSGVAHLHD 124
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLA-KFLIDGGASECMSAIAGSYGYIAPEYA 862
+ I+HRD+K++N+LLN+ + DFGLA ++ G + + + + Y APE
Sbjct: 125 N---WILHRDLKTSNLLLNNRGILKICDFGLAREY---GSPLKPYTQLVVTLWYRAPE-- 176
Query: 863 YTLRVDEKS-----DVYSFGVVLLELLTGR 887
L + K D++S G + ELLT +
Sbjct: 177 --LLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 18/220 (8%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA----EIQTLGNIRHRNIVRL 748
IGRG VY + +GV +A+KK+ F D RA EI L + H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLM--DAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 749 LA-FCSNKETNLLVYEYMRNGSLGEAL-HGKKGA-FLGWNLRYKIAIEAAKGLCYLHHDC 805
A F + E N+ V E G L + H KK + +K ++ L ++H
Sbjct: 68 YASFIEDNELNI-VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--- 123
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
S ++HRD+K N+ + + + D GL +F + ++ G+ Y++PE +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 866 RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKR 905
+ KSD++S G +L E+ + P +GD +++ K+
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKK 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 675 QKLEFSVSDILECVKDGNVIGRGGAGIVYHG-KMPNGVEIAVKKL-LGFGTHSHDHGFRA 732
Q+L ++ ++ E ++ + +G G G V G+ +AVKKL F + H
Sbjct: 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 65
Query: 733 EIQTLGNIRHRNIVRLL-AFCSNKETNLLVYEYMRNGSLGEALHG--KKGAFLGWNLRYK 789
E++ L +++H N++ LL F + Y+ +G L+ K ++++
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 790 IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA 849
I + +GL Y+H S I+HRD+K +N+ +N E + DFGLA+ + M+
Sbjct: 126 I-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTG 176
Query: 850 IAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGR 887
+ Y APE + ++ D++S G ++ ELLTGR
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 66/230 (28%), Positives = 96/230 (41%), Gaps = 56/230 (24%)
Query: 689 KDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA----EIQTLGNIR-- 741
++ IG G G VY + + G +A+KK+ + G EI L +
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLESF 58
Query: 742 -HRNIVRLLAFCSNKETN-----LLVYE--------YMRNGSLGEALHGKKGAFLGWNLR 787
H NIVRLL C T+ LV+E Y+ K G L
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSK-------CPKPG--LPPETI 109
Query: 788 YKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847
+ + +G+ +LH S IVHRD+K NIL+ S + +ADFGLA+ S M
Sbjct: 110 KDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-----SFEM 161
Query: 848 S--AIAGSYGYIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ ++ + Y APE YA + D++S G + EL RRP
Sbjct: 162 ALTSVVVTLWYRAPEVLLQSSYATPV------DMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-10
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 693 VIGRGGAGIVYHG-KMPNGVEIAVKKLL-GFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
IG G G+V +G ++A+KK+ F + E++ L + +H NI+ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71
Query: 751 FCSNKETNL----LVYEYMRNGSLGEALHGKK-------GAFLGWNLRYKIAIEAAKGLC 799
+ +V + M + L +H + FL LR GL
Sbjct: 72 ILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR---------GLK 121
Query: 800 YLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC--MSAIAGSYGYI 857
Y+H S ++HRD+K +N+L+N E + DFG+A+ L M+ + Y
Sbjct: 122 YIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 858 APEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPV 890
APE +L D++S G + E+L GRR +
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 46/135 (34%), Positives = 69/135 (51%), Gaps = 7/135 (5%)
Query: 755 KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDV 814
KE V E++ G L + KG F +L Y+ AA+ +C L S I++RD+
Sbjct: 68 KEHLFFVMEFLNGGDLMFHIQ-DKGRF---DL-YRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 815 KSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVY 874
K +N++L+ +ADFG+ K + G S G+ YIAPE L+ D +
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKYTFSVDWW 180
Query: 875 SFGVVLLELLTGRRP 889
SFGV+L E+L G+ P
Sbjct: 181 SFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-10
Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 5/109 (4%)
Query: 244 SCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSF 303
C+ D +D + L L G IP + L +L +++LS N++ G IP S
Sbjct: 408 DCQFDSTKGKWF-----IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL 462
Query: 304 INLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLG 352
++ L++ +L N +GSIP+ L L +L L L N+ +G +P LG
Sbjct: 463 GSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 66/203 (32%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 693 VIGRGGAGIVYHGKMP-NGVEIAVKKL-----LGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
VIG+G G V K +G AVK L L +H R + L N++H +V
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL--LKNLKHPFLV 59
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
L E V +Y+ G L L ++ FL R+ A E A + YLH S
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRER-CFLEPRARF-YAAEVASAIGYLH---S 114
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
I++RD+K NILL+S + DFGL K ++ E S G+ Y+APE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCGTPEYLAPEVLRKEP 172
Query: 867 VDEKSDVYSFGVVLLELLTGRRP 889
D D + G VL E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 47/136 (34%), Positives = 68/136 (50%), Gaps = 9/136 (6%)
Query: 755 KETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
K+T L ++ EY+ GS AL + L I E KGL YLH S +HRD
Sbjct: 73 KDTKLWIIMEYLGGGS---ALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRD 126
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDV 873
+K+ N+LL+ E +ADFG+A L D + G+ ++APE D K+D+
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADI 184
Query: 874 YSFGVVLLELLTGRRP 889
+S G+ +EL G P
Sbjct: 185 WSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-10
Identities = 65/234 (27%), Positives = 97/234 (41%), Gaps = 51/234 (21%)
Query: 694 IGRGGAGIVYHGKMPN-GVEIAVKKL---LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
IG+GG G VY P +A+KK+ L F E + ++ H IV +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR-FLREAKIAADLIHPGIVPVY 68
Query: 750 AFCSNKETNLLVYEYM----------------RNGSLGEALHGKK--GAFLGWNLRYKIA 791
+ CS+ + VY M + SL + L K GAFL I
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL------SIF 119
Query: 792 IEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF-------LIDGGAS 844
+ + Y+H S ++HRD+K +NILL E + D+G A F L+D
Sbjct: 120 HKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 845 E---------CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
E I G+ Y+APE + E +D+Y+ GV+L ++LT P
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 688 VKDGNVIGRGGAGIVYHGKMPNG---VEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHR 743
+K +VIG G G V ++ ++ A+K++ + + F E++ L + H
Sbjct: 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 68
Query: 744 NIVRLLAFCSNKETNLLVYEYMRNGSLGE--------------ALHGKKGAFLGWNLRYK 789
NI+ LL C ++ L EY +G+L + A+ + L
Sbjct: 69 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 790 IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA 849
A + A+G+ YL +HRD+ + NIL+ + A +ADFGL++ G +
Sbjct: 129 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKK 180
Query: 850 IAGSYG--YIAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
G ++A E SDV+S+GV+L E+++
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 20/225 (8%)
Query: 694 IGRGGAGIVYHGKM-PNGVEIAVKKL--------LGFGTHSHDHGFRAEIQTLGNIRHRN 744
+G+GG G V +M G A KKL G+ G E + L + R
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGY------EGAMVEKRILAKVHSRF 54
Query: 745 IVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH 803
IV L A+ +T+L LV M G L ++ G+ + A+ + L H
Sbjct: 55 IVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP-EPRACFYTAQIISGLEH 112
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAY 863
I++RD+K N+LL++ ++D GLA L DG AG+ G++APE
Sbjct: 113 LHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYAGTPGFMAPELLQ 170
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN 908
D D ++ GV L E++ R P G+ V+ + +R N
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFR----AEIQTLGNIRHRNIVRL 748
IGRG VY + + +A+KK+ F D R EI L + H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIF--EMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 749 L-AFCSNKETNLLVYEYMRNGSLGEALH--GKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
L +F + E N+ V E G L + + K+ + +K ++ + ++H
Sbjct: 68 LDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--- 123
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA--IAGSYGYIAPEYAY 863
S ++HRD+K N+ + + + D GL +F +S+ +A + G+ Y++PE +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSPERIH 179
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDI 899
+ KSD++S G +L E+ + P +GD +++
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 40/156 (25%), Positives = 63/156 (40%), Gaps = 56/156 (35%)
Query: 60 WAGICCSRDRVAS------LDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIG 111
W+G C D L L + L G +P I +L L +++L+GN+ G+I +G
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 112 NLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGG 171
+++SL+ L++S N F+G
Sbjct: 464 SITSLEVLDLSYNSFNG------------------------------------------- 480
Query: 172 NYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELG 207
IP S G+L L L+L GN L+G++P LG
Sbjct: 481 -----SIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 692 NVIGRGGAGIVYHGKMP-NGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVR 747
+VIG G G V ++ +G+ + A+K++ + + F E++ L + H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEAL---------------HGKKGAFLGWNLRYKIAI 792
LL C ++ L EY +G+L + L + L A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL-LHFAA 119
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
+ A+G+ YL +HRD+ + NIL+ + A +ADFGL++ G + G
Sbjct: 120 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMG 171
Query: 853 SYG--YIAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
++A E SDV+S+GV+L E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 10/203 (4%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
IG G G VY + N E+A K++ + EI + + +H NIV
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
++ + E+ GSL + H G + Y ++ E +GL YLH +HRD
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAY-VSRETLQGLYYLHSKGK---MHRD 131
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR---VDEK 870
+K NILL +ADFG++ I ++ S I Y ++APE A R ++
Sbjct: 132 IKGANILLTDNGHVKLADFGVSA-QITATIAKRKSFIGTPY-WMAPEVAAVERKGGYNQL 189
Query: 871 SDVYSFGVVLLELLTGRRPVGDF 893
D+++ G+ +EL + P+ D
Sbjct: 190 CDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 7/153 (4%)
Query: 737 LGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK 796
L N++H +V L + V +Y+ G L L ++ FL R+ A E A
Sbjct: 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARF-YAAEIAS 107
Query: 797 GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGY 856
L YLH S IV+RD+K NILL+S + DFGL K I+ + S G+ Y
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEY 162
Query: 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+APE + D D + G VL E+L G P
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 30/76 (39%), Positives = 49/76 (64%)
Query: 225 GGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTN 284
G IP ++ KL +L ++LS + G IP +G++ L+ + L N +GSIP+ LG LT+
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 285 LVNLDLSNNALTGEIP 300
L L+L+ N+L+G +P
Sbjct: 492 LRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 10/203 (4%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
+G G G VY + + E+A K++ + EI + +H NIV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
++E + EY GSL + H G + Y + E +GL YLH S +HRD
Sbjct: 77 SREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAY-VCRETLQGLAYLH---SKGKMHRD 131
Query: 814 VKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR---VDEK 870
+K NILL + +ADFG+A I ++ S I Y ++APE A + ++
Sbjct: 132 IKGANILLTDNGDVKLADFGVAA-KITATIAKRKSFIGTPY-WMAPEVAAVEKNGGYNQL 189
Query: 871 SDVYSFGVVLLELLTGRRPVGDF 893
D+++ G+ +EL + P+ D
Sbjct: 190 CDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 30/233 (12%)
Query: 686 ECVKDGNVIGRGGAGIVYHGK-MPNGVE-IAVKKLLGFGTHSHDHGFR-------AEIQT 736
ECV + IG G G V+ + + NG +A+K++ + + G A ++
Sbjct: 4 ECVAE---IGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 57
Query: 737 LGNIRHRNIVRLLAFCS----NKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIA 791
L H N+VRL C+ ++ET L LV+E++ + L L + +
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 792 IEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIA 851
+ +GL +LH S +VHRD+K NIL+ S+ + +ADFGLA+ ++++
Sbjct: 117 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 170
Query: 852 GSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSK 904
+ Y APE D++S G + E+ R+P+ F D+ Q K
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL--FRGSSDVDQLGK 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 22/203 (10%)
Query: 694 IGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC 752
IG+G +G VY + G E+A+K++ EI + +H NIV L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 753 SNKETNLLVYEYMRNGSLGEAL------HGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
+ +V EY+ GSL + + G+ A + E + L +LH S
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---------VCRECLQALEFLH---S 133
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
++HRD+KS+NILL + DFG + + S + G+ ++APE
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKA 191
Query: 867 VDEKSDVYSFGVVLLELLTGRRP 889
K D++S G++ +E++ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 47/139 (33%), Positives = 71/139 (51%), Gaps = 23/139 (16%)
Query: 763 EYMRNGSLGEALHGKKGAFLGW--NLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNIL 820
EYM GSL + L+ A G ++ +I KGL +L + + I+HRDVK N+L
Sbjct: 79 EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVL 135
Query: 821 LNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY----------AYTLRVDEK 870
+N + + DFG++ L+ AS + I G Y+APE YT+ +
Sbjct: 136 VNGNGQVKLCDFGVSGNLV---ASLAKTNI-GCQSYMAPERIKSGGPNQNPTYTV----Q 187
Query: 871 SDVYSFGVVLLELLTGRRP 889
SDV+S G+ +LE+ GR P
Sbjct: 188 SDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 40/229 (17%)
Query: 693 VIGRGGAGIV---YHGKMPNGVEIAVKKL-LGFGTHSH-DHGFRAEIQTLGNIRHRNIVR 747
IG G GIV Y V A+KKL F +H +R E+ + + H+NI+
Sbjct: 23 PIGSGAQGIVCAAYDTVTGQNV--AIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIG 79
Query: 748 LL-AFCSNKETN-----LLVYEYMRNGSLGEALH----GKKGAFLGWNLRYKIAIEAAKG 797
LL F K LV E M + +L + + ++ ++L + +
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSYLLYQM----------- 127
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI 857
LC + H S I+HRD+K +NI++ S + DFGLA+ G S M+ + Y
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 184
Query: 858 APEYAYTLRVDEKSDVYSFGVVLLELLTGRR--PVGDFGDGVDIVQWSK 904
APE + E D++S G ++ E++ G P D D QW+K
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-----QWNK 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 60/240 (25%), Positives = 99/240 (41%), Gaps = 39/240 (16%)
Query: 657 KAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHG-KMPNGVEIAV 715
K +S G K T F+K IG+G +G VY + G E+A+
Sbjct: 7 KLRSIVSVGDPKKKYTRFEK-----------------IGQGASGTVYTAIDIATGQEVAI 49
Query: 716 KKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL- 774
K++ EI + ++ NIV L + +V EY+ GSL + +
Sbjct: 50 KQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 108
Query: 775 -----HGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV 829
G+ A + E + L +LH S ++HRD+KS+NILL +
Sbjct: 109 ETCMDEGQIAA---------VCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKL 156
Query: 830 ADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
DFG + + S + G+ ++APE K D++S G++ +E++ G P
Sbjct: 157 TDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 37/109 (33%), Positives = 58/109 (53%), Gaps = 11/109 (10%)
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK-FLIDGGASECMSA 849
A E + GL +LH I++RD+K +N++L+S +ADFG+ K ++DG
Sbjct: 107 AAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRT 160
Query: 850 IAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD 898
G+ YIAPE + D +++GV+L E+L G+ P DG D
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF----DGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 64/201 (31%), Positives = 87/201 (43%), Gaps = 11/201 (5%)
Query: 693 VIGRGGAGIVYHGKMP-NGVEIAVK---KLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRL 748
VIG+G G V K +G AVK K + H L N++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
E V +++ G L L ++ +F R+ A E A L YLH S
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAA-EIASALGYLH---SIN 116
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVD 868
IV+RD+K NILL+S + DFGL K I S+ + G+ Y+APE D
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGI--AQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 869 EKSDVYSFGVVLLELLTGRRP 889
D + G VL E+L G P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 33/85 (38%), Positives = 43/85 (50%)
Query: 336 LGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPI 395
LGL G IP ++ + LQ ++LS N + G IP L S L +L L N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 396 PERLGACYSLTRVRLGQNYLNGSIP 420
PE LG SL + L N L+G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 694 IGRGGAGIVYHG--KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHR----NIVR 747
+G G G V G KM + K+L ++D + E+ N+ + IVR
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILK--NDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIE----AAKGLCYLHH 803
++ C E+ +LV E G L + L K ++ K E + G+ YL
Sbjct: 61 MIGICE-AESWMLVMELAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEE 113
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYG-----YIA 858
VHRD+ + N+LL + A ++DFGL+K L GA E A ++G + A
Sbjct: 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL---GADENYYK-AKTHGKWPVKWYA 166
Query: 859 PEYAYTLRVDEKSDVYSFGVVLLELLT-GRRP 889
PE + KSDV+SFGV++ E + G++P
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 23/159 (14%)
Query: 749 LAFCSNKETNL-LVYEYMRNGSLGEALH--GKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
LA+ +T+L LV M G L ++ G++G + + Y I G+ +LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGILHLH--- 112
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE----- 860
S IV+RD+K N+LL+ ++D GLA L DG + ++ AG+ GY+APE
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGTNGYMAPEILKEE 169
Query: 861 -YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD 898
Y+Y + D ++ G + E++ GR P D + V
Sbjct: 170 PYSYPV------DWFAMGCSIYEMVAGRTPFKDHKEKVA 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 694 IGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHDHG--FRA--EIQTLGNIRHRNIVRL 748
+G G VY G NG +A+K + + + G F A E L ++H NIV L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
KET V+EYM L + + G +N+R + +GL Y+H
Sbjct: 69 HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQ---H 123
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAP-------EY 861
I+HRD+K N+L++ E +ADFGLA+ S+ S+ + Y P +Y
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181
Query: 862 AYTLRVDEKSDVYSFGVVLLELLTGR 887
+ L D++ G + +E+L G+
Sbjct: 182 SSAL------DIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALH--GKKGAFLGWNLRYKI 790
E Q L + R +V L K+ LV M G L ++ G+ G G + Y
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY-- 107
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850
A E GL LH + IV+RD+K NILL+ ++D GLA + +G + +
Sbjct: 108 AAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGR 161
Query: 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
G+ GY+APE R D ++ G +L E++ G+ P
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 67/217 (30%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753
+G AG +Y K+ I K T H R E Q L +R + L +
Sbjct: 22 VGGHDAGKLYAMKVLKKATIVQKA----KTAEHT---RTERQVLEAVRRCPFLVTLHYAF 74
Query: 754 NKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHR 812
+T L L+ +Y+ G L L+ ++ F +R IA E L +LH I++R
Sbjct: 75 QTDTKLHLILDYVNGGELFTHLY-QREHFTESEVRVYIA-EIVLALDHLHQLG---IIYR 129
Query: 813 DVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV--D 868
D+K NILL+S E HV DFGL+K + S G+ Y+APE D
Sbjct: 130 DIKLENILLDS--EGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGGHD 186
Query: 869 EKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKR 905
+ D +S GV+ ELLTG P G+ + S+R
Sbjct: 187 KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR 223
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 66/215 (30%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 694 IGRGGAGIVYH-GKMPNGVEIAVKKLLGFGTHSHDHGFRAE---IQTLGNIRHRNIVRLL 749
IG+G G VY +G AVK L D AE +Q+L N H N+V+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPN--HPNVVKFY 85
Query: 750 AFCSNKETNL-----LVYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLH 802
+ + LV E GS+ E + G G L + I A GL +LH
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY- 861
++ I+HRDVK NNILL + + DFG++ L S G+ ++APE
Sbjct: 146 NN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVI 200
Query: 862 ----AYTLRVDEKSDVYSFGVVLLELLTGRRPVGD 892
Y D + DV+S G+ +EL G P+ D
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 731 RAEIQTLGNIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYK 789
R E Q L +IR + L + +T L L+ +Y+ G L L ++ R+K
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE--------RFK 103
Query: 790 ---IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK-FLIDGGASE 845
+ I + + + L H I++RD+K NILL+S + DFGL+K F D E
Sbjct: 104 EQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED--EVE 161
Query: 846 CMSAIAGSYGYIAPEYAYTLRV--DEKSDVYSFGVVLLELLTGRRP 889
+ G+ Y+AP+ D+ D +S GV++ ELLTG P
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 694 IGRGGAGIVYHGKMPNGVEI-AVKKLLGFGTHSHDHG-----FRAEIQTLGNIRHRNIVR 747
IG G G V+ K EI A+K++ D G R EI L ++H+NIVR
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALR-EICLLKELKHKNIVR 63
Query: 748 LLAFCSNKETNLLVYEYMRNG--SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
L + + LV+EY ++ +G + + +++ KGL + H
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLL----KGLAFCH--- 116
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
S ++HRD+K N+L+N E +ADFGLA+ G C SA + Y P+ +
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGA 174
Query: 866 RVDEKS-DVYSFGVVLLELLTGRRPV 890
++ S D++S G + EL RP+
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 5e-09
Identities = 59/240 (24%), Positives = 99/240 (41%), Gaps = 39/240 (16%)
Query: 657 KAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHG-KMPNGVEIAV 715
K +S G K T F+K IG+G +G VY + G E+A+
Sbjct: 8 KLRSIVSVGDPKKKYTRFEK-----------------IGQGASGTVYTAMDVATGQEVAI 50
Query: 716 KKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL- 774
+++ EI + ++ NIV L + +V EY+ GSL + +
Sbjct: 51 RQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109
Query: 775 -----HGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV 829
G+ A + E + L +LH S ++HRD+KS+NILL +
Sbjct: 110 ETCMDEGQIAA---------VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKL 157
Query: 830 ADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
DFG + + S + G+ ++APE K D++S G++ +E++ G P
Sbjct: 158 TDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 675 QKLEFSVSDILECVKDGNVIGRGGAGIV---YHGKMPNGVEIAVKKL-LGFGTHSHDHGF 730
Q+L +V ++ E ++ +G G G V Y ++ ++AVKKL F + H
Sbjct: 4 QELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRT 61
Query: 731 RAEIQTLGNIRHRNIVRLL-AFCSNKETNLLVYEYMRNGSLGEALHG--KKGAFLGWNLR 787
E++ L +++H N++ LL F Y+ +G L+ K +++
Sbjct: 62 YRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQ 121
Query: 788 YKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847
+ I + +GL Y+H S I+HRD+K +N+ +N E + DFGLA+ A + M
Sbjct: 122 FLI-YQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEM 172
Query: 848 SAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRR--PVGDFGD 895
+ + Y APE + ++ D++S G ++ ELL G+ P D+ D
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID 223
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 50/157 (31%), Positives = 70/157 (44%), Gaps = 7/157 (4%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI 792
E + L N RH + L K+ V EY+ G L L ++ F R+ A
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGA- 102
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
E L YLH S IV+RD+K N++L+ + DFGL K I A+ M G
Sbjct: 103 EIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--MKTFCG 157
Query: 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ Y+APE D + GVV+ E++ GR P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850
A E A GL +LH S I++RD+K +N++L+S +ADFG+ K + G +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTF 161
Query: 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
G+ YIAPE + D ++FGV+L E+L G+ P
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 19/202 (9%)
Query: 694 IGRGGAGIVYHGKMPNGVEIA----VKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
+G+GG G V+ K + EI +KK L F + H E L + +V+LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRH-VLTERDILTTTKSEWLVKLL 67
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIA--IEAAKGLCYLHHDCSP 807
+ E L EY+ G L G + R+ +A EA L L
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELG----- 121
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
+HRD+K N L++++ + DFGL+K G +++ GS Y+APE
Sbjct: 122 -YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKGY 175
Query: 868 DEKSDVYSFGVVLLELLTGRRP 889
D D +S G +L E L G P
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 13/197 (6%)
Query: 694 IGRGGAGIVY---HGKMPNGVEIAVKKLLGFGTHSHDHGFRA--EIQTLGNIRHRNIVRL 748
+G+G G VY K + V K + G + + +A E Q L + H IV+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALH--GKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
A ++ ++ EY L L G L N + I+ G+ Y+H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-- 125
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
I+HRD+K+ NI L + + DFG+++ L+ G+ + + G+ Y++PE
Sbjct: 126 -RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTFTGTPYYMSPEALKHQG 181
Query: 867 VDEKSDVYSFGVVLLEL 883
D KSD++S G +L E+
Sbjct: 182 YDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 64/239 (26%), Positives = 94/239 (39%), Gaps = 70/239 (29%)
Query: 694 IGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHDHGF-----RAEIQTLGNIRHRNIVR 747
+G G G VY ++ G +A+KK+L H+ GF R EI+ L ++H N+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALR-EIKILKKLKHPNVVP 71
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAF-------------LGWNLRYKIAIEA 794
L+ + E + K+G+ L N K+
Sbjct: 72 LID---------MAVER------PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ 116
Query: 795 AK--------GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846
K G+ YLH I+HRD+K+ NIL+++ +ADFGLA+ DG
Sbjct: 117 IKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR-PYDGPPPNP 172
Query: 847 MSAIAGS---YG-------YIAPEYA-----YTLRVDEKSDVYSFGVVLLELLTGRRPV 890
G Y Y PE YT V D++ G V E+ T RRP+
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFT-RRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 7e-09
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 694 IGRGGAGIV---YHGKMPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
IG G GIV Y + V A+KKL F +H E+ + + H+NI+ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 750 AFCSNKET------NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH 803
+ +++ LV E M + +L + + + L Y++ LC + H
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQM-------LCGIKH 134
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAY 863
S I+HRD+K +NI++ S + DFGLA+ G S M+ + Y APE
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 864 TLRVDEKSDVYSFGVVLLELLTGR--RPVGDFGDGVDIVQWSK 904
+ E D++S G ++ E++ + P D+ D QW+K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-----QWNK 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-09
Identities = 38/118 (32%), Positives = 50/118 (42%), Gaps = 14/118 (11%)
Query: 115 SLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYF 174
QF + F GL + N +P I KL L+ ++L GN
Sbjct: 408 DCQFDSTKGKWFIDGLGLD-------------NQGLRGFIPNDISKLRHLQSINLSGNSI 454
Query: 175 FGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVG 232
G IP S G + LE L L+ N G IP LG LT+LR + L N G +P +G
Sbjct: 455 RGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN-GNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 34/105 (32%), Positives = 46/105 (43%), Gaps = 2/105 (1%)
Query: 360 LDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSI 419
L L + L G IP D+ L+ + L N + G IP LG+ SL + L N NGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 420 PDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNN 464
P+ L L + L N LSG +P N ++N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP--AALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 74/289 (25%), Positives = 116/289 (40%), Gaps = 47/289 (16%)
Query: 694 IGRGGAGIVYHG------KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
+G+G G+VY G K +AVK + + F E + ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALH----------GKKGAFLGWNLRYKIAIEAAKG 797
LL S + L+V E M +G L L G+ L + ++A E A G
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 131
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYG-- 855
+ YL+ + VHRD+ + N ++ F + DFG+ + + E G G
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLL 183
Query: 856 ---YIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRK 911
++APE SD++SFGVVL E+ + +P G+ Q K +G
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY----QGLSNEQVLKFVMDG-- 237
Query: 912 EEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
LD + P E + L +C Q N RP E+V +L +
Sbjct: 238 ----GYLD-QPDNCP--ERVTDLM--RMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 48/197 (24%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC 752
IG+G +G V+ + G E+A+K++ EI + +++ NIV L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 753 SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHR 812
+ +V EY+ GSL + + + + E + L +LH + ++HR
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN---QVIHR 139
Query: 813 DVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSD 872
D+KS+N+LL + DFG + + S + G+ ++APE K D
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 873 VYSFGVVLLELLTGRRP 889
++S G++ +E++ G P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 694 IGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHDHGFRA--EIQTLGNIRHRNIVRLL- 749
+G G G V G ++A+KKL S RA E+ L +++H N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 750 AFCSNKETN-----LLVYEYMR---NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
F S + LV YM+ +G L K +L + + GL Y+
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------LCGLKYI 133
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY 861
H S I+HRD+K N+ +N E + DFGLA+ A M+ + Y APE
Sbjct: 134 H---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEV 185
Query: 862 AYT-LRVDEKSDVYSFGVVLLELLTGR 887
+ ++ D++S G ++ E+LTG+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 49/159 (30%), Positives = 72/159 (45%), Gaps = 18/159 (11%)
Query: 736 TLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAA 795
T + RH +V L A ++ V EY G L +H F + A
Sbjct: 55 TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAA-CVV 111
Query: 796 KGLCYLH-HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY 854
GL YLH + IV+RD+K +N+LL++ +ADFGL K G + S G+
Sbjct: 112 LGLQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTP 165
Query: 855 GYIAPEY----AYTLRVDEKSDVYSFGVVLLELLTGRRP 889
++APE +YT V D + GV++ E+L G P
Sbjct: 166 EFLAPEVLTETSYTRAV----DWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 49/157 (31%), Positives = 69/157 (43%), Gaps = 7/157 (4%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI 792
E + L N RH + L + V EY G L L ++ F R+ A
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGA- 102
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
E L YLH S +V+RD+K N++L+ + DFGL K I GA+ M G
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCG 157
Query: 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ Y+APE D + GVV+ E++ GR P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 47/197 (23%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 694 IGRGGAGIV-YHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC 752
IG G GIV + G ++AVKK+ + F E+ + + H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSY 88
Query: 753 SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHR 812
+ +V E++ G+L + + + + + + + L YLH+ ++HR
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQG---VIHR 142
Query: 813 DVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSD 872
D+KS++ILL S ++DFG + ++ G+ ++APE L + D
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 873 VYSFGVVLLELLTGRRP 889
++S G++++E++ G P
Sbjct: 201 IWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 694 IGRGGAGIV---YHGKMPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
IG G GIV Y + V A+KKL F +H E+ + + H+NI+ LL
Sbjct: 32 IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 750 -AFCSNKE----TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
F K ++ + + + +L + + + L Y++ LC + H
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM-------LCGIKHL 142
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT 864
S I+HRD+K +NI++ S + DFGLA+ G S M+ + Y APE
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 865 LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD-IVQWSK 904
+ E D++S G ++ E++ G G G D I QW+K
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 34/90 (37%), Positives = 46/90 (51%), Gaps = 1/90 (1%)
Query: 191 LSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQ 250
L L L G IP ++ L +L+ I L N G IP +G + +L LDLS +G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSG-NSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 251 IPHEIGNLKLLDTVFLHINLLSGSIPKQLG 280
IP +G L L + L+ N LSG +P LG
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 694 IGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFR-------AEIQTLGNIRHRNI 745
IG G G VY + P+ G +A+K + +++ G A ++ L H NI
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 746 VRLLAFCSNKETN-----LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
VRL+ C+ T+ LV+E++ + L L L + + +GL +
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE 860
LH +C IVHRD+K NIL+ S + +ADFGLA+ ++ + + Y APE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPE 177
Query: 861 YAYTLRVDEKSDVYSFGVVLLELLTGRRPV 890
D++S G + E+ R+P+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 58/234 (24%), Positives = 91/234 (38%), Gaps = 72/234 (30%)
Query: 694 IGRGGAGIVYHGKMPN---GVEIAVKKLLGFGTHSHDHGFRA----EIQTLGNIRHRNIV 746
IGRG G VY K N G E A+KK G G EI L ++H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKG--DKEQYTGISQSACREIALLRELKHENVV 65
Query: 747 RLL-AFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRY-----KIAIEAA---- 795
L+ F + + ++ L+++Y A H L +++ +++I +
Sbjct: 66 SLVEVFLEHADKSVYLLFDY--------AEHD-----LWQIIKFHRQAKRVSIPPSMVKS 112
Query: 796 ------KGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH----VADFGLAKFLIDGGASE 845
G+ YLH S ++HRD+K NIL+ + D GLA+
Sbjct: 113 LLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-------- 161
Query: 846 CMSAIAGSYG---------YIAPEYA-----YTLRVDEKSDVYSFGVVLLELLT 885
+ + Y APE YT + D+++ G + ELLT
Sbjct: 162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 7/100 (7%)
Query: 791 AIEAAKGLCYLH-HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA 849
A E L +LH H +++RD+K +NILL++ +ADFG+ K I G + +
Sbjct: 102 AAEVTLALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTT 155
Query: 850 IAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
G+ YIAPE L D ++ GV++ E++ G+ P
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 694 IGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRA----EIQTLGNIRHRNIVRL 748
IG G G+VY G+ G +A+KK+ S + G + EI L ++H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHG-KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
+ L++E++ + L + L KG ++ L + +G+ + H S
Sbjct: 65 QDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SR 120
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAY-TLR 866
++HRD+K N+L+++ +ADFGLA+ G + + Y APE + R
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 867 VDEKSDVYSFGVVLLELLTGRRPV--GD 892
D++S G + E+ T ++P+ GD
Sbjct: 179 YSTPVDIWSIGTIFAEMAT-KKPLFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 693 VIGRGGAGIVYHGKMPNGVE---IAVKKLLGFGT---------HSHDHGFRAEIQTLGNI 740
V+G+GG G V+ + G + I K+L T H+ +AE L +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT-----KAERNILEAV 57
Query: 741 RHRNIVRLL-AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLC 799
+H IV L+ AF + + L+ EY+ G L L ++G F+ + ++ E + L
Sbjct: 58 KHPFIVDLIYAFQTGGKL-YLILEYLSGGELFMHLE-REGIFMEDTACFYLS-EISLALE 114
Query: 800 YLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAP 859
+LH I++RD+K NILL++ + DFGL K I G G+ Y+AP
Sbjct: 115 HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAP 169
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
E + D +S G ++ ++LTG P
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 694 IGRGGAGIVYHGKMPNGV-------EIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
+G+G G+VY G + GV +A+K + + F E + ++V
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLR--------YKIAIEAAKGL 798
RLL S + L++ E M G L L + ++ ++A E A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 799 CYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIA 858
YL+ + VHRD+ + N ++ F + DFG+ + + + +++
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 859 PEYAYTLRVDEKSDVYSFGVVLLELLT 885
PE SDV+SFGVVL E+ T
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 6/157 (3%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI 792
E Q L + + +V L K+ LV M G L H G+ +
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDL--KFHIYNMGNPGFE-EERALF 106
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
AA+ LC L V+RD+K NILL+ ++D GLA + +G E + G
Sbjct: 107 YAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ESIRGRVG 163
Query: 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ GY+APE R D + G ++ E++ G+ P
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 50/179 (27%), Positives = 77/179 (43%), Gaps = 26/179 (14%)
Query: 729 GFRAEIQTLGNIRHRNIVRLLA-FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLR 787
G E L I H +I++L F NK T L++ Y K + +
Sbjct: 129 GTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY------------KTDLYCYLAAK 176
Query: 788 YKIAI--------EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839
IAI + + YLH + I+HRD+K+ NI +N + + DFG A F +
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233
Query: 840 DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD 898
D A++ AG+ APE D++S G+VL E+ T + + DG+D
Sbjct: 234 DINANK-YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE-KDGLD 290
|
Length = 391 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 694 IGRGGAGIVYHGKMPNGV---EIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
IG G G V G++ +G ++ VK+L + F E Q +++H N+++ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGA-FLGWNLR--YKIAIEAAKGLCYLHHDCSP 807
C+ LLV E+ G L L + A + + ++A E A GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLA--KFLIDGGASECMSAIAGSYGYIAPE----- 860
+H D+ N LL + + D+GL+ K+ D + + +IAPE
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPELVDEV 177
Query: 861 YAYTLRVDE--KSDVYSFGVVLLELLT-GRRPVGDFGD 895
+ L VD+ +S+V+S GV + EL G +P D
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 694 IGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC 752
IG G GIV + +G ++AVK ++ E+ + + +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 753 SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHR 812
E ++ E+++ G+L + + + L + + LCYLH S ++HR
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLH---SQGVIHR 141
Query: 813 DVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSD 872
D+KS++ILL ++DFG I + S + Y ++APE + D
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCA-QISKDVPKRKSLVGTPY-WMAPEVISRTPYGTEVD 199
Query: 873 VYSFGVVLLELLTGRRP 889
++S G++++E++ G P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 4e-08
Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 12/149 (8%)
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
+ N ++L + + ++L+ +Y+++G L + L KK L KI + + L L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVKKIIRQLVEALNDL 125
Query: 802 HHDCSPLIVHRDVKSNNILLNSA-FEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE 860
H I+H D+K N+L + A ++ D+GL K + G C G+ Y +PE
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII---GTPSCYD---GTLDYFSPE 176
Query: 861 YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
D D ++ GV+ ELLTG+ P
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 4e-08
Identities = 45/144 (31%), Positives = 68/144 (47%), Gaps = 6/144 (4%)
Query: 694 IGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC 752
+G G VY GK NG +A+K + E L ++H NIV L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 753 SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHR 812
KET LV+EY+ L + + G N++ + + +GL Y+H I+HR
Sbjct: 73 HTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIHQR---YILHR 127
Query: 813 DVKSNNILLNSAFEAHVADFGLAK 836
D+K N+L++ E +ADFGLA+
Sbjct: 128 DLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 44/180 (24%)
Query: 670 KMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDH 728
K+ ++KL+ +G G VY G+ G +A+K++ H+
Sbjct: 3 KLETYKKLD--------------KLGEGSYATVYKGRSKLTGQLVALKEI----RLEHEE 44
Query: 729 G--FRA--EIQTLGNIRHRNIVRLLAFCSNKETNLLVYE--------YMRNGSLGEALHG 776
G F A E L +++H NIV L K+T LV+E YM + G ++H
Sbjct: 45 GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHN 104
Query: 777 KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836
+ FL LR GL Y H ++HRD+K N+L++ E +ADFGLA+
Sbjct: 105 VR-LFLFQLLR---------GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 14/149 (9%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA----EIQTLGNIRHRNIVRL 748
IG G G+VY + G +A+KK+ + D G + EI L + H NIVRL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 749 LAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
L + E L LV+E++ + L + + L L + +G+ Y H S
Sbjct: 64 LDVV-HSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SH 118
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAK 836
++HRD+K N+L++ +ADFGLA+
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 49/155 (31%), Positives = 72/155 (46%), Gaps = 25/155 (16%)
Query: 694 IGRGGAGIVYHGKMPNGVE-IAVKKLLGFGTHSHDHGFRA----EIQTLGNIRHRNIVRL 748
IG G G+VY + E IA+KK+ D G + EI L ++H NIVRL
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIR---LEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLR------YKIAIEAAKGLCYLH 802
+++ LV+EY+ L H N R Y+I +G+ Y H
Sbjct: 67 QDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQI----LRGIAYCH 119
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEA-HVADFGLAK 836
S ++HRD+K N+L++ A +ADFGLA+
Sbjct: 120 ---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 61/220 (27%), Positives = 91/220 (41%), Gaps = 46/220 (20%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD-HGFRAEIQTLGNIRHRNIVRLLA 750
VIG+G G+V G ++A+KK+ H D EI+ L +RH +IV +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 751 FC---SNKETN--LLVYEYMRNGSLGEALHGKKGA-----------FLGWNLRYKIAIEA 794
S +E +V+E M LH A FL LR
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR------- 114
Query: 795 AKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF-LIDGGASECMSAIAGS 853
L Y+H + + HRD+K NIL N+ + + DFGLA+ D + + +
Sbjct: 115 --ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169
Query: 854 YGYIAPEYA------YTLRVDEKSDVYSFGVVLLELLTGR 887
Y APE YT + D++S G + E+LTG+
Sbjct: 170 RWYRAPELCGSFFSKYTPAI----DIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 49/157 (31%), Positives = 69/157 (43%), Gaps = 7/157 (4%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI 792
E + L N RH + L + V EY G L L ++ F R+ A
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA- 102
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
E L YLH S +V+RD+K N++L+ + DFGL K I GA+ M G
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCG 157
Query: 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ Y+APE D + GVV+ E++ GR P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 694 IGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL-AF 751
IG G GIV G ++AVKK+ + F E+ + + +H NIV + ++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSSY 85
Query: 752 CSNKETNLLVYEYMRNGSLGEA-----LHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
E +V E++ G+L + ++ ++ A + + K L +LH +
Sbjct: 86 LVGDEL-WVVMEFLEGGALTDIVTHTRMNEEQIA--------TVCLAVLKALSFLH---A 133
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM---SAIAGSYGYIAPEYAY 863
++HRD+KS++ILL S ++DFG S+ + ++ G+ ++APE
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEVIS 188
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRP 889
L + D++S G++++E++ G P
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-08
Identities = 92/313 (29%), Positives = 137/313 (43%), Gaps = 40/313 (12%)
Query: 268 INLLSGSIPKQLGNLTNLVNLDLSNNALTG--EIPYSFINLRQLKLFNLFMNRLHGSIPD 325
+NL S ++ +L+ L++LDL + + + + +NL L +L +NRL +I
Sbjct: 52 LNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-S 110
Query: 326 YLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILI 385
L +L NL +L L NN T + P L+ LDLS NK+
Sbjct: 111 ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE----------------- 153
Query: 386 LLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPE 445
+P L +L + L N L+ +P L LN +L N +S LP
Sbjct: 154 --------SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPP 203
Query: 446 NGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVL 505
S L +L+LSNN + L SLSN +L L LS N+ +P SIG L +
Sbjct: 204 EIELLSA---LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLE 258
Query: 506 KLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQN 565
LDLS N +S ++G +L LD+S N+LS + P I+ + +L L L N L
Sbjct: 259 TLDLSNNQIS--SISSLGSLTNLRELDLSGNSLS-NALPLIALLLLLLELLL--NLLLTL 313
Query: 566 IPKSIGSMKSLTI 578
+ L
Sbjct: 314 KALELKLNSILLN 326
|
Length = 394 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 6e-08
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLG---FGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
VIGRG G V K+ N ++ K+L + FR E L N ++ I L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL- 66
Query: 750 AFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIA--IEAAKGLCYLHHDCS 806
+ E NL LV +Y G L L + R+ +A + A + LH+
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL- 865
VHRD+K +NIL++ +ADFG L++ G + A+ G+ YI+PE +
Sbjct: 124 ---VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAME 179
Query: 866 ----RVDEKSDVYSFGVVLLELLTGRRP 889
+ + D +S GV + E+L G P
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 48/157 (30%), Positives = 70/157 (44%), Gaps = 6/157 (3%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI 792
E + L N RH + L + V EY G L L ++ F R+ A
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA- 102
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
E L YLH + + +V+RD+K N++L+ + DFGL K I GA+ M G
Sbjct: 103 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCG 158
Query: 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ Y+APE D + GVV+ E++ GR P
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 15/197 (7%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL-AFC 752
+G G G VY + +A K++ + + EI L + H NIV+LL AF
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 71
Query: 753 SNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVH 811
E NL ++ E+ G++ + + +R + + + L YLH + I+H
Sbjct: 72 -YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 812 RDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR----- 866
RD+K+ NIL + +ADFG++ + + + G+ ++APE
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 867 VDEKSDVYSFGVVLLEL 883
D K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 59/226 (26%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA-----EIQTLGNIRHRNIVR 747
IGRG GIV K ++A+KK+ ++ D+ A EI+ L ++ H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI----ANAFDNRIDAKRTLREIKLLRHLDHENVIA 68
Query: 748 LL---------AFCSNKETNLLVYEYM---------RNGSLGEALHGKKGAFLGWNLRYK 789
+ AF +VYE M + +L + H + FL LR
Sbjct: 69 IKDIMPPPHREAF----NDVYIVYELMDTDLHQIIRSSQTLSDD-HCQ--YFLYQLLR-- 119
Query: 790 IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA 849
GL Y+H S ++HRD+K +N+LLN+ + + DFGLA+ + M+
Sbjct: 120 -------GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTE 167
Query: 850 IAGSYGYIAPEY-----AYTLRVDEKSDVYSFGVVLLELLTGRRPV 890
+ Y APE YT + DV+S G + ELL GR+P+
Sbjct: 168 YVVTRWYRAPELLLNCSEYTTAI----DVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 51/150 (34%), Positives = 78/150 (52%), Gaps = 23/150 (15%)
Query: 749 LAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH-HDCS 806
L F +++L LV +YM G L L K+G F ++ IA E L +LH +D
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFSEDRAKFYIA-ELVLALEHLHKYD-- 116
Query: 807 PLIVHRDVKSNNILLNSAFEAHVA--DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT 864
IV+RD+K NILL++ H+A DFGL+K + ++ + G+ Y+APE
Sbjct: 117 --IVYRDLKPENILLDA--TGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPE---- 166
Query: 865 LRVDEKS-----DVYSFGVVLLELLTGRRP 889
+ +DEK D +S GV++ E+ G P
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 44/157 (28%), Positives = 69/157 (43%), Gaps = 6/157 (3%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI 792
E Q L + R +V L K+ LV M G L ++ G++ +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP--GFD-EERAVF 106
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
AA+ C L IV+RD+K NILL+ ++D GLA + +G E + G
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---ETIRGRVG 163
Query: 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ GY+APE R D + G ++ E++ G+ P
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 66/247 (26%), Positives = 102/247 (41%), Gaps = 56/247 (22%)
Query: 675 QKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA- 732
+ EF D + + IG+G G V+ + +A+KK+L + GF
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL---MENEKEGFPIT 57
Query: 733 ---EIQTLGNIRHRNIVRLLAFCSNKETN--------LLVYEYMRNGSLGEALHGKKGAF 781
EI+ L ++H N+V L+ C K T LV+E+ + L L K F
Sbjct: 58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKF 116
Query: 782 LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841
++ K+ GL Y+H I+HRD+K+ NIL+ +ADFGLA+
Sbjct: 117 TLSEIK-KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR----- 167
Query: 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLL-----ELLTGRRPVGDFGDG 896
A++L + K + Y+ VV L ELL G R D+G
Sbjct: 168 --------------------AFSLSKNSKPNRYTNRVVTLWYRPPELLLGER---DYGPP 204
Query: 897 VDIVQWS 903
+D+ W
Sbjct: 205 IDM--WG 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 46/161 (28%), Positives = 72/161 (44%), Gaps = 7/161 (4%)
Query: 732 AEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIA 791
AE L + IV L + E LV ++ G L L ++G F R+ A
Sbjct: 42 AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ-REGRFDLSRARFYTA 100
Query: 792 IEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIA 851
+ LC L + +++RD+K NILL+ + DFGL K ++ + +
Sbjct: 101 ----ELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCK--LNMKDDDKTNTFC 154
Query: 852 GSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGD 892
G+ Y+APE + D ++ GV+L E+LTG P D
Sbjct: 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 39/148 (26%), Positives = 63/148 (42%), Gaps = 18/148 (12%)
Query: 744 NIVRLLAFCSNKETNLLVYEYMRNGSL----GEALHGKKGAFLGWNLRYKIAIEAAKGLC 799
N+V L + ++++ LV ++ G L + L+ + W +A++A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 800 YLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAP 859
LH + IV RD+ NNILL+ + F + D E + + Y AP
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLTGR 887
E E D +S G +L ELLTG+
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 52/179 (29%), Positives = 75/179 (41%), Gaps = 36/179 (20%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLV--------YEYM-RNGSLGEALHGKKGAFLG 783
EI L I HR I+ L+ K T +V + Y+ R+G L
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPL------------- 182
Query: 784 WNLRYKIAIEAA--KGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841
L I I+ + L YLH I+HRDVK+ NI L+ A + DFG A L
Sbjct: 183 -PLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 842 GASECMSAIAGSYGYIAPEYAYTLRVD---EKSDVYSFGVVLLELLTGRRPVGDFGDGV 897
+ +G+ +PE L +D K+D++S G+VL E+ + FG V
Sbjct: 239 PDTPQCYGWSGTLETNSPEL---LALDPYCAKTDIWSAGLVLFEMSVKNVTL--FGKQV 292
|
Length = 392 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 62/236 (26%), Positives = 93/236 (39%), Gaps = 29/236 (12%)
Query: 661 FKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLG 720
F K + SWK++ F+ G +G G G V K E K L
Sbjct: 7 FTKPDTSSWKLSDFEM--------------GETLGTGSFGRVRIAKHKGTGEYYAIKCLK 52
Query: 721 ----FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHG 776
H E L + H IV ++ ++ + E++ G L L
Sbjct: 53 KREILKMKQVQH-VAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR- 110
Query: 777 KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836
K G F ++ A E YLH S I++RD+K N+LL++ V DFG AK
Sbjct: 111 KAGRFPNDVAKFYHA-ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
Query: 837 FLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGD 892
+ D + C G+ Y+APE + + D ++ GV+L E + G P D
Sbjct: 167 KVPDRTFTLC-----GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217
|
Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 5/99 (5%)
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850
A E L +LH I++RD+K +N+LL+ +ADFG+ K I G + S
Sbjct: 102 AAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTF 156
Query: 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
G+ YIAPE + D ++ GV+L E+L G P
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 752 CSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
C + L LV EY+ G L H ++ L A E L +LH I+
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---II 118
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDE- 869
+RD+K +N+LL++ + D+G+ K + G + S G+ YIAPE LR +E
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNYIAPE---ILRGEEY 173
Query: 870 --KSDVYSFGVVLLELLTGRRPVGDFGDGVDI 899
D ++ GV++ E++ GR P D D+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDM 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 18/135 (13%)
Query: 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819
+ + M G L L + G F +R+ A E GL ++H+ +V+RD+K NI
Sbjct: 74 FILDLMNGGDLHYHL-SQHGVFSEKEMRF-YATEIILGLEHMHNR---FVVYRDLKPANI 128
Query: 820 LLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY-----AYTLRVDEKSDVY 874
LL+ ++D GLA D + +++ G++GY+APE AY D +D +
Sbjct: 129 LLDEHGHVRISDLGLA---CDFSKKKPHASV-GTHGYMAPEVLQKGTAY----DSSADWF 180
Query: 875 SFGVVLLELLTGRRP 889
S G +L +LL G P
Sbjct: 181 SLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 40/131 (30%), Positives = 66/131 (50%), Gaps = 10/131 (7%)
Query: 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819
+ + M G L L + G F +R+ A E GL ++H+ +V+RD+K NI
Sbjct: 74 FILDLMNGGDLHYHL-SQHGVFSEAEMRF-YAAEIILGLEHMHNR---FVVYRDLKPANI 128
Query: 820 LLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE-YAYTLRVDEKSDVYSFGV 878
LL+ ++D GLA D + +++ G++GY+APE + D +D +S G
Sbjct: 129 LLDEHGHVRISDLGLA---CDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSADWFSLGC 184
Query: 879 VLLELLTGRRP 889
+L +LL G P
Sbjct: 185 MLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 694 IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL-AFC 752
+G G G VY K +A K++ + + EI+ L H IV+LL AF
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 753 SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHR 812
+ + +++ E+ G++ + ++ I + + L YLH S I+HR
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLH---SMKIIHR 134
Query: 813 DVKSNNILLNSAFEAHVADFGL-AKFLIDGGASECMSAIAGSYGYIAPEYAY--TLR--- 866
D+K+ N+LL + +ADFG+ AK + + + G+ ++APE T++
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNV---KTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 867 VDEKSDVYSFGVVLLEL 883
D K+D++S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 51/179 (28%), Positives = 80/179 (44%), Gaps = 34/179 (18%)
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK-------FLIDGGA 843
+ + A+G+ +L S +HRD+ + NILL+ + DFGLA+ ++ G A
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQW 902
+ ++APE + +SDV+SFGV+L E+ + G P GV I
Sbjct: 236 RLPLK-------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY----PGVQI--- 281
Query: 903 SKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSE 960
EEF L M E A ++ ML C N +RP E+V++L +
Sbjct: 282 --------DEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 691 GNVIGRGGAGIVYHG--KMPNG--VEIAVKKLLGFGTHSHD-HGFRAEIQTLGNIRHRNI 745
G ++G+G G V K +G ++AVK L S D F E + H N+
Sbjct: 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNV 63
Query: 746 VRLLAFCSNKETN------LLVYEYMRNGSLGEALH----GKKGAFLGWNLRYKIAIEAA 795
++L+ +++ +M++G L L G++ L + I+ A
Sbjct: 64 IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123
Query: 796 KGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYG 855
G+ YL S +HRD+ + N +LN VADFGL+K + G A
Sbjct: 124 SGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 856 YIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRP 889
++A E SDV++FGV + E++T G+ P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-07
Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 810 VHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVD- 868
+HRDVK +N+LL+ + +ADFG + G C +A+ G+ YI+PE + D
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 869 ---EKSDVYSFGVVLLELLTGRRP 889
+ D +S GV L E+L G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-07
Identities = 65/216 (30%), Positives = 95/216 (43%), Gaps = 43/216 (19%)
Query: 694 IGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLL- 749
IG G G+V+ P +G +A+KK+ + S FR E++ L +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66
Query: 750 ----AFCSNKETNLLVYEYM---------RNGSLGEALHGKKGAFLGWNLRYKIAIEAAK 796
E +V E M L + H K FL Y+I +
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPL-SSDHVK--VFL-----YQIL----R 114
Query: 797 GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGY 856
GL YLH S I+HRD+K N+L+NS + DFGLA+ + + S+ M+ + Y
Sbjct: 115 GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYY 170
Query: 857 IAPEYA-----YTLRVDEKSDVYSFGVVLLELLTGR 887
APE YT V D++S G + ELL R
Sbjct: 171 RAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 41/105 (39%), Positives = 60/105 (57%), Gaps = 7/105 (6%)
Query: 797 GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK-FLIDGGA-SECMSAIAGSY 854
GL Y+H S ++HRD+K N+L+N+ E + DFGLA+ F + G + M+ +
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 855 GYIAPEYAYTLRVDEKS-DVYSFGVVLLELLTGRRPVGDFGDGVD 898
Y APE + + K+ DV+S G +L ELL GR+PV D VD
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVD 217
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 69/230 (30%), Positives = 102/230 (44%), Gaps = 11/230 (4%)
Query: 68 DRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNF-TGSIEIGNLSSLQFLNISNNQF 126
+ SLDL + N+ P L L L L+ N + + NL +L+ L++S N
Sbjct: 116 TNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDL 175
Query: 127 SGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQ 186
S L S+L NL D N + LP I L L+ LDL N ++ +S L+
Sbjct: 176 S-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLK 232
Query: 187 GLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCE 246
L L L+ N L +P +GNL+NL + L + +G L NL LDLS
Sbjct: 233 NLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS---ISSLGSLTNLRELDLSGNS 288
Query: 247 LDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALT 296
L +P LL + L +NLL +L + L+N ++ +N T
Sbjct: 289 LSNALPL---IALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGET 335
|
Length = 394 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 46/197 (23%), Positives = 91/197 (46%), Gaps = 10/197 (5%)
Query: 694 IGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC 752
IG G GIV + +G +AVKK+ + F E+ + + +H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86
Query: 753 SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHR 812
+ +V E++ G+L + + + + + + K L LH + ++HR
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLH---AQGVIHR 140
Query: 813 DVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSD 872
D+KS++ILL ++DFG + ++ G+ ++APE L + D
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 873 VYSFGVVLLELLTGRRP 889
++S G++++E++ G P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 12/158 (7%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI 792
E+ L N++H NIV L + LV+EY+ + L + L N++
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMF 110
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
+ +GL Y H I+HRD+K N+L+N E +ADFGLA+ ++ S
Sbjct: 111 QLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVV 165
Query: 853 SYGYIAPEYAYTLRVDEKS---DVYSFGVVLLELLTGR 887
+ Y P+ L E S D++ G +L E+ TGR
Sbjct: 166 TLWYRPPD--VLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 41/139 (29%), Positives = 65/139 (46%), Gaps = 8/139 (5%)
Query: 752 CSNKETNLL-VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
C E+ L V EY+ G L H ++ L + E + L YLH I+
Sbjct: 64 CFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---II 118
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEK 870
+RD+K +N+LL+S + D+G+ K + G + S G+ YIAPE
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 871 SDVYSFGVVLLELLTGRRP 889
D ++ GV++ E++ GR P
Sbjct: 177 VDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-07
Identities = 47/190 (24%), Positives = 71/190 (37%), Gaps = 28/190 (14%)
Query: 405 LTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENG--NSSSNPDRLGQLNLS 462
L V + + LN S + L+ + + N L L+L+
Sbjct: 42 LESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLN 101
Query: 463 NNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLK-LDLSRNSLSGEIPPA 521
N L L ++L L L N + IPP IG L+ LK LDLS N + +P
Sbjct: 102 LNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSP 158
Query: 522 IGYCNHLTYLDMSQNNLS----------------------GSIPPEISNVRILNYLNLSR 559
+ +L LD+S N+LS +PPEI + L L+LS
Sbjct: 159 LRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSN 218
Query: 560 NHLNQNIPKS 569
N + + +
Sbjct: 219 NSIIELLSSL 228
|
Length = 394 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 14/164 (8%)
Query: 731 RAEIQTLGNIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYK 789
R E L ++R + L + E L L+ +Y+ G + L+ ++ F +R+
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFY 110
Query: 790 IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAK-FLIDGGASEC 846
E L +LH IV+RD+K NILL+S E HV DFGL+K FL + E
Sbjct: 111 SG-EIILALEHLH---KLGIVYRDIKLENILLDS--EGHVVLTDFGLSKEFLSE--EKER 162
Query: 847 MSAIAGSYGYIAPEYAYTLRVDEKS-DVYSFGVVLLELLTGRRP 889
+ G+ Y+APE K+ D +S G+++ ELLTG P
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 19/233 (8%)
Query: 356 KLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYL 415
L+LSSN L +P+ L L +L L +L + +
Sbjct: 48 NRLALNLSSNTLL-LLPSSLSRLLSLDLLSP-------SGISSLDGSENLLNLLPLPSLD 99
Query: 416 NGSIPDGFIYLPGLNLAELQSNYLSG----SLPENGNSSSNPDRLGQLNLSNNLLSGPLP 471
L L L S L +P L +L+LS+N + LP
Sbjct: 100 LNLNRLRSNISELLELTNLTSLDLDNNNITDIP--PLIGLLKSNLKELDLSDNKIE-SLP 156
Query: 472 FSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYL 531
L N +L+ L LS N S +P + L + LDLS N +S ++PP I + L L
Sbjct: 157 SPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEEL 214
Query: 532 DMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFN 584
D+S N++ + +SN++ L+ L LS N L ++P+SIG++ +L D S N
Sbjct: 215 DLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 63/272 (23%), Positives = 110/272 (40%), Gaps = 38/272 (13%)
Query: 701 IVYHGKMPNGVEIAVKKLLGFGTHSHDHG-----FRAEIQTLGNIRHRNIVRLLAFCSNK 755
+Y G N E+ ++ F H EI+ L I NI+++ F +
Sbjct: 35 SIYKGIF-NNKEVIIRT---FKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90
Query: 756 ETNL----LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH-HDCSPLIV 810
+L L+ EY G L E L +K L + + +AI+ KGL L+ + P
Sbjct: 91 VDDLPRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP--- 145
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYA-YTLRVDE 869
++++ S + L+ ++ + GL K L + SY + ++ YT
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYT----I 201
Query: 870 KSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEE 929
K D+YS GVVL E+ TG+ P + + + N L + P
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPF----ENLTTKEIYDLIINKNNSLKLPLDCPLE------- 250
Query: 930 AMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961
+ + C +SI+RP ++E++ LS +
Sbjct: 251 ---IKCIVEACTSHDSIKRPNIKEILYNLSLY 279
|
Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 58/204 (28%), Positives = 85/204 (41%), Gaps = 14/204 (6%)
Query: 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLG---FGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
VIGRG G V + + ++ KLL S F E + +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLI 809
+ + +V EYM G L L W Y E L +H S +
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFY--TAEVVLALDAIH---SMGL 163
Query: 810 VHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVD- 868
+HRDVK +N+LL+ +ADFG + + G C +A+ G+ YI+PE + D
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 869 ---EKSDVYSFGVVLLELLTGRRP 889
+ D +S GV L E+L G P
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 47/222 (21%)
Query: 689 KDGNVIGRGGAGIVYHGKMPNGVE-IAVKKLLGFGTHSHDHGFR-AEIQTLGNIRHRNIV 746
K GN+IG G G+VY + E +A+KK+L D ++ E+ + N+ H NI+
Sbjct: 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL------QDPQYKNRELLIMKNLNHINII 122
Query: 747 RLLAF----CSNK-ETNLL-----------VYEYMRNGSLGEALHGKKGAFLGWNLRYKI 790
L + C K E N+ V++YM++ + + L L
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKH-------YARNNHALPLFLVKLY 175
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN-SAFEAHVADFGLAKFLIDGGASECMSA 849
+ + + L Y+H S I HRD+K N+L++ + + DFG AK L+ G S +S
Sbjct: 176 SYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSY 230
Query: 850 IAGSYGYIAPEYA-----YTLRVDEKSDVYSFGVVLLELLTG 886
I + Y APE YT + D++S G ++ E++ G
Sbjct: 231 ICSRF-YRAPELMLGATNYTTHI----DLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 46/173 (26%), Positives = 73/173 (42%), Gaps = 29/173 (16%)
Query: 733 EIQTLGNIRHRNIVRLLA-FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIA 791
E++ + I+H NI+ L+ + NL V + M L + + K L + I
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINL-VMDIM-ASDLKKVVDRK--IRLTESQVKCIL 125
Query: 792 IEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA-KFLIDGGASEC---- 846
++ GL LH +HRD+ NI +NS +ADFGLA ++ +
Sbjct: 126 LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 847 -------MSAIAGSYGYIAPEY-----AYTLRVDEKSDVYSFGVVLLELLTGR 887
M++ + Y APE Y V D++S G + ELLTG+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV----DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 51/180 (28%), Positives = 80/180 (44%), Gaps = 34/180 (18%)
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK-------FLIDGGA 843
+ + A+G+ +L S +HRD+ + NILL+ + DFGLA+ ++ G A
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQW 902
+ ++APE + +SDV+SFGV+L E+ + G P GV I
Sbjct: 237 RLPLK-------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY----PGVQI--- 282
Query: 903 SKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEF 961
EEF L M E A ++ ML C Q + ERP +V++L +
Sbjct: 283 --------NEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 80/268 (29%), Positives = 111/268 (41%), Gaps = 22/268 (8%)
Query: 350 NLGQNGKLQVLDLSSNKLTGTIPTDL-CSSNQLRILILLKNFLFGPIPERLGACYSLTRV 408
+L + LD S N L L + N+LR I L +LT +
Sbjct: 73 DLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS-----------ELLELTNLTSL 121
Query: 409 RLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSG 468
L N + P + L +L N + SLP N L L+LS N LS
Sbjct: 122 DLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLR---NLPNLKNLDLSFNDLSD 177
Query: 469 PLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHL 528
LP LSN S+L L LSGN+ S +PP I L + +LDLS NS+ E+ ++ +L
Sbjct: 178 -LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234
Query: 529 TYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSG 588
+ L+ NN +P I N+ L L+LS N +I S+GS+ +L D S N S
Sbjct: 235 SGLE-LSNNKLEDLPESIGNLSNLETLDLSNN-QISSIS-SLGSLTNLRELDLSGNSLSN 291
Query: 589 KLPESGQFTVFNASSFAGNPQLCGTLLN 616
LP + L L
Sbjct: 292 ALPLIALLLLLLELLLNLLLTLKALELK 319
|
Length = 394 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 14/142 (9%)
Query: 752 CSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
C E+ L V E++ G L H ++ L + E + L +LH I+
Sbjct: 64 CFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGII 118
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDE- 869
+RD+K +N+LL++ + D+G+ K I G + S G+ YIAPE LR ++
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPE---ILRGEDY 173
Query: 870 --KSDVYSFGVVLLELLTGRRP 889
D ++ GV++ E++ GR P
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 50/160 (31%), Positives = 68/160 (42%), Gaps = 22/160 (13%)
Query: 751 FCS--NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
FCS K +V EY+ G L GA R A E L YLH +
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCA-TLLKNIGALPVDMARMYFA-ETVLALEYLH---NYG 121
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAKF------------LIDGGASECM-SAIAGSYG 855
IVHRD+K +N+L+ S + DFGL+K I+ E + + G+
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 856 YIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGD 895
YIAPE + D ++ G++L E L G P FGD
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF--FGD 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 10/182 (5%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKI-- 790
E + L + R +V L K+ LV M G L H G++ + I
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDL--KFHIYNMGNPGFDEQRAIFY 107
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850
A E GL L + IV+RD+K NILL+ ++D GLA + +G E +
Sbjct: 108 AAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGR 161
Query: 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910
G+ GY+APE + D + G ++ E++ G+ P + V + +R +
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ 221
Query: 911 KE 912
+E
Sbjct: 222 EE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 68/212 (32%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLG---FGTHSHDHGFRAEIQTLGNIRHRNIVRL- 748
VIGRG G V KM N ++ K+L + FR E L N R I L
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 749 LAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNL-RYKIA--IEAAKGLCYLHHD 804
AF E NL LV +Y G L L K L ++ R+ +A + A + L +
Sbjct: 68 YAF--QDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY- 123
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFG-LAKFLIDGGASECMSAIA-GSYGYIAPEYA 862
VHRD+K +N+LL+ +ADFG + L DG S +A G+ YI+PE
Sbjct: 124 -----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV---QSNVAVGTPDYISPEIL 175
Query: 863 YTL-----RVDEKSDVYSFGVVLLELLTGRRP 889
+ R + D +S GV + E+L G P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 16/185 (8%)
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
I +L +K+ LV EY G L L+ + F ++ +A E + +H
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQM 121
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT 864
VHRD+K N+L++ +ADFG A L + G+ YIAPE T
Sbjct: 122 G---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTT 177
Query: 865 LRVDEKS------DVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
+ D K D +S GV+ E++ GR P F +G ++ R +F
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSP---FHEGTSAKTYNNIMNFQRFLKFPE-- 232
Query: 919 DPRLS 923
DP++S
Sbjct: 233 DPKVS 237
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 3e-06
Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 36/228 (15%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLL--VYEYMRNGSLGEALHGKKGAF--LGWNLRY 788
E+ + ++H+NIVR + NK L + E+ G L + F + +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 789 KIAIEAAKGLCYLHH----DCSPLIVHRDVKSNNILLNSAFE-----------------A 827
I + L Y H+ ++HRD+K NI L++ A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 828 HVADFGLAKFL-IDGGASECMSAIAGSYGYIAPEYAY--TLRVDEKSDVYSFGVVLLELL 884
+ DFGL+K + I+ A C+ G+ Y +PE T D+KSD+++ G ++ EL
Sbjct: 182 KIGDFGLSKNIGIESMAHSCV----GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 885 TGRRPVGDFGDGVDIVQWSKRATN----GRKEEFLSILDPRLSMVPKE 928
+G+ P + ++ KR + G+ +E ++ L++ KE
Sbjct: 238 SGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKE 285
|
Length = 1021 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 58/207 (28%), Positives = 86/207 (41%), Gaps = 17/207 (8%)
Query: 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLG---FGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
VIGRG G V KM + I K+L + FR E L N + I L
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIA--IEAAKGLCYLHHDCSP 807
++ LV +Y G L L + R+ IA + A + LH+
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY---- 123
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL-- 865
VHRD+K +N+LL+ +ADFG + G + A+ G+ YI+PE +
Sbjct: 124 --VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQAMED 180
Query: 866 ---RVDEKSDVYSFGVVLLELLTGRRP 889
+ + D +S GV + E+L G P
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 92/341 (26%), Positives = 123/341 (36%), Gaps = 62/341 (18%)
Query: 148 NNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELG 207
+N LLP + +L L L G N L L L L N L EL
Sbjct: 56 SNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENL-LNLLPLPSLDLNLNRLR-SNISELL 113
Query: 208 NLTNLREIYLGYYNVFEGGIPREVGKLV-NLVHLDLSSCELDGQIPHEIGNLKLLDTVFL 266
LTNL + L N+ + IP +G L NL LDLS ++
Sbjct: 114 ELTNLTSLDLDNNNITD--IPPLIGLLKSNLKELDLSDNKI------------------- 152
Query: 267 HINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDY 326
S+P L NL NL NLDLS N L+ +P
Sbjct: 153 ------ESLPSPLRNLPNLKNLDLSFNDLS-------------------------DLPKL 181
Query: 327 LADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILIL 386
L++L NL L L N + +P + L+ LDLS+N + I SN + L
Sbjct: 182 LSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI---IELLSSLSNLKNLSGL 237
Query: 387 -LKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPE 445
L N +PE +G +L + L N + S L L +L N LS +LP
Sbjct: 238 ELSNNKLEDLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPL 295
Query: 446 NGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLS 486
+ L L L+ L L L N + L S
Sbjct: 296 IALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETS 336
|
Length = 394 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 71/294 (24%), Positives = 123/294 (41%), Gaps = 45/294 (15%)
Query: 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
+ +++G GR GI+ K E+ VK + + E L + H+N
Sbjct: 11 SDLLQEGT-FGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQN 69
Query: 745 IVRLLAFCS-NKETNLLVYEYMRNGSLGEAL----HGKKGAFLGWNLR--YKIAIEAAKG 797
I+ +L C + E ++Y YM G+L L G+ + + +AI+ A G
Sbjct: 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG-----GASECMSAIAG 852
+ YLH ++H+D+ + N +++ + + D L++ L G +E
Sbjct: 130 MSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV--- 183
Query: 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRK 911
++A E SDV+SFGV+L EL+T G+ P + +D + + +G
Sbjct: 184 --KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE----IDPFEMAAYLKDGY- 236
Query: 912 EEFLSILDPRLSM---VPKEEAMHLLFVAMLCI-QENSIERPRMREVVQMLSEF 961
RL+ P E LF M C + ERP ++VQ L++F
Sbjct: 237 ---------RLAQPINCPDE-----LFAVMACCWALDPEERPSFSQLVQCLTDF 276
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 49/184 (26%), Positives = 63/184 (34%), Gaps = 27/184 (14%)
Query: 223 FEGGIPREVG-------KLVNLVHLDLSSCELDGQIPHEIGNLKL---LDTVFLHINLLS 272
G IPR + K L LDLS L + +L L + L+ N L
Sbjct: 62 ETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG 121
Query: 273 GSIPKQLG-----NLTNLVNLDLSNNALTGE----IPYSFINLRQLKLFNLFMNRLHGSI 323
+ L L L L N L G + + R LK NL N + +
Sbjct: 122 DRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAG 181
Query: 324 PDYLA----DLPNLETLGLWQNNFT----GVIPENLGQNGKLQVLDLSSNKLTGTIPTDL 375
LA NLE L L N T + E L L+VL+L N LT L
Sbjct: 182 IRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241
Query: 376 CSSN 379
S+
Sbjct: 242 ASAL 245
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLG---FGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
VIGRG G V + + ++ KLL S F E + +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALH-----GKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
+ +V EYM G L + K F + +A++A + +
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF--YTAEVVLALDAIHSMGF---- 163
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT 864
+HRDVK +N+LL+ + +ADFG + G C +A+ G+ YI+PE +
Sbjct: 164 -----IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKS 217
Query: 865 LRVD----EKSDVYSFGVVLLELLTGRRP 889
D + D +S GV L E+L G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 6e-06
Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 12/148 (8%)
Query: 694 IGRGGAGIVYHG--KMPNGVEIAVKKLLGFGTHSHDHGFRA-EIQTLGNI-RHRNIVRLL 749
+G G G VY K + +A+KK+ +S + E+++L + H NIV+L
Sbjct: 7 LGDGTFGSVYLARNKETGEL-VAIKKMKK-KFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 750 -AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
F N E V+EYM G+L + + +KG ++ I + +GL ++H
Sbjct: 65 EVFRENDELYF-VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--- 119
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAK 836
HRD+K N+L++ +ADFGLA+
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 42/154 (27%), Positives = 59/154 (38%), Gaps = 22/154 (14%)
Query: 237 LVHLDLSSCELDGQI-PHEIGNLKL----LDTVFLHINLLSGSIPKQLGNL----TNLVN 287
L L L++ L + LK L+ + L N L G+ + L +L
Sbjct: 110 LQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKE 169
Query: 288 LDLSNNALTGE-IPY------SFINLRQLKLFNLFMNRLHGS-IPDYLADLPNLETLGLW 339
L+L+NN + I + NL L L N + S + + LA L +LE L L
Sbjct: 170 LNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLG 229
Query: 340 QNNFTGVI-----PENLGQNGKLQVLDLSSNKLT 368
NN T L N L L LS N +T
Sbjct: 230 DNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 59/220 (26%), Positives = 89/220 (40%), Gaps = 31/220 (14%)
Query: 694 IGRGGAGIVYHGKMPN---------GVEIAVKKLLGFGTHSHDH---GFRAEIQTLGNIR 741
+GRG +Y G + E +K +L SH F + +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
H++IV L C N++V E++ G L +H +K L ++K+A + A L YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPWKFKVAKQLASALSYL 121
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA-------SECMSAIAGSY 854
+VH +V + NILL A E + G L D G EC+ I
Sbjct: 122 E---DKDLVHGNVCTKNILL--AREGIDGECGPFIKLSDPGIPITVLSRQECVERIP--- 173
Query: 855 GYIAPEYAYTLRV-DEKSDVYSFGVVLLEL-LTGRRPVGD 892
+IAPE + +D +SFG L E+ G P+ D
Sbjct: 174 -WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 45/194 (23%), Positives = 82/194 (42%), Gaps = 22/194 (11%)
Query: 713 IAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGE 772
+A+K L F+ E ++H NIV LL + ++ +++ Y + L E
Sbjct: 38 VAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE 97
Query: 773 AL-----HGKKGAF---------LGWNLRYKIAIEAAKGLCYL--HHDCSPLIVHRDVKS 816
L H G+ L I + A G+ +L HH +VH+D+ +
Sbjct: 98 FLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLAT 152
Query: 817 NNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSF 876
N+L+ ++D GL + + + M +++PE + SD++S+
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 877 GVVLLELLT-GRRP 889
GVVL E+ + G +P
Sbjct: 213 GVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 49/180 (27%), Positives = 76/180 (42%), Gaps = 34/180 (18%)
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK-------FLIDGGA 843
+ + AKG+ +L S +HRD+ + NILL+ + DFGLA+ ++ G A
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQW 902
+ ++APE + +SDV+SFGV+L E+ + G P GV I
Sbjct: 242 RLPLK-------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKI--- 287
Query: 903 SKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEF 961
EEF L M + ++ ML C +RP E+V+ L
Sbjct: 288 --------DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 8/156 (5%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI 792
E+ L +++H NIV L +++ LV+EY+ + L + L + N++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFL-F 111
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
+ +GL Y H ++HRD+K N+L+N E +ADFGLA+ ++ S
Sbjct: 112 QLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVV 166
Query: 853 SYGYIAPEYAY-TLRVDEKSDVYSFGVVLLELLTGR 887
+ Y P+ + + D++ G + E+ TGR
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 32/176 (18%)
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK-------FLIDGGASE 845
+ AKG+ +L S +HRD+ + NILL + DFGLA+ +++ G A
Sbjct: 222 QVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSK 904
+ ++APE + +SDV+S+G++L E+ + G P G VD ++ K
Sbjct: 279 PVK-------WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP--GMPVD-SKFYK 328
Query: 905 RATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
G + +L P + + M C + ++RP +++VQ++ +
Sbjct: 329 MIKEGYR-----MLSPECAPSEMYDIMK------SCWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 14/200 (7%)
Query: 693 VIGRGGAGIVYHGKMPNGVEI-AVKKLLGFGTHSHDHGFRA----EIQTLGNIRHRNIVR 747
V+G G G+V + EI A+KK F + + E++ L ++ NIV
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKK---FKDSEENEEVKETTLRELKMLRTLKQENIVE 64
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
L + LV+EY+ L E L +R I + K + + H +
Sbjct: 65 LKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN--- 119
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
IVHRD+K N+L++ + DFG A+ L +G + +A + Y +PE
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPELLLGAPY 178
Query: 868 DEKSDVYSFGVVLLELLTGR 887
+ D++S G +L EL G+
Sbjct: 179 GKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 3e-05
Identities = 25/60 (41%), Positives = 33/60 (55%)
Query: 284 NLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNF 343
NL +LDLSNN LT +F L LK+ +L N L P+ + LP+L +L L NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 43/173 (24%)
Query: 732 AEIQTLGNIR-HRNIVRLLAFCSNKETN--LLVYEYMRNGSLGEALHGKKGAF----LGW 784
EIQ L + H NI+RL+ +++T LV+E M + +L E + G+K +
Sbjct: 46 REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKS 104
Query: 785 NLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG-- 842
+ Y++ K L ++H + I HRD+K NIL+ +ADFG + +
Sbjct: 105 YM-YQLL----KSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY 155
Query: 843 ----------ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
A EC+ G YG K D+++ G V E+L+
Sbjct: 156 TEYISTRWYRAPECL-LTDGYYGP-------------KMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 32/104 (30%), Positives = 45/104 (43%), Gaps = 8/104 (7%)
Query: 688 VKDGNVIGRGGAGIVYH------GKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI- 740
+K G +GRG G V K + +AVK L T S E++ L +I
Sbjct: 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG 68
Query: 741 RHRNIVRLLAFCSNKETNLLV-YEYMRNGSLGEALHGKKGAFLG 783
H N+V LL C+ L+V EY + G+L L K+ F
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSP 112
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI 792
E+ L +++H NIV L ++ LV+EY+ + L + + N++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFL-Y 111
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836
+ +GL Y H ++HRD+K N+L+N E +ADFGLA+
Sbjct: 112 QILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 6e-05
Identities = 27/78 (34%), Positives = 41/78 (52%), Gaps = 8/78 (10%)
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY----AYT 864
I+HRD+K+ N+L+N + + DFG A F ++ IAG+ APE YT
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340
Query: 865 LRVDEKSDVYSFGVVLLE 882
V D++S G+V+ E
Sbjct: 341 PSV----DIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-05
Identities = 48/146 (32%), Positives = 64/146 (43%), Gaps = 8/146 (5%)
Query: 694 IGRGGAGIVYHG-KMPNGVEIAVK--KLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
I RG G VY G K N AVK K + H +AE L + IV L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
+ LV EY+ G + LH G F I+ E A L YLH I+
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLH-IYGYFDEEMAVKYIS-EVALALDYLHRHG---II 126
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAK 836
HRD+K +N+L+++ + DFGL+K
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 31/105 (29%), Positives = 55/105 (52%), Gaps = 18/105 (17%)
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK-------FLIDGGASE 845
+ A+G+ +L S +HRDV + N+LL A + DFGLA+ +++ G A
Sbjct: 220 QVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRP 889
+ ++APE + +SDV+S+G++L E+ + G+ P
Sbjct: 277 PVK-------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 31/183 (16%)
Query: 715 VKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL 774
V K+LG H F + + H+++V+L C E N++V EY++ G L L
Sbjct: 34 VLKVLGSD-HRDSLAFFETASLMSQLSHKHLVKLYGVCVRDE-NIMVEEYVKFGPLDVFL 91
Query: 775 H-GKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL--------NSAF 825
H K L W L +A + A L YL +VH +V NIL+ F
Sbjct: 92 HREKNNVSLHWKL--DVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPF 146
Query: 826 EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKS-----DVYSFGVVL 880
++D G+ + E + I +IAPE +R + S D +SFG L
Sbjct: 147 -IKLSDPGIPITV--LSREERVERIP----WIAPEC---IRNGQASLTIAADKWSFGTTL 196
Query: 881 LEL 883
LE+
Sbjct: 197 LEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 9e-05
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 694 IGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC 752
+G G G+V+ +AVKK++ S H R EI+ + + H NIV++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVYEVL 71
Query: 753 SNKETNL--------------LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGL 798
++L +V EYM L L ++G + R + +GL
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL--EQGPLSEEHARL-FMYQLLRGL 127
Query: 799 CYLHHDCSPLIVHRDVKSNNILLNSA-FEAHVADFGLAKFLID------GGASECMSAIA 851
Y+H S ++HRD+K N+ +N+ + DFGLA+ ++D G SE +
Sbjct: 128 KYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPHYSHKGYLSEGLV--- 180
Query: 852 GSYGYIAPEYAYTLRVDEKS-DVYSFGVVLLELLTGR 887
+ Y +P + K+ D+++ G + E+LTG+
Sbjct: 181 -TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 44/177 (24%), Positives = 74/177 (41%), Gaps = 31/177 (17%)
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLV--------YEYMRNGSLGEALHGKKGAFLGW 784
EI LG + H NI+++ ++ ++ Y +M + A K L
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDE----AFDWKDRPLL-K 267
Query: 785 NLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844
R I + + Y+H ++HRD+K NI LN + + DFG A
Sbjct: 268 QTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK---- 319
Query: 845 ECMSAIAGSYGYI------APEYAYTLRVDEKSDVYSFGVVLLELLTGRR-PVGDFG 894
A YG++ +PE E +D++S G++LL++L+ P+GD G
Sbjct: 320 ---EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG 373
|
Length = 501 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 8/125 (6%)
Query: 688 VKDGNVIGRGGAGIVYHG------KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI- 740
+K G +GRG G V K +AVK L THS +E++ L +I
Sbjct: 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 68
Query: 741 RHRNIVRLLAFCSNKETNLLV-YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLC 799
H N+V LL C+ L+V E+ + G+L L K+G F+ + + + G
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYG 128
Query: 800 YLHHD 804
+ D
Sbjct: 129 DISED 133
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 53/219 (24%), Positives = 79/219 (36%), Gaps = 45/219 (20%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA----EIQTLGNIRHRN-IVR 747
IG G G VY + G +A+KK + G EI L + IVR
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTR---LEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 748 LLAFCSNKETN-----LLVYEYMRNG--SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
LL +E N LV+EY+ + ++ G L + KG+ +
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEA-HVADFGLAKFLIDGGASECMSAIAGSYG---- 855
H ++HRD+K N+L++ +AD GL S SY
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGL---------GRAFSIPVKSYTHEIV 173
Query: 856 ---YIAPEY-----AYTLRVDEKSDVYSFGVVLLELLTG 886
Y APE Y+ V D++S G + E+
Sbjct: 174 TLWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 43/223 (19%)
Query: 690 DGNVIGRGGAGIVYHGKMPNGV---EIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
+G +GRG G VY K +G E A+K++ G G EI L ++H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVI 61
Query: 747 RLL-AFCSNKETNL-LVYEYMRNGSLGEALH----------GKKGAFLGWNLRYKIAIEA 794
L F S+ + + L+++Y + + H KK L ++ + +
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEH----DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 795 AKGLCYLHHDCSPLIVHRDVKSNNILLNSA----FEAHVADFGLAKF-------LIDGGA 843
G+ YLH + ++HRD+K NIL+ +AD G A+ L D
Sbjct: 118 LDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD--- 171
Query: 844 SECMSAIAGSYGYIAPEYAYTLRVDEKS-DVYSFGVVLLELLT 885
+ + ++ Y APE R K+ D+++ G + ELLT
Sbjct: 172 ---LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 2e-04
Identities = 17/41 (41%), Positives = 21/41 (51%), Gaps = 2/41 (4%)
Query: 27 NDFHVLVALKQGFEN-PEPALISWNSSNPSSVCSWAGICCS 66
+D L+A K P AL SWN S+ S CSW G+ C
Sbjct: 3 DDRDALLAFKSSLNGDPSGALSSWNPSS-SDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 3e-04
Identities = 20/55 (36%), Positives = 24/55 (43%)
Query: 332 NLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILIL 386
NL++L L N T + L+VLDLS N LT P LR L L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDL 55
|
Length = 60 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 17/166 (10%)
Query: 727 DHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNL 786
DH F +E + L I H V L ++ LV E++ + G+ FL N
Sbjct: 76 DHVF-SERKILNYINHPFCVNLYGSFKDESYLYLVLEFV--------IGGEFFTFLRRNK 126
Query: 787 RYKIAI---EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843
R+ + AA+ + + S IV+RD+K N+LL+ + DFG AK +
Sbjct: 127 RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY 186
Query: 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ C G+ YIAPE + + +D ++ G+ + E+L G P
Sbjct: 187 TLC-----GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 43/223 (19%)
Query: 690 DGNVIGRGGAGIVYHGKMPNGVE---IAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
+G +GRG G VY K +G + A+K++ G G EI L ++H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVI 61
Query: 747 RLL-AFCSNKETNL-LVYEYMRNGSLGEALH----------GKKGAFLGWNLRYKIAIEA 794
L F S+ + + L+++Y + + H KK L + + +
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 795 AKGLCYLHHDCSPLIVHRDVKSNNILLNSA----FEAHVADFGLAKF-------LIDGGA 843
G+ YLH + ++HRD+K NIL+ +AD G A+ L D
Sbjct: 118 LDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD--- 171
Query: 844 SECMSAIAGSYGYIAPEYAYTLRVDEKS-DVYSFGVVLLELLT 885
+ + ++ Y APE R K+ D+++ G + ELLT
Sbjct: 172 ---LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-04
Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 36/222 (16%)
Query: 693 VIGRG--GAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHG----FRAEIQTLGNIRHRNI 745
+IG+ IV+ K P +AVKK S + EI T ++H NI
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKK---INLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEAL--HGKKG------AFLGWNLRYKIAIEAAKG 797
+ + +V M GS + L H +G AF I +
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF--------ILKDVLNA 113
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM-----SAIAG 852
L Y+H +HR VK+++ILL+ + ++ + +I G + + +
Sbjct: 114 LDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170
Query: 853 SYGYIAPEYAYT--LRVDEKSDVYSFGVVLLELLTGRRPVGD 892
+ +++PE +EKSD+YS G+ EL G P D
Sbjct: 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 8e-04
Identities = 27/59 (45%), Positives = 34/59 (57%), Gaps = 4/59 (6%)
Query: 506 KLDLSRNSLSGEIPP-AIGYCNHLTYLDMSQNNLSGSIPPE-ISNVRILNYLNLSRNHL 562
LDLS N L+ IP A +L LD+S NNL+ SI PE S + L L+LS N+L
Sbjct: 4 SLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-04
Identities = 26/93 (27%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
+ A+G+ +L S VHRD+ + N+LL + DFGLA+ ++ +
Sbjct: 245 QVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
++APE + SDV+S+G++L E+ +
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 53/219 (24%), Positives = 83/219 (37%), Gaps = 24/219 (10%)
Query: 694 IGRGGAGIVYHGKM---PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
IG G G V ++ + VK+L + + F + ++H NI++ L
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 751 FCSNKETNLLVYEYMRNGSL-----GEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH-HD 804
C LLV+EY G L E H + L L ++A E A G+ ++H H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEIAAGVTHMHKHN 119
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYA-- 862
+H D+ N L S V D+G+ E ++APE
Sbjct: 120 ----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 863 -----YTLRVDEKSDVYSFGVVLLELL-TGRRPVGDFGD 895
T + S+V++ GV L EL +P D
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 67/299 (22%), Positives = 102/299 (34%), Gaps = 60/299 (20%)
Query: 325 DYLADLPNLETLGLWQNNFTGV----IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQ 380
+ L L L+ L L N + L L+ L LS N+ TG IP
Sbjct: 17 ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNE-TGRIP-------- 67
Query: 381 LRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFI-YLPGLNLAELQSN-- 437
R L L + L L + L N L L +L EL+ N
Sbjct: 68 -RGLQSL--------LQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNN 118
Query: 438 --------YLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSN----FSSLQILLL 485
L+ L + P L +L L N L G +L+ L+ L L
Sbjct: 119 GLGDRGLRLLAKGLKDL------PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNL 172
Query: 486 SGNQFSGPIPPSIGE----LRQVLKLDLSRNSLSGEIPPAIGYC----NHLTYLDMSQNN 537
+ N ++ E + LDL+ N L+ E A+ L L++ NN
Sbjct: 173 ANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNN 232
Query: 538 LSGSIPPEISNVRI-----LNYLNLSRNHLNQNIPKS----IGSMKSLTIADFSFNDFS 587
L+ + +++ + L L+LS N + + K + +SL D N F
Sbjct: 233 LTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 3/93 (3%)
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
+ A G+ +L S VHRD+ + N+L+ + DFGLA+ ++ +
Sbjct: 247 QVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
++APE + SDV+SFG++L E+ T
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 21/59 (35%), Positives = 27/59 (45%)
Query: 261 LDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRL 319
L ++ L N L+ L NL LDLS N LT P +F L L+ +L N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 30/99 (30%), Positives = 45/99 (45%), Gaps = 7/99 (7%)
Query: 691 GNVIGRGGAGIVY----HG--KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHR 743
G +G G G V HG + +++AVK L S +E++ + ++ H
Sbjct: 42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHL 101
Query: 744 NIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFL 782
NIV LL C+ ++ EY R G L + LH K FL
Sbjct: 102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFL 140
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 67/244 (27%), Positives = 98/244 (40%), Gaps = 60/244 (24%)
Query: 693 VIGRGGAGIVYHGKMPNGVEI-AVKKLLG---FGTHSHDHGFRAEIQTLGNIRHRNIVRL 748
VIGRG G V + + I A+KKL H RAE L + +V+L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAH-VRAERDILAEADNPWVVKL 66
Query: 749 LAFCS-NKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKI-----AIEAAKGLCYL 801
+ S E L L+ EY+ G + L KK F R+ I AI++ L Y
Sbjct: 67 --YYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEEETRFYIAETILAIDSIHKLGY- 122
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE---------------- 845
+HRD+K +N+LL++ ++DFGL L +E
Sbjct: 123 --------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 846 ---CMS-------------AIA----GSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
MS A+A G+ YIAPE +++ D +S GV++ E+L
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 886 GRRP 889
G P
Sbjct: 235 GYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 69/306 (22%), Positives = 109/306 (35%), Gaps = 67/306 (21%)
Query: 693 VIGRGG-----------AGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR 741
VIGRG G VY K+ ++ K+ +G RAE L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGH--------IRAERDILVEAD 59
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
+V++ +K L+ E++ G + L KK ++ IA E + +
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-KKDTLTEEETQFYIA-ETVLAIDSI 117
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS------------- 848
H +HRD+K +N+LL+S ++DFGL L +E
Sbjct: 118 HQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 849 --------------------AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRR 888
+ G+ YIAPE ++ D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 889 PVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIER 948
P + Q + + KE I P VP E L + C E+ I
Sbjct: 235 PFCS-----ETPQETYKKVMNWKETL--IFPPE---VPISEKAKDLILRFCCEWEHRIGA 284
Query: 949 PRMREV 954
P + E+
Sbjct: 285 PGVEEI 290
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 995 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.49 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.12 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.11 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.11 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.1 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.97 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.89 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.88 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.83 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.8 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.76 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.49 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.48 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.4 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.39 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.32 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-115 Score=1114.81 Aligned_cols=910 Identities=40% Similarity=0.680 Sum_probs=783.8
Q ss_pred ccchHHHHHHHHHhCCCCCCCCCCCCCCCCCCCceeeeEEeCC-CceeeeecCCCCccccCCccccCCCCCCeEeccCCc
Q 001922 25 LVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSR-DRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNN 103 (995)
Q Consensus 25 ~~~~~~~Ll~~k~~~~~~~~~l~~W~~~~~~~~C~w~gv~C~~-~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~ 103 (995)
.+.|+.||++||+++.+|.+.+.+|+.. .+||.|.||+|+. ++|+.|||++++++|.+|+.+..+++|+.|+|++|+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS--ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC--CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 4479999999999999998889999754 5799999999974 699999999999999999999999999999999999
Q ss_pred ccCcc--c-cCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCc
Q 001922 104 FTGSI--E-IGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPN 180 (995)
Q Consensus 104 l~~~~--~-~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 180 (995)
++|.+ . +..+++|++|+|++|.+++.+|. ..+++|++|+|++|.+++.+|..++.+++|++|+|++|.+.+.+|.
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 182 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCCh
Confidence 98754 2 45899999999999999987775 4689999999999999999999999999999999999999999999
Q ss_pred cccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccc
Q 001922 181 SYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKL 260 (995)
Q Consensus 181 ~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 260 (995)
.|+++++|++|+|++|++++.+|..++++++|++|+|++|++ .+.+|..++++++|++|++++|.+++.+|..++++++
T Consensus 183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l-~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 261 (968)
T PLN00113 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL-SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKN 261 (968)
T ss_pred hhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc-CCcCChhHhcCCCCCEEECcCceeccccChhHhCCCC
Confidence 999999999999999999999999999999999999997654 5578999999999999999999999999999999999
Q ss_pred cCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEecc
Q 001922 261 LDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQ 340 (995)
Q Consensus 261 L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 340 (995)
|++|++++|++++.+|..+.++++|++|++++|.+++.+|..+.++++|+.|++++|.+.+.+|..+..+++|+.|++++
T Consensus 262 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~ 341 (968)
T PLN00113 262 LQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341 (968)
T ss_pred CCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCC
Q 001922 341 NNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIP 420 (995)
Q Consensus 341 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 420 (995)
|.+++.+|..++.+++|+.|+|++|++++.+|..++.+.+|+.|++++|.+.+.+|..+..+++|+.|++++|++++.+|
T Consensus 342 n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p 421 (968)
T PLN00113 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421 (968)
T ss_pred CCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccc
Q 001922 421 DGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGE 500 (995)
Q Consensus 421 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 500 (995)
..|..++.|+.+++++|.+++.+|... ..+++|+.|+|++|++.+.+|..+ ..++|+.|+|++|++++.+|..+..
T Consensus 422 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~ 497 (968)
T PLN00113 422 SEFTKLPLVYFLDISNNNLQGRINSRK---WDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGS 497 (968)
T ss_pred hhHhcCCCCCEEECcCCcccCccChhh---ccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhh
Confidence 999999999999999999999877543 356889999999999999998866 4689999999999999999999999
Q ss_pred hhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEe
Q 001922 501 LRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIAD 580 (995)
Q Consensus 501 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ 580 (995)
+++|+.|+|++|++++.+|..++.+++|++|+|++|.++|.+|..+.++++|+.|+|++|+++|.+|..+..+++|+.++
T Consensus 498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ 577 (968)
T PLN00113 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN 577 (968)
T ss_pred hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCCCCCCcccccccCCCCccCCCCCCC---CCCCCCCcCCCCCCCCCchhhhh-HHHHHHHHH-HHHHHHH
Q 001922 581 FSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLN---NPCNVAPITHQPGKAPGDFKLIF-ALGLLICSL-IFATAAI 655 (995)
Q Consensus 581 ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~~~~~---~~c~~~~~~~~~~~~~~~~~~i~-~~~~~~~~l-~~~~~~~ 655 (995)
+++|+++|.+|..+++.++...++.|||.+||.+.. .+|... ......+..+. +++++++.+ +++....
T Consensus 578 ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (968)
T PLN00113 578 ISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV------RKTPSWWFYITCTLGAFLVLALVAFGFVF 651 (968)
T ss_pred ccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc------cccceeeeehhHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999996532 245422 11112222221 222211111 1111222
Q ss_pred HHhhccc-----ccCCCccccccccc---ccccHHHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCCh
Q 001922 656 IKAKSFK-----KTGSDSWKMTAFQK---LEFSVSDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSH 726 (995)
Q Consensus 656 ~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~ 726 (995)
++++... ......|....+.. ..+...++...++..++||+|+||.||+|+. .+++.||||++.....
T Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--- 728 (968)
T PLN00113 652 IRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--- 728 (968)
T ss_pred HHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---
Confidence 2222111 11112233322221 2246667778889999999999999999976 5789999999853221
Q ss_pred hHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 001922 727 DHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806 (995)
Q Consensus 727 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ 806 (995)
...+|++++++++|||||++++++.+++..|+||||+++|+|.++++ .++|..+.+++.|+++|++|||..++
T Consensus 729 --~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~ 801 (968)
T PLN00113 729 --IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCS 801 (968)
T ss_pred --ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCC
Confidence 12356889999999999999999999999999999999999999995 27899999999999999999997656
Q ss_pred CCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhC
Q 001922 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTG 886 (995)
Q Consensus 807 ~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg 886 (995)
++|+||||||+||+++.++.+++. ||....... .....+++.|+|||++.+..++.++|||||||++|||+||
T Consensus 802 ~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg 874 (968)
T PLN00113 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG 874 (968)
T ss_pred CCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC
Confidence 669999999999999999888875 665543211 1233678999999999999999999999999999999999
Q ss_pred CCCCCCC-CCCchHHHHHHHHhcCChhhhhhhcCCcCC---CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 887 RRPVGDF-GDGVDIVQWSKRATNGRKEEFLSILDPRLS---MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 887 ~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
+.||+.. .......+|++..... ......+|+... ..+.++..++.+++.+||+.||++||+|+||+++|+++.
T Consensus 875 ~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 875 KSPADAEFGVHGSIVEWARYCYSD--CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCCCcccCCCCcHHHHHHHhcCc--cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 9999653 2344566666554332 223344555442 234566778889999999999999999999999999987
Q ss_pred CCCccc
Q 001922 963 RHSSDF 968 (995)
Q Consensus 963 ~~~~~~ 968 (995)
+..++.
T Consensus 953 ~~~~~~ 958 (968)
T PLN00113 953 RSSSSC 958 (968)
T ss_pred cccccc
Confidence 755543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-61 Score=614.68 Aligned_cols=518 Identities=36% Similarity=0.556 Sum_probs=490.2
Q ss_pred CceeeeecCCCCccccCCcccc-CCCCCCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccc
Q 001922 68 DRVASLDLTDLNLCGSVPAQIL-RLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAY 146 (995)
Q Consensus 68 ~~v~~l~l~~~~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls 146 (995)
..+..|||++++++|.+|..+. .+++|++|+|++|+++|.++.+.+++|++|+|++|.+++..|..++.+++|++|+++
T Consensus 93 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~ 172 (968)
T PLN00113 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLG 172 (968)
T ss_pred CCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECc
Confidence 3678899999999999998776 899999999999999998888889999999999999999999999999999999999
Q ss_pred cccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCC
Q 001922 147 NNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGG 226 (995)
Q Consensus 147 ~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~ 226 (995)
+|.+.+.+|..+.++++|++|+|++|.+++.+|..++.+++|++|+|++|++++.+|..++++++|++|++++|++ .+.
T Consensus 173 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l-~~~ 251 (968)
T PLN00113 173 GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL-TGP 251 (968)
T ss_pred cCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCcee-ccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999997665 567
Q ss_pred CCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCcccccc
Q 001922 227 IPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINL 306 (995)
Q Consensus 227 ~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 306 (995)
+|..++++++|++|++++|.+++.+|..+.++++|+.|++++|.+.+.+|..+.++++|+.|++++|.+++..|..+..+
T Consensus 252 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l 331 (968)
T PLN00113 252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331 (968)
T ss_pred cChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeec
Q 001922 307 RQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILIL 386 (995)
Q Consensus 307 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 386 (995)
++|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|++
T Consensus 332 ~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L 411 (968)
T PLN00113 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRL 411 (968)
T ss_pred CCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEEC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcc
Q 001922 387 LKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLL 466 (995)
Q Consensus 387 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l 466 (995)
++|.+.+.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.+++++|.+.+.+|... ...+|+.|+|++|++
T Consensus 412 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~----~~~~L~~L~ls~n~l 487 (968)
T PLN00113 412 QDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF----GSKRLENLDLSRNQF 487 (968)
T ss_pred cCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc----ccccceEEECcCCcc
Confidence 9999999999999999999999999999999999999999999999999999999888643 347899999999999
Q ss_pred cccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCcccc
Q 001922 467 SGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEI 546 (995)
Q Consensus 467 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l 546 (995)
++.+|..+.++++|+.|+|++|++++.+|..++.+++|+.|+|++|.++|.+|..++.+++|++|+|++|+++|.+|..+
T Consensus 488 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 567 (968)
T PLN00113 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567 (968)
T ss_pred CCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCeEeccccccccccCcccccCCcccEEeccCCC-CCCCCC
Q 001922 547 SNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFND-FSGKLP 591 (995)
Q Consensus 547 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~-l~g~~p 591 (995)
.++++|+.|++++|+++|.+|.. +.+..+....+.+|. ++|..|
T Consensus 568 ~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~~ 612 (968)
T PLN00113 568 GNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLCGGDT 612 (968)
T ss_pred hcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCccccCCcc
Confidence 99999999999999999999964 445555666677776 555443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=408.02 Aligned_cols=280 Identities=44% Similarity=0.781 Sum_probs=239.7
Q ss_pred cHHHHHhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC-cc
Q 001922 680 SVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE-TN 758 (995)
Q Consensus 680 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 758 (995)
++..+++.|...+.||+|+||.||+|...+|..||||++....... ..+|..|+.++.+++|||+|+++|||.+.+ +.
T Consensus 69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 69 ELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence 4566788899999999999999999999999999999885443332 455999999999999999999999999888 59
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
++|||||++|+|.++++......++|.++.+|+.++|+||+|||+...++||||||||+|||+|++..+||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999999999999998654438899999999999999999999988888999999999999999999999999999654
Q ss_pred ccCCCCcccccc-ccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC--CCCchHHHHHHHHhcCChhhhh
Q 001922 839 IDGGASECMSAI-AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDF--GDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 839 ~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
... ....... .||.+|+|||+...+..++|+|||||||++.|++||+.|.+.. .....+..|++...... .+.
T Consensus 228 ~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~--~~~ 303 (361)
T KOG1187|consen 228 PEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG--KLR 303 (361)
T ss_pred Ccc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc--chh
Confidence 220 1111222 7999999999999999999999999999999999999998754 24455888887666653 788
Q ss_pred hhcCCcCC--CCCH-HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 916 SILDPRLS--MVPK-EEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 916 ~~~d~~~~--~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
+++|+.+. ..+. .+...+..++.+|++.+|++||+|.||+++|+.+...
T Consensus 304 eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 304 EIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred heeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999974 4443 5778899999999999999999999999999666544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=381.15 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=215.0
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC-cceEEEEec
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE-TNLLVYEYM 765 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~~ 765 (995)
.+..+.||+|..|+||+++++ +++-+|+|++..........++.+|+++++..+||+||.+||+|.... ..+|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 455678999999999999774 678889999966556666788999999999999999999999998888 599999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
++|+|++++.. .+.+++....+++.++++||.|||+ ++ ||||||||+|||+...|.|||||||.+..+...
T Consensus 161 DgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999963 3679999999999999999999996 55 999999999999999999999999999987443
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC-CCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDF-GDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
...+.+||..|||||.+++..|+.++||||||+.++|+.+|+.||... .+..+..+... .+++..-+
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~-----------~Iv~~ppP 300 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC-----------AIVDEPPP 300 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH-----------HHhcCCCC
Confidence 335779999999999999999999999999999999999999999654 22334443333 33443334
Q ss_pred CCCHH-HHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 001922 924 MVPKE-EAMHLLFVAMLCIQENSIERPRMREVVQML 958 (995)
Q Consensus 924 ~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L 958 (995)
..|.+ ++.+++.++..|+++||.+||+++|++++-
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 45554 889999999999999999999999999763
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=384.15 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=208.3
Q ss_pred HHhhccCCCeeeccCceEEEEEE-eCCCcEEEEEEecCCCCCC------hhHHHHHHHHHHhccCCCCceeEeEEEecCC
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHS------HDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE 756 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 756 (995)
..+.|...+.+|+|+||.|-+|. .++|+.||||.+.+..... ....+.+|+++|++++|||||+++++|+.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 35568889999999999999994 5689999999985433222 2334679999999999999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CCeEEeeec
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA---FEAHVADFG 833 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~---~~vkl~DfG 833 (995)
..||||||++||+|.+.+.+ ++.+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999964 456778888899999999999999888 9999999999999766 678999999
Q ss_pred cccccccCCCCccccccccCcccccccccccCCC---CcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCC
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV---DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 910 (995)
+|+... ....+.+.||||.|.|||++.+..+ ..++|+||+||++|-+++|.+||.+......+.+ .+..
T Consensus 325 lAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e---QI~~-- 396 (475)
T KOG0615|consen 325 LAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE---QILK-- 396 (475)
T ss_pred hhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH---HHhc--
Confidence 999874 3456688999999999999987643 3488999999999999999999976544332221 2222
Q ss_pred hhhhhhhcCCcCCCC---CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 911 KEEFLSILDPRLSMV---PKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 911 ~~~~~~~~d~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.++... ....+++..++|.+|+..||++||+++|++++
T Consensus 397 ---------G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 ---------GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ---------CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 233222 33677889999999999999999999999975
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=394.44 Aligned_cols=260 Identities=36% Similarity=0.542 Sum_probs=214.1
Q ss_pred cCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCC-cceEEEEecc
Q 001922 689 KDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE-TNLLVYEYMR 766 (995)
Q Consensus 689 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~~~ 766 (995)
...+.+|.|+||+||+|.+.....||||++..... ....+.|.+|+.++++++|||||+++|++.++. ..++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 34456999999999999996544499999854322 222568999999999999999999999998887 7899999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-CeEEeeeccccccccCCCCc
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-~vkl~DfGla~~~~~~~~~~ 845 (995)
+|+|.++++......+++..+.+++.|||+||.|||+++. ||||||||+|||++.++ .+||+|||+++...... .
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999986557789999999999999999999995531 99999999999999998 99999999998754321 3
Q ss_pred cccccccCcccccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 846 CMSAIAGSYGYIAPEYAY--TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.++...||+.|||||++. ...|+.|+||||||+++|||+||+.||.+... .... .... .....+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~---~~v~----------~~~~Rp 265 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVA---SAVV----------VGGLRP 265 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHH---HHHH----------hcCCCC
Confidence 334478999999999999 56999999999999999999999999987554 2211 1111 111223
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
..+..++..+..++.+||+.||++||++.|++..|+.+.....
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 3455588899999999999999999999999999998876444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=394.10 Aligned_cols=249 Identities=27% Similarity=0.394 Sum_probs=215.7
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecC--CCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLG--FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.+|+.++.||+|+|+.||.++. .+|+.||+|++.+ ...+...+.+.+|++|.++++|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999987 7899999999844 234455778999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
|+|+.++|..+++ ....+++..++.+++||+.|+.|||+++ |+|||||..|++++++.+|||+|||+|..+...+
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999996 4568999999999999999999999777 9999999999999999999999999999886432
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
+...+.||||.|.|||++....++..+||||+|||+|.|++|++||.. ..+.+....+....+
T Consensus 173 --Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~~~Y----------- 235 (592)
T KOG0575|consen 173 --ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKLNEY----------- 235 (592)
T ss_pred --cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHhcCc-----------
Confidence 344678999999999999999999999999999999999999999953 223333333332211
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..|...+.+..+||.++|+.+|.+|||+++|++.
T Consensus 236 -~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 -SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2345677788999999999999999999999964
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=395.54 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=219.4
Q ss_pred ccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
++..+.||+|.||+||.|++....+||+|.++.. ....+.|.+|+++|++++|++||+++++|..++.+|||||||+.
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 4456779999999999999977779999999654 33467799999999999999999999999998899999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.++++...+..+...+...++.|||+||+||++++ +|||||.++||||+++..+||+|||+|+...+.. ....
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~ 361 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTAS 361 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc-eeec
Confidence 99999998767888999999999999999999999766 9999999999999999999999999999554433 3333
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC-CC
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS-MV 925 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~ 925 (995)
....-++.|+|||.+..+.|+.|+|||||||++|||+| |+.||..+.. .+.+..+..+ ++ ..
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----~ev~~~le~G------------yRlp~ 425 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----EEVLELLERG------------YRLPR 425 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----HHHHHHHhcc------------CcCCC
Confidence 44456789999999999999999999999999999999 9999965543 2333333332 22 24
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
|..|+..+.++|..||+.+|++|||++.+...++++....
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 6679999999999999999999999999999999887644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=372.73 Aligned_cols=200 Identities=32% Similarity=0.502 Sum_probs=178.3
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
...|...+.||.|+||+||+|++ +++.+||||.+.... .....+....|+.+++.++|||||++++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 34677788899999999999976 468999999995443 3445666889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC------CCeEEeeecccc
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA------FEAHVADFGLAK 836 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~------~~vkl~DfGla~ 836 (995)
|||.||+|.++++. .+.+++.+++.++.|+|.|+++||+++ ||||||||+|||++.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999964 457999999999999999999999777 9999999999999875 457999999999
Q ss_pred ccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGD 892 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~ 892 (995)
.+.++ ....+.+|++.|||||+++.++|+.|+|+||+|+|+|++++|+.||+.
T Consensus 164 ~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 164 FLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 98644 334678999999999999999999999999999999999999999964
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=350.54 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=209.7
Q ss_pred HhhccCCCeeeccCceEEEEEE-eCCCcEEEEEEecC-CCCCChhHHHHHHHHHHhccCCCCceeEeE-EEecCCc-ceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLG-FGTHSHDHGFRAEIQTLGNIRHRNIVRLLA-FCSNKET-NLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~~-~~~~~~~-~~l 760 (995)
...|++.++||.|.||+||++. ..+|..+|.|.+.- .-+...++....|+.++++++|||||++++ .|.+... .+|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3467788899999999999994 57899999999852 122334566889999999999999999998 4544444 899
Q ss_pred EEEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 761 VYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL--IVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
|||||.+|+|...++. +.+..+++..+|+++.|+++||..+|..- +. |+||||||.||+++.+|.||++|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999974 45678999999999999999999999631 33 9999999999999999999999999999
Q ss_pred ccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
.+... .....+.+|||.||+||.+...+|+.++||||+||++|||+.-++||... ...+..+.+..+
T Consensus 177 ~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qg------- 243 (375)
T KOG0591|consen 177 FLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQG------- 243 (375)
T ss_pred Hhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcC-------
Confidence 87432 22335678999999999999999999999999999999999999999652 555555555544
Q ss_pred hcCCcCCCCC-HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 917 ILDPRLSMVP-KEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 917 ~~d~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.++..| ..++..+..+|..|+..||+.||+.-.+++
T Consensus 244 ----d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 244 ----DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred ----CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 223344 678899999999999999999998444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=360.51 Aligned_cols=243 Identities=26% Similarity=0.347 Sum_probs=205.6
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC--ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.+.|++.++||+|+||+||.++.+ +++-+|+|++.+...- ...+....|..++.+++||+||.++..|++++.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 356889999999999999999764 5788999998543322 3456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
+||+.||.|...++ +.+.+++..++-++.+|+.||.|||+++ |||||+||+|||+|++|.++|+|||+++.....
T Consensus 104 ld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999995 4567999999999999999999999887 999999999999999999999999999964332
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
+ ....+.+||+.|||||++.+..|+.++|+||+|+++|||++|.+||.. .+...+.+.+..+.
T Consensus 179 ~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~----~~~~~~~~~I~~~k----------- 241 (357)
T KOG0598|consen 179 G--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA----EDVKKMYDKILKGK----------- 241 (357)
T ss_pred C--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC----ccHHHHHHHHhcCc-----------
Confidence 2 223457999999999999999999999999999999999999999954 44445555444442
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCC
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERP 949 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RP 949 (995)
+...+.-.+...++++.+.+..||++|.
T Consensus 242 ~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 2233444566788999999999999995
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=388.90 Aligned_cols=480 Identities=27% Similarity=0.386 Sum_probs=349.8
Q ss_pred cccCCCCCCeEeccCCcccCc-cccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCc
Q 001922 87 QILRLDKLTNLSLAGNNFTGS-IEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLK 165 (995)
Q Consensus 87 ~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~ 165 (995)
..++-..++.|.+++|.++.. ..+.++..|.+|++++|+++. .|.+++.+.+++.|+.++|+++. +|..++.+..|+
T Consensus 40 ~wW~qv~l~~lils~N~l~~l~~dl~nL~~l~vl~~~~n~l~~-lp~aig~l~~l~~l~vs~n~ls~-lp~~i~s~~~l~ 117 (565)
T KOG0472|consen 40 NWWEQVDLQKLILSHNDLEVLREDLKNLACLTVLNVHDNKLSQ-LPAAIGELEALKSLNVSHNKLSE-LPEQIGSLISLV 117 (565)
T ss_pred hhhhhcchhhhhhccCchhhccHhhhcccceeEEEeccchhhh-CCHHHHHHHHHHHhhcccchHhh-ccHHHhhhhhhh
Confidence 344556788999999999864 368899999999999999984 56678889999999999999987 788999999999
Q ss_pred eeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCC
Q 001922 166 YLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSC 245 (995)
Q Consensus 166 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n 245 (995)
.|++++|.+. .+|+.++.+..|+.|+..+|+++ ..|+.++++.+|..|++.+|++.. .|+..-+++.|++||..+|
T Consensus 118 ~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~--l~~~~i~m~~L~~ld~~~N 193 (565)
T KOG0472|consen 118 KLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA--LPENHIAMKRLKHLDCNSN 193 (565)
T ss_pred hhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh--CCHHHHHHHHHHhcccchh
Confidence 9999999997 78888999999999999999999 788899999999999999888765 5555555999999999999
Q ss_pred CCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCc
Q 001922 246 ELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPD 325 (995)
Q Consensus 246 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 325 (995)
-++ .+|..++.|.+|+.|+|++|++. .+| .|.++..|++|+++.|+|+....+...++.+|..|||..|+++ ..|+
T Consensus 194 ~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pd 269 (565)
T KOG0472|consen 194 LLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPD 269 (565)
T ss_pred hhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCch
Confidence 887 78889999999999999999998 566 7999999999999999999443344458999999999999999 7899
Q ss_pred cccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCc---cceeec--cccccC--------
Q 001922 326 YLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQ---LRILIL--LKNFLF-------- 392 (995)
Q Consensus 326 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~l--~~N~l~-------- 392 (995)
.++-+.+|++||+|+|.|+ .+|..++++ .|+.|-+.+|.+. ++-..+-+... |++|.= ..-.++
T Consensus 270 e~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~ 346 (565)
T KOG0472|consen 270 EICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTET 346 (565)
T ss_pred HHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH-HHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccc
Confidence 9999999999999999999 578889999 8999999999987 44433332221 222211 000010
Q ss_pred -CCCC----cccccCCCCcEEEecCCccCCCCCCCcccCCC---CceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCC
Q 001922 393 -GPIP----ERLGACYSLTRVRLGQNYLNGSIPDGFIYLPG---LNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNN 464 (995)
Q Consensus 393 -~~~p----~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N 464 (995)
+..| .....+.+.+.|++++-+++ .+|+..+.... .+..+++.|+++. +|....... ..++.+.+++|
T Consensus 347 ~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~e-lPk~L~~lk--elvT~l~lsnn 422 (565)
T KOG0472|consen 347 AMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLCE-LPKRLVELK--ELVTDLVLSNN 422 (565)
T ss_pred cCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHhh-hhhhhHHHH--HHHHHHHhhcC
Confidence 0001 11223445666777777766 45554443333 5556666666652 222111000 11234455555
Q ss_pred cccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCcc
Q 001922 465 LLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPP 544 (995)
Q Consensus 465 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~ 544 (995)
+++ .+|..++.+++|+.|+|++|-+. .+|..++.+..|+.||+|.|+|. .+|..+..+..|+.+-.++|++...-|.
T Consensus 423 ~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~ 499 (565)
T KOG0472|consen 423 KIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPS 499 (565)
T ss_pred ccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChH
Confidence 555 56666666777777777776665 66666777766777777777776 6666666666666666666777644444
Q ss_pred ccccccccCeEeccccccccccCcccccCCcccEEeccCCCCC
Q 001922 545 EISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFS 587 (995)
Q Consensus 545 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 587 (995)
.+.+|++|..|||.+|.|. .+|+.+++|++|+.|++++|+|.
T Consensus 500 ~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 500 GLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 4677777777777777773 36667777777777777777776
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=384.64 Aligned_cols=484 Identities=27% Similarity=0.373 Sum_probs=403.8
Q ss_pred ccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCC
Q 001922 107 SIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQ 186 (995)
Q Consensus 107 ~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 186 (995)
....+.-..|+.|.|++|.+... ...+.++..|.+|++.+|++.. .|.+++.+.+++.|+.++|+++ .+|+.++.+.
T Consensus 38 ~e~wW~qv~l~~lils~N~l~~l-~~dl~nL~~l~vl~~~~n~l~~-lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~ 114 (565)
T KOG0472|consen 38 GENWWEQVDLQKLILSHNDLEVL-REDLKNLACLTVLNVHDNKLSQ-LPAAIGELEALKSLNVSHNKLS-ELPEQIGSLI 114 (565)
T ss_pred hhhhhhhcchhhhhhccCchhhc-cHhhhcccceeEEEeccchhhh-CCHHHHHHHHHHHhhcccchHh-hccHHHhhhh
Confidence 34577788899999999999854 4567889999999999999998 6889999999999999999997 8999999999
Q ss_pred CCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCcccc
Q 001922 187 GLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFL 266 (995)
Q Consensus 187 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l 266 (995)
+|..|+.++|.+. .+|+.++.+..|+.|+..+|++.+ .|+.+..+.+|..|++.+|++....|..+. ++.|++|++
T Consensus 115 ~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~s--lp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~ 190 (565)
T KOG0472|consen 115 SLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQISS--LPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDC 190 (565)
T ss_pred hhhhhhcccccee-ecCchHHHHhhhhhhhcccccccc--CchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhccc
Confidence 9999999999999 788899999999999999888866 899999999999999999999965555555 999999999
Q ss_pred ccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccc-cCCCCcceEEeccCcccc
Q 001922 267 HINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYL-ADLPNLETLGLWQNNFTG 345 (995)
Q Consensus 267 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~ 345 (995)
..|.++ .+|+.++.+.+|+.|||.+|+|. ..| .|.++..|+.|+++.|+|. .+|... ..+++|..|||.+|+++
T Consensus 191 ~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk- 265 (565)
T KOG0472|consen 191 NSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK- 265 (565)
T ss_pred chhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-
Confidence 999998 78889999999999999999999 777 8999999999999999999 666655 48999999999999999
Q ss_pred cCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCccccc-----CCCCcE----EEecCCc--
Q 001922 346 VIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGA-----CYSLTR----VRLGQNY-- 414 (995)
Q Consensus 346 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~-----l~~L~~----L~l~~N~-- 414 (995)
..|+.+.-+.+|++||+|+|.|+ .+|..++++ .|+.|-+.+|.+...--+.+.+ ++.|+. =.++.-.
T Consensus 266 e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~ 343 (565)
T KOG0472|consen 266 EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGG 343 (565)
T ss_pred cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccc
Confidence 78999999999999999999999 788999999 9999999999885322111111 111111 0011100
Q ss_pred -------cCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCC-cEEEcC
Q 001922 415 -------LNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSL-QILLLS 486 (995)
Q Consensus 415 -------l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls 486 (995)
..+..|+ ...+...+.++++.-+++. +|...+....-.-++..+++.|++. .+|..+..+..+ +.+.++
T Consensus 344 ~e~~~t~~~~~~~~-~~~~i~tkiL~~s~~qlt~-VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~ls 420 (565)
T KOG0472|consen 344 TETAMTLPSESFPD-IYAIITTKILDVSDKQLTL-VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLS 420 (565)
T ss_pred ccccCCCCCCcccc-hhhhhhhhhhccccccccc-CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhh
Confidence 0111111 2234567778888888874 4444444444455889999999999 799888877665 456777
Q ss_pred CCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEecccccccccc
Q 001922 487 GNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNI 566 (995)
Q Consensus 487 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~ 566 (995)
+|+++ .+|..++.+++|..|+|++|-+- .+|.+++.+..|+.||+|+|+|. .+|..+..+..|+.+-.++|++....
T Consensus 421 nn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd 497 (565)
T KOG0472|consen 421 NNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVD 497 (565)
T ss_pred cCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccC
Confidence 77776 89999999999999999999997 89999999999999999999998 89999999999999888889996655
Q ss_pred CcccccCCcccEEeccCCCCCCCCCCCCCCcccccccCCCCccC
Q 001922 567 PKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQL 610 (995)
Q Consensus 567 p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~ 610 (995)
|..+.+|.+|..|||.+|.+...+|..|.++++....+.|||..
T Consensus 498 ~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 498 PSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 55699999999999999999999999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=339.80 Aligned_cols=264 Identities=23% Similarity=0.285 Sum_probs=209.0
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
+.|+...++|+|+||+||+++.+ +|+-||||++....+ +...+-..+|++++++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46777889999999999999875 589999999965444 3334556899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
||+. ++.+.+.. .....+...+.+++.|++.|+.|+|+++ +|||||||+||+++.+|.+||||||+|+.+..+
T Consensus 82 ~~dh-TvL~eLe~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 82 YCDH-TVLHELER-YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred ecch-HHHHHHHh-ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 9987 55555553 3445788889999999999999999777 999999999999999999999999999988632
Q ss_pred CccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC---
Q 001922 844 SECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD--- 919 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--- 919 (995)
....+..+.|..|.|||.+.+ .+|+..+||||+||++.||++|.+-|...+|...+....+.... -.+....++.
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~-L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGN-LIPRHQSIFSSNP 233 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcc-cCHHHHHHhccCC
Confidence 233456788999999999887 68999999999999999999999999766554444433333322 2222222222
Q ss_pred -------CcC------CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 -------PRL------SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 -------~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
|.. +...+.....+.+++..|++.||++|++.+|++.+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111 11122345578899999999999999999998753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=363.70 Aligned_cols=267 Identities=20% Similarity=0.248 Sum_probs=216.3
Q ss_pred HHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCC-cce
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKE-TNL 759 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~-~~~ 759 (995)
.+.++|...++||.|+||.||+|+. .+|+.||||++++.-...+...-.+|++.++++. |||||++.+++.+.+ ..|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4567899999999999999999965 5688999999965444433444568999999998 999999999998877 999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+|||||+. .|+++++++ +..+++..++.|+.||++||+|+|++| +.|||+||+|||+.....+||+|||+|+.+.
T Consensus 87 fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 99999976 999999876 788999999999999999999999888 9999999999999999999999999999874
Q ss_pred cCCCCccccccccCccccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh----
Q 001922 840 DGGASECMSAIAGSYGYIAPEYA-YTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF---- 914 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---- 914 (995)
. ....+..+.|..|+|||++ +.+-|+.++||||+|||++|+.+-++-|.+.++.+.+.....-+.......+
T Consensus 162 S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 S---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred c---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 3 3334667899999999986 4667899999999999999999999988765444444444333333222111
Q ss_pred --hhhcCCcCC--------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 915 --LSILDPRLS--------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 915 --~~~~d~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+.-+++ ..-+.++.+..++|.+|+++||.+||||+|++++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 122222221 1223478889999999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=370.46 Aligned_cols=269 Identities=30% Similarity=0.412 Sum_probs=216.9
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCC-CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGF-GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.+++..++.||+|.||+||+|+|. ..||||++... ..+...+.|+.|+.++++-+|.||+-+.|||..+.. .||..
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 445677889999999999999984 37999998432 334456789999999999999999999999988777 99999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
||+|.+|+.+++.. ...++..+.+.|++|||+||.|||.++ |||||+|..||++.+++.|||+|||++..-..-..
T Consensus 468 wCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred hccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999999999854 367889999999999999999999666 99999999999999999999999999975332222
Q ss_pred CccccccccCcccccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTL---RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
........|...|||||+++.. +|++.+||||||+++|||+||..||.. ...+. ....+..+ .+.+
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dq---IifmVGrG-------~l~p 612 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQ---IIFMVGRG-------YLMP 612 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhh---eEEEeccc-------ccCc
Confidence 3333456688999999998743 689999999999999999999999973 22211 11111111 1123
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcccccC
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQS 971 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~ 971 (995)
.......+++.++.+|+..||..++++||.+.+|+..|+++.+..+...-|
T Consensus 613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS 663 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRS 663 (678)
T ss_pred cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccC
Confidence 334455678889999999999999999999999999998888765554443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=389.67 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=225.6
Q ss_pred ccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.+..+.||+|+||+||+|+. .+.+-||||.+++........+|++|++.+..++|||||+++|+|.+++.+++|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 34457899999999999964 245679999997776666788899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCC--------C----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEE
Q 001922 762 YEYMRNGSLGEALHGKK--------G----AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV 829 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~--------~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl 829 (995)
+|||..|+|.+++.... + ..++..+...|+.|||.||+||.++. +|||||..+|+||.++..|||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEe
Confidence 99999999999996421 2 23888899999999999999999776 999999999999999999999
Q ss_pred eeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhc
Q 001922 830 ADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATN 908 (995)
Q Consensus 830 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 908 (995)
+|||+++.+...++........-+++|||||.+..++|++++|||||||++||+++ |+.||+...+.+.+.. +.
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~----i~- 719 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC----IR- 719 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH----HH-
Confidence 99999998876666665555567889999999999999999999999999999999 9999988766433322 22
Q ss_pred CChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcc
Q 001922 909 GRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSD 967 (995)
Q Consensus 909 ~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 967 (995)
+..+-..|++++..++.||..||+..|++||+++||-..|+++.+..+.
T Consensus 720 ----------~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 720 ----------AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred ----------cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 2233346888999999999999999999999999999999998776544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=350.27 Aligned_cols=264 Identities=27% Similarity=0.351 Sum_probs=215.0
Q ss_pred HhhccCCCeeeccCceEEEEEE-eCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.+.|+...+||.|..++||+|+ .+.++.||||++.-.......+.+.+|++.|+.++||||++++..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3568888999999999999996 467899999999655555557889999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
||.+||+.+++.......+++..+..|.+++++||.|||++| .||||||+.|||++++|.|||+|||.+..+.+.+.
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999998777777999999999999999999999888 99999999999999999999999999888776553
Q ss_pred Cccc--cccccCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 844 SECM--SAIAGSYGYIAPEYAYT--LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 844 ~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.... .+..||++|||||+++. ..|+.|+||||||++..|+.+|..||.....-..+.. .+............+
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~---tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL---TLQNDPPTLLTSGLD 258 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH---HhcCCCCCcccccCC
Confidence 3221 45689999999999543 4699999999999999999999999987543222221 222111100000011
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..........+.+++..|+++||++|||++++++.
T Consensus 259 ---~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 259 ---KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ---hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11222345578999999999999999999999854
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=365.58 Aligned_cols=254 Identities=24% Similarity=0.336 Sum_probs=213.4
Q ss_pred HHHHhhccCCCeeeccCceEEEEEE-eCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
.|....|+..++||+|+.|.||.|+ ..+++.||||++... .+...+-+.+|+.+|+..+|+|||.+++.|-.++..|.
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~-~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR-KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEec-cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 3445678888899999999999995 467899999999433 33445668899999999999999999999988899999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
|||||+||+|.|++.. ..+++.+...|++++++||+|||.+| |+|||||.+|||++.+|.+||+|||++..+..
T Consensus 348 VMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 9999999999999953 45899999999999999999999877 99999999999999999999999999998765
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
... ...+.+|||.|||||+.....|++++||||||++++||+.|.+||-. ++..+..+.+......
T Consensus 422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~ng~P-------- 487 (550)
T KOG0578|consen 422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATNGTP-------- 487 (550)
T ss_pred ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhcCCC--------
Confidence 433 44678999999999999999999999999999999999999999954 2222222222222111
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. -..+...+..+.+++.+|++.||++||+++|++++
T Consensus 488 ~-lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 488 K-LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred C-cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1 12355677889999999999999999999999975
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=354.50 Aligned_cols=260 Identities=28% Similarity=0.400 Sum_probs=208.8
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC--cceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE--TNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e 763 (995)
.+..++.||+|+||+||++... +|+..|||.+...... ..+.+.+|++++++++|||||+++|...... .+++.||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 4567789999999999999765 4899999998443222 2566899999999999999999999854444 6899999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCCeEEeeecccccccc-C
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS-AFEAHVADFGLAKFLID-G 841 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~-~~~vkl~DfGla~~~~~-~ 841 (995)
|+.+|+|.+++....+ .+++..+.++.+||++||+|||++| ||||||||+|||++. ++.+||+|||+++.... .
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999986554 7999999999999999999999777 999999999999999 79999999999987643 1
Q ss_pred CCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
..........||+.|||||++..+ ....++||||+||++.||+||+.||... .....+...+... .
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~----------~ 239 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGRE----------D 239 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhcc----------C
Confidence 222334467899999999999864 3345999999999999999999999764 2222222222211 1
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
..+.+|...+....+++.+|+..+|++||||+|++++...-...
T Consensus 240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 22356667888899999999999999999999999876554433
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=360.05 Aligned_cols=244 Identities=29% Similarity=0.447 Sum_probs=206.3
Q ss_pred ccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+...+.+|.|+-|.||+|+. .++.||||++... -..+++-+++++||||+.|.|+|.....+|||||||..
T Consensus 126 IsELeWlGSGaQGAVF~Grl-~netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL-HNETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhhhhccCcccceeeeec-cCceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 34567899999999999998 5689999998322 23478889999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|.|..+++ .+..+.......|..+||.||.|||.+. |||||||.-||||..+..|||+|||-++...+. ..+
T Consensus 197 GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STk 268 (904)
T KOG4721|consen 197 GQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STK 268 (904)
T ss_pred ccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhh
Confidence 99999995 4567888889999999999999999766 999999999999999999999999999876443 333
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC-CCCC
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL-SMVP 926 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~ 926 (995)
...+||..|||||++++.+.++|+|||||||++|||+||..||.+... ..+++.+. ...+ -..|
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVG-----------sNsL~LpvP 333 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVG-----------SNSLHLPVP 333 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEecc-----------CCcccccCc
Confidence 567899999999999999999999999999999999999999965321 11111111 1122 2357
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 927 KEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 927 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
..++..+.-|+++||+..|..||+|++++.+|+....
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 7889999999999999999999999999999987554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=324.02 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=210.5
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.+|...+++|+|.||.||+|++ .+|+.||||+++..... .......+|++.++.++||||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999965 67999999999654322 223457889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
||+. +|..++++ +...++......++.++++|++|+|.+. |+|||+||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~- 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN- 155 (318)
T ss_pred eccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC-
Confidence 9976 99999974 4567889999999999999999999777 9999999999999999999999999999875443
Q ss_pred CccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC---
Q 001922 844 SECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD--- 919 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--- 919 (995)
......+.|..|.|||.+.+. .|+..+||||.|||+.||+-|.+-|...+|-+.+....+.........+.++..
T Consensus 156 -~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 -RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred -cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 233445789999999988765 689999999999999999998777665444444444433333333222222211
Q ss_pred ---------CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 ---------PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+.....-..++....+++..|+..+|.+|++++|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111223456677899999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.80 Aligned_cols=249 Identities=28% Similarity=0.357 Sum_probs=214.6
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.-|+.++.||+|+.|.|..|++ .+|+.+|||.+.+. ........+.+|+-+|+.+.|||++++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3467788999999999999976 57999999998443 23344667899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++|.|++++. .++.+++..+.++++||+.|+.|+|..+ |+|||+||+|+++|..+.+||+|||+|..-.+
T Consensus 92 Eyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-- 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP-- 164 (786)
T ss_pred EecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence 9999999999995 4567888999999999999999999777 99999999999999999999999999986433
Q ss_pred CCccccccccCcccccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVD-EKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
.....+.||+|.|+|||++++.+|+ .++||||+|||+|.|+||+.||++ .++.....++..+..
T Consensus 165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f---------- 229 (786)
T KOG0588|consen 165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVF---------- 229 (786)
T ss_pred -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcc----------
Confidence 3445678999999999999999984 899999999999999999999964 444444444444422
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQML 958 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 958 (995)
..|.+.+.++++|+.+|+..||++|.|++||+++-
T Consensus 230 --~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 230 --EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred --cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 24567778899999999999999999999999873
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=373.66 Aligned_cols=268 Identities=28% Similarity=0.443 Sum_probs=228.8
Q ss_pred hccCCCeeeccCceEEEEEEeC----CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
..++.++||.|.||+|++|+.+ ....||||.++....+..+.+|..|+.||.++.||||+++.|+......++||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4567799999999999999764 346799999988888888899999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
|||++|+|+.+++.+. +.+++.+...+.++||.||.||.+++ +|||||.++|||++.+..+|++|||+++.+.++.
T Consensus 710 EyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999998665 44888899999999999999999888 9999999999999999999999999999875543
Q ss_pred CCcccccc--ccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 843 ASECMSAI--AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 843 ~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
....++. .-+.+|.|||.+....++.++||||+||++||.++ |..||-++.+.+.+... +
T Consensus 786 -~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI----------------e 848 (996)
T KOG0196|consen 786 -EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI----------------E 848 (996)
T ss_pred -CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH----------------H
Confidence 2222222 23579999999999999999999999999999998 99999887765443322 2
Q ss_pred CcCC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcccccCchhh
Q 001922 920 PRLS-MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQSSSSS 975 (995)
Q Consensus 920 ~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~ 975 (995)
..++ ..|.+|+..+.+||..||++|-.+||.+.+++..|+++.+......-.+...
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~ 905 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPES 905 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCC
Confidence 2222 2567899999999999999999999999999999999998766555444333
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=360.50 Aligned_cols=255 Identities=26% Similarity=0.361 Sum_probs=211.2
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC----CChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT----HSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 758 (995)
...|+.++.||+|+||+|+.|++ .+++.||+|.+.+... ....+.+.+|+.++++++ ||||+++++++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 45789999999999999999965 5689999996643211 123456778999999998 99999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CCeEEeeeccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA-FEAHVADFGLAKF 837 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~-~~vkl~DfGla~~ 837 (995)
|+||||+.||+|.+++.. .+++.+..++++++|++.|++|+|..| |+||||||+||+++.+ +++||+|||++..
T Consensus 96 ~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 999999999999999974 577888999999999999999999777 9999999999999999 9999999999997
Q ss_pred cccCCCCccccccccCcccccccccccCC-CC-cccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTLR-VD-EKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
.. .......+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++ .+.....+.+..+.
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d----~~~~~l~~ki~~~~----- 239 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD----SNVPNLYRKIRKGE----- 239 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC----ccHHHHHHHHhcCC-----
Confidence 63 2233456789999999999999977 85 889999999999999999999976 22222222222221
Q ss_pred hhcCCcCCCCCHHH-HHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 916 SILDPRLSMVPKEE-AMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 916 ~~~d~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
-.+|... +..+..++.+|+..+|.+|+++.+++ .-..++.
T Consensus 240 -------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 240 -------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred -------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1133333 77899999999999999999999999 5555554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=353.97 Aligned_cols=251 Identities=25% Similarity=0.317 Sum_probs=207.5
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 761 (995)
+.|..++.||+|+|++|++|+. +.+++||||++.+.. .+....-+..|-.+|.+| .||.|++++..|++...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 4578899999999999999965 568999999874321 122234467788999999 899999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
+||+++|+|.++++ +-+.+++.-++.++.||+.|++|||..| ||||||||+|||+|++|++||+|||.|+.+.+.
T Consensus 153 Le~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999996 3477999999999999999999999777 999999999999999999999999999987542
Q ss_pred CCC-----------ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCC
Q 001922 842 GAS-----------ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910 (995)
Q Consensus 842 ~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 910 (995)
... ......+||..|++||++.....+..+|+|+||||+|+|+.|++||.+..+-
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-------------- 293 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-------------- 293 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--------------
Confidence 211 1124578999999999999999999999999999999999999999764321
Q ss_pred hhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 911 KEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 911 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..|.++++-.+. .++..++.+.+|+.+.+..||.+|++++++.++
T Consensus 294 -liFqkI~~l~y~-fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 -LIFQKIQALDYE-FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -HHHHHHHHhccc-CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 122222222222 344556788999999999999999999998765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=326.29 Aligned_cols=237 Identities=24% Similarity=0.283 Sum_probs=201.1
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
++|+..+.+|.|+||.|.+++.+ +|..+|+|++.+.. ...+.+...+|..+++.+.||+++++++.|.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45677889999999999999764 58889999984322 2234456788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||++||.|..+++ +.+++++..++-++.||+.|++|||+.+ |++||+||+|||+|.+|.+||+|||+|+.+.+.
T Consensus 124 eyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999995 4567999999999999999999999777 999999999999999999999999999987432
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
.-+.||||.|+|||.+...+|..++|.|||||++|||+.|.+||.+... .+.... ++...+
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~K-----------I~~~~v 258 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEK-----------ILEGKV 258 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHH-----------HHhCcc
Confidence 3567999999999999999999999999999999999999999976332 222222 222222
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCC
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIER 948 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~R 948 (995)
..|.-.+.++.+|+...++.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2456677789999999999999999
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=363.99 Aligned_cols=263 Identities=25% Similarity=0.409 Sum_probs=207.3
Q ss_pred HhhccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecC-C
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNK-E 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~ 756 (995)
.++|+..+.||+|+||.||+|.+ .+++.||||++...........+.+|+.+++++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35788899999999999999964 235679999986443344456788999999999 899999999988654 4
Q ss_pred cceEEEEeccCCChhhhhcCCC----------------------------------------------------------
Q 001922 757 TNLLVYEYMRNGSLGEALHGKK---------------------------------------------------------- 778 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 778 (995)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999986421
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccccCccc
Q 001922 779 --GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGY 856 (995)
Q Consensus 779 --~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y 856 (995)
...+++..+.+++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134778888999999999999999777 999999999999999999999999999865432222222334567889
Q ss_pred ccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHH
Q 001922 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLF 935 (995)
Q Consensus 857 ~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~ 935 (995)
+|||++.+..++.++|||||||++|||++ |..||.......... .....+ .....+...+..+.+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~---~~~~~~-----------~~~~~~~~~~~~l~~ 308 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC---QRLKDG-----------TRMRAPENATPEIYR 308 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHHhcC-----------CCCCCCCCCCHHHHH
Confidence 99999999999999999999999999997 999996543222211 111111 111123345667899
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 936 VAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 936 li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
++.+||+.||++||++.|+++.|+++.++
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=361.23 Aligned_cols=367 Identities=23% Similarity=0.205 Sum_probs=307.2
Q ss_pred cccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhcccc
Q 001922 141 EVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYY 220 (995)
Q Consensus 141 ~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n 220 (995)
+.||+++|++..+.+..|.++++|+.+++.+|.++ .+|...+...+|+.|+|.+|.|+.+-.+++.-+..|+.|||+.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 45777777777777778888888888888888886 77776556666888888888888777778888888888888876
Q ss_pred ccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCC
Q 001922 221 NVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIP 300 (995)
Q Consensus 221 ~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 300 (995)
.+.+-. -..|..-.++++|+|++|.|+..-...|.++.+|.+|.|+.|+++...+..|.++++|+.|+|..|+|.-.--
T Consensus 160 ~is~i~-~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ 238 (873)
T KOG4194|consen 160 LISEIP-KPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG 238 (873)
T ss_pred hhhccc-CCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence 665522 2345566789999999999998888899999999999999999997777889999999999999999985557
Q ss_pred ccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCc
Q 001922 301 YSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQ 380 (995)
Q Consensus 301 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 380 (995)
..|.++++|+.|.|..|.|.....+.|..+.++++|+|+.|+++.+-..++.++++|+.|+||+|.|...-++.+.-..+
T Consensus 239 ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftqk 318 (873)
T KOG4194|consen 239 LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQK 318 (873)
T ss_pred hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccc
Confidence 78999999999999999999877888999999999999999999888889999999999999999999888888988999
Q ss_pred cceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEE
Q 001922 381 LRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLN 460 (995)
Q Consensus 381 L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~ 460 (995)
|+.|+|+.|++....++.|..+..|++|+|++|.+...-..+|..+.+|+.|||.+|.+++.+......+..+++|+.|+
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~ 398 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR 398 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence 99999999999999999999999999999999999988888999999999999999999887776666666677777777
Q ss_pred cCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhcccccc
Q 001922 461 LSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLS 510 (995)
Q Consensus 461 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 510 (995)
|.+|+|+.+.-.+|.++.+|+.|||.+|.|..+-|.+|..+ +|++|.+.
T Consensus 399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 77777775555577777777777777777776667777766 66666553
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=353.00 Aligned_cols=248 Identities=26% Similarity=0.358 Sum_probs=212.7
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCC-CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGF-GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
++|...+.||+|+||.||+|+.+ +.+.||+|.+.+. +.+.+.+.+.+|+++++.++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 45666678999999999999764 5788999988443 334456778999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+.| +|+.++. ..+.++++.++.++.|++.||.|||+.+ |.|||+||+||+++..|.+|+||||+|+.+..+
T Consensus 82 ~a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-- 153 (808)
T ss_pred hhhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC--
Confidence 9987 9999995 4567999999999999999999999776 999999999999999999999999999987543
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
....+...|||.|||||+..+++|+..+|+||+|||+||+++|++||.. ..+.+.++.+..+. .
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d~------------v 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKDP------------V 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcCC------------C
Confidence 3345678899999999999999999999999999999999999999953 44555555554431 1
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..|...+..+.+++...+.+||.+|.+..+++.+
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 2455788889999999999999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=385.75 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=220.7
Q ss_pred hccCCCeeeccCceEEEEEEeC--CC----cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP--NG----VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~--~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
..+..+.||+|+||.||.|... +| ..||||.+.+..+......|.+|..+|+.++|||||+++|++-+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 3455688999999999999753 23 34899999887778888899999999999999999999999998999999
Q ss_pred EEEeccCCChhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccc
Q 001922 761 VYEYMRNGSLGEALHGKK-----GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA 835 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla 835 (995)
++|||++|+|..+++..+ ...++......++.|||+|+.||++++ +|||||.++|+|+++...|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998532 456788899999999999999999776 999999999999999999999999999
Q ss_pred cccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
+++.+.++........-+..|||||.+..+.|+.|+|||||||++||++| |..||.+..+...+..+.
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~----------- 918 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL----------- 918 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH-----------
Confidence 97766655544333345679999999999999999999999999999999 999997655433332222
Q ss_pred hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 915 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
....-..|..|+..++++|..||+.+|++||++..+++.+.++..
T Consensus 919 ----~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 919 ----EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ----hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 222234677899999999999999999999999999998888765
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=343.41 Aligned_cols=266 Identities=24% Similarity=0.301 Sum_probs=207.5
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecC--CcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 760 (995)
.+.|+..++||+|+||.||+|+. .+|+.||+|++.-.. .+....-..+|+.+++++.||||+++.+...+. ..+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45567778899999999999965 678999999995433 333445567899999999999999999988665 68999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
|+|||+. +|.-++. ..+-.+++.++..+++|++.||+|+|.+| |+|||||.+|||+|.+|.+||+|||+|+++..
T Consensus 196 VFeYMdh-DL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999987 9988886 44567999999999999999999999777 99999999999999999999999999998754
Q ss_pred CCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh----
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL---- 915 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 915 (995)
.. ....+..+-|..|.|||.+.+. .|+.++|+||+|||+.||++|++.|....+...+..+.+-+.......+.
T Consensus 271 ~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 271 SG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 43 2335677899999999998875 69999999999999999999999987543333333333322222222222
Q ss_pred ---hhcCCcCC------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 916 ---SILDPRLS------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 916 ---~~~d~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..+.+... ......+....+|+..+|..||.+|.||.++++
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 01111100 011234456778999999999999999999875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.03 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=213.5
Q ss_pred HHhhccCCCeeeccCceEEEEEE-eCCCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
...+|++.+.+|+|+||.|-+|. +..|+.||||.+++... ..+.-.+++|++||+.++||||+.++++|+..+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 45678888999999999999995 47899999999865433 3344568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||..+|.|+||+. ..+.+++..++.+++||+.|+.|+|+++ ++|||+|.+|||+|.++++||+|||++-.+.+
T Consensus 131 vMEYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999996 4567999999999999999999999887 99999999999999999999999999988755
Q ss_pred CCCCccccccccCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
. ....+.||++-|.+||.+.+.+| ++.+|.||+||++|.++.|..||+. .+....++.+..+.+. .
T Consensus 206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG----~Dhk~lvrQIs~GaYr------E 272 (668)
T KOG0611|consen 206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG----RDHKRLVRQISRGAYR------E 272 (668)
T ss_pred c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC----chHHHHHHHhhccccc------C
Confidence 4 34467899999999999999998 5899999999999999999999954 4555555555554221 1
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
++.+....-+|++|+..+|++|-|+.+|..+-+
T Consensus 273 -------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 273 -------PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 122334567999999999999999999987643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=356.33 Aligned_cols=259 Identities=26% Similarity=0.383 Sum_probs=209.5
Q ss_pred ccCCCeeeccCceEEEEEEeCC--C---cEEEEEEecC--CCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPN--G---VEIAVKKLLG--FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~--~---~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
....++||+|+||.||+|+.+. + ..||||..+. .........|.+|+++|++++|||||+++|++.....+++
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 3456899999999999997643 2 2289998863 2344556779999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
|||+|.||+|.++++.. +..++..+..+++.++|.||+|||+++ +|||||.++|+|++.++.+||+|||+++.-.
T Consensus 239 vmEl~~gGsL~~~L~k~-~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~- 313 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKN-KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS- 313 (474)
T ss_pred EEEecCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc-
Confidence 99999999999999743 347999999999999999999999766 9999999999999999999999999987532
Q ss_pred CCCCcccc-ccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 841 GGASECMS-AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 841 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
...... ...-+.+|+|||.+....|++++|||||||++||+++ |..||...... +....+...
T Consensus 314 --~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~--------- 378 (474)
T KOG0194|consen 314 --QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKN--------- 378 (474)
T ss_pred --ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhc---------
Confidence 111111 2235689999999999999999999999999999999 89999664332 222222111
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcc
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSD 967 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 967 (995)
......+...+..+..++.+||..+|++||+|.++.+.++.+......
T Consensus 379 -~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 379 -GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111123445677888899999999999999999999999998876554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=347.88 Aligned_cols=265 Identities=25% Similarity=0.372 Sum_probs=205.4
Q ss_pred HhhccCCCeeeccCceEEEEEEeCC-----------------CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCcee
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPN-----------------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 747 (995)
.++|+..+.||+|+||.||+|.+.+ +..||+|.+...........+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999997532 34699998865433334567889999999999999999
Q ss_pred EeEEEecCCcceEEEEeccCCChhhhhcCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 001922 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKK-----------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810 (995)
Q Consensus 748 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii 810 (995)
+++++.+.+..++||||+++|+|.+++.... ...+++..+++++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885321 134677889999999999999999877 99
Q ss_pred ecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh--CCC
Q 001922 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT--GRR 888 (995)
Q Consensus 811 HrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~ 888 (995)
||||||+||+++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999987644333222234456789999999988899999999999999999987 567
Q ss_pred CCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 889 PVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 889 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
||......... .......... ........++.++..+.+++.+||+.||++||+++||.+.|++
T Consensus 241 p~~~~~~~~~~-~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQVI-ENAGEFFRDQ-------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHHHH-HHHHHHhhhc-------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 77654322221 1111111100 0000011223456678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=314.53 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=208.8
Q ss_pred HHHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCCh-------hHHHHHHHHHHhcc-CCCCceeEeEE
Q 001922 681 VSDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSH-------DHGFRAEIQTLGNI-RHRNIVRLLAF 751 (995)
Q Consensus 681 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l-~hpniv~~~~~ 751 (995)
.++..+.|+..+.+|.|..++|.++.+ ++|+++|+|++........ .+...+|+.|++++ .||+|+.+.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 456678899999999999999999854 5789999999843322211 23456799999999 69999999999
Q ss_pred EecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEee
Q 001922 752 CSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVAD 831 (995)
Q Consensus 752 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~D 831 (995)
|+.+...|+|+|.|+.|.|+|++. ..-.+++...++|++|+.+|++|||... |||||+||+||+++++.++||+|
T Consensus 92 yes~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 999999999999999999999995 4567899999999999999999999776 99999999999999999999999
Q ss_pred eccccccccCCCCccccccccCcccccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHH
Q 001922 832 FGLAKFLIDGGASECMSAIAGSYGYIAPEYAY------TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKR 905 (995)
Q Consensus 832 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~ 905 (995)
||+++.+.++ ......||||+|+|||.+. ...|+..+|+||+|||+|.++.|.+||.+. ...-..+
T Consensus 167 FGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR----kQmlMLR- 238 (411)
T KOG0599|consen 167 FGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR----KQMLMLR- 238 (411)
T ss_pred cceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----HHHHHHH-
Confidence 9999988654 3456789999999999875 346888999999999999999999999541 1111112
Q ss_pred HhcCChhhhhhhcCCcCCC---CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 906 ATNGRKEEFLSILDPRLSM---VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 906 ~~~~~~~~~~~~~d~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
-++.+.+.. .-.+.+....++|.+|++.||.+|.|++|++++
T Consensus 239 ----------~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 ----------MIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ----------HHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 222233322 123567789999999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=342.89 Aligned_cols=249 Identities=24% Similarity=0.303 Sum_probs=208.6
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.|+..+.||+|+||.||+|.. ..++.||+|++.-.......+.+++|+.++.+++++||.++|+.|-.+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 466668899999999999965 5688899999966666666788999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
.||++.+.++ .+..+++....-+++++..|+.|+|.++ .+|||||+.||++..+|.||++|||.+..+.....
T Consensus 94 ~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-- 166 (467)
T KOG0201|consen 94 GGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-- 166 (467)
T ss_pred cCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence 9999999995 3445577777789999999999999777 99999999999999999999999999988755433
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
...+.+||+.|||||++....|+.|+||||||++.+||.+|.+|+.+.....-+ .-++.. ..+..
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----flIpk~-----------~PP~L 231 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----FLIPKS-----------APPRL 231 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----EeccCC-----------CCCcc
Confidence 236789999999999999889999999999999999999999999764331110 011111 11222
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...++..+++++..|++++|+.||+|.+++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 23677789999999999999999999999864
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=352.25 Aligned_cols=365 Identities=23% Similarity=0.200 Sum_probs=321.2
Q ss_pred eeeeecCCCCccccCCccccCCCCCCeEeccCCcccCccccCccc-ccceeccccccccCCCcccccccccccccccccc
Q 001922 70 VASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLS-SLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNN 148 (995)
Q Consensus 70 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~-~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n 148 (995)
+..||+++|.|+..-+..|.++++|++++|.+|.++.++.++..+ +|+.|+|.+|.|+.+....++.++.|+.||||.|
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 566999999998887888999999999999999999877666654 5999999999999999999999999999999999
Q ss_pred cccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCC
Q 001922 149 NFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIP 228 (995)
Q Consensus 149 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p 228 (995)
.|+.+.-..|..-.++++|+|++|+|+..--..|.++.+|..|.|++|+++...+..|.+|++|+.|+|..|.+..- --
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv-e~ 238 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV-EG 238 (873)
T ss_pred hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee-hh
Confidence 99998777888888999999999999988888999999999999999999977788889999999999988776441 13
Q ss_pred cccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCC
Q 001922 229 REVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQ 308 (995)
Q Consensus 229 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 308 (995)
-.|.+|.+|+.|.|..|.++..-...|..+.++++|+|..|+++..-..++.+++.|+.|+||+|.|..+-++++.-.++
T Consensus 239 ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftqk 318 (873)
T KOG4194|consen 239 LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQK 318 (873)
T ss_pred hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccc
Confidence 46788999999999999999888888999999999999999998777788999999999999999999888999999999
Q ss_pred CCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCC---cCcCCCccceee
Q 001922 309 LKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPT---DLCSSNQLRILI 385 (995)
Q Consensus 309 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~ 385 (995)
|+.|+|++|+|+...+..|..+..|++|+|++|.++..-...|..+++|+.|||++|.|++.+.+ .|.++++|+.|+
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~ 398 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR 398 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence 99999999999988888999999999999999999877778899999999999999999877765 467788899999
Q ss_pred ccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccC
Q 001922 386 LLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQS 436 (995)
Q Consensus 386 l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 436 (995)
+.+|++....-..|.++.+|+.|+|.+|.|..+-|.+|..+ .|+.|.+.+
T Consensus 399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 99999988777888999999999999999988888888877 666555443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=339.76 Aligned_cols=252 Identities=22% Similarity=0.265 Sum_probs=202.0
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.+.|+..++||+|+||.||+|+. .+|+.+|+|++++... ..+.+.++.|-.+|....+|.||+++..|++.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 34588889999999999999965 4689999999965432 23456688899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc-
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID- 840 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~- 840 (995)
|||++||++..++. +.+.+++..++.++.+++-|+..+|+.| ||||||||+|+|||..|++||+|||++..+..
T Consensus 220 MEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999995 5578999999999999999999999888 99999999999999999999999999854211
Q ss_pred ---------------------CCCC------cc-----------------ccccccCcccccccccccCCCCcccchhhH
Q 001922 841 ---------------------GGAS------EC-----------------MSAIAGSYGYIAPEYAYTLRVDEKSDVYSF 876 (995)
Q Consensus 841 ---------------------~~~~------~~-----------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 876 (995)
.+.. .. ....+|||.|+|||++.+..|+..+|+||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0001 00 013569999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCc---hHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCC---
Q 001922 877 GVVLLELLTGRRPVGDFGDGV---DIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPR--- 950 (995)
Q Consensus 877 Gvil~elltg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt--- 950 (995)
|||+|||+.|.+||....... .+..|....... .....+.+.+++|.+|+. ||++|--
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP---------------~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP---------------EEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC---------------CcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 999999999999997533221 122222222111 011234778899999999 9999974
Q ss_pred HHHHHHH
Q 001922 951 MREVVQM 957 (995)
Q Consensus 951 ~~evl~~ 957 (995)
++||.++
T Consensus 439 ~~EIK~H 445 (550)
T KOG0605|consen 439 AEEIKKH 445 (550)
T ss_pred HHHHhcC
Confidence 6666554
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=343.33 Aligned_cols=265 Identities=25% Similarity=0.354 Sum_probs=223.2
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
....+.++||+|.||+|..+....+..||||+++.......+..|.+|+++|.+++|||||+++|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 45667889999999999999987789999999977666666788999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++|+|.+++.+............+|+.||+.||+||.+.. +||||+.++|+|+|.++++||+|||+++-+..+++..
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 9999999998665444566667789999999999999666 9999999999999999999999999999877777777
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT--GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.....+-+++|||||.+..++++.++|||+||+++||+++ ...||....++............+.. ..+.
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~--------~~~l 766 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR--------QVVL 766 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc--------ceec
Confidence 6666777899999999999999999999999999999887 88899776554333222211111100 0112
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
..|..++..+.++|.+||+.|-++||+++++...|.+.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 35667888999999999999999999999999888764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=346.26 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=216.3
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCc-ceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET-NLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv~ 762 (995)
++|...+++|+|+||.++.+++ .++..||+|++.-.. ....++...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4678889999999999999965 467889999984332 33344568899999999999999999999988887 99999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
+||+||++.+.+.++++..++++...+|+.|++.|+.|||++. |+|||||+.||+++.++.|||+|||+|+.+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999999888889999999999999999999999766 9999999999999999999999999999885543
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
....+..||+.||.||.+.+.+|+.|+||||+||++|||++-+++|.. .++...+..+... .+
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a----~~m~~Li~ki~~~-----------~~ 223 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA----SNMSELILKINRG-----------LY 223 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc----cchHHHHHHHhhc-----------cC
Confidence 234678999999999999999999999999999999999999999954 3333333333322 22
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+..++.++..++..|++.+|+.||++.+++.+
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33667788899999999999999999999999976
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.01 Aligned_cols=251 Identities=24% Similarity=0.281 Sum_probs=202.4
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
|+..+.||+|+||+||+|.. .+|+.||+|++..... ......+.+|++++++++|++|+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 55678899999999999975 5789999998853221 22234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++|+|.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99999998886544556899999999999999999999777 9999999999999999999999999998653321
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......||+.|+|||++.+..++.++||||+||++|||++|+.||................... ...
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------~~~ 223 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED------------QEE 223 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc------------ccc
Confidence 2234578999999999999999999999999999999999999997543322222222111111 111
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPR-----MREVVQ 956 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 956 (995)
.+...+..+.+++.+||+.||++||+ ++++++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 23345667889999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=354.68 Aligned_cols=260 Identities=24% Similarity=0.385 Sum_probs=206.9
Q ss_pred HhhccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 757 (995)
.++|+.++.||+|+||.||+|++ .++..||||++.........+.+.+|+++++.+ +||||+++++++.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999963 245689999986544444456788999999999 89999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCC-----------------------------------------------------------
Q 001922 758 NLLVYEYMRNGSLGEALHGKK----------------------------------------------------------- 778 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 778 (995)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986421
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 779 --------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 779 --------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
...+++..+.+++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788889999999999999999777 999999999999999999999999999876433222
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.......++..|+|||++.+..++.++|||||||++|||++ |..||..........++.. .+. ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~---~~~-----------~~ 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK---EGY-----------RM 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH---hCc-----------cC
Confidence 22222345678999999999999999999999999999998 8999865433322222211 110 01
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
..+...+.++.+++.+||+.||++||+++||++.|++.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11222356789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=354.86 Aligned_cols=261 Identities=24% Similarity=0.388 Sum_probs=205.9
Q ss_pred HhhccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 757 (995)
.++|+..+.||+|+||.||+|+. .++..||+|++...........+.+|+++++.+ +|||||++++++...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 34688899999999999999864 234579999986544444456688999999999 89999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCC-----------------------------------------------------------
Q 001922 758 NLLVYEYMRNGSLGEALHGKK----------------------------------------------------------- 778 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 778 (995)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccc
Q 001922 779 ---------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA 849 (995)
Q Consensus 779 ---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 849 (995)
...+++..+++++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+...........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124778889999999999999999777 99999999999999999999999999986543322222223
Q ss_pred cccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHH
Q 001922 850 IAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKE 928 (995)
Q Consensus 850 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 928 (995)
..++..|+|||++.+..++.++||||+||++|||++ |+.||............. .... .+ ..+..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~---~~~~--------~~---~~~~~ 339 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV---KRGY--------QM---SRPDF 339 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH---Hccc--------Cc---cCCCC
Confidence 345678999999998899999999999999999997 999997543222211111 1110 00 11122
Q ss_pred HHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 929 EAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 929 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
.+..+.+++.+||+.||++||++.+|++.|+++.
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 3567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=308.58 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=212.1
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.+.|++++.+|+|.||.||.|+.+ ++.-||+|++.+.. .....+++.+|++|-+.++||||.+++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 356789999999999999999764 57789999985432 223356788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
+||..+|++...+.......+++...+.++.|+|.|+.|+|..+ |+||||||+|+|++..+.+|++|||-+..-
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~--- 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA--- 174 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec---
Confidence 99999999999998778888999999999999999999999666 999999999999999999999999987642
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
......+.|||..|.+||...+..++..+|+|++|++.||++.|.+||...... +..+++... |
T Consensus 175 -p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----etYkrI~k~---------~-- 238 (281)
T KOG0580|consen 175 -PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----ETYKRIRKV---------D-- 238 (281)
T ss_pred -CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----HHHHHHHHc---------c--
Confidence 244557789999999999999999999999999999999999999999764322 112222211 1
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQML 958 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 958 (995)
-..|...+..+.++|.+|+..+|.+|.+..|+++.-
T Consensus 239 -~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 239 -LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred -ccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 123455677889999999999999999999998763
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.53 Aligned_cols=268 Identities=21% Similarity=0.186 Sum_probs=207.5
Q ss_pred HHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEec--CCcc
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSN--KETN 758 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 758 (995)
.-.+.|+..+.|++|+||.||+|++ ++++.||+|+++-.... .-.-...+|+.++.+++|||||.+.++... -+..
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3456788889999999999999976 46788999998533221 112335789999999999999999998743 4578
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
|+|||||+. +|..++... ++++...++..++.|+++|++|||+.+ |+|||+|++|+|+...|.+||+|||+|+.+
T Consensus 153 y~VMe~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeeHHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 999999987 999999854 367888889999999999999999888 999999999999999999999999999987
Q ss_pred ccCCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 839 IDGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
..+ ...++..+-|..|.|||.+.+. .|++++|+||+|||+.|++++++-|...+....+....+.........+..+
T Consensus 228 gsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 543 3445677889999999998765 6999999999999999999999998765544444444433333222222211
Q ss_pred cCCc------CC---------CCCHH-HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 918 LDPR------LS---------MVPKE-EAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 918 ~d~~------~~---------~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.... .. .++.. .++.-.+++..++..||++|-||.|.++.
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1110 00 01111 33567789999999999999999999864
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=339.15 Aligned_cols=258 Identities=26% Similarity=0.465 Sum_probs=209.9
Q ss_pred hhccCCCeeeccCceEEEEEEeCC------CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
+.|+..+.||+|+||.||+|.... ...||+|.+...........+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467788999999999999997532 25789998865444444567899999999999999999999999889999
Q ss_pred EEEEeccCCChhhhhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 001922 760 LVYEYMRNGSLGEALHGKKG--------------AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF 825 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~ 825 (995)
++|||+++|+|.+++..... ..+++..+..++.|++.|+.|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999864321 45788899999999999999999777 99999999999999999
Q ss_pred CeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHH
Q 001922 826 EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSK 904 (995)
Q Consensus 826 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 904 (995)
.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... +. ..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-~~---~~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-EV---IE 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-HH---HH
Confidence 999999999986544333333344567889999999988899999999999999999998 99999654321 11 11
Q ss_pred HHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 905 RATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 905 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.+.. ......+..++..+.+++.+||+.||++||+++||++.|+++
T Consensus 238 ~i~~-----------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 MIRS-----------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHc-----------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111 111223456778899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.95 Aligned_cols=256 Identities=26% Similarity=0.363 Sum_probs=206.2
Q ss_pred hhccCCCeeeccCceEEEEEEeC----CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
+.|+..+.||+|+||.||+|.++ .+..||+|.+...........+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999653 35689999986544444456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.++++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999743 356889999999999999999999877 999999999999999999999999987653221
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.. .......++..|+|||++.+..++.++||||+||++||+++ |+.||...... .........
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----~~~~~~~~~----------- 224 (266)
T cd05064 161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIKAVEDG----------- 224 (266)
T ss_pred ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHHHCC-----------
Confidence 11 11122345678999999999999999999999999999875 99999654321 111111111
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.....+..++..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11123445677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=335.33 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=200.6
Q ss_pred CCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCCh--hHHHHHHHHHHhccCCCCceeEeEEEec----CCcceEEEEe
Q 001922 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSH--DHGFRAEIQTLGNIRHRNIVRLLAFCSN----KETNLLVYEY 764 (995)
Q Consensus 691 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~ 764 (995)
...||+|++|.||+|.+ +|+.||||++........ .+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999988 788999999854322221 3567899999999999999999999866 3567899999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD-CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
+++|+|.+++.. ...+++....+++.|++.|+.|+|+. + ++||||||+||++++++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999964 35688999999999999999999974 5 8899999999999999999999999998653321
Q ss_pred CccccccccCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 844 SECMSAIAGSYGYIAPEYAYT--LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+.... .+
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----~~~~~~i~~~~---------~~ 240 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----KEIYDLIINKN---------NS 240 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhcC---------CC
Confidence 23468899999999876 6789999999999999999999999975321 12222221110 01
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
...+..++..+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 241 -~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 -LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11233456789999999999999999999999999987654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=373.67 Aligned_cols=482 Identities=28% Similarity=0.328 Sum_probs=399.1
Q ss_pred eeecCCCCccccCCccccCCCCCCeEeccCCcccC-cc-ccCcccccceeccccccccCCCccccccccccccccccccc
Q 001922 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTG-SI-EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNN 149 (995)
Q Consensus 72 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~ 149 (995)
.+|.+..++. .||..+..-..++.|+++.|-+-. +. .+.+.-+|+.|||++|+++ ..|..+..+.+|+.|+++.|-
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 3566666664 688888877779999999998765 22 3445556999999999997 567788899999999999999
Q ss_pred ccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCc
Q 001922 150 FTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPR 229 (995)
Q Consensus 150 i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~ 229 (995)
|.. .|.+..++.+|++|+|.+|.+. ..|..+..+.+|++|+++.|++. .+|..+..++.++.+..++| .....
T Consensus 80 i~~-vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N-~~~~~--- 152 (1081)
T KOG0618|consen 80 IRS-VPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNN-EKIQR--- 152 (1081)
T ss_pred Hhh-Cchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcc-hhhhh---
Confidence 998 6889999999999999999997 89999999999999999999998 88999999999999999977 33222
Q ss_pred ccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCC
Q 001922 230 EVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQL 309 (995)
Q Consensus 230 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 309 (995)
++... ++.++|..|.+.+.++..+..++. .|+|+.|.+. . ..+.++.+|+.|....|+++... -..++|
T Consensus 153 -lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~----~~g~~l 221 (1081)
T KOG0618|consen 153 -LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELE----ISGPSL 221 (1081)
T ss_pred -hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEE----ecCcch
Confidence 22222 889999999999999999988887 7999999987 2 34778899999999999988332 234789
Q ss_pred CEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeecccc
Q 001922 310 KLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKN 389 (995)
Q Consensus 310 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 389 (995)
+.|+.++|.+....+... -.+|+++++++|+++ .+|++++.+.+|+.|+..+|+|+ .+|..+....+|+.|.+..|
T Consensus 222 ~~L~a~~n~l~~~~~~p~--p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~n 297 (1081)
T KOG0618|consen 222 TALYADHNPLTTLDVHPV--PLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYN 297 (1081)
T ss_pred heeeeccCcceeeccccc--cccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhh
Confidence 999999999984444322 258999999999999 56799999999999999999997 89999999999999999999
Q ss_pred ccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCC-CceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccc
Q 001922 390 FLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPG-LNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSG 468 (995)
Q Consensus 390 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~ 468 (995)
.+. .+|..+..+++|+.|+|..|+|....+..+..+.. ++.++.+.|.+.... .........|+.|+|.+|.++.
T Consensus 298 el~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp---~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 298 ELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLP---SYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccc---cccchhhHHHHHHHHhcCcccc
Confidence 984 56777888999999999999997444433333443 677777777776432 1122345679999999999998
Q ss_pred cCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCcccccc
Q 001922 469 PLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISN 548 (995)
Q Consensus 469 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~ 548 (995)
..-..+.++..|+.|+|++|++.......+.++..|+.|+||+|.|+ .+|..+..+..|++|...+|++. ..| ++..
T Consensus 374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~ 450 (1081)
T KOG0618|consen 374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ 450 (1081)
T ss_pred cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh
Confidence 88888999999999999999998555566789999999999999999 79999999999999999999998 788 9999
Q ss_pred ccccCeEeccccccccc-cCcccccCCcccEEeccCCC
Q 001922 549 VRILNYLNLSRNHLNQN-IPKSIGSMKSLTIADFSFND 585 (995)
Q Consensus 549 l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~l~ls~N~ 585 (995)
+++|+.+|||.|+|+.. +|... .-++|++|||++|.
T Consensus 451 l~qL~~lDlS~N~L~~~~l~~~~-p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 451 LPQLKVLDLSCNNLSEVTLPEAL-PSPNLKYLDLSGNT 487 (1081)
T ss_pred cCcceEEecccchhhhhhhhhhC-CCcccceeeccCCc
Confidence 99999999999999754 34333 33899999999997
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.79 Aligned_cols=263 Identities=25% Similarity=0.277 Sum_probs=207.2
Q ss_pred HHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC-------------CChhHHHHHHHHHHhccCCCCceeE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT-------------HSHDHGFRAEIQTLGNIRHRNIVRL 748 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hpniv~~ 748 (995)
...++|++.+.||+|.||.|-+|+. .+++.||||++.+... ....+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3467899999999999999999975 5689999999843211 1123578899999999999999999
Q ss_pred eEEEecC--CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC
Q 001922 749 LAFCSNK--ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE 826 (995)
Q Consensus 749 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~ 826 (995)
+++..++ +..|||+|||..|.+...=. ....+++.++++++++++.||+|||.+| ||||||||+|+|++++|.
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 9999764 57899999999888765432 2223899999999999999999999887 999999999999999999
Q ss_pred eEEeeeccccccccC---CCCccccccccCcccccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCchH
Q 001922 827 AHVADFGLAKFLIDG---GASECMSAIAGSYGYIAPEYAYTLR----VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDI 899 (995)
Q Consensus 827 vkl~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~ 899 (995)
|||+|||.+.....+ +........+|||.|+|||...++. .+.+.||||+||++|.|+.|+.||.+. ..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~----~~ 324 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD----FE 324 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc----hH
Confidence 999999999865322 2222334578999999999887632 357899999999999999999999541 11
Q ss_pred HHHHHHHhcCChhhhhhhcCCcCCC-CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 900 VQWSKRATNGRKEEFLSILDPRLSM-VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
. +.+.+++...+.. ..++..+.+.++|.+|+.+||++|.+..+|..+..--...+
T Consensus 325 ~-----------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 325 L-----------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred H-----------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 1 2233444444432 22356788999999999999999999999987776655533
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=337.54 Aligned_cols=251 Identities=33% Similarity=0.507 Sum_probs=199.4
Q ss_pred CCCeeeccCceEEEEEEeC-----CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 690 DGNVIGRGGAGIVYHGKMP-----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 690 ~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
..+.||.|+||.||+|.+. .+..|+||.+.........+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999875 36789999995544444467899999999999999999999999988889999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++|+|.+++.......+++..+.+|+.||++||.|||+.+ |+||||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999998765678999999999999999999999877 999999999999999999999999999876333222
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
...........|+|||.+....++.++||||||+++||+++ |+.||.+. ...++...+... ...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~----~~~~~~~~~~~~-----------~~~ 224 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY----DNEEIIEKLKQG-----------QRL 224 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS----CHHHHHHHHHTT-----------EET
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc----cccccccccccc-----------ccc
Confidence 33344567789999999999899999999999999999999 78998654 222222222222 111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQML 958 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 958 (995)
..+..++..+.+++.+||+.+|++||+++++++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 23334567789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=356.83 Aligned_cols=263 Identities=25% Similarity=0.332 Sum_probs=216.9
Q ss_pred hhccCCCeeeccCceEEEEEEeCCC-cEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEE-Eec------CC
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNG-VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAF-CSN------KE 756 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~-~~~------~~ 756 (995)
.++++.++|.+|||+.||.|+...+ .+||+|++... ++.....+.+|+++|++++ |+|||.+++. ... .-
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 3567788999999999999987655 99999998654 5556778999999999996 9999999993 311 23
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
++++.||||+||.|-|++..+....+++..+++|+.|+++|+++||.. .++|||||||-+|||+..++..||||||.+.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 568999999999999999876666799999999999999999999977 6889999999999999999999999999987
Q ss_pred ccccCCC-Cccc------cccccCccccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH
Q 001922 837 FLIDGGA-SECM------SAIAGSYGYIAPEYA---YTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRA 906 (995)
Q Consensus 837 ~~~~~~~-~~~~------~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 906 (995)
....... .... -....|+.|+|||.+ ++.++++|+|||||||++|-|+....||++.+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------ 262 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------ 262 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence 5432221 1110 123478999999976 47789999999999999999999999996521
Q ss_pred hcCChhhhhhhcCCcCCCCC-HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcccc
Q 001922 907 TNGRKEEFLSILDPRLSMVP-KEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFN 969 (995)
Q Consensus 907 ~~~~~~~~~~~~d~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 969 (995)
-..+++..+...+ +.++..+.+||..||+.+|++||++-+|+..+.++........
T Consensus 263 -------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 263 -------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred -------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 2345556665444 5789999999999999999999999999999988876544433
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.09 Aligned_cols=267 Identities=24% Similarity=0.314 Sum_probs=208.1
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEec-CCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec-----CCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLL-GFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN-----KET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 757 (995)
...|...+.||+|+||.|..|.. .+|+.||||++. .+.......+..+|++.++.++|+||+.+.+++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 44566678899999999999965 578999999985 45566677888999999999999999999999854 356
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
+|+|+|+|+ -+|...++ .+..++...+.-++.|+++|+.|+|+.+ |+|||+||+|++++.+..+||+|||+|+.
T Consensus 101 vYiV~elMe-tDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELME-TDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHHh-hHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 799999995 49999995 4455899999999999999999999777 99999999999999999999999999998
Q ss_pred cccCCCCccccccccCcccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAY-TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
.........++..+.|..|.|||.+. ...|+.+.||||+|||+.||++|+.-|.+......+............+.+..
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 75443344557788999999999865 56799999999999999999999999865332222222222222221111111
Q ss_pred hcC----------CcCCC-----CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 917 ILD----------PRLSM-----VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 917 ~~d----------~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+-+ +..+. .-+.......+++.+|+..||.+|+|++|.+++
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 110 11111 112455678899999999999999999999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.05 Aligned_cols=259 Identities=27% Similarity=0.337 Sum_probs=203.9
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC-----cceE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE-----TNLL 760 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~l 760 (995)
.|+..+++|.|+||.||+|... +++.||||++...... -.+|+++|+.+.|||||++.-+|.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4677889999999999999764 4689999998543332 246999999999999999998884322 3358
Q ss_pred EEEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CCeEEeeeccccc
Q 001922 761 VYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA-FEAHVADFGLAKF 837 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~-~~vkl~DfGla~~ 837 (995)
|||||+. +|.++++. ..+..++...+.-++.||++|++|||..+ |+||||||+|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999976 99999973 23456777777889999999999999777 9999999999999987 8899999999998
Q ss_pred cccCCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
+..+... .+...|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+....+....+-......+.+..
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 8665443 456788999999998765 699999999999999999999999987655555666665555444333322
Q ss_pred hcCC-------cCC------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 917 ILDP-------RLS------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 917 ~~d~-------~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+-.. ... ......+.+..+++.+++.++|.+|.++.|++.+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 2111 111 1233466788999999999999999999998853
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=347.63 Aligned_cols=262 Identities=22% Similarity=0.349 Sum_probs=208.1
Q ss_pred HhhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 757 (995)
.++|.+++.||+|+||.||+|+.. .+..||||++.........+.+.+|+++++++. ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 357888999999999999999752 234699999865444444567899999999996 9999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCC-----------------------------------------------------------
Q 001922 758 NLLVYEYMRNGSLGEALHGKK----------------------------------------------------------- 778 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 778 (995)
.|+||||+++|+|.++++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999875321
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC
Q 001922 779 -----------------------------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS 823 (995)
Q Consensus 779 -----------------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~ 823 (995)
...+++..+.+++.|++.|++|||+.+ |+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124677888999999999999999777 999999999999999
Q ss_pred CCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q 001922 824 AFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQW 902 (995)
Q Consensus 824 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~ 902 (995)
++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~- 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN- 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH-
Confidence 99999999999986543322222233456788999999998899999999999999999997 9999865432222111
Q ss_pred HHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 903 SKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 903 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
..... .....+...+..+.+++.+||+.+|++||++.+|.++|+++.+
T Consensus 352 --~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 --KIKSG-----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHhcC-----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111 0011233456789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=336.34 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=217.9
Q ss_pred cCCCeeeccCceEEEEEEeCC-CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 689 KDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 689 ~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
....+||-|.||.||.|.|+. .-.||||.++.. ....++|..|+.+|+.++|||+|+++|+|......|||.|||..
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 345689999999999998854 567999998653 34478899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|.|.+|+++..+..++......++.||..||.||..+. +||||+.++|+|+.++-.||++|||+++.+....+...
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH- 423 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH- 423 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecc-
Confidence 99999999877788888889999999999999999777 99999999999999999999999999998865433222
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC-CC
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS-MV 925 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~ 925 (995)
.....++.|.|||-+....++.|+|||+|||++||+.| |..||. +.++.+...-... .++ ..
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP----GidlSqVY~LLEk------------gyRM~~ 487 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP----GIDLSQVYGLLEK------------GYRMDG 487 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC----CccHHHHHHHHhc------------cccccC
Confidence 23345679999999999999999999999999999999 888984 4455444333322 222 35
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
|..|++.++++|+.||++.|.+||+++|+-+.++-|....
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 7789999999999999999999999999999999887653
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=330.55 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=208.8
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
.+.|+..++||+|+||.||+|...++..||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 3568888999999999999999888889999987532 22356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++....+...++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 99999999997666677889999999999999999999777 999999999999999999999999999875432211
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......++..|+|||+.....++.++||||+||++|+|++ |+.||....... .......... .+
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~~~~~~-------~~--- 224 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD----VMSALQRGYR-------MP--- 224 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH----HHHHHHcCCC-------CC---
Confidence 1223345678999999988889999999999999999998 999996432211 1111111100 01
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.....+..+.+++.+|++.+|++||+++++++.|+++
T Consensus 225 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 -RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1123456788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=303.71 Aligned_cols=261 Identities=23% Similarity=0.297 Sum_probs=208.0
Q ss_pred hhccCCCeeeccCceEEEEEE-eCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec-----CCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN-----KETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~ 759 (995)
++|++.+.+|+|+|+.||.++ ..+++-||+|++.-.. ..+.+..++|++..++++|||+++++++... ..+.|
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 578999999999999999997 4678899999985433 4557778999999999999999999887633 34589
Q ss_pred EEEEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 760 LVYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
++++|...|+|.+.+.. .++..+++.+...|+.+|++||.+||+. .++++||||||.||++.+++.+++.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999974 3456899999999999999999999977 45699999999999999999999999999876
Q ss_pred cccCCC-------CccccccccCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh
Q 001922 838 LIDGGA-------SECMSAIAGSYGYIAPEYAY---TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRAT 907 (995)
Q Consensus 838 ~~~~~~-------~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 907 (995)
..-.-. .+.......|..|.|||.+. +...++++|||||||++|+|+.|..||+....
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------------ 246 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------------ 246 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------------
Confidence 431111 11112345789999999875 55678999999999999999999999964211
Q ss_pred cCChhhhhhhcCCcCC--CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 908 NGRKEEFLSILDPRLS--MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 908 ~~~~~~~~~~~d~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
....-...+..+.+. ..+ ..++.+.+++..|++.||.+||++.+++..++++.
T Consensus 247 -~GgSlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 -QGGSLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -cCCeEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111222333332 112 27888999999999999999999999999988754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.20 Aligned_cols=257 Identities=27% Similarity=0.382 Sum_probs=217.3
Q ss_pred hhccCCCeeeccCceEEEEEEeC---CC--cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP---NG--VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~---~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
+.....+.||+|-||.||+|.+. .| -.||||..+........+.|.+|..+|++++|||||+++|+|.+ ...+|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 34556788999999999999753 23 34888998887788888999999999999999999999999975 57899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
|||.++-|.|..+++. +...++......++.||+.||+|||+. .+|||||..+||++.+...||++|||+++.+.+
T Consensus 468 vmEL~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEecccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 9999999999999984 456788889999999999999999955 499999999999999999999999999999877
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
..+.... ...-++.|||||-+.-.+++.++|||.|||.+||++. |..||....+...+ ..+-.
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI---------------~~iEn 607 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI---------------GHIEN 607 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE---------------EEecC
Confidence 6655543 4456789999999999999999999999999999998 99999764332221 11112
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
+.....|+.|+..++.++.+||.+||.+||++.|+...|.++.+
T Consensus 608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 23334678899999999999999999999999999998888765
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=334.91 Aligned_cols=264 Identities=21% Similarity=0.250 Sum_probs=201.8
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.|+..+.||+|+||+||+|+.. +++.||+|++...........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 45788899999999999999764 68899999985443344455678999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++ +|.+++... +..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 85 LDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred CCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 975 999988632 345788999999999999999999777 9999999999999999999999999987643221
Q ss_pred ccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh-------
Q 001922 845 ECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS------- 916 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------- 916 (995)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.....................+.+..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 12234568999999998865 5689999999999999999999999965433222222222221111111111
Q ss_pred --hcCCcCCCC-----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 917 --ILDPRLSMV-----PKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 917 --~~d~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
...+..... ....+....+++.+|++.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111111100 1123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.88 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=199.9
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++|+..+.||+|+||+||+|+.. +++.||+|++...........+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 56888899999999999999875 68899999985443333445678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+. +++.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..... .
T Consensus 85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 157 (303)
T cd07869 85 VH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP--S 157 (303)
T ss_pred CC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC--C
Confidence 95 588888763 3356788889999999999999999777 999999999999999999999999998754221 1
Q ss_pred ccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC-Chhhhhhh-----
Q 001922 845 ECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG-RKEEFLSI----- 917 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~----- 917 (995)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....+.............. ....+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22234568999999998765 457899999999999999999999997654332222222111111 00000000
Q ss_pred cCC-cCCC-CCH---------HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 918 LDP-RLSM-VPK---------EEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 918 ~d~-~~~~-~~~---------~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..+ .... .+. ..+..+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 0000 000 12346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=343.20 Aligned_cols=243 Identities=22% Similarity=0.247 Sum_probs=197.4
Q ss_pred CeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCC
Q 001922 692 NVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNG 768 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 768 (995)
+.||+|+||.||+|+. .+|+.||+|++.... .......+.+|+.++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999976 468899999985422 1223456778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcccc
Q 001922 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS 848 (995)
Q Consensus 769 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~ 848 (995)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~ 153 (323)
T cd05571 81 ELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence 99999863 456889999999999999999999877 999999999999999999999999998753221 12224
Q ss_pred ccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHH
Q 001922 849 AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKE 928 (995)
Q Consensus 849 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 928 (995)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... ....+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~~~~~------------~~~~p~~ 217 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILME------------EIRFPRT 217 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH----HHHHHHHHcC------------CCCCCCC
Confidence 46799999999999999999999999999999999999999964221 1111111111 0112334
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 929 EAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 929 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
.+..+.+++.+||+.||++|| ++++++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 566788999999999999999 79998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=334.11 Aligned_cols=257 Identities=25% Similarity=0.433 Sum_probs=207.1
Q ss_pred hhccCCCeeeccCceEEEEEEeCC------CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
+.|...+.||+|+||.||+|+..+ ++.||+|.+.........+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 456777889999999999997633 47899999865444434567999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCe
Q 001922 760 LVYEYMRNGSLGEALHGKK------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEA 827 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~v 827 (995)
+||||+++++|.+++.... ...+++..+..++.|++.|++|+|+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996432 245788899999999999999999777 9999999999999999999
Q ss_pred EEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHH
Q 001922 828 HVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRA 906 (995)
Q Consensus 828 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~ 906 (995)
||+|||+++.+.............+++.|+|||++.+..++.++||||+||++|||++ |+.||...... . ....+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-~---~~~~~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-E---VIECI 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-H---HHHHH
Confidence 9999999976533322222233446789999999999999999999999999999998 99998653321 1 11111
Q ss_pred hcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 907 TNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 907 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
..+ .....+...+..+.+++.+||+.+|++||+++||++.|++
T Consensus 238 ~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 TQG-----------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HcC-----------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111 1112233456778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=339.06 Aligned_cols=242 Identities=25% Similarity=0.339 Sum_probs=200.4
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC--CChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 761 (995)
+.|...++||+|+||+|+++..+ +++.+|||.+++... ..+.+..+.|.+|+... +||.++.++.+|+..+++|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 45778899999999999999764 578899999966432 23456678888888777 599999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+.||++..+.+ .+.+++..++-++..|+.||.|||+++ |||||||.+|||+|.+|.+||+|||+++.-.-
T Consensus 448 mey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~- 520 (694)
T KOG0694|consen 448 MEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG- 520 (694)
T ss_pred EEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC-
Confidence 99999999655553 356999999999999999999999888 99999999999999999999999999986432
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
......+.||||.|||||++.+..|+.++|+|||||++|||+.|..||..... +++ +..++...
T Consensus 521 -~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-ee~--------------FdsI~~d~ 584 (694)
T KOG0694|consen 521 -QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-EEV--------------FDSIVNDE 584 (694)
T ss_pred -CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-HHH--------------HHHHhcCC
Confidence 23355788999999999999999999999999999999999999999964221 111 11222211
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRM 951 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 951 (995)
..+|...+.+...++.++++.+|++|--+
T Consensus 585 -~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 -VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22566677888999999999999999755
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=334.31 Aligned_cols=264 Identities=20% Similarity=0.221 Sum_probs=201.8
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+|+..+.||+|+||+||+|+.+ +++.||+|++.... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 5778899999999999999875 57889999985432 223355678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
++++.+..+.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 82 VEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence 99877765543 2356889999999999999999999777 99999999999999999999999999987643221
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh---------hh
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE---------FL 915 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------~~ 915 (995)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||....................... +.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 122345789999999999988999999999999999999999999976433222211111111000000 00
Q ss_pred hhcCCcCC-------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 916 SILDPRLS-------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 916 ~~~d~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
....+... ......+..+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 011124567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=316.71 Aligned_cols=275 Identities=23% Similarity=0.277 Sum_probs=211.2
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCC-ceeEeEEEecCC------
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRN-IVRLLAFCSNKE------ 756 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~------ 756 (995)
..|+..++||+|+||+||+|+. .+|+.||+|++.-... +.......+|+.++++++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3455566799999999999975 5788999999954433 334556788999999999999 999999998777
Q ss_pred cceEEEEeccCCChhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKG--AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
..++||||++. +|.+++..... ...+...+..++.||++||+|||+++ |+||||||+||++++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78899999976 99999975442 35677889999999999999999777 99999999999999999999999999
Q ss_pred ccccccCCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
|+...- ........++|..|.|||++.+. .|+..+||||+|||++||++++.-|...++...+....+.........
T Consensus 167 Ara~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 996532 22334667889999999998877 689999999999999999999999977665444444433333322222
Q ss_pred hhhhc---CCc--CCC-C-CH-------HHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCCCCCc
Q 001922 914 FLSIL---DPR--LSM-V-PK-------EEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFPRHSS 966 (995)
Q Consensus 914 ~~~~~---d~~--~~~-~-~~-------~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~~~ 966 (995)
+.... +.. ... . +. .......+++.+|++.+|.+|.+++.++++ +..+....+
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~ 313 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS 313 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence 22111 111 110 0 11 111367889999999999999999999986 666654433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=338.97 Aligned_cols=245 Identities=22% Similarity=0.257 Sum_probs=200.6
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
+|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5778899999999999999764 68899999984321 12234568889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 82 YVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 9999999999963 346889999999999999999999777 999999999999999999999999999865322
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... . .
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~----~~~~~~i~~~-----------~-~ 215 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP----FGIYEKILAG-----------K-L 215 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC-----------C-c
Confidence 1235689999999999998899999999999999999999999964321 1111222111 1 1
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPR-----MREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 957 (995)
..+...+..+.+++.+|++.||.+||+ ++|++++
T Consensus 216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 123334567889999999999999995 8888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.51 Aligned_cols=257 Identities=29% Similarity=0.428 Sum_probs=207.6
Q ss_pred hhccCCCeeeccCceEEEEEEeCC----CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
++|+..+.||+|+||+||+|+++. ...||+|.+...........+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468889999999999999997642 4578999886544444556788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++++|.+++... ...+++..+++++.|++.|++|||+.+ |+||||||+||++++++.++|+|||+++.+...
T Consensus 84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999999743 347899999999999999999999777 999999999999999999999999999876422
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
..........++..|+|||...+..++.++||||||+++|||++ |..||...... +....+...
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~----------- 224 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIKAVEDG----------- 224 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----HHHHHHHcC-----------
Confidence 22111223345678999999998899999999999999999998 99998653221 111111111
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.....+..++..+.+++.+||+.+|++||+++|++++|+++
T Consensus 225 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011234556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=340.97 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=205.6
Q ss_pred hhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEec-CCc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSN-KET 757 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~ 757 (995)
++|++.+.||+|+||.||+|... +++.||+|++...........+.+|+.+++++ +||||+++++++.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 47889999999999999999532 35789999985433333345678899999999 79999999998754 456
Q ss_pred ceEEEEeccCCChhhhhcCCC-----------------------------------------------------------
Q 001922 758 NLLVYEYMRNGSLGEALHGKK----------------------------------------------------------- 778 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 778 (995)
.+++|||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 789999999999999985322
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccccCccccc
Q 001922 779 GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIA 858 (995)
Q Consensus 779 ~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 858 (995)
...+++..+.+++.||+.|++|||+.+ |+||||||+||++++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 126789999999999999999999777 99999999999999999999999999987644332222334456778999
Q ss_pred ccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHH
Q 001922 859 PEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVA 937 (995)
Q Consensus 859 PE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li 937 (995)
||++.+..++.++||||+||++|||++ |..||........... ..... .....+......+.+++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~---~~~~~-----------~~~~~~~~~~~~~~~l~ 309 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR---RLKEG-----------TRMRAPEYATPEIYSIM 309 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHH---HHhcc-----------CCCCCCccCCHHHHHHH
Confidence 999999999999999999999999998 9999965332222111 11111 00112234456789999
Q ss_pred hcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 938 MLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 938 ~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.+||+.+|++||++.|++++|+++.+
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.77 Aligned_cols=252 Identities=24% Similarity=0.415 Sum_probs=203.5
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
+.|+..+.||+|+||.||+|+++++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 356777899999999999999888889999987432 233567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++|+|.++++... ..+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||.++........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 82 ENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 9999999997433 46889999999999999999999877 999999999999999999999999999865432221
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+....+.... ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~~~~i~~~~-----------~~~ 221 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEMISRGF-----------RLY 221 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHCCC-----------CCC
Confidence 1122345678999999988889999999999999999999 8999864321 12222222111 011
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
.+...+..+.+++.+||+.+|++||+++|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12223457899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=310.20 Aligned_cols=253 Identities=25% Similarity=0.321 Sum_probs=202.5
Q ss_pred HhhccCCCeeeccCceEEEEE-EeCCCcEEEEEEecC-CCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHG-KMPNGVEIAVKKLLG-FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.+.|+..+.||+|.|+.||++ +..+|+++|+|.+.. .-.....+.+.+|+.|.+.++||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 346677788999999999998 456899999988732 122335677899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CCeEEeeeccccccc
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA---FEAHVADFGLAKFLI 839 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~---~~vkl~DfGla~~~~ 839 (995)
|+|+|++|..-+-.+ ...++..+-..++||++|+.|+|.++ |||||+||+|+++.+. .-+|++|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999998766432 56788888899999999999999777 9999999999999543 358999999999886
Q ss_pred cCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
++ .......|||+|||||+++..+|+..+|||+.|||+|-++.|+.||.+.. .......+..+.. ++-.
T Consensus 165 ~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~----~~rlye~I~~g~y----d~~~ 233 (355)
T KOG0033|consen 165 DG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRLYEQIKAGAY----DYPS 233 (355)
T ss_pred Cc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc----HHHHHHHHhcccc----CCCC
Confidence 33 33345789999999999999999999999999999999999999997532 2222233332211 0111
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+.+ +...+...+++.+|+..||.+|.|+.|.+.+
T Consensus 234 ~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 234 PEW----DTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ccc----CcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 122 2345678899999999999999999988754
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.59 Aligned_cols=255 Identities=30% Similarity=0.434 Sum_probs=207.4
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
+.|+..+.||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 4577889999999999999988778889999985432 23566889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++....+..+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.+||+|||+++.+.......
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999997655567899999999999999999999877 9999999999999999999999999998764322111
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......+..|+|||+..+..++.++||||||+++|||++ |+.||...... .......... . ..
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~~----------~-~~ 224 (261)
T cd05068 161 -REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQQVDQGY----------R-MP 224 (261)
T ss_pred -cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHcCC----------C-CC
Confidence 112223458999999998899999999999999999999 99998643211 1111111110 0 01
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.+...+..+.+++.+|++.+|++||+++++++.|+++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 2234557789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.54 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=199.3
Q ss_pred CeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCCh
Q 001922 692 NVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSL 770 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 770 (995)
+.||+|+||.||+|+. .+++.||+|.+...........+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999976 468899999875443344456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcccccc
Q 001922 771 GEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850 (995)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 850 (995)
.+++.. .+..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....+..........
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRT-EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 999963 3456889999999999999999999777 999999999999999999999999998765332211111122
Q ss_pred ccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHH
Q 001922 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEE 929 (995)
Q Consensus 851 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 929 (995)
..+..|+|||.+.+..++.++||||+|+++|||++ |..||....... ........ .....+...
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~----~~~~~~~~-----------~~~~~~~~~ 221 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----TREAIEQG-----------VRLPCPELC 221 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH----HHHHHHcC-----------CCCCCcccC
Confidence 33567999999998889999999999999999998 888886432211 11111110 001123345
Q ss_pred HHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 930 AMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 930 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
+..+.+++.+|++.+|++||+++|+.++|++
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 6678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.82 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=203.6
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++|+..+.||+|+||.||+++.. ++..||+|.+...........+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 56888899999999999999765 67888999885433333456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++|+|.+++.. ...+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||++....+.
T Consensus 85 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 85 MDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 999999999964 346889999999999999999999642 3999999999999999999999999998765332
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh-cCCh------------
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRAT-NGRK------------ 911 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~------------ 911 (995)
......|++.|+|||++.+..++.++||||+||++|||++|+.||..... ..+........ ....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhcccccccccCCccccCccccc
Confidence 22345689999999999998999999999999999999999999964321 11111110000 0000
Q ss_pred -------------------hhhhhhcCCcCCC-CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 -------------------EEFLSILDPRLSM-VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 -------------------~~~~~~~d~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....+.....+. .....+..+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000111111 112355678999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=342.75 Aligned_cols=246 Identities=23% Similarity=0.274 Sum_probs=201.1
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.|+..+.||+|+||.||+|+.. +++.||+|.+.... .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46788899999999999999774 58899999985321 2233456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...+.
T Consensus 98 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 99999999999963 356788899999999999999999877 999999999999999999999999999865332
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+... ..
T Consensus 172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~~-----------~~ 232 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT----PFRIYEKILAG-----------RL 232 (329)
T ss_pred ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC----HHHHHHHHhcC-----------Cc
Confidence 124579999999999999999999999999999999999999996422 11112222211 11
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPR-----MREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 957 (995)
..+...+..+.+++.+||+.||++||+ +++++.+
T Consensus 233 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 -KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 122234556889999999999999997 6777754
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.60 Aligned_cols=262 Identities=25% Similarity=0.399 Sum_probs=206.8
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCc----EEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGV----EIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
..|+..+.||+|+||.||+|++. +++ .||+|++..........++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 35788899999999999999753 333 48999885443444456788999999999999999999998764 5789
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
|+||+++|+|.+++... ...+++..+++++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999999743 346888999999999999999999777 99999999999999999999999999987643
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
...........++..|+|||++.+..++.++|||||||++|||++ |+.||..... .++........
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----~~~~~~~~~~~--------- 228 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISSILEKGE--------- 228 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHhCCC---------
Confidence 322222223345678999999999999999999999999999998 9999864321 11111111110
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcc
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSD 967 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 967 (995)
.. ..+..++..+.+++.+||+.+|++||++.+++..+.++.+....
T Consensus 229 -~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~ 274 (316)
T cd05108 229 -RL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 274 (316)
T ss_pred -CC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence 00 11223456788999999999999999999999999988765543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=330.34 Aligned_cols=252 Identities=24% Similarity=0.268 Sum_probs=202.6
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
|+..++||+|+||+||++.. .+++.||+|++..... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 66778999999999999976 4688999999853221 12234567899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++|+|.+++.......+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.++|+|||++..+....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence 99999999886554567899999999999999999999877 9999999999999999999999999998653222
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......|++.|+|||++.+..++.++||||+||++|||++|+.||...............+. .....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~------------~~~~~ 223 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK------------EDQEE 223 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh------------hcccc
Confidence 12345789999999999988999999999999999999999999975332222211111111 11112
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
.+...+..+.+++.+||+.||++|| +++++++.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 3344667789999999999999999 78887654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=331.92 Aligned_cols=258 Identities=24% Similarity=0.401 Sum_probs=206.6
Q ss_pred hhccCCCeeeccCceEEEEEEe-----CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-----PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
..|+..+.||+|+||.||+|.. .++..|++|.+...........+.+|+.++++++||||+++++++..++..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567778999999999999974 35678999998644433344678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 001922 761 VYEYMRNGSLGEALHGKK---------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF 825 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~ 825 (995)
||||+++++|.+++.... ...+++.....++.|++.|+.|||+++ |+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 235788889999999999999999877 99999999999999999
Q ss_pred CeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHH
Q 001922 826 EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSK 904 (995)
Q Consensus 826 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 904 (995)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... .....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----~~~~~ 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----QEVIE 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence 999999999987644333233344456778999999988889999999999999999998 9999864321 11111
Q ss_pred HHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 905 RATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 905 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
...... ....+..++..+.+++.+||+.+|++||++.++.++|+++
T Consensus 238 ~~~~~~-----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 238 MVRKRQ-----------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHcCC-----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 111110 1112334556789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.98 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=204.4
Q ss_pred HhhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
.++|+..+.||+|+||.||+|... .+..||+|++...........+.+|+.+++.++||||+++++++.++...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 567889999999999999998652 35679999885433333455688999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEe
Q 001922 759 LLVYEYMRNGSLGEALHGKK--------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVA 830 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~ 830 (995)
++||||+++|+|.+++.... ....++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEEC
Confidence 99999999999999986422 124577888999999999999999777 9999999999999999999999
Q ss_pred eeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcC
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... ........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~----~~~~~~~~- 236 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----QVLRFVME- 236 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHc-
Confidence 9999876543322222223355788999999998889999999999999999999 78888543211 11111111
Q ss_pred ChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 910 RKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 910 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
......+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 237 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 ----------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11112233455678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=331.45 Aligned_cols=263 Identities=20% Similarity=0.250 Sum_probs=198.6
Q ss_pred hccCCCeeeccCceEEEEEEeC--CCcEEEEEEecCCCC-CChhHHHHHHHHHHhcc---CCCCceeEeEEEe-----cC
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP--NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNI---RHRNIVRLLAFCS-----NK 755 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~-----~~ 755 (995)
+|+..+.||+|+||+||+|+.. .++.||+|++..... ......+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888899999999999999763 467899998854322 22234566777777666 6999999999885 24
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccc
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA 835 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla 835 (995)
...++||||+. ++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56799999996 59999997655566899999999999999999999877 999999999999999999999999999
Q ss_pred cccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....+...+..............+.
T Consensus 158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 865332 22345578999999999988899999999999999999999999997654433333222221111111111
Q ss_pred hh-------cCCcCC----CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 916 SI-------LDPRLS----MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 916 ~~-------~d~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.. ..+... ...+..+..+.+++.+|++.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000000 011234566789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=327.26 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=210.5
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
...|+..+.||.|+||.||+|...+++.+|+|.+... .......+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD-DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc-chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3467888999999999999999888899999998543 222355688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++....+..+++..+++++.|++.|+.|||+.+ |+||||||+||++++++.+||+|||.+..+.+....
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 99999999998766677899999999999999999999877 999999999999999999999999999876432221
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.....++..|+|||...+..++.++||||||+++|+|++ |+.||...... .. ....... ...
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~---~~~~~~~-----------~~~ 223 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EV---YDQITAG-----------YRM 223 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HH---HHHHHhC-----------CcC
Confidence 123446778999999988889999999999999999998 89999653311 11 1111111 011
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
..+..++..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 12334567788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=340.48 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=196.1
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
..|+..+.||+|+||+||+|+.. +++.||+|++...........+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45566788999999999999764 68999999986544444456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++|+|.+.. ..++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-- 222 (353)
T PLN00034 154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-- 222 (353)
T ss_pred CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc--
Confidence 9999987543 3456778889999999999999877 9999999999999999999999999998653321
Q ss_pred ccccccccCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 845 ECMSAIAGSYGYIAPEYAYT-----LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||...... +...........
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~---------- 291 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAICMS---------- 291 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhcc----------
Confidence 11234578999999998743 22356899999999999999999999732211 111111111111
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....+...+..+.+++.+||+.||++||+++|++++
T Consensus 292 -~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 -QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112233456779999999999999999999999875
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.06 Aligned_cols=255 Identities=21% Similarity=0.217 Sum_probs=209.0
Q ss_pred hhccCCCeeeccCceEEEEEEeCC-CcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.|+..+.||+|.-|+||+++.++ +..+|+|++.+... .....+.+.|-+|++.+.||.++.+|..|+.+...|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345667789999999999998754 57899999844322 223456778999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC-
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG- 841 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~- 841 (995)
|||+||+|..+.+++.+..+++..++-++.+++-||+|||-.| ||+|||||+||||.++|.+-|+||.++......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999999999999999999999999999999999999888 999999999999999999999999987643110
Q ss_pred -------------------------------CCC----------------------ccccccccCcccccccccccCCCC
Q 001922 842 -------------------------------GAS----------------------ECMSAIAGSYGYIAPEYAYTLRVD 868 (995)
Q Consensus 842 -------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~ 868 (995)
... .+....+||-.|+|||++++...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 011235699999999999999999
Q ss_pred cccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCC
Q 001922 869 EKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIER 948 (995)
Q Consensus 869 ~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~R 948 (995)
.++|+|+|||++|||+.|+.||........+...+.+. ...+..+ +.+..+++||++.+.+||++|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~-------------l~Fp~~~-~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP-------------LKFPEEP-EVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC-------------CcCCCCC-cchhHHHHHHHHHhccChhhh
Confidence 99999999999999999999998765554444333211 1112222 567789999999999999999
Q ss_pred CC----HHHHHHH
Q 001922 949 PR----MREVVQM 957 (995)
Q Consensus 949 Pt----~~evl~~ 957 (995)
-. +.||-++
T Consensus 380 lg~~rGA~eIK~H 392 (459)
T KOG0610|consen 380 LGSKRGAAEIKRH 392 (459)
T ss_pred hccccchHHhhcC
Confidence 87 7777543
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=330.55 Aligned_cols=262 Identities=24% Similarity=0.413 Sum_probs=208.2
Q ss_pred hhccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
+.|...+.||+|+||+||++.. .++..+|+|.+... .......+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 4678889999999999999964 23456888887432 2333556889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeE
Q 001922 760 LVYEYMRNGSLGEALHGKK-----------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH 828 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vk 828 (995)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999986322 235899999999999999999999877 99999999999999999999
Q ss_pred EeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHh
Q 001922 829 VADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRAT 907 (995)
Q Consensus 829 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 907 (995)
|+|||+++.+.............++..|+|||++.+..++.++|||||||++|+|++ |..||..... ......+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~----~~~~~~i~ 236 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NEVIECIT 236 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH
Confidence 999999986543222222233445778999999998889999999999999999998 9999864322 11112222
Q ss_pred cCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 908 NGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 908 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
.+. ....+...+..+.+++.+||+.+|.+||+++|+.+.|+++.+...
T Consensus 237 ~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 237 QGR-----------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred cCC-----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 111 111122345578999999999999999999999999999886643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=328.82 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=204.5
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCc----EEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGV----EIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
+.|+..+.||+|+||+||+|.+. +++ ++++|++..........++..|+.++++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45677889999999999999763 344 467777643222223456778888999999999999999885 456789
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++...+
T Consensus 86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999999743 456899999999999999999999777 99999999999999999999999999987644
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
...........++..|+|||++.+..++.++||||||+++||+++ |+.||..... ....+. +..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~---~~~~~~-------- 229 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDL---LEKGER-------- 229 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH---HHCCCc--------
Confidence 332222334557789999999998899999999999999999998 9999864321 111111 111100
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCccc
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDF 968 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 968 (995)
...+..++..+..++.+||..+|++||++.|+++.|..+.+..+.+
T Consensus 230 ---~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~ 275 (279)
T cd05111 230 ---LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY 275 (279)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence 0112224456788999999999999999999999999987765443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=340.61 Aligned_cols=247 Identities=21% Similarity=0.225 Sum_probs=200.6
Q ss_pred HhhccCCCeeeccCceEEEEEEeCC--CcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPN--GVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
.+.|+..+.||+|+||.||+|.... +..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568888999999999999997543 3689999884321 22334568889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999963 346889999999999999999999877 99999999999999999999999999986532
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+...
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~i~~~----------- 243 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLIYQKILEG----------- 243 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HHHHHHHhcC-----------
Confidence 1 2345799999999999988899999999999999999999999964321 1111112111
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
. ...+...+..+.+++.+|++.||++|+ +++|++++
T Consensus 244 ~-~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 I-IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C-CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 112333455688999999999999995 88888764
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.55 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=205.1
Q ss_pred hccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
.|+..+.||+|+||.||+|+.. +++.||+|++.........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4566778999999999999753 2578999998644333334668899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC
Q 001922 761 VYEYMRNGSLGEALHGK--------------KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE 826 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~ 826 (995)
++||+.+++|.+++... ....+++..+.+++.|++.|++|+|+++ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998521 1235788889999999999999999777 999999999999999999
Q ss_pred eEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHH
Q 001922 827 AHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKR 905 (995)
Q Consensus 827 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 905 (995)
+||+|||+++...............+++.|+|||++.+..++.++||||+|+++|||++ |..||..... .++...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~ 238 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVIEM 238 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH
Confidence 99999999887644333222234456789999999988889999999999999999998 8888864322 122222
Q ss_pred HhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 906 ATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 906 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
+... .....+.+++..+.+++.+||+.+|++||+++++++.|+.
T Consensus 239 i~~~-----------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRNR-----------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcC-----------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2221 1122344567779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=323.04 Aligned_cols=255 Identities=29% Similarity=0.445 Sum_probs=206.4
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
.++|+..+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++||+++++++++. ....++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 356888899999999999999888888999999854322 3567899999999999999999999885 4568999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++..+......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999999997655566899999999999999999999877 999999999999999999999999999865432211
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......++..|+|||+..+..++.++||||||+++|||++ |..||.+.... .......... ..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~~-----------~~ 222 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----EVLEQVERGY-----------RM 222 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHcCC-----------CC
Confidence 1122335678999999988889999999999999999999 89999653221 1111111110 01
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
..+...+..+.+++.+|++.+|++|||++++.+.|++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 12334567799999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=340.27 Aligned_cols=253 Identities=21% Similarity=0.234 Sum_probs=202.5
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
+|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5778899999999999999875 58899999985322 12234567889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 82 YVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999953 346889999999999999999999877 99999999999999999999999999986532
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+..... . ...+...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~-~---~~~~~~~ 223 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE----TWENLKYWKE-T---LQRPVYD 223 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH----HHHHHHhccc-c---ccCCCCC
Confidence 2234579999999999999999999999999999999999999996532211 1111111000 0 0001111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
......+..+.+++.+|++.+|++||+++|++++
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1112346678899999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=332.85 Aligned_cols=255 Identities=27% Similarity=0.316 Sum_probs=212.8
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEeCC-CcEEEEEEecCCCCCC--hhHHHHHHHHHHhccC-CCCceeEeEEEecCCc
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHS--HDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKET 757 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 757 (995)
.++...|+.++.||+|.||.||+++.+. |+.+|+|.+.+..... ..+.+.+|+++|+++. |||||.++++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3456678889999999999999997754 9999999995544332 3467899999999998 9999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC----CCeEEeeec
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA----FEAHVADFG 833 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~----~~vkl~DfG 833 (995)
+++|||+++||.|.+.+... .+++..+..+++|++.|+.|+|..| |+|||+||+|+++... +.+|++|||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 99999999999999999755 3899999999999999999999777 9999999999999643 479999999
Q ss_pred cccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+........ .+..+..
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----~i~~~~~-- 255 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----AILRGDF-- 255 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----HHHcCCC--
Confidence 9998754 345678899999999999999999999999999999999999999997654333322 1121111
Q ss_pred hhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 914 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
++-+ ..-+..+..+.+++..|+..||.+|+++.+++++
T Consensus 256 --~f~~----~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 --DFTS----EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --CCCC----CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 0111 1223457788999999999999999999999995
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=346.39 Aligned_cols=370 Identities=29% Similarity=0.382 Sum_probs=222.9
Q ss_pred cccccccccccccc-ccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhh
Q 001922 138 VNLEVFDAYNNNFT-ALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIY 216 (995)
Q Consensus 138 ~~L~~L~Ls~n~i~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 216 (995)
+-.+-.|+++|.++ +..|..+..+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+.+.++.|+.|+.+.
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 34455566666666 457888888999999999999986 88999999999999999999998 6778889999999999
Q ss_pred ccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCc
Q 001922 217 LGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALT 296 (995)
Q Consensus 217 L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 296 (995)
+..|++....+|..+..+..|+.||||+|+++ ..|..+.+.+++-.|+|++|+|..+....|.+++.|-.||||+|++.
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 99999988889999999999999999999888 56666666666666666666666433344555556666666666655
Q ss_pred CcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCccc-ccCCCcccCCCCCCeEEecCceecccCCCcC
Q 001922 297 GEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFT-GVIPENLGQNGKLQVLDLSSNKLTGTIPTDL 375 (995)
Q Consensus 297 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 375 (995)
.+|.....+..|+.|.|++|.+.-.--..+..+++|++|.+++.+=+ ..+|.++..+.+|..+|||.|.+.
T Consensus 164 -~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp------- 235 (1255)
T KOG0444|consen 164 -MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP------- 235 (1255)
T ss_pred -hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-------
Confidence 33334444555555555555443221122223333344444433211 123333333333333333333333
Q ss_pred cCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCC
Q 001922 376 CSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDR 455 (995)
Q Consensus 376 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~ 455 (995)
.+|+.+-++.+|++|+||+|+|+
T Consensus 236 ------------------~vPecly~l~~LrrLNLS~N~it--------------------------------------- 258 (1255)
T KOG0444|consen 236 ------------------IVPECLYKLRNLRRLNLSGNKIT--------------------------------------- 258 (1255)
T ss_pred ------------------cchHHHhhhhhhheeccCcCcee---------------------------------------
Confidence 22333333333444444444333
Q ss_pred CcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCC-CCCCccCcccccceeecc
Q 001922 456 LGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSG-EIPPAIGYCNHLTYLDMS 534 (995)
Q Consensus 456 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls 534 (995)
.+........+|+.|+||+|+++ .+|.++++|++|+.|++.+|+|+- -+|+.||.|.+|+++..+
T Consensus 259 -------------eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aa 324 (1255)
T KOG0444|consen 259 -------------ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAA 324 (1255)
T ss_pred -------------eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhh
Confidence 12222233345555555555555 555556666666666666665541 255666666666666666
Q ss_pred CCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCC
Q 001922 535 QNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLP 591 (995)
Q Consensus 535 ~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p 591 (995)
+|.+. .+|..++.|..|+.|.|++|+|-. +|+++.-++.|..||+..|+----+|
T Consensus 325 nN~LE-lVPEglcRC~kL~kL~L~~NrLiT-LPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 325 NNKLE-LVPEGLCRCVKLQKLKLDHNRLIT-LPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred ccccc-cCchhhhhhHHHHHhcccccceee-chhhhhhcCCcceeeccCCcCccCCC
Confidence 66665 556666666666666666666543 56666666666666666665444444
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=330.24 Aligned_cols=260 Identities=23% Similarity=0.405 Sum_probs=208.3
Q ss_pred HhhccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 757 (995)
.++|...+.||+|+||.||+|.. .++..||+|++.........+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 45688899999999999999963 235679999886544444456789999999999 79999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.++||||+.+|+|.++++......+++.++..++.|++.|++|||+.+ |+||||||+||+++.++.++++|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999997655555899999999999999999999777 99999999999999999999999999986
Q ss_pred cccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
..............++..|+|||.+.+..++.++||||+||++|||++ |..||............. ....
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~---~~~~------ 261 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI---KEGY------ 261 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH---HcCC------
Confidence 543222111223346778999999998899999999999999999998 999986543322221111 1110
Q ss_pred hcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 917 ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 917 ~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
....+...+..+.+++.+|++.+|++||+++|+++.|+++
T Consensus 262 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 -----RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0011223456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.76 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=218.6
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
|..-|...+.||+|.|+.|-.|++ -+|++||||++.+.+ +......+.+|++.|+.++|||||++|++.......|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 456688889999999999999965 589999999995443 333456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE-CCCCCeEEeeecccccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL-NSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill-~~~~~vkl~DfGla~~~~~ 840 (995)
.|.-++|+|+||+-.. ...+.+..+.+++.||+.|+.|+|+.+ |||||+||+||++ ..-|.||++|||++-.+.+
T Consensus 96 LELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999999643 345889999999999999999999888 9999999999976 5678999999999988765
Q ss_pred CCCCccccccccCcccccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVD-EKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
+ +...+.||+..|.|||.+.+..|+ +++||||+|||+|.+++|+.||....+.+.+ ..++|
T Consensus 172 G---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImD 233 (864)
T KOG4717|consen 172 G---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMD 233 (864)
T ss_pred c---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhc
Confidence 4 345678999999999999999997 6899999999999999999999765554332 23344
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH--HHccCCCCCc
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ--MLSEFPRHSS 966 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~ 966 (995)
-.+ ..|...+.+++++|..|+..||.+|.+.+|++. +|+.+.+..+
T Consensus 234 CKY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~s 281 (864)
T KOG4717|consen 234 CKY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLS 281 (864)
T ss_pred ccc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcc
Confidence 333 357778899999999999999999999999985 3444444433
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=322.22 Aligned_cols=252 Identities=23% Similarity=0.411 Sum_probs=203.4
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
+.|+..+.||+|+||+||.|++.++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC--cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 357778899999999999998877778999988532 223467899999999999999999999999888999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
.+|+|.+++... ...+++..+++++.||+.|++|||+.+ |+||||||+||+++.++.+||+|||.++...+....
T Consensus 82 ~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 82 SNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999999999643 336899999999999999999999777 999999999999999999999999998865443221
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......++..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+... ....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~-----------~~~~ 221 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----ETVEKVSQG-----------LRLY 221 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHHhcC-----------CCCC
Confidence 1122345678999999988889999999999999999999 99998653321 111111111 0111
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
.+...+..+.+++.+||+.+|++||++.++++.++
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12234577899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=337.30 Aligned_cols=243 Identities=23% Similarity=0.263 Sum_probs=196.2
Q ss_pred CeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCC
Q 001922 692 NVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNG 768 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 768 (995)
+.||+|+||.||+++. .+|+.||+|++.... .......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999976 468999999985422 2223455778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcccc
Q 001922 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS 848 (995)
Q Consensus 769 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~ 848 (995)
+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~ 153 (323)
T cd05595 81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 153 (323)
T ss_pred cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccc
Confidence 99998853 346889999999999999999999777 9999999999999999999999999987532211 1223
Q ss_pred ccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHH
Q 001922 849 AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKE 928 (995)
Q Consensus 849 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 928 (995)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+... . ...+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~~~~~-----------~-~~~p~~ 217 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILME-----------E-IRFPRT 217 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHhcC-----------C-CCCCCC
Confidence 457999999999999999999999999999999999999999643221 111111111 0 112334
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 929 EAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 929 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
.+..+.+++.+||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 566788999999999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=336.44 Aligned_cols=243 Identities=23% Similarity=0.254 Sum_probs=197.1
Q ss_pred CeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCC
Q 001922 692 NVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNG 768 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 768 (995)
+.||+|+||.||+++. .+++.||+|++.... .......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999976 468999999985432 2223456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcccc
Q 001922 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS 848 (995)
Q Consensus 769 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~ 848 (995)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 153 (328)
T cd05593 81 ELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK 153 (328)
T ss_pred CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence 99998853 346889999999999999999999777 999999999999999999999999998753221 12223
Q ss_pred ccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHH
Q 001922 849 AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKE 928 (995)
Q Consensus 849 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 928 (995)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... ....+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~~~~~~~~~~------------~~~~p~~ 217 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILME------------DIKFPRT 217 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH----HHHHHHhccC------------CccCCCC
Confidence 45799999999999998999999999999999999999999964221 1111111111 0112334
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 929 EAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 929 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
.+..+.+++.+|++.||++|| +++|++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 556788999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=331.15 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=207.5
Q ss_pred HhhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 757 (995)
.++|+..+.||+|+||.||+|... ....+|+|.+...........+.+|+.+++++ +||||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 356788899999999999999763 23678999886443333445688999999999 79999999999999999
Q ss_pred ceEEEEeccCCChhhhhcC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC
Q 001922 758 NLLVYEYMRNGSLGEALHG--------------KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS 823 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~--------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~ 823 (995)
.++||||+++|+|.++++. .....+++..+++++.|++.|++|||+.+ |+||||||+||+++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 9999999999999999864 22456889999999999999999999777 999999999999999
Q ss_pred CCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q 001922 824 AFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQW 902 (995)
Q Consensus 824 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~ 902 (995)
++.+||+|||+++.+.............++..|+|||+..+..++.++|||||||++||+++ |..||...... +.
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~ 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----EL 243 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH----HH
Confidence 99999999999987644332222223345678999999988889999999999999999998 99998643221 11
Q ss_pred HHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 903 SKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 903 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
....... .....+..++..+.+++.+||+.+|++|||++|+++.|+++.
T Consensus 244 ~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKLLKEG-----------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHcC-----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111 111123345667889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=329.24 Aligned_cols=262 Identities=24% Similarity=0.428 Sum_probs=208.2
Q ss_pred hhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
.+|...+.||+|+||.||+|+.. ++..+++|.+.. ........+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45677789999999999999642 345688888743 22233456889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 001922 760 LVYEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF 825 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~ 825 (995)
+||||+++++|.+++.... ...+++..+++++.||+.|++|||+++ |+||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 9999999999999996422 235789999999999999999999777 99999999999999999
Q ss_pred CeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHH
Q 001922 826 EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSK 904 (995)
Q Consensus 826 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 904 (995)
.++|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~ 236 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVIE 236 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH
Confidence 999999999986543322222234456789999999998899999999999999999999 99998643221 1111
Q ss_pred HHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 905 RATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 905 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
..... .....+..++..+.+++.+||+.+|++||++++|+++|+++.+..+
T Consensus 237 ~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 237 CITQG-----------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred HHhCC-----------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 11111 1111233356678999999999999999999999999999866433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=334.82 Aligned_cols=241 Identities=22% Similarity=0.248 Sum_probs=194.9
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCCh
Q 001922 694 IGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSL 770 (995)
Q Consensus 694 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 770 (995)
||+|+||.||+|+.. +++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999764 57889999985321 223345678899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcccccc
Q 001922 771 GEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850 (995)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 850 (995)
.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 153 (312)
T cd05585 81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTF 153 (312)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccccc
Confidence 999964 356889999999999999999999777 9999999999999999999999999987542221 222445
Q ss_pred ccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHH
Q 001922 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEA 930 (995)
Q Consensus 851 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 930 (995)
.||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+....+... . ...+...+
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~----~~~~~~~~~~~-----------~-~~~~~~~~ 217 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN----VNEMYRKILQE-----------P-LRFPDGFD 217 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC----HHHHHHHHHcC-----------C-CCCCCcCC
Confidence 79999999999999999999999999999999999999996532 12222222211 1 11233455
Q ss_pred HHHHHHHhcccCCCCCCCCC---HHHHHHH
Q 001922 931 MHLLFVAMLCIQENSIERPR---MREVVQM 957 (995)
Q Consensus 931 ~~l~~li~~cl~~dP~~RPt---~~evl~~ 957 (995)
..+.+++.+||+.||++||+ ++|++.+
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 67889999999999999985 5666543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=350.90 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=202.3
Q ss_pred hccCCCeeeccCceEEEEEEeC-C-CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-N-GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
.|...+.||+|+||.||+|... + ++.||+|++.. ........+.+|+.+++.++|||||++++++...+..|+||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4888899999999999999653 3 57788887632 2233345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 765 MRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 765 ~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
+++|+|.+++.. .....+++..+..++.||+.||.|+|+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998853 23456889999999999999999999777 9999999999999999999999999998764433
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..........+ ..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~----~~~~~~~~~~~-----------~~ 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----QREIMQQVLYG-----------KY 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhC-----------CC
Confidence 2223345679999999999999999999999999999999999999996422 11222221111 11
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
...+...+..+.+++.+||+.||++||+++++++
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1123345567899999999999999999999874
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=323.90 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=206.1
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.|...+.||+|+||.||+|.+. .++.||+|++... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4667788999999999999764 5888999987532 233567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++.......+++..++.++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 9999999997655567899999999999999999999777 999999999999999999999999999876433221
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......++..|+|||++.+..++.++|||||||++|||++ |..||... +..+......... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~----~~~~~~~~~~~~~-----------~~~ 225 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELLEKGY-----------RME 225 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHCCC-----------CCC
Confidence 1122334678999999998899999999999999999998 99998542 1222222221110 011
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.+...+..+.+++.+||+.+|++||++++++++|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2334556799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=322.31 Aligned_cols=254 Identities=30% Similarity=0.437 Sum_probs=205.3
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
++|+..+.||+|+||.||+|+..++..||+|++... ....+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC--ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 568889999999999999998877778999998532 223467899999999999999999999875 45679999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++|+|.+++....+..+++..+..++.|++.||+|+|+.+ |+||||||+||++++++.++|+|||.++.+......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 9999999997655566889999999999999999999777 999999999999999999999999999866433221
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......++..|+|||+..+..++.++||||+|+++||+++ |..||....... ........ ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~----~~~~~~~~-----------~~~~ 223 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERG-----------YRMP 223 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH----HHHHHhcC-----------CCCC
Confidence 1123346678999999988899999999999999999999 888886432211 11111111 0011
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.+...+..+.+++.+|++.+|++||+++++++.|++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 2334567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=326.14 Aligned_cols=258 Identities=25% Similarity=0.356 Sum_probs=206.8
Q ss_pred HhhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
.++|+..+.||+|+||.||+|... .+..||+|.+...........+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 356788899999999999999753 24689999985443334455688999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEe
Q 001922 759 LLVYEYMRNGSLGEALHGKK--------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVA 830 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~ 830 (995)
++||||+++|+|.+++.... ...+++..++.++.|++.|+.|||+.+ |+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999986422 234688899999999999999999777 9999999999999999999999
Q ss_pred eeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcC
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
|||+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |..||..... .... +....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~---~~~~~- 236 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVL---KFVID- 236 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-HHHH---HHHhc-
Confidence 9999987644332222234456789999999988889999999999999999998 9999854221 1111 11111
Q ss_pred ChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 910 RKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 910 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
......+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 237 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 237 ----------GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11112233346789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=321.79 Aligned_cols=255 Identities=29% Similarity=0.425 Sum_probs=206.9
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
.+.|+..++||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++||||+++++++. .+..++||||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 35678889999999999999998889999999985432 23567899999999999999999999874 4678999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++....+..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 99999999997666667899999999999999999999777 99999999999999999999999999976542221
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.......++..|+|||++.+..++.++||||||+++||+++ |+.||...... .......... ..
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~~-----------~~ 222 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP----EVIQNLERGY-----------RM 222 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH----HHHHHHHcCC-----------CC
Confidence 11123345678999999988889999999999999999999 99999654321 1111111110 00
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
..+...+..+.+++.+|++.+|++||+++++++.|+.+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 12223456799999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=336.64 Aligned_cols=252 Identities=23% Similarity=0.248 Sum_probs=199.8
Q ss_pred ccCCCeeeccCceEEEEEEe----CCCcEEEEEEecCCC---CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcce
Q 001922 688 VKDGNVIGRGGAGIVYHGKM----PNGVEIAVKKLLGFG---THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 759 (995)
|+..+.||+|+||+||+++. .+++.||+|++.+.. .....+.+..|+.+++++ +||+|+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 67788999999999999865 357899999984321 222345678899999999 5999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999853 356889999999999999999999877 9999999999999999999999999998653
Q ss_pred cCCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...................
T Consensus 157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--------- 226 (332)
T cd05614 157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--------- 226 (332)
T ss_pred ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC---------
Confidence 32221 22345799999999998765 47889999999999999999999996543333222222222111
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
++ ..+...+..+.+++.+|++.||++|| ++++++++
T Consensus 227 ~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 DP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11 12233456788999999999999999 77788754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.02 Aligned_cols=255 Identities=26% Similarity=0.363 Sum_probs=211.2
Q ss_pred hccCCCeeeccCceEEEEEEeC--CC--cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP--NG--VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.++..++||+|.||.|++|.|. .| ..||||.+...........|.+|+.+|.+++|||++++||+.-+ ....|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3445578999999999999874 33 45899999765555567889999999999999999999999986 6788999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
|.++.|+|.+.++......+-......++.|||.||.||..++ +||||+.++|+++-....|||+|||+.+-+..++
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999998766778888899999999999999999666 9999999999999999999999999999886654
Q ss_pred CCccc-cccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 843 ASECM-SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 843 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
....+ ....-...|+|||.++...|+.++|||+|||++|||+| |..||... .-.++.+.+.. .
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~----~g~qIL~~iD~-----------~ 331 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC----RGIQILKNIDA-----------G 331 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC----CHHHHHHhccc-----------c
Confidence 43332 33445679999999999999999999999999999999 99999542 22222222221 1
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
+.-..|+.|+++++++++.||...|++||+|..+.+.+-.
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 2234577899999999999999999999999999855433
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=324.77 Aligned_cols=249 Identities=24% Similarity=0.275 Sum_probs=197.9
Q ss_pred eeccCceEEEEEEe-CCCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCCh
Q 001922 694 IGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSL 770 (995)
Q Consensus 694 lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 770 (995)
||+|+||+||+++. .+|+.||+|++..... ......+..|++++++++||||+++++++.++.+.++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999976 4689999999843221 12233456799999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcccccc
Q 001922 771 GEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850 (995)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 850 (995)
.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 99887555556889999999999999999999777 9999999999999999999999999988654321 12345
Q ss_pred ccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHH
Q 001922 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEA 930 (995)
Q Consensus 851 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 930 (995)
.|+..|+|||++.+..++.++||||+||++|||++|+.||.................. ..........+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~ 223 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-----------DEVKFEHQNFT 223 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-----------cccccccccCC
Confidence 6899999999999888999999999999999999999999764332222222222111 11111112345
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 931 MHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 931 ~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
..+.+++.+||+.||++||+++|+++.+.
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 67899999999999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.39 Aligned_cols=254 Identities=29% Similarity=0.437 Sum_probs=204.9
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
++|+..+.||+|+||.||+|....+..+|+|++... ....+.+.+|++++++++|||++++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG--TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC--CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 457888899999999999998877778999987432 223467889999999999999999999885 45689999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 9999999997655566899999999999999999999877 999999999999999999999999999865433211
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......++..|+|||+..+..++.++||||+|+++|||++ |+.||....+.... ....... ...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~----~~~~~~~-----------~~~ 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL----EQVERGY-----------RMP 223 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcCC-----------CCC
Confidence 1122345678999999988889999999999999999999 99998653322111 1111110 011
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.+...+..+.+++.+||+.+|++||+++++++.|++.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 2334567799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=321.54 Aligned_cols=251 Identities=25% Similarity=0.438 Sum_probs=202.3
Q ss_pred hccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEecc
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
.|+..+.||+|+||.||+|+++++..+|+|.+... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG--AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC--CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 46778899999999999998877788999988532 2234568889999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
+++|.+++.... ..+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||+++...+.....
T Consensus 83 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 83 NGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 999999997433 46899999999999999999999877 9999999999999999999999999988654322111
Q ss_pred ccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
.....++..|+|||.+.+..++.++||||||+++||+++ |+.||....+... ...+... ... ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~~~--------~~~---~~ 222 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV----VESVSAG--------YRL---YR 222 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH----HHHHHcC--------CcC---CC
Confidence 112234468999999998899999999999999999999 8999865332211 1111111 000 11
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
+...+..+.+++.+||+.+|++||+++|+++.|.
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 2235668999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=333.93 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=201.3
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++|+..+.||+|+||.||+|... ++..+|+|.+...........+.+|++++++++||||+++++++.++++.++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 57888999999999999999775 57888888875443333456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++|+|.+++.. ...+++..+..++.|++.|+.|||+.+ +|+||||||+||++++++.+||+|||++..+...
T Consensus 85 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 85 MDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999999999963 345888999999999999999999631 3999999999999999999999999998765322
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh-------------
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK------------- 911 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~------------- 911 (995)
......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ..............
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK-ELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh-HHHHHhcCcccCCccccccCcccCCcc
Confidence 123346899999999999888999999999999999999999999643221 11110000000000
Q ss_pred -------------hh----hhhhcCCcCCCCC-HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 -------------EE----FLSILDPRLSMVP-KEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 -------------~~----~~~~~d~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.. ...+.....+..+ ...+..+.+++.+||+.||++||+++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00 0000000000000 1134568899999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=328.91 Aligned_cols=264 Identities=24% Similarity=0.334 Sum_probs=203.9
Q ss_pred hhccCCCeeeccCceEEEEEEeCC---------------CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN---------------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 750 (995)
.+|+..+.||+|+||.||+|+... ...||+|++...........+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999986532 23489998865433444567889999999999999999999
Q ss_pred EEecCCcceEEEEeccCCChhhhhcCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 001922 751 FCSNKETNLLVYEYMRNGSLGEALHGKK----------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNIL 820 (995)
Q Consensus 751 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nil 820 (995)
++...+..++||||+++++|.+++.... ...+++..+.+++.|++.|++|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999985421 124678889999999999999999877 999999999999
Q ss_pred ECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCCch
Q 001922 821 LNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT--GRRPVGDFGDGVD 898 (995)
Q Consensus 821 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~Pf~~~~~~~~ 898 (995)
+++++.+||+|||++..+.............++..|+|||+..+..++.++|||||||++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999986543332222233445779999999988889999999999999999998 6678765433222
Q ss_pred HHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 899 IVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
........... ........+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 242 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 IENTGEFFRNQ--------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHhhhhc--------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 21111111100 0000011222345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=333.98 Aligned_cols=243 Identities=25% Similarity=0.323 Sum_probs=195.8
Q ss_pred CeeeccCceEEEEEEe----CCCcEEEEEEecCCC---CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 692 NVIGRGGAGIVYHGKM----PNGVEIAVKKLLGFG---THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.||+|+||.||+++. .+++.||+|.+.... .......+.+|+.++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 357889999985321 222345577899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++|+|.+++.. ...+.+..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 82 LSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 999999999953 356788888899999999999999877 9999999999999999999999999987543222
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... .. .
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~----~~~~~~~~~~-----------~~-~ 218 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR----KKTIDKILKG-----------KL-N 218 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH----HHHHHHHHcC-----------CC-C
Confidence 122345799999999999988899999999999999999999999964321 1112222111 11 1
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
.+...+..+.+++.+|++.+|++|| +++++++.
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 2333456788999999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=325.20 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=209.6
Q ss_pred HhhccCCCeeeccCceEEEEEEeCC-----CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec-CCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPN-----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN-KETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 758 (995)
.++|+..+.||+|+||.||+|.+.+ +..|++|++...........+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999998755 688899988654444456678899999999999999999998755 5778
Q ss_pred eEEEEeccCCChhhhhcCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeee
Q 001922 759 LLVYEYMRNGSLGEALHGKKG------AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADF 832 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~Df 832 (995)
++++||+++++|.+++..... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999864322 46889999999999999999999877 999999999999999999999999
Q ss_pred ccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
|+++.+.+...........++..|+|||++.+..++.++||||+|+++||+++ |+.||... +.... ........
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~---~~~~~~~~- 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-DPFEM---AAYLKDGY- 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-CHHHH---HHHHHcCC-
Confidence 99987644333222233456778999999988889999999999999999999 99999653 22222 22111110
Q ss_pred hhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 912 EEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 912 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.. ..+..++..+.+++.+||+.||++||++.|+++.|+++..
T Consensus 237 ---------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 237 ---------RL-AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---------CC-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 1122345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.18 Aligned_cols=274 Identities=26% Similarity=0.351 Sum_probs=207.7
Q ss_pred ccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc--CCCCceeEeEEEecCC----cceEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI--RHRNIVRLLAFCSNKE----TNLLV 761 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~~~~~~~~----~~~lv 761 (995)
....+++|+|.||.||+|.. +++.||||++ ...+.+.|..|-.|++.. +|+||++++++-..+. .+++|
T Consensus 212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKif----p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIF----PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhhHHHhhcCccceeehhhc-cCceeEEEec----CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34457899999999999998 4589999998 345567788887777654 7999999999876555 88999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCEEECCCCCeEEeeeccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC------SPLIVHRDVKSNNILLNSAFEAHVADFGLA 835 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------~~~iiHrDlkp~Nill~~~~~vkl~DfGla 835 (995)
+||.+.|+|.+|+.. ..++|....+++..+++||+|||+.. .++|+|||||.+|||+..++++.|+|||+|
T Consensus 287 t~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999964 46999999999999999999999853 567999999999999999999999999999
Q ss_pred cccccCCCCccccccccCcccccccccccCC-CC-----cccchhhHHHHHHHHHhCCCCCCC-CCCC------------
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAYTLR-VD-----EKSDVYSFGVVLLELLTGRRPVGD-FGDG------------ 896 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwSlGvil~elltg~~Pf~~-~~~~------------ 896 (995)
..+.++......-..+||.+|||||++.+.- +. .+.||||+|.++|||++...-++. ..++
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 9987665555555689999999999987642 22 368999999999999996554421 1010
Q ss_pred chHHHHHHHHhcCChhhhhhhcCCcCC--CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcccccCchh
Q 001922 897 VDIVQWSKRATNGRKEEFLSILDPRLS--MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQSSSS 974 (995)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~ 974 (995)
..+.+....+. .+...|.++ .........+.+.+..||+.||+.|-|+.=|.+.+.++..........+..
T Consensus 444 Pt~e~mq~~VV-------~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~~~~~s~~ 516 (534)
T KOG3653|consen 444 PTLEEMQELVV-------RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWEDSSGESSS 516 (534)
T ss_pred CCHHHHHHHHH-------hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCccCCcccc
Confidence 01111111110 011112111 111145667889999999999999999999999999988776653333333
Q ss_pred hh
Q 001922 975 SL 976 (995)
Q Consensus 975 ~~ 976 (995)
+.
T Consensus 517 ~~ 518 (534)
T KOG3653|consen 517 SL 518 (534)
T ss_pred cc
Confidence 33
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=349.87 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=205.2
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCC------
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE------ 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 756 (995)
.++|+..+.||+|+||+||+|+. .+++.||||++.... .......+.+|+.++..++|+|++++++.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 46889999999999999999975 578999999984432 2334456788999999999999999988764332
Q ss_pred --cceEEEEeccCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeee
Q 001922 757 --TNLLVYEYMRNGSLGEALHGK--KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADF 832 (995)
Q Consensus 757 --~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~Df 832 (995)
..++||||+++|+|.+++... ....+++..+..++.|++.||.|+|+.+ |+||||||+||+++.++.+||+||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEec
Confidence 357999999999999998642 3456889999999999999999999776 999999999999999999999999
Q ss_pred ccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
|+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||... ............
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~----~~~~~~~~~~~~--- 260 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE----NMEEVMHKTLAG--- 260 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHhcC---
Confidence 9998764332233334567999999999999999999999999999999999999999642 222222222211
Q ss_pred hhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 913 EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 913 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....+...+..+.+++.+||+.||++||++.+++++
T Consensus 261 --------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 --------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1122334456779999999999999999999999864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=325.05 Aligned_cols=258 Identities=24% Similarity=0.335 Sum_probs=202.9
Q ss_pred HhhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
.+.|...+.||+|+||.||+|.+. .+..||+|.+...........+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 356788899999999999999764 35678888875443333455688999999999999999999999888899
Q ss_pred eEEEEeccCCChhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC---CeEEe
Q 001922 759 LLVYEYMRNGSLGEALHGKK-----GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF---EAHVA 830 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~---~vkl~ 830 (995)
++||||+++++|.+++.... ...+++..+.+++.||+.|++|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 99999999999999986432 135889999999999999999999777 99999999999998765 58999
Q ss_pred eeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcC
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..||...... .........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----~~~~~~~~~ 237 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----EVMEFVTGG 237 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHcC
Confidence 9999987633222211122234568999999998899999999999999999997 99998643221 111111111
Q ss_pred ChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 910 RKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 910 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
. ....+...+..+.+++.+|++.+|++||++.+|++.|..
T Consensus 238 ~-----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 238 G-----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred C-----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 0 011233445678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.76 Aligned_cols=260 Identities=25% Similarity=0.332 Sum_probs=205.6
Q ss_pred HhhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
.++|++.+.||+|+||.||+|..+ .+..||+|.+...........+.+|+.+++.++||||+++++++.+++..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 467888999999999999999643 24579999875443333445678899999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEe
Q 001922 759 LLVYEYMRNGSLGEALHGKK--------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVA 830 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~ 830 (995)
|+||||+++|+|.+++.... ....++..+.+++.|++.|+.|||+++ |+||||||+||++++++.++++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999996421 234567778899999999999999777 9999999999999999999999
Q ss_pred eeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcC
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
|||+++.+.............++..|+|||...+..++.++|||||||++|||++ |..||..... .+......
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~-- 235 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----EQVLKFVM-- 235 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH--
Confidence 9999986543332222233345778999999998899999999999999999998 7889854221 12222111
Q ss_pred ChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 910 RKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 910 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
+......+...+..+.+++.+|++.+|++||+++++++.+++..
T Consensus 236 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 ---------DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ---------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111223344578999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.99 Aligned_cols=261 Identities=24% Similarity=0.370 Sum_probs=208.6
Q ss_pred HhhccCCCeeeccCceEEEEEEe--------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecC
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM--------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNK 755 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 755 (995)
.++|...+.||+|+||.||+|+. .++..||+|.+...........+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45788889999999999999964 134578999885433334456788999999999 899999999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL 821 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill 821 (995)
...++||||+.+|+|.+++.... ...+++..+..++.||+.|+.|||+.+ |+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 99999999999999999996432 235788889999999999999999877 9999999999999
Q ss_pred CCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHH
Q 001922 822 NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIV 900 (995)
Q Consensus 822 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 900 (995)
++++.+||+|||.++.+.............+++.|+|||++.+..++.++||||||+++||+++ |..||... ...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~ 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----PVE 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC----CHH
Confidence 9999999999999987644332222233456778999999988889999999999999999998 78888542 222
Q ss_pred HHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
++...+.... ....+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 247 ~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 ELFKLLKEGH-----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHHcCC-----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 2222222211 111233456789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.76 Aligned_cols=260 Identities=20% Similarity=0.319 Sum_probs=209.0
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.+|+..+.||+|+||.||+|+. .+++.||+|++.... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4678889999999999999976 468999999874322 2233456888999999999999999999999999999999
Q ss_pred EeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 763 EYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 763 e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||+++|+|.+++.. .....+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998853 23355788999999999999999999777 99999999999999999999999999886533
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.. .......+++.|+|||.+.+..++.++||||+|+++|||++|+.||.... .....+...+..... +
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~--~~~~~~~~~~~~~~~--------~ 226 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLFSLCQKIEQCDY--------P 226 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc--ccHHHHHHHHhcCCC--------C
Confidence 21 11234568889999999988889999999999999999999999985422 222222222221100 0
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
+......+..+.+++.+||+.+|++||++.||++.++.++
T Consensus 227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1122345677999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.51 Aligned_cols=256 Identities=30% Similarity=0.441 Sum_probs=208.6
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
.++|+..+.||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG--TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC--ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4578889999999999999998878889999998542 23356789999999999999999999999988999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++....+..+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.+|++|||.+..+......
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 99999999997665567899999999999999999999877 999999999999999999999999998866432111
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......++..|+|||.+.+..++.++||||+|+++||+++ |+.||....... ......... ..
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~~~~~~~-----------~~ 223 (261)
T cd05034 160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE----VLEQVERGY-----------RM 223 (261)
T ss_pred -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcCC-----------CC
Confidence 1122234578999999998889999999999999999999 999985432211 111111110 00
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
..+...+..+.+++.+|++.+|++||+++++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 11223356789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.67 Aligned_cols=261 Identities=24% Similarity=0.382 Sum_probs=205.7
Q ss_pred HhhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 757 (995)
.++|..++.||+|+||.||+|++. .+..||+|++.........+.+.+|++++.++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 356788899999999999999753 346899999965433434457889999999997 9999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCC----------------------------------------------------------
Q 001922 758 NLLVYEYMRNGSLGEALHGKKG---------------------------------------------------------- 779 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 779 (995)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999864211
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 001922 780 --------------------------------------AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL 821 (995)
Q Consensus 780 --------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill 821 (995)
..+++..+.+++.|++.|++|||+.+ |+||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 23567778899999999999999766 9999999999999
Q ss_pred CCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHH
Q 001922 822 NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIV 900 (995)
Q Consensus 822 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 900 (995)
++++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999999986533222112223456789999999998889999999999999999998 899986432211111
Q ss_pred HHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
..+..+. ....+...+..+.+++.+||+.+|++||+++||++.|+++.
T Consensus 353 ---~~~~~~~-----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 353 ---NAIKRGY-----------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---HHHHcCC-----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111110 01123345678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.17 Aligned_cols=264 Identities=25% Similarity=0.351 Sum_probs=204.0
Q ss_pred hhccCCCeeeccCceEEEEEEeC-----------------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-----------------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRL 748 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 748 (995)
++|+..+.||+|+||.||+++.. ++..||+|++...........+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998532 2346899988544344445678999999999999999999
Q ss_pred eEEEecCCcceEEEEeccCCChhhhhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 001922 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKK---------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819 (995)
Q Consensus 749 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Ni 819 (995)
++++...+..++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999986432 134678889999999999999999777 99999999999
Q ss_pred EECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCCc
Q 001922 820 LLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT--GRRPVGDFGDGV 897 (995)
Q Consensus 820 ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~Pf~~~~~~~ 897 (995)
++++++.++|+|||+++.+.............+++.|+|||+..++.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986644332222223345678999999888889999999999999999998 778886543322
Q ss_pred hHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 898 DIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
............ ........+..++..+.+++.+||+.||++||+++||++.|++
T Consensus 242 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIENTGEFFRDQ--------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHhhc--------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111100000 0000111223355788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.82 Aligned_cols=267 Identities=26% Similarity=0.343 Sum_probs=204.0
Q ss_pred ccCCCeeeccCceEEEEEEe-----CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecC--CcceE
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-----PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETNLL 760 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 760 (995)
|+..+.||+|+||+||++.. .+++.||+|.+...........+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988643 357889999986543333456788999999999999999999987653 45789
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++++|.+++.. ..+++..++.++.|++.|+.|||+.+ |+||||||+||++++++.++|+|||+++.+..
T Consensus 86 v~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999999964 34899999999999999999999877 99999999999999999999999999987643
Q ss_pred CCCCcc-ccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh-cCChhhhhhhc
Q 001922 841 GGASEC-MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRAT-NGRKEEFLSIL 918 (995)
Q Consensus 841 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 918 (995)
+..... .....++..|+|||...+..++.++||||||+++|||++|+.||....... ........ ......+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchhhhhhhh
Confidence 322111 122345678999999988889999999999999999999999986532211 00000000 00001111111
Q ss_pred CCcC-CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 919 DPRL-SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 919 d~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
+... ...+...+..+.+++.+||+.+|++||++++++++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111 1123445678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.32 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=202.6
Q ss_pred ccCCCeeeccCceEEEEEEeCC----CcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCc-----
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPN----GVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET----- 757 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----- 757 (995)
|+..+.||+|+||.||+|.... +..||+|++..... ......+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4677899999999999997532 36799999854322 2334578899999999999999999998865443
Q ss_pred -ceEEEEeccCCChhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeee
Q 001922 758 -NLLVYEYMRNGSLGEALHGK----KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADF 832 (995)
Q Consensus 758 -~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~Df 832 (995)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999988532 2346889999999999999999999877 999999999999999999999999
Q ss_pred ccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
|+++.+.............++..|+|||++.+..++.++||||+|+++|||++ |..||.+.... +.......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~----~~~~~~~~--- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH----EIYDYLRH--- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHc---
Confidence 99987654333222223345678999999988889999999999999999999 88998653221 11111111
Q ss_pred hhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 912 EEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 912 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
......+..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus 231 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 --------GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111223345667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.11 Aligned_cols=264 Identities=24% Similarity=0.352 Sum_probs=206.2
Q ss_pred hhccCCCeeeccCceEEEEEEeCC-----------------CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN-----------------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRL 748 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 748 (995)
++|+..+.||+|+||.||+|+..+ +..||+|++.........+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 568888999999999999987532 245899988654444445678899999999999999999
Q ss_pred eEEEecCCcceEEEEeccCCChhhhhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 001922 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKK---------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819 (995)
Q Consensus 749 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Ni 819 (995)
++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 999999999999999999999999986432 126889999999999999999999777 99999999999
Q ss_pred EECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCCCCc
Q 001922 820 LLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT--GRRPVGDFGDGV 897 (995)
Q Consensus 820 ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~Pf~~~~~~~ 897 (995)
+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999986544333333334556789999999988889999999999999999998 777875433221
Q ss_pred hHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 898 DIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
. .......... .. .......+..++..+.+++.+|++.||++||+++||++.|++
T Consensus 242 ~-~~~~~~~~~~--~~-----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 V-IENAGHFFRD--DG-----RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred H-HHHHHhcccc--cc-----ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1 1111111000 00 000011223345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.23 Aligned_cols=265 Identities=25% Similarity=0.375 Sum_probs=208.3
Q ss_pred HhhccCCCeeeccCceEEEEEEeC--------CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecC
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP--------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNK 755 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 755 (995)
.++|.+.+.||+|+||.||+|+.. ....+|+|.+...........+.+|+++++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888999999999999999642 24568889876443334456688999999999 699999999999988
Q ss_pred CcceEEEEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL 821 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill 821 (995)
+..++||||+++|+|.+++.... ...+++..+.+++.|++.|+.|||+++ |+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999996432 245888999999999999999999877 9999999999999
Q ss_pred CCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHH
Q 001922 822 NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIV 900 (995)
Q Consensus 822 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 900 (995)
++++.+||+|||.++.+.............++..|+|||++.+..++.++||||||+++|||++ |..||..... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----~ 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----E 243 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH----H
Confidence 9999999999999986543222221222234568999999988889999999999999999999 8999854321 1
Q ss_pred HHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcc
Q 001922 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSD 967 (995)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 967 (995)
......... .....+..++..+.+++.+||+.+|++||+++|+++.|+++....++
T Consensus 244 ~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 244 ELFKLLREG-----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred HHHHHHHcC-----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 111111111 11112334556788999999999999999999999999988764433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.55 Aligned_cols=246 Identities=25% Similarity=0.295 Sum_probs=196.0
Q ss_pred eeccCceEEEEEEe-CCCcEEEEEEecCCCCC--ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCCh
Q 001922 694 IGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSL 770 (995)
Q Consensus 694 lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 770 (995)
||+|+||+||++.. .+++.||+|++...... ...+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999976 46889999998432211 1234577899999999999999999999999999999999999999
Q ss_pred hhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcccc
Q 001922 771 GEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS 848 (995)
Q Consensus 771 ~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~ 848 (995)
.+++.. .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988743 23456899999999999999999999777 99999999999999999999999999986543322 223
Q ss_pred ccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHH
Q 001922 849 AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKE 928 (995)
Q Consensus 849 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 928 (995)
...||+.|+|||++.+..++.++||||+||++|||++|+.||................. ... ...+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-----------~~~-~~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-----------NDS-VTYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc-----------ccC-CCCccc
Confidence 45789999999999999999999999999999999999999975433222211111111 111 122344
Q ss_pred HHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 001922 929 EAMHLLFVAMLCIQENSIERP-----RMREVVQ 956 (995)
Q Consensus 929 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 956 (995)
.+..+.+++.+|++.||++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 567789999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=331.15 Aligned_cols=242 Identities=25% Similarity=0.313 Sum_probs=191.3
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||+||+|+.. +++.||+|.+.... .....+.+..|..++... +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 57889999985422 122334455666676654 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 999999863 346889999999999999999999877 9999999999999999999999999997643222 223
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+....+... ....+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~------------~~~~~~ 217 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----DELFDSILND------------RPHFPR 217 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcC------------CCCCCC
Confidence 456799999999999998999999999999999999999999965322 1222222111 112233
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHH-HHHH
Q 001922 928 EEAMHLLFVAMLCIQENSIERPRMR-EVVQ 956 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 956 (995)
..+..+.+++.+||+.||++||++. ++.+
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 4556788999999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.15 Aligned_cols=262 Identities=27% Similarity=0.405 Sum_probs=206.5
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCc----EEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGV----EIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
++|+..++||+|+||+||+|++ .+++ .||+|.+...........+.+|+.+++.+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4577789999999999999975 3444 4799988554444445678899999999999999999999875 45789
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
+|||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 86 ~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999999643 356889999999999999999999777 99999999999999999999999999987643
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
...........+++.|+|||...+..++.++|||||||++|||++ |..||..... .....+. ....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~---~~~~--------- 228 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-REIPDLL---EKGE--------- 228 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH---HCCC---------
Confidence 222212222345678999999988899999999999999999998 8999864321 1111111 1110
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcc
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSD 967 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 967 (995)
....+...+..+.+++.+||+.||++||++.|+++.++.+.+....
T Consensus 229 --~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~ 274 (279)
T cd05109 229 --RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSR 274 (279)
T ss_pred --cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcC
Confidence 0111233556788999999999999999999999999988776643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.55 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=200.3
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCChh
Q 001922 692 NVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLG 771 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~ 771 (995)
++||+|+||.||+|...++..||+|++...........+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999888889999999855443333456889999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccc
Q 001922 772 EALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIA 851 (995)
Q Consensus 772 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 851 (995)
+++... ...+++..+..++.|++.|+.|+|+.+ ++||||||+||+++.++.+|++|||++......... ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~ 155 (250)
T cd05085 81 SFLRKK-KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQ 155 (250)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCC
Confidence 998643 345789999999999999999999777 999999999999999999999999998764332211 112234
Q ss_pred cCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHH
Q 001922 852 GSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEA 930 (995)
Q Consensus 852 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 930 (995)
++..|+|||+..+..++.++||||||+++|++++ |..||...... .......... ....+...+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~~~~~~~-----------~~~~~~~~~ 220 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QAREQVEKGY-----------RMSCPQKCP 220 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHHHHcCC-----------CCCCCCCCC
Confidence 4678999999988889999999999999999998 99999653221 1111111110 011223356
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 931 MHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 931 ~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
..+.+++.+|++.+|++||++.|++++|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 78999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=326.98 Aligned_cols=258 Identities=23% Similarity=0.344 Sum_probs=203.9
Q ss_pred ccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
|+..+.||+|+||.||+|... ....+++|.+...........+.+|+.+++.++||||+++++.+...+..++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 567789999999999999652 23568888875444333456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 001922 762 YEYMRNGSLGEALHGK----------------------KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~----------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Ni 819 (995)
|||+.+|+|.+++... ....+++..++.++.|++.|+.|||+.+ |+||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheE
Confidence 9999999999987532 1235788899999999999999999777 99999999999
Q ss_pred EECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCch
Q 001922 820 LLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVD 898 (995)
Q Consensus 820 ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~ 898 (995)
++++++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||.... ...
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-PER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-HHH
Confidence 999999999999999986543322222233446778999999988889999999999999999998 999985432 111
Q ss_pred HHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 899 IVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
+.+ ...... ....+...+..+.+++.+||+.+|++||+++|+++.|+++..
T Consensus 238 ~~~---~~~~~~-----------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFN---LLKTGY-----------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHH---HHhCCC-----------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111 111110 011233455678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=331.47 Aligned_cols=260 Identities=26% Similarity=0.291 Sum_probs=203.2
Q ss_pred hhccCCCeeeccCceEEEEEE-eCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-C-----CCceeEeEEEecCCcc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-H-----RNIVRLLAFCSNKETN 758 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~~~~~~~~~~~~ 758 (995)
-+|++.++||+|+||.|.+|. .++++.||||+++.... -..+...|+.++..++ | -|+|+++++|...++.
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 378999999999999999995 46799999999965332 2455677999999996 4 4899999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC--CeEEeeecccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF--EAHVADFGLAK 836 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~--~vkl~DfGla~ 836 (995)
|||+|.+.. +|+++++......++...++.++.||+.||.+||+.+ |||+||||+|||+.+.+ .|||+|||.|+
T Consensus 264 ciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 264 CIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 999999955 9999999888888999999999999999999999887 99999999999997654 69999999999
Q ss_pred ccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
+.... ..+...+..|.|||++.+.+|+.+.||||||||+.||++|.+-|... ++.+....+..+.......+.+
T Consensus 340 ~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~-ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 340 FESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD-NEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred ccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC-CHHHHHHHHHHHhCCCCHHHHH
Confidence 75332 23567788999999999999999999999999999999996666443 3333222222111111000000
Q ss_pred h----------------------------------------cCCcCC--------CCCHHHHHHHHHHHhcccCCCCCCC
Q 001922 917 I----------------------------------------LDPRLS--------MVPKEEAMHLLFVAMLCIQENSIER 948 (995)
Q Consensus 917 ~----------------------------------------~d~~~~--------~~~~~~~~~l~~li~~cl~~dP~~R 948 (995)
. .+.+.+ .........+.+++++|+.+||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 0 000000 1112345668899999999999999
Q ss_pred CCHHHHHHH
Q 001922 949 PRMREVVQM 957 (995)
Q Consensus 949 Pt~~evl~~ 957 (995)
+|+.|++++
T Consensus 494 ~tp~qal~H 502 (586)
T KOG0667|consen 494 ITPAQALNH 502 (586)
T ss_pred CCHHHHhcC
Confidence 999999875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=334.83 Aligned_cols=264 Identities=22% Similarity=0.278 Sum_probs=196.2
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecC-----Ccce
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK-----ETNL 759 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~ 759 (995)
+|+..+.||+|+||.||+|+. .+++.||||++.... ......++.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 467788999999999999976 468999999985322 223345688999999999999999999987543 2479
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 689998853 346889999999999999999999877 9999999999999999999999999998643
Q ss_pred cCCC-CccccccccCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC-------
Q 001922 840 DGGA-SECMSAIAGSYGYIAPEYAYT--LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG------- 909 (995)
Q Consensus 840 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~------- 909 (995)
.... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ...........
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLLGTPSPETIS 233 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH
Confidence 2211 112234578999999999865 678999999999999999999999996532211 11111111100
Q ss_pred -----ChhhhhhhcCCcCCC----CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 910 -----RKEEFLSILDPRLSM----VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 910 -----~~~~~~~~~d~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
....+...+...... ..+..+..+.+++.+||+.||++||+++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000011111110000 001234567899999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=332.51 Aligned_cols=248 Identities=22% Similarity=0.292 Sum_probs=194.7
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||.||+|+.. +++.||+|++.... .......+..|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999764 57899999985432 222345577888888777 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++.. ...+++..+..++.|++.|+.|||+++ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (329)
T cd05618 81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTT 153 (329)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccc
Confidence 999998853 356899999999999999999999877 9999999999999999999999999987532211 122
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC----chHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG----VDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+..... .. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i----------~~-~~~ 222 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI----------LE-KQI 222 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH----------hc-CCC
Confidence 3457999999999999999999999999999999999999999642211 11111111111 11 111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCH------HHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRM------REVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 957 (995)
..|...+..+.+++.+||+.||++||++ ++++++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 2344456678899999999999999984 566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.38 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=207.5
Q ss_pred HhhccCCCeeeccCceEEEEEEeC--------CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecC
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP--------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNK 755 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 755 (995)
.++|...+.||+|+||.||+|+.. ++..+|+|.+...........+.+|+.+++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357889999999999999999652 23569999986543344456688899999999 799999999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL 821 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill 821 (995)
+..|+||||+.+|+|.+++.... ...+++..+.+++.|++.|++|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999997432 135788999999999999999999877 9999999999999
Q ss_pred CCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHH
Q 001922 822 NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIV 900 (995)
Q Consensus 822 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 900 (995)
+.++.+||+|||.++...............+++.|+|||+..+..++.++||||+||++|||++ |..||... ...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~----~~~ 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV----PVE 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC----CHH
Confidence 9999999999999876543222111122234578999999988889999999999999999998 88888532 122
Q ss_pred HHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
+........ .....+...+..+.+++.+||+.+|++||++.|+++.|+++...
T Consensus 250 ~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ELFKLLKEG-----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHcC-----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 222222111 01122334567888999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=333.08 Aligned_cols=262 Identities=26% Similarity=0.395 Sum_probs=203.7
Q ss_pred hhccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEec-CCc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSN-KET 757 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~ 757 (995)
++|+..+.||+|+||.||+|.+ .+++.||||++...........+.+|+.++.++ +||||+++++++.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5789999999999999999963 357889999986543333455688999999999 68999999998754 456
Q ss_pred ceEEEEeccCCChhhhhcCCC-----------------------------------------------------------
Q 001922 758 NLLVYEYMRNGSLGEALHGKK----------------------------------------------------------- 778 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 778 (995)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999986421
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcccccccc
Q 001922 779 ------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852 (995)
Q Consensus 779 ------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~g 852 (995)
...+++..+.+++.|++.|++|||+++ |+||||||+||++++++.+||+|||++..+.............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 123677888899999999999999777 99999999999999999999999999986533222222223345
Q ss_pred CcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHH
Q 001922 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAM 931 (995)
Q Consensus 853 t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 931 (995)
+..|+|||++.+..++.++||||||+++|+|++ |..||........... ...... ....+...+.
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~-----------~~~~~~~~~~ 309 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR---RLKEGT-----------RMRAPDYTTP 309 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH---HHhccC-----------CCCCCCCCCH
Confidence 678999999988899999999999999999997 9999865432222111 111110 0111222345
Q ss_pred HHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 932 HLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 932 ~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.+.+++.+||+.+|++||++.|+++.|+.+.+.
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 688999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=335.03 Aligned_cols=243 Identities=23% Similarity=0.259 Sum_probs=195.7
Q ss_pred CeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCC
Q 001922 692 NVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNG 768 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 768 (995)
+.||+|+||.||+|+. .+++.||+|.+.... .......+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999975 468899999985422 2223456778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 769 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
+|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (325)
T cd05594 81 ELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATM 153 (325)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccc
Confidence 99998853 3468899999999999999999996 56 9999999999999999999999999987532211 122
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... ....+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~----~~~~~~i~~~------------~~~~p~ 217 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILME------------EIRFPR 217 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----HHHHHHHhcC------------CCCCCC
Confidence 345799999999999999999999999999999999999999964221 1111111111 011233
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 928 EEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
..+..+.+++.+|++.||++|+ ++++++++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 3456788999999999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.39 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=205.2
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEecc
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
|+..+.||+|+||.||+++.. +++.||+|.+.........+.+.+|+.++++++||||+++++++.+++..|+||||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 667789999999999999764 6889999988544444455678889999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
+|+|.+++....+..+++..+..++.|++.|+.|||+.+ |+|+||||+||++++++.++++|||.+........ .
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~ 156 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--Y 156 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc--c
Confidence 999999987655667889999999999999999999877 99999999999999999999999999876533221 2
Q ss_pred ccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 926 (995)
.....+++.|+|||++.+..++.++||||+|+++|+|++|+.||... +........... .....+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~----~~~~~~~~~~~~-----------~~~~~~ 221 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN----SWKNLILKVCQG-----------SYKPLP 221 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC----CHHHHHHHHhcC-----------CCCCCC
Confidence 23456889999999999888999999999999999999999999642 111111222111 111223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 927 KEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 927 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+..+.+++.+||+.||++||++.|++..
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 3455678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.69 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=202.5
Q ss_pred hhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
.+|...+.||+|+||.||+|... ++..+|+|.+.. ........+.+|+++++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 45667789999999999999632 356788888743 23334567899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC
Q 001922 760 LVYEYMRNGSLGEALHGKKG-------------AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE 826 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~ 826 (995)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||+.+ |+||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999864321 35789999999999999999999777 999999999999999999
Q ss_pred eEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHH
Q 001922 827 AHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKR 905 (995)
Q Consensus 827 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 905 (995)
+||+|||+++.+.............+++.|+|||+..+..++.++|||||||++|||++ |+.||........ ...
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~ 236 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA----IEC 236 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH----HHH
Confidence 99999999976543222122223345678999999998899999999999999999998 9999864322111 111
Q ss_pred HhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 906 ATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 906 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
.... .....+..++..+.+++.+||+.||++||+++||++.|++
T Consensus 237 ~~~~-----------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 ITQG-----------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHcC-----------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111 1111223455678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=332.47 Aligned_cols=238 Identities=28% Similarity=0.303 Sum_probs=188.7
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHH-HHhccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQ-TLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||+||+|+.. +|+.||+|++.... .......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999764 68999999984321 1122234444544 56788999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (323)
T cd05575 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTT 153 (323)
T ss_pred CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCcc
Confidence 999999863 456889999999999999999999877 999999999999999999999999998753222 1222
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+... .. ..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~-----------~~-~~~~ 217 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----TAEMYDNILNK-----------PL-RLKP 217 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC----HHHHHHHHHcC-----------CC-CCCC
Confidence 34579999999999999999999999999999999999999996432 22222222211 11 1122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHH
Q 001922 928 EEAMHLLFVAMLCIQENSIERPRMR 952 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RPt~~ 952 (995)
..+..+.+++.+|++.||++||+++
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 3456788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.03 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=197.8
Q ss_pred eeeccCceEEEEEEeC---CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCC
Q 001922 693 VIGRGGAGIVYHGKMP---NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGS 769 (995)
Q Consensus 693 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs 769 (995)
.||+|+||.||+|.+. .+..||+|.+.........+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999653 355789998855433344567889999999999999999999886 457899999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc-ccc
Q 001922 770 LGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE-CMS 848 (995)
Q Consensus 770 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~-~~~ 848 (995)
|.+++.. ....+++..+.+++.|++.|++|||+++ ++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 9999863 2456899999999999999999999877 9999999999999999999999999998653322111 112
Q ss_pred ccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 849 AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 849 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
...++..|+|||+..+..++.++||||||+++||+++ |..||...... .+...+..+ .....+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~-----------~~~~~~~ 221 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----EVMSFIEQG-----------KRLDCPA 221 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHHHCC-----------CCCCCCC
Confidence 2234578999999988889999999999999999996 99999654321 111111111 1112334
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 928 EEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.++..+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 4567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=316.25 Aligned_cols=259 Identities=22% Similarity=0.341 Sum_probs=210.2
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.|+..+.||+|+||.||+|... +|+.||+|.+... ......+.+.+|++++++++|++++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46788899999999999999775 7899999987532 22233567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 763 EYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 763 e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||+++|+|.+++.. .....+++..+..++.|++.|++|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999863 23456889999999999999999999877 99999999999999999999999999876533
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
... ......+++.|+|||.+.+..++.++||||+||++|+|++|+.||.... ....+........
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~----------- 223 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCKKIEKC----------- 223 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC--ccHHHHHhhhhcC-----------
Confidence 211 1233468889999999988889999999999999999999999985422 2222222222111
Q ss_pred cCCCCC-HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 921 RLSMVP-KEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 921 ~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
.....+ ...+..+.+++.+||+.+|++||++.+|+++++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111122 256678899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.98 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=204.8
Q ss_pred hhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
++|+..+.||+|+||.||+|+.+ ++..||+|.+...........+.+|+.++++++||||+++++++.+++..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 46788899999999999999753 467899998854433334566889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 001922 760 LVYEYMRNGSLGEALHGKK--------------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Ni 819 (995)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhhe
Confidence 9999999999999996321 134678888999999999999999777 99999999999
Q ss_pred EECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCch
Q 001922 820 LLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVD 898 (995)
Q Consensus 820 ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~ 898 (995)
++++++.++|+|||++..+..............+..|+|||...+..++.++|||||||++|||++ |..||....
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~---- 237 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA---- 237 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----
Confidence 999999999999999876533222222223345678999999988899999999999999999998 888885432
Q ss_pred HHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 899 IVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
..+....+... .....+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 238 ~~~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HEEVIYYVRDG-----------NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHHhcC-----------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 12222222211 1111233456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=331.46 Aligned_cols=237 Identities=24% Similarity=0.283 Sum_probs=191.0
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||+||+|+.+ +++.||+|++.... .....+.+..|..+++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 57899999985321 223345677788888776 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (320)
T cd05590 81 GDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTT 153 (320)
T ss_pred chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccc
Confidence 999998853 346889999999999999999999877 9999999999999999999999999987542211 122
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.... ...+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~----~~~~~~~i~~~~------------~~~~~ 217 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN----EDDLFEAILNDE------------VVYPT 217 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----HHHHHHHHhcCC------------CCCCC
Confidence 34579999999999999899999999999999999999999996432 122222222110 11222
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCH
Q 001922 928 EEAMHLLFVAMLCIQENSIERPRM 951 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RPt~ 951 (995)
..+..+.+++.+|++.||++||++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCC
Confidence 345678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=328.03 Aligned_cols=262 Identities=26% Similarity=0.344 Sum_probs=209.0
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
+|....|...+.||.|+||.||-|+. .+.+.||||++.-.. ....+.++..|+..+++++|||+|.+.|+|-...+.
T Consensus 22 ~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 22 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA 101 (948)
T ss_pred CCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence 33445566677899999999999975 567889999984322 233467799999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
|+|||||- |+-.|++.-. ..++.+..+..|..+.+.||+|||+++ -||||||+.|||+++.|.||++|||.|..+
T Consensus 102 WLVMEYCl-GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 102 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHh-ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc
Confidence 99999995 4888888632 356778888899999999999999776 999999999999999999999999999876
Q ss_pred ccCCCCccccccccCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 839 IDGGASECMSAIAGSYGYIAPEYAY---TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
.+. .+.+|||.|||||++. .+.|+-++||||+|+++.|+...++|+..+..-..+..++ ...
T Consensus 177 ~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA----QNe----- 241 (948)
T KOG0577|consen 177 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNE----- 241 (948)
T ss_pred Cch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH----hcC-----
Confidence 433 4568999999999864 5789999999999999999999999987654322222221 111
Q ss_pred hhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCccc
Q 001922 916 SILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDF 968 (995)
Q Consensus 916 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 968 (995)
.|-+ ...+.+..+.+++..|+++-|.+|||.++++.+---.+...+.+
T Consensus 242 ---sPtL--qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tv 289 (948)
T KOG0577|consen 242 ---SPTL--QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTV 289 (948)
T ss_pred ---CCCC--CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchH
Confidence 1111 23466788999999999999999999999987654444444433
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=319.46 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=198.1
Q ss_pred cCCCeeeccCceEEEEEEeCCC-c--EEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEec------CCcc
Q 001922 689 KDGNVIGRGGAGIVYHGKMPNG-V--EIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN------KETN 758 (995)
Q Consensus 689 ~~~~~lG~G~~g~V~~~~~~~~-~--~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~ 758 (995)
..++.||+|+||.||+|+..+. + .||+|.+.... .....+.+.+|+++++.++||||+++++++.. ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4578899999999999987543 2 58999875432 23335668889999999999999999997632 2256
Q ss_pred eEEEEeccCCChhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 759 LLVYEYMRNGSLGEALHG----KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
++||||+++|+|.+++.. .....+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999988742 12345889999999999999999999777 99999999999999999999999999
Q ss_pred ccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
++.+.............+++.|+|||+..+..++.++||||||+++|||++ |+.||..... ......+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~~--- 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----SEIYDYLRQGN--- 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHcCC---
Confidence 987644332222233456778999999998899999999999999999999 8899864322 12222222111
Q ss_pred hhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 914 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
....+...+..+.+++.+||+.+|++||+++|+++.|+++
T Consensus 232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 --------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=331.82 Aligned_cols=248 Identities=21% Similarity=0.271 Sum_probs=195.7
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
++||+|+||.||+|+.. +++.||+|++.... .......+..|..+++++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999764 68899999985432 222345578899999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (329)
T cd05588 81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT 153 (329)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence 999998853 356899999999999999999999877 999999999999999999999999998753211 1122
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc----hHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV----DIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+..... ... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----------~~~-~~ 222 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI----------LEK-QI 222 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH----------HcC-CC
Confidence 34679999999999999999999999999999999999999996432111 1111111111 111 11
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCC------HHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPR------MREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 957 (995)
..|...+..+.+++.+|++.||++||+ +++++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 123345567889999999999999997 5677643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.35 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=203.4
Q ss_pred hhccCCCeeeccCceEEEEEEeCC-C--cEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN-G--VEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 761 (995)
++|+..+.||+|+||.||+|..++ + ..+++|.++........+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999997643 3 346888775433333456788999999999 799999999999999999999
Q ss_pred EEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCe
Q 001922 762 YEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEA 827 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~v 827 (995)
|||+++++|.+++.... ...+++..++.++.|++.|++|||+.+ |+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996421 135788999999999999999999877 9999999999999999999
Q ss_pred EEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHH
Q 001922 828 HVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRA 906 (995)
Q Consensus 828 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~ 906 (995)
||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||..... .+.....
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~----~~~~~~~ 231 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC----AELYEKL 231 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH
Confidence 99999998643111 11111233567999999988889999999999999999997 9999964321 1111111
Q ss_pred hcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 907 TNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 907 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
... .....+...+..+.+++.+||+.+|.+||+++++++.|+++.+..
T Consensus 232 ~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 PQG-----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred hcC-----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 001123345567899999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=326.91 Aligned_cols=264 Identities=20% Similarity=0.261 Sum_probs=201.9
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.|+..+.||+|+||+||+|+.+ +++.||+|++...........+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46788899999999999999764 57889999986444444445678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++ +|.+++... +..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 86 LDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 975 888887643 445788999999999999999999777 9999999999999999999999999987543221
Q ss_pred ccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC----
Q 001922 845 ECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD---- 919 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---- 919 (995)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.............+.........+..+.+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 12233467899999998765 4688999999999999999999999976443332222222221111111111100
Q ss_pred -----CcCC-----CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 920 -----PRLS-----MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 920 -----~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
+... ......+..+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 1000 011124556789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.84 Aligned_cols=246 Identities=24% Similarity=0.295 Sum_probs=194.7
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHH---hccCCCCceeEeEEEecCCcceEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTL---GNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
|++.+.||+|+||.||+|+. .+++.||||++.... .....+.+.+|.+++ +.++||||+++++++.+++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45678899999999999976 468999999985322 122334566666654 566899999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|..++.. ..+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988853 45899999999999999999999877 999999999999999999999999998753221
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
........|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+... .
T Consensus 155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~----~~~~~~i~~~-----------~ 217 (324)
T cd05589 155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----EEVFDSIVND-----------E 217 (324)
T ss_pred --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC-----------C
Confidence 1223456799999999999999999999999999999999999999964321 1111111111 0
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
...+...+..+.+++.+|++.||++|| +++++++.
T Consensus 218 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 -VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 112334566788999999999999999 56776653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.49 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=192.4
Q ss_pred CeeeccCceEEEEEEeCC---CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCC
Q 001922 692 NVIGRGGAGIVYHGKMPN---GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNG 768 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 768 (995)
+.||+|+||.||+|...+ +..+|+|++...........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999997543 45789998854433334456888999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 769 SLGEALHGKK---GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 769 sL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
+|.+++.... ....++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||.++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999996422 234567788889999999999999777 9999999999999999999999999987543332222
Q ss_pred cccccccCcccccccccccC-------CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 846 CMSAIAGSYGYIAPEYAYTL-------RVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||.......... ...... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~~~~~----~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YTVREQ----QLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHhhcc----cCCC
Confidence 22334578899999987642 35789999999999999996 999996543322111 111111 0111
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
.++.. ....+..+.+++.+|| .+|++||+++||++.|+
T Consensus 231 ~~~~~---~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL---KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc---CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11211 1123456788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=333.54 Aligned_cols=239 Identities=24% Similarity=0.273 Sum_probs=193.1
Q ss_pred CeeeccCceEEEEEEe----CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEecc
Q 001922 692 NVIGRGGAGIVYHGKM----PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
+.||+|+||.||+++. .+|+.||+|++.... .......+..|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 357899999985322 12234457789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~ 154 (318)
T cd05582 82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK 154 (318)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence 9999999853 456899999999999999999999777 9999999999999999999999999988653321 12
Q ss_pred ccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 926 (995)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... . ...+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~~~~i~~~-----------~-~~~p 218 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----KETMTMILKA-----------K-LGMP 218 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----HHHHHHHHcC-----------C-CCCC
Confidence 2345789999999999988899999999999999999999999964321 1111111111 0 1123
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHH
Q 001922 927 KEEAMHLLFVAMLCIQENSIERPRMRE 953 (995)
Q Consensus 927 ~~~~~~l~~li~~cl~~dP~~RPt~~e 953 (995)
...+..+.+++.+||+.||++||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 345567889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.79 Aligned_cols=241 Identities=24% Similarity=0.287 Sum_probs=191.8
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||.||+|+.+ +|+.||+|.+.... .......+..|..++... +||+|+++++++.+.++.|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999765 58899999985422 122344566777777654 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (316)
T cd05620 81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRA 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCce
Confidence 999999853 356889999999999999999999877 999999999999999999999999998753221 1223
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... ....+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~----~~~~~~~~~~------------~~~~~~ 217 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE----DELFESIRVD------------TPHYPR 217 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC------------CCCCCC
Confidence 456799999999999999999999999999999999999999964321 1222221111 111223
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHH-HHH
Q 001922 928 EEAMHLLFVAMLCIQENSIERPRMR-EVV 955 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RPt~~-evl 955 (995)
..+..+.+++.+|++.||++||++. ++.
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 3456788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.32 Aligned_cols=257 Identities=29% Similarity=0.468 Sum_probs=204.4
Q ss_pred hhccCCCeeeccCceEEEEEEeC----CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
++|+..+.||+|+||.||+|... .+..+|+|.+...........+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999753 23478999885443333456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++++|.+++... ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++++|||++..+...
T Consensus 84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999743 356789999999999999999999777 999999999999999999999999999876433
Q ss_pred CCCcc-ccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 842 GASEC-MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 842 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
..... .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... .+.. ..+....
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-~~~~---~~~~~~~--------- 226 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVI---KAIEEGY--------- 226 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-HHHH---HHHhCCC---------
Confidence 21111 112233568999999998889999999999999999887 9999965322 1111 1111110
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
. ...+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 227 -~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 -R-LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -c-CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 011223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=316.17 Aligned_cols=250 Identities=30% Similarity=0.433 Sum_probs=205.6
Q ss_pred CeeeccCceEEEEEEeCC----CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMPN----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||.||+|.... +..|++|.+.........+.+.+|+++++.++|+|++++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999997643 7889999986544433467789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 768 GSLGEALHGKK-------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 768 gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
++|.+++.... ...+++..+++++.|++.|++|||+++ |+||||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997532 467899999999999999999999777 99999999999999999999999999987654
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
...........++..|+|||.+....++.++||||+|+++|||++ |..||..... .+.......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~----------- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EEVLEYLRK----------- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHc-----------
Confidence 332233344567889999999988889999999999999999999 6999976421 112221111
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
......+...+..+.+++.+||+.+|++||+++|+++.|+
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111234445678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.00 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=203.8
Q ss_pred hhccCCCeeeccCceEEEEEEeCC-C---cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN-G---VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
..|+..+.||+|+||.||+|.... + ..||+|.+...........+..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457788999999999999997643 3 369999985543344456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++++|.+++... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||++..+...
T Consensus 84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999743 456889999999999999999999877 999999999999999999999999998765432
Q ss_pred CCCccccccc---cCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 842 GASECMSAIA---GSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 842 ~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
.......... .+..|+|||++.+..++.++||||+||++||+++ |..||..... .+...+ +....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-~~~~~~---i~~~~------- 228 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINA---IEQDY------- 228 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-HHHHHH---HHcCC-------
Confidence 2211111111 2457999999998899999999999999999887 9999965322 111111 11110
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
. ...+.+++..+.+++.+||+.+|++||+++++++.|+++
T Consensus 229 ---~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ---R-LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---c-CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 011234556788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=315.86 Aligned_cols=250 Identities=29% Similarity=0.426 Sum_probs=205.7
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
+.|+..+.||.|+||.||+|.. .|+.||+|++..... ...++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 4677889999999999999987 478999999854332 4567889999999999999999999999889999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++.......+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999997655557899999999999999999999777 9999999999999999999999999998753221
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
.....+..|+|||++....++.++||||+|+++||+++ |+.||..... ........... ...
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~~~-----------~~~ 219 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPHVEKGY-----------RME 219 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHhcCC-----------CCC
Confidence 12345678999999988889999999999999999997 9999864321 11111111110 011
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.+...+..+.+++.+|++.+|++||+++|++++|+.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 2233467789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=314.17 Aligned_cols=249 Identities=29% Similarity=0.416 Sum_probs=202.5
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEE-ecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC-SNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv~e~ 764 (995)
..|+..+.||+|+||.||+|.. .|..||+|.+.. ....+.+.+|+.++++++|++++++++++ ..++..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCC---CchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 4677889999999999999976 478899998743 22355688999999999999999999975 455678999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++.......+++..+.+++.|++.|++|||+++ |+||||||+||++++++.+|++|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999997655556889999999999999999999777 9999999999999999999999999987643221
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
....++..|+|||+..+..++.++||||+||++|||++ |+.||... ...+....+..... .
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~----~~~~~~~~~~~~~~-----------~ 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVEKGYK-----------M 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhcCCC-----------C
Confidence 22345678999999998889999999999999999998 99998542 22222222221110 1
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
..+..++..+.+++.+|++.+|++||+++++++.|+++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 12234566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=337.87 Aligned_cols=254 Identities=20% Similarity=0.218 Sum_probs=195.1
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.|+..+.||+|+||+||+|+. .+++.||+|++.... .......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 467788999999999999965 568899999985422 22234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999999963 346888999999999999999999877 99999999999999999999999999764311000
Q ss_pred ---------------------------------------------CccccccccCcccccccccccCCCCcccchhhHHH
Q 001922 844 ---------------------------------------------SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGV 878 (995)
Q Consensus 844 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 878 (995)
.......+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012347999999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhc--ccCCCCCCCCCHHHHHH
Q 001922 879 VLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML--CIQENSIERPRMREVVQ 956 (995)
Q Consensus 879 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~evl~ 956 (995)
++|||++|+.||.......... .+..... ....+ .....+..+.+++.+ |+..+|..||+++|+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~----~i~~~~~-------~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL----KVINWEN-------TLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH----HHHcccc-------ccCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999996533211111 1111000 00000 011234567778877 55666667999999987
Q ss_pred H
Q 001922 957 M 957 (995)
Q Consensus 957 ~ 957 (995)
+
T Consensus 305 h 305 (381)
T cd05626 305 H 305 (381)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=318.25 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=204.2
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CC---cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NG---VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
+.|+..+.||+|+||.||+|+.+ ++ ..+|+|++.........+.+..|++++++++|||++++.+++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 45677889999999999999764 23 368999885443334456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++++|.+++... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+|++|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999999643 356889999999999999999999877 999999999999999999999999999865432
Q ss_pred CCCcc-ccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 842 GASEC-MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 842 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
..... ......+..|+|||++.+..++.++||||+||++||+++ |+.||..... ......+...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~~~~~i~~~---------- 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVMKAINDG---------- 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHHhcC----------
Confidence 21111 111223457999999988889999999999999999998 9999964322 1222222211
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.....+...+..+.+++.+||+.+|++||++++|++.|+++
T Consensus 227 -~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.50 Aligned_cols=243 Identities=22% Similarity=0.282 Sum_probs=194.5
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||.||+|+.. +++.||+|++.... .....+.+..|.++++.+ +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999764 57899999985422 223345577888888866 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05591 81 GDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT 153 (321)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence 999998853 346888999999999999999999877 9999999999999999999999999987543221 122
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.... ...+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~----~~~~~~i~~~~------------~~~p~ 217 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE----DDLFESILHDD------------VLYPV 217 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH----HHHHHHHHcCC------------CCCCC
Confidence 345789999999999998999999999999999999999999964321 11222222110 01222
Q ss_pred HHHHHHHHHHhcccCCCCCCCC-------CHHHHHHH
Q 001922 928 EEAMHLLFVAMLCIQENSIERP-------RMREVVQM 957 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~ 957 (995)
..+..+.+++.+|++.||++|| ++++++++
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 3456788999999999999999 77888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.62 Aligned_cols=265 Identities=24% Similarity=0.388 Sum_probs=205.7
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCc--EEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGV--EIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 760 (995)
.+.|+..+.||+|+||.||+|.+. ++. .+|+|++...........+.+|++++.++ +||||+++++++.+++..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 346778889999999999999764 444 45777765433334456788999999999 89999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC
Q 001922 761 VYEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE 826 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~ 826 (995)
||||+++++|.+++.... ...+++..++.++.|++.|++|||+.+ |+||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999986422 235789999999999999999999777 999999999999999999
Q ss_pred eEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHH
Q 001922 827 AHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKR 905 (995)
Q Consensus 827 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 905 (995)
+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||..... .+....
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~ 235 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEK 235 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh----HHHHHH
Confidence 999999998642111 11112234668999999988889999999999999999998 9999964322 111111
Q ss_pred HhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCccccc
Q 001922 906 ATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQ 970 (995)
Q Consensus 906 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 970 (995)
..... ....+...+..+.+++.+||+.+|++||+++++++.++.+......+.-
T Consensus 236 ~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~ 289 (303)
T cd05088 236 LPQGY-----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 289 (303)
T ss_pred HhcCC-----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhh
Confidence 11110 0011223455788999999999999999999999999987665544443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=361.37 Aligned_cols=484 Identities=27% Similarity=0.355 Sum_probs=398.7
Q ss_pred eEeccCCcccCcc-ccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccc
Q 001922 96 NLSLAGNNFTGSI-EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYF 174 (995)
Q Consensus 96 ~L~L~~n~l~~~~-~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l 174 (995)
.+|++..+++-.+ .+..-..|+.|+++.|.+-..+-......-+|+.||+++|++.. .|..+..+.+|+.|+++.|.|
T Consensus 2 ~vd~s~~~l~~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~-fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 2 HVDASDEQLELIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISS-FPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred CcccccccCcccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeecccccccc-CCchhhhHHHHhhcccchhhH
Confidence 3566666666433 34444449999999998876554445556669999999999988 799999999999999999999
Q ss_pred cccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCcc
Q 001922 175 FGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHE 254 (995)
Q Consensus 175 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~ 254 (995)
. ..|.+.+.+.+|++|+|.+|++. ..|..+..+++|+.|++++|+... +|..+..++.+..++.++|.....
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~--~Pl~i~~lt~~~~~~~s~N~~~~~---- 152 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGP--IPLVIEVLTAEEELAASNNEKIQR---- 152 (1081)
T ss_pred h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCC--CchhHHhhhHHHHHhhhcchhhhh----
Confidence 7 88899999999999999999999 899999999999999999888754 889999999999999999933222
Q ss_pred ccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcc
Q 001922 255 IGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLE 334 (995)
Q Consensus 255 ~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 334 (995)
++... .+.+++..|.+.+.++..+..++. .|||.+|.+. -..+..+.+|+.++...|++... --.-++|+
T Consensus 153 lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~ 222 (1081)
T KOG0618|consen 153 LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL----EISGPSLT 222 (1081)
T ss_pred hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceE----EecCcchh
Confidence 22222 888999999999999888888777 7999999987 34577889999999999999832 22358899
Q ss_pred eEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCc
Q 001922 335 TLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNY 414 (995)
Q Consensus 335 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~ 414 (995)
.|+.++|.++...+. ..-.+|+++++++|+++ .+|.+++.+.+|+.+...+|++ ..+|..+...++|+.|.+..|.
T Consensus 223 ~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l-~~lp~ri~~~~~L~~l~~~~ne 298 (1081)
T KOG0618|consen 223 ALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRL-VALPLRISRITSLVSLSAAYNE 298 (1081)
T ss_pred eeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhH-HhhHHHHhhhhhHHHHHhhhhh
Confidence 999999999844332 23458999999999999 6779999999999999999999 7889999999999999999999
Q ss_pred cCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCC
Q 001922 415 LNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPI 494 (995)
Q Consensus 415 l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 494 (995)
+. -+|.....+..|+.|+|+.|+|... |+.. ......++..|+.|.|.+....-..=..++.|+.|++.+|+++...
T Consensus 299 l~-yip~~le~~~sL~tLdL~~N~L~~l-p~~~-l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c 375 (1081)
T KOG0618|consen 299 LE-YIPPFLEGLKSLRTLDLQSNNLPSL-PDNF-LAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSC 375 (1081)
T ss_pred hh-hCCCcccccceeeeeeehhcccccc-chHH-HhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccc
Confidence 98 5666777899999999999999744 3321 1122234788888999988433223334678999999999999887
Q ss_pred CCCccchhhhccccccccccCCCCCC-ccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccC
Q 001922 495 PPSIGELRQVLKLDLSRNSLSGEIPP-AIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSM 573 (995)
Q Consensus 495 p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 573 (995)
-+.+....+|+.|+|++|+|. .+|. .+.++..|+.|+||+|+|+ .+|.++.++..|++|...+|+|.. +| .+.++
T Consensus 376 ~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~-fP-e~~~l 451 (1081)
T KOG0618|consen 376 FPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLS-FP-ELAQL 451 (1081)
T ss_pred hhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceee-ch-hhhhc
Confidence 778999999999999999998 5664 6888999999999999999 899999999999999999999965 77 89999
Q ss_pred CcccEEeccCCCCCC-CCCCCCCCcccccccCCCCcc
Q 001922 574 KSLTIADFSFNDFSG-KLPESGQFTVFNASSFAGNPQ 609 (995)
Q Consensus 574 ~~L~~l~ls~N~l~g-~~p~~~~~~~~~~~~~~~n~~ 609 (995)
++|+.+|+|.|+|+- .+|....-..+.-.++.||+|
T Consensus 452 ~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 452 PQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred CcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 999999999999874 344322224566778899996
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=327.02 Aligned_cols=242 Identities=24% Similarity=0.323 Sum_probs=191.7
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||+||+|+.. +++.||+|++.... .......+..|..+++.. +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999764 57889999985431 122344566677787764 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05619 81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKT 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cce
Confidence 999999963 346888999999999999999999777 9999999999999999999999999987532211 122
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+....+... .+ ..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~~~~i~~~---------~~---~~~~ 217 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----EELFQSIRMD---------NP---CYPR 217 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC---------CC---CCCc
Confidence 345789999999999998999999999999999999999999965321 1111111111 11 1223
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHH-HHHH
Q 001922 928 EEAMHLLFVAMLCIQENSIERPRMR-EVVQ 956 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 956 (995)
..+..+.+++.+||+.||++||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 3456788999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=337.31 Aligned_cols=253 Identities=25% Similarity=0.247 Sum_probs=202.8
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
+|+..+.||+|+||+||+|+.. +++.||+|++.... .......+.+|++++..++||||+++++++.++++.|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5778899999999999999764 68999999985322 22345568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC-
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG- 842 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~- 842 (995)
|+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 82 YMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999999999643 57889999999999999999999877 9999999999999999999999999998654332
Q ss_pred --------------------------CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 001922 843 --------------------------ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG 896 (995)
Q Consensus 843 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~ 896 (995)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~- 235 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL- 235 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH-
Confidence 00122345699999999999999999999999999999999999999965331
Q ss_pred chHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCC-HHHHHHH
Q 001922 897 VDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPR-MREVVQM 957 (995)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 957 (995)
......+...... ...+.. ...+..+.+++.+|++ ||++||+ ++|+++.
T Consensus 236 ---~~~~~~i~~~~~~-------~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 ---QETYNKIINWKES-------LRFPPD-PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ---HHHHHHHhccCCc-------ccCCCC-CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1111111110000 001111 1145678899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=349.91 Aligned_cols=267 Identities=25% Similarity=0.314 Sum_probs=206.3
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC--ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
++|+..++||+|+||.||+|... +|+.||+|++...... ...+++.+|++++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999764 5899999998543222 23456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeec
Q 001922 763 EYMRNGSLGEALHGK---------KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFG 833 (995)
Q Consensus 763 e~~~~gsL~~~l~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfG 833 (995)
||++||+|.+++... .....++..+.+++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988631 1234566778899999999999999777 9999999999999999999999999
Q ss_pred cccccccCCC----------------CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 001922 834 LAKFLIDGGA----------------SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV 897 (995)
Q Consensus 834 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~ 897 (995)
+++....... ........||+.|+|||++.+..++.++||||+||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9986521100 00112346999999999999999999999999999999999999999652211
Q ss_pred hHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHHccCCCCCccc
Q 001922 898 DIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERP-RMREVVQMLSEFPRHSSDF 968 (995)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~~~~ 968 (995)
... ... ...++.......+.+..+.+++.+|++.||++|| +++++.+.|+.+.+..+.+
T Consensus 238 ki~---~~~---------~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w 297 (932)
T PRK13184 238 KIS---YRD---------VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEW 297 (932)
T ss_pred hhh---hhh---------hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCccc
Confidence 110 000 0001100001123456788999999999999996 5777888888876655443
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=316.48 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=197.0
Q ss_pred eeeccCceEEEEEEe---CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCC
Q 001922 693 VIGRGGAGIVYHGKM---PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNG 768 (995)
Q Consensus 693 ~lG~G~~g~V~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 768 (995)
.||+|+||.||+|.+ .++..+|+|++..... ....+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 3578899998753322 223456889999999999999999999885 45678999999999
Q ss_pred ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc-cc
Q 001922 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE-CM 847 (995)
Q Consensus 769 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~-~~ 847 (995)
+|.+++.. ...+++..+.+++.|++.|++|+|+.+ |+||||||+||+++.++.+||+|||+++.+....... ..
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 99999963 346889999999999999999999877 9999999999999999999999999998764332211 11
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCC
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 926 (995)
....++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+...+..+. ....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~i~~~~-----------~~~~~ 220 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVTQMIESGE-----------RMECP 220 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHCCC-----------CCCCC
Confidence 22334679999999988889999999999999999998 9999965322 12222222211 11123
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 927 KEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 927 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
...+..+.+++.+||+.||++||++++|++.|+.+
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 34567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=316.14 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=205.6
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
+.|+..+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 567888999999999999998877888999987532 2235678899999999999999999999887 7789999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++....+...++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||.+........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence 9999999997656667889999999999999999999877 99999999999999999999999999976543222 1
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......++..|+|||++....++.++|+|||||++|++++ |+.||...... .... ...... ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~---~~~~~~-----------~~~ 223 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIR---ALERGY-----------RMP 223 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HHHH---HHhCCC-----------CCC
Confidence 1223345678999999998889999999999999999999 99999653221 1111 111110 001
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.+...+..+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 1233456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.97 Aligned_cols=241 Identities=23% Similarity=0.261 Sum_probs=192.8
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCC-CCceeEeEEEecCCcceEEEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRH-RNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 763 (995)
|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+..|.+++..+.| ++|+++++++.+.+..|+|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 667789999999999999764 57889999985422 22334567889999999976 568889999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 82 YVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 9999999999853 346889999999999999999999877 9999999999999999999999999987532211
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... . .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~~~-----------~-~ 218 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQSIMEH-----------N-V 218 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHcC-----------C-C
Confidence 122345799999999999999999999999999999999999999964321 1111112111 0 1
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRM 951 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~ 951 (995)
..+...+..+.+++.+|++.||++|++.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1223345678899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=321.26 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=203.6
Q ss_pred hccCCCeeeccCceEEEEEEe-----CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecC--Ccce
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-----PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETNL 759 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 759 (995)
.|+..+.||+|+||.||.|+. .++..||+|.+...........+.+|++++++++|||++++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467788999999999999974 357889999986544444456789999999999999999999998765 5689
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+||||+++++|.+++... ...+++..+..++.|++.||+|+|+.+ |+||||||+||+++.++.++|+|||+++.+.
T Consensus 85 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence 999999999999998643 345799999999999999999999777 9999999999999999999999999998764
Q ss_pred cCCCC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC-----------CchHHHHHHHHh
Q 001922 840 DGGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGD-----------GVDIVQWSKRAT 907 (995)
Q Consensus 840 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~-----------~~~~~~~~~~~~ 907 (995)
..... .......++..|+|||+..+..++.++||||+|+++|||++++.|+..... ............
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 32221 112234567789999999888899999999999999999998776532110 000111111111
Q ss_pred cCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 908 NGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 908 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
+......+..++..+.+++.+|++.+|++||+++++++.++++
T Consensus 241 -----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 -----------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -----------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111112334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.90 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=205.8
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEec-CCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLL-GFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 763 (995)
..|++.++||+||.+.||++...+.+.||+|++. ...+......|.+|+..+.+++ |.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 3578889999999999999988787888888873 3445556778999999999994 9999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|=+ .+|..++..+.....+| .++.+..|++.|+.++|++| |||.||||.|+++- .|.+||+|||+|..+.....
T Consensus 441 ~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred ccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 875 49999998666555556 66779999999999999998 99999999999885 47899999999998877766
Q ss_pred CccccccccCcccccccccccC-----------CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 844 SECMSAIAGSYGYIAPEYAYTL-----------RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
.-.....+||+.||+||.+... ..+.++||||+|||+|+|+.|+.||.+..+ . ..
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~---------~a 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----Q---------IA 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----H---------HH
Confidence 6667789999999999987532 256789999999999999999999965321 1 13
Q ss_pred hhhhhcCCcC----CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 913 EFLSILDPRL----SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 913 ~~~~~~d~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+..+.||.. +..+... ++.++|+.|+..||.+||++.|+++.
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHhhcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 3455566633 3333322 28899999999999999999999875
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=328.02 Aligned_cols=243 Identities=24% Similarity=0.279 Sum_probs=195.4
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||+||+|+.. +++.||+|++.... .......+..|.++++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 57899999985421 223345577888888888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (318)
T cd05570 81 GDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTT 153 (318)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccc
Confidence 999998853 346899999999999999999999777 9999999999999999999999999987532211 112
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
....|++.|+|||++.+..++.++||||+||++|+|++|+.||.... .......+... ....+.
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~----~~~~~~~i~~~------------~~~~~~ 217 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----EDELFQSILED------------EVRYPR 217 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC----HHHHHHHHHcC------------CCCCCC
Confidence 34568999999999999999999999999999999999999996432 11222222111 011233
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCH-----HHHHHH
Q 001922 928 EEAMHLLFVAMLCIQENSIERPRM-----REVVQM 957 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 957 (995)
..+..+.+++.+||+.||++||++ .++++.
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 455678999999999999999999 888754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=334.23 Aligned_cols=253 Identities=22% Similarity=0.203 Sum_probs=199.5
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.|+..+.||+|+||+||+|+. .+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 577788999999999999976 4688999999854321 2234568889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 82 YQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 99999999999743 356899999999999999999999777 99999999999999999999999999987643322
Q ss_pred CccccccccCcccccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 844 SECMSAIAGSYGYIAPEYAY------TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
. ......||+.|+|||++. ...++.++||||+||++|||++|+.||....... ....+..... .
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----~~~~i~~~~~-----~ 227 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK----TYNNIMNFQR-----F 227 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH----HHHHHHcCCC-----c
Confidence 1 223457899999999986 4567899999999999999999999996532211 1111111100 0
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. ..+. ....+..+.+++..|++ +|++||++++++++
T Consensus 228 ~--~~~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 L--KFPE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred c--CCCC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 0010 11245668889999998 99999999999854
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=313.66 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=200.8
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCChh
Q 001922 692 NVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLG 771 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~ 771 (995)
++||+|+||.||+|...+++.||+|++...........+.+|++++++++||||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999876699999998854433334567899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccc
Q 001922 772 EALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIA 851 (995)
Q Consensus 772 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 851 (995)
+++... ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||.+................
T Consensus 81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 999643 346788999999999999999999777 9999999999999999999999999998654222221112233
Q ss_pred cCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHH
Q 001922 852 GSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEA 930 (995)
Q Consensus 852 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 930 (995)
++..|+|||.+.+..++.++||||+|+++|||++ |..||....... ......... ....+...+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~----~~~~~~~~~-----------~~~~~~~~~ 221 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ----TRERIESGY-----------RMPAPQLCP 221 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH----HHHHHhcCC-----------CCCCCccCC
Confidence 4667999999988889999999999999999999 888886543211 111111110 011233456
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 931 MHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 931 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
..+.+++.+|++.+|++||+++|+++.|++
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=330.27 Aligned_cols=243 Identities=26% Similarity=0.270 Sum_probs=189.2
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEecCCCC--CChhHHHHHHH-HHHhccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT--HSHDHGFRAEI-QTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||+||+|+.. +++.||+|++..... ......+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 577899999853211 11223344444 456788999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~ 153 (325)
T cd05602 81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTT 153 (325)
T ss_pred CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCc
Confidence 999999963 345778888889999999999999877 9999999999999999999999999987543221 122
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... .. ..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~-----------~~-~~~~ 217 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNILNK-----------PL-QLKP 217 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH----HHHHHHHHhC-----------Cc-CCCC
Confidence 456799999999999999999999999999999999999999964321 1111111111 01 1122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 928 EEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+..+.+++.+|++.||.+||++.+.+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 345678899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=317.73 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=190.3
Q ss_pred eeeccCceEEEEEEeCC---CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCC
Q 001922 693 VIGRGGAGIVYHGKMPN---GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGS 769 (995)
Q Consensus 693 ~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs 769 (995)
.||+|+||+||+|+..+ ...+|+|.+...........+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996533 346788876443333334567889999999999999999999999999999999999999
Q ss_pred hhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc
Q 001922 770 LGEALHGKK---GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 770 L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
|.+++.... ....++.....++.||+.|++|||+.+ |+||||||+||++++++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999996533 233567888899999999999999777 99999999999999999999999999875433222222
Q ss_pred ccccccCccccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 847 MSAIAGSYGYIAPEYAYT-------LRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.....+++.|+|||+... ..++.++||||+||++|||++ |..||....+...... ...... . ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---~~~~~~-~---~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ---VVREQD-I---KLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH---HhhccC-c---cCC
Confidence 233456778999998643 356789999999999999999 7888865432221111 111110 0 011
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
. +..+...+..+.+++..|| .||++||+++||++.|.
T Consensus 232 ~---~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 K---PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred C---CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1 1223345566778889998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=314.61 Aligned_cols=250 Identities=27% Similarity=0.404 Sum_probs=198.8
Q ss_pred CeeeccCceEEEEEEeCC----CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMPN----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||.||+|.+.. +..+|+|.+.........+.+.+|+++++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 468999999999996532 26899999865444334567889999999999999999999876 4568999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc-c
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE-C 846 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~-~ 846 (995)
|+|.+++... ..+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||+++.+....... .
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 9999999643 36889999999999999999999877 9999999999999999999999999998764332211 1
Q ss_pred ccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
.....++..|+|||...+..++.++||||||+++|||++ |+.||..... . +....+..... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~---~~~~~~~~~~~-----------~~~ 219 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-A---EVIAMLESGER-----------LPR 219 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-H---HHHHHHHcCCc-----------CCC
Confidence 112223568999999998899999999999999999998 9999965322 1 22222211110 112
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
+..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 3345567899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=315.20 Aligned_cols=250 Identities=26% Similarity=0.344 Sum_probs=205.5
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCC-CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGF-GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
|+..+.||+|+||.||+|... +++.|++|.+... ........+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 566788999999999999764 6889999988432 23344567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++....+..+++..+++++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||+++.+.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-- 156 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-- 156 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc--
Confidence 9999999998655667899999999999999999999777 99999999999999999999999999886643321
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
......+++.|+|||+..+..++.++||||||+++|+|++|+.||..... ......... ......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-----------~~~~~~ 221 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GALILKIIR-----------GVFPPV 221 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHc-----------CCCCCC
Confidence 22345688999999999998899999999999999999999999964321 111111111 112223
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+...+..+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 33556789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=320.06 Aligned_cols=263 Identities=23% Similarity=0.285 Sum_probs=196.6
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC-ChhHHHHHHHHHHhcc---CCCCceeEeEEEec-----CC
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNI---RHRNIVRLLAFCSN-----KE 756 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~-----~~ 756 (995)
+|+..+.||+|+||+||+|+.. +++.||+|.+...... .....+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 3677889999999999999764 6889999988543222 2233456677777665 69999999998854 34
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
..++||||+.+ +|.+++.......+++..+..++.|++.||.|+|+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999975 8999887655556899999999999999999999877 9999999999999999999999999998
Q ss_pred ccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
..... .......+|..|+|||++.+..++.++||||+||++|||++|+.||.......................+..
T Consensus 157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 65322 112345688999999999988999999999999999999999999965433322222222111111111100
Q ss_pred h-------cCCcC----CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 917 I-------LDPRL----SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 917 ~-------~d~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
. ..+.. ....+..+..+.+++.+|++.||++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000 0111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=325.48 Aligned_cols=245 Identities=29% Similarity=0.454 Sum_probs=202.3
Q ss_pred eeeccCceEEEEEEeCC-CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCChh
Q 001922 693 VIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLG 771 (995)
Q Consensus 693 ~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~ 771 (995)
++|+|+||+||.|++.+ ...+|||-+.. +.....+.+.+|+...++++|.|||+++|.+.++++.-|.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe-kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE-KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc-ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 79999999999998754 56688998733 33444556889999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC-CCCCeEEeeeccccccccCCCCccccc
Q 001922 772 EALHGKKGAF-LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN-SAFEAHVADFGLAKFLIDGGASECMSA 849 (995)
Q Consensus 772 ~~l~~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~-~~~~vkl~DfGla~~~~~~~~~~~~~~ 849 (995)
++++.+.+.. -.+.+.-.+.+||++||.|||+.. |||||||-+||++. -.|.+||+|||-++++. +......+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCccccc
Confidence 9998654432 256677788999999999999777 99999999999995 47889999999999874 34455677
Q ss_pred cccCcccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 850 IAGSYGYIAPEYAYTL--RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 850 ~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
..||.-|||||++..+ .|+.++|||||||++.||.||++||...+.+..- .|..-+-.-.+.+|.
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-------------MFkVGmyKvHP~iPe 802 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-------------MFKVGMYKVHPPIPE 802 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-------------hhhhcceecCCCCcH
Confidence 8899999999999866 4889999999999999999999999765443110 010001112245788
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 928 EEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
+.+.+...+|.+|+.+||.+||+++++++
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 99999999999999999999999999985
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=339.87 Aligned_cols=259 Identities=22% Similarity=0.315 Sum_probs=194.9
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecC--------C
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--------E 756 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------~ 756 (995)
..|+..+.||+|+||.||+|.. .+++.||||++... .....+|+.+++.++||||+++++++... .
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 4688899999999999999976 46889999988432 12345799999999999999999876332 2
Q ss_pred cceEEEEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-CeEEeeec
Q 001922 757 TNLLVYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-EAHVADFG 833 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-~vkl~DfG 833 (995)
..++||||+++ ++.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999975 77776642 34567899999999999999999999777 99999999999999765 69999999
Q ss_pred cccccccCCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
+++.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||........+............+
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 998764322 12345689999999988654 68999999999999999999999997654433333333222221111
Q ss_pred hhhhhcCCcC-----C---------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 913 EFLSILDPRL-----S---------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 913 ~~~~~~d~~~-----~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+. ...+.+ + ..+...+..+.+++.+||+.||.+|||+.|++++
T Consensus 294 ~~~-~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLK-EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHH-HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 111 111110 0 1122345678899999999999999999999854
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=333.48 Aligned_cols=257 Identities=20% Similarity=0.232 Sum_probs=195.7
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
..|+..+.||+|+||.||+|.. .+++.||+|+.. ...+.+|++++++++||||+++++++......++|||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 4588889999999999999976 468899999642 23467899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+. ++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...+.. .
T Consensus 165 ~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~ 237 (391)
T PHA03212 165 YK-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A 237 (391)
T ss_pred CC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence 95 689888853 346789999999999999999999777 9999999999999999999999999997543221 1
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC------C-chHHHHHHHHhcCC-------
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGD------G-VDIVQWSKRATNGR------- 910 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~------~-~~~~~~~~~~~~~~------- 910 (995)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... . ..+...........
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 122345799999999999999999999999999999999999988753211 0 11111111110000
Q ss_pred hhhhhhhc---------CCcCCC---CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 911 KEEFLSIL---------DPRLSM---VPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 911 ~~~~~~~~---------d~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
...+.... .+.... .....+..+.+++.+|++.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 000000 01134567889999999999999999999985
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=330.25 Aligned_cols=264 Identities=23% Similarity=0.266 Sum_probs=198.4
Q ss_pred HHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCC----
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE---- 756 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---- 756 (995)
.+.++|+..+.||+|+||.||+|+. .+|+.||+|++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3567899999999999999999976 468899999985432 2334556788999999999999999999986443
Q ss_pred --cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 757 --TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 757 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
..|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999975 67666642 3778888999999999999999877 99999999999999999999999999
Q ss_pred ccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh--
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE-- 912 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 912 (995)
++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......................
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 9764321 22234578999999999999999999999999999999999999997543211111111111000000
Q ss_pred -----hhhhhc--CCcC-----------------CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 913 -----EFLSIL--DPRL-----------------SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 913 -----~~~~~~--d~~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...... .+.. .......+..+.+++.+|++.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 0000 01111234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=319.38 Aligned_cols=252 Identities=25% Similarity=0.285 Sum_probs=200.4
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC--ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
|+..+.||+|+||.||+|.. .+++.||+|++...... .....+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 55667899999999999976 46889999988543222 1234567899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++.......+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999986555556899999999999999999999777 9999999999999999999999999987653222
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......|+..|+|||++.+..++.++||||+|+++|+|++|+.||.............. .... ....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~-~~~~-----------~~~~ 223 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-LVKE-----------VQEE 223 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh-hhhh-----------hhhh
Confidence 11334789999999999998999999999999999999999999975332221111111 1000 0011
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPR-----MREVVQM 957 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 957 (995)
.+...+..+.+++.+||+.||++||+ ++|++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 22334566889999999999999999 8888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=315.65 Aligned_cols=260 Identities=21% Similarity=0.339 Sum_probs=208.9
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
..|+..+.||+|+||.||+|.. .+++.+|||.+.... ......++.+|+.+++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3567788999999999999975 578999999874322 2223456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 763 EYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 763 e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||+++++|.+++.. .....+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 23456899999999999999999999877 99999999999999999999999999876533
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
... ......++..|+|||+..+..++.++||||+|+++|+|++|..||.... .+.....+.+.... .+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~--------~~ 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCKKIEQCD--------YP 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc--chHHHHhhhhhcCC--------CC
Confidence 221 1234568899999999988889999999999999999999999985422 12222222211110 01
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
...+...+..+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1112346678999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=317.58 Aligned_cols=259 Identities=27% Similarity=0.366 Sum_probs=205.0
Q ss_pred hhccCCCeeeccCceEEEEEEeCC----CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
++|...+.||+|+||.||+|.+.+ ...||+|...........+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778899999999999997643 246888987544334445678999999999999999999999875 567899
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++... ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999999999643 345899999999999999999999777 999999999999999999999999999865433
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.... .....++..|+|||.+....++.++||||||+++||+++ |..||......... ......
T Consensus 161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~----~~~~~~----------- 224 (270)
T cd05056 161 SYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI----GRIENG----------- 224 (270)
T ss_pred ccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHcC-----------
Confidence 2211 122334568999999988889999999999999999986 99999654322111 111111
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
.....+..++..+.+++.+|+..+|++||++.++++.|+++..+.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 225 ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 001123345678999999999999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=337.84 Aligned_cols=253 Identities=21% Similarity=0.228 Sum_probs=195.6
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.|+..+.||+|+||+||+|+. .+++.||+|++.... .......+.+|++++++++||||+++++++.++++.|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 577889999999999999965 468899999984321 12234567889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 82 FLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999963 356889999999999999999999777 99999999999999999999999999964321100
Q ss_pred Cc---------------------------------------------cccccccCcccccccccccCCCCcccchhhHHH
Q 001922 844 SE---------------------------------------------CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGV 878 (995)
Q Consensus 844 ~~---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 878 (995)
.. ......||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 00 001246999999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCC---CCHHHHH
Q 001922 879 VLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIER---PRMREVV 955 (995)
Q Consensus 879 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl 955 (995)
++|||++|+.||...... .....+...... ...+. ....+..+.+++.+|+. +|.+| +++.|++
T Consensus 237 il~elltG~~Pf~~~~~~----~~~~~i~~~~~~-------~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 237 IMFECLIGWPPFCSENSH----ETYRKIINWRET-------LYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhhhcCCCCCCCCCHH----HHHHHHHccCCc-------cCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 999999999999643221 111111111000 00000 11234568889999997 66665 5999988
Q ss_pred HH
Q 001922 956 QM 957 (995)
Q Consensus 956 ~~ 957 (995)
++
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 75
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=326.76 Aligned_cols=263 Identities=25% Similarity=0.372 Sum_probs=208.0
Q ss_pred hhccCCCeeeccCceEEEEEEeC--------CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCC
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP--------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKE 756 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 756 (995)
.+|++.+.||+|+||.||+|+.. .+..||+|.+.........+.+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999642 12368999875443344456788999999999 7999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC
Q 001922 757 TNLLVYEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN 822 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~ 822 (995)
..++||||+.+|+|.+++.... ...+++..+..++.|++.|++|||+.+ |+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986432 235788889999999999999999877 99999999999999
Q ss_pred CCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHH
Q 001922 823 SAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQ 901 (995)
Q Consensus 823 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 901 (995)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~ 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VEE 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----HHH
Confidence 999999999999986543322222222344568999999999899999999999999999998 888885432 222
Q ss_pred HHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 902 WSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 902 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
....+... .....+..++..+.+++.+||+.+|++||++.|+++.|+++.....
T Consensus 245 ~~~~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 245 LFKLLKEG-----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHHHcC-----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 22222211 1111233445678899999999999999999999999999885443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=319.04 Aligned_cols=267 Identities=27% Similarity=0.354 Sum_probs=201.5
Q ss_pred hhccCCCeeeccCceEEEEEEe-----CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec--CCcc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-----PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN--KETN 758 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 758 (995)
++|+..+.||+|+||+||+|.. .+++.||+|++... .......+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 3577888999999999999974 35789999998532 23335578899999999999999999998643 3467
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 8999999999999999643 346889999999999999999999877 999999999999999999999999999876
Q ss_pred ccCCCCc-cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh-----h
Q 001922 839 IDGGASE-CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK-----E 912 (995)
Q Consensus 839 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-----~ 912 (995)
....... ......++..|+|||+..+..++.++||||+||++|||++|..|+...... +......... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-----FMRMMGNDKQGQMIVY 233 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-----hhhhcccccccccchH
Confidence 4322211 111223445699999998888999999999999999999988776432110 1110000000 0
Q ss_pred hhhhhcCCc-CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 913 EFLSILDPR-LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 913 ~~~~~~d~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
.+.+.+... ....+...+..+.+++.+||+.+|++|||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 001111111 11122345567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=335.18 Aligned_cols=253 Identities=22% Similarity=0.230 Sum_probs=198.3
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.|+..+.||+|+||+||+|+.. +++.||||++.... .......+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 5778899999999999999764 68899999985321 12234557889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 82 ~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 82 YLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999963 346899999999999999999999877 99999999999999999999999999876432110
Q ss_pred Cc------------------------------------cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCC
Q 001922 844 SE------------------------------------CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGR 887 (995)
Q Consensus 844 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~ 887 (995)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011246999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCC---HHHHHHH
Q 001922 888 RPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPR---MREVVQM 957 (995)
Q Consensus 888 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 957 (995)
.||..... ......+...... ...+ .....+..+.+++.+|+. +|.+|++ ++|++++
T Consensus 237 ~Pf~~~~~----~~~~~~i~~~~~~-------~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNP----QETYRKIINWKET-------LQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCH----HHHHHHHHcCCCc-------cCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99965321 1111111111000 0000 011234567889999996 9999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=333.23 Aligned_cols=254 Identities=23% Similarity=0.236 Sum_probs=199.5
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.+.|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 356888899999999999999764 68899999984321 222344577899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999863 24788888899999999999999777 999999999999999999999999999865432
Q ss_pred CCCccccccccCcccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTL----RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
.. .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+......
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~----- 265 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMDHKNS----- 265 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH----HHHHHHHHcCCCc-----
Confidence 21 122345799999999988653 478999999999999999999999965322 1111122111000
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIE--RPRMREVVQM 957 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 957 (995)
...+. ....+..+.+++.+|++.+|++ ||+++|++++
T Consensus 266 --~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 --LTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --CCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00111 1124567889999999999998 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=318.37 Aligned_cols=251 Identities=23% Similarity=0.286 Sum_probs=200.2
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
|+..+.||+|+||+||+|.. .+++.||+|.+..... ......+.+|++++++++|++|+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 45567899999999999976 4688999998843221 12234467899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999999887555557999999999999999999999777 9999999999999999999999999987643221
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......|+..|+|||++.+..++.++|+||+|+++|||++|+.||...........+........ ..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~------------~~ 223 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE------------EV 223 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc------------cc
Confidence 12345789999999999988999999999999999999999999975433222222222221110 11
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPR-----MREVVQ 956 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 956 (995)
.+...+..+.+++.+|++.||++||+ ++++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 22334566889999999999999999 566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=317.90 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=199.7
Q ss_pred CeeeccCceEEEEEEeCC-------CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 692 NVIGRGGAGIVYHGKMPN-------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.||+|+||.||+|+..+ ++.+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997643 2578999875443334466788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-----CeEEeeecc
Q 001922 765 MRNGSLGEALHGK-----KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-----EAHVADFGL 834 (995)
Q Consensus 765 ~~~gsL~~~l~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-----~vkl~DfGl 834 (995)
+++++|.+++... ....+++..+..++.|++.|++|||+.+ ++||||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999642 2244788999999999999999999776 99999999999999887 899999999
Q ss_pred ccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
++.+.............++..|+|||++.+..++.++|||||||++|||++ |+.||....+ .+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~~---- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQHVTAG---- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----HHHHHHHhcC----
Confidence 986543332222233456789999999999999999999999999999998 9999864321 1111111111
Q ss_pred hhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 914 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
.....+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 230 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 -------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1112233456788999999999999999999999998864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=330.26 Aligned_cols=254 Identities=23% Similarity=0.249 Sum_probs=193.5
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.|+..+.||+|+||+||+|+.. +++.||+|++.... .......+.+|+.++.+++||+|+++++++.+....|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 5778899999999999999764 58899999985321 12234567889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 82 FLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999963 456899999999999999999999777 99999999999999999999999999876432110
Q ss_pred C---------------------------------ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 001922 844 S---------------------------------ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPV 890 (995)
Q Consensus 844 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf 890 (995)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012357999999999999999999999999999999999999999
Q ss_pred CCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccC--CCCCCCCCHHHHHHH
Q 001922 891 GDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQ--ENSIERPRMREVVQM 957 (995)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~evl~~ 957 (995)
..... ......+...... ..-+.. ...+..+.+++.+++. .++..||+++|++++
T Consensus 237 ~~~~~----~~~~~~i~~~~~~----~~~p~~----~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETP----QETYKKVMNWKET----LIFPPE----VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCH----HHHHHHHHcCcCc----ccCCCc----CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 64321 1111112111000 000100 0123456666666443 333456899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.29 Aligned_cols=263 Identities=25% Similarity=0.395 Sum_probs=207.7
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCc----EEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGV----EIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
.+|+..+.||+|+||+||+|..+ +|+ .+|+|.............+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46778899999999999999754 333 5888887544444445678899999999999999999999986 78899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++|+|.+++... ...+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||.++.+..
T Consensus 86 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 99999999999999743 345899999999999999999999777 99999999999999999999999999987643
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
...........++..|+|||......++.++|+||||+++||+++ |+.||.... ..++...+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~~~~~--------- 228 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP----AVEIPDLLEKGE--------- 228 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC----HHHHHHHHhCCC---------
Confidence 322222122234578999999988889999999999999999999 999996532 112222222110
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCccc
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDF 968 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 968 (995)
....+..++..+.+++.+||..+|++||++.++++.|+++.+....+
T Consensus 229 --~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 275 (279)
T cd05057 229 --RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRY 275 (279)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcce
Confidence 11122234567889999999999999999999999999987655443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.05 Aligned_cols=253 Identities=29% Similarity=0.387 Sum_probs=202.5
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC----ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH----SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
+.|+..+.||+|++|.||+|.. .++++||+|.+...... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 3578889999999999999975 46899999987533211 123467889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++++|.+++.. ...+++..+.+++.|++.|+.|||+.+ |+||||+|+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 9999999999999863 345788999999999999999999877 99999999999999999999999999876533
Q ss_pred CCCCc-cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASE-CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
..... ......++..|+|||++.+..++.++||||+|+++|||++|+.||......... .. ....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~-~~~~---------- 222 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FK-IATQ---------- 222 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HH-Hhcc----------
Confidence 21111 112345788999999999988999999999999999999999999653221111 11 1110
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
......+...+..+.+++.+||+.+|++||++.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01112344566778999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=316.03 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=195.9
Q ss_pred CeeeccCceEEEEEEeCC-Cc--EEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMPN-GV--EIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||.||+|+..+ +. .+++|.+...........+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999997643 43 46888775443344456788999999999 799999999999999999999999999
Q ss_pred CChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeec
Q 001922 768 GSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFG 833 (995)
Q Consensus 768 gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfG 833 (995)
|+|.+++.... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986422 235788999999999999999999777 9999999999999999999999999
Q ss_pred cccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||..... ...........
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~~~~~~~-- 228 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKLPQGY-- 228 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH----HHHHHHHhCCC--
Confidence 98632111 11112234567999999988889999999999999999997 9999954321 11111111110
Q ss_pred hhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 913 EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 913 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
....+...+..+.+++.+||+.+|.+||+++++++.|+++.
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 ---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 01122234567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=333.74 Aligned_cols=263 Identities=21% Similarity=0.245 Sum_probs=197.8
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCC-----cceE
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE-----TNLL 760 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~l 760 (995)
|+..+.||+|+||.||+|.. .+++.||+|++.... ......++.+|+.+++.++||||+++++++...+ ..|+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 67788999999999999976 478999999984322 2223456889999999999999999999998766 7899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 82 v~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 82 VTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred Eeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 999996 58888874 3456899999999999999999999777 99999999999999999999999999986533
Q ss_pred CCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh-----
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF----- 914 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----- 914 (995)
.. ........+++.|+|||++.+. .++.++||||+||++|||++|+.||.......................+
T Consensus 156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 22 1222345678999999998764 4789999999999999999999999754322211111111110000000
Q ss_pred --hhhcC--Cc-------CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 915 --LSILD--PR-------LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 915 --~~~~d--~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+. +. ........+..+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 00 001112235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=327.01 Aligned_cols=241 Identities=22% Similarity=0.248 Sum_probs=192.5
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 763 (995)
|+..+.||+|+||.||+|+.. +++.||+|.+.... .......+..|..++..+ +||+|+++++++.+.+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 667789999999999999764 57899999985432 122234566788888777 58999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 82 YVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 9999999999853 346889999999999999999999877 9999999999999999999999999987542211
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... . .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~-----------~-~ 218 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEH-----------N-V 218 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHHHHHHHhC-----------C-C
Confidence 122345789999999999999999999999999999999999999965322 1111111111 1 1
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRM 951 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~ 951 (995)
..+...+..+.+++.+|++.||++|+++
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1233456678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=331.06 Aligned_cols=254 Identities=23% Similarity=0.249 Sum_probs=197.6
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.+.|+..+.||+|+||.||+|+.. +++.||+|.+.+. ........+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 356888899999999999999875 5788999988432 1222345578899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+...
T Consensus 122 ~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 122 MEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 999999999999953 24788899999999999999999777 999999999999999999999999999876432
Q ss_pred CCCccccccccCcccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTL----RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
.. .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+.....
T Consensus 196 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~----~~~~~~i~~~~~------ 264 (370)
T cd05621 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL----VGTYSKIMDHKN------ 264 (370)
T ss_pred Cc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCc------
Confidence 21 122356799999999998654 378899999999999999999999964322 111111111100
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIE--RPRMREVVQM 957 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 957 (995)
....+ .....+..+.+++..|++.+|.+ ||+++|++++
T Consensus 265 -~~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 -SLNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -ccCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00000 11134566788999999866544 8999999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.27 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=200.2
Q ss_pred CeeeccCceEEEEEEeCC--C--cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMPN--G--VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|++|.||+|.+.+ + ..||+|.+.........+.+.+|+.++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997643 2 36899988554333445678999999999999999999999988 889999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC-cc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS-EC 846 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~-~~ 846 (995)
++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+...... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997544357899999999999999999999777 999999999999999999999999999876442211 11
Q ss_pred ccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
.....++..|+|||++.+..++.++||||+|+++|||++ |+.||...... +..+..... ......
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~----------~~~~~~ 222 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS----QILKKIDKE----------GERLER 222 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHhc----------CCcCCC
Confidence 223457789999999998899999999999999999999 99998543221 111111111 000112
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
+...+..+.+++.+|++.+|++||+++++++.|.+
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 23456679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=327.77 Aligned_cols=241 Identities=27% Similarity=0.294 Sum_probs=189.5
Q ss_pred CeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHH-HHhccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQ-TLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||+||+|+. .+|+.||+|++.... .......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999976 468999999984321 1222344555554 46778999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (325)
T cd05604 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTT 153 (325)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCc
Confidence 99999885 3456889999999999999999999877 999999999999999999999999998753221 1222
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+........ ... .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~----~~~~~~~~~~~-----------~~~-~~~ 217 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD----VAEMYDNILHK-----------PLV-LRP 217 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC----HHHHHHHHHcC-----------Ccc-CCC
Confidence 45679999999999999999999999999999999999999996432 11111111111 111 122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 001922 928 EEAMHLLFVAMLCIQENSIERPRMREVV 955 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RPt~~evl 955 (995)
..+..+.+++.+|++.+|++||++++.+
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 3456688899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=335.63 Aligned_cols=252 Identities=20% Similarity=0.208 Sum_probs=193.1
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.|+..+.||+|+||+||+|+. .+++.||+|++.... .......+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 467788999999999999976 468889999985321 12234568889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 9999999999964 346788999999999999999999877 99999999999999999999999999753210000
Q ss_pred ---------------------------------------------CccccccccCcccccccccccCCCCcccchhhHHH
Q 001922 844 ---------------------------------------------SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGV 878 (995)
Q Consensus 844 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv 878 (995)
.......+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC-CCHHHHHHHHHHHhcccCCCCCCCCC---HHHH
Q 001922 879 VLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM-VPKEEAMHLLFVAMLCIQENSIERPR---MREV 954 (995)
Q Consensus 879 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt---~~ev 954 (995)
++|||++|+.||....... ....+... ...... .....+....+++.+|+ .+|++|++ ++|+
T Consensus 237 il~elltG~~Pf~~~~~~~----~~~~i~~~---------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLE----TQMKVINW---------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHH----HHHHHHcc---------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 9999999999996532211 11111110 000000 01123445667777765 59999987 8887
Q ss_pred HHH
Q 001922 955 VQM 957 (995)
Q Consensus 955 l~~ 957 (995)
+++
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=325.72 Aligned_cols=242 Identities=22% Similarity=0.260 Sum_probs=191.5
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEecCCCC--CChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||+||+|+.. +++.||+|++..... ......+.+|..++.++ +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999764 578899999854321 22345578899999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++.. ...+++..+..++.|++.|++|||+++ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (327)
T cd05617 81 GDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT 153 (327)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence 999998853 346899999999999999999999877 999999999999999999999999998753221 1222
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc--hHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV--DIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
....||+.|+|||++.+..++.++||||+||++|||++|+.||....+.. ....+...... .. ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------~~-~~~~ 222 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL----------EK-PIRI 222 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH----------hC-CCCC
Confidence 34679999999999999999999999999999999999999996432211 11111111111 11 1112
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCH
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRM 951 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~ 951 (995)
+...+..+.+++.+|++.||++|+++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 33445678899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=315.56 Aligned_cols=255 Identities=24% Similarity=0.273 Sum_probs=200.4
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
...|+..+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC-ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 45688899999999999999976 56888999988432 22334567889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.++++. ...+++..+..++.|++.|+.|||+.+ |+|||++|+||+++.++.++|+|||++..+....
T Consensus 87 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 87 YCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 9999999999863 346789999999999999999999777 9999999999999999999999999998653221
Q ss_pred CccccccccCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAY---TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.......++..|+|||.+. ...++.++||||+||++|||++|+.||...........+. .. . ...+
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~----~~---~---~~~~ 229 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS----KS---N---FQPP 229 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee----cC---C---CCCC
Confidence 1123346889999999874 3457889999999999999999999986432211111000 00 0 0001
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQML 958 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 958 (995)
.. ......+..+.+++.+||+.+|++||+++++++.+
T Consensus 230 ~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11 11123456789999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=325.09 Aligned_cols=238 Identities=27% Similarity=0.306 Sum_probs=187.9
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHH-HHhccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQ-TLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
++||+|+||.||+|+.. +++.||+|++.... .......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 68899999984321 1122334455544 67888999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (321)
T cd05603 81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT 153 (321)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence 999988853 356788888999999999999999777 999999999999999999999999998753221 1222
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
....||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....+... . ...+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~i~~~-----------~-~~~~~ 217 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR----DVSQMYDNILHK-----------P-LQLPG 217 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC----CHHHHHHHHhcC-----------C-CCCCC
Confidence 3457899999999999889999999999999999999999999643 222222222111 1 11233
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHH
Q 001922 928 EEAMHLLFVAMLCIQENSIERPRMR 952 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RPt~~ 952 (995)
..+..+.+++.+|++.||.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 4456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=302.76 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=208.7
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.|.+..++|+|+||.||+|.+ ..|+.+|+|++. ...+.+++..|+.++++.+.|++|++||.|-....+++|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP---V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP---VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecC---ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 455667899999999999955 569999999983 3455788999999999999999999999998889999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
-.|+..|.++. ++.++++.....+++..+.||+|||... -||||||+.||++..+|.+|++|||.|-.+.+. -.
T Consensus 111 GAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MA 184 (502)
T KOG0574|consen 111 GAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MA 184 (502)
T ss_pred CCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HH
Confidence 99999999974 5678999999999999999999999876 899999999999999999999999999877543 23
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
...++.|||.|||||++..-.|+.++||||+|++..||..|++||.+...-..+ ..++... |.--..
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI----FMIPT~P---------PPTF~K 251 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI----FMIPTKP---------PPTFKK 251 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee----EeccCCC---------CCCCCC
Confidence 346788999999999999999999999999999999999999999763221000 0011111 111134
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
|...+.++.++++.|+-..|++|-|+-++.++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 66788899999999999999999999988775
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.04 Aligned_cols=253 Identities=29% Similarity=0.422 Sum_probs=194.3
Q ss_pred CeeeccCceEEEEEEeC----CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEe-cCCcceEEEEecc
Q 001922 692 NVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS-NKETNLLVYEYMR 766 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~~~ 766 (995)
+.||+|+||.||+|... ++..||+|++.........+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 245789998754333334567889999999999999999999765 4556899999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc-
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE- 845 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~- 845 (995)
+|+|.+++... ....++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||+++.+.+.....
T Consensus 81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 99999999643 334677778889999999999999777 9999999999999999999999999997653322111
Q ss_pred -cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 846 -CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTG-RRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 846 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......++..|+|||+..+..++.++||||||+++|||++| ..||... +.. ......... ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~---~~~~~~~~~-----------~~~ 221 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSF---DITVYLLQG-----------RRL 221 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHH---HHHHHHhcC-----------CCC
Confidence 11233457789999999888899999999999999999995 5555432 111 222222111 111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
..+...+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 1122345678899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=309.71 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=206.1
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+|+..+.||+|+||.||.++. .+++.+++|++.... .......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477788999999999999865 468899999874322 334456688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++.......+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999997655567899999999999999999999777 99999999999999999999999999986543321
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......+++.|+|||+..+..++.++||||+|+++|||++|..||... ...+....+... ....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~----~~~~~~~~~~~~-----------~~~~ 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT----NPLNLVVKIVQG-----------NYTP 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHcC-----------CCCC
Confidence 223456899999999998888899999999999999999999998542 122222222211 1112
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQML 958 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 958 (995)
.+...+..+.+++.+||+.+|++||+++|+++..
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 2334566788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.40 Aligned_cols=251 Identities=22% Similarity=0.414 Sum_probs=201.7
Q ss_pred hccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEecc
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
.|+..+.||+|+||.||+|.+.+++.+|+|.+... ......+.+|++++++++||+++++++++......++||||++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG--AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC--CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 56677899999999999998877889999987532 2234678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
+++|.+++... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.++........ .
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~ 157 (256)
T cd05112 83 HGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S 157 (256)
T ss_pred CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence 99999998643 345789999999999999999999877 999999999999999999999999998765332211 1
Q ss_pred ccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
.....++.+|+|||+..+..++.++||||+|+++|||++ |+.||..... ........... ....
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~-----------~~~~ 222 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----SEVVETINAGF-----------RLYK 222 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHHhCCC-----------CCCC
Confidence 122335678999999998889999999999999999998 9999864221 12222221110 0011
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
+...+..+.+++.+||+.+|++||+++|++++|.
T Consensus 223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2224567999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=336.17 Aligned_cols=253 Identities=20% Similarity=0.211 Sum_probs=195.3
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.|+..+.||+|+||.||+|+. .+++.||+|.+.... .......+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 577889999999999999976 458899999984321 12234567889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC-
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG- 842 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~- 842 (995)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999964 356888899999999999999999877 9999999999999999999999999975321000
Q ss_pred ----------------------------------------CCccccccccCcccccccccccCCCCcccchhhHHHHHHH
Q 001922 843 ----------------------------------------ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLE 882 (995)
Q Consensus 843 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~e 882 (995)
.........||+.|+|||++.+..++.++||||+||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0000113469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCC---CHHHHHHH
Q 001922 883 LLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERP---RMREVVQM 957 (995)
Q Consensus 883 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~~ 957 (995)
|++|+.||....... ....+...... ...+. ....+..+.+++.+|+ .+|++|+ ++.|++++
T Consensus 237 ll~G~~Pf~~~~~~~----~~~~i~~~~~~----~~~~~----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAE----TQLKVINWETT----LHIPS----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHH----HHHHHhccCcc----ccCCC----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999996533211 11111111000 00000 1123455677778776 5999999 89999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.35 Aligned_cols=263 Identities=21% Similarity=0.256 Sum_probs=200.1
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.|+..+.||+|+||.||+|+.. +++.||+|.+...........+.+|+.++++++||||+++++++.+++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999764 57899999985444444455678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 97 5999888643 446789999999999999999999777 9999999999999999999999999987543221
Q ss_pred ccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhc-CChhhhhhhcCC--
Q 001922 845 ECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN-GRKEEFLSILDP-- 920 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~d~-- 920 (995)
.......+++.|+|||++.+. .++.++||||+||++|||++|+.||...... ........... .....+....+.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhchhhhcccc
Confidence 112334578899999987654 5788999999999999999999999653321 11111111111 111111111110
Q ss_pred ----cCCC--------CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 921 ----RLSM--------VPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 921 ----~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..+. .....+..+.+++.+|++.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 11124556889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.98 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=201.2
Q ss_pred hccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCC-----ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTH-----SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
+|+.++.||+|+||+||+|...+++.+|+|.+...... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 36788999999999999998888999999987432211 1234578899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++++|.+++.+ ...+++..+..++.|++.|++|||+.+ |+|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 999999999999963 345789999999999999999999777 999999999999999999999999998764321
Q ss_pred C----CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 842 G----ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 842 ~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
. .........++..|+|||++.+..++.++||||+|+++|+|++|+.||............ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~~~-------- 223 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI----GAH-------- 223 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh----hhc--------
Confidence 1 111223456889999999999888999999999999999999999999653221111110 000
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.......+...+..+.+++.+||+.+|++||++.|+++
T Consensus 224 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 -RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111223345667899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=327.65 Aligned_cols=264 Identities=21% Similarity=0.214 Sum_probs=198.4
Q ss_pred HHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecC-----
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK----- 755 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 755 (995)
.+.++|+..+.||+|+||.||+|.. ..++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3567899999999999999999975 468899999985432 223345678899999999999999999988543
Q ss_pred -CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 756 -ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 756 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
...|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 346999999975 67776642 4788889999999999999999777 99999999999999999999999999
Q ss_pred ccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh---
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK--- 911 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--- 911 (995)
++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.....................
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9865322 2223457899999999999989999999999999999999999999653321111111111110000
Q ss_pred ----hhhhhhcCC---------------c----CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 ----EEFLSILDP---------------R----LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 ----~~~~~~~d~---------------~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.......+. . ....+...+..+.+++.+|++.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 0 001112234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=314.46 Aligned_cols=248 Identities=24% Similarity=0.325 Sum_probs=197.9
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
+|+..++||+|+||.||+|.. .+++.||+|.+...........+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 467778999999999999975 5688999998854333334456889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|..+. .+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 999997653 3678888999999999999999777 999999999999999999999999999865322
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchH---HHHHHHHhcCChhhhhhhcCCcC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDI---VQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
......++..|+|||++.+..++.++||||+|+++|+|++|+.||......... .......... ..+..
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 220 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--------DPPVL 220 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--------CCCCC
Confidence 123457899999999999889999999999999999999999999653322111 1111111110 00111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....+..+.+++.+|++.+|++||+++|+++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 112244568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.86 Aligned_cols=261 Identities=26% Similarity=0.320 Sum_probs=205.2
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.|+..+.||+|+||+||+|... +++.||+|++...........+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777889999999999999764 58889999875544444567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
+++++|.+++.. .+.+++..+..++.|++.|+.|||+ .+ ++||||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999999853 3468899999999999999999996 45 9999999999999999999999999987542221
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.....|+..|+|||++.+..++.++||||+||++|++++|+.||.......+.......+. ..+..+......
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 231 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL----DLLQQIVQEPPP 231 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH----HHHHHHhhccCC
Confidence 1245689999999999888899999999999999999999999976443211000000000 001111111111
Q ss_pred CCC-HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 924 MVP-KEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 924 ~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
..+ ...+..+.+++.+|++.||++||+++|++++..
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 111 235667899999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.24 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=204.2
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
.+...+|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|||++++++.+..+.+.++
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 34456788889999999999999975 468899999885432 2335668899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++++|.+++.. ..+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred eecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999999853 34788899999999999999999777 99999999999999999999999999876533
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
... ......+++.|+|||...+..++.++|||||||++|+|++|+.||........ +....... .+
T Consensus 169 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~---~~~~~~~~---------~~ 234 (296)
T cd06654 169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYLIATNG---------TP 234 (296)
T ss_pred ccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh---HHHHhcCC---------CC
Confidence 221 12334688999999999888899999999999999999999999965322111 11111100 00
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
....+...+..+.+++.+||..+|++||++.|+++.
T Consensus 235 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 235 -ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 011233456678899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=326.37 Aligned_cols=264 Identities=26% Similarity=0.426 Sum_probs=221.6
Q ss_pred ccCCCeeeccCceEEEEEEe-CCC----cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNG----VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.+..++||+|+||+||+|.| ++| -+||+|++..........++.+|+.+|.+++|||++++++++.... ..||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45568999999999999965 444 4578998877666667788999999999999999999999997655 88999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
+||+.|.|.|+++. .+..+.......|..|||+||.|||++. +|||||.++||||.+...+||.|||+++.....+
T Consensus 777 q~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999985 3456777888899999999999999777 9999999999999999999999999999876655
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC-
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP- 920 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~- 920 (995)
...........+.|||-|.+....|+.++|||||||++||++| |..||+..... + +.+.+..
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----e------------I~dlle~g 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----E------------IPDLLEKG 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----H------------hhHHHhcc
Confidence 5544455566789999999999999999999999999999999 99999654321 1 1111111
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcccccCc
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQSS 972 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~ 972 (995)
..-..|+.++.+++.++.+||..|+..||+|+++...+.++.+....+..-+
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~i~ 968 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLVIQ 968 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEeeeh
Confidence 1123577899999999999999999999999999999999988777666554
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=327.98 Aligned_cols=262 Identities=23% Similarity=0.252 Sum_probs=198.2
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecC------
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK------ 755 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 755 (995)
+.++|+..+.||+|+||.||+|.. ..++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 467899999999999999999975 468899999985432 233345678899999999999999999987543
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccc
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA 835 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla 835 (995)
...|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 356999999965 77777742 3778889999999999999999777 999999999999999999999999999
Q ss_pred cccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
+..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.................... ..+.
T Consensus 174 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~ 249 (364)
T cd07875 174 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC-PEFM 249 (364)
T ss_pred cccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC-HHHH
Confidence 865322 122345789999999999999999999999999999999999999965432222221111111100 0000
Q ss_pred hhcC----------C------------c-----CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 916 SILD----------P------------R-----LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 916 ~~~d----------~------------~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+. + . ...........+.+++.+|++.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0 0 000111234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=310.73 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=188.4
Q ss_pred eeeccCceEEEEEEeCCC---cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCC
Q 001922 693 VIGRGGAGIVYHGKMPNG---VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGS 769 (995)
Q Consensus 693 ~lG~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs 769 (995)
.||+|+||+||+|+..++ ..+++|.+...........+.+|+.+++.++||||+++++++.+....|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 34566666443333445678999999999999999999999999999999999999999
Q ss_pred hhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 770 LGEALHGKK--GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 770 L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|.++++... ....++.....++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997432 234567777899999999999999777 999999999999999999999999998643222111222
Q ss_pred cccccCccccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 848 SAIAGSYGYIAPEYAYT-------LRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
....++..|+|||+... ..++.++||||||+++|||++ |..||....+...... ..... .....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~----~~~~~---~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH----VIKDQ---QVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhhc---ccccCC
Confidence 34567889999998743 245789999999999999997 5778754332211111 11110 111122
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
+.. +......+.+++..|| .+|++||+++||++.|.
T Consensus 232 ~~~---~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQL---ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred Ccc---CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222 1224456788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=313.54 Aligned_cols=253 Identities=30% Similarity=0.433 Sum_probs=199.0
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChh-HHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHD-HGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
|+..+.||+|+||+||+++.. +++.||+|.+......... ....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567789999999999999875 4668999998543322211 12355999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++. ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.++|+|||.+..+. ....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNE 153 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STTS
T ss_pred cccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cccc
Confidence 9999999996 3456899999999999999999999887 9999999999999999999999999997641 2223
Q ss_pred cccccccCcccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAY-TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......++..|+|||++. +..++.++||||+|+++|+|++|..||..... .+............ ... .. .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-~~~~~~~~~~~~~~---~~~----~~-~ 224 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-DDQLEIIEKILKRP---LPS----SS-Q 224 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-HHHHHHHHHHHHTH---HHH----HT-T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc-hhhhhhhhhccccc---ccc----cc-c
Confidence 345667899999999998 78899999999999999999999999975411 11111111111100 000 00 0
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
........+.+++.+|++.||++||++.++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111378999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=315.31 Aligned_cols=270 Identities=26% Similarity=0.347 Sum_probs=205.4
Q ss_pred hccCCCeeeccCceEEEEEEeC-----CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec--CCcce
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN--KETNL 759 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 759 (995)
.|+..+.||+|+||.||+|++. ++..||+|.+...........+.+|+++++.+.||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666789999999999999753 3688999998543332245679999999999999999999999877 56789
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||.+....
T Consensus 85 lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 999999999999999743 336899999999999999999999777 9999999999999999999999999998764
Q ss_pred cCCCC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH-hcCChhhhhhh
Q 001922 840 DGGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRA-TNGRKEEFLSI 917 (995)
Q Consensus 840 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 917 (995)
..... .......++..|+|||...+..++.++||||||+++|||++|+.|+........ .+.... .......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL--RMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhc--cccccccccccHHHHHHH
Confidence 32211 111223456679999999888899999999999999999999999865322110 000000 00000111111
Q ss_pred cCCcC-CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 918 LDPRL-SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 918 ~d~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
+.... ...+..++..+.+++.+||+.+|++||+++||+++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 11111 1123345578999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.35 Aligned_cols=247 Identities=27% Similarity=0.428 Sum_probs=200.3
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
+.|+..+.||+|+||.||+|.. +++.||+|.+.. ......+.+|+.++++++|||++++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKC---DVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecC---cchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4678889999999999999975 678899998843 22356788999999999999999999998654 579999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++.......+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 9999999997655556899999999999999999999777 999999999999999999999999998764321
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......+..|+|||++.+..++.++||||+|+++|||++ |+.||..... ........... ...
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~-----------~~~ 217 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL----KEVKECVEKGY-----------RME 217 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH----HHHHHHHhCCC-----------CCC
Confidence 122334578999999988899999999999999999998 9999864321 11212111110 011
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
.+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 223456678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=321.76 Aligned_cols=269 Identities=21% Similarity=0.221 Sum_probs=197.8
Q ss_pred CCeeecc--CceEEEEEEe-CCCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEecc
Q 001922 691 GNVIGRG--GAGIVYHGKM-PNGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 691 ~~~lG~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
.++||+| +|++||+++. .+|+.||+|++...... .....+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 7889999965 57899999998543222 233457789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc-
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE- 845 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~- 845 (995)
+|+|.+++.......+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++++||+.+......+...
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999996544456899999999999999999999877 9999999999999999999999998765432211111
Q ss_pred ----cccccccCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC-------Chh
Q 001922 846 ----CMSAIAGSYGYIAPEYAYT--LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG-------RKE 912 (995)
Q Consensus 846 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-------~~~ 912 (995)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||................... ..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1122356778999999876 468899999999999999999999997643322111111000000 000
Q ss_pred hhh-----hhcCC------------------cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCC
Q 001922 913 EFL-----SILDP------------------RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFP 962 (995)
Q Consensus 913 ~~~-----~~~d~------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 962 (995)
... ...+. .........+..+.+++.+||+.||++|||++|+++. ++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 000 00000 0001122345678999999999999999999999873 44443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=318.65 Aligned_cols=261 Identities=25% Similarity=0.327 Sum_probs=200.6
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.|+..+.||+|+||.||+|+.. ++..+|+|.+..........++.+|++++++++||||+++++++.++++.++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 5778889999999999999764 577888888754333333456889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 82 DGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 999999999643 568899999999999999999996 35 9999999999999999999999999987653321
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh-------------
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK------------- 911 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~------------- 911 (995)
.....++..|+|||+..+..++.++||||||+++|+|++|+.||.... ......+.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCC
Confidence 234568899999999988889999999999999999999999985422 1111111110000000
Q ss_pred ---------hhhhhhcCCcCCCCC-HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 ---------EEFLSILDPRLSMVP-KEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 ---------~~~~~~~d~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...........+..+ ...+..+.+++.+||+.+|++||+++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000001111 1245678999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=310.19 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=200.2
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCC--------hhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHS--------HDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
|..++.||+|+||.||+|.. .+++.||+|.+....... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 66788999999999999976 467899999885432221 124578899999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
++||||+++++|.+++.. ...+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||.++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999963 356788899999999999999999877 999999999999999999999999999876
Q ss_pred ccCCCC----ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 839 IDGGAS----ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 839 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
...... .......|+..|+|||...+..++.++||||+|+++|+|++|+.||........ .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~------- 225 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA----IFKIG------- 225 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH----HHHHh-------
Confidence 422111 111234578899999999888899999999999999999999999965322111 11111
Q ss_pred hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 915 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.......+...+..+.+++.+||+.||++||++.|+++
T Consensus 226 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ----ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11112233455678899999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=322.96 Aligned_cols=241 Identities=22% Similarity=0.245 Sum_probs=192.3
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 763 (995)
|+..+.||+|+||+||+|+.. +++.||+|++.... .....+.+..|..+++.+. |++|+++++++.+.+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456788999999999999764 68899999985321 2223455778888888885 5788889999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 82 YVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 9999999999853 356889999999999999999999877 9999999999999999999999999987542221
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... . .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~~~-----------~-~ 218 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSIMEH-----------N-V 218 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC-----------C-C
Confidence 122345689999999999998999999999999999999999999965321 1112222111 1 1
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRM 951 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~ 951 (995)
..+...+..+.+++.+|++.+|++|++.
T Consensus 219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1233445678899999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=314.33 Aligned_cols=264 Identities=20% Similarity=0.257 Sum_probs=197.8
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 667789999999999999764 68899999985332 2223456888999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 766 RNGSLGEALHGKK-GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 766 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+ ++|.+++.... +..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-- 155 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc--
Confidence 7 58988886433 367899999999999999999999777 9999999999999999999999999987643221
Q ss_pred ccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh---------hh
Q 001922 845 ECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE---------EF 914 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~ 914 (995)
.......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||...................... .+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 112334578899999987654 57889999999999999999999996532211111111111100000 00
Q ss_pred hhhcC----CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 915 LSILD----PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 915 ~~~~d----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..... ..........+.++.+++.+||+.||++|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 00001112245677899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=314.60 Aligned_cols=252 Identities=24% Similarity=0.306 Sum_probs=202.3
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
+|+..+.||+|+||.||+|+.. +++.||+|.+...........+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777889999999999999875 689999998854333334467889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 766 RNGSLGEALHGKK-GAFLGWNLRYKIAIEAAKGLCYLHHD-CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 766 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
++++|..++.... ...+++..+..++.|++.|+.|||+. + |+||||||+||+++.++.+||+|||.+..+...
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999886421 34689999999999999999999963 5 999999999999999999999999998765322
Q ss_pred CccccccccCcccccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 844 SECMSAIAGSYGYIAPEYAYTL------RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
......+++.|+|||.+.+. .++.++||||+||++|+|++|+.||......... ... ..+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~-----------~~~ 222 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQL-----------SAI 222 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHH-----------HHH
Confidence 22334688899999987544 3578999999999999999999999653221111 111 111
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+......+...+..+.+++.+||+.+|++||+++++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1222223445577889999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.76 Aligned_cols=259 Identities=28% Similarity=0.437 Sum_probs=202.2
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCc----EEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGV----EIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
++|+..+.||+|+||.||+|.+. +++ .||+|.+...........+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677889999999999999753 343 46888875433333344688999999999999999999998654 5679
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999998643 345789999999999999999999777 99999999999999999999999999987643
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
...........++..|+|||++.+..++.++||||||+++||+++ |+.||..... .....+ .....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~---~~~~~--------- 228 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-REIPDL---LEKGE--------- 228 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH---HHCCC---------
Confidence 322222233446778999999998899999999999999999997 9999864321 111111 11110
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.. ..+..++..+.+++.+||..+|++||+++++++.++++...
T Consensus 229 -~~-~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 -RL-PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -CC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 11223456788999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=307.30 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=202.4
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEec-CCcceEEEEe
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN-KETNLLVYEY 764 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~ 764 (995)
|+..+.||+|++|.||++... +++.||+|++.... .....+.+.+|++++++++|||++++++.+.. ....|+||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 677889999999999999764 57889999984322 22334568889999999999999999998764 4467899999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++.......+++.++..++.|++.|++|+|+.+ |+||||||+||+++.++.++|+|||++..+....
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-- 156 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-- 156 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC--
Confidence 99999999997655667899999999999999999999877 9999999999999999999999999998653221
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
.......+++.|+|||+..+..++.++||||+|+++|++++|+.||... +..........+ ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~----~~~~~~~~~~~~-----------~~~~ 221 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK----DMNSLVYRIIEG-----------KLPP 221 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHhc-----------CCCC
Confidence 1223456889999999999999999999999999999999999998632 222222222111 1122
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+...+..+.+++.+|++.+|++||++.+++++
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 334566789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.43 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=198.0
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.|+..+.||+|+||.||+|... ++..+++|.+.. ........+.+|+++++.++|||++++++++..++..++||||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT-KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC-CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 3667788999999999999765 467778888743 22334566888999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 85 ~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 85 AGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 99999998763 2346899999999999999999999877 9999999999999999999999999987643221 1
Q ss_pred cccccccCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 846 CMSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
......++..|+|||++. +..++.++||||+||++|||++|+.||........... ...... +
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~~~--------~ 226 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK----IAKSEP--------P 226 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH----HhhcCC--------C
Confidence 223456889999999874 44578899999999999999999999965432111111 111100 0
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus 227 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 T-LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred C-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 01223355678999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=331.34 Aligned_cols=373 Identities=25% Similarity=0.360 Sum_probs=284.6
Q ss_pred CCCCCceeeccCcccc-ccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCccc
Q 001922 160 KLEKLKYLDLGGNYFF-GKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLV 238 (995)
Q Consensus 160 ~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~ 238 (995)
-|+-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++.+
T Consensus 5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-------------- 69 (1255)
T KOG0444|consen 5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-------------- 69 (1255)
T ss_pred ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh--------------
Confidence 3556677888888888 457888888888888888888887 677777777777777666655543
Q ss_pred EEECcCCCCCCccCccccCccccCccccccccccC-CCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCC
Q 001922 239 HLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSG-SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMN 317 (995)
Q Consensus 239 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 317 (995)
+...++.++.|+.++++.|++.. -+|..+..+..|+.||||+|+++ +.|..+...+++..|+||+|
T Consensus 70 ------------vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N 136 (1255)
T KOG0444|consen 70 ------------VHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYN 136 (1255)
T ss_pred ------------hhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccC
Confidence 33344555555555565555532 35667778888888888888888 77888888888888888888
Q ss_pred cCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeecccccc-CCCCC
Q 001922 318 RLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFL-FGPIP 396 (995)
Q Consensus 318 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l-~~~~p 396 (995)
+|..+....|.+++.|-.||||+|++. .+|..+..+..|++|+|++|.+....-..+..+++|++|.+++.+- ...+|
T Consensus 137 ~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~P 215 (1255)
T KOG0444|consen 137 NIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIP 215 (1255)
T ss_pred ccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCC
Confidence 888444445677888888888888887 6677788888888888888887643333333344444444444321 12222
Q ss_pred cccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccC
Q 001922 397 ERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSN 476 (995)
Q Consensus 397 ~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 476 (995)
.++.. +.+|..+|||.|.+. .+|+.+.+
T Consensus 216 tsld~---------------------------------------------------l~NL~dvDlS~N~Lp-~vPecly~ 243 (1255)
T KOG0444|consen 216 TSLDD---------------------------------------------------LHNLRDVDLSENNLP-IVPECLYK 243 (1255)
T ss_pred Cchhh---------------------------------------------------hhhhhhccccccCCC-cchHHHhh
Confidence 22222 345566677777776 79999999
Q ss_pred CCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCccc-CCCccccccccccCeE
Q 001922 477 FSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLS-GSIPPEISNVRILNYL 555 (995)
Q Consensus 477 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~ip~~l~~l~~L~~L 555 (995)
+.+|+.|+||+|+|+ .+.-..+...+|++|+||+|+|+ .+|..+..|++|+.|++.+|+++ .-||..++.|.+|+.+
T Consensus 244 l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf 321 (1255)
T KOG0444|consen 244 LRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVF 321 (1255)
T ss_pred hhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHH
Confidence 999999999999999 67777889999999999999999 89999999999999999999986 2489999999999999
Q ss_pred eccccccccccCcccccCCcccEEeccCCCCCCCCCCCCCCcccccccCCCCccCCCCCCC
Q 001922 556 NLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLN 616 (995)
Q Consensus 556 ~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~~~~~ 616 (995)
..++|.| ..+|..+..+..|+.|.|+.|+|-..+-..--++.+....+-.||.+-.+|-+
T Consensus 322 ~aanN~L-ElVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPPKP 381 (1255)
T KOG0444|consen 322 HAANNKL-ELVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPPKP 381 (1255)
T ss_pred Hhhcccc-ccCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCCCc
Confidence 9999999 56999999999999999999999754333334466777888899999887765
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.73 Aligned_cols=267 Identities=24% Similarity=0.324 Sum_probs=203.5
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc--CCCCceeEeEEEecCC----cc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI--RHRNIVRLLAFCSNKE----TN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~~~~~~~~----~~ 758 (995)
..+....+.||+|.||+||+|+| .|+.||||++. ..+.+.+.+|.++++.+ +|+||+.+++.-..+. .+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~----srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFS----SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEec----ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 34566678899999999999999 68999999993 33455677788877655 9999999998864433 56
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCCEEECCCCCeEEeeec
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-----DCSPLIVHRDVKSNNILLNSAFEAHVADFG 833 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-----~~~~~iiHrDlkp~Nill~~~~~vkl~DfG 833 (995)
++|.+|.+.|||+|++.+ ..++.....+++..+|.||++||. +|.+.|.|||||..|||+..++.+.|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 899999999999999964 468999999999999999999996 357789999999999999999999999999
Q ss_pred cccccccC--CCCccccccccCcccccccccccCC----CC--cccchhhHHHHHHHHHh----------CCCCCCCCCC
Q 001922 834 LAKFLIDG--GASECMSAIAGSYGYIAPEYAYTLR----VD--EKSDVYSFGVVLLELLT----------GRRPVGDFGD 895 (995)
Q Consensus 834 la~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~~--~~~DvwSlGvil~ellt----------g~~Pf~~~~~ 895 (995)
+|-..... .........+||.+|||||++...- +. ..+||||||.++||+.. -+.||++.-+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99765432 1222345678999999999986431 21 46899999999999986 2457876432
Q ss_pred Cc-hHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 896 GV-DIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 896 ~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.. ...+..+-+... .+...++.+ ....++...+.++|+.||..+|.-|-|+=.+-+.+.++.+.
T Consensus 442 ~DPs~eeMrkVVCv~---~~RP~ipnr--W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQ---KLRPNIPNR--WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCHHHHhcceeec---ccCCCCCcc--cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 21 222222111111 111111111 23446778899999999999999999999999998888754
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=313.00 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=198.7
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecC------
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNK------ 755 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~------ 755 (995)
....|+..+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4566788889999999999999764 5788999988432 23356688999999998 699999999998643
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccc
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA 835 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla 835 (995)
...|+||||+.+++|.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 45789999999999999997655567899999999999999999999877 999999999999999999999999998
Q ss_pred cccccCCCCccccccccCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCC
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 910 (995)
....... .......|+..|+|||++. +..++.++||||+||++|||++|+.||....... .... ...
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~---~~~~-~~~-- 230 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFL-IPR-- 230 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH---HHHH-Hhc--
Confidence 7653221 1224457899999999876 3457889999999999999999999996432211 1111 110
Q ss_pred hhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 911 KEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 911 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.+.........+..+.+++.+||+.+|.+||+++|+++
T Consensus 231 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 --------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00111112234567889999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=322.62 Aligned_cols=255 Identities=24% Similarity=0.243 Sum_probs=195.6
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.|+..+.||+|+||+||+++.. +++.||+|++.+. ........+.+|..+++.++||||+++++++.++++.|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 5778899999999999999764 5889999998531 122234558889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred cCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999999999963 2456889999999999999999999777 99999999999999999999999999876543222
Q ss_pred CccccccccCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 844 SECMSAIAGSYGYIAPEYAYT-----LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||.... ..+....+..... .
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~----~~~~~~~i~~~~~-~----- 226 (331)
T cd05597 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHKE-H----- 226 (331)
T ss_pred -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC----HHHHHHHHHcCCC-c-----
Confidence 11223469999999999863 457889999999999999999999996432 1122222211100 0
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCC--CCCCHHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSI--ERPRMREVVQM 957 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~evl~~ 957 (995)
..........+..+.+++.+|+..+++ .||++++++++
T Consensus 227 -~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 -FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 001111122455677888887765443 37899999876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=330.02 Aligned_cols=261 Identities=21% Similarity=0.204 Sum_probs=199.6
Q ss_pred HhhccCCCeeeccCceEEEEEEeC---CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP---NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
..+|+..+.||+|+||.||+|... .+..||+|.+... ....+|++++++++||||+++++++......++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 456888999999999999999643 3578899987431 2356799999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
||++. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||+++.+...
T Consensus 165 ~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 165 MPKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred ehhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 99995 68888883 3467899999999999999999999877 999999999999999999999999999876543
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCch---HHHHHHHHhcCCh-------
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD---IVQWSKRATNGRK------- 911 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~---~~~~~~~~~~~~~------- 911 (995)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||........ +....+.......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 333333356799999999999999999999999999999999999999965432221 1111111110000
Q ss_pred hh----hhhhc---CCcCCC----CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 EE----FLSIL---DPRLSM----VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 ~~----~~~~~---d~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.. +.... .+.... .....+..+.+++.+|++.||++||++.|++.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00000 000000 001234567889999999999999999999875
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.64 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=204.5
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+|+..+.||+|+||.||.++. .+++.||+|++.... .......+.+|+.++++++||||+++++++.+.++.++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 367788999999999999965 468899999985322 223345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++.......+++..+.+++.|++.|++|||+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence 99999999997655556889999999999999999999877 9999999999999999999999999997653322
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
.......|++.|+|||+..+..++.++|||||||++|+|++|+.||.... .......+.. .....
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~~~~~~~~~-----------~~~~~ 220 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN----MKNLVLKIIR-----------GSYPP 220 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC----HHHHHHHHhc-----------CCCCC
Confidence 11233458889999999988889999999999999999999999986421 1122211111 11222
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+...+..+.+++.+||+.+|++||+++||+++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 334556779999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=311.28 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=203.7
Q ss_pred hhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
+.|+..+.||+|+||+||+|+.+ +.+.|++|.+...........+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778889999999999999753 245688888754333324567899999999999999999999999989999
Q ss_pred EEEEeccCCChhhhhcCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeee
Q 001922 760 LVYEYMRNGSLGEALHGKKG-------AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADF 832 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~Df 832 (995)
+||||+++|+|.+++..... ..+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999975431 26899999999999999999999777 999999999999999999999999
Q ss_pred ccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
|++........ .......++..|+|||.+.+..++.++||||+|+++|++++ |..||....+. . ..........
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~---~~~~~~~~~~ 236 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-E---VLNRLQAGKL 236 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-H---HHHHHHcCCc
Confidence 99875432221 12234456788999999988888999999999999999999 88898653321 1 1111111100
Q ss_pred hhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 912 EEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 912 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
. . ..+...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus 237 ~---------~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 237 E---------L-PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred C---------C-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0 0 0122345679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=316.31 Aligned_cols=195 Identities=24% Similarity=0.379 Sum_probs=159.1
Q ss_pred CCeeeccCceEEEEEEeC---CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec--CCcceEEEEec
Q 001922 691 GNVIGRGGAGIVYHGKMP---NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN--KETNLLVYEYM 765 (995)
Q Consensus 691 ~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~ 765 (995)
+++||+|+||+||+|+.. +++.||+|.+... .....+.+|++++++++||||+++++++.. +...++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC---CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 568999999999999764 4678999998532 223457789999999999999999998854 45678999999
Q ss_pred cCCChhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----CCCCCeEEeeecc
Q 001922 766 RNGSLGEALHGK-------KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL----NSAFEAHVADFGL 834 (995)
Q Consensus 766 ~~gsL~~~l~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill----~~~~~vkl~DfGl 834 (995)
. ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||++ +..+.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5 4888877421 2235888999999999999999999777 9999999999999 4567899999999
Q ss_pred ccccccCCC-CccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 001922 835 AKFLIDGGA-SECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGD 892 (995)
Q Consensus 835 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~ 892 (995)
++.+..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 987543221 1122346789999999998764 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=327.28 Aligned_cols=255 Identities=23% Similarity=0.244 Sum_probs=197.5
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.+.|+..+.||+|+||.||+|+.+ +++.||+|.+.... .......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467889999999999999999775 57889999884321 222344577899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 122 ~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 122 MEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999999999863 24788888999999999999999777 999999999999999999999999999876432
Q ss_pred CCCccccccccCcccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTL----RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
.. .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+......
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~----- 265 (371)
T cd05622 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMNHKNS----- 265 (371)
T ss_pred Cc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCc-----
Confidence 21 122356799999999998654 378999999999999999999999964221 1122222211000
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIE--RPRMREVVQML 958 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 958 (995)
...+ .....+..+.+++..|++.++.+ ||+++|++++.
T Consensus 266 --~~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 --LTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred --ccCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0001 11235567888999999844433 77999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=344.99 Aligned_cols=255 Identities=23% Similarity=0.307 Sum_probs=197.4
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEec--CCcce
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN--KETNL 759 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 759 (995)
....|++.+.||+|+||+||+|+.. +++.||+|.+.... .......+..|+.++++++|||||+++++|.+ ...+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3567889999999999999999764 46778888874322 22345668899999999999999999998844 45689
Q ss_pred EEEEeccCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCCEEECC----------
Q 001922 760 LVYEYMRNGSLGEALHGK--KGAFLGWNLRYKIAIEAAKGLCYLHHDCS----PLIVHRDVKSNNILLNS---------- 823 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~----~~iiHrDlkp~Nill~~---------- 823 (995)
+||||+++|+|.+++... ....+++..++.|+.||+.||+|||+.+. ++||||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999998642 23568999999999999999999997431 34999999999999964
Q ss_pred -------CCCeEEeeeccccccccCCCCccccccccCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 001922 824 -------AFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT--LRVDEKSDVYSFGVVLLELLTGRRPVGDFG 894 (995)
Q Consensus 824 -------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~ 894 (995)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2358999999998653321 2234579999999998854 458899999999999999999999996432
Q ss_pred CCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 895 DGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
. .......+... +.+ .....+..+.++|..||+.+|.+||++.|++.
T Consensus 248 ~---~~qli~~lk~~----------p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N---FSQLISELKRG----------PDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c---HHHHHHHHhcC----------CCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2 22222222111 111 11123567889999999999999999999984
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=309.13 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=206.4
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.|+..+.||.|+||+||+|.. .++..+|+|++...........+.+|+++++.++|+|++++++.+..++..++||||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 578889999999999999975 4678899999854433335677899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 766 RNGSLGEALHGKKG-AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 766 ~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
++++|.+++..... ..+++..+..++.|++.|++|||+.+ |+||||+|+||++++++.++|+|||++..+......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999975433 56899999999999999999999777 999999999999999999999999999876543322
Q ss_pred c--cccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 845 E--CMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 845 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
. ......++..|+|||++... .++.++|+||+||++|+|++|+.||.............. .. .+.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~----~~--------~~~ 226 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ----ND--------PPS 226 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc----CC--------CCC
Confidence 1 22344688999999998776 789999999999999999999999975433222222111 10 111
Q ss_pred CCCC--CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 922 LSMV--PKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 922 ~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.... ....+..+.+++.+||+.||++||+++++++.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111 12456778999999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=306.97 Aligned_cols=251 Identities=29% Similarity=0.457 Sum_probs=202.2
Q ss_pred cCCCeeeccCceEEEEEEeCC-----CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 689 KDGNVIGRGGAGIVYHGKMPN-----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 689 ~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
+..+.||.|+||.||+|+..+ +..||+|++...........+.+|+.++++++||||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999997753 378999998554433356778999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++.......+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++++|||++........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 999999999997544333899999999999999999999777 99999999999999999999999999987654322
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
... ....+++.|+|||...+..++.++||||+|+++|+|++ |..||... ............. .
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~----~~~~~~~~~~~~~-----------~ 222 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM----SNEEVLEYLKKGY-----------R 222 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhcCC-----------C
Confidence 221 12336789999999988889999999999999999998 78888542 2222222222111 1
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQML 958 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 958 (995)
...+...+..+.+++.+|++.+|++|||++|+++.|
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 112233567799999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=311.34 Aligned_cols=248 Identities=25% Similarity=0.321 Sum_probs=202.9
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
+|+..+.||.|+||.||+|+.. +++.||+|.+...........+.+|+++++.++|||++++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777888999999999999764 688999999854433444567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++... .+++..++.++.|++.|+.|||+.+ |+||||+|+||++++++.++|+|||+++.+.... .
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 999999999643 7899999999999999999999777 9999999999999999999999999998764332 1
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
......+++.|+|||+..+..++.++||||+|+++|+|++|+.||..... ......+... ..+. .
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~--------~~~~---~ 218 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----MRVLFLIPKN--------NPPS---L 218 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch----HHHHHHhhhc--------CCCC---C
Confidence 22345688899999999988899999999999999999999999964321 1111111111 0111 1
Q ss_pred CHH-HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 926 PKE-EAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 926 ~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+.. .+..+.+++.+||..+|++||+++++++.
T Consensus 219 ~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111 55678899999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=308.38 Aligned_cols=249 Identities=26% Similarity=0.342 Sum_probs=203.3
Q ss_pred hhccCCCeeeccCceEEEEEEeCC-CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.|+..+.||+|+||.||+|...+ ++.|++|.+.... ..+.+.+|++++++++||||+++++++.+....|+++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 467888899999999999998754 7899999984322 256799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+.+++|.+++.. ....+++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 80 CGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999999863 3457899999999999999999999877 99999999999999999999999999987643321
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......++..|+|||++.+..++.++||||||+++|+|++|+.||........... .... ......
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~----~~~~---------~~~~~~ 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM----IPNK---------PPPTLS 220 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh----hccC---------CCCCCC
Confidence 22344578899999999888899999999999999999999999965322211110 0000 000111
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.+...+..+.+++.+||+.+|++||+++|+++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 23345667899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=307.87 Aligned_cols=239 Identities=23% Similarity=0.363 Sum_probs=185.7
Q ss_pred CeeeccCceEEEEEEeCC-------------CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 692 NVIGRGGAGIVYHGKMPN-------------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
+.||+|+||.||+|.... ..+|++|.+... .......+.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 368999999999997532 235788876432 223345688899999999999999999999998999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC-------eEEee
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE-------AHVAD 831 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~-------vkl~D 831 (995)
++||||+++|+|..++.. ....+++..+++++.||+.|++|||+.+ |+||||||+||+++.++. ++++|
T Consensus 80 ~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999998863 3356899999999999999999999776 999999999999987664 89999
Q ss_pred eccccccccCCCCccccccccCcccccccccc-cCCCCcccchhhHHHHHHHHH-hCCCCCCCCCCCchHHHHHHHHhcC
Q 001922 832 FGLAKFLIDGGASECMSAIAGSYGYIAPEYAY-TLRVDEKSDVYSFGVVLLELL-TGRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 832 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tg~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
||++..... .....++..|+|||++. +..++.++|||||||++|||+ +|..||..... .+... ....
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~-~~~~ 224 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL----AEKER-FYEG 224 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch----hHHHH-HHhc
Confidence 999875422 12345788999999886 466899999999999999998 58888754211 11100 1110
Q ss_pred ChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 001922 910 RKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQML 958 (995)
Q Consensus 910 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 958 (995)
... ........+.+++.+||+.||++||++.++++.+
T Consensus 225 -----------~~~-~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 -----------QCM-LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -----------Ccc-CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 0111245688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=292.24 Aligned_cols=251 Identities=23% Similarity=0.248 Sum_probs=201.1
Q ss_pred HHhhccCC-CeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEec----CC
Q 001922 684 ILECVKDG-NVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSN----KE 756 (995)
Q Consensus 684 ~~~~~~~~-~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~----~~ 756 (995)
+++.|.+. ++||-|-.|.|..+.. .+|+++|+|++.. ....++|++..-.. .|||||.++++|+. ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 45556554 6799999999999854 5789999998832 34467788876666 69999999999854 34
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCCeEEeeec
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS---AFEAHVADFG 833 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~---~~~vkl~DfG 833 (995)
.+.+|||.|+||.|+..++++....+++..+..|++||+.|+.|||... |.||||||+|+|.+. +..+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 5679999999999999999888888999999999999999999999766 999999999999965 4568999999
Q ss_pred cccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
+|+.-. ......+.+.||.|.|||++....|+...|+||+||++|-|++|.+||+......--.....++..+
T Consensus 210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g---- 282 (400)
T KOG0604|consen 210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG---- 282 (400)
T ss_pred cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc----
Confidence 998643 2345567899999999999999999999999999999999999999998643211111111222222
Q ss_pred hhhhcCCcCCCC---CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 914 FLSILDPRLSMV---PKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 914 ~~~~~d~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+.+. -...++...++|+.++..+|++|.|+.|+++.
T Consensus 283 -------qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 283 -------QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -------CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 22221 12467788899999999999999999999875
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=314.36 Aligned_cols=250 Identities=24% Similarity=0.300 Sum_probs=201.9
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.+.|+..+.||+|+||.||+|.. .+++.||+|.+.........+.+.+|++++++++||||+++++++..++..|+|||
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 34566667899999999999975 45788999987544334445678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++++|||++..+....
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 83 YLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred ccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 9999999999853 45789999999999999999999777 9999999999999999999999999997654321
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.......++..|+|||++.+..++.++||||||+++|||++|+.||....... . ...... ....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~---~~~~~~-----------~~~~ 219 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-V---LFLIPK-----------NSPP 219 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-H---Hhhhhc-----------CCCC
Confidence 11223467889999999998889999999999999999999999986432211 1 111111 1111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2233456678999999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=310.04 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=204.1
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.+.|+..+.||+|+||.||+|... +++.||+|.+...........+.+|+++++++.||||+++++++.++...++|||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 345677788999999999999764 5889999988543333445678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++.. ..+++..+..++.|++.|++|+|+.+ ++|+||+|+||+++.++.++++|||++........
T Consensus 83 ~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 83 YLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999999853 35788889999999999999999776 99999999999999999999999999976543221
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......++..|+|||++.+..++.++|+||||+++|||++|+.||...... ........ ....
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~-----------~~~~ 219 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM----RVLFLIPK-----------NNPP 219 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH----hHhhhhhc-----------CCCC
Confidence 123346788999999998888999999999999999999999998643211 11111110 1112
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+||+.+|++||+++++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3445677889999999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=315.03 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=205.3
Q ss_pred HHHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 681 VSDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 681 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
..+...+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..+++.+
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 345567899999999999999999975 578999999985432 334566889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+||||+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 93 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred EeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999999853 34788899999999999999999877 9999999999999999999999999987653
Q ss_pred cCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.... ......+++.|+|||...+..++.++||||+||++|++++|+.||........... .... .
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----~~~~---------~ 231 (297)
T cd06656 167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATN---------G 231 (297)
T ss_pred CCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----eccC---------C
Confidence 3221 12345688999999999988899999999999999999999999964322111000 0000 0
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
......+...+..+.+++.+||+.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001123345567889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=320.33 Aligned_cols=255 Identities=23% Similarity=0.235 Sum_probs=196.2
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.|+..+.||+|+||+||+++.+ +++.||+|.+.+.. .......+.+|+.++..++|++|+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5778889999999999999765 47789999884311 12223457889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++... ...+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 82 y~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 82 YYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred ccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999742 346889999999999999999999777 99999999999999999999999999876533221
Q ss_pred CccccccccCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 844 SECMSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+....+.....
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~~~~------- 225 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHKE------- 225 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC----HHHHHHHHhCCCc-------
Confidence 1223457999999999886 3467899999999999999999999996432 2222222221100
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIE--RPRMREVVQM 957 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 957 (995)
....+......+..+.+++.+|+..+|++ |++++|++++
T Consensus 226 ~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00111112234567888999988665544 6899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=310.47 Aligned_cols=254 Identities=23% Similarity=0.287 Sum_probs=198.9
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.+.|+..+.||+|+||.||+|+. .+++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC-chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 34677778899999999999976 46889999988433 22334557889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++.. .+.+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 87 FCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred ccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 9999999999853 346889999999999999999999887 9999999999999999999999999987653221
Q ss_pred CccccccccCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAY---TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.......|+..|+|||++. ...++.++||||+||++|+|++|+.||.............. .. ...+
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~---~~-------~~~~ 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK---SN-------FQPP 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc---cC-------CCCC
Confidence 1223457899999999874 45688999999999999999999999865332111111100 00 0000
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
... .....+..+.+++.+|++.+|++||++++++++
T Consensus 230 ~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 010 011234568899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=323.83 Aligned_cols=262 Identities=23% Similarity=0.282 Sum_probs=196.7
Q ss_pred HHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecC-----
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK----- 755 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 755 (995)
++.++|+..+.||+|+||.||+|.. .+++.||||++..... ......+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3456889999999999999999975 4678999999853221 22345577899999999999999999987543
Q ss_pred -CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 756 -ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 756 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
...|++||++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 7799888752 45889999999999999999999877 99999999999999999999999999
Q ss_pred ccccccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...........+........ ..
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~ 238 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS-PE 238 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC-HH
Confidence 9865321 234568999999999876 5688999999999999999999999965332222222211111111 11
Q ss_pred hhhhcC--------CcCCCCC--------HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 914 FLSILD--------PRLSMVP--------KEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 914 ~~~~~d--------~~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
....+. ..+...+ ......+.+++.+|++.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 100000 0001011 1123457799999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=328.65 Aligned_cols=258 Identities=21% Similarity=0.262 Sum_probs=195.2
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.|.+.+.||+|+||.||+|.+. .++.||||... ...+.+|++++++++|||||++++++..++..++|||++
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 5778889999999999999764 57889999642 223568999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
. ++|.+++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 243 ~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 243 R-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred C-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 5 6898888632 346899999999999999999999877 9999999999999999999999999998654322222
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC-------chHHHHHHHHhcCChhhhhh--
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG-------VDIVQWSKRATNGRKEEFLS-- 916 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~-- 916 (995)
......||+.|+|||++.+..++.++|||||||++|||++|..|+...... ..+.+......... ..+..
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~-~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV-DEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc-ccCCCCc
Confidence 223457999999999999999999999999999999999988776432211 11222222111100 00000
Q ss_pred ------h--------cCCcCCCCC----HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 917 ------I--------LDPRLSMVP----KEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 917 ------~--------~d~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. ..+...... ......+.+++.+||+.||++|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 000000000 0123468889999999999999999999874
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=312.81 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=203.0
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
..+|+..+.||.|+||.||+|.. .+++.||+|.+... .....+.+.+|+.+++.++|||++++++++...+..++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc-cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 45688888999999999999975 57899999988433 33345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++.. ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 97 YLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred ecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999999853 35889999999999999999999777 99999999999999999999999999886543221
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......++..|+|||.+.+..++.++|||||||++|++++|+.||.......... ....... ...
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~----~~~~~~~---------~~~ 235 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIATNGT---------PEL 235 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcCC---------ccc
Confidence 1233468899999999998889999999999999999999999996533211111 1111100 001
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+||..||++||++.++++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1233455678899999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=321.46 Aligned_cols=266 Identities=25% Similarity=0.322 Sum_probs=208.9
Q ss_pred CCCeeeccCceEEEEEE-eCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecC------CcceEEE
Q 001922 690 DGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK------ETNLLVY 762 (995)
Q Consensus 690 ~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~lv~ 762 (995)
..+.+|+|+||.||+|+ ..+|+.||||.+.........++..+|++++++++|||||+++++-++. +...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 34579999999999998 4679999999997777677788899999999999999999999986543 3568999
Q ss_pred EeccCCChhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE--CCCCC--eEEeeeccccc
Q 001922 763 EYMRNGSLGEALHG-KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL--NSAFE--AHVADFGLAKF 837 (995)
Q Consensus 763 e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill--~~~~~--vkl~DfGla~~ 837 (995)
|||.||||+.++.+ .....+++.....+..+++.||.|||+++ |+||||||.||++ .++|. -||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999999999975 33456999999999999999999999888 9999999999998 44454 59999999998
Q ss_pred cccCCCCccccccccCcccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAY-TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
+.++. ...+..||..|++||... .+.|+..+|.|||||++|++.||..||..+..+....+.+..+....+....-
T Consensus 174 l~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 174 LDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred CCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 86543 557889999999999988 48899999999999999999999999988766544333333333332222221
Q ss_pred hcCCc----------CC---CCCHHHHHHHHHHHhcccCCCCCCCC--CHHHHHHHHccC
Q 001922 917 ILDPR----------LS---MVPKEEAMHLLFVAMLCIQENSIERP--RMREVVQMLSEF 961 (995)
Q Consensus 917 ~~d~~----------~~---~~~~~~~~~l~~li~~cl~~dP~~RP--t~~evl~~L~~~ 961 (995)
...+. ++ ...+.....+...+..++..+|++|. .+.+....+.++
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 11111 11 12234455567788899999999998 665555555443
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=327.88 Aligned_cols=253 Identities=22% Similarity=0.260 Sum_probs=194.9
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.|+..+.||+|+||+||+|+.. +++.||+|++.... .......+.+|+.++.+++||+|+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4677889999999999999764 68899999985321 22334567889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 82 FLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999963 356889999999999999999999777 99999999999999999999999999875432110
Q ss_pred C---------------------------------ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 001922 844 S---------------------------------ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPV 890 (995)
Q Consensus 844 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf 890 (995)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011346999999999999999999999999999999999999999
Q ss_pred CCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCC---HHHHHHH
Q 001922 891 GDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPR---MREVVQM 957 (995)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 957 (995)
..... ......+...... . .+.+. ...+..+.+++.+|+ .+|.+|++ ++|++++
T Consensus 237 ~~~~~----~~~~~~i~~~~~~-~--~~p~~-----~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETP----QETYRKVMNWKET-L--VFPPE-----VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCH----HHHHHHHHcCCCc-e--ecCCC-----CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 65322 1111111111000 0 00000 113456777888876 49999985 6777654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=321.20 Aligned_cols=255 Identities=23% Similarity=0.203 Sum_probs=196.1
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
+|+..+.||+|+||+||+++.. +++.||+|.+... ........+.+|..++..++|++|+++++++.+.+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5778899999999999999764 5788999988432 122234457889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++... ...+++..+..++.|++.||.|+|+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 82 y~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 82 YYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999742 346889999999999999999999777 99999999999999999999999999986543222
Q ss_pred CccccccccCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 844 SECMSAIAGSYGYIAPEYAYT-----LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
. ......||+.|+|||++.+ +.++.++||||+||++|||++|+.||..... .+....+..... .
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~-~----- 226 (331)
T cd05624 158 V-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHEE-R----- 226 (331)
T ss_pred e-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH----HHHHHHHHcCCC-c-----
Confidence 1 1234569999999998875 4678899999999999999999999964321 111111111100 0
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIE--RPRMREVVQM 957 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 957 (995)
..++....+.+..+.+++.+|+..++++ |+++++++++
T Consensus 227 -~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 -FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0011111234567888999998876654 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.59 Aligned_cols=253 Identities=25% Similarity=0.290 Sum_probs=202.7
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++|+..+.||+|+||.||+|... +++.+++|.+.... ......+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 46778889999999999999764 57889999885432 22456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+.+++|.+++... ...+++..+..++.|++.|++|||+.+ |+||||+|+||+++.++.+||+|||.+.......
T Consensus 82 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 82 CGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 9999999998643 356889999999999999999999877 9999999999999999999999999987653321
Q ss_pred ccccccccCcccccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 845 ECMSAIAGSYGYIAPEYAYTL---RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
.......++..|+|||...+. .++.++||||+|+++|||++|+.||............. .. ...+.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~----~~-------~~~~~ 224 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS----KS-------NFPPP 224 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hc-------cCCCc
Confidence 122345678899999998776 78999999999999999999999996533221111111 00 00111
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
....+...+..+.+++.+||..+|++||++++++.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11123345678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.91 Aligned_cols=239 Identities=21% Similarity=0.351 Sum_probs=184.8
Q ss_pred eeeccCceEEEEEEeCC-------------------------CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCcee
Q 001922 693 VIGRGGAGIVYHGKMPN-------------------------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747 (995)
Q Consensus 693 ~lG~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 747 (995)
.||+|+||.||+|.... ...||+|.+.... ......+.+|+.++++++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 58999999999996421 1347888774321 222456788999999999999999
Q ss_pred EeEEEecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC--
Q 001922 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-- 825 (995)
Q Consensus 748 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-- 825 (995)
+++++.+....++||||+++|+|..++.. ....+++..+.+++.||++||+|||+.+ |+||||||+||+++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999999864 3456889999999999999999999776 99999999999997654
Q ss_pred -----CeEEeeeccccccccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHH-hCCCCCCCCCCCch
Q 001922 826 -----EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELL-TGRRPVGDFGDGVD 898 (995)
Q Consensus 826 -----~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-tg~~Pf~~~~~~~~ 898 (995)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999988653221 22357788999998865 56899999999999999995 69999865332111
Q ss_pred HHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 899 IVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
..+... . .. .+......+.+++.+||+.+|++||+++++++.|.
T Consensus 231 -~~~~~~---~----------~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 -ERFYEK---K----------HR---LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHHHh---c----------cC---CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111100 0 00 11122346889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.89 Aligned_cols=262 Identities=24% Similarity=0.300 Sum_probs=200.4
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+|+..+.||+|+||.||+|+.+ +++.||+|++..... ......+.+|++++++++|||++++++++..+...++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5778889999999999999875 588999998854322 22345578899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
++++.+..+... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 82 CDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred cCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 999888887743 345899999999999999999999877 99999999999999999999999999987643321
Q ss_pred ccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC----
Q 001922 845 ECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD---- 919 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---- 919 (995)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||................... ........+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDL-IPRHQQIFSTNQF 233 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-ChHHhhhcccccc
Confidence 1223457889999999876 457899999999999999999999997544322222222111110 000000000
Q ss_pred ------CcCC-CC-----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 920 ------PRLS-MV-----PKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 920 ------~~~~-~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
+... .. ....+..+.+++.+||+.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 00 0123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=311.94 Aligned_cols=257 Identities=28% Similarity=0.371 Sum_probs=199.2
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEe-----c
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCS-----N 754 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~-----~ 754 (995)
.+..++|+..+.||+|+||.||+|.. .+++.+|+|++... ......+.+|+.+++++ +||||+++++++. .
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 34567889999999999999999976 45788999987432 22245678899999999 6999999999873 4
Q ss_pred CCcceEEEEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeee
Q 001922 755 KETNLLVYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADF 832 (995)
Q Consensus 755 ~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~Df 832 (995)
++..++||||+++++|.+++.. .....+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.+||+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccC
Confidence 4578999999999999998753 23456888999999999999999999777 999999999999999999999999
Q ss_pred ccccccccCCCCccccccccCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYT-----LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRAT 907 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 907 (995)
|+++.+..... ......|++.|+|||++.. ..++.++||||+||++|||++|+.||............ .
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~----~ 242 (286)
T cd06638 169 GVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI----P 242 (286)
T ss_pred CceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc----c
Confidence 99886543221 2234568999999998753 45788999999999999999999999654322111110 0
Q ss_pred cCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 001922 908 NGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQML 958 (995)
Q Consensus 908 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 958 (995)
... .+.. ..+...+..+.+++.+||+.+|++||+++|+++..
T Consensus 243 ~~~--------~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 243 RNP--------PPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccC--------CCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 0000 11222345688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=333.13 Aligned_cols=259 Identities=17% Similarity=0.182 Sum_probs=190.4
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCC------CCceeEeEEEecC-C
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH------RNIVRLLAFCSNK-E 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~~~~~~~~~-~ 756 (995)
..+|++.+.||+|+||+||+|.. ..++.||||++.... .....+..|+++++.++| ++++.+++++... .
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 46788999999999999999976 457889999985321 223445667777777754 4588899988654 5
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCCC----------
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNSAF---------- 825 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~~~---------- 825 (995)
+.|+|||++ +++|.+++.. ...+++..+..++.||+.||+|||+ .+ ||||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred eEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccc
Confidence 788999988 7789998853 3568999999999999999999996 36 99999999999998765
Q ss_pred ------CeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchH
Q 001922 826 ------EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDI 899 (995)
Q Consensus 826 ------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~ 899 (995)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........+
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred cCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 49999999876421 1224567999999999999999999999999999999999999999754332211
Q ss_pred HHHHHHHhcCChhhh---------hhhcC------CcC------------CCCCHHHHHHHHHHHhcccCCCCCCCCCHH
Q 001922 900 VQWSKRATNGRKEEF---------LSILD------PRL------------SMVPKEEAMHLLFVAMLCIQENSIERPRMR 952 (995)
Q Consensus 900 ~~~~~~~~~~~~~~~---------~~~~d------~~~------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 952 (995)
.. +..........+ ....+ +.. ..........+.+||.+||+.||++|||++
T Consensus 355 ~~-i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 355 HL-MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HH-HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 11 111111000000 00000 000 000011235677999999999999999999
Q ss_pred HHHHH
Q 001922 953 EVVQM 957 (995)
Q Consensus 953 evl~~ 957 (995)
|++++
T Consensus 434 e~L~H 438 (467)
T PTZ00284 434 QMTTH 438 (467)
T ss_pred HHhcC
Confidence 99973
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.68 Aligned_cols=264 Identities=23% Similarity=0.290 Sum_probs=197.3
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.|+..+.||+|+||.||+|..+ +++.||+|.+...........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56788899999999999999765 68899999985433333344577899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+.+ +|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 85 LDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred CCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 975 999988643 346889999999999999999999777 9999999999999999999999999987542211
Q ss_pred ccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC-ChhhhhhhcC---
Q 001922 845 ECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG-RKEEFLSILD--- 919 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d--- 919 (995)
.......++..|+|||+..+ ..++.++||||+|+++|+|++|+.||.......+........... ....+....+
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 11122346889999998865 457899999999999999999999996543222211111111111 0011000000
Q ss_pred ---CcCCCC----------CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 920 ---PRLSMV----------PKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 920 ---~~~~~~----------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
...... .......+.+++.+|++.+|++||+++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0011256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=323.21 Aligned_cols=241 Identities=23% Similarity=0.218 Sum_probs=186.4
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc---CCCCceeEeEEEecCCcceEEEEeccC
Q 001922 694 IGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI---RHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 694 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
||+|+||+||+|+.. +++.||+|++.... .......+..|..++.+. +||+|+++++++.+.+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999764 58999999984321 111223345566666655 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~ 153 (330)
T cd05586 81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT 153 (330)
T ss_pred ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence 999999853 456889999999999999999999877 9999999999999999999999999987542221 122
Q ss_pred cccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCC
Q 001922 848 SAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 926 (995)
...+||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+....+.... .....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~----~~~~~~~i~~~~-----------~~~~~ 218 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED----TQQMYRNIAFGK-----------VRFPK 218 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC----HHHHHHHHHcCC-----------CCCCC
Confidence 356799999999998754 47899999999999999999999996422 222222222111 11111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC----CHHHHHH
Q 001922 927 KEEAMHLLFVAMLCIQENSIERP----RMREVVQ 956 (995)
Q Consensus 927 ~~~~~~l~~li~~cl~~dP~~RP----t~~evl~ 956 (995)
...+..+.+++.+||+.||++|| +++++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 12455678999999999999998 4666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.17 Aligned_cols=256 Identities=29% Similarity=0.387 Sum_probs=198.7
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC--C-------hhHHHHHHHHHHhccCCCCceeEeEEEecCC
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH--S-------HDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE 756 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 756 (995)
+|...+.||+|+||.||+|.. .+++.||+|.+...... . ..+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999965 46889999987422111 0 1245778999999999999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
..++||||+++++|.+++... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++++|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999643 56888999999999999999999777 9999999999999999999999999997
Q ss_pred ccccCCCCccccccccCcccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTLR--VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
...............++..|+|||...... ++.++||||+|+++||+++|..||...... .............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~-- 231 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AAMFKLGNKRSAP-- 231 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---HHHHHhhccccCC--
Confidence 653322222223456889999999987654 789999999999999999999999543221 1111111100000
Q ss_pred hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 915 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+. .......+..+.+++.+||+.+|++||+++++++.
T Consensus 232 --~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 232 --PIP---PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred --cCC---ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000 11122346788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=308.74 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=198.1
Q ss_pred ccCCCeeeccCceEEEEEEeC----CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCC------
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE------ 756 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 756 (995)
|+..++||+|+||+||+|... +++.||+|++.... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999653 46889999985432 2234566889999999999999999999885432
Q ss_pred cceEEEEeccCCChhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeee
Q 001922 757 TNLLVYEYMRNGSLGEALHGK----KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADF 832 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~Df 832 (995)
..++++||+.+|+|.+++... ....+++..+.+++.|++.|++|||+.+ |+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 237889999999999887422 1235788899999999999999999777 999999999999999999999999
Q ss_pred ccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
|.++...............+++.|++||......++.++||||||+++|||++ |+.||..... ..... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~---~~~~~-- 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYN---YLIKG-- 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHH---HHHcC--
Confidence 99986543322222223345678999999988889999999999999999999 8898864321 11111 11111
Q ss_pred hhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 912 EEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 912 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.....+...+..+.+++.+||+.+|++||+++|+++.|+++
T Consensus 232 ---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 ---------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00111223456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.87 Aligned_cols=245 Identities=28% Similarity=0.408 Sum_probs=199.8
Q ss_pred CCCeeeccCceEEEEEEe-CCCcEEE---EEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCc--ceEEEE
Q 001922 690 DGNVIGRGGAGIVYHGKM-PNGVEIA---VKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET--NLLVYE 763 (995)
Q Consensus 690 ~~~~lG~G~~g~V~~~~~-~~~~~va---vK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~lv~e 763 (995)
...+||+|+|-+||+|.+ .+|.+|| ||.-.....+...++|..|+++++.++|||||+++++|.+... ..+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 346899999999999965 4576765 3322233445556899999999999999999999999977654 678999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCCeEEeeeccccccccCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS-AFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~-~~~vkl~DfGla~~~~~~~ 842 (995)
.+..|+|+.|.+ +.+..+......|++||++||.|||++ .++|||||||.+||+|+. -|.|||+|.|+|+.+...
T Consensus 124 L~TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred cccCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 999999999995 456788899999999999999999998 789999999999999975 589999999999976432
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
......|||.|||||... ..|++.+||||||+.+.||+|+.+||..- ....+..+++..+..+.-...+.
T Consensus 200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC---~n~AQIYKKV~SGiKP~sl~kV~--- 269 (632)
T KOG0584|consen 200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC---TNPAQIYKKVTSGIKPAALSKVK--- 269 (632)
T ss_pred ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh---CCHHHHHHHHHcCCCHHHhhccC---
Confidence 224578999999999776 78999999999999999999999999643 33455666666664433222111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.++++++|.+|+.. .++||++.|++.
T Consensus 270 -------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 -------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 34688999999999 999999999985
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=309.16 Aligned_cols=240 Identities=20% Similarity=0.366 Sum_probs=186.8
Q ss_pred CeeeccCceEEEEEEeCC--------CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 692 NVIGRGGAGIVYHGKMPN--------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
+.||+|+||.||+|..+. ..+||+|.+.. ......+.+.+|+.+++.++|||++++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc-hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 368999999999996532 23477777632 222334568889999999999999999999999899999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC--------eEEeeeccc
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE--------AHVADFGLA 835 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~--------vkl~DfGla 835 (995)
|+++|+|.+++... +..+++..+..++.||+.|++|||+.+ |+||||||+||+++.++. ++++|||.+
T Consensus 80 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 80 YVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred cCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999999743 346889999999999999999999777 999999999999987765 699999998
Q ss_pred cccccCCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCC-CCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGR-RPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
...... ....+++.|+|||++.+. .++.++||||+|+++|||++|. .||.... ....... .. .
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~~~~~~~---~~-~---- 220 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKKLQF---YE-D---- 220 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-HHHHHHH---HH-c----
Confidence 754321 234678899999998864 5789999999999999999985 5553321 1111110 00 0
Q ss_pred hhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 914 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
. ...+......+.+++.+||+.+|++||+++++++.|+
T Consensus 221 -------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -------R-HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------c-ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 1122233467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.45 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=202.1
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+|+..+.||+|+||.||+|.. .+++.+|+|++.... .......+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 367788999999999999976 468889999985432 223456788999999999999999999999989999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-CeEEeeeccccccccCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-~vkl~DfGla~~~~~~~~ 843 (995)
+++++|.+++....+..+++..+.+++.|++.|+.|||+.+ |+||||+|+||++++++ .+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999997655566899999999999999999999777 99999999999998654 57999999998764322
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......++..|+|||...+..++.++||||+|+++|+|++|+.||..... .......... ...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~~~~~~-----------~~~ 219 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL----PALVLKIMSG-----------TFA 219 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch----HHHHHHHHhc-----------CCC
Confidence 12235688899999999888889999999999999999999999854321 1111111111 111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+||+.+|++|||++|+++.
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1233356678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.92 Aligned_cols=252 Identities=22% Similarity=0.292 Sum_probs=199.1
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.|++.+.||+|+||.||+|+.. +++.|++|.+... .......+.+|+.+++.++||||+++++++..+...++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 56888899999999999999774 4788999988432 333456688899999999999999999999989999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|..++... ...+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++...... .
T Consensus 91 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~ 164 (292)
T cd06644 91 CPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--L 164 (292)
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--c
Confidence 9999998887533 346889999999999999999999777 999999999999999999999999998754222 1
Q ss_pred ccccccccCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 845 ECMSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.......+++.|+|||++. ...++.++|||||||++|||++|+.||...... .......... .
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~--------~ 232 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKSE--------P 232 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----HHHHHHhcCC--------C
Confidence 1223456888999999874 345688999999999999999999998653221 1111111110 0
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+.. ..+...+..+.+++.+||+.+|++||+++|+++.
T Consensus 233 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 PTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011 1223455678899999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=307.80 Aligned_cols=252 Identities=29% Similarity=0.371 Sum_probs=204.1
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.|+..+.||+|+||.||+|... +++.||+|++...........+.+|++++++++||||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4566778999999999999775 688999998865444445567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
++++|.+++.... ..+++....+++.|++.|++|+|+ .+ ++||||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999997432 678899999999999999999997 66 99999999999999999999999999876532211
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC-CchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGD-GVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
....++..|+|||+..+..++.++||||+|+++|+|++|+.||..... .....+....... ....
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~ 222 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-----------EPPP 222 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-----------CCCC
Confidence 125688899999999888999999999999999999999999965422 1122222222211 1111
Q ss_pred CCCHH-HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKE-EAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+.. .+..+.++|.+||..+|++||++.++++.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 22222 66778999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.81 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=195.4
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEecc
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
+.....||+|+||.||+|+. .+++.||+|.+... .....+.+.+|++++++++|+||+++++++..++..++||||++
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 33446899999999999975 45778999987432 23345678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCCeEEeeeccccccccCCC
Q 001922 767 NGSLGEALHGKKGAFL--GWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS-AFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~-~~~vkl~DfGla~~~~~~~~ 843 (995)
+++|.+++.... ..+ ++..+..++.||+.|++|||+.+ |+||||||+||+++. ++.++|+|||.+.......
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 163 (268)
T cd06624 89 GGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN- 163 (268)
T ss_pred CCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCC-
Confidence 999999997432 233 78888899999999999999777 999999999999986 6789999999987653222
Q ss_pred CccccccccCcccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLR--VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
.......+++.|+|||++.+.. ++.++||||+|+++|+|++|+.||........ ..+... ....
T Consensus 164 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~~~~------------~~~~ 229 (268)
T cd06624 164 -PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMFKVG------------MFKI 229 (268)
T ss_pred -CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHhhhh------------hhcc
Confidence 1223345889999999986543 78899999999999999999999964322111 111000 0011
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
....+...+..+.+++.+||+.+|++||++.|+++.
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 122344566778999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=313.46 Aligned_cols=260 Identities=20% Similarity=0.298 Sum_probs=186.9
Q ss_pred CCCeeeccCceEEEEEEeC---CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEe--cCCcceEEEEe
Q 001922 690 DGNVIGRGGAGIVYHGKMP---NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS--NKETNLLVYEY 764 (995)
Q Consensus 690 ~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lv~e~ 764 (995)
.+.+||+|+||+||+|+.. ++..||+|.+... .....+.+|++++++++||||+++++++. .+...++||||
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCC---CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 3468999999999999864 4578999988532 22345788999999999999999999884 35577999999
Q ss_pred ccCCChhhhhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----CCCCCeEEeeec
Q 001922 765 MRNGSLGEALHG-------KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL----NSAFEAHVADFG 833 (995)
Q Consensus 765 ~~~gsL~~~l~~-------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill----~~~~~vkl~DfG 833 (995)
+.+ +|.+++.. .....+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 865 78777642 12235788999999999999999999777 9999999999999 566789999999
Q ss_pred cccccccCCCC-ccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc---------hHHHH
Q 001922 834 LAKFLIDGGAS-ECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV---------DIVQW 902 (995)
Q Consensus 834 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~---------~~~~~ 902 (995)
+++........ .......+|+.|+|||++.+ ..++.++||||+||++|||+||+.||....... .....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 99875433211 12234578999999999876 457899999999999999999999996432111 01111
Q ss_pred HHHHhcCChhhhhh------------hc-CCcC---------CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 903 SKRATNGRKEEFLS------------IL-DPRL---------SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 903 ~~~~~~~~~~~~~~------------~~-d~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
...........+.. .. .... ..........+.+++.+|++.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 11000000000000 00 0000 0001112345788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.93 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=195.4
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC----CChhHHHHHHHHHHhccCCCCceeEeEEEec--CCcce
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT----HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN--KETNL 759 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 759 (995)
.|+..+.||+|+||.||+|.. .++..||+|++..... ......+.+|+.++++++||||+++++++.+ ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 477889999999999999976 4588999998743221 1223467889999999999999999998865 35678
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
++|||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++...
T Consensus 83 l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 83 IFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 99999999999999963 345788999999999999999999777 9999999999999999999999999987653
Q ss_pred cCCC-CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 840 DGGA-SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 840 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.... ........++..|+|||++.+..++.++||||+||++||+++|+.||......... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~----~~~~~~--------- 224 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI----FKIATQ--------- 224 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH----HHHhcC---------
Confidence 2111 11122345888999999999888999999999999999999999999653221111 111111
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
+.....+......+..++ +||..+|++||+++||++
T Consensus 225 -~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 -PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111223444556677777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=310.17 Aligned_cols=264 Identities=21% Similarity=0.251 Sum_probs=200.0
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
|+..+.||.|+||.||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 677889999999999999764 68899999885332 2223456889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
. ++|.+++....+..+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.+||+|||++....... .
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 155 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--R 155 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--c
Confidence 6 58999987666677899999999999999999999777 9999999999999999999999999987653221 1
Q ss_pred cccccccCcccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh------------
Q 001922 846 CMSAIAGSYGYIAPEYAYTLR-VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE------------ 912 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~------------ 912 (995)
......+++.|+|||+..+.. ++.++||||||+++|||+||+.||....+.....+...........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 123345688999999887644 5889999999999999999999996543322222222211111000
Q ss_pred -hhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 913 -EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 913 -~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+............+..+..+.+++.+|++.||++||+++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000001111234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=310.59 Aligned_cols=264 Identities=23% Similarity=0.259 Sum_probs=197.8
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+|+..+.||+|+||.||+|+.. +|+.||+|++.... .......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677789999999999999764 68899999984322 222335577899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
++ ++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 97 4888877533 456899999999999999999999877 9999999999999999999999999988653221
Q ss_pred ccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh-hhh---hhhcC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK-EEF---LSILD 919 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~d 919 (995)
.......++..|+|||++.+. .++.++||||+||++|||++|+.|+....+................ ..+ ....+
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 122334678899999988764 4689999999999999999999997543332222221111111100 000 00000
Q ss_pred C-cCC---------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 P-RLS---------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ~-~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. ... ...+..+..+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 000 0112345678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.43 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=200.9
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC----CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT----HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
+|+..+.||+|+||.||+|... +++.|++|.+..... ....+.+.+|+++++.++||||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999775 789999998743221 12345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++++|.+++.. ...+++..+..++.|++.|++|||+.+ |+||||+|+||+++.++.+||+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 999999999999963 345889999999999999999999877 999999999999999999999999998765332
Q ss_pred CCCccccccccCcccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLR-VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
. ......++..|+|||.+.... ++.++|+||+|+++|++++|+.||......... ...... .
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~----------~ 218 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV----FKIGRS----------K 218 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH----HHHHhc----------c
Confidence 2 223456889999999987766 899999999999999999999999654311111 111110 1
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.....+...+..+.+++.+||+.+|++||+++++++
T Consensus 219 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 112233345677889999999999999999999976
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.32 Aligned_cols=238 Identities=23% Similarity=0.389 Sum_probs=187.5
Q ss_pred CeeeccCceEEEEEEeCCCc-----------EEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 692 NVIGRGGAGIVYHGKMPNGV-----------EIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999875433 4677766432221 5678899999999999999999999987 77899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-------CeEEeeec
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-------EAHVADFG 833 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-------~vkl~DfG 833 (995)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 78 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 78 VEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999999743 236889999999999999999999777 99999999999999888 79999999
Q ss_pred cccccccCCCCccccccccCcccccccccccC--CCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCC
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTL--RVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGR 910 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 910 (995)
++..... .....++..|+|||++.+. .++.++||||+|+++||+++ |..||..... .....+.. ..
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~~~~~~~~---~~- 222 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-SEKERFYQ---DQ- 222 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-hhHHHHHh---cC-
Confidence 9986532 1234567789999998876 78999999999999999999 5777755321 11111111 00
Q ss_pred hhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 911 KEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 911 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
..... .....+.+++.+||..+|++||++.++++.|+
T Consensus 223 ---------~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 ---------HRLPM---PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---------CCCCC---CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00011 11267889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.48 Aligned_cols=265 Identities=25% Similarity=0.290 Sum_probs=201.5
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+|+..+.||+|+||.||+|+. .+|+.||+|++..... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 367788999999999999976 4689999999854332 33356788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+ +++|.+++... ...+++..++.++.||+.|++|||+.+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 99999998643 356899999999999999999999777 99999999999999999999999999987643321
Q ss_pred ccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh-------
Q 001922 845 ECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS------- 916 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------- 916 (995)
.......++..|+|||++.+. .++.++||||+|+++|||++|..||....+..................+..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 122345688999999988654 468999999999999999999887754332221111111111110000000
Q ss_pred --hcCCcC-----CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 917 --ILDPRL-----SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 917 --~~d~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+.. .....+.+..+.+++.+|++.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 00111345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=295.17 Aligned_cols=259 Identities=22% Similarity=0.280 Sum_probs=221.2
Q ss_pred hccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEE-ecCCcce
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC-SNKETNL 759 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~ 759 (995)
+++...++.+|.||.||.|.|. +.+.|.||.++...++.+...+..|.-.+..+.|||+.++.+++ ++.+..+
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~ 364 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF 364 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence 4566678999999999999543 45678899998878888888899999999999999999999987 4566789
Q ss_pred EEEEeccCCChhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeec
Q 001922 760 LVYEYMRNGSLGEALHG------KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFG 833 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfG 833 (995)
.++.++.-|.|..++.. ...+.++..+...++.|++.|++|||+++ |||.||.++|+++|+...|||+|-.
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccch
Confidence 99999999999999972 23456777788899999999999999888 9999999999999999999999999
Q ss_pred cccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
+++++.+++++.-.+....+..||+||.+.+..|+.++|||||||++|||+| |+.||.+ .+..+....
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae----IDPfEm~~y------- 510 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE----IDPFEMEHY------- 510 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc----cCHHHHHHH-------
Confidence 9999999998888788888999999999999999999999999999999999 9999853 222222222
Q ss_pred hhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 913 EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 913 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
+.|+..-..|.+|+.++..+|.-||+.+|++||++++++..|.++..
T Consensus 511 ----lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 511 ----LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred ----HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 22233334677899999999999999999999999999999998754
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=305.08 Aligned_cols=250 Identities=24% Similarity=0.306 Sum_probs=203.2
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.+.|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.++++++||||+++++++.+++..++|||
T Consensus 3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 45677888999999999999975 46889999987543333345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999999853 35789999999999999999999777 99999999999999999999999999876533221
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......++..|+|||...+..++.++||||+||++|+|++|..||..... ......+... ...
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~-----------~~~ 219 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVLFLIPKN-----------NPP 219 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHHHHHhcC-----------CCC
Confidence 12334678899999999888889999999999999999999999864321 1111111111 111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+||+.+|++||++++++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2233456778899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=320.01 Aligned_cols=190 Identities=24% Similarity=0.316 Sum_probs=161.7
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
..|+..+.||+|+||.||+|+.. +++.||+|.... .....|+.++++++||||+++++++......++||||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 35888999999999999999774 467888887422 1235699999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+. ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 139 ~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 139 YS-SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred cC-CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 95 588888863 3456899999999999999999999877 999999999999999999999999998753211
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPV 890 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf 890 (995)
.......||+.|+|||++.+..++.++||||+||++|||+++..|+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999965554
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.33 Aligned_cols=253 Identities=22% Similarity=0.283 Sum_probs=201.2
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++||||+++++++..+...|+|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 356788889999999999999764 6889999988432 33344568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++... ...+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 83 FCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred ccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 99999999998642 346899999999999999999999877 999999999999999999999999998764322
Q ss_pred CccccccccCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 844 SECMSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
........+++.|+|||++. ...++.++||||+|+++|||++|+.||......... ........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~------- 225 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL----LKILKSEP------- 225 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH----HHHhcCCC-------
Confidence 11223456899999999874 345678999999999999999999999654221111 11111100
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+.. ..+...+..+.+++.+||+.+|++||++.++++.
T Consensus 226 -~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 -PTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001 1233455678899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.06 Aligned_cols=247 Identities=24% Similarity=0.253 Sum_probs=202.9
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.|+.-++||+|+||.||-++. .+|+-||.|++.+. ...........|-+|++++..+.||.+-.+|+..+.+++|+.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 456668999999999999965 46888999887322 122233446789999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
.|.||+|.-++.......+++..+.-++.+|+.||++||+.+ ||.||+||+|||+|+.|+|+|+|.|+|..+.++..
T Consensus 266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 999999999998766678999999999999999999999877 99999999999999999999999999998866543
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
. ...+||.+|||||++.++.|+..+|.||+||++|||+.|+.||......+...+.-+++.. .-.
T Consensus 343 ~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~------------~~~ 407 (591)
T KOG0986|consen 343 I---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE------------DPE 407 (591)
T ss_pred c---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc------------chh
Confidence 3 4458999999999999999999999999999999999999999653322222111111111 112
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRM 951 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~ 951 (995)
.++...+++...+....++.||++|--.
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccC
Confidence 3456677888999999999999999743
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.07 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=198.3
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEec------C
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSN------K 755 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~------~ 755 (995)
....|+..+.+|+|+||.||+|+. .+++.+|+|.+... ......+..|+.+++++ +||||+++++++.. .
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 346788889999999999999976 46788999987432 22345678899999998 69999999999842 4
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccc
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA 835 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla 835 (995)
+..|+||||+.+|+|.+++.......+++..+..++.|++.|++|||+.+ |+||||+|+||++++++.++|+|||++
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcch
Confidence 57799999999999999997655667888889999999999999999777 999999999999999999999999998
Q ss_pred cccccCCCCccccccccCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCC
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 910 (995)
....... .......|++.|+|||.+. ...++.++||||+||++|||++|+.||........... ....
T Consensus 169 ~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~- 241 (282)
T cd06636 169 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRN- 241 (282)
T ss_pred hhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhC-
Confidence 7643211 1223456889999999875 34678899999999999999999999965332111110 0000
Q ss_pred hhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 911 KEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 911 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..........+..+.+++.+||+.||.+||++.|+++
T Consensus 242 ---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 ---------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0111122245667999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=302.74 Aligned_cols=254 Identities=25% Similarity=0.390 Sum_probs=201.9
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC-----ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH-----SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
.|+.++.||+|+||.||+|+. .+++.||+|.+...... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 367788999999999999975 57899999988533211 124568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-CeEEeeeccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLAKFLI 839 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-~vkl~DfGla~~~~ 839 (995)
||||+++++|.+++.. ...+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++ .+||+|||.+..+.
T Consensus 81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 9999999999999963 346788999999999999999999877 99999999999998876 58999999998764
Q ss_pred cCCCC--ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 840 DGGAS--ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 840 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
..... .......++..|+|||.+.+..++.++||||+|+++|++++|..||......... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~-------- 226 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL-ALIFKIASA-------- 226 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-HHHHHHhcc--------
Confidence 33211 1112346888999999998888999999999999999999999999643221111 111111100
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
......+...+..+.+++.+|++.+|++||++.|+++
T Consensus 227 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 --TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1112344556778999999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=311.85 Aligned_cols=252 Identities=23% Similarity=0.252 Sum_probs=201.4
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC--ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
+|+..+.||+|+||+||+|... +++.||+|.+...... .....+..|+++++.++||||+++++++.+....|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5777889999999999999765 5899999998543322 234568889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+.+++|.+++....+..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999997655677899999999999999999999877 99999999999999999999999999875432111
Q ss_pred Cc---------------------------cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 001922 844 SE---------------------------CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG 896 (995)
Q Consensus 844 ~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~ 896 (995)
.. ......|+..|+|||+..+..++.++||||+|+++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 00 111235788999999999888999999999999999999999999643322
Q ss_pred chHHHHHHHHhcCChhhhhhhcCCcCCC-CCHHHHHHHHHHHhcccCCCCCCCCC----HHHHHH
Q 001922 897 VDIVQWSKRATNGRKEEFLSILDPRLSM-VPKEEAMHLLFVAMLCIQENSIERPR----MREVVQ 956 (995)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~ 956 (995)
.... .+.+..... .....+..+.+++.+|++.+|++||+ ++|+++
T Consensus 239 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ETFS---------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHH---------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1111 111111110 11125678999999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.15 Aligned_cols=253 Identities=27% Similarity=0.386 Sum_probs=200.0
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCC-----
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKE----- 756 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~----- 756 (995)
..++|+..+.||+|+||.||+|+.+ +++.+++|.+.... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 3578899999999999999999874 57889999875432 2346789999999999 6999999999996544
Q ss_pred -cceEEEEeccCCChhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeec
Q 001922 757 -TNLLVYEYMRNGSLGEALHGKK--GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFG 833 (995)
Q Consensus 757 -~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfG 833 (995)
..++||||+++++|.+++.... +..+++..++.++.|++.|+.|||+.+ ++||||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999999986433 567899999999999999999999777 9999999999999999999999999
Q ss_pred cccccccCCCCccccccccCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhc
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYT-----LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN 908 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 908 (995)
++....... .......++..|+|||++.. ..++.++||||+|+++|+|++|+.||..........+ ...
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~ 232 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK----IPR 232 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH----hhc
Confidence 987653321 22234568899999998753 3467899999999999999999999965322221111 111
Q ss_pred CChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 909 GRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 909 ~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.. .+.. ..+...+..+.+++.+||+.||++|||++++++
T Consensus 233 ~~--------~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 NP--------PPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cC--------CCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10 0011 112335678899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.80 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=199.9
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
..+.|.....||+|+||.||++.. .++..||+|++.. ......+.+.+|+.+++.++||||+++++.+..++..|+||
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL-RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec-chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 344555567799999999999976 4688999998743 22334556889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++++|.+++.. ..+++..+..++.||+.|++|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 99 e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 99 EFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred eCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 99999999998853 35788999999999999999999777 9999999999999999999999999987653221
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
.......++..|+|||...+..++.++||||+|+++|||++|+.||......... ..... ...+..
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~----~~~~~--------~~~~~~ 238 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM----RRIRD--------NLPPRV 238 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHh--------cCCCcc
Confidence 1223456889999999998888999999999999999999999999643221111 11110 111111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. .....+..+.+++.+|++.||++|||++|+++.
T Consensus 239 ~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 K-DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c-cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1 112345578899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=303.79 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=199.4
Q ss_pred ccCCCeeeccCceEEEEEEeCC--CcEEEEEEecCCC---------CCChhHHHHHHHHHHhc-cCCCCceeEeEEEecC
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPN--GVEIAVKKLLGFG---------THSHDHGFRAEIQTLGN-IRHRNIVRLLAFCSNK 755 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~ 755 (995)
|+..+.||+|+||.||+|.... ++.+|+|.+.... ......++.+|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5677889999999999998754 6789999874221 11223456678887765 7999999999999999
Q ss_pred CcceEEEEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCCCCeEEeee
Q 001922 756 ETNLLVYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNSAFEAHVADF 832 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~~~~vkl~Df 832 (995)
+..++||||+++++|.+++.. .....+++..+++++.|++.|+.|||+ .+ ++||||+|+||+++.++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999998753 234568899999999999999999995 45 999999999999999999999999
Q ss_pred ccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
|.+....... ......++..|+|||++.+..++.++||||||+++|||++|+.||..... ............
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~- 230 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM----LSLATKIVEAVY- 230 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH----HHHHHHHhhccC-
Confidence 9998654332 23455688999999999988899999999999999999999999854221 111111111100
Q ss_pred hhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 913 EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 913 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
. +......+..+.+++.+||+.||++||++.|+.+++++
T Consensus 231 ------~---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 ------E---PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ------C---cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0 00111345678899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=301.81 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=206.5
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
+|+..+.||+|++|.||+|+.. +++.|++|++...........+.+|+.++++++|||++++++++..++..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 4677889999999999999775 589999999855443344677899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
++++|.+++... ..+++..+..++.|+++|++|+|+ .+ ++||||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 82 DGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999999643 568999999999999999999997 66 999999999999999999999999999876432221
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
.....++..|+|||...+..++.++||||||+++|+|++|+.||...... ...+...... ......
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~-----------~~~~~~ 222 (264)
T cd06623 157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAIC-----------DGPPPS 222 (264)
T ss_pred --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHh-----------cCCCCC
Confidence 12456789999999999888999999999999999999999999664321 1111111111 111122
Q ss_pred CCHH-HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 925 VPKE-EAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 925 ~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+.. .+..+.+++.+|++.+|++||++.|+++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 2333 66789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=315.24 Aligned_cols=252 Identities=21% Similarity=0.306 Sum_probs=203.0
Q ss_pred hccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEecc
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
.|++...+|.|+||.||+|..++...+|.-++.........+.+.-|++|+....||+||++++.|...+.++|..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 45566779999999999998776555554444355566667889999999999999999999998888899999999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
||-.+.++-. -+..+++.++.-++.|++.||.|||++. |||||+|+.|||++-+|.++++|||.+.... .....
T Consensus 113 GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qk 186 (1187)
T KOG0579|consen 113 GGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQK 186 (1187)
T ss_pred CchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHHhh
Confidence 9999888763 3567899999999999999999999666 9999999999999999999999999886532 23344
Q ss_pred ccccccCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 847 MSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
..+..|||+|||||+.. ..+|+.++||||||+++.||..+.+|-.....-..+ -.+.... |.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl----lKiaKSe---------PP 253 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL----LKIAKSE---------PP 253 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH----HHHhhcC---------CC
Confidence 56788999999999854 678999999999999999999999997543221111 1222211 11
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
--..|...+..+.+++.+|+..+|..||++.+++++
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 112355677889999999999999999999998764
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=281.57 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=198.2
Q ss_pred cCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEEEecc
Q 001922 689 KDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 689 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
+....+|.|+.|.||+++.+ .|...|||.+.+........++...+.++..-. +|.||+.+|+|..+..+++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 44567999999999999875 578899999977766666777888888776664 8999999999999999999999984
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
. -+..++. +-.+++++...-++...++.||.||.+++ +|+|||+||+|||+|+.|.+|+||||++-++.+...
T Consensus 175 ~-C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--- 247 (391)
T KOG0983|consen 175 T-CAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--- 247 (391)
T ss_pred H-HHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc---
Confidence 3 4455554 34566889888899999999999998755 599999999999999999999999999988765433
Q ss_pred ccccccCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 847 MSAIAGSYGYIAPEYAYT---LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.+...|.+.|||||.+.. ..|+.++||||||+.++|+.||+.||..-..+.+....+ .... .|.++
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv---ln~e--------PP~L~ 316 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV---LNEE--------PPLLP 316 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH---HhcC--------CCCCC
Confidence 345689999999998864 468899999999999999999999997643333222111 1111 12221
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. ....+..+.+++..|++.|+.+||.+.+++++
T Consensus 317 ~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 G-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred c-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 11267789999999999999999999999875
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=305.84 Aligned_cols=264 Identities=21% Similarity=0.240 Sum_probs=196.0
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
..|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.+++.++|+||+++++++.+++..|+||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 5678889999999999999965 468899999985443333345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+. +++.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 157 (291)
T cd07870 85 MH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-- 157 (291)
T ss_pred cc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC--
Confidence 96 6777776533 345778888899999999999999877 9999999999999999999999999987542211
Q ss_pred ccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC-Chhhh--------
Q 001922 845 ECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG-RKEEF-------- 914 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~-------- 914 (995)
.......+++.|+|||++.+. .++.++||||+||++|||++|+.||....+.............. ....+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 112334578899999998754 57889999999999999999999997544322211111111000 00000
Q ss_pred -hhhcC----C-cCCC--CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 915 -LSILD----P-RLSM--VPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 915 -~~~~d----~-~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..... + .... .....+..+.+++.+|++.||++|||++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000 0 0000 00012457889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.52 Aligned_cols=254 Identities=27% Similarity=0.349 Sum_probs=198.3
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecC-----C
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNK-----E 756 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-----~ 756 (995)
..++|+..+.||+|+||.||+|.. .+++.+|+|.+... ......+.+|+.+++++ +|||++++++++... +
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 356788889999999999999976 46889999988432 22345678899999999 799999999998643 3
Q ss_pred cceEEEEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 757 TNLLVYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
..++||||+++++|.++++. ..+..+++..++.++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeeccc
Confidence 57999999999999998853 23456889999999999999999999777 99999999999999999999999999
Q ss_pred ccccccCCCCccccccccCcccccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTL-----RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
+........ ......++..|+|||++... .++.++||||+||++|||++|+.||...........+ ...
T Consensus 175 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~----~~~ 248 (291)
T cd06639 175 SAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI----PRN 248 (291)
T ss_pred chhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH----hcC
Confidence 886543221 12334688999999987543 3678999999999999999999999654322222111 111
Q ss_pred ChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 910 RKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 910 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.. +.. ..+......+.+++.+||+.+|++||++.|++++
T Consensus 249 ~~--------~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 249 PP--------PTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CC--------CCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 001 1122345578999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=308.64 Aligned_cols=262 Identities=24% Similarity=0.298 Sum_probs=199.0
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC----ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH----SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
|+..+.||+|+||.||+|... +++.||+|++...... .....+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 667788999999999999764 6899999998543322 12345678999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+ +|+|.+++.... ..+++..+..++.||++||.|||+++ |+||||+|+||+++.++.++|+|||+++......
T Consensus 82 e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 82 EFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred ccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 999 889999996433 46899999999999999999999877 9999999999999999999999999998764322
Q ss_pred CCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh-----
Q 001922 843 ASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS----- 916 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 916 (995)
.......+++.|+|||.+.+ ..++.++||||+||++|||++|..||....+..................+..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 --RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred --ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 12233456788999998864 4578999999999999999999877765433222222211111110000000
Q ss_pred -hcC------CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 917 -ILD------PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 917 -~~d------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
... ..........+..+.+++.+||+.+|++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000 0001111234677889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=303.71 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=199.1
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC---CCCceeEeEEEecCCcceEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR---HRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~ 762 (995)
.|+..+.||+|+||.||+|.+ .+++.||+|.+...........+.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778899999999999976 5688999998854444445567889999999996 999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ |+||||+|+||++++++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999999853 36889999999999999999999877 9999999999999999999999999998765433
Q ss_pred CCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
. ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.||..... .......... .
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~-----------~ 218 (277)
T cd06917 156 S--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA----FRAMMLIPKS-----------K 218 (277)
T ss_pred c--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh----hhhhhccccC-----------C
Confidence 1 22344688999999988654 568999999999999999999999964321 1111111110 0
Q ss_pred CCCCCH-HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 922 LSMVPK-EEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 922 ~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
....+. ..+..+.+++.+||+.||++||++.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 011111 24567889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=301.64 Aligned_cols=251 Identities=27% Similarity=0.360 Sum_probs=197.1
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC----CChhHHHHHHHHHHhccCCCCceeEeEEEecC--Ccce
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT----HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETNL 759 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 759 (995)
.|+..+.||+|+||.||.|.. .+++.||+|.+..... ......+.+|++++++++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 577889999999999999976 4588999998743211 11235678899999999999999999998664 4678
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+||||+++++|.+++... ..+++....+++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++...
T Consensus 83 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 999999999999998632 45788888999999999999999777 9999999999999999999999999988653
Q ss_pred cCCC-CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 840 DGGA-SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 840 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.... ........++..|+|||++.+..++.++|||||||++|||++|+.||......... . ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~-~~~~---------- 223 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI---F-KIAT---------- 223 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH---H-HHhc----------
Confidence 2111 11223456889999999998888999999999999999999999999653211111 1 1111
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+.....+......+.+++.+|+. +|++||+++|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 224 QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111123455666788889999995 99999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=289.14 Aligned_cols=248 Identities=23% Similarity=0.228 Sum_probs=201.5
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCC--hhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHS--HDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.|+..+++|+|.||+|..++. .+|+.||+|++++..... .......|-++++..+||.+..+...|+..++.|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 4566678999999999999975 468899999986544332 2334567899999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||..||.|+-++.+ ...+++...+-+-.+|+.||.|||+++ ||.||+|.+|.|+|.+|.+||+|||+++.- ..
T Consensus 248 eyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--IK 320 (516)
T ss_pred EEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--cc
Confidence 99999999999864 456888888889999999999999665 999999999999999999999999999852 23
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
....+.+.||||.|+|||++....|+.++|.|.+||++|||++|+.||+.-... .+.+.+ -..-
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-kLFeLI---------------l~ed 384 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-KLFELI---------------LMED 384 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-HHHHHH---------------Hhhh
Confidence 344567899999999999999999999999999999999999999999753221 111111 1111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQ 956 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 956 (995)
-..|...+++...++...+..||.+|. .++||.+
T Consensus 385 ~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 385 LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 124555667788899999999999995 4666654
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=304.78 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=192.9
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHH-HhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQT-LGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
.|+..+.||+|+||.||+|+.. +|+.||+|++..........++..|+.+ ++..+||||+++++++..++..|+||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 4677789999999999999764 6899999998544333334455566665 5666899999999999999999999999
Q ss_pred ccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 765 MRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHD-CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 765 ~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
++ |+|.+++.. .....+++..++.++.|++.|++|||++ + ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 96 588887753 2345789999999999999999999975 5 999999999999999999999999998865322
Q ss_pred CCCccccccccCccccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 842 GASECMSAIAGSYGYIAPEYAYT----LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
. ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||........ .... ....
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~-~~~~-------- 223 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ--QLKQ-VVEE-------- 223 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH--HHHH-HHhc--------
Confidence 1 1123468889999998764 4568899999999999999999999964322211 1111 1100
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..+. ......+..+.+++.+||+.+|++||+++++++
T Consensus 224 ~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQ--LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011 111234567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=332.56 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=194.3
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec------
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN------ 754 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------ 754 (995)
+.....|+..++||+||||.||+++.+ ||+.||||++.-.........+.+|++.+.++.|||||+++..|.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 444566777889999999999999864 8999999999544445556678899999999999999998533200
Q ss_pred ------------------------------------------------------------------------C-------
Q 001922 755 ------------------------------------------------------------------------K------- 755 (995)
Q Consensus 755 ------------------------------------------------------------------------~------- 755 (995)
+
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 001922 756 ----------------------------------ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801 (995)
Q Consensus 756 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~L 801 (995)
...||-||||+...+.+++++.... -.....|++++||++|++|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHH
Confidence 1137889999998888887643211 15677899999999999999
Q ss_pred HhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc----------------cCCCCccccccccCcccccccccccC
Q 001922 802 HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI----------------DGGASECMSAIAGSYGYIAPEYAYTL 865 (995)
Q Consensus 802 H~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~ 865 (995)
|++| ||||||||.||+++++..|||+|||+|+... .+......+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9888 9999999999999999999999999998722 01112234567899999999998765
Q ss_pred C---CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccC
Q 001922 866 R---VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQ 942 (995)
Q Consensus 866 ~---~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~ 942 (995)
. |+.|+|+||+|||++||+. ||. ..++..........+.-+.. .+...+....-..+|.+|++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~---TsMERa~iL~~LR~g~iP~~--------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFG---TSMERASILTNLRKGSIPEP--------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCC---chHHHHHHHHhcccCCCCCC--------cccccccchHHHHHHHHHhc
Confidence 4 9999999999999999984 554 34444444444433211111 11133334445679999999
Q ss_pred CCCCCCCCHHHHHH
Q 001922 943 ENSIERPRMREVVQ 956 (995)
Q Consensus 943 ~dP~~RPt~~evl~ 956 (995)
.||.+||||.|++.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999986
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=303.73 Aligned_cols=259 Identities=24% Similarity=0.328 Sum_probs=200.6
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec--CCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN--KETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 763 (995)
.|+..+.||.|++|.||+|... +++.+|+|.+..........++.+|++++++++||||+++++++.+ .+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 4667789999999999999774 5788999988644444455678999999999999999999998854 346899999
Q ss_pred eccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 764 YMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 764 ~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|+++++|.+++.. .....+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999988753 23456788999999999999999999877 999999999999999999999999998765322
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC-chHHHHHHHHhcCChhhhhhhcCC
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG-VDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
. .....++..|+|||...+..++.++||||+|+++|+|++|+.||...... ....+...............
T Consensus 159 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 230 (287)
T cd06621 159 L----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD---- 230 (287)
T ss_pred c----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhcc----
Confidence 1 12345788999999999889999999999999999999999999754221 11112222111111111100
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. .......+..+.+++.+||+.+|++|||+.|+++.
T Consensus 231 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 231 E-PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred C-CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 00011245678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=315.47 Aligned_cols=272 Identities=22% Similarity=0.301 Sum_probs=201.6
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecC-----Ccc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK-----ETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 758 (995)
.++|+..+.||+|+||.||+|.. .+|+.||+|++...........+.+|+.++++++||||+++++++... .+.
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46788899999999999999975 468999999985433344456688899999999999999999887544 357
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
|+||||+.+ ++.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999964 88887743 45899999999999999999999777 999999999999999999999999999865
Q ss_pred ccCCCCc-cccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 839 IDGGASE-CMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 839 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
....... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...........+.........+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 4322111 1233568899999998654 5688999999999999999999999965322111111111111111111111
Q ss_pred hcCCc----------CCCC-----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCCC
Q 001922 917 ILDPR----------LSMV-----PKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFPR 963 (995)
Q Consensus 917 ~~d~~----------~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 963 (995)
+.+.. .... .+..+..+.+++.+||+.+|++||+++|+++. ++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 11110 0000 11235668899999999999999999999986 555544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=305.82 Aligned_cols=264 Identities=21% Similarity=0.243 Sum_probs=199.1
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
|+..+.||.|++|.||+|.. .+|..||+|++..... ......+.+|++++++++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45678899999999999976 4789999998853322 223456888999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
+ ++|.+++.......+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--R 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--c
Confidence 5 69999987554457899999999999999999999777 9999999999999999999999999997653221 1
Q ss_pred cccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh---------hh
Q 001922 846 CMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE---------FL 915 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------~~ 915 (995)
......++..|+|||++.+. .++.++||||+|+++|+|++|+.||....+........+......... +.
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 11233568899999987654 578999999999999999999999965433222222221111110000 00
Q ss_pred h----hcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 916 S----ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 916 ~----~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. .............+..+.+++.+|++.+|++||+++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 00001111122344678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=311.36 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=207.3
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
....|.+.+.||+|.|++|..|++ .++.+||+|.+.+..- ......+.+|+++|..+.|||||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 355688899999999999999965 5689999999855433 23345588999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+.+|.+++++. +.+...+..+..++.|+.+|++|+|+++ |+|||||++||+++.+..+||+|||++.++.
T Consensus 134 ~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec--
Confidence 99999999999996 3455666888899999999999999777 9999999999999999999999999999875
Q ss_pred CCCccccccccCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
......+.+|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||++.. +.....+... .
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~----lk~Lr~rvl~-----------g 270 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN----LKELRPRVLR-----------G 270 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc----cccccchhee-----------e
Confidence 3345567899999999999999887 589999999999999999999996521 1111011110 0
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. -.++.-.+.++.+++++++-.+|.+|++.+++.+.
T Consensus 271 k-~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 K-YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred e-ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1 12344556678899999999999999999999865
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.35 Aligned_cols=263 Identities=23% Similarity=0.319 Sum_probs=199.2
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
.|+..+.||+|+||.||+|..+ +++.||+|++...... ...+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5777899999999999999875 5889999987543222 2345688899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
++++++.++... ...+++..+..++.|++.|++|||+.+ |+||||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-- 154 (286)
T cd07846 82 VDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 154 (286)
T ss_pred CCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence 999999887753 334889999999999999999999877 9999999999999999999999999988654322
Q ss_pred ccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc-----
Q 001922 845 ECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL----- 918 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 918 (995)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||............. ..............
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII-KCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-HHhCCCchhhHHHhccchH
Confidence 12233467889999998875 447889999999999999999999986432211111111 11110000000000
Q ss_pred -----CCcCC------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 919 -----DPRLS------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 919 -----d~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+... ...+..+..+.+++.+||+.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 0112346779999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=306.39 Aligned_cols=263 Identities=24% Similarity=0.287 Sum_probs=200.5
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778899999999999999765 57899999875422 233356788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
++++.+..+.. ....+++..+..++.|++.|+.|||+.+ |+|||++|+||++++++.+||+|||++.........
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 82 VERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 99877766553 2345889999999999999999999877 999999999999999999999999998876443221
Q ss_pred ccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc--CC-
Q 001922 845 ECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL--DP- 920 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--d~- 920 (995)
......++..|+|||++.+. .++.++||||+|+++|+|++|+.||.............. ............. ++
T Consensus 157 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 157 -PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQK-CLGPLPPSHQELFSSNPR 234 (288)
T ss_pred -cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhCCCCHHHhhhcccCcc
Confidence 22345678899999999887 789999999999999999999999965432211111111 1100000000000 00
Q ss_pred ----cC----------CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 921 ----RL----------SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 921 ----~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.. ...+...+..+.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 0112234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.64 Aligned_cols=249 Identities=21% Similarity=0.304 Sum_probs=198.5
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.|+....||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.+++.++|||++++++++..++..++||||+
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec-ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 344455799999999999976 46889999998432 2333566889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++.. ..+++..++.++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 101 ~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~ 172 (297)
T cd06659 101 QGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 172 (297)
T ss_pred CCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence 99999998753 35789999999999999999999777 9999999999999999999999999987553321 1
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
......++..|+|||++.+..++.++||||+|+++|||++|+.||....... .......... + ....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~--------~-~~~~ 239 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----AMKRLRDSPP--------P-KLKN 239 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhccCC--------C-Cccc
Confidence 1234568899999999998889999999999999999999999996432211 1111111100 0 0011
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
....+..+.+++.+|++.+|++||+++++++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 12344568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=306.62 Aligned_cols=245 Identities=24% Similarity=0.260 Sum_probs=200.0
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
+|+..+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5777889999999999999764 68999999885322 12335668899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 82 YVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred cCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999964 357889999999999999999999877 999999999999999999999999999875432
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.....+++.|+|||.+.+...+.++||||+|+++|+|++|+.||.... ........... . .
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-----------~-~ 215 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN----PIQIYEKILEG-----------K-V 215 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcC-----------C-c
Confidence 234468899999999988888999999999999999999999996432 11111111111 1 1
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
..+...+..+.+++.+||+.+|.+|| +++|+++.
T Consensus 216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 12333467788999999999999999 77777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=313.58 Aligned_cols=298 Identities=23% Similarity=0.264 Sum_probs=213.9
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCC-CCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecC--Cc
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGF-GTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNK--ET 757 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~ 757 (995)
.+.++|+..+.||+|+||.||+|... +++.+|+|++... ........+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35678888999999999999999764 5788999988432 2223345577899999999 999999999988543 46
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.|+||||++ ++|..++... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 799999997 5999988532 6788899999999999999999777 99999999999999999999999999987
Q ss_pred cccCCCC---ccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh--
Q 001922 838 LIDGGAS---ECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK-- 911 (995)
Q Consensus 838 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-- 911 (995)
+...... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.....................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433221 12234568899999998765 45789999999999999999999999654322221111111110000
Q ss_pred ---------hhhhhhcC-CcC---CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCCCCCcccccCchhhh
Q 001922 912 ---------EEFLSILD-PRL---SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFPRHSSDFNQSSSSSL 976 (995)
Q Consensus 912 ---------~~~~~~~d-~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~~~~~~~~~~~~~ 976 (995)
..+...+. ... ....+..+..+.+++.+||+.+|++||+++++++. ++.+... ....++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~--~~~~~~~~~~ 314 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP--SDEPVLPYPI 314 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC--CCCCCCCCCc
Confidence 00000000 000 01111246778999999999999999999999975 5555432 2233334444
Q ss_pred hcccCCCCCCCCc
Q 001922 977 KNLEKDPKGCPNN 989 (995)
Q Consensus 977 ~~~~~~~~~~~~~ 989 (995)
+.+..+++.-+.+
T Consensus 315 ~~~~~~~~~~~~~ 327 (337)
T cd07852 315 TIPLDDNVKLSVA 327 (337)
T ss_pred cCCccccceeeHH
Confidence 5566666554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=299.49 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=200.8
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+|+..+.||+|+||.||+|... +++.|++|.+...... .....+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999764 6889999998543322 3466789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++.. +...++..+..++.|++.|+.|||+.+ |+||||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 999999999963 345788899999999999999999877 999999999999999999999999999876433221
Q ss_pred cc--ccccccCcccccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 845 EC--MSAIAGSYGYIAPEYAYTLR---VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 845 ~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.. .....+++.|+|||++.+.. ++.++||||||+++|++++|+.||......... ........ .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~--------~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI---MFHVGAGH--------K 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH---HHHHhcCC--------C
Confidence 11 12356788999999988766 889999999999999999999999654322111 11111110 0
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
+..+. ....+..+.+++.+||+.+|++||++.|++.
T Consensus 225 ~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111 1123667889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=301.44 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=202.1
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+|+..+.||+|+||.||+|... +|..||+|.+.... .....+.+.+|++++++++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 3667789999999999999764 58889999884322 123455688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC-eEEeeeccccccccCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE-AHVADFGLAKFLIDGGA 843 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~-vkl~DfGla~~~~~~~~ 843 (995)
+++++|.+++....+..+++..+..++.|++.|+.|||+.+ |+||||||+||++++++. +|++|||.+....+..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999999997655556899999999999999999999777 999999999999998864 6999999988654322
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.......|++.|+|||+..+..++.++||||+|+++|||++|+.||... +..++....... ...
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~-----------~~~ 220 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN----NLHQLVLKICQG-----------YFA 220 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHHHHhcc-----------cCC
Confidence 1223346889999999998888999999999999999999999998542 222222222211 111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+|++.+|++||+++|+++.
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 2223345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=300.56 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=201.8
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEec--CCcceEEEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN--KETNLLVYE 763 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 763 (995)
|+..+.+|.|+||.||+|.. .+++.||+|.+.... .....+++..|++++++++||||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 66778899999999999965 467889999885332 23345568889999999999999999998753 456789999
Q ss_pred eccCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 764 YMRNGSLGEALHGK--KGAFLGWNLRYKIAIEAAKGLCYLHHDC--SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 764 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
|+++++|.+++... ....+++..++.++.|++.|++|+|..+ +.+|+||||+|+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999998642 2467899999999999999999999332 3339999999999999999999999999998764
Q ss_pred cCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+..
T Consensus 162 ~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~----------- 224 (265)
T cd08217 162 HDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----QLQLASKIKE----------- 224 (265)
T ss_pred CCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----HHHHHHHHhc-----------
Confidence 3321 1234568999999999998889999999999999999999999996532 1122222211
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
......+...+..+.+++.+|++.+|++||++++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 12223444567789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=340.74 Aligned_cols=259 Identities=26% Similarity=0.363 Sum_probs=209.4
Q ss_pred cHHHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCc
Q 001922 680 SVSDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET 757 (995)
Q Consensus 680 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 757 (995)
.++.+.-++..+..||.|.||.||.|.. .+|+-.|+|-++-.. .......+.+|..++..+.|||+|+++|+-...+.
T Consensus 1229 ~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred HhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 3444555777889999999999999965 568888999773222 23334557899999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.+|.||||++|+|.+.+. .+...++.....+..|++.|++|||++| ||||||||.||+++.+|.+|.+|||.|..
T Consensus 1309 v~IFMEyC~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHHhccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 999999999999999995 3455677777888999999999999888 99999999999999999999999999988
Q ss_pred cccCC--CCccccccccCcccccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 838 LIDGG--ASECMSAIAGSYGYIAPEYAYTL---RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 838 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
+.... .........||+.|||||++.+. ...-++||||+||++.||+||+.||..+.+... .+..+..+
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---IMy~V~~g--- 1457 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---IMYHVAAG--- 1457 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---HHhHHhcc---
Confidence 75542 12223457899999999998754 355789999999999999999999976544322 22222222
Q ss_pred hhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 913 EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 913 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+.+|...+.+-.+++.+|+..||++|+++.|+++.
T Consensus 1458 --------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 --------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2245666788888999999999999999999988764
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=307.65 Aligned_cols=256 Identities=21% Similarity=0.223 Sum_probs=198.3
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+++++.++||||+++++.+..+++.++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 4677889999999999999764 578999998854321 2234567889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++.. ...+++..+..++.|++.|+.|+|+.+ |+||||||+||+++.++.+|++|||+++.......
T Consensus 82 ~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 82 YVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999954 346889999999999999999999777 99999999999999999999999998863211000
Q ss_pred -------------CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCC
Q 001922 844 -------------SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910 (995)
Q Consensus 844 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 910 (995)
........++..|+|||.+.+..++.++|+||||+++||+++|+.||.... ..++........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~----~~~~~~~~~~~~ 232 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT----PEELFGQVISDD 232 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcc
Confidence 001112457889999999988889999999999999999999999996422 112222111110
Q ss_pred hhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 911 KEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 911 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
..........+..+.+++.+||+.+|++||++.++.+.++.
T Consensus 233 ---------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 ---------IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---------cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00111112355678999999999999999996656555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=302.81 Aligned_cols=245 Identities=26% Similarity=0.284 Sum_probs=195.2
Q ss_pred eeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCCh
Q 001922 694 IGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSL 770 (995)
Q Consensus 694 lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 770 (995)
||+|+||+||+|.. .+|+.||+|.+.... .......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999965 468899999884322 122344567899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcccccc
Q 001922 771 GEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850 (995)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 850 (995)
.+++.......+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||.+...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence 99997555457899999999999999999999877 999999999999999999999999998765331 122334
Q ss_pred ccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHH
Q 001922 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEA 930 (995)
Q Consensus 851 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 930 (995)
.++..|+|||+..+..++.++||||+|+++|+|++|+.||................. ......+...+
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~ 222 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL------------EMAVEYPDKFS 222 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc------------cccccCCccCC
Confidence 678899999999888899999999999999999999999965433222222111111 01112233456
Q ss_pred HHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 001922 931 MHLLFVAMLCIQENSIERP-----RMREVVQ 956 (995)
Q Consensus 931 ~~l~~li~~cl~~dP~~RP-----t~~evl~ 956 (995)
..+.+++.+||+.+|++|| ++.++++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 7789999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=303.71 Aligned_cols=265 Identities=20% Similarity=0.211 Sum_probs=198.9
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecC--CcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv 761 (995)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+..... ......+.+|+.++++++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56788899999999999999875 588899999853322 22234567899999999999999999998777 889999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..+...
T Consensus 85 ~e~~~~-~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999974 999988643 346899999999999999999999877 999999999999999999999999999876433
Q ss_pred CCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh----
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS---- 916 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---- 916 (995)
. .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.......................+..
T Consensus 160 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 160 L--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred c--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 2 112334578899999988754 468999999999999999999999975433222222111111100000000
Q ss_pred ----------hcCCcC-CCCCHH-HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 917 ----------ILDPRL-SMVPKE-EAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 917 ----------~~d~~~-~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....+ ...+.. .+..+.+++.+|++.+|++||+++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000 011111 36678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=302.46 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=200.2
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEecc
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
|+..+.||+|++|.||+|+.. +|+.||+|++...........+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 677889999999999999874 6889999998654444445667889999999999999999999999999999999998
Q ss_pred CCChhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 767 NGSLGEALHGKK-GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 767 ~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
+ +|.+++.... ...+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.++++|||++....... .
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~ 155 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--N 155 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--c
Confidence 5 8888876432 346899999999999999999999777 9999999999999999999999999997653221 1
Q ss_pred cccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC-----
Q 001922 846 CMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD----- 919 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d----- 919 (995)
......++..|+|||++.+. .++.++||||+|+++|+|++|+.||.......................+....+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 12334578899999987654 568899999999999999999999976443322222211111111111100000
Q ss_pred CcCC--------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 920 PRLS--------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 920 ~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.... ...+..+..+.+++.+|++.||++||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=301.68 Aligned_cols=248 Identities=23% Similarity=0.251 Sum_probs=201.9
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
+|+..+.||+|+||.||+|+.. +++.||+|.+.... .....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 3677789999999999999775 58999999985322 12345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+.+++|.+++... ..+++..+..++.|+++|+.|||+.+ |+|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999643 57889999999999999999999877 9999999999999999999999999988654332
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......|+..|+|||++.+..++.++|+||+|+++|+|++|+.||...... .......... ....
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~------------~~~~ 219 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQE------------TADV 219 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhc------------cccc
Confidence 223456888999999998888999999999999999999999999754332 1111111111 0112
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCH--HHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRM--REVV 955 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl 955 (995)
..+...+..+.+++.+||+.||.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 2334456789999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=303.56 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=198.6
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
+..+.|+..+.||+|+||+||+|+.. +++.||+|++..... ......+.+|+++++.++||||+++++++.+.+..+
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34456888899999999999999764 688999998843222 223356889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+||||+. |++.+++... ...+++..+..++.|++.|+.|||+.+ |+||||+|+||++++++.++|+|||++....
T Consensus 92 lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 92 LVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9999997 5777777532 346899999999999999999999777 9999999999999999999999999987642
Q ss_pred cCCCCccccccccCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAY---TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
.. ....+++.|+|||++. ...++.++||||||+++|||++|+.||...... .........
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~----~~~~~~~~~------- 229 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQN------- 229 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH----HHHHHHhcC-------
Confidence 21 2346788999999874 456889999999999999999999998643211 111111111
Q ss_pred hcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 001922 917 ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQML 958 (995)
Q Consensus 917 ~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 958 (995)
......+...+..+.+++.+||+.+|++||++++++.+.
T Consensus 230 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 230 ---DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ---CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 011112334567799999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=305.11 Aligned_cols=265 Identities=20% Similarity=0.252 Sum_probs=197.2
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
++|+..+.||+|++|+||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++.++...|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46778889999999999999764 688999998843322 2234568889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCCeEEeeeccccccccCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS-AFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~-~~~vkl~DfGla~~~~~~~ 842 (995)
|++ +++.+++........++..+..++.||+.||+|||+++ |+||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 996 58888886544455688888999999999999999777 999999999999985 457899999999764321
Q ss_pred CCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh------
Q 001922 843 ASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL------ 915 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 915 (995)
........+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||..........+............+.
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 111233457889999998866 457899999999999999999999997543222222211111111000000
Q ss_pred ---hhcC----CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 916 ---SILD----PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 916 ---~~~d----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.... .......+..+..+.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0000011234566889999999999999999999986
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=303.25 Aligned_cols=252 Identities=26% Similarity=0.324 Sum_probs=203.3
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
..+.|+..+.+|+|+||.||+|... +++.|++|++..... ....+.+|++++++++|+|++++++++...+..++|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556777889999999999999775 688999999854322 4567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++++|.+++.... ..+++..+..++.|++.|++|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999997532 47899999999999999999999777 9999999999999999999999999987653321
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
. ......++..|+|||++.+..++.++||||||+++|+|++|+.||........... ..... ...
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~----~~~~~---------~~~ 235 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL----ITTKG---------IPP 235 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcC---------CCC
Confidence 1 12334578899999999888899999999999999999999999864322211111 11110 000
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
...+...+..+.+++.+|++.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0112235667899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=304.66 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=201.7
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
..+|+..+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.++++++|||++++++++...+..|+|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 46788889999999999999975 46788999988432 23335668899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 97 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred cCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999999863 34788899999999999999999777 99999999999999999999999999876543221
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......+++.|+|||...+..++.++||||||+++|++++|+.||........... ...... +. .
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~----~~~~~~--------~~-~ 235 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNGT--------PE-L 235 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee----hhcCCC--------CC-C
Confidence 22334688899999999888899999999999999999999999965322111110 000000 00 0
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+||+.+|++||++++++.+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223345678899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.00 Aligned_cols=260 Identities=19% Similarity=0.210 Sum_probs=185.1
Q ss_pred hhccCCCeeeccCceEEEEEEeCCC----cEEEEEEecCCCCCChhH----------HHHHHHHHHhccCCCCceeEeEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNG----VEIAVKKLLGFGTHSHDH----------GFRAEIQTLGNIRHRNIVRLLAF 751 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~----------~~~~E~~~l~~l~hpniv~~~~~ 751 (995)
++|++.+.||+|+||+||+|...++ ..+|+|+..........+ ....+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5789999999999999999986543 445555432111111011 11223445566789999999987
Q ss_pred EecCC----cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCe
Q 001922 752 CSNKE----TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEA 827 (995)
Q Consensus 752 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~v 827 (995)
+.... ..++++|++. .++.+.+.. ....++..+..++.|++.|++|||+.+ |+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence 65443 3467888774 366666642 233567888899999999999999777 9999999999999999999
Q ss_pred EEeeeccccccccCCCC-----ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHH
Q 001922 828 HVADFGLAKFLIDGGAS-----ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQW 902 (995)
Q Consensus 828 kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~ 902 (995)
+|+|||+|+.+...... .......||+.|+|||+..+..++.++||||+||++|||++|+.||............
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999876432211 1122346999999999999999999999999999999999999999876433332221
Q ss_pred HHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 903 SKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 903 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
...- ....+..+.. ....++..+.+++..|++.+|++||+++++.+.++
T Consensus 246 ~~~~------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCD------FIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHH------HHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1100 0000111111 11234567899999999999999999999998763
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.30 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=199.3
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
..|...+.||+|++|.||+|.. .+++.+++|++.. ......+.+.+|+.+++.++|||++++++++..+++.++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~-~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL-RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEec-cchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 3455567999999999999975 4688999998743 2233345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++.. ..+++..+..++.|++.|++|||+.+ |+||||+|+||+++.++.++++|||.+.......
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-- 169 (285)
T cd06648 98 LEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-- 169 (285)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence 999999999864 45889999999999999999999877 9999999999999999999999999887543221
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
.......|++.|+|||...+..++.++||||+|+++|||++|+.||.... ............. +.. .
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~----~~~~~~~~~~~~~--------~~~-~ 236 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP----PLQAMKRIRDNLP--------PKL-K 236 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC----HHHHHHHHHhcCC--------CCC-c
Confidence 11233468899999999988889999999999999999999999986422 1122222221100 011 1
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.+...+..+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 12224567999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=313.73 Aligned_cols=274 Identities=21% Similarity=0.276 Sum_probs=203.0
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC-CCCChhHHHHHHHHHHhccCCCCceeEeEEEecC-----Cc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF-GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK-----ET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 757 (995)
..+|+..+.||+|+||+||+|+. .+++.||+|++... ........+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45688889999999999999975 46899999998542 2223345677899999999999999999987543 35
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999996 689988853 456899999999999999999999777 99999999999999999999999999986
Q ss_pred cccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh--
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF-- 914 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-- 914 (995)
..... .......++..|+|||.+.. ..++.++||||+||++|+|++|+.||........................
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 54322 22234567889999998765 46889999999999999999999999653211111111111000000000
Q ss_pred ---------hhhc----CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCCCCCc
Q 001922 915 ---------LSIL----DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFPRHSS 966 (995)
Q Consensus 915 ---------~~~~----d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~~~ 966 (995)
.... ++......+..+..+.+++.+|++.+|++||+++|+++. ++.+.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~ 302 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD 302 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence 0000 000011122356678999999999999999999999977 766655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.11 Aligned_cols=260 Identities=22% Similarity=0.218 Sum_probs=195.1
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecC--CcceEEEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNK--ETNLLVYE 763 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~e 763 (995)
|+..+.||+|+||.||+|+. .+++.||+|++.............+|+.++.++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 45677899999999999975 4688999999854333333334557888898885 99999999999877 88999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|++ |++.+.+... ...+++..++.++.|++.||.|||+.+ |+||||+|+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 997 5888887643 356899999999999999999999877 999999999999999 9999999999987543221
Q ss_pred CccccccccCcccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc-
Q 001922 844 SECMSAIAGSYGYIAPEYAY-TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR- 921 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~- 921 (995)
.....++..|+|||+.. +..++.++||||+||++|||++|+.||..... .+...............+.......
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-LDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 12345788999999764 45578899999999999999999999965322 2222222222211111111111100
Q ss_pred -------------CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 922 -------------LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 922 -------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
........+..+.+++.+||+.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 001112456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=303.79 Aligned_cols=253 Identities=27% Similarity=0.381 Sum_probs=195.1
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
.|+..+.||+|+||.||++.. .+++.||+|++...........+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 345567899999999999976 4589999999854433344567889999999996 99999999999888899999999
Q ss_pred ccCCChhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 765 MRNGSLGEAL---HGKKGAFLGWNLRYKIAIEAAKGLCYLHHD-CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 765 ~~~gsL~~~l---~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
+.. ++.++. .......+++..+.+++.|++.|++|||+. + |+||||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 655433 323346789999999999999999999964 5 99999999999999999999999999976543
Q ss_pred CCCCccccccccCcccccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTL---RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
... .....|+..|+|||++.+. .++.++||||+||++|||++|+.||.... ..............
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~------ 228 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVKGDP------ 228 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcCCCC------
Confidence 221 1234688899999998766 68899999999999999999999996532 11111111111100
Q ss_pred cCCcC-CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 918 LDPRL-SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 918 ~d~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+.+ ...+...+..+.+++.+||+.+|++||++++|++.
T Consensus 229 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 --PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 11123456679999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.14 Aligned_cols=264 Identities=20% Similarity=0.191 Sum_probs=196.4
Q ss_pred CCCeeeccCceEEEEEEeCCCcEEEEEEecCC-CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCC
Q 001922 690 DGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGF-GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNG 768 (995)
Q Consensus 690 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 768 (995)
+++.+|.|+++.||+++. +++.||+|++... ........+.+|++++++++||||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455566666666554 6899999998543 23445567999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC-----
Q 001922 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA----- 843 (995)
Q Consensus 769 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~----- 843 (995)
+|.+++.......+++.....++.|++.||+|||+++ |+||||||+||+++.++.+|++|||.+..+.....
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999997655566889999999999999999999877 99999999999999999999999999876543221
Q ss_pred CccccccccCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC-----Chhh---
Q 001922 844 SECMSAIAGSYGYIAPEYAYT--LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG-----RKEE--- 913 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-----~~~~--- 913 (995)
........++..|+|||++.. ..++.++||||+||++|||++|+.||..........+........ ....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 111233457788999999875 357899999999999999999999997643322222111100000 0000
Q ss_pred -hhh----hcCC-----cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 914 -FLS----ILDP-----RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 914 -~~~----~~d~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
... ..++ ............+.+++.+||+.+|++||+++++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 0000 0012233456678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=299.41 Aligned_cols=262 Identities=25% Similarity=0.264 Sum_probs=198.1
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC-ChhHHHHHHHHHHhcc---CCCCceeEeEEEecCCc-----
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNI---RHRNIVRLLAFCSNKET----- 757 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~----- 757 (995)
|+..+.||+|+||.||+|+.. +++.||+|++...... .....+.+|+.+++++ .|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456788999999999999875 4899999998543222 2234466788777666 59999999999987776
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.+++|||+.+ +|.+++.......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8999887544456899999999999999999999877 99999999999999999999999999887
Q ss_pred cccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh---
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF--- 914 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--- 914 (995)
+.... ......++..|+|||++.+..++.++||||+|+++|||++|+.||...........+...........+
T Consensus 157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 53322 112345788999999999989999999999999999999999998764433333332222111100000
Q ss_pred --------hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 915 --------LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 915 --------~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
............+..+..+.+++.+||+.||++||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000001111112234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.24 Aligned_cols=243 Identities=25% Similarity=0.262 Sum_probs=187.8
Q ss_pred eeeccCceEEEEEEeC-CCcEEEEEEecCCCCC--ChhHHHHHHHHHHhc---cCCCCceeEeEEEecCCcceEEEEecc
Q 001922 693 VIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGN---IRHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 693 ~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~---l~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
.||+|+||.||++... +++.+|+|.+...... .....+.+|..+++. ..||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 5889999988543222 112234445444433 369999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
+|+|.+++.. ...+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 9999999853 346899999999999999999999777 9999999999999999999999999987543221
Q ss_pred ccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
.....|+..|+|||...+ ..++.++||||+||++|||++|..||........ ... ...... .. ...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~-~~~~~~--------~~---~~~ 218 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEI-DRMTLT--------VN---VEL 218 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHH-HHHhhc--------CC---cCC
Confidence 123468999999998864 5688999999999999999999999965432211 111 111000 00 123
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
+...+..+.+++.+|++.||++|| +++|++++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 445667889999999999999999 59988775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=295.17 Aligned_cols=243 Identities=26% Similarity=0.311 Sum_probs=196.6
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCCh
Q 001922 694 IGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSL 770 (995)
Q Consensus 694 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 770 (995)
||.|+||.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999874 488999999854322 23346788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcccccc
Q 001922 771 GEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850 (995)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 850 (995)
.+++.. ...+++..+..++.|++.|+.|+|+.+ ++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 999964 345889999999999999999999777 9999999999999999999999999998764332 12334
Q ss_pred ccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHH
Q 001922 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEA 930 (995)
Q Consensus 851 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 930 (995)
.++..|+|||.+.+..++.++|+||+|+++|+|++|..||..... +........... ......+...+
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~----------~~~~~~~~~~~ 220 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE--DPMEIYNDILKG----------NGKLEFPNYID 220 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC--CHHHHHHHHhcc----------CCCCCCCcccC
Confidence 688899999999888899999999999999999999999975432 112222211110 11112333346
Q ss_pred HHHHHHHhcccCCCCCCCCC-----HHHHHH
Q 001922 931 MHLLFVAMLCIQENSIERPR-----MREVVQ 956 (995)
Q Consensus 931 ~~l~~li~~cl~~dP~~RPt-----~~evl~ 956 (995)
..+.+++.+||+.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 78999999999999999999 777766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=304.81 Aligned_cols=273 Identities=22% Similarity=0.268 Sum_probs=198.7
Q ss_pred ccHHHHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCC
Q 001922 679 FSVSDILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE 756 (995)
Q Consensus 679 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 756 (995)
+.+.+..+.|+..+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred CcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 444556778999999999999999999764 688999998853322 222345678999999999999999999986654
Q ss_pred c--------ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeE
Q 001922 757 T--------NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH 828 (995)
Q Consensus 757 ~--------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vk 828 (995)
. .++||||+.+ ++.+++.. ....+++..++.++.|++.|++|||+++ |+||||||+||+++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~k 159 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEH-DLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILK 159 (310)
T ss_pred ccccCCCceEEEEEcCCCc-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEE
Confidence 3 4999999964 88888763 3346899999999999999999999877 99999999999999999999
Q ss_pred EeeeccccccccCCCC--ccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHH
Q 001922 829 VADFGLAKFLIDGGAS--ECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKR 905 (995)
Q Consensus 829 l~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~ 905 (995)
|+|||++..+...... .......++..|+|||.+.+. .++.++||||+|+++|||++|+.||...... ........
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~~ 238 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLISQ 238 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 9999999865432211 112234578899999987664 4688999999999999999999998653321 11111111
Q ss_pred HhcCChhhhhhhc------CC-cCCC----------CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 906 ATNGRKEEFLSIL------DP-RLSM----------VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 906 ~~~~~~~~~~~~~------d~-~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
............. +. .... .+......+.+++.+||+.||++||+++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1111000000000 00 0000 000123456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.24 Aligned_cols=265 Identities=20% Similarity=0.210 Sum_probs=195.6
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccC-CCCceeEeEEEecCCc-----c
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKET-----N 758 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~-----~ 758 (995)
+|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++ ||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 5778899999999999999764 688999998743322 223456788999999995 6999999999876665 7
Q ss_pred eEEEEeccCCChhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCCeEEeeecc
Q 001922 759 LLVYEYMRNGSLGEALHGKK---GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS-AFEAHVADFGL 834 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~-~~~vkl~DfGl 834 (995)
|+||||+++ ++.+++.... +..+++..++.++.||+.||.|||+.+ |+||||+|+||+++. ++.+||+|||+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999985 8988886432 346899999999999999999999777 999999999999998 88999999999
Q ss_pred ccccccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
+..+.... .......+++.|+|||++.+ ..++.++||||+|+++|+|++|..||....+..................
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 158 GRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 87653221 11123356889999998765 4578999999999999999999999965433222222211111110000
Q ss_pred hhhhcC-------Cc-----CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 914 FLSILD-------PR-----LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 914 ~~~~~d-------~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+....+ +. .....+..+..+.++|.+|++.+|++||+++|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 00 000112345678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=292.78 Aligned_cols=249 Identities=29% Similarity=0.412 Sum_probs=201.8
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEecc
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
|+..+.||+|++|.||+|... +++.+++|++..... .....+.+|++++++++||+++++++++......++++||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 567788999999999999875 688999999854332 345678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
+++|.+++.... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999986432 56899999999999999999999777 99999999999999999999999999987644321
Q ss_pred ccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 926 (995)
.....++..|+|||.+.+..++.++||||+|+++|+|++|+.||........... .... .......+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~---------~~~~~~~~ 220 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK----IATN---------GPPGLRNP 220 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH----HHhc---------CCCCcCcc
Confidence 2345688999999999888899999999999999999999999965322111111 1100 00000111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 927 KEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 927 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+..+.+++.+||+.||++||++.|+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1235679999999999999999999999763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=308.34 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=198.0
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC-CCCChhHHHHHHHHHHhccCCCCceeEeEEEecC------
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF-GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK------ 755 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 755 (995)
+.++|+..+.||+|+||.||+|+. .+++.||+|++... ........+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 567899999999999999999976 47899999998432 2233345677899999999999999999988543
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccc
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA 835 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla 835 (995)
.+.|+||||+. ++|.+.+... ++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35699999996 4888887532 788889999999999999999877 999999999999999999999999999
Q ss_pred cccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
+...... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||................. .....+.
T Consensus 166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~ 241 (353)
T cd07850 166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG-TPSDEFM 241 (353)
T ss_pred eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC-CCCHHHH
Confidence 8653321 12344678899999999999999999999999999999999999964322111111111000 0000000
Q ss_pred -----------------------hhcCCcC-----CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 916 -----------------------SILDPRL-----SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 916 -----------------------~~~d~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
....... ...+...+..+.+++.+|++.||++||+++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 00112346678899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=282.13 Aligned_cols=256 Identities=24% Similarity=0.323 Sum_probs=198.8
Q ss_pred CeeeccCceEEEEEE-eCCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEeccCCC
Q 001922 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRNGS 769 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~gs 769 (995)
+.+|+|+|+.|--+. ..+|.+||||++.+. ..-.+.++.+|++++.+. .|+||++++++|+++...|+|||.|.||+
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 579999999999884 578999999999554 334567789999999999 49999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC---eEEeeeccccccccC-----
Q 001922 770 LGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE---AHVADFGLAKFLIDG----- 841 (995)
Q Consensus 770 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~---vkl~DfGla~~~~~~----- 841 (995)
|...++ ++..+++..+.++.++|+.||.|||++| |.|||+||+|||...... ||||||.+...+...
T Consensus 163 lLshI~--~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 163 LLSHIQ--KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHH--HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999996 4467899999999999999999999888 999999999999977654 799999887543211
Q ss_pred CCCccccccccCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCC---CchHHHHHHHHhcCChhh
Q 001922 842 GASECMSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGD---GVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~---~~~~~~~~~~~~~~~~~~ 913 (995)
.......+.+|+..|||||+.. ..-|+.+.|.||+|||+|-|++|+.||...=. +.+.-+..+.+ ...-
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C---Q~~L 314 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC---QNKL 314 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH---HHHH
Confidence 1222335678999999999753 23588999999999999999999999965311 11111111111 1123
Q ss_pred hhhhcCCcCCCCCH---HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 914 FLSILDPRLSMVPK---EEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 914 ~~~~~d~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
|..+-+..+.+... ..+.+..+++...+-.|+.+|-++.+++.
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 34444444443222 35667788999999999999999998886
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=302.98 Aligned_cols=257 Identities=25% Similarity=0.320 Sum_probs=201.8
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC--ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
..+.|+..+.||+|+||.||+|+. .+++.||+|++...... .....+.+|++++++++|||++++++++.+++..++
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 344577788999999999999976 46889999988532222 223468889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+.+ ++.+.+.. ....+++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~g-~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 103 VMEYCLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEeCCCC-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9999974 88777753 2456899999999999999999999877 99999999999999999999999999875422
Q ss_pred CCCCccccccccCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 841 GGASECMSAIAGSYGYIAPEYAY---TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
.....+++.|+|||++. .+.++.++|||||||++|||++|+.||...........+ ...
T Consensus 178 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~-------- 239 (317)
T cd06635 178 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQN-------- 239 (317)
T ss_pred ------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----Hhc--------
Confidence 12346888999999873 456889999999999999999999998653221111111 111
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
..........+..+.+++.+||+.+|++||++.++++....+....
T Consensus 240 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 240 --ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred --cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 0011122345567899999999999999999999998766655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=292.25 Aligned_cols=252 Identities=28% Similarity=0.397 Sum_probs=205.5
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecC--CcceEEEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETNLLVYE 763 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 763 (995)
|+..+.||+|++|.||+|... +++.|++|++..... ....+.+.+|++++++++||||+++++.+.+. ...++|||
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 567789999999999999875 688999999844322 23456788999999999999999999999888 88999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++... ..+++..++.++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 82 YVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 99999999999643 37899999999999999999999877 99999999999999999999999999987654332
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
........++..|+|||......++.++||||+|+++|+|++|..||....+ .......... .....
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~----------~~~~~ 223 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYKIGS----------SGEPP 223 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHhccc----------cCCCc
Confidence 1123445788999999999888899999999999999999999999975441 1111111111 01122
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+|++.+|++||++.|+++.
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 3444557889999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=327.96 Aligned_cols=257 Identities=27% Similarity=0.389 Sum_probs=210.8
Q ss_pred ccCCCeeeccCceEEEEEEeC--------CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcc
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP--------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 758 (995)
..+.+.+|+|+||.||+|... ....||||..+......+.+.+..|+++|+.+ +||||+.++|++..++..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 345569999999999999532 14679999997777677778899999999999 599999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC
Q 001922 759 LLVYEYMRNGSLGEALHGKK------------G--AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA 824 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~ 824 (995)
++|+||+..|+|.++++..+ . ..++....+.++.|||.||+||++.. +||||+.++||+++++
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCC
Confidence 99999999999999997543 0 23888899999999999999999555 9999999999999999
Q ss_pred CCeEEeeeccccccccCCCCccccc-cccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHH
Q 001922 825 FEAHVADFGLAKFLIDGGASECMSA-IAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQW 902 (995)
Q Consensus 825 ~~vkl~DfGla~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~ 902 (995)
..+||+|||+|+...+.+....... ..-+..|||||.+....|+.++|||||||++||++| |..||.......++.+
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~- 533 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE- 533 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-
Confidence 9999999999997655443321111 113567999999999999999999999999999999 9999976332333322
Q ss_pred HHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 903 SKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 903 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.+..+ .....|..+..+++++|+.||+.+|++||++.|+++.++..
T Consensus 534 --~l~~G-----------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 534 --FLKEG-----------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred --HHhcC-----------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 22222 22245677889999999999999999999999999999984
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=303.28 Aligned_cols=265 Identities=23% Similarity=0.247 Sum_probs=196.3
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEecC--CcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 760 (995)
.+.|+..+.||+|+||.||+|.. .+|+.||+|++...... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45688889999999999999976 46899999998533222 2233466799999999999999999998654 46799
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++ +|.+++... ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999965 888888643 356899999999999999999999877 99999999999999999999999999987643
Q ss_pred CCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc-
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL- 918 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 918 (995)
.. .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||....+..................+....
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 161 PA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred cc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 22 11223345788999998865 457899999999999999999999997543222222221111111000000000
Q ss_pred ---------CC-cCC---CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 919 ---------DP-RLS---MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 919 ---------d~-~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.. ... ......+..+.+++.+|++.||++||+++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 000 000113566789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=293.43 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=205.4
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+|+..+.||.|+||.||++... +++.||+|++..... ......+.+|+++++.++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 3667788999999999999764 688999999854332 24456788999999999999999999999989999999999
Q ss_pred ccCCChhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 765 MRNGSLGEALHGKK--GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 765 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
+++++|.+++.... +..+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997543 467899999999999999999999887 9999999999999999999999999998654332
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||.... ........... ..
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~~~-----------~~ 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN----LLELALKILKG-----------QY 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc----HHHHHHHHhcC-----------CC
Confidence 12234568899999999988889999999999999999999999985432 22222221111 11
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+...+..+.+++.+||..+|++||++.|+++.
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 22233456678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=300.13 Aligned_cols=269 Identities=24% Similarity=0.254 Sum_probs=200.3
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCC----
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE---- 756 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---- 756 (995)
...+.|+..+.||+|+||.||+|..+ +++.||+|++..... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34677889999999999999999875 588999999854322 223456778999999999999999999986654
Q ss_pred ------cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEe
Q 001922 757 ------TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVA 830 (995)
Q Consensus 757 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~ 830 (995)
..++||||+++ ++.+.+... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 777777533 446899999999999999999999877 9999999999999999999999
Q ss_pred eeccccccccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
|||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...................
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999987643321 11122346788999998765 357899999999999999999999997543322222222222111
Q ss_pred ChhhhhhhcCC--------------cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 910 RKEEFLSILDP--------------RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 910 ~~~~~~~~~d~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
....+..+... .........+..+.+++.+||+.+|++||+++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111111000 0000111235678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=299.74 Aligned_cols=263 Identities=22% Similarity=0.298 Sum_probs=197.6
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEEEec
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
|+..+.||+|+||+||+|+.. +++.|++|++.............+|+..+++++ |||++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999875 478899999854333333344567999999998 999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
+|+|.+++....+..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 789999987655567899999999999999999999877 99999999999999999999999999986533221
Q ss_pred cccccccCcccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh------hhhhc
Q 001922 846 CMSAIAGSYGYIAPEYAY-TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE------FLSIL 918 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 918 (995)
.....++..|+|||++. ...++.++|+||||+++|||++|+.||....................... .....
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 12346788999999875 44578999999999999999999999965432211111111000000000 00000
Q ss_pred CCcC--------CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 919 DPRL--------SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 919 d~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+... .......+..+.+++.+||+.+|++||+++|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000 00011124678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=304.45 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=193.1
Q ss_pred eeecc--CceEEEEEEe-CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCC
Q 001922 693 VIGRG--GAGIVYHGKM-PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNG 768 (995)
Q Consensus 693 ~lG~G--~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 768 (995)
.||+| +||+||+|++ .+|+.||+|.+..... ....+.+.+|+.+++.++||||++++++|..++..++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 35555 9999999976 4789999999854322 223466888999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc--
Q 001922 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC-- 846 (995)
Q Consensus 769 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~-- 846 (995)
++.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+...........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999997654556889999999999999999999777 99999999999999999999999986543322111110
Q ss_pred ---ccccccCcccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhc-------------
Q 001922 847 ---MSAIAGSYGYIAPEYAYTL--RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN------------- 908 (995)
Q Consensus 847 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~------------- 908 (995)
.....++..|+|||++.+. .++.++||||+||++|||++|+.||..................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 0112345679999998764 4789999999999999999999999754322221111100000
Q ss_pred ---CChhhhh--------------hhcCCcCC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 909 ---GRKEEFL--------------SILDPRLS-MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 909 ---~~~~~~~--------------~~~d~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....+. ...+.... .....++..+.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000000 00001111 1233467789999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=298.77 Aligned_cols=263 Identities=22% Similarity=0.255 Sum_probs=200.9
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
|+..+.||+|++|.||+|... +++.+++|++...... .....+.+|++++++++||+|+++++++.+++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999764 6888999988543222 33566888999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++ ++.+++... ...+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 81 DT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred CC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 75 888888643 357899999999999999999999877 9999999999999999999999999998764432 1
Q ss_pred cccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC-----
Q 001922 846 CMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD----- 919 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d----- 919 (995)
......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||.......................+....+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 12234578899999998776 789999999999999999999999965432222111111111111111111100
Q ss_pred ---------CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 ---------PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.......+..+..+.+++.+||+.||.+||++++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00011223467789999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=322.63 Aligned_cols=270 Identities=17% Similarity=0.183 Sum_probs=187.9
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeCC--CcEEEEEE--------------ecC--CCCCChhHHHHHHHHHHhccCCCC
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMPN--GVEIAVKK--------------LLG--FGTHSHDHGFRAEIQTLGNIRHRN 744 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~--------------~~~--~~~~~~~~~~~~E~~~l~~l~hpn 744 (995)
.+.++|+..+.||+|+||+||+|..+. +..++.|. +.+ .........+.+|+.++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 356789999999999999999986432 22222221 100 011122445789999999999999
Q ss_pred ceeEeEEEecCCcceEEEEeccCCChhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 001922 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKK---GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL 821 (995)
Q Consensus 745 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill 821 (995)
|+++++++...+..|+|+|++. +++.+++.... ........+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 57777764321 122345567789999999999999777 9999999999999
Q ss_pred CCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHH
Q 001922 822 NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQ 901 (995)
Q Consensus 822 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~ 901 (995)
+.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|..++..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999987643221 122345799999999999999999999999999999999998764332222111111
Q ss_pred HHHHHh---cC------ChhhhhhhcCC-cCC----CCCH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 902 WSKRAT---NG------RKEEFLSILDP-RLS----MVPK-----EEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 902 ~~~~~~---~~------~~~~~~~~~d~-~~~----~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+.+. .. ....+.+.++. .+. ..+. ..+..+.+++.+|++.||++||++.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111111 00 00011111110 000 0000 123356778999999999999999999874
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=307.41 Aligned_cols=267 Identities=21% Similarity=0.244 Sum_probs=199.4
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEec----CCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN----KETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~ 758 (995)
...|+..+.||+|+||.||+|.. .+|+.||+|++.... .......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36788889999999999999976 468999999985432 22334567789999999999999999998753 3467
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
++||||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 589998853 345899999999999999999999877 999999999999999999999999999765
Q ss_pred ccCCCC--ccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh---
Q 001922 839 IDGGAS--ECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE--- 912 (995)
Q Consensus 839 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--- 912 (995)
...... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 432211 11234568899999998765 468899999999999999999999996543322211111111110000
Q ss_pred -----hh---hhhcCCcCC----CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 913 -----EF---LSILDPRLS----MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 913 -----~~---~~~~d~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.. ......... ...+..+..+.+++.+|++.+|++||+++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 000010000 0112346779999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=283.46 Aligned_cols=204 Identities=26% Similarity=0.353 Sum_probs=170.1
Q ss_pred HhhccCCCeeeccCceEEEEEEeCC-----CcEEEEEEecCCCCCC-hhHHHHHHHHHHhccCCCCceeEeEEEec-CCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPN-----GVEIAVKKLLGFGTHS-HDHGFRAEIQTLGNIRHRNIVRLLAFCSN-KET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 757 (995)
...|+....||+|+||.||+|..++ ...+|+|+++...+.. ......+|+..++.++|||++.+..+|-. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 5678999999999999999995432 3378999996543332 23456789999999999999999998866 778
Q ss_pred ceEEEEeccCCChhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC----CCeEEe
Q 001922 758 NLLVYEYMRNGSLGEALHG---KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA----FEAHVA 830 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~----~~vkl~ 830 (995)
+++++||.+. +|..+++. .+...++...+..|+.||+.|+.|||+.. |+|||+||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 99998863 33457888999999999999999999777 9999999999999877 899999
Q ss_pred eeccccccccCCC-CccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCC
Q 001922 831 DFGLAKFLIDGGA-SECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGD 892 (995)
Q Consensus 831 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~ 892 (995)
|+|+++.+...-. -.....++-|+.|.|||.+.+. .|+.+.||||.|||+.||+|-++-|..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999998765422 2234567889999999998875 589999999999999999998887754
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=291.21 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=202.4
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+|+..+.||+|++|.||+|+.. +++.|++|.+...... ...+.+.+|++++++++|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3677889999999999999764 5789999998543321 3456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++... ..+++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999999643 57899999999999999999999777 999999999999999999999999999876443221
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ........ .. ....
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~~-~~-----------~~~~ 218 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRIV-QD-----------DHPP 218 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHh-cc-----------CCCC
Confidence 2345688999999998888889999999999999999999999965331 11111111 11 1112
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.+...+..+.+++.+|++.+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 23344667889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=297.94 Aligned_cols=264 Identities=24% Similarity=0.286 Sum_probs=198.1
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecC--CcceEEEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETNLLVYE 763 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 763 (995)
|+..+.||+|+||.||+|+.. +++.+|+|++.... .......+.+|++++++++|||++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999775 58899999985442 233345688899999999999999999999887 88999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++ +|.+++... ...+++..++.++.|++.|++|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 898888643 256899999999999999999999877 99999999999999999999999999987644321
Q ss_pred CccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC---
Q 001922 844 SECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD--- 919 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--- 919 (995)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......................+....+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 11233456889999997765 4578999999999999999999999975432222222111111110011100000
Q ss_pred -----CcCC-------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 -----PRLS-------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 -----~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+... .....++..+.+++.+||+.+|++||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 0001126678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=301.64 Aligned_cols=266 Identities=21% Similarity=0.294 Sum_probs=195.5
Q ss_pred ccCCCeeeccCceEEEEEEeC---CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecC--CcceE
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP---NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETNLL 760 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 760 (995)
|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 667788999999999999764 47899999985432 122345678899999999999999999999887 78999
Q ss_pred EEEeccCCChhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC----CCCeEEeeec
Q 001922 761 VYEYMRNGSLGEALHGK---KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS----AFEAHVADFG 833 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~----~~~vkl~DfG 833 (995)
||||+++ ++.+++... ....+++..++.++.|++.|++|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 777766422 2236889999999999999999999777 999999999999999 8999999999
Q ss_pred cccccccCCC-CccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCc---------hHHHH
Q 001922 834 LAKFLIDGGA-SECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV---------DIVQW 902 (995)
Q Consensus 834 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~---------~~~~~ 902 (995)
++........ ........++..|+|||++.+. .++.++|||||||++|+|++|+.||....... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9986543222 1122345678899999987664 57899999999999999999999997543221 11111
Q ss_pred HHHHhcCChh---------hhhhhcC-CcCCCCC-----------HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 903 SKRATNGRKE---------EFLSILD-PRLSMVP-----------KEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 903 ~~~~~~~~~~---------~~~~~~d-~~~~~~~-----------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.......... .+....+ ......+ ...+..+.+++.+|++.||++|||++|++++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111100000 0000000 0000011 0234568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=298.27 Aligned_cols=256 Identities=24% Similarity=0.239 Sum_probs=200.2
Q ss_pred ccCCCeeeccCceEEEEEEe----CCCcEEEEEEecCCC---CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcce
Q 001922 688 VKDGNVIGRGGAGIVYHGKM----PNGVEIAVKKLLGFG---THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 759 (995)
|+..+.||+|+||.||+++. .+++.||||.+.... .......+.+|+++++++ +||+|+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56678899999999999864 357889999885321 122345678899999999 5999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+||||+++|+|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||+++...
T Consensus 82 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 82 LILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999853 346888999999999999999999777 9999999999999999999999999987654
Q ss_pred cCCCCccccccccCcccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTLR--VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
..... ......++..|+|||...+.. .+.++||||+|+++|||++|..||.............+.....
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 227 (288)
T cd05583 157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-------- 227 (288)
T ss_pred ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--------
Confidence 32211 112346889999999987654 7889999999999999999999996432221112222211111
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
....+...+..+.+++.+||+.+|++|||++++.+.|+..
T Consensus 228 ----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 ----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1112334556788999999999999999999888777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=296.65 Aligned_cols=252 Identities=25% Similarity=0.257 Sum_probs=197.4
Q ss_pred ccCCCeeeccCceEEEEEEe----CCCcEEEEEEecCCC---CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcce
Q 001922 688 VKDGNVIGRGGAGIVYHGKM----PNGVEIAVKKLLGFG---THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 759 (995)
|+..+.||+|+||.||.|+. .+|+.||+|++.... .....+.+.+|+++++++ +|++|+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 56778999999999999975 368899999985322 122345678899999999 5999999999999989999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 82 LILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999964 346788889999999999999999777 9999999999999999999999999987653
Q ss_pred cCCCCccccccccCcccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTL--RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
.... .......|+..|+|||...+. .++.++||||+|+++|+|++|+.||...........+.......
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------- 227 (290)
T cd05613 157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------- 227 (290)
T ss_pred cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--------
Confidence 3221 112245688999999998753 46789999999999999999999996433222222222222211
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
....+...+..+.+++.+||+.+|++|| ++++++..
T Consensus 228 ----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 ----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1112334566788999999999999997 66777553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=297.86 Aligned_cols=246 Identities=21% Similarity=0.314 Sum_probs=195.6
Q ss_pred CCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCC
Q 001922 690 DGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNG 768 (995)
Q Consensus 690 ~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 768 (995)
...+||+|+||.||+|.. .+++.||+|++.. ........+.+|+.+++.++|||++++++++..+++.++||||++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDL-RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecc-cchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 345799999999999976 4788999998743 23334566889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcccc
Q 001922 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS 848 (995)
Q Consensus 769 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~ 848 (995)
+|.+++.. ..+++.....++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++....... ....
T Consensus 103 ~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~ 174 (292)
T cd06657 103 ALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 174 (292)
T ss_pred cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccc
Confidence 99998743 35788999999999999999999877 9999999999999999999999999987653221 1123
Q ss_pred ccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHH
Q 001922 849 AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKE 928 (995)
Q Consensus 849 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 928 (995)
...+++.|+|||...+..++.++|+||+|+++|+|++|+.||...... ... ...... ..+.... ...
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~---~~~~~~--------~~~~~~~-~~~ 241 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAM---KMIRDN--------LPPKLKN-LHK 241 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH---HHHHhh--------CCcccCC-ccc
Confidence 356889999999988888899999999999999999999998642211 111 111111 1111111 122
Q ss_pred HHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 929 EAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 929 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+..+.+++.+||+.+|.+||++.++++.
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 45568889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=293.53 Aligned_cols=248 Identities=25% Similarity=0.300 Sum_probs=203.0
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
|+..+.||+|+||.||+++. .+++.+|+|++.... .......+.+|++++++++||||+++++++.+....++||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 66778999999999999965 468899999985432 2233556788999999999999999999999889999999999
Q ss_pred cCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 766 RNGSLGEALHGK--KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 766 ~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
++++|.+++... .+..+++..++.++.|++.|++|||+.+ ++||||+|+||+++.++.+|++|||++......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 999999998642 2356889999999999999999999777 999999999999999999999999999876433
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......+++.|+|||...+..++.++|+||+|+++|||++|+.||..... ......... ....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~-----------~~~~ 219 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----QDLRYKVQR-----------GKYP 219 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhc-----------CCCC
Confidence 22335688999999999988899999999999999999999999964321 111111111 1222
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+|++.+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 3344667789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=299.19 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=194.7
Q ss_pred HhhccCCCeeeccCceEEEEEEeCC-CcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 762 (995)
.+.|+..+.||+|+||.||+|.+.+ ++.||||.+...........+..|+.++.+.. ||||+++++++.++...|+||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567888999999999999998764 88999999865433334455666777676664 999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
||+. +.+.+++... ...+++..+.+++.|++.|++|||+ .+ |+||||+|+||++++++.+||+|||++..+...
T Consensus 94 e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 4777776532 3478999999999999999999996 35 999999999999999999999999998765432
Q ss_pred CCCccccccccCcccccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLR----VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
.. .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||........ ..........
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~------ 236 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE---VLTKILQEEP------ 236 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH---HHHHHhcCCC------
Confidence 21 12335788999999987553 78899999999999999999999964322111 1111111100
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+... ....++..+.+++.+||+.||++||++++++++
T Consensus 237 --~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 --PSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --CCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111 111245678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=290.80 Aligned_cols=243 Identities=23% Similarity=0.261 Sum_probs=188.7
Q ss_pred HHhhccCCCee--eccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcce
Q 001922 684 ILECVKDGNVI--GRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 684 ~~~~~~~~~~l--G~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 759 (995)
..+.|+..+.+ |+|+||.||++.. .+++.+|+|.+...... . .|+.....+ +|||++++++++...+..+
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN----A--IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc----h--hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 34556665655 9999999999975 46788899887432111 1 122222222 6999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-CeEEeeecccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLAKFL 838 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-~vkl~DfGla~~~ 838 (995)
+||||+++++|.+++... ..+++..+..++.|+++|+.|||+.+ ++||||||+||+++.++ .++|+|||+++..
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999999999643 37899999999999999999999877 99999999999999998 9999999998765
Q ss_pred ccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC-chHHHHHHHHhcCChhhhhhh
Q 001922 839 IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG-VDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 917 (995)
... ....++..|+|||++.+..++.++||||+|+++|||++|+.||...... .....+.....
T Consensus 161 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 224 (267)
T PHA03390 161 GTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ---------- 224 (267)
T ss_pred CCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc----------
Confidence 321 2346889999999999889999999999999999999999999743322 12222222111
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCC-HHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPR-MREVVQ 956 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 956 (995)
.....+...+..+.+++.+|++.+|++||+ ++|+++
T Consensus 225 ---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 ---KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 011122356678999999999999999996 688874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-33 Score=296.13 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=203.3
Q ss_pred cHHHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCc
Q 001922 680 SVSDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET 757 (995)
Q Consensus 680 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 757 (995)
+++.+++-|. .+++|.|.||+||-|++ ++|+.||||++.+.+ .......+++|+.|++++.||.||.+..-|+..+.
T Consensus 559 d~stvYQif~-devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 559 DISTVYQIFA-DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER 637 (888)
T ss_pred hHHHHHHhhh-HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce
Confidence 3344444332 47899999999999965 679999999985433 23345678999999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CCeEEeeecc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA---FEAHVADFGL 834 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~---~~vkl~DfGl 834 (995)
.|.|||.+.| +..+.+-....+++++.....++.||+.||.|||.++ |+|+|+||+|||+.+. -.+||||||+
T Consensus 638 vFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 638 VFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred EEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccc
Confidence 9999999965 6666655567788999999999999999999999777 9999999999999765 3799999999
Q ss_pred ccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
|+.+.+. ......+|||.|+|||++++..|...-|+||+|||+|--++|..||.... ++.+-++.+....
T Consensus 714 ARiIgEk---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE---dIndQIQNAaFMy---- 783 (888)
T KOG4236|consen 714 ARIIGEK---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE---DINDQIQNAAFMY---- 783 (888)
T ss_pred eeecchh---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc---chhHHhhcccccc----
Confidence 9987543 34467899999999999999999999999999999999999999996432 3322222211110
Q ss_pred hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 915 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
| +..-.+.+....++|...++..-++|-+.+..+.
T Consensus 784 -----P--p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 784 -----P--PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -----C--CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 0 1122356667788999999999999998876654
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=291.58 Aligned_cols=251 Identities=27% Similarity=0.364 Sum_probs=197.7
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC----CCChhHHHHHHHHHHhccCCCCceeEeEEEecC--Ccc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG----THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETN 758 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 758 (995)
+.|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 3578889999999999999976 468999999874221 122345688999999999999999999998654 457
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
++||||+++++|.+++.. ...+++....+++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 899999999999999863 235788889999999999999999777 999999999999999999999999999865
Q ss_pred ccCCC-CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 839 IDGGA-SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 839 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
..... ........++..|+|||+..+..++.++|||||||++|++++|+.||......... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~--------- 224 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI---FKIATQ--------- 224 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH---HHHHcC---------
Confidence 32111 11122346889999999998888999999999999999999999999653221111 111111
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
+.....+......+.+++.+|++ +|.+||++.+++.
T Consensus 225 --~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 --PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11123455667789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=294.09 Aligned_cols=245 Identities=24% Similarity=0.320 Sum_probs=194.4
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCCh
Q 001922 694 IGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSL 770 (995)
Q Consensus 694 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 770 (995)
||+|+||.||+|+.. +|+.+++|.+..... ......+.+|++++++++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999875 489999999853322 13355688899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC------C
Q 001922 771 GEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA------S 844 (995)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~------~ 844 (995)
.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9999643 36899999999999999999999877 99999999999999999999999999876432211 1
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
.......++..|+|||......++.++||||||+++|++++|+.||..... ........... . .
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~-----------~-~ 219 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP----EEIFQNILNGK-----------I-E 219 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCC-----------c-C
Confidence 122345678899999999888899999999999999999999999964321 11111111110 0 0
Q ss_pred CCHH--HHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 925 VPKE--EAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 925 ~~~~--~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
.+.. .+..+.+++.+||+.+|++||++.++.+.++
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1112 2677899999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=292.47 Aligned_cols=242 Identities=24% Similarity=0.246 Sum_probs=186.9
Q ss_pred eeeccCceEEEEEEe-CCCcEEEEEEecCCCCC--ChhHHHHHHHH---HHhccCCCCceeEeEEEecCCcceEEEEecc
Q 001922 693 VIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH--SHDHGFRAEIQ---TLGNIRHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 693 ~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~---~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
.||+|+||.||+|.. .+++.||+|.+...... .....+..|.. .++...||+|+++++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999976 45889999988543221 11222344443 3444579999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
+|+|.+++.. ...+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~ 151 (278)
T cd05606 81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (278)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----C
Confidence 9999998853 456899999999999999999999777 999999999999999999999999998765322 1
Q ss_pred ccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
.....|+..|+|||++.++ .++.++||||+|+++|||++|+.||......... ........ ... ..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~---------~~~---~~ 218 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT---------MAV---EL 218 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-HHHHHhhc---------cCC---CC
Confidence 1345789999999998754 6899999999999999999999999754221111 11111100 011 12
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERP-----RMREVVQ 956 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 956 (995)
+...+..+.+++.+|+..+|++|| +++++++
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 333467899999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=303.18 Aligned_cols=266 Identities=22% Similarity=0.233 Sum_probs=197.0
Q ss_pred Hhhcc-CCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCCh-------------hHHHHHHHHHHhccCCCCceeEe
Q 001922 685 LECVK-DGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSH-------------DHGFRAEIQTLGNIRHRNIVRLL 749 (995)
Q Consensus 685 ~~~~~-~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-------------~~~~~~E~~~l~~l~hpniv~~~ 749 (995)
.++|. ..+.||+|+||+||+|... +++.||+|++........ ...+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 44555 4577999999999999754 689999998853322210 12467899999999999999999
Q ss_pred EEEecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEE
Q 001922 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV 829 (995)
Q Consensus 750 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl 829 (995)
+++...+..++||||+. |+|.+++.. ...+++.....++.|++.|+.|||+.+ |+||||+|+||+++.++.++|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 99999999999999997 599999853 346889999999999999999999777 999999999999999999999
Q ss_pred eeeccccccccCCC------------CccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 001922 830 ADFGLAKFLIDGGA------------SECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDG 896 (995)
Q Consensus 830 ~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~ 896 (995)
+|||.+........ ........++..|+|||++.+. .++.++||||+||++|||++|+.||....+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999976541110 1111234567899999998764 4689999999999999999999999754432
Q ss_pred chHHHHHHHHhcCChhhhhhhc------------CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 897 VDIVQWSKRATNGRKEEFLSIL------------DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~------------d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.................+.... .+.........+..+.+++.+|++.+|++||+++|++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 2222221111111111010000 00001111233567889999999999999999999986
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=297.16 Aligned_cols=257 Identities=24% Similarity=0.312 Sum_probs=200.0
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.+.|+..+.||+|+||.||+|+.. +++.+|+|.+... .......++.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344666788999999999999764 5788999988432 1222345678899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+. |++.+++... ...+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 94 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 99996 5888877533 345789999999999999999999777 999999999999999999999999998764321
Q ss_pred CCCccccccccCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 842 GASECMSAIAGSYGYIAPEYAY---TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
....+++.|+|||++. ...++.++|||||||++|+|++|+.||........... .....
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~-------- 230 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNE-------- 230 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH----HhhcC--------
Confidence 2346788999999874 35678899999999999999999999865322111111 11110
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
.........+..+.+++.+||+.+|++||+++++++.-.-.....+
T Consensus 231 --~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 231 --SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred --CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 0011122456678899999999999999999999987655554433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=303.36 Aligned_cols=271 Identities=23% Similarity=0.268 Sum_probs=204.5
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCC-----cce
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE-----TNL 759 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~ 759 (995)
+|+..+.||.|+||.||+|+.. +++.||+|++..... ......+.+|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4678899999999999999875 488999999854322 334567889999999999999999999987765 789
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 489998863 347899999999999999999999777 9999999999999999999999999998764
Q ss_pred cCCC-CccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh-----
Q 001922 840 DGGA-SECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE----- 912 (995)
Q Consensus 840 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~----- 912 (995)
.... ........++..|+|||++.+. .++.++||||+|+++|+|++|+.||......................
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 4321 0122345678899999999887 78999999999999999999999996543221111111111000000
Q ss_pred ------hhhhhcCCc----CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCCC
Q 001922 913 ------EFLSILDPR----LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFPR 963 (995)
Q Consensus 913 ------~~~~~~d~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 963 (995)
.+....... +....+..+..+.+++.+||+.+|++||+++++++. +++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000 001112246678999999999999999999999974 555554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=295.09 Aligned_cols=249 Identities=27% Similarity=0.335 Sum_probs=195.0
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
..+.|...+.||+|+||+||+|+. .+++.|++|++..... ......+.+|+++++.++|||++++++++.+.+..|+
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 344567778899999999999976 4688899998843222 2223567889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+. |++.+++.. ....+++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.+||+|||++....
T Consensus 99 v~e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~- 172 (313)
T cd06633 99 VMEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS- 172 (313)
T ss_pred EEecCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC-
Confidence 999996 588887753 3456889999999999999999999877 9999999999999999999999999986432
Q ss_pred CCCCccccccccCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 841 GGASECMSAIAGSYGYIAPEYAY---TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
......|+..|+|||++. ...++.++||||+||++|+|++|..||......... ........
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~----~~~~~~~~------ 237 (313)
T cd06633 173 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNDS------ 237 (313)
T ss_pred -----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHhcCC------
Confidence 123456889999999874 456888999999999999999999998653221111 11111100
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+. ......+..+.+++.+||+.+|++||++.++++.
T Consensus 238 --~~--~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 --PT--LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 1112234568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=290.52 Aligned_cols=243 Identities=22% Similarity=0.247 Sum_probs=186.4
Q ss_pred CeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC--ChhHHHHHHHHHH-hccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH--SHDHGFRAEIQTL-GNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||.||+|.. .+++.||+|.+...... .....+..|..++ ...+|||++++++++..++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999976 46889999998532211 1122344454443 455899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 999999963 346888999999999999999999777 99999999999999999999999999875422 1
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
....++..|+|||...+..++.++||||+|+++|+|++|..||..... ............ + .......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~-------~-~~~~~~~ 218 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----DAVFDNILSRRI-------N-WPEEVKE 218 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhccc-------C-CCCcccc
Confidence 234678899999999888889999999999999999999999964321 111111111100 0 0011122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 928 EEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.++..+.+++.+||+.+|++||++.++.+.
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 356778999999999999999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=302.11 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=196.5
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCC------
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE------ 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 756 (995)
..+|...+.||+|+||.||+|.. .+|+.||+|++.... .......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 45788889999999999999976 468999999985432 2223456788999999999999999999986543
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
..++|+||+.. ++.++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 45899999964 7776652 35788999999999999999999877 9999999999999999999999999987
Q ss_pred ccccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||............ ..........+.
T Consensus 166 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (342)
T cd07879 166 HADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI-LKVTGVPGPEFV 239 (342)
T ss_pred CCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHhcCCCCHHHH
Confidence 6422 1123467889999998876 46889999999999999999999999753221111111 111111111111
Q ss_pred hhcCC-----------cC-----CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCCC
Q 001922 916 SILDP-----------RL-----SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFPR 963 (995)
Q Consensus 916 ~~~d~-----------~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 963 (995)
+.... .. ....+..+..+.+++.+||+.||++||+++|++++ +++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 11110 00 00011234568899999999999999999999954 766654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=288.75 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=196.2
Q ss_pred hccCCCeeeccCceEEEEEEeCC-CcEEEEEEecCCC----CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFG----THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
+|...+.||+|+||.||+++... +..+++|.++... .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999997643 4445555553211 222334577899999999999999999999988999999
Q ss_pred EEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 762 YEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
|||+++++|.+++.. .....+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998863 33457899999999999999999999877 999999999999975 569999999987654
Q ss_pred cCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.... ......+++.|+|||...+..++.++|+||+|+++|+|++|..||.... ......... .
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~~~~~~~~-----------~ 219 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVLRIV-----------E 219 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHH-----------c
Confidence 3221 2234567889999999988888999999999999999999999985321 111111111 1
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
......+...+..+.+++.+||+.+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11222345667789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=300.08 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=196.1
Q ss_pred HHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCC----
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE---- 756 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---- 756 (995)
.+.++|+..+.||+|+||.||+|.. .+++.||||++.... .......+.+|++++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3456788899999999999999964 578999999985322 2223456788999999999999999999986543
Q ss_pred --cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 757 --TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 757 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
..++||||+ +++|.+++.. ..+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.++++|||+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999 7799988853 45889999999999999999999877 99999999999999999999999999
Q ss_pred ccccccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
+...... .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||.............. ........
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~ 238 (343)
T cd07880 165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK-VTGTPSKE 238 (343)
T ss_pred ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-hcCCCCHH
Confidence 8865321 123457889999998875 4578999999999999999999999975332111111111 11111111
Q ss_pred hhhhcCC-----------c-----CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 914 FLSILDP-----------R-----LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 914 ~~~~~d~-----------~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
+...+.. . +.......+..+.+++.+|++.||++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111100 0 00111234456889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=295.20 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=200.6
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 762 (995)
+|...+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++ ||||+++++++.+++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5778889999999999999764 68999999885422 2233456788999999998 999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++++|.+++.. ...+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 82 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 82 EYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999964 347899999999999999999999877 9999999999999999999999999988654322
Q ss_pred CC------------------ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHH
Q 001922 843 AS------------------ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSK 904 (995)
Q Consensus 843 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~ 904 (995)
.. .......++..|+|||+..+..++.++||||+|+++|++++|+.||...... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~ 232 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----LTFQ 232 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH----HHHH
Confidence 11 1122345788999999998888999999999999999999999999653311 1111
Q ss_pred HHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCH----HHHHH
Q 001922 905 RATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRM----REVVQ 956 (995)
Q Consensus 905 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~ 956 (995)
... . .....+...+..+.+++.+||+.+|++||++ +++++
T Consensus 233 ~~~-----------~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 KIL-----------K-LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHH-----------h-cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111 0 1111233446678999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=318.38 Aligned_cols=277 Identities=23% Similarity=0.208 Sum_probs=213.6
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.+.|++.++||+|+||.|..++.+ +++.||+|++.+.. ......-|..|-.+|..-..+-|+.++.+|++..++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 346788899999999999999875 57778999885422 233456689999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
||||+||+|-.++... ..+++..++.++.+|+-||..+|+.| +|||||||+|||+|..|++||+|||.+-.+...
T Consensus 154 MdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999643 37999999999999999999999888 999999999999999999999999999887643
Q ss_pred CCCccccccccCcccccccccc----c-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 842 GASECMSAIAGSYGYIAPEYAY----T-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
+. ......+|||.|.+||+++ + +.|+..+|+||+||++|||+.|..||+. ..++.-...+.....
T Consensus 229 G~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa----dslveTY~KIm~hk~----- 298 (1317)
T KOG0612|consen 229 GT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA----DSLVETYGKIMNHKE----- 298 (1317)
T ss_pred Cc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH----HHHHHHHHHHhchhh-----
Confidence 32 2335678999999999976 3 5789999999999999999999999964 223322222222200
Q ss_pred hcCCcCCCC-CHHHHHHHHHHHhcccCCCCCCCCC---HHHHHHH--H-----ccCCCCCcccccCchhhhhcccC
Q 001922 917 ILDPRLSMV-PKEEAMHLLFVAMLCIQENSIERPR---MREVVQM--L-----SEFPRHSSDFNQSSSSSLKNLEK 981 (995)
Q Consensus 917 ~~d~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~--L-----~~~~~~~~~~~~~~~~~~~~~~~ 981 (995)
.+.+. ..+.+....++|.+.+. +|+.|-. ++++..+ + ..++...+++...-++..++..+
T Consensus 299 ----~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnF 369 (1317)
T KOG0612|consen 299 ----SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNF 369 (1317)
T ss_pred ----hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccc
Confidence 11111 12466778888888774 6777776 8887654 2 22444555665555555555544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-33 Score=277.16 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=195.5
Q ss_pred CCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEeccC
Q 001922 690 DGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 690 ~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
....||.|+||+|++..+ +.|+..|||++..........++..|.++..+- ++||||+++|+.-.++.-|+.||.|+-
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~ 147 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI 147 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence 345699999999999855 579999999997766666677788888876555 699999999998888889999999964
Q ss_pred CChhhhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 768 GSLGEALH---GKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 768 gsL~~~l~---~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
|+..+.. ......+++...-.|..-.+.||.||.+.. .|||||+||+|||++..|.||+||||++-.+.+.
T Consensus 148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--- 221 (361)
T KOG1006|consen 148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--- 221 (361)
T ss_pred -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH---
Confidence 7765543 344567888888888888999999998743 5999999999999999999999999999876432
Q ss_pred ccccccccCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 845 ECMSAIAGSYGYIAPEYAYT--LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
-..+...|...|||||.+.. ..|+.++||||+|+++||+.||..||....+..+ + ...+..+ |+..
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe--q-l~~Vv~g---------dpp~ 289 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE--Q-LCQVVIG---------DPPI 289 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH--H-HHHHHcC---------CCCe
Confidence 23345678899999998863 3589999999999999999999999976433211 1 1112211 1211
Q ss_pred CC---CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 923 SM---VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 923 ~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
-. ...+.+..+..++..|+.+|-..||.+.++.++
T Consensus 290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11 123467789999999999999999999998754
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=294.49 Aligned_cols=262 Identities=23% Similarity=0.289 Sum_probs=196.7
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC-CCCChhHHHHHHHHHHhccCCCCceeEeEEEec-CCcceE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF-GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN-KETNLL 760 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l 760 (995)
+.++|+..+.||+|+||.||+|.. .+++.||+|++... ........+.+|++++++++||||+++++++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 467788999999999999999975 47899999987532 223345667889999999999999999998865 567899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+ +++|.+++.. ..+++.....++.|++.|+.|||+.+ |+||||+|+||++++++.++|+|||.+.....
T Consensus 88 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred Eeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 99998 5689888853 35788888899999999999999777 99999999999999999999999999875422
Q ss_pred CCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH-----------hc
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRA-----------TN 908 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-----------~~ 908 (995)
......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||...........+.... ..
T Consensus 161 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 161 -----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred -----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 1123457889999998765 568999999999999999999999996532211111111111 11
Q ss_pred CChhhhhhhcCCcCCC----CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 909 GRKEEFLSILDPRLSM----VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 909 ~~~~~~~~~~d~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....+.......... ..+..+..+.+++.+|++.+|++||++++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1001110000000000 011245678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=300.68 Aligned_cols=265 Identities=23% Similarity=0.273 Sum_probs=197.0
Q ss_pred HHHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecC---
Q 001922 681 VSDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--- 755 (995)
Q Consensus 681 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 755 (995)
+..+.++|...+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 344567899999999999999999965 578999999985432 222345678899999999999999999988543
Q ss_pred ---CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeee
Q 001922 756 ---ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADF 832 (995)
Q Consensus 756 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~Df 832 (995)
...|++++++ +++|.+++.. ..+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~df 164 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF 164 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecc
Confidence 3467888887 7799888753 35889999999999999999999877 999999999999999999999999
Q ss_pred ccccccccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
|+++.... ......++..|+|||...+ ..++.++||||+||++|||++|+.||.....................
T Consensus 165 g~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 165 GLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred cccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99876422 1233467889999998766 56789999999999999999999999653322222221111111100
Q ss_pred hhh-----------hhhcCCc----CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 EEF-----------LSILDPR----LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 ~~~-----------~~~~d~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
... ...+... ........+..+.+++.+|++.||++||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 0000000 000001235568899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=302.06 Aligned_cols=265 Identities=20% Similarity=0.245 Sum_probs=193.7
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecC--------
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK-------- 755 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-------- 755 (995)
..+|+..+.||.|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 35788899999999999999976 468899999984433 23456688899999999999999999876543
Q ss_pred ------CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCCeE
Q 001922 756 ------ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS-AFEAH 828 (995)
Q Consensus 756 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~-~~~vk 828 (995)
...|+||||++ ++|.+++.. ..+++..++.++.||+.|+.|||+.+ |+||||||+||+++. ++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35689999997 589888753 35889999999999999999999887 999999999999975 55789
Q ss_pred EeeeccccccccCCCCc-cccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH
Q 001922 829 VADFGLAKFLIDGGASE-CMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRA 906 (995)
Q Consensus 829 l~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 906 (995)
++|||.++......... ......++..|+|||.+.. ..++.++||||+||++|+|++|+.||....+...........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999997653221111 1123457889999997654 567889999999999999999999997543322222221111
Q ss_pred hcCChhhhhhhc---------CCcCCCC-----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 907 TNGRKEEFLSIL---------DPRLSMV-----PKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 907 ~~~~~~~~~~~~---------d~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
............ +...... .+..+..+.+++.+|++.||++||+++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 111100000000 0000001 11244668899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=296.84 Aligned_cols=267 Identities=21% Similarity=0.246 Sum_probs=194.0
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCC------
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE------ 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 756 (995)
.++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888999999999999999764 688999998843322 222345778999999999999999999874433
Q ss_pred --cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 757 --TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 757 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
..++||||+.+ ++...+.. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 46999999965 77777753 3457899999999999999999999877 99999999999999999999999999
Q ss_pred ccccccCCCCc---------cccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHH
Q 001922 835 AKFLIDGGASE---------CMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSK 904 (995)
Q Consensus 835 a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~ 904 (995)
+.......... ......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 98654322111 11234568889999987654 578999999999999999999999965433222221111
Q ss_pred HHhcCChhhh------hhhc----CCcCC----CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 905 RATNGRKEEF------LSIL----DPRLS----MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 905 ~~~~~~~~~~------~~~~----d~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.........+ .... ..... .........+.+++.+|++.+|++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111000000 0000 00000 000122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=290.41 Aligned_cols=262 Identities=24% Similarity=0.296 Sum_probs=198.4
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
|+..+.||+|+||.||+|+.. +++.||+|++.... .......+..|+.++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999775 58999999985433 2333456788999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
+ ++|.+++.... ..+++..+.+++.|++.|+.|||+.+ |+||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 7 59999997432 46899999999999999999999887 99999999999999999999999999986533221
Q ss_pred cccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh-----cC
Q 001922 846 CMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI-----LD 919 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~d 919 (995)
......++..|+|||.+.+. .++.++||||+|+++||+++|+.||.......................+... .+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 22334567789999998766 7889999999999999999999998653322221111111111111111000 00
Q ss_pred CcCC--------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 920 PRLS--------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 920 ~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
...+ ...+..+..+.+++.+||+.+|++||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000 011123567999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=297.07 Aligned_cols=264 Identities=22% Similarity=0.237 Sum_probs=192.0
Q ss_pred ccCCCeeeccCceEEEEEEeC-C--CcEEEEEEecCCC-CCChhHHHHHHHHHHhcc-CCCCceeEeEEEec----CCcc
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-N--GVEIAVKKLLGFG-THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSN----KETN 758 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~--~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~----~~~~ 758 (995)
|+..+.||+|+||.||+|+.. + +..||+|++.... .......+.+|+.+++++ .||||+++++++.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 566788999999999999764 3 6789999885322 222345678899999999 59999999987532 2457
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
|+++||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 82 YLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 88999985 68999885 3456889999999999999999999877 999999999999999999999999999865
Q ss_pred ccCCCC--ccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 839 IDGGAS--ECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 839 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
...... .......|+..|+|||+..+ ..++.++||||+||++|++++|+.||.......................+.
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 432211 11233568999999998765 468899999999999999999999996543221111111111110000000
Q ss_pred hh-----------cCC----cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 916 SI-----------LDP----RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 916 ~~-----------~d~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+ ... .+.......+..+.+++.+|++.||++||+++|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 000 0001111235678899999999999999999999743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=297.38 Aligned_cols=240 Identities=25% Similarity=0.252 Sum_probs=194.3
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.+.|+....+|.|+|+.|..+.. ++++..+||++.+. .....+|+.++... .||||+++++.+.++.+.|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc-----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 34566667799999999998854 57889999998543 22244577666666 6999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE-CCCCCeEEeeeccccccccC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL-NSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill-~~~~~vkl~DfGla~~~~~~ 841 (995)
|++.|+-+.+.+.... ... ..+..|+.+|+.|+.|||++| |||||+||+|||+ ++.+.++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999999988885432 222 566789999999999999887 9999999999999 68999999999999876432
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
..+.+-|..|.|||+....+|++++|+||+|+++|+|++|+.||....++ .+...++..+
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~------------ 529 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMP------------ 529 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCC------------
Confidence 34557788999999999999999999999999999999999999765544 2222222221
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
......+...++|+.+|++.||.+||+++++...
T Consensus 530 --~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 530 --KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1124667789999999999999999999999764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=300.10 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=196.8
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCc---
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET--- 757 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--- 757 (995)
++.++|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+.++++++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34567888999999999999999774 57899999875322 22234557789999999999999999988765554
Q ss_pred ---ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 758 ---NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 758 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
.++|+||+ +++|.+++.. ..+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 6699999863 45899999999999999999999877 99999999999999999999999999
Q ss_pred ccccccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
+...... .....++..|+|||...+ ..++.++||||+|+++||+++|+.||............. .......+.
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~-~~~~~~~~~ 238 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM-NLVGTPDEE 238 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HhcCCCCHH
Confidence 9865322 234467889999998765 367899999999999999999999996533211111111 111100000
Q ss_pred hhh---------h---cCCcC----CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 914 FLS---------I---LDPRL----SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 914 ~~~---------~---~d~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+.. . +.... .......+..+.+++.+|++.+|++|||+.||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000 0 00000 00011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=279.47 Aligned_cols=262 Identities=20% Similarity=0.240 Sum_probs=206.3
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-C-C----CceeEeEEEecCC
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-H-R----NIVRLLAFCSNKE 756 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-p----niv~~~~~~~~~~ 756 (995)
+.++|.+...+|+|+||.|-.+.+ ..+..||+|+++... .-.+..+-|+++++++. + | -+|.+.+||+-.+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 478999999999999999999854 447899999985432 23556778999999993 2 3 3788899999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-------------
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS------------- 823 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~------------- 823 (995)
+.+||+|.+ |-|+++++....-.+++...++.++.|++++++|||+.+ ++|-|+||+||++.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 999999998 669999998777788999999999999999999999777 999999999999842
Q ss_pred -------CCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 001922 824 -------AFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG 896 (995)
Q Consensus 824 -------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~ 896 (995)
+..|+++|||.|++-.. .....+.|..|.|||++.+-.++.++||||+|||++|+.||..-|..-.+.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 34689999999987422 225678899999999999999999999999999999999999999765544
Q ss_pred chHHHHHHHHhcCChhhhhhhc--------------------------CCcC-----CCCCHHHHHHHHHHHhcccCCCC
Q 001922 897 VDIVQWSKRATNGRKEEFLSIL--------------------------DPRL-----SMVPKEEAMHLLFVAMLCIQENS 945 (995)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~--------------------------d~~~-----~~~~~~~~~~l~~li~~cl~~dP 945 (995)
+.+ ..+.++....+....... ++.. ......+...+.+|+.+|+..||
T Consensus 316 EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 316 EHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 433 333333333222221111 0000 01223456679999999999999
Q ss_pred CCCCCHHHHHHH
Q 001922 946 IERPRMREVVQM 957 (995)
Q Consensus 946 ~~RPt~~evl~~ 957 (995)
.+|+|++|++++
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=246.68 Aligned_cols=263 Identities=22% Similarity=0.286 Sum_probs=198.3
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCC-CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGF-GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
.|+..++||+|+||+||+|+.. +++.||+|++.-. .++.......+|+-+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3556678999999999999754 5788999998533 3334456688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
|+. +|..+... -++.++.+.++.++.|+++|+.|+|.+. +.|||+||+|.++..+|..|++|||+++-+.- .-
T Consensus 83 cdq-dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi--pv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI--PV 155 (292)
T ss_pred hhH-HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC--ce
Confidence 965 89988864 4577899999999999999999999766 99999999999999999999999999987632 22
Q ss_pred ccccccccCcccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHH-HHHhcCChhhhhhh---cC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLR-VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWS-KRATNGRKEEFLSI---LD 919 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~d 919 (995)
......+-|..|.+|.++.+.. |+...|+||.|||+.|+.....|.....+..+....+ +......++.+..+ -|
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 3345567789999999988765 7899999999999999999656654444433332222 22222222222211 11
Q ss_pred Cc-CCCCC---------HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 920 PR-LSMVP---------KEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 920 ~~-~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.. ++.++ +.....=++++.+.+.-+|.+|.++++.++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11 11111 122233456788888889999999998876
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=281.04 Aligned_cols=237 Identities=27% Similarity=0.272 Sum_probs=192.1
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEecCCCCC--ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCCh
Q 001922 694 IGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSL 770 (995)
Q Consensus 694 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL 770 (995)
||+|+||.||++... +++.+|+|.+...... .....+..|++++++++|||++++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999764 5889999988543222 2355788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcccccc
Q 001922 771 GEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850 (995)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 850 (995)
.+++... ..+++..+..++.|++.|+.|+|+.+ ++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 9999643 36889999999999999999999877 9999999999999999999999999988753321 122345
Q ss_pred ccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHH
Q 001922 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEA 930 (995)
Q Consensus 851 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 930 (995)
.++..|+|||...+...+.++|+||||+++|++++|+.||..... .......... . ...+...+
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~-----------~-~~~~~~~~ 217 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILKD-----------P-LRFPEFLS 217 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhcC-----------C-CCCCCCCC
Confidence 688899999999888889999999999999999999999954322 1111111111 1 11233336
Q ss_pred HHHHHHHhcccCCCCCCCCCHHH
Q 001922 931 MHLLFVAMLCIQENSIERPRMRE 953 (995)
Q Consensus 931 ~~l~~li~~cl~~dP~~RPt~~e 953 (995)
..+.+++.+||..||++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 67889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=278.86 Aligned_cols=260 Identities=24% Similarity=0.315 Sum_probs=200.7
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCCh------hHHHHHHHHHHhccCCCCceeEeEEEe-cC
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSH------DHGFRAEIQTLGNIRHRNIVRLLAFCS-NK 755 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~-~~ 755 (995)
+.++|-...++|+|+|++||+|.+ ...+.||||+-.......+ .....+|..|.+.+.||.||++|++|. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 455677778899999999999954 4567888887632222211 123567999999999999999999995 45
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC---CCCCeEEeee
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN---SAFEAHVADF 832 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~---~~~~vkl~Df 832 (995)
+..|-|.|||+|.+|+-|++ .+..+++..++.|+.||+.||.||.+. +++|||-|+||.|||+- ..|.+||+||
T Consensus 541 dsFCTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccceeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 67789999999999999995 456789999999999999999999987 78899999999999994 4578999999
Q ss_pred ccccccccCCCCc-----cccccccCcccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHH
Q 001922 833 GLAKFLIDGGASE-----CMSAIAGSYGYIAPEYAYTL----RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWS 903 (995)
Q Consensus 833 Gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~ 903 (995)
|+++.+.+..+.. ......||..|++||++.-+ .++.++||||+|||+|.++.|+.||+......++.+..
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 9999886654432 22456799999999987633 46889999999999999999999998755555544433
Q ss_pred HHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 904 KRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 904 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..+... +-..+. .+..+.+...+|++|+++.-++|..+.++..
T Consensus 698 TIlkAt---------EVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 698 TILKAT---------EVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred chhcce---------eccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 221111 111111 1234556788999999999999998887753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=314.05 Aligned_cols=146 Identities=31% Similarity=0.377 Sum_probs=128.9
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.|.+.+.||+|+||+||+|... +++.||+|++..... ......+..|+.+++.++||||+++++++...++.|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999775 688999999854322 222356888999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
||+.+++|.+++.. ...+++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999963 346888999999999999999999777 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=296.82 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=206.2
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEe-----cCCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCS-----NKET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~-----~~~~ 757 (995)
...|++.++||+|.+|.||+++. ++++.+|+|+.....+ ..+++..|..|++.. .|||++.++++|. .++.
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 34566778999999999999965 5688899998754333 356678889999888 5999999999983 3578
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
+|+|||||.+||..|+++...+..+.|+....|+++++.|+.+||... ++|||||-.||+++.++.||++|||.+..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeee
Confidence 899999999999999998777889999999999999999999999776 99999999999999999999999999987
Q ss_pred cccCCCCccccccccCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYT-----LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
+.. ......+..||+.|||||++.- ..|+.++|+||+|++..||.-|.+|+.++..-..+ ..+...
T Consensus 173 lds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL----F~IpRN--- 243 (953)
T KOG0587|consen 173 LDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL----FLIPRN--- 243 (953)
T ss_pred eec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh----ccCCCC---
Confidence 643 2233467789999999999863 35778999999999999999999999775432111 111111
Q ss_pred hhhhhcCCcC-CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 913 EFLSILDPRL-SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 913 ~~~~~~d~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
|.. ...+..-+..+.++|..|+..|.++||++.+++++
T Consensus 244 -------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 244 -------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111 13466778889999999999999999999988754
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=287.03 Aligned_cols=250 Identities=22% Similarity=0.237 Sum_probs=201.2
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCc-EEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGV-EIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~-~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
..++....+|-|+||.|-.++..... .+|+|.+++. ....+.+.+..|-.+|...+.|.||++|..|.+..++|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556678999999999998774433 3788877442 34445667888999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
|-|-||.+...++ .++.++..++..++..+++|++|||.++ ||+||+||+|.+++.+|-+||.|||+|+.+..+.
T Consensus 500 EaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 9999999999995 5577888888999999999999999777 9999999999999999999999999999985443
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
..-+.||||.|.|||++.+...+.++|.||+|+++||+++|.+||.....- .....+..+.. .
T Consensus 575 ---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm----ktYn~ILkGid-----~----- 637 (732)
T KOG0614|consen 575 ---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM----KTYNLILKGID-----K----- 637 (732)
T ss_pred ---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH----HHHHHHHhhhh-----h-----
Confidence 334679999999999999999999999999999999999999999653221 11111222210 0
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPR-----MREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 957 (995)
-..|........++|++..+.+|.+|-- +.++-++
T Consensus 638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1134455666778999999999999975 5555443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=275.16 Aligned_cols=240 Identities=23% Similarity=0.249 Sum_probs=191.5
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCC--hhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHS--HDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.|....+||+|+||.|.+|..+ +.+-+|||++++....+ +.+--+.|-+++..- +-|.+++++.+|+..+.+|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 3455678999999999999654 45678999986543322 233345677777666 5789999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+.||+|--.++. -+.+.+..+.-++.+||-||-+||++| ||.||+|.+|||+|.+|.+||+|||+++.-.-
T Consensus 430 EyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-- 502 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-- 502 (683)
T ss_pred EEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc--
Confidence 99999999988853 355777788889999999999999777 99999999999999999999999999985321
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
......+.+|||.|+|||.+...+|+..+|+||+||++|||+.|++||+.. +-.+..+.+. +...
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe----DE~elF~aI~-----------ehnv 567 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE----DEDELFQAIM-----------EHNV 567 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHH-----------HccC
Confidence 223346789999999999999999999999999999999999999999642 2222222222 2221
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCC
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERP 949 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RP 949 (995)
.+|...+.+...+....+...|.+|.
T Consensus 568 -syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 -SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -cCcccccHHHHHHHHHHhhcCCcccc
Confidence 25666777788889999999999995
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=275.64 Aligned_cols=220 Identities=23% Similarity=0.178 Sum_probs=176.0
Q ss_pred cCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCChhhhhc
Q 001922 697 GGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALH 775 (995)
Q Consensus 697 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 775 (995)
|.||.||+++. .+++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 89999999976 468899999984321 23345555555679999999999999999999999999999999986
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccccCcc
Q 001922 776 GKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYG 855 (995)
Q Consensus 776 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~ 855 (995)
. ...+++..+..++.|++.|+.|+|+.+ |+||||||+||+++.++.++++|||.+..+... .....++..
T Consensus 78 ~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 78 K--FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred H--hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 4 345889999999999999999999877 999999999999999999999999988765322 123346778
Q ss_pred cccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHH
Q 001922 856 YIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLF 935 (995)
Q Consensus 856 y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~ 935 (995)
|+|||...+..++.++||||+|+++|||++|+.|+....... ... .. ...+...+..+.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------~~~--------~~---~~~~~~~~~~~~~ 207 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------NTH--------TT---LNIPEWVSEEARS 207 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------ccc--------cc---cCCcccCCHHHHH
Confidence 999999988889999999999999999999998874321100 000 00 0123345567889
Q ss_pred HHhcccCCCCCCCCCHH
Q 001922 936 VAMLCIQENSIERPRMR 952 (995)
Q Consensus 936 li~~cl~~dP~~RPt~~ 952 (995)
++.+|++.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=261.27 Aligned_cols=272 Identities=20% Similarity=0.274 Sum_probs=196.6
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEe-cCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec-----
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN----- 754 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~-~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 754 (995)
.+....|+...+||+|.||+||+|+.+ .|++||+|++ .......-.....+|+++++.++|+|++.+++.|..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 334556777788999999999999764 5788899876 222233334556789999999999999999887732
Q ss_pred ---CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEee
Q 001922 755 ---KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVAD 831 (995)
Q Consensus 755 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~D 831 (995)
....|+||++|+. +|.-++.. ...+++.....++++++..||.|+|... |+|||+||+|++++.+|.+||+|
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeec
Confidence 2347999999986 99988863 3467888999999999999999999666 99999999999999999999999
Q ss_pred ecccccccc--CCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHH---H
Q 001922 832 FGLAKFLID--GGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSK---R 905 (995)
Q Consensus 832 fGla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~---~ 905 (995)
||+++.+.. .......+..+-|..|.+||.+.+ .+|+++.|||..|||+.||+||.+-+....+...+..... .
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence 999976532 222333445667999999998876 4689999999999999999999988765333222211111 1
Q ss_pred HhcCChhh-----hhhhcC-CcCCC----CCHH------HHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 001922 906 ATNGRKEE-----FLSILD-PRLSM----VPKE------EAMHLLFVAMLCIQENSIERPRMREVVQML 958 (995)
Q Consensus 906 ~~~~~~~~-----~~~~~d-~~~~~----~~~~------~~~~l~~li~~cl~~dP~~RPt~~evl~~L 958 (995)
+..+..+. +...++ +.++. .-++ ......+++.+++..||.+|+++++++..-
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 11111100 001110 00100 0001 123567899999999999999999998753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=299.10 Aligned_cols=244 Identities=27% Similarity=0.377 Sum_probs=187.6
Q ss_pred CCCeeeccCceE-EEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEeccC
Q 001922 690 DGNVIGRGGAGI-VYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 690 ~~~~lG~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
..+++|.|+.|+ ||+|.+ +|++||||++. ....+...+|++.++.- +|||||++++.-.++...||..|.|..
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLL----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHh----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 346789999985 799988 78899999983 33345578899999988 599999999999999999999999965
Q ss_pred CChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---C--CCeEEeeecccccccc
Q 001922 768 GSLGEALHGK--KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS---A--FEAHVADFGLAKFLID 840 (995)
Q Consensus 768 gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~---~--~~vkl~DfGla~~~~~ 840 (995)
+|.+++... ..........+.+..|++.|+++||..+ |||||+||.||||+. + .+++|+|||+++.+..
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 999999752 1111121345678999999999999776 999999999999976 3 4689999999999865
Q ss_pred CCCC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 841 GGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 841 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
+... .......||-+|+|||++....-+.++||||+||++|+.++ |.+||++..... ..+..+...- .
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~------~NIl~~~~~L--~-- 733 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ------ANILTGNYTL--V-- 733 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh------hhhhcCccce--e--
Confidence 4322 22456779999999999999888889999999999999999 599997632210 0111111100 0
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+... .++ ...++|.+|++++|..||+|.+|+.+
T Consensus 734 --~L~~~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 --HLEPL-PDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred --eeccC-chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 00111 112 77899999999999999999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=257.96 Aligned_cols=247 Identities=21% Similarity=0.278 Sum_probs=196.5
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 760 (995)
.+.|+..++||.|+|++|..++.+ +.+-||+|++++.- ...+.+-++.|-.+..+. +||.+|.++.+|+.....|+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 346788899999999999999764 56788999885432 223344466777777776 69999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
|.||+.||+|--.++ ....++++.++.+..+|+-||.|||++| ||.||+|..||++|..|.+|++|||+++.-..
T Consensus 329 vieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999987774 4457899999999999999999999877 99999999999999999999999999985322
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC---CCchHHHHHHHHhcCChhhhhhh
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFG---DGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
......+.+|||.|.|||.+++..|...+|.|++||+++||+.|+.||+..+ .+.+-.++...+.
T Consensus 404 --~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi---------- 471 (593)
T KOG0695|consen 404 --PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI---------- 471 (593)
T ss_pred --CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH----------
Confidence 2233467899999999999999999999999999999999999999997532 1222222222221
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCC
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERP 949 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 949 (995)
++.. -.+|...+.....+++.-+++||.+|.
T Consensus 472 lekq-iriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 472 LEKQ-IRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhhc-ccccceeehhhHHHHHHhhcCCcHHhc
Confidence 1111 224555566677788999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=266.83 Aligned_cols=237 Identities=28% Similarity=0.384 Sum_probs=193.1
Q ss_pred CceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCChhhhhcC
Q 001922 698 GAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHG 776 (995)
Q Consensus 698 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 776 (995)
+||.||+|+.. +++.+|+|++.........+.+.+|++.+++++|++++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999875 48999999985443333267899999999999999999999999988999999999999999999864
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccccCccc
Q 001922 777 KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGY 856 (995)
Q Consensus 777 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y 856 (995)
.. .+++..++.++.+++.++.|||+.+ |+|+||+|+||+++.++.++++|||.+....... ......++..|
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 32 3889999999999999999999877 9999999999999999999999999998764332 23445688899
Q ss_pred ccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH--HHHHHHH
Q 001922 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK--EEAMHLL 934 (995)
Q Consensus 857 ~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~--~~~~~l~ 934 (995)
++||...+..++.++||||+|+++|++++|..||....+.....+.. ... ....... ..+..+.
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~---~~~-----------~~~~~~~~~~~~~~~~ 218 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI---GKP-----------KPPFPPPEWKISPEAK 218 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---hcc-----------CCCCccccccCCHHHH
Confidence 99999988889999999999999999999999996533322222221 111 1110111 1556789
Q ss_pred HHHhcccCCCCCCCCCHHHHHH
Q 001922 935 FVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 935 ~li~~cl~~dP~~RPt~~evl~ 956 (995)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=242.22 Aligned_cols=201 Identities=26% Similarity=0.386 Sum_probs=168.5
Q ss_pred cCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEecc
Q 001922 689 KDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 689 ~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
..+..||+|+||.|-+.++ .+|...|+|++.........++...|+.+..+. .+|.+|+++|.+.+....++.||.|+
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 3445699999999988865 578999999997666655666778888887665 69999999999988899999999996
Q ss_pred CCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 767 NGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 767 ~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
. ||..+... ..++.+++...-+|+..+++||.|||++- .|||||+||+|||++.+|+||+||||++-.+.+.-
T Consensus 129 t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi-- 203 (282)
T KOG0984|consen 129 T-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI-- 203 (282)
T ss_pred h-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhh--
Confidence 5 88776543 46788999999999999999999999865 49999999999999999999999999998764422
Q ss_pred ccccccccCcccccccccc----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAY----TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGD 895 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~ 895 (995)
..+...|...|||||.+. ...|+.++||||+|+.+.||.+++.||+....
T Consensus 204 -Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 204 -AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred -HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 223356888999999875 34789999999999999999999999976443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-31 Score=258.49 Aligned_cols=264 Identities=23% Similarity=0.292 Sum_probs=196.3
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecC-CCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC-----cceE
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLG-FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE-----TNLL 760 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~l 760 (995)
.+..+.||.|+||.||.+++ ++|+.||.|++.. ...-....++.+|.+++..++|.|++..++..+-.. +.|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 45678899999999999976 5799999999832 223334677889999999999999999988775432 4578
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
+.|.|.. +|..++- ..+.++...+.-+..||++|+.|||+.+ |.||||||.|.++.++...||||||+++....
T Consensus 135 ~TELmQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 8999854 8888884 5667888888889999999999999777 99999999999999999999999999986533
Q ss_pred CCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC-Chhhhhhhc
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG-RKEEFLSIL 918 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 918 (995)
+....++..+-|..|.|||.+++. .|+.++||||+|||+.|++..+.-|..-+.... .+.+...... ..+......
T Consensus 209 -d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ-L~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 209 -RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ-LQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred -hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH-HHHHHHHhCCCcHHHHHHHh
Confidence 334455667789999999999876 589999999999999999998888865332211 1111111111 001111000
Q ss_pred C-------------CcCC-----CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 919 D-------------PRLS-----MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 919 d-------------~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
+ |... ..+.....+...+...++..||++|.+..+.+....
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 0 1110 011233344556888999999999999998887643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=295.71 Aligned_cols=259 Identities=19% Similarity=0.223 Sum_probs=168.8
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-C----CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEE------Ee
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-N----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAF------CS 753 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~------~~ 753 (995)
.+.|+..+.||+|+||.||+|+.. + +..||+|++.... ..+....| .++...+.+++.+... ..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457888999999999999999764 4 6899999874321 11111111 1111122222222211 24
Q ss_pred cCCcceEEEEeccCCChhhhhcCCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 001922 754 NKETNLLVYEYMRNGSLGEALHGKKGA------------------FLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVK 815 (995)
Q Consensus 754 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlk 815 (995)
.+...++||||+.+++|.+++...... ......+..++.|++.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566889999999999999998643211 1123345679999999999999777 9999999
Q ss_pred CCCEEECC-CCCeEEeeeccccccccCCCCccccccccCcccccccccccC----------------------CCCcccc
Q 001922 816 SNNILLNS-AFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL----------------------RVDEKSD 872 (995)
Q Consensus 816 p~Nill~~-~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 872 (995)
|+|||++. ++.+||+|||+++.+..+. ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5789999999998654322 2223456789999999965322 2345679
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC--ChhhhhhhcCCcCCC-------CCHHHHHHHHHHHhcccCC
Q 001922 873 VYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG--RKEEFLSILDPRLSM-------VPKEEAMHLLFVAMLCIQE 943 (995)
Q Consensus 873 vwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~~~~-------~~~~~~~~l~~li~~cl~~ 943 (995)
|||+||++|||+++..|++. ........+... ....+.....+.... .........++++.+|++.
T Consensus 362 VwSlGviL~el~~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS-----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch-----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999997776532 112221111111 001111111111100 0001123456899999999
Q ss_pred CCCCCCCHHHHHHH
Q 001922 944 NSIERPRMREVVQM 957 (995)
Q Consensus 944 dP~~RPt~~evl~~ 957 (995)
||++|||++|++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999975
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=278.26 Aligned_cols=258 Identities=21% Similarity=0.249 Sum_probs=178.3
Q ss_pred HhhccCCCeeeccCceEEEEEEe-----------------CCCcEEEEEEecCCCCCC-------------hhHHHHHHH
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-----------------PNGVEIAVKKLLGFGTHS-------------HDHGFRAEI 734 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~E~ 734 (995)
.+.|++.++||+|+||+||+|.. .+++.||||++....... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 45788899999999999999953 245689999984322110 112234467
Q ss_pred HHHhccCCCCc-----eeEeEEEec--------CCcceEEEEeccCCChhhhhcCCCC----------------------
Q 001922 735 QTLGNIRHRNI-----VRLLAFCSN--------KETNLLVYEYMRNGSLGEALHGKKG---------------------- 779 (995)
Q Consensus 735 ~~l~~l~hpni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------- 779 (995)
.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...+
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766544 667776643 3567999999999999999864211
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccccCcccccc
Q 001922 780 AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAP 859 (995)
Q Consensus 780 ~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 859 (995)
...++..+..++.|++.|+.|+|+.+ |+||||||+||+++.++.+||+|||++..+..+... ......+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 23467788899999999999999777 999999999999999999999999999765332211 11223457899999
Q ss_pred cccccCC--------------------C--CcccchhhHHHHHHHHHhCCC-CCCCCCC--------CchHHHHHHHHhc
Q 001922 860 EYAYTLR--------------------V--DEKSDVYSFGVVLLELLTGRR-PVGDFGD--------GVDIVQWSKRATN 908 (995)
Q Consensus 860 E~~~~~~--------------------~--~~~~DvwSlGvil~elltg~~-Pf~~~~~--------~~~~~~~~~~~~~ 908 (995)
|.+.... + ..+.||||+||++|+|++|.. ||..... ..+...|......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875322 1 134799999999999999876 7643210 1111111110000
Q ss_pred CChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCC---CCCCCHHHHHHH
Q 001922 909 GRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENS---IERPRMREVVQM 957 (995)
Q Consensus 909 ~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~ 957 (995)
...+. .....+...++++.+|+..+| .+|+|++|++++
T Consensus 460 ----------~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 ----------KYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ----------CCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00111 112345678889999999766 689999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=268.85 Aligned_cols=202 Identities=24% Similarity=0.305 Sum_probs=169.1
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.|...+.||-|+||+|.+++.. +...||+|.+.+.. ...+...++.|-.|+.....+-||+++..|++.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 3666788999999999999654 45567899874322 12234557889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc-----
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL----- 838 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~----- 838 (995)
|++||++-.++.+ -+.+++..++.++.++..|+++.|+.| +|||||||+|||||.+|.+||+|||++.-+
T Consensus 710 YIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999999999863 457889999999999999999999888 999999999999999999999999998632
Q ss_pred ----ccCCCCccc--------------------------------cccccCcccccccccccCCCCcccchhhHHHHHHH
Q 001922 839 ----IDGGASECM--------------------------------SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLE 882 (995)
Q Consensus 839 ----~~~~~~~~~--------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~e 882 (995)
..++ +.+. -..+||+.|+|||++....|+..+|+||.|||+||
T Consensus 785 skYYq~gd-H~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 785 SKYYQEGD-HHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred cccccCCC-ccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 1111 0000 12459999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC
Q 001922 883 LLTGRRPVGDFG 894 (995)
Q Consensus 883 lltg~~Pf~~~~ 894 (995)
|+.|+.||.+..
T Consensus 864 m~~g~~pf~~~t 875 (1034)
T KOG0608|consen 864 MLVGQPPFLADT 875 (1034)
T ss_pred HhhCCCCccCCC
Confidence 999999997643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-29 Score=237.86 Aligned_cols=258 Identities=23% Similarity=0.300 Sum_probs=194.0
Q ss_pred HhhccCCCeeeccCceEEEEEE-eCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecC--CcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNK--ETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~l 760 (995)
.+.|++.+++|.|.|++||.|. ..+.++++||.++ +.....+.+|+++++.++ ||||++++++..++ ....+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 3467788899999999999995 4578899999984 344667899999999996 99999999998664 46689
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CCeEEeeeccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA-FEAHVADFGLAKFLI 839 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~-~~vkl~DfGla~~~~ 839 (995)
|+||+.+.+...+.. .++....+..+.|++.||.|+|++| |+|||+||.|+|+|.. -..+++|+|+|.++.
T Consensus 113 iFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred HhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 999999988777653 3556667789999999999999777 9999999999999975 468999999999987
Q ss_pred cCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCch-HHHHHHHHhcC--------
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD-IVQWSKRATNG-------- 909 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~-------- 909 (995)
++... ...+.+..|--||.+.. ..|+..-|+|||||++..|+..+.||....+..+ ++..++-....
T Consensus 185 p~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 65433 34466778889998765 4578999999999999999999999977554433 23322222111
Q ss_pred ----ChhhhhhhcCCcC-----CCCCH----HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 910 ----RKEEFLSILDPRL-----SMVPK----EEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 910 ----~~~~~~~~~d~~~-----~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
-...+.+++...- .+.+. -..++..+++.+.++.|-.+|+|++|.+++
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111222111100 01111 123567789999999999999999998753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=255.56 Aligned_cols=262 Identities=20% Similarity=0.226 Sum_probs=198.4
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-----C---CCceeEeEEEe---
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-----H---RNIVRLLAFCS--- 753 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~~~~~~~--- 753 (995)
.+|...++||.|.|++||+|.+ ...+.||+|+++... .-.+....|++++++++ | .+||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 4788889999999999999954 557789999985432 23566788999999994 2 47999999984
Q ss_pred -cCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---------
Q 001922 754 -NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS--------- 823 (995)
Q Consensus 754 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~--------- 823 (995)
.+.+++||+|+. |..|..+|.....+.++...+.+|++||+.||.|||+++ +|||-||||+|||+..
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence 456899999999 779999998777778999999999999999999999987 5999999999999940
Q ss_pred --------------------------------------------------------------------------------
Q 001922 824 -------------------------------------------------------------------------------- 823 (995)
Q Consensus 824 -------------------------------------------------------------------------------- 823 (995)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred -----------------------------------------------------------------------------CCC
Q 001922 824 -----------------------------------------------------------------------------AFE 826 (995)
Q Consensus 824 -----------------------------------------------------------------------------~~~ 826 (995)
+.+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 002
Q ss_pred eEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC------CCchHH
Q 001922 827 AHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFG------DGVDIV 900 (995)
Q Consensus 827 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~------~~~~~~ 900 (995)
|||+|||-|+-+ +..++....|..|.|||++.+..|++.+||||++|++|||.||.+.|+.-+ |+..+.
T Consensus 393 vKIaDlGNACW~-----~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 393 VKIADLGNACWV-----HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred EEEeeccchhhh-----hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 566666666543 222334457889999999999999999999999999999999999996522 222333
Q ss_pred HHHHHHhcCChh------hhhhhcCC--------------------cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHH
Q 001922 901 QWSKRATNGRKE------EFLSILDP--------------------RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREV 954 (995)
Q Consensus 901 ~~~~~~~~~~~~------~~~~~~d~--------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 954 (995)
.++.-...-... .-.++++. .....+.+....+.+++.-|++.+|++||||.+.
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 333222111000 00111111 0113556788899999999999999999999999
Q ss_pred HHH
Q 001922 955 VQM 957 (995)
Q Consensus 955 l~~ 957 (995)
++.
T Consensus 548 l~h 550 (590)
T KOG1290|consen 548 LKH 550 (590)
T ss_pred hcC
Confidence 865
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=242.40 Aligned_cols=257 Identities=25% Similarity=0.307 Sum_probs=196.7
Q ss_pred hhccCCCeeeccCceEEEEE-EeCCCcEEEEEEec-CCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecC------Cc
Q 001922 686 ECVKDGNVIGRGGAGIVYHG-KMPNGVEIAVKKLL-GFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK------ET 757 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~ 757 (995)
.+|...+.+|.|+- .|-.| ..-.+++||+|++. +........+..+|...+..+.|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788999988 45455 34468999999983 334445567788999999999999999999998543 35
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.|+|||||.. +|...+. ..++-.....++.|++.|+.|+|..+ |+||||||+||++..++.+||.|||+|+.
T Consensus 96 ~y~v~e~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc
Confidence 6999999965 9998886 34677888899999999999999777 99999999999999999999999999986
Q ss_pred cccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC--Chhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG--RKEEFL 915 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~ 915 (995)
-. ..-.++..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+ ...+.+|.+.+... ..+.+.
T Consensus 168 e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g---~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 168 ED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG---KDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred cC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC---chHHHHHHHHHHHhcCCCHHHH
Confidence 32 22355677899999999999988899999999999999999999998863 33344444333221 111111
Q ss_pred hhcCC-------------------cCC--------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 916 SILDP-------------------RLS--------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 916 ~~~d~-------------------~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+-+.+ ..+ ..++-......+++.+|+-.+|++|-++++++++
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11110 000 1112234457789999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=261.11 Aligned_cols=197 Identities=23% Similarity=0.309 Sum_probs=167.5
Q ss_pred hccCCCeeeccCceEEEEEEeCC-CcEEEEEEecCCCCCC-------hhHHHHHHHHHHhccC---CCCceeEeEEEecC
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHS-------HDHGFRAEIQTLGNIR---HRNIVRLLAFCSNK 755 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~ 755 (995)
.|...+.+|+|+||.|+.|.++. ..+|++|.+.+.+.-. ..-.+-.|++||..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 47778899999999999997754 5678888775432211 1123456999999997 99999999999999
Q ss_pred CcceEEEEec-cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 756 ETNLLVYEYM-RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 756 ~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
+++|++||.. +|.+|++++.. +..+++..+.-|++|++.|+++||+.+ |||||||-+||.++.+|-+||+|||.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence 9999999986 56799999964 456889999999999999999999888 99999999999999999999999999
Q ss_pred ccccccCCCCccccccccCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCC
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGD 892 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~ 892 (995)
|.....+. ....+||..|.|||++.+..| +..-|||++|+++|.++....||+.
T Consensus 717 aa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 98764443 356789999999999999888 5778999999999999999999863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-26 Score=235.58 Aligned_cols=211 Identities=34% Similarity=0.526 Sum_probs=181.5
Q ss_pred eeccCceEEEEEEeCC-CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCChhh
Q 001922 694 IGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGE 772 (995)
Q Consensus 694 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~ 772 (995)
||+|.+|.||++.... ++++++|++.........+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998754 899999998543322235678999999999999999999999998899999999999999999
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCCeEEeeeccccccccCCCCccccccc
Q 001922 773 ALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS-AFEAHVADFGLAKFLIDGGASECMSAIA 851 (995)
Q Consensus 773 ~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~-~~~vkl~DfGla~~~~~~~~~~~~~~~~ 851 (995)
++.... ..+++..++.++.++++++.|+|+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 986432 46889999999999999999999877 999999999999999 89999999999986543221 123456
Q ss_pred cCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHH
Q 001922 852 GSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEA 930 (995)
Q Consensus 852 gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 930 (995)
+...|++||..... .++.++|+|++|++++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999998877 788999999999999999
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 931 MHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 931 ~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+.+++.+|++.+|++||+++++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 357789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-28 Score=254.18 Aligned_cols=293 Identities=23% Similarity=0.234 Sum_probs=188.4
Q ss_pred eecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCccccccccccccccccc-cc
Q 001922 73 LDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYN-NN 149 (995)
Q Consensus 73 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~-n~ 149 (995)
+|.++.+|+ +||..+. ...++++|..|+|+... .|+.+++|++||||+|+|+.+.|++|.++++|..|-+.+ |+
T Consensus 51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 344455554 5666543 35778999999998644 699999999999999999999999999999987777665 99
Q ss_pred ccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccC----
Q 001922 150 FTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEG---- 225 (995)
Q Consensus 150 i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~---- 225 (995)
|+.+....|++|..|+.|.+.-|++.-...+.|..+++|..|.+.+|.+..+--..|..+..++.+.+..|.....
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~ 207 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLP 207 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccc
Confidence 9998888999999999999999999877888899999999999999999844445888999999998886653221
Q ss_pred -------CCCcccCCCCcccEEECcCCCCCCccCccccC-ccccCccccccccccCCCC-ccccCcCCCCeEeccCCcCc
Q 001922 226 -------GIPREVGKLVNLVHLDLSSCELDGQIPHEIGN-LKLLDTVFLHINLLSGSIP-KQLGNLTNLVNLDLSNNALT 296 (995)
Q Consensus 226 -------~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~ 296 (995)
..|..++...-..-..+.++++..+-+..|.. ++.+..=..+.+...++-| ..|..+++|+.|+|++|+|+
T Consensus 208 wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~ 287 (498)
T KOG4237|consen 208 WLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKIT 287 (498)
T ss_pred hhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccc
Confidence 11222222222333333333333222222211 1111111111111222222 24555666666666666666
Q ss_pred CcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceec
Q 001922 297 GEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 297 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 368 (995)
++-+.+|.++..++.|+|..|+|..+-...|.++..|++|+|.+|+|+...|..|..+..|.+|+|-.|.+-
T Consensus 288 ~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 288 RIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred hhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 555666666666666666666665444455555666666666666666555666666666666666555543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=233.08 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=197.9
Q ss_pred cCCCeeeccCceEEEEEEeCCCcEEEEEEecC-CCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 689 KDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLG-FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 689 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
....+|.+...|+.|+|+| .|..+++|++.. .......+.|.+|+..++.+.||||.++++.|..+.+..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3445688999999999999 566788887743 23333456799999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|+.+++...+-..+..++.+++.++|+|++|||+.. +-|.---+....|++|++.+++|+ .+-+++ .-..
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kf------sfqe 343 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKF------SFQE 343 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-ccccee------eeec
Confidence 99999999888888899999999999999999999873 434444688999999999988874 111111 1111
Q ss_pred cccccCcccccccccccCCCC---cccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 848 SAIAGSYGYIAPEYAYTLRVD---EKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......|.||+||.++..+-+ .++|+|||++++||+.|...||.+.+.-+ --.+.+ ++.-...
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme---cgmkia-----------leglrv~ 409 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME---CGMKIA-----------LEGLRVH 409 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh---hhhhhh-----------hcccccc
Confidence 234567899999998876543 68999999999999999999997654311 111111 1122235
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
+|+..+..+.+++.-|++.||.+||.++.++-.|+++.
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 67788899999999999999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-27 Score=260.82 Aligned_cols=253 Identities=24% Similarity=0.291 Sum_probs=200.2
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.+.|+....+|.|+||.||+|++ ..++..|+|.++-. ...+...+++|+-+++..+|||||.+++.+-..+..++.||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe-p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE-PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeecc-CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 45678888999999999999976 46788899988432 33345567889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
||.+|+|.+..+ ..+.+++.+.....++..+|++|||..+ -+|||||-.||++++.|.+|+.|||.+..+.. .
T Consensus 93 ycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--t 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--T 165 (829)
T ss_pred ecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--h
Confidence 999999999885 4567889899999999999999999776 89999999999999999999999999887632 2
Q ss_pred CccccccccCccccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 844 SECMSAIAGSYGYIAPEYA---YTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
-.......||+.|||||+. +.+.|...+|||++|+...|+-.-+.|..+... +....-.-..+ .++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---mr~l~LmTkS~--------~qp 234 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---MRALFLMTKSG--------FQP 234 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---HHHHHHhhccC--------CCC
Confidence 3344677899999999985 466799999999999999999988888643211 11110000011 111
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.....+..-.+.+.++++.|+..+|++||++..+++
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111122335667889999999999999999887654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=227.08 Aligned_cols=246 Identities=20% Similarity=0.300 Sum_probs=184.5
Q ss_pred HHHHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeE-EEecCCc
Q 001922 681 VSDILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLA-FCSNKET 757 (995)
Q Consensus 681 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~-~~~~~~~ 757 (995)
.-++.+.|.+.+.+|+|.||.+-+++++ ..+.+|+|.+.. ......+|.+|+.---.+ .|.||+..++ .|+..+.
T Consensus 19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~--p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR--PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc--chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 3455678899999999999999999775 467788888754 334467899998876666 4899998887 4788889
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC--CCCCeEEeeeccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN--SAFEAHVADFGLA 835 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~--~~~~vkl~DfGla 835 (995)
++++|||++.|+|..-+.. ..+.+....+++.|+++|+.|+|++. +||||||.+|||+- +..+||+||||..
T Consensus 97 YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccc
Confidence 9999999999999998854 34778888999999999999999665 99999999999993 3348999999998
Q ss_pred cccccCCCCccccccccCccccccccccc---C--CCCcccchhhHHHHHHHHHhCCCCCCCCC-CCchHHHHHHHHhcC
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAYT---L--RVDEKSDVYSFGVVLLELLTGRRPVGDFG-DGVDIVQWSKRATNG 909 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~~~~~~~~~~~~~ 909 (995)
+.... .......+-.|.|||.... + ...+.+|||.||+++|.++||+.||.... ......+|.+-
T Consensus 171 ~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w---- 241 (378)
T KOG1345|consen 171 RKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW---- 241 (378)
T ss_pred cccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH----
Confidence 76421 1223345667899997542 2 24678999999999999999999997421 12222233221
Q ss_pred ChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCC
Q 001922 910 RKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIER 948 (995)
Q Consensus 910 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~R 948 (995)
.....++.+..-.-.++.+.++.++-+.++|++|
T Consensus 242 -----~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 242 -----LKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred -----hcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 1122233333333356677788899999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=231.94 Aligned_cols=200 Identities=35% Similarity=0.456 Sum_probs=170.2
Q ss_pred ccCCCeeeccCceEEEEEEeCC-CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEecc
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
|+..+.||.|++|.||+|...+ ++.+|+|.+...........+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999998764 889999998543322246678899999999999999999999998899999999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
+++|.+++..... .+++.....++.+++.++.|+|+.+ ++|+|++|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-AL 155 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cc
Confidence 9999999964322 1789999999999999999999877 99999999999999999999999999987644321 12
Q ss_pred ccccccCccccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 001922 847 MSAIAGSYGYIAPEYA-YTLRVDEKSDVYSFGVVLLELLTGRRPVGD 892 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~Pf~~ 892 (995)
.....++..|++||.. ....++.++|||++|++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2345678899999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=237.43 Aligned_cols=267 Identities=24% Similarity=0.298 Sum_probs=197.6
Q ss_pred cHHHHHhhccCCCeeeccCceEEEEEEeC----CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEec
Q 001922 680 SVSDILECVKDGNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSN 754 (995)
Q Consensus 680 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 754 (995)
....+.+.|...++||+|+|++||++... ..+.||+|.+.. .....++..|++++..+ .+.||+++.+++..
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~---ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR---TSSPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc---ccCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 34556778999999999999999999542 467899999843 34456789999999999 59999999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CCeEEeeec
Q 001922 755 KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA-FEAHVADFG 833 (995)
Q Consensus 755 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~-~~vkl~DfG 833 (995)
.+.+.+|+||++..+..++... ++...+..+++.++.||.++|..| ||||||||+|++.+.. +.-.|.|||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 9999999999999898888853 567788889999999999999887 9999999999999864 567999999
Q ss_pred cccccccCC----------------------------------CC--------ccccccccCcccccccccccC-CCCcc
Q 001922 834 LAKFLIDGG----------------------------------AS--------ECMSAIAGSYGYIAPEYAYTL-RVDEK 870 (995)
Q Consensus 834 la~~~~~~~----------------------------------~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~ 870 (995)
+|..+.... +. .......||++|.|||++... ..+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 997321000 00 001134599999999997654 56899
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCCCch-HHHHHHHHhc----------CC--------h---h----hhhhh----cCC
Q 001922 871 SDVYSFGVVLLELLTGRRPVGDFGDGVD-IVQWSKRATN----------GR--------K---E----EFLSI----LDP 920 (995)
Q Consensus 871 ~DvwSlGvil~elltg~~Pf~~~~~~~~-~~~~~~~~~~----------~~--------~---~----~~~~~----~d~ 920 (995)
+||||.|||+..++++++||....++.+ +.+.+..... ++ . . .+... +.+
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 9999999999999999999976544332 2211110000 00 0 0 00000 000
Q ss_pred ------cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 ------RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 ------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.........+..+.+++.+|+..+|.+|.+++|.+.+
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0011112234478899999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-26 Score=242.02 Aligned_cols=262 Identities=21% Similarity=0.195 Sum_probs=195.5
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC------CCCceeEeEEEecCCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR------HRNIVRLLAFCSNKET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~~~ 757 (995)
-.+|......|+|-|++|.+|.. ..|+.||||++.....- ...=..|+++++++. .-|+++++..|...++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 34688888899999999999965 45889999999542211 122356999999995 3589999999999999
Q ss_pred ceEEEEeccCCChhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-CeEEeeeccc
Q 001922 758 NLLVYEYMRNGSLGEALHG-KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLA 835 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-~vkl~DfGla 835 (995)
+|||+|.+. ..|.++++. ...-.+....+..++.|++-||..|-..+ |+|.||||.||||.+.- .+||||||.|
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 999999884 589999974 22345677888999999999999999888 99999999999998865 5699999999
Q ss_pred cccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh---
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE--- 912 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--- 912 (995)
.+..+... +.+.-+..|.|||++.+-+|+...|+||+||.+||+.||+..|....+...+ .+...+......
T Consensus 585 ~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML-rl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 585 SFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML-RLFMELKGKFPNKML 659 (752)
T ss_pred cccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH-HHHHHhcCCCcHHHh
Confidence 88654433 2334567899999999999999999999999999999999999654332221 111111111000
Q ss_pred ------------------------------hhhhhcCC------------cCCCCCHHHHHHHHHHHhcccCCCCCCCCC
Q 001922 913 ------------------------------EFLSILDP------------RLSMVPKEEAMHLLFVAMLCIQENSIERPR 950 (995)
Q Consensus 913 ------------------------------~~~~~~d~------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 950 (995)
.++..+.| .++.........+.+|+..|+..||++|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 00011111 122222345567889999999999999999
Q ss_pred HHHHHHH
Q 001922 951 MREVVQM 957 (995)
Q Consensus 951 ~~evl~~ 957 (995)
..+++.+
T Consensus 740 ~nqAL~H 746 (752)
T KOG0670|consen 740 VNQALKH 746 (752)
T ss_pred HHHHhcC
Confidence 9998764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-27 Score=242.77 Aligned_cols=423 Identities=22% Similarity=0.219 Sum_probs=235.5
Q ss_pred cccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccC-ccccccCCccccCCCCCceee
Q 001922 114 SSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGG-NYFFGKIPNSYGELQGLEYLS 192 (995)
Q Consensus 114 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~ 192 (995)
..-.+++|..|+|+.+++++|+.+++|+.||||+|+|+.+.|++|.++..|..|-+-+ |+|+......|++|.+|+.|.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 3567888999999999999999999999999999999999999999998887776665 888866677888999999999
Q ss_pred ccCCcccccCcccccchhhhhhhhccccccccCCCCc-ccCCCCcccEEECcCCCCCCccCccccCccccCccccccccc
Q 001922 193 LAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPR-EVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLL 271 (995)
Q Consensus 193 Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l 271 (995)
+.-|++.-+..+.|..+++|..|.+-+|.+.. ++. .|..+.+++++.+..|.+. ...+++.+.... .
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~--i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~~~-a---- 214 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQS--ICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLADDL-A---- 214 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhhh--hccccccchhccchHhhhcCccc-----cccccchhhhHH-h----
Confidence 99999988888888888888888887655543 444 6777888888888888742 122222222111 1
Q ss_pred cCCCCccccCcCCCCeEeccCCcCcCcCCcccccc-CCCCEEEccCCcCCCCCC-ccccCCCCcceEEeccCcccccCCC
Q 001922 272 SGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINL-RQLKLFNLFMNRLHGSIP-DYLADLPNLETLGLWQNNFTGVIPE 349 (995)
Q Consensus 272 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~ 349 (995)
..|..++...-..-..+.++++..+.+..|..- ..+..-..+.+...++.| ..|..+++|++|+|++|+++++-+.
T Consensus 215 --~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~ 292 (498)
T KOG4237|consen 215 --MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDG 292 (498)
T ss_pred --hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhh
Confidence 111222233333333333333333333222211 111111111111111222 2344444444444444444444444
Q ss_pred cccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCC-cccCCC
Q 001922 350 NLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDG-FIYLPG 428 (995)
Q Consensus 350 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~ 428 (995)
+|.....++.|.|..|+|...-...|.++..|+.|+|.+|+|+...|..|..+.+|.+|+|-.|.+...---+ ++.
T Consensus 293 aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~--- 369 (498)
T KOG4237|consen 293 AFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE--- 369 (498)
T ss_pred hhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH---
Confidence 4444444444444444444333334444444444444444444444555555555555555555543211000 000
Q ss_pred CceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccc---cCCccccCCCCCcEEEcCCCcccCCCCCCccchhhh-
Q 001922 429 LNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSG---PLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQV- 504 (995)
Q Consensus 429 L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L- 504 (995)
.+..+.-.|..| -..+..++.+.++.+.+.. ..|++.+.. -++.-|+. .+-+
T Consensus 370 ----Wlr~~~~~~~~~-----Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~------------~s~~cP~~---c~c~~ 425 (498)
T KOG4237|consen 370 ----WLRKKSVVGNPR-----CQSPGFVRQIPISDVAFGDFRCGGPEELGCL------------TSSPCPPP---CTCLD 425 (498)
T ss_pred ----HHhhCCCCCCCC-----CCCCchhccccchhccccccccCCccccCCC------------CCCCCCCC---cchhh
Confidence 011111111111 1223445556555554431 111111100 01111221 1222
Q ss_pred ccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCC
Q 001922 505 LKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFN 584 (995)
Q Consensus 505 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N 584 (995)
+...-|++.++ .+|..+- ..-.+|++.+|.++ .+|.+ .++.| .+||++|+++..---.|.++++|.+|-||+|
T Consensus 426 tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 426 TVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 22334555555 5666543 34567888888887 77877 66777 7888888887766677888888888888876
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=269.33 Aligned_cols=341 Identities=23% Similarity=0.271 Sum_probs=253.1
Q ss_pred cccCCCCcccEEECcCCC------CCCccCccccCcc-ccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCc
Q 001922 229 REVGKLVNLVHLDLSSCE------LDGQIPHEIGNLK-LLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPY 301 (995)
Q Consensus 229 ~~~~~l~~L~~L~Ls~n~------l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 301 (995)
..|.+|.+|+.|.+..+. +...+|..+..++ +|+.|.+.+|.+. .+|..| ...+|+.|+|++|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 456777888888776553 2334566666653 6888888888776 566666 4678888888888887 5677
Q ss_pred cccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCcc
Q 001922 302 SFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQL 381 (995)
Q Consensus 302 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 381 (995)
.+..+++|+.|+|++|...+.+|+ +..+++|+.|+|++|.....+|..++.+++|+.|++++|...+.+|..+ ++++|
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL 706 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL 706 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence 777888888888887764446664 7778888888888877666778888888888888888875555777665 67888
Q ss_pred ceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCcc---ccCCC-CCCCCCCCCCCCCc
Q 001922 382 RILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNY---LSGSL-PENGNSSSNPDRLG 457 (995)
Q Consensus 382 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~---l~~~~-~~~~~~~~~~~~L~ 457 (995)
+.|++++|...+.+|.. ..+|++|++++|.+. .+|..+ .+++|..|.+..+. +.+.+ +........+++|+
T Consensus 707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~ 781 (1153)
T PLN03210 707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLT 781 (1153)
T ss_pred CEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccch
Confidence 88888888766666653 356788888888876 455544 46667766665432 11111 00011122346899
Q ss_pred EEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCc
Q 001922 458 QLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNN 537 (995)
Q Consensus 458 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 537 (995)
.|+|++|...+.+|..++++++|+.|+|++|..-+.+|..+ .+++|+.|+|++|..-..+|.. .++|++|+|++|.
T Consensus 782 ~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~ 857 (1153)
T PLN03210 782 RLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTG 857 (1153)
T ss_pred heeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCC
Confidence 99999998887899999999999999999986555788776 7889999999998665566654 3679999999999
Q ss_pred ccCCCccccccccccCeEeccc-cccccccCcccccCCcccEEeccCCC
Q 001922 538 LSGSIPPEISNVRILNYLNLSR-NHLNQNIPKSIGSMKSLTIADFSFND 585 (995)
Q Consensus 538 l~~~ip~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~l~ls~N~ 585 (995)
++ .+|.++..+++|++|+|++ |+|. .+|..+..+++|+.++++++.
T Consensus 858 i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 858 IE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred Cc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 98 7899999999999999998 4564 488888999999999998874
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=267.35 Aligned_cols=346 Identities=22% Similarity=0.213 Sum_probs=184.2
Q ss_pred CccccCCCCCceeeccCcc------ccccCCccccCCC-CCceeeccCCcccccCcccccchhhhhhhhccccccccCCC
Q 001922 155 PVGILKLEKLKYLDLGGNY------FFGKIPNSYGELQ-GLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGI 227 (995)
Q Consensus 155 p~~~~~l~~L~~L~L~~N~------l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~ 227 (995)
+.+|.++++|+.|.+..+. +...+|+.|..++ +|+.|++.+|.+. .+|..| ...+|++|+|.++++.. +
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~--L 626 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK--L 626 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc--c
Confidence 3455666666666665442 2223455555443 4666666666665 445444 34555555555544322 4
Q ss_pred CcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccC
Q 001922 228 PREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLR 307 (995)
Q Consensus 228 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 307 (995)
+..+..+++|+.|+|++|...+.+| .++.+++|++|++++|.....+|..+.++++|+.|++++|..-+.+|..+ +++
T Consensus 627 ~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~ 704 (1153)
T PLN03210 627 WDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLK 704 (1153)
T ss_pred ccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCC
Confidence 4455556666666666554333444 25555666666666554444556666666666666666653333444433 456
Q ss_pred CCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeecc
Q 001922 308 QLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILL 387 (995)
Q Consensus 308 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 387 (995)
+|+.|++++|...+.+|.. .++|+.|+|++|.++ .+|..+ .+++|++|++.++... .++..+
T Consensus 705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~-~l~~~~------------ 766 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSE-KLWERV------------ 766 (1153)
T ss_pred CCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchh-hccccc------------
Confidence 6666666665443344432 245566666666655 344433 3555666655543221 010000
Q ss_pred ccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCccc
Q 001922 388 KNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLS 467 (995)
Q Consensus 388 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~ 467 (995)
....|.......+|+.|++++|...+.+|..+..+++|+.|+++++..-+.+|... .+++|+.|+|++|..-
T Consensus 767 ----~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~----~L~sL~~L~Ls~c~~L 838 (1153)
T PLN03210 767 ----QPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI----NLESLESLDLSGCSRL 838 (1153)
T ss_pred ----cccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC----CccccCEEECCCCCcc
Confidence 00011111122334444444444444444444444444444444433333333322 3456777777776544
Q ss_pred ccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccc-cccCCCCCCccCcccccceeeccCCc
Q 001922 468 GPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSR-NSLSGEIPPAIGYCNHLTYLDMSQNN 537 (995)
Q Consensus 468 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~ 537 (995)
..+|.. .++|+.|+|++|.|+ .+|.++..+++|+.|+|++ |+|+ .+|..+..+++|+.|+++++.
T Consensus 839 ~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 839 RTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 445542 356777888888877 5777777888888888877 4455 577777778888888887764
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=249.31 Aligned_cols=262 Identities=27% Similarity=0.343 Sum_probs=149.8
Q ss_pred cccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEcc
Q 001922 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLF 315 (995)
Q Consensus 236 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 315 (995)
.-..|+|+.|.|+ .+|..+. ++|+.|++++|+++. +|.. +++|++|+|++|+|+. +|.. .++|+.|+++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCc-ccCc---ccccceeecc
Confidence 4567888888887 5666554 367777777777773 4432 4677777777777773 3432 3566777777
Q ss_pred CCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCC
Q 001922 316 MNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPI 395 (995)
Q Consensus 316 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 395 (995)
+|.|+ .+|..+ ++|+.|++++|+++ .+|.. .++|+.|+|++|+|++ +|... ..|+.
T Consensus 271 ~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~------------ 326 (788)
T PRK15387 271 SNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCK------------ 326 (788)
T ss_pred CCchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccc------------
Confidence 77776 344322 45667777777776 34432 3567777777777663 33311 22334
Q ss_pred CcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCcccc
Q 001922 396 PERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLS 475 (995)
Q Consensus 396 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 475 (995)
|++++|.+++ +|.. +.+|++|+|++|+|++ +|..
T Consensus 327 ------------L~Ls~N~L~~-LP~l------------------------------p~~Lq~LdLS~N~Ls~-LP~l-- 360 (788)
T PRK15387 327 ------------LWAYNNQLTS-LPTL------------------------------PSGLQELSVSDNQLAS-LPTL-- 360 (788)
T ss_pred ------------cccccCcccc-cccc------------------------------ccccceEecCCCccCC-CCCC--
Confidence 4444444432 2210 1234455555555552 3322
Q ss_pred CCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeE
Q 001922 476 NFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYL 555 (995)
Q Consensus 476 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L 555 (995)
..+|+.|++++|+|+ .+|... .+|+.|+|++|+|+ .+|... ++|+.|++++|+|+ .+|... .+|+.|
T Consensus 361 -p~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L 427 (788)
T PRK15387 361 -PSELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSL 427 (788)
T ss_pred -Ccccceehhhccccc-cCcccc---cccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhh
Confidence 134555556666655 244322 34566666666666 344432 45666677777766 355432 345666
Q ss_pred eccccccccccCcccccCCcccEEeccCCCCCCCCCC
Q 001922 556 NLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPE 592 (995)
Q Consensus 556 ~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~ 592 (995)
+|++|+|+ .+|..+.++++|+.++|++|+|+|.+|.
T Consensus 428 ~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 428 SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred hhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 77777775 4666676777777777777777766654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-24 Score=267.37 Aligned_cols=197 Identities=17% Similarity=0.153 Sum_probs=138.5
Q ss_pred ccCC-CCceeEeEEE-------ecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 001922 739 NIRH-RNIVRLLAFC-------SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810 (995)
Q Consensus 739 ~l~h-pniv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ii 810 (995)
.++| +||++++++| ...+..+.+|||+ +++|.+++.. ....+++..+..++.||++||+|||+++ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3455 5777788877 2234567889988 5699999963 2456899999999999999999999777 99
Q ss_pred ecCCCCCCEEECCC-------------------CCeEEeeeccccccccCCC--------------CccccccccCcccc
Q 001922 811 HRDVKSNNILLNSA-------------------FEAHVADFGLAKFLIDGGA--------------SECMSAIAGSYGYI 857 (995)
Q Consensus 811 HrDlkp~Nill~~~-------------------~~vkl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~ 857 (995)
||||||+|||++.. +.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4455666666653211000 00011245788999
Q ss_pred cccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHH
Q 001922 858 APEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVA 937 (995)
Q Consensus 858 aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li 937 (995)
|||++.+..++.++|||||||++|||++|..|+.... ..+...... ...+.. .........++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~-----------~~~~~~----~~~~~~~~~~~ 245 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR-----------VLPPQI----LLNWPKEASFC 245 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh-----------hcChhh----hhcCHHHHHHH
Confidence 9999999999999999999999999999988864211 011111100 011110 11223456788
Q ss_pred hcccCCCCCCCCCHHHHHHH
Q 001922 938 MLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 938 ~~cl~~dP~~RPt~~evl~~ 957 (995)
.+||+++|.+||++.|++++
T Consensus 246 ~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHhCCCChhhCcChHHHhhc
Confidence 89999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=209.65 Aligned_cols=167 Identities=21% Similarity=0.202 Sum_probs=127.4
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
|+|.+++.. .+..+++..++.++.|++.||.|||+++ ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence 689999963 3456999999999999999999999654 999999999999999 9998865321
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHH-HHHHHHhcCChhhhhhhcCCcCCCCC
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIV-QWSKRATNGRKEEFLSILDPRLSMVP 926 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~ 926 (995)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.......... .+....... ++.....+
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 132 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD---------DPRDRSNL 132 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC---------CccccccH
Confidence 1258899999999999999999999999999999999999996543222211 111111100 01111112
Q ss_pred HHHHH--HHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 927 KEEAM--HLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 927 ~~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
..... .+.+++.+||+.+|++||++.|+++++..+.
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 23333 6899999999999999999999999887653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=244.27 Aligned_cols=257 Identities=28% Similarity=0.333 Sum_probs=168.7
Q ss_pred CCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEec
Q 001922 284 NLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLS 363 (995)
Q Consensus 284 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 363 (995)
+-..|+|++|.|+ .+|..+. ++|+.|++++|+|+. +|.. .++|++|+|++|+|+. +|.. .++|+.|+|+
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCc-ccCc---ccccceeecc
Confidence 3455666666666 4454443 356666666666663 4431 3566666666666663 3432 2456666666
Q ss_pred CceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCC
Q 001922 364 SNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSL 443 (995)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~ 443 (995)
+|.|+ .+|..+ .+|+.|++++|++.. +|.. .++|+.|++++|++++ +|.
T Consensus 271 ~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~---------------------- 319 (788)
T PRK15387 271 SNPLT-HLPALP---SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---------------------- 319 (788)
T ss_pred CCchh-hhhhch---hhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCC----------------------
Confidence 66666 344322 334455555555532 2221 2346666666666553 121
Q ss_pred CCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccC
Q 001922 444 PENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIG 523 (995)
Q Consensus 444 ~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 523 (995)
.+..|+.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|... .+|+.|++++|+|+ .+|...
T Consensus 320 --------lp~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~-~LP~l~- 381 (788)
T PRK15387 320 --------LPSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPALP- 381 (788)
T ss_pred --------CcccccccccccCcccc-cccc---ccccceEecCCCccC-CCCCCC---cccceehhhccccc-cCcccc-
Confidence 12357788999999984 6642 257999999999999 466543 46788999999999 477643
Q ss_pred cccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCCC-CCCCcccccc
Q 001922 524 YCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPE-SGQFTVFNAS 602 (995)
Q Consensus 524 ~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~ 602 (995)
.+|+.|+|++|+|+ .+|... ++|+.|+|++|+|++ +|... .+|+.|++++|+|+ .+|. .+.+..+..+
T Consensus 382 --~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~L 450 (788)
T PRK15387 382 --SGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTV 450 (788)
T ss_pred --cccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeE
Confidence 57999999999999 577543 679999999999986 77643 46888999999998 5664 4456667778
Q ss_pred cCCCCccCCC
Q 001922 603 SFAGNPQLCG 612 (995)
Q Consensus 603 ~~~~n~~~c~ 612 (995)
.+.||+. +|
T Consensus 451 dLs~N~L-s~ 459 (788)
T PRK15387 451 NLEGNPL-SE 459 (788)
T ss_pred ECCCCCC-Cc
Confidence 8899984 44
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=206.55 Aligned_cols=259 Identities=19% Similarity=0.274 Sum_probs=205.6
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 763 (995)
-.|+++++||+|+||+++.|+. -+++.||||.-. ......++..|...++.+. .++|...+-+...+.+..+|||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP---rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP---RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecc---ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3689999999999999999963 578999999752 2233456888999999994 7999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-----CeEEeeecccccc
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-----EAHVADFGLAKFL 838 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-----~vkl~DfGla~~~ 838 (995)
.. |.||.|++. .-+..++..++..++.|++.-++|+|++. .|.|||||+|+||...+ .+.++|||+|+.+
T Consensus 105 LL-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 105 LL-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hh-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 98 779999886 34567999999999999999999999777 99999999999997654 5899999999998
Q ss_pred ccCCCCcc-----ccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 839 IDGGASEC-----MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 839 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
.++..... .....||.+||+-....+.+.+.+.|+-|+|-++.+.+-|..||.....+..-..+.+.-...+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 77654432 2456799999999999999999999999999999999999999988776666555544333333333
Q ss_pred hhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 914 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
+.+. ....+.++..-+...-+.+-.+-|..+-+...+.+
T Consensus 260 i~~L--------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 260 IEVL--------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred HHHH--------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 3222 22345566666666667777788887766555443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-22 Score=220.44 Aligned_cols=262 Identities=21% Similarity=0.241 Sum_probs=197.1
Q ss_pred hccCCCeeeccCceEEEEEEeCCC--cEEEEEEecCCCCCChhHHHHHHHHHHhccCC----CCceeEeEEE-ecCCcce
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMPNG--VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH----RNIVRLLAFC-SNKETNL 759 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~~~~~~-~~~~~~~ 759 (995)
+|++.+.||+|+||.||.|..... ..+|+|........... .+..|..++..+.. +++..+++.+ ..+...|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 789999999999999999986553 47788876443222222 67888999888863 6889999998 5778899
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-----CCeEEeeecc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA-----FEAHVADFGL 834 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~-----~~vkl~DfGl 834 (995)
+||+.+ |.+|.++........++..++.+++.|++.+|.++|+.| ++||||||.|++++.. ..+.+.|||+
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 999988 789999886555678999999999999999999999887 9999999999999865 3589999999
Q ss_pred cc--ccccCCC----Ccc--ccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH
Q 001922 835 AK--FLIDGGA----SEC--MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRA 906 (995)
Q Consensus 835 a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 906 (995)
++ .+..... ... .....||..|+++.+..+.+.+.+.|+||++.++.|+..|..||................
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99 3322211 111 123459999999999999999999999999999999999999997655433322222211
Q ss_pred hcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 907 TNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 907 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
..... .. . ....+..+.++...+-..+..++|....+...+++....
T Consensus 254 ~~~~~-------~~-~---~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 RKLLT-------DR-F---GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhhcc-------cc-c---cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 11100 00 1 112334455566666668999999999999887765543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=220.22 Aligned_cols=176 Identities=23% Similarity=0.188 Sum_probs=133.3
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC--CCcEEEEEEecCCC----CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCc
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP--NGVEIAVKKLLGFG----THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET 757 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 757 (995)
+...|+..+.||+|+||+||+|.+. +++.||||++.... .....+.+.+|++++++++|+|+++.+..+ +.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CC
Confidence 3567899999999999999999764 57778999874321 122345689999999999999998533322 45
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCEEECCCCCeEEeeecccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDV-KSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDl-kp~Nill~~~~~vkl~DfGla~ 836 (995)
.|+||||++|++|... . .. . ...++.|+++||.|+|+++ |+|||| ||+||+++.++.+||+|||+|+
T Consensus 93 ~~LVmE~~~G~~L~~~-~-~~-~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-R-PH-G------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred cEEEEEccCCCCHHHh-C-cc-c------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 7999999999999732 1 11 1 1467899999999999877 999999 9999999999999999999999
Q ss_pred ccccCCCCcc------ccccccCcccccccccccCC------CCcccchh
Q 001922 837 FLIDGGASEC------MSAIAGSYGYIAPEYAYTLR------VDEKSDVY 874 (995)
Q Consensus 837 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw 874 (995)
.+........ .....+++.|+|||++...+ .+..+|-|
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 7755432222 13566888999999876433 33446666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=196.15 Aligned_cols=262 Identities=19% Similarity=0.226 Sum_probs=200.3
Q ss_pred HhhccCCCeeeccCceEEEEEE-eCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCC-CCceeEeEEEecCCcceEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH-RNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~ 762 (995)
...|+..++||.|+||.+|.|. ..+|++||+|.-..... ..++..|.++++.+++ ..|..+..++.+.++..+||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 4568889999999999999995 46899999998743322 2346779999999974 77888888889999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CCeEEeeeccccccc
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA---FEAHVADFGLAKFLI 839 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~---~~vkl~DfGla~~~~ 839 (995)
|.. |.+|.+++.-. ...++..++.-++-|++.-++|+|.++ +|||||||+|+++.-. ..+.++|||+|+.+.
T Consensus 91 dLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 998 78999988632 345788899999999999999999888 9999999999999754 468999999999876
Q ss_pred cCCCCc-----cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 840 DGGASE-----CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 840 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
+..... ......||.+|.+-....+.+.+.+.|+-|+|.++.++--|..||.+.........+.+.....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK----- 240 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK----- 240 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh-----
Confidence 543222 2245679999999888888888999999999999999999999998866554443332222111
Q ss_pred hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 915 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
+...........|.++.-.+..|-..--++-|+..-+-+.++.+.
T Consensus 241 ---~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 241 ---MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred ---cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 111111222334556666778888888888888777666655543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-22 Score=236.52 Aligned_cols=374 Identities=18% Similarity=0.227 Sum_probs=247.7
Q ss_pred cccchHHHHHHHHHhCCCCCCCCCC----CCCCCCCCCceeee----------------EEeCCCceeeeecCCCCcccc
Q 001922 24 SLVNDFHVLVALKQGFENPEPALIS----WNSSNPSSVCSWAG----------------ICCSRDRVASLDLTDLNLCGS 83 (995)
Q Consensus 24 ~~~~~~~~Ll~~k~~~~~~~~~l~~----W~~~~~~~~C~w~g----------------v~C~~~~v~~l~l~~~~l~~~ 83 (995)
+...+.+.+++..+.+.-| +.+.+ |++. +++|.=.+ |.|..+.|+.+...+.-....
T Consensus 60 ~~~~~~~~~~~~~~~l~~p-~~~~~~~~~~~~~--~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 60 ASPEEIKSKFECLRMLAFP-AYADNIQYSRGGA--DQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASS 136 (754)
T ss_pred CCHHHHHHHHHHHHHhcCC-chhhccccccCCC--CcccccCCcchhhheeeecCCceEEecCCCccccccccccccccc
Confidence 3457889999999999776 34666 9876 56886443 788888888877765322111
Q ss_pred CCccccCCCCCCeEecc-----CCcccCc-----cc---c--CcccccceeccccccccCCCcccccccccccccccccc
Q 001922 84 VPAQILRLDKLTNLSLA-----GNNFTGS-----IE---I--GNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNN 148 (995)
Q Consensus 84 ~~~~~~~l~~L~~L~L~-----~n~l~~~-----~~---~--~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n 148 (995)
.. .-..-..-+.. .+.-.+. .. + +-..+...|+|+++.++.++ ..+. ++|+.|+|++|
T Consensus 137 ~~----~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP-~~Ip--~~L~~L~Ls~N 209 (754)
T PRK15370 137 AS----GSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIP-ACIP--EQITTLILDNN 209 (754)
T ss_pred CC----CCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCC-cccc--cCCcEEEecCC
Confidence 10 00000000000 1111110 01 1 12245778888888888643 3332 47888888888
Q ss_pred cccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCC
Q 001922 149 NFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIP 228 (995)
Q Consensus 149 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p 228 (995)
+|+. +|..+. .+|++|+|++|+++ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|++++|++. .+|
T Consensus 210 ~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~--~LP 278 (754)
T PRK15370 210 ELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS--CLP 278 (754)
T ss_pred CCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC--ccc
Confidence 8886 455443 58889999999887 5676553 47888999999888 5666654 47888888876664 366
Q ss_pred cccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCC
Q 001922 229 REVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQ 308 (995)
Q Consensus 229 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 308 (995)
..+. .+|+.|++++|+|++ +|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++
T Consensus 279 ~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~s 347 (754)
T PRK15370 279 ENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PE 347 (754)
T ss_pred cccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--Cc
Confidence 6554 479999999999984 555443 478899999999984 555443 689999999999985 666554 68
Q ss_pred CCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcC----cCCCcccee
Q 001922 309 LKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDL----CSSNQLRIL 384 (995)
Q Consensus 309 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~L 384 (995)
|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|..+ ..++.+..|
T Consensus 348 L~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L 420 (754)
T PRK15370 348 LQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRI 420 (754)
T ss_pred ccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEE
Confidence 999999999998 5676553 68999999999998 4565554 36899999999998 566544 334778899
Q ss_pred eccccccCCCCCcccccCCCCcEEEecCCccCC-CCCCCcccCCCCceeeccCccccCCC
Q 001922 385 ILLKNFLFGPIPERLGACYSLTRVRLGQNYLNG-SIPDGFIYLPGLNLAELQSNYLSGSL 443 (995)
Q Consensus 385 ~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~l~l~~n~l~~~~ 443 (995)
++.+|.+.. ..+.+|+.+ ++.+.+.| .++.....+..++....-.+...+.+
T Consensus 421 ~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~~Wl 473 (754)
T PRK15370 421 IVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQGWL 473 (754)
T ss_pred EeeCCCccH------HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHHhccC
Confidence 999998852 344555555 34444443 33444444444444333344444443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-22 Score=236.81 Aligned_cols=255 Identities=20% Similarity=0.204 Sum_probs=187.8
Q ss_pred cCCCeeeccCceEEEEEEe-CCCcEEEEEEec----CCCCCCh-hHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 689 KDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLL----GFGTHSH-DHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 689 ~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~----~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
...+++|.|++|.|+.+.. .....++.|.+. ....... ...+..|+-+-..++|||++.....+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999998888754 334444554432 1111111 122556888888899999988887776666666669
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
|||++ +|+..+.+ ..++....+..+++|+..|+.|+|..| |.|||+|++|++++..|.+||+|||.+....-+.
T Consensus 401 E~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 99999953 346778888899999999999999888 9999999999999999999999999987654433
Q ss_pred CC--ccccccccCcccccccccccCCCCc-ccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 843 AS--ECMSAIAGSYGYIAPEYAYTLRVDE-KSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 843 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.. ......+|+..|+|||+..+.+|++ ..||||.|+++..|.+|+.||.......+.... ....... .+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------~~~~~~~-~~~ 547 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------NNYSDQR-NIF 547 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------hcccccc-ccc
Confidence 33 3445678999999999999999974 689999999999999999999654322221100 0000000 011
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..........+.+.+.+|.+|++.+|.+|-|+++|++
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1112233456778889999999999999999999985
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=232.82 Aligned_cols=139 Identities=31% Similarity=0.471 Sum_probs=89.1
Q ss_pred cccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEcc
Q 001922 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLF 315 (995)
Q Consensus 236 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 315 (995)
+.+.|+++++.++ .+|..+. +.|+.|++++|+++ .+|..+. ++|+.|++++|+|+ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 4677888888887 4565443 46777788888777 4555443 47888888888877 4455443 467777777
Q ss_pred CCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccC
Q 001922 316 MNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLF 392 (995)
Q Consensus 316 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 392 (995)
+|++. .+|..+. .+|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|++++|.+.
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT 317 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc
Confidence 77777 4565543 46777777777777 3555443 36777777777776 3444332 24555555555543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-22 Score=231.56 Aligned_cols=253 Identities=21% Similarity=0.232 Sum_probs=189.5
Q ss_pred hccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHH--HhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQT--LGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++...+.+|.+.|=+|.+|+++.|. |+||++.+.......+.|.++++- ...++|||++++..+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5566788999999999999998886 999999776666666666655444 4445899999999888888888999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc-----
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI----- 839 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~----- 839 (995)
+.. +|+|.+. .+.++......-|+.|++.|+..+|+.| |+|||||.+|||++.-..+.|+||..-+...
T Consensus 103 vkh-nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 966 9999995 5567888888889999999999999888 9999999999999999999999999776432
Q ss_pred cCCCCccccccccCcccccccccccC----------C-CCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHh
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTL----------R-VDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRAT 907 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 907 (995)
+.++...+++...-.+|.|||.+... . .+++.||||+||++.|+++ |++||.. ..+..+...-
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~- 251 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGN- 251 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccC-
Confidence 12222233444455699999976431 2 5678999999999999999 7888732 1111111100
Q ss_pred cCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 908 NGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 908 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
....+...+.+ +...+++++..|++.||++|-++++.++.-++.
T Consensus 252 ~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 252 ADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 00001111111 122578899999999999999999999986553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.6e-20 Score=205.01 Aligned_cols=262 Identities=29% Similarity=0.334 Sum_probs=197.4
Q ss_pred ccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCC--hhHHHHHHHHHHhccCCC-CceeEeEEEecCCcceEEEEe
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHS--HDHGFRAEIQTLGNIRHR-NIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lv~e~ 764 (995)
|+..+.+|.|+||.||.+... ..+++|.+....... ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999876 788999986544444 367799999999999988 799999999777778999999
Q ss_pred ccCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-CeEEeeeccccccccCC
Q 001922 765 MRNGSLGEALHGKKG-AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLAKFLIDGG 842 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-~vkl~DfGla~~~~~~~ 842 (995)
+.++++.+++..... ..++......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977753221 26888899999999999999999887 99999999999999998 79999999998654433
Q ss_pred CCc----cccccccCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 843 ASE----CMSAIAGSYGYIAPEYAYT---LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 843 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
... ......|+..|+|||...+ ..+....|+||+|++++++++|..||...............+.........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 221 2456789999999999887 578899999999999999999999976543310111111111111100000
Q ss_pred hhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 916 SILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 916 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.... ..........+.+++..|+..+|..|.+..+....
T Consensus 237 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLS---PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccC---ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000 00002233567889999999999999998877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=182.48 Aligned_cols=140 Identities=19% Similarity=0.175 Sum_probs=107.9
Q ss_pred CCeeeccCceEEEEEEeCCCcEEEEEEecCCCCC-Ch-------h-----------------HHHHHHHHHHhccCCCCc
Q 001922 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTH-SH-------D-----------------HGFRAEIQTLGNIRHRNI 745 (995)
Q Consensus 691 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~-------~-----------------~~~~~E~~~l~~l~hpni 745 (995)
...||+|+||.||+|...+|+.||||++...... .. . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999998878999999998543211 01 0 122359999999988776
Q ss_pred eeEeEEEecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCEEECCC
Q 001922 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL-HHDCSPLIVHRDVKSNNILLNSA 824 (995)
Q Consensus 746 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~iiHrDlkp~Nill~~~ 824 (995)
.....+.. ...++||||++++++..... ....++.....+++.|++.++.|+ |+.+ |+||||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 44333322 23389999999887765432 234688899999999999999999 6777 99999999999998 4
Q ss_pred CCeEEeeecccccc
Q 001922 825 FEAHVADFGLAKFL 838 (995)
Q Consensus 825 ~~vkl~DfGla~~~ 838 (995)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=185.44 Aligned_cols=172 Identities=13% Similarity=0.122 Sum_probs=132.4
Q ss_pred HHhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChh--HH------HHHHHHHHhccCCCCceeEeEEEecC
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHD--HG------FRAEIQTLGNIRHRNIVRLLAFCSNK 755 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~--~~------~~~E~~~l~~l~hpniv~~~~~~~~~ 755 (995)
+..+|+..+++|.|+||.||.+.. ++..+|+|.+.+....... .. +.+|++.+.++.||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 456799999999999999999766 6779999998644332211 12 57899999999999999999886543
Q ss_pred --------CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCe
Q 001922 756 --------ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEA 827 (995)
Q Consensus 756 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~v 827 (995)
...++||||++|.+|.++.. .+. ....+++.++..+|+.| ++|||++|+||+++.++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 35789999999999988742 222 24569999999999888 99999999999999988 9
Q ss_pred EEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHH
Q 001922 828 HVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELL 884 (995)
Q Consensus 828 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 884 (995)
+++|||........ ... ..+.....+..++|+|+||+.+....
T Consensus 174 ~liDfg~~~~~~e~---~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQR---KAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccch---hhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999987654211 100 11333445678999999999887665
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-19 Score=186.24 Aligned_cols=232 Identities=20% Similarity=0.265 Sum_probs=148.4
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCC----------CCceeEeEEE--
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRH----------RNIVRLLAFC-- 752 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h----------pniv~~~~~~-- 752 (995)
+..++.||.|+++.||.+++. +++++|+|.+.... .....+.+++|.-....+.+ -.++-.++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 455778999999999999874 58999999874332 22345667777655555322 1222222211
Q ss_pred -------ecC---C-----cceEEEEeccCCChhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 001922 753 -------SNK---E-----TNLLVYEYMRNGSLGEALHG-----KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHR 812 (995)
Q Consensus 753 -------~~~---~-----~~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHr 812 (995)
... . ..+++|+-+. ++|.+++.. ..........+..+..|+++.+++||..| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 111 1 2367888884 488887642 22223445566777899999999999888 9999
Q ss_pred CCCCCCEEECCCCCeEEeeeccccccccCCCCccccccccCccccccccccc--------CCCCcccchhhHHHHHHHHH
Q 001922 813 DVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT--------LRVDEKSDVYSFGVVLLELL 884 (995)
Q Consensus 813 Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~ell 884 (995)
||+|+|++++.+|.++|+||+........ ......+..|.+||.... ..++.+.|.|++|+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999987654221 111345578999997643 24788999999999999999
Q ss_pred hCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCC
Q 001922 885 TGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIER 948 (995)
Q Consensus 885 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~R 948 (995)
+|..||+......... ....... +.++.+..+|..+++.+|++|
T Consensus 245 C~~lPf~~~~~~~~~~-------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE-------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG-------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc-------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999997532211110 0222344 788899999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=186.57 Aligned_cols=196 Identities=23% Similarity=0.277 Sum_probs=140.6
Q ss_pred CCCCceeEeEEEec---------------------------CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHH
Q 001922 741 RHRNIVRLLAFCSN---------------------------KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIE 793 (995)
Q Consensus 741 ~hpniv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~q 793 (995)
+|||||++.++|.+ +...|+||..++. +|..++..+ ..+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHH
Confidence 59999999887633 2345899998865 999999533 3455666778999
Q ss_pred HHHHHHHHHhcCCCCeEecCCCCCCEEE--CCCC--CeEEeeeccccccccC----CCCccccccccCcccccccccccC
Q 001922 794 AAKGLCYLHHDCSPLIVHRDVKSNNILL--NSAF--EAHVADFGLAKFLIDG----GASECMSAIAGSYGYIAPEYAYTL 865 (995)
Q Consensus 794 i~~~l~~LH~~~~~~iiHrDlkp~Nill--~~~~--~vkl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~ 865 (995)
+++|+.|||++| |.|||+|.+||++ |+++ ...|+|||.+---... .+....-...|.-..||||+....
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999888 9999999999999 3444 4688999976422111 111222334577889999987643
Q ss_pred C-----C-CcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhc
Q 001922 866 R-----V-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML 939 (995)
Q Consensus 866 ~-----~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~ 939 (995)
+ . -.|+|.|+.|.+.||+++...||+.-+...- + ....-...++..+..++..+++++..
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L--~------------~r~Yqe~qLPalp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL--D------------TRTYQESQLPALPSRVPPVARQLVFD 492 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee--c------------hhhhhhhhCCCCcccCChHHHHHHHH
Confidence 2 1 2589999999999999999999976221100 0 00111233445666778889999999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 001922 940 CIQENSIERPRMREVVQM 957 (995)
Q Consensus 940 cl~~dP~~RPt~~evl~~ 957 (995)
.++.||.+|+++.-....
T Consensus 493 lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HhcCCccccCCccHHHhH
Confidence 999999999986544443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-20 Score=207.44 Aligned_cols=226 Identities=27% Similarity=0.272 Sum_probs=181.0
Q ss_pred eeeccCceEEEEEEe----CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEEEecc
Q 001922 693 VIGRGGAGIVYHGKM----PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 693 ~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
++|+|+||.|+.++. +.|.-+|+|...+... .........|..++..++ ||.+|+++..++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 369999999998743 3466788887643221 111224567888888887 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
||.+...+. ....+++.....+...++-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++...+..
T Consensus 81 gg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 81 GGDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred cchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999999885 3456677777778889999999999888 9999999999999999999999999998753322
Q ss_pred ccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 926 (995)
..|||..|||||++. ....++|.||+|++.+||+||..||.. +..+.+... -...|
T Consensus 152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~------------~~~~p 207 (612)
T KOG0603|consen 152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKA------------ELEMP 207 (612)
T ss_pred --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhh------------ccCCc
Confidence 228999999999988 567889999999999999999999954 222222221 12357
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCH
Q 001922 927 KEEAMHLLFVAMLCIQENSIERPRM 951 (995)
Q Consensus 927 ~~~~~~l~~li~~cl~~dP~~RPt~ 951 (995)
.+.......++..+...+|..|--.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 7788888999999999999999654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-19 Score=198.00 Aligned_cols=222 Identities=25% Similarity=0.406 Sum_probs=169.1
Q ss_pred HhccCCCCceeEeEEEecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 001922 737 LGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKS 816 (995)
Q Consensus 737 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp 816 (995)
++.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....+++.....++++|+.||+|+|... --.|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence 4578999999999999999999999999999999999974 4567889999999999999999999642 228999999
Q ss_pred CCEEECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCC-------CCcccchhhHHHHHHHHHhCCCC
Q 001922 817 NNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR-------VDEKSDVYSFGVVLLELLTGRRP 889 (995)
Q Consensus 817 ~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlGvil~elltg~~P 889 (995)
.|+++|....+|++|||+.....+..............-|.|||.++... .+.+.||||+|++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987653211111112223456789999987641 46789999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 890 VGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 890 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
|+......+..+.+..+.......+ -|...... +..+.+..++.+||..+|++||+++++-..++.+....+
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~----rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~ 229 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPF----RPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGS 229 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCc----Ccchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccccc
Confidence 9875544443333333333111111 11111111 344478899999999999999999999999998887654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=172.37 Aligned_cols=185 Identities=16% Similarity=0.057 Sum_probs=137.9
Q ss_pred CCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCC---ChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEEEec
Q 001922 690 DGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTH---SHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 690 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
....++.|+||+||.+.. .+++++.+.+...... .....+.+|+++++++. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999998866 6778887776332221 11235789999999995 5889999886 3469999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDV-KSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDl-kp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
.|.+|.+.... . ...++.|+++++.++|+.| |+|||| ||+||+++.++.++|+|||++....+....
T Consensus 81 ~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 81 AGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred cCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99998765421 1 1347789999999999888 999999 799999999999999999999865432210
Q ss_pred ----cc-------ccccccCcccccccccccC-CCC-cccchhhHHHHHHHHHhCCCCCC
Q 001922 845 ----EC-------MSAIAGSYGYIAPEYAYTL-RVD-EKSDVYSFGVVLLELLTGRRPVG 891 (995)
Q Consensus 845 ----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvil~elltg~~Pf~ 891 (995)
.. .....+++.|++|+...-- ..+ .+.+.++-|.-+|.++|+..|..
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 00 0123367788888754322 333 56789999999999999999864
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-18 Score=174.90 Aligned_cols=141 Identities=20% Similarity=0.161 Sum_probs=109.9
Q ss_pred CCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCC--------------------h-----hHHHHHHHHHHhccCCCCc
Q 001922 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHS--------------------H-----DHGFRAEIQTLGNIRHRNI 745 (995)
Q Consensus 691 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------~-----~~~~~~E~~~l~~l~hpni 745 (995)
.+.||+|+||.||+|+..+|+.||||++....... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987789999999985432110 0 1123578999999999987
Q ss_pred eeEeEEEecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCC
Q 001922 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNSA 824 (995)
Q Consensus 746 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~~ 824 (995)
.....+... ..++||||++|+++..... ....++.....+++.|++.++.++|+ .| |+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence 554444332 3489999999886544321 12356778888999999999999998 77 99999999999999 8
Q ss_pred CCeEEeeeccccccc
Q 001922 825 FEAHVADFGLAKFLI 839 (995)
Q Consensus 825 ~~vkl~DfGla~~~~ 839 (995)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.9e-20 Score=207.17 Aligned_cols=55 Identities=25% Similarity=0.205 Sum_probs=30.2
Q ss_pred eecCCCCcc-ccCCccccCCCCCCeEeccCCcccCcc------ccCcccccceecccccccc
Q 001922 73 LDLTDLNLC-GSVPAQILRLDKLTNLSLAGNNFTGSI------EIGNLSSLQFLNISNNQFS 127 (995)
Q Consensus 73 l~l~~~~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~------~~~~l~~L~~L~Ls~N~i~ 127 (995)
|+|..++++ +.....+..+..|++|+++++.+++.. .+...++|++|+++++.+.
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~ 64 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETG 64 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccC
Confidence 556666665 333444455566666666666664311 2344555666666666554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-19 Score=164.68 Aligned_cols=165 Identities=36% Similarity=0.559 Sum_probs=122.1
Q ss_pred cCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCc
Q 001922 110 IGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLE 189 (995)
Q Consensus 110 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 189 (995)
+.++++.+.|-||+|+++. +|..++.+.+|+.|++++|+|+. +|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 4456677778888888874 44467777888888888888877 6778888888888888888886 7888888888888
Q ss_pred eeeccCCcccc-cCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCcccccc
Q 001922 190 YLSLAGNDLTG-KIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHI 268 (995)
Q Consensus 190 ~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~ 268 (995)
.|||+.|++.. .+|+.|..++.|+.|||++|..- .+|..++++++|+.|.+..|.+- ..|..++.++.|+.|.+.+
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe--~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE--ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc--cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 88888888763 56788888888888888765542 36777777777777777777776 5666677777777777777
Q ss_pred ccccCCCCccccC
Q 001922 269 NLLSGSIPKQLGN 281 (995)
Q Consensus 269 N~l~~~~p~~l~~ 281 (995)
|+++ .+|..+++
T Consensus 183 nrl~-vlppel~~ 194 (264)
T KOG0617|consen 183 NRLT-VLPPELAN 194 (264)
T ss_pred ceee-ecChhhhh
Confidence 7666 44444443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.1e-18 Score=202.02 Aligned_cols=195 Identities=19% Similarity=0.179 Sum_probs=160.2
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC---CCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR---HRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.|.+.+.+|+|+||+||+|...+|+.||+|+-++... .+|.--.+++.+++ -+.|+.+..++.-.+.-++|+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP----WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc----eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 35677789999999999999888899999998744332 22333344555555 355666666666677789999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-------CCCeEEeeeccc
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS-------AFEAHVADFGLA 835 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~-------~~~vkl~DfGla 835 (995)
||.+.|+|.+++. ..+.++|..+..++.|+++.+..||..+ ||||||||+|+|+.. .-.++|+|||.+
T Consensus 774 ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 9999999999996 5677899999999999999999999888 999999999999943 346899999999
Q ss_pred cccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P 889 (995)
.++.--.........++|-.+-.+|...+.++++.+|.|.++.+++-|+.|++-
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 877543333556778899999999999999999999999999999999998773
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.1e-20 Score=168.78 Aligned_cols=163 Identities=29% Similarity=0.454 Sum_probs=106.4
Q ss_pred cccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhh
Q 001922 137 LVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIY 216 (995)
Q Consensus 137 l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 216 (995)
+++.+.|.||+|+++. +|..++.+.+|+.|++++|+|+ .+|.+++.+++|+.|++.-|++. ..|..|+.++.|+.|+
T Consensus 32 ~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 4556677777777776 4556777777777777777775 67777777777777777777777 6677777777777777
Q ss_pred ccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCc
Q 001922 217 LGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALT 296 (995)
Q Consensus 217 L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 296 (995)
|.+||+-+..+|..|.. |+.|+-|+|+.|.+. .+|..++++++|+.|.+.+|.+-
T Consensus 109 ltynnl~e~~lpgnff~------------------------m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll 163 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFY------------------------MTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL 163 (264)
T ss_pred ccccccccccCCcchhH------------------------HHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh
Confidence 77666665555554444 445555555555554 45555666666666666666665
Q ss_pred CcCCccccccCCCCEEEccCCcCCCCCCccccC
Q 001922 297 GEIPYSFINLRQLKLFNLFMNRLHGSIPDYLAD 329 (995)
Q Consensus 297 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 329 (995)
.+|..++.+++|+.|++.+|+++ .+|..+++
T Consensus 164 -~lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 164 -SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred -hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 55666666666666666666666 44544443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.3e-20 Score=203.95 Aligned_cols=252 Identities=27% Similarity=0.234 Sum_probs=125.9
Q ss_pred eEeccCCcccCcc---ccCcccccceeccccccccCC----Ccccccccccccccccccccccc------cCCccccCCC
Q 001922 96 NLSLAGNNFTGSI---EIGNLSSLQFLNISNNQFSGG----LDWNYSSLVNLEVFDAYNNNFTA------LLPVGILKLE 162 (995)
Q Consensus 96 ~L~L~~n~l~~~~---~~~~l~~L~~L~Ls~N~i~~~----~~~~~~~l~~L~~L~Ls~n~i~~------~~p~~~~~l~ 162 (995)
.|+|+.+.+++.. .+..+.+|++|+++++.++.. ++..+...++|++|+++++.+.. .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4677777776432 356667788888888877542 23334455556666666666552 1233455556
Q ss_pred CCceeeccCccccccCCccccCCCC---CceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCC-Cccc
Q 001922 163 KLKYLDLGGNYFFGKIPNSYGELQG---LEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKL-VNLV 238 (995)
Q Consensus 163 ~L~~L~L~~N~l~~~~p~~l~~l~~---L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l-~~L~ 238 (995)
+|++|++++|.+.+..+..+..+.+ |++|++++|++++..... +...+..+ ++|+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~---------------------l~~~l~~~~~~L~ 140 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRL---------------------LAKGLKDLPPALE 140 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHH---------------------HHHHHHhCCCCce
Confidence 6666666666665444444444444 666666666555211000 11122233 5666
Q ss_pred EEECcCCCCCCcc----CccccCccccCccccccccccCC----CCccccCcCCCCeEeccCCcCcCcC----Ccccccc
Q 001922 239 HLDLSSCELDGQI----PHEIGNLKLLDTVFLHINLLSGS----IPKQLGNLTNLVNLDLSNNALTGEI----PYSFINL 306 (995)
Q Consensus 239 ~L~Ls~n~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l 306 (995)
.|++++|.+++.. +..+..++.|++|++++|.+++. ++..+..+++|++|++++|.+++.. +..+..+
T Consensus 141 ~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~ 220 (319)
T cd00116 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220 (319)
T ss_pred EEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhccc
Confidence 6666666666322 22333444555555555555421 2223334455666666666554322 2233344
Q ss_pred CCCCEEEccCCcCCCCCCcccc-----CCCCcceEEeccCcccc----cCCCcccCCCCCCeEEecCceec
Q 001922 307 RQLKLFNLFMNRLHGSIPDYLA-----DLPNLETLGLWQNNFTG----VIPENLGQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 307 ~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~ 368 (995)
++|+.|++++|.+++.....+. ..+.|+.|++++|.++. .+...+..+++|+++++++|.++
T Consensus 221 ~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 5555555555555532221111 12455555555555541 11222333345555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.6e-17 Score=164.46 Aligned_cols=138 Identities=17% Similarity=0.171 Sum_probs=104.9
Q ss_pred ccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-----CCCCceeEeEEEecCC---cce
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-----RHRNIVRLLAFCSNKE---TNL 759 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~---~~~ 759 (995)
+...+.||+|+||.||. ...++.. +||++.... ....+.+.+|+.+++.+ .||||++++++++++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34567899999999996 3334444 799875432 22456789999999999 5799999999998763 333
Q ss_pred -EEEEe--ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCEEECC----CCCeEEee
Q 001922 760 -LVYEY--MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGL-CYLHHDCSPLIVHRDVKSNNILLNS----AFEAHVAD 831 (995)
Q Consensus 760 -lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~~~~iiHrDlkp~Nill~~----~~~vkl~D 831 (995)
+|||| +.+|+|.+++... .+++. ..++.|++.++ +|||+++ |+||||||+||+++. ++.++|+|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 5679999999642 35555 35677888777 9999887 999999999999974 34799999
Q ss_pred ecccc
Q 001922 832 FGLAK 836 (995)
Q Consensus 832 fGla~ 836 (995)
|+.+.
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 55443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-17 Score=182.20 Aligned_cols=175 Identities=22% Similarity=0.285 Sum_probs=132.3
Q ss_pred CcceEEEEeccCCChhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 756 ETNLLVYEYMRNGSLGEALH-GKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
.+.||.|++|+-.+|.+++. +......++.....++.|++.|+.| ++ .+|||+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 35789999999999999997 3456678888999999999999999 55 89999999999999999999999999
Q ss_pred ccccccCC----CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcC
Q 001922 835 AKFLIDGG----ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 835 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
........ .....+...||..||+||.+.+..|+.++||||||++++|++. =..+|+. .
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-------~--------- 466 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-------I--------- 466 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-------H---------
Confidence 88765443 2334467789999999999999999999999999999999997 2333211 0
Q ss_pred ChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHH
Q 001922 910 RKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREV 954 (995)
Q Consensus 910 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 954 (995)
..+.++-|..++......-+.-..++.+++.+.|.+||++.++
T Consensus 467 --~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 --ATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --HhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 1111112222210001111123468899999999999965544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.1e-16 Score=162.67 Aligned_cols=142 Identities=20% Similarity=0.177 Sum_probs=107.9
Q ss_pred ccCCCeeeccCceEEEEEE--eCCCcEEEEEEecCCCCCC-----------------------hhHHHHHHHHHHhccCC
Q 001922 688 VKDGNVIGRGGAGIVYHGK--MPNGVEIAVKKLLGFGTHS-----------------------HDHGFRAEIQTLGNIRH 742 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h 742 (995)
|++.+.||+|+||.||+|. ..+|+.||+|++....... ....+..|++.++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6677899999999999998 5689999999985432100 01235679999999975
Q ss_pred CC--ceeEeEEEecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 001922 743 RN--IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNIL 820 (995)
Q Consensus 743 pn--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nil 820 (995)
.. +.+++++ ...++||||++++++...... ...........++.|++.++.++|+.+ .|+||||||+||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIl 181 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNIL 181 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEE
Confidence 32 3344432 235899999999888776522 234556667789999999999999443 2999999999999
Q ss_pred ECCCCCeEEeeecccccc
Q 001922 821 LNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 821 l~~~~~vkl~DfGla~~~ 838 (995)
++ ++.++++|||.+...
T Consensus 182 i~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-CCCEEEEEChhhhcc
Confidence 99 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.2e-16 Score=160.06 Aligned_cols=135 Identities=21% Similarity=0.373 Sum_probs=112.6
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEecCCCCCC-------hhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 692 NVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHS-------HDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.||+|++|.||+|.+ .|..+++|+........ ...++.+|+.++..+.|++++....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5689999999999987 67889999864322211 123577899999999999988777777777888999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
++|++|.+++.... . .+..++.+++.++.++|+.+ ++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985321 2 67889999999999999877 99999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.4e-16 Score=158.74 Aligned_cols=131 Identities=22% Similarity=0.396 Sum_probs=106.0
Q ss_pred eeeccCceEEEEEEeCCCcEEEEEEecCCCCCC-------hhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHS-------HDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 693 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.||+|+||.||+|.+ ++..+++|+........ ...++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 67899999864322111 1245778999999999887665555555666779999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
+|++|.+.+.... . .++.+++.++.++|+.+ ++|||++|+||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875321 0 68899999999999877 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-15 Score=156.36 Aligned_cols=136 Identities=19% Similarity=0.146 Sum_probs=106.7
Q ss_pred ccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCC---------------------ChhHHHHHHHHHHhccCCCC--
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTH---------------------SHDHGFRAEIQTLGNIRHRN-- 744 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~hpn-- 744 (995)
|...+.||+|+||.||+|..++|+.||||++...... .....+..|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 6667899999999999998888999999987432100 01123567888898887774
Q ss_pred ceeEeEEEecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC
Q 001922 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA 824 (995)
Q Consensus 745 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~ 824 (995)
++..++ ....++||||++|++|.+.... .....++.+++.++.++|+.+ |+||||||+||+++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence 444443 2455899999999998776421 234578899999999999877 9999999999999999
Q ss_pred CCeEEeeecccccc
Q 001922 825 FEAHVADFGLAKFL 838 (995)
Q Consensus 825 ~~vkl~DfGla~~~ 838 (995)
+.++|+|||++...
T Consensus 162 ~~~~liDfg~~~~~ 175 (198)
T cd05144 162 EKIYIIDWPQMVST 175 (198)
T ss_pred CcEEEEECCccccC
Confidence 99999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-16 Score=184.57 Aligned_cols=208 Identities=23% Similarity=0.237 Sum_probs=140.4
Q ss_pred hhccCCCeeeccCceEEEEEEeCC-CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
..|+..+.|..|+||.||.++++. .+.+|+ ++.+.. --.++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~-----lilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN-----LILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccc-----hhhhc---cccccCCccee------------------
Confidence 356778899999999999998764 667788 442110 00111 33333444444
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc----
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID---- 840 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~---- 840 (995)
|+-.+.++. -+.++. +++.+++|+|..+ |+|||+||+|.+|+.-|.+|++|||+++....
T Consensus 136 ---gDc~tllk~--~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKN--IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhccc--CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 444444432 122332 2378999999666 99999999999999999999999999875211
Q ss_pred ----CC----CCcc-ccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 841 ----GG----ASEC-MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 841 ----~~----~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
+. .++. .+..+||+.|.|||++....|+..+|+|++|+|+||.+.|+.||.....++.+.+.+.....
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~--- 276 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE--- 276 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc---
Confidence 10 1111 13468999999999999999999999999999999999999999653222222222211110
Q ss_pred hhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCC
Q 001922 912 EEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERP 949 (995)
Q Consensus 912 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 949 (995)
+.......+.+.++++.+.++.+|..|-
T Consensus 277 ----------wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 277 ----------WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ----------ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1111223455688899999999999995
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=2e-15 Score=178.88 Aligned_cols=138 Identities=22% Similarity=0.341 Sum_probs=111.6
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCC-CC------ChhHHHHHHHHHHhccCCCCceeEeEEEecCCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFG-TH------SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 757 (995)
...|...+.||+|+||+||+|.+... .+++|+..... .. ...+++.+|++++++++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456788999999999999987443 45555432111 11 123467889999999999999988877777778
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.++||||+++++|.+++. ....++.|+++++.|+|+.+ |+|||+||+||++ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999884 34678999999999999877 9999999999999 678999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.1e-16 Score=181.82 Aligned_cols=256 Identities=23% Similarity=0.241 Sum_probs=189.9
Q ss_pred hhccCCCeeeccCceEEEEEEeC--CCcEEEEEEecCC-CCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP--NGVEIAVKKLLGF-GTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 761 (995)
..|...+.||+|+|+.|-..... ....+|+|.+... .......+...|..+-+.+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34667778999999999887543 2345566665332 22333444556777777776 99999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCEEECCCC-CeEEeeeccccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH-HDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLAKFLI 839 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~iiHrDlkp~Nill~~~~-~vkl~DfGla~~~~ 839 (995)
.+|.+++++.+-+........+...+-.++.|+..++.|+| ..+ +.|||+||+|.+++..+ ..++.|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999883222223445556678999999999999 877 99999999999999999 99999999999877
Q ss_pred c-CCCCcccccccc-CcccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCch-HHHHHHHHhcCChhhhh
Q 001922 840 D-GGASECMSAIAG-SYGYIAPEYAYTLR-VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD-IVQWSKRATNGRKEEFL 915 (995)
Q Consensus 840 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 915 (995)
. .+........+| ++.|+|||...+.. .....|+||.|+++..+++|..|+........ ...|..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~----------- 245 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS----------- 245 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc-----------
Confidence 6 555555667788 99999999988754 46889999999999999999999865332211 111111
Q ss_pred hhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 916 SILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 916 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.-+...............+++.+++..+|++|.+.+++..
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 246 -NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -cccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 1000001112233445667888999999999999888743
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.3e-14 Score=173.59 Aligned_cols=148 Identities=25% Similarity=0.500 Sum_probs=93.2
Q ss_pred cccccchHHHHHHHHHhCCCCCCCCCCCCCCCCCC--CceeeeEEeCC------CceeeeecCCCCccccCCccccCCCC
Q 001922 22 AASLVNDFHVLVALKQGFENPEPALISWNSSNPSS--VCSWAGICCSR------DRVASLDLTDLNLCGSVPAQILRLDK 93 (995)
Q Consensus 22 ~~~~~~~~~~Ll~~k~~~~~~~~~l~~W~~~~~~~--~C~w~gv~C~~------~~v~~l~l~~~~l~~~~~~~~~~l~~ 93 (995)
.++...|..||++||+++.+|.. .+|+++ ++. +|.|.||.|+. .+|+.|+|+++++.|.+|..++.+++
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 45567899999999999987643 489753 211 13799999952 14788888888888888887777777
Q ss_pred CCeEeccCCcccCcc--ccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCC-CCCceeecc
Q 001922 94 LTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKL-EKLKYLDLG 170 (995)
Q Consensus 94 L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l-~~L~~L~L~ 170 (995)
|+.|+|++|+++|.+ .++.+++|+.|+|++|++++.+|..++++++|++|+|++|++++.+|..+..+ .++..+++.
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~ 523 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT 523 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEec
Confidence 777777777766543 35566666666666666655555544444444444444444444444444332 233344444
Q ss_pred Cc
Q 001922 171 GN 172 (995)
Q Consensus 171 ~N 172 (995)
+|
T Consensus 524 ~N 525 (623)
T PLN03150 524 DN 525 (623)
T ss_pred CC
Confidence 44
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.2e-14 Score=136.53 Aligned_cols=134 Identities=19% Similarity=0.184 Sum_probs=112.4
Q ss_pred CCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCC--CCceeEeEEEecCCcceEEEEeccCC
Q 001922 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH--RNIVRLLAFCSNKETNLLVYEYMRNG 768 (995)
Q Consensus 691 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~g 768 (995)
.+.+|+|.++.||+++..+ ..+++|....... ...+.+|+.+++.++| ..++++++++...+..+++|||++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 4679999999999998744 7899998743322 4568899999999976 58999999988888899999999987
Q ss_pred ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 769 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
++..+ +......++.+++++++++|.....+++|||++|+||+++..+.++++|||.++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 4556677899999999999975434599999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.6e-14 Score=143.21 Aligned_cols=136 Identities=20% Similarity=0.215 Sum_probs=96.7
Q ss_pred CCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCC-hhHH----------------------HHHHHHHHhccCCCC--c
Q 001922 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHS-HDHG----------------------FRAEIQTLGNIRHRN--I 745 (995)
Q Consensus 691 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~----------------------~~~E~~~l~~l~hpn--i 745 (995)
.+.||+|+||+||+|...+++.||||++....... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988789999999875422111 1111 134566666664432 3
Q ss_pred eeEeEEEecCCcceEEEEeccCCChhhh-hcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECC
Q 001922 746 VRLLAFCSNKETNLLVYEYMRNGSLGEA-LHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNS 823 (995)
Q Consensus 746 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~ 823 (995)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 344433 245899999998554321 11100 11 5567899999999999997 66 99999999999999
Q ss_pred CCCeEEeeecccccc
Q 001922 824 AFEAHVADFGLAKFL 838 (995)
Q Consensus 824 ~~~vkl~DfGla~~~ 838 (995)
++.++++|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=2e-13 Score=143.55 Aligned_cols=137 Identities=20% Similarity=0.248 Sum_probs=105.5
Q ss_pred CCCeee-ccCceEEEEEEeCCCcEEEEEEecCCC------------CCChhHHHHHHHHHHhccCCCCc--eeEeEEEec
Q 001922 690 DGNVIG-RGGAGIVYHGKMPNGVEIAVKKLLGFG------------THSHDHGFRAEIQTLGNIRHRNI--VRLLAFCSN 754 (995)
Q Consensus 690 ~~~~lG-~G~~g~V~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~hpni--v~~~~~~~~ 754 (995)
.+..|| .|+.|+||.++.. +..+++|.+.... ......++.+|++++.+++|+++ +..+++...
T Consensus 35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 456788 8999999999874 7789999874211 01223567889999999998775 666666433
Q ss_pred C-Cc---ceEEEEeccC-CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEE
Q 001922 755 K-ET---NLLVYEYMRN-GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV 829 (995)
Q Consensus 755 ~-~~---~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl 829 (995)
. .. .++||||++| .+|.+++.. ..++.. .+.+++.++.++|+.| |+||||||+|||++.++.++|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 22 2599999997 689988853 234443 3578999999999888 999999999999999999999
Q ss_pred eeeccccc
Q 001922 830 ADFGLAKF 837 (995)
Q Consensus 830 ~DfGla~~ 837 (995)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99999875
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.1e-14 Score=170.32 Aligned_cols=118 Identities=32% Similarity=0.553 Sum_probs=89.0
Q ss_pred hccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccC
Q 001922 504 VLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSF 583 (995)
Q Consensus 504 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~ 583 (995)
++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 56777777777777777777778888888888888777777777888888888888888777887788888888888888
Q ss_pred CCCCCCCCCCC--CCcccccccCCCCccCCCCCCCCCCCC
Q 001922 584 NDFSGKLPESG--QFTVFNASSFAGNPQLCGTLLNNPCNV 621 (995)
Q Consensus 584 N~l~g~~p~~~--~~~~~~~~~~~~n~~~c~~~~~~~c~~ 621 (995)
|+++|.+|..- .+.......+.||+++||.|....|..
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~ 539 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGP 539 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCCCCCCcc
Confidence 88888777531 112234567889999999875557863
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.9e-15 Score=163.07 Aligned_cols=189 Identities=31% Similarity=0.475 Sum_probs=126.8
Q ss_pred CeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCc
Q 001922 358 QVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSN 437 (995)
Q Consensus 358 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n 437 (995)
...||+.|++. .+|..++.+-.|+.+.|..|.+ ..+|..+.++..|+.++++.|++. ..|..+..+|
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~-r~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp---------- 144 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCI-RTIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP---------- 144 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccc-eecchhhhhhhHHHHhhhccchhh-cCChhhhcCc----------
Confidence 34455555554 4455555555555555554444 234444555555555555555554 3344333332
Q ss_pred cccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCC
Q 001922 438 YLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGE 517 (995)
Q Consensus 438 ~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 517 (995)
|+.|-+++|+++ .+|+.++.+..|..||.+.|++. .+|..++.+.+|+.|++..|++. .
T Consensus 145 ------------------Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~ 203 (722)
T KOG0532|consen 145 ------------------LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-D 203 (722)
T ss_pred ------------------ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-h
Confidence 567777888887 78888887788888888888887 78888888888888888888887 6
Q ss_pred CCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCc---ccEEeccC
Q 001922 518 IPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKS---LTIADFSF 583 (995)
Q Consensus 518 ~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~l~ls~ 583 (995)
+|++++.|+ |..||+|.|+++ .||-.|.+|+.|++|-|.+|.|. ..|..+...-. .++|+..-
T Consensus 204 lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA 269 (722)
T KOG0532|consen 204 LPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQA 269 (722)
T ss_pred CCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchh
Confidence 788888555 888888888888 78888888888888888888885 46666544333 34444443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-14 Score=158.64 Aligned_cols=184 Identities=29% Similarity=0.474 Sum_probs=100.5
Q ss_pred CCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEE
Q 001922 162 EKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLD 241 (995)
Q Consensus 162 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~ 241 (995)
.--...||+.|++. .+|..+..+..|+.|.|+.|.+. .+|..+.++..|++|||+
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls----------------------- 129 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLS----------------------- 129 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhc-----------------------
Confidence 33344555555554 55555555555555555555555 455555555555555554
Q ss_pred CcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCC
Q 001922 242 LSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG 321 (995)
Q Consensus 242 Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 321 (995)
.|+++ ..|..++.++ |+.|.+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++.
T Consensus 130 --~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~- 202 (722)
T KOG0532|consen 130 --SNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE- 202 (722)
T ss_pred --cchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-
Confidence 44444 3344444333 444444555544 44455555555555555555555 44555555555555555555555
Q ss_pred CCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCc
Q 001922 322 SIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQ 380 (995)
Q Consensus 322 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 380 (995)
.+|..++.| .|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.++ ..|..+|....
T Consensus 203 ~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGk 258 (722)
T KOG0532|consen 203 DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGK 258 (722)
T ss_pred hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccc
Confidence 344455543 3666666666666 56666666666666666666666 55666655443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.5e-13 Score=153.68 Aligned_cols=194 Identities=35% Similarity=0.488 Sum_probs=107.1
Q ss_pred eEeccCCcccC-ccccCcccccceeccccccccCCCcccccccc-cccccccccccccccCCccccCCCCCceeeccCcc
Q 001922 96 NLSLAGNNFTG-SIEIGNLSSLQFLNISNNQFSGGLDWNYSSLV-NLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY 173 (995)
Q Consensus 96 ~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~-~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~ 173 (995)
.|+++.|.+.. ...+..++.++.|++.+|.++.+.+ ....+. +|+.|++++|++.. +|..+..+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~~i~~-~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPP-LIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccccCcc-ccccchhhcccccccccchhh-hhhhhhccccccccccCCch
Confidence 46666666632 3355566677777777777764433 333342 67777777777666 34556667777777777777
Q ss_pred ccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCc
Q 001922 174 FFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPH 253 (995)
Q Consensus 174 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~ 253 (995)
++ .+|...+.+++|+.|++++|+++ .+|...+.+..|++|++++|.... .+..+.++.++..|.+++|++. ..+.
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~--~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIE--LLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCccee--cchhhhhcccccccccCCceee-eccc
Confidence 75 55555556666777777777776 555555555556666666543322 3444555555555555555554 2233
Q ss_pred cccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCc
Q 001922 254 EIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGE 298 (995)
Q Consensus 254 ~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 298 (995)
.++.++.+++|++++|+++. ++. ++.+.+++.|++++|.+...
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~ 292 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNA 292 (394)
T ss_pred hhccccccceeccccccccc-ccc-ccccCccCEEeccCcccccc
Confidence 44444444444444444442 222 44444444444444444433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.2e-12 Score=147.52 Aligned_cols=152 Identities=18% Similarity=0.191 Sum_probs=104.7
Q ss_pred cHHHHHhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChh--------------------------------
Q 001922 680 SVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHD-------------------------------- 727 (995)
Q Consensus 680 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-------------------------------- 727 (995)
...++...|+ .+.||.|++|.||+|+.++|++||||+..+.....-.
T Consensus 112 ~~~~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~ 190 (437)
T TIGR01982 112 PLEELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEF 190 (437)
T ss_pred CHHHHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHH
Confidence 4455555555 4789999999999999999999999998543211000
Q ss_pred -------HHHHHHHHHHhccC----CCCceeEeEEE-ecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHH
Q 001922 728 -------HGFRAEIQTLGNIR----HRNIVRLLAFC-SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAA 795 (995)
Q Consensus 728 -------~~~~~E~~~l~~l~----hpniv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~ 795 (995)
-+|.+|++.+.+++ |..-+.+-.++ ......++||||++|++|.++...... ..+ ..+++.+++
T Consensus 191 ~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~ 266 (437)
T TIGR01982 191 EKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLA 266 (437)
T ss_pred HHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHH
Confidence 02444555555552 32223333333 334567999999999999987642211 122 344666666
Q ss_pred H-HHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 796 K-GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 796 ~-~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
. .+..+|..| ++|+|++|.||+++.++.++++|||++..+.
T Consensus 267 ~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 267 RSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 5 467889777 9999999999999999999999999998763
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.1e-13 Score=152.61 Aligned_cols=195 Identities=34% Similarity=0.450 Sum_probs=98.8
Q ss_pred ceeccccccccCCCcccccccccccccccccccccccCCccccCCC-CCceeeccCccccccCCccccCCCCCceeeccC
Q 001922 117 QFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLE-KLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAG 195 (995)
Q Consensus 117 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 195 (995)
..|+++.|.+...+ ..+..++.++.|++.+|.++. +|.....+. +|+.|++++|++. .+|..++.+++|+.|++++
T Consensus 96 ~~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 96 PSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred ceeeccccccccCc-hhhhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 35777777763222 223344566666666666666 344445553 6666666666665 4555566666666666666
Q ss_pred CcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCC
Q 001922 196 NDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSI 275 (995)
Q Consensus 196 N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 275 (995)
|+++ .+|...+.+++|+.|++++|++.. +|.....+..|++|.+++|.+. ..+..+.+++.+..+.+.+|++.. +
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~~--l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~ 247 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKISD--LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-L 247 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCcccc--CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-c
Confidence 6666 444444455555555555444433 3443333344555555555322 233344444444444444444441 2
Q ss_pred CccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCC
Q 001922 276 PKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG 321 (995)
Q Consensus 276 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 321 (995)
+..++.+++++.|++++|.++...+ +..+.+++.|++++|.+..
T Consensus 248 ~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 248 PESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSN 291 (394)
T ss_pred cchhccccccceecccccccccccc--ccccCccCEEeccCccccc
Confidence 3344444444444444444442222 4444444444444444443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.2e-12 Score=132.00 Aligned_cols=210 Identities=20% Similarity=0.256 Sum_probs=143.3
Q ss_pred HHHHHHhccCCCCceeEeEEEecC-----CcceEEEEeccCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 001922 732 AEIQTLGNIRHRNIVRLLAFCSNK-----ETNLLVYEYMRNGSLGEALHGK--KGAFLGWNLRYKIAIEAAKGLCYLHHD 804 (995)
Q Consensus 732 ~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~ 804 (995)
.-+.-+-++.|.|+|+++.|+.+. ....++.|||..|++..++++. .+..+....-.+|+.||..||.|||..
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 345556666899999999998654 3467899999999999999752 344566677789999999999999976
Q ss_pred CCCCeEecCCCCCCEEECCCCCeEEeeeccccc--cccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHH
Q 001922 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF--LIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLE 882 (995)
Q Consensus 805 ~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~e 882 (995)
.++|+|+++..+-|++..+|-+|++--.-... ..............+-++|.|||.-.....+.++|||+||....|
T Consensus 196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred -CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 78999999999999999999999853221111 000001111123446789999998777777889999999999999
Q ss_pred HHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHcc
Q 001922 883 LLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960 (995)
Q Consensus 883 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 960 (995)
|.-+..--...........-......+ .... .=+.++.+|++..|..||+|++++.+.-.
T Consensus 275 mailEiq~tnseS~~~~ee~ia~~i~~--------len~----------lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIANVIIG--------LENG----------LQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred HHHheeccCCCcceeehhhhhhhheee--------ccCc----------cccCcCcccccCCCCCCcchhhhhcCcee
Confidence 988766422111111110000000000 0000 01246789999999999999998765433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.7e-12 Score=143.60 Aligned_cols=250 Identities=24% Similarity=0.232 Sum_probs=181.8
Q ss_pred hccCCCeeec--cCceEEEEEEe---CCCcEEEEEEecC-CCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcce
Q 001922 687 CVKDGNVIGR--GGAGIVYHGKM---PNGVEIAVKKLLG-FGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 687 ~~~~~~~lG~--G~~g~V~~~~~---~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 759 (995)
.+.....+|. |.+|.||.++. .+++.+|+|+-+. ........+-.+|+...+.++ |++.++.+..+..++..|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3455677899 99999999865 4688899998422 222233334456777777774 999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCEEECCC-CCeEEeeecc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK----GLCYLHHDCSPLIVHRDVKSNNILLNSA-FEAHVADFGL 834 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~~~~~iiHrDlkp~Nill~~~-~~vkl~DfGl 834 (995)
+-.|++. .++..+.+. ....++....+....+..+ |+.++|... ++|-|+||.||++..+ ...+++|||+
T Consensus 195 iqtE~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeecccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 9999995 688888873 3445777788888888888 999999555 9999999999999999 7889999999
Q ss_pred ccccccCCCCccc---cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 835 AKFLIDGGASECM---SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 835 a~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
...+.++...... ....|...|++||.. .+.++.+.|+|++|.++.+..+|..+...... ..|...
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----~~W~~~------ 338 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN----SSWSQL------ 338 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC----CCcccc------
Confidence 9988766533221 223678899999965 44678899999999999999998887543210 011100
Q ss_pred hhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 EEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....+ ..+.......+...+..|++.+|-.|++++.+...
T Consensus 339 ---r~~~ip--~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 339 ---RQGYIP--LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ---ccccCc--hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 000000 00111223345558899999999999998887643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.2e-12 Score=145.60 Aligned_cols=149 Identities=15% Similarity=0.161 Sum_probs=98.3
Q ss_pred cHHHHHhhccCCCeeeccCceEEEEEEeCC-CcEEEEEEecCCCCCC-------------------------h-------
Q 001922 680 SVSDILECVKDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHS-------------------------H------- 726 (995)
Q Consensus 680 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~-------------------------~------- 726 (995)
..+++...|+. +.+|.|++|.||+|+.++ |++||||+..+..... .
T Consensus 114 ~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e 192 (537)
T PRK04750 114 PVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE 192 (537)
T ss_pred CHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence 45667777876 889999999999999877 9999999986432100 0
Q ss_pred -hH------HHHHHHHHHhccC----CCCceeEeEEEec-CCcceEEEEeccCCChhhhhcCCCCC----CCCHHHHHHH
Q 001922 727 -DH------GFRAEIQTLGNIR----HRNIVRLLAFCSN-KETNLLVYEYMRNGSLGEALHGKKGA----FLGWNLRYKI 790 (995)
Q Consensus 727 -~~------~~~~E~~~l~~l~----hpniv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~i 790 (995)
.+ ++.+|+..+.+++ +...+.+-.++.+ ....++||||++|+++.++-.-...+ .+....+..+
T Consensus 193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~ 272 (537)
T PRK04750 193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF 272 (537)
T ss_pred HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH
Confidence 01 1334544444442 3333444343322 45678999999999998753211111 1222222333
Q ss_pred HHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC----CeEEeeeccccccc
Q 001922 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF----EAHVADFGLAKFLI 839 (995)
Q Consensus 791 ~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~----~vkl~DfGla~~~~ 839 (995)
+.|+ ...| ++|+|+||.||+++.++ .++++|||++..+.
T Consensus 273 ~~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 273 FTQV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3333 4466 99999999999999988 99999999998764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.2e-11 Score=118.64 Aligned_cols=130 Identities=19% Similarity=0.123 Sum_probs=95.8
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCce-eEeEEEecCCcceEEEEeccCCCh
Q 001922 692 NVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIV-RLLAFCSNKETNLLVYEYMRNGSL 770 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~~~~gsL 770 (995)
+.++.|.++.||+++.. ++.|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 56899999999999874 77899998743321 123467899999998665544 444443 2345899999999887
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 771 GEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC--SPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.+.- .. ...++.+++++++.||..+ ...++|||++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~------~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED------FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc------cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6531 01 1245679999999999765 12259999999999999 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.6e-12 Score=127.66 Aligned_cols=132 Identities=27% Similarity=0.354 Sum_probs=108.0
Q ss_pred CCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeec
Q 001922 454 DRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDM 533 (995)
Q Consensus 454 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 533 (995)
..|+++|||+|.|+ .+.+...-++.++.|++|+|.|. .+. .+..+.+|+.||||+|.|+ .+-.+-..|-+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 45778888888887 66777777788999999999987 332 3888889999999999998 67778888889999999
Q ss_pred cCCcccCCCccccccccccCeEecccccccccc-CcccccCCcccEEeccCCCCCCCCC
Q 001922 534 SQNNLSGSIPPEISNVRILNYLNLSRNHLNQNI-PKSIGSMKSLTIADFSFNDFSGKLP 591 (995)
Q Consensus 534 s~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~l~ls~N~l~g~~p 591 (995)
++|.+. .+ ..++.|-+|.+||+++|++...- -..+++++.|+.+.|.+|++.+.+-
T Consensus 360 a~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 360 AQNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 999986 23 36788889999999999996532 3578999999999999999997543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.1e-10 Score=125.80 Aligned_cols=167 Identities=20% Similarity=0.214 Sum_probs=125.2
Q ss_pred EeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCChhhhhcCCCCCCCCHH
Q 001922 706 KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWN 785 (995)
Q Consensus 706 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~ 785 (995)
+..++.+|.|...+.... ...+...+.++.++.++||||+++++.++..+..|+|+|.+. .|..++.... ..
T Consensus 33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KE 104 (690)
T ss_pred eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HH
Confidence 455788898888744332 345567788999999999999999999999999999999985 7888886432 44
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccC
Q 001922 786 LRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865 (995)
Q Consensus 786 ~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 865 (995)
...--+.||+.||.|||+.+ .++|+++.-..|++++.|..||++|.++........ ......---.|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 44557889999999998654 499999999999999999999999998865322111 11111122245566644332
Q ss_pred CCCcccchhhHHHHHHHHHhC
Q 001922 866 RVDEKSDVYSFGVVLLELLTG 886 (995)
Q Consensus 866 ~~~~~~DvwSlGvil~elltg 886 (995)
. -..|.|-||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=9.4e-10 Score=110.16 Aligned_cols=136 Identities=16% Similarity=0.159 Sum_probs=97.1
Q ss_pred CeeeccCceEEEEEEeCC-------CcEEEEEEecCCC------------C---------CChhHHHH----HHHHHHhc
Q 001922 692 NVIGRGGAGIVYHGKMPN-------GVEIAVKKLLGFG------------T---------HSHDHGFR----AEIQTLGN 739 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~------------~---------~~~~~~~~----~E~~~l~~ 739 (995)
..||.|--+.||.|...+ +..+|||..+... . ......+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 4799999864110 0 01122233 79999999
Q ss_pred cCC--CCceeEeEEEecCCcceEEEEeccCCChhh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCC
Q 001922 740 IRH--RNIVRLLAFCSNKETNLLVYEYMRNGSLGE-ALHGKKGAFLGWNLRYKIAIEAAKGLCYL-HHDCSPLIVHRDVK 815 (995)
Q Consensus 740 l~h--pniv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~iiHrDlk 815 (995)
+.. -.+...+++ ...++||||+.+..+.. .+. ...++......+..+++.+|.++ |+.+ |||||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 853 455666654 45689999997654322 222 12344455667889999999998 8777 9999999
Q ss_pred CCCEEECCCCCeEEeeecccccc
Q 001922 816 SNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 816 p~Nill~~~~~vkl~DfGla~~~ 838 (995)
+.||+++ ++.+.++|||.+-..
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 478999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.8e-12 Score=126.03 Aligned_cols=131 Identities=29% Similarity=0.261 Sum_probs=73.0
Q ss_pred ccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEE
Q 001922 258 LKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLG 337 (995)
Q Consensus 258 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 337 (995)
.+.|+++||++|.|+ .+.+++.-++.++.|++|+|.|..+. .+..+.+|+.|||++|.++ .+..+-..+-++++|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 344444555555444 34444555556666666666655222 2555566666666666665 3444555566666666
Q ss_pred eccCcccccCCCcccCCCCCCeEEecCceeccc-CCCcCcCCCccceeeccccccCCC
Q 001922 338 LWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGT-IPTDLCSSNQLRILILLKNFLFGP 394 (995)
Q Consensus 338 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~ 394 (995)
|+.|.+... ..++.+-+|..||+++|+|... --..+++++-|+++.|.+|.+.+.
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 666666522 2355566666666666666521 123456666677777777766543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.4e-11 Score=141.36 Aligned_cols=195 Identities=32% Similarity=0.393 Sum_probs=113.0
Q ss_pred CCCCCCeEeccCCcccCcc-ccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceee
Q 001922 90 RLDKLTNLSLAGNNFTGSI-EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLD 168 (995)
Q Consensus 90 ~l~~L~~L~L~~n~l~~~~-~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~ 168 (995)
.+..+..+++..|.+.... .+..+++|+.|++.+|+|..+.. .+..+++|++|++++|.|+.+ ..+..++.|+.|+
T Consensus 70 ~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELN 146 (414)
T ss_pred HhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhccc-chhhhhcchheeccccccccc--cchhhccchhhhe
Confidence 4556666667777776533 37777777777777777775432 156677777777777777775 3456666677777
Q ss_pred ccCccccccCCccccCCCCCceeeccCCcccccCc-ccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCC
Q 001922 169 LGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIP-GELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCEL 247 (995)
Q Consensus 169 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l 247 (995)
+++|.|+ .+ ..+..+.+|+.+++++|+++..-+ . ...+.+++.++++.|.+.. ...+..+..+..+++..|.+
T Consensus 147 l~~N~i~-~~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~---i~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 147 LSGNLIS-DI-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE---IEGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred eccCcch-hc-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc---ccchHHHHHHHHhhcccccc
Confidence 7777775 22 335557777777777777774433 2 4666667777776554433 22333344444556666666
Q ss_pred CCccCccccCcc--ccCccccccccccCCCCccccCcCCCCeEeccCCcCc
Q 001922 248 DGQIPHEIGNLK--LLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALT 296 (995)
Q Consensus 248 ~~~~~~~~~~l~--~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 296 (995)
+..-+ +..+. .|+.+++++|.+. ..+..+..+..+..|++++|++.
T Consensus 221 ~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 221 SKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred eeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 52211 11111 2455555555554 22233444445555555555444
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.2e-11 Score=131.58 Aligned_cols=210 Identities=22% Similarity=0.191 Sum_probs=147.3
Q ss_pred CcccccceeccccccccCCCc-ccccccccccccccccccccccCC--ccccCCCCCceeeccCccccccCCccc-cCCC
Q 001922 111 GNLSSLQFLNISNNQFSGGLD-WNYSSLVNLEVFDAYNNNFTALLP--VGILKLEKLKYLDLGGNYFFGKIPNSY-GELQ 186 (995)
Q Consensus 111 ~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~ 186 (995)
.++.+|+...|.+..+..... .....+++++.||||.|-+....| .-...|++|+.|+|+.|++.-...... ..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 567888888888888764432 466778899999999988876433 234568899999999998863322222 3577
Q ss_pred CCceeeccCCcccccC-cccccchhhhhhhhccccc-cccCCCCcccCCCCcccEEECcCCCCCCcc-CccccCccccCc
Q 001922 187 GLEYLSLAGNDLTGKI-PGELGNLTNLREIYLGYYN-VFEGGIPREVGKLVNLVHLDLSSCELDGQI-PHEIGNLKLLDT 263 (995)
Q Consensus 187 ~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~~n~-~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~ 263 (995)
.|+.|.|+.|.++... -..+..+++|+.|+|..|+ ++... ....-+..|+.|||++|++.... -...+.++.|+.
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~--~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKA--TSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceec--chhhhhhHHhhccccCCcccccccccccccccchhh
Confidence 8899999999888432 2234567889999998884 33222 23344678899999999887332 145678889999
Q ss_pred cccccccccCC-CCcc-----ccCcCCCCeEeccCCcCcCc-CCccccccCCCCEEEccCCcCCCC
Q 001922 264 VFLHINLLSGS-IPKQ-----LGNLTNLVNLDLSNNALTGE-IPYSFINLRQLKLFNLFMNRLHGS 322 (995)
Q Consensus 264 L~l~~N~l~~~-~p~~-----l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~ 322 (995)
|.++.+.+..+ .|+. ...+++|++|+++.|+|... .-..+..+.+|+.|.+..|.++.+
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 99998888754 2333 35678999999999999632 112345567888888888988743
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.5e-12 Score=132.13 Aligned_cols=252 Identities=24% Similarity=0.260 Sum_probs=160.9
Q ss_pred cccCCCCCCeEeccCCcccCcc------ccCcccccceecccccccc---CCCcccccccccccccccccccccccCCcc
Q 001922 87 QILRLDKLTNLSLAGNNFTGSI------EIGNLSSLQFLNISNNQFS---GGLDWNYSSLVNLEVFDAYNNNFTALLPVG 157 (995)
Q Consensus 87 ~~~~l~~L~~L~L~~n~l~~~~------~~~~l~~L~~L~Ls~N~i~---~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~ 157 (995)
.+.....+++++||+|.|.-.. .+.+.++|+..++|+--.. ..+|..+ .. +..+
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L------~~-----------l~~a 87 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEAL------KM-----------LSKA 87 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHH------HH-----------HHHH
Confidence 3445677888888888775311 3666777888877754322 1122111 11 2245
Q ss_pred ccCCCCCceeeccCccccccCCcc----ccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCC
Q 001922 158 ILKLEKLKYLDLGGNYFFGKIPNS----YGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGK 233 (995)
Q Consensus 158 ~~~l~~L~~L~L~~N~l~~~~p~~----l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~ 233 (995)
+..+++|++||||+|-|.-.-+.. +.++..|++|+|.+|.+.-.--..++. .|.+|.. ++. .+.
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~~--~kk--------~~~ 155 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELAV--NKK--------AAS 155 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHHH--Hhc--------cCC
Confidence 666778999999999886444443 356788999999988876221112221 2444431 121 223
Q ss_pred CCcccEEECcCCCCCCccC----ccccCccccCccccccccccCC----CCccccCcCCCCeEeccCCcCcCc----CCc
Q 001922 234 LVNLVHLDLSSCELDGQIP----HEIGNLKLLDTVFLHINLLSGS----IPKQLGNLTNLVNLDLSNNALTGE----IPY 301 (995)
Q Consensus 234 l~~L~~L~Ls~n~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~ 301 (995)
-++|+++...+|++..... ..|...+.|+.+.++.|.|... +...|..+++|+.|||.+|.++.. +..
T Consensus 156 ~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Lak 235 (382)
T KOG1909|consen 156 KPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAK 235 (382)
T ss_pred CcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence 3579999999999875432 3455668888889998887522 234677889999999999988743 234
Q ss_pred cccccCCCCEEEccCCcCCCCCCccc-----cCCCCcceEEeccCcccc----cCCCcccCCCCCCeEEecCcee
Q 001922 302 SFINLRQLKLFNLFMNRLHGSIPDYL-----ADLPNLETLGLWQNNFTG----VIPENLGQNGKLQVLDLSSNKL 367 (995)
Q Consensus 302 ~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l 367 (995)
.+..+++|+.|++++|.+......+| ...|+|+.|.+.+|.++. .+...+...+.|..|+|++|.+
T Consensus 236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 55667788888888888876544333 235778888888887763 2223344566777777777777
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.5e-11 Score=141.26 Aligned_cols=239 Identities=28% Similarity=0.269 Sum_probs=112.6
Q ss_pred CCCeEeccCCcccCcccc-CcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccC
Q 001922 93 KLTNLSLAGNNFTGSIEI-GNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGG 171 (995)
Q Consensus 93 ~L~~L~L~~n~l~~~~~~-~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~ 171 (995)
.++.++...+.+.+...+ ..+..++.+++..|.|.. +...+..+.+|+.|++.+|+|..+. ..+..+++|++|+|++
T Consensus 50 ~~~~~~~~~~~~~~~~~~~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~ 127 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDLVESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSF 127 (414)
T ss_pred hhhhhcchhccccchhhhHHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcc-cchhhhhcchheeccc
Confidence 344455555444432222 455666666666666654 2223445555556666666555531 1144555555555555
Q ss_pred ccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCcc
Q 001922 172 NYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQI 251 (995)
Q Consensus 172 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 251 (995)
|.|+...+ +..++.|+.|++++|.|+.. ..+..+++|+.+++++|.+...-
T Consensus 128 N~I~~i~~--l~~l~~L~~L~l~~N~i~~~---------------------------~~~~~l~~L~~l~l~~n~i~~ie 178 (414)
T KOG0531|consen 128 NKITKLEG--LSTLTLLKELNLSGNLISDI---------------------------SGLESLKSLKLLDLSYNRIVDIE 178 (414)
T ss_pred cccccccc--hhhccchhhheeccCcchhc---------------------------cCCccchhhhcccCCcchhhhhh
Confidence 55542221 34444455555555555521 12222445555555555555322
Q ss_pred C-ccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCC
Q 001922 252 P-HEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADL 330 (995)
Q Consensus 252 ~-~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 330 (995)
+ . ...+.+++.+++..|.+.. ...+..+..+..+++..|.++...+.....+..|+.+++++|++. ..+..+..+
T Consensus 179 ~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~ 254 (414)
T KOG0531|consen 179 NDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRIS-RSPEGLENL 254 (414)
T ss_pred hhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccc-ccccccccc
Confidence 2 1 3445555555555555542 122333444444455566555222111100012555555555555 222344455
Q ss_pred CCcceEEeccCcccccCCCcccCCCCCCeEEecCceec
Q 001922 331 PNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 331 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 368 (995)
.++..|++.+|++... ..+.....+..+.+..|.+.
T Consensus 255 ~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 255 KNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred ccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 5555556655555432 12333444555555555544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.9e-11 Score=118.49 Aligned_cols=110 Identities=29% Similarity=0.358 Sum_probs=39.9
Q ss_pred ccCCCCCCeEeccCCcccCccccC-cccccceeccccccccCCCcccccccccccccccccccccccCCccc-cCCCCCc
Q 001922 88 ILRLDKLTNLSLAGNNFTGSIEIG-NLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGI-LKLEKLK 165 (995)
Q Consensus 88 ~~~l~~L~~L~L~~n~l~~~~~~~-~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~-~~l~~L~ 165 (995)
+.+...+++|+|++|.|+....++ .+.+|+.|+|++|.|+.+. .+..+++|++|++++|+|+.+. ..+ ..+++|+
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i~-~~l~~~lp~L~ 91 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSIS-EGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S-C-HHHHHH-TT--
T ss_pred cccccccccccccccccccccchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCccc-cchHHhCCcCC
Confidence 344556888899999888766666 5788899999999888653 4777888888888888888753 334 4688888
Q ss_pred eeeccCcccccc-CCccccCCCCCceeeccCCcccc
Q 001922 166 YLDLGGNYFFGK-IPNSYGELQGLEYLSLAGNDLTG 200 (995)
Q Consensus 166 ~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~ 200 (995)
+|+|++|+|... .-..+..+++|++|+|.+|.++.
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 888888888642 12456778888888888888873
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.6e-11 Score=133.24 Aligned_cols=244 Identities=21% Similarity=0.164 Sum_probs=174.4
Q ss_pred hccCCCeeeccCceEEEEEEe--CCCcEEEEEEecCCCCCChhHH-HHHHHHHHhcc-CCCCceeEeEEEecCCcceEEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM--PNGVEIAVKKLLGFGTHSHDHG-FRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.|.....||.|.|+.|+.... .++..|++|...+.......+. -..|+.+...+ .|.++++.+..|..-+..|+--
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL 345 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence 455667899999999999854 3577889987744333222222 24566666666 5899999888887778888999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CCeEEeeeccccccccC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA-FEAHVADFGLAKFLIDG 841 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~-~~vkl~DfGla~~~~~~ 841 (995)
|||++++..... .....+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||.+..+.-
T Consensus 346 e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~- 419 (524)
T KOG0601|consen 346 EFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF- 419 (524)
T ss_pred hhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccce-
Confidence 999999988776 34456778888999999999999999665 9999999999999887 7789999999875311
Q ss_pred CCCccccccccCccc-ccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 842 GASECMSAIAGSYGY-IAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
. .......+..| .+|+......+..+.|++|||.-+.+..+|..--.. ..+| ..+...
T Consensus 420 --~-~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~------~~~~------------~~i~~~ 478 (524)
T KOG0601|consen 420 --S-SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES------GVQS------------LTIRSG 478 (524)
T ss_pred --e-cccccccccccccchhhccccccccccccccccccccccccCcccCcc------cccc------------eeeecc
Confidence 1 11112233344 356666677888999999999999999987663211 1111 112222
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQML 958 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 958 (995)
.....+... ..+..+...+...++..||.+.++..+.
T Consensus 479 ~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 479 DTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred cccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccc
Confidence 222233333 6777888999999999999998876543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-11 Score=131.52 Aligned_cols=228 Identities=26% Similarity=0.224 Sum_probs=144.1
Q ss_pred ceeccccccccCCCcccc----cccccccccccccccccccCC-ccccCCCCCceeeccCcccccc--CCccccCCCCCc
Q 001922 117 QFLNISNNQFSGGLDWNY----SSLVNLEVFDAYNNNFTALLP-VGILKLEKLKYLDLGGNYFFGK--IPNSYGELQGLE 189 (995)
Q Consensus 117 ~~L~Ls~N~i~~~~~~~~----~~l~~L~~L~Ls~n~i~~~~p-~~~~~l~~L~~L~L~~N~l~~~--~p~~l~~l~~L~ 189 (995)
..+.+++-++.++.-+.+ +++.+|+...|.+..+..... .....|++++.||||+|-|..- +-.....|++|+
T Consensus 96 ~~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le 175 (505)
T KOG3207|consen 96 SVLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLE 175 (505)
T ss_pred hHhhhcCceeEEecHHHHHHHhhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccch
Confidence 345556666655433333 567888888888888776322 3566788888899988887632 333446788888
Q ss_pred eeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCc-cCccccCccccCcccccc
Q 001922 190 YLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQ-IPHEIGNLKLLDTVFLHI 268 (995)
Q Consensus 190 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~l~~ 268 (995)
.|+|+.|++..-..... -..++.|+.|.|+.|.++-. +.......++|+.|+|..
T Consensus 176 ~LNls~Nrl~~~~~s~~------------------------~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~ 231 (505)
T KOG3207|consen 176 NLNLSSNRLSNFISSNT------------------------TLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEA 231 (505)
T ss_pred hcccccccccCCccccc------------------------hhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhc
Confidence 88888888872211110 01235677777777777621 122234567777777777
Q ss_pred ccccCCCCccccCcCCCCeEeccCCcCcCcC-CccccccCCCCEEEccCCcCCCC-CCcc-----ccCCCCcceEEeccC
Q 001922 269 NLLSGSIPKQLGNLTNLVNLDLSNNALTGEI-PYSFINLRQLKLFNLFMNRLHGS-IPDY-----LADLPNLETLGLWQN 341 (995)
Q Consensus 269 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~-~p~~-----~~~l~~L~~L~L~~N 341 (995)
|....+.......+..|+.|||++|++-... -...+.++.|..|+++.+.|... .|+. ...+++|++|+++.|
T Consensus 232 N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N 311 (505)
T KOG3207|consen 232 NEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISEN 311 (505)
T ss_pred ccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccC
Confidence 7533333344455667788888888776332 13455677788888888877653 3333 355788888888888
Q ss_pred ccccc-CCCcccCCCCCCeEEecCceec
Q 001922 342 NFTGV-IPENLGQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 342 ~l~~~-~p~~~~~l~~L~~L~L~~N~l~ 368 (995)
++... .-..+..+++|+.|....|.++
T Consensus 312 ~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 312 NIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred ccccccccchhhccchhhhhhccccccc
Confidence 88521 1123455677888888888887
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.5e-09 Score=104.14 Aligned_cols=132 Identities=27% Similarity=0.420 Sum_probs=100.1
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEecCC-CCCC------hhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 692 NVIGRGGAGIVYHGKMPNGVEIAVKKLLGF-GTHS------HDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
..+++|+-+.+|.+.+. |.++++|.-.+. -... ...+..+|+.++.+++--.|....-++.+++...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999774 445666643221 1111 123566799999998765555555566677888999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
++|-.|.+.+... ...++..+-.-+.-||..| |+|+|+.++||++.... +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888643 2457778888889999888 99999999999998765 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.8e-09 Score=102.75 Aligned_cols=144 Identities=19% Similarity=0.202 Sum_probs=107.1
Q ss_pred CCCeeeccCceEEEEEEeCCCcEEEEEEecC-CCCC------ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 690 DGNVIGRGGAGIVYHGKMPNGVEIAVKKLLG-FGTH------SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 690 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~-~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
....+-+|+-+.|+++.+ .|+..+||.-.. .-.. -...+..+|++.+.+++--.|.-..-++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 356789999999999988 677877775321 1111 12356778999999987656655555666777789999
Q ss_pred EeccC-CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC---CeEEeeeccccc
Q 001922 763 EYMRN-GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF---EAHVADFGLAKF 837 (995)
Q Consensus 763 e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~---~vkl~DfGla~~ 837 (995)
||++| .++.+++...-...........++++|-+.+.-||..+ |+|||+..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 47778776433333333444678999999999999877 99999999999997665 358999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-09 Score=113.97 Aligned_cols=143 Identities=22% Similarity=0.268 Sum_probs=110.0
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCC--CCceeEeEEEecC---CcceEEEEecc
Q 001922 692 NVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH--RNIVRLLAFCSNK---ETNLLVYEYMR 766 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~---~~~~lv~e~~~ 766 (995)
+.+|.|.++.||+++..+|+.+++|.............+..|+++++.+++ ..+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999998877789999987443222234568899999999975 3456677776553 26689999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC----------------------------------------- 805 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------- 805 (995)
|.++.+.+.. ..++......++.++++++.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876531 34677777788889999998888531
Q ss_pred ------------CCCeEecCCCCCCEEECC--CCCeEEeeeccccc
Q 001922 806 ------------SPLIVHRDVKSNNILLNS--AFEAHVADFGLAKF 837 (995)
Q Consensus 806 ------------~~~iiHrDlkp~Nill~~--~~~vkl~DfGla~~ 837 (995)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=8e-11 Score=115.40 Aligned_cols=119 Identities=30% Similarity=0.324 Sum_probs=29.8
Q ss_pred CCcccCccccCcccccceeccccccccCCCccccc-ccccccccccccccccccCCccccCCCCCceeeccCccccccCC
Q 001922 101 GNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYS-SLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIP 179 (995)
Q Consensus 101 ~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~-~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 179 (995)
.+.|.....+.+..++++|+|++|.|+.+. .++ .+.+|+.||+++|.|+.+ ..+..+++|++|++++|+|+ .+.
T Consensus 6 ~~~i~~~~~~~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~ 80 (175)
T PF14580_consen 6 ANMIEQIAQYNNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SIS 80 (175)
T ss_dssp --------------------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-C
T ss_pred cccccccccccccccccccccccccccccc--chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccc
Confidence 344444445666667788888888887542 233 456666666776666664 24556666666666666665 333
Q ss_pred ccc-cCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCC
Q 001922 180 NSY-GELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELD 248 (995)
Q Consensus 180 ~~l-~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~ 248 (995)
+.+ ..+++|++|+|++|+|... . --..+..+++|++|+|.+|.++
T Consensus 81 ~~l~~~lp~L~~L~L~~N~I~~l-----~-------------------~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 81 EGLDKNLPNLQELYLSNNKISDL-----N-------------------ELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp HHHHHH-TT--EEE-TTS---SC-----C-------------------CCGGGGG-TT--EEE-TT-GGG
T ss_pred cchHHhCCcCCEEECcCCcCCCh-----H-------------------HhHHHHcCCCcceeeccCCccc
Confidence 333 2456666666666666521 1 1122344566777777777765
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.7e-11 Score=127.23 Aligned_cols=226 Identities=21% Similarity=0.254 Sum_probs=132.3
Q ss_pred cCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCcc---ccccCCc------
Q 001922 110 IGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY---FFGKIPN------ 180 (995)
Q Consensus 110 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~---l~~~~p~------ 180 (995)
+..+..++.|+||+|.|...-...+ -..+.+.++|+..++|+-- +...+|+
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i--------------------~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~ 85 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAI--------------------AKVLASKKELREVNLSDMFTGRLKDEIPEALKMLS 85 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHH--------------------HHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHH
Confidence 5667788888888888864322222 2334445566666665331 1123443
Q ss_pred -cccCCCCCceeeccCCcccccCcccc----cchhhhhhhhccccccccCCCCcccCCC-CcccEEECcCCCCCCccCcc
Q 001922 181 -SYGELQGLEYLSLAGNDLTGKIPGEL----GNLTNLREIYLGYYNVFEGGIPREVGKL-VNLVHLDLSSCELDGQIPHE 254 (995)
Q Consensus 181 -~l~~l~~L~~L~Ls~N~l~~~~~~~l----~~l~~L~~L~L~~n~~~~~~~p~~~~~l-~~L~~L~Ls~n~l~~~~~~~ 254 (995)
.+-..++|++||||+|.|....+..| .+++.|++|+|.+|.+-. ..=+.+ ..|.+|. .|+.
T Consensus 86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~----~ag~~l~~al~~l~--~~kk------- 152 (382)
T KOG1909|consen 86 KALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGP----EAGGRLGRALFELA--VNKK------- 152 (382)
T ss_pred HHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCCh----hHHHHHHHHHHHHH--HHhc-------
Confidence 34556799999999999985555444 456677777776554321 111110 1122222 1221
Q ss_pred ccCccccCccccccccccCC----CCccccCcCCCCeEeccCCcCcCc----CCccccccCCCCEEEccCCcCCCC----
Q 001922 255 IGNLKLLDTVFLHINLLSGS----IPKQLGNLTNLVNLDLSNNALTGE----IPYSFINLRQLKLFNLFMNRLHGS---- 322 (995)
Q Consensus 255 ~~~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~---- 322 (995)
.+.-+.|+.+..++|++... +...|...+.|+.+.++.|.|... +...|..+++|+.|||..|-++..
T Consensus 153 ~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~ 232 (382)
T KOG1909|consen 153 AASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVA 232 (382)
T ss_pred cCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHH
Confidence 23345677777777777632 223456667777777777776522 223456677777777777777633
Q ss_pred CCccccCCCCcceEEeccCcccccCCCccc-----CCCCCCeEEecCceec
Q 001922 323 IPDYLADLPNLETLGLWQNNFTGVIPENLG-----QNGKLQVLDLSSNKLT 368 (995)
Q Consensus 323 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~ 368 (995)
+...++.+++|+.|++++|.+.......|. ..++|++|.|.+|.|+
T Consensus 233 LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 233 LAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred HHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 234556677777777777777654433332 2467777777777765
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.8e-10 Score=138.96 Aligned_cols=125 Identities=29% Similarity=0.348 Sum_probs=56.1
Q ss_pred CCCCeEeccCCcccCccccCcccccceecccccc--ccCCCcccccccccccccccccccccccCCccccCCCCCceeec
Q 001922 92 DKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQ--FSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDL 169 (995)
Q Consensus 92 ~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~--i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L 169 (995)
...++..+-+|.+.....-...+.|+.|-+..|. +..+....|..++.|++|||++|.=-+.+|..++.|-+||+|+|
T Consensus 523 ~~~rr~s~~~~~~~~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L 602 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEHIAGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDL 602 (889)
T ss_pred hheeEEEEeccchhhccCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccc
Confidence 3444444444444332222223345555555553 33333333444445555555444333334444444555555555
Q ss_pred cCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhc
Q 001922 170 GGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYL 217 (995)
Q Consensus 170 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 217 (995)
++..+. .+|..+++|..|.+|++..+.-...+|.....+++|++|.+
T Consensus 603 ~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l 649 (889)
T KOG4658|consen 603 SDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRL 649 (889)
T ss_pred cCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEe
Confidence 554443 44444444445555554444433333444444444444444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.4e-10 Score=131.29 Aligned_cols=247 Identities=22% Similarity=0.198 Sum_probs=167.2
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecC--CCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLG--FGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.+.+-+-.|+++.++.++-. .|.-.+.|.... .-.....+....+-.+.-..++|.+++....+.-....++|++|
T Consensus 806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~ 885 (1205)
T KOG0606|consen 806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHY 885 (1205)
T ss_pred ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHH
Confidence 445567888999999887542 243334433211 11111122223333333334567777665555556778999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc----
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID---- 840 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~---- 840 (995)
..+++|...++.. +..+.+..+.....+..+.+|||.. .+.|||++|.|.+...++..+++|||......-
T Consensus 886 ~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 886 LNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hccCCchhhhhcC--CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 9999999999743 3455556667778899999999954 489999999999999999999999984332110
Q ss_pred --C-------------------CCC----ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC
Q 001922 841 --G-------------------GAS----ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGD 895 (995)
Q Consensus 841 --~-------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~ 895 (995)
. ... .......+|+.|.|||...+......+|+|+.|++++|.++|..||.+...
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 000 112245689999999999999999999999999999999999999965322
Q ss_pred CchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHH
Q 001922 896 GVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMR 952 (995)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 952 (995)
.+..+.+... +..+...+...+....+++.+.+..+|.+|-.+.
T Consensus 1041 ----q~~f~ni~~~---------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 ----QQIFENILNR---------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ----hhhhhccccC---------CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 1111111111 2223445666777888899999999999997655
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.3e-09 Score=133.34 Aligned_cols=206 Identities=24% Similarity=0.321 Sum_probs=136.8
Q ss_pred ccCcccccceeccccccccCCCccccccccccccccccccc--ccccCCccccCCCCCceeeccCccccccCCccccCCC
Q 001922 109 EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNN--FTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQ 186 (995)
Q Consensus 109 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~--i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 186 (995)
...+....++..+.+|.+..+.. . ...++|++|-+..|. +..+....|..++.|++|||++|.=-+.+|..+++|-
T Consensus 518 ~~~~~~~~rr~s~~~~~~~~~~~-~-~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li 595 (889)
T KOG4658|consen 518 QVKSWNSVRRMSLMNNKIEHIAG-S-SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELV 595 (889)
T ss_pred cccchhheeEEEEeccchhhccC-C-CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhh
Confidence 34555778888888888864432 2 234579999999996 6666666788999999999999987789999999999
Q ss_pred CCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCC--CccCccccCccccCcc
Q 001922 187 GLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELD--GQIPHEIGNLKLLDTV 264 (995)
Q Consensus 187 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~--~~~~~~~~~l~~L~~L 264 (995)
+|++|+|++..++ .+|..+++|++|.+|++..+..... +|.....|.+|++|.+..-... ...-..+.++..|+.+
T Consensus 596 ~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~-~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~l 673 (889)
T KOG4658|consen 596 HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLES-IPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENL 673 (889)
T ss_pred hhhcccccCCCcc-ccchHHHHHHhhheecccccccccc-ccchhhhcccccEEEeeccccccchhhHHhhhcccchhhh
Confidence 9999999999999 8899999999999999986655443 3666677999999998766422 1222233344444444
Q ss_pred ccccccccCCCCccccCcCCCC----eEeccCCcCcCcCCccccccCCCCEEEccCCcCCC
Q 001922 265 FLHINLLSGSIPKQLGNLTNLV----NLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG 321 (995)
Q Consensus 265 ~l~~N~l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 321 (995)
....... .+-..+..++.|. .+.+.++... ..+..+..+.+|+.|.+.++.+..
T Consensus 674 s~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 674 SITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred eeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence 4432222 0111122222222 2222222222 334455566666666666666653
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.1e-09 Score=79.11 Aligned_cols=41 Identities=39% Similarity=0.848 Sum_probs=30.6
Q ss_pred cchHHHHHHHHHhCC-CCCCCCCCCCCCCCCCCceeeeEEeC
Q 001922 26 VNDFHVLVALKQGFE-NPEPALISWNSSNPSSVCSWAGICCS 66 (995)
Q Consensus 26 ~~~~~~Ll~~k~~~~-~~~~~l~~W~~~~~~~~C~w~gv~C~ 66 (995)
.+|++||++||+++. +|.+.+.+|+.+...+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 469999999999998 57789999987633579999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=4e-08 Score=104.42 Aligned_cols=143 Identities=18% Similarity=0.130 Sum_probs=101.3
Q ss_pred CCeeeccCceEEEEEEeCCCcEEEEEEecCCCCC----------ChhHHHHHHHHHHhccCCCC--ceeEeEEEec----
Q 001922 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTH----------SHDHGFRAEIQTLGNIRHRN--IVRLLAFCSN---- 754 (995)
Q Consensus 691 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~---- 754 (995)
++.+-......|+++.. +|+.|.||+....... .....+.+|+..+.++...+ .+..+++++.
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 45566555566777766 6788999976322210 11224778999888884322 2233444432
Q ss_pred -CCcceEEEEeccCC-ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-------CC
Q 001922 755 -KETNLLVYEYMRNG-SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS-------AF 825 (995)
Q Consensus 755 -~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~-------~~ 825 (995)
....++|||++++. +|.+++........+...+..++.+++..+.-||+.| |+|+|++++|||++. +.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23468999999876 7998885322334566777889999999999999888 999999999999975 46
Q ss_pred CeEEeeeccccc
Q 001922 826 EAHVADFGLAKF 837 (995)
Q Consensus 826 ~vkl~DfGla~~ 837 (995)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 789999998864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.4e-07 Score=100.59 Aligned_cols=262 Identities=15% Similarity=0.189 Sum_probs=159.3
Q ss_pred ccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEE------EecC-Ccce
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAF------CSNK-ETNL 759 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~------~~~~-~~~~ 759 (995)
...++.+|+|+-+.+|-.-. -...+.|+++..... . -.+.+.++... .||-+-.-+.| ..+. ...-
T Consensus 13 i~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa---~-~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPA---A-QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred cCCCccccCCccceeeecch--hhchhheeecCCCch---H-HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 34678899999999997522 123466776432221 1 12233444444 46644331111 1112 2245
Q ss_pred EEEEeccCC-Chhhhhc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 760 LVYEYMRNG-SLGEALH----GKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 760 lv~e~~~~g-sL~~~l~----~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
+.|..+.+. .+..+.. ++.-...+|....+.++.++.+.+.||.+| .+-+|+.++|+|+++++.|.+.|-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccc
Confidence 777777653 2333332 123356789999999999999999999888 89999999999999999999988654
Q ss_pred ccccccCCCCccccccccCcccccccccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCC---chHHHHHHH
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTG-RRPVGDFGDG---VDIVQWSKR 905 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg-~~Pf~~~~~~---~~~~~~~~~ 905 (995)
-.....+ . ...-.+|...|++||.-. +..-+...|-|.+||++++++.| ++||...... ....+ ..
T Consensus 164 fqi~~ng-~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~ 238 (637)
T COG4248 164 FQINANG-T--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TD 238 (637)
T ss_pred eeeccCC-c--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hh
Confidence 3332211 1 112346889999999644 44556789999999999999985 9999764211 11000 00
Q ss_pred HhcCChhhhhhhcCCcC----CCCC-HHHHHHHHHHHhcccCCC--CCCCCCHHHHHHHHccCCCC
Q 001922 906 ATNGRKEEFLSILDPRL----SMVP-KEEAMHLLFVAMLCIQEN--SIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 906 ~~~~~~~~~~~~~d~~~----~~~~-~~~~~~l~~li~~cl~~d--P~~RPt~~evl~~L~~~~~~ 964 (995)
+..+......+ -.+.+ ...| ...+..+..+..+|+... |.-||+++..+..|.++.++
T Consensus 239 Ia~g~f~ya~~-~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 239 IAHGRFAYASD-QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hhcceeeechh-ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 11110000000 00011 1111 234456777788888654 45799999988887776553
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.5e-08 Score=105.07 Aligned_cols=168 Identities=17% Similarity=0.260 Sum_probs=125.9
Q ss_pred CceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec----CCcceEEEEeccC-CChh
Q 001922 698 GAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN----KETNLLVYEYMRN-GSLG 771 (995)
Q Consensus 698 ~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~~~~-gsL~ 771 (995)
-..+.|++.. .||..|+.|+++..+... ......-+++++++.|+|+|++.++|.. +...++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3467889854 589999999995433322 2123345889999999999999999863 3456899999875 5777
Q ss_pred hhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 772 EALHG-------------KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 772 ~~l~~-------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
++... ..+...++...|.++.|+..||.++|+.| ...+-+.+.+|+++.+.+++|+..|+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeee
Confidence 76532 12345778999999999999999999887 999999999999999999999988877654
Q ss_pred ccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 001922 839 IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRR 888 (995)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~ 888 (995)
.... . |.+ +--.+-|.-.||.++..+.||..
T Consensus 444 ~~d~--------------~--~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDP--------------T--EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCC--------------C--cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 3221 0 101 11245789999999999999865
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.2e-09 Score=85.56 Aligned_cols=60 Identities=37% Similarity=0.583 Sum_probs=32.3
Q ss_pred cccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcc
Q 001922 139 NLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDL 198 (995)
Q Consensus 139 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 198 (995)
+|++|++++|+|+.+.+..|.++++|++|++++|.++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 444555555555554445555555555555555555544555555555555555555543
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.4e-09 Score=84.23 Aligned_cols=61 Identities=38% Similarity=0.547 Sum_probs=52.0
Q ss_pred cccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccc
Q 001922 114 SSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYF 174 (995)
Q Consensus 114 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l 174 (995)
++|++|+|++|+|+.+.+..|.++++|++|++++|+|+.+.|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4688888888888888888888888888888888888888888888888888888888875
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.7e-08 Score=97.71 Aligned_cols=126 Identities=25% Similarity=0.289 Sum_probs=81.9
Q ss_pred EEEEEEeCCCcEEEEEEecCCC--------------C------CC-----hhHHHHHHHHHHhccCCC--CceeEeEEEe
Q 001922 701 IVYHGKMPNGVEIAVKKLLGFG--------------T------HS-----HDHGFRAEIQTLGNIRHR--NIVRLLAFCS 753 (995)
Q Consensus 701 ~V~~~~~~~~~~vavK~~~~~~--------------~------~~-----~~~~~~~E~~~l~~l~hp--niv~~~~~~~ 753 (995)
.||.|...+|..+|+|..+... . .. ......+|++.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999874210 0 00 012466799999999755 456666553
Q ss_pred cCCcceEEEEecc--CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCCEEECCCCCeEEe
Q 001922 754 NKETNLLVYEYMR--NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY-LHHDCSPLIVHRDVKSNNILLNSAFEAHVA 830 (995)
Q Consensus 754 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~~~~iiHrDlkp~Nill~~~~~vkl~ 830 (995)
..++||||++ |..+..+.... ++......++.+++..+.. +|..| |+|||+.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 4589999998 65555544311 1123345567788875555 57777 9999999999999988 99999
Q ss_pred eecccccc
Q 001922 831 DFGLAKFL 838 (995)
Q Consensus 831 DfGla~~~ 838 (995)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=9.8e-08 Score=97.35 Aligned_cols=137 Identities=21% Similarity=0.161 Sum_probs=98.1
Q ss_pred ccCCCeeeccCceEEEEEEeCCCcEEEEEEecCC----------C------C-----CChhHHHHHHHHHHhccCCC--C
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGF----------G------T-----HSHDHGFRAEIQTLGNIRHR--N 744 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~----------~------~-----~~~~~~~~~E~~~l~~l~hp--n 744 (995)
..++..||-|--+.||.|..+.|.++|||.-.-. . . ...+...++|+++|+++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3467899999999999999999999999963211 0 0 11123467899999998643 5
Q ss_pred ceeEeEEEecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC
Q 001922 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA 824 (995)
Q Consensus 745 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~ 824 (995)
+.+.+++ +...+||||++|-.|...-- +....-.++..|++-+.-+-..| |||+|+.+-||+++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 5666554 45589999999977765431 12223334455555555555566 9999999999999999
Q ss_pred CCeEEeeecccccc
Q 001922 825 FEAHVADFGLAKFL 838 (995)
Q Consensus 825 ~~vkl~DfGla~~~ 838 (995)
|.+.++||-.+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999877643
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=6.3e-09 Score=93.66 Aligned_cols=104 Identities=25% Similarity=0.319 Sum_probs=62.7
Q ss_pred CCcEEEcCCCcccccCCccc---cCCCCCcEEEcCCCcccCCCCCCcc-chhhhccccccccccCCCCCCccCcccccce
Q 001922 455 RLGQLNLSNNLLSGPLPFSL---SNFSSLQILLLSGNQFSGPIPPSIG-ELRQVLKLDLSRNSLSGEIPPAIGYCNHLTY 530 (995)
Q Consensus 455 ~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 530 (995)
.+..++||+|++- .+++.. .....|+..+|++|.+. ..|+.|. ..+-++.|+|++|.|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3456677777664 344433 33344555677777776 3444443 3345666666666666 56666666666666
Q ss_pred eeccCCcccCCCccccccccccCeEecccccc
Q 001922 531 LDMSQNNLSGSIPPEISNVRILNYLNLSRNHL 562 (995)
Q Consensus 531 L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l 562 (995)
|+++.|.|. ..|..+..|.+|-+|+..+|.+
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~ 135 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENAR 135 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCcc
Confidence 666666665 5566666666666666666665
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.3e-09 Score=118.39 Aligned_cols=127 Identities=28% Similarity=0.265 Sum_probs=66.6
Q ss_pred cccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEcc
Q 001922 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLF 315 (995)
Q Consensus 236 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 315 (995)
.|...+.+.|.+. ....++.-++.|+.|+|++|+++.. +.+..+++|++|||++|.+..+.--...++. |..|++.
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 4566666666665 4455555566666666666666532 2556666666666666666632222222222 5566666
Q ss_pred CCcCCCCCCccccCCCCcceEEeccCcccccC-CCcccCCCCCCeEEecCceec
Q 001922 316 MNRLHGSIPDYLADLPNLETLGLWQNNFTGVI-PENLGQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 316 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 368 (995)
+|.++. + ..+.+|.+|+.|||++|-|.+.- -..++.+..|+.|+|.+|.+-
T Consensus 241 nN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 665542 1 22445555555666665554311 011333445555555555543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=6.6e-08 Score=110.13 Aligned_cols=150 Identities=20% Similarity=0.293 Sum_probs=103.4
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc-------cccccCccccccccccc
Q 001922 792 IEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM-------SAIAGSYGYIAPEYAYT 864 (995)
Q Consensus 792 ~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~ 864 (995)
.+++.|+.|+|. +.++||+.|.|++|.++..+..||+.|+++.....+...... .-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 355699999997 557999999999999999999999999987654332111110 11224568999999998
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCC-CCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCC
Q 001922 865 LRVDEKSDVYSFGVVLLELLTGRRP-VGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQE 943 (995)
Q Consensus 865 ~~~~~~~DvwSlGvil~elltg~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~ 943 (995)
...+.++|+||+|+.+|.+..|..+ +...+.. ....... ...+-....+..+.+.++.+=+.+++..
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~-----------~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSR-----------NLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhh-----------cccccccccccccCcHHHHHHHHHHhcC
Confidence 8889999999999999999954444 4322111 1111000 0011111223456677788889999999
Q ss_pred CCCCCCCHHHHH
Q 001922 944 NSIERPRMREVV 955 (995)
Q Consensus 944 dP~~RPt~~evl 955 (995)
++..||++.++.
T Consensus 252 ~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 252 DSAVRPTLDLLL 263 (700)
T ss_pred CcccCcchhhhh
Confidence 999999777664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.5e-06 Score=89.47 Aligned_cols=106 Identities=20% Similarity=0.254 Sum_probs=81.8
Q ss_pred hHHHHHHHHHHhccCCC--CceeEeEEEecC----CcceEEEEeccCC-ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 001922 727 DHGFRAEIQTLGNIRHR--NIVRLLAFCSNK----ETNLLVYEYMRNG-SLGEALHGKKGAFLGWNLRYKIAIEAAKGLC 799 (995)
Q Consensus 727 ~~~~~~E~~~l~~l~hp--niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~ 799 (995)
..+..+|...+.++..- .+...+++.+.. ...++|+|++++. +|.+++..... .+......++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 45678898888887532 234455555432 2348999999874 79998864222 556677889999999999
Q ss_pred HHHhcCCCCeEecCCCCCCEEECCCC---CeEEeeeccccc
Q 001922 800 YLHHDCSPLIVHRDVKSNNILLNSAF---EAHVADFGLAKF 837 (995)
Q Consensus 800 ~LH~~~~~~iiHrDlkp~Nill~~~~---~vkl~DfGla~~ 837 (995)
-||+.| |+|+|+++.|||++.++ .+.++||+-++.
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999888 99999999999999887 899999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.5e-06 Score=84.52 Aligned_cols=138 Identities=16% Similarity=0.099 Sum_probs=102.0
Q ss_pred eccCceEEEEEEeCCCcEEEEEEecCCC--C---CChhHHHHHHHHHHhccCCC--CceeEeEEEe---cC--CcceEEE
Q 001922 695 GRGGAGIVYHGKMPNGVEIAVKKLLGFG--T---HSHDHGFRAEIQTLGNIRHR--NIVRLLAFCS---NK--ETNLLVY 762 (995)
Q Consensus 695 G~G~~g~V~~~~~~~~~~vavK~~~~~~--~---~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~---~~--~~~~lv~ 762 (995)
|.||-+-|++... +|..+-+|+-.... . +.....|.+|+..++++..- .+.+.. ++. .+ ...+||+
T Consensus 27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 6788888999876 45578898763111 1 33567799999999999532 234444 332 11 2347999
Q ss_pred EeccC-CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC--eEEeeeccccc
Q 001922 763 EYMRN-GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE--AHVADFGLAKF 837 (995)
Q Consensus 763 e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~--vkl~DfGla~~ 837 (995)
|-+.+ -+|.+++....-...+...+..+..+++..++-||+.| +.|+|+.+.||+++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 58888886544445677778899999999999999888 999999999999987777 99999987764
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.7e-08 Score=113.78 Aligned_cols=125 Identities=29% Similarity=0.290 Sum_probs=71.6
Q ss_pred cceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCcc-ccCCCCCceeecc
Q 001922 116 LQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNS-YGELQGLEYLSLA 194 (995)
Q Consensus 116 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls 194 (995)
|..-+.+.|++. ..+.++.-++.|+.|||++|+++.. ..+..|++|++|||++|.+. .+|.. ..++ .|+.|.|+
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeeec
Confidence 445555556554 3445556667777777777777664 36667777777777777775 44431 1222 37777777
Q ss_pred CCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCC
Q 001922 195 GNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCEL 247 (995)
Q Consensus 195 ~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l 247 (995)
+|.++.. ..+.+|++|+.||+++|-+..-.--..++.|..|+.|.|.+|.+
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 7776632 24556666666666654443322222344455556666666655
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.5e-06 Score=98.25 Aligned_cols=153 Identities=18% Similarity=0.190 Sum_probs=98.8
Q ss_pred cHHHHHhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCC-------------------------hh----H--
Q 001922 680 SVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHS-------------------------HD----H-- 728 (995)
Q Consensus 680 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------~~----~-- 728 (995)
.++++...|+. +.|+.++=|.||+|+.++|++||||+.++..... .. +
T Consensus 120 ~iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~ 198 (517)
T COG0661 120 PIEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEF 198 (517)
T ss_pred CHHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHH
Confidence 45566666653 7899999999999999999999999975321110 00 0
Q ss_pred --------HHHHHHHHHhccC-----CCCceeEeEEEecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHH
Q 001922 729 --------GFRAEIQTLGNIR-----HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAA 795 (995)
Q Consensus 729 --------~~~~E~~~l~~l~-----hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~ 795 (995)
++.+|..-+.+++ .|.+.-..-+++-....+++|||++|-.+.+...-.. ...+.........++.
T Consensus 199 ~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f 277 (517)
T COG0661 199 EKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF 277 (517)
T ss_pred HHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH
Confidence 1333555454442 2333322333344566789999999999998853222 3344322222222221
Q ss_pred HHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 796 KGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 796 ~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+..+-..| ++|.|..|.||+++.+|.+.+.|||+...+.
T Consensus 278 --~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 278 --LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred --HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 12222345 9999999999999999999999999987654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 995 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-57 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-57 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-53 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-35 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-33 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-21 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-20 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 7e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 3e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-06 | ||
| 3t6q_A | 606 | Crystal Structure Of Mouse Rp105MD-1 Complex Length | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 5e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-06 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 5e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-06 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 9e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-05 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-05 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 1e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-04 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 2e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 558 bits (1440), Expect = 0.0
Identities = 183/566 (32%), Positives = 275/566 (48%), Gaps = 16/566 (2%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGG 129
LD++ N +P + L +L ++GN +G I + L+ LNIS+NQF G
Sbjct: 204 FLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262
Query: 130 LDWNYSSLVNLEVFDAYNNNFTALLPVGIL-KLEKLKYLDLGGNYFFGKIPNSYGELQGL 188
+ L +L+ N FT +P + + L LDL GN+F+G +P +G L
Sbjct: 263 IPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320
Query: 189 EYLSLAGNDLTGKIPGE-LGNLTNLREIYLGYYNVFEGGIPREVGKL-VNLVHLDLSSCE 246
E L+L+ N+ +G++P + L + L+ + L + N F G +P + L +L+ LDLSS
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSF-NEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 247 LDGQIPHEIGNLKL--LDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFI 304
G I + L ++L N +G IP L N + LV+L LS N L+G IP S
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 305 NLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSS 364
+L +L+ L++N L G IP L + LETL L N+ TG IP L L + LS+
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 365 NKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFI 424
N+LTG IP + L IL L N G IP LG C SL + L N NG+IP
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 559
Query: 425 YLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILL 484
G + +N+++G + + G L+ S+
Sbjct: 560 KQSGK----IAANFIAGKRYVYIKNDGMKKEC-HGAGNLLEFQGIRSEQLNRLSTRNPCN 614
Query: 485 LSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPP 544
++ + G P+ ++ LD+S N LSG IP IG +L L++ N++SGSIP
Sbjct: 615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674
Query: 545 EISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSF 604
E+ ++R LN L+LS N L+ IP+++ ++ LT D S N+ SG +PE GQF F + F
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKF 734
Query: 605 AGNPQLCGTLLNNPCNVAPITHQPGK 630
NP LCG L + +
Sbjct: 735 LNNPGLCGYPLPRCDPSNADGYAHHQ 760
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 480 bits (1238), Expect = e-156
Identities = 179/590 (30%), Positives = 272/590 (46%), Gaps = 33/590 (5%)
Query: 20 SSAASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSRDRVASLDLTDLN 79
S + SL + H L++ K + L W+S+ + C++ G+ C D+V S+DL+
Sbjct: 5 SPSQSLYREIHQLISFKDVLPDK-NLLPDWSSN--KNPCTFDGVTCRDDKVTSIDLSSKP 61
Query: 80 L---CGSVPAQILRLDKLTNLSLAGNNFTGSI-EIGNLSSLQFLNISNNQFSGGLDWNYS 135
L +V + +L L L +L L+ ++ GS+ +SL L++S N SG + S
Sbjct: 62 LNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 136 --SLVNLEVFDAYNNNFTALLPV-GILKLEKLKYLDLGGNYFFGKIPNSY---GELQGLE 189
S L+ + +N V G LKL L+ LDL N G + L+
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181
Query: 190 YLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDG 249
+L+++GN ++G + + NL + + N F GIP +G L HLD+S +L G
Sbjct: 182 HLAISGNKISGDVD--VSRCVNLEFLDV-SSNNFSTGIP-FLGDCSALQHLDISGNKLSG 237
Query: 250 QIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFI-NLRQ 308
I L + + N G IP L +L L L+ N TGEIP
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDT 295
Query: 309 LKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIP-ENLGQNGKLQVLDLSSNKL 367
L +L N +G++P + LE+L L NNF+G +P + L + L+VLDLS N+
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355
Query: 368 TGTIPTDLCS-SNQLRILILLKNFLFGPIPERLGACY--SLTRVRLGQNYLNGSIPDGFI 424
+G +P L + S L L L N GPI L +L + L N G IP
Sbjct: 356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415
Query: 425 YLPGLNLAELQSNYLSGSLPEN-GNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQIL 483
L L NYLSG++P + G+ S L L L N+L G +P L +L+ L
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSK----LRDLKLWLNMLEGEIPQELMYVKTLETL 471
Query: 484 LLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIP 543
+L N +G IP + + + LS N L+GEIP IG +L L +S N+ SG+IP
Sbjct: 472 ILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531
Query: 544 PEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPES 593
E+ + R L +L+L+ N N IP ++ + N +GK
Sbjct: 532 AELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI----AANFIAGKRYVY 577
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-22
Identities = 51/238 (21%), Positives = 69/238 (28%), Gaps = 99/238 (41%)
Query: 65 CSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNIS 122
+ L G Q+ RL ++ + G N S+ FL++S
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 123 NNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSY 182
N S G IP
Sbjct: 641 YNMLS------------------------------------------------GYIPKEI 652
Query: 183 GELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDL 242
G + L L+L ND++G IP E+G+L L LDL
Sbjct: 653 GSMPYLFILNLGHNDISGSIPDEVGDLR-------------------------GLNILDL 687
Query: 243 SSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIP 300
SS N L G IP+ + LT L +DLSNN L+G IP
Sbjct: 688 SS------------------------NKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 346 bits (891), Expect = e-111
Identities = 115/275 (41%), Positives = 167/275 (60%), Gaps = 12/275 (4%)
Query: 692 NVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAF 751
N++GRGG G VY G++ +G +AVK+L T + F+ E++ + HRN++RL F
Sbjct: 36 NILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95
Query: 752 CSNKETNLLVYEYMRNGSLGEALHGKKGA--FLGWNLRYKIAIEAAKGLCYLHHDCSPLI 809
C LLVY YM NGS+ L + + L W R +IA+ +A+GL YLH C P I
Sbjct: 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 810 VHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDE 869
+HRDVK+ NILL+ FEA V DFGLAK L+D + +A+ G+ G+IAPEY T + E
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 214
Query: 870 KSDVYSFGVVLLELLTGRRPVGDFG-----DGVDIVQWSKRATNGRKEEFLSILDPRL-S 923
K+DV+ +GV+LLEL+TG+R D D V ++ W K ++++ +++D L
Sbjct: 215 KTDVFGYGVMLLELITGQRAF-DLARLANDDDVMLLDWVKGLL--KEKKLEALVDVDLQG 271
Query: 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQML 958
EE L+ VA+LC Q + +ERP+M EVV+ML
Sbjct: 272 NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 328 bits (843), Expect = e-104
Identities = 103/315 (32%), Positives = 156/315 (49%), Gaps = 20/315 (6%)
Query: 657 KAKSFKKTGSDSWKMTAFQKLEFSVSDILECVK---DGNVIGRGGAGIVYHGKMPNGVEI 713
KA + S + F+ + D+ E +IG G G VY G + +G ++
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 714 AVKKLLGFGTHSHDHG---FRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSL 770
A+K+ T G F EI+TL RH ++V L+ FC + +L+Y+YM NG+L
Sbjct: 67 ALKRR----TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 771 GEALHGKKGAF--LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH 828
L+G + W R +I I AA+GL YLH I+HRDVKS NILL+ F
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 829 VADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRR 888
+ DFG++K + + + + G+ GYI PEY R+ EKSDVYSFGVVL E+L R
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 889 PV--GDFGDGVDIVQWSKRATNGRKEEFLSILDPRL-SMVPKEEAMHLLFVAMLCIQENS 945
+ + V++ +W+ + + I+DP L + E A+ C+ +S
Sbjct: 240 AIVQSLPREMVNLAEWAVESH--NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 946 IERPRMREVVQMLSE 960
+RP M +V+ L
Sbjct: 298 EDRPSMGDVLWKLEY 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-102
Identities = 97/274 (35%), Positives = 147/274 (53%), Gaps = 10/274 (3%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHG---FRAEIQTLGNIRHRNIVR 747
GN +G GG G+VY G + N +AVKKL + + F EI+ + +H N+V
Sbjct: 36 GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKG-AFLGWNLRYKIAIEAAKGLCYLHHDCS 806
LL F S+ + LVY YM NGSL + L G L W++R KIA AA G+ +LH +
Sbjct: 95 LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH- 153
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
+HRD+KS NILL+ AF A ++DFGLA+ + S I G+ Y+APE
Sbjct: 154 --HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGE 210
Query: 867 VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926
+ KSD+YSFGVVLLE++TG V + + ++ + + ++ +D +++
Sbjct: 211 ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIED-EEKTIEDYIDKKMNDAD 269
Query: 927 KEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
+ VA C+ E +RP +++V Q+L E
Sbjct: 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = 2e-97
Identities = 105/611 (17%), Positives = 188/611 (30%), Gaps = 82/611 (13%)
Query: 18 NLSSAASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSRDRVASLDLTD 77
LS A + D+ L + S +W +
Sbjct: 21 KLSRTAEYIKDYLALKEIWDALNGKN---WSQQGFGTQPGANWN------------FNKE 65
Query: 78 LNLCGSVP-AQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDW-- 132
L++ G+ P + ++T LSL G +G + IG L+ L+ L + ++
Sbjct: 66 LDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG 125
Query: 133 --NYSSLVNLEVFDAYNNNFTALLPVGI--LKLEKLKYLDLGGNYFFGKIPNSYGELQGL 188
S+ ++ E ++ L + + I S
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185
Query: 189 EYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELD 248
+ N++T + + LT LR+ Y+ + F E + N +
Sbjct: 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYM-GNSPFVAENICEAWENENSEYAQQY----- 238
Query: 249 GQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALT--------GEIP 300
+ NLK L V ++ +P L L + ++++ N +
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 301 YSFINLRQLKLFNLFMNRL-HGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQV 359
++++ + N L + L + L L N G +P G KL
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLAS 357
Query: 360 LDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGA--CYSLTRVRLGQNYLNG 417
L+L+ N++T + Q+ L N L IP A ++ + N +
Sbjct: 358 LNLAYNQITEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGS 416
Query: 418 SIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNF 477
F L P + + +NLSNN +S S
Sbjct: 417 VDGKNFDPLD----------------PTPFKGIN----VSSINLSNNQISKFPKELFSTG 456
Query: 478 SSLQILLLSGNQFSG-------PIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCN--HL 528
S L + L GN + + + +DL N L+ + +L
Sbjct: 457 SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYL 515
Query: 529 TYLDMSQNNLSGSIPPEISNVR------ILNYLNLSRNHLNQNIPKSIGSMKSLTIADFS 582
+D+S N+ S P + N I N + N + P+ I SLT
Sbjct: 516 VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574
Query: 583 FNDFSGKLPES 593
ND + E
Sbjct: 575 SNDIRK-VNEK 584
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 4e-67
Identities = 74/472 (15%), Positives = 150/472 (31%), Gaps = 62/472 (13%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLD 131
+ N+ V ++RL KL + + F + + N Q D
Sbjct: 187 QIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAEN---ICEAWENENSEYAQQYKTED 242
Query: 132 WNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYF--------FGKIPNSYG 183
+ +L +L + YN LP + L +++ +++ N +
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302
Query: 184 ELQGLEYLSLAGNDL-TGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDL 242
+ ++ + + N+L T + L + L + YN EG +P G + L L+L
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC-LYNQLEGKLP-AFGSEIKLASLNL 360
Query: 243 SSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPK--QLGNLTNLVNLDLSNNALTG--- 297
+ ++ + G + ++ + N L IP +++ + +D S N +
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
Query: 298 ----EIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGV------- 346
+ + + NL N++ + + L ++ L N T +
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 347 IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSN--QLRILILLKNFLFGPIPERLGACYS 404
EN L +DL NKLT + D ++ L + L N P + +
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSST 537
Query: 405 LTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPEN-GNSSSNPDRLGQLNLSN 463
L + Q N PE S L QL + +
Sbjct: 538 LKGFGIRNQRD------------------AQGNRTLREWPEGITLCPS----LTQLQIGS 575
Query: 464 NLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLS 515
N + + + ++ +L + N + + L +
Sbjct: 576 NDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-40
Identities = 34/342 (9%), Positives = 89/342 (26%), Gaps = 64/342 (18%)
Query: 267 HINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDY 326
+++ L + + L L +G +P + L +L++ L + + +
Sbjct: 65 ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124
Query: 327 LADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSN--QLRIL 384
P+ + N + T + L
Sbjct: 125 --------------------GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD 164
Query: 385 ILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLP 444
+ + I + T++ N + + + L +L+
Sbjct: 165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAV-----MRLTKLR--------- 209
Query: 445 ENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQV 504
Q + N+ + + L+ +
Sbjct: 210 -------------QFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKDL 251
Query: 505 LKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNL--------SGSIPPEISNVRILNYLN 556
+++ ++P + + ++++ N + + +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 557 LSRNHLNQ-NIPKSIGSMKSLTIADFSFNDFSGKLPESGQFT 597
+ N+L + S+ MK L + + +N GKLP G
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEI 353
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 8e-89
Identities = 101/514 (19%), Positives = 172/514 (33%), Gaps = 22/514 (4%)
Query: 94 LTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTAL 153
+ T + +++ LN+++NQ N++ L D N + L
Sbjct: 6 HEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKL 64
Query: 154 LPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLR 213
P KL LK L+L N ++ L L L N + NL
Sbjct: 65 EPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLI 124
Query: 214 EIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKL--LDTVFLHINLL 271
+ L +N +L NL L LS+ ++ E+ L + L N +
Sbjct: 125 TLDLS-HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
Query: 272 SGSIPKQLGNLTNLVNLDLSNNALTGEIPYSF---INLRQLKLFNLFMNRLHGSIPDYLA 328
P + L L L+N L + + ++ +L ++L +
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243
Query: 329 DL--PNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILIL 386
L NL L L NN V ++ +L+ L N + L +R L L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 387 LKNF---------LFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSN 437
++F L L + + N + G + F L L L ++
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 438 YLSGSLPENGNSSSNPDR-LGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPP 496
+ S N S L LNL+ N +S + S L++L L N+ +
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
Query: 497 S-IGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSG--SIPPEISNVRILN 553
L + ++ LS N + L L + + L S P +R L
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483
Query: 554 YLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFS 587
L+LS N++ + ++ L I D N+ +
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 3e-86
Identities = 123/576 (21%), Positives = 195/576 (33%), Gaps = 34/576 (5%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE--IGNLSSLQFLNISNNQFSGG 129
L+L L LT L L N+ +L L++S+N S
Sbjct: 77 VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 130 LDWNYSSLVNLEVFDAYNNNFTALLP--VGILKLEKLKYLDLGGNYFFGKIPNSYGELQG 187
L NL+ NN AL + I LK L+L N P + +
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196
Query: 188 LEYLSLAGNDLTGKIPGELG---NLTNLREIYLGYYNVFEGGIPREVG--KLVNLVHLDL 242
L L L L + +L T++R + L + K NL LDL
Sbjct: 197 LFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLS-NSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 243 SSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNN--------- 293
S L+ L L+ FL N + L L N+ L+L +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 294 ALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLG- 352
+L +SF L+ L+ N+ N + G + L NL+ L L + + N
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 353 ---QNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPER-LGACYSLTRV 408
+ L +L+L+ NK++ L +L L N + + + ++ +
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435
Query: 409 RLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSG 468
L N + F +P L L+ L + + + L L+LSNN ++
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN-VDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 469 PLPFSLSNFSSLQILLLSGNQFS--------GPIPPSIGELRQVLKLDLSRNSLSGEIPP 520
L L+IL L N + G + L + L+L N
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 521 AIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIG-SMKSLTIA 579
L +D+ NNL+ +N L LNL +N + K G + ++LT
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614
Query: 580 DFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLL 615
D FN F F + + P+L L
Sbjct: 615 DMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYL 650
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 4e-83
Identities = 94/478 (19%), Positives = 154/478 (32%), Gaps = 22/478 (4%)
Query: 138 VNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGND 197
V+ EV D + T +P + + L+L N ++ L L + N
Sbjct: 4 VSHEVADCSHLKLTQ-VPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 198 LTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGN 257
++ P L L+ + L +N + NL L L S + +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQ-HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 258 LKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSF--INLRQLKLFNLF 315
K L T+ L N LS + L NL L LSNN + LK L
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 316 MNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLG---QNGKLQVLDLSSNKLTGTIP 372
N++ P + L L L + E L N ++ L LS+++L+ T
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
Query: 373 TDL--CSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLN 430
T L +L L N L + L L N + L +
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR 299
Query: 431 LAELQSNYLSGSLPENGNSSSNPD------RLGQLNLSNNLLSGPLPFSLSNFSSLQILL 484
L+ ++ S+ + L LN+ +N + G + +L+ L
Sbjct: 300 YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLS 359
Query: 485 LSGNQFSGPIPPSIG----ELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSG 540
LS + S + + L+L++N +S A + HL LD+ N +
Sbjct: 360 LSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQ 419
Query: 541 SIPP-EISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFT 597
+ E + + + LS N Q S + SL F
Sbjct: 420 ELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-53
Identities = 64/333 (19%), Positives = 112/333 (33%), Gaps = 10/333 (3%)
Query: 283 TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNN 342
+ D S+ LT ++P + + NL N+L L +L + N
Sbjct: 4 VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 343 FTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGAC 402
+ + PE + L+VL+L N+L+ L L L+ N +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 403 YSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLS 462
+L + L N L+ + + L L L +N + L L +L LS
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA-LKSEELDIFANSSLKKLELS 179
Query: 463 NNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGE---LRQVLKLDLSRNSLSGEIP 519
+N + P L L L+ Q + + + L LS + LS
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
Query: 520 PAIGYCN--HLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLT 577
+LT LD+S NNL+ + + L Y L N++ S+ + ++
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR 299
Query: 578 IADFSFNDFSGKLPESGQFTVFNASSFAGNPQL 610
+ + + + SF L
Sbjct: 300 YLNLKRSFTKQSI-SLASLPKIDDFSFQWLKCL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 4e-48
Identities = 81/395 (20%), Positives = 138/395 (34%), Gaps = 35/395 (8%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLD 131
L N+ + L + L+L + SI + +L + +
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQW-------- 327
Query: 132 WNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYG----ELQG 187
L LE + +N+ + L LKYL L ++ + +
Sbjct: 328 -----LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382
Query: 188 LEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLSSCE 246
L L+L N ++ L +L + LG N + + L N+ + LS +
Sbjct: 383 LHILNLTKNKISKIESDAFSWLGHLEVLDLG-LNEIGQELTGQEWRGLENIFEIYLSYNK 441
Query: 247 LDGQIPHEIGNLKLLDTVFLHINLLSG--SIPKQLGNLTNLVNLDLSNNALTGEIPYSFI 304
+ + L + L L S P L NL LDLSNN +
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501
Query: 305 NLRQLKLFNLFMNRLH--------GSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGK 356
L +L++ +L N L G +L L +L L L N F + E +
Sbjct: 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561
Query: 357 LQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACY-SLTRVRLGQNYL 415
L+++DL N L + + L+ L L KN + + G + +LT + + N
Sbjct: 562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
Query: 416 NGSIPD-----GFIYLPGLNLAELQSNYLSGSLPE 445
+ + +I N+ EL S+YL + P
Sbjct: 622 DCTCESIAWFVNWINETHTNIPELSSHYLCNTPPH 656
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-35
Identities = 55/336 (16%), Positives = 108/336 (32%), Gaps = 44/336 (13%)
Query: 47 ISWNSSNPSSVCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTG 106
+S + ++ ++ + + + + L+LT + L L L L N
Sbjct: 360 LSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQ 419
Query: 107 SI---EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEK 163
+ E L ++ + +S N++ L +
Sbjct: 420 ELTGQEWRGLENIFEIYLSYNKYLQ------------------------LTRNSFALVPS 455
Query: 164 LKYLDLGGNYF--FGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGY-- 219
L+ L L P+ + L+ L L L+ N++ L L L + L +
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515
Query: 220 -----YNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGS 274
+ GG + L +L L+L S D +L L + L +N L+
Sbjct: 516 LARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575
Query: 275 IPKQLGNLTNLVNLDLSNNALTGEIPYSF-INLRQLKLFNLFMNRLHGSIPDYLA----- 328
N +L +L+L N +T F R L ++ N +
Sbjct: 576 PASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWI 635
Query: 329 DLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSS 364
+ + L +++ P + +++ D SS
Sbjct: 636 NETHTNIPELS-SHYLCNTPPHY-HGFPVRLFDTSS 669
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 3e-84
Identities = 101/620 (16%), Positives = 194/620 (31%), Gaps = 71/620 (11%)
Query: 18 NLSSAASLVNDFHVLVALKQ-----------GFENPEPALISWNSSNPSSVCSWAGI--- 63
L A + D+ L A+ + G N ++WN + + W
Sbjct: 260 QLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNK--ELDMWGDQPGV 317
Query: 64 -CCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNIS 122
+ RV L L G VP I +L +L LS ++ T S + L
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377
Query: 123 NNQFSGGLDWNY------SSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY-FF 175
+ + + L ++ N + P+ LK +G
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437
Query: 176 GKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLV 235
I + L L+ + A + T N Y L
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD------YAKQYENEELSWSNLK 491
Query: 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSG---------SIPKQLGNLTNLV 286
+L ++L +C Q+P + +L L ++ + N + +
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551
Query: 287 NLDLSNNALTGEIPYSFI-NLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTG 345
+ N L + + + +L L + N++ + L L L N
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEE 609
Query: 346 VIPENLGQN-GKLQVLDLSSNKLTGTIPTDLCSSN--QLRILILLKNFLFGPIPERLGA- 401
IPE+ +++ L S NKL IP + + + + N + G +
Sbjct: 610 -IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKI-GSEGRNISCS 666
Query: 402 -----CYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPD-- 454
+ + V L N + + F ++ L +N ++ S+PEN + +
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYK 725
Query: 455 ---RLGQLNLSNNLLSG-PLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLS 510
L ++L N L+ F + L + +S N FS P Q+ +
Sbjct: 726 NTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIR 784
Query: 511 R------NSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQ 564
N + + P I C L L + N++ + +++ L L+++ N
Sbjct: 785 HQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTP--QLYILDIADNPNIS 841
Query: 565 NIPKSIGSMKSLTIADFSFN 584
S+ + ++
Sbjct: 842 IDVTSVCPYIEAGMYVLLYD 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 5e-66
Identities = 83/513 (16%), Positives = 171/513 (33%), Gaps = 48/513 (9%)
Query: 113 LSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGN 172
+ + L+ N ++ G N +N F+ + + V + ++ L L G
Sbjct: 275 KAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGF 333
Query: 173 YFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVG 232
G++P++ G+L L+ LS + T + + +
Sbjct: 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLD 393
Query: 233 KLVNLVHLDLSSCEL-----DGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVN 287
L DL + I + + L DT ++ I K + LT L
Sbjct: 394 YDQRLNLSDLLQDAINRNPEMKPIKKDSR-ISLKDTQIGNLTNRITFISKAIQRLTKLQI 452
Query: 288 LDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVI 347
+ +N+ T + + N + + + ++L +L + L+ +
Sbjct: 453 IYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507
Query: 348 PENLGQNGKLQVLDLSSNKLTG---------TIPTDLCSSNQLRILILLKNFLFG-PIPE 397
P+ L +LQ L+++ N+ + D + +++I + N L P
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567
Query: 398 RLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPEN-GNSSSNPDRL 456
L L + N + + F L +L N + +PE+ + +
Sbjct: 568 SLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQ---V 621
Query: 457 GQLNLSNNLLSG-PLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLK------LDL 509
L S+N L P F+ + + + S N+ +I K + L
Sbjct: 622 EGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTL 680
Query: 510 SRNSLSGEIPPAIGYCNHLTYLDMSQNNLS-------GSIPPEISNVRILNYLNLSRNHL 562
S N + + ++ + +S N ++ N +L ++L N L
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
Query: 563 NQNIPKSI--GSMKSLTIADFSFNDFSGKLPES 593
++ ++ L+ D S+N FS P
Sbjct: 741 -TSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ 771
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-52
Identities = 87/541 (16%), Positives = 164/541 (30%), Gaps = 97/541 (17%)
Query: 8 TLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSR 67
T+ L L+ S + + K+ F + + L + + + +
Sbjct: 360 TVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419
Query: 68 DRVASLDLTDL----NLCGSVPAQILRLDKLTNLSLAGNNFTGSI--------------- 108
D SL T + N + I RL KL + A + FT
Sbjct: 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQ 479
Query: 109 ------EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTAL--------- 153
NL L + + N L L L+ + N +
Sbjct: 480 YENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539
Query: 154 LPVGILKLEKLKYLDLGGNYFFGKIPNSY--GELQGLEYLSLAGNDLTGKIPGELGNLTN 211
L K++ +G N P S ++ L L N + + G
Sbjct: 540 LADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVK 596
Query: 212 LREIYLGYYNVFEGGIPREVGK-LVNLVHLDLSSCELDGQIPH--EIGNLKLLDTVFLHI 268
L ++ L Y N E IP + + L S +L IP+ ++ ++ +V
Sbjct: 597 LTDLKLDY-NQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSY 653
Query: 269 NLLSG-----SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRL---- 319
N + S N + LS N + F + L N +
Sbjct: 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIP 713
Query: 320 ---HGSIPDYLADLPNLETLGLWQNNFTGVIPE-NLGQNGKLQVLDLSSNKLTGTIPTDL 375
+ L T+ L N T + + L +D+S N + + PT
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQP 772
Query: 376 CSSNQLRILILLK------NFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGL 429
+S+QL+ + N + P + C SL ++++G N + + +
Sbjct: 773 LNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL------ 825
Query: 430 NLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNN-LLSGPLPFSLSNFSSLQILLLSGN 488
+L L++++N +S + S+ + + +L +
Sbjct: 826 -----------------------TPQLYILDIADNPNISIDVT-SVCPYIEAGMYVLLYD 861
Query: 489 Q 489
+
Sbjct: 862 K 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-46
Identities = 65/404 (16%), Positives = 118/404 (29%), Gaps = 54/404 (13%)
Query: 197 DLTGKIPG-ELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEI 255
D+ G PG +L N + + L + +G +P +G+L L L +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFG-AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367
Query: 256 GNLKLLDTVFLHINLLSGSIPK-QLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNL 314
D + + K L L DL +A+ +++ +L
Sbjct: 368 DEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISL 425
Query: 315 FMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTD 374
++ N I + + + KLQ++ +++ T
Sbjct: 426 KDTQIGNL------------------TNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV 467
Query: 375 LCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAEL 434
+ LT V L +PD LP L +
Sbjct: 468 D-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNI 522
Query: 435 QSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSG-P 493
N + + + L +QI + N P
Sbjct: 523 ACNRGISAAQLKADWTR------------------LADDEDTGPKIQIFYMGYNNLEEFP 564
Query: 494 IPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEI-SNVRIL 552
S+ ++ ++ LD N + A G LT L + N + IP + + +
Sbjct: 565 ASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQV 621
Query: 553 NYLNLSRNHLNQNIPK--SIGSMKSLTIADFSFNDFSGKLPESG 594
L S N L + IP + S+ + DFS+N +
Sbjct: 622 EGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNIS 664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-34
Identities = 43/352 (12%), Positives = 99/352 (28%), Gaps = 29/352 (8%)
Query: 263 TVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGS 322
V + + + I LD N + I+ FN ++
Sbjct: 256 NVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQ 314
Query: 323 IPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLR 382
L + + L L G +P+ +GQ +L+VL ++ T +
Sbjct: 315 PGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPD 374
Query: 383 ILILLKNFLFGPIPER-LGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSG 441
+ K+ + + L L L Q+ +N + + + L+ +
Sbjct: 375 MSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGN 432
Query: 442 SLPENGNSSSNPDRLGQ------LNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIP 495
+ + + + +N+ + + + +
Sbjct: 433 L---TNRITFISKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEE 484
Query: 496 PSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSG---------SIPPEI 546
S L+ + ++L ++P + L L+++ N + +
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE 544
Query: 547 SNVRILNYLNLSRNHLNQ-NIPKSIGSMKSLTIADFSFNDFSGKLPESGQFT 597
+ + N+L + S+ M L + D N L G
Sbjct: 545 DTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNV 595
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-33
Identities = 40/274 (14%), Positives = 77/274 (28%), Gaps = 34/274 (12%)
Query: 75 LTDLNLCG----SVPAQILR-LDKLTNLSLAGNNFTG---SIEIGNLSSLQFLNISNNQF 126
LTDL L +P D++ L + N ++ + ++ S N+
Sbjct: 597 LTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKI 656
Query: 127 SG-----GLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYF------- 174
+ +N N + + L N
Sbjct: 657 GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS 716
Query: 175 FGKIPNSYGELQGLEYLSLAGNDLTGKIPGEL--GNLTNLREIYLGYYNVFEGGIPREVG 232
+Y L + L N LT + + L L + + Y N F P +
Sbjct: 717 LKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSY-NCFSS-FPTQPL 773
Query: 233 KLVNLVHLDL------SSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLV 286
L + + Q P I L + + N + + ++L L
Sbjct: 774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLY 830
Query: 287 NLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLH 320
LD+++N S + ++ L ++
Sbjct: 831 ILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 4e-81
Identities = 100/530 (18%), Positives = 179/530 (33%), Gaps = 18/530 (3%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE--IGNLSSLQFLNISNNQFSGG 129
L+ + L RL LT L L E + L L ++ N
Sbjct: 37 CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM 96
Query: 130 LDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLE 189
+ S L+ +++ + + + L+ L LG N+ + L+
Sbjct: 97 AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLK 156
Query: 190 YLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDG 249
L N + ++ +L + L GI L+ +
Sbjct: 157 VLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLL 216
Query: 250 QIPHEIGNLKL-----LDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFI 304
I + N + + +S ++ + L + ++ +++L + +F
Sbjct: 217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFH 275
Query: 305 NLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSS 364
L+ +L L +P L L L+ L L N F + + L L +
Sbjct: 276 CFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKG 334
Query: 365 NKLTGTIPTD-LCSSNQLRILILLKNFL--FGPIPERLGACYSLTRVRLGQNYLNGSIPD 421
N + T L + LR L L + + +L L + L N +
Sbjct: 335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE 394
Query: 422 GFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQ 481
F P L L +L L + + N L LNLS++LL +LQ
Sbjct: 395 AFKECPQLELLDLAFTRLKVKDAQ--SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ 452
Query: 482 ILLLSGNQFSGPI---PPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNL 538
L L GN F S+ L ++ L LS LS A + ++D+S N L
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512
Query: 539 SGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSG 588
+ S +S+++ + YLNL+ NH++ +P + + + N
Sbjct: 513 TSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 2e-69
Identities = 91/531 (17%), Positives = 167/531 (31%), Gaps = 24/531 (4%)
Query: 97 LSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPV 156
+ I +S + L S N + +S L+NL D +
Sbjct: 17 YNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 157 GILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIY 216
+L L L N + + L++L ++ L N L +Y
Sbjct: 76 TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135
Query: 217 LGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLS-GSI 275
LG N + L LD + + ++ +L+ + L++N I
Sbjct: 136 LGS-NHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGI 194
Query: 276 PKQLGNLTNLVNLDLSNNALTGEIP--YSFINLRQLKLFNLFMNRLHGSIPDYLADLP-- 331
+ +L+ I ++ L L P L
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM 254
Query: 332 NLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFL 391
++E++ L ++ F + LQ LDL++ L+ +P+ L + L+ L+L N
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313
Query: 392 FGPIPERLGACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNYLSGSLPENGNSS 450
SLT + + N + G L L +L + + +
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE-TSDCCNLQL 372
Query: 451 SNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDL 509
N L LNLS N + L++L L+ + S L + L+L
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 510 SRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSI---PPEISNVRILNYLNLSRNHLNQNI 566
S + L L +L++ N+ + + L L LS L+
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492
Query: 567 PKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNN 617
+ S+K + D S N + T + + + + L +N
Sbjct: 493 QHAFTSLKMMNHVDLSHN----------RLTSSSIEALSHLKGIYLNLASN 533
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 8e-67
Identities = 102/502 (20%), Positives = 172/502 (34%), Gaps = 18/502 (3%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE--IGNLSSLQFLNISNNQFSGG 129
+L LT L + L +L + + N +L+ L + +N S
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 130 LDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLK--YLDLGGNYFFGKIPNSYGELQG 187
L+V D NN L + L++ L+L GN I +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN-DIAGIEPGAFDSAV 203
Query: 188 LEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV---GKLVNLVHLDLSS 244
+ L+ G I L N T + ++ + I V +++ ++L
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 245 CELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFI 304
+ L + L LS +P L L+ L L LS N S
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322
Query: 305 NLRQLKLFNLFMNRLHGSIPDY-LADLPNLETLGLWQNNFT--GVIPENLGQNGKLQVLD 361
N L ++ N + L +L NL L L ++ L LQ L+
Sbjct: 323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN 382
Query: 362 LSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPER-LGACYSLTRVRLGQNYLNGSIP 420
LS N+ QL +L L L + + L + L + L+ S
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
Query: 421 DGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSL 480
F LP L LQ N+ + NS RL L LS LS + ++ +
Sbjct: 443 QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502
Query: 481 QILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSG 540
+ LS N+ + ++ L+ + L+L+ N +S +P + + +++ QN L
Sbjct: 503 NHVDLSHNRLTSSSIEALSHLKG-IYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
Query: 541 SIPPEISNVRILNYLNLSRNHL 562
+ SN+ L + + L
Sbjct: 562 T----CSNIYFLEWYKENMQKL 579
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 2e-80
Identities = 101/520 (19%), Positives = 176/520 (33%), Gaps = 27/520 (5%)
Query: 91 LDKLTNLS--LAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNN 148
++ + N++ NF I S + L++S N +++ S L+V D
Sbjct: 4 VEVVPNITYQCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62
Query: 149 NFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGN 208
+ L L L L GN ++ L L+ L +L +G+
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 209 LTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHI 268
L L+E+ + + + +P L NL HLDLSS ++ ++ L + + L +
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 269 NLLSGSI---PKQLGNLTNLVNLDLSNNALTGEIPY-SFINLRQLKLFNLFMNRLHGSIP 324
+L + L L L NN + + L L++ L +
Sbjct: 183 DLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 325 DYLADLPNLETLGLWQ---------NNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDL 375
D LE L + + I + + L S +
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302
Query: 376 CSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQ 435
+ L L+ +L + LT G + LP L +L
Sbjct: 303 NFG--WQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLS 355
Query: 436 SNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIP 495
N LS S L L+LS N + + + L+ L +
Sbjct: 356 RNGLS-FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE 413
Query: 496 PSI-GELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEI-SNVRILN 553
S+ LR ++ LD+S + L L M+ N+ + P+I + +R L
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 554 YLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPES 593
+L+LS+ L Q P + S+ SL + + S N+F
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 3e-80
Identities = 116/537 (21%), Positives = 185/537 (34%), Gaps = 31/537 (5%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE--IGNLSSLQFLNISNNQFSGG 129
+LDL+ L +L L L+ + +LS L L ++ N
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91
Query: 130 LDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYF-FGKIPNSYGELQGL 188
+S L +L+ A N +L I L+ LK L++ N K+P + L L
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151
Query: 189 EYLSLAGNDLTGKIPGELGNLTNLREIYLG---YYNVFEGGIPREVGKLVNLVHLDLSSC 245
E+L L+ N + +L L + + L N I K + L L L +
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNN 210
Query: 246 ELDGQIP----HEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALT----- 296
+ + L++ V L L NL + L
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 297 -GEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNG 355
+I F L + F+L + + + L L F L
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKS-- 326
Query: 356 KLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFL--FGPIPERLGACYSLTRVRLGQN 413
L+ L +SNK S L L L +N L G + SL + L N
Sbjct: 327 -LKRLTFTSNKGGNAFSEVDLPS--LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 414 YLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFS 473
+ + F+ L L + Q + L + + L L++S+
Sbjct: 384 GVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF--SVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 474 LSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLD 532
+ SSL++L ++GN F P I ELR + LDLS+ L P A + L L+
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 533 MSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSM-KSLTIADFSFNDFSG 588
MS NN + L L+ S NH+ + + + SL + + NDF+
Sbjct: 501 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 5e-74
Identities = 104/551 (18%), Positives = 186/551 (33%), Gaps = 48/551 (8%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE--IGNLSSLQFLNISNNQFSGG 129
LDL+ + L L+ L L GN LSSLQ L +
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 130 LDWNYSSLVNLEVFDAYNNNFTAL-LPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGL 188
++ L L+ + +N + LP L L++LDL N L +
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175
Query: 189 EY----LSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLS 243
L L+ N + PG + L ++ L N + + L L L
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTL-RNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 244 SCELDGQ------IPHEIGNLKLLDTVFLHINLLSGS---IPKQLGNLTNLVNLDLSNNA 294
E + + L L + L I LTN+ + L +
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 295 LTGEIPYSF-INLRQLKLFN----------------LFMNRLHGSIPDYLADLPNLETLG 337
+ +S+ + L+L N L G DLP+LE L
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLD 353
Query: 338 LWQN--NFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPI 395
L +N +F G ++ L+ LDLS N + T+ ++ QL L + L
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMS 412
Query: 396 PER-LGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPD 454
+ +L + + + + F L L + ++ N + + +
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP--DIFTELR 470
Query: 455 RLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSL 514
L L+LS L P + ++ SSLQ+L +S N F L + LD S N +
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
Query: 515 SGEIPPAIGYC-NHLTYLDMSQNNLSGSIPPE--ISNVRILNYLNLSRNHLNQNIPKSIG 571
+ + + L +L+++QN+ + + + + ++ L + + P
Sbjct: 531 MTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP---S 587
Query: 572 SMKSLTIADFS 582
+ + + +
Sbjct: 588 DKQGMPVLSLN 598
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 3e-68
Identities = 104/533 (19%), Positives = 185/533 (34%), Gaps = 58/533 (10%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE--IGNLSSLQFLNISNNQFSGG 129
+L LT + L L L N IG+L +L+ LN+++N
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 130 -LDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKY----LDLGGNYFFGKIPNSYGE 184
L +S+L NLE D +N ++ + L ++ LDL N P ++ E
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 185 LQGLEYLSLAGNDLTGKIPGE-LGNLTNLREIYLGY-----YNVFEGGIPREVGKLVNLV 238
++ L L+L N + + + L L L E + L NL
Sbjct: 200 IR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 239 HLDLSSCELD---GQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNAL 295
+ LD I L + + L + +L+L N
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF 316
Query: 296 TGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQN--NFTGVIPENLGQ 353
+L++L G DLP+LE L L +N +F G ++
Sbjct: 317 GQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 354 NGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPER-LGACYSLTRVRLGQ 412
L+ LDLS N + T+ ++ QL L + L + +L + +
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 413 NYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPF 472
+ + F L L + ++ N + + + L L+LS L P
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD--IFTELRNLTFLDLSQCQLEQLSPT 488
Query: 473 SLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYC-NHLTYL 531
+ ++ SSLQ+L +S N F L + LD S N + + + + L +L
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 548
Query: 532 DMSQNNLSGS--------------------------IPPEISNVRILNYLNLS 558
+++QN+ + + P + + +L+ LN++
Sbjct: 549 NLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLS-LNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-49
Identities = 66/367 (17%), Positives = 112/367 (30%), Gaps = 32/367 (8%)
Query: 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNAL 295
+ +LDLS L + + L + L + +L++L L L+ N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 296 TGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGV-IPENLGQN 354
+F L L+ L + L L+ L + N +PE
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 355 GKLQVLDLSSNKLTGTIPTDLCSSNQLRI----LILLKNFLFGPIPERLGACYSLTRVRL 410
L+ LDLSSNK+ TDL +Q+ + L L N + P L ++ L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTL 207
Query: 411 GQNYLNGSIPDGFIY-LPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGP 469
N+ + ++ I L GL + L S + L L + L+
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA-- 265
Query: 470 LPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLT 529
+ + I L V L ++ Y
Sbjct: 266 ----------------YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQ 307
Query: 530 YLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGK 589
+L++ +++ + L+ S + SL D S N S K
Sbjct: 308 HLELVNCKFGQ-----FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFK 362
Query: 590 LPESGQF 596
S
Sbjct: 363 GCCSQSD 369
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 262 bits (673), Expect = 2e-80
Identities = 92/330 (27%), Positives = 133/330 (40%), Gaps = 37/330 (11%)
Query: 28 DFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSRD----RVASLDLTDLNLCGS 83
D L+ +K+ NP L SW + +W G+ C D RV +LDL+ LNL
Sbjct: 7 DKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 84 --VPAQILRLDKLTNLSLAG-NNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLV 138
+P+ + L L L + G NN G I I L+ L +L I++ SG +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI-------- 117
Query: 139 NLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDL 198
P + +++ L LD N G +P S L L ++ GN +
Sbjct: 118 ----------------PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161
Query: 199 TGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNL 258
+G IP G+ + L N G IP L NL +DLS L+G G+
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSD 220
Query: 259 KLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNR 318
K + L N L+ + K +G NL LDL NN + G +P L+ L N+ N
Sbjct: 221 KNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 319 LHGSIPDYLADLPNLETLGLWQNNFTGVIP 348
L G IP +L + N P
Sbjct: 280 LCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 5e-80
Identities = 84/307 (27%), Positives = 143/307 (46%), Gaps = 16/307 (5%)
Query: 322 SIPDYLADLPNL----ETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGT--IPTDL 375
I L + L T + GV+ + Q ++ LDLS L IP+ L
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 376 CSSNQLRILILLK-NFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAEL 434
+ L L + N L GPIP + L + + ++G+IPD + L +
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 435 QSNYLSGSLPEN-GNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSL-QILLLSGNQFSG 492
N LSG+LP + + + L + N +SG +P S +FS L + +S N+ +G
Sbjct: 133 SYNALSGTLPPSISSLPN----LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 493 PIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRIL 552
IPP+ L + +DLSRN L G+ G + + +++N+L+ + ++ + L
Sbjct: 189 KIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNL 246
Query: 553 NYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCG 612
N L+L N + +P+ + +K L + SFN+ G++P+ G F+ S++A N LCG
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
Query: 613 TLLNNPC 619
+ L C
Sbjct: 307 SPL-PAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 1e-70
Identities = 78/274 (28%), Positives = 125/274 (45%), Gaps = 6/274 (2%)
Query: 167 LDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTG--KIPGELGNLTNLREIYLGYYNVFE 224
D + G + ++ + + L L+G +L IP L NL L +Y+G N
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 225 GGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTN 284
G IP + KL L +L ++ + G IP + +K L T+ N LSG++P + +L N
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 285 LVNLDLSNNALTGEIPYSFINLRQLKLF-NLFMNRLHGSIPDYLADLPNLETLGLWQNNF 343
LV + N ++G IP S+ + +L + NRL G IP A+L NL + L +N
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNML 209
Query: 344 TGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACY 403
G G + Q + L+ N L + + S L L L N ++G +P+ L
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268
Query: 404 SLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSN 437
L + + N L G IP G L +++ +N
Sbjct: 269 FLHSLNVSFNNLCGEIPQGGN-LQRFDVSAYANN 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 3e-75
Identities = 71/316 (22%), Positives = 120/316 (37%), Gaps = 32/316 (10%)
Query: 677 LEFSVSDI---LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAE 733
++ ++ ++ V RG G V+ +AVK S E
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKA-QLLNEYVAVKIFPIQDKQSWQ--NEYE 68
Query: 734 IQTLGNIRHRNIVRLLAFCSNKETN----LLVYEYMRNGSLGEALHGKKGAFLGWNLRYK 789
+ +L ++H NI++ + + L+ + GSL + L + WN
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCH 125
Query: 790 IAIEAAKGLCYLHHD-------CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842
IA A+GL YLH D P I HRD+KS N+LL + A +ADFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 843 ASECMSAIAGSYGYIAPEYA-----YTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV 897
++ G+ Y+APE + + D+Y+ G+VL EL + D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 898 DIVQWSKRATNGRKEEFLSI-----LDPRL-SMVPKEEAMHLLF-VAMLCIQENSIERPR 950
+ + + E+ + P L K M +L C ++ R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 951 MREVVQMLSEFPRHSS 966
V + +++ R ++
Sbjct: 306 AGCVGERITQMQRLTN 321
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 2e-67
Identities = 108/576 (18%), Positives = 180/576 (31%), Gaps = 60/576 (10%)
Query: 54 PSSVCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE--IG 111
P S+ C + D L VP I N+ L+ N
Sbjct: 1 PGSLNP----CIEVVPNITYQCMDQKL-SKVPDDIPS--STKNIDLSFNPLKILKSYSFS 53
Query: 112 NLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGG 171
N S LQ+L++S + D + L +L N + P L L+ L
Sbjct: 54 NFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVE 113
Query: 172 NYFFGKIPNSYGELQGLEYLSLAGNDLTG-KIPGELGNLTNLREIYLGYYNVFEG----- 225
G+L L+ L++A N + K+P NLTNL + L YN +
Sbjct: 114 TKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDL-SYNYIQTITVND 172
Query: 226 ----------------------GIPREVGKLVNLVHLDLSSCELDGQIPHEIGN------ 257
I + + + L L L I
Sbjct: 173 LQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLH 232
Query: 258 -LKLLDTVFLHINLLSGSIPKQLGNLTNLV--NLDLSNNALTGEIPYSFINLRQLKLFNL 314
+L+ F L P + L ++ L+ + F L + +L
Sbjct: 233 VHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSL 292
Query: 315 FMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTD 374
+ + + ++L + + +L L+ L L+ NK + I
Sbjct: 293 AGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPF---LKSLTLTMNKGS--ISFK 345
Query: 375 LCSSNQLRILILLKNFL--FGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLA 432
+ L L L +N L G SL + L N + F+ L L
Sbjct: 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHL 404
Query: 433 ELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSG 492
+ Q + L + S +L L++S +SL L ++GN F
Sbjct: 405 DFQHSTLKRVTEFSAFLSLE--KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462
Query: 493 PIPPSI-GELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRI 551
++ + LDLS+ L + L L+MS NNL + +
Sbjct: 463 NTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYS 522
Query: 552 LNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFS 587
L+ L+ S N + + KSL + + N +
Sbjct: 523 LSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-56
Identities = 85/469 (18%), Positives = 145/469 (30%), Gaps = 33/469 (7%)
Query: 142 VFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGK 201
+ + + + P I K +DL N S+ L++L L+ ++
Sbjct: 15 TYQCMDQKLSKV-PDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 202 IPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLL 261
L +L + L N + P L +L +L +L IG L L
Sbjct: 72 EDKAWHGLHHLSNLIL-TGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 262 DTVFLHINLLSG-SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLF----NLFM 316
+ + N + +P NLTNLV++DLS N + LR+ ++ +
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 317 NRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQN-GKLQVLDLSSNKLTGTIPTDL 375
N + I D L L L N + I + QN L V L + ++
Sbjct: 191 NPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249
Query: 376 CSSN--------QLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLP 427
+ + L F + +++ + L + +
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHF 307
Query: 428 GLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSG 487
+ L + + L L L+ N S SL L LS
Sbjct: 308 KWQSLSIIRCQL------KQFPTLDLPFLKSLTLTMNKGSISFKKV--ALPSLSYLDLSR 359
Query: 488 NQFS--GPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPE 545
N S G S + LDLS N + L +LD + L
Sbjct: 360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFS 418
Query: 546 -ISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPES 593
++ L YL++S + + + SL + N F +
Sbjct: 419 AFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-16
Identities = 32/206 (15%), Positives = 57/206 (27%), Gaps = 32/206 (15%)
Query: 72 SLDLTDLNLCGSVPAQILR-LDKLTNLSLAGNNFTGSIE--IGNLSSLQFLNISNNQFSG 128
LD L L+KL L ++ N + L+SL L ++ N F
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462
Query: 129 GLDWNY-SSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQG 187
N ++ NL D + L +L+ L++ N + Y +L
Sbjct: 463 NTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYS 522
Query: 188 LEYLSLAGNDLTGKIPGELGNLTNLREIYL--------------------------GYYN 221
L L + N + +L L
Sbjct: 523 LSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVKEQKQFLVNVEQ 582
Query: 222 VFEGGIPREVGKLVNLVHLDLSSCEL 247
+ L ++ + S+C +
Sbjct: 583 MTCATPVEMNTSL--VLDFNNSTCYM 606
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 6e-65
Identities = 78/300 (26%), Positives = 129/300 (43%), Gaps = 30/300 (10%)
Query: 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
++ V+GRG G+V K ++A+K++ + S F E++ L + H NIV+
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVK 65
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGA-FLGWNLRYKIAIEAAKGLCYLHHDCS 806
L C N LV EY GSL LHG + + ++ ++G+ YLH
Sbjct: 66 LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 807 PLIVHRDVKSNNILLNSAFE-AHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
++HRD+K N+LL + + DFG A + M+ GS ++APE
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWMAPEVFEGS 178
Query: 866 RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925
EK DV+S+G++L E++T R+P + G + W NG + + L + +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--AVHNGTRPPLIKNLPKPIESL 236
Query: 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQML----SEFPRHSSDFNQSSSSSLKNLEK 981
C ++ +RP M E+V+++ FP SL E
Sbjct: 237 MTR-----------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGED 285
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 4e-63
Identities = 78/280 (27%), Positives = 127/280 (45%), Gaps = 20/280 (7%)
Query: 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLL-GFGTHSHDHGFRAEIQTLGNIRHRNIV 746
+ IG G G V+ + +G ++AVK L+ + F E+ + +RH NIV
Sbjct: 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAF-LGWNLRYKIAIEAAKGLCYLHHDC 805
+ + +V EY+ GSL LH L R +A + AKG+ YLH+
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-R 156
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
+P IVHR++KS N+L++ + V DFGL++ S + AG+ ++APE
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDE 214
Query: 866 RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925
+EKSDVYSFGV+L EL T ++P + ++ Q K RL +
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQP---W-GNLNPAQVVAAVGFKCK---------RLE-I 260
Query: 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965
P+ + + C +RP ++ +L + +
Sbjct: 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 5e-62
Identities = 78/288 (27%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 688 VKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHG------FRAEIQTLGNI 740
++ IG+GG G+V+ G+ + + +A+K L+ + F+ E+ + N+
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 741 RHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
H NIV+L N +V E++ G L L K + W+++ ++ ++ A G+ Y
Sbjct: 81 NHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEY 137
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFE-----AHVADFGLAKFLIDGGASECMSAIAGSYG 855
+ + +P IVHRD++S NI L S E A VADFGL++ +S + G++
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVSGLLGNFQ 191
Query: 856 YIAPE--YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913
++APE A EK+D YSF ++L +LTG P ++ I + G +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-SYGKIKFINMIREEGLRPT 250
Query: 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961
PRL V + C + +RP +V+ LSE
Sbjct: 251 IPEDCPPRLRNVIEL-----------CWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-61
Identities = 78/285 (27%), Positives = 121/285 (42%), Gaps = 35/285 (12%)
Query: 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHG---FRAEIQTLGNIRHRN 744
+ +IG GG G VY G E+AVK R E + ++H N
Sbjct: 9 LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
I+ L C + LV E+ R G L L GK+ + ++ A++ A+G+ YLH +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDE 124
Query: 805 CSPLIVHRDVKSNNILLNSAFEAH--------VADFGLAKFLIDGGASECMSAIAGSYGY 856
I+HRD+KS+NIL+ E + DFGLA+ + AG+Y +
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAW 180
Query: 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKR-ATNGRKEEFL 915
+APE + SDV+S+GV+L ELLTG P F G+D + + A N
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP---F-RGIDGLAVAYGVAMNKLALPIP 236
Query: 916 SILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
S + + ++ C + RP ++ L+
Sbjct: 237 STCPEPFAKLMED-----------CWNPDPHSRPSFTNILDQLTT 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 9e-61
Identities = 80/280 (28%), Positives = 124/280 (44%), Gaps = 21/280 (7%)
Query: 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLL-GFGTHSHDHGFRAEIQTLGNIRHRNIV 746
+ G IG G G VY GK +G ++AVK L T F+ E+ L RH NI+
Sbjct: 26 ITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
+ + + +V ++ SL LH + IA + A+G+ YLH +
Sbjct: 84 LFMGYST-APQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLH---A 138
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE---YAY 863
I+HRD+KSNNI L+ + DFGLA S ++GS ++APE
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923
+ +SDVY+FG+VL EL+TG+ P + + I++ R P LS
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR--GSLS--------PDLS 248
Query: 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963
V + + C+++ ERP ++ + E R
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-57
Identities = 76/337 (22%), Positives = 135/337 (40%), Gaps = 46/337 (13%)
Query: 655 IIKAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIA 714
++ A+SF + S + Q+ + + + G +IG+G G VYHG+ +G E+A
Sbjct: 8 LLSARSFPRKASQT--SIFLQEWDIPFEQL----EIGELIGKGRFGQVYHGRW-HG-EVA 59
Query: 715 VKKLL-GFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEA 773
++ + F+ E+ RH N+V + C + ++ + +L
Sbjct: 60 IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 774 LHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFG 833
+ K L N +IA E KG+ YLH + I+H+D+KS N+ ++ + + DFG
Sbjct: 120 VRDAKIV-LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFG 174
Query: 834 LAKF---LIDGGASECMSAIAGSYGYIAPE---------YAYTLRVDEKSDVYSFGVVLL 881
L L G + + G ++APE L + SDV++ G +
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234
Query: 882 ELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCI 941
EL P F + G K ++ M KE + + + C
Sbjct: 235 ELHAREWP---F-KTQPAEAIIWQMGTGMKPNL-----SQIGM-GKE----ISDILLFCW 280
Query: 942 QENSIERPRMREVVQMLSEFPR------HSSDFNQSS 972
ERP +++ ML + P+ H F +S+
Sbjct: 281 AFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKSA 317
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-57
Identities = 58/280 (20%), Positives = 111/280 (39%), Gaps = 29/280 (10%)
Query: 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLL-GFGTHSHDHGFRAEIQTLGNIRHRNIV 746
+ + +G ++ G+ G +I VK L + F E L H N++
Sbjct: 12 LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 747 RLLAFCSNKETNLL--VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
+L C + + +M GSL LH + + K A++ A+G+ +LH
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT- 129
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE---Y 861
PLI + S +++++ A ++ + G + ++APE
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAPEALQK 182
Query: 862 AYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921
+D++SF V+L EL+T P D ++I K A G R
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADL-SNMEIG--MKVALEGL----------R 229
Query: 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961
+ +P + H+ + +C+ E+ +RP+ +V +L +
Sbjct: 230 PT-IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-57
Identities = 75/339 (22%), Positives = 135/339 (39%), Gaps = 50/339 (14%)
Query: 677 LEFSVSDI---LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAE 733
+E + S+ L+ +K +IGRG G VY G + + +AVK + ++ F E
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINE 55
Query: 734 --IQTLGNIRHRNIVRLLAFC----SNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNL 786
I + + H NI R + ++ LV EY NGSL + L W
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVS 112
Query: 787 RYKIAIEAAKGLCYLHHD------CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL-- 838
++A +GL YLH + P I HRD+ S N+L+ + ++DFGL+ L
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 839 ----IDGGASECMSAIAGSYGYIAPEYA-------YTLRVDEKSDVYSFGVVLLELLTGR 887
G + G+ Y+APE ++ D+Y+ G++ E+ R
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-R 231
Query: 888 RPVGDFGDGVDIVQ---WSKRATNGRKEEFLSI-----LDPRLSMVPKEEAMHLLFVAML 939
G+ V Q ++ + E+ + P+ KE ++ + +
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 940 ---CIQENSIERPRMREVVQMLSEFPRHSSDFNQSSSSS 975
C +++ R + + ++E + N+S S +
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAEL-MMIWERNKSVSPT 329
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 7e-55
Identities = 105/531 (19%), Positives = 175/531 (32%), Gaps = 35/531 (6%)
Query: 95 TNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALL 154
NF I S + L++S N +++ S L+V D +
Sbjct: 10 ITYQCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 155 PVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLRE 214
L L L L GN ++ L L+ L +L +G+L L+E
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 215 IYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLS-- 272
+ + + + +P L NL HLDLSS ++ ++ L + + L ++L
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 273 -GSIPKQLGNLTNLVNLDLSNNALTGEIP-YSFINLRQLKLFNLFM------NRLHGSIP 324
I L L L NN + + L L++ L + L
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 325 DYLADLPNLETLGLWQN---NFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQL 381
L L NL + I + + L S + D +
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGW 306
Query: 382 RILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSG 441
+ L L+ +L SL R+ N + + LP L +L N LS
Sbjct: 307 QHLELVNCKFGQFPTLKLK---SLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLS- 360
Query: 442 SLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-GE 500
S L L+LS N + + + L+ L + S+
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 501 LRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSR 559
LR ++ LD+S + L L M+ N+ + P+I + +R L +L+LS+
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 560 NHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQL 610
L Q P + S+ SL + + + N Q F L
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMASN----------QLKSVPDGIFDRLTSL 520
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-51
Identities = 115/512 (22%), Positives = 182/512 (35%), Gaps = 32/512 (6%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQFSG 128
+LDL+ L +L L L+ +IE G +LS L L ++ N
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS 90
Query: 129 GLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYF-FGKIPNSYGELQG 187
+S L +L+ A N +L I L+ LK L++ N K+P + L
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 188 LEYLSLAGNDLTGKIPGELGNLTNLR--EIYLGYYNVFEGGIPREVGKLVNLVHLDLSSC 245
LE+L L+ N + +L L + + L I K + L L L +
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 246 ELDGQIP----HEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTG---- 297
+ + L++ V L L NL + L
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 298 --EIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNG 355
+I F L + F+L + + D + + L L F L
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIE-RVKD-FSYNFGWQHLELVNCKFGQFPTLKLKS-- 326
Query: 356 KLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFL--FGPIPERLGACYSLTRVRLGQN 413
L+ L +SNK S L L L +N L G + SL + L N
Sbjct: 327 -LKRLTFTSNKGGNAFSEVDLPS--LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 414 YLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFS 473
+ ++ F+ L L + Q + L + E + L L++S+
Sbjct: 384 GVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFS-VFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 474 LSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLD 532
+ SSL++L ++GN F P I ELR + LDLS+ L P A + L L+
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 533 MSQNNLSGSIPPEI-SNVRILNYLNLSRNHLN 563
M+ N L S+P I + L + L N +
Sbjct: 501 MASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-37
Identities = 91/480 (18%), Positives = 158/480 (32%), Gaps = 63/480 (13%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG----NLSSLQFLNISNNQFS 127
L + NL I L L L++A N S ++ NL++L+ L++S+N+
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 128 GGLDWNYSSLVNLEVFDAY---NNNFTALLPVGILKLEKLKYLDLGGNYFFGKIP-NSYG 183
+ L + + + + N + G K +L L L N+ +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 184 ELQGLEYLSLAG------NDLTGKIPGELGNLTNL--REIYLGYYNVFEGGIPREVGKLV 235
L GLE L +L L L NL E L Y + + I L
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 236 NLVHLDLSSCELDGQIPHEIGNLKL--LDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNN 293
N+ L S ++ ++ N L+ V L +L L ++N
Sbjct: 283 NVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSN 335
Query: 294 ALTGEIPYSFINLRQLKLFNLFMNRLH--GSIPDYLADLPNLETLGLWQNNFTGVIPENL 351
+S ++L L+ +L N L G +L+ L L N + N
Sbjct: 336 KGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF 392
Query: 352 GQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLG 411
+L+ LD + L + S + +L + +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLR-----------------------NLIYLDIS 429
Query: 412 QNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLP 471
+ + F L L + ++ N + + + L L+LS L P
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP--DIFTELRNLTFLDLSQCQLEQLSP 487
Query: 472 FSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYL 531
+ ++ SSLQ+L ++ NQ L + K+ L N C + YL
Sbjct: 488 TAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS-------CPRIDYL 540
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-54
Identities = 69/311 (22%), Positives = 121/311 (38%), Gaps = 37/311 (11%)
Query: 678 EFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQT 736
F SD+ G V+G+G G G + +K+L+ F + F E++
Sbjct: 6 IFRPSDL----IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT-FLKEVKV 60
Query: 737 LGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK 796
+ + H N+++ + + + EY++ G+L + + W+ R A + A
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIAS 119
Query: 797 GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS------------ 844
G+ YLH S I+HRD+ S+N L+ VADFGLA+ ++D
Sbjct: 120 GMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSK 904
+ + G+ ++APE DEK DV+SFG+VL E++ D+
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP--------- 227
Query: 905 RATNGRKEEFLSILDPRLSM-VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963
R +F + L P + + C + +RP ++ L
Sbjct: 228 -----RTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
Query: 964 HSSDFNQSSSS 974
H +
Sbjct: 283 HLAGHLPLGPQ 293
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-53
Identities = 111/502 (22%), Positives = 180/502 (35%), Gaps = 64/502 (12%)
Query: 91 LDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNF 150
L + L N T ++ +L + L +D L NL + NN
Sbjct: 23 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQL 80
Query: 151 TALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLT 210
T + P+ L KL + + N P L L L+L N +T P L NLT
Sbjct: 81 TDITPLK--NLTKLVDILMNNNQIADITPL--ANLTNLTGLTLFNNQITDIDP--LKNLT 134
Query: 211 NLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINL 270
NL + L + + + L +L L + D + NL L+ + + N
Sbjct: 135 NLNRLELSSNTISD---ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNK 188
Query: 271 LSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADL 330
+S L LTNL +L +NN ++ P L L +L N+L LA L
Sbjct: 189 VSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL--KDIGTLASL 242
Query: 331 PNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNF 390
NL L L N + + P L KL L L +N+++ P L L L L +N
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 298
Query: 391 LFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSS 450
L P + +LT + L N ++ P +L +LQ
Sbjct: 299 LEDISP--ISNLKNLTYLTLYFNNISDISPVS-------SLTKLQR-------------- 335
Query: 451 SNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLS 510
L NN +S L+N +++ L NQ S P + L ++ +L L+
Sbjct: 336 --------LFFYNNKVSDVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 383
Query: 511 RNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPP-EISNVRILNYLNLSRNHLNQNIPKS 569
+ + Y +++ + +N I P IS+ +++ N + +
Sbjct: 384 DQAWTNAPV---NYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYT-NEV 439
Query: 570 IGSMKSLTIADFSFNDFSGKLP 591
+ FSG +
Sbjct: 440 SYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-46
Identities = 92/449 (20%), Positives = 164/449 (36%), Gaps = 63/449 (14%)
Query: 147 NNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGEL 206
+ + L + LG + + +L + L + I G +
Sbjct: 11 DTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-V 64
Query: 207 GNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFL 266
L NL +I N P + L LV + +++ ++ P + NL L + L
Sbjct: 65 EYLNNLTQINF-SNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119
Query: 267 HINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDY 326
N ++ P L NLTNL L+LS+N ++ + L L+ + N++ P
Sbjct: 120 FNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP-- 172
Query: 327 LADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILIL 386
LA+L LE L + N + L + L+ L ++N+++ P L L L L
Sbjct: 173 LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSL 228
Query: 387 LKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPEN 446
N L L + +LT + L N ++ P L +L
Sbjct: 229 NGNQLKDIGT--LASLTNLTDLDLANNQISNLAPLS-------GLTKLTE---------- 269
Query: 447 GNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLK 506
L L N +S P L+ ++L L L+ NQ P I L+ +
Sbjct: 270 ------------LKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTY 313
Query: 507 LDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNI 566
L L N++S P + L L N +S ++N+ +N+L+ N ++
Sbjct: 314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLT 369
Query: 567 PKSIGSMKSLTIADFSFNDFSGKLPESGQ 595
P + ++ +T + ++
Sbjct: 370 P--LANLTRITQLGLNDQAWTNAPVNYKA 396
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-46
Identities = 92/424 (21%), Positives = 158/424 (37%), Gaps = 34/424 (8%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLD 131
++ ++ L P + L KL ++ + N + NL++L L + NNQ + +D
Sbjct: 72 QINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT-DID 128
Query: 132 WNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYL 191
+L NL + +N + + + L L+ L G L LE L
Sbjct: 129 -PLKNLTNLNRLELSSNTISDISALS--GLTSLQQLSFGNQ---VTDLKPLANLTTLERL 182
Query: 192 SLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQI 251
++ N ++ L LTNL + N P +G L NL L L+ +L
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIA-TNNQISDITP--LGILTNLDELSLNGNQLKD-- 235
Query: 252 PHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKL 311
+ +L L + L N +S P L LT L L L N ++ P L L
Sbjct: 236 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN 291
Query: 312 FNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTI 371
L N+L P +++L NL L L+ NN + + P + KLQ L +NK++
Sbjct: 292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-- 345
Query: 372 PTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNL 431
+ L + + L N + P L +T++ L + + N+
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYK-----ANV 398
Query: 432 AELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFS 491
+ + + S+ + +++ NL S FS + FS
Sbjct: 399 SIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFS 457
Query: 492 GPIP 495
G +
Sbjct: 458 GTVT 461
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 4e-52
Identities = 74/305 (24%), Positives = 113/305 (37%), Gaps = 37/305 (12%)
Query: 684 ILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHR 743
I + ++ IG+G G V+ GK G ++AVK F T EI +RH
Sbjct: 35 IAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVF--FTTEEASWFRETEIYQTVLMRHE 91
Query: 744 NIVRLLAFC---SNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLC 799
NI+ +A + T L L+ +Y NGSL + L L K+A + GLC
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLC 148
Query: 800 YLH-----HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE--CMSAIAG 852
+LH P I HRD+KS NIL+ +AD GLA I + G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 853 SYGYIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRA 906
+ Y+ PE + +D+YSFG++L E+ G V+ Q
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS----GGIVEEYQLPYHD 264
Query: 907 TNGRKEEFLSILD--------PRLSMVPKEEAMHLLFVAML--CIQENSIERPRMREVVQ 956
+ + + P + ++ C N R V +
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
Query: 957 MLSEF 961
L++
Sbjct: 325 TLAKM 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-52
Identities = 58/222 (26%), Positives = 87/222 (39%), Gaps = 23/222 (10%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
+G+G G V+ G G +AVK E+ +RH NI+ +A
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIF--SSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 751 FC---SNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD-- 804
+ T L L+ Y GSL + L L +I + A GL +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 805 ---CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE--CMSAIAGSYGYIAP 859
P I HRD+KS NIL+ + +AD GLA + G+ Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 860 E------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGD 895
E ++ D+++FG+VL E+ G D
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 7e-50
Identities = 74/307 (24%), Positives = 115/307 (37%), Gaps = 35/307 (11%)
Query: 684 ILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHR 743
I + IG+G G V+ GK G E+AVK AEI +RH
Sbjct: 40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFREAEIYQTVMLRHE 96
Query: 744 NIVRLLAFC---SNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLC 799
NI+ +A + T L LV +Y +GSL + L+ + K+A+ A GL
Sbjct: 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLA 153
Query: 800 YLHHD-----CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC--MSAIAG 852
+LH + P I HRD+KS NIL+ +AD GLA + + G
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 853 SYGYIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV----DIVQW 902
+ Y+APE +++D+Y+ G+V E+ G D D+V
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273
Query: 903 SKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-----CIQENSIERPRMREVVQM 957
+ + + R + +P M C N R + +
Sbjct: 274 --DPSVEEMRKVVCEQKLRPN-IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330
Query: 958 LSEFPRH 964
LS+ +
Sbjct: 331 LSQLSQQ 337
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 4e-48
Identities = 102/513 (19%), Positives = 173/513 (33%), Gaps = 76/513 (14%)
Query: 84 VPAQILRLDKLTNLSLAGNNFTG-SIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEV 142
+ + + L +N T +E N+ S + +++ +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM-- 60
Query: 143 FDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKI 202
A+ + + L+L +P LE L + N LT ++
Sbjct: 61 ---------AVSRLRDCLDRQAHELELNNLG-LSSLPE---LPPHLESLVASCNSLT-EL 106
Query: 203 PGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLD 262
P +L +L P L +L +S+ +L+ ++P E+ N L
Sbjct: 107 PELPQSLKSLLVDNN-NLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLK 156
Query: 263 TVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGS 322
+ + N L +P +L + NN L E+P NL L N L
Sbjct: 157 IIDVDNNSLK-KLPDLPPSLE---FIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-K 209
Query: 323 IPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLR 382
+PD +LE++ N L L + +N L T+P S L
Sbjct: 210 LPD---LPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LE 260
Query: 383 ILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGS 442
L + N+L +PE SLT + + +N + + + L LN + + L
Sbjct: 261 ALNVRDNYLTD-LPELPQ---SLTFLDVSENIFS-GLSELPPNLYYLNASSNEIRSLCDL 315
Query: 443 LPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELR 502
P L +LN+SNN L LP L+ L+ S N + +P L+
Sbjct: 316 PP----------SLEELNVSNNKLIE-LPALPPR---LERLIASFNHLAE-VPELPQNLK 360
Query: 503 QVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHL 562
+L + N L E P L N+ +P N L L++ N L
Sbjct: 361 ---QLHVEYNPLR-EFPDIPESVEDLR-----MNSHLAEVPELPQN---LKQLHVETNPL 408
Query: 563 NQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQ 595
+ P S++ L + D E+
Sbjct: 409 -REFPDIPESVEDLRMNSERVVDPYEFAHETTD 440
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-35
Identities = 84/401 (20%), Positives = 133/401 (33%), Gaps = 77/401 (19%)
Query: 91 LDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNF 150
L L ++ N E+ N S L+ +++ NN L +LE A NN
Sbjct: 130 PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLP---DLPPSLEFIAAGNNQL 185
Query: 151 TALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLT 210
L + L L + N K+P+ LE + N L EL NL
Sbjct: 186 EELPELQ--NLPFLTAIYADNNS-LKKLPD---LPLSLESIVAGNNILE--ELPELQNLP 237
Query: 211 NLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINL 270
L IY N+ + +P L L D +L P +L LD +
Sbjct: 238 FLTTIYA-DNNLLK-TLPDLPPSLEALNVRDNYLTDL----PELPQSLTFLDVSENIFSG 291
Query: 271 LSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADL 330
LS P NL L+ S+N + + +L +L + N N+L +P A
Sbjct: 292 LSELPP-------NLYYLNASSNEIR-SLCDLPPSLEELNVSN---NKLI-ELP---ALP 336
Query: 331 PNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNF 390
P LE L N+ +PE L+ L + N L P S LR+ L
Sbjct: 337 PRLERLIASFNHLA-EVPELP---QNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAE- 390
Query: 391 LFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSS 450
+PE +L ++ + N L P+
Sbjct: 391 ----VPELPQ---NLKQLHVETNPLR-------------------------EFPD----- 413
Query: 451 SNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFS 491
P+ + L +++ + P F+ L+ + +
Sbjct: 414 -IPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-30
Identities = 62/328 (18%), Positives = 113/328 (34%), Gaps = 51/328 (15%)
Query: 75 LTDLNLCG----SVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGL 130
L +++ +P L ++ N E+ NL L + NN L
Sbjct: 155 LKIIDVDNNSLKKLPDL---PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK-KL 210
Query: 131 DWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEY 190
++LE A NN L + L L + N +P+ LE
Sbjct: 211 P---DLPLSLESIVAGNNILEELPELQ--NLPFLTTIYADNNL-LKTLPD---LPPSLEA 261
Query: 191 LSLAGNDLTGKIPGELGNLTNLREIY------------LGYYNVFEGGIPREVGKLVNLV 238
L++ N LT +P +LT L L Y N I +L
Sbjct: 262 LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLE 320
Query: 239 HLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGE 298
L++S+ +L ++P L+ L N L+ +P+ NL L + N L E
Sbjct: 321 ELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQNLK---QLHVEYNPLR-E 371
Query: 299 IPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQ 358
P ++ L++ + +P+ NL+ L + N P+ ++
Sbjct: 372 FPDIPESVEDLRMNSHL-----AEVPE---LPQNLKQLHVETNPLR-EFPDIPES---VE 419
Query: 359 VLDLSSNKLTGTIPTDLCSSNQLRILIL 386
L ++S ++ ++++L +
Sbjct: 420 DLRMNSERVVDPYEFAHETTDKLEDDVF 447
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 8e-48
Identities = 118/623 (18%), Positives = 212/623 (34%), Gaps = 56/623 (8%)
Query: 74 DLTDLNLCG----SVPAQILR-LDKLTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQ 125
L L +V A L++L L L +I+ NL +L+ L++ +++
Sbjct: 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84
Query: 126 FSGGLDWNYSSLVNLEVFDAYNNNFT-ALLPVGILK-LEKLKYLDLGGNYFFG-KIPNSY 182
+ L +L Y + A+L G + L+ L LDL N + S+
Sbjct: 85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSF 144
Query: 183 GELQGLEYLSLAGNDLTGKIPGELGNLT--NLREIYLGY---YNVFEGGIPREVGKLVN- 236
G+L L+ + + N + EL L L L Y+ + + N
Sbjct: 145 GKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204
Query: 237 -LVHLDLSSCELDGQIPHEIGN------------LKLLDTVFLHINLLSGSIPKQLGNL- 282
L LD+S I N + + + L
Sbjct: 205 VLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLA 264
Query: 283 -TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQN 341
+++ +LDLS+ + F L+ LK+ NL N+++ + L NL+ L L N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 342 NFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGA 401
+ N K+ +DL N + +L+ L L N L +
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHF 379
Query: 402 CYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNL 461
S+ + L N L ++P + ++L+E + L L L L
Sbjct: 380 IPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENLD-----ILYFLLRVPHLQILIL 433
Query: 462 SNNLLSG-PLPFSLSNFSSLQILLLSGNQFSGPIPPSIGE-----LRQVLKLDLSRNSLS 515
+ N S + S SL+ L L N + L + L L+ N L+
Sbjct: 434 NQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493
Query: 516 GEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKS 575
P + L L ++ N L+ + L L++SRN L P S
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPAN-LEILDISRNQLLAPNP---DVFVS 548
Query: 576 LTIADFSFNDFSGKLPESG--QFTVFNASSFAGNPQLCGTLLNNPCNVAPITHQPGKAPG 633
L++ D + N F + S + + AG P + + + + +
Sbjct: 549 LSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCD 608
Query: 634 DFKLIFALGLLICSLIFATAAII 656
+ +++ +L + + T +
Sbjct: 609 EEEVLKSLKFSLFIVCTVTLTLF 631
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 7e-46
Identities = 116/586 (19%), Positives = 203/586 (34%), Gaps = 64/586 (10%)
Query: 64 CCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLN 120
C R+A +L VP L+ L L+ N ++ L LQ L
Sbjct: 2 CSFDGRIAFYRFCNLT---QVPQ---VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLE 54
Query: 121 ISNNQFSGGLDWN-YSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKI- 178
+ + +D + +L NL + D ++ L P L L L L +
Sbjct: 55 LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVL 114
Query: 179 -PNSYGELQGLEYLSLAGNDLTG-KIPGELGNLTNLREIYLGYYNVFEGGIPREVGK--- 233
+ L+ L L L+ N + + G L +L+ I +F + +
Sbjct: 115 KDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL--VCEHELEPLQ 172
Query: 234 LVNLVHLDLSSCELDGQIPHEI------------------GNLKLLDTVFLHINLLSGSI 275
L L++ L ++ + GN +D N +S S
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 276 PKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFM--NRLHGSIPDYLADLPNL 333
L +++ + + +F L + + +L + + L +L
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDL 292
Query: 334 ETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFG 393
+ L L N + E LQVL+LS N L ++ ++ + L KN +
Sbjct: 293 KVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAI 352
Query: 394 PIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNP 453
+ L + L N L ++P + L N L +LP+ +++
Sbjct: 353 IQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTAN-- 404
Query: 454 DRLGQLNLSNNLLSGPLPFS-LSNFSSLQILLLSGNQFSG-PIPPSIGELRQVLKLDLSR 511
++LS N L L LQIL+L+ N+FS + E + +L L
Sbjct: 405 ----LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGE 460
Query: 512 NSLSGEIPPAI-----GYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHLNQN 565
N L + +HL L ++ N L+ S+PP + S++ L L+L+ N L
Sbjct: 461 NMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-V 518
Query: 566 IPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLC 611
+ + +L I D S N P F + N +C
Sbjct: 519 LSHNDLP-ANLEILDISRNQLLA--PNPDVFVSLSVLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-32
Identities = 76/367 (20%), Positives = 119/367 (32%), Gaps = 39/367 (10%)
Query: 244 SCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSF 303
SC DG+I F L+ +P+ L L LS N + SF
Sbjct: 1 SCSFDGRI------------AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSF 44
Query: 304 INLRQLKLFNLFMNRLHGSI-PDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDL 362
L QL+L L +I + +LPNL L L + + P+ L L L
Sbjct: 45 PFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRL 104
Query: 363 SSNKLTGTI--PTDLCSSNQLRILILLKNFLFG-PIPERLGACYSLTRVRLGQNYLNGSI 419
L+ + + L L L KN + + G SL + N +
Sbjct: 105 YFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC 164
Query: 420 PDGFIYLPGLNLAE--LQSNYLSGSLPENGNSSSNPDR---LGQLNLSNNLLSGPLP--- 471
L G L+ L +N L + + NP R L L++S N + +
Sbjct: 165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNF 224
Query: 472 ---------FSLSNFSSLQILLLSGNQFSGPIPPSIGELRQ--VLKLDLSRNSLSGEIPP 520
FSL + + P + L + V LDLS +
Sbjct: 225 SNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR 284
Query: 521 AIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIAD 580
L L+++ N ++ + L LNLS N L + + + + D
Sbjct: 285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYID 344
Query: 581 FSFNDFS 587
N +
Sbjct: 345 LQKNHIA 351
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 6e-46
Identities = 83/371 (22%), Positives = 149/371 (40%), Gaps = 31/371 (8%)
Query: 75 LTDLNLCGSVPAQILRLDKLTN---LSLAGNNFTGSIEIGNLSSLQFLNISNNQFSG--G 129
L + QI L L + T + L S+ L ++ + + G
Sbjct: 2 AATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVASIQG 61
Query: 130 LDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLE 189
+ L NLE + N T + P+ L KL L +G N ++ L L
Sbjct: 62 I----EYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKI--TDISALQNLTNLR 113
Query: 190 YLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDG 249
L L ++++ P L NLT + + LG + + + L +L ++ ++
Sbjct: 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHN--LSDLSPLSNMTGLNYLTVTESKVKD 169
Query: 250 QIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQL 309
P I NL L ++ L+ N + P L +LT+L N +T P N+ +L
Sbjct: 170 VTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRL 223
Query: 310 KLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTG 369
+ N++ P LA+L L L + N + + + KL++L++ SN+++
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD 279
Query: 370 TIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGL 429
+ L + +QL L L N L E +G +LT + L QN++ P L +
Sbjct: 280 --ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKM 335
Query: 430 NLAELQSNYLS 440
+ A+ + +
Sbjct: 336 DSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-45
Identities = 80/399 (20%), Positives = 150/399 (37%), Gaps = 55/399 (13%)
Query: 164 LKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVF 223
L P++ +L L +T + L ++ ++ + V
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 224 EGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLT 283
I + L NL +L+L+ ++ P + NL L +++ N ++ L NLT
Sbjct: 58 S--IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLT 110
Query: 284 NLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNF 343
NL L L+ + ++ P NL ++ NL N S L+++ L L + ++
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167
Query: 344 TGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACY 403
V P + L L L+ N++ P L S L N + P +
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMT 221
Query: 404 SLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSN 463
L +++G N + P LA L L L +
Sbjct: 222 RLNSLKIGNNKITDLSP----------LANLSQ-------------------LTWLEIGT 252
Query: 464 NLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIG 523
N +S ++ + + L++L + NQ S + L Q+ L L+ N L E IG
Sbjct: 253 NQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIG 308
Query: 524 YCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHL 562
+LT L +SQN+++ P ++++ ++ + + +
Sbjct: 309 GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-44
Identities = 83/447 (18%), Positives = 143/447 (31%), Gaps = 103/447 (23%)
Query: 94 LTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTAL 153
L+ +L+ + + + L ++ ++
Sbjct: 2 AATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVV--TQEELESITKLVVAGEKVASI 59
Query: 154 LPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLR 213
+ L L+YL+L GN P L L L + N +T L NLTNLR
Sbjct: 60 QGIE--YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLR 113
Query: 214 EIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSG 273
E+YL + P + L + L+L +
Sbjct: 114 ELYL-NEDNISDISP--LANLTKMYSLNLGANHN-------------------------L 145
Query: 274 SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNL 333
S L N+T L L ++ + + P NL L +L N++ P LA L +L
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 334 ETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFG 393
+ N T + P + +L L + +NK+T P
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--------------------- 238
Query: 394 PIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGL-NLAELQSNYLSGSLPENGNSSSN 452
L LT + +G N ++ + + +L +L+
Sbjct: 239 -----LANLSQLTWLEIGTNQISD--------INAVKDLTKLKM---------------- 269
Query: 453 PDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRN 512
LN+ +N +S + N S L L L+ NQ IG L + L LS+N
Sbjct: 270 ------LNVGSNQISDISVLN--NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321
Query: 513 SLSGEIPPAIGYCNHLTYLDMSQNNLS 539
++ P + + + D + +
Sbjct: 322 HITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-40
Identities = 74/356 (20%), Positives = 135/356 (37%), Gaps = 50/356 (14%)
Query: 233 KLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSN 292
L + L + + L+ + + + ++ SI + LTNL L+L+
Sbjct: 20 DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNG 75
Query: 293 NALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLG 352
N +T P NL +L + N++ + L +L NL L L ++N + + P L
Sbjct: 76 NQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LA 129
Query: 353 QNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQ 412
K+ L+L +N + + L + L L + ++ + P + L + L
Sbjct: 130 NLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY 186
Query: 413 NYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPF 472
N + P LA L S L N ++ P
Sbjct: 187 NQIEDISP----------LASLTS-------------------LHYFTAYVNQITDITP- 216
Query: 473 SLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLD 532
++N + L L + N+ + P + L Q+ L++ N +S A+ L L+
Sbjct: 217 -VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLN 271
Query: 533 MSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSG 588
+ N +S ++N+ LN L L+ N L + IG + +LT S N +
Sbjct: 272 VGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-35
Identities = 66/336 (19%), Positives = 127/336 (37%), Gaps = 31/336 (9%)
Query: 258 LKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMN 317
L T+ IN + +L + L ++T + L + +
Sbjct: 2 AATLATLPAPINQIFP-----DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGE 54
Query: 318 RLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCS 377
++ SI + L NLE L L N T + P L KL L + +NK+T + L +
Sbjct: 55 KVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQN 108
Query: 378 SNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSN 437
LR L L ++ + P L + + LG N+ S + GLN + +
Sbjct: 109 LTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTES 165
Query: 438 YLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPS 497
+ + N + L L+L+ N + P L++ +SL NQ + P
Sbjct: 166 KVK-DVTPIANLTD----LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP-- 216
Query: 498 IGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNL 557
+ + ++ L + N ++ + + LT+L++ N +S + ++ L LN+
Sbjct: 217 VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNV 272
Query: 558 SRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPES 593
N ++ + ++ L + N + E
Sbjct: 273 GSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEV 306
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 6e-14
Identities = 21/147 (14%), Positives = 54/147 (36%), Gaps = 10/147 (6%)
Query: 451 SNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLS 510
++ + L ++ + S+ L+++G + + I L + L+L+
Sbjct: 19 ADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVASI--QGIEYLTNLEYLNLN 74
Query: 511 RNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSI 570
N ++ + LT L + N ++ + N+ L L L+ ++++ P +
Sbjct: 75 GNQITD--ISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--L 128
Query: 571 GSMKSLTIADFSFNDFSGKLPESGQFT 597
++ + + N L T
Sbjct: 129 ANLTKMYSLNLGANHNLSDLSPLSNMT 155
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 3e-04
Identities = 15/56 (26%), Positives = 23/56 (41%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFS 127
SL L + L I L LT L L+ N+ T + +LS + + +N
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVIK 346
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 56/316 (17%), Positives = 107/316 (33%), Gaps = 18/316 (5%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLD 131
+L + + + N N + + N ++ Q + D
Sbjct: 16 NLYFQGSTALRPYHDVLSQWQRHYNADR--NRWHSAWRQANSNNPQIETRTGRALKATAD 73
Query: 132 -WNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEY 190
++ + + P +L L+++ + ++P++ + GLE
Sbjct: 74 LLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAG-LMELPDTMQQFAGLET 131
Query: 191 LSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFE--------GGIPREVGKLVNLVHLDL 242
L+LA N L +P + +L LRE+ + E LVNL L L
Sbjct: 132 LTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190
Query: 243 SSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYS 302
+ +P I NL+ L ++ + + LS ++ + +L L LDL P
Sbjct: 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPI 248
Query: 303 FINLRQLKLFNLF-MNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLD 361
F LK L + L ++P + L LE L L +P + Q ++
Sbjct: 249 FGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIIL 307
Query: 362 LSSNKLTGTIPTDLCS 377
+ + +
Sbjct: 308 VPPHLQAQLDQHRPVA 323
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-45
Identities = 50/319 (15%), Positives = 109/319 (34%), Gaps = 20/319 (6%)
Query: 94 LTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFT 151
NL G+ + + + + W ++ N ++
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSA----WRQANSNNPQIETRTGRALK 69
Query: 152 ALLP-VGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLT 210
A + L+L + P+ L L+++++ L ++P +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 211 NLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINL 270
L + L N +P + L L L + +C ++P + + +NL
Sbjct: 128 GLETLTLAR-NPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 271 ----LSG----SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGS 322
L S+P + NL NL +L + N+ L+ + + +L +L+ +L +
Sbjct: 186 QSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN 244
Query: 323 IPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLR 382
P L+ L L + +P ++ + +L+ LDL +P+ +
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304
Query: 383 ILILLKNFLFGPIPERLGA 401
I+++ + R A
Sbjct: 305 IILVPPHLQAQLDQHRPVA 323
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-42
Identities = 56/343 (16%), Positives = 108/343 (31%), Gaps = 31/343 (9%)
Query: 252 PHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKL 311
H + + ++ + L N D + + N ++
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQI 60
Query: 312 FNLFMNRLHGSIPDYLADL--PNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTG 369
L + D L D P L L P+ + LQ + + + L
Sbjct: 61 ETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117
Query: 370 TIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGL 429
+P + L L L +N L +P + + L + + +P+
Sbjct: 118 ELPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 430 NLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQ 489
+ N L L L + LP S++N +L+ L + +
Sbjct: 177 GEHQGLVN------------------LQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSP 217
Query: 490 FSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNV 549
S + P+I L ++ +LDL + PP G L L + + ++P +I +
Sbjct: 218 LSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276
Query: 550 RILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPE 592
L L+L +P I + + I + +L +
Sbjct: 277 TQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 8e-38
Identities = 56/320 (17%), Positives = 103/320 (32%), Gaps = 38/320 (11%)
Query: 128 GGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNS------ 181
G ++ E + + + ++ D + + NS
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 182 ---------------YGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGG 226
G L L L + P + L++L+ + + + E
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-- 118
Query: 227 IPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGN----- 281
+P + + L L L+ L +P I +L L + + +P+ L +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 282 ----LTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLG 337
L NL +L L + +P S NL+ LK + + L ++ + LP LE L
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELD 235
Query: 338 LWQNNFTGVIPENLGQNGKLQVLDLSS-NKLTGTIPTDLCSSNQLRILILLKNFLFGPIP 396
L P G L+ L L + L T+P D+ QL L L +P
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 397 ERLGACYSLTRVRLGQNYLN 416
+ + + + +
Sbjct: 295 SLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 49/274 (17%), Positives = 80/274 (29%), Gaps = 21/274 (7%)
Query: 72 SLDLTDLNLCGSVPAQI--LRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFS 127
++ + + L L + LS LQ + I
Sbjct: 59 QIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
Query: 128 GGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNS------ 181
L LE N AL P I L +L+ L + ++P
Sbjct: 118 E-LPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELTELPEPLASTDA 175
Query: 182 ---YGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLV 238
+ L L+ L L + +P + NL NL+ + + + + + L L
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI-RNSPLSA-LGPAIHHLPKLE 232
Query: 239 HLDLSSCELDGQIPHEIGNLKLLDTVFL-HINLLSGSIPKQLGNLTNLVNLDLSNNALTG 297
LDL C P G L + L + L ++P + LT L LDL
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 298 EIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLP 331
+P L + + + P
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 49/282 (17%), Positives = 88/282 (31%), Gaps = 44/282 (15%)
Query: 321 GSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQ 380
GS + E L + + L Q + D + +SN
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 381 LRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLS 440
+I L + L RV L EL+S L
Sbjct: 58 PQIETRTGRAL-KATADLLEDATQPGRVAL----------------------ELRSVPLP 94
Query: 441 GSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGE 500
P+ + L + + L LP ++ F+ L+ L L+ N +P SI
Sbjct: 95 -QFPD---QAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRA-LPASIAS 148
Query: 501 LRQVLKLDLSRNSLSGEIPPAIGYCN---------HLTYLDMSQNNLSGSIPPEISNVRI 551
L ++ +L + E+P + + +L L + + S+P I+N++
Sbjct: 149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQN 207
Query: 552 LNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPES 593
L L + + L+ + +I + L D P
Sbjct: 208 LKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPI 248
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-44
Identities = 88/521 (16%), Positives = 184/521 (35%), Gaps = 46/521 (8%)
Query: 112 NLSSLQFLNISNNQFS---GGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLD 168
+ + + + F+ GL ++ D N T + + L+ L
Sbjct: 3 SCDASGVCDGRSRSFTSIPSGL------TAAMKSLDLSFNKITYIGHGDLRACANLQVLI 56
Query: 169 LGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIP 228
L + +++ L LE+L L+ N L+ G L++L+ + L G+
Sbjct: 57 LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
Query: 229 REVGKLVNLVHLDLSSCELDGQIPHE-IGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVN 287
L NL L + + E +I L L+ + + L + L ++ ++ +
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176
Query: 288 LDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVI 347
L L + + L ++ L L L + + +
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 348 PENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTR 407
E+ + KL L +++ D C+ N L ++ + + + ++ R
Sbjct: 237 DESFNELLKLLRYILELSEVE----FDDCTLNGLGDFNPSESDVVSELGKV--ETVTIRR 290
Query: 408 VRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLS 467
+ + Q YL + + L + ++++ + +P + S + L L+LS NL+
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCS--FSQHLKSLEFLDLSENLMV 347
Query: 468 ---GPLPFSLSNFSSLQILLLSGNQFS--GPIPPSIGELRQVLKLDLSRNSLSGEIPPAI 522
+ SLQ L+LS N + L+ + LD+SRN+ +P +
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSC 406
Query: 523 GYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFS 582
+ + +L++S + + I + L L++S N+L+ + + ++ L S
Sbjct: 407 QWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLD-SFSLFLPRLQEL---YIS 459
Query: 583 FNDFSGKLPESG-------------QFTVFNASSFAGNPQL 610
N LP++ Q F L
Sbjct: 460 RNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSL 499
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-42
Identities = 88/495 (17%), Positives = 166/495 (33%), Gaps = 43/495 (8%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQFSG 128
SLDL+ + + L L L + +IE +L SL+ L++S+N S
Sbjct: 30 SLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSS 88
Query: 129 GLDWNYSSLVNLEVFDAYNNNFTALLPVGIL-KLEKLKYLDLGGNYFFGKIPNSY-GELQ 186
+ L +L+ + N + L + L L+ L +G F +I L
Sbjct: 89 LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148
Query: 187 GLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCE 246
L L + L L ++ ++ + L + + L ++ +L+L
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL-SESAFLLEIFADILSSVRYLELRDTN 207
Query: 247 LDGQIPHEIGNLKLLDTV----FLHINLLSGS---IPKQLGNLTNLVNLDLSNNALTGEI 299
L + ++ + F L S + K L + L ++ + L G
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLG 267
Query: 300 PY-----------SFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIP 348
+ + ++ ++ L + + L ++ + + + V
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPC 327
Query: 349 ENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQ---LRILILLKNFL--FGPIPERLGACY 403
L+ LDLS N + + L+ L+L +N L E L
Sbjct: 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
Query: 404 SLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSN 463
+LT + + +N + +PD + + L S + + P L L++SN
Sbjct: 388 NLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTC-----IPQTLEVLDVSN 440
Query: 464 NLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIG 523
N L L LQ L +S N+ P +L + +SRN L
Sbjct: 441 NNLDS-FSLFLPR---LQELYISRNKLK--TLPDASLFPVLLVMKISRNQLKSVPDGIFD 494
Query: 524 YCNHLTYLDMSQNNL 538
L + + N
Sbjct: 495 RLTSLQKIWLHTNPW 509
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 8e-43
Identities = 70/489 (14%), Positives = 147/489 (30%), Gaps = 26/489 (5%)
Query: 110 IGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDL 169
N + + ++++ L S N++ D N + + + KL+ L+L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 170 GGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPR 229
N + L L L L N + EL ++ ++ N +
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHA-ANNNIS-RVSC 116
Query: 230 EVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSG-SIPKQLGNLTNLVNL 288
G+ ++ L++ ++ + G + + L +N + + + + L +L
Sbjct: 117 SRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 289 DLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIP 348
+L N + ++ + +LK +L N+L + + + L N +I
Sbjct: 175 NLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIE 230
Query: 349 ENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRV 408
+ L + L+ DL N D S N R+ + K + + C T
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKN-QRVQTVAKQTVKKLTGQNEEECTVPTLG 289
Query: 409 RLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPEN-GNSSSNPDRLGQLNLSNNLLS 467
G L L E GS E N R +++
Sbjct: 290 HYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR 349
Query: 468 GPLPFSLSNFSSLQILLLSGNQFSGPIP---PSIGELRQVLKLDLSRNSLSGEIPPAIGY 524
+ + L + + EL L+ + + L
Sbjct: 350 TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQ--- 406
Query: 525 CNHLTYLDMSQNNLS-GSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSF 583
+ L L + + + ++ ++ Q ++ K AD +
Sbjct: 407 -SPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLAL 465
Query: 584 NDFSGKLPE 592
+ L E
Sbjct: 466 ASANATLQE 474
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-40
Identities = 73/508 (14%), Positives = 159/508 (31%), Gaps = 42/508 (8%)
Query: 73 LDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTG--SIEIGNLSSLQFLNISNNQFSGGL 130
+TD +L ++ + + L L+GN + + ++ + L+ LN+S+N L
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74
Query: 131 DWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEY 190
D SL L D NN LL ++ L N ++ S QG +
Sbjct: 75 DL--ESLSTLRTLDLNNNYVQELLV-----GPSIETLHAANNN-ISRVSCSR--GQGKKN 124
Query: 191 LSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQ 250
+ LA N +T + G + ++ + L + L HL+L +
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183
Query: 251 IPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLK 310
+ ++ L T+ L N L+ + + + + + L NN L I + + L+
Sbjct: 184 VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 311 LFNLFMNRLH-GSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTG 369
F+L N H G++ D+ + ++T+ + +N + + +
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLGHYGAYCCE- 297
Query: 370 TIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGL 429
+++L L ++ L GQ +
Sbjct: 298 --DLPAPFADRLIALKRKEHALLS-----------------GQGSETERLECERENQARQ 338
Query: 430 NLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQ 489
+ ++ + + L L + + L L
Sbjct: 339 REIDALKEQYR-TVID--QVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG 395
Query: 490 FSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNV 549
+ + L + + + N + DM Q+ +
Sbjct: 396 QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLK 455
Query: 550 RILNYLNLSRNHLNQNIPKSIGSMKSLT 577
++ +L+ N + + + ++L
Sbjct: 456 KLNGEADLALASANATLQELVVREQNLA 483
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 3e-40
Identities = 56/405 (13%), Positives = 126/405 (31%), Gaps = 26/405 (6%)
Query: 178 IPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNL 237
I + + + L + + N++E+ L N ++ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDL-SGNPLSQISAADLAPFTKL 60
Query: 238 VHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTG 297
L+LSS L ++ +L L T+ L+ N + +L ++ L +NN ++
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 298 EIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGV-IPENLGQNGK 356
+ + L N N++ ++ L L N V E +
Sbjct: 114 VSCSRGQGKKNIYLAN---NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 357 LQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLN 416
L+ L+L N + + + + L+ L L N L + + +T + L N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFAK-LKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 417 GSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSN 476
I + L +L+ N + S + R+ ++ + +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ--RV--QTVAKQTVKKLTGQNEEE 282
Query: 477 FSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSG----EIPPAIGYCNHLTYLD 532
+ + P L + + + + S G + +D
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREID 342
Query: 533 MSQNNLSGSIPPEI-SNVRILNYLNLSRNHLNQNIPKSIGSMKSL 576
+ ++ ++ + L + L++ + + L
Sbjct: 343 ALKEQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAEL 386
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 6e-35
Identities = 51/311 (16%), Positives = 105/311 (33%), Gaps = 17/311 (5%)
Query: 274 SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNL 333
+I + N +++++L + + +K +L N L LA L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 334 ETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFG 393
E L L N + L L+ LDL++N + +L + L N +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-S 112
Query: 394 PIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNP 453
+ G + L N + + +L+ N + ++ +++
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNF-AELAASS 168
Query: 454 DRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNS 513
D L LNL N + + F+ L+ L LS N+ + + P V + L N
Sbjct: 169 DTLEHLNLQYNFIYD-VK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK 225
Query: 514 LSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSM 573
L I A+ + +L + D+ N + +++ + + ++
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283
Query: 574 KSLTIADFSFN 584
T+ +
Sbjct: 284 TVPTLGHYGAY 294
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-34
Identities = 62/367 (16%), Positives = 120/367 (32%), Gaps = 23/367 (6%)
Query: 226 GIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNL 285
I ++ L + + + + L N LS L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 286 VNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTG 345
L+LS+N L E +L L+ +L N + L P++ETL NN +
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS- 112
Query: 346 VIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFG-PIPERLGACYS 404
+ + GQ + + L++NK+T D ++++ L L N + E + +
Sbjct: 113 RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 405 LTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNN 464
L + L N++ + + L +L SN L+ + S++ + ++L NN
Sbjct: 171 LEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAG---VTWISLRNN 224
Query: 465 LLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGY 524
L + +L +L+ L GN F Q + +++ ++
Sbjct: 225 KLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV-QTVAKQTVKKLTGQNEEE 282
Query: 525 CNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQN----IPKSIGSMKSLTIAD 580
C T P + L + + + + D
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREID 342
Query: 581 FSFNDFS 587
+
Sbjct: 343 ALKEQYR 349
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 39/326 (11%), Positives = 86/326 (26%), Gaps = 11/326 (3%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTG---SIEIGNLSSLQFLNISNNQFSG 128
++ L + + ++ L L N + + +L+ LN+ N
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 129 GLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGL 188
+ L+ D +N + + ++ L N I + Q L
Sbjct: 183 DVK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK-LVLIEKALRFSQNL 239
Query: 189 EYLSLAGNDL-TGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCEL 247
E+ L GN G + ++ + G E + +L
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299
Query: 248 DGQIPHEIGNLKLLDTVFLHI-NLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINL 306
+ LK + L + + + N +D I +
Sbjct: 300 PAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRK 359
Query: 307 RQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNK 366
+ L + + L+ L Q + + LQ+L +
Sbjct: 360 QAKITLEQKKKALDEQVSNGRRAHAELDGT-LQQAVGQIELQHATEEQSPLQLLRAIVKR 418
Query: 367 LT-GTIPTDLCSSNQLRILILLKNFL 391
+ +N +R + ++
Sbjct: 419 YEEMYVEQQSVQNNAIRDWDMYQHKE 444
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 75/269 (27%), Positives = 117/269 (43%), Gaps = 30/269 (11%)
Query: 689 KDGNVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
K IGRG VY G VE+A +L T S F+ E + L ++H NIV
Sbjct: 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 747 RLLAFC---SNKETNLLVY-EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
R + +++ E M +G+L L K+ + + + KGL +LH
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 803 HDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY 861
+P I+HRD+K +NI + + D GLA A + G+ ++APE
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEM 201
Query: 862 AYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL-SILDP 920
Y + DE DVY+FG+ +LE+ T P + + + Q +R T+G K + P
Sbjct: 202 -YEEKYDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 921 RLSMVPKEEAMHLLFVAMLCIQENSIERP 949
+ KE + CI++N ER
Sbjct: 258 EV----KE------II-EGCIRQNKDERY 275
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-37
Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 33/286 (11%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
E + G IGRG G V+ G++ + +AVK F E + L H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
IVRL+ C+ K+ +V E ++ G L + L ++ +AA G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLE-- 230
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-----AP 859
S +HRD+ + N L+ ++DFG+++ DG + A +G + AP
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG-----VYAASGGLRQVPVKWTAP 284
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
E R +SDV+SFG++L E + G P + +N ++ +
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNL-------------SN---QQTREFV 328
Query: 919 DPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPR 963
+ + E +F M C +RP + Q L +
Sbjct: 329 EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 3e-37
Identities = 73/345 (21%), Positives = 129/345 (37%), Gaps = 49/345 (14%)
Query: 236 NLVHLDLSSCELDGQIPHEIG-NLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNA 294
L++ L +P + ++ L + N L+ S+P L L ++S N
Sbjct: 41 GNAVLNVGESGL-TTLPDCLPAHITTLV---IPDNNLT-SLPALPPELRTL---EVSGNQ 92
Query: 295 LTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQN 354
LT +P L +L +F+ + L L L ++ N T +P
Sbjct: 93 LT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPPG- 142
Query: 355 GKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNY 414
LQ L +S N+L ++P +L L N L +P L + + N
Sbjct: 143 --LQELSVSDNQLA-SLPALPS---ELCKLWAYNNQL-TSLPMLPS---GLQELSVSDNQ 192
Query: 415 LNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSL 474
L S+P L L + SLP P L +L +S N L+ LP
Sbjct: 193 LA-SLPTLPSELYKLWAYNNRLT----SLPAL------PSGLKELIVSGNRLTS-LPVLP 240
Query: 475 SNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMS 534
S L+ L++SGN+ + +P L L + RN L+ +P ++ + + T +++
Sbjct: 241 SE---LKELMVSGNRLTS-LPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLE 292
Query: 535 QNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIA 579
N LS + + + + + ++L +A
Sbjct: 293 GNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA 337
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 1e-34
Identities = 79/371 (21%), Positives = 129/371 (34%), Gaps = 50/371 (13%)
Query: 185 LQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSS 244
G L++ + LT +P L ++ + + N+ +P L L++S
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS--LPALPP---ELRTLEVSG 90
Query: 245 CELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFI 304
+L +P L L + L + L L + N LT +P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPP 141
Query: 305 NLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSS 364
L++L + + N+L S+P A L L + N T +P LQ L +S
Sbjct: 142 GLQELSVSD---NQL-ASLP---ALPSELCKLWAYNNQLT-SLPMLPSG---LQELSVSD 190
Query: 365 NKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFI 424
N+L ++PT +L L N L +P L + + N L S+P
Sbjct: 191 NQLA-SLPTLPS---ELYKLWAYNNRL-TSLPALPS---GLKELIVSGNRLT-SLPVLPS 241
Query: 425 YLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILL 484
L L + N L+ SLP P L L++ N L+ LP SL + SS +
Sbjct: 242 ELKELMV---SGNRLT-SLPML------PSGLLSLSVYRNQLTR-LPESLIHLSSETTVN 290
Query: 485 LSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPP 544
L GN S ++ E+ A L + + L +
Sbjct: 291 LEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA--AADWLVPAREG 348
Query: 545 EISNVRILNYL 555
E + +
Sbjct: 349 EPAPADRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-34
Identities = 82/406 (20%), Positives = 136/406 (33%), Gaps = 58/406 (14%)
Query: 65 CSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEI-GNLSSLQFLNISN 123
C + A L++ + L ++P + +T L + NN T + L+ L +S
Sbjct: 37 CLNNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT---SLPALPPELRTLEVSG 90
Query: 124 NQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYG 183
NQ + L L+ L +F + AL L L + GN +P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQ-LTSLPV--- 138
Query: 184 ELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLS 243
GL+ LS++ N L +P L L Y N +P L L +S
Sbjct: 139 LPPGLQELSVSDNQLA-SLPALPSELCKLWA----YNNQLT-SLPMLPS---GLQELSVS 189
Query: 244 SCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSF 303
+L +P L L + S+P L L +S N LT +P
Sbjct: 190 DNQL-ASLPTLPSELYKLWAYNNRLT----SLPALPSGLK---ELIVSGNRLT-SLPVLP 240
Query: 304 INLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLS 363
L++L + NRL S+P L +L +++N T +PE+L ++L
Sbjct: 241 SELKELMVSG---NRL-TSLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292
Query: 364 SNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGF 423
N L+ ++ PI A S R +
Sbjct: 293 GNPLS-ERTLQAL--REITSAPGYSG----PIIRFDMAGASAPRETRALHLAA------A 339
Query: 424 IYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGP 469
+L E + N+ + L +L+ + N +
Sbjct: 340 DWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDA 385
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 74/406 (18%), Positives = 131/406 (32%), Gaps = 77/406 (18%)
Query: 107 SIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKY 166
+ + LN+ + + LP + +
Sbjct: 33 KMRACLNNGNAVLNVGESGLTT-------------------------LPDCLPA--HITT 65
Query: 167 LDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGG 226
L + N +P EL+ L ++GN LT +P L L +
Sbjct: 66 LVIPDN-NLTSLPALPPELR---TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH----- 115
Query: 227 IPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLV 286
+P L L + +L +P L+ L + N L+ S+P L
Sbjct: 116 LPAL---PSGLCKLWIFGNQL-TSLPVLPPGLQELS---VSDNQLA-SLPALPSELC--- 164
Query: 287 NLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGV 346
L NN LT +P L++L + + N+L S+P L L + N T
Sbjct: 165 KLWAYNNQLT-SLPMLPSGLQELSVSD---NQLA-SLPT---LPSELYKLWAYNNRLT-S 215
Query: 347 IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLT 406
+P L+ L +S N+LT ++P +L+ L++ N L +P L
Sbjct: 216 LPALPSG---LKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLTS-LPMLPS---GLL 264
Query: 407 RVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLL 466
+ + +N L +P+ I+L L+ N LS + + +
Sbjct: 265 SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQ-----ALREITSAPGYSGPI 317
Query: 467 SGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRN 512
S + L L+ + +P GE + +
Sbjct: 318 IRFDMAGASAPRETRALHLAAADWL--VPAREGEPAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-26
Identities = 61/341 (17%), Positives = 108/341 (31%), Gaps = 53/341 (15%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLD 131
+L+++ L S+P L +L+ S + S L L I NQ + L
Sbjct: 85 TLEVSGNQL-TSLPVLPPGLLELSIFSNPLTHLPAL-----PSGLCKLWIFGNQLTS-LP 137
Query: 132 WNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYL 191
L+ +N +L P +L L N +P GL+ L
Sbjct: 138 ---VLPPGLQELSVSDNQLASL-PALP---SELCKLWAYNNQL-TSLPM---LPSGLQEL 186
Query: 192 SLAGNDLTGKIPGELGNLT-----------------NLREIYLGYYNVFEGGIPREVGKL 234
S++ N L +P L L+E+ + N +P
Sbjct: 187 SVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIV-SGNRLTS-LPVLPS-- 241
Query: 235 VNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNA 294
L L +S L +P L L ++ N L+ +P+ L +L++ ++L N
Sbjct: 242 -ELKELMVSGNRLT-SLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNP 295
Query: 295 LTGEIPYSFINLRQLKLFN---LFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIP--- 348
L+ + + ++ + + S P L L P
Sbjct: 296 LSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADR 355
Query: 349 -ENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLK 388
GQ L ++L+ T + + +I L
Sbjct: 356 WHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSWLA 396
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 56/225 (24%), Positives = 86/225 (38%), Gaps = 35/225 (15%)
Query: 356 KLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYL 415
VL++ + LT T+P L + L++ N L +P L + + N L
Sbjct: 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNL-TSLPALPP---ELRTLEVSGNQL 93
Query: 416 NGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLS 475
S+P L L++ +L +LP L +L + N L+ LP
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLP-ALPSG---------LCKLWIFGNQLTS-LPVLPP 141
Query: 476 NFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQ 535
LQ L +S NQ + +P EL KL N L+ +P L L +S
Sbjct: 142 G---LQELSVSDNQLAS-LPALPSELC---KLWAYNNQLT-SLPMLPS---GLQELSVSD 190
Query: 536 NNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIAD 580
N L+ S+P S L L N L +P +K L ++
Sbjct: 191 NQLA-SLPTLPSE---LYKLWAYNNRLTS-LPALPSGLKELIVSG 230
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-37
Identities = 85/305 (27%), Positives = 129/305 (42%), Gaps = 43/305 (14%)
Query: 686 ECVKDGNVIGRGGAGIVYHG--KMPNGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNIR 741
+ +IG G +G V +G ++P ++ A+K L T F +E +G
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
H NI+RL + ++V EYM NGSL L G F L + G+ YL
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-VGMLRGVGAGMRYL 167
Query: 802 --HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-- 857
VHRD+ + N+L++S V+DFGL++ L D + +A + G I
Sbjct: 168 SDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED----DPDAAYTTTGGKIPI 218
Query: 858 ---APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEE 913
APE SDV+SFGVV+ E+L G RP + D++ G
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM-TNRDVIS---SVEEGY--- 271
Query: 914 FLSILDPRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSDFNQ 970
RL P A+H L ML C ++ +RPR ++V +L R
Sbjct: 272 -------RLPA-PMGCPHALHQL---MLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA 320
Query: 971 SSSSS 975
+++ S
Sbjct: 321 TATVS 325
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-37
Identities = 69/362 (19%), Positives = 124/362 (34%), Gaps = 22/362 (6%)
Query: 202 IPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLL 261
I L ++++ + E L N + + + + + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDM-QTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 262 DTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG 321
+ + L+ + + L + NA+ P+ F N+ L + L N L
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 322 SIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQL 381
+ P L TL + NN + + LQ L LSSN+LT + L S L
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS--L 188
Query: 382 RILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSG 441
+ N L L ++ + N +N + L + +LQ N L+
Sbjct: 189 FHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT- 239
Query: 442 SLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGEL 501
N L +++LS N L + L+ L +S N+ + +
Sbjct: 240 DTAWLLNYP----GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPI 294
Query: 502 RQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNH 561
+ LDLS N L + + L L + N++ ++ S L L LS N
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHND 350
Query: 562 LN 563
+
Sbjct: 351 WD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-35
Identities = 71/357 (19%), Positives = 126/357 (35%), Gaps = 36/357 (10%)
Query: 266 LHINLLSGSIPKQL--GNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSI 323
+HI++ + + L N + N+ + + RQ++L NL ++
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 324 PDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSN-QLR 382
A ++ L + N + P L VL L N L+ ++P + + +L
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT 144
Query: 383 ILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGS 442
L + N L + A SL ++L N L + +P L A + N LS +
Sbjct: 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-T 200
Query: 443 LPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELR 502
L + +L+ S+N ++ L IL L N + +
Sbjct: 201 LAIPIA-------VEELDASHNSINV---VRGPVNVELTILKLQHNNLTD--TAWLLNYP 248
Query: 503 QVLKLDLSRNSLSGEIPP-AIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNH 561
++++DLS N L +I L L +S N L ++ + L L+LS NH
Sbjct: 249 GLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 306
Query: 562 LNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNNP 618
L ++ ++ L N S+ L TL +N
Sbjct: 307 L-LHVERNQPQFDRLENLYLDHN----------SIVTLKLSTHHTLKNL--TLSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-34
Identities = 56/346 (16%), Positives = 117/346 (33%), Gaps = 21/346 (6%)
Query: 73 LDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTG--SIEIGNLSSLQFLNISNNQFSGGL 130
+ + + + L+ ++ + + + + ++ LN+++ Q
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 131 DWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEY 190
+ ++ ++ N L P + L L L N + L
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTT 145
Query: 191 LSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQ 250
LS++ N+L T+L+ + L N + + +L H ++S L
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQL-SSNRLT-HVDL--SLIPSLFHANVSYNLL--- 198
Query: 251 IPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLK 310
+ ++ + N ++ + + L L L +N LT + +N L
Sbjct: 199 --STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLV 251
Query: 311 LFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGT 370
+L N L + + LE L + N + L+VLDLS N L
Sbjct: 252 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-H 309
Query: 371 IPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLN 416
+ + ++L L L N + + L ++L + L N +
Sbjct: 310 VERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 75/381 (19%), Positives = 129/381 (33%), Gaps = 48/381 (12%)
Query: 112 NLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGG 171
++I + +L N ++ N+ L + +++ L+L
Sbjct: 19 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 78
Query: 172 NYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV 231
++ ++ L + N + P N+ L + L N +PR +
Sbjct: 79 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL-ERNDLS-SLPRGI 136
Query: 232 -GKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDL 290
L L +S+ L+ +I + T+L NL L
Sbjct: 137 FHNTPKLTTLSMSNNNLE-RIEDDT-----------------------FQATTSLQNLQL 172
Query: 291 SNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPEN 350
S+N LT + S + L N+ N L LA +E L N+ V+
Sbjct: 173 SSNRLT-HVDLS--LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGP 223
Query: 351 LGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRL 410
+ L +L L N LT L + L + L N L + L R+ +
Sbjct: 224 VNVE--LTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 279
Query: 411 GQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPL 470
N L ++ +P L + +L N+L + N DRL L L +N +
Sbjct: 280 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERN---QPQFDRLENLYLDHNSIV--- 331
Query: 471 PFSLSNFSSLQILLLSGNQFS 491
LS +L+ L LS N +
Sbjct: 332 TLKLSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 34/146 (23%), Positives = 58/146 (39%), Gaps = 8/146 (5%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLD 131
LD + ++ V + +LT L L NN T + + N L +++S N+ +
Sbjct: 209 ELDASHNSIN-VVRGPVNV--ELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMY 265
Query: 132 WNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYL 191
+ + LE NN A L + + LK LDL N+ + + + LE L
Sbjct: 266 HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNH-LLHVERNQPQFDRLENL 323
Query: 192 SLAGNDLTGKIPGELGNLTNLREIYL 217
L N + + L L+ + L
Sbjct: 324 YLDHNSIV-TLK--LSTHHTLKNLTL 346
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 50/291 (17%), Positives = 100/291 (34%), Gaps = 17/291 (5%)
Query: 274 SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNL 333
+I + N +++++L + + +K +L N L LA L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 334 ETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFG 393
E L L N + L L+ LDL++N + +L + L N +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-S 112
Query: 394 PIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNP 453
+ G + L N + + +L+ N + ++ +++
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVN-FAELAASS 168
Query: 454 DRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNS 513
D L LNL N + + F+ L+ L LS N+ + + P V + L N
Sbjct: 169 DTLEHLNLQYNFIYD-VK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK 225
Query: 514 LSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQ 564
L I A+ + +L + D+ N + +++ + +
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKK 274
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 50/332 (15%), Positives = 110/332 (33%), Gaps = 22/332 (6%)
Query: 110 IGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDL 169
N + + ++++ L S N++ D N + + + KL+ L+L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 170 GGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPR 229
N L L L L N + EL ++ ++ N +
Sbjct: 66 SSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHA-ANNNIS-RVSC 116
Query: 230 EVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSG-SIPKQLGNLTNLVNL 288
G+ ++ L++ ++ + G + + L +N + + + + L +L
Sbjct: 117 SRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 289 DLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIP 348
+L N + ++ + +LK +L N+L + + + L N +I
Sbjct: 175 NLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIE 230
Query: 349 ENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRV 408
+ L + L+ DL N D S R+ + K + + ++ +
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQT-VKKLTGQNEEECTVPTL 288
Query: 409 RLGQNYLNGSIPDGFIYLPGLNLAELQSNYLS 440
Y +P F L L ++
Sbjct: 289 GHYGAYCCEDLPAPF----ADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 56/296 (18%), Positives = 110/296 (37%), Gaps = 20/296 (6%)
Query: 73 LDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTG--SIEIGNLSSLQFLNISNNQFSGGL 130
+TD +L ++ + + L L+GN + + ++ + L+ LN+S+N L
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74
Query: 131 DWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEY 190
D SL L D NN LL ++ L N ++ S QG +
Sbjct: 75 D--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAANNN-ISRVSCSR--GQGKKN 124
Query: 191 LSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQ 250
+ LA N +T + G + ++ + L + L HL+L +
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183
Query: 251 IPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLK 310
+ ++ L T+ L N L+ + + + + + L NN L I + + L+
Sbjct: 184 VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 311 LFNLFMNRLH-GSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSN 365
F+L N H G++ D+ + ++T+ + + + L
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK---LTGQNEEECTVPTLGHYGA 293
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 57/303 (18%), Positives = 110/303 (36%), Gaps = 19/303 (6%)
Query: 83 SVPAQILRLDKLTNLSLAGNNFTGSIE--IGNLSSLQFLNISNNQFSGGLDWNYSSLVNL 140
++ ++ + ++ ++ + +++ L++S N S + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 141 EVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTG 200
E+ + +N L + L L+ LDL NY +E L A N+++
Sbjct: 61 ELLNLSSNVLYETLDLE--SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 201 KIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDG-QIPHEIGNLK 259
++ + IYL N + G + +LDL E+D +
Sbjct: 113 RVS--CSRGQGKKNIYLA-NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 260 LLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRL 319
L+ + L N + + Q+ L LDLS+N L + F + + +L N+L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 320 HGSIPDYLADLPNLETLGLWQNNFTGVIPENL-GQNGKLQVLDLSSNKLTGTIPTDLCSS 378
I L NLE L N F + +N ++Q + + K + C+
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 379 NQL 381
L
Sbjct: 286 PTL 288
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 60/340 (17%), Positives = 117/340 (34%), Gaps = 24/340 (7%)
Query: 226 GIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNL 285
I ++ L + + + + L N LS L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 286 VNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTG 345
L+LS+N L E +L L+ +L N + L P++ETL NN +
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 346 VIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFG-PIPERLGACYS 404
+ + GQ + + L++NK+T D ++++ L L N + E + +
Sbjct: 113 RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 405 LTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNN 464
L + L N++ + + L +L SN L+ + S++ + ++L NN
Sbjct: 171 LEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAG---VTWISLRNN 224
Query: 465 LLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGY 524
L + +L +L+ L GN F + +++ ++
Sbjct: 225 KLVL-IEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282
Query: 525 CNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQ 564
C T ++ + L +H +
Sbjct: 283 CTVPTLGHYGAYCCE-----DLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 57/295 (19%), Positives = 107/295 (36%), Gaps = 20/295 (6%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLD 131
LDL+ L A + KL L+L+ N ++++ +LS+L+ L+++NN
Sbjct: 38 ELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ---- 93
Query: 132 WNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYL 191
++E A NNN + + + K + L N G ++YL
Sbjct: 94 -ELLVGPSIETLHAANNNISR-VSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 192 SLAGNDLTG-KIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQ 250
L N++ + L + L Y +++ + +V L LDLSS +L
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD--VKGQVV-FAKLKTLDLSSNKLA-F 205
Query: 251 IPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLK 310
+ E + + + L N L I K L NL + DL N + +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQR 263
Query: 311 LFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSN 365
+ + + + + + TLG + +P ++ L +
Sbjct: 264 VQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR----LIALGHH 313
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-35
Identities = 87/305 (28%), Positives = 132/305 (43%), Gaps = 43/305 (14%)
Query: 686 ECVKDGNVIGRGGAGIVYHG--KMPNGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNIR 741
+ V+G G G V G K+P+ EI A+K L T F E +G
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
H NI+RL + + ++V EYM NGSL L F L + A G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG-MLRGIASGMKYL 163
Query: 802 --HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-- 857
VHRD+ + NIL+NS V+DFGL + L D + +A G I
Sbjct: 164 SDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLED----DPEAAYTTRGGKIPI 214
Query: 858 ---APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEE 913
+PE + SDV+S+G+VL E+++ G RP + D++ K G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVI---KAVDEGY--- 267
Query: 914 FLSILDPRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSDFNQ 970
RL P + A++ L ML C Q++ RP+ ++V +L + R+
Sbjct: 268 -------RLPP-PMDCPAALYQL---MLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKI 316
Query: 971 SSSSS 975
+S++
Sbjct: 317 ITSAA 321
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 82/285 (28%), Positives = 125/285 (43%), Gaps = 29/285 (10%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
E ++ +G+G G V+ G +A+K L F E Q + +RH +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKL 241
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
V+L A S +E +V EYM GSL + L G+ G +L +A + A G+ Y+
Sbjct: 242 VQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--- 297
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
VHRD+++ NIL+ VADFGLA+ LI+ + APE A
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 866 RVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924
R KSDV+SFG++L EL T GR P +++ +R R +
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVER--GYR-------MPC---- 402
Query: 925 VPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSS 966
P E E++H L M C ++ ERP + L ++ +
Sbjct: 403 -PPECPESLHDL---MCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-35
Identities = 69/291 (23%), Positives = 120/291 (41%), Gaps = 31/291 (10%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
+ + +G G G VY G + +AVK L + F E + I+H N
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 277
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
+V+LL C+ + ++ E+M G+L + L + + +A + + + YL
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 335
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG-ASECMSAIAGSYGYIAPEYAY 863
+HR++ + N L+ VADFGL++ + + + + APE
Sbjct: 336 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLA 392
Query: 864 TLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922
+ KSDV++FGV+L E+ T G P G+D+ Q + R+
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPY----PGIDLSQVYELLEKDY----------RM 438
Query: 923 SMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSDFNQ 970
P+ E ++ L M C Q N +RP E+ Q + SS ++
Sbjct: 439 ER-PEGCPEKVYEL---MRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 485
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-34
Identities = 69/331 (20%), Positives = 119/331 (35%), Gaps = 23/331 (6%)
Query: 234 LVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNN 293
L N + + + + + + ++ + L+ + + L + N
Sbjct: 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 294 ALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYL-ADLPNLETLGLWQNNFTGVIPENLG 352
A+ P+ F N+ L + L N L S+P + + P L TL + NN + +
Sbjct: 110 AIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 168
Query: 353 QNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQ 412
LQ L LSSN+LT + L S L + N L L ++ +
Sbjct: 169 ATTSLQNLQLSSNRLT-HVDLSLIPS--LFHANVSYNLL-----STLAIPIAVEELDASH 220
Query: 413 NYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPF 472
N +N + L L LQ N L+ N L +++LS N L +
Sbjct: 221 NSINVVRGPVNVELTILK---LQHNNLT-DTAWLLNYP----GLVEVDLSYNELEKIMYH 272
Query: 473 SLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLD 532
L+ L +S N+ + + + LDLS N L + + L L
Sbjct: 273 PFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330
Query: 533 MSQNNLSGSIPPEISNVRILNYLNLSRNHLN 563
+ N++ ++ S L L LS N +
Sbjct: 331 LDHNSIV-TLKL--STHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-34
Identities = 70/500 (14%), Positives = 155/500 (31%), Gaps = 38/500 (7%)
Query: 73 LDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQFSGG 129
+ + + + L+ ++ + + + ++ LN+++ Q
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEI 90
Query: 130 LDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLE 189
+ ++ ++ N L P + L L L N + L
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 190 YLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDG 249
LS++ N+L T+L+ + L N + + +L H ++S L
Sbjct: 151 TLSMSNNNLERIEDDTFQATTSLQNLQL-SSNRLT-HVDL--SLIPSLFHANVSYNLL-- 204
Query: 250 QIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQL 309
+ ++ + N ++ + L L L +N LT + +N L
Sbjct: 205 ---STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTA-WLLNYPGL 256
Query: 310 KLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTG 369
+L N L + + LE L + N + L+VLDLS N L
Sbjct: 257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL- 314
Query: 370 TIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGL 429
+ + ++L L L N + + L ++L + L N + +
Sbjct: 315 HVERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHNDWDCN----------- 360
Query: 430 NLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQIL-LLSGN 488
+L L N ++ + +L L L + ++ +
Sbjct: 361 SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRA 420
Query: 489 QFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISN 548
Q +I ++ + + + + + + L L+ +
Sbjct: 421 QGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLE--AEVNELRAEVQQLTNEQIQQEQL 478
Query: 549 VRILNYLNLSRNHLNQNIPK 568
++ L+ + N +PK
Sbjct: 479 LQGLH-AEIDTNLRRYRLPK 497
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-33
Identities = 66/362 (18%), Positives = 126/362 (34%), Gaps = 23/362 (6%)
Query: 227 IPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLV 286
I + + + D E L V + + L + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 287 NLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGV 346
L+L++ + Y+F ++ + N + P ++P L L L +N+ + +
Sbjct: 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 138
Query: 347 IPENLGQNGKLQVLDLSSNKLTGTIPTD-LCSSNQLRILILLKNFLFGPIPERLGACYSL 405
KL L +S+N L I D ++ L+ L L N L + L SL
Sbjct: 139 PRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPSL 194
Query: 406 TRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNL 465
+ N L+ ++ + + N ++ + N L L L +N
Sbjct: 195 FHANVSYNLLS-TLAI----PIAVEELDASHNSIN-VVRGPVNVE-----LTILKLQHNN 243
Query: 466 LSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYC 525
L+ L N+ L + LS N+ + +++++ +L +S N L +
Sbjct: 244 LT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 300
Query: 526 NHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFND 585
L LD+S N+L + L L L N + + + + +L S ND
Sbjct: 301 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHND 356
Query: 586 FS 587
+
Sbjct: 357 WD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-33
Identities = 71/357 (19%), Positives = 127/357 (35%), Gaps = 36/357 (10%)
Query: 266 LHINLLSGSIPKQL--GNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSI 323
+HI++ + + L N + N+ + + RQ++L NL ++
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 91
Query: 324 PDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSN-QLR 382
A ++ L + N + P L VL L N L+ ++P + + +L
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT 150
Query: 383 ILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGS 442
L + N L + A SL ++L N L + +P L A + N LS
Sbjct: 151 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-- 205
Query: 443 LPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELR 502
+ + P + +L+ S+N ++ L IL L N + +
Sbjct: 206 ------TLAIPIAVEELDASHNSINV---VRGPVNVELTILKLQHNNLTD--TAWLLNYP 254
Query: 503 QVLKLDLSRNSLSGEIPP-AIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNH 561
++++DLS N L +I L L +S N L ++ + L L+LS NH
Sbjct: 255 GLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 312
Query: 562 LNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNNP 618
L ++ ++ L N S+ L TL +N
Sbjct: 313 L-LHVERNQPQFDRLENLYLDHN----------SIVTLKLSTHHTLKNL--TLSHND 356
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-31
Identities = 74/467 (15%), Positives = 147/467 (31%), Gaps = 36/467 (7%)
Query: 112 NLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGG 171
++I + +L N ++ N+ L + +++ L+L
Sbjct: 25 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 84
Query: 172 NYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV 231
++ ++ L + N + P N+ L + L N +PR +
Sbjct: 85 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL-ERNDLS-SLPRGI 142
Query: 232 -GKLVNLVHLDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLD 289
L L +S+ L+ +I + L + L N L+ + L + +L + +
Sbjct: 143 FHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHAN 198
Query: 290 LSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPE 349
+S N L+ + ++ + N ++ + L L L NN T
Sbjct: 199 VSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTDT--A 248
Query: 350 NLGQNGKLQVLDLSSNKLTGTIPTDLCSS-NQLRILILLKNFLFGPIPERLGACYSLTRV 408
L L +DLS N+L I +L L + N L + +L +
Sbjct: 249 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVL 306
Query: 409 RLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNN-LLS 467
L N+L + L L N + +L + + + L L LS+N
Sbjct: 307 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHT-----LKNLTLSHNDWDC 359
Query: 468 GPLPFSLSNFSSLQILLLSGNQFSGPIPP-------SIGELRQVLKLDLSRNSLSGEIPP 520
L N + + + S L ++ S+ ++
Sbjct: 360 NSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQR 419
Query: 521 AIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIP 567
A G C+ ++ Q+ ++ L N L +
Sbjct: 420 AQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ 466
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 59/322 (18%), Positives = 114/322 (35%), Gaps = 42/322 (13%)
Query: 290 LSNNALTGEIPYSFINLR---QLKLFNLFMNRLHGSIPDYLAD--LPNLETLGLWQNNFT 344
N + Y I+ +++ ++ + D L N + + +
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 345 GVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYS 404
+ L ++++L+L+ ++ ++ ++ L + N + P
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 124
Query: 405 LTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSN 463
LT + L +N L+ S+P G F P L + +N L + + ++ L L LS+
Sbjct: 125 LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIED--DTFQATTSLQNLQLSS 180
Query: 464 NLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIP---- 519
N L+ LS SL +S N S ++ V +LD S NS++ +
Sbjct: 181 NRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN 231
Query: 520 ----------------PAIGYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHL 562
+ L +D+S N L I ++ L L +S N L
Sbjct: 232 VELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL 290
Query: 563 NQNIPKSIGSMKSLTIADFSFN 584
+ + +L + D S N
Sbjct: 291 -VALNLYGQPIPTLKVLDLSHN 311
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 7e-12
Identities = 51/300 (17%), Positives = 106/300 (35%), Gaps = 16/300 (5%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLD 131
LD + N V + +LT L L NN T + + N L +++S N+ +
Sbjct: 215 ELDASH-NSINVVRGPVNV--ELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMY 271
Query: 132 WNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYL 191
+ + LE NN A L + + LK LDL N+ + + + LE L
Sbjct: 272 HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNH-LLHVERNQPQFDRLENL 329
Query: 192 SLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQI 251
L N + + L L+ + L +N ++ R + N+ + + +I
Sbjct: 330 YLDHNSIV-TLK--LSTHHTLKNLTL-SHNDWDCNSLRAL--FRNVARPAVDDADQHCKI 383
Query: 252 PHEIGNLKL---LDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQ 308
+++ + D +L L ++ + + + + + S +Q
Sbjct: 384 DYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQ 443
Query: 309 LKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLT 368
+ +L + + A++ L + Q + + + L+ L + L
Sbjct: 444 GGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEI--DTNLRRYRLPKDGLA 501
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
E +K +G G G V+ ++AVK + F AE + ++H +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKL 245
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
V+L A + KE ++ E+M GSL + L +G+ + + A+G+ ++
Sbjct: 246 VKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--- 301
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI---APEYA 862
+HRD+++ NIL++++ +ADFGLA+ + D +A G+ I APE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEAI 357
Query: 863 YTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD-- 919
KSDV+SFG++L+E++T GR P +N E + L+
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-------------SN---PEVIRALERG 401
Query: 920 ---PRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSS 966
PR P+E L+ M+ C + ERP + +L +F +
Sbjct: 402 YRMPRPENCPEE-----LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-34
Identities = 80/283 (28%), Positives = 120/283 (42%), Gaps = 25/283 (8%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
E ++ +G+G G V+ G +A+K L F E Q + +RH +
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKL 324
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
V+L A S +E +V EYM GSL + L G+ G +L +A + A G+ Y+
Sbjct: 325 VQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--- 380
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
VHRD+++ NIL+ VADFGLA+ LI+ + APE A
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 866 RVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924
R KSDV+SFG++L EL T GR P +++ +R R M
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVER--GYR-------------M 483
Query: 925 VPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSS 966
E L M C ++ ERP + L ++ +
Sbjct: 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 74/300 (24%), Positives = 118/300 (39%), Gaps = 46/300 (15%)
Query: 686 ECVKDGNVIGRGGAGIVYHG--KMPNGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNIR 741
E V ++G G G VY G G +I AVK T + F +E + N+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
H +IV+L+ +E ++ E G LG L K + L +++ K + YL
Sbjct: 72 HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYSLQICKAMAYL 129
Query: 802 --HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-- 857
+ VHRD+ NIL+ S + DFGL++++ D S +
Sbjct: 130 ESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE------DYYKASVTRLPI 178
Query: 858 ---APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEE 913
+PE R SDV+ F V + E+L+ G++P + D++ G
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIG---VLEKGD--- 231
Query: 914 FLSILDPRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSDFNQ 970
RL P ++ L M C + +RPR E+V LS+ + D
Sbjct: 232 -------RLPK-PDLCPPVLYTL---MTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 280
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 64/288 (22%), Positives = 121/288 (42%), Gaps = 35/288 (12%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
+ + +G G G+V +GK ++A+K + + F E + + N+ H +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKL 81
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL--HH 803
V+L C+ + ++ EYM NG L L + F L + + + + YL
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-MCKDVCEAMEYLESKQ 140
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI---APE 860
+HRD+ + N L+N V+DFGL+++++D + ++ GS + PE
Sbjct: 141 -----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWSPPE 191
Query: 861 YAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919
+ KSD+++FGV++ E+ + G+ P F TN E +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-------------TN---SETAEHIA 235
Query: 920 PRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSS 966
L + A ++ M C E + ERP + ++ + + S
Sbjct: 236 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 71/297 (23%), Positives = 113/297 (38%), Gaps = 34/297 (11%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMP-----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI 740
+K +G G G V + G ++AVK L +H + EI+ L N+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 741 RHRNIVRLLAFCSNKETN--LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGL 798
H NIV+ C+ N L+ E++ +GSL E L K A++ KG+
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK-YAVQICKGM 139
Query: 799 CYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI- 857
YL S VHRD+ + N+L+ S + + DFGL K + E +
Sbjct: 140 DYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD--KEYYTVKDD--RDSP 192
Query: 858 ----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKE 912
APE + SDV+SFGV L ELLT + ++ +
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV--T 250
Query: 913 EFLSILD-----PRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPR 963
++ L P P E ++ L M C + R + +++ +
Sbjct: 251 RLVNTLKEGKRLPCPPNCPDE--VYQL---MRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 67/285 (23%), Positives = 127/285 (44%), Gaps = 39/285 (13%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
+ IG G G+V+ G N ++A+K + D F E + + + H +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKL 65
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL--HH 803
V+L C + LV E+M +G L + L ++G F L + ++ +G+ YL
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG-MCLDVCEGMAYLEEAC 124
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI---APE 860
++HRD+ + N L+ V+DFG+ +F++D + ++ G+ + +PE
Sbjct: 125 -----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKFPVKWASPE 175
Query: 861 YAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919
R KSDV+SFGV++ E+ + G+ P + ++V+ + G
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVE---DISTGF--------- 222
Query: 920 PRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEF 961
RL P+ ++ + M C +E +RP +++ L+E
Sbjct: 223 -RLYK-PRLASTHVYQI---MNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 67/293 (22%), Positives = 114/293 (38%), Gaps = 35/293 (11%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNG-VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
+ + +G G G VY G + +AVK L + F E + I+H N
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 70
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
+V+LL C+ + ++ E+M G+L + L + + +A + + + YL
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-----AP 859
+HRD+ + N L+ VADFGL++ + + A + AP
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAP 181
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
E + KSDV++FGV+L E+ T G P + +L
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------------DL---SQVYELL 225
Query: 919 DPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSDFNQ 970
+ M E ++ M C Q N +RP E+ Q + SS ++
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 278
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
E +K +G G G V+ G ++AVK L F AE + ++H+ +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRL 70
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
VRL A + +E ++ EYM NGSL + L G L N +A + A+G+ ++
Sbjct: 71 VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-----APE 860
+HRD+++ NIL++ +ADFGLA+ + D A APE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN------EYTAREGAKFPIKWTAPE 180
Query: 861 YAYTLRVDEKSDVYSFGVVLLELLT-GRRP 889
KSDV+SFG++L E++T GR P
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 76/317 (23%), Positives = 117/317 (36%), Gaps = 35/317 (11%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMP-----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI 740
+K + +G+G G V + G +AVK+L G F+ EIQ L +
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKAL 81
Query: 741 RHRNIVRLLAFCSNKETN--LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGL 798
IV+ LV EY+ +G L + L + L + + KG+
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-LLYSSQICKGM 140
Query: 799 CYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI- 857
YL S VHRD+ + NIL+ S +ADFGLAK L+ + G
Sbjct: 141 EYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAK-LLPLDKDY---YVVREPGQSP 193
Query: 858 ----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKE 912
APE +SDV+SFGVVL EL T + + + ++ +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS-- 251
Query: 913 EFLSILD-----PRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSS 966
L +L+ P P E +H L M C + +RP + L S
Sbjct: 252 RLLELLEEGQRLPAPPACPAE--VHEL---MKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306
Query: 967 DFNQSSSSSLKNLEKDP 983
+ ++ +
Sbjct: 307 GCETHAFTAHPEGKHHS 323
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 90/306 (29%), Positives = 134/306 (43%), Gaps = 44/306 (14%)
Query: 686 ECVKDGNVIGRGGAGIVYHG--KMPNG---VEIAVKKLLGFGTHSHDHGFRAEIQTLGNI 740
CV VIG G G VY G K +G V +A+K L T F E +G
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 741 RHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
H NI+RL S + +++ EYM NG+L + L K G F L + A G+ Y
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL-VGMLRGIAAGMKY 162
Query: 801 L--HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI- 857
L + VHRD+ + NIL+NS V+DFGL++ L D + + S G I
Sbjct: 163 LANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLED----DPEATYTTSGGKIP 213
Query: 858 ----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKE 912
APE + SDV+SFG+V+ E++T G RP + +++ K +G
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVM---KAINDGF-- 267
Query: 913 EFLSILDPRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSDFN 969
RL P + A++ L M+ C Q+ RP+ ++V +L + R
Sbjct: 268 --------RLPT-PMDCPSAIYQL---MMQCWQQERARRPKFADIVSILDKLIRAPDSLK 315
Query: 970 QSSSSS 975
+
Sbjct: 316 TLADFD 321
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 70/315 (22%), Positives = 125/315 (39%), Gaps = 46/315 (14%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKM-----PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI 740
++ V+G G G V+ G + + +K + + +G++
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 741 RHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
H +IVRLL C + LV +Y+ GSL + + +GA L ++ AKG+ Y
Sbjct: 73 DHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-LNWGVQIAKGMYY 130
Query: 801 L--HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI- 857
L H +VHR++ + N+LL S + VADFG+A L + S
Sbjct: 131 LEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK-----QLLYSEAKTP 180
Query: 858 ----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKE 912
A E + + +SDV+S+GV + EL+T G P ++ ++ G
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEK---GE-- 234
Query: 913 EFLSILDPRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSDFN 969
RL+ P+ ++++ M+ C + RP +E+ + R +
Sbjct: 235 --------RLAQ-PQICTIDVYMV---MVKCWMIDENIRPTFKELANEFTRMARDPPRYL 282
Query: 970 QSSSSSLKNLEKDPK 984
S + P+
Sbjct: 283 VIKRESGPGIAPGPE 297
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 86/290 (29%), Positives = 123/290 (42%), Gaps = 39/290 (13%)
Query: 686 ECVKDGNVIGRGGAGIVYHG--KMPNGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNIR 741
V VIGRG G VYHG +G +I AVK L F E + +
Sbjct: 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 84
Query: 742 HRNIVRLLAFCSNKETNLL-VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
H N++ LL C E + L V YM++G L + + +L ++ AKG+ Y
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKY 143
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI--- 857
L S VHRD+ + N +L+ F VADFGLA+ + D E S + +
Sbjct: 144 LA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD---KEYYSVHNKTGAKLPVK 197
Query: 858 --APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEF 914
A E T + KSDV+SFGV+L EL+T G P V+ + GR
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP----DVNTFDITVYLLQGR---- 249
Query: 915 LSILDPRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEF 961
RL P+ + ++ + ML C + RP E+V +S
Sbjct: 250 ------RLLQ-PEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 68/299 (22%), Positives = 114/299 (38%), Gaps = 46/299 (15%)
Query: 686 ECVKDGNVIGRGGAGIVYHG--KMPNG---VEIAVKKLLGFGTHSHDHGFRAEIQTLGNI 740
K V+G G G VY G + +A+K+L + + E + ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 741 RHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
+ ++ RLL C T L+ + M G L + + K L ++ AKG+ Y
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAKGMNY 132
Query: 801 L--HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI- 857
L +VHRD+ + N+L+ + + DFGLAK L G +
Sbjct: 133 LEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVP 182
Query: 858 ----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKE 912
A E +SDV+S+GV + EL+T G +P +I G
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISS---ILEKGE-- 236
Query: 913 EFLSILDPRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSDF 968
RL P ++++ M C ++ RP+ RE++ S+ R +
Sbjct: 237 --------RLPQ-PPICTIDVYMI---MRKCWMIDADSRPKFRELIIEFSKMARDPQRY 283
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-33
Identities = 77/332 (23%), Positives = 131/332 (39%), Gaps = 59/332 (17%)
Query: 644 LICSLIFATAAIIKAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVY 703
L LI + + W ++ ++ K IG+G G V
Sbjct: 163 LCTRLIKPKVMEGTVAAQDEFYRSGW--------ALNMKEL----KLLQTIGKGEFGDVM 210
Query: 704 HGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL-LVY 762
G G ++AVK + + F AE + +RH N+V+LL ++ L +V
Sbjct: 211 LGDY-RGNKVAVKCIKN-DATAQA--FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266
Query: 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL-HHDCSPLIVHRDVKSNNILL 821
EYM GSL + L + + LG + K +++ + + YL ++ VHRD+ + N+L+
Sbjct: 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLV 322
Query: 822 NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-----APEYAYTLRVDEKSDVYSF 876
+ A V+DFGL K G + APE + KSDV+SF
Sbjct: 323 SEDNVAKVSDFGLTKEASS----------TQDTGKLPVKWTAPEALREKKFSTKSDVWSF 372
Query: 877 GVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKE--EAMHL 933
G++L E+ + GR P + + R G ++ P A++
Sbjct: 373 GILLWEIYSFGRVPY----PRIPLKDVVPRVEKGY----------KMDA-PDGCPPAVYD 417
Query: 934 LFVAML-CIQENSIERPRMREVVQMLSEFPRH 964
+ M C ++ RP ++ + L H
Sbjct: 418 V---MKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 85/296 (28%), Positives = 123/296 (41%), Gaps = 39/296 (13%)
Query: 686 ECVKDGNVIGRGGAGIVYHG--KMPNGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNIR 741
V VIGRG G VYHG +G +I AVK L F E + +
Sbjct: 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 148
Query: 742 HRNIVRLLAFCSNKETNLL-VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
H N++ LL C E + L V YM++G L + + +L ++ AKG+ +
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKF 207
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI--- 857
L S VHRD+ + N +L+ F VADFGLA+ + D E S + +
Sbjct: 208 LA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD---KEFDSVHNKTGAKLPVK 261
Query: 858 --APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEF 914
A E T + KSDV+SFGV+L EL+T G P V+ + GR
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP----DVNTFDITVYLLQGR---- 313
Query: 915 LSILDPRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSD 967
RL P+ + ++ + ML C + RP E+V +S
Sbjct: 314 ------RLLQ-PEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 93/504 (18%), Positives = 152/504 (30%), Gaps = 100/504 (19%)
Query: 71 ASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGL 130
AS + + +L LT+L ++ T I L+ L L ++N + L
Sbjct: 21 ASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT-TL 79
Query: 131 DWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEY 190
D S NL +N T L + L KL YL+ N + L Y
Sbjct: 80 DL--SQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKL---TKLDVSQNPLLTY 131
Query: 191 LSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQ 250
L+ A N LT +I + + T L E+ +V L LD S ++
Sbjct: 132 LNCARNTLT-EID--VSHNTQLTELDCHLNKKIT---KLDVTPQTQLTTLDCSFNKITE- 184
Query: 251 IPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLK 310
++ KLL+ + N ++ + L L LD S+N LT
Sbjct: 185 --LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-------------- 225
Query: 311 LFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGT 370
I + L L N T + ++ KL L L
Sbjct: 226 -----------EID--VTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL-E 268
Query: 371 IPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLN 430
I DL + QL + + L + +
Sbjct: 269 I--DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-------------- 310
Query: 431 LAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQF 490
L + N L L L+N L+ +S+ + L+ L
Sbjct: 311 -----------ELDLSQNPK-----LVYLYLNNTELTE---LDVSHNTKLKSLSCVNAHI 351
Query: 491 SGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTY------LDMSQNNLSGSIPP 544
S+G++ + + +P N LT LD N + +I P
Sbjct: 352 QD--FSSVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPM--NIEP 406
Query: 545 EISNVRILNYLNLSRNHLNQNIPK 568
V ++ +L+ + P
Sbjct: 407 GDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-31
Identities = 85/477 (17%), Positives = 154/477 (32%), Gaps = 55/477 (11%)
Query: 124 NQFSGGLDWNYSSLV---NLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPN 180
N G +++ N A A + +L L LD + +
Sbjct: 1 NTLKAGQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSS-ITDMTG 59
Query: 181 SYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHL 240
+L GL L N++T + L TNL + N + V L L +L
Sbjct: 60 -IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLAC-DSNKLT-NLD--VTPLTKLTYL 111
Query: 241 DLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIP 300
+ + +L ++ LL + N L+ I + + T L LD N ++
Sbjct: 112 NCDTNKL---TKLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD 165
Query: 301 YSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVL 360
QL + N++ + ++ L L NN T + +L QN +L L
Sbjct: 166 --VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFL 217
Query: 361 DLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIP 420
D SSNKLT I D+ QL N L + + LT + Q L
Sbjct: 218 DCSSNKLT-EI--DVTPLTQLTYFDCSVNPL-TELD--VSTLSKLTTLHCIQTDLL---- 267
Query: 421 DGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSL 480
+ + +L G ++ +L L+ ++ LS L
Sbjct: 268 ----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKL 320
Query: 481 QILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSG 540
L L+ + + + + ++ L + + +G L ++
Sbjct: 321 VYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTIT 375
Query: 541 SIPPEISNVRI-----LNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPE 592
++N + + L+ N + NI G + ++ + S P
Sbjct: 376 MPKETLTNNSLTIAVSPDLLDQFGNPM--NIEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 43/292 (14%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNG----VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR 741
VIG+G G+VYHG+ + ++ A+K L F E + +
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 742 HRNIVRLLAFCSNKE-TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
H N++ L+ E ++ YM +G L + + + +L ++ A+G+ Y
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARGMEY 139
Query: 801 L--HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI- 857
L VHRD+ + N +L+ +F VADFGLA+ ++D E S + +
Sbjct: 140 LAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILD---REYYSVQQHRHARLP 191
Query: 858 ----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKE 912
A E T R KSDV+SFGV+L ELLT G P +D + GR
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR----HIDPFDLTHFLAQGR-- 245
Query: 913 EFLSILDPRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEF 961
RL P+ ++++ + M C + + RP R +V + +
Sbjct: 246 --------RLPQ-PEYCPDSLYQV---MQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 70/287 (24%), Positives = 120/287 (41%), Gaps = 41/287 (14%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
+ +K IG+G G V G G ++AVK + + F AE + +RH N+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQA--FLAEASVMTQLRHSNL 76
Query: 746 VRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
V+LL ++ L +V EYM GSL + L + + LG + K +++ + + YL
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 134
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-----AP 859
VHRD+ + N+L++ A V+DFGL K + G + AP
Sbjct: 135 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----------SSTQDTGKLPVKWTAP 183
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
E + KSDV+SFG++L E+ + GR P ++ + +
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------------PL---KDVVPRV 227
Query: 919 DPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRH 964
+ M + ++ M C ++ RP ++ + L H
Sbjct: 228 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 80/325 (24%), Positives = 122/325 (37%), Gaps = 54/325 (16%)
Query: 665 GSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMP-----NGVEIAVKKLL 719
GSD +F + K +G+G G V + G +AVKKL
Sbjct: 1 GSDPT--------QFEERHL----KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ 48
Query: 720 GFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC--SNKETNLLVYEYMRNGSLGEALHGK 777
T H F EI+ L +++H NIV+ C + + L+ EY+ GSL + L
Sbjct: 49 H-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH 107
Query: 778 KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837
K L + KG+ YL + +HRD+ + NIL+ + + DFGL K
Sbjct: 108 KERIDHIKLLQ-YTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV 163
Query: 838 LIDGGASECMSAIAGSYGYI---APEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFG 894
L E I APE + SDV+SFGVVL EL T +
Sbjct: 164 LPQD--KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-------YI 214
Query: 895 DGVDIVQWSKRATNGRK-------EEFLSILD-----PRLSMVPKEEAMHLLFVAML-CI 941
+ G + +L PR P E ++++ M C
Sbjct: 215 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE--IYMI---MTECW 269
Query: 942 QENSIERPRMREVVQMLSEFPRHSS 966
N +RP R++ + + + +
Sbjct: 270 NNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 60/290 (20%), Positives = 114/290 (39%), Gaps = 49/290 (16%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
E + +G G G+V GK ++AVK + + F E QT+ + H +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE--FFQEAQTMMKLSHPKL 65
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL--HH 803
V+ CS + +V EY+ NG L L L + + +G+ +L H
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE-MCYDVCEGMAFLESHQ 124
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-----A 858
+HRD+ + N L++ V+DFG+ ++++D ++ A
Sbjct: 125 -----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD------QYVSSVGTKFPVKWSA 173
Query: 859 PEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917
PE + + KSDV++FG+++ E+ + G+ P + TN E +
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-------------TN---SEVVLK 217
Query: 918 LD-----PRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEF 961
+ R + ++ M C E +RP ++++ +
Sbjct: 218 VSQGHRLYRPHLASDT-----IYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 43/293 (14%)
Query: 694 IGRGGAGIVYHG--KMPNG-VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
+G G G V G +M +++A+K L + E Q + + + IVRL+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL--HHDCSPL 808
C E +LV E G L + L GK+ N+ ++ + + G+ YL +
Sbjct: 78 VCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEKN----- 130
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-----APEYAY 863
VHRD+ + N+LL + A ++DFGL+K L +A + G APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD--DSYYTARSA--GKWPLKWYAPECIN 186
Query: 864 TLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922
+ +SDV+S+GV + E L+ G++P G +++ G+ R+
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMA---FIEQGK----------RM 232
Query: 923 SMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSDFNQSS 972
P E ++ L M C +RP V Q + + +
Sbjct: 233 EC-PPECPPELYAL---MSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 61/322 (18%), Positives = 114/322 (35%), Gaps = 41/322 (12%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRH--RNIVR 747
IG GG+ V+ A+K + L + +R EI L ++ I+R
Sbjct: 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH-HDCS 806
L + + +V E N L L KK + W + + + +H H
Sbjct: 74 LYDYEITDQYIYMVMECG-NIDLNSWLK-KKKSIDPWERKS-YWKNMLEAVHTIHQHG-- 128
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE------ 860
IVH D+K N L+ + DFG+A + S + G+ Y+ PE
Sbjct: 129 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 861 -----YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE-EF 914
++ KSDV+S G +L + G+ P F ++ + + E EF
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---FQQIINQISKLHAIIDPNHEIEF 242
Query: 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ---MLSEFPRHSSDFNQS 971
I + + +L C++ + +R + E++ + + + +
Sbjct: 243 PDIPEK--------DLQDVL---KCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 291
Query: 972 SSSSLKNLEKDPKGCPNNKLKQ 993
+ L + N + +
Sbjct: 292 TEEMKYVLGQLVGLNSPNSILK 313
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 59/321 (18%), Positives = 112/321 (34%), Gaps = 39/321 (12%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRH--RNIVR 747
IG GG+ V+ A+K + L + +R EI L ++ I+R
Sbjct: 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH-HDCS 806
L + + +V E N L L KK + W + + + +H H
Sbjct: 121 LYDYEITDQYIYMVMECG-NIDLNSWLK-KKKSIDPWERKS-YWKNMLEAVHTIHQHG-- 175
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE------ 860
IVH D+K N L+ + DFG+A + S + G+ Y+ PE
Sbjct: 176 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 861 -----YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915
++ KSDV+S G +L + G+ P + + + + EF
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH--AIIDPNHEIEFP 290
Query: 916 SILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ---MLSEFPRHSSDFNQSS 972
I + + +L C++ + +R + E++ + + + ++
Sbjct: 291 DIPEK--------DLQDVL---KCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 339
Query: 973 SSSLKNLEKDPKGCPNNKLKQ 993
L + N + +
Sbjct: 340 EEMKYVLGQLVGLNSPNSILK 360
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 54/314 (17%), Positives = 110/314 (35%), Gaps = 64/314 (20%)
Query: 686 ECVKDGNVIGRGGAGIVYHGK--------MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTL 737
E + +G+G ++ G + E+ +K L ++ F +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNYSESFFEAASMM 66
Query: 738 GNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKG 797
+ H+++V C + N+LV E+++ GSL L K ++A + A
Sbjct: 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-LEVAKQLAAA 125
Query: 798 LCYL--HHDCSPLIVHRDVKSNNILLNSAFEAH--------VADFGLAKFLIDGGASECM 847
+ +L + ++H +V + NILL + ++D G++ ++
Sbjct: 126 MHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------- 173
Query: 848 SAIAGSYGYI-----APE-YAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIV 900
PE ++ +D +SFG L E+ + G +P+ D +
Sbjct: 174 ----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-DSQRKL 228
Query: 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLS 959
Q + +L PK + L + C+ RP R +++ L+
Sbjct: 229 Q---FYEDRH----------QLPA-PKAAELANL---INNCMDYEPDHRPSFRAIIRDLN 271
Query: 960 EFPRHSSDFNQSSS 973
+ D S
Sbjct: 272 SL--FTPDLVPRGS 283
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 21/216 (9%)
Query: 686 ECVKDGNVIGRGGAGIVYHG--KMPNGVEI--AVKKLLGFGTHSHDHG--FRAEIQTLGN 739
+ ++ +G G G+V G P+G + AVK L + F E+ + +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 740 IRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLC 799
+ HRN++RL +V E GSL + L +G FL L + A++ A+G+
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL-SRYAVQVAEGMG 135
Query: 800 YL--HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGS---Y 854
YL +HRD+ + N+LL + + DFGL + L + +
Sbjct: 136 YLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN--DDHYVMQEHRKVPF 188
Query: 855 GYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRP 889
+ APE T SD + FGV L E+ T G+ P
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 77/335 (22%), Positives = 120/335 (35%), Gaps = 48/335 (14%)
Query: 651 ATAAIIKAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMP-- 708
I ++ G+ +F + K +G+G G V +
Sbjct: 10 HDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHL----KFLQQLGKGNFGSVEMCRYDPL 65
Query: 709 ---NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN--LLVYE 763
G +AVKKL T H F EI+ L +++H NIV+ C + L+ E
Sbjct: 66 QDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS 823
Y+ GSL + L K L + KG+ YL + +HRD+ + NIL+ +
Sbjct: 125 YLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKGMEYLG---TKRYIHRDLATRNILVEN 180
Query: 824 AFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-----APEYAYTLRVDEKSDVYSFGV 878
+ DFGL K L G APE + SDV+SFGV
Sbjct: 181 ENRVKIGDFGLTKVLPQDK----EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236
Query: 879 VLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK-------EEFLSILDP--RLSMVPKE- 928
VL EL T + + G + +L RL P
Sbjct: 237 VLYELFT-------YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-PDGC 288
Query: 929 -EAMHLLFVAML-CIQENSIERPRMREVVQMLSEF 961
+ ++++ M C N +RP R++ + +
Sbjct: 289 PDEIYMI---MTECWNNNVNQRPSFRDLALRVDQI 320
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 693 VIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRA----EIQTLGNIRHRNIVR 747
++GRGG G VY + +A+K + T S D FR E +T G ++ ++V
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSE--TLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
+ F + + L L ++G L I + L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLR-RQGP-LAPPRAVAIVRQIGSALDAAHAAG-- 154
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
HRDVK NIL+++ A++ DFG+A D ++ + + G+ Y+APE
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESHA 212
Query: 868 DEKSDVYSFGVVLLELLTGRRP-VGD 892
++D+Y+ VL E LTG P GD
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGD 238
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHG----FRAEIQTLGNIRHRNIVRL 748
+G GG VY + +++A+K + F F E+ + H+NIV +
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAI--FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
+ + LV EY+ +L E + G L + + G+ + H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGP-LSVDTAINFTNQILDGIKHAHDMR--- 131
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVD 868
IVHRD+K NIL++S + DFG+AK L + ++ + + G+ Y +PE A D
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATD 190
Query: 869 EKSDVYSFGVVLLELLTGRRP-VGD 892
E +D+YS G+VL E+L G P G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGE 215
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 57/281 (20%), Positives = 103/281 (36%), Gaps = 36/281 (12%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRN--IVR 747
IG GG+ V+ A+K + L + +R EI L ++ + I+R
Sbjct: 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH-HDCS 806
L + + +V E N L L KK + W + + + +H H
Sbjct: 93 LYDYEITDQYIYMVMECG-NIDLNSWLK-KKKSIDPWERKS-YWKNMLEAVHTIHQHG-- 147
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE------ 860
IVH D+K N L+ + DFG+A + S + G+ Y+ PE
Sbjct: 148 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 861 -----YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915
++ KSDV+S G +L + G+ P + + + + EF
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH--AIIDPNHEIEFP 262
Query: 916 SILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
I + + +L C++ + +R + E++
Sbjct: 263 DIPEK--------DLQDVL---KCCLKRDPKQRISIPELLA 292
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 71/292 (24%), Positives = 114/292 (39%), Gaps = 48/292 (16%)
Query: 686 ECVKDGNVIGRGGAGIVYHG--KMPNGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNIR 741
E ++ G IG G G V+ G P + A+K + S F E T+
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
H +IV+L+ + + ++ E G L L +K + +L A + + L YL
Sbjct: 75 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASL-ILYAYQLSTALAYL 132
Query: 802 -HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI--- 857
VHRD+ + N+L++S + DFGL++++ D + S G +
Sbjct: 133 ESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPIK 182
Query: 858 --APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEF 914
APE R SDV+ FGV + E+L G +P N +
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------------KN---NDV 226
Query: 915 LSILDP--RLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEF 961
+ ++ RL M P ++ L M C + RPR E+ LS
Sbjct: 227 IGRIENGERLPM-PPNCPPTLYSL---MTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 53/247 (21%), Positives = 90/247 (36%), Gaps = 28/247 (11%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
+++G+G V+ G+ G A+K E + L + H+NIV+L
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 750 AFCSNKETNL--LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEA----AKGLCYLHH 803
A T L+ E+ GSL L A+ L + G+ +L
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY---GLPESEFLIVLRDVVGGMNHLR- 129
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAH----VADFGLAKFLIDGGASECMSAIAGSYGYIAP 859
IVHR++K NI+ + + DFG A+ L D E ++ G+ Y+ P
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHP 184
Query: 860 E--------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK 911
+ + + D++S GV TG P F + + G+
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 912 EEFLSIL 918
+S +
Sbjct: 245 SGAISGV 251
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 18/213 (8%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHG----FRAEIQTLGNIRHRNI 745
G ++G GG V+ + + + ++AVK L + D FR E Q + H I
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 746 VRLL----AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
V + A +V EY+ +L + +H +G + ++ +A + L +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGP-MTPKRAIEVIADACQALNFS 132
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM-SAIAGSYGYIAPE 860
H + I+HRDVK NI++++ V DFG+A+ + D G S +A+ G+ Y++PE
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 861 YAYTLRVDEKSDVYSFGVVLLELLTGRRP-VGD 892
A VD +SDVYS G VL E+LTG P GD
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 75/305 (24%), Positives = 121/305 (39%), Gaps = 34/305 (11%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPN-----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI 740
+K +G G G V G +AVK L H G++ EI L +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 741 RHRNIVRLLAFCSNKETN--LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGL 798
H +I++ C + LV EY+ GSL + L +G A + +G+
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGM 147
Query: 799 CYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGS----Y 854
YLH + +HRD+ + N+LL++ + DFGLAK + +G + S Y
Sbjct: 148 AYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204
Query: 855 GYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEE 913
APE + SDV+SFGV L ELLT ++++ ++
Sbjct: 205 ---APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL--R 259
Query: 914 FLSILDP--RLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSDF 968
+L+ RL P + ++ L M C + + RP ++ +L H
Sbjct: 260 LTELLERGERLPR-PDKCPAEVYHL---MKNCWETEASFRPTFENLIPILKTV--HEKYQ 313
Query: 969 NQSSS 973
Q+ S
Sbjct: 314 GQAPS 318
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-32
Identities = 71/296 (23%), Positives = 114/296 (38%), Gaps = 46/296 (15%)
Query: 686 ECVKDGNVIGRGGAGIVYHG--KMPNGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNIR 741
E ++ G IG G G V+ G P + A+K + S F E T+
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
H +IV+L+ + + ++ E G L L +K + +L A + + L YL
Sbjct: 450 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASL-ILYAYQLSTALAYL 507
Query: 802 H-HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI--- 857
VHRD+ + N+L++S + DFGL++++ D + S G +
Sbjct: 508 ESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPIK 557
Query: 858 --APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEF 914
APE R SDV+ FGV + E+L G +P N +
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------------KN---NDV 601
Query: 915 LSILDP--RLSMVPK-EEAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSS 966
+ ++ RL M P ++ L M C + RPR E+ LS
Sbjct: 602 IGRIENGERLPMPPNCPPTLYSL---MTKCWAYDPSRRPRFTELKAQLSTILEEEK 654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-32
Identities = 73/313 (23%), Positives = 121/313 (38%), Gaps = 44/313 (14%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLL 749
+V+G G G + + M + ++AVK++L E+Q L H N++R
Sbjct: 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILP----ECFSFADREVQLLRESDEHPNVIRYF 84
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLI 809
+++ + E +L E + K A LG + + GL +LH S I
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLH---SLNI 139
Query: 810 VHRDVKSNNILL-----NSAFEAHVADFGLAKFLIDGGAS-ECMSAIAGSYGYIAPEY-- 861
VHRD+K +NIL+ + +A ++DFGL K L G S S + G+ G+IAPE
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 862 -AYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919
D++S G V +++ G P FG + G +
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHP---FGKSLQRQA---NILLGACSLDCLHPE 253
Query: 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREV--------VQMLSEFPRHSSD---F 968
A L+ I + +RP + V ++ +F + SD
Sbjct: 254 KHED----VIARELI---EKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEK 306
Query: 969 NQSSSSSLKNLEK 981
+K LE+
Sbjct: 307 ESLDGPIVKQLER 319
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 68/324 (20%), Positives = 119/324 (36%), Gaps = 54/324 (16%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNG----VEIAVKKL-LGFGTHSHDHGFRAEIQTLGNI 740
+ G ++G+G G V ++ V++AVK L S F E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 741 RHRNIVRLLAFCSNKETN------LLVYEYMRNGSLGEALHGKKGAFLGWNLRYK----I 790
H ++ +L+ +++ +M++G L L + +NL +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 791 AIEAAKGLCYL--HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS 848
++ A G+ YL + +HRD+ + N +L VADFGL++ + G
Sbjct: 143 MVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR--- 194
Query: 849 AIAGSYGYI-----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQW 902
G + A E SDV++FGV + E++T G+ P G++ +
Sbjct: 195 --QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA----GIENAEI 248
Query: 903 SKRATNGRKEEFLSILDPRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLS 959
G RL P E E ++ L M C + +RP + L
Sbjct: 249 YNYLIGGN----------RLKQ-PPECMEEVYDL---MYQCWSADPKQRPSFTCLRMELE 294
Query: 960 EFPRHSSDFNQSSSSSLKNLEKDP 983
H S + S N+E+
Sbjct: 295 NILGHLSVLSTSQDPLYINIERAH 318
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 101/488 (20%), Positives = 180/488 (36%), Gaps = 30/488 (6%)
Query: 92 DKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFT 151
+ + + + N T + + L++S N S + S L L V +N
Sbjct: 31 ELESMVDYSNRNLT-HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR 89
Query: 152 ALLPVGI-LKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTG-KIPGELGNL 209
+L + L + L+YLD+ N I + L +L L+ ND + E GNL
Sbjct: 90 SL-DFHVFLFNQDLEYLDVSHNRL-QNIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNL 145
Query: 210 TNLREIYLGYYNVFEGGIPREVGKL-VNLVHLDLSSCELDGQIPHEI--GNLKLLDTVFL 266
T L + L F V L ++ + LDL S + G + N +L VF
Sbjct: 146 TKLTFLGL-SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH 204
Query: 267 HINLLSGSIPKQLGNLTNLV--NLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIP 324
+L S + + L +L N+ L++ + + R L N+ + + +
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264
Query: 325 DYLADLPN-----LETLGLWQNNFTGVIPENLGQNGK-----LQVLDLSSNKLTGTIPTD 374
+ +E L ++ T I + L + + + +
Sbjct: 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
Query: 375 LCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAEL 434
++ I +L + + S T + QN S+ G L L L
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 435 QSNYLSGSLPENGNSSSNPDRLGQLNLS-NNLLSGPLPFSLSNFSSLQILLLSGNQFSGP 493
Q N L + + + N L L++S N+L S + + S+ +L LS N +G
Sbjct: 385 QRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443
Query: 494 IPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEI-SNVRIL 552
+ + +V LDL N + IP + + L L+++ N L S+P + + L
Sbjct: 444 VFRCLPPKVKV--LDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSL 499
Query: 553 NYLNLSRN 560
Y+ L N
Sbjct: 500 QYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 8e-23
Identities = 76/442 (17%), Positives = 144/442 (32%), Gaps = 34/442 (7%)
Query: 74 DLTDLNLCG----SVPAQI-LRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQF-S 127
+L L L S+ + L L L ++ N +I ++SL+ L++S N F
Sbjct: 77 ELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMASLRHLDLSFNDFDV 135
Query: 128 GGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLE-KLKYLDLGGNYFFGKIPNSYGELQ 186
+ + +L L F L + + L LDL + G S
Sbjct: 136 LPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195
Query: 187 GLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPR------EVGKLVNLVHL 240
L L + + ++ L + L + + R E+ + L+++
Sbjct: 196 -TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNV 254
Query: 241 DLSSCEL-DGQIPHEIGNLKLLDTVFLHI--NLLSGSIPKQLGN-----LTNLVNLDLSN 292
L E +L+I ++ I ++ L +L+ + N
Sbjct: 255 TLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314
Query: 293 NALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLG 352
+ ++ + L ++ + L QN FT + +
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCS 374
Query: 353 QNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFL----FGPIPERLGACYSLTRV 408
+LQ L L N L + + L L L S+ +
Sbjct: 375 TLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL 433
Query: 409 RLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSG 468
L N L GS+ P + + +L +N + S+P++ L +LN+++N L
Sbjct: 434 NLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQA---LQELNVASNQLKS 487
Query: 469 PLPFSLSNFSSLQILLLSGNQF 490
+SLQ + L N +
Sbjct: 488 VPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 64/349 (18%), Positives = 116/349 (33%), Gaps = 27/349 (7%)
Query: 257 NLKLLDTVFLHINLLSGSIPKQL-GNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLF 315
L++L L N + S+ + +L LD+S+N L I + L+ +L
Sbjct: 77 ELRVLR---LSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLS 129
Query: 316 MNRLHGSIPD--YLADLPNLETLGLWQNNFTGVIPENLGQNGKLQV-LDLSSNKLTGTIP 372
N +P +L L LGL F + + + LDL S + G
Sbjct: 130 FNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGET 188
Query: 373 TDLCSSNQLRILILLKNFLFGPIPERLGACY----SLTRVRLGQNYLNGSIPDGFIYLPG 428
L N + ++ + + L+ ++L + G
Sbjct: 189 ESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG 248
Query: 429 LNLAELQSNYLSGSLPENGNSSSN--PDRLGQLNLSNNLLSGPLPFSLSNFS-----SLQ 481
L + ++ + + P + LN+ N ++ + +S SL
Sbjct: 249 PTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLM 308
Query: 482 ILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGS 541
I + F ++ LS + + T+L+ +QN + S
Sbjct: 309 IEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDS 368
Query: 542 IPPEISNVRILNYLNLSRNHLNQNIPKSIG---SMKSLTIADFSFNDFS 587
+ S ++ L L L RN L +N K +M SL D S N +
Sbjct: 369 VFQGCSTLKRLQTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNSLN 416
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 8e-20
Identities = 60/397 (15%), Positives = 113/397 (28%), Gaps = 49/397 (12%)
Query: 233 KLVNLVHLDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLS 291
L L L LS + + + + L+ + + N L +I + +L +LDLS
Sbjct: 74 FLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLS 129
Query: 292 NNALTGEIPYS--FINLRQLKLFNLFMNRLHGSIPDYLADLP-NLETLGLWQNNFTGVIP 348
N +P F NL +L L + +A L + L L + G
Sbjct: 130 FNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGET 188
Query: 349 ENL-GQNGKLQVLDLSSNKLTGTIPTDL---CSSNQLRILILLKNFLFGPIPERLGACYS 404
E+L N + L N L QL + L +
Sbjct: 189 ESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG 248
Query: 405 LTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLS-------GSLPENGNSSSNPDRLG 457
T + + ++ + ++ + E S + L
Sbjct: 249 PTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLM 308
Query: 458 QLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGE 517
++ N + S F+ + I +LS + L+ ++N +
Sbjct: 309 IEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDS 368
Query: 518 IPPAIGYCNHLTYLDMSQNNL---------------------------SGSIPPEISNVR 550
+ L L + +N L S + +
Sbjct: 369 VFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428
Query: 551 ILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFS 587
+ LNLS N L ++ + + + + D N
Sbjct: 429 SILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM 463
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 60/322 (18%), Positives = 118/322 (36%), Gaps = 20/322 (6%)
Query: 11 FSLLNIPNLSSAASLVNDFHVLVALK-QGFENPEPALISWNSSNPSSVCSWAGICCSRDR 69
+ N L + F V V + + + + I N N + ++
Sbjct: 191 LQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPT 250
Query: 70 VASLDLTDLNLCGSVPAQILRL---DKLTNLSLAGNNFTGSIEIGN-------LSSLQFL 119
+ ++ L + ++ + + L++ T I+ L SL
Sbjct: 251 LLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIE 310
Query: 120 NISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIP 179
++ N F + YS + + ++ + V +L+ N F +
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVF 370
Query: 180 NSYGELQGLEYLSLAGNDLT--GKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNL 237
L+ L+ L L N L K+ N+++L + + ++ R ++
Sbjct: 371 QGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430
Query: 238 VHLDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALT 296
+ L+LSS L G + + +K+LD LH N + SIPK + +L L L++++N L
Sbjct: 431 LVLNLSSNMLTGSVFRCLPPKVKVLD---LHNNRIM-SIPKDVTHLQALQELNVASNQLK 486
Query: 297 GEIPY-SFINLRQLKLFNLFMN 317
+P F L L+ L N
Sbjct: 487 -SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 50/328 (15%), Positives = 107/328 (32%), Gaps = 48/328 (14%)
Query: 274 SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLAD-LPN 332
+PK L LS N+++ L +L++ L NR+ S+ ++ +
Sbjct: 45 HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 333 LETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLF 392
LE L + N + + L+ LDLS N
Sbjct: 102 LEYLDVSHNRLQNISCCPMAS---LRHLDLSFNDFDVL---------------------- 136
Query: 393 GPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSN 452
P+ + G LT + L + + + L+L+ + + +S + S
Sbjct: 137 -PVCKEFGNLTKLTFLGLSAAKFR-QLD--LLPVAHLHLSCILLDLVSYHIKGGETESLQ 192
Query: 453 PDRLGQLNL---SNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPS----IGELRQVL 505
L+L N+L S + S++ LQ+ + N + + + +L
Sbjct: 193 IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLL 252
Query: 506 KLDLSRNSLSGEIPPAIG---YCNHLTYLDMSQNNLSGSIPPEI-----SNVRILNYLNL 557
+ L + + + + + YL++ ++ I E + ++ L ++
Sbjct: 253 NVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHV 312
Query: 558 SRNHLNQNIPKSIGSMKSLTIADFSFND 585
+ + I S +D
Sbjct: 313 KNQVFLFSKEALYSVFAEMNIKMLSISD 340
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 93/503 (18%), Positives = 169/503 (33%), Gaps = 40/503 (7%)
Query: 97 LSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPV 156
+ + N + LNIS N S + SL L + +N L
Sbjct: 5 VDRSKNGLI-HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 157 GILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTG-KIPGELGNLTNLREI 215
++L+YLDL N KI L++L L+ N I E GN++ L+ +
Sbjct: 64 VFKFNQELEYLDLSHN-KLVKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120
Query: 216 YLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSI 275
L E +N+ + L E G+ + L+ +T LHI +
Sbjct: 121 GL-STTHLE-KSSVLPIAHLNISKVLLVLGETYGE-KEDPEGLQDFNTESLHIVFPTNKE 177
Query: 276 PKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLET 335
+ +++ +L + + + + + L L N L
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP--------KLSNLTLNN 229
Query: 336 LGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDL-----CSSNQLRILILLKNF 390
+ N+F ++ L + + +S+ KL G + S L I ++ +
Sbjct: 230 IETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287
Query: 391 LFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSS 450
P ++ + + + +N L+
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTV-----F 341
Query: 451 SNPDRLGQ---LNLSNNLLS--GPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-GELRQV 504
N L + L L N L + + SLQ L +S N S + +
Sbjct: 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401
Query: 505 LKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQ 564
L L++S N L+ I + + LD+ N + SIP ++ + L LN++ N L +
Sbjct: 402 LSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL-K 457
Query: 565 NIPKSI-GSMKSLTIADFSFNDF 586
++P I + SL N +
Sbjct: 458 SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 89/489 (18%), Positives = 166/489 (33%), Gaps = 57/489 (11%)
Query: 73 LDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQFSGG 129
L+++ + + IL L KL L ++ N ++I L++L++S+N+
Sbjct: 26 LNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLV-K 83
Query: 130 LDWNYSSLVNLEVFDAYNNNFTALLPVGIL-KLEKLKYLDLGGNYFFGKIPNSYGELQGL 188
+ + VNL+ D N F AL + +LK+L L + L
Sbjct: 84 ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS 141
Query: 189 EYLSLAGNDLTGKIPGELGNLTNLREIYLG----YYNVFEGGIPREVGKLVNLVHLDLSS 244
+ L + G K + L + L F + V + NL ++
Sbjct: 142 KVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199
Query: 245 CELDGQIPHEIGNL---------KLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNAL 295
D + + + L L + S QL T + +SN L
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKL 259
Query: 296 TG-----EIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPEN 350
G + YS +L+ L + + + N+ + V
Sbjct: 260 QGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC 319
Query: 351 LGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRL 410
+ LD S+N LT T+ + +L LIL N L L+++
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL-----------KELSKI-- 366
Query: 411 GQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPL 470
+ + L ++ N +S + S L LN+S+N+L+ +
Sbjct: 367 ---------AEMTTQMKSLQQLDISQNSVSYDEKK--GDCSWTKSLLSLNMSSNILTDTI 415
Query: 471 PFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPP-AIGYCNHLT 529
L +++L L N+ IP + +L + +L+++ N L +P L
Sbjct: 416 FRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQ 471
Query: 530 YLDMSQNNL 538
+ + N
Sbjct: 472 KIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 72/410 (17%), Positives = 129/410 (31%), Gaps = 45/410 (10%)
Query: 188 LEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLSSCE 246
L+++ N ++ ++ +L+ LR + + +N + + V L +LDLS +
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILII-SHNRIQY-LDISVFKFNQELEYLDLSHNK 80
Query: 247 LDGQIPHEIGNLKLLDTVFLHINLL-SGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFIN 305
L H NLK LD L N + I K+ GN++ L L LS L +
Sbjct: 81 LVKISCHPTVNLKHLD---LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 306 LRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSN 365
L K+ + L + T L T + V +L +
Sbjct: 138 LNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 366 KLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIY 425
+ + + CS + L N L N + +
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKL---------------SNLTLNNIETTWNSFIRI 240
Query: 426 LPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLL 485
L + + +S + L L +S ++ +L I +
Sbjct: 241 LQLVWHTTVWYFSIS-----------------NVKLQGQLDFRDFDYSGTSLKALSIHQV 283
Query: 486 SGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPE 545
+ F P + + + + + +LD S N L+ ++
Sbjct: 284 VSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFEN 343
Query: 546 ISNVRILNYLNLSRNHLNQNIPKSIG---SMKSLTIADFSFNDFSGKLPE 592
++ L L L N L + + K MKSL D S N S +
Sbjct: 344 CGHLTELETLILQMNQL-KELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 59/335 (17%), Positives = 115/335 (34%), Gaps = 16/335 (4%)
Query: 3 FFIVVTLLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSWAG 62
T ++ N L + L+ +
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
Query: 63 ICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG-------NLSS 115
S + +++ T + + Q++ + S++ G ++ +L +
Sbjct: 220 PKLSNLTLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277
Query: 116 LQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFF 175
L + ++ F + Y N+ + + + + + K+ +LD N
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337
Query: 176 GKIPNSYGELQGLEYLSLAGNDLT--GKIPGELGNLTNLREIYLGYYNVFEGGIPREVGK 233
+ + G L LE L L N L KI + +L+++ + +V +
Sbjct: 338 DTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
Query: 234 LVNLVHLDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSN 292
+L+ L++SS L I + +K+LD LH N + SIPKQ+ L L L++++
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCLPPRIKVLD---LHSNKIK-SIPKQVVKLEALQELNVAS 453
Query: 293 NALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYL 327
N L F L L+ L N S P
Sbjct: 454 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 488
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 54/361 (14%), Positives = 116/361 (32%), Gaps = 30/361 (8%)
Query: 9 LLFSLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSRD 68
LL L + + + ++ + +++ + I C +
Sbjct: 144 LLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL-ELSNIKCVLE 202
Query: 69 RVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSG 128
+ ++ L L N+ N+F +++ +++ + +ISN + G
Sbjct: 203 DNKCSYFLSILAKLQTNPKLSNLT-LNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQG 261
Query: 129 GLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGL 188
LD+ L+ L + + F Y +
Sbjct: 262 QLDFRDFDYSGT-------------------SLKALSIHQVVSDVFGFPQSYIYEIFSNM 302
Query: 189 EYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELD 248
+ + ++ + N+ + G L L L L +L
Sbjct: 303 NIKNFTVSGTRMVHMLCPSKISPFLHLDF-SNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 249 GQIPHEIG---NLKLLDTVFLHINLLSGSIPKQL-GNLTNLVNLDLSNNALTGEIPYSFI 304
++ +K L + + N +S K +L++L++S+N LT I
Sbjct: 362 -ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL- 419
Query: 305 NLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSS 364
++K+ +L N++ SIP + L L+ L + N V + LQ + L +
Sbjct: 420 -PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477
Query: 365 N 365
N
Sbjct: 478 N 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-20
Identities = 55/375 (14%), Positives = 124/375 (33%), Gaps = 27/375 (7%)
Query: 240 LDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGE 298
+D S L +P ++ +L+ + N +S + +L+ L L +S+N +
Sbjct: 5 VDRSKNGLI-HVPKDLSQKTTILN---ISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 299 IPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGV-IPENLGQNGKL 357
F ++L+ +L N+L I + NL+ L L N F + I + G +L
Sbjct: 61 DISVFKFNQELEYLDLSHNKLV-KISCHP--TVNLKHLDLSFNAFDALPICKEFGNMSQL 117
Query: 358 QVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNG 417
+ L LS+ L + + N ++L++L L +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTN 175
Query: 418 SIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPD--------RLGQLNLSNNLLSGP 469
+ + +A L+ + + L +N S +L L L+N +
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 470 LPFSLSNF---SSLQILLLSGNQFSGPIPPSIGE-----LRQVLKLDLSRNSLSGEIPPA 521
+ +++ +S + G + + L+ + + +
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295
Query: 522 IGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADF 581
+++ + + + S + +L+ S N L + ++ G + L
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355
Query: 582 SFNDFSGKLPESGQF 596
N +
Sbjct: 356 QMNQLKELSKIAEMT 370
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 69/301 (22%), Positives = 121/301 (40%), Gaps = 39/301 (12%)
Query: 686 ECVKDGNVIGRGGAGIVYHG--KMPNG-VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH 742
+ +G G G V G +M +++A+K L + E Q + + +
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL- 801
IVRL+ C E +LV E G L + L GK+ N+ + + + G+ YL
Sbjct: 396 PYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLHQVSMGMKYLE 453
Query: 802 -HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI--- 857
+ VHR++ + N+LL + A ++DFGL+K L +A + +
Sbjct: 454 EKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWY 506
Query: 858 APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916
APE + +SDV+S+GV + E L+ G++P G +++ G+
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMA---FIEQGK------ 556
Query: 917 ILDPRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSDFNQSSS 973
R+ P E ++ L M C +RP V Q + + + S
Sbjct: 557 ----RMEC-PPECPPELYAL---MSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGS 608
Query: 974 S 974
+
Sbjct: 609 A 609
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 75/364 (20%), Positives = 131/364 (35%), Gaps = 49/364 (13%)
Query: 263 TVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGS 322
V H ++P+ + T LDL N + F + L+ L N +
Sbjct: 15 AVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAV 71
Query: 323 IPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLR 382
P +L NL TLGL N + L LD+S NK+ + +
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYM------- 123
Query: 383 ILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNYLSG 441
F + +L + +G N L I F L L L+ L+
Sbjct: 124 ---------FQDLY-------NLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT- 165
Query: 442 SLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGEL 501
S+P + S+ L L L + ++ +S L++L +S + + P+
Sbjct: 166 SIPTE--ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223
Query: 502 RQVLKLDLSRNSLSGEIPP-AIGYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSR 559
+ L ++ +L+ +P A+ + +L +L++S N +S +I + + L + L
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVG 281
Query: 560 NHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCG-TLLNNP 618
L P + + L + + S N Q T S F L L +NP
Sbjct: 282 GQLAVVEPYAFRGLNYLRVLNVSGN----------QLTTLEESVFHSVGNLETLILDSNP 331
Query: 619 --CN 620
C+
Sbjct: 332 LACD 335
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-28
Identities = 83/417 (19%), Positives = 138/417 (33%), Gaps = 89/417 (21%)
Query: 56 SVCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFT--GSIEIGNL 113
+ C C ++DR ++ +VP I + L L N E +
Sbjct: 1 TGCPPRCECSAQDR--AVLCHRKRF-VAVPEGIPT--ETRLLDLGKNRIKTLNQDEFASF 55
Query: 114 SSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILK-LEKLKYLDLGGN 172
L+ L ++ N S +++L NL +N + P+G+ L L LD+ N
Sbjct: 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLI-PLGVFTGLSNLTKLDISEN 114
Query: 173 YFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVG 232
+ + +L L+ L + NDL I F G
Sbjct: 115 KIVILLDYMFQDLYNLKSLEVGDNDLV-YISH----------------RAFSG------- 150
Query: 233 KLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQ-LGNLTNLVNLDLS 291
L +L L L C L SIP + L +L L+ L L
Sbjct: 151 -LNSLEQLTLEKCNLT-------------------------SIPTEALSHLHGLIVLRLR 184
Query: 292 NNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENL 351
+ + YSF L +LK+ + ++ NL +L + N T V +
Sbjct: 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAV 244
Query: 352 GQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLG 411
L+ L+LS N ++ TI + + L ++L
Sbjct: 245 RHLVYLRFLNLSYNPIS-TIEGS----------------MLHELL-------RLQEIQLV 280
Query: 412 QNYLNGSIPDG-FIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLS 467
L + F L L + + N L+ +L E + + L L L +N L+
Sbjct: 281 GGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEE--SVFHSVGNLETLILDSNPLA 333
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 81/384 (21%), Positives = 142/384 (36%), Gaps = 38/384 (9%)
Query: 235 VNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQL-GNLTNLVNLDLSNN 293
++ ++DLS + L+ L + + I L++L+ L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 294 ALTGEIPYS-FINLRQLKLFNLFMNRLHGSI--PDYLADLPNLETLGLWQNNFTGVIPEN 350
++ F L L++ L L G++ ++ L +LE L L NN + P +
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 351 LGQN-GKLQVLDLSSNKLTGTIPTDL---CSSNQLRILILLKNFLFGPIPERLGA----- 401
N + VLDL+ NK+ +I + +L L L LG
Sbjct: 149 FFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207
Query: 402 ---CYSLTRVRLGQNYLNGSIPDGFIYLPGLN----LAELQSNYLSGSLPENGNSSSNPD 454
S+T + L N S+ F L S + S +
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
Query: 455 --------RLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-GELRQVL 505
+ +LS + + L S+F+ L+ L L+ N+ + I + L +L
Sbjct: 268 TFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLL 326
Query: 506 KLDLSRNSLSGEIPPAI-GYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHLN 563
KL+LS+N L I + + L LD+S N++ ++ + + L L L N L
Sbjct: 327 KLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQL- 383
Query: 564 QNIPKSI-GSMKSLTIADFSFNDF 586
+++P I + SL N +
Sbjct: 384 KSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 70/421 (16%), Positives = 123/421 (29%), Gaps = 63/421 (14%)
Query: 138 VNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIP-NSYGELQGLEYLSLAGN 196
++ D N+ L +L+ L++L + I N++ L L L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 197 DLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLSSCELDGQIPHEI 255
G L NL + L N+ + L +L L L + P
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA-- 147
Query: 256 GNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLF 315
+ FL N+ LDL+ N + +N + L
Sbjct: 148 -------SFFL--------------NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL- 185
Query: 316 MNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDL 375
L ++ + + N +N + LDLS N ++
Sbjct: 186 -------------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232
Query: 376 CSSNQLRILILLKNFLFGPIPERLG---------------ACYSLTRVRLGQNYLNGSIP 420
+ + L + G + L ++ + ++
Sbjct: 233 FDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALL 291
Query: 421 DG-FIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSS 479
F + L L N ++ + +N + L +LNLS N L N
Sbjct: 292 KSVFSHFTDLEQLTLAQNEIN-KIDDN--AFWGLTHLLKLNLSQNFLGSIDSRMFENLDK 348
Query: 480 LQILLLSGNQFSGPIPPSI-GELRQVLKLDLSRNSLSGEIPP-AIGYCNHLTYLDMSQNN 537
L++L LS N + L + +L L N L +P L + + N
Sbjct: 349 LEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 406
Query: 538 L 538
Sbjct: 407 W 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 71/382 (18%), Positives = 132/382 (34%), Gaps = 46/382 (12%)
Query: 94 LTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQFSGGLDWN-YSSLVNLEVFDAYNNN 149
+ + L+ N+ + L LQFL + + N + L +L + N
Sbjct: 32 VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 150 FTALLPVGIL-KLEKLKYLDLGGNYFFGKI--PNSYGELQGLEYLSLAGNDLTGKIPGEL 206
F L G L L+ L L G + N + L LE L L N++ P
Sbjct: 91 FLQL-ETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 207 -GNLTNLREIYLGY-------YNVFEGGIPREVG--KLVNLVHLDLSSCELDGQIPHEIG 256
N+ + L + + +L ++ D++ L +
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 257 NLKLLDTVFLHINLLSGSIPKQLGNLTNLVNL-------------DLSNNALTGEIPYSF 303
+ T+ L N S+ K+ + + + ++F
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 304 INLR--QLKLFNLFMNRLHGSIPDYL-ADLPNLETLGLWQNNFTGVIPENLGQNGKLQVL 360
L +K +L +++ ++ + + +LE L L QN + L L
Sbjct: 270 KGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL 328
Query: 361 DLSSNKLTGTIPTDLCSS-NQLRILILLKNFLFGPIPERLGACYSLTRVR---LGQNYLN 416
+LS N L +I + + + ++L +L L N + + + + L ++ L N L
Sbjct: 329 NLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RALGD--QSFLGLPNLKELALDTNQLK 384
Query: 417 GSIPDG-FIYLPGLNLAELQSN 437
S+PDG F L L L +N
Sbjct: 385 -SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 8e-22
Identities = 61/331 (18%), Positives = 111/331 (33%), Gaps = 46/331 (13%)
Query: 75 LTDLNLCG----SVPAQIL-RLDKLTNLSLAGNNFTGS-IEIG---NLSSLQFLNISNNQ 125
L L L + L L L+L N G+ + L+SL+ L + +N
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 126 FS----GGLDWNYSSLVNLEVFDAYNNNFTAL----------LPVGILKLEKLKYLDLGG 171
++ V D N ++ +L+L + D+
Sbjct: 141 IKKIQPASFF---LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNE 197
Query: 172 NYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREI-YLGYYNVFEGGIPRE 230
+ + + + + L L+GN + + +I L N + G
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG 257
Query: 231 VGKLVNLV-------------HLDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLSGSIP 276
+ DLS ++ + + + L+ + L N ++ I
Sbjct: 258 HTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KID 315
Query: 277 KQ-LGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIP-DYLADLPNLE 334
LT+L+ L+LS N L F NL +L++ +L N + ++ LPNL+
Sbjct: 316 DNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLK 374
Query: 335 TLGLWQNNFTGVIPENLGQNGKLQVLDLSSN 365
L L N V + LQ + L +N
Sbjct: 375 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 57/334 (17%), Positives = 93/334 (27%), Gaps = 68/334 (20%)
Query: 283 TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIP-DYLADLPNLETLGLWQN 341
++ +DLS N++ SF L+ L+ + I + L +L L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 342 NFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGA 401
F + L+VL L+ L G + L F P+
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAV---------------LSGNFFKPLT----- 129
Query: 402 CYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNL 461
SL + L N + P F N+ L+L
Sbjct: 130 --SLEMLVLRDNNIKKIQPASFFL----NMRRFHV----------------------LDL 161
Query: 462 SNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPA 521
+ N + L NF LL L + D++ L E
Sbjct: 162 TFNKVKSICEEDLLNFQGKHFTLLR--------------LSSITLQDMNEYWLGWEKCGN 207
Query: 522 IGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADF 581
+T LD+S N S+ + + + N+ S G +F
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
Query: 582 SFNDFSGKLPE-----SGQFTVFNASSFAGNPQL 610
+F + + S F+ L
Sbjct: 268 TFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDL 301
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 32/173 (18%), Positives = 56/173 (32%), Gaps = 16/173 (9%)
Query: 453 PDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSR 511
P + ++LS N ++ S S LQ L + I + L ++ L L
Sbjct: 29 PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 512 NSLSGEIPPAI-GYCNHLTYLDMSQNNL-SGSIPPEI-SNVRILNYLNLSRNHLNQNIPK 568
N ++ +L L ++Q NL + + L L L N++ + P
Sbjct: 89 NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147
Query: 569 SI-GSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNNPCN 620
S +M+ + D +FN + TLL
Sbjct: 148 SFFLNMRRFHVLDLTFN----------KVKSICEEDLLNFQGKHFTLLRLSSI 190
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 23/220 (10%)
Query: 689 KDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
D V+G+G GIVY G+ + N V IA+K++ + EI +++H+NIV+
Sbjct: 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI-PERDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 748 LLAFCSNKETNLLVY-EYMRNGSLGEALHGKKGAF-LGWNLRYKIAIEAAKGLCYLHHDC 805
L ++ + ++ E + GSL L K G + +GL YLH +
Sbjct: 84 YLG-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 806 SPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPE--- 860
IVHRD+K +N+L+N+ + + +DFG +K L G + C G+ Y+APE
Sbjct: 143 ---IVHRDIKGDNVLINT-YSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEIID 196
Query: 861 ---YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV 897
Y +D++S G ++E+ TG+ P + G+
Sbjct: 197 KGPRGYGK----AADIWSLGCTIIEMATGKPPFYELGEPQ 232
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-31
Identities = 53/247 (21%), Positives = 91/247 (36%), Gaps = 28/247 (11%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
+++G+G V+ G+ G A+K E + L + H+NIV+L
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 750 AFCSNKETNL--LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK----GLCYLHH 803
A T L+ E+ GSL L A+ L + + G+ +L
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY---GLPESEFLIVLRDVVGGMNHLR- 129
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAH----VADFGLAKFLIDGGASECMSAIAGSYGYIAP 859
IVHR++K NI+ + + DFG A+ L D E ++ G+ Y+ P
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHP 184
Query: 860 E--------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK 911
+ + + D++S GV TG P F + + G+
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 912 EEFLSIL 918
+S +
Sbjct: 245 SGAISGV 251
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 63/280 (22%), Positives = 105/280 (37%), Gaps = 37/280 (13%)
Query: 693 VIGRGGAGIVYHGKMPNG---VEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRL 748
+G G G V G +AVK L + AE + + + IVR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL--HHDCS 806
+ C E+ +LV E G L + L ++ + ++ + + G+ YL +
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN--- 137
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGS---YGYIAPEYAY 863
VHRD+ + N+LL + A ++DFGL+K L A + APE
Sbjct: 138 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--ENYYKAQTHGKWPVKWYAPECIN 193
Query: 864 TLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922
+ KSDV+SFGV++ E + G++P E ++L+
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-------------KG---SEVTAMLEKGE 237
Query: 923 SMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEF 961
M ++ M C + RP V L +
Sbjct: 238 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 68/307 (22%), Positives = 116/307 (37%), Gaps = 46/307 (14%)
Query: 691 GNVIGRGGAGIVYHG--KMPNG---VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
V+G G G VY G + +A+K+L + + E + ++ + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL--HH 803
RLL C T L+ + M G L + + K L ++ AKG+ YL
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAKGMNYLEDRR 137
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-----A 858
+VHRD+ + N+L+ + + DFGLAK L G + A
Sbjct: 138 -----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVPIKWMA 187
Query: 859 PEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917
E +SDV+S+GV + EL+T G +P +I G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISS---ILEKGE------- 236
Query: 918 LDPRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRHSSDFNQSSSS 974
RL P ++++ M+ C ++ RP+ RE++ S+ R +
Sbjct: 237 ---RLPQ-PPICTIDVYMI---MVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGD 289
Query: 975 SLKNLEK 981
+L
Sbjct: 290 ERMHLPS 296
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 16/220 (7%)
Query: 675 QKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAE 733
+ +++ + + + +GRG G V+ K G + AVKK+ + E
Sbjct: 47 KPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRVEE 100
Query: 734 IQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIE 793
+ + IV L + E + GSLG+ + K+ L + +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQ 158
Query: 794 AAKGLCYLHHDCSPLIVHRDVKSNNILLNSA-FEAHVADFGLAKFLIDGGASECMSA--- 849
A +GL YLH I+H DVK++N+LL+S A + DFG A L G + +
Sbjct: 159 ALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 850 IAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
I G+ ++APE D K D++S ++L +L G P
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 65/307 (21%), Positives = 118/307 (38%), Gaps = 53/307 (17%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNG----VEIAVKKL-LGFGTHSHDHGFRAEIQTLGNI 740
+ G ++G G G V G + +++AVK + L + F +E + +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 741 RHRNIVRLLAFCSNKETN-----LLVYEYMRNGSLGEALHGKKGAFLGWNLRYK----IA 791
H N++RLL C + +++ +M+ G L L + ++ +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 792 IEAAKGLCYL--HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA 849
++ A G+ YL + +HRD+ + N +L VADFGL+K + G
Sbjct: 154 VDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR---- 204
Query: 850 IAGSYGYI-----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWS 903
G + A E KSDV++FGV + E+ T G P GV +
Sbjct: 205 -QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP----GVQNHEMY 259
Query: 904 KRATNGRKEEFLSILDPRLSMVPKE--EAMHLLFVAML-CIQENSIERPRMREVVQMLSE 960
+G RL P++ + ++ + M C + + ++RP + L +
Sbjct: 260 DYLLHGH----------RLKQ-PEDCLDELYEI---MYSCWRTDPLDRPTFSVLRLQLEK 305
Query: 961 FPRHSSD 967
D
Sbjct: 306 LLESLPD 312
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-30
Identities = 52/208 (25%), Positives = 77/208 (37%), Gaps = 30/208 (14%)
Query: 693 VIGRGGAGIVYHGK--MPNGVEIAVKKLLGFGTHSHDHG----FRAEIQTLGNIRHRNIV 746
I GG G +Y NG + +K L+ HS D AE Q L + H +IV
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLV----HSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 747 RLLAF-----CSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
++ F +V EY+ SL + K L +E L YL
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYL 198
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY 861
H +V+ D+K NI+L + + D G + G + G+ G+ APE
Sbjct: 199 HSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY------LYGTPGFQAPEI 248
Query: 862 AYTLRVDEKSDVYSFGVVLLELLTGRRP 889
T +D+Y+ G L L
Sbjct: 249 VRT-GPTVATDIYTVGRTLAALTLDLPT 275
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 61/299 (20%), Positives = 114/299 (38%), Gaps = 28/299 (9%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
IG G G K +G + +K++ + + R E+ L N++H NIV+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
+ +V +Y G L + ++ +KG + ++ L ++H I+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEK 870
HRD+KS NI L + DFG+A+ L E A G+ Y++PE + K
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEICENKPYNNK 205
Query: 871 SDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEA 930
SD+++ G VL EL T + F + + + +G + S +
Sbjct: 206 SDIWALGCVLYELCTLKHA---F-EAGSMKNLVLKIISGSFPP----VSLHYS----YDL 253
Query: 931 MHLLFVAMLCIQENSIERPRMREVVQM------LSEFPRHSSDFNQSSSSSLKNLEKDP 983
L+ + N +RP + +++ + +F + + P
Sbjct: 254 RSLV---SQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQP 309
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 70/340 (20%), Positives = 119/340 (35%), Gaps = 53/340 (15%)
Query: 672 TAFQKLEFSVSDILE----CVKDGNVIGRGGAGIVYHGKMPNG------VEIAVKKLLGF 721
F S+SD+ E + +G G G VY G++ +++AVK L
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 722 GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL-----HG 776
+ + F E + H+NIVR + ++ E M G L L
Sbjct: 72 CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131
Query: 777 KKGAFLGWNLRYKIAIEAAKGLCYL--HHDCSPLIVHRDVKSNNILLNSAFEAHV---AD 831
+ + L +A + A G YL +H +HRD+ + N LL V D
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGD 186
Query: 832 FGLAKFLIDGGASECMSAIAGSYGYI-----APEYAYTLRVDEKSDVYSFGVVLLELLT- 885
FG+A+ + G + PE K+D +SFGV+L E+ +
Sbjct: 187 FGMARDIYRASYYR-----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241
Query: 886 GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQEN 944
G P +N +E L + M P + ++ M C Q
Sbjct: 242 GYMPYPSK-------------SN---QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQ 285
Query: 945 SIERPRMREVVQMLSEFPRHSSDFNQSSSSSLKNLEKDPK 984
+RP +++ + + N + L ++ +
Sbjct: 286 PEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEE 325
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 65/288 (22%), Positives = 115/288 (39%), Gaps = 38/288 (13%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAF 751
+G GG V + + +G A+K++L + + E H NI+RL+A+
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREE-AQREADMHRLFNHPNILRLVAY 94
Query: 752 CSNKETN----LLVYEYMRNGSLGEAL--HGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
C + L+ + + G+L + KG FL + + + +GL +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG--GASECMS-----AIAGSYGYIA 858
+ HRD+K NILL + + D G G+ + ++ A + Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 859 PE----YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914
PE ++ +DE++DV+S G VL ++ G P + A +
Sbjct: 212 PELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGP---YDMVFQKGDSVALAVQNQ---- 263
Query: 915 LSI-LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961
LSI PR S A+ L +M+ + +RP + ++ L
Sbjct: 264 LSIPQSPRHS-----SALWQLLNSMM--TVDPHQRPHIPLLLSQLEAL 304
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 32/301 (10%), Positives = 71/301 (23%), Gaps = 50/301 (16%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLL--GFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
+ G +V+ + + + A+K + S + +
Sbjct: 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 748 LLAFC--------------------------SNKETNLLVYEYMR--NGSLGEALH--GK 777
LL+ L L
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 778 KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837
G + + + + L +VH +N+ + + D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW- 242
Query: 838 LIDGGASECMSAIAGSYGYIAPEY--AYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGD 895
A + Y E+ A T + + G+ + + P FG
Sbjct: 243 ----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP---FGL 295
Query: 896 GVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVV 955
++ S + + R S+ + +P + L+ L + R E +
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP-DFVKTLI-GRFL--NFDRRRRLLPLEAM 351
Query: 956 Q 956
+
Sbjct: 352 E 352
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 62/303 (20%), Positives = 123/303 (40%), Gaps = 49/303 (16%)
Query: 689 KDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
K+ +IG GG G V+ K +G +K++ ++ E++ L + H NIV
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLDHVNIVH 68
Query: 748 LLAF---------------CSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIA 791
+K L + E+ G+L + + ++G L L ++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 792 IEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIA 851
+ KG+ Y+H S +++RD+K +NI L + + DFGL L +
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSK 182
Query: 852 GSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK 911
G+ Y++PE + ++ D+Y+ G++L ELL +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----------------TS 225
Query: 912 EEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQS 971
+ F + D +S + ++ LL + + +RP E+++ L + S + N+
Sbjct: 226 KFFTDLRDGIISDIFDKKEKTLL---QKLLSKKPEDRPNTSEILRTL-TVWKKSPEKNER 281
Query: 972 SSS 974
++
Sbjct: 282 HTA 284
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 62/273 (22%), Positives = 107/273 (39%), Gaps = 25/273 (9%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL- 749
IG G G + +G + K+L G T + +E+ L ++H NIVR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 750 AFCSNKETNL-LVYEYMRNGSLGEAL--HGKKGAFLGWNLRYKIAIEAAKGLCYLH--HD 804
T L +V EY G L + K+ +L ++ + L H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT 864
++HRD+K N+ L+ + DFGLA+ L + G+ Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 865 LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924
+ +EKSD++S G +L EL P F + + + G+ + R S
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP---F-TAFSQKELAGKIREGKFRR----IPYRYS- 241
Query: 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957
+E ++ + RP + E+++
Sbjct: 242 ---DELNEII---TRMLNLKDYHRPSVEEILEN 268
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 60/273 (21%), Positives = 112/273 (41%), Gaps = 24/273 (8%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKK--LLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
IGRG VY + +GV +A+KK + EI L + H N+++
Sbjct: 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEAL--HGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
A +V E G L + K+ + +K ++ L ++H
Sbjct: 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--- 153
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
S ++HRD+K N+ + + + D GL +F + ++ G+ Y++PE +
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 866 RVDEKSDVYSFGVVLLELLTGRRPVGDF-GDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924
+ KSD++S G +L E+ + P F GD +++ K+ ++ + S
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQC---DYPPLPSDHYS- 264
Query: 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957
EE L+ +CI + +RP + V +
Sbjct: 265 ---EELRQLV---NMCINPDPEKRPDVTYVYDV 291
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 70/312 (22%), Positives = 117/312 (37%), Gaps = 57/312 (18%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVE------IAVKKLLGFGTHSHDHGFRAEIQTLGN 739
+ +G G G V+ + N + +AVK L + S F+ E + L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTM 99
Query: 740 IRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL--HGKKGAFLGWNLRYK-------- 789
++H++IVR C+ L+V+EYMR+G L L HG L
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 790 ---IAIEAAKGLCYL--HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844
+A + A G+ YL H VHRD+ + N L+ + DFG+++ +
Sbjct: 160 LLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 845 ECMSAIAGSYGYI-----APEYAYTLRV-DEKSDVYSFGVVLLELLT-GRRPVGDFGDGV 897
G + PE + R +SDV+SFGVVL E+ T G++P
Sbjct: 215 R-----VGGRTMLPIRWMPPE-SILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL---- 264
Query: 898 DIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQ 956
+N E + + + ++ M C Q +R +++V
Sbjct: 265 ---------SN---TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312
Query: 957 MLSEFPRHSSDF 968
L + +
Sbjct: 313 RLQALAQAPPVY 324
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 55/288 (19%), Positives = 108/288 (37%), Gaps = 44/288 (15%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL-A 750
+GRGG G+V+ K + A+K++ E++ L + H IVR A
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 751 F--------CSNKETNLLVY---EYMRNGSLGEALHGKKGA-FLGWNLRYKIAIEAAKGL 798
+ + +Y + R +L + ++G+ ++ I ++ A+ +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 799 CYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL----------IDGGASECMS 848
+LH S ++HRD+K +NI V DFGL + A +
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 849 AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN 908
G+ Y++PE + K D++S G++L ELL P F
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P---FS-----------TQM 231
Query: 909 GRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
R + + + + ++ + + + +ERP +++
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 58/305 (19%), Positives = 113/305 (37%), Gaps = 55/305 (18%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNG------VEIAVKKLLGFGTHSHDHGFRAEIQTLGN 739
V+ +G G VY G + +A+K L FR E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 740 IRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY----------- 788
++H N+V LL + + +++ Y +G L E L + +
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 789 ---KIAIEAAKGLCYL--HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843
+ + A G+ YL HH +VH+D+ + N+L+ ++D GL + +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
Query: 844 SECMSAIAGSYGYI-----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGV 897
+ + APE + SD++S+GVVL E+ + G +P +
Sbjct: 184 YK-----LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY---- 234
Query: 898 DIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQ 956
+N ++ + ++ R + ++ ++ M+ C E RPR +++
Sbjct: 235 ---------SN---QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 282
Query: 957 MLSEF 961
L +
Sbjct: 283 RLRAW 287
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 66/320 (20%), Positives = 113/320 (35%), Gaps = 49/320 (15%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNG------VEIAVKKLLGFGTHSHDHGFRAEIQTLGN 739
+ + +G G G VY G++ +++AVK L + + F E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 740 IRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL-----HGKKGAFLGWNLRYKIAIEA 794
H+NIVR + ++ E M G L L + + L +A +
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 795 AKGLCYL--HHDCSPLIVHRDVKSNNILLNSAFEAHV---ADFGLAKFLIDGGASECMSA 849
A G YL +H +HRD+ + N LL V DFG+A+ + G
Sbjct: 191 ACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---- 241
Query: 850 IAGSYGYI-----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWS 903
G + PE K+D +SFGV+L E+ + G P
Sbjct: 242 -KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---------- 290
Query: 904 KRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEFP 962
+N +E L + M P + ++ M C Q +RP +++ +
Sbjct: 291 ---SN---QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344
Query: 963 RHSSDFNQSSSSSLKNLEKD 982
+ N + L ++
Sbjct: 345 QDPDVINTALPIEYGPLVEE 364
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 70/308 (22%), Positives = 116/308 (37%), Gaps = 47/308 (15%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVE------IAVKKLLGFGTHSHDHGFRAEIQTLGN 739
E + +G+G G+VY G V+ +A+K + + F E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 740 IRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY--------KIA 791
++VRLL S + L++ E M G L L + A + ++A
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 792 IEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIA 851
E A G+ YL+ + VHRD+ + N ++ F + DFG+ + + +
Sbjct: 145 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----K 196
Query: 852 GSYGYI-----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKR 905
G G + +PE SDV+SFGVVL E+ T +P
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------------ 244
Query: 906 ATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEFPRH 964
+N E+ L + + + +LF M C Q N RP E++ + E
Sbjct: 245 -SN---EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM-- 298
Query: 965 SSDFNQSS 972
F + S
Sbjct: 299 EPGFREVS 306
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 75/343 (21%), Positives = 128/343 (37%), Gaps = 57/343 (16%)
Query: 683 DILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLG-NIR 741
+ V ++G G +G V G +AVK++L EI+ L +
Sbjct: 12 SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML----IDFCDIALMEIKLLTESDD 67
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK----- 796
H N++R + + E N +L + + K NL+ +
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKN--VSDENLKLQKEYNPISLLRQI 124
Query: 797 --GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH-------------VADFGLAKFLIDG 841
G+ +LH S I+HRD+K NIL++++ ++DFGL K L G
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 842 GASEC--MSAIAGSYGYIAPE-------YAYTLRVDEKSDVYSFGVVLLELLT-GRRPVG 891
+S ++ +G+ G+ APE R+ D++S G V +L+ G+ P
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP-- 239
Query: 892 DFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRM 951
FGD R +E + D L EA L+ I + ++RP
Sbjct: 240 -FGDKYSRESNIIRG-IFSLDEMKCLHDRSLI----AEATDLI---SQMIDHDPLKRPTA 290
Query: 952 REVVQ---MLSEFPRHSSDFNQSSSSSLKNLEKDPKGCPNNKL 991
+V++ + + F S L+ +DP K
Sbjct: 291 MKVLRHPLFWPKSKKLE--FLLKVSDRLEIENRDPPSALLMKF 331
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 65/309 (21%), Positives = 121/309 (39%), Gaps = 56/309 (18%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNG------VEIAVKKLLGFGTHSHDHGFRAEIQTLGN 739
+ +G G G V+ + N + +AVK L T + F+ E + L N
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTN 73
Query: 740 IRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY----------- 788
++H +IV+ C + + ++V+EYM++G L + L +
Sbjct: 74 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 789 ---KIAIEAAKGLCYL--HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843
IA + A G+ YL H VHRD+ + N L+ + + DFG+++ +
Sbjct: 134 QMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 844 SECMSAIAGSYGYI-----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGV 897
G + + PE + +SDV+SFGV+L E+ T G++P
Sbjct: 189 YR-----VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL---- 239
Query: 898 DIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQ 956
+N E + + + ++ ML C Q +R ++E+ +
Sbjct: 240 ---------SN---TEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287
Query: 957 MLSEFPRHS 965
+L + +
Sbjct: 288 ILHALGKAT 296
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 76/317 (23%), Positives = 130/317 (41%), Gaps = 44/317 (13%)
Query: 670 KMTAFQKLEFSVSDI-LECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD 727
++ AF + V ++ + + + +G G G+V+ P+G+ +A K + +
Sbjct: 16 RLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR 75
Query: 728 HGFRAEIQTLGNIRHRNIVRLL-AFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWN 785
+ E+Q L IV AF + + + E+M GSL + L KK +
Sbjct: 76 NQIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL--KKAGRIPEQ 131
Query: 786 LRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845
+ K++I KGL YL I+HRDVK +NIL+NS E + DFG++ LID A
Sbjct: 132 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-- 187
Query: 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKR 905
++ G+ Y++PE +SD++S G+ L+E+ GR P+ + + +
Sbjct: 188 --NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245
Query: 906 ATNGRKEEFLSILDPR-------------------LSMVPKEEAMHLL----------FV 936
E P L + E L FV
Sbjct: 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 305
Query: 937 AMLCIQENSIERPRMRE 953
C+ +N ER +++
Sbjct: 306 N-KCLIKNPAERADLKQ 321
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
GN++G+G VY + + G+E+A+K + G + E++ ++H +
Sbjct: 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMV---QRVQNEVKIHCQLKHPS 72
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
I+ L + + LV E NG + L + F R+ + + G+ YLH
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH-- 129
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT 864
S I+HRD+ +N+LL +ADFGLA L E + G+ YI+PE A
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATR 186
Query: 865 LRVDEKSDVYSFGVVLLELLTGRRP 889
+SDV+S G + LL GR P
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-28
Identities = 62/292 (21%), Positives = 102/292 (34%), Gaps = 39/292 (13%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
+G GG G V G ++A+K+ + + + EIQ + + H N+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 750 AF------CSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEA----AKGLC 799
+ + LL EY G L + L+ + G L+ + L
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCG--LKEGPIRTLLSDISSALR 135
Query: 800 YLHHDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSYGY 856
YLH I+HRD+K NI+L + + D G AK L G E + G+ Y
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQY 189
Query: 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDF------------GDGVDIVQWSK 904
+APE + D +SFG + E +TG RP IV +
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249
Query: 905 RATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
+ L + ++ + + ML + +R +
Sbjct: 250 LTGAVKFSSVLPTPNHLSGILAGK--LERWLQCML--MWHQRQRGTDPQNPN 297
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 57/205 (27%), Positives = 85/205 (41%), Gaps = 16/205 (7%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
G +G+GG + A K LL EI ++ H++
Sbjct: 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK---MSMEISIHRSLAHQH 76
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
+V F + + +V E R SL E LH ++ A RY + + G YLH
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL-RQIVLGCQYLH-- 132
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT 864
++HRD+K N+ LN E + DFGLA + G E + G+ YIAPE
Sbjct: 133 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSK 189
Query: 865 LRVDEKSDVYSFGVVLLELLTGRRP 889
+ DV+S G ++ LL G+ P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 16/205 (7%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
G +G+GG + A K LL EI ++ H++
Sbjct: 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK---MSMEISIHRSLAHQH 102
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
+V F + + +V E R SL E LH ++ A RY + + G YLH +
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN 160
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT 864
++HRD+K N+ LN E + DFGLA + G E + G+ YIAPE
Sbjct: 161 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSK 215
Query: 865 LRVDEKSDVYSFGVVLLELLTGRRP 889
+ DV+S G ++ LL G+ P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 65/328 (19%), Positives = 110/328 (33%), Gaps = 44/328 (13%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLD 131
+ +DL L +VP +I T L L N+ + + + F G
Sbjct: 37 VVQCSDLGL-KAVPKEISP--DTTLLDLQNNDIS--------------ELRKDDFKG--- 76
Query: 132 WNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYL 191
L +L NN + + L KL+ L + N +IP L L
Sbjct: 77 -----LQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN-HLVEIPP--NLPSSLVEL 128
Query: 192 SLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQI 251
+ N + G L N+ I +G + G + L +L +S +L I
Sbjct: 129 RIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GI 187
Query: 252 PHEIGNLKLLDTVFLHINLLSGSIPKQ-LGNLTNLVNLDLSNNALTGEIPYSFINLRQLK 310
P + L+ + L N + +I + L + L L L +N + S L L+
Sbjct: 188 PK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLR 244
Query: 311 LFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPEN-------LGQNGKLQVLDLS 363
+L N+L +P L DL L+ + L NN T + N + + L
Sbjct: 245 ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLF 302
Query: 364 SNKLT-GTIPTDLCSS-NQLRILILLKN 389
+N + + +
Sbjct: 303 NNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 56/299 (18%), Positives = 111/299 (37%), Gaps = 27/299 (9%)
Query: 274 SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDY-LADLPN 332
++PK++ + LDL NN ++ F L+ L L N++ I + + L
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRK 103
Query: 333 LETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSS-NQLRILILLKNFL 391
L+ L + +N+ IP NL + L L + N++ +P + S + + + N L
Sbjct: 104 LQKLYISKNHLV-EIPPNLPSS--LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPL 159
Query: 392 -FGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSS 450
L +R+ + L IP LN L N + ++
Sbjct: 160 ENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIEL--EDL 213
Query: 451 SNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLS 510
+L +L L +N + SLS +L+ L L N+ S +P + +L+ + + L
Sbjct: 214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLH 272
Query: 511 RNSLSGEIPP-------AIGYCNHLTYLDMSQNNLS-GSIPPEI-SNVRILNYLNLSRN 560
N+++ ++ + + + N + + P V +
Sbjct: 273 TNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 69/312 (22%), Positives = 121/312 (38%), Gaps = 49/312 (15%)
Query: 261 LDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLH 320
L V L +PK L + LDL NN +T F NL+ L L N++
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 321 GSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQ 380
P A L LE L L +N +PE + + LQ L + N++T +
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKT--LQELRVHENEIT-KVRKS------ 139
Query: 381 LRILILLKNFLFGPIPERLGACYSLTRVRLGQNYL-NGSIPDG-FIYLPGLNLAELQSNY 438
+F + + V LG N L + I +G F + L+ +
Sbjct: 140 ----------VFNGLN-------QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182
Query: 439 LSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPP-S 497
++ ++P+ P L +L+L N ++ SL ++L L LS N S + S
Sbjct: 183 IT-TIPQG-----LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA-VDNGS 235
Query: 498 IGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPE-------ISNVR 550
+ + +L L+ N L ++P + ++ + + NN+S +I +
Sbjct: 236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKA 293
Query: 551 ILNYLNLSRNHL 562
+ ++L N +
Sbjct: 294 SYSGVSLFSNPV 305
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 65/309 (21%), Positives = 110/309 (35%), Gaps = 27/309 (8%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQFSG 128
+ +DL L VP + L L N T I+ G NL +L L + NN+ S
Sbjct: 35 VVQCSDLGL-EKVPKDLPP--DTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISK 90
Query: 129 GLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGL 188
++ LV LE N L P + K L+ L + N + + L +
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLKEL-PEKMPK--TLQELRVHENEITKVRKSVFNGLNQM 147
Query: 189 EYLSLAGNDLTGKI--PGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCE 246
+ L N L G + L I + N+ IP+ + +L L L +
Sbjct: 148 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT--IPQGL--PPSLTELHLDGNK 203
Query: 247 LDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFIN 305
+ ++ L L + L N +S L N +L L L+NN L ++P +
Sbjct: 204 IT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261
Query: 306 LRQLKLFNLFMNRLHG------SIPDYLADLPNLETLGLWQNNFTGV-IPENLGQN-GKL 357
+ +++ L N + P Y + + L+ N I + +
Sbjct: 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321
Query: 358 QVLDLSSNK 366
+ L + K
Sbjct: 322 AAVQLGNYK 330
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 68/312 (21%), Positives = 120/312 (38%), Gaps = 53/312 (16%)
Query: 686 ECVKDGNVIGRGGAGIVYHG------KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGN 739
+ G +G G G V K + +AVK L + +E++ L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 740 I-RHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY---------- 788
+ H NIV LL C+ L++ EY G L L K+ +F+
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 789 ------KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842
+ + AKG+ +L S +HRD+ + NILL + DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 843 ASECMSAIAGSYGYI-----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDG 896
+ APE + +SDV+S+G+ L EL + G P
Sbjct: 200 NYV-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP------- 247
Query: 897 VDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVV 955
+ + +F ++ M+ E A ++ M C + ++RP +++V
Sbjct: 248 -----YPGMPVD---SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
Query: 956 QMLSEFPRHSSD 967
Q++ + S++
Sbjct: 300 QLIEKQISESTN 311
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 33/223 (14%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRL- 748
V+G+G G V + + A+KK+ T +E+ L ++ H+ +VR
Sbjct: 11 IAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 749 ---------LAFCSNKETNLLVY---EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK 796
+ + + ++ EY NG+L + +H + + +++ + +
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRLFRQILE 127
Query: 797 GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID------------GGAS 844
L Y+H S I+HRD+K NI ++ + + DFGLAK + G+S
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 845 ECMSAIAGSYGYIAPE-YAYTLRVDEKSDVYSFGVVLLELLTG 886
+ +++ G+ Y+A E T +EK D+YS G++ E++
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
G +G+G G VY + + +A+K +L G R E++ ++RH N
Sbjct: 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ---LRREVEIQSHLRHPN 70
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
I+RL + + L+ EY G++ L K F I E A L Y H
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYIT-ELANALSYCH-- 126
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE-CMSAIAGSYGYIAPEYAY 863
S ++HRD+K N+LL SA E +ADFG + ++ C G+ Y+ PE
Sbjct: 127 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTLDYLPPEMIE 180
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRP 889
DEK D++S GV+ E L G+ P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 68/334 (20%), Positives = 117/334 (35%), Gaps = 70/334 (20%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNG---VEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-R 741
+K +VIG G G V ++ ++ A+K++ + + F E++ L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSL---------------GEALHGKKGAFLGWNL 786
H NI+ LL C ++ L EY +G+L + L
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 787 RYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846
A + A+G+ YL +HRD+ + NIL+ + A +ADFGL++
Sbjct: 145 -LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEV--- 194
Query: 847 MSAIAGSYGYI-----APE----YAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDG 896
+ + G + A E YT SDV+S+GV+L E+++ G P
Sbjct: 195 --YVKKTMGRLPVRWMAIESLNYSVYT----TNSDVWSYGVLLWEIVSLGGTPYCGM--- 245
Query: 897 VDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVV 955
T E L + ++ M C +E ERP +++
Sbjct: 246 ----------TC---AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 292
Query: 956 QMLSEFPRHSSDFNQSSSSSLKNLEKDPKGCPNN 989
L+ + N K
Sbjct: 293 VSLNRM--------LEERKTYVNTTLYEKFTYAG 318
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 64/302 (21%), Positives = 113/302 (37%), Gaps = 49/302 (16%)
Query: 686 ECVKDGNVIGRGGAGIVYHG------KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGN 739
++ G +G G G V K +++AVK L +E++ + +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 740 I-RHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY---------- 788
+ +H NIV LL C++ L++ EY G L L K
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 789 --KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846
+ + A+G+ +L S +HRDV + N+LL + A + DFGLA+ +++
Sbjct: 166 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI- 221
Query: 847 MSAIAGSYGYI-----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIV 900
+ APE + +SDV+S+G++L E+ + G P
Sbjct: 222 ----VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------- 266
Query: 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLS 959
+ N +F ++ M A ++ M C RP +++ L
Sbjct: 267 -YPGILVN---SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322
Query: 960 EF 961
E
Sbjct: 323 EQ 324
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 19/224 (8%)
Query: 675 QKLEFSVSDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAE 733
++ + I + +G G G V+ + +G+E +K + + AE
Sbjct: 11 RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAE 70
Query: 734 IQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY--KIA 791
I+ L ++ H NI+++ + +V E G L E + + + Y ++
Sbjct: 71 IEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM 130
Query: 792 IEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMS 848
+ L Y H S +VH+D+K NIL + DFGLA+ E +
Sbjct: 131 KQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHST 184
Query: 849 AIAGSYGYIAPE---YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
AG+ Y+APE K D++S GVV+ LLTG P
Sbjct: 185 NAAGTALYMAPEVFKRDV----TFKCDIWSAGVVMYFLLTGCLP 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-26
Identities = 78/326 (23%), Positives = 125/326 (38%), Gaps = 54/326 (16%)
Query: 677 LEFSVSDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLL--GFGTHSHDHGFRAE 733
++ S + + K V+G+G G V K G E AVK + + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 734 IQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY----- 788
+Q L + H NI++L F +K LV E G L + + +K R+
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--------RFSEVDA 128
Query: 789 -KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGAS 844
+I + G+ Y+H + IVHRD+K N+LL S + + DFGL+
Sbjct: 129 ARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--- 182
Query: 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSK 904
+ M G+ YIAPE DEK DV+S GV+L LL+G P F +
Sbjct: 183 KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP---FNGANE------ 232
Query: 905 RATNGRKEEFLSILDPRLSMVPK------EEAMHLLFVAMLCIQENSIERPRMREVVQ-- 956
+ + + + E A L+ ML R R+ +
Sbjct: 233 ------YDILKKVEKGKYTFELPQWKKVSESAKDLI-RKMLTY--VPSMRISARDALDHE 283
Query: 957 -MLSEFPRHSSDFNQSSSSSLKNLEK 981
+ + S S +++ N+ +
Sbjct: 284 WIQTYTKEQISVDVPSLDNAILNIRQ 309
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 53/248 (21%), Positives = 83/248 (33%), Gaps = 52/248 (20%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK----KLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
IG+G G+V A+K + + E++ + + H NI
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI------------- 792
RL +++ LV E G L + L+ G +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 793 ------------------EAAK-------GLCYLHHDCSPLIVHRDVKSNNILLNSAFEA 827
+ L YLH + I HRD+K N L ++
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSF 207
Query: 828 HV--ADFGLAKFL--IDGGASECMSAIAGSYGYIAPE--YAYTLRVDEKSDVYSFGVVLL 881
+ DFGL+K ++ G M+ AG+ ++APE K D +S GV+L
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 882 ELLTGRRP 889
LL G P
Sbjct: 268 LLLMGAVP 275
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-26
Identities = 62/217 (28%), Positives = 92/217 (42%), Gaps = 34/217 (15%)
Query: 691 GNVIGRGGAGIVYHGKM-PNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
+G G G V + VE A+K + + S + E+ L + H N
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV----STSSNSKLLEEVAVLKLLDHPN 97
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY------KIAIEAAKGL 798
I++L F +K LV E + G L + + + ++ I + G+
Sbjct: 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--------KFNEVDAAVIIKQVLSGV 149
Query: 799 CYLHHDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSYG 855
YLH IVHRD+K N+LL S + + DFGL+ + + M G+
Sbjct: 150 TYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTAY 203
Query: 856 YIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGD 892
YIAPE + DEK DV+S GV+L LL G P G
Sbjct: 204 YIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGG 239
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 65/274 (23%), Positives = 99/274 (36%), Gaps = 24/274 (8%)
Query: 56 SVCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG---N 112
S CS CS + L SVP I T L L N S+ G
Sbjct: 3 SRCS-----CSGTEI---RCNSKGLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDK 50
Query: 113 LSSLQFLNISNNQFSGGLDWNYS--SLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLG 170
L+ L L++S+N S + S +L+ D N + L LE+L++LD
Sbjct: 51 LTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQ 109
Query: 171 GNYFFGKIPNSY-GELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPR 229
+ S L+ L YL ++ G L++L + + N F+
Sbjct: 110 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM-AGNSFQENFLP 168
Query: 230 EV-GKLVNLVHLDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQLGNLTNLVN 287
++ +L NL LDLS C+L+ Q+ +L L + + N L +L
Sbjct: 169 DIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227
Query: 288 LDLSNNALTGEIPYSFINL-RQLKLFNLFMNRLH 320
LD S N + + L NL N
Sbjct: 228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 50/235 (21%), Positives = 85/235 (36%), Gaps = 13/235 (5%)
Query: 187 GLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLSSC 245
L L N L G LT L ++ L + G + +L +LDLS
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 246 ELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQ--LGNLTNLVNLDLSNNALTGEIPYSF 303
+ + L+ L+ + + L + + +L NL+ LD+S+ F
Sbjct: 89 GV-ITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146
Query: 304 INLRQLKLFNLFMNRLHGSIPDY-LADLPNLETLGLWQNNFTGVIPENLGQN-GKLQVLD 361
L L++ + N + +L NL L L Q + + LQVL+
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLN 205
Query: 362 LSSNKLTGTIPTDLCSS-NQLRILILLKNFLFGPIPERL--GACYSLTRVRLGQN 413
+S N ++ T N L++L N + ++ SL + L QN
Sbjct: 206 MSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI-MTSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 66/263 (25%), Positives = 102/263 (38%), Gaps = 16/263 (6%)
Query: 332 NLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFL 391
+ + T +P + + L+L SNKL QL L L N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPSS--ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 392 --FGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNS 449
G + SL + L N + ++ F+ L L + Q + L + E
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVF 122
Query: 450 SSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLD 508
S L L++S+ + SSL++L ++GN F P I ELR + LD
Sbjct: 123 LSLR-NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181
Query: 509 LSRNSLSGEIPP-AIGYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHLNQNI 566
LS+ L ++ P A + L L+MS NN S+ + L L+ S NH+
Sbjct: 182 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI-MTS 238
Query: 567 PKSI--GSMKSLTIADFSFNDFS 587
K SL + + NDF+
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 57/283 (20%), Positives = 103/283 (36%), Gaps = 36/283 (12%)
Query: 262 DTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG 321
+ + L+ S+P + ++ L+L +N L F L QL +L N
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN---- 62
Query: 322 SIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQL 381
L G + G L+ LDLS N + T+ ++ QL
Sbjct: 63 ----------GLSFKGCCSQSDFGT--------TSLKYLDLSFNGVI-TMSSNFLGLEQL 103
Query: 382 RILILLKNFLFGPIPER--LGACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNY 438
L + L + E + +L + + + +G F L L + ++ N
Sbjct: 104 EHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNS 161
Query: 439 LSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI 498
+ + + L L+LS L P + ++ SSLQ+L +S N F
Sbjct: 162 FQENFLP--DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 219
Query: 499 GELRQVLKLDLSRNSLSGEIPPAI--GYCNHLTYLDMSQNNLS 539
L + LD S N + + + L +L+++QN+ +
Sbjct: 220 KCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 35/219 (15%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK----KLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
VIG+G +V G + AVK + E ++H +I
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK-------GL 798
V LL S+ +V+E+M L + + A ++ A+ L
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA-----VASHYMRQILEAL 143
Query: 799 CYLH-HDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSY 854
Y H ++ I+HRDVK + +LL S + + FG+A L + G G+
Sbjct: 144 RYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTP 197
Query: 855 GYIAPE----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
++APE Y + DV+ GV+L LL+G P
Sbjct: 198 HFMAPEVVKREPY----GKPVDVWGCGVILFILLSGCLP 232
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 68/312 (21%), Positives = 118/312 (37%), Gaps = 54/312 (17%)
Query: 686 ECVKDGNVIGRGGAGIVYHG--------KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTL 737
+ + G +G G G V K V +AVK L T +E++ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 738 GNI-RHRNIVRLLAFCSNKETNLLVYEYMRNGSL----------GEALHGKKGAFLGWNL 786
I +H+NI+ LL C+ ++ EY G+L G +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 787 RYK----IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842
+K + A+G+ YL S +HRD+ + N+L+ +ADFGLA+ + +
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 843 ASECMSAIAGSYGYI-----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDG 896
+ + G + APE + +SDV+SFGV++ E+ T G P
Sbjct: 212 YYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--- 263
Query: 897 VDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVV 955
EE +L M + L++ M C +RP +++V
Sbjct: 264 ----------PV---EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 956 QMLSEFPRHSSD 967
+ L +++
Sbjct: 311 EDLDRILTLTTN 322
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 1e-25
Identities = 30/241 (12%), Positives = 61/241 (25%), Gaps = 43/241 (17%)
Query: 688 VKDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHD--HGFRAEIQTLGNIR--- 741
+ G V+G+ G V + + E+ L +R
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 742 ----------------------HRNIVRLLA----FCSNKETNLLVYEYMRNGSLGEAL- 774
+ ++R+ L + GE L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 775 -HGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFG 833
H L + R ++ ++ + L LHH +VH ++ +I+L+ + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTGRR 888
S A + D ++ G+ + +
Sbjct: 257 HLVRDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 889 P 889
P
Sbjct: 316 P 316
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 68/331 (20%), Positives = 114/331 (34%), Gaps = 69/331 (20%)
Query: 675 QKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVE------IAVKKLLGFGTHSHDH 728
LE+ ++ IG G G V+ + P + +AVK L +
Sbjct: 40 LSLEYP----RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 95
Query: 729 GFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY 788
F+ E + + NIV+LL C+ + L++EYM G L E L +
Sbjct: 96 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155
Query: 789 ----------------------KIAIEAAKGLCYL--HHDCSPLIVHRDVKSNNILLNSA 824
IA + A G+ YL VHRD+ + N L+
Sbjct: 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGEN 210
Query: 825 FEAHVADFGLAKFLIDGGASECMSAIAGSYGYI-----APEYAYTLRV-DEKSDVYSFGV 878
+ADFGL++ + + A I PE + +SDV+++GV
Sbjct: 211 MVVKIADFGLSRNIYSADYYK-----ADGNDAIPIRWMPPE-SIFYNRYTTESDVWAYGV 264
Query: 879 VLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVA 937
VL E+ + G +P + EE + + + E L+
Sbjct: 265 VLWEIFSYGLQPYYGM-------------AH---EEVIYYVRDGNILACPENCPLELYNL 308
Query: 938 ML-CIQENSIERPRMREVVQMLSEFPRHSSD 967
M C + +RP + ++L +
Sbjct: 309 MRLCWSKLPADRPSFCSIHRILQRMCERAEG 339
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAF 751
VIG G +V P ++A+K++ + EIQ + H NIV +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS--YY 79
Query: 752 CS-NKETNL-LVYEYMRNGSLGEAL--HGKKGAFLGWNLRYK-IAI---EAAKGLCYLHH 803
S + L LV + + GS+ + + KG L IA E +GL YLH
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA---IAGSYGYIAPE 860
+ +HRDVK+ NILL +ADFG++ FL GG G+ ++APE
Sbjct: 140 NG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 861 -----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y D K+D++SFG+ +EL TG P
Sbjct: 197 VMEQVRGY----DFKADIWSFGITAIELATGAAP 226
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 74/305 (24%), Positives = 120/305 (39%), Gaps = 52/305 (17%)
Query: 686 ECVKDGNVIGRGGAGIVYHG------KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGN 739
+ +K G +GRG G V K +AVK L THS +E++ L +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 740 I-RHRNIVRLLAFCSNKET-NLLVYEYMRNGSLGEALHGKKGAFLGWNLRY--------- 788
I H N+V LL C+ +++ E+ + G+L L K+ F+ + +
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 789 -----KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843
+ + AKG+ +L S +HRD+ + NILL+ + DFGLA+ +
Sbjct: 147 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 844 SECMSAIAGSYGYI-----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGV 897
+ APE + +SDV+SFGV+L E+ + G P
Sbjct: 204 YV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------- 250
Query: 898 DIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQ 956
+ + EEF L M + ++ ML C +RP E+V+
Sbjct: 251 ----YPGVKID---EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 957 MLSEF 961
L
Sbjct: 304 HLGNL 308
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 68/287 (23%), Positives = 105/287 (36%), Gaps = 62/287 (21%)
Query: 691 GNVIGRGGAGIVYHGKM-PNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
++G+G G V K E AVK + E++ L + H N
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA----KNKDTSTILREVELLKKLDHPN 82
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY------KIAIEAAKGL 798
I++L + + +V E G L + + +K R+ +I + G+
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--------RFSEHDAARIIKQVFSGI 134
Query: 799 CYLHHDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSYG 855
Y+H IVHRD+K NILL S + + DFGL+ M G+
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAY 188
Query: 856 YIAPEYAYTLR--VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913
YIAPE LR DEK DV+S GV+L LL+G P F +
Sbjct: 189 YIAPE---VLRGTYDEKCDVWSAGVILYILLSGTPP---FYG------------KNEYDI 230
Query: 914 FLSILDPRLSMVPK------EEAMHLLFVAMLCIQENSIERPRMREV 954
+ + + ++A L+ ML + R +
Sbjct: 231 LKRVETGKYAFDLPQWRTISDDAKDLI-RKMLTF--HPSLRITATQC 274
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 74/356 (20%), Positives = 120/356 (33%), Gaps = 64/356 (17%)
Query: 657 KAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAV 715
+ + + + I E +G G G V K E A+
Sbjct: 7 HSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAI 66
Query: 716 KKL------------LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763
K + EI L ++ H NI++L +K+ LV E
Sbjct: 67 KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTE 126
Query: 764 YMRNGSLGEALHGKKGAFLGWNLRY------KIAIEAAKGLCYLHHDCSPLIVHRDVKSN 817
+ G L E + + ++ I + G+CYLH IVHRD+K
Sbjct: 127 FYEGGELFEQIINRH--------KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPE 175
Query: 818 NILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVY 874
NILL + + DFGL+ F + G+ YIAPE + +EK DV+
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPE-VLKKKYNEKCDVW 231
Query: 875 SFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK------E 928
S GV++ LL G P FG ++ + + +
Sbjct: 232 SCGVIMYILLCGYPP---FGG------------QNDQDIIKKVEKGKYYFDFNDWKNISD 276
Query: 929 EAMHLLFVAMLCIQENSIERPRMREVVQ---MLSEFPRHSSDFNQSSSSSLKNLEK 981
EA L+ ML + +R E + + + ++ +L N+ K
Sbjct: 277 EAKELI-KLMLTY--DYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRK 329
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 43/228 (18%), Positives = 85/228 (37%), Gaps = 41/228 (17%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKL----------------LGFGTHSHDHGFRAEI 734
+ +G + + + A+KK S F+ E+
Sbjct: 36 IRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 735 QTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY------ 788
Q + +I++ + +N + ++YEYM N S+ + +
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 789 KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS 848
I Y+H++ + I HRDVK +NIL++ ++DFG +++++D +
Sbjct: 155 CIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IK 208
Query: 849 AIAGSYGYIAPE-------YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
G+Y ++ PE Y K D++S G+ L + P
Sbjct: 209 GSRGTYEFMPPEFFSNESSYN-----GAKVDIWSLGICLYVMFYNVVP 251
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 70/321 (21%), Positives = 117/321 (36%), Gaps = 66/321 (20%)
Query: 686 ECVKDGNVIGRGGAGIVYHG------KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGN 739
E ++ G V+G G G V + K +++AVK L S +E++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 740 I-RHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY---------- 788
+ H NIV LL C+ L++EY G L L K+ F + Y
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 789 -----------KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837
A + AKG+ +L VHRD+ + N+L+ + DFGLA+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 838 LIDGGASECMSAIAGSYGYI-----APE----YAYTLRVDEKSDVYSFGVVLLELLT-GR 887
++ + APE YT KSDV+S+G++L E+ + G
Sbjct: 222 IMSDSNYV-----VRGNARLPVKWMAPESLFEGIYT----IKSDVWSYGILLWEIFSLGV 272
Query: 888 RPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSI 946
P + + F ++ M A +++ M C +S
Sbjct: 273 NP------------YPGIPVD---ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSR 317
Query: 947 ERPRMREVVQMLSEFPRHSSD 967
+RP + L + +
Sbjct: 318 KRPSFPNLTSFLGCQLADAEE 338
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 70/310 (22%), Positives = 116/310 (37%), Gaps = 62/310 (20%)
Query: 686 ECVKDGNVIGRGGAGIVYHG--------KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTL 737
+ + G +G G G V K V +AVK L T +E++ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 738 GNI-RHRNIVRLLAFCSNKETNLLVYEYMRNGSL----------GEALHGKKGAFLGWNL 786
I +H+NI+ LL C+ ++ EY G+L G +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 787 RYK----IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842
+K + A+G+ YL S +HRD+ + N+L+ +ADFGLA+ + +
Sbjct: 201 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 843 ASECMSAIAGSYGYI-----APE----YAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGD 892
+ + G + APE YT +SDV+SFGV++ E+ T G P
Sbjct: 258 YYK-----KTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 893 FGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRM 951
EE +L M + L++ M C +RP
Sbjct: 309 I-------------PV---EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 352
Query: 952 REVVQMLSEF 961
+++V+ L
Sbjct: 353 KQLVEDLDRI 362
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 32/213 (15%)
Query: 691 GNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHD-HGFRAEIQTLGNIRHRNIVRL 748
++G+G G V K E AVK + + D E++ L + H NI++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY------KIAIEAAKGLCYLH 802
+ + +V E G L + + +K R+ +I + G+ Y+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRK--------RFSEHDAARIIKQVFSGITYMH 138
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSYGYIAP 859
IVHRD+K NILL S + + DFGL+ M G+ YIAP
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAP 192
Query: 860 E---YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
E Y DEK DV+S GV+L LL+G P
Sbjct: 193 EVLRGTY----DEKCDVWSAGVILYILLSGTPP 221
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 51/230 (22%), Positives = 86/230 (37%), Gaps = 32/230 (13%)
Query: 680 SVSDILECVKDGNVIGRGGA--GIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQ 735
S C + VIG+G V + P G + V+++ L ++ + E+
Sbjct: 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELH 78
Query: 736 TLGNIRHRNIVRLLAFCS-NKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI- 792
H NIV + + L +V +M GS + + + IA
Sbjct: 79 VSKLFNHPNIVP--YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA---IAYI 133
Query: 793 --EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA-----SE 845
K L Y+HH VHR VK+++IL++ + +++ +I G +
Sbjct: 134 LQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 846 CMSAIAGSYGYIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+++PE Y D KSD+YS G+ EL G P
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGY----DAKSDIYSVGITACELANGHVP 236
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 74/325 (22%), Positives = 122/325 (37%), Gaps = 48/325 (14%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLA 750
V+ GG VY + + +G E A+K+LL + E+ + + H NIV+ +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA-IIQEVCFMKKLSGHPNIVQFCS 93
Query: 751 FCSNKETN--------LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
S + LL+ E + + + L + KI + + + ++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG----------GASECMSAIAG 852
P I+HRD+K N+LL++ + DFG A + E
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 853 SYGYIAPE----YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN 908
+ Y PE Y+ + EK D+++ G +L L + P F DG R N
Sbjct: 213 TPMYRTPEIIDLYSN-FPIGEKQDIWALGCILYLLCFRQHP---FEDGA-----KLRIVN 263
Query: 909 GRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDF 968
G+ + H L AML Q N ER + EVV L E ++
Sbjct: 264 GK---YSIPPHDTQY-----TVFHSLIRAML--QVNPEERLSIAEVVHQLQEI---AAAR 310
Query: 969 NQSSSSSLKNLEKDPKGCPNNKLKQ 993
N + S + L + G + L +
Sbjct: 311 NVNPKSPITELLEQNGGYGSATLSR 335
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-25
Identities = 60/381 (15%), Positives = 110/381 (28%), Gaps = 84/381 (22%)
Query: 83 SVPAQILR-LDKLTNLSLAG---NNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLV 138
A DK +L G N ++ ++ L ++ S
Sbjct: 24 GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS---------- 73
Query: 139 NLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDL 198
LP + ++ L++ N +P LEYL N L
Sbjct: 74 ---------------LPDNLPP--QITVLEITQNA-LISLPE---LPASLEYLDACDNRL 112
Query: 199 TGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNL 258
+ +P +L HLD+ + +L +P L
Sbjct: 113 S-TLPELPASLK----------------------------HLDVDNNQLT-MLPELPALL 142
Query: 259 KLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNR 318
+ ++ N L+ +P+ +L L + NN LT +P +L L + N
Sbjct: 143 EYIN---ADNNQLT-MLPELPTSLE---VLSVRNNQLT-FLPELPESLEALDVST---NL 191
Query: 319 LHGSIPDYLADLPNLETLGLW----QNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTD 374
L S+P + E ++ +N T IPEN+ + L N L+ I
Sbjct: 192 LE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRES 249
Query: 375 LCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAEL 434
L + + + + + + + E
Sbjct: 250 LSQQTAQPDYHGPRIYF--SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEE 307
Query: 435 QSNYLSGSLPENGNSSSNPDR 455
+N S L ++ S +
Sbjct: 308 HANTFSAFLDRLSDTVSARNT 328
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-25
Identities = 70/346 (20%), Positives = 113/346 (32%), Gaps = 38/346 (10%)
Query: 251 IPHEIGNLKLL--DTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQ 308
I I N L ++ + I+ + N + + Q
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLINQ 60
Query: 309 LKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLT 368
L L S+PD L P + L + QN +PE L+ LD N+L+
Sbjct: 61 FSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS 113
Query: 369 GTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPG 428
T+P S L+ L + N L +PE L + N L +P+ L
Sbjct: 114 -TLPELPAS---LKHLDVDNNQLTM-LPELPA---LLEYINADNNQLT-MLPELPTSLEV 164
Query: 429 LNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQ----ILL 484
L++ ++N L+ LPE P+ L L++S NLL LP +
Sbjct: 165 LSV---RNNQLT-FLPEL------PESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFR 213
Query: 485 LSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPP 544
N+ + IP +I L + L N LS I ++ + S+
Sbjct: 214 CRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSD 270
Query: 545 EISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKL 590
N + +N + + + N FS L
Sbjct: 271 GQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL 316
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 50/290 (17%), Positives = 94/290 (32%), Gaps = 36/290 (12%)
Query: 74 DLTDLNLCGSVPAQILR------LDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFS 127
L G + + +++ + L L N + S+ + L I+ N
Sbjct: 35 KWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPPQITVLEITQNALI 93
Query: 128 GGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQG 187
L +LE DA +N + L + LK+LD+ N +P
Sbjct: 94 S-LP---ELPASLEYLDACDNRLSTLPEL----PASLKHLDVDNNQL-TMLPE---LPAL 141
Query: 188 LEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCEL 247
LEY++ N LT +P +L L + N +P +L LD+S+ L
Sbjct: 142 LEYINADNNQLT-MLPELPTSLEVL---SV-RNNQLTF-LPEL---PESLEALDVSTNLL 192
Query: 248 DGQIPHEIGNLKLLDTVFLHINL----LSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSF 303
+ +P + + ++ IP+ + +L + L +N L+ I S
Sbjct: 193 E-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250
Query: 304 INLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQ 353
++ S + + F ++ Q
Sbjct: 251 SQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQ 298
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 73/328 (22%), Positives = 122/328 (37%), Gaps = 54/328 (16%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPN--------GVEIAVKKLLGFGTHSHDHGFRAEIQTL 737
+ + G +G G G V + ++AVK L T +E++ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 738 GNI-RHRNIVRLLAFCSNKETNLLVYEYMRNGSL----------GEALHGKKGAFLGWNL 786
I +H+NI+ LL C+ ++ EY G+L G L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 787 RYK----IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842
K A + A+G+ YL S +HRD+ + N+L+ +ADFGLA+ +
Sbjct: 189 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 843 ASECMSAIAGSYGYI-----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDG 896
+ + G + APE + +SDV+SFGV+L E+ T G P G
Sbjct: 246 YYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP----G 296
Query: 897 VDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVV 955
V EE +L M + L++ M C +RP +++V
Sbjct: 297 V---------PV---EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344
Query: 956 QMLSEFPRHSSDFNQSSSSSLKNLEKDP 983
+ L +S+ + + D
Sbjct: 345 EDLDRIVALTSNQEMGYYHHHHHHDYDI 372
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 63/282 (22%), Positives = 111/282 (39%), Gaps = 23/282 (8%)
Query: 91 LDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSG--GLDWNYSSLVNLEVFDAYNN 148
L ++ +N T ++ +L + L+ + G+ L NL + +N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEGV----QYLNNLIGLELKDN 73
Query: 149 NFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGN 208
T L P + L K+ L+L GN K ++ LQ ++ L L +T P L
Sbjct: 74 QITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAG 127
Query: 209 LTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHI 268
L+NL+ +YL + I + L NL +L + + ++ P + NL L T+
Sbjct: 128 LSNLQVLYLDLNQITN--IS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182
Query: 269 NLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLA 328
N +S I L +L NL+ + L NN ++ P N L + L + Y
Sbjct: 183 NKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 329 DLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGT 370
+L + + + P + NG +L+ N +
Sbjct: 239 NLVVPNVVK--GPSGAPIAPATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 8e-21
Identities = 63/312 (20%), Positives = 113/312 (36%), Gaps = 26/312 (8%)
Query: 279 LGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGL 338
L N + + + +T + +L + + F + +I + L NL L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 339 WQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPER 398
N T + L K+ L+LS N L + ++ L L + P
Sbjct: 71 KDNQITDL--APLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP-- 124
Query: 399 LGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQ 458
L +L + L N + +I L L + + +S L N S L
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS-DLTPLANLSK----LTT 177
Query: 459 LNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEI 518
L +N +S P L++ +L + L NQ S P + + + L+ +++ +
Sbjct: 178 LKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP 233
Query: 519 PPAIGYCNHLTYLDMSQNNLSGSIPP-EISNVRILNYLNLSRNHLNQNIPKSIGSMKSLT 577
Y N+L ++ + I P IS+ NL+ N + S +S+T
Sbjct: 234 V---FYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVT 290
Query: 578 IADFSFNDFSGK 589
+ + FSG
Sbjct: 291 FKNTTVP-FSGT 301
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 56/285 (19%), Positives = 99/285 (34%), Gaps = 46/285 (16%)
Query: 112 NLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGG 171
L++ + + + + L + A+ T + G+ L L L+L
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 172 NYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV 231
N + L + L L+GN L + + L +++ + L + + +
Sbjct: 73 NQ-ITDLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD---VTPL 125
Query: 232 GKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLS 291
L NL L L + I +S L LTNL L +
Sbjct: 126 AGLSNLQVLYLDLNQ---------------------ITNISP-----LAGLTNLQYLSIG 159
Query: 292 NNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENL 351
N ++ P + NL +L N++ I LA LPNL + L N + V L
Sbjct: 160 NAQVSDLTPLA--NLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV--SPL 213
Query: 352 GQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIP 396
L ++ L++ +T +N L + ++K PI
Sbjct: 214 ANTSNLFIVTLTNQTITNQPVF---YNNNLVVPNVVKGPSGAPIA 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 40/217 (18%), Positives = 73/217 (33%), Gaps = 41/217 (18%)
Query: 91 LDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNF 150
L + L L T + LS+LQ L + NQ + N+
Sbjct: 106 LQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQ-----------ITNISPLA------ 148
Query: 151 TALLPVGILKLEKLKYLDLGGNYFFGKIPN--SYGELQGLEYLSLAGNDLTGKIPGELGN 208
L L+YL +G ++ + L L L N ++ I L +
Sbjct: 149 ---------GLTNLQYLSIGNA----QVSDLTPLANLSKLTTLKADDNKIS-DISP-LAS 193
Query: 209 LTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHI 268
L NL E++L + + + NL + L++ + Q NL + + V
Sbjct: 194 LPNLIEVHLKNNQISD---VSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPS 250
Query: 269 NLLSGSIPKQLGNLTNLVNLDLSNN--ALTGEIPYSF 303
P + + + +L+ N + + Y+F
Sbjct: 251 GAP--IAPATISDNGTYASPNLTWNLTSFINNVSYTF 285
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 35/236 (14%), Positives = 74/236 (31%), Gaps = 25/236 (10%)
Query: 691 GNVIGRGGAGIVYHGK------MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
+++G G VY N + +K + ++ L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEFYIGTQLMERLKPSMQHM 128
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKK---GAFLGWNLRYKIAIEAAKGLCYL 801
++ + + ++LV E G+L A++ K + L A+ + +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAH-----------VADFGLAKFLIDGGASECMSAI 850
H I+H D+K +N +L + F + D G + + +A
Sbjct: 189 H---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP-VGDFGDGVDIVQWSKR 905
+ G+ E + + D + + +L G V + G +R
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 59/244 (24%), Positives = 96/244 (39%), Gaps = 54/244 (22%)
Query: 686 ECVKDGNVIGRGGAGIVYHG------KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGN 739
+ + G +G G G V +AVK L + S +E L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 740 IRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY----------- 788
+ H ++++L CS LL+ EY + GSL L + G+
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 789 -----------KIAIEAAKGLCYL--HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA 835
A + ++G+ YL +VHRD+ + NIL+ + ++DFGL+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 836 KFLIDGGASECMSAIAGSYGYI-----APE----YAYTLRVDEKSDVYSFGVVLLELLT- 885
+ + + + S G I A E + YT +SDV+SFGV+L E++T
Sbjct: 198 RDVYEEDSYV-----KRSQGRIPVKWMAIESLFDHIYTT----QSDVWSFGVLLWEIVTL 248
Query: 886 GRRP 889
G P
Sbjct: 249 GGNP 252
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 61/238 (25%), Positives = 100/238 (42%), Gaps = 31/238 (13%)
Query: 671 MTAFQKLEFSVSDILECVKDG----NVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHS 725
+ + KL+ S + + IGRG G V P+G +AVK++
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62
Query: 726 HDHGFRAEIQT-LGNIRHRNIVRLL-AFCSNKETNL-LVYEYMRNGSLGEAL---HGKKG 779
++ + + IV+ A +E + + E M + S + +
Sbjct: 63 EQKQLLMDLDVVMRSSDCPYIVQFYGALF--REGDCWICMELM-STSFDKFYKYVYSVLD 119
Query: 780 AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839
+ + KI + K L +L + I+HRD+K +NILL+ + + DFG++ L+
Sbjct: 120 DVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177
Query: 840 DGGASECMSAIAGSYGYIAPE--------YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
D A + AG Y+APE Y D +SDV+S G+ L EL TGR P
Sbjct: 178 DSIA---KTRDAGCRPYMAPERIDPSASRQGY----DVRSDVWSLGITLYELATGRFP 228
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 54/214 (25%), Positives = 83/214 (38%), Gaps = 36/214 (16%)
Query: 691 GNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
N IGRG G V + A KK+ + D F+ EI+ + ++ H NI+RL
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-FKQEIEIMKSLDHPNIIRLY 72
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY------KIAIEAAKGLCYLHH 803
+ LV E G L E + K+ + +I + + Y H
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKR--------VFRESDAARIMKDVLSAVAYCH- 123
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSYGYIAPE 860
+ HRD+K N L + + DFGLA G + M G+ Y++P+
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSPQ 178
Query: 861 -----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y + D +S GV++ LL G P
Sbjct: 179 VLEGLY------GPECDEWSAGVMMYVLLCGYPP 206
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 691 GNVIGRGGAGIVYHG-KMPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
+G+G +V G+E A K KL + E + ++H N
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL----SARDFQKLEREARICRKLQHPN 66
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK-------G 797
IVRL + + LV++ + G L E + ++ Y A +A+
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--------FYSEA-DASHCIQQILES 117
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFE-AHV--ADFGLAKFLIDGGASECMSAIAGSY 854
+ Y H S IVHR++K N+LL S + A V ADFGLA + D E AG+
Sbjct: 118 IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTP 171
Query: 855 GYIAPE----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
GY++PE Y + D+++ GV+L LL G P
Sbjct: 172 GYLSPEVLKKDPY----SKPVDIWACGVILYILLVGYPP 206
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
G +G+G G VY + N +A+K +L G R EI+ ++RH N
Sbjct: 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ---LRREIEIQSHLRHPN 75
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
I+R+ + +++ L+ E+ G L + L K G F + E A L Y H
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFME-ELADALHYCH-- 131
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS-ECMSAIAGSYGYIAPEYAY 863
++HRD+K N+L+ E +ADFG + C G+ Y+ PE
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-----GTLDYLPPEMIE 185
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRP 889
DEK D++ GV+ E L G P
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 19/233 (8%)
Query: 666 SDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTH 724
+ S + ++ +D E IG+G G V+ G +A+K +
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE 61
Query: 725 SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLG 783
+ EI L + + K+T L ++ EY+ GS + L
Sbjct: 62 DEIEDIQQEITVLSQCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGP----- 115
Query: 784 WNLR-YKIAI---EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839
L +IA E KGL YLH + +HRD+K+ N+LL+ E +ADFG+A L
Sbjct: 116 --LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170
Query: 840 DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGD 892
D + G+ ++APE D K+D++S G+ +EL G P +
Sbjct: 171 DTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 36/247 (14%), Positives = 70/247 (28%), Gaps = 54/247 (21%)
Query: 688 VKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEIQTLGNIR--- 741
+ G V+G+ G V + + E+ L +R
Sbjct: 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134
Query: 742 ----------------------HRNIVRLLAFCSNKETNLLVYEYMR----NGSLGEAL- 774
+ ++R+ + + Y R + GE L
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194
Query: 775 -HGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFG 833
H L + R ++ ++ + L LHH +VH ++ +I+L+ + F
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 834 LAKFLIDGGASECMSAIAGSYGYIAPEY-----------AYTLRVDEKSDVYSFGVVLLE 882
DG S G+ PE + D ++ G+V+
Sbjct: 252 HLVR--DGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 883 LLTGRRP 889
+ P
Sbjct: 306 IWCADLP 312
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 692 NVIGRGGAGIVYHGKM---PNGVEIAVKKLLGFGTHSHDHGFRAEIQ-TLGNIRHRNIVR 747
+GRG G+V KM P+G +AVK++ ++ ++ + V
Sbjct: 13 MELGRGAYGVVE--KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 748 LL-AFCSNKETNL-LVYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHH 803
A +E ++ + E M + SL + KG + ++ KIA+ K L +LH
Sbjct: 71 FYGALF--REGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE--- 860
S ++HRDVK +N+L+N+ + + DFG++ +L+D A AG Y+APE
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERIN 182
Query: 861 -----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y KSD++S G+ ++EL R P
Sbjct: 183 PELNQKGY----SVKSDIWSLGITMIELAILRFP 212
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 32/214 (14%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDH-GFRAEIQTLGNIRHRNIVRL 748
+G+G +V + G E A + + DH E + ++H NIVRL
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY------KIAIEAAKGLCYLH 802
S + + L+++ + G L E + ++ Y + + + + H
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVARE--------YYSEADASHCIQQILEAVLHCH 127
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSYGYIAP 859
+VHR++K N+LL S + +ADFGLA + + AG+ GY++P
Sbjct: 128 ---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSP 182
Query: 860 E----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
E Y + D+++ GV+L LL G P
Sbjct: 183 EVLRKDPY----GKPVDLWACGVILYILLVGYPP 212
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 26/213 (12%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
G +G G IV + G+E A K + E+ L + H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK----GLCY 800
++ L N+ +L+ E + G L + L K+ +L + A K G+ Y
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNY 130
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAH----VADFGLAKFLIDGGASECMSAIAGSYGY 856
LH + I H D+K NI+L + DFGLA + DG I G+ +
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEF 184
Query: 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+APE + ++D++S GV+ LL+G P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 56/243 (23%), Positives = 86/243 (35%), Gaps = 36/243 (14%)
Query: 655 IIKAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHG-KMPNGVEI 713
+++ + + +S+ +FQ+L +G G G V+ +G
Sbjct: 40 TLQSPGYDPSRPESFFQQSFQRLS--------------RLGHGSYGEVFKVRSKEDGRLY 85
Query: 714 AVKKL-LGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRNGSLG 771
AVK+ F AE+ + + +H VRL L E SL
Sbjct: 86 AVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQ 144
Query: 772 EALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVAD 831
+ GA L + + L +LH S +VH DVK NI L + D
Sbjct: 145 QHCE-AWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGD 200
Query: 832 FGLAKFLIDGGASECMSAIAGSYGYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTG 886
FGL L G + G Y+APE Y +DV+S G+ +LE+
Sbjct: 201 FGLLVEL---GTAGAGEVQEGDPRYMAPELLQGSY------GTAADVFSLGLTILEVACN 251
Query: 887 RRP 889
Sbjct: 252 MEL 254
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 65/248 (26%), Positives = 99/248 (39%), Gaps = 35/248 (14%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLA 750
V+G G V + E AVK + H FR E++ L + HRN++ L+
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR-EVEMLYQCQGHRNVLELIE 78
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK-------GLCYLHH 803
F ++ LV+E MR GS+ +H K+ F N EA+ L +LH
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIH-KRRHF---NEL-----EASVVVQDVASALDFLH- 128
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGG-----ASECMSAIAGSYG 855
+ I HRD+K NIL + + DF L + G ++ + GS
Sbjct: 129 --NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 856 YIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910
Y+APE D++ D++S GV+L LL+G P + +
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246
Query: 911 KEEFLSIL 918
F SI
Sbjct: 247 NMLFESIQ 254
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 56/220 (25%), Positives = 86/220 (39%), Gaps = 37/220 (16%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHD--HGFRAEIQTLGNIRH 742
+G G G V ++A++ K D EI+ L + H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK------ 796
I+++ F ++ + V E M G L + + G K R K A
Sbjct: 200 PCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGNK--------RLKEA-TCKLYFYQML 249
Query: 797 -GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAG 852
+ YLH I+HRD+K N+LL+S E + DFG +K L + M + G
Sbjct: 250 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCG 303
Query: 853 SYGYIAPE---YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ Y+APE T + D +S GV+L L+G P
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 35/220 (15%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHD--HGFRAEIQTLGNIR- 741
+VIGRG + +V G E AVK + R E L +
Sbjct: 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY------KIAIEAA 795
H +I+ L+ + LV++ MR G L + L K I
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--------ALSEKETRSIMRSLL 210
Query: 796 KGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYG 855
+ + +LH + IVHRD+K NILL+ + ++DFG + L G E + + G+ G
Sbjct: 211 EAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG---EKLRELCGTPG 264
Query: 856 YIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y+APE ++ D+++ GV+L LL G P
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 56/257 (21%), Positives = 91/257 (35%), Gaps = 33/257 (12%)
Query: 147 NNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGEL 206
+ + P GI +YL+L N +++ L LE L L N + G
Sbjct: 63 RRGLSEV-PQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAF 119
Query: 207 GNLTNLREIYLGYYN--------VFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEI--- 255
L +L + L + N FE L L L L + + IP
Sbjct: 120 NGLASLNTLEL-FDNWLTVIPSGAFEY--------LSKLRELWLRNNPI-ESIPSYAFNR 169
Query: 256 -GNLKLLDTVFLHINLLSGSIPKQ-LGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFN 313
+L LD + L I + L NL L+L + ++P + L L+
Sbjct: 170 VPSLMRLD--LGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELE 224
Query: 314 LFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPT 373
+ N P L +L+ L + + + + L L+L+ N L+ ++P
Sbjct: 225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPH 283
Query: 374 DLCSSN-QLRILILLKN 389
DL + L L L N
Sbjct: 284 DLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 53/257 (20%), Positives = 92/257 (35%), Gaps = 13/257 (5%)
Query: 92 DKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFT 151
++ + + + + G S+ ++LN+ N + L +LEV N+
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 152 ALLPVGILKLEKLKYLDLGGNYFFGKI----PNSYGELQGLEYLSLAGNDLTGKIPGELG 207
+ L L L+L N + ++ L L L L N +
Sbjct: 113 QIEVGAFNGLASLNTLELFDN----WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168
Query: 208 NLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFL 266
+ +L + LG E I L NL +L+L C + +P+ + L L+ + +
Sbjct: 169 RVPSLMRLDLGELKKLEY-ISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEM 225
Query: 267 HINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDY 326
N P L++L L + N+ ++ +F L L NL N L D
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285
Query: 327 LADLPNLETLGLWQNNF 343
L L L L N +
Sbjct: 286 FTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 63/280 (22%), Positives = 102/280 (36%), Gaps = 39/280 (13%)
Query: 263 TVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGS 322
V LS +P+ + +N L+L N + +F +L L++ L N +
Sbjct: 58 KVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-Q 113
Query: 323 IPDY-LADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQL 381
I L +L TL L+ N T + KL+ L L +N + +IP+
Sbjct: 114 IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYA------ 166
Query: 382 RILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNYLS 440
SL R+ LG+ I +G F L L L +
Sbjct: 167 -----------------FNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209
Query: 441 GSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPP-SIG 499
+P L +L +S N P S SSL+ L + +Q S I +
Sbjct: 210 -DMPNLTPLVG----LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFD 263
Query: 500 ELRQVLKLDLSRNSLSGEIPP-AIGYCNHLTYLDMSQNNL 538
L +++L+L+ N+LS +P +L L + N
Sbjct: 264 GLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 53/278 (19%), Positives = 101/278 (36%), Gaps = 28/278 (10%)
Query: 354 NGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQN 413
+ + + + L+ +P + + R L L++N + + + L ++LG+N
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 414 YLNGSIPDG-FIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPF 472
+ I G F L LN EL N+L+ +P + +L +L L NN + +
Sbjct: 110 SIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSG--AFEYLSKLRELWLRNNPIESIPSY 165
Query: 473 SLSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYL 531
+ + SL L L + I L + L+L ++ P + L L
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEEL 223
Query: 532 DMSQNNLSGSIPPE-ISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKL 590
+MS N+ I P + L L + + ++ + + SL + + N
Sbjct: 224 EMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN------ 276
Query: 591 PESGQFTVFNASSFAGNPQLCG-TLLNNP----CNVAP 623
+ F L L +NP C++
Sbjct: 277 ----NLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILW 310
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 57/220 (25%), Positives = 86/220 (39%), Gaps = 37/220 (16%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHD--HGFRAEIQTLGNIRH 742
+G G G V ++A+K K D EI+ L + H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK------ 796
I+++ F ++ + V E M G L + + G K R K A
Sbjct: 75 PCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGNK--------RLKEA-TCKLYFYQML 124
Query: 797 -GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAG 852
+ YLH I+HRD+K N+LL+S E + DFG +K L + M + G
Sbjct: 125 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCG 178
Query: 853 SYGYIAPE---YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ Y+APE T + D +S GV+L L+G P
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 19/240 (7%)
Query: 657 KAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAV 715
+ ++ D WK Q +E +L+ +G G G+V+ G A
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187
Query: 716 KKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALH 775
K ++ + R EIQT+ +RH +V L + +++YE+M G L E +
Sbjct: 188 KFVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246
Query: 776 GKKGAFLGWNLRYKIAIEAAK----GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV-- 829
+ A+E + GLC++H VH D+K NI+ + +
Sbjct: 247 DEHNKM-----SEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKL 298
Query: 830 ADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
DFGL L + + G+ + APE A V +D++S GV+ LL+G P
Sbjct: 299 IDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 52/240 (21%), Positives = 91/240 (37%), Gaps = 19/240 (7%)
Query: 657 KAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAV 715
K + K D WK Q +E + + +G G G+V+ G
Sbjct: 22 KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81
Query: 716 KKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALH 775
K + + EI + + H ++ L +K +L+ E++ G L + +
Sbjct: 82 KFINTPYPLDKYT-VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140
Query: 776 GKKGAFLGWNLRYKIAIEAAK----GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV-- 829
+ + + I + GL ++H IVH D+K NI+ + + V
Sbjct: 141 AE-----DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKI 192
Query: 830 ADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
DFGLA L E + + + APE V +D+++ GV+ LL+G P
Sbjct: 193 IDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 67/300 (22%), Positives = 105/300 (35%), Gaps = 31/300 (10%)
Query: 46 LISWNSSNPSSVCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFT 105
L+ + S + +C ++ + + NL VP I L+L N
Sbjct: 21 LLMGCVAETGSAQTCPSVCSCSNQFSKVICVRKNL-REVPDGIST--NTRLLNLHENQIQ 77
Query: 106 GSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLK 165
I N F L +LE+ N+ + L L
Sbjct: 78 --------------IIKVNSFKH--------LRHLEILQLSRNHIRTIEIGAFNGLANLN 115
Query: 166 YLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEG 225
L+L N ++ L L+ L L N + + +LR + LG
Sbjct: 116 TLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSY 175
Query: 226 GIPREV-GKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQ-LGNLT 283
I L NL +L+L+ C L +IP+ + L LD + L N LS +I L
Sbjct: 176 -ISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLM 231
Query: 284 NLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNF 343
+L L + + + +F NL+ L NL N L D L +LE + L N +
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 5e-21
Identities = 59/255 (23%), Positives = 97/255 (38%), Gaps = 13/255 (5%)
Query: 263 TVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGS 322
V L +P + TN L+L N + SF +LR L++ L N +
Sbjct: 47 KVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTI 103
Query: 323 IPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSS-NQL 381
L NL TL L+ N T + KL+ L L +N + +IP+ + L
Sbjct: 104 EIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSL 162
Query: 382 RILILLKNFLFGPIPER-LGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLS 440
R L L + I E +L + L L IP+ L L+ +L N+LS
Sbjct: 163 RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS 220
Query: 441 GSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-G 499
++ S L +L + + + + N SL + L+ N + +P +
Sbjct: 221 -AIRP--GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL-LPHDLFT 276
Query: 500 ELRQVLKLDLSRNSL 514
L + ++ L N
Sbjct: 277 PLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 59/274 (21%), Positives = 106/274 (38%), Gaps = 28/274 (10%)
Query: 354 NGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQN 413
+ + + L +P + S R+L L +N + L ++L +N
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 414 YLNGSIPDG-FIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPF 472
++ +I G F L LN EL N L+ ++P + +L +L L NN + +
Sbjct: 99 HIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNG--AFVYLSKLKELWLRNNPIESIPSY 154
Query: 473 SLSNFSSLQILLLSG-NQFSGPIPPSI-GELRQVLKLDLSRNSLSGEIPPAIGYCNHLTY 530
+ + SL+ L L + S I L + L+L+ +L P + L
Sbjct: 155 AFNRIPSLRRLDLGELKRLSY-ISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDE 211
Query: 531 LDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGK 589
LD+S N+LS +I P + L L + ++ + + +++SL + + N
Sbjct: 212 LDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN----- 265
Query: 590 LPESGQFTVFNASSFAGNPQLCG-TLLNNP--CN 620
T+ F L L +NP CN
Sbjct: 266 -----NLTLLPHDLFTPLHHLERIHLHHNPWNCN 294
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 58/222 (26%), Positives = 83/222 (37%), Gaps = 9/222 (4%)
Query: 147 NNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGEL 206
A+ PVGI + + L GN S+ + L L L N L
Sbjct: 20 QQGLQAV-PVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 207 GNLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLSSCELDGQIPHEI-GNLKLLDTV 264
L L ++ L N + L L L L C L ++ + L L +
Sbjct: 77 TGLALLEQLDLSD-NAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYL 134
Query: 265 FLHINLLSGSIPKQ-LGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSI 323
+L N L ++P +L NL +L L N ++ +F L L L NR+
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 324 PDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSN 365
P DL L TL L+ NN + + E L LQ L L+ N
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 62/292 (21%), Positives = 100/292 (34%), Gaps = 62/292 (21%)
Query: 56 SVCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSS 115
C C + + L +VP I + L GN +
Sbjct: 4 GACV-----CYNEPKVTTSCPQQGL-QAVPVGIPA--ASQRIFLHGNRIS---------- 45
Query: 116 LQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFF 175
++ F NL + ++N + L L+ LDL N
Sbjct: 46 ----HVPAASFRA--------CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 176 GKIP-NSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKL 234
+ ++ L L L L L ++ +F G L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGP----------------GLFRG--------L 128
Query: 235 VNLVHLDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQ-LGNLTNLVNLDLSN 292
L +L L L +P + +L L +FLH N +S S+P++ L +L L L
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQ 186
Query: 293 NALTGEIPYSFINLRQLKLFNLFMNRLHGSIP-DYLADLPNLETLGLWQNNF 343
N + P++F +L +L LF N L ++P + LA L L+ L L N +
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 54/255 (21%), Positives = 86/255 (33%), Gaps = 37/255 (14%)
Query: 288 LDLSNNALTGEIPYSF-INLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGV 346
L +P +++ L NR+ NL L L N +
Sbjct: 16 TSCPQQGLQ-AVPVGIPAASQRIFLHG---NRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 347 IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLT 406
L+ LDLS N ++ F + L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPA----------------TFHGLG-------RLH 108
Query: 407 RVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNL 465
+ L + L + G F L L LQ N L +LP+ ++ + L L L N
Sbjct: 109 TLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPD--DTFRDLGNLTHLFLHGNR 164
Query: 466 LSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSRNSLSGEIPP-AIG 523
+S + SL LLL N+ + + P +L +++ L L N+LS +P A+
Sbjct: 165 ISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLS-ALPTEALA 222
Query: 524 YCNHLTYLDMSQNNL 538
L YL ++ N
Sbjct: 223 PLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 46/229 (20%), Positives = 78/229 (34%), Gaps = 25/229 (10%)
Query: 404 SLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSN 463
+ R+ L N ++ F L + L SN L+ + + + L QL+LS+
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAA--AFTGLALLEQLDLSD 89
Query: 464 NLLSGPLPFS-LSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSRNSLSGEIPP- 520
N + + L L L + P + L + L L N+L +P
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDD 147
Query: 521 AIGYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIA 579
+LT+L + N +S S+P + L+ L L +N + P + + L
Sbjct: 148 TFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206
Query: 580 DFSFNDFSGKLPESGQFTVFNASSFAGNPQLCG-TLLNNP----CNVAP 623
N + + A L L +NP C P
Sbjct: 207 YLFAN----------NLSALPTEALAPLRALQYLRLNDNPWVCDCRARP 245
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 33/214 (15%)
Query: 691 GNVIGRGGAGIVYHG-KMPNGVEIAVKKLLGFGTHSHDH-GFRAEIQTLGNIRHRNIVRL 748
+G+G +V G+E A K + + D E + ++H NIVRL
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY--KIAIEAAK----GLCYLH 802
+ + LV++ + G L E + ++ Y A + + Y H
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELFEDIVARE--------FYSEADASHCIQQILESIAYCH 145
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSYGYIAP 859
S IVHR++K N+LL S + +ADFGLA + D E AG+ GY++P
Sbjct: 146 ---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYLSP 199
Query: 860 E----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
E Y + D+++ GV+L LL G P
Sbjct: 200 EVLKKDPY----SKPVDIWACGVILYILLVGYPP 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 26/213 (12%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
G +G G IV + G+E A K + E+ L + H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK----GLCY 800
I+ L N+ +L+ E + G L + L K+ +L + A K G+ Y
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNY 130
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAH----VADFGLAKFLIDGGASECMSAIAGSYGY 856
LH + I H D+K NI+L + DFGLA + DG I G+ +
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEF 184
Query: 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+APE + ++D++S GV+ LL+G P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGN-IRHRNIVRLL- 749
+G G G V+ + G IAVK++ G + ++ + IV+
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 750 AFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
F T++ + E M + L + + + K+ + K L YL
Sbjct: 92 TFI--TNTDVFIAMELMGTCAE--KLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG-- 145
Query: 809 IVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE-----YAY 863
++HRDVK +NILL+ + + DFG++ L+D A AG Y+APE
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPT 202
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRP 889
D ++DV+S G+ L+EL TG+ P
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFP 228
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 60/209 (28%), Positives = 85/209 (40%), Gaps = 27/209 (12%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
+ +GRG IVY K A+K L R EI L + H NI++L
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY--KIAIEAAK----GLCYLHH 803
LV E + G L + + K Y + A +A K + YLH
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKG--------YYSERDAADAVKQILEAVAYLH- 165
Query: 804 DCSPLIVHRDVKSNNILLNSAFE-AHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPE 860
IVHRD+K N+L + A + ADFGL+K + M + G+ GY APE
Sbjct: 166 --ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPE 220
Query: 861 YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ D++S G++ LL G P
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 30/224 (13%)
Query: 682 SDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQ 735
S + + + G +G G IV + G E A K +L E+
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 736 TLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY--KIAIE 793
L IRH NI+ L NK +L+ E + G L + L K+ A +
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--------SLTEDEATQ 112
Query: 794 AAK----GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH----VADFGLAKFLIDGGASE 845
K G+ YLH S I H D+K NI+L + + DFG+A + G
Sbjct: 113 FLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG---N 166
Query: 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
I G+ ++APE + ++D++S GV+ LL+G P
Sbjct: 167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 9e-23
Identities = 55/257 (21%), Positives = 100/257 (38%), Gaps = 25/257 (9%)
Query: 90 RLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFS--GGLDWNYSSLVNLEVFDAYN 147
+ +L + T ++ L+S+ + +N+ G+ L N+
Sbjct: 19 AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQ----YLPNVTKLFLNG 74
Query: 148 NNFTALLPVGILKLEKLKYLDLGGNYFFGKIPN--SYGELQGLEYLSLAGNDLTGKIPGE 205
N T + P+ L+ L +L L N KI + S +L+ L+ LSL N ++ I G
Sbjct: 75 NKLTDIKPLT--NLKNLGWLFLDEN----KIKDLSSLKDLKKLKSLSLEHNGIS-DING- 126
Query: 206 LGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVF 265
L +L L +YLG + + + +L L L L ++ I + L L ++
Sbjct: 127 LVHLPQLESLYLGNNKITD---ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLY 181
Query: 266 LHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPD 325
L N +S + + L L NL L+L + + NL L P+
Sbjct: 182 LSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPE 237
Query: 326 YLADLPNLETLGLWQNN 342
++D + E + +
Sbjct: 238 IISDDGDYEKPNVKWHL 254
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 3e-17
Identities = 58/274 (21%), Positives = 99/274 (36%), Gaps = 23/274 (8%)
Query: 91 LDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFS--GGLDWNYSSLVNLEVFDAYNN 148
L +T L L GN T + NL +L +L + N+ L L L+ +N
Sbjct: 64 LPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKDLSSL----KDLKKLKSLSLEHN 119
Query: 149 NFTALLPVGILKLEKLKYLDLGGNYFFGKIPN--SYGELQGLEYLSLAGNDLTGKIPGEL 206
+ + G++ L +L+ L LG N KI + L L+ LSL N ++ I L
Sbjct: 120 GISDI--NGLVHLPQLESLYLGNN----KITDITVLSRLTKLDTLSLEDNQIS-DIVP-L 171
Query: 207 GNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFL 266
LT L+ +YL ++ + R + L NL L+L S E + + NL + +TV
Sbjct: 172 AGLTKLQNLYLSKNHISD---LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 228
Query: 267 HINLLSG----SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGS 322
L S +L N ++ + F+ + +
Sbjct: 229 TDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKE 288
Query: 323 IPDYLADLPNLETLGLWQNNFTGVIPENLGQNGK 356
+ D+ + P+ + G
Sbjct: 289 VYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGY 322
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.2 bits (210), Expect = 4e-17
Identities = 56/291 (19%), Positives = 95/291 (32%), Gaps = 67/291 (23%)
Query: 279 LGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGL 338
+ +L ++T + + L + + + S+ + LPN+ L L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 72
Query: 339 WQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPER 398
N T + + L L L L NK+ DL S
Sbjct: 73 NGNKLTDI--KPLTNLKNLGWLFLDENKIK-----DLSS--------------------- 104
Query: 399 LGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQ 458
L L + L N ++ I +G ++LP L
Sbjct: 105 LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLE---------------------------S 135
Query: 459 LNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEI 518
L L NN ++ LS + L L L NQ S I P + L ++ L LS+N +S ++
Sbjct: 136 LYLGNNKITDITV--LSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DL 190
Query: 519 PPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKS 569
+ +L L++ SN+ + N + + L S
Sbjct: 191 RA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.5 bits (190), Expect = 1e-14
Identities = 55/321 (17%), Positives = 98/321 (30%), Gaps = 47/321 (14%)
Query: 233 KLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSN 292
+ +L + + L +D + + + + S+ + + L N+ L L+
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 293 NALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLG 352
N LT +I NL+ L L N++ + L DL L++L L N + + L
Sbjct: 75 NKLT-DIK-PLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDI--NGLV 128
Query: 353 QNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQ 412
+L+ L L +NK+T T L +L L L N + I L L + L +
Sbjct: 129 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSK 184
Query: 413 NYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPF 472
N+++ +L L L L L +
Sbjct: 185 NHIS-------------DLRALAGL----------------KNLDVLELFSQECLNKPIN 215
Query: 473 SLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLK----LDLSRNSLSGEIPPAIGYCNHL 528
SN + + P S + L N +S +
Sbjct: 216 HQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAK 275
Query: 529 TYLDMSQNNLSGSIPPEISNV 549
+ +V
Sbjct: 276 ARFHGRVTQPLKEVYTVSYDV 296
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 20/206 (9%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
+GRG GIV+ + K + GT + EI L RHRNI+ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHRNILHLH 67
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK----GLCYLHHDC 805
+ E ++++E++ + E ++ + L + + L +LH
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLH--- 119
Query: 806 SPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAY 863
S I H D++ NI+ + + + +FG A+ L G + + + Y APE
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQ 176
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRP 889
V +D++S G ++ LL+G P
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 56/221 (25%), Positives = 84/221 (38%), Gaps = 36/221 (16%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK--------KLLGFGTHSHDHGFRAEIQTLGNI- 740
++GRG + +V P E AVK E+ L +
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 741 RHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY------KIAIEA 794
H NI++L LV++ M+ G L + L K KI
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--------TLSEKETRKIMRAL 133
Query: 795 AKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY 854
+ +C LH IVHRD+K NILL+ + DFG + L G E + + G+
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTP 187
Query: 855 GYIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y+APE ++ D++S GV++ LL G P
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 57/213 (26%), Positives = 81/213 (38%), Gaps = 34/213 (15%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK----KLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
V+G G V+ K G A+K D EI L I+H NI
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-----RDSSLENEIAVLKKIKHENI 68
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY------KIAIEAAKGLC 799
V L + LV + + G L + + + Y + + +
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERG--------VYTEKDASLVIQQVLSAVK 120
Query: 800 YLHHDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSYGY 856
YLH IVHRD+K N+L + E + DFGL+K +G MS G+ GY
Sbjct: 121 YLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGY 173
Query: 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+APE + D +S GV+ LL G P
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 52/226 (23%), Positives = 84/226 (37%), Gaps = 38/226 (16%)
Query: 680 SVSDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLG 738
+ +G G I + AVK + + + + EI L
Sbjct: 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII----SKRMEANTQKEITALK 60
Query: 739 NIR-HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK- 796
H NIV+L ++ LV E + G L E + KK F + EA+
Sbjct: 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK-KKKHF---SET-----EASYI 111
Query: 797 ------GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECM 847
+ ++H +VHRD+K N+L + + DFG A+ + +
Sbjct: 112 MRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL 166
Query: 848 SAIAGSYGYIAPE----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ Y APE Y DE D++S GV+L +L+G+ P
Sbjct: 167 KTPCFTLHYAAPELLNQNGY----DESCDLWSLGVILYTMLSGQVP 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 30/215 (13%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
G +G G +V + G++ A K + E+ L I+H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY--KIAIEAAK----GL 798
++ L NK +L+ E + G L + L K+ + A E K G+
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKE--------SLTEEEATEFLKQILNGV 127
Query: 799 CYLHHDCSPLIVHRDVKSNNILLNSAFEAH----VADFGLAKFLIDGGASECMSAIAGSY 854
YLH S I H D+K NI+L + DFGLA + G I G+
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTP 181
Query: 855 GYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
++APE + ++D++S GV+ LL+G P
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-22
Identities = 62/321 (19%), Positives = 112/321 (34%), Gaps = 49/321 (15%)
Query: 64 CCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLN 120
S DR + +L S+P+ + + + +L L+ N T I +LQ L
Sbjct: 27 SLSCDRNGICKGSSGSL-NSIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALV 82
Query: 121 ISNNQFSGGLDWN-YSSLVNLEVFDAYNNNFTALLPVGIL-KLEKLKYLDLGGNYFFGKI 178
+++N + ++ + +SSL +LE D N + L L L +L+L GN +
Sbjct: 83 LTSNGINT-IEEDSFSSLGSLEHLDLSYNYLSNL-SSSWFKPLSSLTFLNLLGNPYKTLG 140
Query: 179 PNS-YGELQGLEYLSLAGNDLTGKIP-GELGNLTNLREIYLGYYNVFEGGIPREV-GKLV 235
S + L L+ L + D KI + LT L E+ + ++ + +
Sbjct: 141 ETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS--YEPKSLKSIQ 198
Query: 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNAL 295
N+ HL L + LL+ +++ L+L + L
Sbjct: 199 NVSHLILHMKQHI----------LLLEIFV--------------DVTSSVECLELRDTDL 234
Query: 296 TG----EIP----YSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVI 347
E+ S I + + L + L + L L +N V
Sbjct: 235 DTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVP 293
Query: 348 PENLGQNGKLQVLDLSSNKLT 368
+ LQ + L +N
Sbjct: 294 DGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 52/283 (18%), Positives = 95/283 (33%), Gaps = 29/283 (10%)
Query: 187 GLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLSSC 245
++ L L+ N +T +L NL+ + L + I + L +L HLDLS
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT--IEEDSFSSLGSLEHLDLSYN 110
Query: 246 ELDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQ--LGNLTNLVNLDLSNNALTGEIPY- 301
L + L L + L N ++ + +LT L L + N +I
Sbjct: 111 YL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 302 SFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLD 361
F L L+ + + L P L + N+ L L ++ + ++ L+
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLE 228
Query: 362 LSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPD 421
L L ++L + ++ + V++ L +
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKF----------------TFRNVKITDESLF-QVMK 271
Query: 422 GFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNN 464
+ GL E N L S+P+ L ++ L N
Sbjct: 272 LLNQISGLLELEFSRNQLK-SVPD--GIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 54/286 (18%), Positives = 95/286 (33%), Gaps = 33/286 (11%)
Query: 347 IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLT 406
IP L + ++ LDLS+N++T +DL L+ L+L N + I E + SL
Sbjct: 46 IPSGLTEA--VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEE--DSFSSLG 100
Query: 407 RVR---LGQNYLNGSIPDG-FIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLS 462
+ L NYL ++ F L L L N +L E S +
Sbjct: 101 SLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGN 158
Query: 463 NNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPP-A 521
+ + + + L+ L + + P S+ ++ V L L +
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF 217
Query: 522 IGYCNHLTYLDMSQNNLSGSIPPEISNVR--------ILNYLNLSRNHLNQNIPKSIGSM 573
+ + + L++ +L E+S + ++ L + K + +
Sbjct: 218 VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL-FQVMKLLNQI 276
Query: 574 KSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCG-TLLNNP 618
L +FS N Q F L L NP
Sbjct: 277 SGLLELEFSRN----------QLKSVPDGIFDRLTSLQKIWLHTNP 312
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 7e-22
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
V ++G G G V+ + G+++A K + G + + EI + + H N++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE-VKNEISVMNQLDHANLI 149
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK----GLCYLH 802
+L +K +LV EY+ G L + + + +NL I K G+ ++H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDE-----SYNLTELDTILFMKQICEGIRHMH 204
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPE 860
I+H D+K NIL + + DFGLA+ E + G+ ++APE
Sbjct: 205 ---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EKLKVNFGTPEFLAPE 258
Query: 861 ---YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y + V +D++S GV+ LL+G P
Sbjct: 259 VVNYDF---VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 24/202 (11%), Positives = 47/202 (23%), Gaps = 43/202 (21%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA----EIQTLGNIRHRNIVR 747
G + ++A+ + L I + R
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDP--QGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
+L + L+V E++R GSL E + A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG-- 149
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
+ + + ++ + +A +
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD-------A 179
Query: 868 DEKSDVYSFGVVLLELLTGRRP 889
+ + D+ G L LL R P
Sbjct: 180 NPQDDIRGIGASLYALLVNRWP 201
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 18/219 (8%)
Query: 676 KLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEI 734
+ E +G G G VY G +A+K++ S EI
Sbjct: 19 DEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEI 75
Query: 735 QTLGNIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI- 792
+ ++V+ K T+L +V EY GS+ + + + +IA
Sbjct: 76 SIMQQCDSPHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT----EDEIATI 130
Query: 793 --EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850
KGL YLH +HRD+K+ NILLN+ A +ADFG+A L D A + +
Sbjct: 131 LQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTV 185
Query: 851 AGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
G+ ++APE + + +D++S G+ +E+ G+ P
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 39/175 (22%), Positives = 68/175 (38%), Gaps = 14/175 (8%)
Query: 723 THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEAL-HGKKGAF 781
+ S +I+ + +N V L S K + + R +L + +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 782 LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID- 840
+ I I+ A+ + +LH S ++HRD+K +NI V DFGL +
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 841 ---------GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTG 886
A + G+ Y++PE + K D++S G++L ELL
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 55/218 (25%), Positives = 85/218 (38%), Gaps = 44/218 (20%)
Query: 691 GNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLG-NIRHRNIVRL 748
IG G + +E AVK + D EI+ L +H NI+ L
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIID---KSKRDP--TEEIEILLRYGQHPNIITL 81
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK-------GLCYL 801
+ + +V E M+ G L + + ++ F + R EA+ + YL
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKIL-RQKFF---SER-----EASAVLFTITKTVEYL 132
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAH----VADFGLAKFLIDGGASECMSAIAGSYGYI 857
H + +VHRD+K +NIL + DFG AK L + + ++
Sbjct: 133 H---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFV 187
Query: 858 APE------YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
APE Y D D++S GV+L +LTG P
Sbjct: 188 APEVLERQGY------DAACDIWSLGVLLYTMLTGYTP 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 73/289 (25%), Positives = 123/289 (42%), Gaps = 67/289 (23%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
IG+G V + + G E+A+K +L S FR E++ + + H N
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL---NPTSLQKLFR-EVRIMKILNHPN 75
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEAL--HGKKGAFLGWNLRYKIAIEAAK------ 796
IV+L ++T L+ EY G + + L HG+ ++ K EA
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--------MKEK---EARSKFRQIV 124
Query: 797 -GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYG 855
+ Y H IVHRD+K+ N+LL++ +ADFG + G + A G+
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPP 178
Query: 856 YIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG 909
Y APE Y + DV+S GV+L L++G P F DG ++ + +R G
Sbjct: 179 YAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSGSLP---F-DGQNLKELRERVLRG 229
Query: 910 RKE--EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
+ ++S + +LL L + N I+R + ++++
Sbjct: 230 KYRIPFYMS-----------TDCENLL-KRFLVL--NPIKRGTLEQIMK 264
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 5e-21
Identities = 54/276 (19%), Positives = 82/276 (29%), Gaps = 23/276 (8%)
Query: 111 GNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLE---KLKYL 167
G S L + + G + ++L+ + + G L++ L+ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 168 DLGGNYFFGKIPNSYGELQG--LEYLSLAGNDLTG--KIPGELGNL--TNLREIYLGYYN 221
L G P E G L L+L EL L+ + +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI-AQA 159
Query: 222 VFEGGIPREVGKLVNLVHLDLSSCELDGQI-------PHEIGNLKLLDTVFLHINLLSGS 274
+V L LDLS G+ P + L++L + SG
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219
Query: 275 IPKQLGNLTNLVNLDLSNNALTGEIP-YSFINLRQLKLFNLFMNRLHGSIPDYLADLPNL 333
L LDLS+N+L S QL NL L +P L L
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKL 276
Query: 334 ETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTG 369
L L N + + ++ L L N
Sbjct: 277 SVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 8e-20
Identities = 58/260 (22%), Positives = 88/260 (33%), Gaps = 24/260 (9%)
Query: 250 QIPHEIGNLKLLDTVFLHINLLSGSIPK--QLGNLTNLVNLDLSNNALTGEIPYSFINLR 307
Q I +L L + S + ++ ++ L L L N +TG P +
Sbjct: 60 QFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119
Query: 308 QLKLFNLFMNRLHGS-IPDYLADL-----PNLETLGLWQNNFTGVIPENLGQNGKLQVLD 361
L L + + + +LA+L P L+ L + Q + E + L LD
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 362 LSSNKLTG--TIPTDLCSSN--QLRILILLKNF---LFGPIPERLGACYSLTRVRLGQNY 414
LS N G + + LC L++L L G A L + L N
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 415 LNGSIPD-GFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFS 473
L + + LN L L +P+ P +L L+LS N L P
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG-----LPAKLSVLDLSYNRLDR-NPSP 292
Query: 474 LSNFSSLQILLLSGNQFSGP 493
+ L L GN F
Sbjct: 293 DE-LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 5e-19
Identities = 57/329 (17%), Positives = 100/329 (30%), Gaps = 38/329 (11%)
Query: 241 DLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIP 300
+ SC P L + + S+ L + +L + +
Sbjct: 11 ESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKS--- 67
Query: 301 YSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQ--NGKLQ 358
++L++L + + + + L+ L L TG P L + L
Sbjct: 68 ---LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124
Query: 359 VLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGS 418
+L+L + + L L+ +L L + + Q +
Sbjct: 125 ILNLRNVSWAT----------RDAWLAELQQWLKP----------GLKVLSIAQAHSLNF 164
Query: 419 IPDGFIYLPGLNLAELQSNYLSGSLP-ENGNSSSNPDRLGQLNLSNNL---LSGPLPFSL 474
+ P L+ +L N G + L L L N SG
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224
Query: 475 SNFSSLQILLLSGNQFSGPIPPSIGELRQVLK-LDLSRNSLSGEIPPAIGYCNHLTYLDM 533
+ LQ L LS N + L L+LS L ++P + L+ LD+
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDL 281
Query: 534 SQNNLSGSIPPEISNVRILNYLNLSRNHL 562
S N L + P + + L+L N
Sbjct: 282 SYNRLDRN--PSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 52/272 (19%), Positives = 88/272 (32%), Gaps = 19/272 (6%)
Query: 341 NNFTGVIPENLGQNGKLQVLDLSSNKLTGTIP-TDLCSSNQLRILILLKNFLFGPIPERL 399
N E G L+ L + TD+ S L+ L + + I
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 400 GACYSLTRVR---LGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPD-- 454
++ ++ L + G+ P + G +L L +S + + +
Sbjct: 89 LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK 148
Query: 455 -RLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI----GELRQVLKLDL 509
L L+++ + F +L L LS N G + + L L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 510 SRN---SLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHLNQN 565
+ SG L LD+S N+L + LN LNLS L Q
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ- 267
Query: 566 IPKSIGSMKSLTIADFSFNDFSGKLPESGQFT 597
+PK + + L++ D S+N P +
Sbjct: 268 VPKGLPA--KLSVLDLSYNRLDR-NPSPDELP 296
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-21
Identities = 49/210 (23%), Positives = 78/210 (37%), Gaps = 20/210 (9%)
Query: 690 DGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHG-FRAEIQTLGNIRHR-NIV 746
+GRG +V G E A K L EI L + ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK----GLCYLH 802
L N +L+ EY G + + + I K G+ YLH
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS----ENDVIRLIKQILEGVYYLH 148
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSYGYIAP 859
IVH D+K NILL+S + + DFG+++ + + I G+ Y+AP
Sbjct: 149 ---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA---CELREIMGTPEYLAP 202
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
E + +D+++ G++ LLT P
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 40/238 (16%), Positives = 86/238 (36%), Gaps = 44/238 (18%)
Query: 682 SDILECVKDGNVIGRGGAGIVYHG-KMPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGN 739
S + IG G G V+ K +G A+K+ + E+
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 740 I-RHRNIVRLLAFCSNKETNLLVY-EYMRNGSLGEAL--HGKKGAFLGWNLRYKIAIEAA 795
+ +H ++VR + ++ ++L+ EY GSL +A+ + + ++ + ++
Sbjct: 67 LGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 796 KGLCYLHHDCSPLIVHRDVKSNNILLN-------------------SAFEAHVADFGLAK 836
+GL Y+H S +VH D+K +NI ++ + + D G
Sbjct: 126 RGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 837 FLIDGGASECMSAIAGSYGYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ G ++A E Y + K+D+++ + ++
Sbjct: 183 RI------SSPQVEEGDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAEPL 230
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-21
Identities = 31/210 (14%), Positives = 63/210 (30%), Gaps = 37/210 (17%)
Query: 91 LDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSG--GLDWNYSSLVNLEVFDAYNN 148
N L G + T +I ++SL ++ ++N + G+ N++ N
Sbjct: 22 FKAYLNGLL-GQSSTANITEAQMNSLTYITLANINVTDLTGI----EYAHNIKDLTINNI 76
Query: 149 NFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGN 208
+ T P+ L L+ L + G + L L L ++ + I ++
Sbjct: 77 HATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 209 LTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHI 268
L + I L Y + L L L++ +
Sbjct: 135 LPKVNSIDLSYNGAITD--IMPLKTLPELKSLNIQFDGVHDYRG---------------- 176
Query: 269 NLLSGSIPKQLGNLTNLVNLDLSNNALTGE 298
+ + L L + + G+
Sbjct: 177 ----------IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-18
Identities = 33/186 (17%), Positives = 70/186 (37%), Gaps = 11/186 (5%)
Query: 161 LEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYY 220
+ LG + + ++ L Y++LA ++T + G + N++++ +
Sbjct: 22 FKAYLNGLLGQS---STANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNI 76
Query: 221 NVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLG 280
+ + L NL L + ++ + L L + + + SI ++
Sbjct: 77 HATN---YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 281 NLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQ 340
L + ++DLS N +I L +LK N+ + +H + D P L L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 341 NNFTGV 346
G
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 34/178 (19%), Positives = 67/178 (37%), Gaps = 11/178 (6%)
Query: 139 NLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYG--ELQGLEYLSLAGN 196
+ + ++ + ++ L Y+ L + + G ++ L++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANI----NVTDLTGIEYAHNIKDLTINNI 76
Query: 197 DLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIG 256
T P + L+NL + + +V IP + L +L LD+S D I +I
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIP-NLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 257 NLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYS-FINLRQLKLFN 313
L ++++ L N I L L L +L++ + + F L QL F+
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFS 190
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 26/182 (14%), Positives = 61/182 (33%), Gaps = 11/182 (6%)
Query: 208 NLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLH 267
LG + ++ +L ++ L++ + I + + ++
Sbjct: 21 TFKAYLNGLLGQSST----ANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTIN 74
Query: 268 INLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYL 327
+ P + L+NL L + +T + + L L L ++ + SI +
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 328 ADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILL 387
LP + ++ L N I L +L+ L++ + + + +L L
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189
Query: 388 KN 389
Sbjct: 190 SQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-13
Identities = 29/212 (13%), Positives = 58/212 (27%), Gaps = 37/212 (17%)
Query: 281 NLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQ 340
+N L ++ +L + L N+ + L G + N++ L +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 341 NNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLG 400
+ T + L+ L + +T +L L +L + + I ++
Sbjct: 76 IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 401 ACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLN 460
+ + L N I L L L LN
Sbjct: 134 TLPKVNSIDLSYNGAITDIM---------PLKTLPE-------------------LKSLN 165
Query: 461 LSNNLLSGPLPFSLSNFSSLQILLLSGNQFSG 492
+ + + + +F L L G
Sbjct: 166 IQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 26/133 (19%), Positives = 52/133 (39%), Gaps = 5/133 (3%)
Query: 456 LGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLS 515
+ L ++N + P +S S+L+ L + G + P++ L + LD+S ++
Sbjct: 68 IKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
Query: 516 GEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKS 575
I I + +D+S N I P + + L LN+ + ++ + + I
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DY-RGIEDFPK 182
Query: 576 LTIADFSFNDFSG 588
L G
Sbjct: 183 LNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 33/160 (20%), Positives = 62/160 (38%), Gaps = 10/160 (6%)
Query: 404 SLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSN 463
SLT + L + + G Y + + + + + P +G S+ L +L +
Sbjct: 45 SLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNPISGLSN-----LERLRIMG 97
Query: 464 NLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIG 523
++ +LS +SL +L +S + I I L +V +DLS N +I P +
Sbjct: 98 KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LK 156
Query: 524 YCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLN 563
L L++ + + I + LN L +
Sbjct: 157 TLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 16/103 (15%), Positives = 34/103 (33%), Gaps = 5/103 (4%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGG 129
L + ++ + L LT L ++ + SI +I L + +++S N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 130 LDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGN 172
+ +L L+ + + + KL L
Sbjct: 152 IM-PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 17/85 (20%), Positives = 31/85 (36%), Gaps = 7/85 (8%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE-IGNLSSLQFLNISNNQFSG-- 128
LD++ S+ +I L K+ ++ L+ N I + L L+ LNI +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYR 175
Query: 129 GLDWNYSSLVNLEVFDAYNNNFTAL 153
G+ L A++
Sbjct: 176 GI----EDFPKLNQLYAFSQTIGGK 196
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 53/257 (20%), Positives = 99/257 (38%), Gaps = 25/257 (9%)
Query: 90 RLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFS--GGLDWNYSSLVNLEVFDAYN 147
+ +L + T ++ L+S+ + +N+ G+ L N+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGI----QYLPNVTKLFLNG 77
Query: 148 NNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYG--ELQGLEYLSLAGNDLTGKIPGE 205
N T + P+ L+ L +L L N K+ + +L+ L+ LSL N ++ I G
Sbjct: 78 NKLTDIKPLA--NLKNLGWLFLDEN----KVKDLSSLKDLKKLKSLSLEHNGIS-DING- 129
Query: 206 LGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVF 265
L +L L +YLG + + + +L L L L ++ I + L L ++
Sbjct: 130 LVHLPQLESLYLGNNKITD---ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLY 184
Query: 266 LHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPD 325
L N +S + + L L NL L+L + + NL L P+
Sbjct: 185 LSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPE 240
Query: 326 YLADLPNLETLGLWQNN 342
++D + E + +
Sbjct: 241 IISDDGDYEKPNVKWHL 257
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 61/313 (19%), Positives = 110/313 (35%), Gaps = 50/313 (15%)
Query: 279 LGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGL 338
+ +L ++T + + L + + + S+ + LPN+ L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75
Query: 339 WQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPER 398
N T + + L L L L NK+ DL
Sbjct: 76 NGNKLTDI--KPLANLKNLGWLFLDENKV-----KDL---------------------SS 107
Query: 399 LGACYSLTRVRLGQNYLNGSIPDGFIYLPGL-NLAELQSNYLSGSLPENGNSSSNPDRLG 457
L L + L N ++ + GL +L +L+S YL + + S +L
Sbjct: 108 LKDLKKLKSLSLEHNGIS--------DINGLVHLPQLESLYLGNNKITDITVLSRLTKLD 159
Query: 458 QLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGE 517
L+L +N +S +P L+ + LQ L LS N S + + L+ + L+L +
Sbjct: 160 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQECLNK 215
Query: 518 IPPAIGYCNHLTYLDMSQNNLSGSIPPE-ISNVRILNYLNLSRNHLNQNIPKSIGSMKSL 576
I + ++L + +N + PE IS+ N+ + S + +
Sbjct: 216 ---PINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPV 272
Query: 577 TIADFSFNDFSGK 589
TI F G+
Sbjct: 273 TIGKAKAR-FHGR 284
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 46/214 (21%), Positives = 89/214 (41%), Gaps = 28/214 (13%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHR- 743
G ++G GG G VY G + + + +A+K ++ +G + E+ L +
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 744 -NIVRLLAFCSNKETNLLVYEYMRNGSLGE-----ALHGKKGAFLGWNLRYKIAIEAAKG 797
++RLL + ++ +L+ E + G L L + +
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPV--QDLFDFITERGA----LQEELARSFFWQVLEA 161
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNS-AFEAHVADFGLAKFLIDGGASECMSAIAGSYGY 856
+ + H + ++HRD+K NIL++ E + DFG L D ++ G+ Y
Sbjct: 162 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTRVY 214
Query: 857 IAPEYAYTLRVD-EKSDVYSFGVVLLELLTGRRP 889
PE+ R + V+S G++L +++ G P
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTL----GNI 740
G ++G+GG G V+ G + + +++A+K ++LG+ S E+ L
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 741 RHRNIVRLLAFCSNKETNLLVYEYMRNGSLGE-----ALHGKKGAFLGWNLRYKIAIEAA 795
H ++RLL + +E +LV E + G LG +
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGP----LGEGPSRCFFGQVV 149
Query: 796 KGLCYLHHDCSPLIVHRDVKSNNILLNS-AFEAHVADFGLAKFLIDGGASECMSAIAGSY 854
+ + H S +VHRD+K NIL++ A + DFG L D ++ G+
Sbjct: 150 AAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF----DGTR 202
Query: 855 GYIAPEYAYTLRVD-EKSDVYSFGVVLLELLTGRRP 889
Y PE+ + + V+S G++L +++ G P
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-20
Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 28/217 (12%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNI-RHRNIVR-- 747
++G G G VY G+ + G A+K + + T + + EI L HRNI
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDV---TGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 748 ---LLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI---EAAKGLCY 800
+ + L LV E+ GS+ + + KG L IA E +GL +
Sbjct: 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EEWIAYICREILRGLSH 144
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE 860
LH ++HRD+K N+LL E + DFG++ L + G+ ++APE
Sbjct: 145 LHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPE 199
Query: 861 YAYTLRV-----DEKSDVYSFGVVLLELLTGRRPVGD 892
D KSD++S G+ +E+ G P+ D
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHG--FRAEIQTLGNIRHRNIVRL 748
IG G G VY + + N +A+KK+ G S++ E++ L +RH N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 749 LAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI---EAAKGLCYLHHD 804
C +E LV EY GS + L K +IA A +GL YLH
Sbjct: 120 RG-CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQ----EVEIAAVTHGALQGLAYLH-- 171
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT 864
S ++HRDVK+ NILL+ + DFG A + ++ G+ ++APE
Sbjct: 172 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILA 224
Query: 865 LRV---DEKSDVYSFGVVLLELLTGRRPVGD 892
+ D K DV+S G+ +EL + P+ +
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 52/219 (23%), Positives = 81/219 (36%), Gaps = 41/219 (18%)
Query: 690 DGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVR 747
V+G G G V + A+K L R E++ + +IVR
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVR 119
Query: 748 LLAFCSNKETN----LLVYEYMRNGSLGEALHGKKGAFLGWNLRY------KIAIEAAKG 797
++ N L+V E + G L + + + + +I +
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG------DQAFTEREASEIMKSIGEA 173
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSY 854
+ YLH S I HRDVK N+L S + DFG AK ++ +
Sbjct: 174 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTP 227
Query: 855 GYIAPE----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y+APE Y D+ D++S GV++ LL G P
Sbjct: 228 YYVAPEVLGPEKY----DKSCDMWSLGVIMYILLCGYPP 262
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 52/232 (22%), Positives = 82/232 (35%), Gaps = 48/232 (20%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
+G G G V +AVK + + + + EI + H N
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-----IKKEICINKMLNHEN 66
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEAL--HGKKGAFLGWNLRYKIAIEAAK------ 796
+V+ L EY G L + + + +A +
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--------MPEP---DAQRFFHQLM 115
Query: 797 -GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYG 855
G+ YLH I HRD+K N+LL+ ++DFGLA ++ + G+
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 856 YIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQ 901
Y+APE + E DV+S G+VL +L G P + D Q
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQ 216
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 23/209 (11%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
+G G G VY K G A K + D + EI+ L H IV+LL
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED--YIVEIEILATCDHPYIVKLL 82
Query: 750 AFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI---EAAKGLCYLHHDC 805
+ L ++ E+ G++ + +I + + + L +LH
Sbjct: 83 G-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT----EPQIQVVCRQMLEALNFLH--- 134
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
S I+HRD+K+ N+L+ + +ADFG++ + + G+ ++APE
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCE 192
Query: 866 RV-----DEKSDVYSFGVVLLELLTGRRP 889
+ D K+D++S G+ L+E+ P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 53/222 (23%), Positives = 82/222 (36%), Gaps = 36/222 (16%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRA--EIQTLGNIRH 742
+ +G G G V+ E+ VK K+L + EI L + H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGE-----ALHGKKGAFLGWNLRYKIAIEAAKG 797
NI+++L N+ LV E +G + H + L L I +
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSG--LDLFAFIDRHPR----LDEPLASYIFRQLVSA 142
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYI 857
+ YL I+HRD+K NI++ F + DFG A +L G G+ Y
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYC 196
Query: 858 APE------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDF 893
APE Y + +++S GV L L+ P +
Sbjct: 197 APEVLMGNPYR-----GPELEMWSLGVTLYTLVFEENPFCEL 233
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 23/231 (9%)
Query: 666 SDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGT 723
SD + + + SV D + IG+G +G VY + G E+A++++ L
Sbjct: 1 SDEEILEKLRSI-VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 724 HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFL 782
EI + ++ NIV L L +V EY+ GSL + +
Sbjct: 60 KKEL--IINEILVMRENKNPNIVNYLD-SYLVGDELWVVMEYLAGGSLTDVVTETC---- 112
Query: 783 GWNLR-YKIAI---EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838
+ +IA E + L +LH S ++HRD+KS+NILL + DFG +
Sbjct: 113 ---MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 839 IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+ S + G+ ++APE K D++S G++ +E++ G P
Sbjct: 167 TPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 50/212 (23%), Positives = 78/212 (36%), Gaps = 34/212 (16%)
Query: 693 VIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLG-NIRHRNIVRLLA 750
V+G G G V G + A+K L R E+ +IV +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLL------YDSPKARQEVDHHWQASGGPHIVCILD 89
Query: 751 FCSNKETN----LLVYEYMRNGSLGEALHGKKGAFLGWNLRY------KIAIEAAKGLCY 800
N L++ E M G L + + + + +I + + +
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERG------DQAFTEREAAEIMRDIGTAIQF 143
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSYGYI 857
LH I HRDVK N+L S + + DFG AK + + Y+
Sbjct: 144 LHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYV 196
Query: 858 APEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
APE + D+ D++S GV++ LL G P
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 63/324 (19%), Positives = 108/324 (33%), Gaps = 63/324 (19%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
+G G G V +AVK + + ++ + EI + H N
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKK-EICINKMLNHEN 66
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEAL--HGKKGAFLGWNLRYKIAIEAAK------ 796
+V+ L EY G L + + + +A +
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--------MPEP---DAQRFFHQLM 115
Query: 797 -GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYG 855
G+ YLH I HRD+K N+LL+ ++DFGLA ++ + G+
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 856 YIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQ-WSKRATN 908
Y+APE + E DV+S G+VL +L G P + D Q +S
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYSDWKEK 224
Query: 909 GRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ---MLSEFPRHS 965
+D + LL +L EN R + ++ + + +
Sbjct: 225 KTYLNPWKKIDS--------APLALL-HKIL--VENPSARITIPDIKKDRWYNKPLKKGA 273
Query: 966 SDFNQSSSSSLKNLEKDPKGCPNN 989
+S ++ K +N
Sbjct: 274 KRPRVTSGGVSESPSGFSKHIQSN 297
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 47/203 (23%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAF 751
IG G GIV + +G ++AVK + L E+ + + +H N+V +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHFNVVEMYK- 109
Query: 752 CSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLR-YKIAI---EAAKGLCYLHHDCS 806
L ++ E+++ G+L + + + L +IA + L YLH +
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLH---A 159
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
++HRD+KS++ILL ++DFG + ++ G+ ++APE
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSL 217
Query: 867 VDEKSDVYSFGVVLLELLTGRRP 889
+ D++S G++++E++ G P
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPP 240
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 50/222 (22%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
G+ +G G G V G+ G ++AVK K+ + EIQ L RH +
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK---IKREIQNLKLFRHPH 72
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEAL--HGKKGAFLGWNLRYKIAIEAAK------ 796
I++L S +V EY+ G L + + HG+ + EA +
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--------VEEM---EARRLFQQIL 121
Query: 797 -GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG--ASECMSAIAGS 853
+ Y H ++VHRD+K N+LL++ A +ADFGL+ + DG + C GS
Sbjct: 122 SAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GS 173
Query: 854 YGYIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y APE YA + D++S GV+L LL G P
Sbjct: 174 PNYAAPEVISGRLYA-----GPEVDIWSCGVILYALLCGTLP 210
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 53/228 (23%)
Query: 689 KDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA-----EIQTLGNIRH 742
+ + G+G G V GK G+ +A+KK++ +Q L + H
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-------QDPRFRNRELQIMQDLAVLHH 78
Query: 743 RNIVRLL-AFCSNKETNL------LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAA 795
NIV+L F + E + +V EY+ + LH R ++A
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLH----RCCRNYYRRQVAPPPI 129
Query: 796 ----------KGLCYLHHDCSPLIVHRDVKSNNILLNSA-FEAHVADFGLAKFLIDGGAS 844
+ + LH S + HRD+K +N+L+N A + DFG AK L +
Sbjct: 130 LIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 845 ECMSAIAGSYGYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
++ I Y Y APE YT V D++S G + E++ G
Sbjct: 189 --VAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 40/230 (17%)
Query: 671 MTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHG 729
M ++KLE IG G G V+ K +A+K++ D G
Sbjct: 1 MQKYEKLEK--------------IGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEG 43
Query: 730 F-----RAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGW 784
R EI L ++H+NIVRL + + LV+E+ + L + G
Sbjct: 44 VPSSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPE 101
Query: 785 NLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844
++ + KGL + H ++HRD+K N+L+N E +A+FGLA+ G
Sbjct: 102 IVK-SFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF--GIPV 155
Query: 845 ECMSAIAGSYGYIAPEY-----AYTLRVDEKSDVYSFGVVLLELLTGRRP 889
C SA + Y P+ Y+ + D++S G + EL RP
Sbjct: 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSI----DMWSAGCIFAELANAGRP 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 61/228 (26%), Positives = 98/228 (42%), Gaps = 39/228 (17%)
Query: 670 KMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHG 729
M +QKLE +G G G+VY K G +A+K++ + D G
Sbjct: 19 LMEKYQKLEK--------------VGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEG 61
Query: 730 F-----RAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGW 784
R EI L + H NIV L+ ++ LV+E+M L + L K
Sbjct: 62 IPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDS 119
Query: 785 NLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844
++ + +G+ + H I+HRD+K N+L+NS +ADFGLA+ G
Sbjct: 120 QIK-IYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF--GIPV 173
Query: 845 ECMSAIAGSYGYIAPEY-----AYTLRVDEKSDVYSFGVVLLELLTGR 887
+ + Y AP+ Y+ V D++S G + E++TG+
Sbjct: 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-18
Identities = 72/222 (32%), Positives = 98/222 (44%), Gaps = 55/222 (24%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGF--RAEIQTLGNIRHRNIVRLL 749
VIG G G+VY K +G +A+KK+L D F R E+Q + + H NIVRL
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNR-ELQIMRKLDHCNIVRLR 113
Query: 750 -AFCSNKETNL-----LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAA-------- 795
F S+ E LV +Y+ E ++ R K +
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYV-----PETVY----RVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 796 --KGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV---ADFGLAKFLIDGGASECMSAI 850
+ L Y+H S I HRD+K N+LL+ + V DFG AK L+ G + +S I
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPN--VSYI 217
Query: 851 AGSYGYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
Y Y APE YT + DV+S G VL ELL G+
Sbjct: 218 CSRY-YRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQ 254
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 5e-18
Identities = 72/243 (29%), Positives = 107/243 (44%), Gaps = 54/243 (22%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
G+ +G G G V GK G ++AVK K+ + R EIQ L RH +
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR---SLDVVGKIRREIQNLKLFRHPH 77
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEAL--HGKKGAFLGWNLRYKIAIEAAK------ 796
I++L S +V EY+ G L + + +G+ L K E+ +
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR--------LDEK---ESRRLFQQIL 126
Query: 797 -GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG--ASECMSAIAGS 853
G+ Y H ++VHRD+K N+LL++ A +ADFGL+ + DG + C GS
Sbjct: 127 SGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GS 178
Query: 854 YGYIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRAT 907
Y APE YA + D++S GV+L LL G P F D + K+
Sbjct: 179 PNYAAPEVISGRLYA-----GPEVDIWSSGVILYALLCGTLP---F-DDDHVPTLFKKIC 229
Query: 908 NGR 910
+G
Sbjct: 230 DGI 232
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-18
Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 46/221 (20%)
Query: 689 KDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRL 748
+ VIG G G+V+ K+ E+A+KK+L R E+Q + ++H N+V L
Sbjct: 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVL---QDKRFKN-R-ELQIMRIVKHPNVVDL 97
Query: 749 L-AFCSNKETNL-----LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK------ 796
F SN + LV EY+ E ++ + + L+ + + K
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYV-----PETVY--RASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 797 --GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV---ADFGLAKFLIDGGASECMSAIA 851
L Y+H S I HRD+K N+LL+ + V DFG AK LI G + +S I
Sbjct: 151 LRSLAYIH---SIGICHRDIKPQNLLLDP--PSGVLKLIDFGSAKILIAGEPN--VSYIC 203
Query: 852 GSYGYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
Y Y APE YT + D++S G V+ EL+ G+
Sbjct: 204 SRY-YRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQ 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-18
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 37/215 (17%)
Query: 731 RAEIQTLGNIRHRNIVRL-LAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRY 788
E+Q + + H +V L +F E ++ +V + + G L L + F ++
Sbjct: 63 FKELQIMQGLEHPFLVNLWYSFQD--EEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKL 119
Query: 789 KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS 848
I E L YL + I+HRD+K +NILL+ H+ DF +A L ++
Sbjct: 120 FIC-ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQIT 172
Query: 849 AIAGSYGYIAPE-------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQ 901
+AG+ Y+APE Y+ V D +S GV ELL GRRP
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP------------ 216
Query: 902 WSKRATNGRKEEFLSILDPRLSMVPK--EEAMHLL 934
+ R++ KE + ++ +E + LL
Sbjct: 217 YHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLL 251
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-18
Identities = 59/219 (26%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
G+++G G G V AVK KL + + + EIQ L +RH+N
Sbjct: 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIP--NGEANVKKEIQLLRRLRHKN 67
Query: 745 IVRLLAFCSNKETN--LLVYEYMRNGS---LGEALHGKKGAFLGWNLRYKIAIEAAK--- 796
+++L+ N+E +V EY G L + +A
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--------FPVC---QAHGYFC 116
Query: 797 ----GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
GL YLH S IVH+D+K N+LL + ++ G+A+ L A + G
Sbjct: 117 QLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG 173
Query: 853 SYGYIAPEYAYTLRVDE--KSDVYSFGVVLLELLTGRRP 889
S + PE A L K D++S GV L + TG P
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 671 MTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGF 730
M + LE IG G G+VY + G A+KK+ D G
Sbjct: 1 MEKYHGLEK--------------IGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGI 43
Query: 731 -----RAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWN 785
R EI L ++H NIV+L K+ +LV+E++ + L + L +G
Sbjct: 44 PSTTIR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVT 101
Query: 786 LRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845
+ ++ G+ Y H ++HRD+K N+L+N E +ADFGLA+ G
Sbjct: 102 AK-SFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAF--GIPVR 155
Query: 846 CMSAIAGSYGYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
+ + Y AP+ Y+ + D++S G + E++ G
Sbjct: 156 KYTHEIVTLWYRAPDVLMGSKKYSTTI----DIWSVGCIFAEMVNGT 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 60/250 (24%), Positives = 88/250 (35%), Gaps = 69/250 (27%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
+G G G V ++A+K L EI L +RH +
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK---KSDMHMRVEREISYLKLLRHPH 70
Query: 745 IVRLLAFCSNKETNLLVYEY---------MRNGSLGEALHGKKGAFLGWNLRYKIAIEAA 795
I++L + ++V EY + + E E
Sbjct: 71 IIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTED-------------------EGR 111
Query: 796 K-------GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG--ASEC 846
+ + Y H IVHRD+K N+LL+ +ADFGL+ + DG + C
Sbjct: 112 RFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC 168
Query: 847 MSAIAGSYGYIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIV 900
GS Y APE YA + DV+S G+VL +L GR P F D I
Sbjct: 169 -----GSPNYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGRLP---F-DDEFIP 214
Query: 901 QWSKRATNGR 910
K+ +
Sbjct: 215 NLFKKVNSCV 224
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 58/219 (26%), Positives = 81/219 (36%), Gaps = 46/219 (21%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
IG G G+ + +AVK + G ++ R EI ++RH NIVR
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVK-YIERGAAIDENVQR-EIINHRSLRHPNIVRFK 82
Query: 750 AFCSNKETNLLVYEYMRNGSLGE--ALHGKKGAFLGWNLRYKIAIEAAK-------GLCY 800
++ EY G L E G+ EA G+ Y
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGR--------FSED---EARFFFQQLLSGVSY 131
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAH--VADFGLAKFLIDGGA--SECMSAIAGSYGY 856
H S I HRD+K N LL+ + + DFG +K + S G+ Y
Sbjct: 132 CH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPAY 183
Query: 857 IAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
IAPE Y + +DV+S GV L +L G P
Sbjct: 184 IAPEVLLRQEYD-----GKIADVWSCGVTLYVMLVGAYP 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 54/240 (22%), Positives = 88/240 (36%), Gaps = 59/240 (24%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-----KLLGFGTHSHDHGFRA------------ 732
+ IG+G G+V + A+K KL+ R
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 733 --------EIQTLGNIRHRNIVRLL-AFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFL 782
EI L + H N+V+L+ E +L +V+E + G + E
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLK--- 132
Query: 783 GWNLRYKIAIEAAK-------GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA 835
+A G+ YLH I+HRD+K +N+L+ +ADFG++
Sbjct: 133 ----PLSED-QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 836 KFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEK------SDVYSFGVVLLELLTGRRP 889
A +S G+ ++APE +L K DV++ GV L + G+ P
Sbjct: 185 NEFKGSDAL--LSNTVGTPAFMAPE---SLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 5e-17
Identities = 64/258 (24%), Positives = 102/258 (39%), Gaps = 44/258 (17%)
Query: 693 VIGRGGAGIVYHGKMPNGVEI-AVKKL-----LGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
+IGRGG G VY + + ++ A+K L + R + + IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 747 RLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
+ ++ + L + + M G L L + G F ++R+ A E GL ++H
Sbjct: 256 CM-SYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAA-EIILGLEHMH--- 309
Query: 806 SPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPE--- 860
+ +V+RD+K NILL+ HV +D GLA A G++GY+APE
Sbjct: 310 NRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQ 363
Query: 861 --YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
AY D +S G +L +LL G P + + T + E L
Sbjct: 364 KGVAYDSSA----DWFSLGCMLFKLLRGHSP------------FRQHKTKDKHEIDRMTL 407
Query: 919 DPRLSMVPK--EEAMHLL 934
+ + E LL
Sbjct: 408 TMAVELPDSFSPELRSLL 425
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 676 KLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEI 734
+E+ D + V+ +GRG V+ + N ++ VK L R EI
Sbjct: 29 VVEWGNQDDYQLVR---KLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKR-EI 81
Query: 735 QTLGNIR-HRNIVRLLAFC--SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIA 791
+ L N+R NI+ L T LV+E++ N + +++R+ +
Sbjct: 82 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYM- 136
Query: 792 IEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLAKFLIDGGASECMSAI 850
E K L Y H S I+HRDVK +N++++ + + D+GLA+F G + +
Sbjct: 137 YEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QEYNVR 190
Query: 851 AGSYGYIAPE-------YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
S + PE Y Y+L D++S G +L ++ + P
Sbjct: 191 VASRYFKGPELLVDYQMYDYSL------DMWSLGCMLASMIFRKEP 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-16
Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 693 VIGRGGAGIVYHGKMPNGVEI-AVKKLLGFGTHSHDH--GFRAEIQTLGNIRHRNIVRLL 749
V+GRGG G V+ +M ++ A KKL G E + L + R IV L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL- 250
Query: 750 AFCSNKETNL-LVYEYMRNGSLG---EALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
A+ +T+L LV M G + + F + A + GL +LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLH--- 306
Query: 806 SPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPE--- 860
I++RD+K N+LL+ + +V +D GLA L G AG+ G++APE
Sbjct: 307 QRNIIYRDLKPENVLLDD--DGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLL 362
Query: 861 -YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y V D ++ GV L E++ R P
Sbjct: 363 GEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 57/244 (23%), Positives = 98/244 (40%), Gaps = 41/244 (16%)
Query: 657 KAKSFKKTGSDSW---KMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVE 712
S G+++ M ++ L ++G G G+V + G
Sbjct: 7 HHSSGVDLGTENLYFQSMEKYENLG--------------LVGEGSYGMVMKCRNKDTGRI 52
Query: 713 IAVKKLLGFGTHSHDHGFRA----EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNG 768
+A+KK L D + EI+ L +RH N+V LL C K+ LV+E++ +
Sbjct: 53 VAIKKFL---ESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DH 108
Query: 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH 828
++ + L ++ K + G+ + H I+HRD+K NIL++ +
Sbjct: 109 TILDDLELFPNGLDYQVVQ-KYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVK 164
Query: 829 VADFGLAKFLIDGGASECMSAIAGSYGYIAPE-----YAYTLRVDEKSDVYSFGVVLLEL 883
+ DFG A+ L E + Y APE Y V DV++ G ++ E+
Sbjct: 165 LCDFGFARTL--AAPGEVYDDEVATRWYRAPELLVGDVKYGKAV----DVWAIGCLVTEM 218
Query: 884 LTGR 887
G
Sbjct: 219 FMGE 222
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-16
Identities = 63/242 (26%), Positives = 98/242 (40%), Gaps = 31/242 (12%)
Query: 659 KSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEI-AVKK 717
S WK Q + + + + V+G+GG G V ++ ++ A KK
Sbjct: 163 DSIYFNRFLQWKWLERQPV--TKNT-FRQYR---VLGKGGFGEVCACQVRATGKMYACKK 216
Query: 718 LLGFGTHSHDH--GFRAEIQTLGNIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEAL 774
L E Q L + R +V L A+ + L LV M G L +
Sbjct: 217 LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHI 275
Query: 775 H-GKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV--AD 831
+ + F + A E GL LH IV+RD+K NILL+ H+ +D
Sbjct: 276 YHMGQAGFPEARAVFYAA-EICCGLEDLH---RERIVYRDLKPENILLDD--HGHIRISD 329
Query: 832 FGLAKFLIDGGASECMSAIAGSYGYIAPE----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
GLA + +G + + G+ GY+APE YT D ++ G +L E++ G+
Sbjct: 330 LGLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSP----DWWALGCLLYEMIAGQ 382
Query: 888 RP 889
P
Sbjct: 383 SP 384
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-16
Identities = 59/242 (24%), Positives = 92/242 (38%), Gaps = 63/242 (26%)
Query: 670 KMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDH 728
+ ++KL+F +G G VY + +A+KK+
Sbjct: 8 RAKRYEKLDF--------------LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD 53
Query: 729 GFRA----EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGW 784
G EI+ L + H NI+ LL +K LV+++M L +
Sbjct: 54 GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPS 112
Query: 785 NLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844
+++ + +GL YLH I+HRD+K NN+LL+ +ADFGLAK
Sbjct: 113 HIK-AYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK-------- 160
Query: 845 ECMSAIAGSYG--------------YIAPEY-----AYTLRVDEKSDVYSFGVVLLELLT 885
S+G Y APE Y + V D+++ G +L ELL
Sbjct: 161 --------SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV----DMWAVGCILAELLL 208
Query: 886 GR 887
Sbjct: 209 RV 210
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 82.9 bits (204), Expect = 2e-16
Identities = 45/223 (20%), Positives = 74/223 (33%), Gaps = 11/223 (4%)
Query: 81 CGSVPAQILRLDKLTNLSLAGNN-FTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVN 139
++L L+ E+ + LQ L N + +L
Sbjct: 338 PECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDP 397
Query: 140 LEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLT 199
L F+ L V ++ L L + F + E + L LA DLT
Sbjct: 398 LLYEKETLQYFSTLKAVDPMRAAYLDDLR---SKFLLENSVLKMEYADVRVLHLAHKDLT 454
Query: 200 GKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLK 259
+ L L + + L + + +P + L L L S L+ + + NL
Sbjct: 455 -VLCH-LEQLLLVTHLDLSHNRLRA--LPPALAALRCLEVLQASDNALE-NVD-GVANLP 508
Query: 260 LLDTVFLHINLLSG-SIPKQLGNLTNLVNLDLSNNALTGEIPY 301
L + L N L + + L + LV L+L N+L E
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 75.6 bits (185), Expect = 4e-14
Identities = 63/325 (19%), Positives = 107/325 (32%), Gaps = 18/325 (5%)
Query: 25 LVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSRDRVASLDLTDLNLCGSV 84
L+ L + E A +S S P +V S G A L + G
Sbjct: 235 LLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRN 294
Query: 85 PAQILRLDKLTNLSLAGNN--FTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEV 142
+ L L SL T + S + + ++ + ++ L
Sbjct: 295 RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCR-DSATDEQLFR 353
Query: 143 FDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKI 202
+ + + +L + ++L+ L+ + I L L Y +
Sbjct: 354 CE-LSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS--- 409
Query: 203 PGELGNLTNLREIYLGY-YNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLL 261
L + +R YL + F + ++ L L+ +L + H + L L+
Sbjct: 410 --TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLV 465
Query: 262 DTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG 321
+ L N L ++P L L L L S+NAL + NL +L+ L NRL
Sbjct: 466 THLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL-Q 521
Query: 322 SIPD--YLADLPNLETLGLWQNNFT 344
L P L L L N+
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 3e-12
Identities = 45/240 (18%), Positives = 82/240 (34%), Gaps = 14/240 (5%)
Query: 338 LWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPE 397
+ + + + +L +LS K T + ++L S +L+ L + I
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL 390
Query: 398 RLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLG 457
+ A L + Y + + + A L S L EN +
Sbjct: 391 LMRALDPLLYEKETLQYFST-----LKAVDPMRAAYLDDLR-SKFLLENSVLKMEYADVR 444
Query: 458 QLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGE 517
L+L++ L+ L + L LS N+ +PP++ LR + L S N+L
Sbjct: 445 VLHLAHKDLTVLC--HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-N 500
Query: 518 IPPAIGYCNHLTYLDMSQNNLSG-SIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSL 576
+ + L L + N L + + + L LNL N L + +
Sbjct: 501 VDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL-CQEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.5 bits (164), Expect = 1e-11
Identities = 39/257 (15%), Positives = 76/257 (29%), Gaps = 22/257 (8%)
Query: 163 KLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNV 222
L L + + L + + L L
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCR-DSATDEQLFRCELSVEKS 361
Query: 223 FEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNL 282
+ E+ L L+ + + I ++ LD + L + L
Sbjct: 362 TV--LQSELESCKELQELEPEN---KWCLLTIILLMRALDPLLYEKETL-----QYFSTL 411
Query: 283 TNLVNLDLSN-----NALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLG 337
+ + + + E + +++ +L L ++ +L L + L
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLD 469
Query: 338 LWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFG-PIP 396
L N +P L L+VL S N L + + + +L+ L+L N L
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAI 526
Query: 397 ERLGACYSLTRVRLGQN 413
+ L +C L + L N
Sbjct: 527 QPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 6e-11
Identities = 49/319 (15%), Positives = 87/319 (27%), Gaps = 64/319 (20%)
Query: 188 LEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCEL 247
L SL + +E L R+ L +LS E
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW--CRDSATDEQLFRCELS-VEK 360
Query: 248 DGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLR 307
+ E+ + K L + +I + L L+ + + ++
Sbjct: 361 STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST---LKAVDPM 417
Query: 308 QLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKL 367
+ + ++ + ++ L L + T + +L Q + LDLS N+L
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRL 475
Query: 368 TGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLP 427
+P L + L +L N L ++
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE-------------------------NVD------- 502
Query: 428 GLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSG-PLPFSLSNFSSLQILLLS 486
+A L L +L L NN L L + L +L L
Sbjct: 503 --GVANLPR-------------------LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQ 541
Query: 487 GNQFSGPIPPSIGELRQVL 505
GN L ++L
Sbjct: 542 GNSLCQ-EEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 7e-08
Identities = 27/133 (20%), Positives = 47/133 (35%), Gaps = 5/133 (3%)
Query: 452 NPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSR 511
L L L + L ++F E V L L+
Sbjct: 391 LMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAH 450
Query: 512 NSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIG 571
L+ + + +T+LD+S N L ++PP ++ +R L L S N L +N+ +
Sbjct: 451 KDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL-ENVD-GVA 505
Query: 572 SMKSLTIADFSFN 584
++ L N
Sbjct: 506 NLPRLQELLLCNN 518
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 55/241 (22%), Positives = 98/241 (40%), Gaps = 51/241 (21%)
Query: 675 QKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSH-DHGFRA 732
+++ +++S + ++G G G+V P G +A+KK+ F R
Sbjct: 3 KRIVYNISSDFQLKS---LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR- 58
Query: 733 EIQTLGNIRHRNIVRLL-AFCSNKETNL----LVYEYM--------RNGSLGEALHGKKG 779
EI+ L + +H NI+ + + N ++ E M L + H +
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD-HIQ-- 115
Query: 780 AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839
F+ Y+ + + LH ++HRD+K +N+L+NS + V DFGLA+ +
Sbjct: 116 YFI-----YQTL----RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163
Query: 840 DGGASECMSAIAGSY--GYI------APE-----YAYTLRVDEKSDVYSFGVVLLELLTG 886
+ A S ++ APE Y+ + DV+S G +L EL
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLR 219
Query: 887 R 887
R
Sbjct: 220 R 220
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 34/216 (15%)
Query: 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSH-----DHGFRA-----EIQTLGNIRH 742
I G G V G G+ +A+K++ + F EI+ L + H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 743 RNIVRLL-AFCSNKETNL----LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKG 797
NI+ L F +E + LV E MR L + +H ++ +++Y G
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY-FMYHILLG 146
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA-IAGSYGY 856
L LH +VHRD+ NILL + + DF LA+ + A + + + Y
Sbjct: 147 LHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRW-Y 199
Query: 857 IAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
APE +T V D++S G V+ E+ +
Sbjct: 200 RAPELVMQFKGFTKLV----DMWSAGCVMAEMFNRK 231
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 38/227 (16%)
Query: 671 MTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHG 729
M ++K+ IG G G+V+ + G +A+KK F D
Sbjct: 2 MEKYEKIG--------------KIGEGSYGVVFKCRNRDTGQIVAIKK---FLESEDDPV 44
Query: 730 FRA----EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWN 785
+ EI+ L ++H N+V LL K LV+EY + ++ L +
Sbjct: 45 IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHL 103
Query: 786 LRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845
++ I + + + + H +HRDVK NIL+ + DFG A+ L G S+
Sbjct: 104 VK-SITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLL--TGPSD 157
Query: 846 CMSAIAGSYGYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
+ Y +PE Y V DV++ G V ELL+G
Sbjct: 158 YYDDEVATRWYRSPELLVGDTQYGPPV----DVWAIGCVFAELLSGV 200
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 52/261 (19%), Positives = 82/261 (31%), Gaps = 28/261 (10%)
Query: 54 PSSVCSWAG--ICCSRDRVASL------DLTDLNLCG----SVPAQILR-LDKLTNLSLA 100
+C + C +V + + +L + L + ++
Sbjct: 3 HHRICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEIS 62
Query: 101 GNNFTGSIEIG---NLSSLQFLNISN-NQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPV 156
N+ IE NL L + I N + +L NL+ N L V
Sbjct: 63 QNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV 122
Query: 157 GILKLEKLKYLDLGGNYFFGKIPNS--YGELQGLEYLSLAGNDLTGKIPGELGNLTNLRE 214
+ + LD+ N I + G L L N + +I N T L E
Sbjct: 123 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDE 181
Query: 215 IYLGYYNVFEGGIPREV-GKLVNLVHLDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLS 272
+ L N E +P +V V LD+S + +P NLK L L
Sbjct: 182 LNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRA--RSTYNLK 237
Query: 273 GSIPKQLGNLTNLVNLDLSNN 293
+P L L L+ L+
Sbjct: 238 -KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 51/256 (19%), Positives = 86/256 (33%), Gaps = 20/256 (7%)
Query: 240 LDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGE 298
++ +IP ++ N L + L +L +++S N +
Sbjct: 14 FLCQESKVT-EIPSDLPRNAIELR---FVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 299 IP-YSFINLRQLK-LFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGK 356
I F NL +L + N L P+ +LPNL+ L + + + + +
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 129
Query: 357 LQVLDLSSNKLTGTIPTDLCS--SNQLRILILLKNFLFGPIPER-LGACYSLTRVRLGQN 413
+LD+ N TI + S + IL L KN + I N
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDNN 188
Query: 414 YLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLN-LSNNLLSGPLPF 472
L D F G + ++ + SLP G + L +L S L LP
Sbjct: 189 NLEELPNDVFHGASGPVILDISRTRIH-SLPSYG-----LENLKKLRARSTYNLKK-LP- 240
Query: 473 SLSNFSSLQILLLSGN 488
+L +L L+
Sbjct: 241 TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 42/237 (17%), Positives = 76/237 (32%), Gaps = 18/237 (7%)
Query: 139 NLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKI----PNSYGELQGLEYLSLA 194
+ VF + T + P + + L K+ ++ LE + ++
Sbjct: 10 SNRVFLCQESKVTEI-PSDLPR--NAIELRFVLT----KLRVIQKGAFSGFGDLEKIEIS 62
Query: 195 GNDLTGKIP-GELGNLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLSSCELDGQIP 252
ND+ I NL L EI + N I E L NL +L +S+ + +P
Sbjct: 63 QNDVLEVIEADVFSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLISNTGI-KHLP 120
Query: 253 HEI-GNLKLLDTVFLHINLLSGSIPKQL--GNLTNLVNLDLSNNALTGEIPYSFINLRQL 309
+ + + N+ +I + G V L L+ N + +F +
Sbjct: 121 DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLD 180
Query: 310 KLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNK 366
+L N L D L + + + L KL+ + K
Sbjct: 181 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 38/244 (15%), Positives = 77/244 (31%), Gaps = 15/244 (6%)
Query: 322 SIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSS-NQ 380
IP L N L + G L+ +++S N + I D+ S+ +
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 381 LRILILLKNFLFGPIPER-LGACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNY 438
L + + K I +L + + + +PD I+ L ++Q N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
Query: 439 LSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI 498
++ N + L L+ N + + + ++ L N +P +
Sbjct: 140 NIHTIERN-SFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEE-LPNDV 197
Query: 499 -GELRQVLKLDLSRNSLSGEIPPAI-GYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLN 556
+ LD+SR + +P L +P + + L +
Sbjct: 198 FHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEAS 252
Query: 557 LSRN 560
L+
Sbjct: 253 LTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 23/119 (19%), Positives = 43/119 (36%), Gaps = 6/119 (5%)
Query: 453 PDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSR 511
P +L L + S F L+ + +S N I + L ++ ++ + +
Sbjct: 29 PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 512 -NSLSGEIPP-AIGYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHLNQNIP 567
N+L I P A +L YL +S + +P + L++ N I
Sbjct: 89 ANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE 145
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 5e-16
Identities = 64/216 (29%), Positives = 91/216 (42%), Gaps = 35/216 (16%)
Query: 693 VIGRGGAGIVYHGKMPNGVEI-AVKKL-----LGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
VIGRG G V K+ N ++ A+K L L + FR E L N + I
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVNGDSKWIT 137
Query: 747 RLL-AFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
L AF + NL LV +Y G L L + R+ +A E + +H
Sbjct: 138 TLHYAFQD--DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVH-- 192
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPE-- 860
VHRD+K +NIL++ H+ ADFG L++ G + A+ G+ YI+PE
Sbjct: 193 -QLHYVHRDIKPDNILMDM--NGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEIL 248
Query: 861 -------YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y D +S GV + E+L G P
Sbjct: 249 QAMEGGKGRYGPEC----DWWSLGVCMYEMLYGETP 280
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 43/229 (18%)
Query: 671 MTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDH 728
M + KL+ +G G VY GK +A+K++ L H+
Sbjct: 1 METYIKLDK--------------LGEGTYATVYKGKSKLTDNLVALKEIRLE-----HEE 41
Query: 729 GF-----RAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLG 783
G R E+ L +++H NIV L +++ LV+EY+ + L + L
Sbjct: 42 GAPCTAIR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINM 99
Query: 784 WNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843
N++ + +GL Y H ++HRD+K N+L+N E +ADFGLA+
Sbjct: 100 HNVK-LFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK--SIP 153
Query: 844 SECMSAIAGSYGYIAPEY-----AYTLRVDEKSDVYSFGVVLLELLTGR 887
++ + Y P+ Y+ ++ D++ G + E+ TGR
Sbjct: 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 44/233 (18%)
Query: 670 KMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHD 727
+ F++LE +G G VY G GV +A+K++ L +
Sbjct: 3 SSSQFKQLEK--------------LGNGTYATVYKGLNKTTGVYVALKEVKLD-----SE 43
Query: 728 HGF-----RAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN---GSLGEALHGKKG 779
G R EI + ++H NIVRL + LV+E+M N + G
Sbjct: 44 EGTPSTAIR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP 102
Query: 780 AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839
L NL + +GL + H + I+HRD+K N+L+N + + DFGLA+
Sbjct: 103 RGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF- 158
Query: 840 DGGASECMSAIAGSYGYIAPEY-----AYTLRVDEKSDVYSFGVVLLELLTGR 887
G S+ + Y AP+ Y+ +D ++S G +L E++TG+
Sbjct: 159 -GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSID----IWSCGCILAEMITGK 206
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 41/212 (19%), Positives = 79/212 (37%), Gaps = 14/212 (6%)
Query: 187 GLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLSSC 245
+ L L L NL N+ IY+ +V + L + H+++ +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYV-SIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 246 ELDGQIPHEI-GNLKLLDTVFLHINLLSGSIP--KQLGNLTNLVNLDLSNNALTGEIPY- 301
I + L LL + + L P ++ + L++++N IP
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 302 SFINLR-QLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENL--GQNGKLQ 358
+F L + L+ N S+ Y + L+ + L +N + VI ++ G
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 359 VLDLSSNKLTGTIPTDLCSSNQLRILILLKNF 390
+LD+S +T +P+ L+ LI +
Sbjct: 209 LLDVSQTSVT-ALPSKGLEH--LKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 36/221 (16%), Positives = 71/221 (32%), Gaps = 15/221 (6%)
Query: 274 SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYL-ADLPN 332
IP + L L L ++F NL + + ++ + + +L
Sbjct: 25 RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81
Query: 333 LETLGLWQNNFTGVIPEN-LGQNGKLQVLDLSSNKLTGTIP--TDLCSSNQLRILILLKN 389
+ + + I + L + L+ L + + L P T + S++ IL + N
Sbjct: 82 VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDN 140
Query: 390 FLFGPIPERL--GACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENG 447
IP G C ++L N S+ L+ L N + ++
Sbjct: 141 PYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDA 199
Query: 448 NSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGN 488
L++S ++ LP L+ L+
Sbjct: 200 F-GGVYSGPSLLDVSQTSVTA-LPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 38/218 (17%), Positives = 70/218 (32%), Gaps = 28/218 (12%)
Query: 54 PSSVCS---WAGICCSRDRVASL-----DLTDLNLCG----SVPAQILR-LDKLTNLSLA 100
S C + + + L L ++P+ L ++ + ++
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVS 63
Query: 101 GNNFTGSIEIG---NLSSLQFLNISNNQFSGGLDWN-YSSLVNLEVFDAYNNNFTALLPV 156
+ +E NLS + + I N + +D + L L+ +N +
Sbjct: 64 IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDL 123
Query: 157 GILK-LEKLKYLDLGGNYFFGKIPNSYGELQGL----EYLSLAGNDLTGKIPGELGNLTN 211
+ + L++ N + IP QGL L L N T + G N T
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPV--NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTK 180
Query: 212 LREIYLGYYNVFEGGIPREV--GKLVNLVHLDLSSCEL 247
L +YL I ++ G LD+S +
Sbjct: 181 LDAVYLNKNKYLT-VIDKDAFGGVYSGPSLLDVSQTSV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 30/233 (12%), Positives = 71/233 (30%), Gaps = 31/233 (13%)
Query: 330 LPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKN 389
P+ +TL L + + + + + +S + + +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESH--------------- 74
Query: 390 FLFGPIPERLGACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNYLSGSLPENGN 448
F + +T + + I LP L + + L P+
Sbjct: 75 -SFYNLS-------KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125
Query: 449 SSSNPDRLGQLNLSNNLLSGPLPFSLSNFSS-LQILLLSGNQFSGPIPPSIGELRQVLKL 507
S N ++ + + L L N F+ + ++ +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAV 184
Query: 508 DLSRNSLSGEIPPAI--GYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNL 557
L++N I G + + LD+SQ +++ ++P + +++ L N
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 38/256 (14%), Positives = 81/256 (31%), Gaps = 43/256 (16%)
Query: 332 NLETLGLWQNNFTGV--IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKN 389
E + + + +P + Q L L L TIP+
Sbjct: 12 QEEDFRVTCKDIQRIPSLPPST------QTLKLIETHLR-TIPSHA-------------- 50
Query: 390 FLFGPIPERLGACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNYLSGSLPENGN 448
F +P +++R+ + + + F L + E+++ + +
Sbjct: 51 --FSNLP-------NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPD-- 99
Query: 449 SSSNPDRLGQLNLSNNLLSG-PLPFSLSNFSSLQILLLSGNQFSGPIPPSI--GELRQVL 505
+ L L + N L P + + IL ++ N + IP + G + L
Sbjct: 100 ALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL 159
Query: 506 KLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEI--SNVRILNYLNLSRNHLN 563
L L N + + L + +++N I + + L++S+ +
Sbjct: 160 TLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV- 217
Query: 564 QNIPKSI-GSMKSLTI 578
+P +K L
Sbjct: 218 TALPSKGLEHLKELIA 233
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 13/163 (7%)
Query: 731 RAEIQTLGNIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYK 789
E + + H V+L F + L Y +NG L + + K G+F R+
Sbjct: 78 TRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFY 135
Query: 790 IAIEAAKGLCYLH-HDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASEC 846
A E L YLH I+HRD+K NILLN + H+ DFG AK L
Sbjct: 136 TA-EIVSALEYLHGKG----IIHRDLKPENILLNE--DMHIQITDFGTAKVLSPESKQAR 188
Query: 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
++ G+ Y++PE + SD+++ G ++ +L+ G P
Sbjct: 189 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-16
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 683 DILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEIQTLGN 739
+L+ ++ IG G GIV +A+KKL + +R E+ +
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKC 80
Query: 740 IRHRNIVRLL-AFCSNKETNL-----LVYEYMRNGSLGEALHGK-----KGAFLGWNLRY 788
+ H+NI+ LL F K +V E M + +L + + + L Y
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL-----Y 134
Query: 789 KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS 848
++ G+ +LH S I+HRD+K +NI++ S + DFGLA+ G S M+
Sbjct: 135 QML----CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMT 184
Query: 849 AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGR 887
+ Y APE + E D++S G ++ E++ G
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 41/217 (18%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSH-DHGFRAEIQTLGNIRHRNIVRLL 749
+ IG G G+V N V +A+KK+ F ++ R EI+ L RH NI+ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 91
Query: 750 -AFCSNKETNL----LVYEYM--------RNGSLGEALHGKKGAFLGWNLRYKIAIEAAK 796
+ + +V + M + L H FL Y+I +
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-HICY--FL-----YQIL----R 139
Query: 797 GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL-IDGGASECMSAIAGSYG 855
GL Y+H S ++HRD+K +N+LLN+ + + DFGLA+ D + ++ +
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 856 YIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
Y APE YT + D++S G +L E+L+ R
Sbjct: 197 YRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNR 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 59/210 (28%), Positives = 83/210 (39%), Gaps = 21/210 (10%)
Query: 693 VIGRGGAGIVYHGKMPNGVEI-AVKKLLGFGTHSHDHG--FRAEIQTLGNIRHRNIVRLL 749
VIGRG V KM ++ A+K + + FR E L N R I +L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL- 126
Query: 750 AFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
F E L LV EY G L L R+ +A E + +H
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVH---RLG 182
Query: 809 IVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
VHRD+K +NILL+ H+ ADFG L G + A+ G+ Y++PE +
Sbjct: 183 YVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVG 239
Query: 867 VDEKSDVY-------SFGVVLLELLTGRRP 889
+ Y + GV E+ G+ P
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 46/248 (18%), Positives = 86/248 (34%), Gaps = 74/248 (29%)
Query: 670 KMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDH 728
+ ++++ +G G G VY +A+K++ +
Sbjct: 32 SIDRYRRITK--------------LGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEE 74
Query: 729 GF-----RAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLG 783
G R E+ L ++HRNI+ L + + L++EY L + + K
Sbjct: 75 GVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMD-KNPDVSM 131
Query: 784 WNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH-----VADFGLAKFL 838
++ + G+ + H S +HRD+K N+LL+ + + + DFGLA+
Sbjct: 132 RVIK-SFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA- 186
Query: 839 IDGGASECMSAIAGSYG--------------YIAPEY-----AYTLRVDEKSDVYSFGVV 879
+G Y PE Y+ V D++S +
Sbjct: 187 ---------------FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSV----DIWSIACI 227
Query: 880 LLELLTGR 887
E+L
Sbjct: 228 WAEMLMKT 235
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 53/183 (28%), Positives = 78/183 (42%), Gaps = 11/183 (6%)
Query: 188 LEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLSSCE 246
+ L L N L+ LT LR +YL N + +P + +L NL L ++ +
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYL-NDNKLQT-LPAGIFKELKNLETLWVTDNK 96
Query: 247 LDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQL-GNLTNLVNLDLSNNALTGEIPY-SF 303
L +P + L L + L N L S+P ++ +LT L L L N L +P F
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 304 INLRQLKLFNLFMNRLHGSIPDYL-ADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDL 362
L LK L+ N+L +P+ L L+TL L N V KL++L L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 363 SSN 365
N
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 56/206 (27%), Positives = 79/206 (38%), Gaps = 29/206 (14%)
Query: 138 VNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGND 197
+ + D +N ++L +L KL+ L L N + EL+ LE L + N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 198 LTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLSSCELDGQIPHEIG 256
L G L NL E+ L N + +P V L L +L L EL +P
Sbjct: 97 LQALPIGVFDQLVNLAELRL-DRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPK--- 150
Query: 257 NLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFM 316
VF LT+L L L NN L +F L +LK L
Sbjct: 151 ------GVF--------------DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190
Query: 317 NRLHGSIPDYLAD-LPNLETLGLWQN 341
N+L +P+ D L L+ L L +N
Sbjct: 191 NQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 55/209 (26%), Positives = 83/209 (39%), Gaps = 33/209 (15%)
Query: 283 TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYL-ADLPNLETLGLWQN 341
+ LDL +N L+ +F L +L+L L N+L ++P + +L NLETL + N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 342 NFTGVIPENLGQN-GKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLG 400
+P + L L L N+L ++P + + L
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPR--------------------VFDSLT 133
Query: 401 ACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQL 459
LT + LG N L S+P G F L L L +N L +PE + L L
Sbjct: 134 K---LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEG--AFDKLTELKTL 186
Query: 460 NLSNNLLSGPLPFSLSNFSSLQILLLSGN 488
L NN L + + L++L L N
Sbjct: 187 KLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 41/152 (26%), Positives = 58/152 (38%), Gaps = 11/152 (7%)
Query: 75 LTDLNLCG----SVPAQIL-RLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQF 126
L L L ++PA I L L L + N ++ IG L +L L + NQ
Sbjct: 63 LRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL 121
Query: 127 SGGLDWNYSSLVNLEVFDAYNNNFTALLPVGIL-KLEKLKYLDLGGNYFFGKIPNSYGEL 185
+ SL L N + LP G+ KL LK L L N ++ +L
Sbjct: 122 KSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKL 180
Query: 186 QGLEYLSLAGNDLTGKIPGELGNLTNLREIYL 217
L+ L L N L G +L L+ + L
Sbjct: 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 45/167 (26%), Positives = 66/167 (39%), Gaps = 23/167 (13%)
Query: 90 RLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQFS---GGLDWNYSSLVNLEVF 143
RL KL L L N ++ G L +L+ L +++N+ G+ + LVNL
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGV---FDQLVNLAEL 114
Query: 144 DAYNNNFTALLPVGIL-KLEKLKYLDLGGNYFFGKI----PNSYGELQGLEYLSLAGNDL 198
N + LP + L KL YL LG N ++ + +L L+ L L N L
Sbjct: 115 RLDRNQLKS-LPPRVFDSLTKLTYLSLGYN----ELQSLPKGVFDKLTSLKELRLYNNQL 169
Query: 199 TGKIPGELGNLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLSS 244
G LT L+ + L N + +P L L L L
Sbjct: 170 KRVPEGAFDKLTELKTLKL-DNNQLK-RVPEGAFDSLEKLKMLQLQE 214
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 54/221 (24%), Positives = 83/221 (37%), Gaps = 41/221 (18%)
Query: 322 SIPDYLADLP-NLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQ 380
+IP +++P + + L L N + + + + KL++L L+ NKL T+P +
Sbjct: 30 AIP---SNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKE-- 83
Query: 381 LRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNYL 439
LKN L + + N L ++P G F L L L N L
Sbjct: 84 ------LKN---------------LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL 121
Query: 440 SGSLPENGNSSSNPDRLGQ---LNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPP 496
SLP D L + L+L N L +SL+ L L NQ +P
Sbjct: 122 K-SLPPRV-----FDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR-VPE 174
Query: 497 SI-GELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQN 536
+L ++ L L N L A L L + +N
Sbjct: 175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 33/118 (27%), Positives = 59/118 (50%), Gaps = 7/118 (5%)
Query: 453 PDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSR 511
P +L+L +N LS + + L++L L+ N+ +P I EL+ + L ++
Sbjct: 36 PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTD 94
Query: 512 NSLSGEIPPAI-GYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHLNQNIP 567
N L +P + +L L + +N L S+PP + ++ L YL+L N L Q++P
Sbjct: 95 NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL-QSLP 149
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 683 DILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEIQTLGN 739
++ + +G G G V +G ++A+KKL +R E+ L +
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKH 79
Query: 740 IRHRNIVRLL-AFCSNKETNL-----LVYEYMRNGSLGEALHG-KKGAFLGWNLRYKIAI 792
++H N++ LL F LV +M L F ++Y +
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQY-LVY 133
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA-IA 851
+ KGL Y+H S +VHRD+K N+ +N E + DFGLA+ A M+ +
Sbjct: 134 QMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVV 185
Query: 852 GSYGYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
+ Y APE Y V D++S G ++ E+LTG+
Sbjct: 186 TRW-YRAPEVILSWMHYNQTV----DIWSVGCIMAEMLTGK 221
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 54/239 (22%), Positives = 80/239 (33%), Gaps = 43/239 (17%)
Query: 138 VNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKI----PNSYGELQGLEYLSL 193
+ + D N L +L+ LDL +I +Y L L L L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC----EIQTIEDGAYQSLSHLSTLIL 83
Query: 194 AGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPH 253
GN + + F G L +L L L + +
Sbjct: 84 TGNPIQ-SLAL----------------GAFSG--------LSSLQKLVAVETNLA-SLEN 117
Query: 254 EI-GNLKLLDTVFLHINLLSGSIPKQ--LGNLTNLVNLDLSNNALTGEIPYSFINLRQLK 310
G+LK L + + NL+ S NLTNL +LDLS+N + L Q+
Sbjct: 118 FPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 311 LFN----LFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSN 365
L N L +N ++ I L+ L L N V + LQ + L +N
Sbjct: 177 LLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 50/217 (23%), Positives = 77/217 (35%), Gaps = 21/217 (9%)
Query: 283 TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYL-ADLPNLETLGLWQN 341
+ NLDLS N L YSF + +L++ +L + +I D L +L TL L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 342 NFTGV---IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSS-NQLRILILLKNFL-FGPIP 396
+ L LQ L L ++ L+ L + N + +P
Sbjct: 87 PIQSLALGAFSGL---SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 397 ERLGACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAE----LQSNYLSGSLPENGNSSS 451
E +L + L N + SI L + L L N ++ + +
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPG---AF 197
Query: 452 NPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGN 488
RL +L L N L +SLQ + L N
Sbjct: 198 KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 50/222 (22%), Positives = 78/222 (35%), Gaps = 33/222 (14%)
Query: 114 SSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGIL-KLEKLKYLDLGGN 172
S + L++S N +++ S L+V D + G L L L L GN
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGN 86
Query: 173 YFFGKI----PNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGY--------Y 220
I ++ L L+ L +L +G+L L+E+ + +
Sbjct: 87 ----PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 221 NVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEI----GNLKLLD-TVFLHINLLSGSI 275
F L NL HLDLSS ++ I + LL+ ++ L +N ++ I
Sbjct: 143 EYFSN--------LTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 276 PKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMN 317
L L L N L F L L+ L N
Sbjct: 193 QPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 51/210 (24%), Positives = 78/210 (37%), Gaps = 31/210 (14%)
Query: 90 RLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQFSGGLDWN-YSSLVNLEVFDA 145
+L L L+ +IE G +LS L L ++ N L +S L +L+ A
Sbjct: 50 SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVA 107
Query: 146 YNNNFTALLPVGILKLEKLKYLDLGGNYF-FGKIPNSYGELQGLEYLSLAGNDLTGKIPG 204
N +L I L+ LK L++ N K+P + L LE+L L+ N +
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167
Query: 205 ELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTV 264
+L L + + L LDLS ++ I L +
Sbjct: 168 DLRVLHQMPLLNL---------------------SLDLSLNPMN-FIQPGAFKEIRLKEL 205
Query: 265 FLHINLLSGSIPKQ-LGNLTNLVNLDLSNN 293
L N L S+P LT+L + L N
Sbjct: 206 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 56/248 (22%), Positives = 91/248 (36%), Gaps = 41/248 (16%)
Query: 347 IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLT 406
IP+NL + + LDLS N L + + F P L
Sbjct: 22 IPDNLPFS--TKNLDLSFNPLR-HLGSYS----------------FFSFP-------ELQ 55
Query: 407 RVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNL 465
+ L + + +I DG + L L+ L N + SL + S L +L
Sbjct: 56 VLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALG--AFSGLSSLQKLVAVETN 111
Query: 466 LSGPLPFSLSNFSSLQILLLSGNQF-SGPIPPSIGELRQVLKLDLSRNSLSGEIPP-AIG 523
L+ F + + +L+ L ++ N S +P L + LDLS N + I +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLR 170
Query: 524 YCNHLTY----LDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSI-GSMKSLTI 578
+ + LD+S N ++ I P L L L N L +++P I + SL
Sbjct: 171 VLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQK 228
Query: 579 ADFSFNDF 586
N +
Sbjct: 229 IWLHTNPW 236
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 61/212 (28%), Positives = 87/212 (41%), Gaps = 30/212 (14%)
Query: 693 VIGRGGAGIVYHGKMPNGVEI-AVKKLLGFGTHSHDHG--FRAEIQTLGNIRHRNIVRLL 749
VIGRG G V + + ++ A+K L F F E + +V+L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 750 -AFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
AF ++ L +V EYM G L + R+ A E L +H S
Sbjct: 136 YAFQDDR--YLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTA-EVVLALDAIH---SM 187
Query: 808 LIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPE----- 860
+HRDVK +N+LL+ H+ ADFG + G C +A+ G+ YI+PE
Sbjct: 188 GFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQ 244
Query: 861 ---YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y D +S GV L E+L G P
Sbjct: 245 GGDGYYGREC----DWWSVGVFLYEMLVGDTP 272
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-15
Identities = 55/239 (23%), Positives = 98/239 (41%), Gaps = 42/239 (17%)
Query: 674 FQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA 732
+ +E D + + IG+G G V+ + G ++A+KK+L + GF
Sbjct: 5 YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPI 61
Query: 733 ----EIQTLGNIRHRNIVRLLAFCSNKETNL--------LVYEYMRNGSLGEALHGKKGA 780
EI+ L ++H N+V L+ C K + LV+++ + L L
Sbjct: 62 TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK 120
Query: 781 FLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840
F ++ ++ GL Y+H + I+HRD+K+ N+L+ +ADFGLA+
Sbjct: 121 FTLSEIK-RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF-- 174
Query: 841 GGASECMSAIAGSYG-------YIAPEY-----AYTLRVDEKSDVYSFGVVLLELLTGR 887
S ++ Y Y PE Y + D++ G ++ E+ T
Sbjct: 175 ---SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 49/228 (21%)
Query: 683 DILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEIQTLGN 739
++ +D +G G G V G ++A+KKL +R E++ L +
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKH 80
Query: 740 IRHRNIVRLL-AFCSNKETNL-----LVYEYM--------RNGSLGEALHGKKGAFLGWN 785
+RH N++ LL F ++ + LV +M ++ LGE + +
Sbjct: 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED-RIQ--FLV--- 134
Query: 786 LRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845
Y++ KGL Y+H + I+HRD+K N+ +N E + DFGLA+ A
Sbjct: 135 --YQML----KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADS 180
Query: 846 CMSA-IAGSYGYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
M+ + + Y APE YT V D++S G ++ E++TG+
Sbjct: 181 EMTGYVVTRW-YRAPEVILNWMRYTQTV----DIWSVGCIMAEMITGK 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 8e-15
Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 23/207 (11%)
Query: 693 VIGRGGAGIVYHGKMPNGVEI-AVKKLLGFGTHSHDHG--FRAEIQTLGNIRHRNIVRLL 749
++G+G G V K A+K L + D E + L N RH + L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 750 AFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
+ L V EY G L L ++ F R+ A E L YLH + +
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGA-EIVSALDYLHSEKN-- 269
Query: 809 IVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPE----YA 862
+V+RD+K N++L+ + H+ DFGL K I GA+ M G+ Y+APE
Sbjct: 270 VVYRDLKLENLMLDK--DGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDND 325
Query: 863 YTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y V D + GVV+ E++ GR P
Sbjct: 326 YGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 9e-15
Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 29/218 (13%)
Query: 683 DILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEIQTLGN 739
+L+ ++ IG G GIV +A+KKL + +R E+ +
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKC 117
Query: 740 IRHRNIVRLL-AFCSNKETNL-----LVYEYMRNGSLGEALHGKKGAFLGWN----LRYK 789
+ H+NI+ LL F K LV E M L L L Y+
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQ 172
Query: 790 IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA 849
+ G+ +LH S I+HRD+K +NI++ S + DFGLA+ G S M+
Sbjct: 173 ML----CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTP 222
Query: 850 IAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGR 887
+ Y APE + E D++S G ++ E++ +
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 57/251 (22%), Positives = 91/251 (36%), Gaps = 74/251 (29%)
Query: 670 KMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDH 728
+ ++ + IG G G VY + +G +A+K + +
Sbjct: 7 ATSRYEPVAE--------------IGVGAYGTVYKARDPHSGHFVALKSVR---VPNGGG 49
Query: 729 GFRA-------EI---QTLGNIRHRNIVRLLAFCSNKETNL-----LVYEYMRNGSLGEA 773
G E+ + L H N+VRL+ C+ T+ LV+E++ + L
Sbjct: 50 GGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTY 108
Query: 774 LHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFG 833
L L + + +GL +LH +C IVHRD+K NIL+ S +ADFG
Sbjct: 109 LDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFG 165
Query: 834 LAKFLIDGGASECMSAIAGSYG-------------YIAPEY----AYTLRVDEKSDVYSF 876
LA+ Y Y APE Y V D++S
Sbjct: 166 LAR----------------IYSYQMALTPVVVTLWYRAPEVLLQSTYATPV----DMWSV 205
Query: 877 GVVLLELLTGR 887
G + E+ +
Sbjct: 206 GCIFAEMFRRK 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 55/249 (22%), Positives = 95/249 (38%), Gaps = 74/249 (29%)
Query: 671 MTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK--MPNGVEIAVKKLLGFGTHSHDH 728
++ + IG G G V+ + G +A+K++ + +
Sbjct: 10 DQQYECVAE--------------IGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEE 52
Query: 729 GF-----RAEIQTLGNIR---HRNIVRLL----AFCSNKETNL-LVYEYMRNGSLGEALH 775
G R E+ L ++ H N+VRL +++ET L LV+E++ + L L
Sbjct: 53 GMPLSTIR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLD 110
Query: 776 GKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA 835
+ + + +GL +LH +VHRD+K NIL+ S+ + +ADFGLA
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 836 KFLIDGGASECMSAIAGSYG-------------YIAPEY----AYTLRVDEKSDVYSFGV 878
+ Y Y APE +Y V D++S G
Sbjct: 168 R----------------IYSFQMALTSVVVTLWYRAPEVLLQSSYATPV----DLWSVGC 207
Query: 879 VLLELLTGR 887
+ E+ +
Sbjct: 208 IFAEMFRRK 216
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 54/229 (23%), Positives = 76/229 (33%), Gaps = 36/229 (15%)
Query: 261 LDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLH 320
V L+ ++P L + L LS N L + + +L NL L
Sbjct: 12 HLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL- 67
Query: 321 GSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQ 380
+ LP L TL L N +P L VLD+S N+LT ++P
Sbjct: 68 TKLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLG------ 118
Query: 381 LRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNYL 439
+ E L + L N L ++P G P L L +N L
Sbjct: 119 ----------ALRGLGE-------LQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNL 160
Query: 440 SGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGN 488
+ LP + + L L L N L +P L L GN
Sbjct: 161 T-ELPA--GLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 52/231 (22%), Positives = 83/231 (35%), Gaps = 40/231 (17%)
Query: 357 LQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLN 416
++ LT +P D +P+ T + L +N L
Sbjct: 12 HLEVNCDKRNLT-ALPPD--------------------LPK------DTTILHLSENLLY 44
Query: 417 GSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSN 476
+ L L L+ L +G LG L+LS+N L LP
Sbjct: 45 TFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPV----LGTLDLSHNQLQS-LPLLGQT 98
Query: 477 FSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSRNSLSGEIPPAI-GYCNHLTYLDMS 534
+L +L +S N+ + +P L ++ +L L N L +PP + L L ++
Sbjct: 99 LPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLA 156
Query: 535 QNNLSGSIPPEI-SNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFN 584
NNL+ +P + + + L+ L L N L IPK L A N
Sbjct: 157 NNNLT-ELPAGLLNGLENLDTLLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 54/177 (30%), Positives = 73/177 (41%), Gaps = 13/177 (7%)
Query: 73 LDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDW 132
L L++ L A ++ +LT L+L T G L L L++S+NQ L
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPL 94
Query: 133 NYSSLVNLEVFDAYNNNFTALLPVGIL-KLEKLKYLDLGGNYFFGKI----PNSYGELQG 187
+L L V D N T+ LP+G L L +L+ L L GN ++ P
Sbjct: 95 LGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGN----ELKTLPPGLLTPTPK 149
Query: 188 LEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSS 244
LE LSLA N+LT G L L NL + L N IP+ L L
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLL-QENSLY-TIPKGFFGSHLLPFAFLHG 204
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 689 KDGNVIGRGGAGIVYHGK---MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
+G +GRG G VY K + + A+K++ G G R EI L ++H N+
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS--ACR-EIALLRELKHPNV 80
Query: 746 VRLL-AFCSNKETNL-LVYEYMRN------GSLGEALHGKKGAFLGWNLRYKIAIEAAKG 797
+ L F S+ + + L+++Y + + KK L + + + G
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAH----VADFGLAKFLIDGGASECMSAIAGS 853
+ YLH + ++HRD+K NIL+ +AD G A+ + ++ +
Sbjct: 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPV 195
Query: 854 ---YGYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
+ Y APE YT + D+++ G + ELLT
Sbjct: 196 VVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-14
Identities = 73/434 (16%), Positives = 130/434 (29%), Gaps = 81/434 (18%)
Query: 210 TNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIG-------NLKLLD 262
+++ + + + + + L + L C L +I L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 263 TVFLHINLLSGSIPKQLGNL-----TNLVNLDLSNNALTGE----IPYSFINLRQLKLFN 313
L N L + + L L N LTG + + L L+ +
Sbjct: 63 ---LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119
Query: 314 LFMNRLHGSIPDYLADL-----PNLETLGLWQNNFT----GVIPENLGQNGKLQVLDLSS 364
L N L + L + LE L L + + + L + L +S+
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179
Query: 365 NKLTGT----IPTDLCSSN-QLRILILLKNFL----FGPIPERLGACYSLTRVRLGQNYL 415
N + + L S QL L L + + + + SL + LG N L
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
Query: 416 NGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGP----LP 471
G L + +S L L + ++ L
Sbjct: 240 GDV---GMAEL--------------CPGLLHPSSR-----LRTLWIWECGITAKGCGDLC 277
Query: 472 FSLSNFSSLQILLLSGNQFSGPIPPSIGEL-----RQVLKLDLSRNSLSGE----IPPAI 522
L SL+ L L+GN+ + E Q+ L + S + +
Sbjct: 278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVL 337
Query: 523 GYCNHLTYLDMSQNNLSGSIPPEISNV-----RILNYLNLSRNHLN----QNIPKSIGSM 573
L L +S N L + E+ +L L L+ ++ ++ ++ +
Sbjct: 338 AQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 397
Query: 574 KSLTIADFSFNDFS 587
SL D S N
Sbjct: 398 HSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-14
Identities = 93/523 (17%), Positives = 156/523 (29%), Gaps = 124/523 (23%)
Query: 114 SSLQFLNISNNQFS-GGLDWNYSSLVNLEVFDAYNNNFTAL----LPVGILKLEKLKYLD 168
+Q L+I + S L +V + T + + L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 169 LGGNYFFG----------KIPNSYGELQGLEYLSLAGNDLTGK----IPGELGNLTNLRE 214
L N + P+ ++ LSL LTG + L L L+E
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCK-----IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQE 117
Query: 215 IYLGYYNVFEGGIPR--EVGKLVN--LVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINL 270
++L + + G+ E L L L C L + ++
Sbjct: 118 LHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV------------ 165
Query: 271 LSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADL 330
L + L +SNN + L Q L +
Sbjct: 166 --------LRAKPDFKELTVSNNDINEA---GVRVLCQG----LKDSPC----------- 199
Query: 331 PNLETLGLWQNNFT----GVIPENLGQNGKLQVLDLSSNKLTGT-----IPTDLCSSNQL 381
LE L L T + + L+ L L SNKL P L S++L
Sbjct: 200 -QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 258
Query: 382 RILILLKNFL----FGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSN 437
R L + + + G + L A SL + L N L G L
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE---------GARL------ 303
Query: 438 YLSGSLPENGNSSSNPDRLGQLNLSNNLLSG----PLPFSLSNFSSLQILLLSGNQFSGP 493
L +L E G L L + + + L+ L L +S N+
Sbjct: 304 -LCETLLEPGCQ------LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356
Query: 494 IPPSIGE-LRQVL----KLDLSRNSLSGE----IPPAIGYCNHLTYLDMSQNNLSGSIPP 544
+ + L Q L L+ +S + + + L LD+S N L +
Sbjct: 357 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 416
Query: 545 EIS-----NVRILNYLNLSRNHLNQNIPKSIGSM----KSLTI 578
++ +L L L + ++ + + ++ SL +
Sbjct: 417 QLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 459
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 80/417 (19%), Positives = 129/417 (30%), Gaps = 81/417 (19%)
Query: 72 SLDLTDLNLCGS------VPAQILRLDKLTNLSLAGNNFT--GSIEIG----NLSSLQFL 119
SLD+ L++ + L + + L T +I +L L
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 120 NISNNQFSG--------GLDWNYSSLVNLEVFDAYNNNFTA----LLPVGILKLEKLKYL 167
N+ +N+ GL + L N T +L + L L+ L
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKL---SLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 168 DLGGNYF----------FGKIPNSYGELQGLEYLSLAGNDLTGK----IPGELGNLTNLR 213
L N P LE L L L+ + L + +
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQC-----RLEKLQLEYCSLSAASCEPLASVLRAKPDFK 173
Query: 214 EIYLGYYNVFEGGIPREVGKL----VNLVHLDLSSCELDGQ----IPHEIGNLKLLDTVF 265
E+ + ++ E G+ L L L L SC + + + + L +
Sbjct: 174 ELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 266 LHINLLSGS-----IPKQLGNLTNLVNLDLSNNALTGE----IPYSFINLRQLKLFNLFM 316
L N L P L + L L + +T + + LK +L
Sbjct: 234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293
Query: 317 NRLHGSIPDYLADL-----PNLETLGLWQNNFTGV----IPENLGQNGKLQVLDLSSNKL 367
N L L + LE+L + +FT L QN L L +S+N+L
Sbjct: 294 NELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL 353
Query: 368 TGTIPTDLC-----SSNQLRILILLKNFL----FGPIPERLGACYSLTRVRLGQNYL 415
+LC + LR+L L + + L A +SL + L N L
Sbjct: 354 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 68/362 (18%), Positives = 111/362 (30%), Gaps = 71/362 (19%)
Query: 93 KLTNLSLAGNNFT--GSIEIG----NLSSLQFLNISNNQF--------SGGLDWNYSSLV 138
K+ LSL T G + L +LQ L++S+N GL L
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145
Query: 139 NLEVFDAYNNNFTA----LLPVGILKLEKLKYLDLGGNYF----------FGKIPNSYGE 184
L++ + +A L + K L + N K
Sbjct: 146 KLQL---EYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPC--- 199
Query: 185 LQGLEYLSLAGNDLTGK----IPGELGNLTNLREIYLGYYNVFEGGIPR--EVGKLVN-- 236
LE L L +T + G + + +LRE+ LG + + G+ +
Sbjct: 200 --QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSR 257
Query: 237 LVHLDLSSCELDGQ----IPHEIGNLKLLDTVFLHINLLSGSIPKQLGNL-----TNLVN 287
L L + C + + + + + L + L N L + L L +
Sbjct: 258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317
Query: 288 LDLSNNALTGE----IPYSFINLRQLKLFNLFMNRLHGSIPDYLADL-----PNLETLGL 338
L + + + T R L + NRL + L L L L
Sbjct: 318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL 377
Query: 339 WQNNFTGV----IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSS-----NQLRILILLKN 389
+ + + L N L+ LDLS+N L L S L L+L
Sbjct: 378 ADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDI 437
Query: 390 FL 391
+
Sbjct: 438 YW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 59/341 (17%), Positives = 98/341 (28%), Gaps = 72/341 (21%)
Query: 93 KLTNLSLAGNNFT--GSIEIG----NLSSLQFLNISNNQFS--------GGLDWNYSSLV 138
+L L L + + + + L +SNN + GL S
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLK---DSPC 199
Query: 139 NLEVFDAYNNNFTA----LLPVGILKLEKLKYLDLGGNYFFGK-----IPNSYGELQGLE 189
LE + T+ L + L+ L LG N P L
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259
Query: 190 YLSLAGNDLTGK----IPGELGNLTNLREIYLGYYNVFEGGIPR--EVGKLVN--LVHLD 241
L + +T K + L +L+E+ L + + G E L L
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW 319
Query: 242 LSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPY 301
+ SC ++ L L+ L +SNN L
Sbjct: 320 VKSCSFTAACCSHFSSV--------------------LAQNRFLLELQISNNRLEDAGVR 359
Query: 302 SF-----INLRQLKLFNLFMNRLH----GSIPDYLADLPNLETLGLWQNNFT--GV--IP 348
L++ L + S+ L +L L L N G+ +
Sbjct: 360 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 419
Query: 349 ENLGQNG-KLQVLDLSSNKLTGTIPTDLCS---SN-QLRIL 384
E++ Q G L+ L L + + L + LR++
Sbjct: 420 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 48/261 (18%), Positives = 84/261 (32%), Gaps = 49/261 (18%)
Query: 354 NGKLQVLDLSSNKLTGTIPTDLCSSNQ-LRILILLKNFL----FGPIPERLGACYSLTRV 408
+ +Q LD+ +L+ +L Q +++ L L I L +L +
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 409 RLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLS- 467
L N L G + L LQ+ ++ +L+L N L+
Sbjct: 62 NLRSNELG---DVGVHCV----LQGLQTPSC---------------KIQKLSLQNCCLTG 99
Query: 468 ---GPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQ-----VLKLDLSRNSLSGE-- 517
G L +L +LQ L LS N + E + KL L SLS
Sbjct: 100 AGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC 159
Query: 518 --IPPAIGYCNHLTYLDMSQNNLSGSIPPEIS-----NVRILNYLNLSRNHLN----QNI 566
+ + L +S N+++ + + + L L L + +++
Sbjct: 160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 219
Query: 567 PKSIGSMKSLTIADFSFNDFS 587
+ S SL N
Sbjct: 220 CGIVASKASLRELALGSNKLG 240
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 49/219 (22%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEIQTLGNIRHRNIVRL 748
+ +G G G V G+ +AVKKL +R E++ L +++H N++ L
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 93
Query: 749 L-AFCSNKETNL-----LVYEYM--------RNGSLGEALHGKKGAFLGWNLRYKIAIEA 794
L F + LV M + L + H + + Y+I
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQ--FLI-----YQIL--- 142
Query: 795 AKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSA-IAGS 853
+GL Y+H S I+HRD+K +N+ +N E + DFGLA+ ++ M+ +A
Sbjct: 143 -RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATR 193
Query: 854 YGYIAPE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
+ Y APE Y V D++S G ++ ELLTGR
Sbjct: 194 W-YRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGR 227
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 43/224 (19%), Positives = 67/224 (29%), Gaps = 44/224 (19%)
Query: 91 LDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFS--GGLDWNYSSLVNLEVFDAYNN 148
L +L + T + LS +Q N N+ G+ NL+ +N
Sbjct: 18 LANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQSLAGM----QFFTNLKELHLSHN 73
Query: 149 NFTALLPVGILKLEKLKYLDLGGNYFFGKIPN-SYGELQGLEYLSLAGNDLTGKIPGELG 207
+ L P+ L KL+ L + N ++ N + L L L N+L L
Sbjct: 74 QISDLSPLK--DLTKLEELSVNRN----RLKNLNGIPSACLSRLFLDNNELR-DTDS-LI 125
Query: 208 NLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLH 267
+L NL + + + +G L L LDL
Sbjct: 126 HLKNLEILSIRNNKLKS---IVMLGFLSKLEVLDLHGN---------------------E 161
Query: 268 INLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKL 311
I G L L + +DL+ E L
Sbjct: 162 ITNTGG-----LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNT 200
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 43/236 (18%), Positives = 82/236 (34%), Gaps = 18/236 (7%)
Query: 135 SSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLA 194
L N + + T L+ +L ++ + + + L+ L L+
Sbjct: 16 PGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSN-IQSLAGM-QFFTNLKELHLS 71
Query: 195 GNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHE 254
N ++ + L +LT L E+ + + L L L + EL +
Sbjct: 72 HNQIS-DLSP-LKDLTKLEELSVNRNRLKN----LNGIPSACLSRLFLDNNEL--RDTDS 123
Query: 255 IGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNL 314
+ +LK L+ + + N L SI LG L+ L LDL N +T + L+++ +L
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDL 179
Query: 315 FMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGT 370
+ Y +L T+ + + P + G + T
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVK--DPDGRWISPYYISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 47/245 (19%), Positives = 84/245 (34%), Gaps = 49/245 (20%)
Query: 147 NNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGEL 206
+ P L +LG + EL G++ + +++ + G +
Sbjct: 6 PTPINQVFPDP--GLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SLAG-M 59
Query: 207 GNLTNLREIYLGYYNV--FEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTV 264
TNL+E++L + + + L L L ++ L + +
Sbjct: 60 QFFTNLKELHLSHNQISDLSP-----LKDLTKLEELSVNRNRL-----KNLNGIPSA--- 106
Query: 265 FLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIP 324
L L L NN L + S I+L+ L++ ++ N+L SI
Sbjct: 107 -------------------CLSRLFLDNNELR-DTD-SLIHLKNLEILSIRNNKLK-SIV 144
Query: 325 DYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRIL 384
L L LE L L N T L + K+ +DL+ K + +L I
Sbjct: 145 M-LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV---NEPVKYQPELYIT 198
Query: 385 ILLKN 389
+K+
Sbjct: 199 NTVKD 203
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 38/211 (18%), Positives = 70/211 (33%), Gaps = 42/211 (19%)
Query: 279 LGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGL 338
L N V +L ++T + L ++ FN + + S+ + NL+ L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 339 WQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPER 398
N + + L KL+ L ++ N+L L L L N L
Sbjct: 71 SHNQISDL--SPLKDLTKLEELSVNRNRLKNLNGIPSAC---LSRLFLDNNEL------- 118
Query: 399 LGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQ 458
D I+L L + +++N L + +L
Sbjct: 119 -------------------RDTDSLIHLKNLEILSIRNNKLK-----SIVMLGFLSKLEV 154
Query: 459 LNLSNNLLSGPLPFSLSNFSSLQILLLSGNQ 489
L+L N ++ L+ + + L+G +
Sbjct: 155 LDLHGNEITNTGG--LTRLKKVNWIDLTGQK 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 26/125 (20%), Positives = 49/125 (39%), Gaps = 5/125 (4%)
Query: 89 LRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNN 148
+ L+ L L N + + +L +L+ L+I NN+ + L LEV D + N
Sbjct: 103 IPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGN 160
Query: 149 NFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLS-LAGNDLTGKIPGELG 207
T + +L+K+ ++DL G + EL + G ++ G
Sbjct: 161 EITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGG 218
Query: 208 NLTNL 212
+ +
Sbjct: 219 SYVDG 223
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 16/92 (17%), Positives = 37/92 (40%), Gaps = 6/92 (6%)
Query: 472 FSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYL 531
F ++ L + + EL V + +++ + + + +L L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68
Query: 532 DMSQNNLSGSIPPEISNVRILNYLNLSRNHLN 563
+S N +S + P + ++ L L+++RN L
Sbjct: 69 HLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK 98
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 8e-14
Identities = 75/352 (21%), Positives = 122/352 (34%), Gaps = 96/352 (27%)
Query: 686 ECVKDGNVIGRGGAGIVYHG------KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGN 739
+ +K G +GRG G V K +AVK L THS +E++ L +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 740 I-RHRNIVRLLAFCS-NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLR---------Y 788
I H N+V LL C+ +++ E+ + G+L L K+ F+ + + Y
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 789 KIAIEA----------------------AKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE 826
AI K L + + +P +++D + L+ +F+
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 827 A-------------H-----------------VADFGLAKFLIDGGASECMSAIAGSYGY 856
H + DFGLA+ + +
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----DYVRKGDAR 256
Query: 857 I-----APEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGR 910
+ APE + +SDV+SFGV+L E+ + G P GV I
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKI----------- 301
Query: 911 KEEFLSILDPRLSMVPKEEAMHLLFVAML-CIQENSIERPRMREVVQMLSEF 961
EEF L M + ++ ML C +RP E+V+ L
Sbjct: 302 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 56/254 (22%), Positives = 92/254 (36%), Gaps = 87/254 (34%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRA--EIQTLGNIRHRNIVRLL 749
+G G GIV + +G A+KK+L E+ + + H NI++L+
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVL-------QDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 750 -AFCSNKETNL-------------------------------------LVYEYMRNGSLG 771
F + + ++ EY+
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-----P 121
Query: 772 EALHGKKGAFLGWNLRYKIAIEAA----------KGLCYLHHDCSPLIVHRDVKSNNILL 821
+ LH L +R +I + + ++H S I HRD+K N+L+
Sbjct: 122 DTLH----KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLV 174
Query: 822 NSAFEAHV---ADFGLAKFLIDGGASECMSAIAGSYGYIAPE-----YAYTLRVDEKSDV 873
NS + + DFG AK LI S ++ I + Y APE YT + D+
Sbjct: 175 NS--KDNTLKLCDFGSAKKLIPSEPS--VAYICSRF-YRAPELMLGATEYTPSI----DL 225
Query: 874 YSFGVVLLELLTGR 887
+S G V EL+ G+
Sbjct: 226 WSIGCVFGELILGK 239
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 55/220 (25%), Positives = 80/220 (36%), Gaps = 24/220 (10%)
Query: 65 CSRDRVASL------DLTDLNLCG----SVPAQILRLDKLTNLSLAGNNFTGSIEIGNLS 114
S + NL Q L+ + + ++ I L
Sbjct: 5 VSTPIKQIFPDDAFAETIKANLKKKSVTDAVTQN-ELNSIDQIIANNSDIKSVQGIQYLP 63
Query: 115 SLQFLNISNNQFS--GGLDWNYSSLVNLEVFDAYNNNFTALLPVGIL-KLEKLKYLDLGG 171
++++L + N+ L L NL N +L P G+ KL LK L L
Sbjct: 64 NVRYLALGGNKLHDISALK----ELTNLTYLILTGNQLQSL-PNGVFDKLTNLKELVLVE 118
Query: 172 NYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV 231
N + +L L YL+LA N L G LTNL E+ L YN + +P V
Sbjct: 119 NQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL-SYNQLQ-SLPEGV 176
Query: 232 -GKLVNLVHLDLSSCELDGQIPHEI-GNLKLLDTVFLHIN 269
KL L L L +L +P + L L ++LH N
Sbjct: 177 FDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 60/237 (25%), Positives = 88/237 (37%), Gaps = 48/237 (20%)
Query: 233 KLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLG---NLTNLVNLD 289
+L ++ + ++ ++ I L + + L N L + LTNL L
Sbjct: 39 ELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKL-----HDISALKELTNLTYLI 91
Query: 290 LSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLAD-LPNLETLGLWQNNFTGVIP 348
L+ N L F L LK L N+L S+PD + D L NL L L N +
Sbjct: 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPK 150
Query: 349 ENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRV 408
+ L LDLS N+L ++P + F ++L L +
Sbjct: 151 GVFDKLTNLTELDLSYNQLQ-SLPEGV--------------F------DKLT---QLKDL 186
Query: 409 RLGQNYLNGSIPDG-FIYLPGLNLAELQSN----------YLSGSLPENGNSSSNPD 454
RL QN L S+PDG F L L L N YLS + ++ N
Sbjct: 187 RLYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWINKHSGVVRNSA 242
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 53/232 (22%), Positives = 95/232 (40%), Gaps = 64/232 (27%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSH-DHGFRAEIQTLGNIRHRNIVRLL- 749
+G GG G+V+ +A+KK++ H R EI+ + + H NIV++
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIV-LTDPQSVKHALR-EIKIIRRLDHDNIVKVFE 75
Query: 750 ------AFCSNKETNL-------LVYEYM--------RNGSLGEALHGKKGAFLGWNLRY 788
+ ++ +L +V EYM G L E H + F+ Y
Sbjct: 76 ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE-HAR--LFM-----Y 127
Query: 789 KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLAKFL-IDGGASEC 846
++ +GL Y+H S ++HRD+K N+ +N+ + DFGLA+ +
Sbjct: 128 QLL----RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 847 MSAIAGSYGYI------APE-----YAYTLRVDEKSDVYSFGVVLLELLTGR 887
+S + +P YT + D+++ G + E+LTG+
Sbjct: 181 LS------EGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 40/214 (18%)
Query: 731 RAEIQTLGNIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYK 789
+ E L + H IV+L + E L L+ +++R G L L K+ F ++++
Sbjct: 74 KMERDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFY 131
Query: 790 IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECM 847
+A E A L +LH S I++RD+K NILL+ E H+ DFGL+K ID
Sbjct: 132 LA-ELALALDHLH---SLGIIYRDLKPENILLDE--EGHIKLTDFGLSKESIDHEKK--A 183
Query: 848 SAIAGSYGYIAPE----YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWS 903
+ G+ Y+APE +T D +SFGV++ E+LTG P F
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP---FQG-------- 228
Query: 904 KRATNGRKEEFLSILDPRLSMVPK---EEAMHLL 934
RKE IL +L M P+ EA LL
Sbjct: 229 ----KDRKETMTMILKAKLGM-PQFLSPEAQSLL 257
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 53/166 (31%), Positives = 74/166 (44%), Gaps = 21/166 (12%)
Query: 731 RAEIQTLGNIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYK 789
E + L N RH + L + L V EY G L L ++ F R+
Sbjct: 53 VTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFY 110
Query: 790 IAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECM 847
A E L YLH S +V+RD+K N++L+ + H+ DFGL K I GA+ M
Sbjct: 111 GA-EIVSALEYLH---SRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGAT--M 162
Query: 848 SAIAGSYGYIAPE----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
G+ Y+APE Y V D + GVV+ E++ GR P
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 4e-13
Identities = 71/257 (27%), Positives = 112/257 (43%), Gaps = 46/257 (17%)
Query: 693 VIGRGGAGIVYHGKMPNGVEI----AVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVR 747
V+G+G G V + E+ +KK + + E + L + + +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC-TMVEKRVLALPGKPPFLTQ 406
Query: 748 LLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
L C L V EY+ G L + + G F + + A E A GL +L S
Sbjct: 407 LH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAA-EIAIGLFFLQ---S 460
Query: 807 PLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPE---- 860
I++RD+K +N++L+S E H+ ADFG+ K I G + G+ YIAPE
Sbjct: 461 KGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAY 516
Query: 861 YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920
Y V D ++FGV+L E+L G+ P F +G D E F SI++
Sbjct: 517 QPYGKSV----DWWAFGVLLYEMLAGQAP---F-EGED-----------EDELFQSIMEH 557
Query: 921 RLSMVPK---EEAMHLL 934
++ PK +EA+ +
Sbjct: 558 NVAY-PKSMSKEAVAIC 573
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 9e-13
Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 23/167 (13%)
Query: 731 RAEIQTLGNIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYK 789
+AE L ++H IV L + L L+ EY+ G L L ++G F+ +
Sbjct: 69 KAERNILEEVKHPFIVDL-IYAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFY 126
Query: 790 IAIEAAKGLCYLH-HDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASEC 846
+A E + L +LH I++RD+K NI+LN + HV DFGL K I G
Sbjct: 127 LA-EISMALGHLHQKG----IIYRDLKPENIMLNH--QGHVKLTDFGLCKESIHDG--TV 177
Query: 847 MSAIAGSYGYIAPE----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
G+ Y+APE + V D +S G ++ ++LTG P
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 50/244 (20%), Positives = 77/244 (31%), Gaps = 67/244 (27%)
Query: 691 GNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRL 748
V+G G G V + A+K L R E++ + +IVR+
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRI 76
Query: 749 LAFCSNKETN----LLVYEYMRNGSLGEALHGKKGAFLGWNLRY------KIAIEAAKGL 798
+ N L+V E + G L + + + + +I + +
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG------DQAFTEREASEIMKSIGEAI 130
Query: 799 CYLH-HDCSPLIVHRDVKSNNILLNSAFEAH---VADFGLAKFLIDGGASECMSAIAGSY 854
YLH + I HRDVK N+L S + DFG AK Y
Sbjct: 131 QYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-----------TGEKY 175
Query: 855 GYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914
D+ D++S GV++ LL G P F +S
Sbjct: 176 -------------DKSCDMWSLGVIMYILLCGYPP---F--------YSNHGLAISPGMK 211
Query: 915 LSIL 918
I
Sbjct: 212 TRIR 215
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 55/260 (21%), Positives = 83/260 (31%), Gaps = 63/260 (24%)
Query: 678 EFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEI 734
V D +IGRG G VY +A+KK+ D R EI
Sbjct: 21 NVHVPDNYIIKH---LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EI 76
Query: 735 QTLGNIRHRNIVRLL-AFCSNKETNL----LVYEYM--------RNGSLGEALHGKKGAF 781
L ++ I+RL + +V E + H K
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK--TI 134
Query: 782 LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841
L Y + G ++H I+HRD+K N LLN V DFGLA+ +
Sbjct: 135 L-----YNLL----LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 842 GASECMSAIAGSYG--------------------YIAPE-----YAYTLRVDEKSDVYSF 876
+ ++ + + Y APE YT + D++S
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWST 238
Query: 877 GVVLLELLTGRRPVGDFGDG 896
G + ELL + +
Sbjct: 239 GCIFAELLNMLQSHINDPTN 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 68/250 (27%), Positives = 108/250 (43%), Gaps = 61/250 (24%)
Query: 676 KLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRA 732
+++ V E VK +G+G GIV+ G +AVKK+ +S D FR
Sbjct: 2 RVDRHVLRKYELVK---KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR- 57
Query: 733 EIQTLGNIR-HRNIVRLL-AFCSNKETNL-LVYEYM--------RNGSLGEALHGKKGAF 781
EI L + H NIV LL ++ + ++ LV++YM R L H +
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV-HKQ--YV 114
Query: 782 LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841
+ Y++ K + YLH S ++HRD+K +NILLN+ VADFGL++ ++
Sbjct: 115 V-----YQLI----KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
Query: 842 GASECMSAIAGSYG-------------------YIAPE-----YAYTLRVDEKSDVYSFG 877
++ + Y APE YT + D++S G
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLG 218
Query: 878 VVLLELLTGR 887
+L E+L G+
Sbjct: 219 CILGEILCGK 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 46/202 (22%), Positives = 69/202 (34%), Gaps = 36/202 (17%)
Query: 651 ATAAIIKAKSFKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPN 709
+ + + + S ++ + D E +IG G G V
Sbjct: 21 SGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRH---LIGTGSYGHVCEAYDKLE 77
Query: 710 GVEIAVKKLLGFGTHSHD--HGFRAEIQTLGNIRHRNIVRLL-AFCSNKETNL----LVY 762
+A+KK+L D R EI L + H ++V++L +V
Sbjct: 78 KRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136
Query: 763 EYM---------RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRD 813
E L E H K L Y + G+ Y+H S I+HRD
Sbjct: 137 EIADSDFKKLFRTPVYLTEL-HIKT--LL-----YNLL----VGVKYVH---SAGILHRD 181
Query: 814 VKSNNILLNSAFEAHVADFGLA 835
+K N L+N V DFGLA
Sbjct: 182 LKPANCLVNQDCSVKVCDFGLA 203
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 60/218 (27%), Positives = 88/218 (40%), Gaps = 40/218 (18%)
Query: 731 RAEIQTLGNIRHRN-IVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRY 788
R E Q L +IR +V L + ET L L+ +Y+ G L L ++ F ++
Sbjct: 106 RTERQVLEHIRQSPFLVTL-HYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQI 163
Query: 789 KIAIEAAKGLCYLH-HDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASE 845
+ E L +LH I++RD+K NILL+S HV DFGL+K +
Sbjct: 164 YVG-EIVLALEHLHKLG----IIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETER 216
Query: 846 CMSAIAGSYGYIAPE------YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDI 899
G+ Y+AP+ + V D +S GV++ ELLTG P F
Sbjct: 217 AYD-FCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP---F------ 262
Query: 900 VQWSKRATNGRKEEFLSILDPRLSMVPK---EEAMHLL 934
N + E IL P+ A L+
Sbjct: 263 --TVDGEKNSQAEISRRILKSEPPY-PQEMSALAKDLI 297
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 49/195 (25%), Positives = 79/195 (40%), Gaps = 25/195 (12%)
Query: 232 GKLVNLVHLDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQ--LGNLTNLVNL 288
+++ L + +P + LLD L N LS + + LTNL +L
Sbjct: 20 SNILSCSKQQLPN------VPQSLPSYTALLD---LSHNNLS-RLRAEWTPTRLTNLHSL 69
Query: 289 DLSNNALTGEIPY-SFINLRQLKLFNLFMNRLHGSIP-DYLADLPNLETLGLWQNNFTGV 346
LS+N L I +F+ + L+ +L N LH ++ +DL LE L L+ N+ V
Sbjct: 70 LLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVV 127
Query: 347 IPENLGQNGKLQVLDLSSNKLTGTIPTD----LCSSNQLRILILLKNFLFGPIPERLGAC 402
+LQ L LS N+++ P + +L +L L N L L
Sbjct: 128 DRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKL 186
Query: 403 YSLTRVRLGQNYLNG 417
+ + L YL+
Sbjct: 187 PAWVKNGL---YLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 57/297 (19%), Positives = 91/297 (30%), Gaps = 78/297 (26%)
Query: 55 SSVCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG--- 111
+ C C+ + + + L +VP + L L+ NN + +
Sbjct: 13 PANCL-----CASNIL---SCSKQQL-PNVPQSLPSY--TALLDLSHNNLS-RLRAEWTP 60
Query: 112 -NLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLG 170
L++L L +S+N + ++ E F + L+YLDL
Sbjct: 61 TRLTNLHSLLLSHNHL---------NFISSEAFV---------------PVPNLRYLDLS 96
Query: 171 GNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPRE 230
N L L+ +L L + L Y N + R
Sbjct: 97 SN-----------HLHTLD-------------EFLFSDLQALEVLLL-YNNHIV-VVDRN 130
Query: 231 V-GKLVNLVHLDLSSCELDGQIPHEI----GNLKLLDTVFLHINLLSGSIPKQLGNLTNL 285
+ L L LS ++ + P E+ L L + L N L L L
Sbjct: 131 AFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW 189
Query: 286 V--NLDLSNNALT---GEIPY-SFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETL 336
V L L NN L S RQL F L+ L ++ +L+
Sbjct: 190 VKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFF 246
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 35/159 (22%), Positives = 62/159 (38%), Gaps = 11/159 (6%)
Query: 433 ELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSG 492
+L N LS L + + L L LS+N L+ + +L+ L LS N
Sbjct: 45 DLSHNNLS-RLRAEW-TPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT 102
Query: 493 PIPPSI-GELRQVLKLDLSRNSLSGEIPP-AIGYCNHLTYLDMSQNNLSGSIPPEI---- 546
+ + +L+ + L L N + + A L L +SQN +S P E+
Sbjct: 103 -LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDG 159
Query: 547 SNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFND 585
+ + L L+LS N L + + + + ++
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 14/168 (8%)
Query: 404 SLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLS 462
+ L N L+ + L L+ L N+L+ + + L L+LS
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSE--AFVPVPNLRYLDLS 96
Query: 463 NNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSRNSLSGEIPP- 520
+N L F S+ +L++LLL N + + ++ Q+ KL LS+N +S P
Sbjct: 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQIS-RFPVE 154
Query: 521 ---AIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQN 565
L LD+S N L +P ++ L + +L+ N
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLK-KLPLTD--LQKLPAWVKNGLYLHNN 199
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 9e-12
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 26/167 (15%)
Query: 731 RAEIQTLGNIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYK 789
E + L + +V+L F +NL +V EY+ G + L + G F + R+
Sbjct: 89 LNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFY 146
Query: 790 IAIEAAKGLCYLH-HDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASEC 846
A + YLH D +++RD+K N+L++ + ++ DFG AK + + C
Sbjct: 147 AA-QIVLTFEYLHSLD----LIYRDLKPENLLIDQ--QGYIQVTDFGFAKRVKGRTWTLC 199
Query: 847 MSAIAGSYGYIAPE----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
G+ +APE Y V D ++ GV++ E+ G P
Sbjct: 200 -----GTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 29/184 (15%)
Query: 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819
V EY+ G L + ++ + R+ A E + L YLH I++RD+K +N+
Sbjct: 87 FVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKLDNV 141
Query: 820 LLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPE----YAYTLRVDEKSDV 873
LL+S E H+ D+G+ K + G + S G+ YIAPE Y V D
Sbjct: 142 LLDS--EGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSV----DW 193
Query: 874 YSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK---EEA 930
++ GV++ E++ GR P F + N F IL+ ++ + P+ +A
Sbjct: 194 WALGVLMFEMMAGRSP---F---DIVGSSDNPDQNTEDYLFQVILEKQIRI-PRSLSVKA 246
Query: 931 MHLL 934
+L
Sbjct: 247 ASVL 250
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 49/167 (29%), Positives = 74/167 (44%), Gaps = 26/167 (15%)
Query: 731 RAEIQTLGNIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYK 789
E L + H I+R+ + ++ +Y+ G L L K F ++
Sbjct: 54 NDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFY 111
Query: 790 IAIEAAKGLCYLH-HDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASEC 846
A E L YLH D I++RD+K NILL+ H+ DFG AK++ D + C
Sbjct: 112 AA-EVCLALEYLHSKD----IIYRDLKPENILLDK--NGHIKITDFGFAKYVPDVTYTLC 164
Query: 847 MSAIAGSYGYIAPE----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
G+ YIAPE Y + D +SFG+++ E+L G P
Sbjct: 165 -----GTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 19/136 (13%)
Query: 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819
V E++ G L + K F R+ A E L +LH I++RD+K +N+
Sbjct: 101 FVMEFVNGGDLMFHIQ-KSRRFDEARARFYAA-EIISALMFLH---DKGIIYRDLKLDNV 155
Query: 820 LLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPE----YAYTLRVDEKSDV 873
LL+ E H ADFG+ K I G + + G+ YIAPE Y V D
Sbjct: 156 LLDH--EGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAV----DW 207
Query: 874 YSFGVVLLELLTGRRP 889
++ GV+L E+L G P
Sbjct: 208 WAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 29/184 (15%)
Query: 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819
V EY+ G L + ++ + R+ A E + L YLH I++RD+K +N+
Sbjct: 130 FVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKLDNV 184
Query: 820 LLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPE----YAYTLRVDEKSDV 873
LL+S E H+ D+G+ K + G + S G+ YIAPE Y V D
Sbjct: 185 LLDS--EGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSV----DW 236
Query: 874 YSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK---EEA 930
++ GV++ E++ GR P F + N F IL+ ++ + P+ +A
Sbjct: 237 WALGVLMFEMMAGRSP---F---DIVGSSDNPDQNTEDYLFQVILEKQIRI-PRSLSVKA 289
Query: 931 MHLL 934
+L
Sbjct: 290 ASVL 293
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 51/158 (32%), Positives = 72/158 (45%), Gaps = 21/158 (13%)
Query: 739 NIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKG 797
H + + + NL V EY+ G L + F + A E G
Sbjct: 74 AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAA-EIILG 130
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYG 855
L +LH S IV+RD+K +NILL+ + H+ ADFG+ K + G A + G+
Sbjct: 131 LQFLH---SKGIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAK--TNTFCGTPD 183
Query: 856 YIAPE----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
YIAPE Y V D +SFGV+L E+L G+ P
Sbjct: 184 YIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 47/136 (34%), Positives = 69/136 (50%), Gaps = 19/136 (13%)
Query: 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819
V EY+ G L + + G F + + A E A GL +L S I++RD+K +N+
Sbjct: 98 FVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAA-EIAIGLFFLQ---SKGIIYRDLKLDNV 152
Query: 820 LLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPE----YAYTLRVDEKSDV 873
+L+S E H+ ADFG+ K I G + G+ YIAPE Y V D
Sbjct: 153 MLDS--EGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSV----DW 204
Query: 874 YSFGVVLLELLTGRRP 889
++FGV+L E+L G+ P
Sbjct: 205 WAFGVLLYEMLAGQAP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 55/158 (34%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 739 NIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKG 797
N++H +V L F L V +Y+ G L L ++ FL R+ A E A
Sbjct: 95 NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAA-EIASA 151
Query: 798 LCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYG 855
L YLH S IV+RD+K NILL+S + H+ DFGL K I+ ++ S G+
Sbjct: 152 LGYLH---SLNIVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNST--TSTFCGTPE 204
Query: 856 YIAPE----YAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
Y+APE Y V D + G VL E+L G P
Sbjct: 205 YLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 54/365 (14%), Positives = 103/365 (28%), Gaps = 86/365 (23%)
Query: 188 LEYLSLAGNDLTGK----IPGELGNLTNLREIYLGYYNVFEGG---IPREVGKLVNLVHL 240
+E SL + +T + + L +++EI L + + + +L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 241 DLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALT---- 296
+ S L+ + + L L + LS+NA
Sbjct: 66 EFSDIFTGRVKDEIPEALR--------------LLLQALLKCPKLHTVRLSDNAFGPTAQ 111
Query: 297 ---GEIPYSFINLRQLKLFNLFMNRL-------------HGSIPDYLADLPNLETLGLWQ 340
+ L L L N N L ++ + P L ++ +
Sbjct: 112 EPLIDFLSKHTPLEHLYLHN---NGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 341 NNFTGV----IPENLGQNGKLQVLDLSSNKLT-----GTIPTDLCSSNQLRILILLKNFL 391
N + + L + + N + + L +L++L L N
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT- 227
Query: 392 FGP-----IPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPEN 446
F + L + +L + L L+ G + + +
Sbjct: 228 FTHLGSSALAIALKSWPNLRELGLNDCLLS---ARGAA-------------AVVDAFSKL 271
Query: 447 GNSSSNPDRLGQLNLSNNLLSGP----LPFSL-SNFSSLQILLLSGNQFSGPIPPSIGEL 501
N L L L N + L + L L L+GN+F + E+
Sbjct: 272 ENIG-----LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEI 325
Query: 502 RQVLK 506
R+V
Sbjct: 326 REVFS 330
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 56/315 (17%), Positives = 104/315 (33%), Gaps = 72/315 (22%)
Query: 275 IPKQLGNLTNLVNLDLSNNALT-------GEIPYSFINLRQLKLFNLFMNRLHGSIP--- 324
+ L ++ + LS N + E S +L + ++F R+ IP
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 325 ----DYLADLPNLETLGLWQNNFT--GVIP--ENLGQNGKLQVLDLSSNKLT-------- 368
L P L T+ L N F P + L ++ L+ L L +N L
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143
Query: 369 -----GTIPTDLCSSNQLRILILLKNFLFGP----IPERLGACYSLTRVRLGQNYLNGSI 419
+ ++ LR +I +N L + + L V++ QN +
Sbjct: 144 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR--- 200
Query: 420 PDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGP----LPFSLS 475
P+G +L L L L L+L +N + L +L
Sbjct: 201 PEGIEHL------------LLEGLAYCQE-------LKVLDLQDNTFTHLGSSALAIALK 241
Query: 476 NFSSLQILLLSGNQFSGPIPPSIGEL------RQVLKLDLSRNSLSGEIPPAIG-----Y 524
++ +L+ L L+ S ++ + + L L N + + +
Sbjct: 242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 301
Query: 525 CNHLTYLDMSQNNLS 539
L +L+++ N S
Sbjct: 302 MPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 49/298 (16%), Positives = 83/298 (27%), Gaps = 69/298 (23%)
Query: 94 LTNLSLAGNNFTG------SIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYN 147
+ SL + T + S++ + +S N
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG-------------------- 45
Query: 148 NNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELG 207
L I + L+ + F G++ + + L L A L
Sbjct: 46 TEAARWLSENIASKKDLEIAEFSDI-FTGRVKD--EIPEALRLLLQA-----------LL 91
Query: 208 NLTNLREIYLGYYNVFEGGIPREVGKL----VNLVHLDLSSCELDGQIPHEIGNLKLLDT 263
L + L N F + L HL L + L Q +I
Sbjct: 92 KCPKLHTVRLS-DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA----- 145
Query: 264 VFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGE----IPYSFINLRQLKLFNLFMNRL 319
L ++ K+ N L ++ N L +F + R L + N +
Sbjct: 146 ------LQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI 199
Query: 320 H-----GSIPDYLADLPNLETLGLWQNNFTG----VIPENLGQNGKLQVLDLSSNKLT 368
+ + LA L+ L L N FT + L L+ L L+ L+
Sbjct: 200 RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 44/274 (16%), Positives = 80/274 (29%), Gaps = 67/274 (24%)
Query: 333 LETLGLWQNNFTGV----IPENLGQNGKLQVLDLSSNKLTGT----IPTDLCSSNQLRIL 384
+E L + T + L ++ ++ + LS N + + ++ S L I
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 385 ILLKNFL----------FGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAEL 434
F + + L C L VRL N P L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG---PTAQEPL-------- 114
Query: 435 QSNYLSGSLPENGNSSSNPDRLGQLNLSNN-------------LLSGPLPFSLSNFSSLQ 481
++LS L L L NN L + N L+
Sbjct: 115 -IDFLS-----------KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR 162
Query: 482 ILLLSGNQFSGPIPPSIGELRQVLK----LDLSRNSLSGE-----IPPAIGYCNHLTYLD 532
++ N+ + Q + + + +N + E + + YC L LD
Sbjct: 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD 222
Query: 533 MSQNNLSG----SIPPEISNVRILNYLNLSRNHL 562
+ N + ++ + + L L L+ L
Sbjct: 223 LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 256
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 53/333 (15%), Positives = 94/333 (28%), Gaps = 106/333 (31%)
Query: 93 KLTNLSLAGNNFTGSIE-------------IGNLSSLQFLNISNNQF--------SGGLD 131
L + + FTG ++ + L + +S+N F L
Sbjct: 61 DLEIAEFS-DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL- 118
Query: 132 WNYSSLVNLEVFDAYNNNFT---------ALLPVGILKLEK----LKYLDLGGNYFFGKI 178
S LE +NN AL + + K K L+ + G N
Sbjct: 119 ---SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL---- 171
Query: 179 PNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLV--- 235
E ++ + + L + + + GI + + +
Sbjct: 172 -----ENGSMKEWAKT-----------FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215
Query: 236 -NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNA 294
L LDL +G S ++ L + NL L L++
Sbjct: 216 QELKVLDLQDNTFT-----HLG---------------SSALAIALKSWPNLRELGLNDCL 255
Query: 295 LTGE---------IPYSFINLRQLKLFNLFMNRLHGSIPDYLAD-----LPNLETLGLWQ 340
L+ I L+ L+L N + L +P+L L L
Sbjct: 256 LSARGAAAVVDAFSKLENIGLQTLRLQY---NEIELDAVRTLKTVIDEKMPDLLFLELNG 312
Query: 341 NNFT------GVIPENLGQNGKLQVLDLSSNKL 367
N F+ I E G+ ++ +L +
Sbjct: 313 NRFSEEDDVVDEIREVFSTRGRGELDELDDMEE 345
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 40/173 (23%), Positives = 62/173 (35%), Gaps = 31/173 (17%)
Query: 56 SVCSWAGICCSRDRV--ASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG-- 111
+ C+ CS + V LT +P + +T + L N I G
Sbjct: 7 AACT-----CSNNIVDCRGKGLT------EIPTNLPE--TITEIRLEQNTIK-VIPPGAF 52
Query: 112 -NLSSLQFLNISNNQFS----GGLDWNYSSLVNLEVFDAYNNNFTALLPVGIL-KLEKLK 165
L+ +++SNNQ S L +L Y N T LP + L L+
Sbjct: 53 SPYKKLRRIDLSNNQISELAPDAFQ----GLRSLNSLVLYGNKITE-LPKSLFEGLFSLQ 107
Query: 166 YLDLGGNYFFGKIPN-SYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYL 217
L L N + ++ +L L LSL N L G L ++ ++L
Sbjct: 108 LLLLNANK-INCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHL 159
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 30/132 (22%), Positives = 54/132 (40%), Gaps = 2/132 (1%)
Query: 283 TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNN 342
+ + L N + P +F ++L+ +L N++ PD L +L +L L+ N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 343 FTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSS-NQLRILILLKNFLFGPIPERLGA 401
T + LQ+L L++NK+ + D + L +L L N L
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 402 CYSLTRVRLGQN 413
++ + L QN
Sbjct: 151 LRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 36/163 (22%), Positives = 56/163 (34%), Gaps = 41/163 (25%)
Query: 189 EYLSLAGNDLTGKIPGELGNLTNLREIYLGY-------YNVFEGGIPREVGKLVNLVHLD 241
+ L N + PG LR I L + F+G L +L L
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQG--------LRSLNSLV 86
Query: 242 LSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQL-GNLTNLVNLDLSNNALTGEIP 300
L N ++ +PK L L +L L L+ N +
Sbjct: 87 LYG------------------------NKIT-ELPKSLFEGLFSLQLLLLNANKINCLRV 121
Query: 301 YSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNF 343
+F +L L L +L+ N+L + L ++T+ L QN F
Sbjct: 122 DAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 31/129 (24%), Positives = 60/129 (46%), Gaps = 11/129 (8%)
Query: 459 LNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSRNSLSGE 517
+ L N + P + S + L+ + LS NQ S + P LR + L L N ++ E
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 518 IPPAI-GYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHLNQNIPK----SIG 571
+P ++ L L ++ N ++ + + ++ LN L+L N L Q I K +
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL-QTIAKGTFSPLR 152
Query: 572 SMKSLTIAD 580
+++++ +A
Sbjct: 153 AIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 27/132 (20%), Positives = 55/132 (41%), Gaps = 7/132 (5%)
Query: 165 KYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFE 224
+ L N P ++ + L + L+ N ++ P L +L + L Y N
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVL-YGNKIT 93
Query: 225 GGIPREV-GKLVNLVHLDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQ-LGN 281
+P+ + L +L L L++ ++ + + +L L+ + L+ N L +I K
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSP 150
Query: 282 LTNLVNLDLSNN 293
L + + L+ N
Sbjct: 151 LRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 37/171 (21%), Positives = 66/171 (38%), Gaps = 33/171 (19%)
Query: 322 SIPDYLADLP-NLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQ 380
IP +LP + + L QN + P KL+ +DLS+N+++ + D
Sbjct: 25 EIP---TNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQG-- 78
Query: 381 LRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSNYL 439
L++ L + L N + +P F L L L L +N +
Sbjct: 79 ------LRS---------------LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKI 116
Query: 440 SGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQF 490
+ L + + + L L+L +N L + S ++Q + L+ N F
Sbjct: 117 N-CLRVD--AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 23/106 (21%), Positives = 39/106 (36%), Gaps = 9/106 (8%)
Query: 75 LTDLNLCG----SVPAQIL-RLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQF 126
L ++L + L L +L L GN T + L SLQ L ++ N+
Sbjct: 58 LRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKI 116
Query: 127 SGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGN 172
+ + L NL + Y+N + L ++ + L N
Sbjct: 117 NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 2e-10
Identities = 104/679 (15%), Positives = 184/679 (27%), Gaps = 214/679 (31%)
Query: 296 TGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTG-VIPENLGQN 354
TGE Y + ++ L ++ + + + ++ + I +
Sbjct: 11 TGEHQYQYKDI------------LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSK 58
Query: 355 GKLQVLDLSSNKLTGTIPTDLCSSNQLRIL------ILLKN--FLFGPI------PERLG 400
+ L T L S + ++ +L N FL PI P +
Sbjct: 59 DAVSGTLR----LFWT----LLSKQE-EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMT 109
Query: 401 ACYSLTRVRLGQNYLNGSIPDGFIYLPGL------NLAELQSN-YLS-----GSLPENGN 448
Y R RL + N + L EL+ + GS G
Sbjct: 110 RMYIEQRDRLYND--NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS----GK 163
Query: 449 SSSNPDRLGQLNLSNNLLSGPLPF-----SLSNFSS-------LQILLL-------SGNQ 489
+ + + + + F +L N +S LQ LL S +
Sbjct: 164 TW-----VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218
Query: 490 FSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNV 549
S I I ++ L+ L Y N L L + N
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKP----------YENCLLVLL------------NVQNA 256
Query: 550 RILNYLNL-------SRNHLNQNIPKSIG-SMKSLTIADFSFNDFSGKLPESGQFTVFNA 601
+ N NL +R K + + + T S + S L ++
Sbjct: 257 KAWNAFNLSCKILLTTRF-------KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL-- 307
Query: 602 SSFAGNPQLCGTLLNNPCNVAPITHQPGKAPGDFKLIFALGLLICSLIFATAAIIKAKSF 661
+ L P S+I A I+
Sbjct: 308 LKYLDCR--PQDLPREVLTTNP--------------------RRLSII---AESIR--DG 340
Query: 662 KKTGSDSWKMTAFQKLEFSVSDILECVKDG--------------NV-IGRGGAGIVYHGK 706
T D+WK KL + L ++ + I +++
Sbjct: 341 LAT-WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV 399
Query: 707 MPNGVEIAVKKLLGF---------GTHS-HDHGFRAEIQTLGNIR-HRNIVR----LLAF 751
+ + V + V KL + T S +++ HR+IV F
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF 459
Query: 752 CSNKETNLLV----YEY----MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH 803
S+ + Y + ++N E + + FL + R+ +E K + H
Sbjct: 460 DSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL--DFRF---LE-QK----IRH 509
Query: 804 DCSPLIVH-------RDVK--SNNILLNSA-FEAHVADFGLAKFLIDGGA----SECMS- 848
D + + +K I N +E V + FL S+
Sbjct: 510 DSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNA--ILDFLPKIEENLICSKYTDL 567
Query: 849 ---AIAGSYGYIAPEYAYT 864
A+ I E A+
Sbjct: 568 LRIALMAEDEAIFEE-AHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 8e-09
Identities = 73/454 (16%), Positives = 135/454 (29%), Gaps = 121/454 (26%)
Query: 209 LTNLR-EIYLGYYNVFEGGIPREVGK--LVNLVHLDLS-SCELDGQIPHEIGNLKLLDTV 264
L LR + V G GK + V L C++D +I + NLK ++
Sbjct: 144 LLELRPAKNVLIDGV--LGS----GKTWVALDVCLSYKVQCKMDFKI-FWL-NLKNCNS- 194
Query: 265 FLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIP 324
++ + L L ++ + ++ + I+ Q +L L ++ +
Sbjct: 195 -------PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY---E 244
Query: 325 DYLADLPNLETLGLWQ----------------------NNFTGVIPENLGQNG--KLQVL 360
+ L L N++ W T I + +V
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK 304
Query: 361 DLSSNKLTGTIPTDL----CSSNQLRI-LI--LLKNFLFGPIPERLG-----ACYSLTRV 408
L L P DL ++N R+ +I +++ C LT +
Sbjct: 305 SLLLKYL-DCRPQDLPREVLTTNPRRLSIIAESIRDG-----LATWDNWKHVNCDKLTTI 358
Query: 409 RLGQNYLNGSIPDGFIYLPGLNLAELQSNYLS-GSLPENGN-------------SSSNPD 454
++ LN L AE + + P + + S+
Sbjct: 359 I--ESSLN-----------VLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM 405
Query: 455 RLGQLNLSNNLLSG-PLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKL----DL 509
+ +L+ P ++S S+ + L + + SI + + K DL
Sbjct: 406 VVVNKLHKYSLVEKQPKESTIS-IPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDL 464
Query: 510 SRNSLSGEIPPAIGYCNHLT--------------YLDMS--QNNLSGSIPPEISNVRILN 553
L IG+ HL +LD + + ++ ILN
Sbjct: 465 IPPYLDQYFYSHIGH--HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN 522
Query: 554 YLN---LSRNHLNQNIPKSIGSMKSLTIADFSFN 584
L + ++ N PK I DF
Sbjct: 523 TLQQLKFYKPYICDNDPKY--ERLVNAILDFLPK 554
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 1e-06
Identities = 42/312 (13%), Positives = 80/312 (25%), Gaps = 115/312 (36%)
Query: 696 RGGAGIVYHGKMPNGVEIAVKKLLGFGTHS------HDHGFRAEIQ------TLGNIRHR 743
R ++ G + G G + + ++ L N
Sbjct: 148 RPAKNVLIDG-VL-----------GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSP 195
Query: 744 N--IVRLLAFCSNKETNLLVY-EYMRNGSLG-EALHGKKGAFLGWNLRYKIAIEAAKGLC 799
+ L + N ++ N L ++ + L Y+
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK-PYENC-------- 246
Query: 800 YLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAP 859
L+V +V++ +AF + C
Sbjct: 247 --------LLVLLNVQNAKAW--NAF-----NLS------------C------------- 266
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLTGR-RPVGDFGDG-----VDIVQWSKRATNGRKEE 913
++ LLT R + V DF + + S T +
Sbjct: 267 ------KI---------------LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 914 -FLSILDPRLSMVPKE-EAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSD-FNQ 970
L LD R +P+E + +++ I E +R+ + + + D
Sbjct: 306 LLLKYLDCRPQDLPREVLTTNPRRLSI--IAE------SIRDGLATWDNWKHVNCDKLTT 357
Query: 971 SSSSSLKNLEKD 982
SSL LE
Sbjct: 358 IIESSLNVLEPA 369
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 21/165 (12%)
Query: 733 EIQTLGNIRHR------NIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNL 786
EI+ L ++R + N++ +L + + + +E + +L E + KK F G++L
Sbjct: 143 EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELI--KKNKFQGFSL 199
Query: 787 RY--KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH--VADFGLAKFLIDGG 842
K A + L LH I+H D+K NILL + V DFG + +
Sbjct: 200 PLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---- 252
Query: 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGR 887
+ + S Y APE R D++S G +L ELLTG
Sbjct: 253 -HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 39/168 (23%), Positives = 60/168 (35%), Gaps = 26/168 (15%)
Query: 58 CSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG---NLS 114
C + CS + L +P I + L L N FT G L
Sbjct: 11 CEGTTVDCS-----NQKLN------KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLP 57
Query: 115 SLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGIL-KLEKLKYLDLGGNY 173
L+ +N SNN+ + + + + +N + + LE LK L L N
Sbjct: 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENV-QHKMFKGLESLKTLMLRSN- 115
Query: 174 FFGKI----PNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYL 217
+I +S+ L + LSL N +T PG L +L + L
Sbjct: 116 ---RITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNL 160
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 30/141 (21%), Positives = 55/141 (39%), Gaps = 7/141 (4%)
Query: 226 GIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNL 285
IP+ +L L + + + E G I ++ L+ ++ N ++ + +
Sbjct: 29 HIPQYTAEL-RLNNNEFTVLEATG-IFKKLPQLRKIN---FSNNKITDIEEGAFEGASGV 83
Query: 286 VNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLAD-LPNLETLGLWQNNFT 344
+ L++N L F L LK L NR+ + + L ++ L L+ N T
Sbjct: 84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 345 GVIPENLGQNGKLQVLDLSSN 365
V P L L+L +N
Sbjct: 143 TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 27/133 (20%), Positives = 51/133 (38%), Gaps = 8/133 (6%)
Query: 167 LDLGGNYFFGKIPNSY-GELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEG 225
L L N F +L L ++ + N +T G + + EI L N E
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILL-TSNRLE- 94
Query: 226 GIPREV-GKLVNLVHLDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLSGSIPKQ-LGNL 282
+ ++ L +L L L S + + ++ L + + L+ N ++ ++ L
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTL 152
Query: 283 TNLVNLDLSNNAL 295
+L L+L N
Sbjct: 153 HSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 20/124 (16%), Positives = 45/124 (36%), Gaps = 9/124 (7%)
Query: 459 LNLSNNLLSGPLPFSL-SNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSRNSLSG 516
L L+NN + + L+ + S N+ + I V ++ L+ N L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLE- 94
Query: 517 EIPPAI-GYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHLNQNIPKSI-GSM 573
+ + L L + N ++ + + + + L+L N + + ++
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI-TTVAPGAFDTL 152
Query: 574 KSLT 577
SL+
Sbjct: 153 HSLS 156
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 25/114 (21%), Positives = 46/114 (40%), Gaps = 6/114 (5%)
Query: 262 DTVFLHINLLSGSIPK-QLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLH 320
+ L+ N + L L ++ SNN +T +F + L NRL
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 321 GSIPDYLAD-LPNLETLGLWQNNFTGVIPENLGQN-GKLQVLDLSSNKLTGTIP 372
++ + L +L+TL L N T + + +++L L N++T T+
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVA 145
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 38/149 (25%), Positives = 60/149 (40%), Gaps = 14/149 (9%)
Query: 347 IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSS-NQLRILILLKNFLFGPIPERLGACYSL 405
IPE++ Q L L++N+ T T + QLR + N + I E GA
Sbjct: 26 IPEHIPQY--TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEE--GAFEGA 80
Query: 406 TRVR---LGQNYLNGSIPDG-FIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNL 461
+ V L N L ++ F L L L+SN ++ + + S + L+L
Sbjct: 81 SGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGND--SFIGLSSVRLLSL 136
Query: 462 SNNLLSGPLPFSLSNFSSLQILLLSGNQF 490
+N ++ P + SL L L N F
Sbjct: 137 YDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 56/271 (20%), Positives = 92/271 (33%), Gaps = 17/271 (6%)
Query: 55 SSVC-SWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNL 113
S VC W + +LDLT NL V ++L + E +
Sbjct: 33 SGVCKRWYRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP 92
Query: 114 SSLQFLNISNNQFS-GGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGN 172
+Q +++SN+ L S L+ + + + K L L+L G
Sbjct: 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 152
Query: 173 YFFG-----KIPNSYGELQGLEYLSLAG-NDLTGKIPGEL--GNLTNLREIYLGYY--NV 222
F + +S L+ L+L+ D T K + ++ L Y N+
Sbjct: 153 SGFSEFALQTLLSS---CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL 209
Query: 223 FEGGIPREVGKLVNLVHLDLSSCE-LDGQIPHEIGNLKLLDTVFL-HINLLSGSIPKQLG 280
+ + V + NLVHLDLS L E L L + L + +LG
Sbjct: 210 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 269
Query: 281 NLTNLVNLDLSNNALTGEIPYSFINLRQLKL 311
+ L L + G + L L++
Sbjct: 270 EIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 31/189 (16%), Positives = 58/189 (30%), Gaps = 10/189 (5%)
Query: 209 LTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLH- 267
++ + L + + + + L +L L L I + + L + L
Sbjct: 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 151
Query: 268 -INLLSGSIPKQLGNLTNLVNLDLS------NNALTGEIPYSFINLRQLKLFNLFMNRLH 320
++ L + + L L+LS + + + + QL L N
Sbjct: 152 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK 211
Query: 321 GSIPDYLADLPNLETLGL-WQNNFTGVIPENLGQNGKLQVLDLSS-NKLTGTIPTDLCSS 378
+ + PNL L L + Q LQ L LS + +L
Sbjct: 212 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 271
Query: 379 NQLRILILL 387
L+ L +
Sbjct: 272 PTLKTLQVF 280
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 44/143 (30%), Positives = 59/143 (41%), Gaps = 17/143 (11%)
Query: 83 SVPAQILRLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQF----SGGLDWNYS 135
SVPA I L L N T +E G +L +L+ L + +NQ G D
Sbjct: 33 SVPAGIP--TNAQILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLGALPVGVFD---- 85
Query: 136 SLVNLEVFDAYNNNFTALLPVGIL-KLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLA 194
SL L V D N T LP + +L LK L + N ++P L L +L+L
Sbjct: 86 SLTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNK-LTELPRGIERLTHLTHLALD 143
Query: 195 GNDLTGKIPGELGNLTNLREIYL 217
N L G L++L YL
Sbjct: 144 QNQLKSIPHGAFDRLSSLTHAYL 166
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 38/133 (28%), Positives = 54/133 (40%), Gaps = 4/133 (3%)
Query: 138 VNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGND 197
N ++ ++N T L P L LK L LG N + L L L L N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99
Query: 198 LTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEI-G 256
LT L +L+E+++ N +PR + +L +L HL L +L IPH
Sbjct: 100 LTVLPSAVFDRLVHLKELFM-CCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFD 156
Query: 257 NLKLLDTVFLHIN 269
L L +L N
Sbjct: 157 RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 37/138 (26%), Positives = 53/138 (38%), Gaps = 20/138 (14%)
Query: 165 KYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYN--- 221
+ L L N P + L L+ L L N L G +LT L + L N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDL-GTNQLT 101
Query: 222 -----VFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIP 276
VF+ +LV+L L + +L ++P I L L + L N L SIP
Sbjct: 102 VLPSAVFD--------RLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIP 151
Query: 277 KQ-LGNLTNLVNLDLSNN 293
L++L + L N
Sbjct: 152 HGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 43/136 (31%), Positives = 57/136 (41%), Gaps = 11/136 (8%)
Query: 283 TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLAD-LPNLETLGLWQN 341
TN L L +N +T P F +L LK L N+L ++P + D L L L L N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 342 NFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPE---- 397
T + + L+ L + NKLT +P + L L L +N L IP
Sbjct: 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL-KSIPHGAFD 156
Query: 398 RLGACYSLTRVRLGQN 413
RL SLT L N
Sbjct: 157 RLS---SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 31/103 (30%), Positives = 48/103 (46%), Gaps = 3/103 (2%)
Query: 266 LHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPD 325
LH N ++ P +L NL L L +N L F +L QL + +L N+L +P
Sbjct: 47 LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLPS 105
Query: 326 YLAD-LPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKL 367
+ D L +L+ L + N T +P + + L L L N+L
Sbjct: 106 AVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 37/122 (30%), Positives = 57/122 (46%), Gaps = 7/122 (5%)
Query: 459 LNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSRNSLSGE 517
L L +N ++ P + +L+ L L NQ +P + L Q+ LDL N L+
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 518 IPPAI-GYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSI-GSMKS 575
+P A+ HL L M N L+ +P I + L +L L +N L ++IP + S
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL-KSIPHGAFDRLSS 160
Query: 576 LT 577
LT
Sbjct: 161 LT 162
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 31/102 (30%), Positives = 41/102 (40%), Gaps = 7/102 (6%)
Query: 77 DLNLCGSVPAQIL----RLDKLTNLSLAGNNFTGSIE-IGNLSSLQFLNISNNQFSGGLD 131
L+ C S +I L LSL S+ + L L+ L +S N+ GGLD
Sbjct: 30 VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRIFGGLD 88
Query: 132 WNYSSLVNLEVFDAYNNNFTALLPVGILK-LEKLKYLDLGGN 172
L NL + N + + LK LE LK LDL
Sbjct: 89 MLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 33/127 (25%), Positives = 51/127 (40%), Gaps = 6/127 (4%)
Query: 246 ELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGN---LTNLVNLDLSNNALTGEIPYS 302
++ +I E+ N L ++ + K G NL L L N L + +
Sbjct: 9 DMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-N 66
Query: 303 FINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGV-IPENLGQNGKLQVLD 361
L +LK L NR+ G + LPNL L L N + E L + L+ LD
Sbjct: 67 LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126
Query: 362 LSSNKLT 368
L + ++T
Sbjct: 127 LFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 6e-07
Identities = 43/156 (27%), Positives = 57/156 (36%), Gaps = 30/156 (19%)
Query: 159 LKLEKLKYLDLGGNYF-FGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYL 217
++ L L GKI E LE+LSL L + L L L+++ L
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLEL 78
Query: 218 GYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPK 277
N GG+ KL NL HL+LS LK + T+ +
Sbjct: 79 -SENRIFGGLDMLAEKLPNLTHLNLSGN-----------KLKDISTL------------E 114
Query: 278 QLGNLTNLVNLDLSNNALTGEIPYS---FINLRQLK 310
L L L +LDL N +T Y F L QL
Sbjct: 115 PLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLT 150
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 36/148 (24%), Positives = 52/148 (35%), Gaps = 29/148 (19%)
Query: 197 DLTGKIPGELG--NLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHE 254
D+ +I EL +RE+ L +G I + VNL L L + L
Sbjct: 9 DMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----S 63
Query: 255 IGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNL 314
+ NL L L L+LS N + G + L L NL
Sbjct: 64 VSNLP---------------------KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102
Query: 315 FMNRLHG-SIPDYLADLPNLETLGLWQN 341
N+L S + L L L++L L+
Sbjct: 103 SGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 32/111 (28%), Positives = 43/111 (38%), Gaps = 7/111 (6%)
Query: 305 NLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSS 364
+R+L L N N G I A+ NLE L L V NL + KL+ L+LS
Sbjct: 25 AVRELVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80
Query: 365 NKLTGTIPTDLCSSNQLRILILLKNFL--FGPIPERLGACYSLTRVRLGQN 413
N++ G + L L L N L + E L L + L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 29/108 (26%), Positives = 50/108 (46%), Gaps = 4/108 (3%)
Query: 112 NLSSLQFLNISNNQFS-GGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLG 170
++++ L + N + + G ++ + VNLE N ++ + KL KLK L+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 171 GNYFFGKIPNSYGELQGLEYLSLAGNDLTG-KIPGELGNLTNLREIYL 217
N FG + +L L +L+L+GN L L L L+ + L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDL 127
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 29/112 (25%), Positives = 42/112 (37%), Gaps = 6/112 (5%)
Query: 281 NLTNLVNLDLSNNALT-GEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLW 339
+ L L N G+I L+ +L L S+ + L LP L+ L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 340 QNNFTGVIPENLGQNGKLQVLDLSSNKLT--GTIPTDLCSSNQLRILILLKN 389
+N G + + L L+LS NKL T+ L L+ L L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 31/136 (22%), Positives = 57/136 (41%), Gaps = 9/136 (6%)
Query: 452 NPDRLGQLNLSNNLLS-GPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLS 510
P + +L L N + G + + F +L+ L L ++ +L ++ KL+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELS 79
Query: 511 RNSLSGEIPPAIGYCNHLTYLDMSQNNLS--GSIPPEISNVRILNYLNLSRN---HLNQN 565
N + G + +LT+L++S N L ++ P + + L L+L +LN
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVTNLNDY 138
Query: 566 IPKSIGSMKSLTIADF 581
+ LT D
Sbjct: 139 RESVFKLLPQLTYLDG 154
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 48/155 (30%), Positives = 64/155 (41%), Gaps = 16/155 (10%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQF-- 126
LDL L A L KLT L+L N ++ G +L+ L L ++NNQ
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS 97
Query: 127 --SGGLDWNYSSLVNLEVFDAYNNNFTALLPVGIL-KLEKLKYLDLGGNYFFGKIPNS-Y 182
G D L L+ N + LP G+ +L KLK L L N IP +
Sbjct: 98 LPLGVFD----HLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQ-LQSIPAGAF 151
Query: 183 GELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYL 217
+L L+ LSL+ N L G L L+ I L
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL 186
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 51/183 (27%), Positives = 73/183 (39%), Gaps = 24/183 (13%)
Query: 283 TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLAD-LPNLETLGLWQN 341
+ LDL + L +F L +L NL N+L ++ + D L L TLGL N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANN 93
Query: 342 NFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSS-NQLRILILLKNFLFGPIPE--- 397
+ +L L L N+L ++P+ + +L+ L L N L IP
Sbjct: 94 QLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAF 151
Query: 398 -RLGACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSN----------YLSGSLPE 445
+L +L + L N L S+P G F L L L N YLS + E
Sbjct: 152 DKLT---NLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQWIRE 207
Query: 446 NGN 448
N N
Sbjct: 208 NSN 210
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 50/177 (28%), Positives = 68/177 (38%), Gaps = 23/177 (12%)
Query: 165 KYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYN--- 221
+ LDL ++ L L +L+L N L G +LT L + L N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL-ANNQLA 96
Query: 222 VFEGGIPREVGKLVNLVHLDLSSCELDGQIPH----EIGNLKLLDTVFLHINLLSGSIPK 277
G+ L L L L +L +P + LK L L+ N L SIP
Sbjct: 97 SLPLGVF---DHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELR---LNTNQLQ-SIPA 148
Query: 278 QLG---NLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPD--YLAD 329
G LTNL L LS N L +F L +L+ LF N+ S + YL+
Sbjct: 149 --GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQ 203
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 30/110 (27%), Positives = 44/110 (40%), Gaps = 17/110 (15%)
Query: 75 LTDLNLCG----SVPAQIL-RLDKLTNLSLAGNNFTGSIEIG---NLSSLQFLNISNNQF 126
L L L S+P + L +L L L GN S+ G L+ L+ L ++ NQ
Sbjct: 85 LGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143
Query: 127 S----GGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGN 172
G D L NL+ N ++ +L KL+ + L GN
Sbjct: 144 QSIPAGAFD----KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 28/113 (24%), Positives = 50/113 (44%), Gaps = 7/113 (6%)
Query: 458 QLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI-GELRQVLKLDLSRNSLSG 516
+L+L + L+ + + L L L NQ + + +L ++ L L+ N L+
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA- 96
Query: 517 EIPPAI-GYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHLNQNIP 567
+P + + L L + N L S+P + + L L L+ N L Q+IP
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIP 147
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 33/178 (18%)
Query: 733 EIQTLGNIR-----------HRNIVRLL---AFCSNKETNL-LVYEYMRNGSLGEALHGK 777
EI+ L + +I++LL ++ +V+E + +L + K
Sbjct: 65 EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALI--K 121
Query: 778 KGAFLGWNLRY--KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH------V 829
K G L Y +I+ + GL Y+H C I+H D+K N+L+ +
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKI 179
Query: 830 ADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGR 887
AD G A + E + + Y +PE +D++S ++ EL+TG
Sbjct: 180 ADLGNACW-----YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 48/208 (23%), Positives = 85/208 (40%), Gaps = 24/208 (11%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHR------N 744
++IG+G G V +A+K ++ + + E++ L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQA-QIEVRLLELMNKHDTEMKYY 117
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRY--KIAIEAAKGLCYLH 802
IV L + LV+E + +L + L + F G +L K A + L +L
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSY-NLYDLL--RNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 803 -HDCSPLIVHRDVKSNNILLNSAFEAH--VADFGLAKFLIDGGASECMSAIAGSYGYIAP 859
+ S I+H D+K NILL + + + DFG + + + S Y +P
Sbjct: 175 TPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSSCQ-----LGQRIYQYIQSRFYRSP 227
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLTGR 887
E + D D++S G +L+E+ TG
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 28/85 (32%), Positives = 39/85 (45%), Gaps = 3/85 (3%)
Query: 90 RLDKLTNLSLAGNNFTGSIE-IGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNN 148
++L LS T SI + L+ L+ L +S+N+ SGGL+ NL + N
Sbjct: 40 EFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98
Query: 149 NFTALLPVGILK-LEKLKYLDLGGN 172
L + LK LE LK LDL
Sbjct: 99 KIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-08
Identities = 33/124 (26%), Positives = 48/124 (38%), Gaps = 8/124 (6%)
Query: 246 ELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFIN 305
EL + P ++ L L + N G + L L N LT I +
Sbjct: 10 ELRNRTPSDVKELVLDN---SRSNE--GKLEGLTDEFEELEFLSTINVGLT-SIA-NLPK 62
Query: 306 LRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGV-IPENLGQNGKLQVLDLSS 364
L +LK L NR+ G + PNL L L N + E L + L+ LDL +
Sbjct: 63 LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFN 122
Query: 365 NKLT 368
++T
Sbjct: 123 CEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 28/135 (20%), Positives = 47/135 (34%), Gaps = 27/135 (20%)
Query: 208 NLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLH 267
++++E+ L EG + + L L + L I NL
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLP-------- 61
Query: 268 INLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG-SIPDY 326
L L L+LS+N ++G + L NL N++ S +
Sbjct: 62 -------------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP 108
Query: 327 LADLPNLETLGLWQN 341
L L NL++L L+
Sbjct: 109 LKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 26/110 (23%), Positives = 43/110 (39%), Gaps = 5/110 (4%)
Query: 305 NLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSS 364
++++L L N N G + + LE L T + NL + KL+ L+LS
Sbjct: 18 DVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSD 73
Query: 365 NKLTGTIPTDLCSSNQLRILILLKNFLFGP-IPERLGACYSLTRVRLGQN 413
N+++G + L L L N + E L +L + L
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 43/155 (27%), Positives = 59/155 (38%), Gaps = 30/155 (19%)
Query: 160 KLEKLKYLDLGGNYF-FGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLG 218
+K L L + GK+ E + LE+LS LT I L L L+++ L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLEL- 71
Query: 219 YYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQ 278
N GG+ K NL HL+LS + I +L ++
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNK--------IKDLSTIEP--------------- 108
Query: 279 LGNLTNLVNLDLSNNALTGEIPYS---FINLRQLK 310
L L NL +LDL N +T Y F L QL
Sbjct: 109 LKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLT 143
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 25/111 (22%), Positives = 43/111 (38%), Gaps = 4/111 (3%)
Query: 281 NLTNLVNLDLSNNALT-GEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLW 339
+++ L L N+ G++ +L+ + L SI + L L L+ L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 340 QNNFTGVIPENLGQNGKLQVLDLSSNKLTG-TIPTDLCSSNQLRILILLKN 389
N +G + + L L+LS NK+ + L L+ L L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 28/108 (25%), Positives = 47/108 (43%), Gaps = 4/108 (3%)
Query: 112 NLSSLQFLNISNNQFS-GGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLG 170
S ++ L + N++ + G L+ LE N T++ + KL KLK L+L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 171 GNYFFGKIPNSYGELQGLEYLSLAGNDLTG-KIPGELGNLTNLREIYL 217
N G + + L +L+L+GN + L L NL+ + L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDL 120
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 23/111 (20%), Positives = 47/111 (42%), Gaps = 4/111 (3%)
Query: 476 NFSSLQILLLSGNQFS-GPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMS 534
S ++ L+L ++ + G + E ++ L L+ I + N L L++S
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 535 QNNLSGSIPPEISNVRILNYLNLSRNHL-NQNIPKSIGSMKSLTIADFSFN 584
N +SG + L +LNLS N + + + + + +++L D
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 29/114 (25%), Positives = 48/114 (42%), Gaps = 10/114 (8%)
Query: 452 NPDRLGQLNLSNN-LLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIG---ELRQVLKL 507
P + +L L N+ G L F L+ L + SI +L ++ KL
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKL 69
Query: 508 DLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSG-SIPPEISNVRILNYLNLSRN 560
+LS N +SG + C +LT+L++S N + S + + L L+L
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 8/111 (7%)
Query: 160 KLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGY 219
+ E+L++L I N +L L+ L L+ N ++G + NL + L
Sbjct: 40 EFEELEFLSTINVGL-TSIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97
Query: 220 YNVFEGGIPREVGKLVNLVHLDLSSCELDGQ------IPHEIGNLKLLDTV 264
+ + + KL NL LDL +CE+ + + L LD
Sbjct: 98 NKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 24/112 (21%), Positives = 45/112 (40%), Gaps = 11/112 (9%)
Query: 430 NLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSS---LQILLLS 486
++ EL + + + + + L L+ N L+ S++N L+ L LS
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKLELS 72
Query: 487 GNQFSGPIPPSIGELRQVLKLDLSRNSLS--GEIPPAIGYCNHLTYLDMSQN 536
N+ SG + + + L+LS N + I P + +L LD+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNC 123
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 39/120 (32%), Positives = 57/120 (47%), Gaps = 17/120 (14%)
Query: 251 IPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLK 310
IP ++ L +L N + +PK+L N +L +DLSNN ++ SF N+ QL
Sbjct: 29 IPRDVTEL------YLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 311 LFNLFMNRLHGSIPDYLAD-LPNLETLGLWQNNFTGVIPE----NLGQNGKLQVLDLSSN 365
L NRL IP D L +L L L N+ + V+PE +L L L + +N
Sbjct: 82 TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDL---SALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 25/107 (23%), Positives = 40/107 (37%), Gaps = 6/107 (5%)
Query: 165 KYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFE 224
L L GN F +P + L + L+ N ++ N+T L + L YN
Sbjct: 34 TELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLIL-SYNRLR 91
Query: 225 GGIPREV-GKLVNLVHLDLSSCELDGQIPHEI-GNLKLLDTVFLHIN 269
IP L +L L L ++ +P +L L + + N
Sbjct: 92 -CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 29/134 (21%), Positives = 50/134 (37%), Gaps = 26/134 (19%)
Query: 58 CSWAGICCSRDRVAS-----------LDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTG 106
C + CS + L L D N VP ++ LT + L+ N +
Sbjct: 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYL-DGNQFTLVPKELSNYKHLTLIDLSNNRIS- 67
Query: 107 SIEIG---NLSSLQFLNISNNQFS----GGLDWNYSSLVNLEVFDAYNNNFTALLPVGIL 159
++ N++ L L +S N+ D L +L + + N+ + +P G
Sbjct: 68 TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFD----GLKSLRLLSLHGNDISV-VPEGAF 122
Query: 160 -KLEKLKYLDLGGN 172
L L +L +G N
Sbjct: 123 NDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 26/141 (18%)
Query: 317 NRLHGSIPDYLADLP-NLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDL 375
N+ +P +P ++ L L N FT ++P+ L L ++DLS+N+++ T+
Sbjct: 19 NKGLKVLP---KGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQS 73
Query: 376 CSS-NQLRILILLKNFLFGPIPE----RLGACYSLTRVRLGQNYLNGSIPDG-FIYLPGL 429
S+ QL LIL N L IP L SL + L N ++ +P+G F L L
Sbjct: 74 FSNMTQLLTLILSYNRL-RCIPPRTFDGLK---SLRLLSLHGNDIS-VVPEGAFNDLSAL 128
Query: 430 NLAELQSN---------YLSG 441
+ + +N +LS
Sbjct: 129 SHLAIGANPLYCDCNMQWLSD 149
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 34/146 (23%), Positives = 60/146 (41%), Gaps = 11/146 (7%)
Query: 245 CELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFI 304
E + E ++L I + + L L +L LS N + +I S
Sbjct: 15 EERKSVVATEAEKVEL----HGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KIS-SLS 67
Query: 305 NLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSS 364
+ L++ +L N + I + A LE L + N + + + L+VL +S+
Sbjct: 68 GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSN 124
Query: 365 NKLTGTIPTD-LCSSNQLRILILLKN 389
NK+T D L + ++L L+L N
Sbjct: 125 NKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 37/183 (20%), Positives = 60/183 (32%), Gaps = 44/183 (24%)
Query: 191 LSLAGNDLTGKIPGELGNLTNLREIYLGYYN--VFEGGIPREVGKLVNLVHLDLSSCELD 248
L + K+ L L + + L N + + NL L L +
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLIK 83
Query: 249 GQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQ 308
+I + L+ +++ N ++ S+ + L NL L +SNN +T N +
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT--------NWGE 132
Query: 309 LKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNG----------KLQ 358
+ D LA L LE L L N EN + L+
Sbjct: 133 I---------------DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177
Query: 359 VLD 361
LD
Sbjct: 178 KLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 31/151 (20%), Positives = 54/151 (35%), Gaps = 7/151 (4%)
Query: 237 LVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALT 296
V L ++ + + LK + L N + I L + NL L L N +
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK 83
Query: 297 GEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIP-ENLGQNG 355
+I L+ + N++ S+ + L NL L + N T + L
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALD 140
Query: 356 KLQVLDLSSNKLTGTIPTDLCSSNQLRILIL 386
KL+ L L+ N L + +S ++
Sbjct: 141 KLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 43/176 (24%), Positives = 66/176 (37%), Gaps = 36/176 (20%)
Query: 65 CSRDRVASLDLTDLNLCGSVPAQILRLD-------KLTNLSLAGNNFTGSIE-IGNLSSL 116
R V + + + L G +P I ++D +L+L+ NN I + + +L
Sbjct: 15 EERKSVVATEAEKVELHGMIP-PIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENL 72
Query: 117 QFLNISNNQFS--GGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYF 174
+ L++ N LD +L L N +L GI KL L+ L + N
Sbjct: 73 RILSLGRNLIKKIENLDAVADTLEEL---WISYNQIASLS--GIEKLVNLRVLYMSNN-- 125
Query: 175 FGKIPN-----SYGELQGLEYLSLAGNDLTGKIPGE----------LGNLTNLREI 215
KI N L LE L LAGN L + L NL+++
Sbjct: 126 --KITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 34/148 (22%), Positives = 62/148 (41%), Gaps = 16/148 (10%)
Query: 159 LKLEKLKYLDLGGNY-FFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYL 217
+ + + ++L G K+ + L+ ++L+L+ N++ KI L + NLR + L
Sbjct: 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSL 77
Query: 218 GYYNVFEGGIPREVGKLVNLVHLDLSS---CELDGQIPHEIGNLKLLDTVFLHINLLS-- 272
G + + I L L +S L G I L L +++ N ++
Sbjct: 78 GRNLIKK--IENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNW 130
Query: 273 GSIPKQLGNLTNLVNLDLSNNALTGEIP 300
G I +L L L +L L+ N L +
Sbjct: 131 GEI-DKLAALDKLEDLLLAGNPLYNDYK 157
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 25/144 (17%), Positives = 53/144 (36%), Gaps = 14/144 (9%)
Query: 445 ENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI---GEL 501
++ +++ +L+ + + +LS + + L LS N I +
Sbjct: 17 RKSVVATEAEKV-ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGM 69
Query: 502 RQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNH 561
+ L L RN + +I + L L +S N ++ S+ I + L L +S N
Sbjct: 70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNK 126
Query: 562 LNQ-NIPKSIGSMKSLTIADFSFN 584
+ + ++ L + N
Sbjct: 127 ITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 23/106 (21%), Positives = 42/106 (39%), Gaps = 7/106 (6%)
Query: 73 LDLTDLNLCGSVPAQI----LRLDKLTNLSLAGNNFTGSIE-IGNLSSLQFLNISNNQFS 127
+ +L+L G I LD+ + + N ++ L L+ L ++NN+
Sbjct: 19 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRIC 77
Query: 128 GGLDWNYSSLVNLEVFDAYNNNFTALLPVGILK-LEKLKYLDLGGN 172
+ +L +L NN+ L + L L+ L YL + N
Sbjct: 78 RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 27/114 (23%), Positives = 39/114 (34%), Gaps = 6/114 (5%)
Query: 278 QLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLG 337
Q N LDL + I L Q + N + + D L L+TL
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70
Query: 338 LWQNNFTGVIPENLGQNGKLQVLDLSSNKLT--GTIPTDLCSSNQLRILILLKN 389
+ N + L L L++N L G + L S L L +L+N
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 22/128 (17%), Positives = 51/128 (39%), Gaps = 8/128 (6%)
Query: 288 LDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVI 347
+ L+ + + + N + + +L ++ I + A L + + N +
Sbjct: 2 VKLTAELIE-QAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL- 57
Query: 348 PENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFL--FGPIPERLGACYSL 405
+ +L+ L +++N++ + L LIL N L G + + L + SL
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSL 115
Query: 406 TRVRLGQN 413
T + + +N
Sbjct: 116 TYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 25/113 (22%), Positives = 41/113 (36%), Gaps = 4/113 (3%)
Query: 257 NLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFM 316
N + L + I L +D S+N + ++ F LR+LK +
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNN 73
Query: 317 NRLHGSIPDYLADLPNLETLGLWQNNFTGV-IPENLGQNGKLQVLDLSSNKLT 368
NR+ LP+L L L N+ + + L L L + N +T
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 35/152 (23%), Positives = 51/152 (33%), Gaps = 34/152 (22%)
Query: 196 NDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCE---LDGQIP 252
+L + N RE+ L Y + I L +D S E LDG
Sbjct: 6 AELIEQAAQ-YTNAVRDRELDLRGYKIPV--IENLGATLDQFDAIDFSDNEIRKLDG--- 59
Query: 253 HEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLF 312
L+ L T+ ++ N + L +L L L+NN+L L L
Sbjct: 60 --FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV--------ELGDL--- 106
Query: 313 NLFMNRLHGSIPDYLADLPNLETLGLWQNNFT 344
D LA L +L L + +N T
Sbjct: 107 ------------DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 23/124 (18%), Positives = 40/124 (32%), Gaps = 8/124 (6%)
Query: 97 LSLAGNNFTGSIEIGNLSSLQFLNISNNQFS--GGLDWNYSSLVNLEVFDAYNNNFTALL 154
+ L + + N + L++ + L ++L + D +N L
Sbjct: 2 VKLTAELIEQAAQYTNAVRDRELDLRGYKIPVIENLG---ATLDQFDAIDFSDNEIRKL- 57
Query: 155 PVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTG-KIPGELGNLTNLR 213
G L +LK L + N L L L L N L L +L +L
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 214 EIYL 217
+ +
Sbjct: 117 YLCI 120
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 27/131 (20%), Positives = 44/131 (33%), Gaps = 14/131 (10%)
Query: 459 LNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLK----LDLSRNSL 514
+ L+ L+ +N + L L G + P I L L +D S N +
Sbjct: 2 VKLTAELIEQAA--QYTNAVRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNEI 54
Query: 515 SGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHL-NQNIPKSIGSM 573
++ L L ++ N + + L L L+ N L + S+
Sbjct: 55 R-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASL 112
Query: 574 KSLTIADFSFN 584
KSLT N
Sbjct: 113 KSLTYLCILRN 123
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 22/124 (17%), Positives = 35/124 (28%), Gaps = 24/124 (19%)
Query: 268 INLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYL 327
+ L NL L + N + L
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLE-----------------------LRDL 52
Query: 328 ADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILL 387
L L L + ++ V P+ +L L+LS N L ++ L+ L+L
Sbjct: 53 RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLS 111
Query: 388 KNFL 391
N L
Sbjct: 112 GNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 20/95 (21%), Positives = 34/95 (35%), Gaps = 2/95 (2%)
Query: 251 IPHEIGNLKLLDTVFLHINLLSGSIPKQ-LGNLTNLVNLDLSNNALTGEIPYSFINLRQL 309
H + + L +++ + + L L L NL + + L P +F +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 310 KLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFT 344
NL N L S+ +L+ L L N
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 3e-06
Identities = 20/122 (16%), Positives = 32/122 (26%), Gaps = 23/122 (18%)
Query: 64 CCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE---IGNLSSLQFLN 120
C L T + + LT L + +E + L L+ L
Sbjct: 6 CPHGSS--GLRCTRDGA-LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 121 ISNNQ--------FSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGN 172
I + F L + N + L ++ L+ L L GN
Sbjct: 63 IVKSGLRFVAPDAFHF--------TPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGN 113
Query: 173 YF 174
Sbjct: 114 PL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 16/95 (16%), Positives = 31/95 (32%), Gaps = 4/95 (4%)
Query: 494 IPPSIGELRQVLKLDLSRNSLSGEIPP-AIGYCNHLTYLDMSQNNLSGSIPPEI-SNVRI 551
+ + +L + + + L L + ++ L + P+
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 552 LNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDF 586
L+ LNLS N L +++ SL S N
Sbjct: 82 LSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 20/97 (20%), Positives = 32/97 (32%), Gaps = 5/97 (5%)
Query: 202 IPGELGNLTNLREIYLGYYNVFEGGIPREV-GKLVNLVHLDLSSCELDGQIPHEI-GNLK 259
L NL E+Y+ + + L L +L + L + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 260 LLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALT 296
L + L N L S+ + +L L LS N L
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 17/114 (14%), Positives = 32/114 (28%), Gaps = 4/114 (3%)
Query: 401 ACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLN 460
+ + +R ++ L +++ L L L
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELR--DLRGLGELRNLT 62
Query: 461 LSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSL 514
+ + L P + L L LS N + + + +L LS N L
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 16/103 (15%), Positives = 31/103 (30%), Gaps = 5/103 (4%)
Query: 512 NSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPE-ISNVRILNYLNLSRNHLNQNIPKSI 570
+ + + +LT L + + + + L L + ++ L P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 571 GSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFA--GNPQLC 611
L+ + SFN L + GNP C
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSW-KTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 16/91 (17%), Positives = 29/91 (31%), Gaps = 3/91 (3%)
Query: 155 PVGILKLEKLKYLDLGGNYFFGKIPN-SYGELQGLEYLSLAGNDLTGKIPGELGNLTNLR 213
+ E L L + + L L L++ + L P L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 214 EIYLGYYNVFEGGIPREVGKLVNLVHLDLSS 244
+ L +N E + + + ++L L LS
Sbjct: 84 RLNL-SFNALE-SLSWKTVQGLSLQELVLSG 112
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 41/147 (27%), Positives = 61/147 (41%), Gaps = 24/147 (16%)
Query: 83 SVPAQI------LRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQF----SGGLDW 132
SVP I L L+ + SL F L+SL L + N+ +G +
Sbjct: 21 SVPTGIPAQTTYLDLETNSLKSLPNGVFDE------LTSLTQLYLGGNKLQSLPNGVFN- 73
Query: 133 NYSSLVNLEVFDAYNNNFTALLPVGIL-KLEKLKYLDLGGNYFFGKIPN-SYGELQGLEY 190
L +L + N +L P G+ KL +LK L L N +P+ + +L L+
Sbjct: 74 ---KLTSLTYLNLSTNQLQSL-PNGVFDKLTQLKELALNTNQ-LQSLPDGVFDKLTQLKD 128
Query: 191 LSLAGNDLTGKIPGELGNLTNLREIYL 217
L L N L G LT+L+ I+L
Sbjct: 129 LRLYQNQLKSVPDGVFDRLTSLQYIWL 155
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 40/132 (30%), Positives = 56/132 (42%), Gaps = 7/132 (5%)
Query: 165 KYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFE 224
YLDL N + EL L L L GN L G LT+L + L N +
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL-STNQLQ 89
Query: 225 GGIPREV-GKLVNLVHLDLSSCELDGQIPHEI-GNLKLLDTVFLHINLLSGSIPK-QLGN 281
+P V KL L L L++ +L +P + L L + L+ N L S+P
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDR 146
Query: 282 LTNLVNLDLSNN 293
LT+L + L +N
Sbjct: 147 LTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 45/184 (24%), Positives = 69/184 (37%), Gaps = 38/184 (20%)
Query: 283 TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLAD-LPNLETLGLWQN 341
LDL N+L F L L L N+L S+P+ + + L +L L L N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 342 NFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGA 401
+ + +L+ L L++N+L ++P + F ++L
Sbjct: 87 QLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGV--------------F------DKLT- 124
Query: 402 CYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQSN----------YLSGSLPENGNSS 450
L +RL QN L S+PDG F L L L N YLS + ++
Sbjct: 125 --QLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWINKHSGVV 181
Query: 451 SNPD 454
N
Sbjct: 182 RNSA 185
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 33/107 (30%), Positives = 43/107 (40%), Gaps = 10/107 (9%)
Query: 266 LHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPD 325
L N L LT+L L L N L F L L NL N+L S+P+
Sbjct: 35 LETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPN 93
Query: 326 YLAD-LPNLETLGLWQNNFTGVIPE----NLGQNGKLQVLDLSSNKL 367
+ D L L+ L L N +P+ L Q L+ L L N+L
Sbjct: 94 GVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQ---LKDLRLYQNQL 136
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 24/209 (11%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH-RNIVRLLAF 751
IG G G +Y G + G E+A+K H E + ++ I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ---LHIESKIYKMMQGGVGIPTIRWC 73
Query: 752 CSNKETNLLVYEYMRNG-SLGEALHGKKGAFLGWNLR--YKIAIEAAKGLCYLHHDCSPL 808
+ + N++V E + G SL + + F +L+ +A + + Y+H S
Sbjct: 74 GAEGDYNVMVMELL--GPSLEDLFNFCSRKF---SLKTVLLLADQMISRIEYIH---SKN 125
Query: 809 IVHRDVKSNNILL---NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYA--Y 863
+HRDVK +N L+ ++ DFGLAK D + + YA
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 864 TLRVDEKS---DVYSFGVVLLELLTGRRP 889
T E+S D+ S G VL+ G P
Sbjct: 186 THLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 38/183 (20%), Positives = 66/183 (36%), Gaps = 42/183 (22%)
Query: 733 EIQTLGNIRHR------NIVRLLAF-------CSNKETNLLVYEYMRNGSLGEALHGKKG 779
EI L I+ + V + + C + +E + + E L K+
Sbjct: 66 EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC-------IAFELLGK-NTFEFL--KEN 115
Query: 780 AFLGWNLRY--KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837
F + L + +A + L +LH + + H D+K NIL ++ + + +
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCE 172
Query: 838 ----------LID-GGA---SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLEL 883
+ D G A E + I + Y PE L + DV+S G +L E
Sbjct: 173 EKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232
Query: 884 LTG 886
G
Sbjct: 233 YRG 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 30/181 (16%), Positives = 60/181 (33%), Gaps = 41/181 (22%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHG----------------FRAEI 734
G IG+GG G +Y M + + D+G +
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 735 QTLGNIRHRNIVRLLAF----CSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLR--- 787
+++ + + + K ++ + G L N +
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR-----FGSDLQ----KIYEANAKRFS 150
Query: 788 ----YKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN--SAFEAHVADFGLAKFLIDG 841
++++ L Y+H VH D+K++N+LLN + + ++ D+GLA
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 842 G 842
G
Sbjct: 208 G 208
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 40/160 (25%), Positives = 63/160 (39%), Gaps = 21/160 (13%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH-RNIVRL 748
G IG G G + GK + +A+K E + + I ++
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ---LHLEYRFYKQLGSGDGIPQV 70
Query: 749 LAFCSNKETNLLVYEYMRNG-SLGEALHGKKGAFLGWNLR--YKIAIEAAKGLCYLHHDC 805
F + N +V E + G SL + F +L+ IAI+ + Y+H
Sbjct: 71 YYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTF---SLKTVLMIAIQLISRMEYVH--- 122
Query: 806 SPLIVHRDVKSNNILL-----NSAFEAHVADFGLAKFLID 840
S +++RDVK N L+ + H+ DF LAK ID
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 37/254 (14%), Positives = 59/254 (23%), Gaps = 63/254 (24%)
Query: 679 FSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKL-------LGFGTHSHDHGFR 731
+ C K IG G G V+ + +A+K + +
Sbjct: 17 LPTEKLQRCEK----IGEGVFGEVFQTIADHT-PVAIKIIAIEGPDLVNGSHQKTFEEIL 71
Query: 732 AEIQTL---------GNIRHRNIVRLLAFCSNK----ETNLLVYEYMR--NGSL------ 770
EI R + L + + L +++ GS
Sbjct: 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131
Query: 771 ---------------GEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVK 815
G L + I + L HRD+
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 816 SNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSD--V 873
N+LL + K S G YTL E+ V
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTI-----------PSCGLQVSIIDYTLSRLERDGIVV 238
Query: 874 YSFGVVLLELLTGR 887
+ + +L TG
Sbjct: 239 FCDVSMDEDLFTGD 252
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 32/174 (18%), Positives = 56/174 (32%), Gaps = 27/174 (15%)
Query: 691 GNVIGRGGAGIVYHGK---------MPNGVEIAVK------KLLGFGTHSHDHGFRAEIQ 735
+ R GI+Y P + ++K +L ++
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 736 ---TLGNIRHRNIVRLLAFCSNKET-NLLVYEYMRNG-SLGEALHGKKGAFLGWNLRYKI 790
L + I + F +++ LV + G SL AL L ++
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQV 164
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGG 842
A L +LH VH +V + NI ++ ++ V A +G A G
Sbjct: 165 ACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 2e-06
Identities = 21/142 (14%), Positives = 50/142 (35%), Gaps = 18/142 (12%)
Query: 236 NLVHLDLSSCELDGQIPHEIG-----NLKLLDTVFLHINLLSGSIPKQL------GNLTN 284
NL L++ S L + +I NL+ L + N
Sbjct: 194 NLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPN 253
Query: 285 LVNLDLSNNALTGEIPYSFIN---LRQLKLFNLFMNRLHGS----IPDYLADLPNLETLG 337
L L + + + F+ L QL+ ++ L + D++ + +L+ +
Sbjct: 254 LKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFIN 313
Query: 338 LWQNNFTGVIPENLGQNGKLQV 359
+ N + + + L ++ +++
Sbjct: 314 MKYNYLSDEMKKELQKSLPMKI 335
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.4 bits (114), Expect = 7e-06
Identities = 21/131 (16%), Positives = 46/131 (35%), Gaps = 17/131 (12%)
Query: 185 LQGLEYLSLAGNDLTGKIPGELG--NLTNLR--EIYLGYYNVFEGGIPREV------GKL 234
L+ L + L + ++ +L NL +Y+G + G +
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251
Query: 235 VNLVHLDLSSCELDGQIPHEIGN---LKLLDTVFLHINLLSGS----IPKQLGNLTNLVN 287
NL L + E + L L+T+ + +L+ + + + +L
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 288 LDLSNNALTGE 298
+++ N L+ E
Sbjct: 312 INMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 1e-05
Identities = 34/163 (20%), Positives = 59/163 (36%), Gaps = 20/163 (12%)
Query: 393 GPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSN 452
+ L A L +++ ++ G P L E+ S L S+ E+ S
Sbjct: 162 VDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 453 PDRLGQLNL---SNNLLSGPLP------FSLSNFSSLQILLLSGNQFSGPIPPSIGE--- 500
P L +L L + FS F +L+ L + + + E
Sbjct: 219 P-NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 501 LRQVLKLDLSRNSLSGE----IPPAIGYCNHLTYLDMSQNNLS 539
L Q+ +D+S L+ E + + HL +++M N LS
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 1e-05
Identities = 25/128 (19%), Positives = 47/128 (36%), Gaps = 18/128 (14%)
Query: 282 LTNLVNLDLSNNALTGEIPYS-----FINLRQLKLFNLFMNRLHGSIPDYLADL------ 330
NL +L++ + L + NL +L L+ + + L
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251
Query: 331 PNLETLGLWQNNFTGVIPENLGQ---NGKLQVLDLSSNKLTGTIPTDLCSSNQ----LRI 383
PNL+ LG+ V+ E + +L+ +D+S+ LT L L+
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 384 LILLKNFL 391
+ + N+L
Sbjct: 312 INMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 5e-05
Identities = 27/161 (16%), Positives = 52/161 (32%), Gaps = 21/161 (13%)
Query: 273 GSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLA--DL 330
+ L + L NL + NL+ L++ + L S+ + + DL
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIIS---GGLPDSVVEDILGSDL 218
Query: 331 PNLETLGLW---QNNFTGVIPENL------GQNGKLQVLDLSSNKLTGTIPTDLCSS--- 378
PNLE L L+ ++ + L+ L + + + S
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 379 NQLRILILLKNFL----FGPIPERLGACYSLTRVRLGQNYL 415
QL + + L + + + L + + NYL
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.9 bits (97), Expect = 8e-04
Identities = 19/169 (11%), Positives = 56/169 (33%), Gaps = 24/169 (14%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTG----SIEIGNLSSLQFLNISNNQFS 127
L+ + ++ L +L + I +L +L+ L +
Sbjct: 173 LLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVED 232
Query: 128 GGLD---------WNYSSLVNLEVFDAYNNNFTALLPVGILK---LEKLKYLDLGGNYF- 174
G D ++ NL+ + ++ L+ L +L+ +D+
Sbjct: 233 YGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
Query: 175 ---FGKIPNSYGELQGLEYLSLAGNDLTG----KIPGELGNLTNLREIY 216
+ + +++ L+++++ N L+ ++ L ++ +
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 50/209 (23%), Positives = 83/209 (39%), Gaps = 24/209 (11%)
Query: 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAF 751
IG G G +Y G + E+A+K H E + ++ I + F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ---LLYESKIYRILQGGTGIPNVRWF 71
Query: 752 CSNKETNLLVYEYMRNG-SLGEALHGKKGAFLGWNLR--YKIAIEAAKGLCYLHHDCSPL 808
+ N+LV + + G SL + + +L+ +A + + ++H S
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSRKL---SLKTVLMLADQMINRVEFVH---SKS 123
Query: 809 IVHRDVKSNNILL---NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYA--Y 863
+HRD+K +N L+ A + ++ DFGLAK D + + YA
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 864 TLRVDEKS---DVYSFGVVLLELLTGRRP 889
T E+S D+ S G VL+ L G P
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 58/414 (14%), Positives = 122/414 (29%), Gaps = 61/414 (14%)
Query: 187 GLEYLSLAGNDLTGKIPGELG-NLTNLREIYLGY-YNVFEGGIPREVGKLVNLVHLDLSS 244
LE + L +T + + N + + L G+ NL LDL
Sbjct: 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRE 165
Query: 245 CELDGQIPHEIGNLKLLDTVFLHINLLSGSIP------KQLG-NLTNLVNLDLSNNALTG 297
++D H + + T + +N+ + ++L NL +L L+
Sbjct: 166 SDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE 225
Query: 298 EIPYSFINLRQLKLFNLFM------NRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENL 351
++ QL+ ++ + L+ L L + + +P
Sbjct: 226 KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVY 285
Query: 352 GQNGKLQVLDLSSNKLTGT-IPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRL 410
+L L+LS + + LC +L+ L +L + C L +R+
Sbjct: 286 SVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRV 345
Query: 411 GQNYLNGSIPDGFIYLPGL------------------------------NLAELQSNYLS 440
+ P+ + GL N + L
Sbjct: 346 FPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC 405
Query: 441 GSLPENGNS-------------SSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSG 487
P+ + + L +L+LS L + + +++L ++
Sbjct: 406 IIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAF 465
Query: 488 NQFSGPIPPSIGE-LRQVLKLDLSRNSLSGE-IPPAIGYCNHLTYLDMSQNNLS 539
S + + KL++ + + + L MS ++S
Sbjct: 466 AGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 54/360 (15%), Positives = 110/360 (30%), Gaps = 45/360 (12%)
Query: 93 KLTNLSLAGNNFTGSIEIG------NLSSLQFLNISN--NQFSGG----LDWNYSSLVNL 140
L L L ++ +SL LNIS ++ S L +L +L
Sbjct: 157 NLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSL 216
Query: 141 EVFDAYNNNFTALLPVGILKLEKLK---YLDLGGNYFFGKIPNSYGELQGLEYLSLAGND 197
++ A A L +LE+L Y + + + + L LS +
Sbjct: 217 KLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDA 276
Query: 198 LTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGN 257
+ +P + L + L Y V + + + + L L + D +
Sbjct: 277 VPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLAST 336
Query: 258 LKLLDTVFLHINLLSGSIPKQLGNLT------------NLVNLDLSNNALTGE----IPY 301
K L L + + + LT L ++ +T I
Sbjct: 337 CKDL--RELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIAR 394
Query: 302 SFINLRQLKLFNL--------FMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQ 353
+ N+ + +L + + L + +L L L T + E +G
Sbjct: 395 NRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSL-SGLLTDKVFEYIGT 453
Query: 354 NGK-LQVLDLSSNKLTGTIPTDLCSS-NQLRILILLKNFLFGP-IPERLGACYSLTRVRL 410
K +++L ++ + + S + LR L + + ++ + +
Sbjct: 454 YAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWM 513
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 45/332 (13%), Positives = 99/332 (29%), Gaps = 42/332 (12%)
Query: 74 DLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE--IGNLSSLQFLNISNNQFSG-GL 130
++ + + +L LS + + S L LN+S L
Sbjct: 247 AEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDL 306
Query: 131 DWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEY 190
L+ + A L V + L+ L + + F PN QGL
Sbjct: 307 VKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366
Query: 191 LSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGK-LVNLVHLDLSSCELDG 249
+S+ L + + + + + N+ L E
Sbjct: 367 VSM--------------GCPKLESVLYFCRQMTNAAL-ITIARNRPNMTRFRLCIIEPKA 411
Query: 250 QIPHEIGNLKLLDTVFLHI-------------NLLSGSIPKQLG-NLTNLVNLDLSNNAL 295
+ L+ LD F I LL+ + + +G + L ++
Sbjct: 412 ---PDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGD 468
Query: 296 TGE----IPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENL 351
+ + +LR+L++ + ++ + L + +L + + + + L
Sbjct: 469 SDLGMHHVLSGCDSLRKLEIRD--CPFGDKALLANASKLETMRSLWMSSCSVSFGACKLL 526
Query: 352 GQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRI 383
GQ +++ + + C ++ I
Sbjct: 527 GQKMPKLNVEVIDERGAPDSRPESCPVERVFI 558
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 52/335 (15%), Positives = 100/335 (29%), Gaps = 45/335 (13%)
Query: 93 KLTNLSLAGNNFT-----GSIEIG-NLSSLQFLNISNNQFSG-------GLDWNYSSLVN 139
K+ L + ++F+ E+ + +SL+ LN +F+ + N SLV+
Sbjct: 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224
Query: 140 LEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLT 199
++V D L+ G +P Y L L G
Sbjct: 225 VKVGDFEILELVGFF----KAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM 280
Query: 200 GK--IPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGN 257
G +P +R++ L Y + + K NL L+ + D +
Sbjct: 281 GPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQY 340
Query: 258 LKLLDTVFLHINLLSGSIPKQLGNLT------------NLVNLDLSNNALTGE----IPY 301
K L + + + + G ++ L + + + +T E I
Sbjct: 341 CKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGT 400
Query: 302 SFINLRQLKLFNLF------MNRLHGSIPDYLADLPNLETLGLWQN--NFTGVIPENLGQ 353
NL +L L L + L L + T + +GQ
Sbjct: 401 YLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQ 460
Query: 354 NGK-LQVLDLSSNKLTGTIPTDLCSS-NQLRILIL 386
++ + L + + L+ L +
Sbjct: 461 YSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEM 495
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 45/274 (16%), Positives = 85/274 (31%), Gaps = 34/274 (12%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNL----SSLQFLNISNNQFS 127
LN +P + + L L G ++ G E+ L + ++ L++
Sbjct: 247 EFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLE 306
Query: 128 G-GLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGEL- 185
NLEV + N L V ++LK L + + + G +
Sbjct: 307 TEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVS 366
Query: 186 -----------QGLEYLSLAGNDLTGK----IPGELGNLTNLREIYLGYYN-----VFEG 225
Q LEY+++ +D+T + I L NL + R + L +
Sbjct: 367 QRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN 426
Query: 226 GIPREVGKLVNLVHLDLSSC--ELDGQIPHEIG-NLKLLDTVFL-HINLLSGSIPKQLGN 281
G+ + L L IG + + L ++ + +
Sbjct: 427 GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRG 486
Query: 282 LTNLVNLDLSNNALT----GEIPYSFINLRQLKL 311
NL L++ + +LR L +
Sbjct: 487 CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWV 520
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 51/188 (27%), Positives = 72/188 (38%), Gaps = 47/188 (25%)
Query: 733 EIQTLGNIRHR-----NIVRLLAF-------CSNKETNLLVYEYMRNGSLGEALHGKKGA 780
E L I++ NIV+ C L++E + SL E + +
Sbjct: 81 EADILKKIQNDDINNNNIVKYHGKFMYYDHMC-------LIFEPLGP-SLYEII--TRNN 130
Query: 781 FLGWNLRY--KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF- 837
+ G+++ IE K L YL S + H D+K NILL+ +
Sbjct: 131 YNGFHIEDIKLYCIEILKALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTD 187
Query: 838 ---------------LID-GGA---SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGV 878
LID G A S+ +I + Y APE L D SD++SFG
Sbjct: 188 GKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247
Query: 879 VLLELLTG 886
VL EL TG
Sbjct: 248 VLAELYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 7e-06
Identities = 41/176 (23%), Positives = 73/176 (41%), Gaps = 28/176 (15%)
Query: 733 EIQTLGNIRHR------NIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNL 786
EIQ L ++ V++L + + +V+E + S + + K+ FL + L
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFI--KENGFLPFRL 117
Query: 787 RY--KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF------- 837
+ K+A + K + +LH + H D+K NIL + + + +
Sbjct: 118 DHIRKMAYQICKSVNFLH-SNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 838 ---LID-GGA---SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTG 886
++D G A E S + + Y APE L + DV+S G +L+E G
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 21/160 (13%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH-RNIVRL 748
G IG G G+++ G + N ++A+K R E +T + I +
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ---LRDEYRTYKLLAGCTGIPNV 71
Query: 749 LAFCSNKETNLLVYEYMRNG-SLGEALHGKKGAFLGWNLR--YKIAIEAAKGLCYLHHDC 805
F N+LV + + G SL + L F +++ A + + +H
Sbjct: 72 YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKF---SVKTVAMAAKQMLARVQSIH--- 123
Query: 806 SPLIVHRDVKSNNILL-----NSAFEAHVADFGLAKFLID 840
+V+RD+K +N L+ +A +V DFG+ KF D
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 59/338 (17%), Positives = 115/338 (34%), Gaps = 69/338 (20%)
Query: 93 KLTNLSLAGNNFT--GSIEIG-----NLSSLQFLNISNNQ--------FSGGLDWNYSSL 137
+T+L L+ NN ++E+ +S+ LN+S N L +++
Sbjct: 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82
Query: 138 VNLEVFDAYNNNFT-----ALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGEL-----QG 187
+L + N + L+ + LDLG N F K + + +
Sbjct: 83 TSL---NLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 188 LEYLSLAGNDLTGKIPGELGNL-----TNLREIYLGYYNVFEGGIPR--EVGKLVN--LV 238
+ L+L GNDL K EL + N+ + L N+ + + +
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVT 199
Query: 239 HLDLSSCELDGQ--------IPHEIGNLKLLDTVFLHINLLSGSIPKQLGNL----TNLV 286
LDLS+ L + ++ L+ L +N L G + L L +L
Sbjct: 200 SLDLSANLLGLKSYAELAYIFSSIPNHVVSLN---LCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 287 NLDLSNNALTG-------EIPYSFINLRQLKLFNLFMNRLHGSIPDYLADL-----PNLE 334
+ L + + + +F N++++ L + +H S +++L +
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKAD 316
Query: 335 TLGLWQNNFTGV-----IPENLGQNGKLQVLDLSSNKL 367
L E+L +L+ + L
Sbjct: 317 VPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 61/342 (17%), Positives = 98/342 (28%), Gaps = 69/342 (20%)
Query: 279 LGNLTNLVNLDLSNNALTGEIPYSFI-----NLRQLKLFNLFMNRLHGSIPDYLADL--- 330
+ +LDLS N L I + NL N L D L +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 331 --PNLETLGLWQNNFTGVIPENLGQ-----NGKLQVLDLSSNKLTGTIPTDLCSSNQLRI 383
N+ +L L N + + L + + VLDL N + ++ +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA----- 132
Query: 384 LILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYL------PGLNLAELQSN 437
N S+T + L N L L N+ L
Sbjct: 133 ---FSNL-----------PASITSLNLRGNDLG---IKSSDELIQILAAIPANVNSL--- 172
Query: 438 YLSG-SLPENGNSS------SNPDRLGQLNLSNNLLSGPLPFSL-----SNFSSLQILLL 485
L G +L + S P + L+LS NLL L S + + L L
Sbjct: 173 NLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNL 232
Query: 486 SGNQFSGPIPPSIGELRQVLK----LDLSRNSLSG-------EIPPAIGYCNHLTYLDMS 534
N GP ++ L+ LK + L + + + A + +D +
Sbjct: 233 CLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKN 292
Query: 535 QNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSL 576
+ S ISN+ L ++
Sbjct: 293 GKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTN 334
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 31/106 (29%), Positives = 46/106 (43%), Gaps = 4/106 (3%)
Query: 114 SSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGIL-KLEKLKYLDLGGN 172
SS L + +N+ + L L N +L P G+ KL KL L L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSL-PDGVFDKLTKLTILYLHEN 86
Query: 173 YFFGKIPNS-YGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYL 217
+PN + +L L+ L+L N L G LT+L++I+L
Sbjct: 87 K-LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWL 131
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 31/107 (28%), Positives = 45/107 (42%), Gaps = 5/107 (4%)
Query: 165 KYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFE 224
L+L N + +L L LSL+ N + G LT L +YL + N +
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYL-HENKLQ 89
Query: 225 GGIPREV-GKLVNLVHLDLSSCELDGQIPHEI-GNLKLLDTVFLHIN 269
+P V KL L L L + +L +P I L L ++LH N
Sbjct: 90 -SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 29/101 (28%), Positives = 40/101 (39%), Gaps = 2/101 (1%)
Query: 266 LHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPD 325
L N L LT L L LS N + F L +L + L N+L S+P+
Sbjct: 35 LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLPN 93
Query: 326 YLAD-LPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSN 365
+ D L L+ L L N V + LQ + L +N
Sbjct: 94 GVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 9/105 (8%)
Query: 266 LHINLLSGSIPKQL-GNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIP 324
L+ N L L G L +LV L+L N LTG P +F ++ L N++ I
Sbjct: 36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EIS 94
Query: 325 DYLAD-LPNLETLGLWQNNFTGVIP---ENLGQNGKLQVLDLSSN 365
+ + L L+TL L+ N + V+P E+L L L+L+SN
Sbjct: 95 NKMFLGLHQLKTLNLYDNQISCVMPGSFEHL---NSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 35/175 (20%), Positives = 56/175 (32%), Gaps = 58/175 (33%)
Query: 56 SVCSWAGICCSRDRV--ASLDLTDLNLCGSVPA------QILRLD--KLTNLSLAGNNFT 105
++C C V L +P L L+ +L +S G
Sbjct: 4 AMCH-----CEGTTVDCTGRGLK------EIPRDIPLHTTELLLNDNELGRISSDG---- 48
Query: 106 GSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLE--VFDAYNNNFTALLPVGILKLEK 163
G L L L + NQ L +E F+
Sbjct: 49 ---LFGRLPHLVKLELKRNQ-----------LTGIEPNAFE---------------GASH 79
Query: 164 LKYLDLGGNYFFGKIPN-SYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYL 217
++ L LG N +I N + L L+ L+L N ++ +PG +L +L + L
Sbjct: 80 IQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 7/101 (6%)
Query: 481 QILLLSGNQFSGPIPPSI-GELRQVLKLDLSRNSLSGEIPP-AIGYCNHLTYLDMSQNNL 538
LLL+ N+ + G L ++KL+L RN L+ I P A +H+ L + +N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 539 SGSIPPEI-SNVRILNYLNLSRNHLNQNIPKSI-GSMKSLT 577
I ++ + L LNL N + + + SLT
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLT 129
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 68/402 (16%), Positives = 118/402 (29%), Gaps = 85/402 (21%)
Query: 118 FLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYL----DLGGNY 173
L+ N L +L LE A L + E L +L +
Sbjct: 6 LLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQR 65
Query: 174 FFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELG-----NLTNLREIYLGYYNVFEGGIP 228
F ++ L L L+LAG +T + L E+ L + G+
Sbjct: 66 FSAEV------LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLR 119
Query: 229 REVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNL 288
+ + L L L + K L + LH + + L
Sbjct: 120 TLLPVFLRARKLGLQLNSLGPE------ACKDLRDLLLH-------------DQCQITTL 160
Query: 289 DLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG--SIPDYLADLPNLETLGLWQNNFT-- 344
LSNN LT G + + LA ++ L L
Sbjct: 161 RLSNNPLTAA----------------------GVAVLMEGLAGNTSVTHLSLLHTGLGDE 198
Query: 345 GV--IPENLGQNGKLQVLDLSSNKLTGT----IPTDLCSSNQLRILILLKNFLFGP---- 394
G+ + L +N +LQ L+++ N T + L +L L N L
Sbjct: 199 GLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL-SSEGRQ 257
Query: 395 -IPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNP 453
+ + GA RV + + L+E+Q N + + +
Sbjct: 258 VLRDLGGAAEGGARVVVSLTEGTAVSEYW-----SVILSEVQRN---LNSWDRARVQRHL 309
Query: 454 DRLGQLNLSNNLLSGPLPFSLSNF----SSLQILLLSGNQFS 491
+ L +L ++ + P+ + ++ LL
Sbjct: 310 E-LLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 35/181 (19%), Positives = 61/181 (33%), Gaps = 44/181 (24%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVK-------------------KLLGFGTHSHDHGF 730
G IG GG G++Y + A + +
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 731 RAEIQTLGNIRHRNIVRLLAF----CSNKETNLLVYEYMRNG-SLGEALHGKKGAFLGWN 785
R ++ LG I + +V E + G L + + G+ G F
Sbjct: 102 RKQLDYLG------IPLFYGSGLTEFKGRSYRFMVMERL--GIDL-QKISGQNGTF---K 149
Query: 786 LR--YKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL--NSAFEAHVADFGLAKFLIDG 841
++ I L Y+H + VH D+K+ N+LL + + ++AD+GL+
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 842 G 842
G
Sbjct: 207 G 207
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 32/179 (17%), Positives = 55/179 (30%), Gaps = 57/179 (31%)
Query: 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNI 819
+V+E + + L + + L KI + +GL YLH C I+H D+K NI
Sbjct: 122 MVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178
Query: 820 LLN-------------------------------------------------SAFEAHVA 830
LL+ + +A
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
D G A + + + + Y + E + +D++S + EL TG
Sbjct: 239 DLGNACW-----VHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 995 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.75 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.69 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.51 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.49 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.49 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.25 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.24 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.24 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.22 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.21 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.2 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.97 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.92 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.89 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.81 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.81 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.78 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.74 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.41 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.39 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.32 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.23 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.17 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.03 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.02 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.82 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.65 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.63 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.62 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.59 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.34 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.27 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.99 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.81 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.79 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.76 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.75 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.49 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.43 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.38 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.07 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.07 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.04 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.69 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.59 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.22 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.99 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-85 Score=812.18 Aligned_cols=597 Identities=35% Similarity=0.532 Sum_probs=491.5
Q ss_pred cccccccchHHHHHHHHHhCCCCCCCCCCCCCCCCCCCceeeeEEeCCCceeeeecCCCCcccc---CC-----------
Q 001922 20 SSAASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSRDRVASLDLTDLNLCGS---VP----------- 85 (995)
Q Consensus 20 ~~~~~~~~~~~~Ll~~k~~~~~~~~~l~~W~~~~~~~~C~w~gv~C~~~~v~~l~l~~~~l~~~---~~----------- 85 (995)
+++++...|++|||+||+++.||. .+++|+.+ ++||+|.||+|+.++|++|||++.++.|. +|
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~~--~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKN-LLPDWSSN--KNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTT-SSTTCCTT--SCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred ccccCCHHHHHHHHHHHhhCCCcc-cccCCCCC--CCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 445556789999999999999998 99999854 57999999999989999999999999887 44
Q ss_pred ------------ccccCCCCCCeEeccCCcccCcc----ccCcccccceeccccccccCCCcccc-cccccccccccccc
Q 001922 86 ------------AQILRLDKLTNLSLAGNNFTGSI----EIGNLSSLQFLNISNNQFSGGLDWNY-SSLVNLEVFDAYNN 148 (995)
Q Consensus 86 ------------~~~~~l~~L~~L~L~~n~l~~~~----~~~~l~~L~~L~Ls~N~i~~~~~~~~-~~l~~L~~L~Ls~n 148 (995)
+.|+.+++|++|+|++|.++|.+ .++++++|++|+|++|.+++..+..+ .++++|++|++++|
T Consensus 82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 46778899999999999998733 57888999999999998887777655 66777777777777
Q ss_pred cccccCCcc---c----------------------cCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCc
Q 001922 149 NFTALLPVG---I----------------------LKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIP 203 (995)
Q Consensus 149 ~i~~~~p~~---~----------------------~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 203 (995)
++++..|.. + ..+++|++|+|++|.+++.+|. ++.+++|++|+|++|++++.+|
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~ 240 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFS 240 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHH
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCccc
Confidence 776655443 2 3456666666666666665665 7777777777777777777777
Q ss_pred ccccchhhhhhhhcccccccc---------------------CCCCcccCCC-CcccEEECcCCCCCCccCccccCcccc
Q 001922 204 GELGNLTNLREIYLGYYNVFE---------------------GGIPREVGKL-VNLVHLDLSSCELDGQIPHEIGNLKLL 261 (995)
Q Consensus 204 ~~l~~l~~L~~L~L~~n~~~~---------------------~~~p~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L 261 (995)
..++++++|++|++++|.+.. +.+|..+..+ ++|++|+|++|++++.+|..|+.+++|
T Consensus 241 ~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L 320 (768)
T 3rgz_A 241 RAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320 (768)
T ss_dssp HHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTC
T ss_pred HHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCc
Confidence 777777777777777655431 2344444443 666666666666666666666666666
Q ss_pred CccccccccccCCCCcc-ccCcCCCCeEeccCCcCcCcCCccccccC-CCCEEEccCCcCCCCCCccccC--CCCcceEE
Q 001922 262 DTVFLHINLLSGSIPKQ-LGNLTNLVNLDLSNNALTGEIPYSFINLR-QLKLFNLFMNRLHGSIPDYLAD--LPNLETLG 337 (995)
Q Consensus 262 ~~L~l~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L~ 337 (995)
++|++++|++++.+|.. +.++++|++|++++|.+++.+|..+.+++ +|+.|++++|++++.+|..+.. +++|++|+
T Consensus 321 ~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~ 400 (768)
T 3rgz_A 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400 (768)
T ss_dssp CEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEE
T ss_pred cEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEE
Confidence 66666666666555544 66666666666666666666666666665 6777777777776666666655 67888888
Q ss_pred eccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCC
Q 001922 338 LWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNG 417 (995)
Q Consensus 338 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 417 (995)
+++|++++.+|..++.+++|++|+|++|++++.+|..++.+++|+.|++++|.+.+.+|..+..+++|++|++++|++.+
T Consensus 401 L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 480 (768)
T 3rgz_A 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTG 480 (768)
T ss_dssp CCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCS
T ss_pred CCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccC
Confidence 88888888889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCC
Q 001922 418 SIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPS 497 (995)
Q Consensus 418 ~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 497 (995)
.+|..+..+++|+.+++++|++++.+|.. +..+++|++|+|++|+++|.+|..+.++++|+.|+|++|+++|.+|..
T Consensus 481 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~ 557 (768)
T 3rgz_A 481 EIPSGLSNCTNLNWISLSNNRLTGEIPKW---IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557 (768)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCSCCCGG---GGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGG
T ss_pred cCCHHHhcCCCCCEEEccCCccCCcCChH---HhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChH
Confidence 99999999999999999999999888864 345788999999999999999999999999999999999998877754
Q ss_pred c----------------------------------------------------------------------cchhhhccc
Q 001922 498 I----------------------------------------------------------------------GELRQVLKL 507 (995)
Q Consensus 498 ~----------------------------------------------------------------------~~l~~L~~L 507 (995)
+ +.+++|+.|
T Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~L 637 (768)
T 3rgz_A 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637 (768)
T ss_dssp GGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEE
T ss_pred HhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEE
Confidence 3 335678999
Q ss_pred cccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCC
Q 001922 508 DLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFS 587 (995)
Q Consensus 508 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 587 (995)
||++|+++|.+|.+++.+++|++|+|++|+++|.+|.+|+++++|+.|||++|+++|.+|..++.+++|+.||+|+|+|+
T Consensus 638 dLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 717 (768)
T 3rgz_A 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717 (768)
T ss_dssp ECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred ECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccccccCCCCccCCCCCCCCCCCCCCc
Q 001922 588 GKLPESGQFTVFNASSFAGNPQLCGTLLNNPCNVAPI 624 (995)
Q Consensus 588 g~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~c~~~~~ 624 (995)
|.||+.+++.+++..+|.|||++||.|++ +|.....
T Consensus 718 g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~~~ 753 (768)
T 3rgz_A 718 GPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPSNA 753 (768)
T ss_dssp EECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSCC-
T ss_pred ccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCCcc
Confidence 99999999999999999999999999998 8986643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-65 Score=637.37 Aligned_cols=494 Identities=34% Similarity=0.521 Sum_probs=352.5
Q ss_pred ccCCCCCCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCcee
Q 001922 88 ILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYL 167 (995)
Q Consensus 88 ~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L 167 (995)
+.++++|++|++++|.+++..++..+++|++|+|++|.+++.+|. +.++++|++|++++|++++.+|..+..+++|++|
T Consensus 174 ~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L 252 (768)
T 3rgz_A 174 SDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLL 252 (768)
T ss_dssp TTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEE
T ss_pred hccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEE
Confidence 334444444444444444444456667777777777777766665 7777777777777777777777777777777777
Q ss_pred eccCccccccCCccccCCCCCceeeccCCcccccCcccccch-hhhhhhhccccccccCCCCcccCCCCcccEEECcCCC
Q 001922 168 DLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNL-TNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCE 246 (995)
Q Consensus 168 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l-~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~ 246 (995)
+|++|.+++.+|.. .+++|++|+|++|++++.+|..+..+ ++|++|++++|.+ .+.+|..++.+++|++|++++|+
T Consensus 253 ~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l-~~~~p~~~~~l~~L~~L~L~~n~ 329 (768)
T 3rgz_A 253 NISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHF-YGAVPPFFGSCSLLESLALSSNN 329 (768)
T ss_dssp ECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEE-EECCCGGGGGCTTCCEEECCSSE
T ss_pred ECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcC-CCccchHHhcCCCccEEECCCCc
Confidence 77777776655543 56666666666666666666666654 7777777775443 34566667777777777777777
Q ss_pred CCCccCcc-ccCccccCccccccccccCCCCccccCcC-CCCeEeccCCcCcCcCCccccc--cCCCCEEEccCCcCCCC
Q 001922 247 LDGQIPHE-IGNLKLLDTVFLHINLLSGSIPKQLGNLT-NLVNLDLSNNALTGEIPYSFIN--LRQLKLFNLFMNRLHGS 322 (995)
Q Consensus 247 l~~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~ 322 (995)
+++.+|.. +..+++|++|++++|++++.+|..+.+++ +|++|++++|.+++.+|..+.. +++|+.|++++|++++.
T Consensus 330 l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~ 409 (768)
T 3rgz_A 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409 (768)
T ss_dssp EEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEE
T ss_pred ccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccc
Confidence 76666654 66777777777777777766666666665 6666666666666666655554 55666666666666666
Q ss_pred CCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccC
Q 001922 323 IPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGAC 402 (995)
Q Consensus 323 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 402 (995)
+|..+..+++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..+..+++|+.|++++|++.+.+|..+.++
T Consensus 410 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 489 (768)
T 3rgz_A 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred cCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcC
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCc----------
Q 001922 403 YSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPF---------- 472 (995)
Q Consensus 403 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~---------- 472 (995)
++|++|++++|++.+.+|.++..+++|+.+++++|+++|.+|.. ...+++|++|++++|+++|.+|.
T Consensus 490 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~---l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~ 566 (768)
T 3rgz_A 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE---LGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIA 566 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGG---GGGCTTCCEEECCSSEEESBCCGGGGTTTTCBC
T ss_pred CCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHH---HcCCCCCCEEECCCCccCCcCChHHhcccchhh
Confidence 66666666666666666666666666666666666666655543 23345566666666666655554
Q ss_pred ------------------------------------------------------------cccCCCCCcEEEcCCCcccC
Q 001922 473 ------------------------------------------------------------SLSNFSSLQILLLSGNQFSG 492 (995)
Q Consensus 473 ------------------------------------------------------------~~~~l~~L~~L~Ls~N~l~~ 492 (995)
.+.++++|+.|||++|+++|
T Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g 646 (768)
T 3rgz_A 567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG 646 (768)
T ss_dssp CSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBS
T ss_pred hhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccc
Confidence 45556789999999999999
Q ss_pred CCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCccccc
Q 001922 493 PIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGS 572 (995)
Q Consensus 493 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 572 (995)
.+|..++.+++|+.|+|++|+++|.+|..|+.+++|++|||++|+++|.+|.++.++++|++|||++|+|+|.+|.. +.
T Consensus 647 ~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~ 725 (768)
T 3rgz_A 647 YIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQ 725 (768)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SS
T ss_pred cCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999964 45
Q ss_pred CCcccEEeccCCC-CCCC
Q 001922 573 MKSLTIADFSFND-FSGK 589 (995)
Q Consensus 573 l~~L~~l~ls~N~-l~g~ 589 (995)
+.++....+.+|+ |+|.
T Consensus 726 ~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 726 FETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp GGGSCGGGGCSCTEEEST
T ss_pred hccCCHHHhcCCchhcCC
Confidence 6666666788886 7775
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-60 Score=581.16 Aligned_cols=553 Identities=21% Similarity=0.180 Sum_probs=479.2
Q ss_pred ceeeeEEeCC-----------CceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccc
Q 001922 58 CSWAGICCSR-----------DRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNN 124 (995)
Q Consensus 58 C~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N 124 (995)
|.++.|.|+. .+++.|||+++++++..+..|.++++|++|+|++|.+++.. .++++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 5556677753 36899999999999877778999999999999999999854 5889999999999999
Q ss_pred cccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcc
Q 001922 125 QFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPG 204 (995)
Q Consensus 125 ~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~ 204 (995)
.++++++..|.++++|++|++++|+++++.|..|+++++|++|+|++|.+++..|..++.+++|++|++++|++++..+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99998888999999999999999999998889999999999999999999998899999999999999999999988887
Q ss_pred ccc--chhhhhhhhccccccccCCCCcccCCC---------------------------CcccEEECcCCCCCCccCccc
Q 001922 205 ELG--NLTNLREIYLGYYNVFEGGIPREVGKL---------------------------VNLVHLDLSSCELDGQIPHEI 255 (995)
Q Consensus 205 ~l~--~l~~L~~L~L~~n~~~~~~~p~~~~~l---------------------------~~L~~L~Ls~n~l~~~~~~~~ 255 (995)
.++ .+++|++|++++|.+. +..|..+..+ ++|+.|++++|.+++..|..+
T Consensus 164 ~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~ 242 (680)
T 1ziw_A 164 ELDIFANSSLKKLELSSNQIK-EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242 (680)
T ss_dssp HHGGGTTCEESEEECTTCCCC-CBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred HhhccccccccEEECCCCccc-ccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence 765 4589999999977553 4455555433 567888899999998888899
Q ss_pred cCccc--cCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCC-----CCCc---
Q 001922 256 GNLKL--LDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG-----SIPD--- 325 (995)
Q Consensus 256 ~~l~~--L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----~~p~--- 325 (995)
..++. |+.|++++|++++..|..|..+++|++|++++|.+++..|..|.++++|+.|++++|...+ .+|.
T Consensus 243 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~ 322 (680)
T 1ziw_A 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322 (680)
T ss_dssp GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECT
T ss_pred hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccCh
Confidence 88865 9999999999998888899999999999999999999999999999999999999886554 2333
Q ss_pred -cccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceeccc--CCCcCcCC--CccceeeccccccCCCCCcccc
Q 001922 326 -YLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGT--IPTDLCSS--NQLRILILLKNFLFGPIPERLG 400 (995)
Q Consensus 326 -~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l--~~L~~L~l~~N~l~~~~p~~l~ 400 (995)
.|..+++|++|++++|++++..+..|..+++|++|++++|.+++. .+..+..+ ++|+.|++++|++.+..|..+.
T Consensus 323 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~ 402 (680)
T 1ziw_A 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402 (680)
T ss_dssp TTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTT
T ss_pred hhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhh
Confidence 688899999999999999998888999999999999999985432 22334333 5899999999999999999999
Q ss_pred cCCCCcEEEecCCccCCCCC-CCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCccc--ccCCccccCC
Q 001922 401 ACYSLTRVRLGQNYLNGSIP-DGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLS--GPLPFSLSNF 477 (995)
Q Consensus 401 ~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~--~~~p~~~~~l 477 (995)
.+++|+.|++++|.+.+.+| ..|..+++|+.+++++|++.+..+.. +..+++|+.|++++|.++ +.+|..+.++
T Consensus 403 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~---~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l 479 (680)
T 1ziw_A 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS---FALVPSLQRLMLRRVALKNVDSSPSPFQPL 479 (680)
T ss_dssp TCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTT---TTTCTTCCEEECTTSCCBCTTCSSCTTTTC
T ss_pred CCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhh---hhcCcccccchhccccccccccCCcccccC
Confidence 99999999999999988776 68889999999999999998765543 456789999999999987 5789999999
Q ss_pred CCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCC--------CCccCcccccceeeccCCcccCCCccccccc
Q 001922 478 SSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEI--------PPAIGYCNHLTYLDMSQNNLSGSIPPEISNV 549 (995)
Q Consensus 478 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--------p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l 549 (995)
++|+.|+|++|++++..|..|..+++|+.|+|++|++++.. +..++.+++|++|+|++|+++...+..|.++
T Consensus 480 ~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 559 (680)
T 1ziw_A 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccc
Confidence 99999999999999888888999999999999999998532 2348899999999999999994444568999
Q ss_pred cccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCCCC-C-CCcccccccCCCCccCCCCC
Q 001922 550 RILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPES-G-QFTVFNASSFAGNPQLCGTL 614 (995)
Q Consensus 550 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~-~~~~~~~~~~~~n~~~c~~~ 614 (995)
++|+.|+|++|+|++..+..+..+++|+.|++++|++++.+|.. + .+..+....+.||||.|++.
T Consensus 560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99999999999999877777899999999999999999987752 1 35667778899999999954
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=561.19 Aligned_cols=507 Identities=19% Similarity=0.263 Sum_probs=379.1
Q ss_pred cccccchHHHHHHHHHhCCCCC--------CCCCCCCCCCCCCCcee---eeEEeCC-CceeeeecCCCCccccCCcccc
Q 001922 22 AASLVNDFHVLVALKQGFENPE--------PALISWNSSNPSSVCSW---AGICCSR-DRVASLDLTDLNLCGSVPAQIL 89 (995)
Q Consensus 22 ~~~~~~~~~~Ll~~k~~~~~~~--------~~l~~W~~~~~~~~C~w---~gv~C~~-~~v~~l~l~~~~l~~~~~~~~~ 89 (995)
++....|+.||.+||+++.++. +..++|+.+ ++||.| .||+|+. +||+.|+|++++++|.+|+.++
T Consensus 25 ~~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~--~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~ 102 (636)
T 4eco_A 25 TAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN--KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIG 102 (636)
T ss_dssp CCHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS--SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGG
T ss_pred hhhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC--CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHh
Confidence 3445679999999999976442 245589865 679999 9999965 6999999999999999999999
Q ss_pred CCCCCCeEeccCCccc------C------ccccCcccccceeccccccccCCCcccccc-cccccccccccccccccCCc
Q 001922 90 RLDKLTNLSLAGNNFT------G------SIEIGNLSSLQFLNISNNQFSGGLDWNYSS-LVNLEVFDAYNNNFTALLPV 156 (995)
Q Consensus 90 ~l~~L~~L~L~~n~l~------~------~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~-l~~L~~L~Ls~n~i~~~~p~ 156 (995)
+|++|++|+|++|.+. | .++-..+..|+ +++++|.+.+.++..+.. +..+..+++....+..
T Consensus 103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~---- 177 (636)
T 4eco_A 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK---- 177 (636)
T ss_dssp GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC----
T ss_pred cCccceEEECcCCccccCCccccccccccCchHHHHHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc----
Confidence 9999999999999872 2 11112266788 999999999888877763 3455555555443332
Q ss_pred cccCCCCCceeecc--CccccccCCccccCCCCCceeeccCCccccc-----------------Cccccc--chhhhhhh
Q 001922 157 GILKLEKLKYLDLG--GNYFFGKIPNSYGELQGLEYLSLAGNDLTGK-----------------IPGELG--NLTNLREI 215 (995)
Q Consensus 157 ~~~~l~~L~~L~L~--~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-----------------~~~~l~--~l~~L~~L 215 (995)
.....++.+.+. +|++++ +|..|+++++|++|+|++|++++. +|..++ ++++|++|
T Consensus 178 --~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L 254 (636)
T 4eco_A 178 --SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDV 254 (636)
T ss_dssp --CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred --ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEE
Confidence 122233333333 467776 777777777777777777777764 777777 77777777
Q ss_pred hccccccccCCCCcccCCCCcccEEECcCCC-CCC-ccCccccCc------cccCccccccccccCCCCc--cccCcCCC
Q 001922 216 YLGYYNVFEGGIPREVGKLVNLVHLDLSSCE-LDG-QIPHEIGNL------KLLDTVFLHINLLSGSIPK--QLGNLTNL 285 (995)
Q Consensus 216 ~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~-l~~-~~~~~~~~l------~~L~~L~l~~N~l~~~~p~--~l~~l~~L 285 (995)
+|++|++ .+.+|..++++++|++|++++|+ +++ .+|..++.+ ++|++|++++|+++ .+|. .++++++|
T Consensus 255 ~L~~n~l-~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L 332 (636)
T 4eco_A 255 EVYNCPN-LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKL 332 (636)
T ss_dssp EEECCTT-CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTC
T ss_pred EecCCcC-CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCC
Confidence 7775443 45677788888888888888887 887 788887776 88888888888888 7777 88888889
Q ss_pred CeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCC-cceEEeccCcccccCCCcccCCC--CCCeEEe
Q 001922 286 VNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPN-LETLGLWQNNFTGVIPENLGQNG--KLQVLDL 362 (995)
Q Consensus 286 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L 362 (995)
++|++++|.++|.+| .|..+++|+.|++++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++ +|++|++
T Consensus 333 ~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~L 409 (636)
T 4eco_A 333 GMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDF 409 (636)
T ss_dssp CEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEEC
T ss_pred CEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEEC
Confidence 999999998888888 8888888999999999888 77888888888 999999999988 6787777655 8899999
Q ss_pred cCceecccCCCcCc-------CCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcc-cCCCCceeec
Q 001922 363 SSNKLTGTIPTDLC-------SSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFI-YLPGLNLAEL 434 (995)
Q Consensus 363 ~~N~l~~~~p~~~~-------~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~l~l 434 (995)
++|++++.+|..+. .+.+|+.|++++|.+....+..+..+++|++|++++|+++ .+|..+. ....
T Consensus 410 s~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~------ 482 (636)
T 4eco_A 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENE------ 482 (636)
T ss_dssp CSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTE------
T ss_pred cCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccc------
Confidence 99999888888887 7788999999999988554455666899999999999998 5554332 1110
Q ss_pred cCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCcccc--CCCCCcEEEcCCCcccCCCCCCccchhhhcccccccc
Q 001922 435 QSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLS--NFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRN 512 (995)
Q Consensus 435 ~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 512 (995)
....+++|++|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..++.+++|+.|+|++|
T Consensus 483 --------------~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N 546 (636)
T 4eco_A 483 --------------NFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546 (636)
T ss_dssp --------------ECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSC
T ss_pred --------------cccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCC
Confidence 0112347888999999998 6888776 89999999999999986 8888889999999999665
Q ss_pred ccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCC
Q 001922 513 SLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFS 587 (995)
Q Consensus 513 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 587 (995)
+ ++++|++.+.+|.+++++++|++|+|++|++ +.+|..+. ++|+.||+++|++.
T Consensus 547 ~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 547 R------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp B------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred c------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence 4 4455555555555555555555555555555 44555444 45555555555444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=550.31 Aligned_cols=531 Identities=22% Similarity=0.209 Sum_probs=446.0
Q ss_pred eeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCcccccccccccccccccc
Q 001922 71 ASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNN 148 (995)
Q Consensus 71 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n 148 (995)
..+|+++++++ .+|..+. +++++|+|++|++++.. .+.++++|++|+|++|.+++..+..|.++++|++|+|++|
T Consensus 7 ~~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 7 EVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp SEEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred CeeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 45899999996 5787665 79999999999999855 5999999999999999999999999999999999999999
Q ss_pred cccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCC
Q 001922 149 NFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIP 228 (995)
Q Consensus 149 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p 228 (995)
+++++.+..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|++++|.+. +..+
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~ 162 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ-ALKS 162 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCC-CBCH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccc-ccCH
Confidence 999977778999999999999999999877889999999999999999999999999999999999999977654 3344
Q ss_pred cccC--CCCcccEEECcCCCCCCccCccccCc---------------------------cccCccccccccccCCCCccc
Q 001922 229 REVG--KLVNLVHLDLSSCELDGQIPHEIGNL---------------------------KLLDTVFLHINLLSGSIPKQL 279 (995)
Q Consensus 229 ~~~~--~l~~L~~L~Ls~n~l~~~~~~~~~~l---------------------------~~L~~L~l~~N~l~~~~p~~l 279 (995)
..+. .+++|++|++++|.+++..|..+..+ ++|+.|++++|.+++..|..+
T Consensus 163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~ 242 (680)
T 1ziw_A 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242 (680)
T ss_dssp HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence 4443 56899999999999998888877655 456777778888887778888
Q ss_pred cCcCC--CCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccc-----cCC----
Q 001922 280 GNLTN--LVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTG-----VIP---- 348 (995)
Q Consensus 280 ~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----~~p---- 348 (995)
.+++. |+.|+|++|.+++..|..|..+++|+.|++++|++.+..|..|..+++|+.|++++|...+ .+|
T Consensus 243 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~ 322 (680)
T 1ziw_A 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322 (680)
T ss_dssp GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECT
T ss_pred hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccCh
Confidence 87765 8899999988888888888888889999999888888888888888889999888876543 223
Q ss_pred CcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCC--CcccccC--CCCcEEEecCCccCCCCCCCcc
Q 001922 349 ENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPI--PERLGAC--YSLTRVRLGQNYLNGSIPDGFI 424 (995)
Q Consensus 349 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--p~~l~~l--~~L~~L~l~~N~l~~~~p~~~~ 424 (995)
..|..+++|++|++++|++++..|..|..+++|+.|++++|.+.... +..+..+ .+|+.|++++|++.+..|..|.
T Consensus 323 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~ 402 (680)
T 1ziw_A 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402 (680)
T ss_dssp TTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTT
T ss_pred hhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhh
Confidence 26778888999999999998888888888899999999988754322 2233332 5789999999999999999999
Q ss_pred cCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCccc--CCCCCCccchh
Q 001922 425 YLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFS--GPIPPSIGELR 502 (995)
Q Consensus 425 ~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~ 502 (995)
.+++|+.+++++|.+++.+|.. .+..+++|++|++++|++++..+..+..+++|+.|++++|.++ +.+|..++.++
T Consensus 403 ~l~~L~~L~L~~N~l~~~~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~ 480 (680)
T 1ziw_A 403 WLGHLEVLDLGLNEIGQELTGQ--EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480 (680)
T ss_dssp TCTTCCEEECCSSCCEEECCSG--GGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCT
T ss_pred CCCCCCEEeCCCCcCccccCcc--cccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCC
Confidence 9999999999999998876643 2456788999999999999888889999999999999999987 57888999999
Q ss_pred hhccccccccccCCCCCCccCcccccceeeccCCcccCCCc--------cccccccccCeEeccccccccccCcccccCC
Q 001922 503 QVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIP--------PEISNVRILNYLNLSRNHLNQNIPKSIGSMK 574 (995)
Q Consensus 503 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip--------~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 574 (995)
+|+.|+|++|++++..|..|..+++|++|+|++|++++..+ ..+.++++|++|+|++|+++...+..|..++
T Consensus 481 ~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~ 560 (680)
T 1ziw_A 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred CCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccccc
Confidence 99999999999998777789999999999999999985322 2378899999999999999865455789999
Q ss_pred cccEEeccCCCCCCCCCCC-CCCcccccccCCCC
Q 001922 575 SLTIADFSFNDFSGKLPES-GQFTVFNASSFAGN 607 (995)
Q Consensus 575 ~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n 607 (995)
+|+.|++++|++++.+|.. ..+..+....+.+|
T Consensus 561 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N 594 (680)
T 1ziw_A 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CcceeECCCCCCCcCCHhHhCCCCCCCEEECCCC
Confidence 9999999999999766543 34555666666666
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-57 Score=548.03 Aligned_cols=490 Identities=19% Similarity=0.164 Sum_probs=252.6
Q ss_pred CCCeEeccCCcccCcc--ccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeecc
Q 001922 93 KLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLG 170 (995)
Q Consensus 93 ~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~ 170 (995)
.+++|+|++|++++.. .|.++++|++|+|++|+++++.|..|.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 113 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence 4555555555555432 35555555555555555555555555555555555555555555555555555555555555
Q ss_pred CccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCccc--EEECcCCCCC
Q 001922 171 GNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLV--HLDLSSCELD 248 (995)
Q Consensus 171 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~--~L~Ls~n~l~ 248 (995)
+|.+++..|..|+.+++|++|+|++|++++.....+..+++|++|++++|.+. +..|..+..+++|+ .|++++|.++
T Consensus 114 ~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~l~L~l~~n~l~ 192 (606)
T 3t6q_A 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIA 192 (606)
T ss_dssp TSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCC-EECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred ccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccc-ccChhhhhhhcccceeEEecCCCccC
Confidence 55555444555555555555555555555433333333555555555544332 22344455555555 5555566555
Q ss_pred CccCccccCccccCcccccccccc--------------------------CCCCccccCcC--CCCeEeccCCcCcCcCC
Q 001922 249 GQIPHEIGNLKLLDTVFLHINLLS--------------------------GSIPKQLGNLT--NLVNLDLSNNALTGEIP 300 (995)
Q Consensus 249 ~~~~~~~~~l~~L~~L~l~~N~l~--------------------------~~~p~~l~~l~--~L~~L~Ls~N~l~~~~p 300 (995)
+..|..+.. ..|+.|++++|... ...+..+..+. +|+.|++++|.+++..+
T Consensus 193 ~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~ 271 (606)
T 3t6q_A 193 GIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271 (606)
T ss_dssp EECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT
T ss_pred ccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH
Confidence 544444332 35555555554310 11112222222 45566666666655555
Q ss_pred ccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCc-CcCCC
Q 001922 301 YSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTD-LCSSN 379 (995)
Q Consensus 301 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~ 379 (995)
..|.++++|+.|++++|+++ .+|..+..+++|++|++++|++++..|..+..+++|++|++++|.+.+.+|.. +..++
T Consensus 272 ~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 350 (606)
T 3t6q_A 272 NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350 (606)
T ss_dssp TTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT
T ss_pred HHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccC
Confidence 55555666666666666655 45555555566666666666665555555555666666666666555444433 55555
Q ss_pred ccceeeccccccCCCC--CcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCc
Q 001922 380 QLRILILLKNFLFGPI--PERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLG 457 (995)
Q Consensus 380 ~L~~L~l~~N~l~~~~--p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~ 457 (995)
+|+.|++++|.+.+.. |..+..+++|++|++++|++.+..|..|..+++|+.+++++|++.+..+.. .+..+++|+
T Consensus 351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~--~~~~l~~L~ 428 (606)
T 3t6q_A 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS--PFQNLHLLK 428 (606)
T ss_dssp TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCC--TTTTCTTCC
T ss_pred cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccch--hhhCcccCC
Confidence 5555555555555443 455555555555555555555555555555555555555555554433221 122334444
Q ss_pred EEEcCCCcccccCCccccCCCCCcEEEcCCCcccC---CCCCCccchhhhccccccccccCCCCCCccCcccccceeecc
Q 001922 458 QLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSG---PIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMS 534 (995)
Q Consensus 458 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 534 (995)
+|++++|.+++..|..+..+++|+.|+|++|++++ ..+..+..+++|+.|+|++|++++..|..|+.+++|++|+|+
T Consensus 429 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 508 (606)
T 3t6q_A 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508 (606)
T ss_dssp EEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred EEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECC
Confidence 55555554444444444444455555555554443 112334444444444444444444444444444444444444
Q ss_pred CCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCC
Q 001922 535 QNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSG 588 (995)
Q Consensus 535 ~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g 588 (995)
+|++++.+|..+.+++.| +|+|++|++++.+|..+..+++|+.+++++|++.+
T Consensus 509 ~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 561 (606)
T 3t6q_A 509 HNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561 (606)
T ss_dssp SSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEEC
T ss_pred CCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccc
Confidence 444444444444444444 44444444444444444444444444444444443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=557.91 Aligned_cols=499 Identities=20% Similarity=0.279 Sum_probs=370.0
Q ss_pred ccccccchHHHHHHHHHhCCCCCCCCCCCCCCC---CCCC--cee------------eeEEeCC-CceeeeecCCCCccc
Q 001922 21 SAASLVNDFHVLVALKQGFENPEPALISWNSSN---PSSV--CSW------------AGICCSR-DRVASLDLTDLNLCG 82 (995)
Q Consensus 21 ~~~~~~~~~~~Ll~~k~~~~~~~~~l~~W~~~~---~~~~--C~w------------~gv~C~~-~~v~~l~l~~~~l~~ 82 (995)
.+++...|++||++||+++.+| +|+.++ ..++ |.| .||+|+. +||+.|+|+++++.|
T Consensus 263 ~~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G 337 (876)
T 4ecn_A 263 ETAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337 (876)
T ss_dssp CCCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEE
T ss_pred ccccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCC
Confidence 3455667999999999999887 897654 1234 999 9999984 899999999999999
Q ss_pred cCCccccCCCCCCeEec-cCCcccCccccCcccc------cc--eeccc----------ccccc-----------CCCcc
Q 001922 83 SVPAQILRLDKLTNLSL-AGNNFTGSIEIGNLSS------LQ--FLNIS----------NNQFS-----------GGLDW 132 (995)
Q Consensus 83 ~~~~~~~~l~~L~~L~L-~~n~l~~~~~~~~l~~------L~--~L~Ls----------~N~i~-----------~~~~~ 132 (995)
.+|+.|++|++|++|+| ++|.++|...+..... ++ .+... ...++ ...+.
T Consensus 338 ~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i 417 (876)
T 4ecn_A 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417 (876)
T ss_dssp EECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred cCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence 99999999999999999 8899887643331111 00 00000 00000 00011
Q ss_pred ccccccccccccccc--ccccccCCccccCCCCCceeeccCccccc-----------------cCCcccc--CCCCCcee
Q 001922 133 NYSSLVNLEVFDAYN--NNFTALLPVGILKLEKLKYLDLGGNYFFG-----------------KIPNSYG--ELQGLEYL 191 (995)
Q Consensus 133 ~~~~l~~L~~L~Ls~--n~i~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~l~--~l~~L~~L 191 (995)
.......++.+.+.. |++++ +|..|+++++|++|+|++|.+++ .+|..++ ++++|++|
T Consensus 418 ~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L 496 (876)
T 4ecn_A 418 KKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496 (876)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred ccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEE
Confidence 112223444444443 67777 67777777777777777777776 3677766 77777777
Q ss_pred eccCCcccccCcccccchhhhhhhhccccccccC-CCCcccCCCC-------cccEEECcCCCCCCccCc--cccCcccc
Q 001922 192 SLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEG-GIPREVGKLV-------NLVHLDLSSCELDGQIPH--EIGNLKLL 261 (995)
Q Consensus 192 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~-~~p~~~~~l~-------~L~~L~Ls~n~l~~~~~~--~~~~l~~L 261 (995)
+|++|++.+.+|..|+++++|++|+|++|+.+.+ .+|..++.++ +|++|+|++|+++ .+|. .++++++|
T Consensus 497 ~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L 575 (876)
T 4ecn_A 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKL 575 (876)
T ss_dssp EEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTC
T ss_pred ECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCC
Confidence 7777777777777777777777777776654555 5665554444 8888888888888 7777 78888888
Q ss_pred CccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCC-CCEEEccCCcCCCCCCccccCCCC--cceEEe
Q 001922 262 DTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQ-LKLFNLFMNRLHGSIPDYLADLPN--LETLGL 338 (995)
Q Consensus 262 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L 338 (995)
+.|++++|+++ .+| .|+.+++|+.|+|++|.++ .+|..+.++++ |+.|+|++|+++ .+|..+..++. |+.|+|
T Consensus 576 ~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~L 651 (876)
T 4ecn_A 576 GLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDF 651 (876)
T ss_dssp CEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEEC
T ss_pred CEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEEC
Confidence 88888888888 677 7888888888888888888 77778888888 888888888888 67777776654 888888
Q ss_pred ccCcccccCCCcc---c--CCCCCCeEEecCceecccCCCcCc-CCCccceeeccccccCCCCCccccc--------CCC
Q 001922 339 WQNNFTGVIPENL---G--QNGKLQVLDLSSNKLTGTIPTDLC-SSNQLRILILLKNFLFGPIPERLGA--------CYS 404 (995)
Q Consensus 339 ~~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~l~~--------l~~ 404 (995)
++|++++.+|... . .+++|+.|+|++|+++ .+|..+. .+++|+.|+|++|.+. .+|..+.. +++
T Consensus 652 s~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~ 729 (876)
T 4ecn_A 652 SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYL 729 (876)
T ss_dssp CSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGG
T ss_pred cCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCC
Confidence 8888887665322 2 3347888888888888 5666544 7788888888888887 45554333 338
Q ss_pred CcEEEecCCccCCCCCCCcc--cCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcE
Q 001922 405 LTRVRLGQNYLNGSIPDGFI--YLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQI 482 (995)
Q Consensus 405 L~~L~l~~N~l~~~~p~~~~--~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 482 (995)
|+.|+|++|+++ .+|..+. .++ +|+.|+|++|++++ +|..+.++++|+.
T Consensus 730 L~~L~Ls~N~L~-~lp~~l~~~~l~---------------------------~L~~L~Ls~N~L~~-lp~~l~~L~~L~~ 780 (876)
T 4ecn_A 730 LTTIDLRFNKLT-SLSDDFRATTLP---------------------------YLSNMDVSYNCFSS-FPTQPLNSSQLKA 780 (876)
T ss_dssp CCEEECCSSCCC-CCCGGGSTTTCT---------------------------TCCEEECCSSCCSS-CCCGGGGCTTCCE
T ss_pred ccEEECCCCCCc-cchHHhhhccCC---------------------------CcCEEEeCCCCCCc-cchhhhcCCCCCE
Confidence 999999999998 6777664 443 46666677777765 6777777778888
Q ss_pred EEcCC------CcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEe
Q 001922 483 LLLSG------NQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLN 556 (995)
Q Consensus 483 L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~ 556 (995)
|+|++ |++.+.+|..++.+++|+.|+|++|+| +.+|..+. ++|+.|||++|++...-+..+.....+..+.
T Consensus 781 L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~ 857 (876)
T 4ecn_A 781 FGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYV 857 (876)
T ss_dssp EECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCE
T ss_pred EECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchhee
Confidence 87765 888889999999999999999999999 68998876 6999999999999876677787777888899
Q ss_pred cccccccc
Q 001922 557 LSRNHLNQ 564 (995)
Q Consensus 557 L~~N~l~~ 564 (995)
|.+|++..
T Consensus 858 L~~n~~~~ 865 (876)
T 4ecn_A 858 LLYDKTQD 865 (876)
T ss_dssp EECCTTSE
T ss_pred ecCCCccc
Confidence 99988753
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-57 Score=548.26 Aligned_cols=493 Identities=18% Similarity=0.167 Sum_probs=443.1
Q ss_pred cccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeec
Q 001922 114 SSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSL 193 (995)
Q Consensus 114 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 193 (995)
.++++|+|++|.|+++.+..|.++++|++|+|++|+++++.|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 37899999999999999999999999999999999999999999999999999999999999899999999999999999
Q ss_pred cCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccC--ccccccccc
Q 001922 194 AGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLD--TVFLHINLL 271 (995)
Q Consensus 194 s~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~--~L~l~~N~l 271 (995)
++|++++..+..++++++|++|++++|.+.....|..+ .+++|++|++++|.+++..+..++.+++|+ .|++++|.+
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l 191 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF-PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTC-CCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCccccc-CCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence 99999988789999999999999998877654445544 499999999999999988889999999999 899999999
Q ss_pred cCCCCccccCcCCCCeEeccCCcCc--------------------------CcCCccccccC--CCCEEEccCCcCCCCC
Q 001922 272 SGSIPKQLGNLTNLVNLDLSNNALT--------------------------GEIPYSFINLR--QLKLFNLFMNRLHGSI 323 (995)
Q Consensus 272 ~~~~p~~l~~l~~L~~L~Ls~N~l~--------------------------~~~p~~~~~l~--~L~~L~L~~N~l~~~~ 323 (995)
++..|..+.. .+|+.|++++|... ...+..|.++. +|+.|++++|++++..
T Consensus 192 ~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~ 270 (606)
T 3t6q_A 192 AGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270 (606)
T ss_dssp CEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCC
T ss_pred CccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccC
Confidence 9887776654 68999999987510 12233344443 7899999999999888
Q ss_pred CccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCc-ccccC
Q 001922 324 PDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPE-RLGAC 402 (995)
Q Consensus 324 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~l~~l 402 (995)
+..|..+++|++|++++|+++ .+|..+..+++|++|++++|++++..|..+..+++|+.|++++|.+.+.+|. .+..+
T Consensus 271 ~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l 349 (606)
T 3t6q_A 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL 349 (606)
T ss_dssp TTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTC
T ss_pred HHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhcc
Confidence 888999999999999999999 7888999999999999999999988899999999999999999999877765 49999
Q ss_pred CCCcEEEecCCccCCCC--CCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCcc-ccCCCC
Q 001922 403 YSLTRVRLGQNYLNGSI--PDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFS-LSNFSS 479 (995)
Q Consensus 403 ~~L~~L~l~~N~l~~~~--p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~-~~~l~~ 479 (995)
++|++|++++|.+.+.. |..+..+++|+.+++++|.+.+..|.. +..+++|++|++++|++++..|.. +.++++
T Consensus 350 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 426 (606)
T 3t6q_A 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA---FKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426 (606)
T ss_dssp TTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTT---TTTCTTCSEEECTTCCEECCTTCCTTTTCTT
T ss_pred CcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHH---hcCCccCCeEECCCCcCCCcccchhhhCccc
Confidence 99999999999999877 889999999999999999998776653 456789999999999999876654 899999
Q ss_pred CcEEEcCCCcccCCCCCCccchhhhccccccccccCCC---CCCccCcccccceeeccCCcccCCCccccccccccCeEe
Q 001922 480 LQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGE---IPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLN 556 (995)
Q Consensus 480 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~ 556 (995)
|+.|++++|++++..|..++.+++|+.|+|++|.+++. .+..++.+++|++|+|++|++++..|..|.++++|++|+
T Consensus 427 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 506 (606)
T 3t6q_A 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506 (606)
T ss_dssp CCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEE
Confidence 99999999999999999999999999999999999862 346799999999999999999988899999999999999
Q ss_pred ccccccccccCcccccCCcccEEeccCCCCCCCCCCC-CCCcccccccCCCCccCCCC
Q 001922 557 LSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPES-GQFTVFNASSFAGNPQLCGT 613 (995)
Q Consensus 557 L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~~c~~ 613 (995)
|++|++++.+|..+..++.| .|++++|++++.+|.. +.+..+....+.|||+.|.+
T Consensus 507 Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 507 LSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp CCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred CCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 99999999999999999999 9999999999888853 34566778889999999973
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=554.43 Aligned_cols=522 Identities=22% Similarity=0.205 Sum_probs=450.3
Q ss_pred eecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCC-Cccccccccccccccccccc
Q 001922 73 LDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGG-LDWNYSSLVNLEVFDAYNNN 149 (995)
Q Consensus 73 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~Ls~n~ 149 (995)
.|.++++++ .+|. -.++|++|+|++|.|++.. .+.++++|++|+|++|.+.+. .+..|.++++|++|+|++|+
T Consensus 9 ~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~ 84 (844)
T 3j0a_A 9 AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84 (844)
T ss_dssp EEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCC
T ss_pred EEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCc
Confidence 455667776 4666 4579999999999999743 699999999999999965544 48899999999999999999
Q ss_pred ccccCCccccCCCCCceeeccCccccccCCcc--ccCCCCCceeeccCCcccccCc-ccccchhhhhhhhccccccccCC
Q 001922 150 FTALLPVGILKLEKLKYLDLGGNYFFGKIPNS--YGELQGLEYLSLAGNDLTGKIP-GELGNLTNLREIYLGYYNVFEGG 226 (995)
Q Consensus 150 i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~n~~~~~~ 226 (995)
|+++.|..|.++++|++|+|++|.+++.+|.. |+.+++|++|+|++|.+++..+ ..|+++++|++|+|++|.+ .+.
T Consensus 85 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i-~~~ 163 (844)
T 3j0a_A 85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI-FLV 163 (844)
T ss_dssp CCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCC-CCC
T ss_pred CcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcC-Cee
Confidence 99999999999999999999999999877765 9999999999999999998765 5799999999999997655 445
Q ss_pred CCcccCCC--CcccEEECcCCCCCCccCccccCccc------cCccccccccccCCCCccccCc---CCCCeEeccC---
Q 001922 227 IPREVGKL--VNLVHLDLSSCELDGQIPHEIGNLKL------LDTVFLHINLLSGSIPKQLGNL---TNLVNLDLSN--- 292 (995)
Q Consensus 227 ~p~~~~~l--~~L~~L~Ls~n~l~~~~~~~~~~l~~------L~~L~l~~N~l~~~~p~~l~~l---~~L~~L~Ls~--- 292 (995)
.+..+..+ ++|+.|+++.|.+.+..|..++.+.+ |+.|++++|.+++..+..+... ++++.|++++
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~ 243 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred CHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence 67777777 89999999999999988888777665 9999999999998888776543 5788888773
Q ss_pred ------CcCcCcCCcccccc--CCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecC
Q 001922 293 ------NALTGEIPYSFINL--RQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSS 364 (995)
Q Consensus 293 ------N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 364 (995)
|.+.+..+..|.++ ++|+.|++++|.+.+..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++
T Consensus 244 ~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~ 323 (844)
T 3j0a_A 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323 (844)
T ss_dssp BCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEES
T ss_pred cccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCC
Confidence 44454555666665 6899999999999988899999999999999999999999999999999999999999
Q ss_pred ceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCC
Q 001922 365 NKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLP 444 (995)
Q Consensus 365 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~ 444 (995)
|++++..|..+..+++|+.|++++|.+.+..+..+..+++|+.|++++|.+++.. .+++|+.+++++|+++ .+|
T Consensus 324 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~-----~~~~L~~L~l~~N~l~-~l~ 397 (844)
T 3j0a_A 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH-----FIPSIPDIFLSGNKLV-TLP 397 (844)
T ss_dssp CCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS-----SCCSCSEEEEESCCCC-CCC
T ss_pred CCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc-----CCCCcchhccCCCCcc-ccc
Confidence 9999888999999999999999999999988889999999999999999998532 3788999999999998 344
Q ss_pred CCCCCCCCCCCCcEEEcCCCcccccC-CccccCCCCCcEEEcCCCcccCCCCC-CccchhhhccccccccccC-----CC
Q 001922 445 ENGNSSSNPDRLGQLNLSNNLLSGPL-PFSLSNFSSLQILLLSGNQFSGPIPP-SIGELRQVLKLDLSRNSLS-----GE 517 (995)
Q Consensus 445 ~~~~~~~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~ 517 (995)
.. ...++.|++++|++++.. +..+.++++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +.
T Consensus 398 ~~------~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~ 471 (844)
T 3j0a_A 398 KI------NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETEL 471 (844)
T ss_dssp CC------CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCC
T ss_pred cc------ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCcccccccccc
Confidence 32 357899999999999642 23456899999999999999965543 4567899999999999997 44
Q ss_pred CCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCCCCCCCc
Q 001922 518 IPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFT 597 (995)
Q Consensus 518 ~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~ 597 (995)
.|..|..+++|++|+|++|+|++.+|..|.++++|+.|+|++|+|++..|..+. ++|+.|||++|+++|.+|.. +.
T Consensus 472 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~ 547 (844)
T 3j0a_A 472 CWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FV 547 (844)
T ss_dssp CSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CS
T ss_pred chhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hC
Confidence 556789999999999999999998888899999999999999999987777666 89999999999999999964 66
Q ss_pred ccccccCCCCccCCCCCC
Q 001922 598 VFNASSFAGNPQLCGTLL 615 (995)
Q Consensus 598 ~~~~~~~~~n~~~c~~~~ 615 (995)
.+....+.|||+.|++++
T Consensus 548 ~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 548 SLSVLDITHNKFICECEL 565 (844)
T ss_dssp SCCEEEEEEECCCCSSSC
T ss_pred CcCEEEecCCCccccccc
Confidence 777888999999997654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=541.62 Aligned_cols=527 Identities=21% Similarity=0.175 Sum_probs=415.9
Q ss_pred eeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCccccccccccccccccccc
Q 001922 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNN 149 (995)
Q Consensus 72 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~ 149 (995)
.++.++.+++ .+|..+. +++++|+|++|++++.. .+.++++|++|+|++|.++++.+..|.++++|++|+|++|+
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 3456666665 5676654 78999999999999754 58999999999999999999999999999999999999999
Q ss_pred ccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccc-cCcccccchhhhhhhhccccccccCCCC
Q 001922 150 FTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTG-KIPGELGNLTNLREIYLGYYNVFEGGIP 228 (995)
Q Consensus 150 i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~n~~~~~~~p 228 (995)
++++.|..|+++++|++|+|++|.+++..+..|+++++|++|+|++|++++ .+|..|+++++|++|++++|++.. ..|
T Consensus 92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~-~~~ 170 (606)
T 3vq2_A 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITV 170 (606)
T ss_dssp CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE-ECT
T ss_pred ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee-cCh
Confidence 999889999999999999999999987777889999999999999999986 569999999999999999776543 456
Q ss_pred cccCCCCccc----EEECcCCCCCCccCccccCccccCcccccccccc-CCCCccccCcCCCCeEeccCCcCcC------
Q 001922 229 REVGKLVNLV----HLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLS-GSIPKQLGNLTNLVNLDLSNNALTG------ 297 (995)
Q Consensus 229 ~~~~~l~~L~----~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~------ 297 (995)
..++.+++|+ +|++++|.+++..+..+... +|+.|++++|.++ +..|..+.++++|+.+++..+.+.+
T Consensus 171 ~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~ 249 (606)
T 3vq2_A 171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249 (606)
T ss_dssp TTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSC
T ss_pred hhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccc
Confidence 6677776665 89999999996666665554 8999999999886 4567788899999988886554432
Q ss_pred cCCccccccC--CCCEEEc-cCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCc
Q 001922 298 EIPYSFINLR--QLKLFNL-FMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTD 374 (995)
Q Consensus 298 ~~p~~~~~l~--~L~~L~L-~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 374 (995)
..+..+.++. .++.+++ ..|.+.+.+|. +..+++|+.|++++|.++ .+| .+..+++|++|++++|++ +.+| .
T Consensus 250 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~ 324 (606)
T 3vq2_A 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-T 324 (606)
T ss_dssp CCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-C
T ss_pred cChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccc-c
Confidence 1222233332 3455566 66777777776 778888888888888886 455 677788888888888888 5777 4
Q ss_pred CcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCC--CCCCcccCCCCceeeccCccccCCCCCCCCCCCC
Q 001922 375 LCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGS--IPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSN 452 (995)
Q Consensus 375 ~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~ 452 (995)
+ .+++|+.|++++|...+.+ .+..+++|+.|++++|.+++. +|..+..+++|+.+++++|.+++. | ..+..
T Consensus 325 ~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~---~~~~~ 397 (606)
T 3vq2_A 325 L-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-S---ANFMG 397 (606)
T ss_dssp C-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEE-C---CCCTT
T ss_pred C-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccc-h---hhccC
Confidence 4 7888888888888654433 566788888888888888766 377778888888888888887753 3 23455
Q ss_pred CCCCcEEEcCCCcccccCC-ccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCC-CCCCccCcccccce
Q 001922 453 PDRLGQLNLSNNLLSGPLP-FSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSG-EIPPAIGYCNHLTY 530 (995)
Q Consensus 453 ~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~ 530 (995)
+++|++|++++|++++..| ..+.++++|+.|++++|++++..|..++.+++|+.|+|++|.+++ .+|..++.+++|++
T Consensus 398 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 477 (606)
T 3vq2_A 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477 (606)
T ss_dssp CTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred CCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCE
Confidence 6788888888888887776 577888888888888888888888888888888888888888886 36888888888888
Q ss_pred eeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCCCCCCCc-ccccccCCCCcc
Q 001922 531 LDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFT-VFNASSFAGNPQ 609 (995)
Q Consensus 531 L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~-~~~~~~~~~n~~ 609 (995)
|+|++|++++.+|..+.++++|++|+|++|++++.+|..+..+++|+.|++++|+++..++....+. .+....+.|||+
T Consensus 478 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~ 557 (606)
T 3vq2_A 478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557 (606)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCC
T ss_pred EECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCc
Confidence 8888888888778888888888888888888888888888888888888888888884333333333 355667788888
Q ss_pred CCCCCC
Q 001922 610 LCGTLL 615 (995)
Q Consensus 610 ~c~~~~ 615 (995)
.|++++
T Consensus 558 ~c~c~~ 563 (606)
T 3vq2_A 558 ACICEH 563 (606)
T ss_dssp CCSSTT
T ss_pred ccCCcc
Confidence 887543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=532.87 Aligned_cols=511 Identities=19% Similarity=0.146 Sum_probs=450.8
Q ss_pred CceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCccccccccccccccc
Q 001922 68 DRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDA 145 (995)
Q Consensus 68 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L 145 (995)
.+++.|||+++++++..+..|.++++|++|+|++|++++.. .|.++++|++|+|++|++++..|..|.++++|++|++
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 36889999999999988889999999999999999999754 5899999999999999999999999999999999999
Q ss_pred ccccccccCCccccCCCCCceeeccCccccc-cCCccccCCCCCceeeccCCcccccCcccccchhhhh----hhhcccc
Q 001922 146 YNNNFTALLPVGILKLEKLKYLDLGGNYFFG-KIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLR----EIYLGYY 220 (995)
Q Consensus 146 s~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~----~L~L~~n 220 (995)
++|.++++.+..|+++++|++|+|++|.+++ .+|..|+++++|++|+|++|++++..|..++.+++|+ +|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 9999999888999999999999999999986 5799999999999999999999999999999999887 6999987
Q ss_pred ccccCCCCcccCCCCcccEEECcCCCCC-CccCccccCccccCccccccccccC------CCCccccCcC--CCCeEec-
Q 001922 221 NVFEGGIPREVGKLVNLVHLDLSSCELD-GQIPHEIGNLKLLDTVFLHINLLSG------SIPKQLGNLT--NLVNLDL- 290 (995)
Q Consensus 221 ~~~~~~~p~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~------~~p~~l~~l~--~L~~L~L- 290 (995)
.+.. ++.......+|++|++++|.++ +..|..+.+++.|+.+.+..+.+.+ ..+..+..+. .++.+++
T Consensus 192 ~l~~--~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 269 (606)
T 3vq2_A 192 PIDF--IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269 (606)
T ss_dssp CCCE--ECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEEC
T ss_pred Ccce--eCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecc
Confidence 7653 4555555559999999999997 4667888999999988886655432 1222333333 4667777
Q ss_pred cCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceeccc
Q 001922 291 SNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGT 370 (995)
Q Consensus 291 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 370 (995)
..|.+++..|. |..+++|+.|++++|.+. .+| .+..+++|+.|++++|++ +.+| .+ .+++|++|++++|+..+.
T Consensus 270 ~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~ 343 (606)
T 3vq2_A 270 YTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSIS 343 (606)
T ss_dssp CCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEE
T ss_pred ccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccc
Confidence 78889988887 999999999999999997 456 888999999999999999 5778 45 899999999999976655
Q ss_pred CCCcCcCCCccceeeccccccCCC--CCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCC
Q 001922 371 IPTDLCSSNQLRILILLKNFLFGP--IPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGN 448 (995)
Q Consensus 371 ~p~~~~~l~~L~~L~l~~N~l~~~--~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~ 448 (995)
+ .+..+++|+.|++++|.+.+. +|..+..+++|++|++++|.+.+ +|..+..+++|+.+++++|++.+..|..
T Consensus 344 ~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~-- 418 (606)
T 3vq2_A 344 F--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFS-- 418 (606)
T ss_dssp C--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTT--
T ss_pred h--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChh--
Confidence 4 677899999999999999876 48889999999999999999986 6688999999999999999999876532
Q ss_pred CCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccC-CCCCCccchhhhccccccccccCCCCCCccCcccc
Q 001922 449 SSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSG-PIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNH 527 (995)
Q Consensus 449 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 527 (995)
.+..+++|++|++++|++++..|..+.++++|+.|+|++|++++ .+|..++.+++|+.|+|++|++++..|..++.+++
T Consensus 419 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 498 (606)
T 3vq2_A 419 AFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498 (606)
T ss_dssp TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred hhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhccccc
Confidence 34567899999999999999999999999999999999999997 47999999999999999999999988999999999
Q ss_pred cceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCC-cccEEeccCCCCCCCCCC
Q 001922 528 LTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMK-SLTIADFSFNDFSGKLPE 592 (995)
Q Consensus 528 L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~l~ls~N~l~g~~p~ 592 (995)
|++|+|++|++++.+|..+.++++|++|+|++|+|+ .+|..+..++ +|+.+++++|++.+..+.
T Consensus 499 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 999999999999988999999999999999999998 4888899997 699999999999986663
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-54 Score=537.05 Aligned_cols=542 Identities=22% Similarity=0.190 Sum_probs=456.7
Q ss_pred ceeeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc---ccCcccccceeccccccccCCCcccc
Q 001922 58 CSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI---EIGNLSSLQFLNISNNQFSGGLDWNY 134 (995)
Q Consensus 58 C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~---~~~~l~~L~~L~Ls~N~i~~~~~~~~ 134 (995)
|.|..|-+-..+++.|||+++.+++..|..|.++++|++|+|++|.+.+.+ .+.++++|++|+|++|.|++..|..|
T Consensus 14 ~~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~ 93 (844)
T 3j0a_A 14 CNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF 93 (844)
T ss_dssp CCSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence 567777664468999999999999999999999999999999999776543 59999999999999999999999999
Q ss_pred cccccccccccccccccccCCcc--ccCCCCCceeeccCccccccCC-ccccCCCCCceeeccCCcccccCcccccch--
Q 001922 135 SSLVNLEVFDAYNNNFTALLPVG--ILKLEKLKYLDLGGNYFFGKIP-NSYGELQGLEYLSLAGNDLTGKIPGELGNL-- 209 (995)
Q Consensus 135 ~~l~~L~~L~Ls~n~i~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l-- 209 (995)
.++++|++|+|++|.+++..|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..++.+
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~ 173 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHH
T ss_pred cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccC
Confidence 99999999999999999866655 9999999999999999987655 579999999999999999999999999988
Q ss_pred hhhhhhhccccccccCCCCcccCCCCc------ccEEECcCCCCCCccCccccCc---cccCcccccc---------ccc
Q 001922 210 TNLREIYLGYYNVFEGGIPREVGKLVN------LVHLDLSSCELDGQIPHEIGNL---KLLDTVFLHI---------NLL 271 (995)
Q Consensus 210 ~~L~~L~L~~n~~~~~~~p~~~~~l~~------L~~L~Ls~n~l~~~~~~~~~~l---~~L~~L~l~~---------N~l 271 (995)
++|+.|+++.|.+. +..|..+..+.+ |++|++++|.+++..+..+... ..++.|.++. |.+
T Consensus 174 ~~L~~L~L~~n~l~-~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l 252 (844)
T 3j0a_A 174 KTLSFFSLAANSLY-SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252 (844)
T ss_dssp CSSCCCEECCSBSC-CCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSS
T ss_pred CccceEECCCCccc-cccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccccc
Confidence 89999999976654 456666666555 9999999999998888877653 5667777663 334
Q ss_pred cCCCCccccCc--CCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCC
Q 001922 272 SGSIPKQLGNL--TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPE 349 (995)
Q Consensus 272 ~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 349 (995)
.+..+..|.++ ++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..|.
T Consensus 253 ~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 332 (844)
T 3j0a_A 253 KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332 (844)
T ss_dssp TTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSC
T ss_pred CCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHH
Confidence 43444455554 6899999999999999999999999999999999999998899999999999999999999988899
Q ss_pred cccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCC
Q 001922 350 NLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGL 429 (995)
Q Consensus 350 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 429 (995)
.|..+++|++|+|++|++++..+..|..+++|+.|++++|.+.+. ..+++|+.|++++|++. .+|.. ...+
T Consensus 333 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~---~~~l 403 (844)
T 3j0a_A 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI---NLTA 403 (844)
T ss_dssp SCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---CTTC
T ss_pred HhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---cccc
Confidence 999999999999999999988888899999999999999998653 33789999999999998 44544 4678
Q ss_pred ceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCc-cccCCCCCcEEEcCCCccc-----CCCCCCccchhh
Q 001922 430 NLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPF-SLSNFSSLQILLLSGNQFS-----GPIPPSIGELRQ 503 (995)
Q Consensus 430 ~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~ 503 (995)
+.++++.|++++.-.. .....+++|++|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|..+++
T Consensus 404 ~~L~ls~N~l~~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~ 481 (844)
T 3j0a_A 404 NLIHLSENRLENLDIL--YFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481 (844)
T ss_dssp CEEECCSCCCCSSTTH--HHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCC
T ss_pred ceeecccCccccCchh--hhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCccc
Confidence 9999999999864211 1123568899999999999965544 4567899999999999997 455677899999
Q ss_pred hccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccC
Q 001922 504 VLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSF 583 (995)
Q Consensus 504 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~ 583 (995)
|+.|+|++|+|++..|..|..+++|++|+|++|+|++..|..+. ++|+.|+|++|+|++.+|..+ .+|+.+++++
T Consensus 482 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~ 556 (844)
T 3j0a_A 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITH 556 (844)
T ss_dssp EECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEE
T ss_pred ccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecC
Confidence 99999999999998889999999999999999999976666665 899999999999999988776 4789999999
Q ss_pred CCCCCCCCCCCCCcccccccCCCCccCCCCCCCCCCC
Q 001922 584 NDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNNPCN 620 (995)
Q Consensus 584 N~l~g~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~c~ 620 (995)
|++.+..+.. .|......+|..+||.+....|.
T Consensus 557 Np~~C~c~~~----~f~~~~~~~~~~~~~~~~~~~C~ 589 (844)
T 3j0a_A 557 NKFICECELS----TFINWLNHTNVTIAGPPADIYCV 589 (844)
T ss_dssp ECCCCSSSCC----SHHHHHHHTTTTTCCCGGGCCCS
T ss_pred CCcccccccH----HHHHHHHhcCcccccccccCccC
Confidence 9998766532 22211123455555555444554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=494.29 Aligned_cols=505 Identities=20% Similarity=0.162 Sum_probs=415.7
Q ss_pred ecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCccccccccccccccccccccc
Q 001922 74 DLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFT 151 (995)
Q Consensus 74 ~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~ 151 (995)
+.++.+++ .+|..+. +++++|+|++|++++.. .+.++++|++|+|++|+++++.+..|.++++|++|++++|+++
T Consensus 13 ~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~ 89 (570)
T 2z63_A 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89 (570)
T ss_dssp ECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred EeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCC
Confidence 33344444 4666543 57999999999998754 6899999999999999999988899999999999999999999
Q ss_pred ccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccc-cCcccccchhhhhhhhccccccccCCCCcc
Q 001922 152 ALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTG-KIPGELGNLTNLREIYLGYYNVFEGGIPRE 230 (995)
Q Consensus 152 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~ 230 (995)
++.|..|.++++|++|++++|++++..+..|+.+++|++|+|++|.+++ .+|..|+++++|++|++++|.+. +..+..
T Consensus 90 ~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~-~~~~~~ 168 (570)
T 2z63_A 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTD 168 (570)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCC-EECGGG
T ss_pred ccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccc-eecHHH
Confidence 9888999999999999999999986666679999999999999999987 46888999999999999876654 345667
Q ss_pred cCCCCcc----cEEECcCCCCCCccCccccCccccCccccccccccC-CCCccccCcCCCCeEeccCCcC------cCcC
Q 001922 231 VGKLVNL----VHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSG-SIPKQLGNLTNLVNLDLSNNAL------TGEI 299 (995)
Q Consensus 231 ~~~l~~L----~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l------~~~~ 299 (995)
+..+++| +.|++++|.+++..|..+..+ +|+.|++++|.... .++..+..+++++.+.+..+.+ ....
T Consensus 169 ~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~ 247 (570)
T 2z63_A 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247 (570)
T ss_dssp GHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECC
T ss_pred ccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcc
Confidence 7777777 889999999988777777766 78888888875432 2445566777777666543322 2223
Q ss_pred CccccccCC--CCEEEccCC-cCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCc
Q 001922 300 PYSFINLRQ--LKLFNLFMN-RLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLC 376 (995)
Q Consensus 300 p~~~~~l~~--L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 376 (995)
...|.++.+ ++.+++++| .+.+..|..+..+++|+.|++++|.++ .+|..+..+ +|++|++++|.+. .+|. .
T Consensus 248 ~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~ 322 (570)
T 2z63_A 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--L 322 (570)
T ss_dssp TTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--C
T ss_pred hhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--c
Confidence 334444443 466777777 777788888888899999999999988 578788888 8999999999988 6665 4
Q ss_pred CCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCC--CCCcccCCCCceeeccCccccCCCCCCCCCCCCCC
Q 001922 377 SSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSI--PDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPD 454 (995)
Q Consensus 377 ~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~--p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~ 454 (995)
.+++|+.|++++|.+.+..+. ..+++|++|++++|.+.+.. |..+..+++|+.+++++|.+.+..+. +..++
T Consensus 323 ~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~----~~~l~ 396 (570)
T 2z63_A 323 KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN----FLGLE 396 (570)
T ss_dssp BCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE----EETCT
T ss_pred cccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc----ccccC
Confidence 678899999999988776665 77889999999999988654 67788889999999999988765432 34567
Q ss_pred CCcEEEcCCCcccccCC-ccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccC-CCCCCccCcccccceee
Q 001922 455 RLGQLNLSNNLLSGPLP-FSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLS-GEIPPAIGYCNHLTYLD 532 (995)
Q Consensus 455 ~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ 532 (995)
+|++|++++|++++..| ..+.++++|+.|++++|++++..|..+..+++|+.|+|++|.++ +.+|..++.+++|++|+
T Consensus 397 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~ 476 (570)
T 2z63_A 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476 (570)
T ss_dssp TCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEE
Confidence 89999999999997766 57889999999999999999889999999999999999999997 57899999999999999
Q ss_pred ccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCCCCC
Q 001922 533 MSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESG 594 (995)
Q Consensus 533 Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~ 594 (995)
|++|++++..|..+.++++|++|+|++|++++.+|..+..+++|+.+++++|+++|.+|...
T Consensus 477 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred CCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence 99999998889999999999999999999999888889999999999999999999988643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=450.78 Aligned_cols=258 Identities=22% Similarity=0.356 Sum_probs=216.7
Q ss_pred hccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
.++..+.||+|+||+||+|++. +++.||||++.........+.|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566788999999999999862 4688999999765555566789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC
Q 001922 761 VYEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE 826 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~ 826 (995)
|||||++|+|.+++.... ...+++..+.+++.|||+||+|||+++ ||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999996432 246899999999999999999999877 999999999999999999
Q ss_pred eEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHH
Q 001922 827 AHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKR 905 (995)
Q Consensus 827 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 905 (995)
+||+|||+|+.+...+.........||++|||||++.++.|+.++|||||||++|||+| |+.||..... .+....
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~----~~~~~~ 259 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVVEM 259 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----HHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence 99999999987755444444456789999999999999999999999999999999999 8999965432 222222
Q ss_pred HhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 906 ATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 906 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
+..+ .....|.+++..+.+++.+||+.||++||||+||++.|+++.
T Consensus 260 i~~~-----------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 260 IRNR-----------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHTT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHcC-----------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 2222 122245567788999999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=451.73 Aligned_cols=262 Identities=24% Similarity=0.405 Sum_probs=216.6
Q ss_pred hhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
++|...+.||+|+||+||+|++. +++.||||++... .....++|.+|++++++++|||||+++++|.+++..|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 46778899999999999999763 4788999999543 3344667999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeE
Q 001922 760 LVYEYMRNGSLGEALHGK-----------KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAH 828 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vk 828 (995)
+|||||++|+|.++++.. ....+++..+.+++.||++||+|||+++ ||||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 999999999999999642 2357999999999999999999999877 99999999999999999999
Q ss_pred EeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHh
Q 001922 829 VADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRAT 907 (995)
Q Consensus 829 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 907 (995)
|+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+....+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~----~~~~~~i~ 244 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NEVIECIT 244 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH
Confidence 999999987654443333345679999999999999999999999999999999999 9999975432 22222222
Q ss_pred cCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 908 NGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 908 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
.+ .....|..++..+.+++.+||+.||++|||++||++.|+++.+..+
T Consensus 245 ~~-----------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 245 QG-----------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp HT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred cC-----------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 22 1122345567789999999999999999999999999998765443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=452.56 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=209.0
Q ss_pred hhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
+.|...++||+|+||+||+|++. +++.||||++.. ......++|.+|++++++++|||||+++++|.+++..|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34666788999999999999864 478899999954 23444677999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC
Q 001922 760 LVYEYMRNGSLGEALHGKK-------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE 826 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~ 826 (995)
+|||||++|+|.++++... ...+++..+.+|+.|||.||+|||+.+ ||||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 9999999999999997432 346899999999999999999999877 999999999999999999
Q ss_pred eEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHH
Q 001922 827 AHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKR 905 (995)
Q Consensus 827 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~ 905 (995)
+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+....
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~----~~~~~~ 272 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN----TEAIDC 272 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH----HHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH----HHHHHH
Confidence 99999999997655444444456789999999999999999999999999999999999 9999975432 222222
Q ss_pred HhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 906 ATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 906 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
+..+. ....|..++..+.+++.+||+.||++|||++||+++|+.+.+..+
T Consensus 273 i~~g~-----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 273 ITQGR-----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp HHHTC-----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred HHcCC-----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 22211 112344567789999999999999999999999999999876543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=444.16 Aligned_cols=263 Identities=30% Similarity=0.430 Sum_probs=208.5
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++++..+.||+|+||+||+|++.. .||||+++... .....+.|.+|++++++++|||||++++++.+ +..|+||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 356678899999999999998743 69999985432 23345679999999999999999999998864 568999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
|++|+|.++++.. ...+++..+.+|+.|||.||+|||+++ ||||||||+|||+++++.+||+|||+|+........
T Consensus 113 ~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999999999743 456999999999999999999999877 999999999999999999999999999876544444
Q ss_pred ccccccccCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 845 ECMSAIAGSYGYIAPEYAYT---LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
......+||+.|||||++.+ +.|+.++|||||||++|||+||+.||.+......+... +..+ ...+.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~---~~~~-------~~~p~ 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM---VGRG-------YASPD 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH---HHTT-------CCCCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH---HhcC-------CCCCC
Confidence 44456789999999999864 46899999999999999999999999764433222221 1111 12233
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
....+.+++..+.+++.+||+.||++||||+||++.|+.++..-
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 33445567788999999999999999999999999998876543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-51 Score=487.22 Aligned_cols=488 Identities=20% Similarity=0.222 Sum_probs=319.7
Q ss_pred CceeeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCcccc
Q 001922 57 VCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNY 134 (995)
Q Consensus 57 ~C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~ 134 (995)
.|.|.|| |+ +++++++ .+|+.+. ++|++|+|++|++++.. .+.++++|++|+|++|++++..+..|
T Consensus 3 ~C~~~~~-c~--------~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~ 70 (549)
T 2z81_A 3 SCDASGV-CD--------GRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70 (549)
T ss_dssp EECTTSE-EE--------CTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTT
T ss_pred cCCCCce-EE--------CCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhc
Confidence 5999998 74 4455555 5777654 68899999999888743 58888888888888888888888888
Q ss_pred cccccccccccccccccccCCccccCCCCCceeeccCccccc-cCCccccCCCCCceeeccCCcccccC-cccccchhhh
Q 001922 135 SSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFG-KIPNSYGELQGLEYLSLAGNDLTGKI-PGELGNLTNL 212 (995)
Q Consensus 135 ~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L 212 (995)
.++++|++|++++|++++..|..|+++++|++|+|++|.+++ ..|..|+.+++|++|++++|++.+.+ +..|+++++|
T Consensus 71 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L 150 (549)
T 2z81_A 71 YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150 (549)
T ss_dssp TTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEE
T ss_pred cccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccccc
Confidence 888888888888888888777778888888888888888875 35667888888888888888743333 3566666666
Q ss_pred hhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCC--C-ccccCcCCCCeEe
Q 001922 213 REIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSI--P-KQLGNLTNLVNLD 289 (995)
Q Consensus 213 ~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--p-~~l~~l~~L~~L~ 289 (995)
++|++++|.+ .+..|..+..+++|++|+++.|.+.......+..+++|++|++++|++++.. | .....+++|+.|+
T Consensus 151 ~~L~L~~n~l-~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~ 229 (549)
T 2z81_A 151 NELEIKALSL-RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229 (549)
T ss_dssp EEEEEEETTC-CEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEE
T ss_pred CeeeccCCcc-cccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhccccee
Confidence 6666665443 3345566666666666666666655322222234566666666666665431 1 1223345566666
Q ss_pred ccCCcCcCcCCc----cccccCCCCEEEccCCcCCCCC------CccccCCCCcceEEeccCccccc-----CCCcccCC
Q 001922 290 LSNNALTGEIPY----SFINLRQLKLFNLFMNRLHGSI------PDYLADLPNLETLGLWQNNFTGV-----IPENLGQN 354 (995)
Q Consensus 290 Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~------p~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l 354 (995)
+++|.+++..+. .+..+++|+.+++++|.+.+.. ...+..+++|+.|+++++.+... ++..+...
T Consensus 230 l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~ 309 (549)
T 2z81_A 230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL 309 (549)
T ss_dssp EESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHS
T ss_pred ccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhc
Confidence 666655543322 2234455555555555554321 11233444555555555544321 01111222
Q ss_pred CCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCC---CCcccCCCCce
Q 001922 355 GKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIP---DGFIYLPGLNL 431 (995)
Q Consensus 355 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~ 431 (995)
.+|+.|++++|+++ .+|..+. ..+++|++|++++|++.+.+| ..+..+++|+.
T Consensus 310 ~~L~~L~l~~n~l~-~ip~~~~-----------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~ 365 (549)
T 2z81_A 310 EKVKRITVENSKVF-LVPCSFS-----------------------QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365 (549)
T ss_dssp TTCCEEEEESSCCC-CCCHHHH-----------------------HHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCE
T ss_pred ccceEEEeccCccc-cCCHHHH-----------------------hcCccccEEEccCCccccccccchhhhhccccCcE
Confidence 34444444444444 3333331 345555555555555554432 22444555555
Q ss_pred eeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccc
Q 001922 432 AELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSR 511 (995)
Q Consensus 432 l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 511 (995)
+++++|++++..+. ......+++|++|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+. ++|+.|+|++
T Consensus 366 L~Ls~N~l~~~~~~-~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~ 440 (549)
T 2z81_A 366 LVLSQNHLRSMQKT-GEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSN 440 (549)
T ss_dssp EECTTSCCCCHHHH-HHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCS
T ss_pred EEccCCcccccccc-hhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCC
Confidence 55555555432110 001234567888888999888 67888888999999999999988 4554442 5899999999
Q ss_pred cccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCC
Q 001922 512 NSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLP 591 (995)
Q Consensus 512 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p 591 (995)
|+|++.+ +.+++|++|+|++|+|+ .+|. ...+++|++|+|++|+|++.+|..+..+++|+.|++++|++.+..|
T Consensus 441 N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 441 NNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp SCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 9998642 57889999999999998 7886 5788999999999999999888889999999999999999988777
Q ss_pred C
Q 001922 592 E 592 (995)
Q Consensus 592 ~ 592 (995)
.
T Consensus 515 ~ 515 (549)
T 2z81_A 515 R 515 (549)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=479.49 Aligned_cols=488 Identities=22% Similarity=0.190 Sum_probs=419.8
Q ss_pred ceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCcccccccccccccccc
Q 001922 69 RVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAY 146 (995)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls 146 (995)
+++.|||+++++++..+..|.++++|++|+|++|++++.. .+.++++|++|+|++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 6889999999999888889999999999999999999754 58999999999999999999999999999999999999
Q ss_pred cccccccCCccccCCCCCceeeccCccccc-cCCccccCCCCCceeeccCCcccccCcccccchhhh----hhhhccccc
Q 001922 147 NNNFTALLPVGILKLEKLKYLDLGGNYFFG-KIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNL----REIYLGYYN 221 (995)
Q Consensus 147 ~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L----~~L~L~~n~ 221 (995)
+|+++++.+..|+++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..+..++.+++| +.|++++|.
T Consensus 109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~ 188 (570)
T 2z63_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (570)
T ss_dssp TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred ccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCC
Confidence 999999877789999999999999999987 479999999999999999999999889999999999 889999766
Q ss_pred cccCCCCcccCCCCcccEEECcCCCCCC-ccCccccCccccCcccccccccc------CCCCccccCcC--CCCeEeccC
Q 001922 222 VFEGGIPREVGKLVNLVHLDLSSCELDG-QIPHEIGNLKLLDTVFLHINLLS------GSIPKQLGNLT--NLVNLDLSN 292 (995)
Q Consensus 222 ~~~~~~p~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~------~~~p~~l~~l~--~L~~L~Ls~ 292 (995)
+. +..|..+..+ +|+.|++++|.... .++..+..++.++.+.+..+.+. ......+..+. .++.+++++
T Consensus 189 l~-~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 189 MN-FIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CC-EECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred ce-ecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 54 3445555555 89999999986542 34555666666666555433222 12222333333 357788888
Q ss_pred C-cCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccC
Q 001922 293 N-ALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTI 371 (995)
Q Consensus 293 N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 371 (995)
| .+.+..|..|..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.++ .+|. ..+++|++|++++|.+.+..
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~ 341 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAF 341 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBC
T ss_pred chhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccc
Confidence 8 788888999999999999999999998 588888888 9999999999998 5554 57889999999999988776
Q ss_pred CCcCcCCCccceeeccccccCCCC--CcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCC
Q 001922 372 PTDLCSSNQLRILILLKNFLFGPI--PERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNS 449 (995)
Q Consensus 372 p~~~~~l~~L~~L~l~~N~l~~~~--p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~ 449 (995)
+. ..+++|+.|++++|.+.+.. |..+..+++|+.|++++|.+.+..+. +..+++|+.+++++|.+.+..+.. .
T Consensus 342 ~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~--~ 416 (570)
T 2z63_A 342 SE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFS--V 416 (570)
T ss_dssp CC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSC--T
T ss_pred cc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchh--h
Confidence 65 77899999999999987654 77888999999999999999876655 889999999999999998765532 3
Q ss_pred CCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCccc-CCCCCCccchhhhccccccccccCCCCCCccCccccc
Q 001922 450 SSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFS-GPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHL 528 (995)
Q Consensus 450 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 528 (995)
+..+++|++|++++|++++..|..+.++++|+.|+|++|+++ +.+|..++.+++|+.|+|++|++++..|..++.+++|
T Consensus 417 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 496 (570)
T 2z63_A 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496 (570)
T ss_dssp TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred hhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCC
Confidence 456789999999999999999999999999999999999998 6789999999999999999999998889999999999
Q ss_pred ceeeccCCcccCCCccccccccccCeEeccccccccccCc
Q 001922 529 TYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPK 568 (995)
Q Consensus 529 ~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~ 568 (995)
++|+|++|++++..|..+.++++|+.|+|++|++++..|.
T Consensus 497 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 497 QVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 9999999999988888899999999999999999987664
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=445.54 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=206.5
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
++|+..+.||+|+||+||+|++ .+|+.||||++.... .....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5789999999999999999976 469999999995433 23345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
||+||+|.+++....+..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 999999999998666677899999999999999999999887 999999999999999999999999999875321
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||... +..+....+... ...
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~----~~~~~~~~i~~~-----------~~~ 243 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG----SMKNLVLKIISG-----------SFP 243 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHT-----------CCC
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHHHHHcC-----------CCC
Confidence 12234568999999999999999999999999999999999999999643 222222222222 112
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+||+.||++|||++|++++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2333456678999999999999999999999863
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=478.27 Aligned_cols=481 Identities=20% Similarity=0.198 Sum_probs=318.2
Q ss_pred EeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccc
Q 001922 97 LSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFG 176 (995)
Q Consensus 97 L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~ 176 (995)
.+.++|+++.... .-.++|++|+|++|++++..+..|.++++|++|++++|+++++.|..|.++++|++|+|++|++++
T Consensus 10 c~~~~~~l~~ip~-~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~ 88 (549)
T 2z81_A 10 CDGRSRSFTSIPS-GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSS 88 (549)
T ss_dssp EECTTSCCSSCCS-CCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCS
T ss_pred EECCCCccccccc-cCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCc
Confidence 4555565554321 112556666666666665555556666666666666666666555556666666666666666655
Q ss_pred cCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccC-ccc
Q 001922 177 KIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIP-HEI 255 (995)
Q Consensus 177 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~-~~~ 255 (995)
..|..|+.+++|++|+|++|++++ ...|..+.++++|++|++++|.+.+.+| ..+
T Consensus 89 ~~~~~~~~l~~L~~L~Ls~n~l~~------------------------~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~ 144 (549)
T 2z81_A 89 LSSSWFGPLSSLKYLNLMGNPYQT------------------------LGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144 (549)
T ss_dssp CCHHHHTTCTTCCEEECTTCCCSS------------------------SCSSCSCTTCTTCCEEEEEESSSCCEECTTTT
T ss_pred cCHHHhccCCCCcEEECCCCcccc------------------------cchhhhhhccCCccEEECCCCccccccCHhhh
Confidence 444455566666666666665553 2233444445555555555555222222 345
Q ss_pred cCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCC--C-ccccCCCC
Q 001922 256 GNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSI--P-DYLADLPN 332 (995)
Q Consensus 256 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p-~~~~~l~~ 332 (995)
..+++|++|++++|.+++..|..+..+++|++|++++|.+.......+..+++|+.|++++|++++.. | .....+++
T Consensus 145 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~ 224 (549)
T 2z81_A 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224 (549)
T ss_dssp TTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCC
T ss_pred hcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhc
Confidence 55555555555555555555555555555555555555554222222234555555555555555431 1 12233556
Q ss_pred cceEEeccCcccccCC----CcccCCCCCCeEEecCceecccC------CCcCcCCCccceeeccccccCC-----CCCc
Q 001922 333 LETLGLWQNNFTGVIP----ENLGQNGKLQVLDLSSNKLTGTI------PTDLCSSNQLRILILLKNFLFG-----PIPE 397 (995)
Q Consensus 333 L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~------p~~~~~l~~L~~L~l~~N~l~~-----~~p~ 397 (995)
|+.|++++|.+++..+ ..+..+++|+.|++++|.+.+.. ...+..+.+|+.|++.++.+.. .++.
T Consensus 225 L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~ 304 (549)
T 2z81_A 225 MKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304 (549)
T ss_dssp CCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCH
T ss_pred ccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchh
Confidence 6666666666654332 22344556666666666665421 1223455666666666665432 2233
Q ss_pred ccccCCCCcEEEecCCccCCCCCCCc-ccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCC--ccc
Q 001922 398 RLGACYSLTRVRLGQNYLNGSIPDGF-IYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLP--FSL 474 (995)
Q Consensus 398 ~l~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p--~~~ 474 (995)
.+....+|++|++++|.+. .+|..+ ..+++|+.+++++|++++.+|........+++|++|+|++|++++..+ ..+
T Consensus 305 ~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 383 (549)
T 2z81_A 305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383 (549)
T ss_dssp HHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHG
T ss_pred hhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhh
Confidence 3445678999999999997 566665 579999999999999998765443445667899999999999986533 468
Q ss_pred cCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCe
Q 001922 475 SNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNY 554 (995)
Q Consensus 475 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~ 554 (995)
..+++|+.|+|++|+++ .+|..++.+++|+.|+|++|+++ .+|..+. ++|++|+|++|++++.+ ..+++|++
T Consensus 384 ~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~ 455 (549)
T 2z81_A 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQE 455 (549)
T ss_dssp GGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCE
T ss_pred hcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcE
Confidence 89999999999999999 78999999999999999999998 4665553 68999999999999743 57899999
Q ss_pred EeccccccccccCcccccCCcccEEeccCCCCCCCCCC-CCCCcccccccCCCCccCCCC
Q 001922 555 LNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPE-SGQFTVFNASSFAGNPQLCGT 613 (995)
Q Consensus 555 L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~~c~~ 613 (995)
|+|++|+|+ .+|. ...+++|+.|++++|++++.+|. .+.+..+....+.|||+.|.+
T Consensus 456 L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 456 LYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp EECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred EECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 999999998 5776 57899999999999999998886 356777788899999998873
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=484.45 Aligned_cols=460 Identities=20% Similarity=0.237 Sum_probs=323.6
Q ss_pred cccceeccccccccCCCcccccccccccccccccccccc------------cCCccccCCCCCceeeccCccccccCCcc
Q 001922 114 SSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTA------------LLPVGILKLEKLKYLDLGGNYFFGKIPNS 181 (995)
Q Consensus 114 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~------------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 181 (995)
.+++.|+|++|.++|.+|..++++++|++|+|++|.+.. .+|... +.+|+ +++++|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 467788888888887777777777777777777776521 122222 23344 555555555544444
Q ss_pred ccC-CCCCceeeccCCcccccCcccccchhhhhhhhccc-cccccCCCCcccCCCCcccEEECcCCCCCCc---------
Q 001922 182 YGE-LQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGY-YNVFEGGIPREVGKLVNLVHLDLSSCELDGQ--------- 250 (995)
Q Consensus 182 l~~-l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~-n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~--------- 250 (995)
+.. +..+..+++....+.. .....++.++++. +|.+.+ +|..++++++|++|+|++|.+++.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~ 230 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE 230 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred HHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc
Confidence 432 1222333333222221 1112333344432 344444 677777777777777777777764
Q ss_pred --------cCcccc--CccccCccccccccccCCCCccccCcCCCCeEeccCCc-CcC-cCCcccccc------CCCCEE
Q 001922 251 --------IPHEIG--NLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNA-LTG-EIPYSFINL------RQLKLF 312 (995)
Q Consensus 251 --------~~~~~~--~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l------~~L~~L 312 (995)
+|..++ ++++|++|++++|.+.+.+|..++++++|++|+|++|+ +++ .+|..+..+ ++|+.|
T Consensus 231 ~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L 310 (636)
T 4eco_A 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310 (636)
T ss_dssp TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEE
T ss_pred ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEE
Confidence 677776 77777777777777777777777777777777777776 776 667666665 777777
Q ss_pred EccCCcCCCCCCc--cccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCc-cceeecccc
Q 001922 313 NLFMNRLHGSIPD--YLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQ-LRILILLKN 389 (995)
Q Consensus 313 ~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~l~~N 389 (995)
++++|+++ .+|. .+..+++|++|++++|+++|.+| .++.+++|++|+|++|+++ .+|..+..+++ |+.|++++|
T Consensus 311 ~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N 387 (636)
T 4eco_A 311 YIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHN 387 (636)
T ss_dssp ECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSS
T ss_pred ECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCC
Confidence 77777777 6666 67777777777777777776667 6777777777777777777 66666777766 777777777
Q ss_pred ccCCCCCcccccCC--CCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCccc
Q 001922 390 FLFGPIPERLGACY--SLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLS 467 (995)
Q Consensus 390 ~l~~~~p~~l~~l~--~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~ 467 (995)
.+. .+|..+..+. +|+.|++++|.+.+.+|..+.... .......+|++|+|++|+++
T Consensus 388 ~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~--------------------~~~~~~~~L~~L~Ls~N~l~ 446 (636)
T 4eco_A 388 KLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD--------------------PTPFKGINVSSINLSNNQIS 446 (636)
T ss_dssp CCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTC--------------------SSCCCCCCEEEEECCSSCCC
T ss_pred cCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccc--------------------cccccCCCCCEEECcCCccC
Confidence 766 5666665544 667777777776666665543110 01113457899999999999
Q ss_pred ccCCccccCCCCCcEEEcCCCcccCCCCCCccc-h-------hhhccccccccccCCCCCCccC--cccccceeeccCCc
Q 001922 468 GPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGE-L-------RQVLKLDLSRNSLSGEIPPAIG--YCNHLTYLDMSQNN 537 (995)
Q Consensus 468 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~ 537 (995)
+..+..+..+++|+.|+|++|+++ .+|..+.. . ++|+.|+|++|+++ .+|..+. .+++|++|+|++|+
T Consensus 447 ~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~ 524 (636)
T 4eco_A 447 KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNS 524 (636)
T ss_dssp SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSC
T ss_pred cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCC
Confidence 544444667999999999999999 66655443 2 39999999999999 7999887 99999999999999
Q ss_pred ccCCCccccccccccCeEec------cccccccccCcccccCCcccEEeccCCCCCCCCCCCCCCcccccccCCCCccCC
Q 001922 538 LSGSIPPEISNVRILNYLNL------SRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLC 611 (995)
Q Consensus 538 l~~~ip~~l~~l~~L~~L~L------~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c 611 (995)
+++ +|..+.++++|+.|+| ++|++.+.+|..+..+++|+.|++++|++ +.+|..- ...+....+.+||..|
T Consensus 525 l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 525 FSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI-TPNISVLDIKDNPNIS 601 (636)
T ss_dssp CSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CTTCCEEECCSCTTCE
T ss_pred CCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhH-hCcCCEEECcCCCCcc
Confidence 997 9999999999999999 56889999999999999999999999999 7888652 3667788899999887
Q ss_pred C
Q 001922 612 G 612 (995)
Q Consensus 612 ~ 612 (995)
-
T Consensus 602 ~ 602 (636)
T 4eco_A 602 I 602 (636)
T ss_dssp E
T ss_pred c
Confidence 5
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=431.36 Aligned_cols=249 Identities=21% Similarity=0.249 Sum_probs=210.2
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
++|+..+.||+|+||+||+|+. .+|+.||||++.+. ......+.+.+|++++++++|||||+++++|++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688999999999999999976 56899999998532 12334567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
|||+||+|.+++.. .+.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999999963 457999999999999999999999887 9999999999999999999999999999876544
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
......+.+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..+....+.... +
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~----~~~~~~~~i~~~~-----------~ 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NEGLIFAKIIKLE-----------Y 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTC-----------C
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCC-----------C
Confidence 444456779999999999999999999999999999999999999999642 2222222222221 1
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVV 955 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 955 (995)
..|...+..+.+++.+|++.||++|||++|+.
T Consensus 252 -~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12334456789999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=435.02 Aligned_cols=250 Identities=21% Similarity=0.304 Sum_probs=208.3
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.|+..+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++|||||+++++|.+++..||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 46888889999999999999764 69999999985432 33456688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
|+||+|.+++.. ..+++..++.++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 153 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 999999999964 35899999999999999999999887 9999999999999999999999999998764332
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+....+... ..+.. .
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~--------~~~~~-~ 291 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMIRDN--------LPPRL-K 291 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHS--------SCCCC-S
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHHcC--------CCCCC-C
Confidence 23356789999999999999999999999999999999999999996532 12222222211 11111 1
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+...+..+.+++.+||+.||++|||++|++++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 223456678999999999999999999999763
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=432.96 Aligned_cols=254 Identities=24% Similarity=0.274 Sum_probs=206.9
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.+.|+..++||+|+||+||+|++ .+|+.||||++..... ..+|+.++++++|||||++++++.+++..|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35677888999999999999986 4689999999954221 2469999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-CeEEeeeccccccccCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLAKFLIDGG 842 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-~vkl~DfGla~~~~~~~ 842 (995)
||+||+|.++++. .+.+++..+..++.||+.||+|||+++ ||||||||+|||++.+| .+||+|||+|+.+....
T Consensus 131 y~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred ccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999964 356999999999999999999999777 99999999999999998 69999999999765433
Q ss_pred CCc---cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 843 ASE---CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 843 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.............. ..
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~--------- 272 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS----EP--------- 272 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH----SC---------
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc----CC---------
Confidence 221 12346799999999999999999999999999999999999999976544333222211 11
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
+.....++..+..+.+++.+||+.||++|||++|+++.+....
T Consensus 273 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 273 PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1111234456678999999999999999999999998876644
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=439.99 Aligned_cols=263 Identities=26% Similarity=0.388 Sum_probs=217.9
Q ss_pred HhhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCC-CCceeEeEEEec-CC
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH-RNIVRLLAFCSN-KE 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~-~~ 756 (995)
.++|+.++.||+|+||+||+|++. .++.||||++.........+.|.+|++++++++| ||||+++++|.+ ++
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 467889999999999999999753 2367999999665555556779999999999965 999999999865 45
Q ss_pred cceEEEEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC
Q 001922 757 TNLLVYEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN 822 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~ 822 (995)
..|+|||||++|+|.++++... ...+++..+..++.|||+||+|||+++ ||||||||+|||++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeC
Confidence 7899999999999999996432 345899999999999999999999777 99999999999999
Q ss_pred CCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHH
Q 001922 823 SAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQ 901 (995)
Q Consensus 823 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 901 (995)
+++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||++|||+| |+.||........+..
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999997755444444456789999999999999999999999999999999998 9999976544433332
Q ss_pred HHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 902 WSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 902 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.+.. + .....|..++..+.+++.+||+.||++|||++||+++|+++.+.
T Consensus 300 ~i~~---g-----------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 300 RLKE---G-----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHH---T-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHc---C-----------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 2221 1 11123445667899999999999999999999999999887643
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=479.82 Aligned_cols=457 Identities=21% Similarity=0.256 Sum_probs=294.0
Q ss_pred CCCCeEeccCCcccCcc--ccCcccccceecc-ccccccCCCccccccc----c-----ccccccc-------ccccccc
Q 001922 92 DKLTNLSLAGNNFTGSI--EIGNLSSLQFLNI-SNNQFSGGLDWNYSSL----V-----NLEVFDA-------YNNNFTA 152 (995)
Q Consensus 92 ~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~L-s~N~i~~~~~~~~~~l----~-----~L~~L~L-------s~n~i~~ 152 (995)
.+++.|+|++|+++|.+ .+++|++|++|+| ++|.++|..+...... + .++.... ....+..
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57899999999999855 6999999999999 8898887644321111 0 0000000 0011111
Q ss_pred c-----------CCccccCCCCCceeeccC--ccccccCCccccCCCCCceeeccCCcccc-cCcccccchhhhhhhhcc
Q 001922 153 L-----------LPVGILKLEKLKYLDLGG--NYFFGKIPNSYGELQGLEYLSLAGNDLTG-KIPGELGNLTNLREIYLG 218 (995)
Q Consensus 153 ~-----------~p~~~~~l~~L~~L~L~~--N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~ 218 (995)
. .+........++.+.++. |.+++ +|..|+++++|++|+|++|++++ .+|..+... +
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~--------s 473 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA--------N 473 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT--------T
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccccc--------c
Confidence 1 111112334455565654 88987 89999999999999999999997 222222111 1
Q ss_pred ccccccCCCCcccC--CCCcccEEECcCCCCCCccCccccCccccCcccccccc-ccC-CCCccccCcC-------CCCe
Q 001922 219 YYNVFEGGIPREVG--KLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINL-LSG-SIPKQLGNLT-------NLVN 287 (995)
Q Consensus 219 ~n~~~~~~~p~~~~--~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~-l~~-~~p~~l~~l~-------~L~~ 287 (995)
.+...+.+|..++ ++++|++|+|++|++.+.+|..|+++++|+.|++++|+ +++ .+|..+++++ +|++
T Consensus 474 -~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~ 552 (876)
T 4ecn_A 474 -SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552 (876)
T ss_dssp -SHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCE
T ss_pred -cccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccE
Confidence 1333455777766 77778888888887777777777778888888888877 776 6676555554 7888
Q ss_pred EeccCCcCcCcCCc--cccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCC-CCeEEecC
Q 001922 288 LDLSNNALTGEIPY--SFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGK-LQVLDLSS 364 (995)
Q Consensus 288 L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~ 364 (995)
|+|++|.++ .+|. .|.++++|+.|+|++|+++ .+| .|..+++|+.|+|++|+++ .+|..+..+++ |++|+|++
T Consensus 553 L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~ 628 (876)
T 4ecn_A 553 FYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSH 628 (876)
T ss_dssp EECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCS
T ss_pred EEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcC
Confidence 888888887 6777 7788888888888888887 666 7777888888888888887 67777777777 88888888
Q ss_pred ceecccCCCcCcCCCc--cceeeccccccCCCCCccc---c--cCCCCcEEEecCCccCCCCCCC-cccCCCCceeeccC
Q 001922 365 NKLTGTIPTDLCSSNQ--LRILILLKNFLFGPIPERL---G--ACYSLTRVRLGQNYLNGSIPDG-FIYLPGLNLAELQS 436 (995)
Q Consensus 365 N~l~~~~p~~~~~l~~--L~~L~l~~N~l~~~~p~~l---~--~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~l~l~~ 436 (995)
|+++ .+|..+..+.. |+.|++++|.+.+.+|... . .+.+|+.|++++|++.. +|.. +..+++|+.|+|++
T Consensus 629 N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~-lp~~~~~~l~~L~~L~Ls~ 706 (876)
T 4ecn_A 629 NKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSN 706 (876)
T ss_dssp SCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCS-CCHHHHHTTCCCSEEECCS
T ss_pred CCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCc-cCHHHHccCCCCCEEECCC
Confidence 8887 67777766644 7888888888777665322 2 23477788888888873 4443 33566666666666
Q ss_pred ccccCCCCCCCCCC-----CCCCCCcEEEcCCCcccccCCcccc--CCCCCcEEEcCCCcccCCCCCCccchhhhccccc
Q 001922 437 NYLSGSLPENGNSS-----SNPDRLGQLNLSNNLLSGPLPFSLS--NFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDL 509 (995)
Q Consensus 437 n~l~~~~~~~~~~~-----~~~~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 509 (995)
|+++ .+|...... .++++|++|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..++.+++|+.|+|
T Consensus 707 N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~L 783 (876)
T 4ecn_A 707 NLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGI 783 (876)
T ss_dssp CCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEEC
T ss_pred CcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEEC
Confidence 6665 344332211 11225666666666666 4555554 56666666666666664 5556666666666666
Q ss_pred cccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCC
Q 001922 510 SRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSG 588 (995)
Q Consensus 510 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g 588 (995)
++|. ++++|++.+.+|..|.++++|+.|+|++|+| +.+|..+. ++|+.|||++|++..
T Consensus 784 s~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 784 RHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNIS 841 (876)
T ss_dssp CCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCE
T ss_pred CCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCc
Confidence 5522 2233555555555555566666666666665 45555544 356666666665543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=464.33 Aligned_cols=453 Identities=21% Similarity=0.196 Sum_probs=300.0
Q ss_pred CeEeccCCcccCcc-ccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCcc
Q 001922 95 TNLSLAGNNFTGSI-EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY 173 (995)
Q Consensus 95 ~~L~L~~n~l~~~~-~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~ 173 (995)
++|++++|+++... .+. ++|++|+|++|.+++..+..|.++++|++|+|++|+|+++.|..|.++++|++|+|++|+
T Consensus 3 ~~l~ls~n~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 3 FLVDRSKNGLIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp CEEECTTSCCSSCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred ceEecCCCCccccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 46888888888643 233 788888888888888777788888888888888888888777888888888888888888
Q ss_pred ccccCCccccCCCCCceeeccCCcccc-cCcccccchhhhhhhhccccccccCCCCcccCCCCcc--cEEECcCCCC--C
Q 001922 174 FFGKIPNSYGELQGLEYLSLAGNDLTG-KIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNL--VHLDLSSCEL--D 248 (995)
Q Consensus 174 l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L--~~L~Ls~n~l--~ 248 (995)
++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|.+.. ..+..+++| ++|++++|.+ .
T Consensus 81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred ee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch----hhccccccceeeEEEeeccccccc
Confidence 87 45554 67888888888888876 356667777666666666555433 234445555 6666666666 4
Q ss_pred CccCccccCcc-ccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCc-------CC
Q 001922 249 GQIPHEIGNLK-LLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNR-------LH 320 (995)
Q Consensus 249 ~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-------l~ 320 (995)
+..|..+..++ ....+++++|++.+.++. ..+.++++|+.|++++|. +.
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~-----------------------~~~~~l~~L~~L~l~~n~~~~~~~~~~ 210 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILD-----------------------VSVKTVANLELSNIKCVLEDNKCSYFL 210 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCC-----------------------CCCTTCSEEEECCEEECCSTTTTHHHH
T ss_pred ccccccccccccceEEEEeccCcchhhhhh-----------------------hhhhcccceeeccccccccccccceee
Confidence 45555554443 222334444444433222 233444444444444444 33
Q ss_pred CCCCccccCCCCcceEEeccCcccccCCCccc---CCCCCCeEEecCceecccCCCcC-----cCCCccceeeccccccC
Q 001922 321 GSIPDYLADLPNLETLGLWQNNFTGVIPENLG---QNGKLQVLDLSSNKLTGTIPTDL-----CSSNQLRILILLKNFLF 392 (995)
Q Consensus 321 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~ 392 (995)
+.+| .+..+++|+.|++++|.+++..+..+. ..++|++|++++|+++|.+|..+ ..++.|+.+++++|.+
T Consensus 211 ~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~- 288 (520)
T 2z7x_B 211 SILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF- 288 (520)
T ss_dssp HHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-
T ss_pred cchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-
Confidence 3333 455555566666655555532221111 13466666666666666666666 6666666666666666
Q ss_pred CCCC-cccccC---CCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccc
Q 001922 393 GPIP-ERLGAC---YSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSG 468 (995)
Q Consensus 393 ~~~p-~~l~~l---~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~ 468 (995)
.+| ..+..+ .+|+.|++++|.+.+.. .+..+++|+.+++++|++++.+|.. ...+++|++|+|++|++++
T Consensus 289 -~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~---~~~l~~L~~L~L~~N~l~~ 362 (520)
T 2z7x_B 289 -GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFEN---CGHLTELETLILQMNQLKE 362 (520)
T ss_dssp -CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTT---CCCCSSCCEEECCSSCCCB
T ss_pred -ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhh---hccCCCCCEEEccCCccCc
Confidence 344 344433 45777777777665322 1145566666666666666554432 2455678888888888876
Q ss_pred --cCCccccCCCCCcEEEcCCCcccCCCCC-CccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccc
Q 001922 469 --PLPFSLSNFSSLQILLLSGNQFSGPIPP-SIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPE 545 (995)
Q Consensus 469 --~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~ 545 (995)
.+|..+.++++|+.|+|++|++++.+|. .+..+++|+.|+|++|++++.+|..+. ++|++|+|++|+++ .+|..
T Consensus 363 l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~ 439 (520)
T 2z7x_B 363 LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQ 439 (520)
T ss_dssp HHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGG
T ss_pred cccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchh
Confidence 5567788888888888888888875554 477788888888888888877777664 78888888888888 78888
Q ss_pred cccccccCeEeccccccccccCcc-cccCCcccEEeccCCCCCCCCC
Q 001922 546 ISNVRILNYLNLSRNHLNQNIPKS-IGSMKSLTIADFSFNDFSGKLP 591 (995)
Q Consensus 546 l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~l~ls~N~l~g~~p 591 (995)
+..+++|++|+|++|+|++ +|.. +..+++|+.|++++|++++..+
T Consensus 440 ~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 440 VVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp GGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccCC
Confidence 8888888888888888875 5554 8888888888888888877544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=437.69 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=209.2
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.+.|+..+.||+|+||+||+|++ .+|+.||||++... .....+.+.+|+.++++++|||||+++++|.+++.+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST-TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 45688899999999999999976 46899999999543 33445678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
||+||+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 229 y~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 229 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 9999999999963 35899999999999999999999887 9999999999999999999999999998764432
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. ..+....+... ..+...
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~--------~~~~~~ 368 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMIRDN--------LPPRLK 368 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHS--------CCCCCS
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHHcC--------CCCCCc
Confidence 23356789999999999999999999999999999999999999996432 12222222211 111111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+...+..+.+++.+||+.||++|||++|++++
T Consensus 369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 122345678999999999999999999999763
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=420.03 Aligned_cols=249 Identities=30% Similarity=0.425 Sum_probs=198.6
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEec----CCcceEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN----KETNLLV 761 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv 761 (995)
|+..+.||+|+||+||+|.+ .+++.||+|++.... .....++|.+|++++++++|||||+++++|.+ ++..|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 35567899999999999976 468899999985432 33345679999999999999999999999865 3467999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCCeEEeeecccccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS-AFEAHVADFGLAKFLID 840 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~-~~~vkl~DfGla~~~~~ 840 (995)
||||+||+|.+++.. ...+++..+..++.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999964 457899999999999999999999653 34999999999999984 79999999999985422
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||....+ .......+.......
T Consensus 185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~---~~~~~~~i~~~~~~~------- 249 (290)
T 3fpq_A 185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYRRVTSGVKPA------- 249 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---HHHHHHHHTTTCCCG-------
T ss_pred ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc---HHHHHHHHHcCCCCC-------
Confidence 22346789999999998865 699999999999999999999999965332 222223332221110
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+||+.||++|||++|++++
T Consensus 250 ---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112234568899999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=413.65 Aligned_cols=247 Identities=26% Similarity=0.331 Sum_probs=193.0
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.+|+..+.||+|+||+||+|+. .+|+.||||++.+.. ......++.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5789999999999999999976 469999999985432 2233567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...+.
T Consensus 93 Ey~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG- 165 (275)
T ss_dssp ECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence 999 6799999964 356999999999999999999999887 999999999999999999999999999876432
Q ss_pred CCccccccccCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.+. ......+.+....
T Consensus 166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~----~~~~~~~~i~~~~----------- 228 (275)
T 3hyh_A 166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE----SIPVLFKNISNGV----------- 228 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTC-----------
T ss_pred --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHcCC-----------
Confidence 23345789999999999998886 58999999999999999999999642 2223333332221
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+...+..+.+++.+||+.||++|||++|++++
T Consensus 229 -~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 -YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11233445678899999999999999999999873
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=461.37 Aligned_cols=451 Identities=22% Similarity=0.232 Sum_probs=365.2
Q ss_pred ceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCC
Q 001922 117 QFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGN 196 (995)
Q Consensus 117 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 196 (995)
++||+++|+++.++ ..+. ++|++|++++|+++++.|..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~~ip-~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLIHVP-KDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCSSCC-CSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCccccc-cccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46788888887543 3333 67777777777777766677777777777777777777666777777777777777777
Q ss_pred cccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCC-ccCccccCccccCccccccccccCCC
Q 001922 197 DLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDG-QIPHEIGNLKLLDTVFLHINLLSGSI 275 (995)
Q Consensus 197 ~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~ 275 (995)
+++ .+| .. .+++|++|+|++|++++ .+|..|+.+++|++|++++|.+++
T Consensus 80 ~l~-~lp-------------------------~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~-- 129 (520)
T 2z7x_B 80 KLV-KIS-------------------------CH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK-- 129 (520)
T ss_dssp CCC-EEE-------------------------CC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG--
T ss_pred cee-ecC-------------------------cc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch--
Confidence 776 233 22 45677888888888876 457778888888888888888775
Q ss_pred CccccCcCCC--CeEeccCCcC--cCcCCccccccC-CCCEEEccCCcCCCCCCc-cccCCCCcceEEeccCc-------
Q 001922 276 PKQLGNLTNL--VNLDLSNNAL--TGEIPYSFINLR-QLKLFNLFMNRLHGSIPD-YLADLPNLETLGLWQNN------- 342 (995)
Q Consensus 276 p~~l~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~------- 342 (995)
..+..+++| +.|++++|.+ .+..|..|..+. +...+++++|++.+.+++ .+..+++|+.|++++|.
T Consensus 130 -~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 208 (520)
T 2z7x_B 130 -SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208 (520)
T ss_dssp -GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHH
T ss_pred -hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccce
Confidence 356677777 9999999999 778888887766 345678899998876654 67889999999999998
Q ss_pred ccccCCCcccCCCCCCeEEecCceecccCCCcCc---CCCccceeeccccccCCCCCccc-----ccCCCCcEEEecCCc
Q 001922 343 FTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLC---SSNQLRILILLKNFLFGPIPERL-----GACYSLTRVRLGQNY 414 (995)
Q Consensus 343 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~l~~N~l~~~~p~~l-----~~l~~L~~L~l~~N~ 414 (995)
+.+.+| .++.+++|+.|++++|.+++..+..+. ..++|+.|++++|.+.|.+|..+ +.+++|+.+++++|.
T Consensus 209 ~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~ 287 (520)
T 2z7x_B 209 FLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287 (520)
T ss_dssp HHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECC
T ss_pred eecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccc
Confidence 777776 789999999999999999864433222 14589999999999999999999 999999999999999
Q ss_pred cCCCCC-CCcccC---CCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcc
Q 001922 415 LNGSIP-DGFIYL---PGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQF 490 (995)
Q Consensus 415 l~~~~p-~~~~~l---~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 490 (995)
+ .+| ..+..+ .+++.+++++|.+.... ....+++|++|++++|++++.+|..+.++++|+.|+|++|++
T Consensus 288 ~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~-----~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 360 (520)
T 2z7x_B 288 F--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML-----CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360 (520)
T ss_dssp C--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC-----CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCC
T ss_pred e--ecchhhhhcccccCceeEEEcCCCcccccc-----chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCcc
Confidence 9 556 445444 67999999999986432 124678999999999999998999999999999999999999
Q ss_pred cC--CCCCCccchhhhccccccccccCCCCCCc-cCcccccceeeccCCcccCCCccccccccccCeEeccccccccccC
Q 001922 491 SG--PIPPSIGELRQVLKLDLSRNSLSGEIPPA-IGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIP 567 (995)
Q Consensus 491 ~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p 567 (995)
++ .+|..++.+++|+.|+|++|.+++.+|.. +..+++|++|+|++|++++.+|..+. ++|+.|+|++|+++ .+|
T Consensus 361 ~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip 437 (520)
T 2z7x_B 361 KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIP 437 (520)
T ss_dssp CBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCC
T ss_pred CccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccc
Confidence 96 55678999999999999999999867764 88999999999999999988888775 79999999999998 689
Q ss_pred cccccCCcccEEeccCCCCCCCCCC-CCCCcccccccCCCCccCCC
Q 001922 568 KSIGSMKSLTIADFSFNDFSGKLPE-SGQFTVFNASSFAGNPQLCG 612 (995)
Q Consensus 568 ~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~~c~ 612 (995)
..+..+++|+.|++++|++++.++. ...+..+....+.|||+.|.
T Consensus 438 ~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 438 KQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp GGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred hhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCccc
Confidence 9888999999999999999964443 34566777788999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=421.23 Aligned_cols=248 Identities=24% Similarity=0.253 Sum_probs=198.0
Q ss_pred hhccCCCeeeccCceEEEEEEeC----CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
++|+..+.||+|+||+||+|+.. +++.||||++.+.. ......++.+|++++++++|||||++++++++++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999752 47889999985422 12234468889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
|||||+||+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...+
T Consensus 104 vmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999999964 356899999999999999999999887 99999999999999999999999999986543
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||... +..+....+....
T Consensus 179 ~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~----~~~~~~~~i~~~~---------- 242 (304)
T 3ubd_A 179 HE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK----DRKETMTMILKAK---------- 242 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCC----------
T ss_pred CC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc----CHHHHHHHHHcCC----------
Confidence 22 2234678999999999999999999999999999999999999999643 2222222222211
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCH-----HHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRM-----REVVQ 956 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 956 (995)
...|...+..+.+++.+||+.||++|||+ +|+++
T Consensus 243 --~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 --LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred --CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11233456678999999999999999984 56654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=456.12 Aligned_cols=553 Identities=20% Similarity=0.159 Sum_probs=393.4
Q ss_pred CCCCCCCCCCCCCCCCCceeeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccce
Q 001922 41 NPEPALISWNSSNPSSVCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQF 118 (995)
Q Consensus 41 ~~~~~l~~W~~~~~~~~C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~ 118 (995)
|+...+++|+.+.|. .|+.-.|.... ...|.++.+|+ .||+.+. +++++|||++|+|++.. .|.++++|++
T Consensus 8 ~~~~~~~~~~~~~p~---~~~~c~~~~~~-~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~ 80 (635)
T 4g8a_A 8 DDDDKLAAANSSIPE---SWEPCVEVVPN-ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQV 80 (635)
T ss_dssp --------------------CCSEEEETT-TEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCcchhhcccCCCCC---CCCCccccCCC-CEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCE
Confidence 566678888765442 23222221111 12244455555 5676553 46888888888888743 5888888888
Q ss_pred eccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcc
Q 001922 119 LNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDL 198 (995)
Q Consensus 119 L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 198 (995)
|+|++|+|+++.+++|.++++|++|+|++|+|+++.+..|.++++|++|+|++|++++..+..|+++++|++|+|++|++
T Consensus 81 L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l 160 (635)
T 4g8a_A 81 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 160 (635)
T ss_dssp EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCcc
Confidence 88888888888888888888888888888888887777888888888888888888876667788888888888888888
Q ss_pred ccc-CcccccchhhhhhhhccccccccCCCCcccCCCCcc----cEEECcCCCCCCccCccccCccccCccccccccccC
Q 001922 199 TGK-IPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNL----VHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSG 273 (995)
Q Consensus 199 ~~~-~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L----~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 273 (995)
++. +|..++++++|++|++++|++. +..+..+..+.++ ..++++.|.++...+..+. ...+..+++.+|....
T Consensus 161 ~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~-~~~~~~l~l~~n~~~~ 238 (635)
T 4g8a_A 161 QSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLHKLTLRNNFDSL 238 (635)
T ss_dssp CCCCCCGGGGGCTTCCEEECCSSCCC-EECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTT-TCEEEEEEEESCCSSH
T ss_pred ccCCCchhhccchhhhhhcccCcccc-ccccccccchhhhhhhhhhhhcccCcccccCccccc-chhhhhhhhhcccccc
Confidence 753 5777888888888888866553 3445555554443 4688888888855444443 3456677777776543
Q ss_pred -CCCccccCcCCCCeEeccCCc------CcCcCCccccccCCCCEEEccCCcCCCC---CCccccCCCCcceEEeccCcc
Q 001922 274 -SIPKQLGNLTNLVNLDLSNNA------LTGEIPYSFINLRQLKLFNLFMNRLHGS---IPDYLADLPNLETLGLWQNNF 343 (995)
Q Consensus 274 -~~p~~l~~l~~L~~L~Ls~N~------l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~L~~N~l 343 (995)
..+..+..+..++...+..+. +.......+..+..+....+..+..... .+..+..+.+++.+++.+|.+
T Consensus 239 ~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 318 (635)
T 4g8a_A 239 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTI 318 (635)
T ss_dssp HHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEE
T ss_pred cccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccc
Confidence 233456667777766664332 3333445566666777766665544322 334456677888888888887
Q ss_pred cccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCC--CCCC
Q 001922 344 TGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNG--SIPD 421 (995)
Q Consensus 344 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~p~ 421 (995)
.... .+.....|+.|++++|.+.+..+. .+..|+.+++..|.+... .....+++|+.+++++|.+.. ..+.
T Consensus 319 ~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~ 391 (635)
T 4g8a_A 319 ERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQ 391 (635)
T ss_dssp EECG--GGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCH
T ss_pred cccc--ccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhcccccccccccc
Confidence 7432 356667888888888888754433 456677788888876543 334578888899998888753 4556
Q ss_pred CcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCC-ccccCCCCCcEEEcCCCcccCCCCCCccc
Q 001922 422 GFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLP-FSLSNFSSLQILLLSGNQFSGPIPPSIGE 500 (995)
Q Consensus 422 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 500 (995)
.+..+.+++.+++..+.+.+..+ .+..+..|+.++++.|+.....+ ..+.++++++.+++++|++++..|..+..
T Consensus 392 ~~~~~~~L~~L~~~~~~~~~~~~----~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~ 467 (635)
T 4g8a_A 392 SDFGTISLKYLDLSFNGVITMSS----NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 467 (635)
T ss_dssp HHHSCSCCCEEECCSCSEEEECS----CCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred chhhhhhhhhhhccccccccccc----cccccccccchhhhhcccccccccccccccccccccccccccccccccccccc
Confidence 66778888888888887765432 24456788999998888775554 45778899999999999999888888899
Q ss_pred hhhhcccccccccc-CCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEE
Q 001922 501 LRQVLKLDLSRNSL-SGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIA 579 (995)
Q Consensus 501 l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l 579 (995)
+++|+.|+|++|.+ .+.+|..|..+++|++|+|++|+|++.+|.+|.++++|++|+|++|+|++..|..+..+++|++|
T Consensus 468 ~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L 547 (635)
T 4g8a_A 468 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 547 (635)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEE
T ss_pred chhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEE
Confidence 99999999999874 44578889999999999999999998888889999999999999999998888889999999999
Q ss_pred eccCCCCCCCCCCC-CCC-cccccccCCCCccCCCC
Q 001922 580 DFSFNDFSGKLPES-GQF-TVFNASSFAGNPQLCGT 613 (995)
Q Consensus 580 ~ls~N~l~g~~p~~-~~~-~~~~~~~~~~n~~~c~~ 613 (995)
||++|+|++.+|.. ..+ +.+....+.||||.|++
T Consensus 548 ~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 548 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp ECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred ECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 99999999988863 223 45666778899999983
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=417.79 Aligned_cols=266 Identities=26% Similarity=0.313 Sum_probs=201.1
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC----cceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE----TNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~lv 761 (995)
++|...+.||+|+||+||+|++ +|+.||||++... ......+..|+..+.+++|||||++++++.+++ ..|+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~--~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc--chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 4577888999999999999988 6899999998432 111222345666677889999999999997653 57999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC-----SPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
||||++|+|.++++.. .+++..+.+++.|++.||+|||+++ .++||||||||+|||++.++.+||+|||+|+
T Consensus 80 ~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999999743 5899999999999999999999751 2359999999999999999999999999998
Q ss_pred ccccCCCCc--cccccccCcccccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCC-----------c
Q 001922 837 FLIDGGASE--CMSAIAGSYGYIAPEYAYTL------RVDEKSDVYSFGVVLLELLTGRRPVGDFGDG-----------V 897 (995)
Q Consensus 837 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~Pf~~~~~~-----------~ 897 (995)
......... .....+||+.|||||++.+. .++.++|||||||++|||+||+.||....+. .
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 765433211 22346799999999998754 4678999999999999999998876432211 1
Q ss_pred hHHHHHHHHhcCChhhhhhhcCCcCCC--CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 898 DIVQWSKRATNGRKEEFLSILDPRLSM--VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
........+... ..+|..+. .+.+++..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus 237 ~~~~~~~~~~~~-------~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKVVCEQ-------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTS-------CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhcc-------cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 111222111111 11222221 1235677899999999999999999999999999987653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=453.19 Aligned_cols=508 Identities=23% Similarity=0.183 Sum_probs=426.9
Q ss_pred ceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCcccccccccccccccc
Q 001922 69 RVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAY 146 (995)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls 146 (995)
.++.|||++|+|++..+..|.++++|++|+|++|+|++.. .|.+|++|++|+|++|+|+++++..|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 5889999999999877789999999999999999999754 58999999999999999999999999999999999999
Q ss_pred cccccccCCccccCCCCCceeeccCccccc-cCCccccCCCCCceeeccCCcccccCcccccchhhhhh----hhccccc
Q 001922 147 NNNFTALLPVGILKLEKLKYLDLGGNYFFG-KIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLRE----IYLGYYN 221 (995)
Q Consensus 147 ~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~----L~L~~n~ 221 (995)
+|+++++.+..|+++++|++|+|++|.+++ .+|..++.+++|++|+|++|++++..+..+..+.+++. ++++.|.
T Consensus 133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~ 212 (635)
T 4g8a_A 133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 212 (635)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCc
Confidence 999999888899999999999999999975 46888999999999999999999999999998888764 4555554
Q ss_pred cccCCCCcccCCCCcccEEECcCCCCCCc-cCccccCccccCcccccccc------ccCCCCccccCcCCCCeEeccCCc
Q 001922 222 VFEGGIPREVGKLVNLVHLDLSSCELDGQ-IPHEIGNLKLLDTVFLHINL------LSGSIPKQLGNLTNLVNLDLSNNA 294 (995)
Q Consensus 222 ~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~l~~N~------l~~~~p~~l~~l~~L~~L~Ls~N~ 294 (995)
+.. ++........+..+++++|..... .+..+..+..++...+..+. +.......+..+..+..+++..+.
T Consensus 213 l~~--i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~ 290 (635)
T 4g8a_A 213 MNF--IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 290 (635)
T ss_dssp CCE--ECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred ccc--cCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence 432 445555566788999999876533 34455666666665554332 333344556667777777777655
Q ss_pred CcC---cCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccC
Q 001922 295 LTG---EIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTI 371 (995)
Q Consensus 295 l~~---~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 371 (995)
... ..+..+..+.+++.+.+.+|.+.... .+....+|+.|++.+|.+.+..+ ..+..|+.+++++|.+...
T Consensus 291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~- 364 (635)
T 4g8a_A 291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA- 364 (635)
T ss_dssp CCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB-
T ss_pred hcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC-
Confidence 432 33456777889999999999987433 35667899999999999986544 3567899999999998743
Q ss_pred CCcCcCCCccceeeccccccC--CCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCC
Q 001922 372 PTDLCSSNQLRILILLKNFLF--GPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNS 449 (995)
Q Consensus 372 p~~~~~l~~L~~L~l~~N~l~--~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~ 449 (995)
.....+++|+.|++++|.+. +..+..+..+.+|+.+++..|.+.. .+..+..++.|+.+++..+......+.. .
T Consensus 365 -~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~--~ 440 (635)
T 4g8a_A 365 -FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS--V 440 (635)
T ss_dssp -CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSC--T
T ss_pred -cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccc--c
Confidence 34567899999999999885 4567777888999999999999875 5667889999999999999888765543 3
Q ss_pred CCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCccc-CCCCCCccchhhhccccccccccCCCCCCccCccccc
Q 001922 450 SSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFS-GPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHL 528 (995)
Q Consensus 450 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 528 (995)
+..+..++.++++.|++++..+..+..++.|+.|+|++|++. +..|..|..+++|+.|+|++|+|++..|..|+.+++|
T Consensus 441 ~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L 520 (635)
T 4g8a_A 441 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 520 (635)
T ss_dssp TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred cccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCC
Confidence 456789999999999999999999999999999999999854 4678899999999999999999999889999999999
Q ss_pred ceeeccCCcccCCCccccccccccCeEeccccccccccCcccccC-CcccEEeccCCCCCC
Q 001922 529 TYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSM-KSLTIADFSFNDFSG 588 (995)
Q Consensus 529 ~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~l~ls~N~l~g 588 (995)
++|+|++|+|++..|..|.++++|++|+|++|+|++.+|..+..+ ++|+.|+|++|++..
T Consensus 521 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 521 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp CEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred CEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 999999999998888999999999999999999999999999998 689999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=409.44 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=191.1
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC-------
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE------- 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------- 756 (995)
.++|+..+.||+|+||+||+|++ .+|+.||||++.........+.+.+|++++++++|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 35688899999999999999976 4689999999865444445567899999999999999999999986544
Q ss_pred -----cceEEEEeccCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEe
Q 001922 757 -----TNLLVYEYMRNGSLGEALHGKKG-AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVA 830 (995)
Q Consensus 757 -----~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~ 830 (995)
+.|+|||||++|+|.+++..... ...++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 36899999999999999975432 34566778899999999999999887 9999999999999999999999
Q ss_pred eeccccccccCCCC----------ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHH
Q 001922 831 DFGLAKFLIDGGAS----------ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIV 900 (995)
Q Consensus 831 DfGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~ 900 (995)
|||+|+.+...... ......+||+.|||||++.+..|+.++||||+||++|||++ ||.. ..+..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~---~~~~~ 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST---QMERV 234 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS---HHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC---ccHHH
Confidence 99999876543221 11234679999999999999999999999999999999996 7743 11111
Q ss_pred HHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.....+... ..+......+....+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~-----------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTLTDVRNL-----------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHTT-----------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHhcC-----------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111211111 111112234456778999999999999999999987
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=439.00 Aligned_cols=458 Identities=19% Similarity=0.184 Sum_probs=303.6
Q ss_pred CCCCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccC
Q 001922 92 DKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGG 171 (995)
Q Consensus 92 ~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~ 171 (995)
...+++++++|++++... .-.++|++|+|++|.|+++.+..|.++++|++|+|++|+|+++.|..|.++++|++|+|++
T Consensus 31 ~~~~~l~ls~~~L~~ip~-~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 31 ELESMVDYSNRNLTHVPK-DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp --CCEEECTTSCCCSCCT-TSCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CCCcEEEcCCCCCccCCC-CCCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 344889999999987442 1238899999999999998888999999999999999999998889999999999999999
Q ss_pred ccccccCCccccCCCCCceeeccCCccccc-CcccccchhhhhhhhccccccccCCCCcccCCCCcc--cEEECcCCCC-
Q 001922 172 NYFFGKIPNSYGELQGLEYLSLAGNDLTGK-IPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNL--VHLDLSSCEL- 247 (995)
Q Consensus 172 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L--~~L~Ls~n~l- 247 (995)
|+++ .+|.. .+++|++|+|++|++++. +|..|+++++|++|++++|.+.. ..+..+++| ++|++++|.+
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~L~~n~l~ 182 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ----LDLLPVAHLHLSCILLDLVSYH 182 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT----TTTGGGTTSCEEEEEEEESSCC
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc----CchhhhhhceeeEEEeeccccc
Confidence 9997 56665 789999999999999863 35778888888888777665543 233344444 7777777777
Q ss_pred -CCccCccccCcc--ccCccccccccccCCCCc-cccCcCCCCeEeccCCcC-----cCcCCccccccCCCCEEEccCCc
Q 001922 248 -DGQIPHEIGNLK--LLDTVFLHINLLSGSIPK-QLGNLTNLVNLDLSNNAL-----TGEIPYSFINLRQLKLFNLFMNR 318 (995)
Q Consensus 248 -~~~~~~~~~~l~--~L~~L~l~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l-----~~~~p~~~~~l~~L~~L~L~~N~ 318 (995)
++..|..+..+. .+ .++++.|.+.+.++. .+..+++|+.|++++|.. .+ ....|.++++|+.|+++++.
T Consensus 183 ~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~ 260 (562)
T 3a79_B 183 IKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIE 260 (562)
T ss_dssp CCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEE
T ss_pred ccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCc
Confidence 666666665543 22 345556655544333 344555666666665531 11 11223344444444444443
Q ss_pred CCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcC-----cCCCccceeeccccccCC
Q 001922 319 LHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDL-----CSSNQLRILILLKNFLFG 393 (995)
Q Consensus 319 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~ 393 (995)
+.+. .+.+. +..+ ...+|++|++++|+++|.+|..+ ..++.|+.+++..|.+
T Consensus 261 l~~~-------------------~~~~~-~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-- 317 (562)
T 3a79_B 261 TTWK-------------------CSVKL-FQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-- 317 (562)
T ss_dssp ECHH-------------------HHHHH-HHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--
T ss_pred CcHH-------------------HHHHH-HHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--
Confidence 3321 11111 1111 12355555555555555555554 4455555555555544
Q ss_pred CCC-cccccC---CCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccc-
Q 001922 394 PIP-ERLGAC---YSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSG- 468 (995)
Q Consensus 394 ~~p-~~l~~l---~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~- 468 (995)
.+| ..+..+ .+|+.|++++|.+.... ....+++|+.+++++|++++.+|.. ...+++|++|+|++|++++
T Consensus 318 ~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~---~~~l~~L~~L~L~~N~l~~~ 392 (562)
T 3a79_B 318 LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQG---CSTLKRLQTLILQRNGLKNF 392 (562)
T ss_dssp SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTT---CCSCSSCCEEECCSSCCCBT
T ss_pred ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhh---hcccCCCCEEECCCCCcCCc
Confidence 233 222211 34666666666654221 1144555666666666665544432 2445677788888888875
Q ss_pred -cCCccccCCCCCcEEEcCCCcccCCCCC-CccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCcccc
Q 001922 469 -PLPFSLSNFSSLQILLLSGNQFSGPIPP-SIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEI 546 (995)
Q Consensus 469 -~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l 546 (995)
.+|..+.++++|+.|+|++|++++.+|. .+..+++|+.|+|++|++++.+|..+. ++|++|+|++|+++ .+|..+
T Consensus 393 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~ 469 (562)
T 3a79_B 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDV 469 (562)
T ss_dssp THHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTT
T ss_pred ccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhh
Confidence 3356678888888888888888874554 477888888888888888877776654 68888888888888 788877
Q ss_pred ccccccCeEeccccccccccCcc-cccCCcccEEeccCCCCCCCCC
Q 001922 547 SNVRILNYLNLSRNHLNQNIPKS-IGSMKSLTIADFSFNDFSGKLP 591 (995)
Q Consensus 547 ~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~l~ls~N~l~g~~p 591 (995)
.++++|++|+|++|+|++ +|.. +..+++|+.+++++|++.+..|
T Consensus 470 ~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 470 THLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp TSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred cCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 788888888888888875 5555 8888888888888888887665
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=435.78 Aligned_cols=455 Identities=19% Similarity=0.184 Sum_probs=351.0
Q ss_pred cccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCcee
Q 001922 112 NLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYL 191 (995)
Q Consensus 112 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 191 (995)
.+...+++++++|++++++. .+. ++|++|++++|.|+++.|..|.++++|++|+|++|++++..|..|+++++|++|
T Consensus 29 ~~~~~~~l~ls~~~L~~ip~-~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 105 (562)
T 3a79_B 29 SNELESMVDYSNRNLTHVPK-DLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYL 105 (562)
T ss_dssp ----CCEEECTTSCCCSCCT-TSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEE
T ss_pred ccCCCcEEEcCCCCCccCCC-CCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEE
Confidence 34445889999998887443 332 678888888888888777788888888888888888887777788888888888
Q ss_pred eccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCc-cCccccCccccCcccccccc
Q 001922 192 SLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQ-IPHEIGNLKLLDTVFLHINL 270 (995)
Q Consensus 192 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~l~~N~ 270 (995)
+|++|+++ .+|.. .+++|++|+|++|++++. +|..|+++++|++|++++|+
T Consensus 106 ~Ls~N~l~-~lp~~---------------------------~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~ 157 (562)
T 3a79_B 106 DVSHNRLQ-NISCC---------------------------PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAK 157 (562)
T ss_dssp ECTTSCCC-EECSC---------------------------CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSB
T ss_pred ECCCCcCC-ccCcc---------------------------ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCc
Confidence 88888877 33322 345667777777777652 35677777777777777777
Q ss_pred ccCCCCccccCcCCC--CeEeccCCcC--cCcCCccccccC--CCCEEEccCCcCCCCCCc-cccCCCCcceEEeccCc-
Q 001922 271 LSGSIPKQLGNLTNL--VNLDLSNNAL--TGEIPYSFINLR--QLKLFNLFMNRLHGSIPD-YLADLPNLETLGLWQNN- 342 (995)
Q Consensus 271 l~~~~p~~l~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~- 342 (995)
+++. .+..+++| ++|++++|.+ ++..|..|..+. .| .+++++|.+.+.+++ .+..+++|+.|++++|+
T Consensus 158 l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~ 233 (562)
T 3a79_B 158 FRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233 (562)
T ss_dssp CCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCST
T ss_pred cccC---chhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEeccccccc
Confidence 7643 34444555 8888888888 777888777755 33 567888888776554 46678899999999985
Q ss_pred ----ccccCCCcccCCCCCCeEEecCceecccC----CCcCcCCCccceeeccccccCCCCCccc-----ccCCCCcEEE
Q 001922 343 ----FTGVIPENLGQNGKLQVLDLSSNKLTGTI----PTDLCSSNQLRILILLKNFLFGPIPERL-----GACYSLTRVR 409 (995)
Q Consensus 343 ----l~~~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~l~~N~l~~~~p~~l-----~~l~~L~~L~ 409 (995)
+.+. ...+..+++|+.|+|++|.+++.. +..+ ...+|+.|++++|.+.|.+|..+ ..++.|+.++
T Consensus 234 ~~~~l~~~-~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~ 311 (562)
T 3a79_B 234 NCQRLMTF-LSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEH 311 (562)
T ss_dssp THHHHHHH-HHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEE
T ss_pred ccchHHHH-HHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhh
Confidence 3332 235778889999999988876432 1122 23489999999999999999988 7788888888
Q ss_pred ecCCccCCCCC-CCccc---CCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEc
Q 001922 410 LGQNYLNGSIP-DGFIY---LPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLL 485 (995)
Q Consensus 410 l~~N~l~~~~p-~~~~~---l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 485 (995)
++.|.+ .+| ..+.. -.+++.+++++|.+.... ....+++|++|++++|++++.+|..+.++++|+.|+|
T Consensus 312 ~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 384 (562)
T 3a79_B 312 VKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV-----CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384 (562)
T ss_dssp EEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC-----CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEEC
T ss_pred ccccee--ecChhhhhhhhccCcceEEEccCCCccccc-----CccCCCCceEEECCCCccccchhhhhcccCCCCEEEC
Confidence 888877 445 22222 267999999999986432 1246789999999999999999999999999999999
Q ss_pred CCCcccCC--CCCCccchhhhccccccccccCCCCCC-ccCcccccceeeccCCcccCCCccccccccccCeEecccccc
Q 001922 486 SGNQFSGP--IPPSIGELRQVLKLDLSRNSLSGEIPP-AIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHL 562 (995)
Q Consensus 486 s~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l 562 (995)
++|++++. +|..++.+++|+.|+|++|++++.+|. .+..+++|++|+|++|++++.+|..+. ++|++|+|++|+|
T Consensus 385 ~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l 462 (562)
T 3a79_B 385 QRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRI 462 (562)
T ss_dssp CSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCC
T ss_pred CCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcC
Confidence 99999963 356789999999999999999985665 588999999999999999988887765 7999999999999
Q ss_pred ccccCcccccCCcccEEeccCCCCCCCCCC-CCCCcccccccCCCCccCCCC
Q 001922 563 NQNIPKSIGSMKSLTIADFSFNDFSGKLPE-SGQFTVFNASSFAGNPQLCGT 613 (995)
Q Consensus 563 ~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~~c~~ 613 (995)
+ .+|..+..+++|+.|++++|++++.++. .+.+..+....+.|||+.|.+
T Consensus 463 ~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 463 M-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp C-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred c-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 7 5888888999999999999999964443 456677778889999999973
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=407.00 Aligned_cols=266 Identities=20% Similarity=0.266 Sum_probs=202.7
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEec------CCc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSN------KET 757 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~ 757 (995)
++|+..+.||+|+||+||+|++ .+|+.||||++...... ....++.+|++++++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5788999999999999999976 57999999999543322 234568899999999999999999999754 357
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.|+|||||+ |+|.+++. ..+.+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999996 68999995 3567999999999999999999999887 99999999999999999999999999987
Q ss_pred cccCC--CCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 838 LIDGG--ASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 838 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
+.... ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||........+...............
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 64322 12234567899999999998875 4699999999999999999999999654322222222221111111000
Q ss_pred -----------hhhcCCcCCC----CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 915 -----------LSILDPRLSM----VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 915 -----------~~~~d~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+.+..+. ..+..+..+.+|+.+||+.||++|||++|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000111000 011234578899999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=398.11 Aligned_cols=264 Identities=24% Similarity=0.270 Sum_probs=201.0
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC----CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCc
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKET 757 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 757 (995)
++.++|++.+.||+|+||+||+|+.+ +++.||+|++... ....++.+|+++++.+ +|||||+++++|.+.++
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 35578999999999999999999652 4688999998542 3356688999999998 69999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CCeEEeeecccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA-FEAHVADFGLAK 836 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~-~~vkl~DfGla~ 836 (995)
.|+||||+++|+|.+++. .+++..++.++.|++.||+|||++| |+||||||+|||++.+ +.+||+|||+|+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 999999999999999994 3889999999999999999999888 9999999999999877 799999999998
Q ss_pred ccccCCC--------------------------CccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCC
Q 001922 837 FLIDGGA--------------------------SECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRP 889 (995)
Q Consensus 837 ~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~P 889 (995)
...+... .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6543211 1112345799999999998775 489999999999999999999999
Q ss_pred CCCCCCCchHHHHHHHHhcCC-----------------------hhhhhhh---cCCcCC-------------CCCHHHH
Q 001922 890 VGDFGDGVDIVQWSKRATNGR-----------------------KEEFLSI---LDPRLS-------------MVPKEEA 930 (995)
Q Consensus 890 f~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~---~d~~~~-------------~~~~~~~ 930 (995)
|....+..+............ ....... .+...+ ......+
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 976554333222211111000 0000000 000000 0011234
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 931 MHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 931 ~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.++.+++.+|++.||++|||++|++++
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 567899999999999999999999863
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=401.62 Aligned_cols=402 Identities=23% Similarity=0.256 Sum_probs=204.1
Q ss_pred CCCCCCeEeccCCcccCcc-ccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceee
Q 001922 90 RLDKLTNLSLAGNNFTGSI-EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLD 168 (995)
Q Consensus 90 ~l~~L~~L~L~~n~l~~~~-~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~ 168 (995)
..++|++|++++|++.... .++++++|++|++++|.+.+..|..++.+.+|+.++++.|.. .++++|+
T Consensus 9 ~~~~L~~L~l~~n~l~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~ 77 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELE 77 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEE
T ss_pred ccccchhhhcccCchhhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEE
Confidence 3467777777777773222 477777777777777777777777777777777777766642 4578888
Q ss_pred ccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCC
Q 001922 169 LGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELD 248 (995)
Q Consensus 169 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~ 248 (995)
+++|.+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|.+.. +|.. .++|++|++++|+++
T Consensus 78 l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~--l~~~---~~~L~~L~L~~n~l~ 144 (454)
T 1jl5_A 78 LNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA--LSDL---PPLLEYLGVSNNQLE 144 (454)
T ss_dssp CTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC--CCSC---CTTCCEEECCSSCCS
T ss_pred ecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc--ccCC---CCCCCEEECcCCCCC
Confidence 88888874 4442 3678888888888886 5543 2556666666554432 2211 145666666666666
Q ss_pred CccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCcccc
Q 001922 249 GQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLA 328 (995)
Q Consensus 249 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 328 (995)
+ +| .++++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .|.++++|+.|++++|++++ +|...
T Consensus 145 ~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~- 214 (454)
T 1jl5_A 145 K-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP- 214 (454)
T ss_dssp S-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC-
T ss_pred C-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc-
Confidence 4 44 36666666666666666653 33322 356666666666654 33 45566666666666666653 33221
Q ss_pred CCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEE
Q 001922 329 DLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRV 408 (995)
Q Consensus 329 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L 408 (995)
++|++|++++|+++ .+|. ++.+++|++|++++|++++ +|.. +++|+.|++++|++
T Consensus 215 --~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l----------------- 269 (454)
T 1jl5_A 215 --LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYL----------------- 269 (454)
T ss_dssp --TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCC-----------------
T ss_pred --CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcc-----------------
Confidence 35566666666555 3442 5555566666666665553 3322 24444455555544
Q ss_pred EecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCC-CCCcEEEcCC
Q 001922 409 RLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNF-SSLQILLLSG 487 (995)
Q Consensus 409 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~ 487 (995)
.+ +|.. +++|+.+++++|++++. |. .+++|++|++++|++++ ++ .+ ++|+.|++++
T Consensus 270 -------~~-l~~~---~~~L~~L~ls~N~l~~l-~~------~~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~ 326 (454)
T 1jl5_A 270 -------TD-LPEL---PQSLTFLDVSENIFSGL-SE------LPPNLYYLNASSNEIRS-LC----DLPPSLEELNVSN 326 (454)
T ss_dssp -------SC-CCCC---CTTCCEEECCSSCCSEE-SC------CCTTCCEEECCSSCCSE-EC----CCCTTCCEEECCS
T ss_pred -------cc-cCcc---cCcCCEEECcCCccCcc-cC------cCCcCCEEECcCCcCCc-cc----CCcCcCCEEECCC
Confidence 43 2221 13444445555544431 11 11456777777777764 22 22 4677777777
Q ss_pred CcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccC--CCccccccccccCeEeccccccccc
Q 001922 488 NQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSG--SIPPEISNVRILNYLNLSRNHLNQN 565 (995)
Q Consensus 488 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~ip~~l~~l~~L~~L~L~~N~l~~~ 565 (995)
|++++ +|.. +++|+.|+|++|+++ .+|. .+++|++|+|++|++++ .+|.++.++ +.|.+.|.
T Consensus 327 N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~ 390 (454)
T 1jl5_A 327 NKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAE 390 (454)
T ss_dssp SCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC----
T ss_pred Ccccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccc
Confidence 77774 5543 366777777777777 4665 36777777777777776 566655433 34555566
Q ss_pred cCcccccCCcccEEeccCCCCCC--CCCC
Q 001922 566 IPKSIGSMKSLTIADFSFNDFSG--KLPE 592 (995)
Q Consensus 566 ~p~~~~~l~~L~~l~ls~N~l~g--~~p~ 592 (995)
+|.. +++|+.|++++|+++| .+|.
T Consensus 391 i~~~---~~~L~~L~ls~N~l~~~~~iP~ 416 (454)
T 1jl5_A 391 VPEL---PQNLKQLHVETNPLREFPDIPE 416 (454)
T ss_dssp -----------------------------
T ss_pred cccc---cCcCCEEECCCCcCCccccchh
Confidence 6653 3567777777777776 5553
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=406.50 Aligned_cols=390 Identities=21% Similarity=0.216 Sum_probs=267.3
Q ss_pred cccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhcccc
Q 001922 141 EVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYY 220 (995)
Q Consensus 141 ~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n 220 (995)
+.++.++++++.+ |. + .++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+
T Consensus 13 ~~~~c~~~~l~~l-p~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i------------------ 70 (455)
T 3v47_A 13 YNAICINRGLHQV-PE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVI------------------ 70 (455)
T ss_dssp TEEECCSSCCSSC-CC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEE------------------
T ss_pred cccCcCCCCcccC-CC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceE------------------
Confidence 3455666666553 33 2 256667777777666666666666666777776666665332
Q ss_pred ccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCcc--ccCcCCCCeEeccCCcCcCc
Q 001922 221 NVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQ--LGNLTNLVNLDLSNNALTGE 298 (995)
Q Consensus 221 ~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~--l~~l~~L~~L~Ls~N~l~~~ 298 (995)
.+..|.++++|++|+|++|++++..|..|+.+++|++|++++|++++.++.. +..+++|++|+|++|.+++.
T Consensus 71 ------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 144 (455)
T 3v47_A 71 ------RNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI 144 (455)
T ss_dssp ------CTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSC
T ss_pred ------CcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCcc
Confidence 1234455566666666666666555666666666666666666666533333 66666777777777776666
Q ss_pred CCcc-ccccCCCCEEEccCCcCCCCCCccccCC--CCcceEEeccCcccccCCCcc--------cCCCCCCeEEecCcee
Q 001922 299 IPYS-FINLRQLKLFNLFMNRLHGSIPDYLADL--PNLETLGLWQNNFTGVIPENL--------GQNGKLQVLDLSSNKL 367 (995)
Q Consensus 299 ~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~--------~~l~~L~~L~L~~N~l 367 (995)
.|.. |.++++|+.|++++|++++..|..+..+ .+|+.|++++|.+++..+..+ ..+++|++|+|++|++
T Consensus 145 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l 224 (455)
T 3v47_A 145 QPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF 224 (455)
T ss_dssp CCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCC
T ss_pred CcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcc
Confidence 5554 5666667777777766666666666554 566666666666665443332 2345566666666666
Q ss_pred cccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCC
Q 001922 368 TGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENG 447 (995)
Q Consensus 368 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~ 447 (995)
++..|..+... ....+|+.|++++|.+.+.... ...++. +....+.
T Consensus 225 ~~~~~~~~~~~---------------------~~~~~L~~L~l~~~~~~~~~~~-~~~~~~-----~~~~~~~------- 270 (455)
T 3v47_A 225 KESMAKRFFDA---------------------IAGTKIQSLILSNSYNMGSSFG-HTNFKD-----PDNFTFK------- 270 (455)
T ss_dssp CHHHHHHHHHH---------------------TTTCCEEEEECTTCTTTSCCTT-CCSSCC-----CCTTTTG-------
T ss_pred cccchhhhhcc---------------------ccccceeeEeeccccccccccc-hhhhcc-----Ccccccc-------
Confidence 55555444322 0013444444444443322110 000000 0000010
Q ss_pred CCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccc
Q 001922 448 NSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNH 527 (995)
Q Consensus 448 ~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 527 (995)
.....+|++|++++|++++..|..+.++++|+.|+|++|++++..|..|+.+++|+.|+|++|.+++..|..++.+++
T Consensus 271 --~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 348 (455)
T 3v47_A 271 --GLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDK 348 (455)
T ss_dssp --GGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTT
T ss_pred --cccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCccc
Confidence 012357999999999999999999999999999999999999888999999999999999999999878899999999
Q ss_pred cceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCCCCC
Q 001922 528 LTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESG 594 (995)
Q Consensus 528 L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~ 594 (995)
|++|+|++|++++..|.+|.++++|++|+|++|++++..+..+..+++|+.|++++|++++.+|...
T Consensus 349 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 349 LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred CCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence 9999999999998889999999999999999999998777778999999999999999999998643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=410.84 Aligned_cols=250 Identities=23% Similarity=0.237 Sum_probs=200.4
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHH---HHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFR---AEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~---~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
+.|+..++||+|+||+||+|+.+ +|+.||||++.+.. .......+. .++.+++.++|||||+++++|++.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 46888999999999999999764 68999999984321 111222333 3466777889999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 269 lVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999964 456999999999999999999999777 9999999999999999999999999998764
Q ss_pred cCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.. ...+.+||+.|||||++.. ..|+.++||||+||++|||++|+.||...... +.......+...
T Consensus 344 ~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-~~~~i~~~i~~~--------- 409 (689)
T 3v5w_A 344 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEIDRMTLTM--------- 409 (689)
T ss_dssp SC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-CHHHHHHHHHHC---------
T ss_pred CC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhcCC---------
Confidence 32 2345689999999999964 57999999999999999999999999653222 122222222111
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPR-----MREVVQM 957 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 957 (995)
. ...|...+..+.+++.+||+.||++|++ ++||.++
T Consensus 410 --~-~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 410 --A-VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp --C-CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred --C-CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 0 1123445677899999999999999998 6887754
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=396.92 Aligned_cols=419 Identities=21% Similarity=0.233 Sum_probs=276.5
Q ss_pred CCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCcccccccccccccc
Q 001922 67 RDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFD 144 (995)
Q Consensus 67 ~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~ 144 (995)
..++..++++++++ |.+|+.|+++++|++|++++|+++|.. .++++++|+.+++++|.. .++++|+
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~ 77 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELE 77 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEE
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEE
Confidence 35788899999999 899999999999999999999998744 689999999999988864 5688999
Q ss_pred cccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhcccccccc
Q 001922 145 AYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFE 224 (995)
Q Consensus 145 Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~ 224 (995)
+++|+++++ |.. .++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|.+..
T Consensus 78 l~~~~l~~l-p~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~ 145 (454)
T 1jl5_A 78 LNNLGLSSL-PEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK 145 (454)
T ss_dssp CTTSCCSCC-CSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS
T ss_pred ecCCccccC-CCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC
Confidence 999999984 442 4789999999999986 7754 4789999999999995 3322 2789999999877654
Q ss_pred CCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCcccc
Q 001922 225 GGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFI 304 (995)
Q Consensus 225 ~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 304 (995)
+| .++.+++|++|++++|++++ +|..+ .+|++|++++|++++ +| .++++++|++|++++|++++ +|...
T Consensus 146 --lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~- 214 (454)
T 1jl5_A 146 --LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP- 214 (454)
T ss_dssp --CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC-
T ss_pred --Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc-
Confidence 77 59999999999999999996 55543 589999999999997 56 69999999999999999996 44433
Q ss_pred ccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCcccee
Q 001922 305 NLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRIL 384 (995)
Q Consensus 305 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 384 (995)
++|+.|++++|+++ .+|. +..+++|++|++++|++++ +|.. .++|++|++++|++++ +|.. .++|+.|
T Consensus 215 --~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L 282 (454)
T 1jl5_A 215 --LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFL 282 (454)
T ss_dssp --TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred --CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEE
Confidence 58999999999999 6774 8999999999999999996 5543 4789999999999995 6653 3677788
Q ss_pred eccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCC
Q 001922 385 ILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNN 464 (995)
Q Consensus 385 ~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N 464 (995)
++++|.+.+. |.. ..+|+.|++++|++++. + . .+++|++|++++|
T Consensus 283 ~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i-~------------------------~------~~~~L~~L~Ls~N 327 (454)
T 1jl5_A 283 DVSENIFSGL-SEL---PPNLYYLNASSNEIRSL-C------------------------D------LPPSLEELNVSNN 327 (454)
T ss_dssp ECCSSCCSEE-SCC---CTTCCEEECCSSCCSEE-C------------------------C------CCTTCCEEECCSS
T ss_pred ECcCCccCcc-cCc---CCcCCEEECcCCcCCcc-c------------------------C------CcCcCCEEECCCC
Confidence 8888877651 111 14566666666666531 1 0 1246888888888
Q ss_pred cccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCC--CCCCccCcccccceeeccCCcccCCC
Q 001922 465 LLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSG--EIPPAIGYCNHLTYLDMSQNNLSGSI 542 (995)
Q Consensus 465 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~i 542 (995)
++++ +|.. +++|+.|++++|+++ .+|. .+++|+.|+|++|++++ .+|.+++.+ +.|.+.|.+
T Consensus 328 ~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i 391 (454)
T 1jl5_A 328 KLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEV 391 (454)
T ss_dssp CCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC-----
T ss_pred cccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhccccccc
Confidence 8885 5554 578899999999998 4666 46789999999999987 677766543 457777888
Q ss_pred ccccccccccCeEecccccccc--ccCcccccCCcccEEeccCCCCCCCCCC
Q 001922 543 PPEISNVRILNYLNLSRNHLNQ--NIPKSIGSMKSLTIADFSFNDFSGKLPE 592 (995)
Q Consensus 543 p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~l~ls~N~l~g~~p~ 592 (995)
|.. +++|+.|+|++|++++ .+|.+ ++.|.+.+|.+.+.+|.
T Consensus 392 ~~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 392 PEL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEF 434 (454)
T ss_dssp ----------------------------------------------------
T ss_pred ccc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCcccc
Confidence 864 5788999999999987 66644 55667888888888774
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=412.61 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=209.3
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.++|++.+.||+|+||+||+|+. .+|+.||+|++... .....+.+.+|+++|+.++|||||+++++|.+.+..|+||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 456899999999999999999976 46899999998542 2334567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC--CCeEEeeecccccccc
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA--FEAHVADFGLAKFLID 840 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~--~~vkl~DfGla~~~~~ 840 (995)
|||+||+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+.+
T Consensus 234 E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 234 EFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp ECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred eecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999999963 3457899999999999999999999887 9999999999999854 8999999999998743
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+... .+....+...... +.
T Consensus 310 ~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~----~~~~~~i~~~~~~-----~~- 376 (573)
T 3uto_A 310 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWN-----MD- 376 (573)
T ss_dssp T---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHTTCCC-----CC-
T ss_pred C---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHHhCCCC-----CC-
Confidence 2 334567899999999999999999999999999999999999999965322 2222222221100 00
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.......+..+.+||.+||+.||++||+++|++++
T Consensus 377 --~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 377 --DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp --SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00112345668899999999999999999999884
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=378.23 Aligned_cols=276 Identities=35% Similarity=0.583 Sum_probs=229.0
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+..++|+..+.||+|+||+||+|++.+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 345689999999999999999999888999999998543 3445677999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 763 EYMRNGSLGEALHGKK--GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||+++|+|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999996533 235899999999999999999999887 99999999999999999999999999987543
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCC--CchHHHHHHHHhcCChhhhhhhc
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGD--GVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
...........||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ......|....... ..+...+
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 269 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN--GQLEQIV 269 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT--TCCCSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc--ccHHHhc
Confidence 3333333455689999999999989999999999999999999999999976432 22334443332222 2233444
Q ss_pred CCcC-CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 919 DPRL-SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 919 d~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
++.. ...+.+.+..+.+++.+||+.||++||+++|+++.|+.+.+.
T Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 4444 346778999999999999999999999999999999977543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=375.82 Aligned_cols=293 Identities=28% Similarity=0.459 Sum_probs=170.6
Q ss_pred ccccchHHHHHHHHHhCCCCCCCCCCCCCCCCCCCce--eeeEEeCC----CceeeeecCCCCccc--cCCccccCCCCC
Q 001922 23 ASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCS--WAGICCSR----DRVASLDLTDLNLCG--SVPAQILRLDKL 94 (995)
Q Consensus 23 ~~~~~~~~~Ll~~k~~~~~~~~~l~~W~~~~~~~~C~--w~gv~C~~----~~v~~l~l~~~~l~~--~~~~~~~~l~~L 94 (995)
.|.+.|++||++||+++.||. .+++|+.+ ++||. |.||+|+. ++|+.|+|++++++| .+|+.+.++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~--~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT--SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCC--CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 466789999999999999886 79999764 57898 99999975 578888888888877 677666555555
Q ss_pred CeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccc
Q 001922 95 TNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYF 174 (995)
Q Consensus 95 ~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l 174 (995)
++|+|++ .|.+.+.+|..|.++++|++|++++|++++.+|..|.++++|++|+|++|.+
T Consensus 79 ~~L~L~~---------------------~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 137 (313)
T 1ogq_A 79 NFLYIGG---------------------INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL 137 (313)
T ss_dssp SEEEEEE---------------------ETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEE
T ss_pred CeeeCCC---------------------CCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCcc
Confidence 5555542 2444444455555555555555555555555566666666666666666666
Q ss_pred cccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCcc
Q 001922 175 FGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHE 254 (995)
Q Consensus 175 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~ 254 (995)
++.+|..|+.+++|++|+|++|++++.+|..+++++ ++|++|++++|++++.+|..
T Consensus 138 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~------------------------~~L~~L~L~~N~l~~~~~~~ 193 (313)
T 1ogq_A 138 SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS------------------------KLFTSMTISRNRLTGKIPPT 193 (313)
T ss_dssp ESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCC------------------------TTCCEEECCSSEEEEECCGG
T ss_pred CCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhh------------------------hcCcEEECcCCeeeccCChH
Confidence 666666666666666666666666654444333221 14555555555555555554
Q ss_pred ccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcc
Q 001922 255 IGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLE 334 (995)
Q Consensus 255 ~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 334 (995)
+..++ |+.|++++|++++.+|..+..+++|+.|+|++|.+++.+|. +..+++|+.|++++|++++.+|..+..+++|+
T Consensus 194 ~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 271 (313)
T 1ogq_A 194 FANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271 (313)
T ss_dssp GGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCC
T ss_pred HhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCC
Confidence 44443 44455555554444455555555555555555555543332 44444444444444444444444444444444
Q ss_pred eEEeccCcccccCCCcccCCCCCCeEEecCce
Q 001922 335 TLGLWQNNFTGVIPENLGQNGKLQVLDLSSNK 366 (995)
Q Consensus 335 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 366 (995)
.|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 272 ~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 272 SLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp EEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred EEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 4444444444444433 344444444444444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=375.65 Aligned_cols=278 Identities=40% Similarity=0.687 Sum_probs=226.3
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
....++|+..+.||+|+||.||+|+..+++.||||++...........+.+|++++++++||||+++++++.+++..++|
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 105 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEE
T ss_pred HHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEE
Confidence 33467899999999999999999998889999999986554444455789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 762 YEYMRNGSLGEALHGKK--GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+||+|||+++...
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 185 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccC
Confidence 99999999999997543 3458999999999999999999998822239999999999999999999999999998764
Q ss_pred cCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC----CCCCchHHHHHHHHhcCChhhhh
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGD----FGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~----~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
... ........||+.|+|||++.+..++.++||||+|+++|+|++|+.||.. .........|....... ....
T Consensus 186 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 262 (326)
T 3uim_A 186 YKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE--KKLE 262 (326)
T ss_dssp SSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS--CCST
T ss_pred ccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc--hhhh
Confidence 332 2223455699999999999988999999999999999999999999952 22334444554433332 2233
Q ss_pred hhcCCcC-CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 916 SILDPRL-SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 916 ~~~d~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
...+... ...+...+..+.+++.+||+.||++|||++||+++|++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 3344433 3467788999999999999999999999999999998743
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=382.54 Aligned_cols=261 Identities=24% Similarity=0.373 Sum_probs=215.1
Q ss_pred HhhccCCCeeeccCceEEEEEEe--------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecC
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM--------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNK 755 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 755 (995)
.++|+..+.||+|+||.||+|++ .++..||||++.........+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 35788899999999999999975 245679999986544444456789999999999 899999999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL 821 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill 821 (995)
+..|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999997532 235789999999999999999999887 9999999999999
Q ss_pred CCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHH
Q 001922 822 NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIV 900 (995)
Q Consensus 822 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 900 (995)
+.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-ELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Confidence 9999999999999987655443333345567889999999999999999999999999999999 99999653321 111
Q ss_pred HHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
..+... .....+..++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 316 ---~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 316 ---KLLKEG-----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ---HHHHTT-----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHhcC-----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111 1122344566789999999999999999999999999988653
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=386.51 Aligned_cols=364 Identities=21% Similarity=0.207 Sum_probs=236.8
Q ss_pred ccCCccccCCCCCCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCC
Q 001922 82 GSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKL 161 (995)
Q Consensus 82 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l 161 (995)
+..+..++++++|++|++++|.+++...++.+++|++|+|++|+|+++. ++.+++|++|++++|+++++ | ++++
T Consensus 32 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~N~l~~~-~--~~~l 105 (457)
T 3bz5_A 32 ATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLTNL-D--VTPL 105 (457)
T ss_dssp TTSEEEHHHHTTCCEEECCSSCCCCCTTGGGCTTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSCC-C--CTTC
T ss_pred cccccChhHcCCCCEEEccCCCcccChhhcccCCCCEEEccCCcCCeEc---cccCCCCCEEECcCCCCcee-e--cCCC
Confidence 3344566777778888888888777656777778888888888777752 67777777777777777774 3 6777
Q ss_pred CCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEE
Q 001922 162 EKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLD 241 (995)
Q Consensus 162 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~ 241 (995)
++|++|+|++|++++ +| ++.+++|++|++++|++++. + ++++++ |++|+
T Consensus 106 ~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~-------------------------L~~L~ 154 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQ-------------------------LTELD 154 (457)
T ss_dssp TTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTT-------------------------CCEEE
T ss_pred CcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCc-------------------------CCEEE
Confidence 777777777777765 33 67777777777777777753 1 444444 45555
Q ss_pred CcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCC
Q 001922 242 LSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG 321 (995)
Q Consensus 242 Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 321 (995)
+++|+..+.+ .+..+++|+.|++++|++++ +| +..+++|+.|++++|.+++. .+..+++|+.|++++|++++
T Consensus 155 l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 155 CHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp CTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC
T ss_pred CCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc
Confidence 5555333333 24455555555555555554 23 55566666666666666643 25566666666666666665
Q ss_pred CCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCccccc
Q 001922 322 SIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGA 401 (995)
Q Consensus 322 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~ 401 (995)
+| +..+++|+.|++++|++++.. ++.+++|+.|++++|+ |+.|++++|.+.+.+| ++.
T Consensus 227 -ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~ 284 (457)
T 3bz5_A 227 -ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEG 284 (457)
T ss_dssp -CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTT
T ss_pred -cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccc
Confidence 34 556666666666666666542 3445566666666553 3455666666666555 356
Q ss_pred CCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCc
Q 001922 402 CYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQ 481 (995)
Q Consensus 402 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 481 (995)
+++|+.|++++|.+.+.+|.. .+.|+.+++++| ++|++|++++|++++. + ++++++|+
T Consensus 285 l~~L~~L~Ls~n~~l~~l~~~---~~~L~~L~l~~~----------------~~L~~L~L~~N~l~~l-~--l~~l~~L~ 342 (457)
T 3bz5_A 285 CRKIKELDVTHNTQLYLLDCQ---AAGITELDLSQN----------------PKLVYLYLNNTELTEL-D--VSHNTKLK 342 (457)
T ss_dssp CTTCCCCCCTTCTTCCEEECT---TCCCSCCCCTTC----------------TTCCEEECTTCCCSCC-C--CTTCTTCS
T ss_pred cccCCEEECCCCcccceeccC---CCcceEechhhc----------------ccCCEEECCCCccccc-c--cccCCcCc
Confidence 677777777777766666542 234444444333 4678888888888863 3 77888888
Q ss_pred EEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccc
Q 001922 482 ILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEIS 547 (995)
Q Consensus 482 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~ 547 (995)
.|++++|+|++ ++.|..|++++|.++|. +.+..|..++|++|+++|.+|..+.
T Consensus 343 ~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 343 SLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp EEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred EEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence 88888888875 24567778888888764 4566777888888888888877654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=389.58 Aligned_cols=352 Identities=21% Similarity=0.196 Sum_probs=207.4
Q ss_pred CCCCeEeccCCcccCcc--ccCcccccceeccccccccCC-CcccccccccccccccccccccccCCccccCCCCCceee
Q 001922 92 DKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGG-LDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLD 168 (995)
Q Consensus 92 ~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~ 168 (995)
++|++|+|++|++++.. .+.++++|++|+|++|.+.+. .+..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 45555666665555432 355555666666666555432 244555556666666666666555555555566666666
Q ss_pred ccCccccccCCcc--ccCCCCCceeeccCCcccccCccc-ccchhhhhhhhccccccccCCCCcccCCC--CcccEEECc
Q 001922 169 LGGNYFFGKIPNS--YGELQGLEYLSLAGNDLTGKIPGE-LGNLTNLREIYLGYYNVFEGGIPREVGKL--VNLVHLDLS 243 (995)
Q Consensus 169 L~~N~l~~~~p~~--l~~l~~L~~L~Ls~N~l~~~~~~~-l~~l~~L~~L~L~~n~~~~~~~p~~~~~l--~~L~~L~Ls 243 (995)
|++|.+++.+|.. |+.+++|++|+|++|++++..|.. ++++++|++|++++|.+ .+..+..+..+ .+|+.|+++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l-~~~~~~~l~~l~~~~L~~L~l~ 188 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLLRLS 188 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB-SCCCTTTSGGGTTCEEEEEECT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc-cccChhhhhccccccccccccc
Confidence 6666555433333 555556666666666665554544 55556666666654433 22334444443 456666666
Q ss_pred CCCCCCccCccc--------cCccccCccccccccccCCCCccccCc---CCCCeEeccCCcCcCc----------CCcc
Q 001922 244 SCELDGQIPHEI--------GNLKLLDTVFLHINLLSGSIPKQLGNL---TNLVNLDLSNNALTGE----------IPYS 302 (995)
Q Consensus 244 ~n~l~~~~~~~~--------~~l~~L~~L~l~~N~l~~~~p~~l~~l---~~L~~L~Ls~N~l~~~----------~p~~ 302 (995)
+|.+.+..+..+ ..+++|++|++++|++++..|..+... ++|+.|++++|.+.+. .+..
T Consensus 189 ~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~ 268 (455)
T 3v47_A 189 SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268 (455)
T ss_dssp TCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTT
T ss_pred cCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccc
Confidence 666654433322 244556666666666655555544433 5566666665543321 1222
Q ss_pred cccc--CCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCc
Q 001922 303 FINL--RQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQ 380 (995)
Q Consensus 303 ~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 380 (995)
+..+ ++|+.|++++|++.+..|..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..+..+++
T Consensus 269 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 348 (455)
T 3v47_A 269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDK 348 (455)
T ss_dssp TGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTT
T ss_pred cccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCccc
Confidence 2222 46667777777776666666666777777777777776666666666677777777777776666666666677
Q ss_pred cceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCC
Q 001922 381 LRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLP 444 (995)
Q Consensus 381 L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~ 444 (995)
|+.|++++|++.+..|..+..+++|++|++++|++++..+..|..+++|+.+++++|.+++..|
T Consensus 349 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 349 LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 7777777777766666667777777777777777766666666667777777777777766554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=375.62 Aligned_cols=267 Identities=27% Similarity=0.397 Sum_probs=213.8
Q ss_pred HhhccCCCeeeccCceEEEEEEeC----CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
..+|+..+.||+|+||+||+|++. .+..||||++.........+.+.+|+.++++++||||+++++++.+++..|+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357888899999999999999874 3456999999655445556679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 128 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999643 456899999999999999999999887 99999999999999999999999999987644
Q ss_pred CCCC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 841 GGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 841 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+...
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~~~~~--------- 270 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----DVISSVEEG--------- 270 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHHHHHTT---------
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHHcC---------
Confidence 3221 12233456788999999998899999999999999999999 99999653221 122222111
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCccccc
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQ 970 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 970 (995)
.....+..++..+.+++.+||+.||++||+++|+++.|+++.+.......
T Consensus 271 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~ 320 (325)
T 3kul_A 271 --YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA 320 (325)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC----
T ss_pred --CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccccc
Confidence 11122334567899999999999999999999999999998766554433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=360.37 Aligned_cols=277 Identities=35% Similarity=0.571 Sum_probs=228.3
Q ss_pred HHHHHhhccCC------CeeeccCceEEEEEEeCCCcEEEEEEecCCC---CCChhHHHHHHHHHHhccCCCCceeEeEE
Q 001922 681 VSDILECVKDG------NVIGRGGAGIVYHGKMPNGVEIAVKKLLGFG---THSHDHGFRAEIQTLGNIRHRNIVRLLAF 751 (995)
Q Consensus 681 ~~~~~~~~~~~------~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 751 (995)
+..++..|... +.||+|+||.||+|+. +++.||||++.... .....+.+.+|+.++++++||||++++++
T Consensus 20 l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 98 (307)
T 2nru_A 20 LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98 (307)
T ss_dssp HHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 34445555544 8999999999999987 68899999985432 23345678999999999999999999999
Q ss_pred EecCCcceEEEEeccCCChhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEe
Q 001922 752 CSNKETNLLVYEYMRNGSLGEALHGK-KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVA 830 (995)
Q Consensus 752 ~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~ 830 (995)
+.+.+..++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~ 175 (307)
T 2nru_A 99 SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKIS 175 (307)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred EecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEe
Confidence 99999999999999999999998643 2356899999999999999999999887 9999999999999999999999
Q ss_pred eeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCC
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 910 (995)
|||+++...............||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...........+.......
T Consensus 176 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 253 (307)
T 2nru_A 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE- 253 (307)
T ss_dssp CCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTT-
T ss_pred ecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhh-
Confidence 9999987644333333345679999999998765 58899999999999999999999998765554444444443332
Q ss_pred hhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 911 KEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 911 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
...+.+.+++.....+...+..+.+++.+||+.||++||+++++++.|+++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 254 EKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 23345666677777788899999999999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=362.90 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=208.4
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
..++|+..+.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 356899999999999999999975 578999999985432 334567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++|+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999999643 5889999999999999999999887 9999999999999999999999999998764432
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||............. ... .+.
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~---------~~~- 235 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNG---------TPE- 235 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHC---------SCC-
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCC---------CCC-
Confidence 2 2345679999999999999999999999999999999999999996532211111111 110 000
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+...+..+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234456678999999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=384.11 Aligned_cols=259 Identities=26% Similarity=0.380 Sum_probs=211.4
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++|+..+.||+|+||+||+|++. +++.||||++.........+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 56888899999999999999875 78999999986443333345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++|+|.+++.. .+..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...+....
T Consensus 194 ~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 194 VQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 999999999973 3446899999999999999999999887 999999999999999999999999999865332221
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||...... +....+..+ ...
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----~~~~~~~~~-----------~~~ 334 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----QTREFVEKG-----------GRL 334 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----HHHHHHHTT-----------CCC
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcC-----------CCC
Confidence 11122346778999999998899999999999999999998 99999654321 111111111 011
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
..+..++..+.+++.+||+.||++|||++++++.|+++.+
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 1234456778999999999999999999999999988753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.31 Aligned_cols=260 Identities=22% Similarity=0.391 Sum_probs=213.4
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
.++|+..+.||+|+||+||+|+..++..||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 35788899999999999999999888899999985432 2356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++... +..+++..++.++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY- 159 (268)
T ss_dssp CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred cCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence 9999999999642 345899999999999999999999887 99999999999999999999999999987644322
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||...... ......... ...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~~~-----------~~~ 224 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----EVVLKVSQG-----------HRL 224 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHHHHTT-----------CCC
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH----HHHHHHHcC-----------CCC
Confidence 22234456778999999998899999999999999999999 99999643221 111111111 111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
..+...+..+.+++.+||+.||++|||++|+++.|+++.+...
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 1223345678999999999999999999999999999987653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=371.67 Aligned_cols=269 Identities=25% Similarity=0.325 Sum_probs=208.0
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCc----ceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET----NLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~lv 761 (995)
.+|+..+.||+|+||+||+|++. ++.||||++... ......+..|+.++++++||||+++++++.+... .++|
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 46888999999999999999874 789999998432 2234456678999999999999999999977543 6999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEecCCCCCCEEECCCCCeEEee
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD----------CSPLIVHRDVKSNNILLNSAFEAHVAD 831 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------~~~~iiHrDlkp~Nill~~~~~vkl~D 831 (995)
|||+++|+|.+++... .+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|
T Consensus 101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999643 489999999999999999999976 6 99999999999999999999999
Q ss_pred eccccccccCCCCccccccccCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH
Q 001922 832 FGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT-----LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRA 906 (995)
Q Consensus 832 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 906 (995)
||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+...........
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999987655443333445679999999999876 356678999999999999999999997643322111000000
Q ss_pred hcCChhhhhhhc-----CCcCCC--CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 907 TNGRKEEFLSIL-----DPRLSM--VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 907 ~~~~~~~~~~~~-----d~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
............ .+.... .....+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000011111111 111111 123567779999999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=367.52 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=207.3
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
..+|+..+.||+|+||.||+|++ .+|+.||||++.... .....+++.+|++++++++||||+++++++.+.+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35688899999999999999986 679999999985432 2334566889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred ECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 99999999999964 346899999999999999999999887 999999999999999999999999999876433
Q ss_pred CCccccccccCcccccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVD-EKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
......+||+.|+|||++.+..+. .++||||+||++|||++|+.||... +.......+..+.
T Consensus 168 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~----------- 230 (328)
T 3fe3_A 168 --GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGK----------- 230 (328)
T ss_dssp --CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCC-----------
T ss_pred --CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCC-----------
Confidence 233566899999999999888775 7999999999999999999999643 2222222222211
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...|...+..+.+++.+||+.||++|||++|+++.
T Consensus 231 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 -YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11233345678899999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=378.48 Aligned_cols=261 Identities=28% Similarity=0.419 Sum_probs=202.3
Q ss_pred hhccCCCeeeccCceEEEEEEeC----CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.+|+..+.||+|+||.||+|+.. ++..||||++.........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999764 57789999986544444566799999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++.. .+..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 999999999999974 3456899999999999999999999887 999999999999999999999999999876433
Q ss_pred CCCc-cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 842 GASE-CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 842 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .+....+...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----~~~~~~i~~~---------- 266 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEG---------- 266 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----HHHHHHHHTT----------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcC----------
Confidence 2111 1122345778999999999999999999999999999998 9999965422 1122222111
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
.....+..++..+.+++.+||+.||++||+++|+++.|+++.+..
T Consensus 267 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 -YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 001123345677999999999999999999999999999886543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.48 Aligned_cols=256 Identities=23% Similarity=0.435 Sum_probs=212.4
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
++|+..+.||+|+||+||+|++.+++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc--ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 468888999999999999999988999999998543 233567999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++.. ....+++..++.++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 88 ~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 162 (269)
T ss_dssp TTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence 99999999974 3456899999999999999999999887 9999999999999999999999999998653321 11
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||..... ......+... ....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~----~~~~~~~~~~-----------~~~~ 227 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVVEDISTG-----------FRLY 227 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTT-----------CCCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH----HHHHHHHhcC-----------ccCC
Confidence 2234456788999999998999999999999999999999 9999965322 2222222211 1112
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.+...+..+.+++.+||+.||++||+++|++++|+++.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 233345678999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=372.05 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=215.1
Q ss_pred HhhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
.++|+..+.||+|+||.||+|+.. +++.||||++.........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 457888999999999999999864 34789999986544444456789999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 001922 759 LLVYEYMRNGSLGEALHGKK----------------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKS 816 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp 816 (995)
++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCc
Confidence 99999999999999997532 256899999999999999999999887 99999999
Q ss_pred CCEEECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 001922 817 NNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGD 895 (995)
Q Consensus 817 ~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~ 895 (995)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 999999999999999999987644333333345678899999999998899999999999999999999 9999965321
Q ss_pred CchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 896 GVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
.+....+... .....+..++..+.+++.+||+.||++||+++|+++.|+++.....
T Consensus 283 ----~~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 283 ----EEVIYYVRDG-----------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp ----HHHHHHHHTT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred ----HHHHHHHhCC-----------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 2222222211 1222344556789999999999999999999999999999886543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=366.20 Aligned_cols=261 Identities=24% Similarity=0.409 Sum_probs=210.7
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++|+.++.||+|+||+||+|++. +++.||+|++.. ......+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 56888899999999999999874 689999998843 2344566789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+......
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999743 456899999999999999999999887 999999999999999999999999999876433221
Q ss_pred c------------cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 845 E------------CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 845 ~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
. ......||+.|+|||++.+..++.++||||+|+++|||++|..||............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---------- 234 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---------- 234 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------
Confidence 1 111457999999999999999999999999999999999999998653321110000
Q ss_pred hhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 913 EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 913 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
......+. ..+..++..+.+++.+||+.||++||+++|+++.|+++...
T Consensus 235 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 235 NVRGFLDR---YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp CHHHHHHH---TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhccccc---cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00000000 01223445688999999999999999999999999988754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=363.30 Aligned_cols=263 Identities=29% Similarity=0.428 Sum_probs=203.8
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
..+|+..+.||+|+||+||+|+. +++.||||++...... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45788899999999999999987 6889999998543322 234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 764 YMRNGSLGEALHGKK-GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 999999999997432 124899999999999999999999542 239999999999999999999999999997543221
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
.......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .+........ ...
T Consensus 194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~~~~~~----------~~~ 257 (309)
T 3p86_A 194 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP----AQVVAAVGFK----------CKR 257 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH----HHHHHHHHHS----------CCC
T ss_pred --cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhc----------CCC
Confidence 223456799999999999999999999999999999999999999965322 1111111100 111
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
...+...+..+.+++.+||+.||++||+++|+++.|+.+.+..
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 258 LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 1234445667999999999999999999999999999887653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=376.01 Aligned_cols=263 Identities=25% Similarity=0.355 Sum_probs=217.2
Q ss_pred HhhccCCCeeeccCceEEEEEEeC--------CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecC
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP--------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNK 755 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 755 (995)
.++|+..+.||+|+||+||+|+.. .+..||||++..........++.+|+++++++ +||||+++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357888999999999999999752 34679999996654444557789999999999 899999999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL 821 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill 821 (995)
+..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 99999999999999999997543 245899999999999999999999887 9999999999999
Q ss_pred CCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHH
Q 001922 822 NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIV 900 (995)
Q Consensus 822 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 900 (995)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~----~~ 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VE 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----HH
Confidence 9999999999999987655443344455668899999999999999999999999999999999 999996432 22
Q ss_pred HHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
+....+.... ....+..++..+.+++.+||+.||++||+++|+++.|+++....
T Consensus 301 ~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 301 ELFKLLKEGH-----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHHTTC-----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHHcCC-----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 2222222211 11123345667999999999999999999999999999887543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=362.71 Aligned_cols=270 Identities=20% Similarity=0.250 Sum_probs=215.9
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC--cceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE--TNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~ 762 (995)
++|+..+.||+|+||+||+|+.. +++.||||++.........+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888999999999999999875 589999999965444445677889999999999999999999987655 779999
Q ss_pred EeccCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----CCCCCeEEeeeccccc
Q 001922 763 EYMRNGSLGEALHGKKG-AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL----NSAFEAHVADFGLAKF 837 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill----~~~~~vkl~DfGla~~ 837 (995)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999975332 33899999999999999999999887 9999999999999 7888899999999987
Q ss_pred cccCCCCccccccccCcccccccccc--------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAY--------TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
+.... ......||+.|+|||++. +..++.++||||+||++|||++|+.||...............+..+
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 64432 223457999999999876 5678999999999999999999999997655544433333333322
Q ss_pred Chhhh----hhhcC---------CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 910 RKEEF----LSILD---------PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 910 ~~~~~----~~~~d---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
..... ..... +.....+...+..+.+++.+||+.||++||+++|+++...+-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11110 00000 111235578889999999999999999999999999987653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=365.50 Aligned_cols=255 Identities=22% Similarity=0.246 Sum_probs=206.0
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.++|+..+.||+|+||+||+|+.. +++.||||++.........+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999765 7899999998544444445668899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++|+|.+++. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 86 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999996 3456899999999999999999999887 99999999999999999999999999987654433
Q ss_pred CccccccccCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
........||+.|+|||++.+..+ +.++||||+||++|+|++|+.||............. .... ..
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~~~~-----------~~ 227 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--KEKK-----------TY 227 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH--HTTC-----------TT
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--hccc-----------cc
Confidence 333456689999999999987775 789999999999999999999997644332211110 1100 00
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.......+..+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01112345667899999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=374.02 Aligned_cols=262 Identities=26% Similarity=0.396 Sum_probs=213.5
Q ss_pred HhhccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCC-
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKE- 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~- 756 (995)
.++|+..+.||+|+||.||+|++ .+++.||||++.........+.+.+|+++++++ +||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 46789999999999999999963 346889999996544444456799999999999 7999999999987754
Q ss_pred cceEEEEeccCCChhhhhcCCCC---------------------------------------------------------
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKG--------------------------------------------------------- 779 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 779 (995)
..++||||+++|+|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 48999999999999999975432
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcccccccc
Q 001922 780 -------AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852 (995)
Q Consensus 780 -------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~g 852 (995)
..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.+.............|
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 12889999999999999999999887 99999999999999999999999999987654443344455678
Q ss_pred CcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHH
Q 001922 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAM 931 (995)
Q Consensus 853 t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 931 (995)
|+.|+|||++.+..++.++||||||+++|||++ |+.||................. ....+...+.
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~ 323 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--------------RMRAPDYTTP 323 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC--------------CCCCCTTCCH
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC--------------CCCCCCCCCH
Confidence 999999999999999999999999999999998 9999976543333322222111 1112333456
Q ss_pred HHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 932 HLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 932 ~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.+.+++.+||+.||++||+++|++++|+++..
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 78999999999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=368.39 Aligned_cols=265 Identities=24% Similarity=0.368 Sum_probs=213.7
Q ss_pred HhhccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 757 (995)
.++|+..+.||+|+||.||+|+. .+++.||+|++.........+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46788899999999999999975 246689999996554455567899999999999 89999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 001922 758 NLLVYEYMRNGSLGEALHGKKG---------------------AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKS 816 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp 816 (995)
.++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 9999999999999999975432 24789999999999999999999887 99999999
Q ss_pred CCEEECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 001922 817 NNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGD 895 (995)
Q Consensus 817 ~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~ 895 (995)
+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987655443333445668889999999999999999999999999999998 9999976544
Q ss_pred CchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 896 GVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
.......... . .....+...+..+.+++.+||+.||++||+++|++++|+.+.....
T Consensus 281 ~~~~~~~~~~---~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 281 DANFYKLIQN---G-----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp SHHHHHHHHT---T-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHHHHHHHhc---C-----------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 3333222211 1 0011233446679999999999999999999999999998876544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=377.63 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=214.5
Q ss_pred HhhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
.++|+..+.||+|+||+||+|++. +++.||||++...........+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 457888999999999999999842 46789999986554455566788999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC---CeEEe
Q 001922 759 LLVYEYMRNGSLGEALHGKK-----GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF---EAHVA 830 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~---~vkl~ 830 (995)
++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997422 245899999999999999999999887 99999999999999655 59999
Q ss_pred eeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcC
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ......+...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~----~~~~~~i~~~ 302 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----QEVLEFVTSG 302 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHTT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcC
Confidence 9999986644333333345678999999999999999999999999999999998 9999965321 2222222221
Q ss_pred ChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 910 RKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 910 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.....+..++..+.+++.+||+.||++||+++||++.|+.+.+.
T Consensus 303 -----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 303 -----------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp -----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11122334566789999999999999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=365.39 Aligned_cols=261 Identities=23% Similarity=0.343 Sum_probs=214.4
Q ss_pred HhhccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
.++|+..+.||+|+||.||+|+. .+++.||+|++.........+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45788899999999999999975 345789999986544444557789999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 001922 759 LLVYEYMRNGSLGEALHGKKG----------------------AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKS 816 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp 816 (995)
++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999975322 34889999999999999999999887 99999999
Q ss_pred CCEEECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCC
Q 001922 817 NNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGD 895 (995)
Q Consensus 817 ~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~ 895 (995)
+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654433333344567889999999998889999999999999999999 9999965432
Q ss_pred CchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 896 GVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
. ..... .... .....+...+..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 259 ~-~~~~~---~~~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 E-RLFNL---LKTG-----------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp G-GHHHH---HHTT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-HHHHH---hhcC-----------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2 11111 1111 1112233456679999999999999999999999999988653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=384.23 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=213.5
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
++|+..+.||+|+||+||+|++.++..||||++.... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 5678889999999999999999888999999996432 34678999999999999999999999986 56789999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++|+|.+++....+..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~ 340 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 340 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-H
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-e
Confidence 9999999997544456889999999999999999999887 99999999999999999999999999987533211 1
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......+|+.|+|||++....++.++|||||||++|||++ |+.||...... +....+..+. ...
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~----~~~~~i~~~~-----------~~~ 405 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRALERGY-----------RMP 405 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHHHTC-----------CCC
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcCC-----------CCC
Confidence 1223456789999999998999999999999999999999 99999654321 1112111110 011
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
.+..++..+.++|.+||+.||++|||+++|++.|+++.....
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 234456789999999999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=359.42 Aligned_cols=266 Identities=21% Similarity=0.249 Sum_probs=209.4
Q ss_pred HHhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.++|+..+.||+|+||+||+|+..+|+.||+|++..... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4578999999999999999999998899999999854322 233467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++ +|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 99 e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 99 EFMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp ECCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred cCCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99975 88888864 3456899999999999999999999887 9999999999999999999999999998764322
Q ss_pred CCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC--
Q 001922 843 ASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD-- 919 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-- 919 (995)
.......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....+..................+....+
T Consensus 174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 22344578999999999876 5689999999999999999999999987665555555444333322211111110
Q ss_pred -------CcCCCC-----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 920 -------PRLSMV-----PKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 920 -------~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
...... .+..+..+.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000011 1123457889999999999999999999987
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=359.48 Aligned_cols=265 Identities=25% Similarity=0.344 Sum_probs=208.6
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC--ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.++|+..+.||+|+||.||+|+. .+++.||+|++...... ...+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35788999999999999999976 46899999998443222 2345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 999999999999964 346899999999999999999999887 999999999999999999999999999876433
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
.. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ........... ......
T Consensus 165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~-~~~~~~----- 234 (294)
T 4eqm_A 165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA---VSIAIKHIQDS-VPNVTT----- 234 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH---HHHHHHHHSSC-CCCHHH-----
T ss_pred cc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhhcc-CCCcch-----
Confidence 22 222345799999999999999999999999999999999999999965321 11111111111 111100
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHHccCCCCCc
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERP-RMREVVQMLSEFPRHSS 966 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~~ 966 (995)
..+...+..+.+++.+|++.||++|| +++++.+.|+++.....
T Consensus 235 --~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 235 --DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp --HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred --hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 11223456789999999999999998 89999999999876543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=376.71 Aligned_cols=357 Identities=20% Similarity=0.190 Sum_probs=216.0
Q ss_pred ccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCC
Q 001922 109 EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGL 188 (995)
Q Consensus 109 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 188 (995)
.++++++|++|+|++|.+++. | .+..+++|++|++++|+++++ | ++.+++|++|+|++|.+++. | ++.+++|
T Consensus 37 ~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L 108 (457)
T 3bz5_A 37 SEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKL 108 (457)
T ss_dssp EHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTC
T ss_pred ChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcC
Confidence 455555555555555555543 2 344455555555555555442 2 44445555555555554432 2 4444445
Q ss_pred ceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCcccccc
Q 001922 189 EYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHI 268 (995)
Q Consensus 189 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~ 268 (995)
++|++++|++++ +| ++.+++|++|++++|++++. .++.+++|+.|++++
T Consensus 109 ~~L~L~~N~l~~--------------------------l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~ 157 (457)
T 3bz5_A 109 TYLNCDTNKLTK--------------------------LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHL 157 (457)
T ss_dssp CEEECCSSCCSC--------------------------CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTT
T ss_pred CEEECCCCcCCe--------------------------ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCC
Confidence 555555444442 11 44556777777777777753 266677777777777
Q ss_pred ccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCC
Q 001922 269 NLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIP 348 (995)
Q Consensus 269 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 348 (995)
|+..+.+ .+..+++|++|++++|++++. | +..+++|+.|++++|++++. .+..+++|+.|++++|++++ +|
T Consensus 158 n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip 228 (457)
T 3bz5_A 158 NKKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID 228 (457)
T ss_dssp CSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC
T ss_pred CCccccc--ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC
Confidence 7544444 366667777777777777753 3 66666777777777777653 26666667777777777665 34
Q ss_pred CcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCC
Q 001922 349 ENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPG 428 (995)
Q Consensus 349 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 428 (995)
++.+++|++|++++|++++.. +..+++|+.|++++|. |+.|++++
T Consensus 229 --~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~---------------- 273 (457)
T 3bz5_A 229 --VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTH---------------- 273 (457)
T ss_dssp --CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTT----------------
T ss_pred --ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCC----------------
Confidence 566666666666666666432 2334444555444432 33444444
Q ss_pred CceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhcccc
Q 001922 429 LNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLD 508 (995)
Q Consensus 429 L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 508 (995)
|.+.+.+|. ..+++|+.|++++|.+.+.+|. ...+|+.|++++| ++|+.|+
T Consensus 274 --------n~~~~~~~~-----~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~ 324 (457)
T 3bz5_A 274 --------NTQLIYFQA-----EGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLY 324 (457)
T ss_dssp --------CTTCCEEEC-----TTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEE
T ss_pred --------CccCCcccc-----cccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEE
Confidence 444444432 2345677777777776666664 3345555556555 4678888
Q ss_pred ccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCC
Q 001922 509 LSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSG 588 (995)
Q Consensus 509 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g 588 (995)
|++|+|++ ++ ++.+++|++|++++|+|++ ++.|..|++++|.++|. ..+..|..+++++|+|+|
T Consensus 325 L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g 388 (457)
T 3bz5_A 325 LNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTI 388 (457)
T ss_dssp CTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEE
T ss_pred CCCCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEE
Confidence 88888886 33 7788888888888888875 24566677888888875 355667778888888888
Q ss_pred CCCCC
Q 001922 589 KLPES 593 (995)
Q Consensus 589 ~~p~~ 593 (995)
.||..
T Consensus 389 ~ip~~ 393 (457)
T 3bz5_A 389 AVSPD 393 (457)
T ss_dssp ECCTT
T ss_pred EcChh
Confidence 88863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=366.71 Aligned_cols=260 Identities=25% Similarity=0.391 Sum_probs=204.3
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCc----EEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGV----EIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
++|+..+.||+|+||+||+|++. +++ +||+|.+...........+.+|+.++++++||||+++++++.++ ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 56888899999999999999863 344 35888875544445567899999999999999999999999875 4789
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+.+|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 94 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 99999999999999743 456899999999999999999999887 99999999999999999999999999987654
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...... ...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~---~~~---------- 235 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSIL---EKG---------- 235 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHH---HTT----------
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-HHHHHH---HcC----------
Confidence 443333345567889999999999999999999999999999999 99999654322 221111 111
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
.....+..++..+.+++.+||+.||++||+++|+++.|+++.+..
T Consensus 236 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 236 -ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred -CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 111123345667899999999999999999999999999887643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=361.98 Aligned_cols=254 Identities=22% Similarity=0.262 Sum_probs=207.2
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC-----ChhHHHHHHHHHHhccCCCCceeEeEEEecCCc
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH-----SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET 757 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 757 (995)
+.+.|+..+.||+|+||+||+|+.+ +|+.||+|.+...... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4567999999999999999999764 6899999998543322 135678999999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC----CeEEeeec
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF----EAHVADFG 833 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~----~vkl~DfG 833 (995)
.|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 9999999999999999953 457899999999999999999999887 99999999999998877 79999999
Q ss_pred cccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
+++.+.+.. .....+||+.|+|||++.+..++.++||||+||++|+|++|..||.... .......+.......
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~ 237 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANITAVSYDF 237 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHHTTCCCC
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCC
Confidence 998764432 2345679999999999999999999999999999999999999996532 122222222211000
Q ss_pred hhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 914 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
++. .....+..+.+++.+||+.||++|||++|++++
T Consensus 238 -----~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 238 -----DEE---FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp -----CHH---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----Cch---hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 001234568899999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=367.38 Aligned_cols=262 Identities=25% Similarity=0.398 Sum_probs=208.8
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCc----EEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGV----EIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
++|+..+.||+|+||+||+|++. +++ +||+|.+...........+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46788899999999999999764 344 378888754443444556788999999999999999999986 467899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+.+|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999743 456888999999999999999999887 99999999999999999999999999998755
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
...........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||....... .... ....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~---~~~~---------- 233 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDL---LEKG---------- 233 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-HHHH---HHTT----------
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-HHHH---HHcC----------
Confidence 444444455678889999999999999999999999999999999 999997543222 1111 1111
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcc
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSD 967 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 967 (995)
.....+..++..+.+++.+||+.||++||+++|+++.|+++.+..+.
T Consensus 234 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~ 280 (325)
T 3kex_A 234 -ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR 280 (325)
T ss_dssp -CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHH
T ss_pred -CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 01112223445678899999999999999999999999998765443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=360.19 Aligned_cols=258 Identities=21% Similarity=0.369 Sum_probs=209.6
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
.++|+..+.||+|+||+||+|++.++..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 35788889999999999999999888899999985432 2356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 101 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 175 (283)
T 3gen_A 101 MANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-Y 175 (283)
T ss_dssp CTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-H
T ss_pred cCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-c
Confidence 9999999999742 456899999999999999999999887 9999999999999999999999999998653321 1
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+... ...
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~~~~-----------~~~ 240 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAEHIAQG-----------LRL 240 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHHHHTT-----------CCC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh----HHHHHHhcc-----------cCC
Confidence 11233456788999999998899999999999999999998 99999653321 122222211 111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
..+...+..+.+++.+||+.||++||+++|+++.|+++...
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 12233456788999999999999999999999999887543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=361.57 Aligned_cols=262 Identities=24% Similarity=0.383 Sum_probs=216.7
Q ss_pred HhhccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 757 (995)
.++|+..+.||+|+||+||+|++ .+++.||+|++.........+.+.+|+.+++++ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35788899999999999999974 356889999996554444567789999999999 89999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 001922 758 NLLVYEYMRNGSLGEALHGKKG----------------AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL 821 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill 821 (995)
.++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999975432 24899999999999999999999887 9999999999999
Q ss_pred CCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHH
Q 001922 822 NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIV 900 (995)
Q Consensus 822 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 900 (995)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 9999999999999987655443333345567889999999999999999999999999999999 999997654433332
Q ss_pred HHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
........ ...+...+..+.+++.+||+.||++||+++|++++|+++..
T Consensus 259 ~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 259 KMIKEGFR--------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHTCC--------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCCC--------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 22221110 11223345678999999999999999999999999988654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=361.20 Aligned_cols=253 Identities=21% Similarity=0.221 Sum_probs=206.4
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.++|+..+.||+|+||+||+|+.. +++.||+|.+.. .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC--CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec--CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 3567899999999999999999764 588899999853 2334566889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC--CCCeEEeeecccccccc
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS--AFEAHVADFGLAKFLID 840 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~--~~~vkl~DfGla~~~~~ 840 (995)
||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+++.+..
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 81 EFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999999963 3356899999999999999999999887 999999999999987 78999999999987643
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.. ......||+.|+|||++.+..++.++||||+||++|+|++|..||..... ......+..........
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~---- 225 (321)
T 1tki_A 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEE---- 225 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTCCCCCHH----
T ss_pred CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH----HHHHHHHHcCCCCCChh----
Confidence 32 23456799999999999988899999999999999999999999965322 12222222111000000
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....+..+.+++.+|++.||++|||++|++++
T Consensus 226 ----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 ----AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001235678899999999999999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=381.62 Aligned_cols=263 Identities=30% Similarity=0.418 Sum_probs=210.7
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
+.|+..+.||+|+||+||+|++..+..||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 4678889999999999999999888889999986432 335679999999999999999999999876 6789999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++|+|.+++....+..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...+... .
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 336 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce-e
Confidence 9999999997544456899999999999999999999887 99999999999999999999999999987643322 1
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .+....+..+ ....
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~~~i~~~-----------~~~~ 401 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQVERG-----------YRMP 401 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTT-----------CCCC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcC-----------CCCC
Confidence 2233457889999999999999999999999999999999 9999965332 1222222211 1112
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCccccc
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQ 970 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 970 (995)
.+..++..+.+++.+||+.||++|||++++++.|+++.....+.++
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~ 447 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 447 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccc
Confidence 2345667899999999999999999999999999998766544433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.59 Aligned_cols=262 Identities=30% Similarity=0.460 Sum_probs=200.3
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
..+|+..+.||+|+||+||+|+.. ..||+|++..... ....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 356888999999999999999864 3699999854332 23346789999999999999999999965 4567899999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence 9999999999964 3456899999999999999999999887 99999999999999999999999999986543333
Q ss_pred CccccccccCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAY---TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
........||+.|+|||++. +..++.++||||+|+++|+|++|+.||................. ..+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------~~~ 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS----------LSP 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS----------CCC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc----------cCc
Confidence 33344567999999999986 56788899999999999999999999976544333333222111 112
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
........++..+.+++.+||+.||++||+++|+++.|+++.+
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 2222334556789999999999999999999999999998875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=362.63 Aligned_cols=249 Identities=22% Similarity=0.239 Sum_probs=206.0
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
++|+..+.||+|+||+||+|+.+ +|+.||+|++.+.. .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999774 68999999985321 2233566889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 85 EYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999963 346899999999999999999999887 9999999999999999999999999998643221
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+... .
T Consensus 160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~i~~~-----------~- 221 (337)
T 1o6l_A 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERLFELILME-----------E- 221 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-----------C-
T ss_pred --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC----HHHHHHHHHcC-----------C-
Confidence 22345689999999999999999999999999999999999999996422 12222222111 0
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
...+...+..+.+++.+||+.||++|| +++|++++
T Consensus 222 ~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112334566789999999999999999 89999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=359.43 Aligned_cols=255 Identities=22% Similarity=0.250 Sum_probs=207.1
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC-----ChhHHHHHHHHHHhccCCCCceeEeEEEecCC
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH-----SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE 756 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 756 (995)
++.+.|+..+.||+|+||.||+|+.. +|+.||+|++...... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45678999999999999999999874 6899999998543222 23567899999999999999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC----CeEEeee
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF----EAHVADF 832 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~----~vkl~Df 832 (995)
..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999999953 457899999999999999999999887 99999999999999887 7999999
Q ss_pred ccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
|+++.+.... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .....+......
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~~~~~~~~ 235 (326)
T 2y0a_A 163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANVSAVNYE 235 (326)
T ss_dssp TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHHTCCC
T ss_pred CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHHHhcCCC
Confidence 9998764322 224567999999999999999999999999999999999999999643221 111111111000
Q ss_pred hhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 913 EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 913 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
... ......+..+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 FED--------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCH--------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCc--------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0011234568899999999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=376.80 Aligned_cols=252 Identities=28% Similarity=0.390 Sum_probs=208.6
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC-cceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE-TNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~ 764 (995)
++|+..+.||+|+||.||+|++. ++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+ ..|+||||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 46788899999999999999884 7899999995432 4567999999999999999999999986654 78999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++|+|.+++.......+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 99999999998655555799999999999999999999887 999999999999999999999999999854221
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||......... ..+..+ ...
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~----~~i~~~-----------~~~ 405 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----PRVEKG-----------YKM 405 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH----HHHHTT-----------CCC
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcC-----------CCC
Confidence 123367889999999999999999999999999999998 99999765432221 111111 111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
..+..++..+.++|.+||+.||++|||++++++.|+++...
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 23445667899999999999999999999999999987643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=382.75 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=215.1
Q ss_pred hhccCCCeeeccCceEEEEEEeCC-CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
..|+..+.||+|+||.||+|++.. +..||||++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc--ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 457788999999999999998754 889999998543 23467799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence 99999999998656667999999999999999999999887 9999999999999999999999999998764322 1
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||...... ...+ .+... ...
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~~~~---~~~~~-----------~~~ 438 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYE---LLEKD-----------YRM 438 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHH---HHHTT-----------CCC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-HHHH---HHHcC-----------CCC
Confidence 22233456789999999998899999999999999999999 99999654322 1111 11111 011
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
..+..++..+.++|.+||+.||++||+++|+++.|+.+.+..
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 234456678999999999999999999999999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.20 Aligned_cols=270 Identities=25% Similarity=0.345 Sum_probs=207.3
Q ss_pred HhhccCCCeeeccCceEEEEEEe-----CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec--CCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-----PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN--KET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 757 (995)
.++|+..+.||+|+||+||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 35788899999999999999974 36889999998532 33345678999999999999999999999854 356
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred eEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 89999999999999999743 345899999999999999999999887 99999999999999999999999999987
Q ss_pred cccCCCC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh----
Q 001922 838 LIDGGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE---- 912 (995)
Q Consensus 838 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---- 912 (995)
....... .......++..|+|||++.+..++.++||||+|+++|||++|..||.... ..+..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~-----~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH-----HHHHHHHCTTCCTHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh-----HHHHhhhcCccccchhH
Confidence 6433221 22234457788999999999999999999999999999999999985421 1111111110000
Q ss_pred -hh-hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 913 -EF-LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 913 -~~-~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.. ...........+..++..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00 01111112223445677899999999999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=353.30 Aligned_cols=265 Identities=21% Similarity=0.268 Sum_probs=203.5
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++|+..+.||+|+||+||+|+..+|+.||+|++..... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888899999999999999988899999999854322 22346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++ +|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..... .
T Consensus 82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--V 154 (288)
T ss_dssp CSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc--c
Confidence 976 999988743 356889999999999999999999887 999999999999999999999999999875322 1
Q ss_pred ccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh-----hc
Q 001922 845 ECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS-----IL 918 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 918 (995)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||.......................+.. ..
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 222345789999999998764 589999999999999999999999976443333333322222111111100 01
Q ss_pred CCcCC--------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 919 DPRLS--------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 919 d~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
++... ......+..+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11110 1112345678899999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=363.07 Aligned_cols=261 Identities=24% Similarity=0.371 Sum_probs=213.3
Q ss_pred HhhccCCCeeeccCceEEEEEEeC--------CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecC
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP--------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNK 755 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 755 (995)
.++|+..+.||+|+||.||+|++. +++.||+|++...........+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367889999999999999999763 46789999986544444556789999999999 899999999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKKG--------------AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL 821 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill 821 (995)
+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999975431 34889999999999999999999887 9999999999999
Q ss_pred CCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHH
Q 001922 822 NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIV 900 (995)
Q Consensus 822 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~ 900 (995)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.... ..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~ 266 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VE 266 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC----HH
Confidence 9999999999999987654433333344567889999999988889999999999999999999 999996532 12
Q ss_pred HHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 901 QWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
+....+... .....+..++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 267 ~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 ELFKLLKEG-----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHHHHT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcC-----------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 222221111 0111233455678999999999999999999999999998865
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=361.81 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=215.0
Q ss_pred HhhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
.++|+..+.||+|+||.||+|++. +++.||+|++...........+.+|+.++++++||||+++++++.+++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 467899999999999999999753 36789999986544444456788999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEe
Q 001922 759 LLVYEYMRNGSLGEALHGKK--------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVA 830 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~ 830 (995)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEEC
Confidence 99999999999999986421 245689999999999999999999887 9999999999999999999999
Q ss_pred eeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcC
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |..||.... ..+.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~~~~~~~~- 255 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----NEQVLRFVME- 255 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----HHHHHHHHHT-
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC----HHHHHHHHHc-
Confidence 9999987644333333344567899999999999999999999999999999999 899986532 1222222211
Q ss_pred ChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 910 RKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 910 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
......+...+..+.+++.+||+.||++||+++|+++.|+++...
T Consensus 256 ----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 256 ----------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ----------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 112223344566789999999999999999999999999998663
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.67 Aligned_cols=258 Identities=26% Similarity=0.349 Sum_probs=199.3
Q ss_pred HhhccCCCeeeccCceEEEEEEeCC----CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPN----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
.++|+..+.||+|+||.||+|.+.. +..||+|++.........+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4578899999999999999997643 45699999865444444567899999999999999999999985 467899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999999743 446899999999999999999999887 99999999999999999999999999987644
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.... ......+|+.|+|||++.+..++.++||||+|+++|||++ |..||........ . ..+...
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-~---~~i~~~---------- 233 (281)
T 1mp8_A 169 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-I---GRIENG---------- 233 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-H---HHHHTT----------
T ss_pred cccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-H---HHHHcC----------
Confidence 3221 2234457789999999998899999999999999999997 9999975432221 1 111111
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.....+...+..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 234 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 234 -ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1112334456778999999999999999999999999988653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=361.20 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=204.2
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
..+|+..+.||+|+||+||+|++ .+++.||+|++.... .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35788899999999999999986 578999999984321 122245688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+ +|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....++
T Consensus 88 ~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 6799998853 346899999999999999999999888 999999999999999999999999999876433
Q ss_pred CCCccccccccCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||....... ....+..
T Consensus 162 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------------~~~~i~~ 222 (336)
T 3h4j_B 162 ---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----------------LFKKVNS 222 (336)
T ss_dssp ---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----------------CBCCCCS
T ss_pred ---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHHc
Confidence 22345679999999999988776 689999999999999999999996532111 1111111
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1222344456778999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=359.83 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=203.3
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC-----
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE----- 756 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 756 (995)
...++|+..+.||+|+||.||+|+.. +++.||||++.........+.+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 45678999999999999999999875 799999999965555556778999999999999999999999985543
Q ss_pred ----------------------------------------------------cceEEEEeccCCChhhhhcCCCC-CCCC
Q 001922 757 ----------------------------------------------------TNLLVYEYMRNGSLGEALHGKKG-AFLG 783 (995)
Q Consensus 757 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~-~~~~ 783 (995)
..++||||+++|+|.+++..... ...+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 27999999999999999975332 3456
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC----------ccccccccC
Q 001922 784 WNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS----------ECMSAIAGS 853 (995)
Q Consensus 784 ~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~----------~~~~~~~gt 853 (995)
+..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++........ .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 7778999999999999999887 999999999999999999999999999876543211 122345799
Q ss_pred cccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHH
Q 001922 854 YGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHL 933 (995)
Q Consensus 854 ~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l 933 (995)
+.|+|||++.+..++.++||||+||++|||++|..|+.. ......... ....+......+..+
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~------~~~~~~~~~-----------~~~~~~~~~~~~~~~ 302 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME------RVRIITDVR-----------NLKFPLLFTQKYPQE 302 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHH-----------TTCCCHHHHHHCHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH------HHHHHHHhh-----------ccCCCcccccCChhH
Confidence 999999999999999999999999999999998777521 111111111 111122233455678
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHH
Q 001922 934 LFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 934 ~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+++.+||+.||++||+++|+++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 899999999999999999999873
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=354.89 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=204.8
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-TCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc-chhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 3566678999999999999875 7999999998543 3344667899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 125 ~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 196 (321)
T 2c30_A 125 QGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 196 (321)
T ss_dssp CSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--c
Confidence 99999999863 35899999999999999999999887 9999999999999999999999999998764322 1
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .+....+.... .+.. ..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----~~~~~~~~~~~--------~~~~-~~ 263 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAMKRLRDSP--------PPKL-KN 263 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSS--------CCCC-TT
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCC--------CCCc-Cc
Confidence 22456799999999999999999999999999999999999999964321 11222221111 1111 11
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+...+..+.+++.+||+.||++||+++|+++.
T Consensus 264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 264 SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22345678899999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=361.61 Aligned_cols=255 Identities=22% Similarity=0.283 Sum_probs=206.7
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
.+.++|+..+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45678999999999999999999764 689999999854332 2334668899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC---CeEEeeeccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF---EAHVADFGLAKF 837 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~---~vkl~DfGla~~ 837 (995)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++ .+||+|||++..
T Consensus 106 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999999953 456899999999999999999999887 99999999999998654 599999999987
Q ss_pred cccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
..+.. ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... .......+.......
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~---- 249 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAGAYDY---- 249 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHTCCCC----
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHhCCCCC----
Confidence 64332 2235679999999999999999999999999999999999999996532 122222222111000
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+ .....+..+.+++.+||+.||++||+++|++++
T Consensus 250 ~~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTT----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Ccc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 112345678899999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=362.90 Aligned_cols=263 Identities=21% Similarity=0.296 Sum_probs=197.2
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCC----cEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc-
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNG----VEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN- 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~- 758 (995)
.++|+..+.||+|+||+||+|+.... ..||||++.... .....+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 35788899999999999999986543 279999985432 333457789999999999999999999999876655
Q ss_pred -----eEEEEeccCCChhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEE
Q 001922 759 -----LLVYEYMRNGSLGEALHGK----KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV 829 (995)
Q Consensus 759 -----~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl 829 (995)
++||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 9999999999999998532 2235899999999999999999999887 999999999999999999999
Q ss_pred eeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhc
Q 001922 830 ADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATN 908 (995)
Q Consensus 830 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~ 908 (995)
+|||+++...............+++.|+|||.+.+..++.++||||+||++|||++ |+.||.......... ...
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----~~~- 253 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN----YLI- 253 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----HHH-
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH----HHh-
Confidence 99999987655443333345567889999999999999999999999999999999 999997543322111 111
Q ss_pred CChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 909 GRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 909 ~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
.......+...+..+.+++.+||+.||++||++.|+++.|+++....
T Consensus 254 ----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 254 ----------GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ----------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ----------cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11112233445667999999999999999999999999999987754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=371.61 Aligned_cols=258 Identities=21% Similarity=0.245 Sum_probs=206.9
Q ss_pred HHHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 681 VSDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 681 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
...+.++|+..+.||+|+||+||+|.. .+|+.||+|++..... ....+.+.+|++++++++||||+++++++.+++..
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 345678899999999999999999975 5789999999854332 22345688999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC---CCCCeEEeeeccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN---SAFEAHVADFGLA 835 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~---~~~~vkl~DfGla 835 (995)
|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++
T Consensus 86 ~lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EEEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 999999999999999964 356899999999999999999999887 99999999999998 4678999999999
Q ss_pred cccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
+...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ......+..+...
T Consensus 161 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~--- 231 (444)
T 3soa_A 161 IEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ----HRLYQQIKAGAYD--- 231 (444)
T ss_dssp BCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHTCCC---
T ss_pred EEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHhCCCC---
Confidence 8764322 223456799999999999999999999999999999999999999965321 2222222211110
Q ss_pred hhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 916 SILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 916 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+.. ...+..+.+++.+||+.||++|||++|+++.
T Consensus 232 -~~~~~~----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 -FPSPEW----DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -CCTTTT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCcccc----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 001111 2345678899999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=351.84 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=202.8
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhc--cCCCCceeEeEEEec----CCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGN--IRHRNIVRLLAFCSN----KETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~----~~~~ 758 (995)
.++|+..+.||+|+||+||+|++ +++.||||++.. .....+..|.+++.. ++||||+++++++.+ ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46788999999999999999988 789999999843 234556667776666 799999999998643 3457
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCEEECCCCCeEEe
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH--------HDCSPLIVHRDVKSNNILLNSAFEAHVA 830 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~iiHrDlkp~Nill~~~~~vkl~ 830 (995)
++||||+++|+|.++++. ..+++..+++++.|++.||+||| +.+ |+||||||+||+++.++.+||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999953 46899999999999999999999 777 9999999999999999999999
Q ss_pred eeccccccccCCCCc--cccccccCcccccccccccC------CCCcccchhhHHHHHHHHHhC----------CCCCCC
Q 001922 831 DFGLAKFLIDGGASE--CMSAIAGSYGYIAPEYAYTL------RVDEKSDVYSFGVVLLELLTG----------RRPVGD 892 (995)
Q Consensus 831 DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg----------~~Pf~~ 892 (995)
|||+++......... ......||+.|+|||++.+. .++.++||||+||++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999998654432221 12334799999999998876 456799999999999999999 888865
Q ss_pred CCCCch-HHHHHHHHhcCChhhhhhhcCCcCC--CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 893 FGDGVD-IVQWSKRATNGRKEEFLSILDPRLS--MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 893 ~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
...... ............ ..+..+ ..+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQ-------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSC-------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccC-------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 433222 222222111110 011111 12345788899999999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=366.45 Aligned_cols=276 Identities=21% Similarity=0.215 Sum_probs=210.0
Q ss_pred HhhccCCCeeecc--CceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 685 LECVKDGNVIGRG--GAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
..+|+..+.||+| +||+||+|+.. +++.||||++..... ....+.+.+|+.++++++|||||++++++.+++..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578999999999 99999999875 689999999854322 2234568889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++|+|.+++.......+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999998665677999999999999999999999887 99999999999999999999999999875433
Q ss_pred CCC-----CccccccccCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCC---
Q 001922 841 GGA-----SECMSAIAGSYGYIAPEYAYT--LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR--- 910 (995)
Q Consensus 841 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--- 910 (995)
... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....................
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 221 111233478999999999987 6789999999999999999999999976544333222211100000
Q ss_pred ----hhhh-------------hhh----------cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccC
Q 001922 911 ----KEEF-------------LSI----------LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEF 961 (995)
Q Consensus 911 ----~~~~-------------~~~----------~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 961 (995)
.... ... .+......+...+..+.+++.+||+.||++|||++|+++. ++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 0000 000 0000001233456679999999999999999999999965 6655
Q ss_pred CC
Q 001922 962 PR 963 (995)
Q Consensus 962 ~~ 963 (995)
..
T Consensus 341 ~~ 342 (389)
T 3gni_B 341 KR 342 (389)
T ss_dssp --
T ss_pred hh
Confidence 54
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=360.67 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=203.4
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCc----EEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGV----EIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
++|+..+.||+|+||+||+|++. +++ +||+|.+...........+.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 56888899999999999999763 344 457787755555556778999999999999999999999998654 789
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+.+|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 94 v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 99999999999999743 456899999999999999999999887 99999999999999999999999999987654
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
...........+|+.|+|||++.+..++.++||||+||++|||++ |+.||...... ..... ....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~---~~~~---------- 235 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSI---LEKG---------- 235 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHH---HHTT----------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHH---HHcC----------
Confidence 433333344567889999999999999999999999999999999 99999654322 11111 1111
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.....+...+..+.+++.+||+.||++||+++|+++.|+++.+.
T Consensus 236 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 236 -ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11112334566789999999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=361.12 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=205.1
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+++++.++|||||++++++.+.+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888999999999999999764 58899999984321 223356788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 94 ~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999999964 456899999999999999999999887 999999999999999999999999999876432
Q ss_pred CCCccccccccCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYT---LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .......+...
T Consensus 169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~--------- 235 (384)
T 4fr4_A 169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFETT--------- 235 (384)
T ss_dssp ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHHC---------
T ss_pred ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhhc---------
Confidence 23356689999999999864 458999999999999999999999997543322 22222211111
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCC-HHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPR-MREVVQ 956 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 956 (995)
....+...+..+.+++.+||+.||++||+ ++++.+
T Consensus 236 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11233445677899999999999999998 777664
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=368.17 Aligned_cols=273 Identities=20% Similarity=0.260 Sum_probs=217.9
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC--cceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE--TNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~ 762 (995)
++|+..+.||+|+||+||+|++. +++.||||++.........+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888999999999999999875 589999999965444445677889999999999999999999997655 679999
Q ss_pred EeccCCChhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----CCCCCeEEeeeccccc
Q 001922 763 EYMRNGSLGEALHGKK-GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL----NSAFEAHVADFGLAKF 837 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill----~~~~~vkl~DfGla~~ 837 (995)
||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997532 233899999999999999999999887 9999999999999 7778899999999987
Q ss_pred cccCCCCccccccccCccccccccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYT--------LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........+....+..+
T Consensus 166 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 166 LEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 6432 22345679999999998765 567889999999999999999999997655444333333333332
Q ss_pred Chhhhhhhc----C---------CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 910 RKEEFLSIL----D---------PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 910 ~~~~~~~~~----d---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
........+ + +.....+...+..+.+++.+||+.||++||+++|+++.++++...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 211110000 0 111234578889999999999999999999999999999887654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=359.60 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=208.7
Q ss_pred hhccCCCeeeccCceEEEEEEe-----CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecC--Ccc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-----PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETN 758 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 758 (995)
+.|+..+.||+|+||.||+|++ .+++.||+|++.........+.+.+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588889999999999999983 468999999996555555567899999999999999999999999776 668
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++..+
T Consensus 101 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence 9999999999999999632 356899999999999999999999887 999999999999999999999999999876
Q ss_pred ccCCCC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCC-----------CCchHHHHHHHH
Q 001922 839 IDGGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFG-----------DGVDIVQWSKRA 906 (995)
Q Consensus 839 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~-----------~~~~~~~~~~~~ 906 (995)
...... .......+|..|+|||++.+..++.++||||+|+++|+|++|+.|+.... ............
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 543221 22344568889999999999999999999999999999999999864310 011111111111
Q ss_pred hcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 907 TNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 907 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
. .......+...+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus 257 ~-----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 K-----------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp H-----------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred h-----------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1 11112234456678999999999999999999999999998763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=364.71 Aligned_cols=254 Identities=21% Similarity=0.245 Sum_probs=203.3
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 760 (995)
.++|+..++||+|+||+||+|+.+ +++.||+|++.+.. .....+.+..|..++.++ +||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357889999999999999999875 57889999985432 222345578899999887 89999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999964 356899999999999999999999887 99999999999999999999999999986322
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCch-----HHHHHHHHhcCChhhhh
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD-----IVQWSKRATNGRKEEFL 915 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~ 915 (995)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||........ .......+...
T Consensus 206 ~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------ 277 (396)
T 4dc2_A 206 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------ 277 (396)
T ss_dssp T--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC------
T ss_pred C--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc------
Confidence 2 2233567899999999999999999999999999999999999999965332111 11111111111
Q ss_pred hhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCH------HHHHHH
Q 001922 916 SILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRM------REVVQM 957 (995)
Q Consensus 916 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 957 (995)
. ...|...+..+.+++.+||+.||++||++ +|++++
T Consensus 278 -----~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 278 -----Q-IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -----C-CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -----c-cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1 12334456678999999999999999985 566653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.92 Aligned_cols=264 Identities=24% Similarity=0.281 Sum_probs=204.5
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
++|+..+.||+|+||+||+|+.. +++.||+|++..... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999874 689999999854333 3334678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++ ++.+.+.. ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-- 154 (292)
T ss_dssp CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC--
T ss_pred cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc--
Confidence 9976 66666543 3456899999999999999999999887 999999999999999999999999999876432
Q ss_pred CccccccccCcccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhc-CChhhhhhhc---
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLR-VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN-GRKEEFLSIL--- 918 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--- 918 (995)
........||+.|+|||++.+.. ++.++||||+||++|||++|..||....+..+.......... .....+....
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 22234567899999999988766 799999999999999999999987544333332222222111 1111110000
Q ss_pred C----------CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 919 D----------PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 919 d----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
+ .......+..+..+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0111122345667889999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=348.55 Aligned_cols=256 Identities=23% Similarity=0.421 Sum_probs=211.6
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
++|+..+.||+|+||.||+|++.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 4688889999999999999998888999999995432 23567899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 86 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 160 (267)
T ss_dssp TTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence 999999999743 356889999999999999999999887 9999999999999999999999999998653221 11
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.... .......+... ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~i~~~-----------~~~~ 225 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTG-----------FRLY 225 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTT-----------CCCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC----HHHHHHHHhcC-----------CcCC
Confidence 1233457789999999998899999999999999999999 899996532 12222222221 1111
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.+...+..+.+++.+||+.||++||+++|+++.|+++.+
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 233345678999999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=354.09 Aligned_cols=267 Identities=22% Similarity=0.282 Sum_probs=194.1
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.++|+..+.||+|+||+||+|... +|+.||+|++...........+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888999999999999999764 6899999998654444455778899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 764 YMRNGSLGEALHGK----KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 764 ~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
|++ |+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999988632 2345889999999999999999999887 9999999999999999999999999998754
Q ss_pred cCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh-
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI- 917 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 917 (995)
... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+..................+...
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 321 22245578999999999876 46899999999999999999999999764433222222222211111110000
Q ss_pred ----cCCcCC-------------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 918 ----LDPRLS-------------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 918 ----~d~~~~-------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+... ..+...+..+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000 0011234578999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.93 Aligned_cols=254 Identities=28% Similarity=0.403 Sum_probs=196.9
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCC---CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGT---HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
++|+..+.||+|+||.||+|++ .++.||||++..... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 4678889999999999999987 488999999854322 223467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC--------CCCeEEeeecc
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS--------AFEAHVADFGL 834 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~--------~~~vkl~DfGl 834 (995)
||+++++|.+++. ...+++..++.++.|++.|+.|||+++..+|+||||||+||+++. ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999999985 346899999999999999999999876445889999999999986 67899999999
Q ss_pred ccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
++...... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||...... .........
T Consensus 163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~----- 229 (271)
T 3dtc_A 163 AREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----AVAYGVAMN----- 229 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHHHHTS-----
T ss_pred cccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHhhhcC-----
Confidence 98654322 22457899999999999999999999999999999999999999653221 111111111
Q ss_pred hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 915 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
......+..++..+.+++.+||+.||++||+++|++++|+++
T Consensus 230 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 -----KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111123344566799999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=356.08 Aligned_cols=262 Identities=26% Similarity=0.396 Sum_probs=213.4
Q ss_pred HhhccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCC-
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKE- 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~- 756 (995)
.++|+..+.||+|+||+||+|++ .+++.||||++...........+.+|+.+++++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 46789999999999999999974 356889999996544444456789999999999 6999999999987654
Q ss_pred cceEEEEeccCCChhhhhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKG--------------AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN 822 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~ 822 (995)
..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEEC
Confidence 58999999999999999975432 22789999999999999999999887 99999999999999
Q ss_pred CCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHH
Q 001922 823 SAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQ 901 (995)
Q Consensus 823 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 901 (995)
.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...........
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 999999999999987654433333445668899999999999999999999999999999998 9999976543333222
Q ss_pred HHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 902 WSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 902 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
...... ....+...+..+.+++.+||+.||++||+++|+++.|+++.+
T Consensus 263 ~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 263 RLKEGT--------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp HHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhccCc--------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 211110 011223345678999999999999999999999999988753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=351.56 Aligned_cols=263 Identities=18% Similarity=0.217 Sum_probs=211.0
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.++|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+|+.+++++ +|++++++++++.+....++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 35688899999999999999985 578999999985332 234578899999999 7999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC-----eEEeeeccccc
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE-----AHVADFGLAKF 837 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~-----vkl~DfGla~~ 837 (995)
||+ +++|.+++... +..+++..++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||+++.
T Consensus 86 e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 999 99999999743 446899999999999999999999777 999999999999988776 99999999987
Q ss_pred cccCCCC-----ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 838 LIDGGAS-----ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 838 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.............. +......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~ 239 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEKKQS 239 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-HHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH-HHhhccC
Confidence 6543322 123456799999999999999999999999999999999999999977543333222211 1111000
Q ss_pred hhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 913 EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 913 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.... ......+..+.+++.+||+.||++||++++|++.|+++.+
T Consensus 240 ~~~~-------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 240 TPLR-------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp SCHH-------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccHH-------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0000 0111245678999999999999999999999999998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.96 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=202.2
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
++|+..+.||+|+||+||+|++ .++.||+|++.. ....+.+.+|++++++++||||+++++++. +..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 4678889999999999999988 478999999842 345677899999999999999999999886 4589999999
Q ss_pred cCCChhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC-eEEeeeccccccccCCC
Q 001922 766 RNGSLGEALHGKKG-AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE-AHVADFGLAKFLIDGGA 843 (995)
Q Consensus 766 ~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~-vkl~DfGla~~~~~~~~ 843 (995)
++|+|.+++..... ..+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999975432 34788999999999999999999832244999999999999998887 799999999765321
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ..... ...
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~-----------~~~ 223 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW--AVHNG-----------TRP 223 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH--HHHTT-----------CCC
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH--HHhcC-----------CCC
Confidence 23446899999999999999999999999999999999999999764433221111 11111 111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcc
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSD 967 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 967 (995)
..+...+..+.+++.+||+.||++||+++|+++.|+.+.+..+.
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 12234456788999999999999999999999999988765443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=343.82 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=209.5
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
..++|+..+.||+|+||.||+|+.. +++.||+|++.........+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4678999999999999999999874 689999999865444455677899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+..+....
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 85 EYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp ECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999999963 456899999999999999999999887 9999999999999999999999999998764433
Q ss_pred CCccccccccCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCchH-HHHHHHHhcCChhhhhhhcCC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDI-VQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.........|++.|+|||++.+..+ +.++||||+|+++|||++|+.||......... ..+.. .. .
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-~--------- 226 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---KK-T--------- 226 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---TC-T---------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---cc-c---------
Confidence 3333345679999999999987765 78999999999999999999999765433221 11111 00 0
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
........+..+.+++.+||+.||++|||++|+++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00111234567889999999999999999999976
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=355.81 Aligned_cols=252 Identities=23% Similarity=0.281 Sum_probs=204.0
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC----CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF----GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
+.+.|+..+.||+|+||+||+|+. .+++.||||++... ......+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356799999999999999999976 46899999998421 1222467789999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC---eEEeeec
Q 001922 759 LLVYEYMRNGSLGEALHGK--KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE---AHVADFG 833 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~---vkl~DfG 833 (995)
|+||||+++|+|.+++... .+..+++..++.++.||+.||.|||+++ |+||||||+||+++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999998887532 2345899999999999999999999887 999999999999987654 9999999
Q ss_pred cccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... . .....+...
T Consensus 179 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~---~~~~~i~~~---- 247 (351)
T 3c0i_A 179 VAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--E---RLFEGIIKG---- 247 (351)
T ss_dssp TCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--H---HHHHHHHHT----
T ss_pred ceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--H---HHHHHHHcC----
Confidence 998764422 22345679999999999999999999999999999999999999996521 1 111111111
Q ss_pred hhhhcCCcCCCCC---HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 914 FLSILDPRLSMVP---KEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 914 ~~~~~d~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.....+ ...+..+.+++.+||+.||++||++.|+++
T Consensus 248 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 -------KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------CCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111 123567889999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=362.71 Aligned_cols=249 Identities=22% Similarity=0.248 Sum_probs=200.0
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 760 (995)
.++|+..+.||+|+||+||+|+.+ +++.||||++.+.. .....+.+.+|..+++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 457888999999999999999864 58999999985321 122345678899999988 69999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999964 356899999999999999999999887 99999999999999999999999999985432
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+....+...
T Consensus 177 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~~~~i~~~----------- 239 (353)
T 3txo_A 177 N--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN----EDDLFEAILND----------- 239 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-----------
T ss_pred C--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC----HHHHHHHHHcC-----------
Confidence 2 222345689999999999999899999999999999999999999996532 22222222211
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCH------HHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRM------REVVQ 956 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 956 (995)
. ...+...+..+.+++.+|++.||++||++ +|+++
T Consensus 240 ~-~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 E-VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred C-CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1 11233355678899999999999999998 77775
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=349.68 Aligned_cols=256 Identities=29% Similarity=0.431 Sum_probs=210.3
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
++|+..+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 5788899999999999999998888899999985432 34677999999999999999999999986 45689999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++++|.+++....+..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T 165 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence 9999999996543346899999999999999999999887 99999999999999999999999999987643321 1
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... .+........ ....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~-----------~~~~ 230 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----PEVIQNLERG-----------YRMV 230 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTT-----------CCCC
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH----HHHHHHHhcc-----------cCCC
Confidence 2234457789999999998889999999999999999999 9999965322 1222222211 0111
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.+...+..+.+++.+|++.||++||+++++++.|+++..
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 233455678999999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=352.61 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=204.4
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
++|+..+.||+|+||+||+|+.. +|+.||+|++.+.. .....+.+.+|..+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999774 68999999985321 1233566888999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp CCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 99999999999964 356899999999999999999999777 99999999999999999999999999987532
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... ..
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~-----------~~ 220 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILNA-----------EL 220 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHC-----------CC
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC-----------CC
Confidence 22356799999999999999999999999999999999999999965321 1122222111 11
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
..+...+..+.+++.+|++.||++|| +++|++++
T Consensus 221 -~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 12334456789999999999999999 89999854
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=356.88 Aligned_cols=261 Identities=18% Similarity=0.229 Sum_probs=209.1
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 763 (995)
++|+..+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++..++..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 5688899999999999999986 578999999985332 234588999999999 89999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC-----eEEeeecccccc
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE-----AHVADFGLAKFL 838 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~-----vkl~DfGla~~~ 838 (995)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+++.+
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999743 457999999999999999999999887 999999999999999887 999999999876
Q ss_pred ccCCCCc-----cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 839 IDGGASE-----CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 839 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+....+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKRAT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHHHS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhccC
Confidence 5433221 12456799999999999999999999999999999999999999976543322 22222221110000
Q ss_pred hhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 914 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
..... ....+ .+.+++.+||+.||.+||++++|.+.|+++..
T Consensus 240 ~~~~~-------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 240 PIEVL-------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp CHHHH-------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHHHH-------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 00000 01123 79999999999999999999999999987653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=360.77 Aligned_cols=262 Identities=23% Similarity=0.369 Sum_probs=214.1
Q ss_pred HhhccCCCeeeccCceEEEEEEeCC------CcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPN------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 757 (995)
.++|+..+.||+|+||+||+|+... +..||+|.+.........+.+.+|+.+++++ +||||+++++++.+++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 3568888999999999999997632 2479999996554444567789999999999 89999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 001922 758 NLLVYEYMRNGSLGEALHGKK------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF 825 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~ 825 (995)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 999999999999999986421 345789999999999999999999887 99999999999999999
Q ss_pred CeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHH
Q 001922 826 EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSK 904 (995)
Q Consensus 826 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~ 904 (995)
.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||..............
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 999999999987654433333345567889999999999899999999999999999999 9999976544333332222
Q ss_pred HHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 905 RATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 905 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.... ...+...+..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 282 ~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 282 DGYQ--------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCC--------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 1110 11122345678999999999999999999999999987653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=362.69 Aligned_cols=255 Identities=19% Similarity=0.237 Sum_probs=206.8
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.+.+.|+..+.||+|+||+||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 34678999999999999999999764 6889999988432 223455788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC--CCCeEEeeeccccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS--AFEAHVADFGLAKFLI 839 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~--~~~vkl~DfGla~~~~ 839 (995)
|||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++. .+.+||+|||+++.+.
T Consensus 127 ~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 127 LEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999999964 3456899999999999999999999887 999999999999974 4679999999998764
Q ss_pred cCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+...... .+
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~i~~~~~~-----~~ 270 (387)
T 1kob_A 203 PDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWE-----FD 270 (387)
T ss_dssp TTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHHCCCC-----CC
T ss_pred CCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCC-----CC
Confidence 322 22445799999999999999999999999999999999999999965322 1111111111000 00
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.......+..+.+++.+||+.||++|||++|+++.
T Consensus 271 ---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 ---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11122345678899999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.14 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=207.0
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecC--CcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~ 762 (995)
++|+..+.||+|+||+||+|++ +++.||||++..... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5688889999999999999998 488999999854332 23345689999999999999999999999877 7889999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++|+|.+++.......+++..++.++.|++.||+|||+.+ ..|+||||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec---
Confidence 9999999999998665557999999999999999999999542 339999999999999999999999999875431
Q ss_pred CCccccccccCcccccccccccCCCCc---ccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDE---KSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.....||+.|+|||++.+..++. ++||||+|+++|||++|+.||......... .......
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~---------- 227 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG---MKVALEG---------- 227 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH---HHHHHSC----------
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH---HHHHhcC----------
Confidence 12346899999999988765544 799999999999999999999653221111 1111111
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.....+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 228 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 -LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1112334456679999999999999999999999999998765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=344.22 Aligned_cols=255 Identities=30% Similarity=0.521 Sum_probs=203.5
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChh------HHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHD------HGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
++|+..+.||+|+||+||+|+. .+++.||+|++......... +.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5688889999999999999976 57899999998543332221 57889999999999999999999996654
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC-----eEEeeec
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE-----AHVADFG 833 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~-----vkl~DfG 833 (995)
++||||+++|+|.+++.. ....+++..++.++.|++.|++|||+++ ++|+||||||+||+++.++. +||+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 799999999999998864 3457899999999999999999999542 23999999999999988776 9999999
Q ss_pred cccccccCCCCccccccccCcccccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAY--TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
+++.... ......||+.|+|||++. ...++.++||||+|+++|||++|+.||........ .........
T Consensus 175 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~-- 245 (287)
T 4f0f_A 175 LSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--KFINMIREE-- 245 (287)
T ss_dssp TCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--HHHHHHHHS--
T ss_pred ccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH--HHHHHHhcc--
Confidence 9985422 234567999999999984 45678999999999999999999999976443222 111111111
Q ss_pred hhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 912 EEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 912 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
......+...+..+.+++.+||+.||++||+++|+++.|+++
T Consensus 246 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 --------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 011123345567899999999999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=357.81 Aligned_cols=252 Identities=24% Similarity=0.295 Sum_probs=190.8
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.+.|+..+.||+|+||+||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 3467889999999999999999875 57899999985432 3456888999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCCeEEeeeccccccc
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS---AFEAHVADFGLAKFLI 839 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~---~~~vkl~DfGla~~~~ 839 (995)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+++...
T Consensus 128 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 128 ELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999953 456899999999999999999999887 999999999999975 8899999999998653
Q ss_pred cCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+...... ...
T Consensus 203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~i~~~~~~----~~~ 272 (349)
T 2w4o_A 203 HQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM---FRRILNCEYY----FIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH---HHHHHTTCCC----CCT
T ss_pred cc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH---HHHHHhCCCc----cCC
Confidence 32 2224567999999999999999999999999999999999999999654332211 1111111100 001
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
......+..+.+++.+||+.||++||+++|+++.
T Consensus 273 ----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 ----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112345678899999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=351.86 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=215.5
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.++|+..+.||+|+||+||+|.+. +++.||+|++.. .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS--CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 456888899999999999999875 488899999854 33446778999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 165 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence 999999999998766677999999999999999999999888 9999999999999999999999999998764332
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
........+|+.|+|||++.+..++.++||||+|+++|+|++ |..||...... ..... .... ..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~~~~---~~~~-----------~~ 230 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYEL---LEKD-----------YR 230 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHH---HHTT-----------CC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH---Hhcc-----------CC
Confidence 223344567889999999998999999999999999999999 99999653322 11111 1111 01
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
...+...+..+.+++.+|++.||++||+++|+++.|+++...
T Consensus 231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 122334556799999999999999999999999999887653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=374.88 Aligned_cols=254 Identities=24% Similarity=0.275 Sum_probs=210.3
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.|+..++||+|+||.||+|+.. +|+.||+|++.... .......+.+|++++++++||||+++++++.+.+..|+||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 46888899999999999999774 68999999984321 2233556889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||++||+|.+++.......+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999997655556999999999999999999999887 9999999999999999999999999998764332
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||...............+....
T Consensus 341 ---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~------------ 405 (576)
T 2acx_A 341 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP------------ 405 (576)
T ss_dssp ---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC------------
T ss_pred ---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc------------
Confidence 22445899999999999999999999999999999999999999976543333333322222110
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
...+...+..+.+++.+||+.||++|| +++|++++
T Consensus 406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 112334556789999999999999999 78888764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=363.61 Aligned_cols=259 Identities=30% Similarity=0.429 Sum_probs=198.0
Q ss_pred hccCCCeeeccCceEEEEEEeC--CC--cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEe-cCCcceEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP--NG--VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS-NKETNLLV 761 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv 761 (995)
.|+..+.||+|+||+||+|+.. ++ ..||||.+.........+.+.+|+.++++++||||+++++++. ..+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3566789999999999999753 22 4589998865555555678999999999999999999999864 45678999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 170 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999974 3456889999999999999999999887 999999999999999999999999999876433
Q ss_pred CCCc--cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 842 GASE--CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 842 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ..... ...
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-~~~~~---~~~--------- 312 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYL---LQG--------- 312 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-HHHHH---HTT---------
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-HHHHH---HcC---------
Confidence 2211 1233457889999999999999999999999999999999 677776543322 22111 111
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.....+..++..+.+++.+||+.||++||+++|+++.|+++...
T Consensus 313 --~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 313 --RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11122334566799999999999999999999999999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=349.11 Aligned_cols=257 Identities=25% Similarity=0.332 Sum_probs=208.8
Q ss_pred hccCCC-eeeccCceEEEEEEeC---CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 687 CVKDGN-VIGRGGAGIVYHGKMP---NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 687 ~~~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+|...+ .||+|+||.||+|.+. +++.||+|++.........+.+.+|++++++++||||+++++++. .+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEE
Confidence 444544 8999999999999753 578899999965544445677899999999999999999999994 56789999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 89 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 89 EMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp ECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 99999999999963 3456899999999999999999999887 9999999999999999999999999998764332
Q ss_pred CC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 843 AS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 843 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.. .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... . ....+...
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~---~~~~i~~~----------- 229 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-E---VMAFIEQG----------- 229 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-H---HHHHHHTT-----------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-H---HHHHHhcC-----------
Confidence 21 11233456889999999988889999999999999999998 99999654321 1 11122111
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.....+...+..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 230 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 230 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1112334556789999999999999999999999999988753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=365.15 Aligned_cols=147 Identities=26% Similarity=0.339 Sum_probs=88.3
Q ss_pred CCCCCCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeec
Q 001922 90 RLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDL 169 (995)
Q Consensus 90 ~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L 169 (995)
.++++++|+++++.++....+..+++|++|+|++|.+++..+ +..+++|++|++++|.+++..+ +.++++|++|+|
T Consensus 44 ~l~~l~~L~l~~~~i~~l~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 119 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119 (466)
T ss_dssp HHHTCCEEECCSSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HhccccEEecCCCCCccCcchhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence 356677777777777655556667777777777777776554 6667777777777777766443 666777777777
Q ss_pred cCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCC
Q 001922 170 GGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELD 248 (995)
Q Consensus 170 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~ 248 (995)
++|.+++. +. +..+++|++|++++|.+++. + .++++++|++|+++ ++... + ..+..+++|++|++++|.++
T Consensus 120 ~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~--~-~~~~~l~~L~~L~l~~n~l~ 190 (466)
T 1o6v_A 120 FNNQITDI-DP-LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTD--L-KPLANLTTLERLDISSNKVS 190 (466)
T ss_dssp CSSCCCCC-GG-GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCC--C-GGGTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCC-hH-HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccC--c-hhhccCCCCCEEECcCCcCC
Confidence 77766643 22 66667777777777766642 2 35555555555554 22211 1 12444455555555555444
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=383.42 Aligned_cols=262 Identities=29% Similarity=0.417 Sum_probs=214.7
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
++|+..+.||+|+||+||+|++..+..||||++.... ...+.|.+|++++++++||||+++++++.+ +..|+||||+
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 5678889999999999999999888899999996432 335679999999999999999999999976 6789999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++|+|.+++....+..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.... ..
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 419 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HH
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-ee
Confidence 9999999997544456899999999999999999999887 9999999999999999999999999998653211 11
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+....+..+. ...
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----~~~~~~i~~~~-----------~~~ 484 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQVERGY-----------RMP 484 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----HHHHHHHHTTC-----------CCC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCC-----------CCC
Confidence 1223456789999999999999999999999999999999 9999965322 12222222110 111
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcccc
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFN 969 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 969 (995)
.+..++..+.++|.+||+.||++||++++|++.|+++.......+
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~ 529 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence 234556789999999999999999999999999999876654443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=360.32 Aligned_cols=253 Identities=23% Similarity=0.246 Sum_probs=197.3
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.++|+..+.||+|+||+||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 357889999999999999999875 78999999985432 234668899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC--eEEeeeccccccccC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE--AHVADFGLAKFLIDG 841 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~--vkl~DfGla~~~~~~ 841 (995)
|+++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||+++.....
T Consensus 97 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 97 YASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred eCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999999853 346899999999999999999999887 999999999999987765 999999999753222
Q ss_pred CCCccccccccCcccccccccccCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEK-SDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||...............+.....
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------- 239 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY--------- 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC---------
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC---------
Confidence 22244579999999999988887655 89999999999999999999876555554444443332211
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+ .....+..+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 SIP-DDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCC-TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCC-CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000 011234568899999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=358.33 Aligned_cols=262 Identities=30% Similarity=0.452 Sum_probs=205.7
Q ss_pred hhccCCCeeeccCceEEEEEEeCC-----CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN-----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
++|+..+.||+|+||+||+|+... +..||+|++...........+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456778899999999999997642 245999998654444445678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 9999999999999974 3456899999999999999999999887 99999999999999999999999999987643
Q ss_pred CCCC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 841 GGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 841 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..... ......+...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~~~~~~~~~~--------- 266 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMKAINDG--------- 266 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTT---------
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHCC---------
Confidence 3211 11223446789999999999999999999999999999999 9999965322 1122222111
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
.....+...+..+.+++.+||+.||++||+++|+++.|+++.+...
T Consensus 267 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 267 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp --CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred --CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 1111233456678999999999999999999999999998876443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=367.52 Aligned_cols=257 Identities=24% Similarity=0.229 Sum_probs=204.4
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.++|+..++||+|+||+||+|+.+ +++.||+|++.+.. .......+.+|..++..++||||++++++|.+++..|+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 467899999999999999999875 47889999984311 112233488899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 153 ~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp ECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 999999999999974 2456899999999999999999999887 999999999999999999999999999876433
Q ss_pred CCCccccccccCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 842 GASECMSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
.. ......+||+.|+|||++. ...++.++||||+||++|||++|+.||..... .+....+.... . .
T Consensus 229 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~-~---~ 299 (437)
T 4aw2_A 229 GT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHK-E---R 299 (437)
T ss_dssp SC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTHH-H---H
T ss_pred CC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh----hHHHHhhhhcc-c---c
Confidence 22 2224468999999999987 55789999999999999999999999965322 12222221110 0 0
Q ss_pred hcCCcCCCCCHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 001922 917 ILDPRLSMVPKEEAMHLLFVAMLCIQENSIE--RPRMREVVQM 957 (995)
Q Consensus 917 ~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 957 (995)
...+......+..+.+++.+|+..+|++ ||+++|++++
T Consensus 300 ---~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 300 ---FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0111111224567889999999999988 9999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=356.42 Aligned_cols=253 Identities=21% Similarity=0.250 Sum_probs=203.9
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC--CChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 761 (995)
++|+..+.||+|+||.||+|+.+ +++.||+|++..... ....+.+.+|..+++++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888899999999999999874 588999999854322 22345678899999988 899999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999999963 346899999999999999999999887 999999999999999999999999999864322
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCch-----HHHHHHHHhcCChhhhhh
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD-----IVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 916 (995)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||........ .......+..
T Consensus 164 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-------- 233 (345)
T 3a8x_A 164 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-------- 233 (345)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH--------
T ss_pred C--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc--------
Confidence 1 223456899999999999999999999999999999999999999965332111 1111111111
Q ss_pred hcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCH------HHHHHH
Q 001922 917 ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRM------REVVQM 957 (995)
Q Consensus 917 ~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 957 (995)
.. ...+...+..+.+++.+||+.||++||++ +|++++
T Consensus 234 ---~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 234 ---KQ-IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ---CC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ---CC-CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11 11334456678999999999999999995 666643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.32 Aligned_cols=260 Identities=30% Similarity=0.434 Sum_probs=205.2
Q ss_pred hhccCCCeeeccCceEEEEEEeCC----CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEE-ecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC-SNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~l 760 (995)
.+|+..+.||+|+||+||+|+..+ +..||+|.+.........+.+.+|+.++++++||||+++++++ ..++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 357788999999999999997643 2358999986544444567789999999999999999999985 55668899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.+.+
T Consensus 105 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999974 3456889999999999999999999887 99999999999999999999999999986643
Q ss_pred CCC--CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 841 GGA--SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 841 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
... ........+|+.|+|||.+.+..++.++||||+|+++|+|++ |.+||..... .+...... ..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~~~~~~~~---~~-------- 248 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLL---QG-------- 248 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-TTHHHHHH---TT--------
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-HHHHHHHh---cC--------
Confidence 221 112234567889999999999999999999999999999999 5555544322 22221111 11
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.....+...+..+.+++.+||+.||++||+++|+++.|+++...
T Consensus 249 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 249 ---RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11112333456789999999999999999999999999987653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.80 Aligned_cols=265 Identities=25% Similarity=0.346 Sum_probs=208.6
Q ss_pred ccCCCeeeccCceEEEEEEeC-----CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecC--CcceE
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK--ETNLL 760 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 760 (995)
|+..+.||+|+||+||++++. +++.||||++...........+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999988652 68899999996554444566789999999999999999999999774 56799
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999643 3899999999999999999999887 99999999999999999999999999987654
Q ss_pred CCCC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCC----hhhhh
Q 001922 841 GGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR----KEEFL 915 (995)
Q Consensus 841 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~ 915 (995)
.... .......+|+.|+|||++.+..++.++||||+|+++|+|++|+.||...... ......... .....
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccchhHHHHH
Confidence 3221 1233456888999999999989999999999999999999999998642110 000000000 00011
Q ss_pred hhcC-CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 916 SILD-PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 916 ~~~d-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
..+. ......+..++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111 11122344566789999999999999999999999999988754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=346.41 Aligned_cols=249 Identities=22% Similarity=0.277 Sum_probs=195.8
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC-------------------------ChhHHHHHHHHHHhc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH-------------------------SHDHGFRAEIQTLGN 739 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~ 739 (995)
++|+..+.||+|+||.||+|+. .+++.||||++...... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 5788899999999999999976 46889999998543211 123568899999999
Q ss_pred cCCCCceeEeEEEec--CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 001922 740 IRHRNIVRLLAFCSN--KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSN 817 (995)
Q Consensus 740 l~hpniv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~ 817 (995)
++||||+++++++.+ .+..|+||||+++++|.+++. ...+++..++.++.|++.||+|||+++ |+||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 999999999999976 567899999999999998764 346899999999999999999999887 999999999
Q ss_pred CEEECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCC
Q 001922 818 NILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR---VDEKSDVYSFGVVLLELLTGRRPVGDFG 894 (995)
Q Consensus 818 Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~Pf~~~~ 894 (995)
||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++||||+||++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999998764322 2234567999999999987665 4788999999999999999999996421
Q ss_pred CCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 895 DGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.......+..... ..+ .....+..+.+++.+||+.||++||+++|+++
T Consensus 245 ----~~~~~~~~~~~~~---------~~~-~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 ----IMCLHSKIKSQAL---------EFP-DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ----HHHHHHHHHHCCC---------CCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----HHHHHHHHhcccC---------CCC-CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2222222211100 000 11234457889999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=366.75 Aligned_cols=268 Identities=24% Similarity=0.307 Sum_probs=195.4
Q ss_pred HHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccC-CCCceeEeEEEecCC--c
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKE--T 757 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~--~ 757 (995)
.+.++|+..+.||+|+||.||+|.. .+|+.||||++.... ......++.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4677899999999999999999976 568999999985432 2334556788999999997 999999999996543 6
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.|+||||++ |+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999997 599999864 36889999999999999999999887 99999999999999999999999999986
Q ss_pred cccCC-------------------CCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 001922 838 LIDGG-------------------ASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV 897 (995)
Q Consensus 838 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~ 897 (995)
+.... ........+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 53211 1112344679999999999876 678999999999999999999999997643322
Q ss_pred hHHHHHHHHhcCChhhhhhhcCC------------------cCCCC-------------CHHHHHHHHHHHhcccCCCCC
Q 001922 898 DIVQWSKRATNGRKEEFLSILDP------------------RLSMV-------------PKEEAMHLLFVAMLCIQENSI 946 (995)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~d~------------------~~~~~-------------~~~~~~~l~~li~~cl~~dP~ 946 (995)
.+..............+..+..+ ..... ...++..+.+++.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 22222222211111111100000 00000 012345788999999999999
Q ss_pred CCCCHHHHHHH
Q 001922 947 ERPRMREVVQM 957 (995)
Q Consensus 947 ~RPt~~evl~~ 957 (995)
+|||++|++++
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999876
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=356.44 Aligned_cols=247 Identities=20% Similarity=0.211 Sum_probs=205.5
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 357888999999999999999874 68999999984321 223356788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999964 245899999999999999999999887 999999999999999999999999999875322
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+....+....
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~----------- 254 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQIYEKIVSGK----------- 254 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCC-----------
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC----HHHHHHHHHcCC-----------
Confidence 234679999999999999999999999999999999999999996432 222222222211
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPR-----MREVVQM 957 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 957 (995)
...+...+..+.+++.+||+.||++||+ ++|++++
T Consensus 255 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1123345667899999999999999998 8888764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=348.91 Aligned_cols=260 Identities=27% Similarity=0.371 Sum_probs=208.6
Q ss_pred hccCCCeeeccCceEEEEEEeC-C---CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc-eEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-N---GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN-LLV 761 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-~lv 761 (995)
.|+.++.||+|+||+||+|++. + +..||+|++.........+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566789999999999999753 2 2379999986544444567789999999999999999999999766655 999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+.+|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 102 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999999974 3466889999999999999999999887 999999999999999999999999999865432
Q ss_pred C--CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 842 G--ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 842 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
. .........+|+.|+|||.+.+..++.++||||+|+++|+|++|..|+....+............
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------ 245 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR------------ 245 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC------------
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC------------
Confidence 2 11222345688999999999999999999999999999999997666554434333332222111
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
....+...+..+.+++.+||+.||++|||++|+++.|+++...
T Consensus 246 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 246 --RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1112333456789999999999999999999999999987653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=350.30 Aligned_cols=267 Identities=22% Similarity=0.259 Sum_probs=204.9
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC----CCChhHHHHHHHHHHhccC---CCCceeEeEEEecC
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG----THSHDHGFRAEIQTLGNIR---HRNIVRLLAFCSNK 755 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~ 755 (995)
..++|+..+.||+|+||+||+|+. .+++.||+|++.... .......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 356899999999999999999986 568999999985322 1122346778888887775 99999999999765
Q ss_pred C-----cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEe
Q 001922 756 E-----TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVA 830 (995)
Q Consensus 756 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~ 830 (995)
. ..++||||+. |+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 4 4799999997 59999998766666999999999999999999999887 9999999999999999999999
Q ss_pred eeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCC
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 910 (995)
|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....................
T Consensus 163 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 163 DFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp SCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999865332 223456799999999999999999999999999999999999999976443333333333222211
Q ss_pred hhhhhhhc-------CCcCC----CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 911 KEEFLSIL-------DPRLS----MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 911 ~~~~~~~~-------d~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+.... .+... ...++.+..+.+++.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 11111000 00000 0111345678899999999999999999999863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.72 Aligned_cols=250 Identities=24% Similarity=0.305 Sum_probs=195.9
Q ss_pred HhhccCCCeeeccCceEEEEEEe----CCCcEEEEEEecCCCC---CChhHHHHHHHHHHhccCCCCceeEeEEEecCCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM----PNGVEIAVKKLLGFGT---HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 757 (995)
.++|+..+.||+|+||.||+|+. .+++.||+|++..... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788999999999999999986 4789999999854321 2234557889999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999999963 346889999999999999999999887 99999999999999999999999999976
Q ss_pred cccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ......+...
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~-------- 236 (327)
T 3a62_A 171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR----KKTIDKILKC-------- 236 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHT--------
T ss_pred cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhC--------
Confidence 43221 122456799999999999999999999999999999999999999965321 1222222111
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
. ...+...+..+.+++.+||+.||++|| +++|++++
T Consensus 237 ---~-~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 237 ---K-LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---C-CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---C-CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0 112334456789999999999999999 78888764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=359.85 Aligned_cols=280 Identities=25% Similarity=0.272 Sum_probs=209.4
Q ss_pred hhccCCCeeeccCceEEEEEEe-----CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEe--cCCcc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-----PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS--NKETN 758 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~ 758 (995)
++|+..+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++. +....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 5788899999999999999983 46889999998543 3334566899999999999999999999885 45668
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999999642 345899999999999999999999887 999999999999999999999999999876
Q ss_pred ccCCCC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 839 IDGGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 839 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
...... .......+|+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ...+...............
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-LRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHCC----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh-hhhcccccccccHHHHHHH
Confidence 433221 12234568889999999999889999999999999999999999985421100 0000000000000011111
Q ss_pred -cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcccccC
Q 001922 918 -LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQS 971 (995)
Q Consensus 918 -~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~ 971 (995)
........+..++..+.+++.+||+.||++||+++|++++|+++..........
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 311 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH 311 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----------
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccc
Confidence 111112234456678999999999999999999999999999998766554433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=358.09 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=208.8
Q ss_pred HhhccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
.++|+..+.||+|+||.||+|++ .+++.||||++...........+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788999999999999999974 357789999986544444566789999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CCeEEe
Q 001922 759 LLVYEYMRNGSLGEALHGKKG-----AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA---FEAHVA 830 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~---~~vkl~ 830 (995)
|+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.+ ..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975322 45889999999999999999999887 9999999999999954 469999
Q ss_pred eeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcC
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..... ......+...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~~ 261 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----QEVLEFVTSG 261 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHTT
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH----HHHHHHHhcC
Confidence 9999986644433333345568899999999998899999999999999999998 9999964321 1222222211
Q ss_pred ChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 910 RKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 910 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.....+..++..+.+++.+||+.||++||+++|+++.|+.+...
T Consensus 262 -----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 262 -----------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp -----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 11122334556789999999999999999999999999987654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=354.15 Aligned_cols=264 Identities=22% Similarity=0.335 Sum_probs=200.2
Q ss_pred HhhccCCCeeeccCceEEEEEEeC----CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCC---
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE--- 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 756 (995)
.++|+..+.||+|+||.||+|+.. .++.||+|++..... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 457888999999999999999653 345899999854322 233466889999999999999999999997654
Q ss_pred --cceEEEEeccCCChhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEe
Q 001922 757 --TNLLVYEYMRNGSLGEALHG----KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVA 830 (995)
Q Consensus 757 --~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~ 830 (995)
..++||||+++|+|.+++.. .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEe
Confidence 34999999999999999842 23457899999999999999999999777 9999999999999999999999
Q ss_pred eeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcC
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||......... . ....
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-~---~~~~- 264 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY-D---YLLH- 264 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-H---HHHT-
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-H---HHHc-
Confidence 9999987654433333345567889999999999999999999999999999999 88998654322111 1 1111
Q ss_pred ChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 910 RKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 910 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
......+...+..+.+++.+||+.||++||++++++++|+++.+..+
T Consensus 265 ----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 265 ----------GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp ----------TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ----------CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 11122334456679999999999999999999999999998765544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=347.40 Aligned_cols=258 Identities=26% Similarity=0.340 Sum_probs=205.6
Q ss_pred HhhccCCCeeeccCceEEEEEEeCC----CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPN----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
.++|+..+.||+|+||+||+|++.. +..||+|.+.........+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 3578889999999999999997532 346999998654444456778999999999999999999999875 45689
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 9999999999999964 3356899999999999999999999887 99999999999999999999999999987643
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
... .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||........ ..... ..
T Consensus 166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~-~~~~~---~~---------- 230 (281)
T 3cc6_A 166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-IGVLE---KG---------- 230 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-HHHHH---HT----------
T ss_pred ccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-HHHHh---cC----------
Confidence 322 12234567889999999998899999999999999999998 9999965433221 11111 11
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.....+...+..+.+++.+||+.||++||+++|+++.|+++.+
T Consensus 231 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 231 -DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 0011223345678999999999999999999999999988754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=358.09 Aligned_cols=249 Identities=24% Similarity=0.294 Sum_probs=203.7
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 760 (995)
.++|+..+.||+|+||.||+|+.+ +++.||+|++.... .......+..|..+++.+ +||||+++++++.+.+..|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 457888999999999999999874 68899999985321 123355678899999877 89999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 96 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 9999999999999964 346899999999999999999999887 99999999999999999999999999986432
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....
T Consensus 171 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~---------- 234 (345)
T 1xjd_A 171 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHSIRMDN---------- 234 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCC----------
T ss_pred CC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC----HHHHHHHHHhCC----------
Confidence 22 22345689999999999999999999999999999999999999996432 222222222111
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHH-HHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMR-EVVQ 956 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 956 (995)
...+...+..+.+++.+||+.||++||++. |+.+
T Consensus 235 --~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 --PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 112333556788999999999999999997 6653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=367.86 Aligned_cols=248 Identities=28% Similarity=0.400 Sum_probs=205.6
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.+|+..+.||+|+||.||+|++. +|+.||||++.... .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888999999999999999874 79999999984321 1223467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++|+|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....+.
T Consensus 96 E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999995 3457999999999999999999999777 9999999999999999999999999998764432
Q ss_pred CCccccccccCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
.....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+... ......+..+ .
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~-----------~ 232 (476)
T 2y94_A 171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV----PTLFKKICDG-----------I 232 (476)
T ss_dssp ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS----HHHHHHHHTT-----------C
T ss_pred ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH----HHHHHHHhcC-----------C
Confidence 2345689999999999988776 6899999999999999999999965322 1222222221 1
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. ..+...+..+.+++.+||+.||++|||++|++++
T Consensus 233 ~-~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 F-YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp C-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred c-CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1 1223345678899999999999999999999973
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=355.99 Aligned_cols=263 Identities=25% Similarity=0.249 Sum_probs=203.9
Q ss_pred cHHHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC----CCCChhHHHHHHHHHHhccCCCCceeEeEEEec
Q 001922 680 SVSDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF----GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN 754 (995)
Q Consensus 680 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 754 (995)
++.++.++|+..+.||+|+||+||+|+. .+++.||+|++... ......+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4577889999999999999999999976 46889999998432 133456779999999999999999999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCC--------------------------------------CCCCCCHHHHHHHHHHHHH
Q 001922 755 KETNLLVYEYMRNGSLGEALHGK--------------------------------------KGAFLGWNLRYKIAIEAAK 796 (995)
Q Consensus 755 ~~~~~lv~e~~~~gsL~~~l~~~--------------------------------------~~~~~~~~~~~~i~~qi~~ 796 (995)
.+..++||||+++|+|.+++... ....+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998520 0122357778899999999
Q ss_pred HHHHHHhcCCCCeEecCCCCCCEEECCCC--CeEEeeeccccccccCCC--CccccccccCccccccccccc--CCCCcc
Q 001922 797 GLCYLHHDCSPLIVHRDVKSNNILLNSAF--EAHVADFGLAKFLIDGGA--SECMSAIAGSYGYIAPEYAYT--LRVDEK 870 (995)
Q Consensus 797 ~l~~LH~~~~~~iiHrDlkp~Nill~~~~--~vkl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 870 (995)
||+|||+.+ |+||||||+||+++.++ .+||+|||+++.+..... ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999887 99999999999998776 899999999987643221 112345679999999999875 678999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCC
Q 001922 871 SDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPR 950 (995)
Q Consensus 871 ~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 950 (995)
+||||||+++|||++|+.||........... ....... ...+ .....+..+.+++.+||+.||++||+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~----~~~~~~~----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQ----VLNKKLC----FENP----NYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCC----TTSG----GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHH----HHhcccc----cCCc----ccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999999965432222211 1111000 0000 11124567889999999999999999
Q ss_pred HHHHHHH
Q 001922 951 MREVVQM 957 (995)
Q Consensus 951 ~~evl~~ 957 (995)
+.|+++.
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999873
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=349.16 Aligned_cols=255 Identities=22% Similarity=0.267 Sum_probs=207.5
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCC-----hhHHHHHHHHHHhccCCCCceeEeEEEecCC
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHS-----HDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE 756 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 756 (995)
.+.+.|+..+.||+|+||.||+|+.. +|+.||+|++....... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 35678999999999999999999874 68999999985433221 3567999999999999999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC----CeEEeee
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF----EAHVADF 832 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~----~vkl~Df 832 (995)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999999964 456899999999999999999999887 99999999999999888 7999999
Q ss_pred ccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
|+++...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+......
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~ 236 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYD 236 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHTTCCC
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhcccc
Confidence 9998764432 22345799999999999999999999999999999999999999964321 1222222111100
Q ss_pred hhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 913 EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 913 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. ++ ......+..+.+++.+||+.||++|||++|++++
T Consensus 237 ~-----~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 237 F-----DE---EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C-----CH---HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c-----Ch---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00 0011234568899999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=361.56 Aligned_cols=269 Identities=17% Similarity=0.195 Sum_probs=204.7
Q ss_pred HhhccCCCeeeccCceEEEEEEeCC------CcEEEEEEecCCCCCC----------hhHHHHHHHHHHhccCCCCceeE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPN------GVEIAVKKLLGFGTHS----------HDHGFRAEIQTLGNIRHRNIVRL 748 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~ 748 (995)
.+.|+..+.||+|+||+||+|++.. ++.||||++....... ....+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3478999999999999999998754 4789999985432110 01123345566777789999999
Q ss_pred eEEEecC----CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC--
Q 001922 749 LAFCSNK----ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN-- 822 (995)
Q Consensus 749 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~-- 822 (995)
++++... ...|+||||+ +++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 9998664 4579999999 9999999974 3467999999999999999999999887 99999999999999
Q ss_pred CCCCeEEeeeccccccccCCCCc-----cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 001922 823 SAFEAHVADFGLAKFLIDGGASE-----CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV 897 (995)
Q Consensus 823 ~~~~vkl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~ 897 (995)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 88999999999998764332211 1133459999999999999999999999999999999999999997643333
Q ss_pred hHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 898 DIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
........... ......+++.+. ....+..+.+++..||+.+|++||+++++++.|+++.+
T Consensus 269 ~~~~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 269 KYVRDSKIRYR---ENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HHHHHHHHHHH---HCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhh---hhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 33322222111 122222222221 12235678999999999999999999999999888654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=355.65 Aligned_cols=271 Identities=20% Similarity=0.255 Sum_probs=200.7
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++|+..+.||+|+||+||+|+.. +++.||+|++...........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999875 68999999985433333333456799999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
++ |+|.+++... +..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... .
T Consensus 82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--T 154 (324)
T ss_dssp CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--c
Confidence 97 5999988743 456899999999999999999999887 999999999999999999999999999865322 1
Q ss_pred ccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC----
Q 001922 845 ECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD---- 919 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---- 919 (995)
.......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.......................+....+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 22344578999999999876 5689999999999999999999999976433332322222222211111111110
Q ss_pred -----CcCCC-----CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCCC
Q 001922 920 -----PRLSM-----VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFPR 963 (995)
Q Consensus 920 -----~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 963 (995)
+.... .....+..+.+++.+|++.||++|||++|+++. +.++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 00000 011234578899999999999999999999873 555443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=350.28 Aligned_cols=252 Identities=20% Similarity=0.327 Sum_probs=202.0
Q ss_pred hhccCCCeeeccCceEEEEEEeCC-C-------cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN-G-------VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET 757 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 757 (995)
++|+..+.||+|+||+||+|+... + ..||+|++... .....+.+.+|+.++++++||||+++++++.+++.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 578888999999999999997543 3 47999998432 33445679999999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC--------eEE
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE--------AHV 829 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~--------vkl 829 (995)
.++||||+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999743 345899999999999999999999887 999999999999998887 999
Q ss_pred eeeccccccccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhc
Q 001922 830 ADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN 908 (995)
Q Consensus 830 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 908 (995)
+|||++..... .....+|+.|+|||++.+ ..++.++||||+|+++|||++|..|+....+........ ..
T Consensus 163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~---~~ 233 (289)
T 4fvq_A 163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---ED 233 (289)
T ss_dssp CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---HT
T ss_pred ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh---hc
Confidence 99999875422 133468899999999987 678999999999999999999655543322221111111 11
Q ss_pred CChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 909 GRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 909 ~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
. . ..+...+..+.+++.+||+.||++|||++|+++.|+++...
T Consensus 234 ~----------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 234 R----------H---QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp T----------C---CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred c----------C---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0 0 01112244688999999999999999999999999998763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.83 Aligned_cols=268 Identities=26% Similarity=0.360 Sum_probs=204.4
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc--CCCCceeEeEEEecC----
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI--RHRNIVRLLAFCSNK---- 755 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~~~~~~~---- 755 (995)
..+.++|+..+.||+|+||.||+|+.. ++.||||++.. .....+..|.+++... +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec----cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 345678999999999999999999884 89999999842 2234455566666555 899999999998776
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEECCCCCeEEe
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC-----SPLIVHRDVKSNNILLNSAFEAHVA 830 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~iiHrDlkp~Nill~~~~~vkl~ 830 (995)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 6789999999999999999643 5899999999999999999999760 1139999999999999999999999
Q ss_pred eeccccccccCCCCc--cccccccCcccccccccccCCCCcc------cchhhHHHHHHHHHhC----------CCCCCC
Q 001922 831 DFGLAKFLIDGGASE--CMSAIAGSYGYIAPEYAYTLRVDEK------SDVYSFGVVLLELLTG----------RRPVGD 892 (995)
Q Consensus 831 DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltg----------~~Pf~~ 892 (995)
|||+++.+....... ......||+.|+|||++.+..++.+ +|||||||++|||++| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998664332211 1134579999999999987766654 9999999999999999 666655
Q ss_pred CCCCch-HHHHHHHHhcCChhhhhhhcCCcCC--CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 893 FGDGVD-IVQWSKRATNGRKEEFLSILDPRLS--MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 893 ~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
...... ........... ...+..+ ..+..++..+.+++.+||+.||++||+++|++++|+++.+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIK-------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TSCSSCCHHHHHHHHTTS-------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hcCCCCchhhhHHHHhhh-------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 332221 11111111111 0111111 11237888999999999999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=343.08 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=200.8
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.++|+..+.||+|+||+||+|+. .++..||+|++.........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 457899999999999999999976 4688999999866555556788999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---CCCCCeEEeeeccccc
Q 001922 763 EYMRNGSLGEALHGK--KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL---NSAFEAHVADFGLAKF 837 (995)
Q Consensus 763 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill---~~~~~vkl~DfGla~~ 837 (995)
||+++|+|.+++... .+..+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999988532 2456899999999999999999999887 9999999999999 4567899999999986
Q ss_pred cccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
+... .......||+.|+|||++. ..++.++||||+|+++|||++|+.||.... ...........
T Consensus 177 ~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~----~~~~~~~~~~~-------- 240 (285)
T 3is5_A 177 FKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEVQQKATYK-------- 240 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC--------
T ss_pred cCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC----HHHHHhhhccC--------
Confidence 5432 2224567999999999875 568999999999999999999999996532 11111111111
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.+.........+..+.+++.+||+.||++||+++|+++
T Consensus 241 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 241 -EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111113456889999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=354.92 Aligned_cols=250 Identities=23% Similarity=0.242 Sum_probs=204.0
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 760 (995)
.++|+..+.||+|+||+||+|+.+ +++.||+|++.... .....+.+..|..++..+ +||+|+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 357888999999999999999875 47889999985321 123356688899999988 79999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999963 346899999999999999999999887 99999999999999999999999999986432
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+...
T Consensus 174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~~~~i~~~----------- 236 (353)
T 2i0e_A 174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----EDELFQSIMEH----------- 236 (353)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-----------
T ss_pred CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC----HHHHHHHHHhC-----------
Confidence 21 22345689999999999999999999999999999999999999996432 22222222211
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPR-----MREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 957 (995)
.. ..+...+..+.+++.+||+.||++||+ ++|++++
T Consensus 237 ~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 NV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CC-CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CC-CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 123345667899999999999999995 5777654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=357.79 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=196.5
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCC--CCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRH--RNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~ 762 (995)
++|+..+.||+|+||.||+|...+++.||||++..... ....+.+.+|+.++++++| |||+++++++.+++..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 46888999999999999999988899999999854322 2234678899999999976 99999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
|+ .+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++ ++.+||+|||+++.+....
T Consensus 89 e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 89 EC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp CC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred eC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 95 57899999964 356889999999999999999999887 99999999999997 6789999999998765443
Q ss_pred CCccccccccCccccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 843 ASECMSAIAGSYGYIAPEYAYT-----------LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
.........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+. .....
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~-------- 231 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLH-------- 231 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHH--------
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHH--------
Confidence 3333345679999999999864 67889999999999999999999999653321 11111
Q ss_pred hhhhhhcCCcC-CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 EEFLSILDPRL-SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 ~~~~~~~d~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+++.. ...+...+..+.+++.+||+.||++|||++|+++.
T Consensus 232 ----~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 ----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111 11222334578899999999999999999999865
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=353.76 Aligned_cols=262 Identities=25% Similarity=0.327 Sum_probs=196.6
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCC--hhHHHHHHHHHHhccCCCCceeEeEEEecCCcc---
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHS--HDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN--- 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~--- 758 (995)
.++|+..+.||+|+||.||+|+. .+++.||||++....... ....+.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46789999999999999999986 578999999996533222 235688999999999999999999998765544
Q ss_pred -eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 759 -LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 759 -~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 999999999999999964 346899999999999999999999887 99999999999999999999999999987
Q ss_pred cccCCCC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 838 LIDGGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 838 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
+...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... ...............
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----~~~~~~~~~~~~~~~- 240 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----SVAYQHVREDPIPPS- 240 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHCCCCCHH-
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhcCCCCCcc-
Confidence 6443221 2223456899999999999999999999999999999999999999653221 111111111000000
Q ss_pred hcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHH-HHHHHccCCC
Q 001922 917 ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMRE-VVQMLSEFPR 963 (995)
Q Consensus 917 ~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-vl~~L~~~~~ 963 (995)
......+..+.+++.+||+.||++||++.+ +.+.+.++..
T Consensus 241 -------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 241 -------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp -------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred -------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 001124567889999999999999997555 4455555443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=368.54 Aligned_cols=321 Identities=22% Similarity=0.163 Sum_probs=204.0
Q ss_pred cEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCC
Q 001922 238 VHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMN 317 (995)
Q Consensus 238 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 317 (995)
+.++.++++++ .+|..+. +.++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 35566666665 4444432 45666677777766666666777777777777777777666777777777777777777
Q ss_pred cCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCc
Q 001922 318 RLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPE 397 (995)
Q Consensus 318 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 397 (995)
++++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|.+++..|..|..+++|+.|++++|.+.+..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 77755555667777777777777777766677777777777777777777766666777777777777777777666666
Q ss_pred ccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCC
Q 001922 398 RLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNF 477 (995)
Q Consensus 398 ~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 477 (995)
.+..+++|+.|++++|.+.+..+..|..+++|+.+++++|.+.+.+|..... ..+|++|+|++|++++..+..+.++
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~---~~~L~~L~l~~n~l~~~~~~~~~~l 247 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY---GLNLTSLSITHCNLTAVPYLAVRHL 247 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTT---TCCCSEEEEESSCCCSCCHHHHTTC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCccccc---CccccEEECcCCcccccCHHHhcCc
Confidence 6777777777777777777766666666666666555555554444432211 2256666666666664333455566
Q ss_pred CCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEec
Q 001922 478 SSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNL 557 (995)
Q Consensus 478 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L 557 (995)
++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|
T Consensus 248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 327 (477)
T 2id5_A 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLIL 327 (477)
T ss_dssp TTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEEC
T ss_pred cccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEc
Confidence 66666666666666555555555566666666666665555555555556666666666555444444555555555555
Q ss_pred ccccccc
Q 001922 558 SRNHLNQ 564 (995)
Q Consensus 558 ~~N~l~~ 564 (995)
++|++..
T Consensus 328 ~~N~l~c 334 (477)
T 2id5_A 328 DSNPLAC 334 (477)
T ss_dssp CSSCEEC
T ss_pred cCCCccC
Confidence 5555543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=361.28 Aligned_cols=210 Identities=30% Similarity=0.428 Sum_probs=98.4
Q ss_pred ceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccc
Q 001922 69 RVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNN 148 (995)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n 148 (995)
+++.|++.++++.. +| .+..+++|++|+|++|.+++...+.++++|++|+|++|.+++..+ +..+++|++|++++|
T Consensus 47 ~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n 122 (466)
T 1o6v_A 47 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 122 (466)
T ss_dssp TCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred cccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchhhhccccCCEEECCCCccccChh--hcCCCCCCEEECCCC
Confidence 44455555554442 33 244555555555555555544445555555555555555554443 555555555555555
Q ss_pred cccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCC
Q 001922 149 NFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIP 228 (995)
Q Consensus 149 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p 228 (995)
.++++.+ +..+++|++|++++|.+++ ++ .++.+++|++|+++ |.+.+..+ ++++++|++|++++|.+.. +
T Consensus 123 ~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~--~- 192 (466)
T 1o6v_A 123 QITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--I- 192 (466)
T ss_dssp CCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCC--C-
T ss_pred CCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCC--C-
Confidence 5555322 5555555555555555542 22 25555555555554 33332221 5555555555555444322 1
Q ss_pred cccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCc
Q 001922 229 REVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALT 296 (995)
Q Consensus 229 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 296 (995)
..+..+++|++|++++|.+++..| ++.+++|+.|++++|++++. ..+..+++|++|++++|.++
T Consensus 193 ~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~ 256 (466)
T 1o6v_A 193 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQIS 256 (466)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccc
Confidence 224444555555555555543322 33344444444444444321 12333334444444444433
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=359.59 Aligned_cols=253 Identities=23% Similarity=0.258 Sum_probs=192.1
Q ss_pred HhhccCC-CeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhc-cCCCCceeEeEEEec----CCc
Q 001922 685 LECVKDG-NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGN-IRHRNIVRLLAFCSN----KET 757 (995)
Q Consensus 685 ~~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~----~~~ 757 (995)
.+.|... ++||+|+||+||+|+.. +++.||||++.. ...+.+|+.++.+ .+||||+++++++.. ...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 4456655 68999999999999764 688999999842 3457788888754 489999999998865 567
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCCeEEeeecc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS---AFEAHVADFGL 834 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~---~~~vkl~DfGl 834 (995)
.|+||||+++|+|.+++.......+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 899999999999999998655567999999999999999999999887 999999999999998 78899999999
Q ss_pred ccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...............+..+...
T Consensus 211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~-- 285 (400)
T 1nxk_A 211 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-- 285 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC--
T ss_pred ccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc--
Confidence 9865322 22345678999999999999999999999999999999999999997643221100011111111000
Q ss_pred hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 915 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.-.+ .....+..+.+++.+||+.||++|||++|++++
T Consensus 286 --~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 --FPNP----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp --CCTT----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCCc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001 112345678999999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=352.62 Aligned_cols=263 Identities=24% Similarity=0.395 Sum_probs=209.0
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEE--EEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEI--AVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 761 (995)
++|+..+.||+|+||.||+|+.. ++..+ |+|++.........+.+.+|+++++++ +||||+++++++.+.+..|+|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999764 55544 999886554555567789999999999 899999999999999999999
Q ss_pred EEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCe
Q 001922 762 YEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEA 827 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~v 827 (995)
|||+++|+|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997532 347899999999999999999999887 9999999999999999999
Q ss_pred EEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHH
Q 001922 828 HVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRA 906 (995)
Q Consensus 828 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~ 906 (995)
||+|||+++..... .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||.... .......+
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~----~~~~~~~~ 254 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAELYEKL 254 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHG
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc----HHHHHHHh
Confidence 99999998753221 12233457889999999988889999999999999999998 999996532 22222222
Q ss_pred hcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcccc
Q 001922 907 TNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFN 969 (995)
Q Consensus 907 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 969 (995)
... .....+...+..+.+++.+||+.||++||+++|+++.|+++......+.
T Consensus 255 ~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 255 PQG-----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp GGT-----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred hcC-----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 211 1111233455679999999999999999999999999998876554443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=347.85 Aligned_cols=266 Identities=23% Similarity=0.272 Sum_probs=200.3
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.++|+..+.||+|+||+||+|+.. +|+.||+|++...... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 467889999999999999999874 5899999998543322 22456788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999999998853 356899999999999999999999887 9999999999999999999999999998764322
Q ss_pred CCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh------
Q 001922 843 ASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL------ 915 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 915 (995)
.......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||.........................
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 22245578999999999876 568999999999999999999999997644332222222221111000000
Q ss_pred -----hhcCCcCCC----CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 916 -----SILDPRLSM----VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 916 -----~~~d~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...++.... ..+..+..+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000 001345568899999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=356.00 Aligned_cols=267 Identities=16% Similarity=0.165 Sum_probs=202.2
Q ss_pred hhccCCCeeeccCceEEEEEEeC----CCcEEEEEEecCCCCCC----------hhHHHHHHHHHHhccCCCCceeEeEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFGTHS----------HDHGFRAEIQTLGNIRHRNIVRLLAF 751 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~~~~ 751 (995)
++|+..+.||+|+||+||+|+.. ++..||+|++....... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888999999999999999875 57889999985432211 11235678888999999999999999
Q ss_pred Eec----CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC--
Q 001922 752 CSN----KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-- 825 (995)
Q Consensus 752 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-- 825 (995)
+.. ....|+||||+ +++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 877 67889999999 99999999643 37899999999999999999999887 99999999999999887
Q ss_pred CeEEeeeccccccccCCCC-----ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC-chH
Q 001922 826 EAHVADFGLAKFLIDGGAS-----ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG-VDI 899 (995)
Q Consensus 826 ~vkl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~-~~~ 899 (995)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 9999999999876432211 1124457999999999999999999999999999999999999999643222 222
Q ss_pred HHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 900 VQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.................... ....+..+.+++.+||+.||++||++++|++.|+++...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAP------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSC------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred HHHHHhhcccccHHHHhhcc------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 22222222211111111110 113455799999999999999999999999999987653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=356.10 Aligned_cols=247 Identities=21% Similarity=0.261 Sum_probs=195.4
Q ss_pred CCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCC
Q 001922 690 DGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNG 768 (995)
Q Consensus 690 ~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 768 (995)
..+.||+|+||.||+|+. .+|+.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 356899999999999976 46899999998542 2234567899999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE--CCCCCeEEeeeccccccccCCCCcc
Q 001922 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL--NSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 769 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill--~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||+++.+.... .
T Consensus 172 ~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~ 244 (373)
T 2x4f_A 172 ELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244 (373)
T ss_dssp EEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred cHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence 99998864 3356899999999999999999999887 9999999999999 667899999999998764332 2
Q ss_pred ccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 926 (995)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.... ..+...... .... ..
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~i~~~~~~----~~~~----~~ 312 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL----NNILACRWD----LEDE----EF 312 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCC----SCSG----GG
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhccCC----CChh----hh
Confidence 23457999999999999989999999999999999999999999653322111 111111000 0000 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 927 KEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 927 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
...+..+.+++.+||+.||++||+++|+++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 224567899999999999999999999997
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=364.05 Aligned_cols=254 Identities=23% Similarity=0.262 Sum_probs=202.9
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.++|+..++||+|+||+||+|+.+ +++.||+|++.+.. .......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 457888999999999999999875 58899999984311 112234578899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||++||+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 148 ~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp ECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 999999999999964 35889999999999999999999887 999999999999999999999999999876433
Q ss_pred CCCccccccccCcccccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLR----VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
.. ......+||+.|+|||++.+.. ++.++||||+||++|||++|+.||.... .......+..... ..
T Consensus 222 ~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~~~~~i~~~~~----~~ 292 (410)
T 3v8s_A 222 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYSKIMNHKN----SL 292 (410)
T ss_dssp SE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHTHHH----HC
T ss_pred Cc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC----hhhHHHHHHhccc----cc
Confidence 21 1234568999999999987665 7899999999999999999999996432 1222222211100 00
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCC--CCCHHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIE--RPRMREVVQM 957 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 957 (995)
.-+. ....+..+.+++.+|++.+|.+ ||+++|++++
T Consensus 293 ~~p~----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 TFPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCT----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cCCC----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0011 1124567889999999999999 9999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=360.59 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=197.1
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccC--CCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIR--HRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~ 762 (995)
..|+..+.||+|+||+||+|...+++.||||++.... .....+.+.+|+.++++++ ||||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 3588899999999999999998889999999985432 2234567899999999996 599999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
| +.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++ ++.+||+|||+++.+....
T Consensus 136 E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 5678999999743 46888899999999999999999777 99999999999996 5899999999998765443
Q ss_pred CCccccccccCccccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 843 ASECMSAIAGSYGYIAPEYAYT-----------LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+... ...
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~------- 278 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLH------- 278 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHH-------
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH---HHH-------
Confidence 3333345689999999999865 4688999999999999999999999965332111 111
Q ss_pred hhhhhhcCCcCC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 EEFLSILDPRLS-MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 ~~~~~~~d~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.++++... ..+...+..+.+++.+||+.||++||+++|+++.
T Consensus 279 ----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 ----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11121111 1122234578899999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=351.19 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=181.3
Q ss_pred CCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEEEeccCC
Q 001922 691 GNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVYEYMRNG 768 (995)
Q Consensus 691 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g 768 (995)
++.||+|+||+||+|+.. +++.||||++.. .....+.+|+.+++++. ||||+++++++.++...|+||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999774 689999999843 23566889999999997 999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC---CeEEeeeccccccccCCCCc
Q 001922 769 SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF---EAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 769 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~---~vkl~DfGla~~~~~~~~~~ 845 (995)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+++...... .
T Consensus 92 ~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 164 (325)
T 3kn6_A 92 ELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q 164 (325)
T ss_dssp BHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence 99999964 356899999999999999999999887 99999999999997765 79999999998654322 2
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC---chHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG---VDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ....+....+..+ ..
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-----------~~ 233 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-----------DF 233 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-----------CC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-----------CC
Confidence 234567899999999999999999999999999999999999999753321 1122222222221 11
Q ss_pred CCCC---HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 923 SMVP---KEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 923 ~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.... ...+..+.+++.+||+.||++||+++|+++.
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1111 2346678999999999999999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=363.17 Aligned_cols=256 Identities=23% Similarity=0.202 Sum_probs=202.4
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.++|+..+.||+|+||+||+|+.+ +|+.||+|++.+.. .......+.+|..++..++||||+++++++.+.+..|+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 457889999999999999999874 68999999984311 112234478899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++... +..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 140 mE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 9999999999999642 346899999999999999999999887 999999999999999999999999999876433
Q ss_pred CCCccccccccCcccccccccc-------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 842 GASECMSAIAGSYGYIAPEYAY-------TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
.. ......+||+.|+|||++. ...++.++||||+||++|||++|+.||..... ......+.....
T Consensus 216 ~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~--- 287 (412)
T 2vd5_A 216 GT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST----AETYGKIVHYKE--- 287 (412)
T ss_dssp SC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTHHH---
T ss_pred Cc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH----HHHHHHHHhccc---
Confidence 22 1223468999999999987 35689999999999999999999999965322 111111111100
Q ss_pred hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCC---CCHHHHHHH
Q 001922 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIER---PRMREVVQM 957 (995)
Q Consensus 915 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~ 957 (995)
. ...+..+...+..+.++|.+||. +|++| |+++|++++
T Consensus 288 --~--~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 288 --H--LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --H--CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --C--cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0 01111123355678999999999 99998 689999865
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=340.61 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=204.3
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
++.++|+..+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 45778999999999999999999764 57789999985432 23467799999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---CCCCCeEEeeecccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL---NSAFEAHVADFGLAKFL 838 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill---~~~~~vkl~DfGla~~~ 838 (995)
|||+++++|.+++.. ...+++..++.++.|++.|+.|||+++ |+||||||+||++ +.++.+||+|||++..+
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 85 MELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999999864 345899999999999999999999887 9999999999999 78899999999999876
Q ss_pred ccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 839 IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.... ......||+.|+|||++.+. ++.++||||+|+++|||++|+.||....+.. ....+....
T Consensus 160 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~-------- 223 (277)
T 3f3z_A 160 KPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VMLKIREGT-------- 223 (277)
T ss_dssp CTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCC--------
T ss_pred cCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhCC--------
Confidence 4332 23456799999999988654 8999999999999999999999996533211 111111110
Q ss_pred CCcCCCCCH----HHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 919 DPRLSMVPK----EEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 919 d~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
. ..+. ..+..+.+++.+|++.||++||++.|+++
T Consensus 224 ---~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 ---F-TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---C-CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---C-CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0111 23567899999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=346.99 Aligned_cols=247 Identities=22% Similarity=0.241 Sum_probs=193.7
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC-ChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 760 (995)
..++|+..++||+|+||+||+|+.. +++.||||++...... .....+..|+..+.++ +||||+++++++.+++..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999875 7899999998543222 2233455566665555 89999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+ +++|.+++... +..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 135 v~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 99999 67999988643 456999999999999999999999887 99999999999999999999999999987643
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+... . .+. ....... .+
T Consensus 210 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~--~~~-~~~~~~~-------~~ 271 (311)
T 3p1a_A 210 A---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----E--GWQ-QLRQGYL-------PP 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----H--HHH-HHTTTCC-------CH
T ss_pred C---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----c--HHH-HHhccCC-------Cc
Confidence 2 22344579999999998876 7899999999999999999997776431 1 111 1111100 00
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..+...+..+.+++.+||+.||++|||++|+++
T Consensus 272 ---~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 ---EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 011124567899999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=379.72 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=202.6
Q ss_pred eeeccCceEEEEEEeC---CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccCCC
Q 001922 693 VIGRGGAGIVYHGKMP---NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGS 769 (995)
Q Consensus 693 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs 769 (995)
.||+|+||.||+|.+. ++..||||++.........+.+.+|++++++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999763 4667999999665555567789999999999999999999999976 56899999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC-Ccccc
Q 001922 770 LGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA-SECMS 848 (995)
Q Consensus 770 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~-~~~~~ 848 (995)
|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+..... .....
T Consensus 422 L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 9999964 3566899999999999999999999887 99999999999999999999999999987643221 11122
Q ss_pred ccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCH
Q 001922 849 AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927 (995)
Q Consensus 849 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 927 (995)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||...... + ....+..+ .....+.
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~---~~~~i~~~-----------~~~~~p~ 562 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-E---VMAFIEQG-----------KRMECPP 562 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-H---HHHHHHTT-----------CCCCCCT
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-H---HHHHHHcC-----------CCCCCCC
Confidence 3346789999999999999999999999999999998 99999764332 1 11222211 1112344
Q ss_pred HHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 928 EEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 928 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.++..+.++|.+||+.||++||++++|++.|+.+..
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 566789999999999999999999999999988643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=350.71 Aligned_cols=254 Identities=22% Similarity=0.252 Sum_probs=203.2
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 760 (995)
++.+.|+..+.||+|+||+||+|+.+ +++.||+|++..... ...+|++++.++ +||||+++++++.+++..|+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 35678999999999999999999764 688999999854322 235688888888 79999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC----CCeEEeeecccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA----FEAHVADFGLAK 836 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~----~~vkl~DfGla~ 836 (995)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||++.++ +.+||+|||+++
T Consensus 94 v~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 94 VTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999999964 356899999999999999999999887 9999999999998543 359999999998
Q ss_pred ccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....+ ....+....+..+...
T Consensus 169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~---- 241 (342)
T 2qr7_A 169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFS---- 241 (342)
T ss_dssp ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCC----
T ss_pred cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcc----
Confidence 764332 223456789999999999888899999999999999999999999975332 2222233333222110
Q ss_pred hcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 917 ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 917 ~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.. .......+..+.+++.+||+.||++||+++|++++
T Consensus 242 -~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 -LS---GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp -CC---STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -cC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 01122345678899999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=367.92 Aligned_cols=254 Identities=25% Similarity=0.295 Sum_probs=208.5
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.|+..++||+|+||.||+|+.+ +|+.||+|++.... .......+.+|++++++++||||+++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 46788899999999999999874 68999999984321 1223466889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 763 EYMRNGSLGEALHGKK--GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||++||+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999987533 456899999999999999999999887 99999999999999999999999999987644
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...............+....
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~---------- 409 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA---------- 409 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC----------
T ss_pred CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc----------
Confidence 322 22345899999999999999999999999999999999999999976544333333333322211
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCH-----HHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRM-----REVVQ 956 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 956 (995)
...+...+..+.+++.+||+.||++||++ +++.+
T Consensus 410 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 --VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11234456778999999999999999965 66664
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=354.32 Aligned_cols=260 Identities=23% Similarity=0.217 Sum_probs=203.9
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-----CCCceeEeEEEecCCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-----HRNIVRLLAFCSNKETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~~~~~~~~~~ 758 (995)
.++|+..+.||+|+||+||+|+. .+++.||||++.. .......+..|+.+++.++ ||||+++++++...+..
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 56799999999999999999987 5688999999853 2233456788999999986 99999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---------------
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS--------------- 823 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~--------------- 823 (995)
++||||+ +++|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccc
Confidence 9999999 899999998766667999999999999999999999887 999999999999976
Q ss_pred ----------CCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 001922 824 ----------AFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDF 893 (995)
Q Consensus 824 ----------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~ 893 (995)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 789999999999864322 23457899999999999999999999999999999999999999754
Q ss_pred CCCchHHHHHHHHhcCChhhh-hhhc--------CC-----cCCC-----------------CCHHHHHHHHHHHhcccC
Q 001922 894 GDGVDIVQWSKRATNGRKEEF-LSIL--------DP-----RLSM-----------------VPKEEAMHLLFVAMLCIQ 942 (995)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~-~~~~--------d~-----~~~~-----------------~~~~~~~~l~~li~~cl~ 942 (995)
......... ........... .... +. ..+. .+......+.+++.+||+
T Consensus 263 ~~~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 263 EHMEHLAMM-ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SHHHHHHHH-HHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred cHHHHHHHH-HHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 322222221 11111111110 0000 00 0000 000112567899999999
Q ss_pred CCCCCCCCHHHHHH
Q 001922 943 ENSIERPRMREVVQ 956 (995)
Q Consensus 943 ~dP~~RPt~~evl~ 956 (995)
.||++|||++|+++
T Consensus 342 ~dP~~Rpta~elL~ 355 (360)
T 3llt_A 342 IDPTLRPSPAELLK 355 (360)
T ss_dssp SSGGGSCCHHHHTT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.47 Aligned_cols=253 Identities=21% Similarity=0.352 Sum_probs=208.1
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec-------
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN------- 754 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------- 754 (995)
.+..+|+..+.||+|+||.||+|+.. +++.||+|++... .+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC-----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 45678999999999999999999875 7899999998532 2347789999999999999999998854
Q ss_pred ---------CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 001922 755 ---------KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF 825 (995)
Q Consensus 755 ---------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~ 825 (995)
....++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 445799999999999999997655567999999999999999999999887 99999999999999999
Q ss_pred CeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHH
Q 001922 826 EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKR 905 (995)
Q Consensus 826 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~ 905 (995)
.+||+|||++....... ......||+.|+|||++.+..++.++||||+|+++|||++|..|+.. .......
T Consensus 160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~------~~~~~~~ 230 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE------TSKFFTD 230 (284)
T ss_dssp EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH------HHHHHHH
T ss_pred CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh------HHHHHHH
Confidence 99999999998764432 22345799999999999999999999999999999999999998732 1111111
Q ss_pred HhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCc
Q 001922 906 ATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966 (995)
Q Consensus 906 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 966 (995)
.. ... .+...+..+.+++.+||+.||++||+++|+++.|+.+.+...
T Consensus 231 ~~-----------~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 231 LR-----------DGI---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HH-----------TTC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred hh-----------ccc---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11 111 122234568899999999999999999999999998876543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=348.02 Aligned_cols=260 Identities=20% Similarity=0.228 Sum_probs=207.0
Q ss_pred cHHHHHhhccCC-CeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccC-CCCceeEeEEEecC
Q 001922 680 SVSDILECVKDG-NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNK 755 (995)
Q Consensus 680 ~~~~~~~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 755 (995)
..+.+.++|... +.||+|+||+||+|+.. +++.||+|++..... ......+.+|+.++++++ ||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 346677788877 89999999999999764 689999999854322 233567889999999995 69999999999999
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCCeEEeee
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS---AFEAHVADF 832 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~---~~~vkl~Df 832 (995)
+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 99999999999999999997666678999999999999999999999887 999999999999998 789999999
Q ss_pred ccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
|+++...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||......... ..+....
T Consensus 179 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~-- 249 (327)
T 3lm5_A 179 GMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY----LNISQVN-- 249 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTC--
T ss_pred ccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH----HHHHhcc--
Confidence 9998764322 223457999999999999999999999999999999999999999653221111 1111110
Q ss_pred hhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 913 EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 913 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...........+..+.+++.+||+.||++|||++|+++.
T Consensus 250 ------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 250 ------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000111222345678899999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=355.11 Aligned_cols=247 Identities=26% Similarity=0.268 Sum_probs=192.7
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHH-HhccCCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQT-LGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
++|+..+.||+|+||+||+|+.+ +++.||+|++.+.. .......+..|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888999999999999999875 58889999985432 12233456667776 5778999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999999964 346889999999999999999999887 999999999999999999999999999864322
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+... .
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~~~~i~~~-----------~ 255 (373)
T 2r5t_A 193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----TAEMYDNILNK-----------P 255 (373)
T ss_dssp C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB----HHHHHHHHHHS-----------C
T ss_pred C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhc-----------c
Confidence 2 22345689999999999999999999999999999999999999996422 22222222211 1
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVV 955 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 955 (995)
. ..+...+..+.+++.+||+.||++||++.+.+
T Consensus 256 ~-~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 256 L-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp C-CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred c-CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 1 12233456788999999999999999985433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=339.83 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=184.2
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.++|+..+.||+|+||.||+|+. .+++.||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 45788999999999999999986 578999999984321 122246788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 999999999999974 3456899999999999999999999887 999999999999999999999999999875432
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
. .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.......... . .....
T Consensus 166 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~-----------~~~~~ 228 (278)
T 3cok_A 166 H--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----K-----------VVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred C--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----H-----------Hhhcc
Confidence 2 12234578999999999998889999999999999999999999996532211110 0 00011
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
. ..+...+..+.+++.+||+.||++||+++++++
T Consensus 229 ~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 Y-EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp C-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c-CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1 123334567889999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=351.14 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=204.4
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCC-------hhHHHHHHHHHHhccCCCCceeEeEEEe
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHS-------HDHGFRAEIQTLGNIRHRNIVRLLAFCS 753 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~ 753 (995)
.+..++|+..+.||+|+||+||+|+. .+++.||||++....... ....+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45678899999999999999999975 568899999985433211 2345778999999999999999999999
Q ss_pred cCCcceEEEEeccCC-ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeee
Q 001922 754 NKETNLLVYEYMRNG-SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADF 832 (995)
Q Consensus 754 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~Df 832 (995)
+.+..++||||+.+| +|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 999999999999776 99999964 446899999999999999999999887 999999999999999999999999
Q ss_pred ccccccccCCCCccccccccCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
|+++...... ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.....
T Consensus 175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------------- 235 (335)
T 3dls_A 175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------------- 235 (335)
T ss_dssp TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------------
T ss_pred ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------------
Confidence 9998764432 2234679999999999988877 7899999999999999999999964211
Q ss_pred hhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 EEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..... ...+...+..+.+++.+||+.||++||+++|+++.
T Consensus 236 -----~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -----TVEAA-IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----GTTTC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----HHhhc-cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 01122245678999999999999999999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=342.72 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=204.8
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
+.++|+..+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3567899999999999999999764 58999999985432 223346688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC---eEEeeecccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE---AHVADFGLAKFL 838 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~---vkl~DfGla~~~ 838 (995)
|||+++++|.+.+.. ...+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 84 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999998863 356899999999999999999999887 999999999999987655 999999999876
Q ss_pred ccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 839 IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... ............. ..
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~----~~ 227 (284)
T 3kk8_A 159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYAQIKAGAYD----YP 227 (284)
T ss_dssp CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCC----CC
T ss_pred ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch----hHHHHHHHhcccc----CC
Confidence 4322 22446799999999999999999999999999999999999999965322 1111111111000 00
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+ .....+..+.+++.+||+.||++||+++|+++.
T Consensus 228 ~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 SP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ch----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 01 112345678899999999999999999999873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.08 Aligned_cols=252 Identities=28% Similarity=0.398 Sum_probs=199.8
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec-CCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN-KETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e 763 (995)
.++|+..+.||+|+||+||+|+. .|+.||||++.. ....+.+.+|++++++++||||+++++++.+ .+..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCC---CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecc---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 35788899999999999999987 588999999853 2345678999999999999999999998754 457899999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++.......+++..++.++.|++.|+.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999997543334789999999999999999999887 999999999999999999999999998864322
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
.....+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... + ....+... ..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~---~~~~~~~~-----------~~ 232 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-D---VVPRVEKG-----------YK 232 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-G---HHHHHTTT-----------CC
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-H---HHHHHhcC-----------CC
Confidence 123467889999999998899999999999999999998 99999653221 1 11111111 11
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
...+...+..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 12334456779999999999999999999999999998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=360.55 Aligned_cols=256 Identities=22% Similarity=0.279 Sum_probs=195.4
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-------CCChhHHHHHHHHHHhccCCCCceeEeEEEe
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-------THSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 753 (995)
..+.++|+..+.||+|+||+||+|.. .+++.||||++.... .......+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45678899999999999999999976 468999999985321 1112234789999999999999999999986
Q ss_pred cCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC---CeEEe
Q 001922 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF---EAHVA 830 (995)
Q Consensus 754 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~---~vkl~ 830 (995)
. +..|+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++ .+||+
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred c-CceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 4 457999999999999999853 456899999999999999999999887 99999999999997654 59999
Q ss_pred eeccccccccCCCCccccccccCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT---LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRAT 907 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 907 (995)
|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.................
T Consensus 285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~ 361 (419)
T 3i6u_A 285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 361 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC
T ss_pred ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC
Confidence 99999876432 22345679999999999853 5688999999999999999999999976544433332222111
Q ss_pred cCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 908 NGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 908 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..... ......+..+.+++.+||+.||++||+++|++++
T Consensus 362 ~~~~~-----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 362 YNFIP-----------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCCCH-----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCc-----------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 10000 0001235678899999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=355.72 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=202.0
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC--ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
..+.|+..+.||+|+||+||+|+. .+++.||||++...... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 346688889999999999999976 57899999998543222 223568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+. |++.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 132 v~e~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEECCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 999997 588888753 2356899999999999999999999887 99999999999999999999999999986532
Q ss_pred CCCCccccccccCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 841 GGASECMSAIAGSYGYIAPEYAY---TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....+....
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----~~~~~~~~~~------- 269 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNE------- 269 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSC-------
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcC-------
Confidence 13457999999999874 567899999999999999999999999653221 1111111110
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
.+ ...+...+..+.+++.+||+.||++|||++++++...
T Consensus 270 -~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 270 -SP--ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp -CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred -CC--CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 01 1112234567889999999999999999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=363.77 Aligned_cols=262 Identities=21% Similarity=0.223 Sum_probs=196.8
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCC------
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE------ 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 756 (995)
.++|+..+.||+|+||+||+|.. .+++.||||++.... ......++.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46799999999999999999976 468999999985432 2334567889999999999999999999996543
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
+.|+||||+++ ++.+.+.. .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 46999999976 57776642 3889999999999999999999887 9999999999999999999999999998
Q ss_pred ccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh----
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE---- 912 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---- 912 (995)
..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......................
T Consensus 213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 213 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp ----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 75432 22345689999999999999999999999999999999999999996543222222222211111100
Q ss_pred ---hhhhhcCCc--CCC-----------------CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 913 ---EFLSILDPR--LSM-----------------VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 913 ---~~~~~~d~~--~~~-----------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....+... ... .....+..+.+++.+||+.||++|||++|++++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001111100 000 011236778999999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=368.32 Aligned_cols=250 Identities=22% Similarity=0.240 Sum_probs=196.2
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.++|+..+.||+|+||.||+|+. .+|+.||||++... ........+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35788899999999999999976 46899999998532 2223345678899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+||+++.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999964 3468999999999999999999997 77 99999999999999999999999999986432
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+....
T Consensus 302 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~---------- 365 (446)
T 4ejn_A 302 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILMEE---------- 365 (446)
T ss_dssp -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCC----------
T ss_pred C--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHHHHHHHhCC----------
Confidence 2 2223457899999999999999999999999999999999999999965321 12222211110
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
...+...+..+.+++.+||+.||++|| +++|++++
T Consensus 366 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 --IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 112334556789999999999999999 99999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=345.32 Aligned_cols=257 Identities=24% Similarity=0.335 Sum_probs=204.5
Q ss_pred hhccCCC-eeeccCceEEEEEEe---CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGN-VIGRGGAGIVYHGKM---PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~-~lG~G~~g~V~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
++|+..+ .||+|+||+||+|.+ .+++.||||++..... ....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4677777 899999999999954 3468899999854332 22356789999999999999999999999 5677899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 95 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 9999999999999964 346899999999999999999999887 99999999999999999999999999987644
Q ss_pred CCCC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 841 GGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 841 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.... .......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||..... ......+...
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~~--------- 236 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKG--------- 236 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTT---------
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHcC---------
Confidence 3221 11223456789999999988889999999999999999999 9999965322 1122222111
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.....+...+..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 237 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 237 --ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1112334456789999999999999999999999999988643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.38 Aligned_cols=260 Identities=22% Similarity=0.266 Sum_probs=205.7
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC-----ChhHHHHHHHHHHhccCCCCceeEeEEEecCCc
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH-----SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET 757 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 757 (995)
+.++|+..+.||+|+||.||+|+.. +++.||+|.+...... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3567999999999999999999875 6899999998543221 235778999999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC----CeEEeeec
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF----EAHVADFG 833 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~----~vkl~DfG 833 (995)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999999963 346899999999999999999999887 99999999999999877 89999999
Q ss_pred cccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
++....... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+.......
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~ 230 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDF 230 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTTCCCC
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch----HHHHHHhHhcccCC
Confidence 998764322 22345689999999999999999999999999999999999999965321 11111111110000
Q ss_pred hhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH--HHccCCC
Q 001922 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ--MLSEFPR 963 (995)
Q Consensus 914 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~ 963 (995)
.. ......+..+.+++.+||+.||++||+++|+++ .++++.+
T Consensus 231 -----~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 231 -----DE---EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp -----CH---HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred -----cc---hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 00 001123456889999999999999999999997 3555443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=343.00 Aligned_cols=261 Identities=19% Similarity=0.254 Sum_probs=203.7
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEE-ecCCcceEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC-SNKETNLLV 761 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv 761 (995)
+.++|+..+.||+|+||+||+|+. .+++.||||++.... ....+.+|++++++++|++++..+.++ ...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 457899999999999999999986 578899999874322 223478899999999988877666655 667788999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---CCCCCeEEeeecccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL---NSAFEAHVADFGLAKFL 838 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill---~~~~~vkl~DfGla~~~ 838 (995)
|||+ +++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||+++..
T Consensus 84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999 99999999732 346899999999999999999999887 9999999999999 78899999999999876
Q ss_pred ccCCCC-----ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHH---HHHHHhcCC
Q 001922 839 IDGGAS-----ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQ---WSKRATNGR 910 (995)
Q Consensus 839 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~---~~~~~~~~~ 910 (995)
...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 122356799999999999999999999999999999999999999976543322111 111111110
Q ss_pred hhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 911 KEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 911 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.. . .....+..+.+++.+||+.||++||+++++++.|+++..
T Consensus 239 ~~----~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 239 IE----V-------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HH----H-------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hh----h-------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00 0 011234678999999999999999999999999998765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=353.83 Aligned_cols=253 Identities=15% Similarity=0.136 Sum_probs=206.2
Q ss_pred HhhccCCCeeeccCceEEEEEE------eCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC---CCCceeEeEEEecC
Q 001922 685 LECVKDGNVIGRGGAGIVYHGK------MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR---HRNIVRLLAFCSNK 755 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~ 755 (995)
.+.|+..+.||+|+||+||+|. ..+++.||||++.. .....+..|++++++++ |+||+++++++...
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC----CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 3568888999999999999993 45688999999843 23566888888888886 99999999999999
Q ss_pred CcceEEEEeccCCChhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---------
Q 001922 756 ETNLLVYEYMRNGSLGEALHG---KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS--------- 823 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~--------- 823 (995)
+..|+||||+++|+|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999963 13467999999999999999999999777 999999999999998
Q ss_pred --CCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHH
Q 001922 824 --AFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQ 901 (995)
Q Consensus 824 --~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~ 901 (995)
++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999986643333444566789999999999999999999999999999999999999985421110
Q ss_pred HHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCC-CCHHHHHHHHccCCCC
Q 001922 902 WSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIER-PRMREVVQMLSEFPRH 964 (995)
Q Consensus 902 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~~~~ 964 (995)
..........+ ....+.+++..|++.+|.+| |+++++.+.|+++...
T Consensus 293 --------------~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 --------------CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------------EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------------eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 00111111111 24567789999999999999 5788888888876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.29 Aligned_cols=248 Identities=18% Similarity=0.254 Sum_probs=201.3
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcce
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 759 (995)
...++|+..+.||+|+||+||+|+.. +++.||+|++.... .......+.+|+.++.++ +||||+++++++.+++..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 34678999999999999999999875 78999999985432 233456788899999999 8999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-------------
Q 001922 760 LVYEYMRNGSLGEALHGKK--GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA------------- 824 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~------------- 824 (995)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence 9999999999999996422 256899999999999999999999887 9999999999999844
Q ss_pred ------CCeEEeeeccccccccCCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 001922 825 ------FEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV 897 (995)
Q Consensus 825 ------~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~ 897 (995)
..+||+|||.+...... ....||+.|+|||++.+. .++.++||||+|+++|+|++|..|+... .
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~ 235 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---D 235 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---H
T ss_pred cccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---h
Confidence 47999999999876432 234589999999998766 5678999999999999999998876421 1
Q ss_pred hHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 898 DIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.. . .+........+...+..+.+++.+||+.||++||+++|+++.
T Consensus 236 ~~----~-----------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 QW----H-----------EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HH----H-----------HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HH----H-----------HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11 1 111122223344456678999999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.63 Aligned_cols=263 Identities=21% Similarity=0.336 Sum_probs=201.3
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
..+|+..+.||+|+||.||+|.. .+|+.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45788999999999999999976 578999999985422 223356688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 762 YEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
|||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999863 23456899999999999999999999887 9999999999999999999999999998654
Q ss_pred cCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... ...............
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~-------- 255 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCKKIEQCDY-------- 255 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-----CCHHHHHHHHHTTCS--------
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc--hhHHHHHHHhhcccC--------
Confidence 322 12234568999999999999999999999999999999999999996432 222222222222110
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
+ .......+..+.+++.+||+.||++||+++|+++.|+++...
T Consensus 256 ~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 256 P--PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp C--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C--CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0 011123456789999999999999999999999999987653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=346.56 Aligned_cols=264 Identities=22% Similarity=0.280 Sum_probs=205.7
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEe----cCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS----NKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~~~~~l 760 (995)
++|+..+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++. .....++
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 5788999999999999999986 57899999988442 3334567889999999999999999999986 3457799
Q ss_pred EEEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 761 VYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
||||+++|+|.+++.. ..+..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999864 23567899999999999999999999887 999999999999999999999999998764
Q ss_pred ccCCCCc-------cccccccCcccccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCCC-CchHHHHHHHHh
Q 001922 839 IDGGASE-------CMSAIAGSYGYIAPEYAYTLR---VDEKSDVYSFGVVLLELLTGRRPVGDFGD-GVDIVQWSKRAT 907 (995)
Q Consensus 839 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~Pf~~~~~-~~~~~~~~~~~~ 907 (995)
....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... ........ .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~ 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV---Q 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH---H
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh---h
Confidence 3211100 112345799999999987554 68999999999999999999999953110 00111100 0
Q ss_pred cCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcc
Q 001922 908 NGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSD 967 (995)
Q Consensus 908 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 967 (995)
.......+...+..+.+++.+||+.||++||+++|+++.|+++....+.
T Consensus 262 -----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 262 -----------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp -----------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred -----------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 0000011223456799999999999999999999999999998765544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=341.62 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=200.3
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.++|+..+.||+|+||+||+|+.. +++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 357888999999999999999764 57789999984321 112245688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++.. ...+++..++.++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999999963 346899999999999999999999777 999999999999999999999999998654322
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... .......+... .
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~---------~-- 223 (279)
T 3fdn_A 163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQETYKRISRV---------E-- 223 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHT---------C--
T ss_pred ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc----HHHHHHHHHhC---------C--
Confidence 2234578999999999999999999999999999999999999996422 11111111111 0
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+...+..+.+++.+||+.||++||+++|++++
T Consensus 224 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11233345678899999999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.40 Aligned_cols=250 Identities=24% Similarity=0.303 Sum_probs=208.3
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.+.|+..+.||+|+||.||+|+. .+++.||+|++.........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45688899999999999999976 46899999998655555556789999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 9999999999953 46899999999999999999999887 9999999999999999999999999998764332
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+... ...
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~-----------~~~ 237 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVLFLIPKN-----------NPP 237 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHS-----------CCC
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----HHHHHHhhcC-----------CCC
Confidence 122455789999999999999999999999999999999999999965321 1111111111 011
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+||+.||++||+++|+++.
T Consensus 238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1222345678999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.65 Aligned_cols=264 Identities=21% Similarity=0.225 Sum_probs=200.6
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC--ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
..++|+..+.||+|+||.||+|+.. +++.||+|++...... ...+.+.+|+.++++++||||+++++++.+++..|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3567899999999999999999864 6889999998543222 223668899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 112 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999999964 346899999999999999999999887 99999999999999999999999999986543
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
... .......|++.|+|||++.+..++.++||||||+++|||++|+.||.... ............ +
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~---------~ 252 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ----LSVMGAHINQAI---------P 252 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH----HHHHHHHHHSCC---------C
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch----HHHHHHHhccCC---------C
Confidence 221 22234578999999999999999999999999999999999999996421 111111111110 0
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHHccCCCCCc
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERP-RMREVVQMLSEFPRHSS 966 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~~ 966 (995)
.....+...+..+.+++.+||+.||++|| +++++++.|++......
T Consensus 253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 01112334456788999999999999999 99999999998876554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=348.82 Aligned_cols=269 Identities=22% Similarity=0.262 Sum_probs=201.6
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCC----hhHHHHHHHHHHhccCCCCceeEeEEEecCC
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHS----HDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE 756 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 756 (995)
....++|+..+.||+|+||.||+|+.. +|+.||||++....... ....+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 445678999999999999999999874 58999999985322211 1346789999999999999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999986 89888864 3456888899999999999999999887 9999999999999999999999999998
Q ss_pred ccccCCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
.+.... .......||+.|+|||++.+. .++.++||||+||++|||++|..||....+..................+.
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 764322 223456789999999998764 58899999999999999999999986543333333333322221111111
Q ss_pred hhcC-------CcCCCCC-----HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 916 SILD-------PRLSMVP-----KEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 916 ~~~d-------~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+... ......+ ...+..+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1100 0001111 2345679999999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=347.91 Aligned_cols=265 Identities=26% Similarity=0.343 Sum_probs=211.1
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhc--cCCCCceeEeEEEecCC---
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGN--IRHRNIVRLLAFCSNKE--- 756 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~~--- 756 (995)
..+.++|+..+.||+|+||+||+|+. +++.||||++.. .....+.+|.++++. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 44677899999999999999999988 589999999842 335667888888887 68999999999998765
Q ss_pred -cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCEEECCCCCe
Q 001922 757 -TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH--------HDCSPLIVHRDVKSNNILLNSAFEA 827 (995)
Q Consensus 757 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~iiHrDlkp~Nill~~~~~v 827 (995)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred ceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999964 35899999999999999999999 666 9999999999999999999
Q ss_pred EEeeeccccccccCCCCc--cccccccCcccccccccccC------CCCcccchhhHHHHHHHHHhC----------CCC
Q 001922 828 HVADFGLAKFLIDGGASE--CMSAIAGSYGYIAPEYAYTL------RVDEKSDVYSFGVVLLELLTG----------RRP 889 (995)
Q Consensus 828 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg----------~~P 889 (995)
||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998764432211 22445799999999998765 334789999999999999999 788
Q ss_pred CCCCCCCc-hHHHHHHHHhcCChhhhhhhcCCcCC--CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 890 VGDFGDGV-DIVQWSKRATNGRKEEFLSILDPRLS--MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 890 f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
|....... ....+....... ...+..+ ....+++..+.+++.+||+.||++||+++||+++|+++.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQ-------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTS-------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccccCcCcccHHHHHHHHHHH-------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 86643322 222332222211 0111111 12236778899999999999999999999999999987654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.91 Aligned_cols=260 Identities=19% Similarity=0.248 Sum_probs=206.3
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEE-ecCCcceEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFC-SNKETNLLVY 762 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv~ 762 (995)
.++|+..+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++++++|++++..+.++ ...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 45788999999999999999986 578999999985432 234688999999999988877666655 6677889999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC---CCCCeEEeeeccccccc
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN---SAFEAHVADFGLAKFLI 839 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~---~~~~vkl~DfGla~~~~ 839 (995)
||+ +++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+||+++ .++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Eec-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 999 8999999973 2356899999999999999999999887 99999999999994 78899999999998765
Q ss_pred cCCCCc-----cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCch---HHHHHHHHhcCCh
Q 001922 840 DGGASE-----CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD---IVQWSKRATNGRK 911 (995)
Q Consensus 840 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~---~~~~~~~~~~~~~ 911 (995)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 433211 12456799999999999999999999999999999999999999986443221 1111111111100
Q ss_pred hhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 912 EEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 912 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.. .....+..+.+++.+||+.||++||+++++++.|+++..
T Consensus 240 ~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 240 EV-----------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HH-----------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred HH-----------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 00 011234678999999999999999999999999998764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=354.31 Aligned_cols=256 Identities=25% Similarity=0.272 Sum_probs=206.0
Q ss_pred HhhccCCCeeeccCceEEEEEEe----CCCcEEEEEEecCCC---CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCC
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM----PNGVEIAVKKLLGFG---THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKE 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 756 (995)
.++|+..+.||+|+||+||+|+. .+++.||||++.... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35789999999999999999987 378999999985322 122345577899999999 6999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999964 346899999999999999999999887 9999999999999999999999999998
Q ss_pred ccccCCCCccccccccCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYT--LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....................
T Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---- 282 (355)
T 1vzo_A 208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---- 282 (355)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----
T ss_pred ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC----
Confidence 6533221 22234679999999999885 3478999999999999999999999976544444443333322211
Q ss_pred hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHHH
Q 001922 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQML 958 (995)
Q Consensus 915 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 958 (995)
...+...+..+.+++.+||+.||++|| +++|+++..
T Consensus 283 --------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 112334556788999999999999999 999998753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=338.84 Aligned_cols=254 Identities=25% Similarity=0.304 Sum_probs=203.0
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC---CCChhHHHHHHHHHHhccCCCCceeEeEEE--ecCCc
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG---THSHDHGFRAEIQTLGNIRHRNIVRLLAFC--SNKET 757 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~~ 757 (995)
+.++|+..+.||+|+||.||+|.. .+++.||+|++.... .......+.+|++++++++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 457899999999999999999987 468899999985321 123456789999999999999999999998 45568
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.++||||++++ +.+++.......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999876 777776655677999999999999999999999887 99999999999999999999999999987
Q ss_pred cccCCCCccccccccCcccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTLR--VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
..............||+.|+|||++.+.. ++.++||||+|+++|||++|+.||... ........+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~i~~~~----- 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIGKGS----- 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHCC-----
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc----hHHHHHHHHhcCC-----
Confidence 65433334445567999999999987644 478999999999999999999999642 2222222222111
Q ss_pred hhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 916 SILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 916 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+..++..+.+++.+||+.||++||+++|+++.
T Consensus 230 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 -------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11223455678899999999999999999999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=346.98 Aligned_cols=255 Identities=23% Similarity=0.275 Sum_probs=196.8
Q ss_pred HhhccC-CCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKD-GNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~-~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 761 (995)
.+.|++ .+.||+|+||+||+|+. .+++.||||++... .......+.+|++++.++ +||||+++++++.+.+..|+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC-SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC-cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 345666 47899999999999975 46899999998543 334467789999999885 799999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC---eEEeeecccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE---AHVADFGLAKFL 838 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~---vkl~DfGla~~~ 838 (995)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++. +||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999964 346899999999999999999999887 999999999999998776 999999998765
Q ss_pred ccCCC-----CccccccccCccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCch----------
Q 001922 839 IDGGA-----SECMSAIAGSYGYIAPEYAYT-----LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVD---------- 898 (995)
Q Consensus 839 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~---------- 898 (995)
..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 111234569999999999875 5688999999999999999999999976432210
Q ss_pred -HHHHHHHHhcCChhhhhhhcCCcCCCCCH----HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 899 -IVQWSKRATNGRKEEFLSILDPRLSMVPK----EEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 899 -~~~~~~~~~~~~~~~~~~~~d~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.......+.. ... ..+. ..+..+.+++.+||+.||++||+++|+++.
T Consensus 245 ~~~~~~~~i~~-----------~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQE-----------GKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHH-----------CCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhc-----------cCc-ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0111111111 111 1111 235678999999999999999999999873
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=355.44 Aligned_cols=262 Identities=18% Similarity=0.171 Sum_probs=206.4
Q ss_pred hhccCCCeeeccCceEEEEEEeCC---------CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCcee---------
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN---------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR--------- 747 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~--------- 747 (995)
++|+..+.||+|+||.||+|+... ++.||+|++... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 578899999999999999998753 789999998532 35788999999999999987
Q ss_pred ------EeEEEec-CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 001922 748 ------LLAFCSN-KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNIL 820 (995)
Q Consensus 748 ------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nil 820 (995)
+++++.. +...|+||||+ +++|.+++.......+++..++.++.||+.||.|||+++ |+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 5677765 67889999999 999999998654567999999999999999999999887 999999999999
Q ss_pred ECCCC--CeEEeeeccccccccCCCC-----ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 001922 821 LNSAF--EAHVADFGLAKFLIDGGAS-----ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDF 893 (995)
Q Consensus 821 l~~~~--~vkl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~ 893 (995)
++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999876432211 1123457999999999999999999999999999999999999999765
Q ss_pred C-CCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 894 G-DGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 894 ~-~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
. ....+........... ....+... .....+..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 272 ~~~~~~~~~~~~~~~~~~----~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKP----GPFVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp TTCHHHHHHHHHHHHHSC----CCEECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHhccCCh----hhhhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 4 2222222222221111 01111110 011234678999999999999999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=350.06 Aligned_cols=265 Identities=23% Similarity=0.321 Sum_probs=199.9
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCC------
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE------ 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 756 (995)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ......++.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 45788999999999999999976 568999999985432 2223456889999999999999999999997653
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 7899999964 35889999999999999999999887 9999999999999999999999999998
Q ss_pred ccccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||........+.......... ...+.
T Consensus 177 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~-~~~~~ 250 (367)
T 1cm8_A 177 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP-PAEFV 250 (367)
T ss_dssp ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC-CHHHH
T ss_pred cccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC-CHHHH
Confidence 7532 2244578999999999877 679999999999999999999999997543222222222211111 11111
Q ss_pred hhc----------------CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCC
Q 001922 916 SIL----------------DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFP 962 (995)
Q Consensus 916 ~~~----------------d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 962 (995)
..+ ...+.......+..+.+++.+|++.||++|||++|++++ ++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 000 011111223446678999999999999999999999984 55543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=341.71 Aligned_cols=257 Identities=23% Similarity=0.254 Sum_probs=201.3
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEec--CCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSN--KETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv 761 (995)
++|+..+.||+|+||+||+|+. .+++.||||++.. ...+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 5788999999999999999975 5789999999842 33577899999999997 9999999999987 5678999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-CeEEeeecccccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLAKFLID 840 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-~vkl~DfGla~~~~~ 840 (995)
|||+++++|.+++. .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+++.+..
T Consensus 112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999999985 3788999999999999999999887 99999999999999777 899999999987643
Q ss_pred CCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhc-----------
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN----------- 908 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~----------- 908 (995)
.. ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||....+..+..........
T Consensus 184 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 32 2245578999999999877 67899999999999999999999999654332222111111110
Q ss_pred --CChhhhhhhcCCcC---------CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 909 --GRKEEFLSILDPRL---------SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 909 --~~~~~~~~~~d~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....+........ ...+...+..+.+++.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000101100000 01112246778999999999999999999999873
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=365.01 Aligned_cols=271 Identities=21% Similarity=0.220 Sum_probs=188.0
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEec-----CCc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN-----KET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 757 (995)
.++|+..+.||+|+||+||+|+.. +++.||||++.... ......++.+|++++++++|||||++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999764 68999999985432 22345678899999999999999999999843 356
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.|+||||+ +|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 4699999963 456999999999999999999999887 99999999999999999999999999987
Q ss_pred cccCCCC-------------------------ccccccccCccccccccc-ccCCCCcccchhhHHHHHHHHHh------
Q 001922 838 LIDGGAS-------------------------ECMSAIAGSYGYIAPEYA-YTLRVDEKSDVYSFGVVLLELLT------ 885 (995)
Q Consensus 838 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ellt------ 885 (995)
+...... ......+||+.|+|||++ ....++.++||||+||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 6432111 123456789999999976 56679999999999999999999
Q ss_pred -----CCCCCCCCCCC-------------------chHHHHHHHHhcCChhhh------------hhhcCCc----CCCC
Q 001922 886 -----GRRPVGDFGDG-------------------VDIVQWSKRATNGRKEEF------------LSILDPR----LSMV 925 (995)
Q Consensus 886 -----g~~Pf~~~~~~-------------------~~~~~~~~~~~~~~~~~~------------~~~~d~~----~~~~ 925 (995)
|+.+|...... .+................ ...+... +...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 55555332100 011111111111100000 0000000 0011
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccC
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEF 961 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 961 (995)
.+..+..+.+++.+||+.||++|||++|++++ ++++
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 12335678899999999999999999999985 4444
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=349.34 Aligned_cols=268 Identities=24% Similarity=0.337 Sum_probs=197.0
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHH--HhccCCCCceeEeEEEec-----CCcc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQT--LGNIRHRNIVRLLAFCSN-----KETN 758 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~hpniv~~~~~~~~-----~~~~ 758 (995)
++|+..+.||+|+||+||+|+. +++.||||++.. .....+..|.++ +..++||||+++++++.. ....
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF----ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeec----cchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 5688889999999999999987 689999999842 223445555554 455899999999986532 3356
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEecCCCCCCEEECCCCCeEE
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD---------CSPLIVHRDVKSNNILLNSAFEAHV 829 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------~~~~iiHrDlkp~Nill~~~~~vkl 829 (995)
++||||+++|+|.+++... ..++..++.++.||+.||+|||+. + |+||||||+||+++.++.+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred EEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence 8999999999999999643 358899999999999999999976 5 999999999999999999999
Q ss_pred eeeccccccccCCC------CccccccccCccccccccccc-------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 001922 830 ADFGLAKFLIDGGA------SECMSAIAGSYGYIAPEYAYT-------LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG 896 (995)
Q Consensus 830 ~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~ 896 (995)
+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987643221 122234579999999999876 45678999999999999999998887543221
Q ss_pred chHHH-HHHHHhcC-Chhhhhhhc-----CCcCC---CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 897 VDIVQ-WSKRATNG-RKEEFLSIL-----DPRLS---MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 897 ~~~~~-~~~~~~~~-~~~~~~~~~-----d~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
..... +....... ........+ .+..+ ......+..+.+++.+||+.||++|||++|+++.|+++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 11000 00000000 000000000 11111 12234777899999999999999999999999999987643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=351.58 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=204.2
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++|+..+.||+|+||+||+|+.. +++.||+|++.........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 46888899999999999999875 68999999986544444556789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD-CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999964 34688999999999999999999985 7 999999999999999999999999999765322
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC--------------
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG-------------- 909 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~-------------- 909 (995)
......||+.|+|||++.+..++.++||||+||++|+|++|+.||...................
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 1234578999999999999999999999999999999999999996532111100000000000
Q ss_pred -------------ChhhhhhhcCCcCC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 910 -------------RKEEFLSILDPRLS-MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 910 -------------~~~~~~~~~d~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.......+...... ......+..+.+++.+||+.||++|||++|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000111111 1112245678999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=346.74 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=204.8
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCC-------hhHHHHHHHHHHhcc-CCCCceeEeEEE
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHS-------HDHGFRAEIQTLGNI-RHRNIVRLLAFC 752 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l-~hpniv~~~~~~ 752 (995)
..+.++|+..+.||+|+||.||+|+.. +|+.||||++....... ..+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 456678999999999999999999875 79999999985433211 134578899999999 799999999999
Q ss_pred ecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeee
Q 001922 753 SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADF 832 (995)
Q Consensus 753 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~Df 832 (995)
......|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEec
Confidence 999999999999999999999963 346899999999999999999999887 999999999999999999999999
Q ss_pred ccccccccCCCCccccccccCccccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYT------LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRA 906 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 906 (995)
|++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+
T Consensus 245 G~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~~~~i 317 (365)
T 2y7j_A 245 GFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----ILMLRMI 317 (365)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred CcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----HHHHHHH
Confidence 9998764332 2345679999999998863 3588999999999999999999999965321 1111111
Q ss_pred hcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 907 TNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 907 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
......... +.. ...+..+.+++.+||+.||++||+++|+++.
T Consensus 318 ~~~~~~~~~----~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 318 MEGQYQFSS----PEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHTCCCCCH----HHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhCCCCCCC----ccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111000000 000 1234568899999999999999999999873
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=363.43 Aligned_cols=259 Identities=24% Similarity=0.304 Sum_probs=206.3
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
.+.++|+..+.||+|+||+||+|+.. +++.||||++.... .......+.+|++++++++||||+++++++.+....|+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 46788999999999999999999874 78999999984321 23345678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC---CCCCeEEeeeccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN---SAFEAHVADFGLAKF 837 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~---~~~~vkl~DfGla~~ 837 (995)
||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+++.
T Consensus 99 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999998864 346899999999999999999999887 99999999999995 456799999999987
Q ss_pred cccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
+... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......+......
T Consensus 174 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~----- 240 (486)
T 3mwu_A 174 FQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----YDILKRVETGKYA----- 240 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCC-----
T ss_pred CCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCC-----
Confidence 6432 22345679999999999875 589999999999999999999999965322 1222222211100
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCC
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFP 962 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 962 (995)
... ......+..+.+++.+||+.||++|||+.|++++ +++..
T Consensus 241 --~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 241 --FDL-PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp --SCS-GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred --CCC-cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 000 0112345678899999999999999999999975 44443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.02 Aligned_cols=265 Identities=16% Similarity=0.186 Sum_probs=195.0
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
..++|+..+.||+|+||+||+|+. .+++.||||++...... .....+.+|++++++++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 356899999999999999999975 47889999998543222 2245577899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE-----CCCCCeEEeeecccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL-----NSAFEAHVADFGLAK 836 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill-----~~~~~vkl~DfGla~ 836 (995)
|||+++ +|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||++ +..+.+||+|||+++
T Consensus 112 ~e~~~~-~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCSE-EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCCC-CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 999975 999999643 45899999999999999999999887 9999999999999 455569999999998
Q ss_pred ccccCCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
.+... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.......................+.
T Consensus 186 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 186 AFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 76432 1223445789999999998875 48999999999999999999999997543333333322222111111110
Q ss_pred hhc-----CCcC---CCC------CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 916 SIL-----DPRL---SMV------PKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 916 ~~~-----d~~~---~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
... .... ... +...+..+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 0000 000 0113467889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=342.09 Aligned_cols=256 Identities=23% Similarity=0.284 Sum_probs=201.0
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-------CChhHHHHHHHHHHhccCCCCceeEeEEEe
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-------HSHDHGFRAEIQTLGNIRHRNIVRLLAFCS 753 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 753 (995)
..+.++|+..+.||+|+||.||+|+.. +++.||||++..... ......+.+|++++++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 446778999999999999999999764 578999999854221 112345789999999999999999999997
Q ss_pred cCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC---eEEe
Q 001922 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE---AHVA 830 (995)
Q Consensus 754 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~---vkl~ 830 (995)
..+ .|+||||+++++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++. +||+
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred CCc-eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 654 899999999999999985 3457899999999999999999999887 999999999999987664 9999
Q ss_pred eeccccccccCCCCccccccccCcccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAY---TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRAT 907 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~ 907 (995)
|||+++..... .......||+.|+|||++. ...++.++||||+||++|+|++|+.||.................
T Consensus 160 Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 160 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236 (322)
T ss_dssp CCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred cCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence 99999875322 2223457899999999864 56788999999999999999999999976544433333222111
Q ss_pred cCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 908 NGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 908 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...... .....+..+.+++.+||+.||++||+++|+++.
T Consensus 237 ~~~~~~-----------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 237 YNFIPE-----------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CCCCHH-----------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCch-----------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 110000 011235678899999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=343.80 Aligned_cols=268 Identities=25% Similarity=0.359 Sum_probs=208.5
Q ss_pred hhccCCCeeeccCceEEEEEEe-----CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC--cc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-----PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE--TN 758 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~ 758 (995)
++|+..+.||+|+||.||+|++ .+++.||||++.. ......+.+.+|++++++++||||+++++++...+ ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS-CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 4678889999999999999983 4688999999854 23444567899999999999999999999986543 78
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 9999999999999999743 356899999999999999999999887 999999999999999999999999999876
Q ss_pred ccCCCC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh-----h
Q 001922 839 IDGGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK-----E 912 (995)
Q Consensus 839 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-----~ 912 (995)
...... .......++..|+|||++.+..++.++||||+|+++|||++|..||... ...+......... .
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP-----PAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH-----HHHHHHHHCTTCCTHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC-----HHHHHHhhccccchhhhHH
Confidence 443221 1123345778899999999888999999999999999999999998531 0111111110000 0
Q ss_pred hhhhhcC-CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 913 EFLSILD-PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 913 ~~~~~~d-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.+...+. ......+..++..+.+++.+||+.||++||+++|+++.|+++.+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0011111 11112334566789999999999999999999999999988753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=363.79 Aligned_cols=253 Identities=27% Similarity=0.330 Sum_probs=206.2
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC--CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT--HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
+.++|+..+.||+|+||+||+|+.. +++.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4678999999999999999999875 789999999854322 3446779999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---CCCCCeEEeeeccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL---NSAFEAHVADFGLAKF 837 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill---~~~~~vkl~DfGla~~ 837 (995)
||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.+||+|||+++.
T Consensus 104 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999999964 356899999999999999999999887 9999999999999 5678999999999987
Q ss_pred cccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
+.... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......+......
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~----- 245 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE----YDILKKVEKGKYT----- 245 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCC-----
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHcCCCC-----
Confidence 64332 2345679999999998866 689999999999999999999999965322 1222222211100
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
... ......+..+.+++.+||+.||++|||++|++++
T Consensus 246 --~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 --FEL-PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --CCS-GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCC-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 000 0112345678899999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=341.11 Aligned_cols=253 Identities=24% Similarity=0.282 Sum_probs=203.8
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.+.++|+..+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 45678999999999999999999874 68999999985432 22345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---CCCCCeEEeeecccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL---NSAFEAHVADFGLAKFL 838 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill---~~~~~vkl~DfGla~~~ 838 (995)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||+++..
T Consensus 85 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 85 MQLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp ECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEcCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999999863 346889999999999999999999887 9999999999999 78899999999998754
Q ss_pred ccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 839 IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.. .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+......
T Consensus 160 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~------ 225 (304)
T 2jam_A 160 QN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE----SKLFEKIKEGYYE------ 225 (304)
T ss_dssp CC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHCCCC------
T ss_pred CC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHcCCCC------
Confidence 22 122345689999999999999999999999999999999999999965321 1122222111100
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.........+..+.+++.+|++.||++||+++|+++.
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 226 --FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp --CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred --CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011122345678999999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=362.45 Aligned_cols=254 Identities=28% Similarity=0.362 Sum_probs=200.6
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
.+.++|+..+.||+|+||+||+|+.. +++.||+|++.... .......+.+|+.++++++||||+++++++.+....|+
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45678999999999999999999874 68899999985432 23345678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CCeEEeeeccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA---FEAHVADFGLAKF 837 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~---~~vkl~DfGla~~ 837 (995)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.. +.+||+|||+++.
T Consensus 114 v~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 114 VMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999998863 346899999999999999999999887 9999999999999764 4599999999987
Q ss_pred cccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
+... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||..... ......+...... .
T Consensus 189 ~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~----~ 256 (494)
T 3lij_A 189 FENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD----QEILRKVEKGKYT----F 256 (494)
T ss_dssp CBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCC----C
T ss_pred CCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCC----C
Confidence 6432 2234567999999999876 4689999999999999999999999965322 2222222211100 0
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+.. ...+..+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 DSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred Cchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 01111 1234568899999999999999999999853
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.22 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=196.0
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
++|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 56888999999999999999875 78999999984321 1223457889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 91 EYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999964 345889999999999999999999888 9999999999999999999999999998764322
Q ss_pred CCccccccccCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
......|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||.... .......+...
T Consensus 166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~------------ 226 (276)
T 2h6d_A 166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH----VPTLFKKIRGG------------ 226 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC------------
T ss_pred ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHhhcC------------
Confidence 2234578999999999988765 689999999999999999999996422 12222222111
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
....+...+..+.+++.+||+.||++||+++|+++.
T Consensus 227 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 227 VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111223345678899999999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=348.88 Aligned_cols=261 Identities=19% Similarity=0.281 Sum_probs=206.7
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCCh----------------hHHHHHHHHHHhccCCCCceeE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSH----------------DHGFRAEIQTLGNIRHRNIVRL 748 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~E~~~l~~l~hpniv~~ 748 (995)
.++|+..+.||+|+||.||+|+. +++.||+|++........ .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35789999999999999999988 899999999843211111 1779999999999999999999
Q ss_pred eEEEecCCcceEEEEeccCCChhhh------hcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEE
Q 001922 749 LAFCSNKETNLLVYEYMRNGSLGEA------LHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILL 821 (995)
Q Consensus 749 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill 821 (995)
++++.+.+..++||||+++|+|.++ +.......+++..++.++.|++.||.|||+ .+ |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999999 654446789999999999999999999998 77 9999999999999
Q ss_pred CCCCCeEEeeeccccccccCCCCccccccccCcccccccccccC-CCCc-ccchhhHHHHHHHHHhCCCCCCCCCCCchH
Q 001922 822 NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL-RVDE-KSDVYSFGVVLLELLTGRRPVGDFGDGVDI 899 (995)
Q Consensus 822 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltg~~Pf~~~~~~~~~ 899 (995)
+.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||+|+++|||++|+.||.........
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99999999999999875332 33456799999999999877 6666 999999999999999999999764443222
Q ss_pred HHHHHHHhcCChhhh-------hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 900 VQWSKRATNGRKEEF-------LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 900 ~~~~~~~~~~~~~~~-------~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.. .+........ ...............+..+.+++.+||+.||++||+++|+++
T Consensus 262 ~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FN---NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HH---HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HH---HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22 2221110000 000000000011345667899999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=342.50 Aligned_cols=272 Identities=20% Similarity=0.254 Sum_probs=207.8
Q ss_pred HhhccCCCeeeccCceEEEEEEe--CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhcc---CCCCceeEeEEEe-----
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM--PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNI---RHRNIVRLLAFCS----- 753 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~----- 753 (995)
.++|+..+.||+|+||.||+|+. .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 46789999999999999999987 467889999884322 222234567788877776 8999999999986
Q ss_pred cCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeec
Q 001922 754 NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFG 833 (995)
Q Consensus 754 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfG 833 (995)
.....++||||++ |+|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCc
Confidence 5567899999997 69999998665566899999999999999999999887 9999999999999999999999999
Q ss_pred cccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
+++.... ........||+.|+|||++.+..++.++||||+|+++|+|++|+.||.......................
T Consensus 166 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 166 LARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 9986532 1223456789999999999999999999999999999999999999975433222222222221111111
Q ss_pred hhhhc-----------CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCCC
Q 001922 914 FLSIL-----------DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFPR 963 (995)
Q Consensus 914 ~~~~~-----------d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 963 (995)
+.... ...........+..+.+++.+||+.||++||+++|+++. ++++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 11000 000111223455678899999999999999999999953 554443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=354.10 Aligned_cols=273 Identities=20% Similarity=0.231 Sum_probs=199.7
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecC-----Cc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK-----ET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 757 (995)
.++|+..+.||+|+||.||+|+. .+++.||||++.... ......++.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46799999999999999999976 458889999995432 223456788999999999999999999999765 56
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.|+||||++ |+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999996 599999963 456899999999999999999999887 99999999999999999999999999987
Q ss_pred cccCCCC--------------------ccccccccCccccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCCC---
Q 001922 838 LIDGGAS--------------------ECMSAIAGSYGYIAPEYA-YTLRVDEKSDVYSFGVVLLELLTGRRPVGDF--- 893 (995)
Q Consensus 838 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~Pf~~~--- 893 (995)
....... ......+||+.|+|||++ ....++.++||||+||++|||++|..||...
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 6433211 123567899999999985 5667999999999999999999865555321
Q ss_pred -------CCC-----------------chHHHHHHHHhcC-Chhhh--------hhh---cCCcCCC----CCHHHHHHH
Q 001922 894 -------GDG-----------------VDIVQWSKRATNG-RKEEF--------LSI---LDPRLSM----VPKEEAMHL 933 (995)
Q Consensus 894 -------~~~-----------------~~~~~~~~~~~~~-~~~~~--------~~~---~d~~~~~----~~~~~~~~l 933 (995)
.+. .+........... ....+ ... ....... ..+..+..+
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 000 0011111111111 00000 000 0000000 002245678
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHH--HccCCC
Q 001922 934 LFVAMLCIQENSIERPRMREVVQM--LSEFPR 963 (995)
Q Consensus 934 ~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 963 (995)
.+++.+||+.||++|||++|++++ ++++..
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 899999999999999999999974 555544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=350.83 Aligned_cols=261 Identities=23% Similarity=0.281 Sum_probs=200.3
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec--------
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN-------- 754 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------- 754 (995)
..++|+..+.||+|+||+||+|+. .+|+.||||++...... ..+|+++++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 346789999999999999999976 57899999998543222 3469999999999999999999843
Q ss_pred ------------------------------CCcceEEEEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 001922 755 ------------------------------KETNLLVYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLH 802 (995)
Q Consensus 755 ------------------------------~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH 802 (995)
..+.++||||+++ +|.+.+.. ..+..+++..++.++.||+.||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3347899999984 88777753 34567999999999999999999999
Q ss_pred hcCCCCeEecCCCCCCEEEC-CCCCeEEeeeccccccccCCCCccccccccCcccccccccccC-CCCcccchhhHHHHH
Q 001922 803 HDCSPLIVHRDVKSNNILLN-SAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVL 880 (995)
Q Consensus 803 ~~~~~~iiHrDlkp~Nill~-~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil 880 (995)
+.+ |+||||||+||+++ .++.+||+|||+++.+.... ......+|+.|+|||++.+. .++.++||||+||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 777 99999999999997 68899999999998764332 22345789999999998765 489999999999999
Q ss_pred HHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC--------C------CCCHHHHHHHHHHHhcccCCCCC
Q 001922 881 LELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL--------S------MVPKEEAMHLLFVAMLCIQENSI 946 (995)
Q Consensus 881 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~--------~------~~~~~~~~~l~~li~~cl~~dP~ 946 (995)
|||++|+.||.....................+.+.. .++.. . ..+...+..+.+++.+||+.||+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIR-MNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH-HCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH-hCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999976544333444433333222221111 11111 0 02233556789999999999999
Q ss_pred CCCCHHHHHHH
Q 001922 947 ERPRMREVVQM 957 (995)
Q Consensus 947 ~RPt~~evl~~ 957 (995)
+|||+.|++++
T Consensus 312 ~R~t~~e~l~h 322 (383)
T 3eb0_A 312 LRINPYEAMAH 322 (383)
T ss_dssp GSCCHHHHHTS
T ss_pred hCCCHHHHhcC
Confidence 99999999853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.42 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=203.0
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
++|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999775 57889999984321 1223467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++|+|.+++.. ...+++..++.++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 99999999999964 346899999999999999999999777 999999999999999999999999998765321
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
......|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+... +.
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~---------~~-- 229 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH----TETHRRIVNV---------DL-- 229 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTT---------CC--
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH----hHHHHHHhcc---------cc--
Confidence 22345789999999999999999999999999999999999999964321 1111111111 11
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..+...+..+.+++.+|++.||++||+++|+++
T Consensus 230 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 -KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 122334567889999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=340.75 Aligned_cols=261 Identities=22% Similarity=0.326 Sum_probs=205.5
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEe--cCCcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCS--NKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~l 760 (995)
.++|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457888999999999999999774 68999999985433 2234566889999999999999999999874 4667899
Q ss_pred EEEeccCCChhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 761 VYEYMRNGSLGEALHGK--KGAFLGWNLRYKIAIEAAKGLCYLHHDC--SPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999642 2345899999999999999999999764 2349999999999999999999999999998
Q ss_pred ccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
...... .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.... .......+...
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~i~~~------- 231 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----QKELAGKIREG------- 231 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHT-------
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC----HHHHHHHHhhc-------
Confidence 754321 12234578999999999999899999999999999999999999996532 11222222211
Q ss_pred hcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 917 ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 917 ~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
.....+...+..+.+++.+||+.||++||+++|+++.+....
T Consensus 232 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 232 ----KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ----ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 111233345677999999999999999999999998765543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=345.80 Aligned_cols=268 Identities=19% Similarity=0.245 Sum_probs=202.9
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEec--------
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN-------- 754 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------- 754 (995)
..+|+..+.||+|+||+||+|+. .+|+.||+|++..... ......+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999987 5789999999854332 3335568899999999999999999999876
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 755 KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 755 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
.+..++||||+++ ++.+.+.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 3467999999975 77777763 3356899999999999999999999887 99999999999999999999999999
Q ss_pred ccccccCC--CCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 835 AKFLIDGG--ASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 835 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
++.+.... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....................
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98764322 1222345678999999998876 45899999999999999999999999754332222222222111111
Q ss_pred hhhhhhcC-----------CcCCCCCH-----HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 EEFLSILD-----------PRLSMVPK-----EEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 ~~~~~~~d-----------~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...-. ........ ..+..+.+++.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11100000 00000000 013558899999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=335.13 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=198.5
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.|.....||+|+||.||+|+. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 345556899999999999986 56889999998543 3334567899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCCeEEeeeccccccccCCC
Q 001922 766 RNGSLGEALHGKK-GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS-AFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 766 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~-~~~vkl~DfGla~~~~~~~~ 843 (995)
++++|.+++.... ....++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 9999999997542 335678889999999999999999887 999999999999987 8999999999998764321
Q ss_pred CccccccccCcccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLR--VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
.......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||......... ....... ..
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~-----------~~ 243 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--MFKVGMF-----------KV 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--HHHHHHH-----------CC
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--HHhhccc-----------cc
Confidence 2223457899999999987654 789999999999999999999999653322111 1110000 01
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
....+...+..+.+++.+||+.||++||+++|+++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11233445667899999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=337.16 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=205.4
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
..+|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457888999999999999999875 57889999985432 223456688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++++|.+++.. ...+++..++.++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999999998863 346899999999999999999999887 999999999999999999999999999876432
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
. .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... .+....+... .
T Consensus 169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~-----------~ 231 (294)
T 2rku_A 169 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----KETYLRIKKN-----------E 231 (294)
T ss_dssp T--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTT-----------C
T ss_pred c--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhhc-----------c
Confidence 2 222446789999999999998899999999999999999999999965321 1111111111 1
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+...+..+.+++.+||+.||++||+++|+++.
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 -YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11223345678899999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=355.68 Aligned_cols=262 Identities=19% Similarity=0.245 Sum_probs=207.4
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCC-CCceeEeEEEecCCcceEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH-RNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~ 762 (995)
.++|++.+.||+|+||.||+|++ .+++.||||++..... ...+..|+++++.++| +++..+..++...+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 46789999999999999999986 5689999998743322 2347889999999986 55666666777788899999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---CCCCCeEEeeeccccccc
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL---NSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill---~~~~~vkl~DfGla~~~~ 839 (995)
||+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 83 e~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 999 89999999732 456899999999999999999999887 9999999999999 588999999999998765
Q ss_pred cCCCCc-----cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 840 DGGASE-----CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 840 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 443221 123567999999999999999999999999999999999999999876544333222221111000000
Q ss_pred hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 915 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
.. ....++..+.+++.+||+.+|++||++++|++.|+++.
T Consensus 238 ~~--------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 238 EA--------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HH--------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HH--------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 00 01123467899999999999999999999999998864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=346.89 Aligned_cols=265 Identities=23% Similarity=0.330 Sum_probs=201.5
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.++|+..+.||+|+||.||+|+.. +++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467899999999999999999875 5899999998543322 22455788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++++|.++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 104 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999999988753 346899999999999999999999887 9999999999999999999999999998654322
Q ss_pred CCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh---------
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE--------- 912 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--------- 912 (995)
.......||+.|+|||++.+. .++.++||||+||++|+|++|+.||....+.................
T Consensus 179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 222445789999999998875 68999999999999999999999997644333332222221111000
Q ss_pred hhhhhcCCcCC-CC-----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 913 EFLSILDPRLS-MV-----PKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 913 ~~~~~~d~~~~-~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.+.....+... .. .+..+..+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000001110 01 1134667999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=375.36 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=199.4
Q ss_pred CeeeccCceEEEEEEe---CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKM---PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
+.||+|+||+||+|.+ ..++.||||++..... ....+.+.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 5799999999999954 3467899999854322 2335779999999999999999999999964 568899999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC-Ccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA-SEC 846 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~-~~~ 846 (995)
|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+..... ...
T Consensus 454 g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 999999963 456899999999999999999999887 99999999999999999999999999987644322 222
Q ss_pred ccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... .+....+... .....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~~i~~~-----------~~~~~ 593 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKG-----------ERMGC 593 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTT-----------CCCCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcC-----------CCCCC
Confidence 234457889999999999999999999999999999998 9999965322 1122222211 11223
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
+..++..+.++|.+||+.||++||++++|++.|+++.
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 4456678999999999999999999999999998753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=337.55 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=188.2
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhH-HHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDH-GFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.++|+..+.||+|+||+||+|+. .+++.||+|++.......... .+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 35788899999999999999986 578999999985443332223 3445555688889999999999999999999999
Q ss_pred EeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 763 EYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHD-CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 763 e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
||+++ +|.+++.. ..+..+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99975 88887753 2456799999999999999999999987 7 9999999999999999999999999998764
Q ss_pred cCCCCccccccccCccccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 840 DGGASECMSAIAGSYGYIAPEYA----YTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
... ......||+.|+|||++ .+..++.++||||+|+++|+|++|+.||....... ..........
T Consensus 162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~------ 230 (290)
T 3fme_A 162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQLKQVVEEP------ 230 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--HHHHHHHHSC------
T ss_pred ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--HHHHHHhccC------
Confidence 322 22345799999999996 56678999999999999999999999996533221 1111111111
Q ss_pred hhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 916 SILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 916 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.....+...+..+.+++.+||+.||++|||++|+++
T Consensus 231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 -----SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111112234567899999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=344.54 Aligned_cols=264 Identities=27% Similarity=0.375 Sum_probs=187.1
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.++|+..+.||+|+||.||+|.. .+++.||||++.........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 35688889999999999999976 46889999988544334445678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 764 YMRNGSLGEALHG------KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 764 ~~~~gsL~~~l~~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
|+++++|.+++.. .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999863 23456899999999999999999999887 99999999999999999999999999987
Q ss_pred cccCCC---CccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 838 LIDGGA---SECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 838 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
...... ........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.......... ..........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~ 247 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---LTLQNDPPSL 247 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HHHTSSCCCT
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH---HHhccCCCcc
Confidence 643221 111234578999999999876 568999999999999999999999997643322211 1111110000
Q ss_pred hhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 914 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....++ ......+..+.+++.+||+.||++||+++|+++.
T Consensus 248 ~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDK---EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccc---hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000011 1112334578899999999999999999999873
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=350.26 Aligned_cols=269 Identities=20% Similarity=0.222 Sum_probs=199.3
Q ss_pred HHHHHhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCCh----------hHHHHHHHHHHhccCCCCceeEeE
Q 001922 681 VSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSH----------DHGFRAEIQTLGNIRHRNIVRLLA 750 (995)
Q Consensus 681 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~~~ 750 (995)
...+.++|+..+.||+|+||.||+|...+|+.||||++........ .+.+.+|++++++++||||+++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 4455678999999999999999999988899999999854322211 267899999999999999999999
Q ss_pred EEec-----CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 001922 751 FCSN-----KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF 825 (995)
Q Consensus 751 ~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~ 825 (995)
++.. ....|+||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 171 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNN 171 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTC
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCC
Confidence 9843 346799999997 588888873 3457899999999999999999999887 99999999999999999
Q ss_pred CeEEeeeccccccccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHH
Q 001922 826 EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSK 904 (995)
Q Consensus 826 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~ 904 (995)
.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..............
T Consensus 172 ~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 172 DITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp CEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999754322 22244578999999999876 6789999999999999999999999975433222222222
Q ss_pred HHhcCChhh--------hhhhcCCcCC--------CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 905 RATNGRKEE--------FLSILDPRLS--------MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 905 ~~~~~~~~~--------~~~~~d~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
......... ..+....... ......+..+.+++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 222111111 1111111111 0112235668899999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=346.90 Aligned_cols=266 Identities=22% Similarity=0.272 Sum_probs=206.4
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecC-----Ccc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK-----ETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 758 (995)
..+|+..+.||+|+||.||+|+.. +++.||||++...........+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457899999999999999999764 68889999996544444456788999999999999999999999654 367
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
|+||||++ |+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 499999864 35899999999999999999999887 999999999999999999999999999876
Q ss_pred ccCCC-CccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 839 IDGGA-SECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 839 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
..... ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.......................+..
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 43221 112245589999999998654 4589999999999999999999999976544444444333222222111111
Q ss_pred hcC----------CcCCCC-----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 917 ILD----------PRLSMV-----PKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 917 ~~d----------~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+ +..... ....+..+.+++.+||+.||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 100 000001 12235678899999999999999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=345.28 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=205.3
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
..+|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457888999999999999999875 57889999985432 223456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 999999999999863 346899999999999999999999887 999999999999999999999999999876432
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+....
T Consensus 195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~----------- 257 (335)
T 2owb_A 195 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----KETYLRIKKNE----------- 257 (335)
T ss_dssp T--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTC-----------
T ss_pred c--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH----HHHHHHHhcCC-----------
Confidence 2 222456799999999999998999999999999999999999999964321 11111111110
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+...+..+.+++.+||+.||++||+++|+++.
T Consensus 258 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 -YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01222345678899999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=361.41 Aligned_cols=259 Identities=27% Similarity=0.340 Sum_probs=203.9
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC------------ChhHHHHHHHHHHhccCCCCceeEe
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH------------SHDHGFRAEIQTLGNIRHRNIVRLL 749 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~~ 749 (995)
.+.++|+..+.||+|+||+||+|+.. +++.||+|++...... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999864 5789999998543211 2356788999999999999999999
Q ss_pred EEEecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC---C
Q 001922 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF---E 826 (995)
Q Consensus 750 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~---~ 826 (995)
+++.++...|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999999864 346899999999999999999999887 99999999999998876 6
Q ss_pred eEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH
Q 001922 827 AHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRA 906 (995)
Q Consensus 827 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 906 (995)
+||+|||+++.+... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||..... ......+
T Consensus 188 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i 259 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND----QDIIKKV 259 (504)
T ss_dssp EEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred EEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 999999999876432 2234567999999999886 4689999999999999999999999965322 2222222
Q ss_pred hcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCC
Q 001922 907 TNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFP 962 (995)
Q Consensus 907 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 962 (995)
......... +. ....+..+.+++.+||+.||++|||++|+++. +++..
T Consensus 260 ~~~~~~~~~----~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 260 EKGKYYFDF----ND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHCCCCCCH----HH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HcCCCCCCc----cc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 221100000 00 01234678999999999999999999999864 44443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=350.45 Aligned_cols=267 Identities=24% Similarity=0.306 Sum_probs=201.0
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC------cce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE------TNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~~ 759 (995)
.+|+..+.||+|+||+||+|+...+..||+|++...... ..+|+++++.++||||+++++++.... ..+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 468899999999999999999888788999998543222 236999999999999999999985433 378
Q ss_pred EEEEeccCCChhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC-CCCCeEEeeeccccc
Q 001922 760 LVYEYMRNGSLGEALH-GKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN-SAFEAHVADFGLAKF 837 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~-~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~-~~~~vkl~DfGla~~ 837 (995)
+||||++++.+..... ......+++..++.++.||+.||+|||+++ |+||||||+||+++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999998744333322 123457899999999999999999999887 99999999999999 799999999999987
Q ss_pred cccCCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.............+.........+..
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 643322 2345789999999998765 589999999999999999999999976543333433333322222111111
Q ss_pred h----cCCcC---CC------CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCCC
Q 001922 917 I----LDPRL---SM------VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFPR 963 (995)
Q Consensus 917 ~----~d~~~---~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 963 (995)
. ..... .. .+...+..+.+++.+||+.||++|||+.|++++ ++++..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 1 00001 00 112245678999999999999999999999975 555443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=335.50 Aligned_cols=251 Identities=29% Similarity=0.417 Sum_probs=198.0
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEec----CCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN----KETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~ 759 (995)
..|+..+.||+|+||+||+|.. .++..||+|++.... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3477788999999999999976 467889999985432 23345678899999999999999999998865 35689
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC-CCCCeEEeeecccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN-SAFEAHVADFGLAKFL 838 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~-~~~~vkl~DfGla~~~ 838 (995)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ .+|+||||||+||+++ .++.+||+|||++...
T Consensus 106 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 99999999999999964 356889999999999999999999542 2399999999999998 7899999999999754
Q ss_pred ccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 839 IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
... ......||+.|+|||++. +.++.++||||+|+++|+|++|+.||....+... ............
T Consensus 183 ~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~----- 249 (290)
T 1t4h_A 183 RAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---IYRRVTSGVKPA----- 249 (290)
T ss_dssp CTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHHHHTTTCCCG-----
T ss_pred ccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH---HHHHHhccCCcc-----
Confidence 322 223457999999999876 4589999999999999999999999965433222 222222211100
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+||+.||++||+++|+++.
T Consensus 250 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0112233568899999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=350.76 Aligned_cols=262 Identities=21% Similarity=0.221 Sum_probs=204.5
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc------CCCCceeEeEEEecCC
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI------RHRNIVRLLAFCSNKE 756 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~~ 756 (995)
+..+|+..+.||+|+||+||+|... +++.||||++... ......+.+|+++++.+ .|+||+++++++....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 3457899999999999999999764 5889999998532 22345677888888877 4779999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC--eEEeeecc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE--AHVADFGL 834 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~--vkl~DfGl 834 (995)
..++||||+. ++|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999996 69999998666667999999999999999999999888 999999999999999987 99999999
Q ss_pred ccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........+..+........ ..+
T Consensus 249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~-~~~ 322 (429)
T 3kvw_A 249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS-QKL 322 (429)
T ss_dssp CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC-HHH
T ss_pred ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-HHH
Confidence 976432 22345789999999999999999999999999999999999999976443333333332221111 111
Q ss_pred hh-------hcCCc--------------------------------CCC-----CCHHHHHHHHHHHhcccCCCCCCCCC
Q 001922 915 LS-------ILDPR--------------------------------LSM-----VPKEEAMHLLFVAMLCIQENSIERPR 950 (995)
Q Consensus 915 ~~-------~~d~~--------------------------------~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt 950 (995)
.+ .++.. ... .+...+..+.+++.+||+.||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 00 00000 000 00112466889999999999999999
Q ss_pred HHHHHHH
Q 001922 951 MREVVQM 957 (995)
Q Consensus 951 ~~evl~~ 957 (995)
++|++++
T Consensus 403 a~e~L~H 409 (429)
T 3kvw_A 403 PGQALRH 409 (429)
T ss_dssp HHHHHTS
T ss_pred HHHHhCC
Confidence 9999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=339.72 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=200.6
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
...+.|+..+.||+|+||.||+|... +|+.||+|++... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34567899999999999999999775 5899999998542 2356789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 103 MEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred eecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999999863 3456899999999999999999999887 999999999999999999999999999876432
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
. .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||...... .......... .+.
T Consensus 179 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~--------~~~ 244 (314)
T 3com_A 179 M--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM----RAIFMIPTNP--------PPT 244 (314)
T ss_dssp B--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSC--------CCC
T ss_pred c--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhcCC--------Ccc
Confidence 2 1224457899999999999999999999999999999999999999653221 1111111110 000
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
...+...+..+.+++.+||+.||++||+++++++
T Consensus 245 -~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 -FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1123334567899999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=352.54 Aligned_cols=258 Identities=26% Similarity=0.302 Sum_probs=197.5
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecC------Ccce
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK------ETNL 759 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~ 759 (995)
.|+..+.||+|+||+||+|++. +|+.||||++..... ...+|++++++++|||||++++++... .+.+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 5888899999999999999874 589999999854322 234699999999999999999988432 2367
Q ss_pred EEEEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CCeEEeeecccc
Q 001922 760 LVYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA-FEAHVADFGLAK 836 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~-~~vkl~DfGla~ 836 (995)
+||||+++ ++.+.+.. .....+++..++.++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999976 66666542 23467899999999999999999999777 9999999999999965 568999999998
Q ss_pred ccccCCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
.+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||........+.+..+.......+.+.
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 7643322 2345789999999998765 78999999999999999999999997654333444444433322222222
Q ss_pred hhcCCcC--------CC------CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 916 SILDPRL--------SM------VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 916 ~~~d~~~--------~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.. ++.+ .. .+...+..+.+++.+||+.||++||++.|++++
T Consensus 283 ~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 283 EM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 11 1111 11 112345678999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=346.16 Aligned_cols=261 Identities=23% Similarity=0.249 Sum_probs=192.6
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCC------
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE------ 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 756 (995)
.++|+..+.||+|+||.||+|.. .+++.||||++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46789999999999999999976 468899999985432 2233456889999999999999999999997654
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
..|+||||+++ +|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 67999999975 78888852 4889999999999999999999887 9999999999999999999999999998
Q ss_pred ccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||................... ...+..
T Consensus 176 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~ 251 (371)
T 2xrw_A 176 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP-CPEFMK 251 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC-CHHHHT
T ss_pred ccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-CHHHHH
Confidence 65322 22345679999999999999999999999999999999999999996532211111111100000 000000
Q ss_pred -----------------------hcC----CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 917 -----------------------ILD----PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 917 -----------------------~~d----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
... +.........+..+.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000 00000112346789999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=339.33 Aligned_cols=261 Identities=21% Similarity=0.275 Sum_probs=205.8
Q ss_pred HhhccCCCeeeccCceEEEEEEe--CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCC------ceeEeEEEecCC
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM--PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN------IVRLLAFCSNKE 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~~~~~~~~~~ 756 (995)
.++|+..+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+++++.++|++ ++++++++.+.+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 45789999999999999999976 36889999998532 233566889999999997664 999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-------------
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS------------- 823 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~------------- 823 (995)
..++||||+ +++|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 889999998665567899999999999999999999887 999999999999987
Q ss_pred ------CCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 001922 824 ------AFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV 897 (995)
Q Consensus 824 ------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~ 897 (995)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 668999999999864321 234578999999999999999999999999999999999999997543322
Q ss_pred hHHHHHHHHhcCChhhhhhh---------------------------cCC--cCCCCCHHHHHHHHHHHhcccCCCCCCC
Q 001922 898 DIVQWSKRATNGRKEEFLSI---------------------------LDP--RLSMVPKEEAMHLLFVAMLCIQENSIER 948 (995)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~---------------------------~d~--~~~~~~~~~~~~l~~li~~cl~~dP~~R 948 (995)
.... ...........+... ..+ .........+..+.+++.+||+.||++|
T Consensus 242 ~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 242 HLAM-MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHH-HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHH-HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 2222 222211111111000 000 0012234567889999999999999999
Q ss_pred CCHHHHHHH
Q 001922 949 PRMREVVQM 957 (995)
Q Consensus 949 Pt~~evl~~ 957 (995)
||++|+++.
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999854
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=337.87 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=198.7
Q ss_pred HhhccCCCeeeccCceEEEEEEeC--CCc--EEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP--NGV--EIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~--~~~--~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
.++|+..+.||+|+||+||+|++. +++ .||+|++.... .....+.+.+|++++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888999999999999999753 333 68999885432 2334567889999999999999999999998654 8
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 9999999999999999743 356889999999999999999999887 999999999999999999999999999876
Q ss_pred ccCCCCc-cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 839 IDGGASE-CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 839 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
....... ......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||..... .+....+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~~~------ 241 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----SQILHKIDKEG------ 241 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTSC------
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH----HHHHHHHHccC------
Confidence 4432211 2234567889999999998889999999999999999999 9999965322 22222222110
Q ss_pred hcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 917 ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 917 ~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
.....+...+..+.+++.+||+.||++||+++++++.|+++....
T Consensus 242 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 242 ----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ----CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 001122345667999999999999999999999999999876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=347.21 Aligned_cols=262 Identities=19% Similarity=0.166 Sum_probs=203.9
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC--------CCCceeEeEEEe--
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR--------HRNIVRLLAFCS-- 753 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~~~~~~~-- 753 (995)
.++|+..+.||+|+||+||+|+. .+++.||||++.. .....+.+.+|+.++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS--AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec--CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 36789999999999999999976 4688999999853 2233567889999999996 788999999987
Q ss_pred --cCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEECCCC-----
Q 001922 754 --NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD-CSPLIVHRDVKSNNILLNSAF----- 825 (995)
Q Consensus 754 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~iiHrDlkp~Nill~~~~----- 825 (995)
+....++||||+ ++++.+.+.......+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 566889999999 56777777655556799999999999999999999987 7 99999999999999775
Q ss_pred --------------------------------------------CeEEeeeccccccccCCCCccccccccCcccccccc
Q 001922 826 --------------------------------------------EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY 861 (995)
Q Consensus 826 --------------------------------------------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 861 (995)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999875332 234578999999999
Q ss_pred cccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc---h--HHHHHHHHhcCChhhhh-------hhcCC---------
Q 001922 862 AYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV---D--IVQWSKRATNGRKEEFL-------SILDP--------- 920 (995)
Q Consensus 862 ~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~---~--~~~~~~~~~~~~~~~~~-------~~~d~--------- 920 (995)
+.+..++.++|||||||++|||++|+.||....... . ................. .....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999997644321 1 11111111111100000 00000
Q ss_pred -----------cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 -----------RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.....+...+..+.+++.+||+.||++|||++|++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0012356778899999999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=348.80 Aligned_cols=261 Identities=23% Similarity=0.274 Sum_probs=185.6
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecC------C
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK------E 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~ 756 (995)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ......++.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999975 568999999985432 223456788999999999999999999998654 5
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 6799998853 46899999999999999999999887 9999999999999999999999999998
Q ss_pred ccccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........+............+.+.
T Consensus 181 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 181 HTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 6532 2244679999999999876 678999999999999999999999996543322222222222211111111
Q ss_pred hhcC----------CcCCCCC-----HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 916 SILD----------PRLSMVP-----KEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 916 ~~~d----------~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+.. +.....+ ...+..+.+++.+||+.||++|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 0001111 1234668899999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=372.22 Aligned_cols=257 Identities=26% Similarity=0.341 Sum_probs=205.8
Q ss_pred HhhccCCCeeeccCceEEEEEEeC----CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
.++|+..+.||+|+||+||+|++. .+..||+|++.........+.+.+|+.++++++||||+++++++. .+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 357888999999999999999764 246799999865444444577899999999999999999999985 467899
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++|+|.+++... +..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 468 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 99999999999999743 446899999999999999999999887 99999999999999999999999999987644
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .+....+...
T Consensus 544 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----~~~~~~i~~~---------- 608 (656)
T 2j0j_A 544 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENG---------- 608 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHHT----------
T ss_pred Ccc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHcC----------
Confidence 322 12234567889999999998899999999999999999997 9999965322 1122222111
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
.....+..++..+.+++.+||+.||++||+++|+++.|+++.
T Consensus 609 -~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 609 -ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111233445678999999999999999999999999998764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=341.71 Aligned_cols=262 Identities=24% Similarity=0.373 Sum_probs=200.0
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.++|+..+.||+|+||.||+|+... .||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 3568899999999999999998743 59999985432 22334557889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC-
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG- 842 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~- 842 (995)
|+++++|.+++.. .+..+++..++.++.|++.||+|||+++ |+||||||+||+++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 110 LCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred cccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 9999999999964 3456889999999999999999999887 99999999999998 6899999999987543211
Q ss_pred --CCccccccccCccccccccccc---------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 843 --ASECMSAIAGSYGYIAPEYAYT---------LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 843 --~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
.........|++.|+|||++.+ ..++.++||||||+++|||++|+.||..... ...........
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~- 259 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMGTGM- 259 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH----HHHHHHHHTTC-
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhccCC-
Confidence 1122234568999999999864 3578899999999999999999999965322 11222222111
Q ss_pred hhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCcc
Q 001922 912 EEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSD 967 (995)
Q Consensus 912 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 967 (995)
.+.. .....+..+.+++.+||+.||++||++++++++|+++.+....
T Consensus 260 -------~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 260 -------KPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp -------CCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred -------CCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1111 1112345688999999999999999999999999999876544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=356.23 Aligned_cols=242 Identities=13% Similarity=0.113 Sum_probs=188.9
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC--CCCChhHHHHHHHH---HHhccCCCCceeEe-------EE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF--GTHSHDHGFRAEIQ---TLGNIRHRNIVRLL-------AF 751 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~---~l~~l~hpniv~~~-------~~ 751 (995)
.++|+..+.||+|+||+||+|+. .+|+.||||++... ......+.+.+|+. ++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45788889999999999999986 56999999998532 23334577899994 55555799999998 77
Q ss_pred EecCCc-----------------ceEEEEeccCCChhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 001922 752 CSNKET-----------------NLLVYEYMRNGSLGEALHGKK-----GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLI 809 (995)
Q Consensus 752 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i 809 (995)
+.+++. .|+||||+ +|+|.+++.... ...+++..++.++.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 679999997421 122335888899999999999999887 9
Q ss_pred EecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccC-----------CCCcccchhhHHH
Q 001922 810 VHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL-----------RVDEKSDVYSFGV 878 (995)
Q Consensus 810 iHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGv 878 (995)
+||||||+||+++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999998632 12345567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 879 VLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 879 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
++|||++|+.||......... ..+.. ... ..+..+.+++.+||+.||++||++.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~~---------------~~~~~-~~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS---------------EWIFR-SCK----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS---------------GGGGS-SCC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch---------------hhhhh-hcc----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999653221110 00111 111 23456889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=340.19 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=199.4
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
..++|+..+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3567899999999999999999875 5889999998543 3344677899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 96 EFCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp ECCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred EeCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999998864 2355899999999999999999999887 999999999999999999999999997643211
Q ss_pred CCccccccccCccccccccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 843 ASECMSAIAGSYGYIAPEYA-----YTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
........||+.|+|||++ .+..++.++||||+|+++|+|++|+.||....... .........
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~------- 238 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----VLLKIAKSD------- 238 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSC-------
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HHHHHhccC-------
Confidence 1112345689999999987 36678999999999999999999999996533211 111111110
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
+.....+...+..+.+++.+||+.||++||+++|+++
T Consensus 239 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 239 --PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0011123345667899999999999999999999976
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.26 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=197.4
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEec------C
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSN------K 755 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~------~ 755 (995)
..++|+..+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|+.+++++ +||||+++++++.. .
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC--cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 356789999999999999999987 47899999998543 23456789999999999 79999999999976 4
Q ss_pred CcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccc
Q 001922 756 ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA 835 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla 835 (995)
+..++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 67899999999999999998655567899999999999999999999887 999999999999999999999999999
Q ss_pred cccccCCCCccccccccCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCC
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 910 (995)
....... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||........ ...+....
T Consensus 177 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~ 250 (326)
T 2x7f_A 177 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----LFLIPRNP 250 (326)
T ss_dssp C---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSC
T ss_pred eecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH----HHHhhcCc
Confidence 8653321 1223457899999999987 56788999999999999999999999965332111 11111110
Q ss_pred hhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 911 KEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 911 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.+ ...+...+..+.+++.+||+.||++||+++|+++
T Consensus 251 --------~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 251 --------AP--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --------CC--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --------cc--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 01 1112234567889999999999999999999987
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=352.68 Aligned_cols=330 Identities=21% Similarity=0.162 Sum_probs=207.0
Q ss_pred cccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEcc
Q 001922 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLF 315 (995)
Q Consensus 236 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 315 (995)
++++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..|.++++|+.|+|+
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 112 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS 112 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECT
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECC
Confidence 44555555555554445555555555555555555555445555555555555555555554444445555555555555
Q ss_pred CCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCC
Q 001922 316 MNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPI 395 (995)
Q Consensus 316 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 395 (995)
+|++.+..|..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|.+.+..
T Consensus 113 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~ 192 (477)
T 2id5_A 113 ENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIR 192 (477)
T ss_dssp TSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEEC
T ss_pred CCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeC
Confidence 55555555555555555555555555555555555555555555555555555443344555555555555555555555
Q ss_pred CcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCcccc
Q 001922 396 PERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLS 475 (995)
Q Consensus 396 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 475 (995)
+..+..+++|+.|++++|.+.+.+|.......+|+.+++++|.+++..+. .+..+++|+.|+|++|++++..+..|.
T Consensus 193 ~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~---~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 269 (477)
T 2id5_A 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL---AVRHLVYLRFLNLSYNPISTIEGSMLH 269 (477)
T ss_dssp TTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHH---HHTTCTTCCEEECCSSCCCEECTTSCT
T ss_pred hhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHH---HhcCccccCeeECCCCcCCccChhhcc
Confidence 55555555555555555555555555554445556666666655532111 123457899999999999988888899
Q ss_pred CCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeE
Q 001922 476 NFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYL 555 (995)
Q Consensus 476 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L 555 (995)
++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|.++...+. ..-...+..+
T Consensus 270 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~-~~~~~~~~~~ 348 (477)
T 2id5_A 270 ELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL-LWVFRRRWRL 348 (477)
T ss_dssp TCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG-HHHHTTTTSS
T ss_pred ccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch-HhHHhhhhcc
Confidence 999999999999999998999999999999999999999977777889999999999999999854331 1112223334
Q ss_pred eccccccccccCcc
Q 001922 556 NLSRNHLNQNIPKS 569 (995)
Q Consensus 556 ~L~~N~l~~~~p~~ 569 (995)
.+.++...-.-|..
T Consensus 349 ~~~~~~~~C~~p~~ 362 (477)
T 2id5_A 349 NFNRQQPTCATPEF 362 (477)
T ss_dssp CCTTCCCBEEESGG
T ss_pred ccCccCceeCCchH
Confidence 44555444434443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=369.54 Aligned_cols=249 Identities=23% Similarity=0.248 Sum_probs=205.3
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 760 (995)
.++|+..++||+|+||+||+|+.. +++.||||++.... .....+.+..|..++..+ +||+|+++++++++.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 356888899999999999999764 57889999985321 223356678899999988 79999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 420 V~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 9999999999999964 346899999999999999999999887 99999999999999999999999999986432
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+....+...
T Consensus 495 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~----~~~~~~~~i~~~----------- 557 (674)
T 3pfq_A 495 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----DEDELFQSIMEH----------- 557 (674)
T ss_dssp TT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHSS-----------
T ss_pred CC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC----CHHHHHHHHHhC-----------
Confidence 22 2235678999999999999999999999999999999999999999652 222222222222
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCH-----HHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRM-----REVVQ 956 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 956 (995)
. ...+...+..+.+++.+||+.||++||++ +||++
T Consensus 558 ~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 N-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp C-CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred C-CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1 12334456778999999999999999997 77764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=348.32 Aligned_cols=266 Identities=20% Similarity=0.282 Sum_probs=184.2
Q ss_pred HhhccC-CCeeeccCceEEEEEEeC---CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEe--cCCcc
Q 001922 685 LECVKD-GNVIGRGGAGIVYHGKMP---NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS--NKETN 758 (995)
Q Consensus 685 ~~~~~~-~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~ 758 (995)
.+.|+. +++||+|+||+||+|++. +++.||+|++... .....+.+|+.++++++||||+++++++. .....
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS---SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC---CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 445665 668999999999999865 5788999998532 22456889999999999999999999994 46788
Q ss_pred eEEEEeccCCChhhhhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----CCCCCe
Q 001922 759 LLVYEYMRNGSLGEALHG-------KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL----NSAFEA 827 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~-------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill----~~~~~v 827 (995)
|+||||+.+ +|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+||++ +.++.+
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence 999999965 88887752 12235899999999999999999999887 9999999999999 678899
Q ss_pred EEeeeccccccccCCC-CccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCC---------
Q 001922 828 HVADFGLAKFLIDGGA-SECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDG--------- 896 (995)
Q Consensus 828 kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~--------- 896 (995)
||+|||+++.+..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||......
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 9999999987643211 1223456799999999998874 5899999999999999999999999653321
Q ss_pred chHHHHHHHHhcCChhhhhhh------------c-CCcCCCCCH---------HHHHHHHHHHhcccCCCCCCCCCHHHH
Q 001922 897 VDIVQWSKRATNGRKEEFLSI------------L-DPRLSMVPK---------EEAMHLLFVAMLCIQENSIERPRMREV 954 (995)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~------------~-d~~~~~~~~---------~~~~~l~~li~~cl~~dP~~RPt~~ev 954 (995)
..+..............+..+ + ......... ..+..+.+++.+||+.||++|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 111111111111111100000 0 000000000 014567899999999999999999999
Q ss_pred HHH
Q 001922 955 VQM 957 (995)
Q Consensus 955 l~~ 957 (995)
+++
T Consensus 332 L~h 334 (405)
T 3rgf_A 332 MQD 334 (405)
T ss_dssp HTS
T ss_pred hcC
Confidence 975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=337.21 Aligned_cols=252 Identities=22% Similarity=0.275 Sum_probs=195.4
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccC--CCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIR--HRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv 761 (995)
.++|+..+.||+|+||.||+|+..+++.||||++.... .....+.+.+|++++++++ ||||+++++++.+.+..++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 35688899999999999999998889999999985432 2234567889999999997 59999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|| +.+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||++++ +.+||+|||+++.+...
T Consensus 107 ~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 107 ME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred Ee-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 99 557899999964 346889999999999999999999887 999999999999964 89999999999876543
Q ss_pred CCCccccccccCccccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCC
Q 001922 842 GASECMSAIAGSYGYIAPEYAYT-----------LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 910 (995)
..........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ... ..
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~-~~----- 251 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKL-HA----- 251 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHH-HH-----
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--HHH-HH-----
Confidence 33333345679999999999865 468889999999999999999999996543221 111 11
Q ss_pred hhhhhhhcCCcC-CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 911 KEEFLSILDPRL-SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 911 ~~~~~~~~d~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..++.. ...+...+..+.+++.+||+.||++||+++|+++.
T Consensus 252 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 ------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111 11222235678899999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=342.02 Aligned_cols=267 Identities=22% Similarity=0.237 Sum_probs=194.0
Q ss_pred HHHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCc--
Q 001922 681 VSDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET-- 757 (995)
Q Consensus 681 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-- 757 (995)
.....++|+..+.||+|+||+||+|+. .+++.||||++.... .......+|++.++.++||||+++++++...+.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 345577899999999999999999987 468999999985432 224456778888899999999999999865333
Q ss_pred -----ceEEEEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCCEEECC-CCCe
Q 001922 758 -----NLLVYEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLH--HDCSPLIVHRDVKSNNILLNS-AFEA 827 (995)
Q Consensus 758 -----~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~~iiHrDlkp~Nill~~-~~~v 827 (995)
.++||||+++ ++.+.+.. .....+++..+..++.|++.|+.||| +.+ |+||||||+||+++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999986 55544431 34567889999999999999999999 777 999999999999997 8999
Q ss_pred EEeeeccccccccCCCCccccccccCcccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH
Q 001922 828 HVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR-VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRA 906 (995)
Q Consensus 828 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 906 (995)
||+|||+++.+.... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||.............+..
T Consensus 172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 999999998764332 223457899999999986654 8999999999999999999999997654433344433332
Q ss_pred hcCChhhhhhhcCCcC-----------------CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 907 TNGRKEEFLSILDPRL-----------------SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 907 ~~~~~~~~~~~~d~~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...... ....+++.. ...+...+..+.+++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSRE-VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHH-HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHH-HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 222211 111111111 11122256789999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=342.53 Aligned_cols=271 Identities=20% Similarity=0.272 Sum_probs=203.1
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecC-----Ccc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK-----ETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 758 (995)
.++|+..+.||+|+||.||+|+.. +|+.||||++...........+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467889999999999999999874 68899999996544444456688999999999999999999988654 678
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccc
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
++||||+. |+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.+
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 599999864 35899999999999999999999887 999999999999999999999999999876
Q ss_pred ccCCCCc--------cccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcC
Q 001922 839 IDGGASE--------CMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNG 909 (995)
Q Consensus 839 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 909 (995)
....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 4322111 1223578999999998754 678999999999999999999999997543222222221111111
Q ss_pred Chhh---------hhhhcC--CcCCC-----CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCC
Q 001922 910 RKEE---------FLSILD--PRLSM-----VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFP 962 (995)
Q Consensus 910 ~~~~---------~~~~~d--~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 962 (995)
.... ...... +.... .....+..+.+++.+||+.||++|||++|+++. ++.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0000 000000 00000 112345678899999999999999999999873 44443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.66 Aligned_cols=254 Identities=25% Similarity=0.302 Sum_probs=203.7
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
..+.++|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 446778999999999999999999875 68999999984332 2344677899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CCeEEeeecccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA---FEAHVADFGLAK 836 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~---~~vkl~DfGla~ 836 (995)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||++.
T Consensus 98 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999998853 346899999999999999999999887 9999999999999764 469999999998
Q ss_pred ccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
...... ......|++.|+|||++.+ .++.++||||+|+++|+|++|+.||..... ......+.......
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~--- 241 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----YDILKRVETGKYAF--- 241 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCC---
T ss_pred eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCC---
Confidence 754322 2234468999999998865 489999999999999999999999965321 12222222111000
Q ss_pred hcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 917 ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 917 ~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..+. ....+..+.+++.+||+.||++||+++|+++
T Consensus 242 -~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 -DLPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -CSGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -Cchh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000 1123557889999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=332.62 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=203.4
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC--------ChhHHHHHHHHHHhccC-CCCceeEeEEE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH--------SHDHGFRAEIQTLGNIR-HRNIVRLLAFC 752 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 752 (995)
...++|+..+.||+|+||.||+|+.. +++.||||++...... ...+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999874 6889999998543211 12345788999999995 99999999999
Q ss_pred ecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeee
Q 001922 753 SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADF 832 (995)
Q Consensus 753 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~Df 832 (995)
.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999999964 356899999999999999999999887 999999999999999999999999
Q ss_pred ccccccccCCCCccccccccCcccccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAY------TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRA 906 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 906 (995)
|++....... ......|++.|+|||++. ...++.++||||+|+++|+|++|+.||..... ......+
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~ 241 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----MLMLRMI 241 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH----HHHHHHH
Confidence 9998764332 224457899999999875 45688999999999999999999999965321 1111111
Q ss_pred hcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 907 TNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 907 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
...... . ........+..+.+++.+||+.||++||+++|+++
T Consensus 242 ~~~~~~-------~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 MSGNYQ-------F-GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHTCCC-------C-CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hcCCcc-------c-CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111000 0 00111245667899999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=342.69 Aligned_cols=259 Identities=21% Similarity=0.254 Sum_probs=198.5
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc----
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN---- 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~---- 758 (995)
.++|...+.||+|+||+||+|.. .+|+.||||++...... .....+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 45788899999999999999976 46899999998543222 2346688999999999999999999999877655
Q ss_pred --eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 759 --LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 759 --~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
++||||+. ++|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 58888874 34899999999999999999999887 9999999999999999999999999998
Q ss_pred ccccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
.... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.................... ..+.
T Consensus 193 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~ 266 (371)
T 4exu_A 193 HADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG-TEFV 266 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-HHHH
T ss_pred cccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc-HHHH
Confidence 6532 2234578999999999887 6789999999999999999999999975433222222222221111 1111
Q ss_pred hhc------------CCcCC----CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 916 SIL------------DPRLS----MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 916 ~~~------------d~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+ ..... ......+..+.+++.+||+.||++|||++|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 100 00000 0112345678999999999999999999999875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=342.93 Aligned_cols=334 Identities=20% Similarity=0.179 Sum_probs=238.0
Q ss_pred CcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEc
Q 001922 235 VNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNL 314 (995)
Q Consensus 235 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 314 (995)
.++++|++++|.++...+..+..+++|++|++++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|+.|++
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 45666666666666444444566666666666666666555556666677777777777776666666666677777777
Q ss_pred cCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCC
Q 001922 315 FMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGP 394 (995)
Q Consensus 315 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 394 (995)
++|+++...+..|..+++|++|++++|++++..|..+..+++|++|++++|++++. .+..+++|+.|++++|.+.+
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~- 200 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST- 200 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc-
Confidence 77776644444456667777777777777666666666666777777777766642 23444555555555555432
Q ss_pred CCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccc
Q 001922 395 IPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSL 474 (995)
Q Consensus 395 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~ 474 (995)
+....+|++|++++|.+... | . ....+|+.|++++|++++. ..+
T Consensus 201 ----~~~~~~L~~L~l~~n~l~~~-~------------------------~-----~~~~~L~~L~l~~n~l~~~--~~l 244 (390)
T 3o6n_A 201 ----LAIPIAVEELDASHNSINVV-R------------------------G-----PVNVELTILKLQHNNLTDT--AWL 244 (390)
T ss_dssp ----EECCSSCSEEECCSSCCCEE-E------------------------C-----CCCSSCCEEECCSSCCCCC--GGG
T ss_pred ----cCCCCcceEEECCCCeeeec-c------------------------c-----cccccccEEECCCCCCccc--HHH
Confidence 22234566666666655422 1 1 1125788999999999853 578
Q ss_pred cCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCe
Q 001922 475 SNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNY 554 (995)
Q Consensus 475 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~ 554 (995)
..+++|+.|+|++|++++..|..++.+++|+.|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..+..+++|++
T Consensus 245 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~ 322 (390)
T 3o6n_A 245 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322 (390)
T ss_dssp GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred cCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCE
Confidence 89999999999999999888999999999999999999998 47888888999999999999998 68888999999999
Q ss_pred EeccccccccccCcccccCCcccEEeccCCCCCCCCCCCCCCcccccccCCCCccCCCCC
Q 001922 555 LNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTL 614 (995)
Q Consensus 555 L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~~~ 614 (995)
|+|++|++++. | +..+++|+.|++++|++.+.-.. .-+..+....+.+++..|+.+
T Consensus 323 L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 323 LYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp EECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred EECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence 99999999764 4 77889999999999998864221 123445556678888888854
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=337.75 Aligned_cols=259 Identities=21% Similarity=0.247 Sum_probs=198.4
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC-ChhHHHHHHHHHHhccCCCCceeEeEEEecCCc------
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH-SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET------ 757 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~------ 757 (995)
++|...+.||+|+||.||+|+. .+|+.||||++...... .....+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5688889999999999999976 46899999998543222 234568899999999999999999999977654
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.|+||||++ ++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 58888874 24899999999999999999999887 99999999999999999999999999986
Q ss_pred cccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
... ......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||..........................
T Consensus 176 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 176 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 432 1234578999999999876 6789999999999999999999999975432222222222111111110000
Q ss_pred -----------hc----CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 917 -----------IL----DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 917 -----------~~----d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+ .+.........+..+.+++.+|++.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 011122233456789999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=337.43 Aligned_cols=254 Identities=22% Similarity=0.242 Sum_probs=174.3
Q ss_pred HHhhccCC-CeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec----CCc
Q 001922 684 ILECVKDG-NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN----KET 757 (995)
Q Consensus 684 ~~~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 757 (995)
+.++|... ++||+|+||+||+|+.. +++.||||++... .....+....++.++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 35678874 56999999999999875 6899999998431 2222233334566799999999999865 455
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCCeEEeeecc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS---AFEAHVADFGL 834 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~---~~~vkl~DfGl 834 (995)
.++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999998766667999999999999999999999887 999999999999986 45599999999
Q ss_pred ccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
++..... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.....................
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 250 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY--- 250 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc---
Confidence 9865322 223457899999999998888999999999999999999999999654322111111111110000
Q ss_pred hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 915 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.... ......+..+.+++.+||+.||++|||++|+++.
T Consensus 251 -~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 251 -GFPN----PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -CCCT----TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -ccCc----hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 1112345678899999999999999999999973
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=332.87 Aligned_cols=254 Identities=23% Similarity=0.338 Sum_probs=194.6
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec--------
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN-------- 754 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------- 754 (995)
+.++|+..+.||+|+||.||+|+. .+++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 567899999999999999999986 4789999999843 22335678899999999999999999998754
Q ss_pred -----CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEE
Q 001922 755 -----KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV 829 (995)
Q Consensus 755 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl 829 (995)
....|+||||+++|+|.+++.. .+..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 4567999999999999999974 3456788999999999999999999887 999999999999999999999
Q ss_pred eeeccccccccCC------------CCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCC
Q 001922 830 ADFGLAKFLIDGG------------ASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDG 896 (995)
Q Consensus 830 ~DfGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~ 896 (995)
+|||+++...... .........||+.|+|||++.+. .++.++||||+|+++|||++ ||...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--- 231 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--- 231 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence 9999998653221 01222345689999999998764 68999999999999999998 55321
Q ss_pred chHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 897 VDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.+............. ......+...+..+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 MERVNILKKLRSVSI--------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHHHSTTC--------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHhcccccc--------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 122222222221100 00112334455678899999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=347.07 Aligned_cols=253 Identities=10% Similarity=0.030 Sum_probs=179.9
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCC--ChhHHHHHHHHHHhcc--CCCCceeEe-------EEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNI--RHRNIVRLL-------AFCS 753 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l--~hpniv~~~-------~~~~ 753 (995)
..|+..+.||+|+||+||+|++. +++.||||++...... ...+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 34788899999999999999864 7899999999654321 2345577885555444 699988755 4443
Q ss_pred cC-----------------CcceEEEEeccCCChhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeE
Q 001922 754 NK-----------------ETNLLVYEYMRNGSLGEALHGKKGAFLGWNLR------YKIAIEAAKGLCYLHHDCSPLIV 810 (995)
Q Consensus 754 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~qi~~~l~~LH~~~~~~ii 810 (995)
.. ...|+||||++ |+|.+++... +..+++..+ ..++.||+.||+|||+++ |+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 32 33799999998 7999999743 223345555 678899999999999887 99
Q ss_pred ecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccccCccccccccccc--CCCCcccchhhHHHHHHHHHhCCC
Q 001922 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT--LRVDEKSDVYSFGVVLLELLTGRR 888 (995)
Q Consensus 811 HrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~ 888 (995)
||||||+||+++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999986522 1124567799999999987 679999999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 889 PVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS-MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 889 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
||......... .+ .............. ......+..+.+++.+||+.||++||+++|+++
T Consensus 292 Pf~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKG-SW-------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTT-CC-------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCccccc-ch-------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99764221110 00 00000000011111 111245667999999999999999999999975
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=361.74 Aligned_cols=334 Identities=20% Similarity=0.171 Sum_probs=241.2
Q ss_pred CcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEc
Q 001922 235 VNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNL 314 (995)
Q Consensus 235 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 314 (995)
.+++.|++++|.++...+..+..+++|+.|++++|.+++..|..|..+++|++|+|++|.|++..|..|+++++|++|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 34566666666666544445566666666666666666655556666666666666666666666666666666666666
Q ss_pred cCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCC
Q 001922 315 FMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGP 394 (995)
Q Consensus 315 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 394 (995)
++|.|++..+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++. + +..+++|+.|++++|.+.+
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~--~~~l~~L~~L~l~~n~l~~- 206 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSLIPSLFHANVSYNLLST- 206 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-C--GGGCTTCSEEECCSSCCSE-
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-C--hhhhhhhhhhhcccCcccc-
Confidence 66666655555556666666666666666666666666666666666666666643 1 3344555555555555432
Q ss_pred CCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccc
Q 001922 395 IPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSL 474 (995)
Q Consensus 395 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~ 474 (995)
+....+|+.|++++|.+....+. .+.+|+.|+|++|.+++ +..+
T Consensus 207 ----l~~~~~L~~L~ls~n~l~~~~~~------------------------------~~~~L~~L~L~~n~l~~--~~~l 250 (597)
T 3oja_B 207 ----LAIPIAVEELDASHNSINVVRGP------------------------------VNVELTILKLQHNNLTD--TAWL 250 (597)
T ss_dssp ----EECCTTCSEEECCSSCCCEEECS------------------------------CCSCCCEEECCSSCCCC--CGGG
T ss_pred ----ccCCchhheeeccCCcccccccc------------------------------cCCCCCEEECCCCCCCC--Chhh
Confidence 22334566666666665422111 12468899999999986 4678
Q ss_pred cCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCe
Q 001922 475 SNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNY 554 (995)
Q Consensus 475 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~ 554 (995)
..+++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++ +|..++.+++|++|+|++|.++ .+|..+..+++|++
T Consensus 251 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~ 328 (597)
T 3oja_B 251 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 328 (597)
T ss_dssp GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred ccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCE
Confidence 899999999999999998889999999999999999999985 7888888999999999999998 78989999999999
Q ss_pred EeccccccccccCcccccCCcccEEeccCCCCCCCCCCCCCCcccccccCCCCccCCCCC
Q 001922 555 LNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTL 614 (995)
Q Consensus 555 L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~~~ 614 (995)
|+|++|++++. | +..+++|+.|++++|++++..+. ..+..+....+.+++..|+.+
T Consensus 329 L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 329 LYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp EECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred EECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence 99999999774 3 77889999999999999875432 234556666788999999964
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.39 Aligned_cols=257 Identities=24% Similarity=0.292 Sum_probs=185.7
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEe--------cC
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCS--------NK 755 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--------~~ 755 (995)
.+|+..++||+|+||.||+|++ .+++.||+|++... .......+.+|+.+++++. ||||+++++++. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 4688899999999999999986 46899999998433 2334566889999999996 999999999983 33
Q ss_pred CcceEEEEeccCCChhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 756 ETNLLVYEYMRNGSLGEALHG-KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
...++||||+. |+|.+++.. .....+++..++.++.||+.||.|||+.+ ++|+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 45799999996 699998864 23456999999999999999999999542 2399999999999999999999999999
Q ss_pred ccccccCCCCc----------cccccccCccccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHH
Q 001922 835 AKFLIDGGASE----------CMSAIAGSYGYIAPEYA---YTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQ 901 (995)
Q Consensus 835 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~ 901 (995)
++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98764322111 11245689999999998 56678999999999999999999999996432110
Q ss_pred HHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 902 WSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 902 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
..... ... ..+...+..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 261 ~~~~~-----------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 IVNGK-----------YSI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ----------------CCC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCc-----------ccC---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00000 000 0111223457889999999999999999999999998865
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=338.10 Aligned_cols=265 Identities=20% Similarity=0.184 Sum_probs=202.8
Q ss_pred HHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CC-----CceeEeEEEecCC
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HR-----NIVRLLAFCSNKE 756 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~~~~~~~~~~ 756 (995)
+.++|+..+.||+|+||+||+|+.. +++.||||++... ......+..|+.+++.++ |+ +|+++++++...+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 3578999999999999999999764 6888999998532 223456778888888885 44 4999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC--CCCCeEEeeecc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN--SAFEAHVADFGL 834 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~--~~~~vkl~DfGl 834 (995)
..++||||+. |+|.+++.......+++..++.++.|++.||.|||.+ ..+|+||||||+||+++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999996 5999999866556799999999999999999999942 23399999999999995 477899999999
Q ss_pred ccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||........+...............
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9876322 23467899999999999999999999999999999999999999764333223222222111110000
Q ss_pred ------hhhc----CC--------------------------------------cCCCCCHHHHHHHHHHHhcccCCCCC
Q 001922 915 ------LSIL----DP--------------------------------------RLSMVPKEEAMHLLFVAMLCIQENSI 946 (995)
Q Consensus 915 ------~~~~----d~--------------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~ 946 (995)
...+ +. ............+.+++.+||+.||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 0000 00 00011234456889999999999999
Q ss_pred CCCCHHHHHHH
Q 001922 947 ERPRMREVVQM 957 (995)
Q Consensus 947 ~RPt~~evl~~ 957 (995)
+|||++|+++.
T Consensus 363 ~Rpta~e~L~h 373 (382)
T 2vx3_A 363 TRIQPYYALQH 373 (382)
T ss_dssp TSCCHHHHTTS
T ss_pred hCCCHHHHhcC
Confidence 99999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.83 Aligned_cols=264 Identities=19% Similarity=0.258 Sum_probs=193.7
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEe----------
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCS---------- 753 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~---------- 753 (995)
..+|+..+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 467889999999999999999875 4899999998532 3334567889999999999999999999873
Q ss_pred ----cCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC-CCCCeE
Q 001922 754 ----NKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN-SAFEAH 828 (995)
Q Consensus 754 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~-~~~~vk 828 (995)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+||+++ +++.+|
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467799999997 599999953 45889999999999999999999887 99999999999997 567999
Q ss_pred EeeeccccccccCCC-CccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHH
Q 001922 829 VADFGLAKFLIDGGA-SECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRA 906 (995)
Q Consensus 829 l~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 906 (995)
|+|||+++....... ........+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||................
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999987543211 112234567999999998765 678999999999999999999999997643322222222221
Q ss_pred hcCChhhhhhhcC------------CcC--CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 907 TNGRKEEFLSILD------------PRL--SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 907 ~~~~~~~~~~~~d------------~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.........+... +.. .......+..+.+++.+||+.||++||+++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111111111000 000 0011234567899999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=334.25 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=179.2
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHH-HHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQ-TLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
++|+..+.||+|+||.||+|... +|+.||||++...........+..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57888999999999999999874 689999999965443333445556665 6777899999999999999999999999
Q ss_pred eccCCChhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 764 YMRNGSLGEALHG---KKGAFLGWNLRYKIAIEAAKGLCYLHHD-CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 764 ~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
|+++ +|.+++.. .....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9985 88777752 2356789999999999999999999987 7 9999999999999999999999999998764
Q ss_pred cCCCCccccccccCccccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 840 DGGASECMSAIAGSYGYIAPEYA----YTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||......... .......
T Consensus 178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~------ 245 (327)
T 3aln_A 178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---LTQVVKG------ 245 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCS------
T ss_pred ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---HHHHhcC------
Confidence 322 22334799999999998 4567899999999999999999999999653221110 0000000
Q ss_pred hhcCCcCC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 916 SILDPRLS-MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 916 ~~~d~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..+.+. ......+..+.+++.+||+.||++||+++|+++
T Consensus 246 --~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 --DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 001111 111234567899999999999999999999986
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=339.16 Aligned_cols=346 Identities=17% Similarity=0.140 Sum_probs=180.0
Q ss_pred CCCCCCCCCCCCce-eeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccc
Q 001922 46 LISWNSSNPSSVCS-WAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNIS 122 (995)
Q Consensus 46 l~~W~~~~~~~~C~-w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls 122 (995)
+++|... .+||. |.+..|....+. ++-..... .....-..+++++.|++++|.++... .+..+++|++|+|+
T Consensus 3 ~~~~~~~--~~C~~~~~~~~c~~~~~~-i~~~~~~~--~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~ 77 (390)
T 3o6n_A 3 VKPRQPE--YKCIDSNLQYDCVFYDVH-IDMQTQDV--YFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77 (390)
T ss_dssp ----CCE--ECBCC------EEEESCE-ECSSCCCC--EESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECT
T ss_pred cCCCCCc--cceehhhhhhccceeeee-eecccccc--cccccccccCCceEEEecCCchhhCChhHhcccccCcEEECC
Confidence 6789875 35654 555555322111 11111111 11111234567777777777776543 25677777777777
Q ss_pred cccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccC
Q 001922 123 NNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKI 202 (995)
Q Consensus 123 ~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 202 (995)
+|.++++.+..|..+++|++|++++|+++++.|..|.++++|++|+|++|.++...+..|+.+++|++|+|++|++++..
T Consensus 78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~ 157 (390)
T 3o6n_A 78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE 157 (390)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccC
Confidence 77777777777777777777777777777776777777777777777777776444444577777777777777777666
Q ss_pred cccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCc
Q 001922 203 PGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNL 282 (995)
Q Consensus 203 ~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 282 (995)
+..++++++|++|++++|.+... .+..+++|++|++++|.+++ +...+.|+.|++++|.++.. |.. ..
T Consensus 158 ~~~~~~l~~L~~L~l~~n~l~~~----~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~ 225 (390)
T 3o6n_A 158 DDTFQATTSLQNLQLSSNRLTHV----DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGP--VN 225 (390)
T ss_dssp TTTTSSCTTCCEEECCSSCCSBC----CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--CC
T ss_pred hhhccCCCCCCEEECCCCcCCcc----ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeec-ccc--cc
Confidence 66666666666666655444321 23444555555555555542 12223455555555555432 211 12
Q ss_pred CCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEe
Q 001922 283 TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDL 362 (995)
Q Consensus 283 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 362 (995)
++|+.|++++|.+++. ..+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+|
T Consensus 226 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L 302 (390)
T 3o6n_A 226 VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 302 (390)
T ss_dssp SSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEEC
T ss_pred ccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEEC
Confidence 4455555555555432 244444555555555555554444445555555555555555543 2333344445555555
Q ss_pred cCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCcc
Q 001922 363 SSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYL 415 (995)
Q Consensus 363 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l 415 (995)
++|+++ .+|..+..+++|+.|++++|.+... + +..+++|+.|++++|++
T Consensus 303 ~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~ 351 (390)
T 3o6n_A 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDW 351 (390)
T ss_dssp CSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCE
T ss_pred CCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCc
Confidence 555444 3333344444444444444444322 1 33334444444444444
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=333.46 Aligned_cols=260 Identities=20% Similarity=0.246 Sum_probs=202.5
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CC-cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCC------ceeEeEEEecCC
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NG-VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN------IVRLLAFCSNKE 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~~~~~~~~~~ 756 (995)
.++|+..+.||+|+||+||+|... ++ +.||+|++.. .....+.+.+|+.++++++|++ ++.+++++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc--cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 467899999999999999999764 34 6899999853 2233566888999999998766 899999999999
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---------------
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILL--------------- 821 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill--------------- 821 (995)
..++||||+ ++++.+++.......+++..++.++.||+.||.|||+++ |+||||||+||++
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 999999999 668888776555567999999999999999999999777 9999999999999
Q ss_pred ----CCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCc
Q 001922 822 ----NSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV 897 (995)
Q Consensus 822 ----~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~ 897 (995)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999999864322 234579999999999999999999999999999999999999997543322
Q ss_pred hHHHHHHHHhcCChhhhhhh---------------------------cCC--cCCCCCHHHHHHHHHHHhcccCCCCCCC
Q 001922 898 DIVQWSKRATNGRKEEFLSI---------------------------LDP--RLSMVPKEEAMHLLFVAMLCIQENSIER 948 (995)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~---------------------------~d~--~~~~~~~~~~~~l~~li~~cl~~dP~~R 948 (995)
....... ........+... ..+ .........+..+.+++.+||+.||++|
T Consensus 247 ~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 247 HLVMMEK-ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHH-HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHH-HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 2222222 111111110000 000 0011223456789999999999999999
Q ss_pred CCHHHHHH
Q 001922 949 PRMREVVQ 956 (995)
Q Consensus 949 Pt~~evl~ 956 (995)
||++|+++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=339.38 Aligned_cols=260 Identities=20% Similarity=0.226 Sum_probs=201.5
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-----------CCCceeEeEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-----------HRNIVRLLAFCS 753 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~~~ 753 (995)
.+|+..+.||+|+||+||+|+. .+++.||||++.. .....+.+.+|+.++++++ ||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 4688899999999999999986 5689999999853 2233566888999998886 899999999987
Q ss_pred cCC----cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEEC------
Q 001922 754 NKE----TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD-CSPLIVHRDVKSNNILLN------ 822 (995)
Q Consensus 754 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~iiHrDlkp~Nill~------ 822 (995)
..+ ..++||||+ +++|.+++.......+++..+..++.||+.||+|||++ + |+||||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 544 789999999 88999999866666799999999999999999999987 7 99999999999994
Q ss_pred CCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC------
Q 001922 823 SAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG------ 896 (995)
Q Consensus 823 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~------ 896 (995)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4457999999999875332 23457899999999999999999999999999999999999999753311
Q ss_pred chHHHHHHHHhcCChhhhh-------hhcC--------------------CcCCCCCHHHHHHHHHHHhcccCCCCCCCC
Q 001922 897 VDIVQWSKRATNGRKEEFL-------SILD--------------------PRLSMVPKEEAMHLLFVAMLCIQENSIERP 949 (995)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~-------~~~d--------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 949 (995)
....+........ ...+. ..++ ......+...+..+.+++.+||+.||++||
T Consensus 248 ~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 248 DHIAQIIELLGEL-PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHCSC-CHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHhcCCC-CHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 1111111111110 00000 0000 001134567889999999999999999999
Q ss_pred CHHHHHHH
Q 001922 950 RMREVVQM 957 (995)
Q Consensus 950 t~~evl~~ 957 (995)
|++|+++.
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999874
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=331.24 Aligned_cols=259 Identities=29% Similarity=0.503 Sum_probs=190.1
Q ss_pred CCCEEEccCCcCCC--CCCccccCCCCcceEEecc-CcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCcccee
Q 001922 308 QLKLFNLFMNRLHG--SIPDYLADLPNLETLGLWQ-NNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRIL 384 (995)
Q Consensus 308 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 384 (995)
+++.|+|++|.+++ .+|..+..+++|++|+|++ |.+++.+|..|+.+++|++|+|++|++++.+|..+.
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-------- 122 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS-------- 122 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGG--------
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHh--------
Confidence 45566666666665 5555666666666666663 555555555566666666666666655555555444
Q ss_pred eccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCC
Q 001922 385 ILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNN 464 (995)
Q Consensus 385 ~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N 464 (995)
.+++|++|++++|.+.+.+|..+..+ ++|++|+|++|
T Consensus 123 ----------------~l~~L~~L~Ls~N~l~~~~p~~~~~l---------------------------~~L~~L~L~~N 159 (313)
T 1ogq_A 123 ----------------QIKTLVTLDFSYNALSGTLPPSISSL---------------------------PNLVGITFDGN 159 (313)
T ss_dssp ----------------GCTTCCEEECCSSEEESCCCGGGGGC---------------------------TTCCEEECCSS
T ss_pred ----------------CCCCCCEEeCCCCccCCcCChHHhcC---------------------------CCCCeEECcCC
Confidence 44455555555555554455444333 23445555555
Q ss_pred cccccCCccccCCC-CCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCc
Q 001922 465 LLSGPLPFSLSNFS-SLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIP 543 (995)
Q Consensus 465 ~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip 543 (995)
++++.+|..+..++ +|+.|+|++|++++.+|..++.+. |+.|+|++|.+++.+|..++.+++|++|+|++|++++.+|
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 238 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecC
Confidence 55556666677776 788888888888877888888776 8888888888888888888889999999999999987666
Q ss_pred cccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCCCCCCCcccccccCCCCccCCCCCCCCCCC
Q 001922 544 PEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNNPCN 620 (995)
Q Consensus 544 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~c~ 620 (995)
. +..+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.+|..+++..+....+.|||++||.|++ +|.
T Consensus 239 ~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C~ 313 (313)
T 1ogq_A 239 K-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-ACT 313 (313)
T ss_dssp G-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CCC
T ss_pred c-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CCC
Confidence 5 88889999999999999989999999999999999999999999998888888999999999999999888 674
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=356.00 Aligned_cols=348 Identities=17% Similarity=0.151 Sum_probs=192.1
Q ss_pred CCCCCCCCCCCCCCce----eeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccc
Q 001922 44 PALISWNSSNPSSVCS----WAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQ 117 (995)
Q Consensus 44 ~~l~~W~~~~~~~~C~----w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~ 117 (995)
..+++|.++ ++||. |.++.|+. + ++......... ..-..+.+++.|++++|.++... .+.++++|+
T Consensus 7 ~~l~~~~~~--~~C~~~~~~~~c~~~~~-~---i~~~~~~~~~~--~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~ 78 (597)
T 3oja_B 7 YNVKPRQPE--YKCIDSNLQYDCVFYDV-H---IDMQTQDVYFG--FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78 (597)
T ss_dssp ----CCCSE--ECCCCC--CCSEEECSC-E---ECSSCCCCEES--CSSGGGCCCSEEEESSCEESEECTHHHHHCCCCS
T ss_pred ccccCCCCC--CcCcccCcCceeEecCc-e---ecccccccccC--cccccCCCceEEEeeCCCCCCcCHHHHccCCCCc
Confidence 457889875 35663 66666542 1 11111111111 11123456666666666665533 255566666
Q ss_pred eeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCc
Q 001922 118 FLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGND 197 (995)
Q Consensus 118 ~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 197 (995)
+|+|++|.|+++++..|..+++|++|+|++|.|+++.|..|+++++|++|+|++|.+++..+..|+.+++|++|+|++|.
T Consensus 79 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~ 158 (597)
T 3oja_B 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN 158 (597)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCc
Confidence 66666666666666666666666666666666666655566666666666666666654444445666666666666666
Q ss_pred ccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCc
Q 001922 198 LTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPK 277 (995)
Q Consensus 198 l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 277 (995)
+++..|..|+++++| ++|+|++|.+++. .++.+++|+.|++++|.+++
T Consensus 159 l~~~~~~~~~~l~~L-------------------------~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~---- 206 (597)
T 3oja_B 159 LERIEDDTFQATTSL-------------------------QNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST---- 206 (597)
T ss_dssp CCBCCTTTTTTCTTC-------------------------CEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE----
T ss_pred CCCCChhhhhcCCcC-------------------------cEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc----
Confidence 665555555555444 4455555544432 13334445555555554442
Q ss_pred cccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCC
Q 001922 278 QLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKL 357 (995)
Q Consensus 278 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 357 (995)
+...++|+.|++++|.++...+.. .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|+.+++|
T Consensus 207 -l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 280 (597)
T 3oja_B 207 -LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 280 (597)
T ss_dssp -EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSC
T ss_pred -ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCC
Confidence 223345566666666555332221 1456666666666654 2455566666666666666666656666666666
Q ss_pred CeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCc
Q 001922 358 QVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSN 437 (995)
Q Consensus 358 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n 437 (995)
++|+|++|.+++ +|..+..+++|+.|+|++|.+. .+|..+..+++|+.|++++|.+.+.. +..++.|+.+++++|
T Consensus 281 ~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N 355 (597)
T 3oja_B 281 ERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHN 355 (597)
T ss_dssp CEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSS
T ss_pred CEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCC
Confidence 666666666653 4555555666666666666664 35555666666666666666665442 445566667777777
Q ss_pred cccCC
Q 001922 438 YLSGS 442 (995)
Q Consensus 438 ~l~~~ 442 (995)
.+.+.
T Consensus 356 ~~~~~ 360 (597)
T 3oja_B 356 DWDCN 360 (597)
T ss_dssp CEEHH
T ss_pred CCCCh
Confidence 66643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=342.84 Aligned_cols=252 Identities=24% Similarity=0.318 Sum_probs=188.1
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.|...+.||+|+||+||.+...+|+.||||++.. ...+.+.+|+++++++ +||||+++++++.+++..|+||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 34556788999999999877667899999999843 2245678899999886 899999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCC-----CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-------------CC
Q 001922 765 MRNGSLGEALHGKKGAF-----LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA-------------FE 826 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~-------------~~ 826 (995)
+. |+|.+++....... .++..++.++.||+.||+|||+.+ |+||||||+||+++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 96 59999997533211 122345679999999999999887 9999999999999754 48
Q ss_pred eEEeeeccccccccCCCC--ccccccccCccccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 001922 827 AHVADFGLAKFLIDGGAS--ECMSAIAGSYGYIAPEYAYT-------LRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDG 896 (995)
Q Consensus 827 vkl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~ 896 (995)
+||+|||+++.+...... .......||+.|+|||++.+ ..++.++||||+||++|||++ |+.||.+....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999876543221 12234679999999999865 568999999999999999999 99999653221
Q ss_pred chHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 897 VDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.......... ........+...+..+.+++.+||+.||++||++.|+++
T Consensus 247 --~~~i~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 --ESNIIRGIFS---------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHHHTCCC---------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHhcCCCC---------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111110000 001111234567889999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=341.62 Aligned_cols=248 Identities=24% Similarity=0.293 Sum_probs=185.8
Q ss_pred hccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.|+..++||+|+||+||.....+++.||||++.... ...+.+|+++++++ +|||||++++++.+....|+||||+
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 577788999999999766556689999999985322 23356899999999 7999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-----CCCeEEeeecccccccc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS-----AFEAHVADFGLAKFLID 840 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~-----~~~vkl~DfGla~~~~~ 840 (995)
. |+|.+++.... ....+..++.++.||+.||.|||+.+ |+||||||+||+++. ...+||+|||+++....
T Consensus 101 ~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 6 59999997543 23444456789999999999999887 999999999999953 23588999999987643
Q ss_pred CCC-CccccccccCcccccccccc---cCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 841 GGA-SECMSAIAGSYGYIAPEYAY---TLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 841 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
... ........||+.|+|||++. ...++.++||||+||++|||++ |..||..... .... .....
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--~~~~---~~~~~------ 244 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--RQAN---ILLGA------ 244 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--HHHH---HHTTC------
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--HHHH---HHhcc------
Confidence 321 12234567999999999987 4567889999999999999999 9999854221 1111 11100
Q ss_pred hhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 916 SILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 916 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
............+..+.+++.+||+.||++||+++|+++
T Consensus 245 --~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 --CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 001111123345667889999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.49 Aligned_cols=253 Identities=22% Similarity=0.336 Sum_probs=181.0
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhH-HHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDH-GFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.++|+..+.||+|+||.||+|+.. +|+.||||++.......... .+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888899999999999999874 68999999986543332222 3444556788889999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD-CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
||+ ++.+..+.. .....+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 445555543 3345689999999999999999999984 7 999999999999999999999999999765432
Q ss_pred CCCccccccccCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 842 GASECMSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
. ......||+.|+|||++. ...++.++||||+|+++|||++|+.||.......... ........
T Consensus 179 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~----- 247 (318)
T 2dyl_A 179 K---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL---TKVLQEEP----- 247 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH---HHHHHSCC-----
T ss_pred c---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHH---HHHhccCC-----
Confidence 2 223457999999999984 4568899999999999999999999997543322211 11111110
Q ss_pred hcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 917 ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 917 ~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+..+ .....+..+.+++.+||+.||++||+++|+++.
T Consensus 248 ---~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 ---PLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ---CCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---CCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111 111245578899999999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=332.83 Aligned_cols=242 Identities=20% Similarity=0.336 Sum_probs=197.6
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCC-----hhHHHHHHHHHHhccC--CCCceeEeEEEecCC
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHS-----HDHGFRAEIQTLGNIR--HRNIVRLLAFCSNKE 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~ 756 (995)
.++|+..+.||+|+||.||+|+. .+++.||||++....... ....+.+|+.++++++ ||||+++++++.+++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 45788999999999999999975 568899999985432221 2245678999999996 599999999999999
Q ss_pred cceEEEEeccC-CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC-CCCCeEEeeecc
Q 001922 757 TNLLVYEYMRN-GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN-SAFEAHVADFGL 834 (995)
Q Consensus 757 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~-~~~~vkl~DfGl 834 (995)
..++||||+.+ ++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++ .++.+||+|||+
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 99999999976 899999964 356899999999999999999999887 99999999999999 788999999999
Q ss_pred ccccccCCCCccccccccCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||... . ... ...
T Consensus 197 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~--~~~---~~~---- 259 (320)
T 3a99_A 197 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E--EII---RGQ---- 259 (320)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H--HHH---HCC----
T ss_pred ccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----h--hhh---ccc----
Confidence 9876432 2234579999999999887766 68899999999999999999999531 0 000 000
Q ss_pred hhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 914 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+...+..+.+++.+||+.||++||+++|+++.
T Consensus 260 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 ---------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122345578899999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=329.13 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=191.3
Q ss_pred HHHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC-----ChhHHHHHHHHHHhcc----CCCCceeEeEE
Q 001922 682 SDILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH-----SHDHGFRAEIQTLGNI----RHRNIVRLLAF 751 (995)
Q Consensus 682 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l----~hpniv~~~~~ 751 (995)
+.+.++|+..+.||+|+||.||+|+. .+++.||||++...... .....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34567899999999999999999976 46889999998543221 1223356799999888 89999999999
Q ss_pred EecCCcceEEEEe-ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC-CCCCeEE
Q 001922 752 CSNKETNLLVYEY-MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN-SAFEAHV 829 (995)
Q Consensus 752 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~-~~~~vkl 829 (995)
+.+.+..++|||| +.+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 789999999964 346899999999999999999999888 99999999999999 8899999
Q ss_pred eeeccccccccCCCCccccccccCcccccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhc
Q 001922 830 ADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVD-EKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN 908 (995)
Q Consensus 830 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 908 (995)
+|||+++...... .....|++.|+|||++.+..+. .++||||+|+++|||++|+.||... ... ..
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~----~~ 247 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEI----LE 247 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHH----HH
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHH----hh
Confidence 9999998764322 2345789999999998877664 5899999999999999999999531 000 00
Q ss_pred CChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 909 GRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 909 ~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. . ...+...+..+.+++.+||+.||++||+++|+++.
T Consensus 248 ~-----------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 A-----------E-LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp T-----------C-CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred h-----------c-cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 11223345678899999999999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=351.33 Aligned_cols=261 Identities=24% Similarity=0.289 Sum_probs=199.3
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec------CC
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN------KE 756 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 756 (995)
...+|+..+.||+|+||+||+|.. .+|+.||||++.........+.+.+|++++++++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 357899999999999999999976 46899999998654444456678999999999999999999999765 67
Q ss_pred cceEEEEeccCCChhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCC---eEEeee
Q 001922 757 TNLLVYEYMRNGSLGEALHGKK-GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFE---AHVADF 832 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~---vkl~Df 832 (995)
..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 7899999999999999997532 336888899999999999999999887 999999999999997765 899999
Q ss_pred ccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChh
Q 001922 833 GLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912 (995)
Q Consensus 833 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 912 (995)
|++....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... ....|..........
T Consensus 169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~---~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW---QPVQWHGKVREKSNE 242 (676)
T ss_dssp CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC---HHHHSSTTCC-----
T ss_pred cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc---chhhhhhhhhcccch
Confidence 9998764432 2244679999999999999999999999999999999999999996421 112221111110000
Q ss_pred h--hhhhcC---------CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHH
Q 001922 913 E--FLSILD---------PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMRE 953 (995)
Q Consensus 913 ~--~~~~~d---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 953 (995)
. ..+... +.........+..+.+++.+||+.||++|||++|
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0 000000 1112244567889999999999999999999977
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=318.45 Aligned_cols=304 Identities=23% Similarity=0.334 Sum_probs=133.0
Q ss_pred CCCCCCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeec
Q 001922 90 RLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDL 169 (995)
Q Consensus 90 ~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L 169 (995)
.+++|++|++++|.++....+..+++|++|+|++|++++..+ +..+++|++|++++|.++.+ ..+..+++|++|++
T Consensus 42 ~l~~L~~L~l~~~~i~~~~~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l 117 (347)
T 4fmz_A 42 ELESITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYL 117 (347)
T ss_dssp HHTTCSEEECCSSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred hcccccEEEEeCCccccchhhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEEC
Confidence 345555555555555544445555555555555555554433 55555555555555555542 23555555555555
Q ss_pred cCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCC
Q 001922 170 GGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDG 249 (995)
Q Consensus 170 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~ 249 (995)
++|.+++ ++. +..+++|++|++++|.....++ .+..+++|++|++++|.+.. ++. +..+++|++|++++|.+++
T Consensus 118 ~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~--~~~-~~~l~~L~~L~l~~n~l~~ 191 (347)
T 4fmz_A 118 NEDNISD-ISP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKD--VTP-IANLTDLYSLSLNYNQIED 191 (347)
T ss_dssp TTSCCCC-CGG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCC--CGG-GGGCTTCSEEECTTSCCCC
T ss_pred cCCcccC-chh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCC--chh-hccCCCCCEEEccCCcccc
Confidence 5555542 222 5555555555555554332222 13333333333333332221 111 3334444444444444442
Q ss_pred ccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccC
Q 001922 250 QIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLAD 329 (995)
Q Consensus 250 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 329 (995)
..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|++++. +.+..
T Consensus 192 ~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~ 263 (347)
T 4fmz_A 192 ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKD 263 (347)
T ss_dssp CGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTT
T ss_pred ccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhc
Confidence 221 3444444444444444443222 3444444444444444443222 44444444444444444421 23444
Q ss_pred CCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEE
Q 001922 330 LPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVR 409 (995)
Q Consensus 330 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~ 409 (995)
+++|++|++++|++++. ..+..+++|++|++++|++++..|..+..+++|+.|++++|.+.+..| +..+++|++|+
T Consensus 264 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 339 (347)
T 4fmz_A 264 LTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSAD 339 (347)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEES
T ss_pred CCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceee
Confidence 44444444444444432 224444444444444444444333334444444444444444433333 33344444444
Q ss_pred ecCCcc
Q 001922 410 LGQNYL 415 (995)
Q Consensus 410 l~~N~l 415 (995)
+++|.|
T Consensus 340 l~~N~i 345 (347)
T 4fmz_A 340 FANQVI 345 (347)
T ss_dssp SSCC--
T ss_pred hhhhcc
Confidence 444433
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=316.57 Aligned_cols=317 Identities=25% Similarity=0.329 Sum_probs=244.5
Q ss_pred ccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccC
Q 001922 99 LAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKI 178 (995)
Q Consensus 99 L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 178 (995)
+....+++...+..+++|++|++++|.+.... .+..+++|++|++++|+++++.+ +..+++|++|+|++|.+++ +
T Consensus 29 ~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~--~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~ 103 (347)
T 4fmz_A 29 LQKASVTDVVTQEELESITKLVVAGEKVASIQ--GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-I 103 (347)
T ss_dssp HTCSCTTSEECHHHHTTCSEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C
T ss_pred ccccccCCcccchhcccccEEEEeCCccccch--hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-c
Confidence 34445555566778999999999999998763 48889999999999999998644 8999999999999999974 4
Q ss_pred CccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCc
Q 001922 179 PNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNL 258 (995)
Q Consensus 179 p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 258 (995)
| .|..+++|++|++++|++++..+ +..+++|++|++++|.... .+..+..+++|++|++++|.+.+..+ +..+
T Consensus 104 ~-~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~--~~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l 176 (347)
T 4fmz_A 104 S-ALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS--DLSPLSNMTGLNYLTVTESKVKDVTP--IANL 176 (347)
T ss_dssp G-GGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCC--CCGGGTTCTTCCEEECCSSCCCCCGG--GGGC
T ss_pred h-HHcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCcc--cccchhhCCCCcEEEecCCCcCCchh--hccC
Confidence 4 69999999999999999995533 8888999999998775554 23447888889999999988875544 7788
Q ss_pred cccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEe
Q 001922 259 KLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGL 338 (995)
Q Consensus 259 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 338 (995)
++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|++|++
T Consensus 177 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l 250 (347)
T 4fmz_A 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEI 250 (347)
T ss_dssp TTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEEC
Confidence 888888888888875433 7788888888888888886554 7788888888888888885444 778888888888
Q ss_pred ccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCC
Q 001922 339 WQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGS 418 (995)
Q Consensus 339 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 418 (995)
++|++++. ..+..+++|++|++++|++++. ..+..+++|+.|++++|.+.+..|..+..+++|++|++++|++++.
T Consensus 251 ~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 251 GTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp CSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred CCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 88888753 4577888888888888888753 3467777777777777777777777777777777777777777765
Q ss_pred CCCCcccCCCCceeeccCccc
Q 001922 419 IPDGFIYLPGLNLAELQSNYL 439 (995)
Q Consensus 419 ~p~~~~~l~~L~~l~l~~n~l 439 (995)
.| +..+++|+.+++++|.|
T Consensus 327 ~~--~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 327 RP--LASLSKMDSADFANQVI 345 (347)
T ss_dssp GG--GGGCTTCSEESSSCC--
T ss_pred cC--hhhhhccceeehhhhcc
Confidence 55 44455444444444443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.71 Aligned_cols=232 Identities=13% Similarity=0.077 Sum_probs=183.3
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCC--hhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHS--HDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
..+|+..+.||+|+||.||+|++. +++.||||++....... ....+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357888999999999999999875 48999999986543322 236789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||++|++|.+++... .....+.+++.|++.||.|||+++ |+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999532 355567889999999999999887 9999999999999999999998443
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
|++ .++.++|||||||++|||++|+.||........+.... ......
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~------------~~~~~~ 221 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------------RDTAGQ 221 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC------------BCTTSC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH------------HHhccC
Confidence 333 36889999999999999999999997643221110000 000000
Q ss_pred CC---CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 922 LS---MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 922 ~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
.. ......+..+.+++.+||+.||++| |++|+++.|+++....
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00 0112345678999999999999999 9999999999987654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=350.00 Aligned_cols=240 Identities=23% Similarity=0.240 Sum_probs=193.2
Q ss_pred HhhccCCCeeeccCceEEEEEEeC--CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCc-----
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP--NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET----- 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----- 757 (995)
.++|++.+.||+|+||+||+|.+. +++.||||++...........+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367899999999999999999874 5899999998654444445678899999999999999999999987665
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.|+||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+||+++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999988743 6899999999999999999999887 9999999999999985 899999999987
Q ss_pred cccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
.... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||...... .
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------~-------- 283 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------G-------- 283 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------S--------
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------c--------
Confidence 5332 3457999999999987654 88999999999999999999987531100 0
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCC-HHHHHHHHccC
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPR-MREVVQMLSEF 961 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~~~ 961 (995)
+. ........+..+.+++.+||+.||++||+ ++++.+.+.++
T Consensus 284 ~~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 284 LP--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp CC--TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cc--ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 00011234467889999999999999995 66666666554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=330.97 Aligned_cols=240 Identities=14% Similarity=0.114 Sum_probs=178.8
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC--ChhHHHHHHHHHHhccCC-CCce----------------
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRH-RNIV---------------- 746 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h-pniv---------------- 746 (995)
.|+.++.||+|+||+||+|++ .+|+.||||++...... ...+.+.+|+.+++.++| ++..
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 467788999999999999985 56999999998533222 235678999999999976 2211
Q ss_pred -----eEeEEEec-----CCcceEEEEeccCCChhhhhc-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 001922 747 -----RLLAFCSN-----KETNLLVYEYMRNGSLGEALH-----GKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVH 811 (995)
Q Consensus 747 -----~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 811 (995)
.+..++.. ....+++|+++ +++|.+++. ...+..+++..+..++.|++.||+|||+++ |+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 11111111 12356777766 679999984 334556788899999999999999999887 999
Q ss_pred cCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccccCccccccccc----------ccCCCCcccchhhHHHHHH
Q 001922 812 RDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYA----------YTLRVDEKSDVYSFGVVLL 881 (995)
Q Consensus 812 rDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvil~ 881 (995)
|||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999998864321 345567 999999998 5566889999999999999
Q ss_pred HHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 882 ELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 882 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
||++|+.||....... ....++.. ... .+..+.+++.+||+.||++||++.|+++
T Consensus 309 elltg~~Pf~~~~~~~---------------~~~~~~~~-~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALG---------------GSEWIFRS-CKN----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGS---------------CSGGGGSS-CCC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhh---------------hHHHHHhh-ccc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999996532110 01111111 112 2356899999999999999999877753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.20 Aligned_cols=229 Identities=23% Similarity=0.271 Sum_probs=180.6
Q ss_pred HHhhccCC-CeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHH-hccCCCCceeEeEEEec----CC
Q 001922 684 ILECVKDG-NVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTL-GNIRHRNIVRLLAFCSN----KE 756 (995)
Q Consensus 684 ~~~~~~~~-~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~----~~ 756 (995)
+.+.|... +.||+|+||.||+|.. .+++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 34566665 7899999999999976 5689999999842 34577888888 55589999999999876 67
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCCeEEeeec
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS---AFEAHVADFG 833 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~---~~~vkl~DfG 833 (995)
..++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 7899999999999999998766667999999999999999999999887 999999999999998 7889999999
Q ss_pred cccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
++.... +..++.++||||+||++|||++|+.||......... ..
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--------~~---- 209 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--------PG---- 209 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------CC----
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--------HH----
Confidence 987531 234678899999999999999999999653221100 00
Q ss_pred hhhhcCCcCCCCC----HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 914 FLSILDPRLSMVP----KEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 914 ~~~~~d~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
....+.......+ ...+..+.+++.+||+.||++||+++|+++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 210 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000001112 1346679999999999999999999999973
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=314.58 Aligned_cols=271 Identities=21% Similarity=0.272 Sum_probs=157.7
Q ss_pred cccccchHHHHHHHHHhC-CCCCCCCCCCCC--CCCCCCceeeeEEeCC----------CceeeeecCCCCccccCCccc
Q 001922 22 AASLVNDFHVLVALKQGF-ENPEPALISWNS--SNPSSVCSWAGICCSR----------DRVASLDLTDLNLCGSVPAQI 88 (995)
Q Consensus 22 ~~~~~~~~~~Ll~~k~~~-~~~~~~l~~W~~--~~~~~~C~w~gv~C~~----------~~v~~l~l~~~~l~~~~~~~~ 88 (995)
.++..+|++||++||+++ .||.+.+.+|.. ....++|.|.|+.|.. .+|+.|+|++++++ .+|+.+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 445678999999999999 578778899941 1135789999999952 34555555555554 444444
Q ss_pred cCCCCCCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceee
Q 001922 89 LRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLD 168 (995)
Q Consensus 89 ~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~ 168 (995)
.+ +++|++|+|++|.++ .+|..+..+++|++|+|++|+++ .+|..+.++++|++|+
T Consensus 101 ~~----------------------l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 101 FR----------------------LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp GG----------------------GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred hh----------------------CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 44 455555555555555 34445555555555555555555 3455566666666666
Q ss_pred ccCccccccCCcccc---------CCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccE
Q 001922 169 LGGNYFFGKIPNSYG---------ELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVH 239 (995)
Q Consensus 169 L~~N~l~~~~p~~l~---------~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~ 239 (995)
|++|++.+.+|..++ ++++|++|+|++|+++ .+|..++++++| ++
T Consensus 157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L-------------------------~~ 210 (328)
T 4fcg_A 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL-------------------------KS 210 (328)
T ss_dssp EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTC-------------------------CE
T ss_pred CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCC-------------------------CE
Confidence 666655555665544 3777777777777776 445444444433 34
Q ss_pred EECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcC
Q 001922 240 LDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRL 319 (995)
Q Consensus 240 L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 319 (995)
|+|++|++++ +|..+..+++|++|++++|.+.+.+|..+..+++|++|+|++|.+.+.+|..+.++++|+.|+|++|++
T Consensus 211 L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~ 289 (328)
T 4fcg_A 211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289 (328)
T ss_dssp EEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTT
T ss_pred EEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCc
Confidence 4444444442 233344444444444444444444555555555555555555555555555555556666666666555
Q ss_pred CCCCCccccCCCCcceEEeccCccc
Q 001922 320 HGSIPDYLADLPNLETLGLWQNNFT 344 (995)
Q Consensus 320 ~~~~p~~~~~l~~L~~L~L~~N~l~ 344 (995)
.+.+|..+..+++|+.+++..|.+.
T Consensus 290 ~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 290 LSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhhccHHHhhccCceEEeCCHHHHH
Confidence 5556666666666666665555443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-32 Score=304.52 Aligned_cols=288 Identities=23% Similarity=0.261 Sum_probs=188.0
Q ss_pred CCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEec
Q 001922 284 NLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLS 363 (995)
Q Consensus 284 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 363 (995)
+++.+++++|.++ .+|..+. ++|+.|++++|++++..|..|..+++|++|+|++|++++..|..|+.+++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 3455555555554 3333332 345555555555554444455555555555555555555445555555555555555
Q ss_pred CceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccC--CCCCCCcccCCCCceeeccCccccC
Q 001922 364 SNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLN--GSIPDGFIYLPGLNLAELQSNYLSG 441 (995)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~l~l~~n~l~~ 441 (995)
+|+++ .+|..+. ++|+.|++++|.+.+..+..+..+++|+.|++++|.++ +..|..+..+ +|+.+++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 55555 3444333 45555555555555544455556666666666666664 2455555555 56666666666654
Q ss_pred CCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCc
Q 001922 442 SLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPA 521 (995)
Q Consensus 442 ~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 521 (995)
+|... .++|++|++++|++++..+..+.++++|+.|+|++|++++..+..++.+++|+.|+|++|+++ .+|..
T Consensus 187 -l~~~~-----~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~ 259 (332)
T 2ft3_A 187 -IPKDL-----PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259 (332)
T ss_dssp -CCSSS-----CSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTT
T ss_pred -cCccc-----cCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChh
Confidence 23221 257888888888888777788888889999999999988777778888888999999999888 78888
Q ss_pred cCcccccceeeccCCcccCCCccccccc------cccCeEeccccccc--cccCcccccCCcccEEeccCCC
Q 001922 522 IGYCNHLTYLDMSQNNLSGSIPPEISNV------RILNYLNLSRNHLN--QNIPKSIGSMKSLTIADFSFND 585 (995)
Q Consensus 522 ~~~l~~L~~L~Ls~N~l~~~ip~~l~~l------~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~l~ls~N~ 585 (995)
++.+++|++|+|++|++++..+..|..+ ..|+.|+|++|++. +..|..+..+++|+.+++++|+
T Consensus 260 l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp GGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred hhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 8888899999999999886666666553 56888999999887 5677788888888888888874
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=303.78 Aligned_cols=302 Identities=22% Similarity=0.233 Sum_probs=190.7
Q ss_pred CCCCCCCCCCCC-ceeeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccc
Q 001922 46 LISWNSSNPSSV-CSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNIS 122 (995)
Q Consensus 46 l~~W~~~~~~~~-C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls 122 (995)
+..|....|..| |.|+.+.|+... ++ .+|..+. +.++.|+|++|++++.. .+.++++|++|+|+
T Consensus 18 i~~~~~~cp~~c~c~l~~l~~~~~~----------l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 84 (330)
T 1xku_A 18 IEPMGPVCPFRCQCHLRVVQCSDLG----------LE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILI 84 (330)
T ss_dssp ----CCCCCTTCEEETTEEECTTSC----------CC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cccccCCCCCCCcCCCeEEEecCCC----------cc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECC
Confidence 455654433333 778777776433 22 3444332 46777777777776643 36666677777777
Q ss_pred cccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccC
Q 001922 123 NNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKI 202 (995)
Q Consensus 123 ~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 202 (995)
+|+++++.|..|..+++|++|++++|+++. +|..+. ++|++|++++|.+++..+..|..+++|++|++++|.++.
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-- 159 (330)
T 1xku_A 85 NNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS-- 159 (330)
T ss_dssp SSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG--
T ss_pred CCcCCeeCHHHhcCCCCCCEEECCCCcCCc-cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc--
Confidence 666666666666666666666666666654 333332 456666666666655555555666666666666665542
Q ss_pred cccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCc
Q 001922 203 PGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNL 282 (995)
Q Consensus 203 ~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 282 (995)
.+..+..+..+++|++|++++|.++. +|..+. ++|++|++++|++++..|..+..+
T Consensus 160 ---------------------~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l 215 (330)
T 1xku_A 160 ---------------------SGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGL 215 (330)
T ss_dssp ---------------------GGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTC
T ss_pred ---------------------cCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCC
Confidence 11234455566667777777777663 344333 667777777777776667777777
Q ss_pred CCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccC------CCC
Q 001922 283 TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQ------NGK 356 (995)
Q Consensus 283 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------l~~ 356 (995)
++|++|+|++|.+++..+..|..+++|+.|++++|+++ .+|..+..+++|++|++++|++++..+..|.. ...
T Consensus 216 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~ 294 (330)
T 1xku_A 216 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 294 (330)
T ss_dssp TTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCC
T ss_pred CCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCccccccccc
Confidence 77777777777777776777777777888888888777 66777777778888888888877666666643 356
Q ss_pred CCeEEecCceecc--cCCCcCcCCCccceeeccccc
Q 001922 357 LQVLDLSSNKLTG--TIPTDLCSSNQLRILILLKNF 390 (995)
Q Consensus 357 L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~ 390 (995)
|+.|++++|++.. ..|..|..+..++.+++++|+
T Consensus 295 l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 295 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ccceEeecCcccccccCccccccccceeEEEecccC
Confidence 7788888887752 455667777888888888774
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=312.21 Aligned_cols=240 Identities=15% Similarity=0.144 Sum_probs=185.4
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCC-------CCChhHHHHHHHHHHhccC---------CCCceeE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFG-------THSHDHGFRAEIQTLGNIR---------HRNIVRL 748 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~---------hpniv~~ 748 (995)
.++|+..+.||+|+||+||+|++ +|+.||||++.... .....+.+.+|+.++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999988 78999999985432 2223467889999998886 6676666
Q ss_pred eEEE-----------------ec-------------CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 001922 749 LAFC-----------------SN-------------KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGL 798 (995)
Q Consensus 749 ~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l 798 (995)
.+++ .+ .+..|+||||+++|++.+.+.. ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 6653 22 6789999999999987777742 4589999999999999999
Q ss_pred HHHH-hcCCCCeEecCCCCCCEEECCCC--------------------CeEEeeeccccccccCCCCccccccccCcccc
Q 001922 799 CYLH-HDCSPLIVHRDVKSNNILLNSAF--------------------EAHVADFGLAKFLIDGGASECMSAIAGSYGYI 857 (995)
Q Consensus 799 ~~LH-~~~~~~iiHrDlkp~Nill~~~~--------------------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 857 (995)
+||| +.+ |+||||||+|||++.++ .+||+|||+|+...+ ....||+.|+
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~ 244 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSM 244 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTT
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeeccc
Confidence 9999 888 99999999999999887 899999999987643 2347999999
Q ss_pred cccccccCCCCcccchhhHHHH-HHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC--C-cCCCCCHHHHHHH
Q 001922 858 APEYAYTLRVDEKSDVYSFGVV-LLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD--P-RLSMVPKEEAMHL 933 (995)
Q Consensus 858 aPE~~~~~~~~~~~DvwSlGvi-l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~-~~~~~~~~~~~~l 933 (995)
|||++.+.. +.++||||+|++ .+++++|..||.. ..|...... ....... . .....+...+..+
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-------VLWLHYLTD----KMLKQMTFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-------HHHHHHHHH----HHHHTCCCSSCCCSHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-------hhhhhHHHH----hhhhhhccCcccchhhhhhcCHHH
Confidence 999998766 899999998777 7888889999832 111111110 0000000 0 0111234678899
Q ss_pred HHHHhcccCCCCCCCCCHHHHH
Q 001922 934 LFVAMLCIQENSIERPRMREVV 955 (995)
Q Consensus 934 ~~li~~cl~~dP~~RPt~~evl 955 (995)
.+++.+||+.| |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999976 899988
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-32 Score=299.58 Aligned_cols=290 Identities=23% Similarity=0.244 Sum_probs=211.6
Q ss_pred cccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEe
Q 001922 259 KLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGL 338 (995)
Q Consensus 259 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 338 (995)
.+++.++++++.++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|++++|++++..|..|..+++|++|++
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 35666777777766 3454443 46777777777777666666777777777777777777666667777777777777
Q ss_pred ccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccC--CCCCcccccCCCCcEEEecCCccC
Q 001922 339 WQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLF--GPIPERLGACYSLTRVRLGQNYLN 416 (995)
Q Consensus 339 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~l~~l~~L~~L~l~~N~l~ 416 (995)
++|+++ .+|..+. ++|++|++++|++++..+..+..+++|+.|++++|.+. +..+..+..+++|+.|++++|.++
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 777776 3444443 56777777777766555555566666666666666553 244555555555555555555554
Q ss_pred CCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCC
Q 001922 417 GSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPP 496 (995)
Q Consensus 417 ~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 496 (995)
. +|... .++|++|++++|++++..|..+..+++|+.|+|++|++++..+.
T Consensus 185 ~-------------------------l~~~~-----~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 234 (330)
T 1xku_A 185 T-------------------------IPQGL-----PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG 234 (330)
T ss_dssp S-------------------------CCSSC-----CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTT
T ss_pred c-------------------------CCccc-----cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChh
Confidence 2 22211 25789999999999988889999999999999999999988888
Q ss_pred CccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccc------cccCeEecccccccc--ccCc
Q 001922 497 SIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNV------RILNYLNLSRNHLNQ--NIPK 568 (995)
Q Consensus 497 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l------~~L~~L~L~~N~l~~--~~p~ 568 (995)
.+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|++++..+..|+.. ..|+.|+|++|++.. ..|.
T Consensus 235 ~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~ 313 (330)
T 1xku_A 235 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313 (330)
T ss_dssp TGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGG
T ss_pred hccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcc
Confidence 9999999999999999998 799999999999999999999997666666543 788999999999864 5678
Q ss_pred ccccCCcccEEeccCCC
Q 001922 569 SIGSMKSLTIADFSFND 585 (995)
Q Consensus 569 ~~~~l~~L~~l~ls~N~ 585 (995)
.+..+++++.++|++|+
T Consensus 314 ~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 314 TFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp GGTTCCCGGGEEC----
T ss_pred ccccccceeEEEecccC
Confidence 89999999999999985
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=303.92 Aligned_cols=246 Identities=24% Similarity=0.276 Sum_probs=114.5
Q ss_pred CCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeec
Q 001922 92 DKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDL 169 (995)
Q Consensus 92 ~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L 169 (995)
++|++|+|++|++++.. .+.++++|++|+|++|++++..+..|.++++|++|++++|+++. +|..+. ++|++|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCS-CCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCc-cCcccc--ccCCEEEC
Confidence 45555666555555432 34555555555555555554444444444444444444444443 222222 34444444
Q ss_pred cCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCC
Q 001922 170 GGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDG 249 (995)
Q Consensus 170 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~ 249 (995)
++|++++..+..|..+++|++|++++|.++. .+..+..+..+ +|++|++++|++++
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~-----------------------~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN-----------------------SGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBG-----------------------GGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCcccc-----------------------CCCCcccccCC-ccCEEECcCCCCCc
Confidence 4444443333334444444444444444431 01223333334 55555555555553
Q ss_pred ccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccC
Q 001922 250 QIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLAD 329 (995)
Q Consensus 250 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 329 (995)
+|..+. ++|++|++++|.+++..+..+..+++|++|+|++|.+++..+..|..+++|+.|++++|+++ .+|..+..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 333222 34555555555555444445555555555555555555444445555555555555555554 44444555
Q ss_pred CCCcceEEeccCcccccCCCcccCC------CCCCeEEecCceec
Q 001922 330 LPNLETLGLWQNNFTGVIPENLGQN------GKLQVLDLSSNKLT 368 (995)
Q Consensus 330 l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~ 368 (995)
+++|+.|++++|++++..+..|... ..|+.|++++|++.
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCccc
Confidence 5555555555555554444433321 33444444444443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-36 Score=350.85 Aligned_cols=363 Identities=20% Similarity=0.128 Sum_probs=182.4
Q ss_pred cccceeccccccccCCCccc-cccccccccccccccccccc----CCccccCCCCCceeeccCccccccCCccc-cCCC-
Q 001922 114 SSLQFLNISNNQFSGGLDWN-YSSLVNLEVFDAYNNNFTAL----LPVGILKLEKLKYLDLGGNYFFGKIPNSY-GELQ- 186 (995)
Q Consensus 114 ~~L~~L~Ls~N~i~~~~~~~-~~~l~~L~~L~Ls~n~i~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~- 186 (995)
++|++|+|++|+++...... +..+++|++|++++|+++.. ++..+..+++|++|+|++|.+++..+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 56777777777776543333 56666777777777776642 34556666677777777776654333332 2233
Q ss_pred ---CCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCcccc-----Cc
Q 001922 187 ---GLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIG-----NL 258 (995)
Q Consensus 187 ---~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-----~l 258 (995)
+|++|+|++|+++.... ..++..+..+++|++|++++|.+++..+..+. ..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~---------------------~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~ 141 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGC---------------------GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGH---------------------HHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred CCCceeEEEccCCCCCHHHH---------------------HHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCC
Confidence 46666666666653110 01223334444555555555555433222221 12
Q ss_pred cccCccccccccccCC----CCccccCcCCCCeEeccCCcCcCcCCccccc-----cCCCCEEEccCCcCCCC----CCc
Q 001922 259 KLLDTVFLHINLLSGS----IPKQLGNLTNLVNLDLSNNALTGEIPYSFIN-----LRQLKLFNLFMNRLHGS----IPD 325 (995)
Q Consensus 259 ~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~----~p~ 325 (995)
++|++|++++|++++. ++..+..+++|++|++++|.+++..+..+.. .++|+.|++++|.+++. ++.
T Consensus 142 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 221 (461)
T 1z7x_W 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred CcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHH
Confidence 3344444444444432 2333444455555555555555433333321 33555555555555532 244
Q ss_pred cccCCCCcceEEeccCcccccC-----CCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccc
Q 001922 326 YLADLPNLETLGLWQNNFTGVI-----PENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLG 400 (995)
Q Consensus 326 ~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~ 400 (995)
.+..+++|++|++++|++++.. +..+..+++|++|+|++|.+++... ..++..+.
T Consensus 222 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~--------------------~~l~~~l~ 281 (461)
T 1z7x_W 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGC--------------------GDLCRVLR 281 (461)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHH--------------------HHHHHHHH
T ss_pred HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHH--------------------HHHHHHHh
Confidence 4444555555555555554321 1112234455555555555442100 01344455
Q ss_pred cCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCccccc----CCccccC
Q 001922 401 ACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGP----LPFSLSN 476 (995)
Q Consensus 401 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~----~p~~~~~ 476 (995)
.+++|++|++++|.+.+..+..+... + ....++|++|+|++|.+++. ++..+..
T Consensus 282 ~~~~L~~L~Ls~n~i~~~~~~~l~~~----------------l------~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~ 339 (461)
T 1z7x_W 282 AKESLKELSLAGNELGDEGARLLCET----------------L------LEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339 (461)
T ss_dssp HCTTCCEEECTTCCCHHHHHHHHHHH----------------H------TSTTCCCCEEECTTSCCBGGGHHHHHHHHHH
T ss_pred hCCCcceEECCCCCCchHHHHHHHHH----------------h------ccCCccceeeEcCCCCCchHHHHHHHHHHhh
Confidence 56666666666666543222211110 0 00123566777777776644 4555666
Q ss_pred CCCCcEEEcCCCcccCCCCCCccc-----hhhhccccccccccCC----CCCCccCcccccceeeccCCccc
Q 001922 477 FSSLQILLLSGNQFSGPIPPSIGE-----LRQVLKLDLSRNSLSG----EIPPAIGYCNHLTYLDMSQNNLS 539 (995)
Q Consensus 477 l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 539 (995)
+++|+.|+|++|++++..+..+.. .++|+.|+|++|.+++ .+|..+..+++|++|+|++|+++
T Consensus 340 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp CSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred CCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 677777777777776433333322 3355555555555553 34555555555555555555554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-35 Score=345.17 Aligned_cols=384 Identities=18% Similarity=0.145 Sum_probs=244.4
Q ss_pred cccccccccccccccccCCcc-ccCCCCCceeeccCccccc----cCCccccCCCCCceeeccCCcccccCcccccchhh
Q 001922 137 LVNLEVFDAYNNNFTALLPVG-ILKLEKLKYLDLGGNYFFG----KIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTN 211 (995)
Q Consensus 137 l~~L~~L~Ls~n~i~~~~p~~-~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 211 (995)
.++|++||+++|+++...... +..+++|++|+|++|.+++ .++..+..+++|++|+|++|.+++..+..+..
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~--- 78 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ--- 78 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHH---
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHH---
Confidence 357888888888887654333 6778888888888888874 35666777888888888888887433322211
Q ss_pred hhhhhccccccccCCCCcccCC-CCcccEEECcCCCCCC----ccCccccCccccCccccccccccCCCCcccc-----C
Q 001922 212 LREIYLGYYNVFEGGIPREVGK-LVNLVHLDLSSCELDG----QIPHEIGNLKLLDTVFLHINLLSGSIPKQLG-----N 281 (995)
Q Consensus 212 L~~L~L~~n~~~~~~~p~~~~~-l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~-----~ 281 (995)
.+.. ..+|++|+|++|+++. .++..+..+++|++|++++|.+++..+..+. .
T Consensus 79 ------------------~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~ 140 (461)
T 1z7x_W 79 ------------------GLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDP 140 (461)
T ss_dssp ------------------TTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTST
T ss_pred ------------------HHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcC
Confidence 0111 1268889999998874 4466777777777777777777643333222 2
Q ss_pred cCCCCeEeccCCcCcCcC----CccccccCCCCEEEccCCcCCCCCCcccc-----CCCCcceEEeccCccccc----CC
Q 001922 282 LTNLVNLDLSNNALTGEI----PYSFINLRQLKLFNLFMNRLHGSIPDYLA-----DLPNLETLGLWQNNFTGV----IP 348 (995)
Q Consensus 282 l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~p 348 (995)
.++|++|+|++|.+++.. +..+..+++|+.|++++|.+++..+..+. ..++|++|++++|.+++. ++
T Consensus 141 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 220 (461)
T 1z7x_W 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 220 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHH
T ss_pred CCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHH
Confidence 456777777777777533 44455567777777777776644333332 245667777777766642 34
Q ss_pred CcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCC----CCCCcc
Q 001922 349 ENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGS----IPDGFI 424 (995)
Q Consensus 349 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~ 424 (995)
..+..+++|++|+|++|++++.....+ .+..+..+++|++|++++|.++.. ++..+.
T Consensus 221 ~~l~~~~~L~~L~Ls~n~l~~~~~~~l-------------------~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~ 281 (461)
T 1z7x_W 221 GIVASKASLRELALGSNKLGDVGMAEL-------------------CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHH-------------------HHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHH
T ss_pred HHHHhCCCccEEeccCCcCChHHHHHH-------------------HHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHh
Confidence 555566666666666666653211000 012223467888888888887643 233332
Q ss_pred cCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccC-----CCCCcEEEcCCCcccCC----CC
Q 001922 425 YLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSN-----FSSLQILLLSGNQFSGP----IP 495 (995)
Q Consensus 425 ~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~----~p 495 (995)
.+ ++|++|+|++|.+++..+..+.. .++|+.|+|++|.+++. ++
T Consensus 282 ~~---------------------------~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 334 (461)
T 1z7x_W 282 AK---------------------------ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334 (461)
T ss_dssp HC---------------------------TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred hC---------------------------CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence 22 45667777777776544433332 36889999999988754 45
Q ss_pred CCccchhhhccccccccccCCCCCCccCc-----ccccceeeccCCcccC----CCccccccccccCeEecccccccccc
Q 001922 496 PSIGELRQVLKLDLSRNSLSGEIPPAIGY-----CNHLTYLDMSQNNLSG----SIPPEISNVRILNYLNLSRNHLNQNI 566 (995)
Q Consensus 496 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~ip~~l~~l~~L~~L~L~~N~l~~~~ 566 (995)
..+..+++|+.|+|++|.+++..+..+.. .++|++|+|++|++++ .+|..+..+++|++|+|++|++++.-
T Consensus 335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~ 414 (461)
T 1z7x_W 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 414 (461)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHH
T ss_pred HHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHH
Confidence 55666788888888888887654444443 5688888888888875 67888888888888888888887642
Q ss_pred Ccccc-----cCCcccEEeccCCCCC
Q 001922 567 PKSIG-----SMKSLTIADFSFNDFS 587 (995)
Q Consensus 567 p~~~~-----~l~~L~~l~ls~N~l~ 587 (995)
...+. ...+|+.|++.++.+.
T Consensus 415 ~~~l~~~l~~~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 415 ILQLVESVRQPGCLLEQLVLYDIYWS 440 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred HHHHHHHhccCCcchhheeecccccC
Confidence 11111 1234566666555544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-31 Score=289.48 Aligned_cols=282 Identities=22% Similarity=0.277 Sum_probs=172.0
Q ss_pred CceeeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCC--Ccc
Q 001922 57 VCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGG--LDW 132 (995)
Q Consensus 57 ~C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~--~~~ 132 (995)
.|.|.+|.|+...++ .+|..+. ++|++|+|++|+++... .+.++++|++|+|++|.++.. .+.
T Consensus 6 ~C~~~~l~c~~~~l~-----------~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 72 (306)
T 2z66_A 6 SCSGTEIRCNSKGLT-----------SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72 (306)
T ss_dssp EEETTEEECCSSCCS-----------SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEH
T ss_pred eeCCCEEEcCCCCcc-----------cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCccc
Confidence 389999999865433 3454332 57888888888887644 267788888888888877633 245
Q ss_pred cccccccccccccccccccccCCccccCCCCCceeeccCccccccCC-ccccCCCCCceeeccCCcccccCcccccchhh
Q 001922 133 NYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIP-NSYGELQGLEYLSLAGNDLTGKIPGELGNLTN 211 (995)
Q Consensus 133 ~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 211 (995)
.+..+++|++|++++|.++. +|..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+++..+..+.+++
T Consensus 73 ~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~- 150 (306)
T 2z66_A 73 SDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS- 150 (306)
T ss_dssp HHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCT-
T ss_pred ccccccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCc-
Confidence 55566777777777777765 45556777777777777777764443 4566777777777777777655555555444
Q ss_pred hhhhhccccccccCCCCcccCCCCcccEEECcCCCCCC-ccCccccCccccCccccccccccCCCCccccCcCCCCeEec
Q 001922 212 LREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDG-QIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDL 290 (995)
Q Consensus 212 L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L 290 (995)
+|++|++++|.+++ ..|..+..+++|++|++++|++++..|..+..+++|++|+|
T Consensus 151 ------------------------~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 206 (306)
T 2z66_A 151 ------------------------SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206 (306)
T ss_dssp ------------------------TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred ------------------------CCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEEC
Confidence 45555555555543 34455555555555555555555555555666666666666
Q ss_pred cCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCC-CcceEEeccCcccccCC--CcccCCCCCCeEEecCcee
Q 001922 291 SNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLP-NLETLGLWQNNFTGVIP--ENLGQNGKLQVLDLSSNKL 367 (995)
Q Consensus 291 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l 367 (995)
++|.+++..+..|..+++|+.|++++|++++..|..+..++ +|++|+|++|.+++.-+ .....+...+.+.+..+.+
T Consensus 207 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~ 286 (306)
T 2z66_A 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERM 286 (306)
T ss_dssp TTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGC
T ss_pred CCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhcccccc
Confidence 66666655555566666666666666666666666666653 66666666666654211 0011122334445555666
Q ss_pred cccCCCcCcC
Q 001922 368 TGTIPTDLCS 377 (995)
Q Consensus 368 ~~~~p~~~~~ 377 (995)
....|..+.+
T Consensus 287 ~C~~p~~~~g 296 (306)
T 2z66_A 287 ECATPSDKQG 296 (306)
T ss_dssp BEEESGGGTT
T ss_pred ccCCchhhCC
Confidence 6666665544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-31 Score=294.57 Aligned_cols=277 Identities=20% Similarity=0.243 Sum_probs=163.6
Q ss_pred CCceeeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCccc
Q 001922 56 SVCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWN 133 (995)
Q Consensus 56 ~~C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~ 133 (995)
..|.|.|+ | |+++++++ .+|..+. ++|++|+|++|++++.. .+.++++|++|+|++|++++..+..
T Consensus 28 ~~C~~~~~-c--------~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 95 (353)
T 2z80_A 28 LSCDRNGI-C--------KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS 95 (353)
T ss_dssp CEECTTSE-E--------ECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT
T ss_pred CCCCCCeE-e--------eCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhh
Confidence 46899887 5 34455554 4666544 36777777777776533 3666666666666666666655555
Q ss_pred ccccccccccccccccccccCCccccCCCCCceeeccCccccccCC-ccccCCCCCceeeccCCc-ccccCcccccchhh
Q 001922 134 YSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIP-NSYGELQGLEYLSLAGND-LTGKIPGELGNLTN 211 (995)
Q Consensus 134 ~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~-l~~~~~~~l~~l~~ 211 (995)
|.++++|++|++++|+++++.+..|.++++|++|+|++|++++..+ ..|..+++|++|++++|+ +++.
T Consensus 96 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~---------- 165 (353)
T 2z80_A 96 FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI---------- 165 (353)
T ss_dssp TTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEE----------
T ss_pred cCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccccc----------
Confidence 5555566666666665555444445555555555555555552222 245555555555555552 3322
Q ss_pred hhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEecc
Q 001922 212 LREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLS 291 (995)
Q Consensus 212 L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls 291 (995)
.+..+.++++|++|++++|++++..|..+..+++|++|++++|+++...+..+..+++|+.|+++
T Consensus 166 ---------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~ 230 (353)
T 2z80_A 166 ---------------QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230 (353)
T ss_dssp ---------------CTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEE
T ss_pred ---------------CHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECC
Confidence 33445555666666666666666666666666666666666666653333334446677777777
Q ss_pred CCcCcCcCCcccc---ccCCCCEEEccCCcCCC----CCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecC
Q 001922 292 NNALTGEIPYSFI---NLRQLKLFNLFMNRLHG----SIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSS 364 (995)
Q Consensus 292 ~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 364 (995)
+|.+++..+..+. ....++.++++++.+++ .+|..+..+++|++|+|++|+++...+..|..+++|++|+|++
T Consensus 231 ~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 310 (353)
T 2z80_A 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHT 310 (353)
T ss_dssp SCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeC
Confidence 7777655444332 24456666666666654 2455666677777777777777643333346677777777777
Q ss_pred ceecc
Q 001922 365 NKLTG 369 (995)
Q Consensus 365 N~l~~ 369 (995)
|++++
T Consensus 311 N~~~~ 315 (353)
T 2z80_A 311 NPWDC 315 (353)
T ss_dssp SCBCC
T ss_pred CCccC
Confidence 76664
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-32 Score=332.69 Aligned_cols=454 Identities=16% Similarity=0.081 Sum_probs=248.9
Q ss_pred CceeeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCccc---Ccc--c------------cCccccccee
Q 001922 57 VCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFT---GSI--E------------IGNLSSLQFL 119 (995)
Q Consensus 57 ~C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~---~~~--~------------~~~l~~L~~L 119 (995)
|++|.++.+...+. +.+.+ ......+..+..+++|++|+|+++... +.. . ...+++|++|
T Consensus 41 ck~W~~~~~~~~~~--l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L 117 (592)
T 3ogk_B 41 CRRWFKIDSETREH--VTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSV 117 (592)
T ss_dssp CHHHHHHHHHHCCE--EEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEE
T ss_pred hHHHHHhhhccccE--EEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeE
Confidence 45799986543322 22221 122233445567889999999874321 100 1 1267888888
Q ss_pred ccccccccCCCccccccc-c-ccccccccccc-ccc-cCCccccCCCCCceeeccCcccccc----CCccccCCCCCcee
Q 001922 120 NISNNQFSGGLDWNYSSL-V-NLEVFDAYNNN-FTA-LLPVGILKLEKLKYLDLGGNYFFGK----IPNSYGELQGLEYL 191 (995)
Q Consensus 120 ~Ls~N~i~~~~~~~~~~l-~-~L~~L~Ls~n~-i~~-~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L 191 (995)
+|++|.+++..+..+... + +|++|+|++|. ++. .++.....+++|++|+|++|.+++. ++..+..+++|++|
T Consensus 118 ~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L 197 (592)
T 3ogk_B 118 HFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVL 197 (592)
T ss_dssp EEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEE
T ss_pred EeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEE
Confidence 888887776555555553 3 48888887775 221 1222334677888888888877654 33344567778888
Q ss_pred eccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccc
Q 001922 192 SLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLL 271 (995)
Q Consensus 192 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l 271 (995)
+|++|.+++.....+ +..+..+++|++|++++|.+.+ ++..+..+++|+.|+++.+..
T Consensus 198 ~L~~n~~~~~~~~~l---------------------~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~ 255 (592)
T 3ogk_B 198 NFYMTEFAKISPKDL---------------------ETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNE 255 (592)
T ss_dssp ECTTCCCSSCCHHHH---------------------HHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCC
T ss_pred EeeccCCCccCHHHH---------------------HHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhccccccc
Confidence 888777763222111 1122234556666666666653 445566666666666654222
Q ss_pred c---CCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCC-ccccCCCCcceEEeccCcccccC
Q 001922 272 S---GSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIP-DYLADLPNLETLGLWQNNFTGVI 347 (995)
Q Consensus 272 ~---~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~ 347 (995)
. +..+..+..+++|+.|+++++... .+|..+..+++|+.|++++|.+++... ..+..+++|+.|+++++-..+.+
T Consensus 256 ~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l 334 (592)
T 3ogk_B 256 DIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGL 334 (592)
T ss_dssp CTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHH
T ss_pred ccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHH
Confidence 1 223345666777777777775433 566667777778888887777654333 33567778888888733222333
Q ss_pred CCcccCCCCCCeEEecC-----------ceecccCC-CcCcCCCccceeeccccccCCCCCccccc-CCCCcEEEecCCc
Q 001922 348 PENLGQNGKLQVLDLSS-----------NKLTGTIP-TDLCSSNQLRILILLKNFLFGPIPERLGA-CYSLTRVRLGQNY 414 (995)
Q Consensus 348 p~~~~~l~~L~~L~L~~-----------N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~l~~-l~~L~~L~l~~N~ 414 (995)
+..+..+++|++|+|++ |.+++... .....+++|+.|++..|.+.+..+..+.. +++|+.|+++++.
T Consensus 335 ~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~ 414 (592)
T 3ogk_B 335 EVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLD 414 (592)
T ss_dssp HHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECS
T ss_pred HHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecC
Confidence 33345567788888773 44443211 11222444555555444444433333333 4444444443110
Q ss_pred cCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCccccc-----CCccccCCCCCcEEEcCCCc
Q 001922 415 LNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGP-----LPFSLSNFSSLQILLLSGNQ 489 (995)
Q Consensus 415 l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~ 489 (995)
..|.+++. ++..+.++++|+.|+|++|.
T Consensus 415 -----------------------------------------------~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~ 447 (592)
T 3ogk_B 415 -----------------------------------------------REERITDLPLDNGVRSLLIGCKKLRRFAFYLRQ 447 (592)
T ss_dssp -----------------------------------------------CCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCG
T ss_pred -----------------------------------------------CCccccCchHHHHHHHHHHhCCCCCEEEEecCC
Confidence 02222221 22224445566666665322
Q ss_pred --ccCCCCCCccc-hhhhccccccccccCC-CCCCccCcccccceeeccCCcccCC-CccccccccccCeEecccccccc
Q 001922 490 --FSGPIPPSIGE-LRQVLKLDLSRNSLSG-EIPPAIGYCNHLTYLDMSQNNLSGS-IPPEISNVRILNYLNLSRNHLNQ 564 (995)
Q Consensus 490 --l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-ip~~l~~l~~L~~L~L~~N~l~~ 564 (995)
+++..+..++. +++|+.|+|++|++++ .++..+..+++|++|+|++|.+++. ++..+..+++|++|+|++|+++.
T Consensus 448 ~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 448 GGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp GGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred CCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 33322223322 4556666666666654 2344456667777777777776644 33344567777777777777765
Q ss_pred ccCcccc-cCCcccEEeccC
Q 001922 565 NIPKSIG-SMKSLTIADFSF 583 (995)
Q Consensus 565 ~~p~~~~-~l~~L~~l~ls~ 583 (995)
.-...+. .++.+....+..
T Consensus 528 ~~~~~l~~~~p~l~~~~~~~ 547 (592)
T 3ogk_B 528 TGQDLMQMARPYWNIELIPS 547 (592)
T ss_dssp TCTTGGGGCCTTEEEEEECC
T ss_pred HHHHHHHHhCCCcEEEEecC
Confidence 4333332 456555554443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=278.32 Aligned_cols=250 Identities=22% Similarity=0.220 Sum_probs=191.0
Q ss_pred CeEeccCCcccCccccCcccccceeccccccccCCCccccccccccccccccccccccc--CCccccCCCCCceeeccCc
Q 001922 95 TNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTAL--LPVGILKLEKLKYLDLGGN 172 (995)
Q Consensus 95 ~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~--~p~~~~~l~~L~~L~L~~N 172 (995)
+.++.+++.++.... .-.++|++|+|++|+++.+++..|.++++|++|++++|+++.. .|..+..+++|++|+|++|
T Consensus 10 ~~l~c~~~~l~~ip~-~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n 88 (306)
T 2z66_A 10 TEIRCNSKGLTSVPT-GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88 (306)
T ss_dssp TEEECCSSCCSSCCS-CCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSC
T ss_pred CEEEcCCCCcccCCC-CCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCC
Confidence 456777776664321 2235677777777777766655666667777777777666643 2455556666666666666
Q ss_pred cccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccC
Q 001922 173 YFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIP 252 (995)
Q Consensus 173 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~ 252 (995)
.++ .+|..+..+++|++|++++|++++..+ ...+..+++|++|++++|.+++..+
T Consensus 89 ~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~------------------------~~~~~~l~~L~~L~l~~n~l~~~~~ 143 (306)
T 2z66_A 89 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE------------------------FSVFLSLRNLIYLDISHTHTRVAFN 143 (306)
T ss_dssp SEE-EEEEEEETCTTCCEEECTTSEEESSTT------------------------TTTTTTCTTCCEEECTTSCCEECST
T ss_pred ccc-cChhhcCCCCCCCEEECCCCccccccc------------------------chhhhhccCCCEEECCCCcCCccch
Confidence 665 455556666666666666666653221 1356677889999999999988888
Q ss_pred ccccCccccCccccccccccC-CCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCC
Q 001922 253 HEIGNLKLLDTVFLHINLLSG-SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLP 331 (995)
Q Consensus 253 ~~~~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 331 (995)
..+..+++|++|++++|.+++ .+|..+..+++|++|++++|.+++..|..|..+++|+.|++++|++++..+..+..++
T Consensus 144 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 223 (306)
T 2z66_A 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223 (306)
T ss_dssp TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCT
T ss_pred hhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcc
Confidence 889999999999999999986 5788899999999999999999988888999999999999999999987777888899
Q ss_pred CcceEEeccCcccccCCCcccCCC-CCCeEEecCceeccc
Q 001922 332 NLETLGLWQNNFTGVIPENLGQNG-KLQVLDLSSNKLTGT 370 (995)
Q Consensus 332 ~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~ 370 (995)
+|+.|+|++|++++..|..+..++ +|++|+|++|++++.
T Consensus 224 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 224 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp TCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred cCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 999999999999988888888884 899999999999854
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=281.78 Aligned_cols=279 Identities=19% Similarity=0.159 Sum_probs=150.1
Q ss_pred ccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccC
Q 001922 237 LVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFM 316 (995)
Q Consensus 237 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 316 (995)
....++++|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.+++..|..|.++++|++|++++
T Consensus 33 ~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 33 NGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp TSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence 334555555555 3344333 3555566666665554444555666666666666666655555566666666666666
Q ss_pred CcCCCCCCccccCCCCcceEEeccCcccccCC-CcccCCCCCCeEEecCc-eecccCCCcCcCCCccceeeccccccCCC
Q 001922 317 NRLHGSIPDYLADLPNLETLGLWQNNFTGVIP-ENLGQNGKLQVLDLSSN-KLTGTIPTDLCSSNQLRILILLKNFLFGP 394 (995)
Q Consensus 317 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 394 (995)
|++++..+..|..+++|++|++++|++++..+ ..+..+++|++|++++| .+++..+..+..+++|+.|++++|.+.+.
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 189 (353)
T 2z80_A 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSY 189 (353)
T ss_dssp SCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred CcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCcc
Confidence 66654444445556666666666666653322 24555666666666665 34444455555566666666666666555
Q ss_pred CCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccc
Q 001922 395 IPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSL 474 (995)
Q Consensus 395 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~ 474 (995)
.|..+..+++|++|++++|++....+..+..+++|+.+++++|.+++..+.......
T Consensus 190 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~----------------------- 246 (353)
T 2z80_A 190 EPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE----------------------- 246 (353)
T ss_dssp CTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-----------------------------
T ss_pred CHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccccc-----------------------
Confidence 555666666666666666655422222222334444444444333322211111111
Q ss_pred cCCCCCcEEEcCCCcccC----CCCCCccchhhhccccccccccCCCCCCc-cCcccccceeeccCCcccCCCc
Q 001922 475 SNFSSLQILLLSGNQFSG----PIPPSIGELRQVLKLDLSRNSLSGEIPPA-IGYCNHLTYLDMSQNNLSGSIP 543 (995)
Q Consensus 475 ~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~ip 543 (995)
....++.++|++|.+++ .+|..+..+++|+.|+|++|+++ .+|.. |+.+++|++|+|++|.+++..|
T Consensus 247 -~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 247 -TNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp -CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred -ccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 22344455555555443 24555666667777777777776 45554 4777788888888887775443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-32 Score=329.46 Aligned_cols=378 Identities=12% Similarity=0.055 Sum_probs=249.5
Q ss_pred CCCCCceeeccCCcccccCcccccch--hhhhhhhcccccccc-CCCCcccCCCCcccEEECcCCCCCCc----cCcccc
Q 001922 184 ELQGLEYLSLAGNDLTGKIPGELGNL--TNLREIYLGYYNVFE-GGIPREVGKLVNLVHLDLSSCELDGQ----IPHEIG 256 (995)
Q Consensus 184 ~l~~L~~L~Ls~N~l~~~~~~~l~~l--~~L~~L~L~~n~~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~ 256 (995)
.+++|++|+|++|.+++..+..++.. .+|++|+|++|.... ..++.....+++|++|+|++|.+++. ++..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 45666666666666665555555543 336666665544211 11222233567778888888777654 233345
Q ss_pred CccccCccccccccccC----CCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCC---CCCCccccC
Q 001922 257 NLKLLDTVFLHINLLSG----SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLH---GSIPDYLAD 329 (995)
Q Consensus 257 ~l~~L~~L~l~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~ 329 (995)
.+++|++|++++|.+++ .++..+.++++|+.|++++|.+.+ +|..+.++++|+.|+++.+... +..+..+..
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 268 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF 268 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence 56777777777777762 234445567778888888877774 5567777778888877754322 233445666
Q ss_pred CCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCC-CcCcCCCccceeeccccccCCCCCcccccCCCCcEE
Q 001922 330 LPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIP-TDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRV 408 (995)
Q Consensus 330 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L 408 (995)
+++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++++...+.++.....+++|++|
T Consensus 269 ~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L 347 (592)
T 3ogk_B 269 PRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRL 347 (592)
T ss_dssp CTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEE
T ss_pred cccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEE
Confidence 777777777775433 556666777778888888777654333 224566777777776333223334444566777777
Q ss_pred EecC-----------CccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccC-
Q 001922 409 RLGQ-----------NYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSN- 476 (995)
Q Consensus 409 ~l~~-----------N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~- 476 (995)
++++ |.+++.....+ ...+++|++|+++.|++++..+..+..
T Consensus 348 ~L~~g~~~~~~~~~~~~~~~~~~~~l--------------------------~~~~~~L~~L~l~~~~l~~~~~~~l~~~ 401 (592)
T 3ogk_B 348 RIERGADEQGMEDEEGLVSQRGLIAL--------------------------AQGCQELEYMAVYVSDITNESLESIGTY 401 (592)
T ss_dssp EEECCCCSSTTSSTTCCCCHHHHHHH--------------------------HHHCTTCSEEEEEESCCCHHHHHHHHHH
T ss_pred EeecCccccccccccCccCHHHHHHH--------------------------HhhCccCeEEEeecCCccHHHHHHHHhh
Confidence 7773 33321100000 012457888888888888777777765
Q ss_pred CCCCcEEEcC----CCcccCC-----CCCCccchhhhcccccccc--ccCCCCCCccCc-ccccceeeccCCcccC-CCc
Q 001922 477 FSSLQILLLS----GNQFSGP-----IPPSIGELRQVLKLDLSRN--SLSGEIPPAIGY-CNHLTYLDMSQNNLSG-SIP 543 (995)
Q Consensus 477 l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~ip 543 (995)
+++|+.|+|+ .|++++. ++..+..+++|+.|+|++| .+++..+..++. +++|++|+|++|++++ .++
T Consensus 402 ~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 481 (592)
T 3ogk_B 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM 481 (592)
T ss_dssp CCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHH
T ss_pred CCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHH
Confidence 8999999996 7788753 2333667899999999854 376655555544 8899999999999986 456
Q ss_pred cccccccccCeEeccccccccc-cCcccccCCcccEEeccCCCCCCC
Q 001922 544 PEISNVRILNYLNLSRNHLNQN-IPKSIGSMKSLTIADFSFNDFSGK 589 (995)
Q Consensus 544 ~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~l~ls~N~l~g~ 589 (995)
..+..+++|++|+|++|++++. ++..+..+++|+.|++++|++++.
T Consensus 482 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 482 EFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 6678899999999999998765 445556799999999999998764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-28 Score=270.00 Aligned_cols=234 Identities=22% Similarity=0.295 Sum_probs=140.6
Q ss_pred cCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEE
Q 001922 282 LTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLD 361 (995)
Q Consensus 282 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 361 (995)
.++++.|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|+++ .+|..++.+++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 357788888888887 66667777888888888888887 67777778888888888888887 6677788888888888
Q ss_pred ecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccC
Q 001922 362 LSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSG 441 (995)
Q Consensus 362 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~ 441 (995)
|++|++.+.+|..+... ..+..+.++++|++|++++|+++ .
T Consensus 157 L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~----------------------- 197 (328)
T 4fcg_A 157 IRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-S----------------------- 197 (328)
T ss_dssp EEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-C-----------------------
T ss_pred CCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-c-----------------------
Confidence 88877777777665431 11223445555555555555554 2
Q ss_pred CCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCc
Q 001922 442 SLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPA 521 (995)
Q Consensus 442 ~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 521 (995)
+|..+.++++|+.|+|++|++++ +|..++.+++|+.|+|++|++.+.+|..
T Consensus 198 ----------------------------lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~ 248 (328)
T 4fcg_A 198 ----------------------------LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPI 248 (328)
T ss_dssp ----------------------------CCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCC
T ss_pred ----------------------------chHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHH
Confidence 33334444444444444444442 3334444445555555555554455555
Q ss_pred cCcccccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCC
Q 001922 522 IGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDF 586 (995)
Q Consensus 522 ~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l 586 (995)
++.+++|++|+|++|++.+.+|..+.++++|++|+|++|++.+.+|..++++++|+.++++.|.+
T Consensus 249 ~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 249 FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp TTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred hcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 55555555555555555555555555555555555555555555555555555555555554433
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=298.70 Aligned_cols=292 Identities=24% Similarity=0.252 Sum_probs=179.1
Q ss_pred CCCCCCCCCCCCCCCceeeeEEe--------CCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCccccCccc
Q 001922 43 EPALISWNSSNPSSVCSWAGICC--------SRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLS 114 (995)
Q Consensus 43 ~~~l~~W~~~~~~~~C~w~gv~C--------~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~ 114 (995)
...+++|... .+||.|+|..| ....++.|++++++++ .+|..+. ++|++|+|++|+|++... .++
T Consensus 9 ~~~w~~W~~~--~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~--~l~ 81 (622)
T 3g06_A 9 DAVWSAWRRA--APAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA--LPP 81 (622)
T ss_dssp -CHHHHHHHT--CCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC--CCT
T ss_pred HHHHHHHHhc--CCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC--cCC
Confidence 3456778654 45899977543 3346888999999987 7787765 789999999998886444 678
Q ss_pred ccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeecc
Q 001922 115 SLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLA 194 (995)
Q Consensus 115 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 194 (995)
+|++|+|++|+|++++. .+++|++|++++|+|+++ |. .+++|++|+|++|++++ +|.. +++|++|+|+
T Consensus 82 ~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls 149 (622)
T 3g06_A 82 ELRTLEVSGNQLTSLPV----LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVS 149 (622)
T ss_dssp TCCEEEECSCCCSCCCC----CCTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred CCCEEEcCCCcCCcCCC----CCCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECc
Confidence 88888888888886544 667888888888888874 33 56778888888888873 5553 3778888888
Q ss_pred CCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCC
Q 001922 195 GNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGS 274 (995)
Q Consensus 195 ~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 274 (995)
+|++++ +|.. +.+ |+.|++++|.+++ +| ..+++|+.|++++|++++
T Consensus 150 ~N~l~~-l~~~---~~~-------------------------L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~- 195 (622)
T 3g06_A 150 DNQLAS-LPAL---PSE-------------------------LCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS- 195 (622)
T ss_dssp SSCCSC-CCCC---CTT-------------------------CCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-
T ss_pred CCcCCC-cCCc---cCC-------------------------CCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-
Confidence 888774 3322 233 4444555555442 22 223445555555555543
Q ss_pred CCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCC
Q 001922 275 IPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQN 354 (995)
Q Consensus 275 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 354 (995)
+|.. +++|+.|++++|.++ .+|.. +++|+.|++++|+|++ +| ..+++|+.|+|++|+|+. +|. .+
T Consensus 196 l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~ 260 (622)
T 3g06_A 196 LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LP 260 (622)
T ss_dssp CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CC
T ss_pred CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---cc
Confidence 2221 245555555555555 22321 2455555555555553 33 234555666666665552 333 34
Q ss_pred CCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCC
Q 001922 355 GKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACY 403 (995)
Q Consensus 355 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~ 403 (995)
++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.+..|..+..+.
T Consensus 261 ~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 261 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred ccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 55666666666665 4555555666666666666666555555554443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=284.45 Aligned_cols=247 Identities=23% Similarity=0.254 Sum_probs=166.9
Q ss_pred eeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCccccccc
Q 001922 60 WAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSL 137 (995)
Q Consensus 60 w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l 137 (995)
|..|.|+... ++ .+|..+. +++++|+|++|+|++.. .|.++++|++|+|++|+|+++.+..|.++
T Consensus 56 ~~~v~c~~~~----------l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l 122 (452)
T 3zyi_A 56 FSKVVCTRRG----------LS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGL 122 (452)
T ss_dssp SCEEECCSSC----------CS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred CcEEEECCCC----------cC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCc
Confidence 4667776533 32 3555443 45666666666665432 35555555555555555555554555555
Q ss_pred ccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhc
Q 001922 138 VNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYL 217 (995)
Q Consensus 138 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 217 (995)
++|++|+|++|+|+.+.+..|..+++|++|+|++|.+++..+..|..+++|++|+|++
T Consensus 123 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~---------------------- 180 (452)
T 3zyi_A 123 ASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGE---------------------- 180 (452)
T ss_dssp TTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCC----------------------
T ss_pred ccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCC----------------------
Confidence 5555555555555544444444555555555555555443344444445555555444
Q ss_pred cccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcC
Q 001922 218 GYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTG 297 (995)
Q Consensus 218 ~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 297 (995)
|+......+..+..+++|++|+|++|++++. | .+..+++|+.|++++|++++..|..|.++++|+.|+|++|++++
T Consensus 181 --~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 256 (452)
T 3zyi_A 181 --LKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256 (452)
T ss_dssp --CTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCE
T ss_pred --CCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCce
Confidence 3333333334567778888888888888854 3 57788889999999999988888889999999999999999998
Q ss_pred cCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccc
Q 001922 298 EIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTG 345 (995)
Q Consensus 298 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 345 (995)
..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 257 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 257 IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred ECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 888899999999999999999998888888899999999999998863
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-31 Score=311.39 Aligned_cols=236 Identities=19% Similarity=0.136 Sum_probs=127.4
Q ss_pred ccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCcccee
Q 001922 305 NLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRIL 384 (995)
Q Consensus 305 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 384 (995)
.+++|+.|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|.|++..+ .++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 44588999999999988888888889999999999999887665 8888889999999998884322 1455555
Q ss_pred eccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCC
Q 001922 385 ILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNN 464 (995)
Q Consensus 385 ~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N 464 (995)
++++|.+.+..+.. +++|+.|++++|.+++..|..|..+ ++|++|+|++|
T Consensus 105 ~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l---------------------------~~L~~L~Ls~N 154 (487)
T 3oja_A 105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCR---------------------------SRVQYLDLKLN 154 (487)
T ss_dssp ECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGG---------------------------SSEEEEECTTS
T ss_pred ECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCC---------------------------CCCCEEECCCC
Confidence 55555554433321 2334444444444443333322221 23344444444
Q ss_pred cccccCCcccc-CCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCc
Q 001922 465 LLSGPLPFSLS-NFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIP 543 (995)
Q Consensus 465 ~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip 543 (995)
.+++..|..+. .+++|+.|+|++|.|++. |. +..+++|+.|+|++|.|++ +|+.++.+++|+.|+|++|.|+ .+|
T Consensus 155 ~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp 230 (487)
T 3oja_A 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIE 230 (487)
T ss_dssp CCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EEC
T ss_pred CCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc-ccc
Confidence 44444444443 344455555555544432 11 1224444444444444443 3333444444444444444444 244
Q ss_pred cccccccccCeEeccccccc-cccCcccccCCcccEEec
Q 001922 544 PEISNVRILNYLNLSRNHLN-QNIPKSIGSMKSLTIADF 581 (995)
Q Consensus 544 ~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~l~l 581 (995)
..+..+++|+.|+|++|++. +.+|..+..++.|+.+++
T Consensus 231 ~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~ 269 (487)
T 3oja_A 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269 (487)
T ss_dssp TTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHH
T ss_pred hhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEec
Confidence 44444444444444444444 334444444444444443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-29 Score=274.31 Aligned_cols=254 Identities=21% Similarity=0.174 Sum_probs=183.1
Q ss_pred cCcccccceeccccccccCCCccccccccccccccccccccc-ccCCcccc-------CCCCCceeeccCccccccCCcc
Q 001922 110 IGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFT-ALLPVGIL-------KLEKLKYLDLGGNYFFGKIPNS 181 (995)
Q Consensus 110 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~ 181 (995)
++..++|++|++++|.+ .+|..+... |++|+|++|+++ ..+|..+. ++++|++|+|++|.+++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 56678888999999988 455555443 888899999884 45666665 7899999999999999888887
Q ss_pred c--cCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCcc
Q 001922 182 Y--GELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLK 259 (995)
Q Consensus 182 l--~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 259 (995)
+ +.+++|++|+|++|++++. |..++.+... .+++|++|+|++|++++..|..|+.++
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~--------------------~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQW--------------------LKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTT--------------------CCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHh--------------------hcCCCcEEEeeCCCCccchHHHhccCC
Confidence 6 8899999999999999976 7666665210 124566666667777666666666777
Q ss_pred ccCccccccccccCC--CCccc--cCcCCCCeEeccCCcCcCc---CCccccccCCCCEEEccCCcCCCCCC-ccccCCC
Q 001922 260 LLDTVFLHINLLSGS--IPKQL--GNLTNLVNLDLSNNALTGE---IPYSFINLRQLKLFNLFMNRLHGSIP-DYLADLP 331 (995)
Q Consensus 260 ~L~~L~l~~N~l~~~--~p~~l--~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~ 331 (995)
+|++|++++|++.+. .+..+ ..+++|++|+|++|+|++. ....+.++++|+.|++++|++++..| ..+..++
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 777777777766543 22333 6777777777777777732 22334566778888888888776664 4455677
Q ss_pred CcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCC
Q 001922 332 NLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFG 393 (995)
Q Consensus 332 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 393 (995)
+|++|+|++|+++ .+|..+. ++|++|+|++|+|++. |. +..+++|+.|++++|++.+
T Consensus 254 ~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 254 QLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp TCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 8888888888887 5666665 6788888888888754 55 7778888888888887754
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.4e-28 Score=279.32 Aligned_cols=246 Identities=21% Similarity=0.194 Sum_probs=191.5
Q ss_pred eEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCcccc
Q 001922 96 NLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFF 175 (995)
Q Consensus 96 ~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~ 175 (995)
.++.+++.++... -.-.++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.|..|.++++|++|+|++|+++
T Consensus 58 ~v~c~~~~l~~iP-~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~ 136 (452)
T 3zyi_A 58 KVVCTRRGLSEVP-QGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136 (452)
T ss_dssp EEECCSSCCSSCC-SCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred EEEECCCCcCccC-CCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCC
Confidence 3445555554322 111256777777777777666666666666666666666666666666666666666666666666
Q ss_pred ccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCC-CCCCccCcc
Q 001922 176 GKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSC-ELDGQIPHE 254 (995)
Q Consensus 176 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n-~l~~~~~~~ 254 (995)
+..+..|..+++|++|+|++|++++. .+..+..+++|++|++++| .+....+..
T Consensus 137 ~~~~~~~~~l~~L~~L~L~~N~l~~~-------------------------~~~~~~~l~~L~~L~l~~~~~l~~i~~~~ 191 (452)
T 3zyi_A 137 VIPSGAFEYLSKLRELWLRNNPIESI-------------------------PSYAFNRVPSLMRLDLGELKKLEYISEGA 191 (452)
T ss_dssp BCCTTTSSSCTTCCEEECCSCCCCEE-------------------------CTTTTTTCTTCCEEECCCCTTCCEECTTT
T ss_pred ccChhhhcccCCCCEEECCCCCccee-------------------------CHhHHhcCCcccEEeCCCCCCccccChhh
Confidence 55555566666666666666666532 2335667889999999995 555444557
Q ss_pred ccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcc
Q 001922 255 IGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLE 334 (995)
Q Consensus 255 ~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 334 (995)
|..+++|+.|++++|++++. | .+..+++|+.|+|++|.|++..|..|.++++|+.|++++|++++..+..|..+++|+
T Consensus 192 ~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 269 (452)
T 3zyi_A 192 FEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLV 269 (452)
T ss_dssp TTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred ccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCC
Confidence 99999999999999999954 4 588999999999999999999999999999999999999999999999999999999
Q ss_pred eEEeccCcccccCCCcccCCCCCCeEEecCceecc
Q 001922 335 TLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTG 369 (995)
Q Consensus 335 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 369 (995)
.|+|++|++++..+..|..+++|+.|+|++|++..
T Consensus 270 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 270 ELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp EEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred EEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 99999999998888889999999999999999873
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=277.67 Aligned_cols=227 Identities=24% Similarity=0.252 Sum_probs=140.6
Q ss_pred cceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccC
Q 001922 116 LQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAG 195 (995)
Q Consensus 116 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 195 (995)
++.|+|++|+|+++.+..|.++++|++|+|++|+|+.+.+..|.++++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 66 l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 145 (440)
T 3zyj_A 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRN 145 (440)
T ss_dssp CSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCS
T ss_pred CcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCC
Confidence 33344444444444444444455555555555555554555555556666666666666544444555566666666666
Q ss_pred CcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCC
Q 001922 196 NDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSI 275 (995)
Q Consensus 196 N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 275 (995)
|++++..+..|.++++|++|++++|+......+..+.++++|++|+|++|+++ .+
T Consensus 146 N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-------------------------~~ 200 (440)
T 3zyj_A 146 NPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-------------------------EI 200 (440)
T ss_dssp CCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-------------------------SC
T ss_pred CcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-------------------------cc
Confidence 66554444444444444444443333222222234445555666666666554 22
Q ss_pred CccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCC
Q 001922 276 PKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNG 355 (995)
Q Consensus 276 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 355 (995)
| .+..+++|+.|+|++|.|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..+..|..++
T Consensus 201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 2 256677788888888888877777888888888888888888877777888888888888888888877777788888
Q ss_pred CCCeEEecCceec
Q 001922 356 KLQVLDLSSNKLT 368 (995)
Q Consensus 356 ~L~~L~L~~N~l~ 368 (995)
+|+.|+|++|++.
T Consensus 280 ~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 280 HLERIHLHHNPWN 292 (440)
T ss_dssp TCCEEECCSSCEE
T ss_pred CCCEEEcCCCCcc
Confidence 8888888888886
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-27 Score=280.64 Aligned_cols=268 Identities=26% Similarity=0.353 Sum_probs=166.6
Q ss_pred cccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEcc
Q 001922 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLF 315 (995)
Q Consensus 236 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 315 (995)
+++.|++++|.++ .+|..+. ++|+.|++++|.++. +|. .+++|++|+|++|+|++ +|. .+++|++|+++
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence 4778888888887 5565554 677777777777773 444 45677777777777773 443 55677777777
Q ss_pred CCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCC
Q 001922 316 MNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPI 395 (995)
Q Consensus 316 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 395 (995)
+|+|++ +|. .+++|+.|++++|++++ +|.. +++|++|+|++|++++ +|.. +.+|+.|++++|.+.+ +
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l 176 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-L 176 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-C
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCCc---cCCCCEEECCCCCCCC-C
Confidence 777764 333 45667777777777764 4432 3667777777777663 3332 2344555555555433 2
Q ss_pred CcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCcccc
Q 001922 396 PERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLS 475 (995)
Q Consensus 396 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 475 (995)
| ..+++|+.|++++|.+++ +|. .+++|+.|++++|.++ .+|..
T Consensus 177 ~---~~~~~L~~L~Ls~N~l~~-------------------------l~~------~~~~L~~L~L~~N~l~-~l~~~-- 219 (622)
T 3g06_A 177 P---MLPSGLQELSVSDNQLAS-------------------------LPT------LPSELYKLWAYNNRLT-SLPAL-- 219 (622)
T ss_dssp C---CCCTTCCEEECCSSCCSC-------------------------CCC------CCTTCCEEECCSSCCS-SCCCC--
T ss_pred c---ccCCCCcEEECCCCCCCC-------------------------CCC------ccchhhEEECcCCccc-ccCCC--
Confidence 2 223444444444444432 111 1245667777777776 34432
Q ss_pred CCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeE
Q 001922 476 NFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYL 555 (995)
Q Consensus 476 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L 555 (995)
+++|+.|+|++|+|++ +| ..+++|+.|+|++|.|+ .+|. .+++|++|+|++|+|+ .+|..+.++++|+.|
T Consensus 220 -~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L 289 (622)
T 3g06_A 220 -PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTV 289 (622)
T ss_dssp -CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEE
T ss_pred -CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEE
Confidence 3667777777777774 44 34466777777777777 4555 4567777777777777 667777777777777
Q ss_pred eccccccccccCcccccCC
Q 001922 556 NLSRNHLNQNIPKSIGSMK 574 (995)
Q Consensus 556 ~L~~N~l~~~~p~~~~~l~ 574 (995)
+|++|++++.+|..+..++
T Consensus 290 ~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 290 NLEGNPLSERTLQALREIT 308 (622)
T ss_dssp ECCSCCCCHHHHHHHHHHH
T ss_pred EecCCCCCCcCHHHHHhcc
Confidence 7777777777776665544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=265.74 Aligned_cols=225 Identities=24% Similarity=0.210 Sum_probs=150.0
Q ss_pred ceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCC
Q 001922 117 QFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGN 196 (995)
Q Consensus 117 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 196 (995)
+.++.+++.++.++.. + .++|++|++++|+|+++.+..|..+++|++|+|++|.+++..|..|..+++|++|+|++|
T Consensus 14 ~~~~c~~~~l~~ip~~-~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVG-I--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSSCCTT-C--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcccCCcC-C--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 5667777777654321 1 245666666666666655556666666666666666666555666666666666666666
Q ss_pred c-ccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCC
Q 001922 197 D-LTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSI 275 (995)
Q Consensus 197 ~-l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 275 (995)
+ ++... |..+..+++|++|++++|.+++..+..+..+++|++|++++|++++..
T Consensus 91 ~~l~~~~-------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 145 (285)
T 1ozn_A 91 AQLRSVD-------------------------PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145 (285)
T ss_dssp TTCCCCC-------------------------TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccccC-------------------------HHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccC
Confidence 5 44333 344555566677777777776666666677777777777777776655
Q ss_pred CccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCC
Q 001922 276 PKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNG 355 (995)
Q Consensus 276 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 355 (995)
+..+..+++|++|+|++|.+++..+..|.++++|+.|++++|++++..|..|..+++|+.|++++|++++..+..+..++
T Consensus 146 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 225 (285)
T 1ozn_A 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred HhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc
Confidence 56677777777777777777766666677777777777777777766677777777777777777777765556677777
Q ss_pred CCCeEEecCceecc
Q 001922 356 KLQVLDLSSNKLTG 369 (995)
Q Consensus 356 ~L~~L~L~~N~l~~ 369 (995)
+|++|+|++|++..
T Consensus 226 ~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 226 ALQYLRLNDNPWVC 239 (285)
T ss_dssp TCCEEECCSSCEEC
T ss_pred ccCEEeccCCCccC
Confidence 77777777777764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-29 Score=276.24 Aligned_cols=263 Identities=19% Similarity=0.180 Sum_probs=134.4
Q ss_pred ccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCccc
Q 001922 265 FLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFT 344 (995)
Q Consensus 265 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 344 (995)
+++.+.+...+...+..+++|++|+|++|.+++..|..|.++++|+.|+|++|++++..+ +..+++|++|++++|+++
T Consensus 16 ~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~ 93 (317)
T 3o53_A 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93 (317)
T ss_dssp SCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEE
T ss_pred eccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccc
Confidence 333343333333334444555555665555555555555555555555555555554332 555566666666666655
Q ss_pred ccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcc
Q 001922 345 GVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFI 424 (995)
Q Consensus 345 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~ 424 (995)
+.. ..++|++|++++|++++..+.. +++|+.|++++|.+.+..+..+..+++|+.|++++|
T Consensus 94 ~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N----------- 154 (317)
T 3o53_A 94 ELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN----------- 154 (317)
T ss_dssp EEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTS-----------
T ss_pred ccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCC-----------
Confidence 322 2255666666666655433222 233444444444443333333333333333333333
Q ss_pred cCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccc-cCCCCCcEEEcCCCcccCCCCCCccchhh
Q 001922 425 YLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSL-SNFSSLQILLLSGNQFSGPIPPSIGELRQ 503 (995)
Q Consensus 425 ~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 503 (995)
++++..+..+ ..+++|+.|+|++|++++. |. ...+++
T Consensus 155 ----------------------------------------~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~ 192 (317)
T 3o53_A 155 ----------------------------------------EIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAK 192 (317)
T ss_dssp ----------------------------------------CCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTT
T ss_pred ----------------------------------------CCCcccHHHHhhccCcCCEEECCCCcCccc-cc-cccccc
Confidence 3333333333 2345555555555555532 21 223555
Q ss_pred hccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccccccc-cccCcccccCCcccEEecc
Q 001922 504 VLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLN-QNIPKSIGSMKSLTIADFS 582 (995)
Q Consensus 504 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~l~ls 582 (995)
|+.|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+++ +.+|..+..++.|+.++++
T Consensus 193 L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 193 LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp CCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred CCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 666666666665 34444666666666666666665 45556666666666666666665 5556666666666666666
Q ss_pred -CCCCCCCCCC
Q 001922 583 -FNDFSGKLPE 592 (995)
Q Consensus 583 -~N~l~g~~p~ 592 (995)
.+.++|..|.
T Consensus 271 ~~~~l~~~~~~ 281 (317)
T 3o53_A 271 TVKKLTGQNEE 281 (317)
T ss_dssp HHHHHHSSSSC
T ss_pred CchhccCCchh
Confidence 4445555554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=275.18 Aligned_cols=227 Identities=23% Similarity=0.216 Sum_probs=112.8
Q ss_pred CCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEec
Q 001922 284 NLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLS 363 (995)
Q Consensus 284 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 363 (995)
+++.|+|++|.|++..+..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 65 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 144 (440)
T 3zyj_A 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144 (440)
T ss_dssp TCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECC
T ss_pred CCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCC
Confidence 44555555555554444455555555555555555554444445555555555555555554444445555555555555
Q ss_pred CceecccCCCcCcCCCccceeeccccccCCC-CCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCC
Q 001922 364 SNKLTGTIPTDLCSSNQLRILILLKNFLFGP-IPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGS 442 (995)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~ 442 (995)
+|++++..+..|..+++|+.|++++|...+. .+..+.++++|+.|++++|.++. +|.
T Consensus 145 ~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~--------------------- 202 (440)
T 3zyj_A 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN--------------------- 202 (440)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CCC---------------------
T ss_pred CCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-ccc---------------------
Confidence 5555543333444444444444444222111 12234444455555555554431 110
Q ss_pred CCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCcc
Q 001922 443 LPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAI 522 (995)
Q Consensus 443 ~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 522 (995)
...+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|
T Consensus 203 -------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 275 (440)
T 3zyj_A 203 -------LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLF 275 (440)
T ss_dssp -------CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred -------cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHh
Confidence 1123345555555555555555555556666666666666655555555555555555555555554444445
Q ss_pred CcccccceeeccCCccc
Q 001922 523 GYCNHLTYLDMSQNNLS 539 (995)
Q Consensus 523 ~~l~~L~~L~Ls~N~l~ 539 (995)
..+++|+.|+|++|.+.
T Consensus 276 ~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 276 TPLHHLERIHLHHNPWN 292 (440)
T ss_dssp SSCTTCCEEECCSSCEE
T ss_pred ccccCCCEEEcCCCCcc
Confidence 55555555555555554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-27 Score=256.96 Aligned_cols=176 Identities=25% Similarity=0.200 Sum_probs=92.0
Q ss_pred cEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCC
Q 001922 238 VHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMN 317 (995)
Q Consensus 238 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 317 (995)
++++.+++.++ .+|..+ .++|+.|++++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|+.|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 45666666665 333322 245555556555555544455555666666666666665555555555566666666655
Q ss_pred c-CCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCC
Q 001922 318 R-LHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIP 396 (995)
Q Consensus 318 ~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 396 (995)
+ +.+..|..|..+++|++|++++|++++..|..+..+++|++|+|++|++++..+..+..+++|+.|++++|.+.+..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 4 554445555555555555555555555555555555555555555555554333334444444444444444433333
Q ss_pred cccccCCCCcEEEecCCccC
Q 001922 397 ERLGACYSLTRVRLGQNYLN 416 (995)
Q Consensus 397 ~~l~~l~~L~~L~l~~N~l~ 416 (995)
..+..+++|+.|++++|++.
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCC
T ss_pred HHhcCccccCEEECCCCccc
Confidence 33334444444444444433
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-29 Score=273.89 Aligned_cols=263 Identities=17% Similarity=0.173 Sum_probs=173.2
Q ss_pred CeEeccCCcccCcc--ccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCc
Q 001922 95 TNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGN 172 (995)
Q Consensus 95 ~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N 172 (995)
+.++++.+.+.... .+..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+ +..+++|++|+|++|
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 33445555543221 23445566666666666666655566666666666666666655433 556666666666666
Q ss_pred cccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccC
Q 001922 173 YFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIP 252 (995)
Q Consensus 173 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~ 252 (995)
++++.. ..++|++|++++|++++..+. .+++|++|++++|++++..+
T Consensus 91 ~l~~l~-----~~~~L~~L~l~~n~l~~~~~~----------------------------~~~~L~~L~l~~N~l~~~~~ 137 (317)
T 3o53_A 91 YVQELL-----VGPSIETLHAANNNISRVSCS----------------------------RGQGKKNIYLANNKITMLRD 137 (317)
T ss_dssp EEEEEE-----ECTTCCEEECCSSCCSEEEEC----------------------------CCSSCEEEECCSSCCCSGGG
T ss_pred cccccc-----CCCCcCEEECCCCccCCcCcc----------------------------ccCCCCEEECCCCCCCCccc
Confidence 655322 225566666666655532211 23567888888888887777
Q ss_pred ccccCccccCccccccccccCCCCcccc-CcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCC
Q 001922 253 HEIGNLKLLDTVFLHINLLSGSIPKQLG-NLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLP 331 (995)
Q Consensus 253 ~~~~~l~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 331 (995)
..+..+++|++|++++|.+++..+..+. .+++|++|+|++|.|++..+ ...+++|+.|++++|++++ +|..+..++
T Consensus 138 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~ 214 (317)
T 3o53_A 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAA 214 (317)
T ss_dssp BCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGT
T ss_pred hhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCc-chhhhcccC
Confidence 7777788888888888888776666653 67888888888888875522 2347788888888888875 444477788
Q ss_pred CcceEEeccCcccccCCCcccCCCCCCeEEecCceec-ccCCCcCcCCCccceeecccc-ccCCCCC
Q 001922 332 NLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLT-GTIPTDLCSSNQLRILILLKN-FLFGPIP 396 (995)
Q Consensus 332 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N-~l~~~~p 396 (995)
+|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|++.++ .+.+..|
T Consensus 215 ~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp TCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred cccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 8888888888888 45667778888888888888887 677777777888888887743 4444444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-28 Score=269.65 Aligned_cols=236 Identities=22% Similarity=0.169 Sum_probs=118.2
Q ss_pred cccCCCCCceeeccCccccccCCccccCCCCCceeeccCCccc-ccCcccccchhhhhhhhccccccccCCCCcccCCCC
Q 001922 157 GILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLT-GKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLV 235 (995)
Q Consensus 157 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~ 235 (995)
.++..++|++|++++|.+ .+|..+... |++|+|++|+++ ..+|..+.. ..++ +.+++
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~-~~~~-----------------~~~l~ 95 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILF-GALR-----------------VLGIS 95 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHH-HHHH-----------------HHTTS
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHH-HHHH-----------------hcCcC
Confidence 345566677777777777 566655543 677777777773 334443330 0000 00334
Q ss_pred cccEEECcCCCCCCccCccc--cCccccCccccccccccCCCCccccCc-----CCCCeEeccCCcCcCcCCccccccCC
Q 001922 236 NLVHLDLSSCELDGQIPHEI--GNLKLLDTVFLHINLLSGSIPKQLGNL-----TNLVNLDLSNNALTGEIPYSFINLRQ 308 (995)
Q Consensus 236 ~L~~L~Ls~n~l~~~~~~~~--~~l~~L~~L~l~~N~l~~~~p~~l~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~ 308 (995)
+|++|+|++|++++.+|..+ ..+++|++|++++|++++. |..+..+ ++|++|+|++|++++..|..|.++++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 55555555555555555443 4555555555555555544 4444444 55555555555555555555555555
Q ss_pred CCEEEccCCcCCCC--CCccc--cCCCCcceEEeccCcccc---cCCCcccCCCCCCeEEecCceecccCC-CcCcCCCc
Q 001922 309 LKLFNLFMNRLHGS--IPDYL--ADLPNLETLGLWQNNFTG---VIPENLGQNGKLQVLDLSSNKLTGTIP-TDLCSSNQ 380 (995)
Q Consensus 309 L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~---~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~ 380 (995)
|+.|++++|++.+. .|..+ ..+++|++|+|++|++++ .....+..+++|++|+|++|++++.+| ..+..+++
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 254 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTT
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCC
Confidence 55555555554432 12222 455555555555555552 111222344555555555555554443 23333445
Q ss_pred cceeeccccccCCCCCcccccCCCCcEEEecCCccCCC
Q 001922 381 LRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGS 418 (995)
Q Consensus 381 L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 418 (995)
|+.|++++|.+. .+|..+. ++|++|++++|++++.
T Consensus 255 L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~ 289 (312)
T 1wwl_A 255 LNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN 289 (312)
T ss_dssp CCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC
T ss_pred CCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC
Confidence 555555555544 3444333 4555555555555443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-30 Score=314.83 Aligned_cols=456 Identities=16% Similarity=0.134 Sum_probs=252.7
Q ss_pred CceeeeEEeCCCceeeeecCCCCccccCCc-cccCCCCCCeEeccCCcccCccc-----------------cCcccccce
Q 001922 57 VCSWAGICCSRDRVASLDLTDLNLCGSVPA-QILRLDKLTNLSLAGNNFTGSIE-----------------IGNLSSLQF 118 (995)
Q Consensus 57 ~C~w~gv~C~~~~v~~l~l~~~~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~-----------------~~~l~~L~~ 118 (995)
|++|+++.. .....+++.... +..|. .+..+++|++|+|+++....... ...+++|++
T Consensus 34 ck~W~~~~~--~~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~ 109 (594)
T 2p1m_B 34 CKSWYEIER--WCRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEE 109 (594)
T ss_dssp CHHHHHHHH--HHCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCE
T ss_pred HHHHHHhhh--hhceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCe
Confidence 557888722 223345554432 22332 45678889999999875321110 235667788
Q ss_pred eccccccccCCCccccc-ccccccccccccc-ccccc-CCccccCCCCCceeeccCccccccCCcccc----CCCCCcee
Q 001922 119 LNISNNQFSGGLDWNYS-SLVNLEVFDAYNN-NFTAL-LPVGILKLEKLKYLDLGGNYFFGKIPNSYG----ELQGLEYL 191 (995)
Q Consensus 119 L~Ls~N~i~~~~~~~~~-~l~~L~~L~Ls~n-~i~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~----~l~~L~~L 191 (995)
|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|++|
T Consensus 110 L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L 189 (594)
T 2p1m_B 110 IRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL 189 (594)
T ss_dssp EEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEE
T ss_pred EEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEE
Confidence 88887777665555554 5677777777777 44432 333344677777777777776654443333 45577777
Q ss_pred eccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCC-CCCCccCccccCccccCccc-----
Q 001922 192 SLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSC-ELDGQIPHEIGNLKLLDTVF----- 265 (995)
Q Consensus 192 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~----- 265 (995)
+|++|. .......+..+ +..+++|++|++++| .+. .++..+..+++|+.|+
T Consensus 190 ~l~~~~-~~~~~~~l~~l---------------------~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~ 246 (594)
T 2p1m_B 190 NISCLA-SEVSFSALERL---------------------VTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYT 246 (594)
T ss_dssp ECTTCC-SCCCHHHHHHH---------------------HHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCC
T ss_pred EecccC-CcCCHHHHHHH---------------------HHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEccccccc
Confidence 777775 11111111111 112345555555555 222 2444455555555555
Q ss_pred --cccccccCCCCccccCcCCCCeE-eccCCcCcCcCCccccccCCCCEEEccCCcCCCCCC-ccccCCCCcceEEeccC
Q 001922 266 --LHINLLSGSIPKQLGNLTNLVNL-DLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIP-DYLADLPNLETLGLWQN 341 (995)
Q Consensus 266 --l~~N~l~~~~p~~l~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N 341 (995)
++.|.+.+ ++..+.++++|+.| .+.+... +.++..+..+++|+.|++++|.+++... ..+..+++|+.|++++|
T Consensus 247 ~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 324 (594)
T 2p1m_B 247 AEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324 (594)
T ss_dssp CCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG
T ss_pred CccchhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc
Confidence 33344443 34467778888888 4444332 2445555567888888888888664322 23557788888888887
Q ss_pred ccccc-CCCcccCCCCCCeEEecCc---------eecccCCCcCc-CCCccceeeccccccCCCCCcccc-cCCCCcEEE
Q 001922 342 NFTGV-IPENLGQNGKLQVLDLSSN---------KLTGTIPTDLC-SSNQLRILILLKNFLFGPIPERLG-ACYSLTRVR 409 (995)
Q Consensus 342 ~l~~~-~p~~~~~l~~L~~L~L~~N---------~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~L~ 409 (995)
++.. ++.....+++|++|+|+++ .+++.....+. .+++|+.|.+..|.+.+..+..+. .+++|+.|+
T Consensus 325 -~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~ 403 (594)
T 2p1m_B 325 -IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFR 403 (594)
T ss_dssp -GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEE
T ss_pred -cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeE
Confidence 4422 2222334778888888543 33321111111 133444444433333322222222 233344443
Q ss_pred ecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccc-----cCCccccCCCCCcEEE
Q 001922 410 LGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSG-----PLPFSLSNFSSLQILL 484 (995)
Q Consensus 410 l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~ 484 (995)
++.|...+ -|+++. .++..+..+++|+.|+
T Consensus 404 L~~~~~~~---------------------------------------------~~~l~~~~~~~~~~~l~~~~~~L~~L~ 438 (594)
T 2p1m_B 404 LCIIEPKA---------------------------------------------PDYLTLEPLDIGFGAIVEHCKDLRRLS 438 (594)
T ss_dssp EEESSTTC---------------------------------------------CCTTTCCCTHHHHHHHHHHCTTCCEEE
T ss_pred eecccCCC---------------------------------------------cccccCCchhhHHHHHHhhCCCccEEe
Confidence 33110000 022221 1222245567777777
Q ss_pred cCCCcccCCCCCCccc-hhhhccccccccccCCCCCCcc-CcccccceeeccCCcccCCCcc-ccccccccCeEeccccc
Q 001922 485 LSGNQFSGPIPPSIGE-LRQVLKLDLSRNSLSGEIPPAI-GYCNHLTYLDMSQNNLSGSIPP-EISNVRILNYLNLSRNH 561 (995)
Q Consensus 485 Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~ip~-~l~~l~~L~~L~L~~N~ 561 (995)
|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|++|+|++|.+++..+. .+..+++|++|+|++|+
T Consensus 439 L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 439 LSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp CCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred ecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 766 555433344444 6678888888887765444444 5578888888888888654443 34458888999998888
Q ss_pred cccccCccc-ccCCcccEEeccCCCCCC
Q 001922 562 LNQNIPKSI-GSMKSLTIADFSFNDFSG 588 (995)
Q Consensus 562 l~~~~p~~~-~~l~~L~~l~ls~N~l~g 588 (995)
++......+ ..++.|+...+..+....
T Consensus 518 ~~~~~~~~l~~~lp~l~i~~~~~~~~~~ 545 (594)
T 2p1m_B 518 VSFGACKLLGQKMPKLNVEVIDERGAPD 545 (594)
T ss_dssp CBHHHHHHHHHHCTTEEEEEECSSSCGG
T ss_pred CCHHHHHHHHHhCCCCEEEEecCCCccc
Confidence 865444445 457788777777665443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-28 Score=286.31 Aligned_cols=186 Identities=18% Similarity=0.098 Sum_probs=129.9
Q ss_pred eeccCceEEEEEE-eCCCcEEEEEEecCCCCC---------ChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEEE
Q 001922 694 IGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTH---------SHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 694 lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.+.|++|.+..++ .-.|+.|+||.+...... ...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666665543 235888999998543211 2235689999999999 6999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||++|++|.+++.. ++.++.. +|+.||+.||+|+|++| ||||||||+|||++++|.+||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999964 3456653 58999999999999888 9999999999999999999999999998764332
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPV 890 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf 890 (995)
......+||+.|||||++.+ .+..++|+||+|++.+++.++..|+
T Consensus 394 --~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 --SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred --ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 23355789999999999875 4677899999999988877665543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-27 Score=275.89 Aligned_cols=240 Identities=21% Similarity=0.227 Sum_probs=184.2
Q ss_pred CcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeE
Q 001922 281 NLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVL 360 (995)
Q Consensus 281 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 360 (995)
.+++|++|+|++|.+++..|..|..+++|+.|+|++|.+++..| +..+++|++|+|++|.+++..+ .++|++|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 34578888888888888777888888888888888888886555 7888888888888888885432 3788888
Q ss_pred EecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCcccc
Q 001922 361 DLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLS 440 (995)
Q Consensus 361 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~ 440 (995)
+|++|.+++..+.. +++|+.|++++|.+.+..|..++.+++|+.|++++|.+++.+|..+..
T Consensus 105 ~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~--------------- 166 (487)
T 3oja_A 105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA--------------- 166 (487)
T ss_dssp ECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGG---------------
T ss_pred ECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhh---------------
Confidence 88888888665543 467888888888888888888888888888888888888766665531
Q ss_pred CCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCC
Q 001922 441 GSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPP 520 (995)
Q Consensus 441 ~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 520 (995)
.+++|+.|+|++|.|++..+ +..+++|+.|+|++|+|++ +|..++.+++|+.|+|++|.|++ +|.
T Consensus 167 -----------~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~ 231 (487)
T 3oja_A 167 -----------SSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEK 231 (487)
T ss_dssp -----------GTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECT
T ss_pred -----------hCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cch
Confidence 12456777777777775422 3357888888888888885 44458888888888888888884 777
Q ss_pred ccCcccccceeeccCCccc-CCCccccccccccCeEecccc
Q 001922 521 AIGYCNHLTYLDMSQNNLS-GSIPPEISNVRILNYLNLSRN 560 (995)
Q Consensus 521 ~~~~l~~L~~L~Ls~N~l~-~~ip~~l~~l~~L~~L~L~~N 560 (995)
.++.+++|+.|+|++|.+. +.+|..+..++.|+.++++.+
T Consensus 232 ~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~~ 272 (487)
T 3oja_A 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272 (487)
T ss_dssp TCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHHH
T ss_pred hhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecccc
Confidence 7888888888888888887 677777888888888777643
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=240.72 Aligned_cols=217 Identities=24% Similarity=0.266 Sum_probs=121.6
Q ss_pred CCCceeeeEEeCC-CceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCccccCcccccceeccccccccCCCccc
Q 001922 55 SSVCSWAGICCSR-DRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWN 133 (995)
Q Consensus 55 ~~~C~w~gv~C~~-~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~ 133 (995)
.++|.|.|+.|+. ..++.+++++++++ .+|..+. +++++|+|++|++++ +.+..
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~----------------------~~~~~ 56 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSS----------------------LPSKA 56 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSC----------------------CCTTS
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCe----------------------eCHHH
Confidence 3689999999975 35667888888776 3565443 345555555555554 44444
Q ss_pred ccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhh
Q 001922 134 YSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLR 213 (995)
Q Consensus 134 ~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 213 (995)
|.++++|++|++++|+++.+.+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|
T Consensus 57 ~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~------- 129 (270)
T 2o6q_A 57 FHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVF------- 129 (270)
T ss_dssp SSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTT-------
T ss_pred hcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHh-------
Confidence 4444444444444444444444444555555555555555554444455555556666666555553332222
Q ss_pred hhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCC
Q 001922 214 EIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNN 293 (995)
Q Consensus 214 ~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N 293 (995)
..+++|++|+|++|.+++..+..|..+++|+.|++++|++++..+..|.++++|++|+|++|
T Consensus 130 ------------------~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (270)
T 2o6q_A 130 ------------------DSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191 (270)
T ss_dssp ------------------TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred ------------------CcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC
Confidence 23334444444444444333334444555555555555555444445666666666666666
Q ss_pred cCcCcCCccccccCCCCEEEccCCcCCC
Q 001922 294 ALTGEIPYSFINLRQLKLFNLFMNRLHG 321 (995)
Q Consensus 294 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 321 (995)
++++..+..|..+++|+.|++++|.+..
T Consensus 192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 192 QLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 6665555556666666777777666653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=235.04 Aligned_cols=216 Identities=24% Similarity=0.238 Sum_probs=107.2
Q ss_pred cCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccC
Q 001922 83 SVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILK 160 (995)
Q Consensus 83 ~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~ 160 (995)
.+|..+. ++|++|+|++|++++.. .+.++++|++|+|++|+++++. +..|.+
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~------------------------~~~~~~ 74 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE------------------------DGAYQS 74 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEEC------------------------TTTTTT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccC------------------------HHHccC
Confidence 3454432 35666666666665432 3455555555555555554444 444445
Q ss_pred CCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEE
Q 001922 161 LEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHL 240 (995)
Q Consensus 161 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L 240 (995)
+++|++|+|++|.+++..+..|.++++|++|++++|++++..+..++++++|++|++++|.+....+|..+..+++|++|
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L 154 (276)
T 2z62_A 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154 (276)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEE
T ss_pred CcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEE
Confidence 55555555555555444444455555555555555555433332333333333333322222222234444555556666
Q ss_pred ECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCC
Q 001922 241 DLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLH 320 (995)
Q Consensus 241 ~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 320 (995)
++++|++++..+..+..+++|+.+.+ .|++++|.+++..+..+.. .+|+.|++++|+++
T Consensus 155 ~Ls~N~l~~~~~~~~~~l~~L~~l~l--------------------~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~ 213 (276)
T 2z62_A 155 DLSSNKIQSIYCTDLRVLHQMPLLNL--------------------SLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLK 213 (276)
T ss_dssp ECCSSCCCEECGGGGHHHHTCTTCCE--------------------EEECCSSCCCEECTTSSCS-CCEEEEECCSSCCS
T ss_pred ECCCCCCCcCCHHHhhhhhhccccce--------------------eeecCCCcccccCccccCC-CcccEEECCCCcee
Confidence 66666665544444444444441110 5566666665444444433 35666666666666
Q ss_pred CCCCccccCCCCcceEEeccCcccc
Q 001922 321 GSIPDYLADLPNLETLGLWQNNFTG 345 (995)
Q Consensus 321 ~~~p~~~~~l~~L~~L~L~~N~l~~ 345 (995)
+..+..|..+++|+.|+|++|++++
T Consensus 214 ~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 214 SVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp CCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred ecCHhHhcccccccEEEccCCcccc
Confidence 5555555666666666666666654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-28 Score=296.17 Aligned_cols=408 Identities=15% Similarity=0.130 Sum_probs=219.6
Q ss_pred cccccccccccccccccccc---cCC------------ccccCCCCCceeeccCccccccCCcccc-CCCCCceeeccCC
Q 001922 133 NYSSLVNLEVFDAYNNNFTA---LLP------------VGILKLEKLKYLDLGGNYFFGKIPNSYG-ELQGLEYLSLAGN 196 (995)
Q Consensus 133 ~~~~l~~L~~L~Ls~n~i~~---~~p------------~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N 196 (995)
.+..+++|+.|+++++.... ..| .....+++|++|+|++|.+++..+..+. .+++|++|+|++|
T Consensus 61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~ 140 (594)
T 2p1m_B 61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC 140 (594)
T ss_dssp HHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred HHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCc
Confidence 34556677777777654221 111 1123455666666666666555444443 4556666666665
Q ss_pred -ccccc-CcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCcccc----CccccCcccccccc
Q 001922 197 -DLTGK-IPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIG----NLKLLDTVFLHINL 270 (995)
Q Consensus 197 -~l~~~-~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~----~l~~L~~L~l~~N~ 270 (995)
.++.. ++..+.+++ +|++|+|++|.+++..+..+. .+++|+.|++++|.
T Consensus 141 ~~~~~~~l~~~~~~~~-------------------------~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~ 195 (594)
T 2p1m_B 141 EGFSTDGLAAIAATCR-------------------------NLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA 195 (594)
T ss_dssp EEEEHHHHHHHHHHCT-------------------------TCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC
T ss_pred CCCCHHHHHHHHHhCC-------------------------CCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC
Confidence 33321 222223444 445555554444433222222 33345555554443
Q ss_pred --ccC-CCCccccCcCCCCeEeccCC-cCcCcCCccccccCCCCEEEccCCc-------CCCCCCccccCCCCcceE-Ee
Q 001922 271 --LSG-SIPKQLGNLTNLVNLDLSNN-ALTGEIPYSFINLRQLKLFNLFMNR-------LHGSIPDYLADLPNLETL-GL 338 (995)
Q Consensus 271 --l~~-~~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~-------l~~~~p~~~~~l~~L~~L-~L 338 (995)
++. .++..+..+++|++|++++| .+++ ++..+..+++|+.|+++.+. +.+ ++..+.++++|+.| .+
T Consensus 196 ~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~ 273 (594)
T 2p1m_B 196 SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGF 273 (594)
T ss_dssp SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECC
T ss_pred CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCC
Confidence 110 01111223455566666555 2332 44455555556665543332 221 22345555666665 33
Q ss_pred ccCcccccCCCcccCCCCCCeEEecCceecccCCC-cCcCCCccceeeccccccC-CCCCcccccCCCCcEEEecCCccC
Q 001922 339 WQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPT-DLCSSNQLRILILLKNFLF-GPIPERLGACYSLTRVRLGQNYLN 416 (995)
Q Consensus 339 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~-~~~p~~l~~l~~L~~L~l~~N~l~ 416 (995)
.+... +.++..+..+++|++|+|++|.+++.... .+..+++|+.|++++| +. ..++.....+++|++|++.++.-.
T Consensus 274 ~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~ 351 (594)
T 2p1m_B 274 WDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPF 351 (594)
T ss_dssp BTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTT
T ss_pred cccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCccc
Confidence 32222 23333344456666666666665432211 1334555666666555 22 112222234666777777443210
Q ss_pred CCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCcccc-CCCCCcEEEcC--C----Cc
Q 001922 417 GSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLS-NFSSLQILLLS--G----NQ 489 (995)
Q Consensus 417 ~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~ 489 (995)
| ....+.+++..... .....++|+.|+++.|++++..+..+. .+++|+.|+|+ + |.
T Consensus 352 g---------------~~~~~~l~~~~l~~--l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~ 414 (594)
T 2p1m_B 352 V---------------MEPNVALTEQGLVS--VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDY 414 (594)
T ss_dssp C---------------SSCSSCCCHHHHHH--HHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCT
T ss_pred c---------------cccCCCCCHHHHHH--HHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccc
Confidence 0 00011111000000 001135688888888888866666665 58999999999 4 56
Q ss_pred ccCCCC-----CCccchhhhccccccccccCCCCCCccCc-ccccceeeccCCcccCCCcccc-ccccccCeEecccccc
Q 001922 490 FSGPIP-----PSIGELRQVLKLDLSRNSLSGEIPPAIGY-CNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHL 562 (995)
Q Consensus 490 l~~~~p-----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~ip~~l-~~l~~L~~L~L~~N~l 562 (995)
+++... ..+..+++|+.|+|++ .+++..+..++. +++|++|+|++|.+++..+..+ ..+++|+.|+|++|++
T Consensus 415 l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 415 LTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp TTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred ccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 652211 1256678999999987 677655556665 8899999999999987666666 6789999999999999
Q ss_pred ccccCc-ccccCCcccEEeccCCCCC
Q 001922 563 NQNIPK-SIGSMKSLTIADFSFNDFS 587 (995)
Q Consensus 563 ~~~~p~-~~~~l~~L~~l~ls~N~l~ 587 (995)
++..+. .+..+++|+.|++++|+++
T Consensus 494 ~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 494 GDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp CHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred cHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 765544 4455899999999999874
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.1e-25 Score=236.51 Aligned_cols=227 Identities=28% Similarity=0.323 Sum_probs=128.7
Q ss_pred CCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCcc
Q 001922 94 LTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY 173 (995)
Q Consensus 94 L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~ 173 (995)
+..+++..+.+.+......+++|+.|++++|.++.. ..+..+++|++|+|++|.
T Consensus 21 l~~l~l~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~--------------------------~~l~~l~~L~~L~l~~n~ 74 (272)
T 3rfs_A 21 TIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSV--------------------------QGIQYLPNVRYLALGGNK 74 (272)
T ss_dssp HHHHHHTCSCTTSEECHHHHTTCCEEECTTSCCCCC--------------------------TTGGGCTTCCEEECTTSC
T ss_pred HHHHHhcCcccccccccccccceeeeeeCCCCcccc--------------------------cccccCCCCcEEECCCCC
Confidence 334455555555444455555555555555555432 234555566666666666
Q ss_pred ccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCc
Q 001922 174 FFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPH 253 (995)
Q Consensus 174 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~ 253 (995)
+++ + ..++.+++|++|+|++|.+++..+..|+ .+++|++|++++|++++..+.
T Consensus 75 l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~-------------------------~l~~L~~L~L~~n~l~~~~~~ 127 (272)
T 3rfs_A 75 LHD-I-SALKELTNLTYLILTGNQLQSLPNGVFD-------------------------KLTNLKELVLVENQLQSLPDG 127 (272)
T ss_dssp CCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTT-------------------------TCTTCCEEECTTSCCCCCCTT
T ss_pred CCC-c-hhhcCCCCCCEEECCCCccCccChhHhc-------------------------CCcCCCEEECCCCcCCccCHH
Confidence 553 2 2455666666666666665543332222 233444444444444444444
Q ss_pred cccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCc
Q 001922 254 EIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNL 333 (995)
Q Consensus 254 ~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 333 (995)
.+..+++|++|++++|++++..+..+..+++|++|++++|++++..+..|.++++|+.|++++|++++..+..+..+++|
T Consensus 128 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 207 (272)
T 3rfs_A 128 VFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL 207 (272)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred HhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCC
Confidence 44455555555555555554444455666666666666666666655566666666666666666666666666667777
Q ss_pred ceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCc
Q 001922 334 ETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQ 380 (995)
Q Consensus 334 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 380 (995)
+.|++++|.+.+. +++|++|+++.|.++|.+|..++.+..
T Consensus 208 ~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 208 QYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred CEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence 7777777766543 335677777777777777777665544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-24 Score=230.38 Aligned_cols=229 Identities=22% Similarity=0.186 Sum_probs=108.2
Q ss_pred EeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCcee
Q 001922 288 LDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKL 367 (995)
Q Consensus 288 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 367 (995)
.+.++..++ .+|..+. ++|+.|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 344444444 3333332 3455555555555544444455555555555555555544444444555555555555554
Q ss_pred cccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCC
Q 001922 368 TGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENG 447 (995)
Q Consensus 368 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~ 447 (995)
++.. +..+.++++|++|++++|.+.+..+..+..
T Consensus 89 ~~~~------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~---------------------- 122 (276)
T 2z62_A 89 QSLA------------------------LGAFSGLSSLQKLVAVETNLASLENFPIGH---------------------- 122 (276)
T ss_dssp CEEC------------------------TTTTTTCTTCCEEECTTSCCCCSTTCCCTT----------------------
T ss_pred CccC------------------------hhhhcCCccccEEECCCCCccccCchhccc----------------------
Confidence 4333 334444444455555554444322222211
Q ss_pred CCCCCCCCCcEEEcCCCccccc-CCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCccc
Q 001922 448 NSSSNPDRLGQLNLSNNLLSGP-LPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCN 526 (995)
Q Consensus 448 ~~~~~~~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 526 (995)
+++|++|++++|++++. +|..+.++++|+.|+|++|++++..+..+..+.+|+.|++
T Consensus 123 -----l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l----------------- 180 (276)
T 2z62_A 123 -----LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL----------------- 180 (276)
T ss_dssp -----CTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCE-----------------
T ss_pred -----CCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccce-----------------
Confidence 22344444444444432 3555555556666666666655444444555544441110
Q ss_pred ccceeeccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCC
Q 001922 527 HLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLP 591 (995)
Q Consensus 527 ~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p 591 (995)
+|++++|++++ +|.......+|++|+|++|++++..+..+..+++|+.|++++|++++..|
T Consensus 181 ---~L~ls~n~l~~-~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 181 ---SLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp ---EEECCSSCCCE-ECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ---eeecCCCcccc-cCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 45555555553 22222223355555555555555444445555666666666666655544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=232.65 Aligned_cols=229 Identities=23% Similarity=0.216 Sum_probs=186.7
Q ss_pred ccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhc
Q 001922 138 VNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYL 217 (995)
Q Consensus 138 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 217 (995)
.++..+++..+.+... ..+..+++|+.|++++|.++ .++ .++.+++|++|+|++|++++.
T Consensus 19 ~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~~---------------- 78 (272)
T 3rfs_A 19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDI---------------- 78 (272)
T ss_dssp HHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCCC----------------
T ss_pred HHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCCc----------------
Confidence 3444555555555543 34556778888888888876 333 477788888888888887731
Q ss_pred cccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcC
Q 001922 218 GYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTG 297 (995)
Q Consensus 218 ~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 297 (995)
..+..+++|++|++++|.+++..+..+..+++|++|++++|++++..+..|..+++|++|++++|.+++
T Consensus 79 -----------~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 147 (272)
T 3rfs_A 79 -----------SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS 147 (272)
T ss_dssp -----------GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred -----------hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCc
Confidence 134456789999999999998888888999999999999999998888888999999999999999998
Q ss_pred cCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcC
Q 001922 298 EIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCS 377 (995)
Q Consensus 298 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 377 (995)
..+..|..+++|+.|++++|++++..+..+..+++|+.|++++|++++..|..+..+++|++|+|++|++.+.
T Consensus 148 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~------- 220 (272)
T 3rfs_A 148 LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT------- 220 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------
T ss_pred cCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------
Confidence 8888889999999999999999988888889999999999999999988888889999999999999988744
Q ss_pred CCccceeeccccccCCCCCcccccCCC
Q 001922 378 SNQLRILILLKNFLFGPIPERLGACYS 404 (995)
Q Consensus 378 l~~L~~L~l~~N~l~~~~p~~l~~l~~ 404 (995)
++.|+.|++..|.+.|.+|..++.+..
T Consensus 221 ~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 221 CPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred CcHHHHHHHHHHhCCCcccCcccccCC
Confidence 446888888888888888888776654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-25 Score=259.05 Aligned_cols=186 Identities=15% Similarity=0.193 Sum_probs=145.5
Q ss_pred cCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCCh-------hHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 689 KDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSH-------DHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 689 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
...+.||+|+||+||+|+. .++.+++|+......... .+++.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4567899999999999955 578899998744222211 24478999999999999999666666677788999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++++|.+++.. +..++.|+++||.|||+++ |+||||||+||+++. .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999964 4579999999999999887 999999999999999 9999999999976432
Q ss_pred CCCc-----cccccccCccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 001922 842 GASE-----CMSAIAGSYGYIAPEYAYT--LRVDEKSDVYSFGVVLLELLTGRRPV 890 (995)
Q Consensus 842 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~Pf 890 (995)
.... ......||+.|+|||++.. ..|+...|+|+..+-..+-+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1111 1235679999999999987 56888899999999988888877776
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-26 Score=255.62 Aligned_cols=265 Identities=20% Similarity=0.202 Sum_probs=167.4
Q ss_pred CceeeeEEeCCCceeeeecCCCCccccCCccccCC--CCCCeEeccCCcccCcc-ccCcccccceeccccccccCC-Ccc
Q 001922 57 VCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRL--DKLTNLSLAGNNFTGSI-EIGNLSSLQFLNISNNQFSGG-LDW 132 (995)
Q Consensus 57 ~C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~-~~~~l~~L~~L~Ls~N~i~~~-~~~ 132 (995)
|..|+++.|+...++.+|++++++. +..+..+ ++++.|++++|.+++.. .+..+++|++|+|++|.+++. .+.
T Consensus 36 c~~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~ 112 (336)
T 2ast_B 36 CKRWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHG 112 (336)
T ss_dssp CHHHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHH
T ss_pred HHHHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHH
Confidence 5679999987666788888887765 4455555 77778888887777643 456677777777777776654 555
Q ss_pred cccccccccccccccccccccCCccccCCCCCceeeccCc-ccccc-CCccccCCCCCceeeccCC-ccccc-Ccccccc
Q 001922 133 NYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGN-YFFGK-IPNSYGELQGLEYLSLAGN-DLTGK-IPGELGN 208 (995)
Q Consensus 133 ~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~-~~~~l~~ 208 (995)
.+..+++|++|++++|.+++..+..++.+++|++|+|++| .+++. ++..+..+++|++|+|++| .+++. ++..+.
T Consensus 113 ~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~- 191 (336)
T 2ast_B 113 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA- 191 (336)
T ss_dssp HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHH-
T ss_pred HHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHH-
Confidence 5666667777777766666656666666666666666666 45542 4555666666666666666 66542 333334
Q ss_pred hhhhhhhhccccccccCCCCcccCCCC-cccEEECcCC--CCC-CccCccccCccccCcccccccc-ccCCCCccccCcC
Q 001922 209 LTNLREIYLGYYNVFEGGIPREVGKLV-NLVHLDLSSC--ELD-GQIPHEIGNLKLLDTVFLHINL-LSGSIPKQLGNLT 283 (995)
Q Consensus 209 l~~L~~L~L~~n~~~~~~~p~~~~~l~-~L~~L~Ls~n--~l~-~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~l~~l~ 283 (995)
.++ +|++|++++| .++ +.++..+..+++|+.|++++|. +++..+..+..++
T Consensus 192 ------------------------~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~ 247 (336)
T 2ast_B 192 ------------------------HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 247 (336)
T ss_dssp ------------------------HSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred ------------------------hcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCC
Confidence 444 5555666555 333 2344455556666666666666 5545555666677
Q ss_pred CCCeEeccCCc-CcCcCCccccccCCCCEEEccCCcCCCCCCccccCC-CCcceEEeccCcccccCCCcccC
Q 001922 284 NLVNLDLSNNA-LTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADL-PNLETLGLWQNNFTGVIPENLGQ 353 (995)
Q Consensus 284 ~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~ 353 (995)
+|++|++++|. +.......+.++++|+.|++++| ++.. .+..+ .+|+.|++++|++++..|..++.
T Consensus 248 ~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 248 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHHhhCcceEEecccCccccCCcccc
Confidence 77777777774 32222235666777777777777 3322 23333 23666667888888777776664
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.5e-24 Score=233.27 Aligned_cols=227 Identities=17% Similarity=0.154 Sum_probs=159.2
Q ss_pred CCCCeEeccCCcccCcc-----ccCcccccceeccccccccCCCcccc--cccccccccccccccccccCC----ccccC
Q 001922 92 DKLTNLSLAGNNFTGSI-----EIGNLSSLQFLNISNNQFSGGLDWNY--SSLVNLEVFDAYNNNFTALLP----VGILK 160 (995)
Q Consensus 92 ~~L~~L~L~~n~l~~~~-----~~~~l~~L~~L~Ls~N~i~~~~~~~~--~~l~~L~~L~Ls~n~i~~~~p----~~~~~ 160 (995)
..++.|.++++.++... ....+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 34677777777765321 23345668888888888887777776 777788888888887776544 34456
Q ss_pred CCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEE
Q 001922 161 LEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHL 240 (995)
Q Consensus 161 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L 240 (995)
+++|++|+|++|++++..|..|+.+++|++|+|++|++.+... -..+..+..+++|++|
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---------------------~~~~~~~~~l~~L~~L 202 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERG---------------------LMAALCPHKFPAIQNL 202 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHH---------------------HHTTSCTTSSCCCCSC
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchh---------------------hhHHHhhhcCCCCCEE
Confidence 7777777777777776667777777777777777777653200 0011223456677777
Q ss_pred ECcCCCCCCccCc----cccCccccCccccccccccCCCCccccCc---CCCCeEeccCCcCcCcCCccccccCCCCEEE
Q 001922 241 DLSSCELDGQIPH----EIGNLKLLDTVFLHINLLSGSIPKQLGNL---TNLVNLDLSNNALTGEIPYSFINLRQLKLFN 313 (995)
Q Consensus 241 ~Ls~n~l~~~~~~----~~~~l~~L~~L~l~~N~l~~~~p~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 313 (995)
+|++|+++. ++. .+..+++|++|+|++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|+
T Consensus 203 ~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~ 278 (310)
T 4glp_A 203 ALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLD 278 (310)
T ss_dssp BCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEE
T ss_pred ECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEE
Confidence 777777763 222 24667788888888888887767666666 58888888888888 5566664 7888899
Q ss_pred ccCCcCCCCCCccccCCCCcceEEeccCcccc
Q 001922 314 LFMNRLHGSIPDYLADLPNLETLGLWQNNFTG 345 (995)
Q Consensus 314 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 345 (995)
|++|+|++. |. +..+++|+.|+|++|+++.
T Consensus 279 Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 279 LSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 999988854 33 6778889999999998874
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-23 Score=225.64 Aligned_cols=203 Identities=26% Similarity=0.219 Sum_probs=142.8
Q ss_pred ccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhh
Q 001922 134 YSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLR 213 (995)
Q Consensus 134 ~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 213 (995)
++++++++++++++|+++. +|..+. +++++|+|++|.+++..|..|..+++|++|+|++|.+++..
T Consensus 6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~----------- 71 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ----------- 71 (290)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE-----------
T ss_pred ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCccc-----------
Confidence 4555666666666666665 333332 45666666666666555566666666666666666665321
Q ss_pred hhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCC
Q 001922 214 EIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNN 293 (995)
Q Consensus 214 ~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N 293 (995)
. ...+++|++|+|++|+++ .+|..+..+++|++|++++|++++..+..|.++++|++|+|++|
T Consensus 72 ---------------~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N 134 (290)
T 1p9a_G 72 ---------------V-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134 (290)
T ss_dssp ---------------C-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred ---------------C-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence 1 135567888888888887 56667777777777778877777666677788888888888888
Q ss_pred cCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceec
Q 001922 294 ALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 294 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 368 (995)
+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++ .+|..+..+.+|+.|+|++|++.
T Consensus 135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 888777777777888888888888888666666777888888888888887 56666777778888888888775
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-22 Score=217.73 Aligned_cols=201 Identities=26% Similarity=0.218 Sum_probs=120.4
Q ss_pred cccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEcc
Q 001922 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLF 315 (995)
Q Consensus 236 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 315 (995)
+.+.+++++++++ .+|..+. +.|+.|++++|++++..+..|.++++|++|+|++|.++...+..|.++++|+.|+++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 3556666666666 3444333 456666666666665555566666666666666666665555555666666666666
Q ss_pred CCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCC
Q 001922 316 MNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPI 395 (995)
Q Consensus 316 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 395 (995)
+|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+.+..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 66666555555666666666666666666655555666666666666666666444444566666666666666666555
Q ss_pred CcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccc
Q 001922 396 PERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYL 439 (995)
Q Consensus 396 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l 439 (995)
+..+..+++|+.|++++|++++..+..|..+++|+.+++++|.+
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPW 217 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCe
Confidence 55566666666666666666655444454444444444444433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.2e-23 Score=224.38 Aligned_cols=205 Identities=22% Similarity=0.147 Sum_probs=173.0
Q ss_pred ccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCC
Q 001922 109 EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGL 188 (995)
Q Consensus 109 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 188 (995)
++.++++|++|++++|.++.+++... +++++|+|++|+|+++.|..|..+++|++|+|++|.+++..+ .+.+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTC
T ss_pred cccccCCccEEECCCCCCCcCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcC
Confidence 46788999999999999997655433 689999999999999999999999999999999999985443 3789999
Q ss_pred ceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCcccccc
Q 001922 189 EYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHI 268 (995)
Q Consensus 189 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~ 268 (995)
++|+|++|+++ .+| ..+..+++|++|+|++|++++..+..|..+++|++|++++
T Consensus 80 ~~L~Ls~N~l~-~l~-------------------------~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~ 133 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLP-------------------------LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133 (290)
T ss_dssp CEEECCSSCCS-SCC-------------------------CCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred CEEECCCCcCC-cCc-------------------------hhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCC
Confidence 99999999987 333 3345566788888888888877777888888888888888
Q ss_pred ccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccc
Q 001922 269 NLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTG 345 (995)
Q Consensus 269 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 345 (995)
|++++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus 134 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 8888777777888899999999999999777777888999999999999998 677777788899999999998863
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-25 Score=250.13 Aligned_cols=266 Identities=19% Similarity=0.179 Sum_probs=159.7
Q ss_pred EEECcCCCCCCccCccccCccccCccccccccccCCCC----ccccCcC-CCCeEeccCCcCcCcCCcccccc-----CC
Q 001922 239 HLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIP----KQLGNLT-NLVNLDLSNNALTGEIPYSFINL-----RQ 308 (995)
Q Consensus 239 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p----~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 308 (995)
+++++.|.+++.+|..+...++|++|++++|.+++..+ ..+..++ +|++|+|++|.|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35677777777777666666667777777777776555 5666777 77777777777777666666665 77
Q ss_pred CCEEEccCCcCCCCCCcccc----CC-CCcceEEeccCcccccCCCcccC-----CCCCCeEEecCceecccCCCcCcCC
Q 001922 309 LKLFNLFMNRLHGSIPDYLA----DL-PNLETLGLWQNNFTGVIPENLGQ-----NGKLQVLDLSSNKLTGTIPTDLCSS 378 (995)
Q Consensus 309 L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~p~~~~~l 378 (995)
|+.|+|++|++++..+..+. .+ ++|++|+|++|++++..+..+.. .++|++|+|++|++++..+..+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l--- 158 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL--- 158 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH---
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH---
Confidence 77777777777765555333 33 67777777777777655444332 2467777777777764322221
Q ss_pred CccceeeccccccCCCCCcccccCC-CCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCC-CCC
Q 001922 379 NQLRILILLKNFLFGPIPERLGACY-SLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNP-DRL 456 (995)
Q Consensus 379 ~~L~~L~l~~N~l~~~~p~~l~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~-~~L 456 (995)
+..+..+. +|++|++++|++++..+..+... .... .+|
T Consensus 159 -----------------~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~-----------------------l~~~~~~L 198 (362)
T 3goz_A 159 -----------------IQILAAIPANVNSLNLRGNNLASKNCAELAKF-----------------------LASIPASV 198 (362)
T ss_dssp -----------------HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHH-----------------------HHTSCTTC
T ss_pred -----------------HHHHhcCCccccEeeecCCCCchhhHHHHHHH-----------------------HHhCCCCC
Confidence 12222232 56666666666654433322111 0001 245
Q ss_pred cEEEcCCCccccc----CCccccC-CCCCcEEEcCCCcccCCCC----CCccchhhhccccccccccCCC-------CCC
Q 001922 457 GQLNLSNNLLSGP----LPFSLSN-FSSLQILLLSGNQFSGPIP----PSIGELRQVLKLDLSRNSLSGE-------IPP 520 (995)
Q Consensus 457 ~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~-------~p~ 520 (995)
++|+|++|.+++. ++..+.. .++|+.|+|++|++++..+ ..+..+++|+.|+|++|.+.+. ++.
T Consensus 199 ~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~ 278 (362)
T 3goz_A 199 TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGA 278 (362)
T ss_dssp CEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHT
T ss_pred CEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHH
Confidence 5566666665532 3444444 3477777777777765433 2345566777777777774432 233
Q ss_pred ccCcccccceeeccCCcccCCCccccc
Q 001922 521 AIGYCNHLTYLDMSQNNLSGSIPPEIS 547 (995)
Q Consensus 521 ~~~~l~~L~~L~Ls~N~l~~~ip~~l~ 547 (995)
.+..+++|++|||++|++.+..|..+.
T Consensus 279 ~~~~l~~L~~LdL~~N~l~~~~~~~~~ 305 (362)
T 3goz_A 279 AFPNIQKIILVDKNGKEIHPSHSIPIS 305 (362)
T ss_dssp TSTTCCEEEEECTTSCBCCGGGCHHHH
T ss_pred HhccCCceEEEecCCCcCCCcchHHHH
Confidence 566777788888888887765454443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.3e-25 Score=248.05 Aligned_cols=111 Identities=18% Similarity=0.232 Sum_probs=58.4
Q ss_pred CCcEEEcCCCcccCCCCCCccch-----hhhccccccccccCCC----CCCccCc-ccccceeeccCCcccCCCc----c
Q 001922 479 SLQILLLSGNQFSGPIPPSIGEL-----RQVLKLDLSRNSLSGE----IPPAIGY-CNHLTYLDMSQNNLSGSIP----P 544 (995)
Q Consensus 479 ~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~ip----~ 544 (995)
+|+.|+|++|++++..+..++.. ++|+.|||++|.+++. ++..+.. .++|++|+|++|.+++..+ .
T Consensus 168 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 247 (362)
T 3goz_A 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKL 247 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHH
T ss_pred cccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHH
Confidence 45555555555543333333322 3455555555555431 3333333 2366666666666664433 2
Q ss_pred ccccccccCeEeccccccccc-------cCcccccCCcccEEeccCCCCCCC
Q 001922 545 EISNVRILNYLNLSRNHLNQN-------IPKSIGSMKSLTIADFSFNDFSGK 589 (995)
Q Consensus 545 ~l~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~l~ls~N~l~g~ 589 (995)
.+..+++|+.|+|++|++.+. ++..+..+++|+.||+++|++.+.
T Consensus 248 ~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 248 LKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp TTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 234556666666666664322 334566677777777777776654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-23 Score=229.51 Aligned_cols=224 Identities=19% Similarity=0.130 Sum_probs=157.8
Q ss_pred ccceeccccccccCCCcc---cccccccccccccccccccccCCccc--cCCCCCceeeccCccccccCC----ccccCC
Q 001922 115 SLQFLNISNNQFSGGLDW---NYSSLVNLEVFDAYNNNFTALLPVGI--LKLEKLKYLDLGGNYFFGKIP----NSYGEL 185 (995)
Q Consensus 115 ~L~~L~Ls~N~i~~~~~~---~~~~l~~L~~L~Ls~n~i~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~l~~l 185 (995)
.++.|.+.++.++...-. .+..+++|++|++++|++++..|..+ ..+++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 456666666655421100 11223446666666666665555555 555666666666666654333 223345
Q ss_pred CCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCc--c--CccccCcccc
Q 001922 186 QGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQ--I--PHEIGNLKLL 261 (995)
Q Consensus 186 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~--~--~~~~~~l~~L 261 (995)
++|++|+|++|++++. .+..+..+++|++|+|++|++.+. + +..+..+++|
T Consensus 145 ~~L~~L~Ls~n~l~~~-------------------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L 199 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAF-------------------------SCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAI 199 (310)
T ss_dssp SCCCEEEEECCSSCCC-------------------------CTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCC
T ss_pred cCCCEEEeeCCCcchh-------------------------hHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCC
Confidence 5555555555555533 345566778889999999988652 2 2334789999
Q ss_pred CccccccccccCCCCc----cccCcCCCCeEeccCCcCcCcCCcccccc---CCCCEEEccCCcCCCCCCccccCCCCcc
Q 001922 262 DTVFLHINLLSGSIPK----QLGNLTNLVNLDLSNNALTGEIPYSFINL---RQLKLFNLFMNRLHGSIPDYLADLPNLE 334 (995)
Q Consensus 262 ~~L~l~~N~l~~~~p~----~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 334 (995)
++|++++|+++. ++. .+.++++|++|+|++|+|++..|..+..+ ++|+.|+|++|+|+ .+|..+. ++|+
T Consensus 200 ~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~ 275 (310)
T 4glp_A 200 QNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLR 275 (310)
T ss_dssp CSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCS
T ss_pred CEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCC
Confidence 999999999973 333 35788999999999999998888888776 69999999999999 6677664 8999
Q ss_pred eEEeccCcccccCCCcccCCCCCCeEEecCceecc
Q 001922 335 TLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTG 369 (995)
Q Consensus 335 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 369 (995)
.|+|++|++++. |. +..+++|+.|+|++|+|+.
T Consensus 276 ~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 276 VLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred EEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 999999999964 44 7888999999999999874
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-24 Score=241.44 Aligned_cols=253 Identities=19% Similarity=0.237 Sum_probs=131.1
Q ss_pred CCeEeccCCcccCccccCcc--cccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccC
Q 001922 94 LTNLSLAGNNFTGSIEIGNL--SSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGG 171 (995)
Q Consensus 94 L~~L~L~~n~l~~~~~~~~l--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~ 171 (995)
++.+++++|.+.. ..+..+ ++++.|++++|.+++..+. +..+++|++|+|++
T Consensus 49 ~~~l~l~~~~~~~-~~~~~~~~~~l~~L~l~~n~l~~~~~~-------------------------~~~~~~L~~L~L~~ 102 (336)
T 2ast_B 49 WQTLDLTGKNLHP-DVTGRLLSQGVIAFRCPRSFMDQPLAE-------------------------HFSPFRVQHMDLSN 102 (336)
T ss_dssp SSEEECTTCBCCH-HHHHHHHHTTCSEEECTTCEECSCCCS-------------------------CCCCBCCCEEECTT
T ss_pred heeeccccccCCH-HHHHhhhhccceEEEcCCccccccchh-------------------------hccCCCCCEEEccC
Confidence 4556666555542 223333 4555555555555544333 23344444455554
Q ss_pred cccccc-CCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccC-CCCcccCCCCcccEEECcCC-CCC
Q 001922 172 NYFFGK-IPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEG-GIPREVGKLVNLVHLDLSSC-ELD 248 (995)
Q Consensus 172 N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~-~~p~~~~~l~~L~~L~Ls~n-~l~ 248 (995)
|.+++. +|..+..+++|++|+|++|.+++..+..++.+++|++|++++|..+.+ .++..+..+++|++|++++| .++
T Consensus 103 ~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~ 182 (336)
T 2ast_B 103 SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT 182 (336)
T ss_dssp CEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCC
T ss_pred CCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcC
Confidence 444433 444444445555555555544444444444444444444433311111 13333445667777777777 776
Q ss_pred Cc-cCccccCcc-ccCccccccc--ccc-CCCCccccCcCCCCeEeccCCc-CcCcCCccccccCCCCEEEccCCc-CCC
Q 001922 249 GQ-IPHEIGNLK-LLDTVFLHIN--LLS-GSIPKQLGNLTNLVNLDLSNNA-LTGEIPYSFINLRQLKLFNLFMNR-LHG 321 (995)
Q Consensus 249 ~~-~~~~~~~l~-~L~~L~l~~N--~l~-~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~ 321 (995)
+. ++..+..++ +|++|++++| .++ +.+|..+..+++|++|++++|. +++..+..+..+++|+.|++++|. +..
T Consensus 183 ~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~ 262 (336)
T 2ast_B 183 EKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 262 (336)
T ss_dssp HHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG
T ss_pred hHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCH
Confidence 43 455566666 7777777777 333 3345555666677777777776 555556666666666666666664 221
Q ss_pred CCCccccCCCCcceEEeccCcccccCCCcccCC-CCCCeEEecCceecccCCCcCc
Q 001922 322 SIPDYLADLPNLETLGLWQNNFTGVIPENLGQN-GKLQVLDLSSNKLTGTIPTDLC 376 (995)
Q Consensus 322 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~ 376 (995)
.....+..+++|+.|++++| ++ ...+..+ ..|+.|++++|++++..|..++
T Consensus 263 ~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 263 ETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp GGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred HHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence 11124555666666666666 22 1123332 2255555666666655555443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-22 Score=220.27 Aligned_cols=209 Identities=24% Similarity=0.312 Sum_probs=126.3
Q ss_pred eEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCcccc
Q 001922 96 NLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFF 175 (995)
Q Consensus 96 ~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~ 175 (995)
.+.+..+.+++......+++|++|++++|.++... .+..+++|++|++++|+++++.+ +..+++|++|+|++|.++
T Consensus 23 ~~~l~~~~~~~~~~~~~l~~L~~L~l~~~~i~~l~--~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~ 98 (308)
T 1h6u_A 23 KIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98 (308)
T ss_dssp HHHTTCSSTTSEECHHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred HHHhCCCCcCceecHHHcCCcCEEEeeCCCccCch--hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCC
Confidence 34455555555555566667777777777666532 45566666666666666666433 666666666666666665
Q ss_pred ccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccc
Q 001922 176 GKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEI 255 (995)
Q Consensus 176 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 255 (995)
+ ++ .+..+++|++|+|++|++++. + .+..+++|++|++++|.+++..+ +
T Consensus 99 ~-~~-~~~~l~~L~~L~l~~n~l~~~-~--------------------------~l~~l~~L~~L~l~~n~l~~~~~--l 147 (308)
T 1h6u_A 99 N-VS-AIAGLQSIKTLDLTSTQITDV-T--------------------------PLAGLSNLQVLYLDLNQITNISP--L 147 (308)
T ss_dssp C-CG-GGTTCTTCCEEECTTSCCCCC-G--------------------------GGTTCTTCCEEECCSSCCCCCGG--G
T ss_pred C-ch-hhcCCCCCCEEECCCCCCCCc-h--------------------------hhcCCCCCCEEECCCCccCcCcc--c
Confidence 3 22 466666666666666666532 1 13344556666666666654332 5
Q ss_pred cCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcce
Q 001922 256 GNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLET 335 (995)
Q Consensus 256 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 335 (995)
..+++|+.|++++|++++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.
T Consensus 148 ~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~ 221 (308)
T 1h6u_A 148 AGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221 (308)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCE
T ss_pred cCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCE
Confidence 556666666666666664322 6666677777777777664433 6666677777777777664432 666677777
Q ss_pred EEeccCcccc
Q 001922 336 LGLWQNNFTG 345 (995)
Q Consensus 336 L~L~~N~l~~ 345 (995)
|++++|++++
T Consensus 222 L~l~~N~i~~ 231 (308)
T 1h6u_A 222 VTLTNQTITN 231 (308)
T ss_dssp EEEEEEEEEC
T ss_pred EEccCCeeec
Confidence 7777777663
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-24 Score=246.54 Aligned_cols=248 Identities=20% Similarity=0.194 Sum_probs=146.8
Q ss_pred CCccccCCCCCceeeccCccccccCC----ccccCCCCCceeeccCCc---ccccCcccccchhhhhhhhccccccccCC
Q 001922 154 LPVGILKLEKLKYLDLGGNYFFGKIP----NSYGELQGLEYLSLAGND---LTGKIPGELGNLTNLREIYLGYYNVFEGG 226 (995)
Q Consensus 154 ~p~~~~~l~~L~~L~L~~N~l~~~~p----~~l~~l~~L~~L~Ls~N~---l~~~~~~~l~~l~~L~~L~L~~n~~~~~~ 226 (995)
++..+..+++|++|+|++|.+++..+ ..|..+++|++|+|++|. +++.+|..+..+.
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~---------------- 87 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL---------------- 87 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHH----------------
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHH----------------
Confidence 44556666667777777776665433 335566777777777643 3334443332111
Q ss_pred CCcccCCCCcccEEECcCCCCCC----ccCccccCccccCccccccccccCCCCcc----ccCc---------CCCCeEe
Q 001922 227 IPREVGKLVNLVHLDLSSCELDG----QIPHEIGNLKLLDTVFLHINLLSGSIPKQ----LGNL---------TNLVNLD 289 (995)
Q Consensus 227 ~p~~~~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~p~~----l~~l---------~~L~~L~ 289 (995)
..+..+++|++|+|++|.+++ .+|..+..+++|++|+|++|.+++..+.. +..+ ++|++|+
T Consensus 88 --~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~ 165 (386)
T 2ca6_A 88 --QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165 (386)
T ss_dssp --HHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEE
T ss_pred --HHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEE
Confidence 223344556666666666654 24445555566666666666654332222 2222 6777777
Q ss_pred ccCCcCc-CcCC---ccccccCCCCEEEccCCcCCC-----CCCccccCCCCcceEEeccCccc----ccCCCcccCCCC
Q 001922 290 LSNNALT-GEIP---YSFINLRQLKLFNLFMNRLHG-----SIPDYLADLPNLETLGLWQNNFT----GVIPENLGQNGK 356 (995)
Q Consensus 290 Ls~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~ 356 (995)
|++|+++ +.++ ..+..+++|+.|++++|+|+. ..|..+..+++|+.|+|++|.++ +.+|..+..+++
T Consensus 166 L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~ 245 (386)
T 2ca6_A 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245 (386)
T ss_dssp CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred CCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCC
Confidence 7777776 2333 345566677777777777662 23335666777777777777775 455666677777
Q ss_pred CCeEEecCceeccc----CCCcC--cCCCccceeeccccccCC----CCCccc-ccCCCCcEEEecCCccCCCC
Q 001922 357 LQVLDLSSNKLTGT----IPTDL--CSSNQLRILILLKNFLFG----PIPERL-GACYSLTRVRLGQNYLNGSI 419 (995)
Q Consensus 357 L~~L~L~~N~l~~~----~p~~~--~~l~~L~~L~l~~N~l~~----~~p~~l-~~l~~L~~L~l~~N~l~~~~ 419 (995)
|++|+|++|++++. +|..+ +.+++|+.|+|++|.+.+ .+|..+ .++++|+.|++++|++++..
T Consensus 246 L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred cCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 77777777777654 34444 336667777777777665 356655 45677777777777777554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=213.90 Aligned_cols=196 Identities=16% Similarity=0.166 Sum_probs=84.5
Q ss_pred cccccccccccccccCCccccCCCCCceeeccCcc-ccccCCccccCCCCCceeeccC-CcccccCcccccchhhhhhhh
Q 001922 139 NLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY-FFGKIPNSYGELQGLEYLSLAG-NDLTGKIPGELGNLTNLREIY 216 (995)
Q Consensus 139 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~l~~l~~L~~L~ 216 (995)
+|++|++++|+|+++.+..|.++++|++|++++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 34444444444444444444444444444444443 4433333444444444444444 444433333333333333333
Q ss_pred ccccccccCCCCcccCCCCccc---EEECcCC-CCCCccCccccCccccCccccccccccCCCCccccCcCCCC-eEecc
Q 001922 217 LGYYNVFEGGIPREVGKLVNLV---HLDLSSC-ELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLV-NLDLS 291 (995)
Q Consensus 217 L~~n~~~~~~~p~~~~~l~~L~---~L~Ls~n-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~-~L~Ls 291 (995)
+++|.+.. +|. +..+++|+ +|++++| ++++..+.. |.++++|+ .|+++
T Consensus 112 l~~n~l~~--lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~------------------------~~~l~~L~~~L~l~ 164 (239)
T 2xwt_C 112 IFNTGLKM--FPD-LTKVYSTDIFFILEITDNPYMTSIPVNA------------------------FQGLCNETLTLKLY 164 (239)
T ss_dssp EEEECCCS--CCC-CTTCCBCCSEEEEEEESCTTCCEECTTT------------------------TTTTBSSEEEEECC
T ss_pred CCCCCCcc--ccc-cccccccccccEEECCCCcchhhcCccc------------------------ccchhcceeEEEcC
Confidence 33222211 222 23333333 5555555 554333333 44444444 44444
Q ss_pred CCcCcCcCCccccccCCCCEEEccCCc-CCCCCCccccCC-CCcceEEeccCcccccCCCcccCCCCCCeEEecCc
Q 001922 292 NNALTGEIPYSFINLRQLKLFNLFMNR-LHGSIPDYLADL-PNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSN 365 (995)
Q Consensus 292 ~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 365 (995)
+|.++...+..|.. ++|+.|++++|+ +++..+..|..+ ++|+.|++++|++++. |.. .+++|+.|+++++
T Consensus 165 ~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 165 NNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp SCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 44444222223333 445555555552 443334444555 5555555555555532 221 3445555555543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=7.3e-25 Score=249.51 Aligned_cols=255 Identities=21% Similarity=0.228 Sum_probs=177.0
Q ss_pred CCccccCCCCCCeEeccCCcccCcc------ccCcccccceeccccccccCCCcccccccccccccccccccccccCCcc
Q 001922 84 VPAQILRLDKLTNLSLAGNNFTGSI------EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVG 157 (995)
Q Consensus 84 ~~~~~~~l~~L~~L~L~~n~l~~~~------~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~ 157 (995)
++..+..+++|++|+|++|++++.. .+..+++|++|+|++|.+. ++++.+|..
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~---------------------~l~~~~~~~ 82 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG---------------------RVKDEIPEA 82 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTT---------------------SCGGGSHHH
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccC---------------------ccccchhHH
Confidence 4444555555666666666555321 1445555555555554332 222333333
Q ss_pred -------ccCCCCCceeeccCccccc----cCCccccCCCCCceeeccCCcccccCcccccc-hhhhhhhhccccccccC
Q 001922 158 -------ILKLEKLKYLDLGGNYFFG----KIPNSYGELQGLEYLSLAGNDLTGKIPGELGN-LTNLREIYLGYYNVFEG 225 (995)
Q Consensus 158 -------~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~-l~~L~~L~L~~n~~~~~ 225 (995)
+..+++|++|+|++|.+++ .+|..+..+++|++|+|++|.+++..+..+.. +..+....+. +
T Consensus 83 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~------~ 156 (386)
T 2ca6_A 83 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKA------K 156 (386)
T ss_dssp HHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHH------H
T ss_pred HHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhc------c
Confidence 4678889999999998876 47778888889999999999887554444443 2222221111 0
Q ss_pred CCCcccCCCCcccEEECcCCCCC-CccC---ccccCccccCccccccccccC-----CCCccccCcCCCCeEeccCCcCc
Q 001922 226 GIPREVGKLVNLVHLDLSSCELD-GQIP---HEIGNLKLLDTVFLHINLLSG-----SIPKQLGNLTNLVNLDLSNNALT 296 (995)
Q Consensus 226 ~~p~~~~~l~~L~~L~Ls~n~l~-~~~~---~~~~~l~~L~~L~l~~N~l~~-----~~p~~l~~l~~L~~L~Ls~N~l~ 296 (995)
..++|++|+|++|+++ +.++ ..+..+++|++|++++|+++. ..+..+..+++|++|+|++|.++
T Consensus 157 -------~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~ 229 (386)
T 2ca6_A 157 -------NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229 (386)
T ss_dssp -------TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred -------cCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCC
Confidence 1167888888888887 3334 356677888888888888872 34447888899999999999986
Q ss_pred ----CcCCccccccCCCCEEEccCCcCCCC----CCcccc--CCCCcceEEeccCcccc----cCCCcc-cCCCCCCeEE
Q 001922 297 ----GEIPYSFINLRQLKLFNLFMNRLHGS----IPDYLA--DLPNLETLGLWQNNFTG----VIPENL-GQNGKLQVLD 361 (995)
Q Consensus 297 ----~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~--~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~ 361 (995)
+.+|..+..+++|+.|+|++|+|++. ++..+. .+++|+.|+|++|++++ .+|..+ .++++|++|+
T Consensus 230 ~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~ 309 (386)
T 2ca6_A 230 HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 309 (386)
T ss_dssp HHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEE
T ss_pred cHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEE
Confidence 56778888899999999999998865 456663 48999999999999997 477777 6689999999
Q ss_pred ecCceecccCC
Q 001922 362 LSSNKLTGTIP 372 (995)
Q Consensus 362 L~~N~l~~~~p 372 (995)
|++|++++..+
T Consensus 310 l~~N~l~~~~~ 320 (386)
T 2ca6_A 310 LNGNRFSEEDD 320 (386)
T ss_dssp CTTSBSCTTSH
T ss_pred ccCCcCCcchh
Confidence 99999986553
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=213.16 Aligned_cols=197 Identities=17% Similarity=0.208 Sum_probs=156.3
Q ss_pred CCceeeccCccccccCCccccCCCCCceeeccCCc-ccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEE
Q 001922 163 KLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGND-LTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLD 241 (995)
Q Consensus 163 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~ 241 (995)
+|++|+|++|++++..+..|+.+++|++|++++|+ +++..+.. |.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~-------------------------f~~l~~L~~L~ 86 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHS-------------------------FYNLSKVTHIE 86 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTT-------------------------EESCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhH-------------------------cCCCcCCcEEE
Confidence 67888888888876666677778888888888886 66444334 44455667777
Q ss_pred CcC-CCCCCccCccccCccccCccccccccccCCCCccccCcCCCC---eEeccCC-cCcCcCCccccccCCCC-EEEcc
Q 001922 242 LSS-CELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLV---NLDLSNN-ALTGEIPYSFINLRQLK-LFNLF 315 (995)
Q Consensus 242 Ls~-n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~L~ 315 (995)
+++ |++++..+..|..+++|++|++++|++++ +|. +..+++|+ +|++++| .+++..+..|.++++|+ .|+++
T Consensus 87 l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~ 164 (239)
T 2xwt_C 87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY 164 (239)
T ss_dssp EEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECC
T ss_pred CCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcC
Confidence 776 77776666677778888888888888875 555 78888888 9999999 99988888899999999 99999
Q ss_pred CCcCCCCCCccccCCCCcceEEeccCc-ccccCCCcccCC-CCCCeEEecCceecccCCCcCcCCCccceeeccccc
Q 001922 316 MNRLHGSIPDYLADLPNLETLGLWQNN-FTGVIPENLGQN-GKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNF 390 (995)
Q Consensus 316 ~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 390 (995)
+|+++...+..|.. ++|+.|+|++|+ +++..+..|..+ ++|++|+|++|+++ .+|.. .+.+|+.|+++++.
T Consensus 165 ~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 165 NNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNTW 237 (239)
T ss_dssp SCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC-
T ss_pred CCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCcc
Confidence 99999444445555 899999999995 998888889999 99999999999999 45554 57788888887763
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=225.43 Aligned_cols=201 Identities=18% Similarity=0.123 Sum_probs=104.9
Q ss_pred ceeeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCC-Ccccc
Q 001922 58 CSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGG-LDWNY 134 (995)
Q Consensus 58 C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~-~~~~~ 134 (995)
|+|+.|.|+..++ + ++|..+ .+++++|+|++|+|+... .|.++++|++|+|++|++.+. .+..|
T Consensus 9 C~~~~v~C~~~~L----------t-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f 75 (350)
T 4ay9_X 9 CSNRVFLCQESKV----------T-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 75 (350)
T ss_dssp EETTEEEEESTTC----------C-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSB
T ss_pred eeCCEEEecCCCC----------C-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHh
Confidence 7888888875443 3 466654 246777777777776533 366666666666666666442 33455
Q ss_pred cccccccc-cccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccC-CcccccCcccccchhhh
Q 001922 135 SSLVNLEV-FDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAG-NDLTGKIPGELGNLTNL 212 (995)
Q Consensus 135 ~~l~~L~~-L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~l~~l~~L 212 (995)
.++++|+. +.++.|+++.+.|..|..+++|++|++++|++++..+..+....++..|++.+ |+++...+
T Consensus 76 ~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~--------- 146 (350)
T 4ay9_X 76 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER--------- 146 (350)
T ss_dssp CSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECT---------
T ss_pred hcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccc---------
Confidence 55555443 33444555555555555555555555555555544444444444455555533 23332211
Q ss_pred hhhhccccccccCCCCcccCCC-CcccEEECcCCCCCCccCccccCccccCcccccc-ccccCCCCccccCcCCCCeEec
Q 001922 213 REIYLGYYNVFEGGIPREVGKL-VNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHI-NLLSGSIPKQLGNLTNLVNLDL 290 (995)
Q Consensus 213 ~~L~L~~n~~~~~~~p~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~l~~l~~L~~L~L 290 (995)
..+..+ ..++.|+|++|+|+. ++.......+|+.|++.+ |.++.+.+++|.++++|++|||
T Consensus 147 ----------------~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdL 209 (350)
T 4ay9_X 147 ----------------NSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209 (350)
T ss_dssp ----------------TSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEEC
T ss_pred ----------------cchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhc
Confidence 122222 245666666666663 333333334455555542 3444333334455555555555
Q ss_pred cCCcCcC
Q 001922 291 SNNALTG 297 (995)
Q Consensus 291 s~N~l~~ 297 (995)
++|+|+.
T Consensus 210 s~N~l~~ 216 (350)
T 4ay9_X 210 SRTRIHS 216 (350)
T ss_dssp TTSCCCC
T ss_pred CCCCcCc
Confidence 5555553
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=4.1e-22 Score=218.83 Aligned_cols=214 Identities=25% Similarity=0.395 Sum_probs=146.4
Q ss_pred ccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceee
Q 001922 113 LSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLS 192 (995)
Q Consensus 113 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 192 (995)
+..+..+.+..+.+++.. .+..+++|++|++++|.++.+ | .+..+++|++|+|++|.+++. +. +..+++|++|+
T Consensus 18 l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~ 91 (308)
T 1h6u_A 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELE 91 (308)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEE
Confidence 344445556666555432 244566666677766666653 3 466666666666666666533 32 66666666666
Q ss_pred ccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCcccccccccc
Q 001922 193 LAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLS 272 (995)
Q Consensus 193 Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 272 (995)
|++|++++. ..+..+++|++|++++|++++. + .+..+++|+.|++++|+++
T Consensus 92 L~~n~l~~~---------------------------~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~ 142 (308)
T 1h6u_A 92 LSGNPLKNV---------------------------SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQIT 142 (308)
T ss_dssp CCSCCCSCC---------------------------GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred ccCCcCCCc---------------------------hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccC
Confidence 666666531 1345567888888888888854 3 2778888888888888887
Q ss_pred CCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCccc
Q 001922 273 GSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLG 352 (995)
Q Consensus 273 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 352 (995)
+..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..+ +.
T Consensus 143 ~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~ 214 (308)
T 1h6u_A 143 NISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LA 214 (308)
T ss_dssp CCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GT
T ss_pred cCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--cc
Confidence 5433 7778888888888888875444 7778888888888888875443 7778888888888888875542 77
Q ss_pred CCCCCCeEEecCceecc
Q 001922 353 QNGKLQVLDLSSNKLTG 369 (995)
Q Consensus 353 ~l~~L~~L~L~~N~l~~ 369 (995)
.+++|++|+|++|++++
T Consensus 215 ~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 215 NTSNLFIVTLTNQTITN 231 (308)
T ss_dssp TCTTCCEEEEEEEEEEC
T ss_pred CCCCCCEEEccCCeeec
Confidence 77888888888888873
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.3e-22 Score=205.50 Aligned_cols=183 Identities=23% Similarity=0.246 Sum_probs=127.4
Q ss_pred CceeeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCcccc
Q 001922 57 VCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNY 134 (995)
Q Consensus 57 ~C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~ 134 (995)
.|.|.+|.|+...++ .+|..+ .++|++|+|++|++++.. .+.++++|++|+|++|+++++.+..|
T Consensus 6 ~C~~~~v~c~~~~l~-----------~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 72 (208)
T 2o6s_A 6 SCSGTTVECYSQGRT-----------SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72 (208)
T ss_dssp EEETTEEECCSSCCS-----------SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred EECCCEEEecCCCcc-----------CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhc
Confidence 489999999864433 234333 357888888888887644 36778888888888888887777777
Q ss_pred cccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhh
Q 001922 135 SSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLRE 214 (995)
Q Consensus 135 ~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 214 (995)
..+++|++|++++|+++++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+.
T Consensus 73 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~------- 145 (208)
T 2o6s_A 73 NKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFD------- 145 (208)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT-------
T ss_pred CCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhc-------
Confidence 7778888888888888776666677777888888888877766666677777788888877777754443344
Q ss_pred hhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCC
Q 001922 215 IYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTN 284 (995)
Q Consensus 215 L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~ 284 (995)
.+++|++|++++|.+.+ .++.|+.|+++.|+++|.+|..++.++.
T Consensus 146 ------------------~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 146 ------------------RLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ------------------TCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ------------------cCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 44555666666665543 2345666666666666666666665544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4.9e-21 Score=203.80 Aligned_cols=180 Identities=22% Similarity=0.175 Sum_probs=127.7
Q ss_pred cccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEcc
Q 001922 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLF 315 (995)
Q Consensus 236 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 315 (995)
+.++++++++.++ .+|..+. +.++.|++++|.+++..+..|.++++|++|+|++|.|++..+..|.++++|+.|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4566777777776 4454443 466777777777776666677777777777777777777666677777777777777
Q ss_pred CCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCC
Q 001922 316 MNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPI 395 (995)
Q Consensus 316 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 395 (995)
+|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++.+..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 77777666666777777777777777777666666677777777777777777555556677777777777777777666
Q ss_pred CcccccCCCCcEEEecCCccCCC
Q 001922 396 PERLGACYSLTRVRLGQNYLNGS 418 (995)
Q Consensus 396 p~~l~~l~~L~~L~l~~N~l~~~ 418 (995)
+..+..+++|+.|++++|++.+.
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHHhCCCCCCEEEeeCCceeCC
Confidence 66677777777777777777654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.9e-21 Score=216.26 Aligned_cols=122 Identities=20% Similarity=0.184 Sum_probs=78.1
Q ss_pred CccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCC-ccccCCCCcce-EEec
Q 001922 262 DTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIP-DYLADLPNLET-LGLW 339 (995)
Q Consensus 262 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L~ 339 (995)
++++.++++++ .+|..+ .+++++|+|++|+|+.+.+.+|.++++|+.|+|++|++.+.+| .+|.+++++.+ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 45667777777 455544 2467777777777775555667777777777777777655444 45667766654 5555
Q ss_pred cCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeec
Q 001922 340 QNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILIL 386 (995)
Q Consensus 340 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 386 (995)
+|+++...|..|..+++|++|++++|++++..+..+....++..|++
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l 135 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 135 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhh
Confidence 67777666777777777777777777776544444444444444444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-21 Score=210.48 Aligned_cols=145 Identities=17% Similarity=0.083 Sum_probs=116.0
Q ss_pred ccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCC-----------------ChhHHHHHHHHHHhccCCCCceeEeE
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTH-----------------SHDHGFRAEIQTLGNIRHRNIVRLLA 750 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~hpniv~~~~ 750 (995)
|+.++.||+|+||.||+|++.+|+.||+|.+...... .....+.+|++++++++ | +++.+
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 5566899999999999998877999999998532211 12456889999999999 4 66666
Q ss_pred EEecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEe
Q 001922 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVA 830 (995)
Q Consensus 751 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~ 830 (995)
++.. +..|+||||++||+|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++ ++.+||+
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEEC
T ss_pred EEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEE
Confidence 5543 56799999999999999 531 123469999999999999887 99999999999999 9999999
Q ss_pred eeccccccccCCCCccccccccCccccccccccc
Q 001922 831 DFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT 864 (995)
Q Consensus 831 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 864 (995)
|||+|+. +..|+|||++..
T Consensus 235 DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 235 DFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp CCTTCEE---------------TTSTTHHHHHHH
T ss_pred ECCCCeE---------------CCCCCHHHHHHH
Confidence 9999864 235788998753
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.8e-22 Score=234.80 Aligned_cols=211 Identities=25% Similarity=0.313 Sum_probs=155.3
Q ss_pred CCCCCCCCCCCCCc-----eeeeE-EeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCccccCcccccce
Q 001922 45 ALISWNSSNPSSVC-----SWAGI-CCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQF 118 (995)
Q Consensus 45 ~l~~W~~~~~~~~C-----~w~gv-~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~ 118 (995)
.+.+|..+ .+.| .|.|+ .|...+++.|+|+++++++ +|..+. ++|++|+|++|+|+... ..+++|++
T Consensus 32 ~l~~W~~~--~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~ip--~~l~~L~~ 104 (571)
T 3cvr_A 32 AWDKWEKQ--ALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALISLP--ELPASLEY 104 (571)
T ss_dssp HHHHHHTT--CCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSCCC--CCCTTCCE
T ss_pred HHHHHhcc--CCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcccc--cccCCCCE
Confidence 45667543 2356 79999 7988899999999999987 787663 78999999999988533 66788888
Q ss_pred eccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcc
Q 001922 119 LNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDL 198 (995)
Q Consensus 119 L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 198 (995)
|+|++|+|++++ . +.. +|++|+|++|+|++ +|. .+++|++|+|++|.|++ +|. .+++|++|+|++|+|
T Consensus 105 L~Ls~N~l~~ip-~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 105 LDACDNRLSTLP-E-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQL 172 (571)
T ss_dssp EECCSSCCSCCC-C-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred EEccCCCCCCcc-h-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCC
Confidence 888888888743 3 544 77778888877777 444 56777777777777764 554 456777777777777
Q ss_pred cccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCcccc-------Cccccccccc
Q 001922 199 TGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLL-------DTVFLHINLL 271 (995)
Q Consensus 199 ~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-------~~L~l~~N~l 271 (995)
++ +|. | . ++|++|+|++|+|+ .+|. +.. +| +.|+|++|+|
T Consensus 173 ~~-lp~-l-------------------------~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l 219 (571)
T 3cvr_A 173 TF-LPE-L-------------------------P--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRI 219 (571)
T ss_dssp SC-CCC-C-------------------------C--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCC
T ss_pred CC-cch-h-------------------------h--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcc
Confidence 74 333 2 2 46777777777777 4454 443 55 8888888888
Q ss_pred cCCCCccccCcCCCCeEeccCCcCcCcCCccccccCC
Q 001922 272 SGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQ 308 (995)
Q Consensus 272 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 308 (995)
+ .+|..+..+++|+.|+|++|.|++.+|..|..++.
T Consensus 220 ~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 220 T-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp C-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred e-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 8 57777888999999999999999888888877654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2.1e-20 Score=198.83 Aligned_cols=179 Identities=23% Similarity=0.206 Sum_probs=143.4
Q ss_pred cccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEe
Q 001922 259 KLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGL 338 (995)
Q Consensus 259 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 338 (995)
...+.++++++.++ .+|..+. ++|+.|+|++|.+++..+..|.++++|+.|+|++|+|++..+..|..+++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 35677888888888 4665554 58899999999998888888888999999999999998888888888899999999
Q ss_pred ccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCC
Q 001922 339 WQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGS 418 (995)
Q Consensus 339 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 418 (995)
++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.+..+..+..+++|+.|++++|++++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99999877778888888999999999988866666678888888888888888877777788888888888888888877
Q ss_pred CCCCcccCCCCceeeccCcccc
Q 001922 419 IPDGFIYLPGLNLAELQSNYLS 440 (995)
Q Consensus 419 ~p~~~~~l~~L~~l~l~~n~l~ 440 (995)
.+..|..+++|+.+++++|.+.
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBC
T ss_pred CHHHHhCCCCCCEEEeeCCcee
Confidence 7666666655555555555443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=9.2e-21 Score=223.06 Aligned_cols=189 Identities=28% Similarity=0.414 Sum_probs=134.2
Q ss_pred CcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEec
Q 001922 332 NLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLG 411 (995)
Q Consensus 332 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~ 411 (995)
+|+.|+|++|++++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|++++|.+.+ +|. +.. +|+.|+++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 78889999988886 666553 67888888888888 566 345677777777777766 555 444 66677777
Q ss_pred CCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCccc
Q 001922 412 QNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFS 491 (995)
Q Consensus 412 ~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 491 (995)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|+
T Consensus 129 ~N~l~~-lp~------------------------------~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~ 173 (571)
T 3cvr_A 129 NNQLTM-LPE------------------------------LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLT 173 (571)
T ss_dssp SSCCSC-CCC------------------------------CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS
T ss_pred CCcCCC-CCC------------------------------cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCC
Confidence 666664 332 13456777777777774 554 4567778888888877
Q ss_pred CCCCCCccchhhhccccccccccCCCCCCccCccccc-------ceeeccCCcccCCCccccccccccCeEecccccccc
Q 001922 492 GPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHL-------TYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQ 564 (995)
Q Consensus 492 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~ 564 (995)
+ +|. |. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++
T Consensus 174 ~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 174 F-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp C-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCH
T ss_pred C-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCC
Confidence 5 665 55 77788888888887 5666 554 66 88888888887 678878788888888888888888
Q ss_pred ccCcccccCCc
Q 001922 565 NIPKSIGSMKS 575 (995)
Q Consensus 565 ~~p~~~~~l~~ 575 (995)
.+|..+..++.
T Consensus 245 ~~p~~l~~l~~ 255 (571)
T 3cvr_A 245 RIRESLSQQTA 255 (571)
T ss_dssp HHHHHHHHHHH
T ss_pred cCHHHHHHhhc
Confidence 88877776544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.7e-21 Score=238.17 Aligned_cols=274 Identities=18% Similarity=0.160 Sum_probs=122.9
Q ss_pred ccchHHHHHHHHHhCCC-CCCCCCCCCCCCCCCCceeeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCc
Q 001922 25 LVNDFHVLVALKQGFEN-PEPALISWNSSNPSSVCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNN 103 (995)
Q Consensus 25 ~~~~~~~Ll~~k~~~~~-~~~~l~~W~~~~~~~~C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~ 103 (995)
...++++|+++..+... ....-..|... ++..+.|.++.++..+++.++|.++++.. ++. ..++.++|+.|.
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~ 202 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGD-STPSGTATNSAVSTPLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYS 202 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCC-CCccccCCCceecCCccceEEeeCCCCCc-chh-----hHhhcCccCccc
Confidence 45689999999877642 22234467543 34578899999999999999999888775 233 235566677766
Q ss_pred ccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCcccc
Q 001922 104 FTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYG 183 (995)
Q Consensus 104 l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 183 (995)
|. .++++.|.+. .++..|..+++|+.|+|++|.+.. +|..+..+++|++|+|++|.|+ .+|..|+
T Consensus 203 i~------------~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~ 267 (727)
T 4b8c_D 203 ID------------EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIFN-ISANIFKYDFLTRLYLNGNSLT-ELPAEIK 267 (727)
T ss_dssp --------------------------------CCCCCCEEECTTSCCSC-CCGGGGGCCSCSCCBCTTSCCS-CCCGGGG
T ss_pred cc------------Ccccccccee-cChhhhccCCCCcEEECCCCCCCC-CChhhcCCCCCCEEEeeCCcCc-ccChhhh
Confidence 54 3455566665 566777788888888888888875 5666668888888888888887 7788888
Q ss_pred CCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccc-cC
Q 001922 184 ELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKL-LD 262 (995)
Q Consensus 184 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~ 262 (995)
.+++|++|+|++|+|+ .+|..|+++++|++|+|++|.+. .+|..|+.+++|++|+|++|.|++.+|..+..+.. +.
T Consensus 268 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~ 344 (727)
T 4b8c_D 268 NLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT--TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGL 344 (727)
T ss_dssp GGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC--CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHH
T ss_pred CCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC--ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhh
Confidence 8888888888888888 66888888888888888876653 47777888888888888888888888877765532 23
Q ss_pred ccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCc
Q 001922 263 TVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNN 342 (995)
Q Consensus 263 ~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 342 (995)
.++|++|.+++.+|. .|+.|++++|... -..+ +.|.+..+..+..+..+....+++|-
T Consensus 345 ~l~l~~N~l~~~~p~------~l~~l~l~~n~~~---~~~~-------------~~l~~~~~~~~~~l~~~~~~~ls~Ni 402 (727)
T 4b8c_D 345 IFYLRDNRPEIPLPH------ERRFIEINTDGEP---QREY-------------DSLQQSTEHLATDLAKRTFTVLSYNT 402 (727)
T ss_dssp HHHHHHCCCCCCCCC------C---------------------------------------------------------C
T ss_pred HHhhccCcccCcCcc------ccceeEeeccccc---cccc-------------CCccccccchhhcccccceeeeeccc
Confidence 467788888777665 3555666666110 0111 12222333444555566666777776
Q ss_pred ccc
Q 001922 343 FTG 345 (995)
Q Consensus 343 l~~ 345 (995)
+.+
T Consensus 403 l~~ 405 (727)
T 4b8c_D 403 LCQ 405 (727)
T ss_dssp CCG
T ss_pred ccc
Confidence 653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=7.8e-20 Score=188.49 Aligned_cols=163 Identities=25% Similarity=0.229 Sum_probs=123.6
Q ss_pred CcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEc
Q 001922 235 VNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNL 314 (995)
Q Consensus 235 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 314 (995)
++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|.+++..+..|.++++|+.|++
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 46778888888887666666777888888888888887666666777888888888888888766667778888888888
Q ss_pred cCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCC
Q 001922 315 FMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGP 394 (995)
Q Consensus 315 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 394 (995)
++|+|++..+..|..+++|++|++++|++++..+..+..+++|++|+|++|.+.+ .+++|+.|+++.|.+.|.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ 180 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGV 180 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTT
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCce
Confidence 8888887666667778888888888888887666667778888888888887663 344677777777777777
Q ss_pred CCcccccCCC
Q 001922 395 IPERLGACYS 404 (995)
Q Consensus 395 ~p~~l~~l~~ 404 (995)
+|..++.+..
T Consensus 181 ip~~~~~l~~ 190 (208)
T 2o6s_A 181 VRNSAGSVAP 190 (208)
T ss_dssp BBCTTSSBCT
T ss_pred eeccCccccC
Confidence 7777665543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=6.7e-20 Score=218.33 Aligned_cols=189 Identities=25% Similarity=0.316 Sum_probs=93.6
Q ss_pred CCCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCc
Q 001922 93 KLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGN 172 (995)
Q Consensus 93 ~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N 172 (995)
.+..++++.+.+++...+..|++|+.|+|++|.|..+. .+..+++|+.|+|++|+|+++.| +..+++|++|+|++|
T Consensus 22 ~l~~l~l~~~~i~~~~~~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N 97 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN 97 (605)
T ss_dssp HHHHHHTTCSCTTSEECHHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred HHHHHhccCCCcccccchhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCC
Confidence 34445555555555555556666666666666665432 35555555555555555555433 555555555555555
Q ss_pred cccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccC
Q 001922 173 YFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIP 252 (995)
Q Consensus 173 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~ 252 (995)
.+++ +| .+..+++|++|+|++|++++. . .+..+++|+.|+|++|.+++.
T Consensus 98 ~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~-------------------------~l~~l~~L~~L~Ls~N~l~~l-- 146 (605)
T 1m9s_A 98 KIKD-LS-SLKDLKKLKSLSLEHNGISDI--N-------------------------GLVHLPQLESLYLGNNKITDI-- 146 (605)
T ss_dssp CCCC-CT-TSTTCTTCCEEECTTSCCCCC--G-------------------------GGGGCTTCSEEECCSSCCCCC--
T ss_pred CCCC-Ch-hhccCCCCCEEEecCCCCCCC--c-------------------------cccCCCccCEEECCCCccCCc--
Confidence 5542 22 455555555555555555521 1 122334455555555555432
Q ss_pred ccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCC
Q 001922 253 HEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLH 320 (995)
Q Consensus 253 ~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 320 (995)
..+..+++|+.|+|++|++++..| +..+++|+.|+|++|.|++. ..+..+++|+.|+|++|++.
T Consensus 147 ~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 147 TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence 334444444444444444443332 44444444444444444432 13444444444444444444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=8.2e-20 Score=189.78 Aligned_cols=138 Identities=16% Similarity=0.148 Sum_probs=124.9
Q ss_pred CCCcEEEcCCCcccccCC-ccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceee
Q 001922 454 DRLGQLNLSNNLLSGPLP-FSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLD 532 (995)
Q Consensus 454 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 532 (995)
..+++|+|++|+|++..| ..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|+.+++|++|+
T Consensus 32 ~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 111 (220)
T 2v70_A 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLM 111 (220)
T ss_dssp TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEE
T ss_pred CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEE
Confidence 346789999999997655 4588999999999999999988888999999999999999999987777899999999999
Q ss_pred ccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCC
Q 001922 533 MSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLP 591 (995)
Q Consensus 533 Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p 591 (995)
|++|+|++..|..|..+++|++|+|++|+|++..|..+..+++|+.|++++|++.+..+
T Consensus 112 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 112 LRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99999998889999999999999999999999889999999999999999999987655
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=216.28 Aligned_cols=193 Identities=23% Similarity=0.334 Sum_probs=109.8
Q ss_pred cccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCcee
Q 001922 112 NLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYL 191 (995)
Q Consensus 112 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 191 (995)
.+..+..++|+.+.+.+..+ +..+++|+.|++++|.|..+ | .+..+++|++|+|++|++++..| +..+++|++|
T Consensus 19 ~l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L 92 (605)
T 1m9s_A 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL 92 (605)
T ss_dssp HHHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred HHHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence 45556666666666664432 44566666666666666553 2 45666666666666666654333 5566666666
Q ss_pred eccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccc
Q 001922 192 SLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLL 271 (995)
Q Consensus 192 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l 271 (995)
+|++|++++ + ..+..+++|++|+|++|.+++. ..+..+++|+.|+|++|++
T Consensus 93 ~Ls~N~l~~--------------------------l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l 143 (605)
T 1m9s_A 93 FLDENKIKD--------------------------L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKI 143 (605)
T ss_dssp ECCSSCCCC--------------------------C-TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred ECcCCCCCC--------------------------C-hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCcc
Confidence 666666552 1 1345566777777777777642 3355566666666666666
Q ss_pred cCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccc
Q 001922 272 SGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTG 345 (995)
Q Consensus 272 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 345 (995)
++. ..+..+++|+.|+|++|.|++..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++
T Consensus 144 ~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 144 TDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 543 345555556666666555554444 55555555555555555532 234555555555555555543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=8.8e-20 Score=198.34 Aligned_cols=190 Identities=25% Similarity=0.315 Sum_probs=125.2
Q ss_pred CCCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCc
Q 001922 93 KLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGN 172 (995)
Q Consensus 93 ~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N 172 (995)
++..+.+..+.+++...+..+++|++|++++|.++... .+..+++|++|++++|+++++.+ +..+++|++|+|++|
T Consensus 25 ~~~~~~l~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~--~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 25 ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHHHTTCSCTTSEECHHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHHHhcCCCcccccchhhcCcccEEEccCCCcccCh--hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCC
Confidence 34445566666666556667777777777777776552 36667777777777777776543 677777777777777
Q ss_pred cccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccC
Q 001922 173 YFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIP 252 (995)
Q Consensus 173 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~ 252 (995)
.+++ +| .+..+++|++|+|++|++++. .. +..+++|++|++++|++++.
T Consensus 101 ~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~-------------------------l~~l~~L~~L~l~~n~l~~~-- 149 (291)
T 1h6t_A 101 KVKD-LS-SLKDLKKLKSLSLEHNGISDI--NG-------------------------LVHLPQLESLYLGNNKITDI-- 149 (291)
T ss_dssp CCCC-GG-GGTTCTTCCEEECTTSCCCCC--GG-------------------------GGGCTTCCEEECCSSCCCCC--
T ss_pred cCCC-Ch-hhccCCCCCEEECCCCcCCCC--hh-------------------------hcCCCCCCEEEccCCcCCcc--
Confidence 7764 33 367777777777777777642 12 33445666666666666643
Q ss_pred ccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCC
Q 001922 253 HEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG 321 (995)
Q Consensus 253 ~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 321 (995)
..+..+++|+.|++++|++++..+ +..+++|+.|++++|.|++. + .+..+++|+.|++++|++..
T Consensus 150 ~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 150 TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 456666677777777777765433 67777777777777777743 3 36777777777777777764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.7e-19 Score=187.21 Aligned_cols=156 Identities=29% Similarity=0.289 Sum_probs=111.1
Q ss_pred CCCceeeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc--ccCcccccceeccccccccCCCcc
Q 001922 55 SSVCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI--EIGNLSSLQFLNISNNQFSGGLDW 132 (995)
Q Consensus 55 ~~~C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~ 132 (995)
.+.|+|.+|.|+..+++ .+|..+. ++|++|+|++|+|++.. .+.++++|++|+|++|+|+.+.+.
T Consensus 16 ~~~Cs~~~v~c~~~~l~-----------~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~ 82 (229)
T 3e6j_A 16 QCSCSGTTVDCRSKRHA-----------SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG 82 (229)
T ss_dssp TCEEETTEEECTTSCCS-----------SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred CCEEeCCEeEccCCCcC-----------ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChh
Confidence 45799999999864432 4555443 67888888888887753 477778888888888888777767
Q ss_pred cccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhh
Q 001922 133 NYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNL 212 (995)
Q Consensus 133 ~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 212 (995)
.|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..
T Consensus 83 ~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~------- 154 (229)
T 3e6j_A 83 VFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGA------- 154 (229)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTT-------
T ss_pred hcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHH-------
Confidence 7777777777777777777766666777777777777777776 66777777777777777777777443333
Q ss_pred hhhhccccccccCCCCcccCCCCcccEEECcCCCCCC
Q 001922 213 REIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDG 249 (995)
Q Consensus 213 ~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~ 249 (995)
+..+++|++|+|++|.+..
T Consensus 155 ------------------~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 155 ------------------FDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp ------------------TTTCTTCCEEECTTSCBCT
T ss_pred ------------------HhCCCCCCEEEeeCCCccC
Confidence 4445666777777777664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5e-21 Score=226.72 Aligned_cols=186 Identities=20% Similarity=0.150 Sum_probs=96.2
Q ss_pred CCCCCceeeccCccccccCCccccCCCCCceeeccCCc-------------ccccCcccccchhhhhhhh-ccccccccC
Q 001922 160 KLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGND-------------LTGKIPGELGNLTNLREIY-LGYYNVFEG 225 (995)
Q Consensus 160 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-------------l~~~~~~~l~~l~~L~~L~-L~~n~~~~~ 225 (995)
.+++|+.|+|++|+++ .+|..++.+++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+
T Consensus 347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~--- 422 (567)
T 1dce_A 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL--- 422 (567)
T ss_dssp TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH---
T ss_pred cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc---
Confidence 3445555555555553 445555555555555554443 4456666677777777776 443221
Q ss_pred CCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccc
Q 001922 226 GIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFIN 305 (995)
Q Consensus 226 ~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 305 (995)
.+|..+.+++|.++...+ ..|+.|+|++|.+++ +|. ++.+++|+.|+|++|.|+ .+|..|++
T Consensus 423 ---------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ---------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 234444444444442211 124455555555553 333 555555555555555555 44555555
Q ss_pred cCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccC-CCcccCCCCCCeEEecCceecc
Q 001922 306 LRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVI-PENLGQNGKLQVLDLSSNKLTG 369 (995)
Q Consensus 306 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~ 369 (995)
+++|+.|+|++|+|++ +| .+..+++|+.|+|++|+|++.. |..++.+++|+.|+|++|++++
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~ 547 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCC
Confidence 5555555555555553 34 4555555555555555555444 5555555555555555555553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-19 Score=196.20 Aligned_cols=192 Identities=24% Similarity=0.310 Sum_probs=102.3
Q ss_pred cccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCcee
Q 001922 112 NLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYL 191 (995)
Q Consensus 112 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 191 (995)
.+..+..+++..+.+++.. .+..+++|++|++++|.++.+ + .+..+++|++|+|++|++++..+ +..+++|++|
T Consensus 22 ~l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L 95 (291)
T 1h6t_A 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWL 95 (291)
T ss_dssp HHHHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEE
Confidence 3444555556665555432 234455555666665555553 2 25555555555555555553322 5555555555
Q ss_pred eccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccc
Q 001922 192 SLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLL 271 (995)
Q Consensus 192 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l 271 (995)
+|++|++++. ..+..+++|++|++++|++++. ..
T Consensus 96 ~l~~n~l~~~---------------------------~~l~~l~~L~~L~L~~n~i~~~--~~----------------- 129 (291)
T 1h6t_A 96 FLDENKVKDL---------------------------SSLKDLKKLKSLSLEHNGISDI--NG----------------- 129 (291)
T ss_dssp ECCSSCCCCG---------------------------GGGTTCTTCCEEECTTSCCCCC--GG-----------------
T ss_pred ECCCCcCCCC---------------------------hhhccCCCCCEEECCCCcCCCC--hh-----------------
Confidence 5555555421 1134455666666666666532 23
Q ss_pred cCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcc
Q 001922 272 SGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENL 351 (995)
Q Consensus 272 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 351 (995)
+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..+ +..+++|+.|++++|++++. + .+
T Consensus 130 -------l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l 196 (291)
T 1h6t_A 130 -------LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-AL 196 (291)
T ss_dssp -------GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GG
T ss_pred -------hcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hh
Confidence 44445555555555555533 345555555555555555554333 55556666666666666542 2 25
Q ss_pred cCCCCCCeEEecCceec
Q 001922 352 GQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 352 ~~l~~L~~L~L~~N~l~ 368 (995)
..+++|+.|++++|+++
T Consensus 197 ~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 197 AGLKNLDVLELFSQECL 213 (291)
T ss_dssp TTCTTCSEEEEEEEEEE
T ss_pred ccCCCCCEEECcCCccc
Confidence 56666666666666665
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-20 Score=222.92 Aligned_cols=202 Identities=21% Similarity=0.188 Sum_probs=156.5
Q ss_pred cccccccccccccccccCCccccCCCCCceeeccCcc-------------ccccCCccccCCCCCceee-ccCCcccccC
Q 001922 137 LVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY-------------FFGKIPNSYGELQGLEYLS-LAGNDLTGKI 202 (995)
Q Consensus 137 l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~l~~l~~L~~L~-Ls~N~l~~~~ 202 (995)
+++|+.|+|++|+++. +|..++.|++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+
T Consensus 348 ~~~L~~L~Ls~n~L~~-Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~---- 422 (567)
T 1dce_A 348 DEQLFRCELSVEKSTV-LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL---- 422 (567)
T ss_dssp TTTSSSCCCCHHHHHH-HHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH----
T ss_pred CccceeccCChhhHHh-hHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc----
Confidence 3444444444444443 34444444455555544443 5567888899999999998 676644
Q ss_pred cccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCc
Q 001922 203 PGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNL 282 (995)
Q Consensus 203 ~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 282 (995)
.+|+.++++.|.+.. +|. ..|+.|+|++|.|++ +|. ++.+++|+.|+|++|+|+ .+|..++++
T Consensus 423 -------~~L~~l~l~~n~i~~--l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 485 (567)
T 1dce_A 423 -------DDLRSKFLLENSVLK--MEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAAL 485 (567)
T ss_dssp -------HHHHHHHHHHHHHHH--HHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred -------chhhhhhhhcccccc--cCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcC
Confidence 467777887665543 221 258999999999996 566 999999999999999999 789999999
Q ss_pred CCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCC-CccccCCCCcceEEeccCcccccCCCc---ccCCCCCC
Q 001922 283 TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSI-PDYLADLPNLETLGLWQNNFTGVIPEN---LGQNGKLQ 358 (995)
Q Consensus 283 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~---~~~l~~L~ 358 (995)
++|+.|+|++|.|++ +| .|.++++|+.|+|++|+|++.. |..+..+++|+.|+|++|++++.+|.. +..+++|+
T Consensus 486 ~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~ 563 (567)
T 1dce_A 486 RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 563 (567)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCS
T ss_pred CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccC
Confidence 999999999999996 56 8999999999999999999887 999999999999999999999765532 23478899
Q ss_pred eEEe
Q 001922 359 VLDL 362 (995)
Q Consensus 359 ~L~L 362 (995)
.|++
T Consensus 564 ~L~l 567 (567)
T 1dce_A 564 SILT 567 (567)
T ss_dssp EEEC
T ss_pred ccCC
Confidence 8875
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=3e-18 Score=179.21 Aligned_cols=137 Identities=25% Similarity=0.232 Sum_probs=122.7
Q ss_pred CCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeec
Q 001922 454 DRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDM 533 (995)
Q Consensus 454 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 533 (995)
++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 57889999999999888889999999999999999998666677899999999999999999766777899999999999
Q ss_pred cCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCC
Q 001922 534 SQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLP 591 (995)
Q Consensus 534 s~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p 591 (995)
++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+++|+.|++++|++.+..+
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 999998 789999999999999999999988777788999999999999999987655
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.6e-18 Score=177.31 Aligned_cols=109 Identities=25% Similarity=0.306 Sum_probs=44.3
Q ss_pred ccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEec
Q 001922 260 LLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLW 339 (995)
Q Consensus 260 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 339 (995)
.|+.|++++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 112 (220)
T 2v9t_B 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112 (220)
T ss_dssp TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence 33444444444443333334444444444444444443334444444444444444444443333333344444444444
Q ss_pred cCcccccCCCcccCCCCCCeEEecCceec
Q 001922 340 QNNFTGVIPENLGQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 340 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 368 (995)
+|++++..|..|..+++|++|+|++|+|+
T Consensus 113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (220)
T 2v9t_B 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence 44444333333444444444444444443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.3e-18 Score=176.78 Aligned_cols=150 Identities=25% Similarity=0.257 Sum_probs=71.2
Q ss_pred EEECcCCCCCCccCccccCccccCccccccccccCCCC-ccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCC
Q 001922 239 HLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIP-KQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMN 317 (995)
Q Consensus 239 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 317 (995)
.+++++|.++ .+|..+. +.++.|++++|++++..+ ..|..+++|++|+|++|.|++..+..|.++++|+.|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4555555555 2333332 223445555555544322 23444555555555555555444444555555555555555
Q ss_pred cCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeecccccc
Q 001922 318 RLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFL 391 (995)
Q Consensus 318 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 391 (995)
+|++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..|..|..+++|+.|++++|.+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 165 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCC
Confidence 55544444455555555555555555544444455555555555555555444444444444444444444433
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=5.3e-18 Score=176.08 Aligned_cols=152 Identities=22% Similarity=0.235 Sum_probs=118.3
Q ss_pred ccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCc
Q 001922 263 TVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNN 342 (995)
Q Consensus 263 ~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 342 (995)
.+++++|.++ .+|..+. ++|+.|+|++|.|++..+..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 4555555555 3454443 578888888888887777788888888888888888887778888888888888888888
Q ss_pred ccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCC
Q 001922 343 FTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNG 417 (995)
Q Consensus 343 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 417 (995)
|+...+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.+.+..+..+..+++|+.|++++|++..
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 886666667888888888888888887777778778888888888888777777777777777777777777753
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.1e-18 Score=193.85 Aligned_cols=176 Identities=26% Similarity=0.189 Sum_probs=109.7
Q ss_pred cEEECcCCCCCCccCccccCccccCccccccccccCCCCcccc-CcCCCCeEeccCCcCcCcCCccccccCCCCEEEccC
Q 001922 238 VHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLG-NLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFM 316 (995)
Q Consensus 238 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 316 (995)
+.+++++++++ .+|..+. +.++.|+|++|+|++..+..+. ++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 46777777776 3454443 3466677777777666666665 677777777777777766666677777777777777
Q ss_pred CcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcC---cCCCccceeeccccccCC
Q 001922 317 NRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDL---CSSNQLRILILLKNFLFG 393 (995)
Q Consensus 317 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~ 393 (995)
|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..| ..+++|+.|+|++|++.+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 77776556666777777777777777776666677777777777777777764222223 345555555555555554
Q ss_pred CCCcccccCCC--CcEEEecCCccC
Q 001922 394 PIPERLGACYS--LTRVRLGQNYLN 416 (995)
Q Consensus 394 ~~p~~l~~l~~--L~~L~l~~N~l~ 416 (995)
..+..+..+.. ++.|++++|.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 44444444444 245555555554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-18 Score=176.45 Aligned_cols=155 Identities=23% Similarity=0.319 Sum_probs=118.7
Q ss_pred cEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCC-CccchhhhccccccccccCCCCCCccCcccccceeeccC
Q 001922 457 GQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPP-SIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQ 535 (995)
Q Consensus 457 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 535 (995)
+.+++++|+++ .+|..+.. +|+.|+|++|+|++..+. .|+.+++|+.|+|++|+|++..|..|+.+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 57888888886 56765543 788888888888865554 478888888888888888887788888888888888888
Q ss_pred CcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCCCCCCCcccccccCCCCccCCCCC
Q 001922 536 NNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTL 614 (995)
Q Consensus 536 N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~~~ 614 (995)
|+|++..|..|.++++|++|+|++|+|++.+|..+..+++|+.|++++|++++..+...-...+....+.++...|+.|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 8888777777888888888888888888888888888888888888888888776532111112233455666667644
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.7e-19 Score=197.42 Aligned_cols=282 Identities=16% Similarity=0.148 Sum_probs=185.2
Q ss_pred CCCCCeEeccCCcccCc--cccCc-ccccceecccccccc--CCCcccccccccccccccccccccccCCccccC-----
Q 001922 91 LDKLTNLSLAGNNFTGS--IEIGN-LSSLQFLNISNNQFS--GGLDWNYSSLVNLEVFDAYNNNFTALLPVGILK----- 160 (995)
Q Consensus 91 l~~L~~L~L~~n~l~~~--~~~~~-l~~L~~L~Ls~N~i~--~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~----- 160 (995)
+.++++|.++++ +.+. ..+.. +++|++|||++|+|. ......+ +.+..+.+..|.| .+.+|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhccccccc
Confidence 667888888864 2221 12334 788999999999987 3322222 2244455555533 3456667
Q ss_pred ---CCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccc---cCCCCcccCCC
Q 001922 161 ---LEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVF---EGGIPREVGKL 234 (995)
Q Consensus 161 ---l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~---~~~~p~~~~~l 234 (995)
+++|+.|+|.+ .++...+.+|.++++|+.|++++|.++.+.+.+|.++.++..+.++.+... ...-...|..+
T Consensus 97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~ 175 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG 175 (329)
T ss_dssp EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccc
Confidence 88888888888 777666777888888888888888888777788888777776665532111 11112344455
Q ss_pred Cccc-EEECcCCCCCCccCccc----cCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCC
Q 001922 235 VNLV-HLDLSSCELDGQIPHEI----GNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQL 309 (995)
Q Consensus 235 ~~L~-~L~Ls~n~l~~~~~~~~----~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 309 (995)
.+|+ .+.+.... .++..+ ....+++.+.+.++-...........+++|+.|+|++|.++.+.+.+|.++++|
T Consensus 176 ~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L 252 (329)
T 3sb4_A 176 EPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYL 252 (329)
T ss_dssp CCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTC
T ss_pred cccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCC
Confidence 5665 44443321 112111 123444555444332111111111236788888888888887777788888888
Q ss_pred CEEEccCCcCCCCCCccccCCCCcc-eEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceee
Q 001922 310 KLFNLFMNRLHGSIPDYLADLPNLE-TLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILI 385 (995)
Q Consensus 310 ~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 385 (995)
+.+++.+| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.|++++|+++...+..|.++++|+.++
T Consensus 253 ~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 253 LKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 88888887 7766777888888888 888887 77767778888888888888888888866677888888888776
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.6e-19 Score=215.23 Aligned_cols=75 Identities=21% Similarity=0.253 Sum_probs=30.9
Q ss_pred ccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccC
Q 001922 339 WQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLN 416 (995)
Q Consensus 339 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 416 (995)
+.|.+. ..|..+..+++|+.|+|++|.+. .+|..+..+++|+.|+|++|.+. .+|..++.+.+|+.|+|++|.|+
T Consensus 209 ~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 209 IENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp --------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 334444 44555555555555555555555 44444444444444444444443 34444444444444444444444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.4e-18 Score=185.73 Aligned_cols=170 Identities=25% Similarity=0.295 Sum_probs=80.8
Q ss_pred cccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCcee
Q 001922 112 NLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYL 191 (995)
Q Consensus 112 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 191 (995)
.+.++..+++++|.+++.. .+..+++|++|++++|+|+.+ | .+..+++|++|+|++|++++..+ +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 3444444555555544332 344455555555555555542 2 45555666666666666653322 5566666666
Q ss_pred eccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccc
Q 001922 192 SLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLL 271 (995)
Q Consensus 192 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l 271 (995)
+|++|++++. |.. .. ++|++|+|++|++++. ..+..+++|+.|++++|++
T Consensus 91 ~L~~N~l~~l-~~~-~~--------------------------~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i 140 (263)
T 1xeu_A 91 SVNRNRLKNL-NGI-PS--------------------------ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKL 140 (263)
T ss_dssp ECCSSCCSCC-TTC-CC--------------------------SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCC
T ss_pred ECCCCccCCc-Ccc-cc--------------------------CcccEEEccCCccCCC--hhhcCcccccEEECCCCcC
Confidence 6666665532 110 00 2344444444444421 1244444444444444444
Q ss_pred cCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCC
Q 001922 272 SGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG 321 (995)
Q Consensus 272 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 321 (995)
++. + .+..+++|++|+|++|++++. ..+..+++|+.|++++|++.+
T Consensus 141 ~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 141 KSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp CBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred CCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 432 2 344455555555555555543 344455555555555555543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.5e-18 Score=189.84 Aligned_cols=163 Identities=23% Similarity=0.154 Sum_probs=134.6
Q ss_pred CccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCcccc-ccCCCCEEEccCCcCCCCCCccccCCCCcceEEecc
Q 001922 262 DTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFI-NLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQ 340 (995)
Q Consensus 262 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 340 (995)
+.+++++|.++ .+|..+. ..++.|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57888999888 4666554 4689999999999988888887 899999999999999987778899999999999999
Q ss_pred CcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCccc---ccCCCCcEEEecCCccCC
Q 001922 341 NNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERL---GACYSLTRVRLGQNYLNG 417 (995)
Q Consensus 341 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l---~~l~~L~~L~l~~N~l~~ 417 (995)
|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++.+..+..+ ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99998888888999999999999999998888889899999999999998877655555 568888888888888886
Q ss_pred CCCCCcccCC
Q 001922 418 SIPDGFIYLP 427 (995)
Q Consensus 418 ~~p~~~~~l~ 427 (995)
..+..+..++
T Consensus 178 l~~~~~~~l~ 187 (361)
T 2xot_A 178 LPLTDLQKLP 187 (361)
T ss_dssp CCHHHHHHSC
T ss_pred cCHHHhhhcc
Confidence 5555555544
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-17 Score=177.86 Aligned_cols=137 Identities=20% Similarity=0.157 Sum_probs=105.3
Q ss_pred ccCCCeeeccCceEEEEEEe-CCCcE--EEEEEecCCCCCC-----------------------hhHHHHHHHHHHhccC
Q 001922 688 VKDGNVIGRGGAGIVYHGKM-PNGVE--IAVKKLLGFGTHS-----------------------HDHGFRAEIQTLGNIR 741 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~ 741 (995)
|+..+.||+|+||.||+|.. .+|+. ||||++....... ....+.+|+.+++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678999999999999987 68889 9999874321110 0135788999999998
Q ss_pred CCCc--eeEeEEEecCCcceEEEEeccC-C----ChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecC
Q 001922 742 HRNI--VRLLAFCSNKETNLLVYEYMRN-G----SLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH-HDCSPLIVHRD 813 (995)
Q Consensus 742 hpni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~iiHrD 813 (995)
|+++ +..+++ +..++||||+.+ | +|.++... .++..+..++.|++.|+.||| +.+ |+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 8764 333332 367999999942 4 66665432 123456789999999999999 888 99999
Q ss_pred CCCCCEEECCCCCeEEeeecccccc
Q 001922 814 VKSNNILLNSAFEAHVADFGLAKFL 838 (995)
Q Consensus 814 lkp~Nill~~~~~vkl~DfGla~~~ 838 (995)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.5e-17 Score=175.96 Aligned_cols=170 Identities=25% Similarity=0.295 Sum_probs=91.2
Q ss_pred chhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCe
Q 001922 208 NLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVN 287 (995)
Q Consensus 208 ~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~ 287 (995)
++.++..++++.+.+.. ++ .+..+++|++|++++|.++. ++ .+..+++|+.|++++|++++..+ +.++++|++
T Consensus 17 ~l~~l~~l~l~~~~i~~--~~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~ 89 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD--LV-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEE 89 (263)
T ss_dssp HHHHHHHHHHTCSCTTS--EE-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCE
T ss_pred HHHHHHHHHhcCCCccc--cc-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCE
Confidence 44455555555443322 22 34455566666666666652 33 45555666666666666654332 566666666
Q ss_pred EeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCcee
Q 001922 288 LDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKL 367 (995)
Q Consensus 288 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 367 (995)
|+|++|++++..+ +.. ++|+.|++++|++++. ..+..+++|+.|+|++|++++. + .+..+++|++|+|++|++
T Consensus 90 L~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 90 LSVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp EECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCC
T ss_pred EECCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcC
Confidence 6666666664322 112 5666666666666542 2355666666666666666543 2 455566666666666666
Q ss_pred cccCCCcCcCCCccceeeccccccCC
Q 001922 368 TGTIPTDLCSSNQLRILILLKNFLFG 393 (995)
Q Consensus 368 ~~~~p~~~~~l~~L~~L~l~~N~l~~ 393 (995)
++. ..+..+++|+.|++++|.+.+
T Consensus 163 ~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 163 TNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp CBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred cch--HHhccCCCCCEEeCCCCcccC
Confidence 543 344455555555555555433
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.6e-17 Score=167.81 Aligned_cols=108 Identities=22% Similarity=0.332 Sum_probs=51.8
Q ss_pred CCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCc-CcCcCCccccccCCCC
Q 001922 232 GKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNA-LTGEIPYSFINLRQLK 310 (995)
Q Consensus 232 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~ 310 (995)
..+++|++|++++|++++..+..++.+++|++|++++|++++..|..+..+++|++|++++|. ++ .+| .+..+++|+
T Consensus 85 ~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~ 162 (197)
T 4ezg_A 85 SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELK 162 (197)
T ss_dssp TTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCC
T ss_pred hcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCC
Confidence 344555555555555554444444444444444455454444444445555555555555554 33 222 344455555
Q ss_pred EEEccCCcCCCCCCccccCCCCcceEEeccCcc
Q 001922 311 LFNLFMNRLHGSIPDYLADLPNLETLGLWQNNF 343 (995)
Q Consensus 311 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 343 (995)
.|++++|++++ ++ .+..+++|+.|++++|++
T Consensus 163 ~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 163 SLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp EEECTTBCCCC-CT-TGGGCSSCCEEEECBC--
T ss_pred EEECCCCCCcC-hH-HhccCCCCCEEEeeCccc
Confidence 55555555443 22 344444455555544444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=3.6e-17 Score=165.94 Aligned_cols=162 Identities=19% Similarity=0.188 Sum_probs=122.5
Q ss_pred CCcEEEcCCCcccccCCc-cccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeec
Q 001922 455 RLGQLNLSNNLLSGPLPF-SLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDM 533 (995)
Q Consensus 455 ~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 533 (995)
++++|+|++|++++..+. .+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|++|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 688999999999876664 4889999999999999999888999999999999999999999888888999999999999
Q ss_pred cCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCCCCCCCcccccccCCCCccCCCC
Q 001922 534 SQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGT 613 (995)
Q Consensus 534 s~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~~ 613 (995)
++|+|++.+|..+..+++|++|+|++|++++..+-..- ...++...+..+.....-|. .+......++..+..-|..
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~-~~~l~~~~~~~~~~~C~~P~--~l~~~~l~~l~~~~~~C~~ 186 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH-HHHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCC
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHH-HHHHHHcCCCCCCCCCCCCh--HHcCCChhhCcHhhcCcCC
Confidence 99999998899999999999999999999886552210 11122223444444433343 2344444556666666776
Q ss_pred CCCCCC
Q 001922 614 LLNNPC 619 (995)
Q Consensus 614 ~~~~~c 619 (995)
+.+..|
T Consensus 187 ~~~~~c 192 (192)
T 1w8a_A 187 ENSEGC 192 (192)
T ss_dssp C---CC
T ss_pred CCCCCC
Confidence 555444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.6e-17 Score=165.99 Aligned_cols=152 Identities=16% Similarity=0.214 Sum_probs=100.2
Q ss_pred CCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCE
Q 001922 232 GKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKL 311 (995)
Q Consensus 232 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 311 (995)
..+++|++|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|.+++..+..|..+++|+.
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 45667777777777777 444 56677777777777775542 235677777777777777777666777777777777
Q ss_pred EEccCCcCCCCCCccccCCCCcceEEeccCc-ccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccc
Q 001922 312 FNLFMNRLHGSIPDYLADLPNLETLGLWQNN-FTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNF 390 (995)
Q Consensus 312 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 390 (995)
|++++|++++..|..+..+++|++|++++|+ ++ .+| .+..+++|++|++++|++++ ++ .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 7777777776666677777777777777776 44 334 46667777777777777763 22 44455555555555554
Q ss_pred c
Q 001922 391 L 391 (995)
Q Consensus 391 l 391 (995)
+
T Consensus 193 i 193 (197)
T 4ezg_A 193 I 193 (197)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-17 Score=184.67 Aligned_cols=284 Identities=12% Similarity=0.069 Sum_probs=210.1
Q ss_pred cccccceeccccccccCCCcccccc-ccccccccccccccc--ccCCccccCCCCCceeeccCccccccCCccccC----
Q 001922 112 NLSSLQFLNISNNQFSGGLDWNYSS-LVNLEVFDAYNNNFT--ALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGE---- 184 (995)
Q Consensus 112 ~l~~L~~L~Ls~N~i~~~~~~~~~~-l~~L~~L~Ls~n~i~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~---- 184 (995)
.+.+|+.|.++++ +....-..+.. +++|++|||++|+|. ...+..+ +.++.+.+..|.| .+..|.+
T Consensus 23 ~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~ 95 (329)
T 3sb4_A 23 EANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNG 95 (329)
T ss_dssp HHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETT
T ss_pred hhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhcccccc
Confidence 4678899999875 22111123333 788999999999998 4333333 3356666666644 2455666
Q ss_pred ----CCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCC----CCCccCcccc
Q 001922 185 ----LQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCE----LDGQIPHEIG 256 (995)
Q Consensus 185 ----l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~----l~~~~~~~~~ 256 (995)
+++|+.|+|.+ .++.+.+.+|.++++|++|+++.|.+.. ..+..|..+.++..+.+..+. ........|.
T Consensus 96 ~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~-i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~ 173 (329)
T 3sb4_A 96 VTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPN-LLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFI 173 (329)
T ss_dssp EEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCE-ECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEE
T ss_pred cccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccc-cchhhhcCCCceEEecCcchhhhhccccccccccc
Confidence 99999999999 8997888899999999999999776543 345678888888888877632 2323344566
Q ss_pred CccccC-ccccccccccCCCCcc----ccCcCCCCeEeccCCcCcCcCCccc-cccCCCCEEEccCCcCCCCCCccccCC
Q 001922 257 NLKLLD-TVFLHINLLSGSIPKQ----LGNLTNLVNLDLSNNALTGEIPYSF-INLRQLKLFNLFMNRLHGSIPDYLADL 330 (995)
Q Consensus 257 ~l~~L~-~L~l~~N~l~~~~p~~----l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l 330 (995)
++..|+ .+.+.... .++.. -....+++.+.+.++-.. .....+ ..+++|+.++|++|+++.+.+.+|.++
T Consensus 174 ~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~ 249 (329)
T 3sb4_A 174 EGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQK 249 (329)
T ss_dssp ESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTC
T ss_pred cccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCC
Confidence 666665 33333221 12221 123567888888776332 222222 247899999999999997778899999
Q ss_pred CCcceEEeccCcccccCCCcccCCCCCC-eEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEE
Q 001922 331 PNLETLGLWQNNFTGVIPENLGQNGKLQ-VLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVR 409 (995)
Q Consensus 331 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~ 409 (995)
++|+.|+|.+| ++.+.+.+|.++++|+ .+++.+ .++...+..|.++.+|+.++++.|.+....+..|.++++|+.++
T Consensus 250 ~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 250 KYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 99999999998 8878889999999999 999998 78767788999999999999999999988899999999999987
Q ss_pred e
Q 001922 410 L 410 (995)
Q Consensus 410 l 410 (995)
.
T Consensus 328 ~ 328 (329)
T 3sb4_A 328 K 328 (329)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=158.70 Aligned_cols=135 Identities=21% Similarity=0.196 Sum_probs=120.9
Q ss_pred CCCCcEEEcCCCccc-ccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCccccccee
Q 001922 453 PDRLGQLNLSNNLLS-GPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYL 531 (995)
Q Consensus 453 ~~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 531 (995)
+++|++|++++|+++ +.+|..+..+++|+.|+|++|++++. ..++.+++|+.|+|++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 467999999999998 78898899999999999999999965 789999999999999999998788888889999999
Q ss_pred eccCCcccCCC-ccccccccccCeEeccccccccccC---cccccCCcccEEeccCCCCCCC
Q 001922 532 DMSQNNLSGSI-PPEISNVRILNYLNLSRNHLNQNIP---KSIGSMKSLTIADFSFNDFSGK 589 (995)
Q Consensus 532 ~Ls~N~l~~~i-p~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~l~ls~N~l~g~ 589 (995)
+|++|++++.. +..+..+++|++|+|++|++++..+ ..+..+++|+.|++++|.+...
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 99999998532 2789999999999999999987555 4899999999999999998753
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-16 Score=155.02 Aligned_cols=129 Identities=22% Similarity=0.259 Sum_probs=115.6
Q ss_pred CCCCcEEEcCCCccc-ccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCccccccee
Q 001922 453 PDRLGQLNLSNNLLS-GPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYL 531 (995)
Q Consensus 453 ~~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 531 (995)
+++++.|++++|.++ +.+|..+..+++|+.|+|++|++++. ..++.+++|+.|+|++|.+++.+|..++.+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 367999999999998 78898899999999999999999965 789999999999999999998788888889999999
Q ss_pred eccCCcccCC-CccccccccccCeEeccccccccccC---cccccCCcccEEeccC
Q 001922 532 DMSQNNLSGS-IPPEISNVRILNYLNLSRNHLNQNIP---KSIGSMKSLTIADFSF 583 (995)
Q Consensus 532 ~Ls~N~l~~~-ip~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~l~ls~ 583 (995)
++++|++++. .|..+..+++|++|+|++|++++..+ ..+..+++|+.||+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999863 34889999999999999999988655 5789999999999874
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.7e-16 Score=157.64 Aligned_cols=128 Identities=23% Similarity=0.299 Sum_probs=102.9
Q ss_pred cEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCC
Q 001922 457 GQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQN 536 (995)
Q Consensus 457 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 536 (995)
+.+++++|+++ .+|..+. ++|+.|+|++|+|+ .+|..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46788888887 5665543 57888888888887 67778888888888888888888777777888888888888888
Q ss_pred cccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCC
Q 001922 537 NLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSG 588 (995)
Q Consensus 537 ~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g 588 (995)
+|++..|..|..+++|++|+|++|+|++..+..+..+++|+.|++++|++.+
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 8887777788888888888888888887666678888888888888777654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=6.9e-16 Score=154.34 Aligned_cols=134 Identities=21% Similarity=0.191 Sum_probs=113.0
Q ss_pred CcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccC
Q 001922 456 LGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQ 535 (995)
Q Consensus 456 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 535 (995)
.+.+++++|+++ .+|..+ .++|+.|+|++|++++..+..++.+++|+.|+|++|++++..+..++.+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 467888888888 456544 36899999999999977777788999999999999999976666788999999999999
Q ss_pred CcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCCC
Q 001922 536 NNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPE 592 (995)
Q Consensus 536 N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~ 592 (995)
|++++..+..+..+++|++|+|++|++++..+..+..+++|+.|++++|++++..|.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 999977777788999999999999999876666678899999999999999987763
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=6.9e-16 Score=152.89 Aligned_cols=136 Identities=24% Similarity=0.240 Sum_probs=109.1
Q ss_pred CcccEEECcCCCCC-CccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEE
Q 001922 235 VNLVHLDLSSCELD-GQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFN 313 (995)
Q Consensus 235 ~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 313 (995)
++|++|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|+|++|.+++.+|..+.++++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 67899999999987 67787788888888888888888865 6788888888888888888877777777788888888
Q ss_pred ccCCcCCCCC-CccccCCCCcceEEeccCcccccCC---CcccCCCCCCeEEecCceecccCCC
Q 001922 314 LFMNRLHGSI-PDYLADLPNLETLGLWQNNFTGVIP---ENLGQNGKLQVLDLSSNKLTGTIPT 373 (995)
Q Consensus 314 L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p~ 373 (995)
+++|++++.. +..+..+++|+.|++++|++++..+ ..+..+++|++|++++|.+. .+|.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 8888888542 2677888888888888888886544 36778888888888888876 4454
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=4.9e-16 Score=171.17 Aligned_cols=138 Identities=11% Similarity=0.030 Sum_probs=99.5
Q ss_pred ccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCC-------------CChhHH--------HHHHHHHHhccCCCCce
Q 001922 688 VKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGT-------------HSHDHG--------FRAEIQTLGNIRHRNIV 746 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------~~~~~~--------~~~E~~~l~~l~hpniv 746 (995)
|++++.||+|+||.||+|...+|+.||||+++.... ...... ..+|+..+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 788899999999999999998999999998742110 001111 23456666666444432
Q ss_pred eEeEEEecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-
Q 001922 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF- 825 (995)
Q Consensus 747 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~- 825 (995)
...-+.. ...++||||++|++|.++... .....++.|++.+|.|+|+.| ||||||||.|||+++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCeeeec--cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 1111111 234799999999998776531 123467899999999999888 99999999999998876
Q ss_pred ---------CeEEeeecccccc
Q 001922 826 ---------EAHVADFGLAKFL 838 (995)
Q Consensus 826 ---------~vkl~DfGla~~~ 838 (995)
.+.|+||+.+-..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 3899999987653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.2e-15 Score=149.90 Aligned_cols=128 Identities=28% Similarity=0.340 Sum_probs=99.9
Q ss_pred cEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCC
Q 001922 238 VHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMN 317 (995)
Q Consensus 238 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 317 (995)
+.+++++|.++ .+|..+. ++|+.|++++|+++ .+|..|.++++|++|+|++|.|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 56788888887 4555443 57778888888887 56677888888888888888888777777888888888888888
Q ss_pred cCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecc
Q 001922 318 RLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTG 369 (995)
Q Consensus 318 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 369 (995)
+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 8887777778888888888888888886666677788888888888888763
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.4e-15 Score=147.23 Aligned_cols=128 Identities=21% Similarity=0.222 Sum_probs=90.5
Q ss_pred CcccEEECcCCCCC-CccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEE
Q 001922 235 VNLVHLDLSSCELD-GQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFN 313 (995)
Q Consensus 235 ~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 313 (995)
++|++|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|++++|.+++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56788888888877 66677777777777777777777754 5677777777777777777766676666677777777
Q ss_pred ccCCcCCCC-CCccccCCCCcceEEeccCcccccCC---CcccCCCCCCeEEecC
Q 001922 314 LFMNRLHGS-IPDYLADLPNLETLGLWQNNFTGVIP---ENLGQNGKLQVLDLSS 364 (995)
Q Consensus 314 L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~ 364 (995)
+++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|++|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 777777753 23666777777777777777775544 3566677777776653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.2e-14 Score=164.38 Aligned_cols=265 Identities=11% Similarity=0.077 Sum_probs=123.5
Q ss_pred cccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeec
Q 001922 114 SSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSL 193 (995)
Q Consensus 114 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 193 (995)
..++.+.+.+ .++.+...+|.+. +|+.+++..+ ++.+...+|.++ +|+.+++.. .++...+.+|.++++|+.++|
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4455555433 3444444555543 4555555444 555555555553 455555553 444344455555555555555
Q ss_pred cCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccC
Q 001922 194 AGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSG 273 (995)
Q Consensus 194 s~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 273 (995)
++|+++......|. .++|+.+.+ ..+ ++.....+|.++++|+.+.+..| ++.
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~l-------------------------p~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~ 239 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLL-------------------------PVT-LKEIGSQAFLKTSQLKTIEIPEN-VST 239 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEEC-------------------------CTT-CCEECTTTTTTCTTCCCEECCTT-CCE
T ss_pred CCCcceEechhhEe-ecccCEEEe-------------------------CCc-hheehhhHhhCCCCCCEEecCCC-ccC
Confidence 55555533333333 234444444 321 33233333444444444444332 222
Q ss_pred CCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCC-----CCCCccccCCCCcceEEeccCcccccCC
Q 001922 274 SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLH-----GSIPDYLADLPNLETLGLWQNNFTGVIP 348 (995)
Q Consensus 274 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p 348 (995)
+-..+|.+ .+|+.+.+. |.++.+...+|.++++|+.+++.+|.+. ...+.+|.++++|+.++|. +.++.+..
T Consensus 240 I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~ 316 (401)
T 4fdw_A 240 IGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQ 316 (401)
T ss_dssp ECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECT
T ss_pred cccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhh
Confidence 22333433 344444442 2333344444444445555544444432 2333445555555555555 23444444
Q ss_pred CcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCC-CCcEEEecCCccC
Q 001922 349 ENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACY-SLTRVRLGQNYLN 416 (995)
Q Consensus 349 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~-~L~~L~l~~N~l~ 416 (995)
.+|.++++|+.++|..| ++..-+..|.++ +|+.+++.+|.+....+..|.++. +++.|++..+.+.
T Consensus 317 ~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 317 GLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp TTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred hhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 45555555555555333 333334445445 555555555554444444555552 5666766666543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=9e-15 Score=146.16 Aligned_cols=131 Identities=23% Similarity=0.211 Sum_probs=90.7
Q ss_pred ccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccC
Q 001922 237 LVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFM 316 (995)
Q Consensus 237 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 316 (995)
.+.+++++|+++ .+|..+. ++|+.|++++|++++..+..|..+++|++|++++|.|++..+..|.++++|+.|++++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 466777777777 3343332 5677777777777766556667777777777777777766666677777777777777
Q ss_pred CcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceeccc
Q 001922 317 NRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGT 370 (995)
Q Consensus 317 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 370 (995)
|+|++..+..+..+++|++|++++|++++..+..+..+++|++|+|++|++++.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 777766666667777777777777777765555566677777777777777643
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.8e-14 Score=161.46 Aligned_cols=266 Identities=12% Similarity=0.082 Sum_probs=204.9
Q ss_pred CCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEE
Q 001922 161 LEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHL 240 (995)
Q Consensus 161 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L 240 (995)
+..++.+.+.. .++.....+|.+. +|+.+.+..| ++.+...+|.+. +|+.+.+.. ++. ..-+..|.++++|+.+
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLE-QLKEDIFYYCYNLKKA 185 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCC-EECSSTTTTCTTCCEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-Ccc-EehHHHhhCcccCCee
Confidence 34555555543 3443444555553 5666666554 554555556553 466666652 222 2234578888999999
Q ss_pred ECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCC
Q 001922 241 DLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLH 320 (995)
Q Consensus 241 ~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 320 (995)
++++|+++......|. ..+|+.+.+..+ ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++
T Consensus 186 ~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~ 260 (401)
T 4fdw_A 186 DLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT 260 (401)
T ss_dssp ECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC
T ss_pred ecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc
Confidence 9999999866666666 589999999855 77677789999999999999986 66677888988 89999999 56677
Q ss_pred CCCCccccCCCCcceEEeccCccc-----ccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCC
Q 001922 321 GSIPDYLADLPNLETLGLWQNNFT-----GVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPI 395 (995)
Q Consensus 321 ~~~p~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 395 (995)
.+...+|.++++|+.+++.+|.+. .+.+..|.++++|+.++|.+ .++..-...|.++.+|+.+.+..| +...-
T Consensus 261 ~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~ 338 (401)
T 4fdw_A 261 NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQIN 338 (401)
T ss_dssp EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEEC
T ss_pred EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEc
Confidence 677889999999999999998875 57788999999999999995 577666788999999999999665 66667
Q ss_pred CcccccCCCCcEEEecCCccCCCCCCCcccCC-CCceeeccCcccc
Q 001922 396 PERLGACYSLTRVRLGQNYLNGSIPDGFIYLP-GLNLAELQSNYLS 440 (995)
Q Consensus 396 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~l~l~~n~l~ 440 (995)
+..|.++ +|+.+++++|.+....+..|..++ .+..+.+..+.+.
T Consensus 339 ~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 339 FSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp TTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred HHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 7889999 999999999999988888998885 6888888877654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=8.3e-15 Score=146.21 Aligned_cols=130 Identities=18% Similarity=0.193 Sum_probs=107.4
Q ss_pred CCCCCcEEEcCCCcccccCCccccCC-CCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccce
Q 001922 452 NPDRLGQLNLSNNLLSGPLPFSLSNF-SSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTY 530 (995)
Q Consensus 452 ~~~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 530 (995)
.+.+|+.|++++|+++. +|. +..+ ++|+.|+|++|+|++. ..++.+++|+.|+|++|+|++..|..++.+++|++
T Consensus 17 ~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 92 (176)
T 1a9n_A 17 NAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92 (176)
T ss_dssp CTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred CcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence 35678899999999984 454 4444 4999999999999864 67889999999999999998544444588999999
Q ss_pred eeccCCcccCCCcc--ccccccccCeEeccccccccccCcc----cccCCcccEEeccCCCCC
Q 001922 531 LDMSQNNLSGSIPP--EISNVRILNYLNLSRNHLNQNIPKS----IGSMKSLTIADFSFNDFS 587 (995)
Q Consensus 531 L~Ls~N~l~~~ip~--~l~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~l~ls~N~l~ 587 (995)
|+|++|+++ .+|. .+..+++|+.|+|++|+++. +|.. +..+++|+.||+++|...
T Consensus 93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 999999996 6776 88899999999999999975 6664 889999999999998765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=7.7e-15 Score=146.47 Aligned_cols=109 Identities=19% Similarity=0.194 Sum_probs=67.3
Q ss_pred ccCCCCCCeEeccCCcccCccccCccc-ccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCce
Q 001922 88 ILRLDKLTNLSLAGNNFTGSIEIGNLS-SLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKY 166 (995)
Q Consensus 88 ~~~l~~L~~L~L~~n~l~~~~~~~~l~-~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~ 166 (995)
+.++.+|++|++++|+++....+..+. +|++|+|++|.|++. ..|..+++|++|++++|+|+++.+..|..+++|++
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 92 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92 (176)
T ss_dssp EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred cCCcCCceEEEeeCCCCchhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence 445566666677666666544444444 666666666666654 45666666666666666666654444566666666
Q ss_pred eeccCccccccCCc--cccCCCCCceeeccCCccc
Q 001922 167 LDLGGNYFFGKIPN--SYGELQGLEYLSLAGNDLT 199 (995)
Q Consensus 167 L~L~~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~ 199 (995)
|+|++|.|+ .+|. .+..+++|++|++++|.++
T Consensus 93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 666666664 3444 5666666666666666665
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.7e-13 Score=152.91 Aligned_cols=67 Identities=6% Similarity=-0.035 Sum_probs=35.9
Q ss_pred ccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeecc
Q 001922 126 FSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLA 194 (995)
Q Consensus 126 i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 194 (995)
++.+...+|.++.+|+.+.+.. .++.+...+|.++++|+.++|..+ ++..-..+|.++.+|+.+.+.
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p 125 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLP 125 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhccc
Confidence 4445555566666666666642 355555556666666666666533 333334455555555555444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.49 E-value=4.8e-13 Score=151.97 Aligned_cols=74 Identities=8% Similarity=0.015 Sum_probs=49.1
Q ss_pred ccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCC
Q 001922 109 EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGEL 185 (995)
Q Consensus 109 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 185 (995)
.|.++++|+.+.|.. .++.+...+|.++++|+.+++.++ ++.+...+|.++.+|+.+.+..+ +......+|.+.
T Consensus 66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~ 139 (394)
T 4fs7_A 66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGC 139 (394)
T ss_dssp TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTC
T ss_pred HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecc
Confidence 577777788887764 366666777777888888877644 66666677777777777766544 333344445444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.49 E-value=6.5e-16 Score=157.58 Aligned_cols=125 Identities=23% Similarity=0.240 Sum_probs=89.8
Q ss_pred CCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeecc
Q 001922 455 RLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMS 534 (995)
Q Consensus 455 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 534 (995)
+|++|+|++|++++ +| .+.++++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++ +| .++.+++|++|+|+
T Consensus 49 ~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~ 123 (198)
T 1ds9_A 49 ACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMS 123 (198)
T ss_dssp TCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEES
T ss_pred CCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECC
Confidence 34445555555553 44 5666777788888888877 567777777888888888888875 55 57778888888888
Q ss_pred CCcccCCCc--cccccccccCeEeccccccccccCcc----------cccCCcccEEeccCCCCC
Q 001922 535 QNNLSGSIP--PEISNVRILNYLNLSRNHLNQNIPKS----------IGSMKSLTIADFSFNDFS 587 (995)
Q Consensus 535 ~N~l~~~ip--~~l~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~~L~~l~ls~N~l~ 587 (995)
+|++++ +| ..+..+++|++|+|++|++++.+|.. +..+++|+.|| +|.++
T Consensus 124 ~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 124 NNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCcCCc-hhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 888874 33 36778888888888888887766653 77788888876 55554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.48 E-value=4.3e-16 Score=158.92 Aligned_cols=132 Identities=21% Similarity=0.238 Sum_probs=113.5
Q ss_pred CcEEEcCCCcccccCCc------cccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccc
Q 001922 456 LGQLNLSNNLLSGPLPF------SLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLT 529 (995)
Q Consensus 456 L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 529 (995)
++.++++.|.++|.+|. .+..+++|+.|+|++|++++ +| .+..+++|+.|+|++|.++ .+|..+..+++|+
T Consensus 20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 34444555555554444 89999999999999999996 67 8999999999999999999 7899898899999
Q ss_pred eeeccCCcccCCCccccccccccCeEeccccccccccC-cccccCCcccEEeccCCCCCCCCCC
Q 001922 530 YLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIP-KSIGSMKSLTIADFSFNDFSGKLPE 592 (995)
Q Consensus 530 ~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~g~~p~ 592 (995)
+|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|+.|++++|++++.+|.
T Consensus 97 ~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 97 ELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp EEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred EEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 99999999995 66 79999999999999999987433 5789999999999999999988775
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=7.3e-14 Score=138.30 Aligned_cols=106 Identities=24% Similarity=0.282 Sum_probs=61.3
Q ss_pred CcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccC
Q 001922 456 LGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQ 535 (995)
Q Consensus 456 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 535 (995)
.+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 356666666666 3554442 5566666666666655555566666666666666666644444455566666666666
Q ss_pred CcccCCCccccccccccCeEecccccccc
Q 001922 536 NNLSGSIPPEISNVRILNYLNLSRNHLNQ 564 (995)
Q Consensus 536 N~l~~~ip~~l~~l~~L~~L~L~~N~l~~ 564 (995)
|+|++..|..|.++++|++|+|++|+++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 66654444445555555555555555544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-13 Score=136.76 Aligned_cols=109 Identities=22% Similarity=0.210 Sum_probs=91.7
Q ss_pred CcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccc
Q 001922 480 LQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSR 559 (995)
Q Consensus 480 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~ 559 (995)
.+.|++++|+++ .+|..+. ++|+.|+|++|+|++..|..|+.+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 578899999988 5776664 7888999999999887788888999999999999999876666678899999999999
Q ss_pred cccccccCcccccCCcccEEeccCCCCCCCCC
Q 001922 560 NHLNQNIPKSIGSMKSLTIADFSFNDFSGKLP 591 (995)
Q Consensus 560 N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p 591 (995)
|+|++..|..+..+++|+.|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 99988767778889999999999998887655
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.5e-13 Score=136.47 Aligned_cols=105 Identities=23% Similarity=0.262 Sum_probs=64.0
Q ss_pred cEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCC
Q 001922 457 GQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQN 536 (995)
Q Consensus 457 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 536 (995)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|+.+++|+.|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56677777765 4555443 56666666666666655666666666666666666666543444566666666666666
Q ss_pred cccCCCccccccccccCeEecccccccc
Q 001922 537 NLSGSIPPEISNVRILNYLNLSRNHLNQ 564 (995)
Q Consensus 537 ~l~~~ip~~l~~l~~L~~L~L~~N~l~~ 564 (995)
+|++..+..|..+++|++|+|++|++..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 6664333346666666666666666644
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.8e-13 Score=134.56 Aligned_cols=108 Identities=19% Similarity=0.218 Sum_probs=84.8
Q ss_pred cEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEecccc
Q 001922 481 QILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRN 560 (995)
Q Consensus 481 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N 560 (995)
+.+++++|+++ .+|..+. .+|+.|+|++|+|++..|..|+.+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 67888888886 6676664 67888888888888777778888888888888888888655555678888888888888
Q ss_pred ccccccCcccccCCcccEEeccCCCCCCCCC
Q 001922 561 HLNQNIPKSIGSMKSLTIADFSFNDFSGKLP 591 (995)
Q Consensus 561 ~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p 591 (995)
+|++..+..+..+++|+.|+|++|++....+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 8877555568888888888888888876544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.3e-10 Score=131.87 Aligned_cols=326 Identities=12% Similarity=0.075 Sum_probs=162.3
Q ss_pred cccCCC-CCCeEeccCCccc--CccccCcccccceecccccc---ccCCCcccccccccccccccccccccccCCccccC
Q 001922 87 QILRLD-KLTNLSLAGNNFT--GSIEIGNLSSLQFLNISNNQ---FSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILK 160 (995)
Q Consensus 87 ~~~~l~-~L~~L~L~~n~l~--~~~~~~~l~~L~~L~Ls~N~---i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~ 160 (995)
+|.++. .|+++.+..+ ++ |...|.++++|+.+.++.|. ++.+...+|.++.+|+.+.+..+ ++.+...+|..
T Consensus 58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~ 135 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHH 135 (394)
T ss_dssp TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTT
T ss_pred hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhh
Confidence 455553 4777777653 44 23367888888888887764 55566777888888887777543 56666677788
Q ss_pred CCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEE
Q 001922 161 LEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHL 240 (995)
Q Consensus 161 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L 240 (995)
+.+|+.+.+..+ +.......|..+.+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-.. .-...+..+.+++..
T Consensus 136 c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~--i~~~af~~c~~l~~~ 210 (394)
T 4gt6_A 136 CEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR--IGTNAFSECFALSTI 210 (394)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE--ECTTTTTTCTTCCEE
T ss_pred hcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc--cccchhhhcccccee
Confidence 888888888644 33355566777778888877654 44344445543 45666655422111 123445556666666
Q ss_pred ECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCC
Q 001922 241 DLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLH 320 (995)
Q Consensus 241 ~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 320 (995)
....+.... ....+..-..... .....+.....+..+.+.. .++.....+|.++..|+.+.+..+...
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~ 278 (394)
T 4gt6_A 211 TSDSESYPA-IDNVLYEKSANGD----------YALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS 278 (394)
T ss_dssp EECCSSSCB-SSSCEEEECTTSC----------EEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE
T ss_pred ccccccccc-ccceeeccccccc----------ccccccccccccceEEcCC-cceEcccceeeecccccEEecccccce
Confidence 555444331 1111100000000 0000011112222333221 122233344555555555555433322
Q ss_pred CCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccc
Q 001922 321 GSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLG 400 (995)
Q Consensus 321 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~ 400 (995)
....+|.++++|+.+.+. +.++.+....|.++.+|+.++|..+ ++..-...|.++.+|+.+.+..+ +...-...|.
T Consensus 279 -I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~ 354 (394)
T 4gt6_A 279 -IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFS 354 (394)
T ss_dssp -ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGT
T ss_pred -ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhh
Confidence 334445555555555553 3344344445555555555555443 33233444555555555555433 3333445566
Q ss_pred cCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCcc
Q 001922 401 ACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNY 438 (995)
Q Consensus 401 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~ 438 (995)
+|.+|+.+++.++.... ..|....+|+.+.+..+.
T Consensus 355 ~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 355 NCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp TCTTCCEEEESSCHHHH---HTCBCCCCC---------
T ss_pred CCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCC
Confidence 66666666666654321 234444555555554443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=6.3e-14 Score=156.99 Aligned_cols=167 Identities=21% Similarity=0.194 Sum_probs=95.9
Q ss_pred CCCCceeeccCccccccCCccccCC-----CCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCC
Q 001922 161 LEKLKYLDLGGNYFFGKIPNSYGEL-----QGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLV 235 (995)
Q Consensus 161 l~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~ 235 (995)
+++|++|+|++|.++......|... ++|++|+|++|.++......+.. .++
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~------------------------~L~ 126 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLP------------------------VFL 126 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHH------------------------HHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHH------------------------HHH
Confidence 4678899999998875544444332 68889999988887432222211 122
Q ss_pred cccEEECcCCCCCCccCcccc-----CccccCccccccccccC----CCCccccCcCCCCeEeccCCcCcCcC----Ccc
Q 001922 236 NLVHLDLSSCELDGQIPHEIG-----NLKLLDTVFLHINLLSG----SIPKQLGNLTNLVNLDLSNNALTGEI----PYS 302 (995)
Q Consensus 236 ~L~~L~Ls~n~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~----p~~ 302 (995)
+|++|+|++|.++......++ ..+.|++|+|++|.++. .++..+..+++|++|+|++|.|++.. +..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 456666666666543333332 23456666666665543 13334455666777777777766432 344
Q ss_pred ccccCCCCEEEccCCcCCCC----CCccccCCCCcceEEeccCcccccCCCcc
Q 001922 303 FINLRQLKLFNLFMNRLHGS----IPDYLADLPNLETLGLWQNNFTGVIPENL 351 (995)
Q Consensus 303 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 351 (995)
+...++|+.|+|++|.|++. ++..+...++|++|+|++|.|+......+
T Consensus 207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 55556677777777766542 22333445667777777776664433333
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.3e-10 Score=131.97 Aligned_cols=316 Identities=11% Similarity=0.097 Sum_probs=194.8
Q ss_pred ccCccc-ccceeccccccccCCCccccccccccccccccccc---ccccCCccccCCCCCceeeccCccccccCCccccC
Q 001922 109 EIGNLS-SLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNN---FTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGE 184 (995)
Q Consensus 109 ~~~~l~-~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~---i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 184 (995)
.|.++. .|+.+.+..+ ++.+...+|.++++|+.+.+..|. ++.+...+|.++.+|+.+.+..+ ++......|..
T Consensus 58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~ 135 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHH 135 (394)
T ss_dssp TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTT
T ss_pred hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhh
Confidence 466664 5888888654 666777788888888888877664 66666677777778877777654 44345566777
Q ss_pred CCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCcc
Q 001922 185 LQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTV 264 (995)
Q Consensus 185 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 264 (995)
+.+|+.+.+..+ ++.+....|.++.+|+.+.+.. ++.. +........+|+.+.+..+-.. ..
T Consensus 136 c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~-~~~~--I~~~aF~~~~l~~i~ip~~~~~-i~------------- 197 (394)
T 4gt6_A 136 CEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPD-SVTA--IEERAFTGTALTQIHIPAKVTR-IG------------- 197 (394)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCT-TCCE--ECTTTTTTCCCSEEEECTTCCE-EC-------------
T ss_pred hcccccccccce-eeeecccceecccccccccccc-eeeE--eccccccccceeEEEECCcccc-cc-------------
Confidence 777777777643 3334455566666666555542 1111 1111112234554444332211 22
Q ss_pred ccccccccCCCCccccCcCCCCeEeccCCcCcCcCCc-------------cccccCCCCEEEccCCcCCCCCCccccCCC
Q 001922 265 FLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPY-------------SFINLRQLKLFNLFMNRLHGSIPDYLADLP 331 (995)
Q Consensus 265 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 331 (995)
..+|.++.+++......+......-. .+.....+..+.+. +.+......+|.++.
T Consensus 198 -----------~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~ 265 (394)
T 4gt6_A 198 -----------TNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCA 265 (394)
T ss_dssp -----------TTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCS
T ss_pred -----------cchhhhccccceecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecc
Confidence 33444444554444443333211111 11122334444443 233334566889999
Q ss_pred CcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEec
Q 001922 332 NLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLG 411 (995)
Q Consensus 332 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~ 411 (995)
+|+.+.+.++..+ .....|.++.+|+.+.+. +.++......|.++.+|+.+.+..+ +...-...|.+|.+|+++.+.
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred cccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence 9999999876554 777889999999999996 4566566678899999999999865 555556789999999999997
Q ss_pred CCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcc
Q 001922 412 QNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLL 466 (995)
Q Consensus 412 ~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l 466 (995)
.+ ++.+-..+|.+..+|+.+++.++..... .+.....|+.+.+..|.+
T Consensus 343 ~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~~------~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 343 SS-VTKIPESAFSNCTALNNIEYSGSRSQWN------AISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TT-CCBCCGGGGTTCTTCCEEEESSCHHHHH------TCBCCCCC----------
T ss_pred cc-cCEEhHhHhhCCCCCCEEEECCceeehh------hhhccCCCCEEEeCCCCE
Confidence 65 7767778999999999999988765421 223345678887776654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=8.8e-14 Score=155.81 Aligned_cols=45 Identities=22% Similarity=0.311 Sum_probs=22.4
Q ss_pred cccCcCCCCeEeccCCcCcCcC----CccccccCCCCEEEccCCcCCCC
Q 001922 278 QLGNLTNLVNLDLSNNALTGEI----PYSFINLRQLKLFNLFMNRLHGS 322 (995)
Q Consensus 278 ~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~ 322 (995)
.+...++|+.|+|++|.|++.. +..+...++|+.|+|++|.|++.
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 3444455555555555555322 22233345566666666655543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.21 E-value=9.4e-12 Score=138.79 Aligned_cols=104 Identities=21% Similarity=0.243 Sum_probs=75.8
Q ss_pred EEEcCCC-cccccCCccccCCCCCcEEEcCC-CcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccC
Q 001922 458 QLNLSNN-LLSGPLPFSLSNFSSLQILLLSG-NQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQ 535 (995)
Q Consensus 458 ~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 535 (995)
.++++++ +|+ .+|. +..+++|+.|+|++ |+|++..+..|+.+.+|+.|+|++|+|++..|..|+.|++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4677777 777 4666 77778888888875 888766667777777778888888877776677777777777777777
Q ss_pred CcccCCCccccccccccCeEecccccccc
Q 001922 536 NNLSGSIPPEISNVRILNYLNLSRNHLNQ 564 (995)
Q Consensus 536 N~l~~~ip~~l~~l~~L~~L~L~~N~l~~ 564 (995)
|+|++..|..+..+. |+.|+|++|++..
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 777754444444444 7777777777754
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.20 E-value=1e-11 Score=138.44 Aligned_cols=104 Identities=17% Similarity=0.098 Sum_probs=61.3
Q ss_pred EEEcCCC-cccCCCCCCccchhhhccccccc-cccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEeccc
Q 001922 482 ILLLSGN-QFSGPIPPSIGELRQVLKLDLSR-NSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSR 559 (995)
Q Consensus 482 ~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~ 559 (995)
.++++++ +|+ .+|. +..+.+|+.|+|++ |.|++..|..|+.|++|++|+|++|+|++..|..|.+|++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3455665 565 3555 66666666666664 666654445566666666666666666665555666666666666666
Q ss_pred cccccccCcccccCCcccEEeccCCCCCC
Q 001922 560 NHLNQNIPKSIGSMKSLTIADFSFNDFSG 588 (995)
Q Consensus 560 N~l~~~~p~~~~~l~~L~~l~ls~N~l~g 588 (995)
|+|++..|..+..++ |+.|+|++|++..
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 666554444444443 6666666666553
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=1.2e-10 Score=124.25 Aligned_cols=145 Identities=13% Similarity=0.030 Sum_probs=111.5
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 761 (995)
.....|+.....+.|+++.||++... ++.+++|....... .....+.+|+.+++.+. +..+.++++++.+.+..|+|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 44556777777888999999999764 68999999843211 22345889999999884 67788899999888889999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC------------------------------------ 805 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------ 805 (995)
|||++|.++.+.... ......++.+++++++.||+..
T Consensus 89 ~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999999876421 1123467889999999999810
Q ss_pred --------------------CCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 806 --------------------SPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 806 --------------------~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
...++|||++|.||++++...+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876556799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.97 E-value=1.1e-09 Score=116.60 Aligned_cols=129 Identities=15% Similarity=0.063 Sum_probs=97.5
Q ss_pred eccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCC--ceeEeEEEecCCcceEEEEeccCCChhh
Q 001922 695 GRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN--IVRLLAFCSNKETNLLVYEYMRNGSLGE 772 (995)
Q Consensus 695 G~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~~gsL~~ 772 (995)
+.|..+.||++...+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 456669999998777888999987432 2345788999999986544 456888888778889999999998884
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 001922 773 ALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC----------------------------------------------- 805 (995)
Q Consensus 773 ~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------------- 805 (995)
... .+ ...++.++++.+..||+..
T Consensus 104 -~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 -SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp -TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred -cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 211 11 1256788888888888642
Q ss_pred --------CCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 806 --------SPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 806 --------~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
...++|||++|.||+++.++.+.|+|||.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=2.8e-09 Score=119.19 Aligned_cols=141 Identities=15% Similarity=0.215 Sum_probs=105.1
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEec--CCCCCChhHHHHHHHHHHhccC--CCCceeEeEEEecC---CcceEEEEe
Q 001922 692 NVIGRGGAGIVYHGKMPNGVEIAVKKLL--GFGTHSHDHGFRAEIQTLGNIR--HRNIVRLLAFCSNK---ETNLLVYEY 764 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~---~~~~lv~e~ 764 (995)
+.++.|.++.||+++.. +..+++|+.. ..........+.+|+.+++.+. +..+++++.++.+. +..|+||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 56899999999999875 4688888764 2222223456888999999996 45578888888766 457999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC--------------------------------------- 805 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------- 805 (995)
++|..+.+.. ...++...+..++.+++++|+.||...
T Consensus 123 v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 123 VSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred cCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 9998875422 123677888899999999999999731
Q ss_pred ----------------CCCeEecCCCCCCEEECCCCC--eEEeeeccccc
Q 001922 806 ----------------SPLIVHRDVKSNNILLNSAFE--AHVADFGLAKF 837 (995)
Q Consensus 806 ----------------~~~iiHrDlkp~Nill~~~~~--vkl~DfGla~~ 837 (995)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999998864
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.92 E-value=2.5e-08 Score=112.32 Aligned_cols=298 Identities=11% Similarity=0.074 Sum_probs=131.7
Q ss_pred CCCCCeEeccCCccc--CccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceee
Q 001922 91 LDKLTNLSLAGNNFT--GSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLD 168 (995)
Q Consensus 91 l~~L~~L~L~~n~l~--~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~ 168 (995)
..+|+++.+.. .++ |...|.++++|+.++|..+ ++.+...+|.+. +|+.+.+.. +++.+...+|... +|+.++
T Consensus 45 ~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~-~l~~I~~~aF~~~-~L~~i~ 119 (379)
T 4h09_A 45 RDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGME-RVKKFGDYVFQGT-DLDDFE 119 (379)
T ss_dssp GGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECT-TCCEECTTTTTTC-CCSEEE
T ss_pred ccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCc-eeeEeccceeccC-Cccccc
Confidence 34555555543 233 1224666666666666533 555555566554 455554432 2444444555543 566666
Q ss_pred ccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccC-----------CCCcccCCCCcc
Q 001922 169 LGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEG-----------GIPREVGKLVNL 237 (995)
Q Consensus 169 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~-----------~~p~~~~~l~~L 237 (995)
+..+- +......|.+ .+|+...+..+ ++......|.++.+++...+..++.... .....+.....+
T Consensus 120 lp~~~-~~i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (379)
T 4h09_A 120 FPGAT-TEIGNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTG 196 (379)
T ss_dssp CCTTC-CEECTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCC
T ss_pred CCCcc-cccccccccc-ceeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccc
Confidence 65442 2122333333 24444444332 3323344445555554444332211100 001111222222
Q ss_pred cEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCC
Q 001922 238 VHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMN 317 (995)
Q Consensus 238 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 317 (995)
..+.+....- ......+....+|+.+.+..+ ++.....+|.++..|+.+.+..+
T Consensus 197 ~~~~~~~~~~-------------------------~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~ 250 (379)
T 4h09_A 197 TEFTIPSTVK-------------------------TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN 250 (379)
T ss_dssp SEEECCTTCC-------------------------EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT
T ss_pred ccccccccee-------------------------EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC
Confidence 3222222111 122233444444555544433 22233444455555555555443
Q ss_pred cCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCc
Q 001922 318 RLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPE 397 (995)
Q Consensus 318 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 397 (995)
++.....+|.++.+|+.+.+..+ ++......|..+.+|+.+.+.++.++..-...|.++.+|+.+.+..+ +...-..
T Consensus 251 -v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~ 327 (379)
T 4h09_A 251 -VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVY 327 (379)
T ss_dssp -CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTT
T ss_pred -ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHH
Confidence 33333444555555555555432 33333444555555555555555444333444555555555555433 3333344
Q ss_pred ccccCCCCcEEEecCCccCCCCCCCcccC
Q 001922 398 RLGACYSLTRVRLGQNYLNGSIPDGFIYL 426 (995)
Q Consensus 398 ~l~~l~~L~~L~l~~N~l~~~~p~~~~~l 426 (995)
.|.+|.+|+.+.+..+ ++.+-..+|.+.
T Consensus 328 aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 328 AFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp TTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred HhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 5666666666666543 444444555443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.89 E-value=3.1e-08 Score=111.57 Aligned_cols=302 Identities=13% Similarity=0.046 Sum_probs=205.2
Q ss_pred cCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCc
Q 001922 110 IGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLE 189 (995)
Q Consensus 110 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 189 (995)
+....+|+.+.+.. .++.+...+|.++.+|+.+++.. .++.+...+|.++ +|+.+.+..+ ++.....+|.. .+|+
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~ 116 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLD 116 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCS
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCC-cceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcc
Confidence 55667888888864 46667788899999999999864 4777777888887 6777777644 44344445554 4788
Q ss_pred eeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccc
Q 001922 190 YLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHIN 269 (995)
Q Consensus 190 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N 269 (995)
.+.+..+ ++......|.+. +|+.+.+.. ++. ..-...+..+.+++...+..+........ .. ..+
T Consensus 117 ~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~-~v~-~i~~~~f~~~~~l~~~~~~~~~~~~~~~~-~~----------~~~ 181 (379)
T 4h09_A 117 DFEFPGA-TTEIGNYIFYNS-SVKRIVIPK-SVT-TIKDGIGYKAENLEKIEVSSNNKNYVAEN-YV----------LYN 181 (379)
T ss_dssp EEECCTT-CCEECTTTTTTC-CCCEEEECT-TCC-EECSCTTTTCTTCCEEEECTTCSSEEEET-TE----------EEE
T ss_pred cccCCCc-cccccccccccc-eeeeeeccc-eee-ccccchhcccccccccccccccceeeccc-ce----------ecc
Confidence 8888765 332334444443 333333321 111 11123455556666665554433211100 00 001
Q ss_pred cccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCC
Q 001922 270 LLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPE 349 (995)
Q Consensus 270 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 349 (995)
.. ......+.....+..+.+..+.-. .....+....+|+.+.+..+ +......+|.++.+|+.+.+..+ ++.+...
T Consensus 182 ~~-~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~ 257 (379)
T 4h09_A 182 KN-KTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSF 257 (379)
T ss_dssp TT-SSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTT
T ss_pred cc-cceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCcc
Confidence 11 122334556667777776655433 56677888899999998765 44456678889999999999876 6667788
Q ss_pred cccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCC
Q 001922 350 NLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGL 429 (995)
Q Consensus 350 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 429 (995)
.|..+.+|+.+.+..+ +.......|..+.+|+.+.+.++.+...-...|.+|.+|+.+.+..+ ++.+-..+|.+..+|
T Consensus 258 aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 335 (379)
T 4h09_A 258 LLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKAL 335 (379)
T ss_dssp TTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred ccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCC
Confidence 8999999999999765 55455667899999999999998887777889999999999999865 776777899999999
Q ss_pred ceeeccCc
Q 001922 430 NLAELQSN 437 (995)
Q Consensus 430 ~~l~l~~n 437 (995)
+.+.+..+
T Consensus 336 ~~i~ip~~ 343 (379)
T 4h09_A 336 STISYPKS 343 (379)
T ss_dssp CCCCCCTT
T ss_pred CEEEECCc
Confidence 98887654
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.81 E-value=7.1e-10 Score=122.91 Aligned_cols=59 Identities=24% Similarity=0.333 Sum_probs=30.4
Q ss_pred cCCCCeEeccCCcCcCc----CCccccccCCCCEEEccCCcCCCCCCccccC-CCCcceEEeccCc
Q 001922 282 LTNLVNLDLSNNALTGE----IPYSFINLRQLKLFNLFMNRLHGSIPDYLAD-LPNLETLGLWQNN 342 (995)
Q Consensus 282 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~ 342 (995)
+++|++|+|+.|.|++. ++..+..+++|+.|+|++|.|+...-..+.. + ...+++++|+
T Consensus 278 ~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp GGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred CCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 45666666666666543 2223344566666666666655333222322 2 2446666665
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.81 E-value=5.6e-11 Score=124.77 Aligned_cols=143 Identities=19% Similarity=0.204 Sum_probs=89.3
Q ss_pred CceeeeEEeCCC--ceeeeecCC---CCccccCCc-cccCCCCCCeEeccCCcccCccc---cCcccccce--ecccccc
Q 001922 57 VCSWAGICCSRD--RVASLDLTD---LNLCGSVPA-QILRLDKLTNLSLAGNNFTGSIE---IGNLSSLQF--LNISNNQ 125 (995)
Q Consensus 57 ~C~w~gv~C~~~--~v~~l~l~~---~~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~---~~~l~~L~~--L~Ls~N~ 125 (995)
.|.|.|+.|..+ +|+.+...+ ..+.+.+++ .+..++. .|...+|.-++... +...+.|+. ++++.|+
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 588999999754 666554443 223333432 2222222 23444455454443 444455665 6777774
Q ss_pred cc---CCCccccccccccccccccccccccc--CCccccCCCCCceeeccCccccccCCccccCCC--CCceeeccCCcc
Q 001922 126 FS---GGLDWNYSSLVNLEVFDAYNNNFTAL--LPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQ--GLEYLSLAGNDL 198 (995)
Q Consensus 126 i~---~~~~~~~~~l~~L~~L~Ls~n~i~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l 198 (995)
.. +.......++++|+.|+|++|+|+++ +|..+..+++|++|+|++|+|++. ..+..+. +|++|+|++|.+
T Consensus 155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl 232 (267)
T 3rw6_A 155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL 232 (267)
T ss_dssp HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence 33 22233335678888888888888883 456777888899999999988754 3344444 888899999988
Q ss_pred cccCc
Q 001922 199 TGKIP 203 (995)
Q Consensus 199 ~~~~~ 203 (995)
.+.+|
T Consensus 233 ~~~~~ 237 (267)
T 3rw6_A 233 CDTFR 237 (267)
T ss_dssp GGGCS
T ss_pred ccccC
Confidence 86555
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.78 E-value=5.3e-10 Score=123.96 Aligned_cols=39 Identities=23% Similarity=0.418 Sum_probs=18.5
Q ss_pred CCCcceEEeccCccccc----CCCcccCCCCCCeEEecCceec
Q 001922 330 LPNLETLGLWQNNFTGV----IPENLGQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 330 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 368 (995)
+++|++|+|+.|.+++. ++..+..+++|+.|+|++|.|+
T Consensus 278 ~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp GGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 44555555555555432 1222233455555555555554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.74 E-value=4.5e-09 Score=114.50 Aligned_cols=186 Identities=19% Similarity=0.169 Sum_probs=121.3
Q ss_pred CCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCC--ceeEeEEEecCC---cceEEEEe
Q 001922 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRN--IVRLLAFCSNKE---TNLLVYEY 764 (995)
Q Consensus 691 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~~~~~~~~~~---~~~lv~e~ 764 (995)
.+.++.|.+..||++. ..+++|+... ......+.+|+++++.+. +.. +.+.+......+ ..|+||||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3568999999999863 4688888632 123567889999998883 322 334444443333 34899999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC--------------------------------------- 805 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------- 805 (995)
++|.++.+... ..++...+..++.++++.++.||+..
T Consensus 98 i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 98 IKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99988875432 23567777888889999888888611
Q ss_pred ----------------CCCeEecCCCCCCEEECC--CCCeEEeeeccccccccCCCCcccccc----cc---------Cc
Q 001922 806 ----------------SPLIVHRDVKSNNILLNS--AFEAHVADFGLAKFLIDGGASECMSAI----AG---------SY 854 (995)
Q Consensus 806 ----------------~~~iiHrDlkp~Nill~~--~~~vkl~DfGla~~~~~~~~~~~~~~~----~g---------t~ 854 (995)
...++|+|++|.||++++ ...+.|+||+.+..- +....-..... .+ ..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~-~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS-DPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE-CTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC-ChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 134899999999999998 456789999988642 11110000000 00 00
Q ss_pred cccc-ccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 001922 855 GYIA-PEYAYTLRVDEKSDVYSFGVVLLELLTGRRPV 890 (995)
Q Consensus 855 ~y~a-PE~~~~~~~~~~~DvwSlGvil~elltg~~Pf 890 (995)
++.. |+.... .....+.|++|.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1111 221111 123368999999999999998876
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.41 E-value=1e-08 Score=107.63 Aligned_cols=78 Identities=24% Similarity=0.343 Sum_probs=42.9
Q ss_pred hhhhccccccccccCC--CCCCccCcccccceeeccCCcccCCCcccccccc--ccCeEeccccccccccCc-------c
Q 001922 501 LRQVLKLDLSRNSLSG--EIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVR--ILNYLNLSRNHLNQNIPK-------S 569 (995)
Q Consensus 501 l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~--~L~~L~L~~N~l~~~~p~-------~ 569 (995)
+++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++. .++..+. +|++|+|++|++.+.+|. .
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i 246 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI 246 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence 4455555555555554 3344555566666666666666532 2344444 666666666666655542 2
Q ss_pred cccCCcccEEe
Q 001922 570 IGSMKSLTIAD 580 (995)
Q Consensus 570 ~~~l~~L~~l~ 580 (995)
+..+++|+.||
T Consensus 247 l~~~P~L~~LD 257 (267)
T 3rw6_A 247 RERFPKLLRLD 257 (267)
T ss_dssp HHHCTTCCEES
T ss_pred HHHCcccCeEC
Confidence 45566666665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=5.7e-08 Score=97.02 Aligned_cols=116 Identities=10% Similarity=-0.006 Sum_probs=83.9
Q ss_pred CCccccCCCCCCeEeccCC-cccCc--c----ccCcccccceeccccccccCCC----cccccccccccccccccccccc
Q 001922 84 VPAQILRLDKLTNLSLAGN-NFTGS--I----EIGNLSSLQFLNISNNQFSGGL----DWNYSSLVNLEVFDAYNNNFTA 152 (995)
Q Consensus 84 ~~~~~~~l~~L~~L~L~~n-~l~~~--~----~~~~l~~L~~L~Ls~N~i~~~~----~~~~~~l~~L~~L~Ls~n~i~~ 152 (995)
+...+...+.|++|+|++| .+... . .+...++|++|+|++|.|.... ...+...+.|++|+|++|.|..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 4445667788889999988 88642 1 3566788899999999887532 2334455778888888888876
Q ss_pred c----CCccccCCCCCceeec--cCcccccc----CCccccCCCCCceeeccCCccc
Q 001922 153 L----LPVGILKLEKLKYLDL--GGNYFFGK----IPNSYGELQGLEYLSLAGNDLT 199 (995)
Q Consensus 153 ~----~p~~~~~l~~L~~L~L--~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 199 (995)
. +...+...+.|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3 3456677788999999 78888754 3445556688999999988886
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.31 E-value=2.5e-08 Score=99.63 Aligned_cols=86 Identities=19% Similarity=0.245 Sum_probs=46.7
Q ss_pred hhhccccccccccCCC----CCCccCcccccceeeccCCcccCC----CccccccccccCeEec--cccccccc----cC
Q 001922 502 RQVLKLDLSRNSLSGE----IPPAIGYCNHLTYLDMSQNNLSGS----IPPEISNVRILNYLNL--SRNHLNQN----IP 567 (995)
Q Consensus 502 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----ip~~l~~l~~L~~L~L--~~N~l~~~----~p 567 (995)
++|++|+|++|.|... +...+...++|++|+|++|.|... +...+...+.|++|+| ++|.++.. +.
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 4455555555554321 222333445666666666666532 3445555566777777 66666543 23
Q ss_pred cccccCCcccEEeccCCCCC
Q 001922 568 KSIGSMKSLTIADFSFNDFS 587 (995)
Q Consensus 568 ~~~~~l~~L~~l~ls~N~l~ 587 (995)
..+...++|+.|+|++|.+.
T Consensus 145 ~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 145 NMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCcCEEeccCCCCC
Confidence 34444566777777776653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=5.7e-06 Score=88.10 Aligned_cols=135 Identities=16% Similarity=0.114 Sum_probs=96.8
Q ss_pred eeeccCce-EEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEEEeccCCC
Q 001922 693 VIGRGGAG-IVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVYEYMRNGS 769 (995)
Q Consensus 693 ~lG~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~gs 769 (995)
.+..|..| .||+.... ++..+++|+-. ......+.+|..+++.+. +--+.++++++.+++..|+|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~----~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGK----GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEE----THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECC----CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 35556665 68988654 46678898863 234566888999998884 3336678888888889999999999988
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 001922 770 LGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC-------------------------------------------- 805 (995)
Q Consensus 770 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-------------------------------------------- 805 (995)
+.+..... ......+..+++..+..||...
T Consensus 107 ~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 87765321 1223346667777777777510
Q ss_pred -----------CCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 806 -----------SPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 806 -----------~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
...++|+|+.+.||+++..+.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11278999999999999877778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=1.1e-05 Score=87.63 Aligned_cols=135 Identities=19% Similarity=0.193 Sum_probs=94.3
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCC---CceeEeEEEe-cCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHR---NIVRLLAFCS-NKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~-~~~~~~lv~e~~~~ 767 (995)
+.++.|....||+. |..+++|+.. .......+..|+++++.+.+. .+.+.+.+.. ..+..|+||||++|
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 46888999999997 5678888852 222356788999999999642 2456666663 45567899999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC------------------------------------------ 805 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------ 805 (995)
.++.+.... .++......++.++++.++.||+..
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888763211 1344455555666666666665421
Q ss_pred ---------------CCCeEecCCCCCCEEECC---CCCe-EEeeeccccc
Q 001922 806 ---------------SPLIVHRDVKSNNILLNS---AFEA-HVADFGLAKF 837 (995)
Q Consensus 806 ---------------~~~iiHrDlkp~Nill~~---~~~v-kl~DfGla~~ 837 (995)
...++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224699999999999987 4554 8999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1e-05 Score=89.92 Aligned_cols=81 Identities=5% Similarity=-0.018 Sum_probs=55.5
Q ss_pred Cee-eccCceEEEEEEeC-------CCcEEEEEEecCCC--CCChhHHHHHHHHHHhccC-C--CCceeEeEEEecC---
Q 001922 692 NVI-GRGGAGIVYHGKMP-------NGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIR-H--RNIVRLLAFCSNK--- 755 (995)
Q Consensus 692 ~~l-G~G~~g~V~~~~~~-------~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h--pniv~~~~~~~~~--- 755 (995)
+.| +.|....+|+.... +++.+++|...... .......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88889999998654 26688888753221 0101245788999998884 3 2466778777655
Q ss_pred CcceEEEEeccCCChhh
Q 001922 756 ETNLLVYEYMRNGSLGE 772 (995)
Q Consensus 756 ~~~~lv~e~~~~gsL~~ 772 (995)
+..|+||||++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=6.4e-05 Score=84.85 Aligned_cols=75 Identities=19% Similarity=0.204 Sum_probs=49.5
Q ss_pred CeeeccCceEEEEEEeC-CCcEEEEEEecCCCC------CChhHHHHHHHHHHhccCC--CCce-eEeEEEecCCcceEE
Q 001922 692 NVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT------HSHDHGFRAEIQTLGNIRH--RNIV-RLLAFCSNKETNLLV 761 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--pniv-~~~~~~~~~~~~~lv 761 (995)
+.+|.|.++.||+++.. +++.++||....... ....+++..|.++++.+.. |..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999754 468899998643211 1234567789999888742 4434 45543 34567899
Q ss_pred EEeccCC
Q 001922 762 YEYMRNG 768 (995)
Q Consensus 762 ~e~~~~g 768 (995)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.65 E-value=8e-06 Score=79.25 Aligned_cols=34 Identities=9% Similarity=-0.041 Sum_probs=14.2
Q ss_pred ccceeccccccccCCCcccccccccccccccccc
Q 001922 115 SLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNN 148 (995)
Q Consensus 115 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n 148 (995)
+|++|||+++.|+...-..+.++++|++|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 3555555555544333233333333333333333
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.63 E-value=1.1e-05 Score=78.28 Aligned_cols=84 Identities=13% Similarity=0.071 Sum_probs=55.1
Q ss_pred CCCCeEeccCCcCcCcCCccccccCCCCEEEccCCc-CCCCCCccccCC----CCcceEEeccCc-ccccCCCcccCCCC
Q 001922 283 TNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNR-LHGSIPDYLADL----PNLETLGLWQNN-FTGVIPENLGQNGK 356 (995)
Q Consensus 283 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~ 356 (995)
.+|+.||++++.|+...-..+.++++|+.|+|++|. |++..-..++.+ ++|++|+|++|. ++...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 467777777777776655666677777777777774 554433445543 357777777764 66544445666777
Q ss_pred CCeEEecCce
Q 001922 357 LQVLDLSSNK 366 (995)
Q Consensus 357 L~~L~L~~N~ 366 (995)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7777777764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00025 Score=78.11 Aligned_cols=138 Identities=15% Similarity=0.203 Sum_probs=79.1
Q ss_pred eeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-----CCCceeEe-E--EEecCCcceEEEEe
Q 001922 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-----HRNIVRLL-A--FCSNKETNLLVYEY 764 (995)
Q Consensus 693 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~-~--~~~~~~~~~lv~e~ 764 (995)
.++.|..+.||++...+| .+++|+... ....+..|..+++.+. .|.++... + +....+..++||||
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHR-----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECS-----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCC-----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 466678899999987554 589998843 1334555666666553 24443311 1 12235667899999
Q ss_pred ccCCChh--------------hhhcC--C-C--C-------CCCCHHHH-------------------------------
Q 001922 765 MRNGSLG--------------EALHG--K-K--G-------AFLGWNLR------------------------------- 787 (995)
Q Consensus 765 ~~~gsL~--------------~~l~~--~-~--~-------~~~~~~~~------------------------------- 787 (995)
++|.++. ..+|. . . . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 01111 0 0 0 01122211
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 788 YKIAIEAAKGLCYLHH----------DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 788 ~~i~~qi~~~l~~LH~----------~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
..+..++..++.+|++ .....++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666653 013459999999999999888899999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00025 Score=76.50 Aligned_cols=136 Identities=17% Similarity=0.159 Sum_probs=90.7
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC---CCCceeEeEEEecCCcceEEEEeccCC
Q 001922 692 NVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR---HRNIVRLLAFCSNKETNLLVYEYMRNG 768 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~~~g 768 (995)
+.|+.|....+|+... +++.+++|+... .....+..|+..++.+. ...+++++.+....+..++||||+++.
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINER----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEG----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCc----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 4689999999999976 567899998632 23566889999998884 356778888887778899999999987
Q ss_pred Chhh-----------hhcCCCC--------------------CCCCHHHHH---HHHH----------------HHHHHH
Q 001922 769 SLGE-----------ALHGKKG--------------------AFLGWNLRY---KIAI----------------EAAKGL 798 (995)
Q Consensus 769 sL~~-----------~l~~~~~--------------------~~~~~~~~~---~i~~----------------qi~~~l 798 (995)
.+.. .+|.... ..-+|...+ ++.. +++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6531 1221111 012454322 1111 111111
Q ss_pred -HHHHh-cCCCCeEecCCCCCCEEECCCCCeEEeeec
Q 001922 799 -CYLHH-DCSPLIVHRDVKSNNILLNSAFEAHVADFG 833 (995)
Q Consensus 799 -~~LH~-~~~~~iiHrDlkp~Nill~~~~~vkl~DfG 833 (995)
..|.. ...+.++|+|+.+.|++++.++ +.|.|++
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 1245699999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00056 Score=73.18 Aligned_cols=76 Identities=18% Similarity=0.185 Sum_probs=54.5
Q ss_pred CCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCC--C-CceeEeEEEecCCcceEEEEecc
Q 001922 690 DGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH--R-NIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 690 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--p-niv~~~~~~~~~~~~~lv~e~~~ 766 (995)
..+.+|.|..+.||+.+..||+.|++|+.... .......|..|+..++.+.- + -+.+++++. ..++||||++
T Consensus 19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~ 93 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVELADGTPLFVKALPDD-APALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVD 93 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEECCTT-CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCC
T ss_pred EEEecCCCCCeEEEEEEECCCCEEEEEEeCCC-CcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeec
Confidence 34568999999999999999999999986332 23334567889999988842 1 234445442 3489999998
Q ss_pred CCCh
Q 001922 767 NGSL 770 (995)
Q Consensus 767 ~gsL 770 (995)
++..
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0011 Score=75.12 Aligned_cols=79 Identities=13% Similarity=0.062 Sum_probs=47.1
Q ss_pred CCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccC---CCCcccchhhHHHHHHH
Q 001922 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL---RVDEKSDVYSFGVVLLE 882 (995)
Q Consensus 806 ~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~e 882 (995)
...++|||++|.|||++.++ ++++||+.+..-.+ ...-......-...|.+|+..... .-....++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p-~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM-GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECH-HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCch-HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34599999999999999876 99999998874211 100000000012346666654321 11223455577777787
Q ss_pred HHhC
Q 001922 883 LLTG 886 (995)
Q Consensus 883 lltg 886 (995)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.99 E-value=9e-05 Score=73.26 Aligned_cols=112 Identities=11% Similarity=0.059 Sum_probs=72.3
Q ss_pred ccCCCCCCeEeccCC-cccCc--c----ccCcccccceeccccccccCCCcc----ccccccccccccccccccccc---
Q 001922 88 ILRLDKLTNLSLAGN-NFTGS--I----EIGNLSSLQFLNISNNQFSGGLDW----NYSSLVNLEVFDAYNNNFTAL--- 153 (995)
Q Consensus 88 ~~~l~~L~~L~L~~n-~l~~~--~----~~~~l~~L~~L~Ls~N~i~~~~~~----~~~~l~~L~~L~Ls~n~i~~~--- 153 (995)
+.+-+.|++|+|++| +|... . .+..-+.|+.|+|++|+|...... .+..-+.|++|+|++|.|...
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 345567888888885 77531 1 355667888888888888744333 333456778888888887653
Q ss_pred -CCccccCCCCCceeeccCc---cccc----cCCccccCCCCCceeeccCCccc
Q 001922 154 -LPVGILKLEKLKYLDLGGN---YFFG----KIPNSYGELQGLEYLSLAGNDLT 199 (995)
Q Consensus 154 -~p~~~~~l~~L~~L~L~~N---~l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 199 (995)
+-.++..-+.|++|+|++| .+.. .+...+..-+.|+.|+++.|.+.
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 2234455567888888755 3332 23445556677888888877654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.00017 Score=71.24 Aligned_cols=92 Identities=12% Similarity=0.081 Sum_probs=51.5
Q ss_pred ccccCcCCCCeEeccCCcCcCcCCc----cccccCCCCEEEccCCcCCCC----CCccccCCCCcceEEeccC---cccc
Q 001922 277 KQLGNLTNLVNLDLSNNALTGEIPY----SFINLRQLKLFNLFMNRLHGS----IPDYLADLPNLETLGLWQN---NFTG 345 (995)
Q Consensus 277 ~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N---~l~~ 345 (995)
+++..-+.|+.|+|++|.|.+.... .+..-+.|+.|+|++|.|... +-+.+..-+.|++|+|++| .+..
T Consensus 64 ~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~ 143 (197)
T 1pgv_A 64 EAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGN 143 (197)
T ss_dssp HHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCH
T ss_pred HHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCH
Confidence 3444556666777777766643322 233446677777777776643 2233444556777777654 3332
Q ss_pred ----cCCCcccCCCCCCeEEecCceec
Q 001922 346 ----VIPENLGQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 346 ----~~p~~~~~l~~L~~L~L~~N~l~ 368 (995)
.+...+...+.|+.|+++.|.+.
T Consensus 144 ~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 144 QVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 12334555667777777766543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0036 Score=69.27 Aligned_cols=140 Identities=14% Similarity=0.169 Sum_probs=83.4
Q ss_pred CeeeccCceEEEEEEeC--------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEE
Q 001922 692 NVIGRGGAGIVYHGKMP--------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.+..|-...+|++... +++.+++|+.-. .......+.+|..+++.+. +.-..++++++.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 45677888999999864 257889988522 1223556778999998884 3334566776654 2899
Q ss_pred EeccCCChhhh-----------------hcCCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 001922 763 EYMRNGSLGEA-----------------LHGKK---GAFLG--WNLRYKIAIEAAK-------------------GLCYL 801 (995)
Q Consensus 763 e~~~~gsL~~~-----------------l~~~~---~~~~~--~~~~~~i~~qi~~-------------------~l~~L 801 (995)
||++|.++... +|... +.... +.+..++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665421 11111 11122 3444455544321 22333
Q ss_pred ----HhcC-CCCeEecCCCCCCEEECCC----CCeEEeeeccccc
Q 001922 802 ----HHDC-SPLIVHRDVKSNNILLNSA----FEAHVADFGLAKF 837 (995)
Q Consensus 802 ----H~~~-~~~iiHrDlkp~Nill~~~----~~vkl~DfGla~~ 837 (995)
.... ...++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2221 2348999999999999876 7899999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0022 Score=70.09 Aligned_cols=139 Identities=15% Similarity=0.122 Sum_probs=71.4
Q ss_pred eeeccCceE-EEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCC--CceeEeEEEecCCcceEEEEeccCCC
Q 001922 693 VIGRGGAGI-VYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHR--NIVRLLAFCSNKETNLLVYEYMRNGS 769 (995)
Q Consensus 693 ~lG~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~~~~~~~lv~e~~~~gs 769 (995)
.++.|+... +|+....+++.+++|...... .+.+..|+.+++.+... .+.+++.+..+ .-+++||++.+..
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~ 98 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDAL 98 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCB
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcc
Confidence 455565554 677765447778777643221 12345677777776422 24456655332 2378999997766
Q ss_pred hhhhhcC---------------------CCC---CCCCHHHHH-------HH-------------HHHHHHHHHHHH---
Q 001922 770 LGEALHG---------------------KKG---AFLGWNLRY-------KI-------------AIEAAKGLCYLH--- 802 (995)
Q Consensus 770 L~~~l~~---------------------~~~---~~~~~~~~~-------~i-------------~~qi~~~l~~LH--- 802 (995)
+.+.+.. ... ...+..... .+ ...+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 6443321 000 111211100 00 001112222221
Q ss_pred hcCCCCeEecCCCCCCEEECCC----CCeEEeeeccccc
Q 001922 803 HDCSPLIVHRDVKSNNILLNSA----FEAHVADFGLAKF 837 (995)
Q Consensus 803 ~~~~~~iiHrDlkp~Nill~~~----~~vkl~DfGla~~ 837 (995)
......++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123459999999999999875 6789999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0038 Score=70.74 Aligned_cols=72 Identities=14% Similarity=0.195 Sum_probs=49.7
Q ss_pred CeeeccCceEEEEEEeCC--------CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCC-ceeEeEEEecCCcceEEE
Q 001922 692 NVIGRGGAGIVYHGKMPN--------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN-IVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~ 762 (995)
+.|+.|....||++...+ ++.+++|+.... ...+.+..|..+++.+...+ ..++++.+.+ .+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 457889999999998653 578999987321 11245668999998885333 3566666543 3899
Q ss_pred EeccCCCh
Q 001922 763 EYMRNGSL 770 (995)
Q Consensus 763 e~~~~gsL 770 (995)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0048 Score=66.34 Aligned_cols=71 Identities=10% Similarity=0.066 Sum_probs=45.1
Q ss_pred CCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCc-eeEeEEEecCCcceEEEEec-cCC
Q 001922 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI-VRLLAFCSNKETNLLVYEYM-RNG 768 (995)
Q Consensus 691 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~-~~g 768 (995)
.+.++.|....+|++ +.+++|+....... .....+|+.+++.+....+ .+++++ +.+..++|+||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 567899999999998 56888887432111 1123568888877743233 345544 344558999999 665
Q ss_pred Ch
Q 001922 769 SL 770 (995)
Q Consensus 769 sL 770 (995)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0018 Score=70.40 Aligned_cols=142 Identities=13% Similarity=0.127 Sum_probs=78.4
Q ss_pred CeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCC--ceeEeEE------EecCCcceEEEE
Q 001922 692 NVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN--IVRLLAF------CSNKETNLLVYE 763 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~------~~~~~~~~lv~e 763 (995)
+.++.|....+|+....+| .+++|..... ...+.+..|+.+++.+.... +.+++.. ....+..+++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~---~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR---VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC---CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 3467788899999987655 6889987432 12344667888877774212 2222211 122355689999
Q ss_pred eccCCChhh--------------hhcCC----CCC---CC---CHHHHHH------------HHHHHHHHHHHHHhc---
Q 001922 764 YMRNGSLGE--------------ALHGK----KGA---FL---GWNLRYK------------IAIEAAKGLCYLHHD--- 804 (995)
Q Consensus 764 ~~~~gsL~~--------------~l~~~----~~~---~~---~~~~~~~------------i~~qi~~~l~~LH~~--- 804 (995)
|++|..+.. .+|.. ... .. .|...+. +...+...+.++++.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 999865421 01110 000 01 1221100 001234445555532
Q ss_pred -CCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 805 -CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 805 -~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
....++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 123499999999999999876668999997753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.49 E-value=0.016 Score=65.85 Aligned_cols=73 Identities=16% Similarity=0.122 Sum_probs=47.1
Q ss_pred CeeeccCceEEEEEEeCC-CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCc-eeEeEEEecCCcceEEEEeccCCC
Q 001922 692 NVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI-VRLLAFCSNKETNLLVYEYMRNGS 769 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~gs 769 (995)
+.|+.|-...+|++...+ +..+++|+..... .. ......|..+++.+...++ .++++++.. .+||||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 468889999999998765 4788888763321 11 1112578888888864444 566776632 35999998755
Q ss_pred h
Q 001922 770 L 770 (995)
Q Consensus 770 L 770 (995)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.43 E-value=0.011 Score=64.16 Aligned_cols=140 Identities=15% Similarity=0.117 Sum_probs=80.5
Q ss_pred eeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCC--ceeEeEE-----EecCCcceEEEEec
Q 001922 693 VIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN--IVRLLAF-----CSNKETNLLVYEYM 765 (995)
Q Consensus 693 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~-----~~~~~~~~lv~e~~ 765 (995)
.++ |....||++...+|+.+++|...... .....+..|..+++.+.... +++++.. ....+..++||+|+
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 466 88889999887778789999984321 23556777888888774222 3333332 12234557899999
Q ss_pred cCCChhh----h----------hcC----CC---CCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 001922 766 RNGSLGE----A----------LHG----KK---GAFLGWNLR----YKI---------------AIEAAKGLCYLHHD- 804 (995)
Q Consensus 766 ~~gsL~~----~----------l~~----~~---~~~~~~~~~----~~i---------------~~qi~~~l~~LH~~- 804 (995)
+|.++.. . +|. .. ....++... ..+ ...+...+..+.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8755421 0 110 00 011222111 001 11111222233221
Q ss_pred ---CCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 805 ---CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 805 ---~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
....++|||+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 133488999999999999 4 899999998753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0032 Score=58.04 Aligned_cols=55 Identities=25% Similarity=0.315 Sum_probs=27.3
Q ss_pred cccccccccC-CCCCCccCcccccceeeccCCcccCCCccccccccccCeEecccccc
Q 001922 506 KLDLSRNSLS-GEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHL 562 (995)
Q Consensus 506 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l 562 (995)
.++.+++.|+ ..+|..+. ++|++|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4445555553 23443321 2455556666666533334455555555555555555
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.07 E-value=0.009 Score=54.98 Aligned_cols=37 Identities=27% Similarity=0.253 Sum_probs=19.6
Q ss_pred CcceEEeccCcccccCCCcccCCCCCCeEEecCceec
Q 001922 332 NLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 332 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 368 (995)
+|+.|+|++|+|+.+.+..|..+++|++|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 3555555555555444444555555555555555543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.07 E-value=0.019 Score=62.79 Aligned_cols=31 Identities=16% Similarity=0.359 Sum_probs=27.4
Q ss_pred CCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 807 ~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4499999999999999888899999987764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.04 E-value=0.01 Score=65.77 Aligned_cols=73 Identities=10% Similarity=0.051 Sum_probs=43.4
Q ss_pred CeeeccCceEEEEEEeCC---------CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCC-ceeEeEEEecCCcceEE
Q 001922 692 NVIGRGGAGIVYHGKMPN---------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN-IVRLLAFCSNKETNLLV 761 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv 761 (995)
+.++.|....+|++...+ ++.+++|+..... ........|..+++.+...+ +.++++.+. .++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence 357788889999997654 2678888763211 11112467888888875333 345665442 3789
Q ss_pred EEeccCCCh
Q 001922 762 YEYMRNGSL 770 (995)
Q Consensus 762 ~e~~~~gsL 770 (995)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.69 E-value=0.02 Score=56.73 Aligned_cols=103 Identities=17% Similarity=0.103 Sum_probs=66.4
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCccc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 847 (995)
-+|.+++. ..+.+++++++|.++.|.+.+|.-.-... .+ ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~-~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILR-LYNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHH-HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 37888887 45678999999999999999987762211 01 1222356889999999888763 1110
Q ss_pred cccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 001922 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889 (995)
Q Consensus 848 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~P 889 (995)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888653 3456788999999999999874443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.22 E-value=0.18 Score=56.34 Aligned_cols=73 Identities=11% Similarity=0.040 Sum_probs=47.9
Q ss_pred CeeeccCceEEEEEEeCC--------CcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEE
Q 001922 692 NVIGRGGAGIVYHGKMPN--------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.+..|-...+|+....+ ++.+++++.... .. ......+|..+++.+. +.-..++++.+. .++||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 457778899999998753 578888886322 11 1122457888888884 333445555442 37899
Q ss_pred EeccCCCh
Q 001922 763 EYMRNGSL 770 (995)
Q Consensus 763 e~~~~gsL 770 (995)
||++|.++
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.99 E-value=1.5 Score=48.68 Aligned_cols=29 Identities=28% Similarity=0.517 Sum_probs=24.9
Q ss_pred eEecCCCCCCEEE------CCCCCeEEeeeccccc
Q 001922 809 IVHRDVKSNNILL------NSAFEAHVADFGLAKF 837 (995)
Q Consensus 809 iiHrDlkp~Nill------~~~~~vkl~DfGla~~ 837 (995)
++|+|+.+.||++ +++..++++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 995 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-28 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-06 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-08 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 9e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 4e-68
Identities = 76/277 (27%), Positives = 118/277 (42%), Gaps = 19/277 (6%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
G IG G G VY GK V + + + F+ E+ L RH NI+ +
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMG 71
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
+ + + +V ++ SL LH + F IA + A+G+ YLH I+
Sbjct: 72 YSTAPQL-AIVTQWCEGSSLYHHLHIIETKF-EMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR---V 867
HRD+KSNNI L+ + DFGLA S ++GS ++APE
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 868 DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927
+SDVY+FG+VL EL+TG+ P + + I+ R L P LS V
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG----------YLSPDLSKVRS 236
Query: 928 EEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964
+ + C+++ ERP +++ + R
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 6e-64
Identities = 72/276 (26%), Positives = 120/276 (43%), Gaps = 21/276 (7%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
E +K +G G G V+ G ++AVK L F AE + ++H+ +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRL 70
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
VRL A + + ++ EYM NGSL + L G L N +A + A+G+ ++
Sbjct: 71 VRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
+HRD+++ NIL++ +ADFGLA+ + D + APE
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYG 185
Query: 866 RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925
KSDV+SFG++L E++T R +++Q +R + +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP--------- 236
Query: 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961
EE L+ LC +E +RP + +L +F
Sbjct: 237 --EELYQLM---RLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-59
Identities = 73/276 (26%), Positives = 113/276 (40%), Gaps = 21/276 (7%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI 745
E ++ +G+G G V+ G +A+K L F E Q + +RH +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
V+L A S + +V EYM GSL + L G+ G +L +A + A G+ Y+
Sbjct: 75 VQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
VHRD+++ NIL+ VADFGLA+ I+ + APE A
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 866 RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925
R KSDV+SFG++L EL T R +++ +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--------------VERGYRMPC 235
Query: 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961
P E L + C ++ ERP + L ++
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 6e-59
Identities = 58/270 (21%), Positives = 114/270 (42%), Gaps = 21/270 (7%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
IG G G+V+ G N ++A+K + + F E + + + H +V+L
Sbjct: 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
C + LV+E+M +G L + + + ++ +G+ YL C ++
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEK 870
HRD+ + N L+ V+DFG+ +F++D + + +PE R K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSK 182
Query: 871 SDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEA 930
SDV+SFGV++ E+ + + + ++V+ I P+ +
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--------------ISTGFRLYKPRLAS 228
Query: 931 MHLLFVAMLCIQENSIERPRMREVVQMLSE 960
H+ + C +E +RP +++ L+E
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-58
Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 31/288 (10%)
Query: 678 EFSVSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTL 737
++ ++ K IG+G G V G G ++AVK + + F AE +
Sbjct: 3 ALNMKEL----KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK---NDATAQAFLAEASVM 54
Query: 738 GNIRHRNIVRLLAFCSNKETNL-LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAK 796
+RH N+V+LL ++ L +V EYM GSL + L + + LG + K +++ +
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 797 GLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGY 856
+ YL + VHRD+ + N+L++ A V+DFGL K S +
Sbjct: 115 AMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKW 166
Query: 857 IAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916
APE + KSDV+SFG++L E+ + R + + R G K +
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEKGYKMDAPD 223
Query: 917 ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964
P + V C ++ RP ++ + L H
Sbjct: 224 GCPPAVYE-----------VMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (504), Expect = 1e-57
Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 25/296 (8%)
Query: 678 EFSVSDILECVKDGNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFGTHSHDHGFRAE 733
EF+ + CVK VIG G G V G + + +A+K L T F +E
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE 77
Query: 734 IQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIE 793
+G H N++ L + +++ E+M NGSL L G F +
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVGMLRG 136
Query: 794 AAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGS 853
A G+ YL VHRD+ + NIL+NS V+DFGL++FL D + ++ G
Sbjct: 137 IAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193
Query: 854 YG---YIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGR 910
+ APE + SDV+S+G+V+ E+++ D++ ++
Sbjct: 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ----- 248
Query: 911 KEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966
D RL P + L + + C Q++ RP+ ++V L + R+ +
Sbjct: 249 --------DYRLPP-PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (503), Expect = 2e-57
Identities = 67/315 (21%), Positives = 117/315 (37%), Gaps = 49/315 (15%)
Query: 674 FQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPN------GVEIAVKKLLGFGTHSHD 727
LE+ ++I + IG G G V+ + P +AVK L +
Sbjct: 5 LLSLEYPRNNI----EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 728 HGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAF------ 781
F+ E + + NIV+LL C+ + L++EYM G L E L
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 782 ----------------LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF 825
L + IA + A G+ YL VHRD+ + N L+
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENM 177
Query: 826 EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT 885
+ADFGL++ + + A ++ PE + R +SDV+++GVVL E+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 886 GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENS 945
+++ + + D + P+ + L + LC +
Sbjct: 238 YGLQPYYGMAHEEVIYY--------------VRDGNILACPENCPLELYNLMRLCWSKLP 283
Query: 946 IERPRMREVVQMLSE 960
+RP + ++L
Sbjct: 284 ADRPSFCSIHRILQR 298
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 5e-57
Identities = 73/293 (24%), Positives = 109/293 (37%), Gaps = 29/293 (9%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
IG+G G V+ GK G E+AVK AEI +RH NI+ +A
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIA 64
Query: 751 FCSNKETNL----LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC- 805
+ LV +Y +GSL + L+ + K+A+ A GL +LH +
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 806 ----SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG--ASECMSAIAGSYGYIAP 859
P I HRD+KS NIL+ +AD GLA + G+ Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 860 EYAYT------LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG----VDIVQWSKRATNG 909
E +++D+Y+ G+V E+ G D D+V
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 910 RKEEFLSILDPRL--SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
RK L P + E + + C N R + + LS+
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 5e-57
Identities = 81/322 (25%), Positives = 129/322 (40%), Gaps = 28/322 (8%)
Query: 667 DSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPN----GVEIAVKKLLGFG 722
+ + A Q + S ++ V VIGRG G VYHG + + + AVK L
Sbjct: 10 NPELVQAVQHVVIGPSSLI--VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 67
Query: 723 THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN-LLVYEYMRNGSLGEALHGKKGAF 781
F E + + H N++ LL C E + L+V YM++G L +
Sbjct: 68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHN 126
Query: 782 LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841
++ AKG+ +L VHRD+ + N +L+ F VADFGLA+ + D
Sbjct: 127 PTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183
Query: 842 GASE--CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDI 899
+ ++A E T + KSDV+SFGV+L EL+T P V+
Sbjct: 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVNT 240
Query: 900 VQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959
+ GR+ P+ L V + C + RP E+V +S
Sbjct: 241 FDITVYLLQGRRLLQ-----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
Query: 960 E-FPRHSSDFNQSSSSSLKNLE 980
F + +++ N++
Sbjct: 290 AIFSTFIGEHYVHVNATYVNVK 311
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 6e-57
Identities = 64/270 (23%), Positives = 111/270 (41%), Gaps = 10/270 (3%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
+ +G G G+V+ P+G+ +A K + + + E+Q L IV
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
+ + E+M GSL + L + + K++I KGL YL I+
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHK--IM 127
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEK 870
HRDVK +NIL+NS E + DFG++ LID A+ + G+ Y++PE +
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQ 183
Query: 871 SDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEA 930
SD++S G+ L+E+ GR P+ D ++ G E +
Sbjct: 184 SDIWSMGLSLVEMAVGRYPI-PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 931 MHLLFVAMLCIQENSIERPRMREVVQMLSE 960
+A+ + + + P + + S
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSL 272
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-56
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 24/289 (8%)
Query: 686 ECVKDGNVIGRGGAGIVYHGKMPNG-----VEIAVKKLLGFGTHSHDHGFRAEIQTLGNI 740
CV VIG G G VY G + V +A+K L T F E +G
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 741 RHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
H NI+RL S + +++ EYM NG+L + +K + A G+ Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG-ASECMSAIAGSYGYIAP 859
L + VHRD+ + NIL+NS V+DFGL++ L D A+ S + AP
Sbjct: 126 LANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919
E + SDV+SFG+V+ E++T ++++ I D
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA--------------IND 228
Query: 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDF 968
P + + + M C Q+ RP+ ++V +L + R
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-56
Identities = 52/270 (19%), Positives = 111/270 (41%), Gaps = 21/270 (7%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
+G G G+V +GK ++A+K + + F E + + N+ H +V+L
Sbjct: 9 LKELGTGQFGVVKYGKWRGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
C+ + ++ EYM NG L L + F ++ + + + YL +
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMRHRF-QTQQLLEMCKDVCEAMEYLESKQ---FL 122
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEK 870
HRD+ + N L+N V+DFGL+++++D + + PE + K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 871 SDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEA 930
SD+++FGV++ E+ + + + + ++ G + + ++
Sbjct: 182 SDIWAFGVLMWEIYSLGKM---PYERFTNSETAEHIAQGLRLYRPHLASEKVYT------ 232
Query: 931 MHLLFVAMLCIQENSIERPRMREVVQMLSE 960
+ C E + ERP + ++ + +
Sbjct: 233 -----IMYSCWHEKADERPTFKILLSNILD 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (488), Expect = 1e-55
Identities = 70/294 (23%), Positives = 117/294 (39%), Gaps = 25/294 (8%)
Query: 674 FQKLEFSVSDILECVKDGNVIGRGGAGIVYHGKMPN-GVEIAVKKLLGFGTHSHDHGFRA 732
+ K E +DI + +G G G VY G + +AVK L F
Sbjct: 9 YDKWEMERTDI----TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLK 62
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAI 792
E + I+H N+V+LL C+ + ++ E+M G+L + L + + +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
+ + + YL +HRD+ + N L+ VADFGL++ + G +
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKF 178
Query: 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912
+ APE + KSDV++FGV+L E+ T G+D+ Q + +
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQVYELLEKDYRM 235
Query: 913 EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966
E P+ + + C Q N +RP E+ Q + SS
Sbjct: 236 ER-----------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 6e-55
Identities = 67/317 (21%), Positives = 119/317 (37%), Gaps = 45/317 (14%)
Query: 675 QKLEFSVSDILECVKDGNVIGRGGAGIVYHG------KMPNGVEIAVKKLLGFGTHSHDH 728
K EF + + G +G G G V K + +AVK L +
Sbjct: 16 HKWEFPRNRL----SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE 71
Query: 729 GFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAF------ 781
+E++ L + H NIV LL C+ L++ EY G L L K+ +F
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 782 ----------LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVAD 831
L + + AKG+ +L +HRD+ + NILL + D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188
Query: 832 FGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVG 891
FGLA+ + + ++APE + +SDV+S+G+ L EL +
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 892 DFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV-PKEEAMHLLFVAMLCIQENSIERPR 950
+F ++ M+ P+ + + C + ++RP
Sbjct: 249 PGMP--------------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT 294
Query: 951 MREVVQMLSEFPRHSSD 967
+++VQ++ + S++
Sbjct: 295 FKQIVQLIEKQISESTN 311
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-54
Identities = 64/272 (23%), Positives = 111/272 (40%), Gaps = 23/272 (8%)
Query: 694 IGRGGAGIVYHGKM---PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
+G G G V G +++A+K L + E Q + + + IVRL+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
C + +LV E G L + L GK+ + + ++ + + G+ YL V
Sbjct: 77 VCQAEAL-MLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN---FV 131
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLI-DGGASECMSAIAGSYGYIAPEYAYTLRVDE 869
HRD+ + N+LL + A ++DFGL+K L D SA + APE +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 870 KSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEE 929
+SDV+S+GV + E L+ + G +++ + ++ G++ E P L
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPPECPPELYA----- 243
Query: 930 AMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961
+ C +RP V Q +
Sbjct: 244 ------LMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 8e-54
Identities = 61/274 (22%), Positives = 107/274 (39%), Gaps = 25/274 (9%)
Query: 691 GNVIGRGGAGIVYHGKM-PNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRL 748
IG G G + +G + K+L G T + +E+ L ++H NIVR
Sbjct: 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 68
Query: 749 LAFCSNKETNLL--VYEYMRNGSLGEALH--GKKGAFLGWNLRYKIAIEAAKGLCYLH-- 802
++ L V EY G L + K+ +L ++ + L H
Sbjct: 69 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYA 862
D ++HRD+K N+ L+ + DFGLA+ L + A G+ Y++PE
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSPEQM 186
Query: 863 YTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922
+ +EKSD++S G +L EL P + + + G+ + R
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPF----TAFSQKELAGKIREGKFRR----IPYRY 238
Query: 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
S +E ++ + RP + E+++
Sbjct: 239 S----DELNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-53
Identities = 69/320 (21%), Positives = 117/320 (36%), Gaps = 48/320 (15%)
Query: 667 DSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHG------KMPNGVEIAVKKLLG 720
D + K EF ++ + G V+G G G V + K +++AVK L
Sbjct: 22 DFREYEYDLKWEFPRENL----EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE 77
Query: 721 FGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKG 779
S +E++ + + H NIV LL C+ L++EY G L L K+
Sbjct: 78 KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKRE 137
Query: 780 AF---------------------LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNN 818
F L + A + AKG+ +L VHRD+ + N
Sbjct: 138 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARN 194
Query: 819 ILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGV 878
+L+ + DFGLA+ ++ ++APE + KSDV+S+G+
Sbjct: 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 254
Query: 879 VLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAM 938
+L E+ + + + K NG K + + + +
Sbjct: 255 LLWEIFSLGVN--PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYI-----------IMQ 301
Query: 939 LCIQENSIERPRMREVVQML 958
C +S +RP + L
Sbjct: 302 SCWAFDSRKRPSFPNLTSFL 321
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 2e-53
Identities = 75/273 (27%), Positives = 119/273 (43%), Gaps = 28/273 (10%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRL 748
IGRG VY G VE+A +L T S F+ E + L ++H NIVR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 749 LAFC----SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
K+ +LV E M +G+L L K + + + KGL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR 131
Query: 805 CSPLIVHRDVKSNNILLNSA-FEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAY 863
P I+HRD+K +NI + + D GLA + A+ G+ ++APE Y
Sbjct: 132 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEM-Y 185
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923
+ DE DVY+FG+ +LE+ T P + + + Q +R T+G +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTSG-------VKPASFD 235
Query: 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
V E ++ CI++N ER +++++
Sbjct: 236 KVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-53
Identities = 63/278 (22%), Positives = 107/278 (38%), Gaps = 27/278 (9%)
Query: 690 DGNVIGRGGAGIVYHGKMPN---GVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNI 745
+ +G G G V G +AVK L + AE + + + I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 746 VRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC 805
VR++ C E+ +LV E G L + L + + ++ + + G+ YL
Sbjct: 71 VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN 127
Query: 806 SPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG-GASECMSAIAGSYGYIAPEYAYT 864
VHRD+ + N+LL + A ++DFGL+K L + + + APE
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 865 LRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923
+ KSDV+SFGV++ E + G++P G+ + + G + +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPY----RGMKGSEVTAMLEKGERMGCPAGCPR--- 237
Query: 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961
E L+ LC + RP V L +
Sbjct: 238 -----EMYDLM---NLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (467), Expect = 2e-52
Identities = 78/325 (24%), Positives = 132/325 (40%), Gaps = 39/325 (12%)
Query: 679 FSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEIQ 735
F D + D IG G G VY + + N +A+KK+ G S++ E++
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 736 TLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAA 795
L +RH N ++ + T LV EY + KK L + A
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGAL 125
Query: 796 KGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYG 855
+GL YLH S ++HRDVK+ NILL+ + DFG A + ++ G+
Sbjct: 126 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPY 176
Query: 856 YIAPEYAYTL---RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912
++APE + + D K DV+S G+ +EL + P + + A N
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQN---- 229
Query: 913 EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ---MLSEFPRHS-SDF 968
E ++ S E + + C+Q+ +RP +++ +L E P D
Sbjct: 230 ESPALQSGHWS----EYFRNFV---DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 282
Query: 969 NQSSSSSLKNLEKDPKGCPNNKLKQ 993
Q + +++ L+ K+K+
Sbjct: 283 IQRTKDAVRELDNLQY----RKMKK 303
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-52
Identities = 65/297 (21%), Positives = 114/297 (38%), Gaps = 24/297 (8%)
Query: 689 KDGNVIGRGGAGIVYHGKMPN-----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHR 743
K V+G G G VY G + +A+K+L + + E + ++ +
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71
Query: 744 NIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH 803
++ RLL C T L+ + M G L + + K G ++ AKG+ YL
Sbjct: 72 HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLED 129
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAY 863
+VHRD+ + N+L+ + + DFGLAK L ++A E
Sbjct: 130 RR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923
+SDV+S+GV + EL+T DG+ + S G +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPASEISSILEKGERLPQ--------- 234
Query: 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQSSSSSLKNLE 980
P + + + + C ++ RP+ RE++ S+ R + +L
Sbjct: 235 --PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 7e-52
Identities = 69/269 (25%), Positives = 112/269 (41%), Gaps = 28/269 (10%)
Query: 691 GNVIGRGGAGIVYHGKMP-NGVEIAVKKLL--GFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
G +G+G G VY + + +A+K L +H R E++ ++RH NI+R
Sbjct: 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
L + + L+ EY G++ L E A L Y H S
Sbjct: 71 LYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SK 125
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
++HRD+K N+LL SA E +ADFG + + + G+ Y+ PE
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEMIEGRMH 181
Query: 868 DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927
DEK D++S GV+ E L G+ P + + KR + ++
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFT-----FPDFVT---- 228
Query: 928 EEAMHLLFVAMLCIQENSIERPRMREVVQ 956
E A L+ ++ N +RP +REV++
Sbjct: 229 EGARDLI---SRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-51
Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 38/300 (12%)
Query: 691 GNVIGRGGAGIVYHGKMPNG---VEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIV 746
+VIG G G V ++ ++ A+K++ + + F E++ L + H NI+
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGK--------------KGAFLGWNLRYKIAI 792
LL C ++ L EY +G+L + L + L A
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 793 EAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAG 852
+ A+G+ YL +HRD+ + NIL+ + A +ADFGL++
Sbjct: 135 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG---RL 188
Query: 853 SYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKE 912
++A E SDV+S+GV+L E+++ G+ + ++ G +
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGMTCAELYEKLPQGYRL 245
Query: 913 EFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQSS 972
E D E L+ C +E ERP +++ L+ + ++
Sbjct: 246 EKPLNCDD--------EVYDLM---RQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 294
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-51
Identities = 57/268 (21%), Positives = 92/268 (34%), Gaps = 20/268 (7%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
+G G G V +AVK + + EI + H N+V+
Sbjct: 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLI 809
L EY G L + + G + + + G+ YLH I
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 810 VHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVD- 868
HRD+K N+LL+ ++DFGLA ++ + G+ Y+APE
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 869 EKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPKE 928
E DV+S G+VL +L G P ++S +D
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKIDS-------- 234
Query: 929 EAMHLLFVAMLCIQENSIERPRMREVVQ 956
+ LL + EN R + ++ +
Sbjct: 235 APLALL---HKILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 66/277 (23%), Positives = 106/277 (38%), Gaps = 25/277 (9%)
Query: 691 GNVIGRGGAGIVYHGKMP----NGVEIAVKKLLGFGTHSHD--HGFRAEIQTLGNIRHRN 744
+G G G+V G+ V +AVK L + F E+ + ++ HRN
Sbjct: 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
++RL +V E GSL + L +G FL + A++ A+G+ YL
Sbjct: 73 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESK 130
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS-AIAGSYGYIAPEYAY 863
+HRD+ + N+LL + + DFGL + L M + + APE
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 864 TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923
T SD + FGV L E+ T + +G I+ + RL
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE------------GERLP 235
Query: 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
P++ + V + C +RP + L E
Sbjct: 236 R-PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-50
Identities = 64/275 (23%), Positives = 100/275 (36%), Gaps = 24/275 (8%)
Query: 691 GNVIGRGGAGIVYHGKMPN----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIV 746
G IG G G V+ G + + +A+K + S F E T+ H +IV
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
+L+ + ++ E G L + + L A + + L YL
Sbjct: 72 KLIGVITENPV-WIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
VHRD+ + N+L++S + DFGL++++ D S ++APE R
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRR 185
Query: 867 VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926
SDV+ FGV + E+L GV R NG + P L
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS-- 240
Query: 927 KEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961
+ C + RPR E+ LS
Sbjct: 241 ---------LMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (453), Expect = 4e-50
Identities = 63/299 (21%), Positives = 115/299 (38%), Gaps = 23/299 (7%)
Query: 661 FKKTGSDSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLL 719
+ D WK Q +E +L+ +G G G+V+ G A K ++
Sbjct: 1 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 60
Query: 720 GFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKG 779
S R EIQT+ +RH +V L + +++YE+M G L E + +
Sbjct: 61 -TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 119
Query: 780 AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKF 837
+ + + + KGLC++H + VH D+K NI+ + + DFGL
Sbjct: 120 K-MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175
Query: 838 LIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV 897
L + + G+ + APE A V +D++S GV+ LL+G P G
Sbjct: 176 LDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF----GGE 228
Query: 898 DIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
+ + + + +S E+ + + + R + + ++
Sbjct: 229 NDDETLRNVKSC-DWNMDDSAFSGIS----EDGKDFI---RKLLLADPNTRMTIHQALE 279
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 4e-49
Identities = 56/271 (20%), Positives = 105/271 (38%), Gaps = 24/271 (8%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
+G G G VY + +A K++ + + EI L + H NIV+LL
Sbjct: 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 76
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
+ ++ E+ G++ +A+ + L + + + L YLH I+
Sbjct: 77 AFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKII 132
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL----- 865
HRD+K+ NIL + +ADFG++ + + G+ ++APE
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 866 RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925
D K+DV+S G+ L+E+ P ++ ++ + R S
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPH----HELNPMRVLLKIAKSEPPTL--AQPSRWS-- 242
Query: 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
L C+++N R +++Q
Sbjct: 243 --SNFKDFL---KKCLEKNVDARWTTSQLLQ 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 4e-49
Identities = 65/305 (21%), Positives = 114/305 (37%), Gaps = 40/305 (13%)
Query: 679 FSVSDI---------LECVKDGNVIGRGGAGIVYHG------KMPNGVEIAVKKLLGFGT 723
FS +D+ E + +G+G G+VY G K +A+K + +
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63
Query: 724 HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAF-- 781
F E + ++VRLL S + L++ E M G L L + A
Sbjct: 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123
Query: 782 ------LGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLA 835
+ ++A E A G+ YL+ + VHRD+ + N ++ F + DFG+
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 836 KFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGD 895
+ + + +++PE SDV+SFGVVL E+ T
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240
Query: 896 GVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVV 955
++++ +++ L P L + +C Q N RP E++
Sbjct: 241 NEQVLRF--------------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286
Query: 956 QMLSE 960
+ E
Sbjct: 287 SSIKE 291
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 1e-48
Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 27/280 (9%)
Query: 680 SVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLG 738
SV D + IG+G +G VY + G E+A++++ EI +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMR 72
Query: 739 NIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGL 798
++ NIV L + +V EY+ GSL + + + E + L
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQAL 129
Query: 799 CYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIA 858
+LH + ++HRD+KS+NILL + DFG + S + G+ ++A
Sbjct: 130 EFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMA 184
Query: 859 PEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
PE K D++S G++ +E++ G P + + + ATNG
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPLRALYLIATNGT-------- 233
Query: 919 DPRLSMVPK--EEAMHLLFVAMLCIQENSIERPRMREVVQ 956
P L K L C+ + +R +E++Q
Sbjct: 234 -PELQNPEKLSAIFRDFL---NRCLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 5e-47
Identities = 67/293 (22%), Positives = 114/293 (38%), Gaps = 40/293 (13%)
Query: 691 GNVIGRGGAGIVYHGKMP--------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-R 741
G +G G G V + ++AVK L T +E++ + I +
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAF--------------LGWNLR 787
H+NI+ LL C+ ++ EY G+L E L ++ L
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 788 YKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847
A + A+G+ YL S +HRD+ + N+L+ +ADFGLA+ + +
Sbjct: 138 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRAT 907
+ ++APE + +SDV+SFGV+L E+ T GV + + K
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGVPVEELFKLLK 251
Query: 908 NGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
G + + S L M + C +RP +++V+ L
Sbjct: 252 EGHRMDKPSNCTNELYM-----------MMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-46
Identities = 65/298 (21%), Positives = 110/298 (36%), Gaps = 38/298 (12%)
Query: 691 GNVIGRGGAGIVYHG------KMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN 744
G +GRG G V K +AVK L THS +E++ L +I H
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77
Query: 745 IVRLL--AFCSNKETNLLVYEYMRNGSLGEALHGKKGAF--------------LGWNLRY 788
V L A +++ E+ + G+L L K+ F L
Sbjct: 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137
Query: 789 KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMS 848
+ + AKG+ +L +HRD+ + NILL+ + DFGLA+ +
Sbjct: 138 CYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 849 AIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN 908
++APE + +SDV+SFGV+L E+ + + ++ +R
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVKIDEEFCRRLKE 252
Query: 909 GRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966
G + P + + C +RP E+V+ L + ++
Sbjct: 253 GTRMRAPDYTTPEMYQ-----------TMLDCWHGEPSQRPTFSELVEHLGNLLQANA 299
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 8e-46
Identities = 57/269 (21%), Positives = 97/269 (36%), Gaps = 28/269 (10%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLL--GFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
G ++G G V + + E A+K L + E + + H V+
Sbjct: 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
L + E Y +NG L + + E L YLH
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLH---GK 127
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
I+HRD+K NILLN + DFG AK L ++ G+ Y++PE
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 868 DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927
+ SD+++ G ++ +L+ G P F G + + + K I+ K
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPP---FRAGNEYLIFQK------------IIKLEYDFPEK 232
Query: 928 --EEAMHLLFVAMLCIQENSIERPRMREV 954
+A L+ + ++ +R E+
Sbjct: 233 FFPKARDLV---EKLLVLDATKRLGCEEM 258
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 163 bits (414), Expect = 7e-45
Identities = 60/293 (20%), Positives = 112/293 (38%), Gaps = 23/293 (7%)
Query: 667 DSWKMTAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHS 725
D WK Q +E + + +G G G+V+ G K +
Sbjct: 10 DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-TPYPL 68
Query: 726 HDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWN 785
+ + EI + + H ++ L +K +L+ E++ G L + + + +
Sbjct: 69 DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA-AEDYKMSEA 127
Query: 786 LRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGA 843
+A +GL ++H IVH D+K NI+ + + V DFGLA L
Sbjct: 128 EVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184
Query: 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWS 903
+ + + + APE V +D+++ GV+ LL+G P D ++ +Q
Sbjct: 185 VKVTT---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-DDLETLQNV 240
Query: 904 KRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
KR EF +S EA + +Q+ +R + + ++
Sbjct: 241 KRC----DWEFDEDAFSSVS----PEAKDFI---KNLLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 3e-44
Identities = 70/302 (23%), Positives = 118/302 (39%), Gaps = 26/302 (8%)
Query: 683 DILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR 741
DI + +V+G G V + +A+K + + EI L I+
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
H NIV L + L+ + + G L + + K F ++ + + YL
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYL 123
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFE---AHVADFGLAKFLIDGGASECMSAIAGSYGYIA 858
H IVHRD+K N+L S E ++DFGL+K G +S G+ GY+A
Sbjct: 124 HDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVA 177
Query: 859 PEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
PE + D +S GV+ LL G P F D D + + + EF S
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPP---FYDENDAKLFEQILKA--EYEFDSPY 232
Query: 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFPRHSSDFNQSSSSSL 976
+S + A + ++++ +R + +Q ++ + +QS S +
Sbjct: 233 WDDIS----DSAKDFI---RHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285
Query: 977 KN 978
K
Sbjct: 286 KK 287
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 155 bits (393), Expect = 7e-43
Identities = 70/277 (25%), Positives = 118/277 (42%), Gaps = 26/277 (9%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLL--GFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
G ++G GG V+ + + ++AVK L S FR E Q + H IV
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 748 LLAFCSNKETNL----LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH 803
+ + +V EY+ +L + +H + + ++ +A + L + H
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ 129
Query: 804 DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC-MSAIAGSYGYIAPEYA 862
+ I+HRDVK NI++++ V DFG+A+ + D G S +A+ G+ Y++PE A
Sbjct: 130 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 863 YTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922
VD +SDVYS G VL E+LTG P F + + S L
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDP--IPPSARHEGL 241
Query: 923 SMVPKEEAMHLLFVAMLCIQENSIERPR-MREVVQML 958
S + ++ + + +N R + E+ L
Sbjct: 242 S----ADLDAVV---LKALAKNPENRYQTAAEMRADL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 5e-42
Identities = 60/320 (18%), Positives = 111/320 (34%), Gaps = 37/320 (11%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
+GRG GIV+ + K + GT + EI L RHRNI+ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHRNILHLH 67
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLI 809
+ E ++++E++ + E ++ L + + L +LH S I
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 810 VHRDVKSNNILLNSAFEAHV--ADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
H D++ NI+ + + + +FG A+ L G + + + Y APE V
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVV 180
Query: 868 DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927
+D++S G ++ LL+G P Q + N + F +S
Sbjct: 181 STATDMWSLGTLVYVLLSGINPF----LAETNQQIIENIMNA-EYTFDEEAFKEIS---- 231
Query: 928 EEAMHLLFVAMLCIQENSIERPRMREVVQ-------------MLSEFPRHSSDFNQSSSS 974
EAM + + + R E +Q + +H ++
Sbjct: 232 IEAMDFV---DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
Query: 975 SLKNLEKDPKGCPNNKLKQD 994
L + + ++
Sbjct: 289 DLNMVVSAARISCGGAIRSQ 308
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (382), Expect = 3e-41
Identities = 53/291 (18%), Positives = 98/291 (33%), Gaps = 27/291 (9%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
G IG G G +Y G + G E+A+K + E + ++ + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 750 AFC-SNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
+C + + N++V E + L +A + + Y+H S
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKN 123
Query: 809 IVHRDVKSNNILLNS---AFEAHVADFGLAKFLIDGGASECM-----SAIAGSYGYIAPE 860
+HRDVK +N L+ ++ DFGLAK D + + + G+ Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 861 YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920
+ + D+ S G VL+ G Q +R + + + +L
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLG-SLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE-FPRHSSDFNQ 970
E L C ++P + Q+ F R ++
Sbjct: 243 GYP----SEFATYL---NFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 149 bits (378), Expect = 7e-41
Identities = 67/282 (23%), Positives = 105/282 (37%), Gaps = 36/282 (12%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDH--------GFRAEIQTLGNIR 741
++GRG + +V P E AVK + G S E+ L +
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67
Query: 742 -HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
H NI++L LV++ M+ G L + L K L KI + +C
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICA 125
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE 860
LH IVHRD+K NILL+ + DFG + L G E + + G+ Y+APE
Sbjct: 126 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPE 179
Query: 861 YAYTLRVD------EKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914
D ++ D++S GV++ LL G P + + +G +F
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF----WHRKQMLMLRMIMSG-NYQF 234
Query: 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
S S + L+ + +R E +
Sbjct: 235 GSPEWDDYS----DTVKDLV---SRFLVVQPQKRYTAEEALA 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (372), Expect = 6e-40
Identities = 53/282 (18%), Positives = 93/282 (32%), Gaps = 28/282 (9%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRN-IVRL 748
G IG G G+++ G + N ++A+K S R E +T + I +
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEP---RRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 749 LAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPL 808
F N+LV + + G E L G A + + +H
Sbjct: 67 YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--- 121
Query: 809 IVHRDVKSNNILLNSAFEAH-----VADFGLAKFLIDGGASEC-----MSAIAGSYGYIA 858
+V+RD+K +N L+ + V DFG+ KF D + ++G+ Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 859 PEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918
+ D+ + G V + L G P Q +R ++ L L
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSE 960
EE + P + + S+
Sbjct: 241 CAGFP----EEFYKYM---HYARNLAFDATPDYDYLQGLFSK 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 62/295 (21%), Positives = 114/295 (38%), Gaps = 35/295 (11%)
Query: 672 TAFQKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHG- 729
T F++ +V D + + +G G +V + G++ A K + T S G
Sbjct: 1 TVFRQ--ENVDDYYDTGE---ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 55
Query: 730 ----FRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWN 785
E+ L I+H N++ L NK +L+ E + G L + L K+
Sbjct: 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 115
Query: 786 LRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS----AFEAHVADFGLAKFLIDG 841
+ + L +++ S I H D+K NI+L + DFGLA + G
Sbjct: 116 TEF-----LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170
Query: 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQ 901
+ + G+ ++APE + ++D++S GV+ LL+G P D Q
Sbjct: 171 NEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-----DTKQ 222
Query: 902 WSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
+ + EF S A + + ++ +R +++ +Q
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTS----ALAKDFI---RRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (369), Expect = 3e-39
Identities = 56/266 (21%), Positives = 99/266 (37%), Gaps = 29/266 (10%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLL--GFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
+G G G V+ + NG A+K L E L + H I+R
Sbjct: 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
+ + + ++ +Y+ G L L + Y + L + S
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALEYLHSK 123
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
I++RD+K NILL+ + DFG AK++ + + G+ YIAPE T
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEVVSTKPY 178
Query: 868 DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927
++ D +SFG+++ E+L G P + ++ ++ N P +
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPF----YDSNTMKTYEKILNAELR-----FPPFFN---- 225
Query: 928 EEAMHLLFVAMLCIQENSIERPRMRE 953
E+ LL I + +R +
Sbjct: 226 EDVKDLL---SRLITRDLSQRLGNLQ 248
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-39
Identities = 69/331 (20%), Positives = 114/331 (34%), Gaps = 48/331 (14%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRL 748
V+G G G V + A+K L R E++ + +IVR+
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRI 70
Query: 749 LAFCSNKETN----LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
+ N L+V E + G L + + +I + + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-- 128
Query: 805 CSPLIVHRDVKSNNILLNSAFE---AHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY 861
S I HRDVK N+L S + DFG AK + + Y+APE
Sbjct: 129 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC---YTPYYVAPEV 184
Query: 862 AYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921
+ D+ D++S GV++ LL G P G+ I K + EF +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ-------------------MLSEFP 962
+S EE L+ ++ +R + E + +L E
Sbjct: 244 VS----EEVKMLI---RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK 296
Query: 963 RHSSDFNQSSSSSLKNLEKDPKGCPNNKLKQ 993
D + +S+L + D + K++
Sbjct: 297 ERWEDVKEEMTSALATMRVDYEQIKIKKIED 327
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-38
Identities = 65/291 (22%), Positives = 103/291 (35%), Gaps = 27/291 (9%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHG----FRAEIQTLGNIRHRNIV 746
+ +G G VY + +A+KK+ G EI+ L + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
LL +K LV+++M + L + + +GL YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
I+HRD+K NN+LL+ +ADFGLAK + + Y APE + R
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH--QVVTRWYRAPELLFGAR 176
Query: 867 V-DEKSDVYSFGVVLLELLTGRRP------------VGDFGDGVDIVQWSKRATNGRKEE 913
+ D+++ G +L ELL + + QW +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFP 962
F S L + LL + N R + ++M S P
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 5e-38
Identities = 56/203 (27%), Positives = 84/203 (41%), Gaps = 11/203 (5%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEIQTLG-NIRHRNIV 746
++G+G G V+ + A+K L D E + L H +
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 747 RLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
+ KE V EY+ G L + + A E GL +LH
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKG- 123
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLR 866
IV+RD+K +NILL+ +ADFG+ K + G A + G+ YIAPE +
Sbjct: 124 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQK 179
Query: 867 VDEKSDVYSFGVVLLELLTGRRP 889
+ D +SFGV+L E+L G+ P
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 58/276 (21%), Positives = 109/276 (39%), Gaps = 40/276 (14%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKL-----LGFGTHSHDHGFRAEIQTLGNIR--H 742
G ++G GG G VY G + + + +A+K + +G + E+ L +
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 743 RNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
++RLL + ++ +L+ E ++GA L L + + + + H
Sbjct: 69 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH 127
Query: 803 HDCSPLIVHRDVKSNNILLN-SAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEY 861
+ ++HRD+K NIL++ + E + DFG L D + G+ Y PE+
Sbjct: 128 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEW 180
Query: 862 AYTLRV-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920
R + V+S G++L +++ G P F +I++
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIRGQV------------FFRQ 225
Query: 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
R+S E HL+ C+ +RP E+
Sbjct: 226 RVS----SECQHLI---RWCLALRPSDRPTFEEIQN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (352), Expect = 2e-37
Identities = 54/282 (19%), Positives = 106/282 (37%), Gaps = 26/282 (9%)
Query: 692 NVIGRGGAGIVYHGKMPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLA 750
IG G G+VY + G A+KK+ L EI L ++H NIV+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 751 FCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIV 810
K+ +LV+E++ + G L ++ G+ Y H ++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRR---VL 122
Query: 811 HRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEK 870
HRD+K N+L+N E +ADFGLA+ + I + + +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 871 SDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD----------- 919
D++S G + E++ G + +++ + + + ++ +
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 920 ---PRLSMVPK--EEAMHLLFVAMLCIQENSIERPRMREVVQ 956
P S + E + LL ++ + +R ++ ++
Sbjct: 242 EPLPWESFLKGLDESGIDLL---SKMLKLDPNQRITAKQALE 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (357), Expect = 3e-37
Identities = 61/270 (22%), Positives = 91/270 (33%), Gaps = 29/270 (10%)
Query: 691 GNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHG-----FRAEIQTLGNIRHRN 744
+IGRGG G VY + G A+K L R + +
Sbjct: 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68
Query: 745 IVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHD 804
IV + + + + M G L L A E GL ++H+
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAEIILGLEHMHNR 126
Query: 805 CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYT 864
+V+RD+K NILL+ ++D GLA + + A G++GY+APE
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQK 179
Query: 865 -LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923
+ D +D +S G +L +LL G P R T E P
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTKDKHEIDRMTLTMAVELPDSFSP--- 234
Query: 924 MVPKEEAMHLLFVAMLCIQENSIERPRMRE 953
E LL +Q + R
Sbjct: 235 -----ELRSLL---EGLLQRDVNRRLGCLG 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-37
Identities = 62/284 (21%), Positives = 104/284 (36%), Gaps = 28/284 (9%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
IG G G+VY + G +A+KK+ L T EI L + H NIV+LL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLI 809
+ LV+E++ + L + + + L + +GL + H +
Sbjct: 68 DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123
Query: 810 VHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE-YAYTLRVD 868
+HRD+K N+L+N+ +ADFGLA+ + + Y APE
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 869 EKSDVYSFGVVLLELLTGRRP-------------VGDFGDGVDIVQWSKRATNGRKEEFL 915
D++S G + E++T R G ++V + K F
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 916 SILDPRLSMVPK---EEAMHLLFVAMLCIQENSIERPRMREVVQ 956
S V E+ LL + + +R + +
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLL---SQMLHYDPNKRISAKAALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-37
Identities = 66/327 (20%), Positives = 124/327 (37%), Gaps = 29/327 (8%)
Query: 689 KDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
+ + IG G G+V N V +A+KK+ F ++ EI+ L RH NI+
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 70
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGK-KGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
+ + Y+ +G L+ K L + + +GL Y+H S
Sbjct: 71 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 127
Query: 807 PLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC-MSAIAGSYGYIAPEYAYTL 865
++HRD+K +N+LLN+ + + DFGLA+ ++ + Y APE
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 866 RVD-EKSDVYSFGVVLLELLTGRRP----------------VGDFGDGVDIVQWSKRATN 908
+ + D++S G +L E+L+ R +G + +A N
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 909 GRKEEFLSILDPRLSMVPK--EEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSS 966
P + P +A+ LL + N +R + + + ++
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLL---DKMLTFNPHKRIEVEQALAH-PYLEQYYD 303
Query: 967 DFNQSSSSSLKNLEKDPKGCPNNKLKQ 993
++ + + + + P KLK+
Sbjct: 304 PSDEPIAEAPFKFDMELDDLPKEKLKE 330
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-36
Identities = 61/210 (29%), Positives = 84/210 (40%), Gaps = 19/210 (9%)
Query: 689 KDGNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVR 747
D VIG G G+VY K +G +A+KK+L E+Q + + H NIVR
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 748 LLAFCSNKETN------LLVYEYMRNGSLGEALH-GKKGAFLGWNLRYKIAIEAAKGLCY 800
L F + LV +Y+ A H + L + + L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAH-VADFGLAKFLIDGGASECMSAIAGSYGYIAP 859
+H S I HRD+K N+LL+ + DFG AK L+ G +S I Y
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPE 192
Query: 860 EYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
DV+S G VL ELL G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-36
Identities = 57/290 (19%), Positives = 103/290 (35%), Gaps = 33/290 (11%)
Query: 691 GNVIGRGGAGIVYHGK--MPNGVEIAVKKL-LGFGTHSHDHGFRAEI---QTLGNIRHRN 744
IG G G V+ + G +A+K++ + G E+ + L H N
Sbjct: 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71
Query: 745 IVRLLAFCSNKETNLLVYEYM----RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCY 800
+VRL C+ T+ + + L L + + + +GL +
Sbjct: 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 801 LHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPE 860
LH +VHRD+K NIL+ S+ + +ADFGLA+ ++++ + Y APE
Sbjct: 132 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 185
Query: 861 YAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSK--------------RA 906
D++S G + E+ + F D+ Q K R
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPL---FRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 907 TNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
++ F S + + + + C+ N +R +
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 62/285 (21%), Positives = 102/285 (35%), Gaps = 30/285 (10%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
IG G G V+ K +A+K++ L EI L ++H+NIVRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLI 809
+ + LV+E+ + + KGL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 810 VHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV-D 868
+HRD+K N+L+N E +A+FGLA+ C SA + Y P+ + ++
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 869 EKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK- 927
D++S G + EL RP+ D D ++ R EE + P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 928 ----------------EEAMHLLFVAMLCIQENSIERPRMREVVQ 956
LL ++ N ++R E +Q
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLL---QNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 5e-34
Identities = 47/211 (22%), Positives = 83/211 (39%), Gaps = 18/211 (8%)
Query: 692 NVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
IG+G G V+ + G ++A+KK+ + EI+ L ++H N+V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 750 AFCSNKETN--------LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
C K + LV+++ + G + L R + L L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGL 130
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS--ECMSAIAGSYGYIAP 859
++ I+HRD+K+ N+L+ +ADFGLA+ S + + Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 860 EYAYTLR-VDEKSDVYSFGVVLLELLTGRRP 889
E R D++ G ++ E+ T
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-32
Identities = 59/266 (22%), Positives = 91/266 (34%), Gaps = 26/266 (9%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEIQTLGNIRHRNIVR 747
++G+G G V + G A+K L + D E + L N RH +
Sbjct: 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 748 LLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSP 807
L + V EY G L L + E L + S
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSAL---EYLHSR 124
Query: 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRV 867
+V+RD+K N++L+ + DFGL K I GA+ G+ Y+APE
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDY 182
Query: 868 DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVPK 927
D + GVV+ E++ GR P D + + LS
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELILMEEIR-----FPRTLS---- 229
Query: 928 EEAMHLLFVAMLCIQENSIERPRMRE 953
EA LL ++++ +R
Sbjct: 230 PEAKSLL---AGLLKKDPKQRLGGGP 252
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 7e-31
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 16/220 (7%)
Query: 675 QKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRA 732
K + V + ++ +G G G V G ++A+KKL F +
Sbjct: 10 TKTAWEVRAVYRDLQ---PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGK--KGAFLGWNLRYKI 790
E++ L ++RH N++ LL + ET ++ GK K LG + +
Sbjct: 67 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL 126
Query: 791 AIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAI 850
+ KGL Y+H HRD+K N+ +N E + DFGLA+ M+
Sbjct: 127 VYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGY 178
Query: 851 AGSYGYIAPEYAY-TLRVDEKSDVYSFGVVLLELLTGRRP 889
+ Y APE +R + D++S G ++ E++TG+
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (302), Expect = 3e-30
Identities = 43/200 (21%), Positives = 74/200 (37%), Gaps = 13/200 (6%)
Query: 693 VIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHD--HGFRAEIQTLGNIRHRNIVRLL 749
+G G G V K +G A+K L E + L + +V+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 750 AFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLI 809
+ +V EY+ G + L A + YLH +
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLD---L 162
Query: 810 VHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDE 869
++RD+K N+L++ V DFG AK + + G+ +APE + ++
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNK 217
Query: 870 KSDVYSFGVVLLELLTGRRP 889
D ++ GV++ E+ G P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-30
Identities = 64/284 (22%), Positives = 104/284 (36%), Gaps = 30/284 (10%)
Query: 691 GNVIGRGGAGIVYHGK----MPNGVEIAVKKLLGFGTHSHDHG---FRAEIQTLGNIRHR 743
V+G G G V+ + G A+K L R E Q L +IR
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88
Query: 744 -NIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLH 802
+V L + L+ +Y+ G L L ++ + I + + L
Sbjct: 89 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEIVLALE 143
Query: 803 HDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYA 862
H I++RD+K NILL+S + DFGL+K + +E G+ Y+AP+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIV 202
Query: 863 YTLR--VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920
D+ D +S GV++ ELLTG P G+ + S+R
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-----YPQ 257
Query: 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964
+S A L+ + ++ +R + E H
Sbjct: 258 EMS----ALAKDLI---QRLLMKDPKKRLGCGP--RDADEIKEH 292
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (291), Expect = 7e-29
Identities = 56/297 (18%), Positives = 105/297 (35%), Gaps = 49/297 (16%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRL 748
+GRG V+ + N ++ VK L + EI+ L N+R NI+ L
Sbjct: 40 VRKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGPNIITL 95
Query: 749 LAFCSNKETNL--LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCS 806
+ + LV+E++ N + L E K L Y H
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG- 149
Query: 807 PLIVHRDVKSNNILLNSAF-EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTL 865
I+HRDVK +N++++ + + D+GLA+F G + + S + PE
Sbjct: 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLVDY 204
Query: 866 R-VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQ----------------------- 901
+ D D++S G +L ++ + P D D +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 902 --WSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956
++ ++ + + + EA+ L ++ + R RE ++
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL---DKLLRYDHQSRLTAREAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-28
Identities = 69/315 (21%), Positives = 116/315 (36%), Gaps = 41/315 (13%)
Query: 683 DILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRAEIQTLGNI 740
+L+ ++ IG G GIV +A+KKL F +H E+ + +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 741 RHRNIVRLLAFCSNKETN------LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEA 794
H+NI+ LL + ++T LV E M + +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQM 128
Query: 795 AKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSY 854
G+ +LH I+HRD+K +NI++ S + DFGLA+ G S M+ +
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTR 182
Query: 855 GYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914
Y APE + E D++S G ++ E++ + F I QW+K
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL---FPGRDYIDQWNK---------- 229
Query: 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQSSSS 974
++ P E M L + EN + + S+ N+ +S
Sbjct: 230 --VI--EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 285
Query: 975 SLKN-----LEKDPK 984
++ L DP
Sbjct: 286 QARDLLSKMLVIDPA 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-28
Identities = 51/222 (22%), Positives = 99/222 (44%), Gaps = 17/222 (7%)
Query: 675 QKLEFSVSDILECVKDGNVIGRGGAGIVYHGK-MPNGVEIAVKKL-LGFGTHSHDHGFRA 732
Q+L ++ ++ E ++ + +G G G V G+ +AVKKL F + H
Sbjct: 7 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 66
Query: 733 EIQTLGNIRHRNIVRLLAFCSNKET-----NLLVYEYMRNGSLGEALHGKKGAFLGWNLR 787
E++ L +++H N++ LL + + ++ + ++ L + +K L +
Sbjct: 67 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHV 123
Query: 788 YKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASECM 847
+ + +GL Y+H HRD+K +N+ +N E + DFGLA+ E
Sbjct: 124 QFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT----DDEMT 176
Query: 848 SAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRP 889
+A + + ++ D++S G ++ ELLTGR
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 110 bits (275), Expect = 5e-27
Identities = 86/308 (27%), Positives = 130/308 (42%), Gaps = 15/308 (4%)
Query: 27 NDFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSRD----RVASLDLTDLNLCG 82
D L+ +K+ NP L SW + +W G+ C D RV +LDL+ LNL
Sbjct: 6 QDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 83 --SVPAQILRLDKLTNLSLAGN-NFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSL 137
+P+ + L L L + G N G I I L+ L +L I++ SG + S +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 138 VNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEY-LSLAGN 196
L D N + LP I L L + GN G IP+SYG L ++++ N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 197 DLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIG 256
LTGKIP NL + + K +H + ++G
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH---LAKNSLAFDLGKVG 241
Query: 257 NLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFM 316
K L+ + L N + G++P+ L L L +L++S N L GEIP NL++ +
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYAN 300
Query: 317 NRLHGSIP 324
N+ P
Sbjct: 301 NKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 91.7 bits (226), Expect = 1e-20
Identities = 72/284 (25%), Positives = 120/284 (42%), Gaps = 10/284 (3%)
Query: 340 QNNFTGVIPENLGQNGKLQVLDLSSNKLTG--TIPTDLCSSNQLRILILLKN-FLFGPIP 396
+ GV+ + Q ++ LDLS L IP+ L + L L + L GPIP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 397 ERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRL 456
+ L + + ++G+IPD + L + N LSG+LP + +S N
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV-- 152
Query: 457 GQLNLSNNLLSGPLPFSLSNFSSLQI-LLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLS 515
+ N +SG +P S +FS L + +S N+ +G IPP+ L
Sbjct: 153 -GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML-- 209
Query: 516 GEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKS 575
+ + T N ++ + LN L+L N + +P+ + +K
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269
Query: 576 LTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNNPC 619
L + SFN+ G++P+ G F+ S++A N LCG+ L C
Sbjct: 270 LHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL-PAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 78.6 bits (192), Expect = 3e-16
Identities = 65/282 (23%), Positives = 103/282 (36%), Gaps = 28/282 (9%)
Query: 280 GNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLW 339
+ NLDLS L P IP LA+LP L L +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYP----------------------IPSSLANLPYLNFLYIG 84
Query: 340 QN-NFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPER 398
N G IP + + +L L ++ ++G IP L L L N L G +P
Sbjct: 85 GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144
Query: 399 LGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQ 458
+ + +L + N ++G+IPD + L + S L + L
Sbjct: 145 ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN---RLTGKIPPTFANLNLAF 201
Query: 459 LNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEI 518
++LS N+L G L + +G + + LDL N + G +
Sbjct: 202 VDLSRNMLEGD-ASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL 260
Query: 519 PPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRN 560
P + L L++S NNL G I P+ N++ + + N
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 73.2 bits (178), Expect = 2e-14
Identities = 63/272 (23%), Positives = 97/272 (35%), Gaps = 52/272 (19%)
Query: 180 NSYGELQGLEYLSLAGNDLTGK--IPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNL 237
++ + + L L+G +L IP L NL L +Y+G N G IP + KL L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 238 VHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTG 297
+L ++ + G IP + +K L T+ N LSG++P + +L NLV + N ++G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 298 EIPYSFINLRQLKLFNLFMN---------------------------------------- 317
IP S+ + +L
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 318 -------RLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGT 370
+ NL L L N G +P+ L Q L L++S N L G
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 371 IPTDLCSSNQLRILILLKNFLFGPIPERLGAC 402
IP + + + N P L AC
Sbjct: 284 IP-QGGNLQRFDVSAYANNKCLCGSP--LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 47.4 bits (111), Expect = 5e-06
Identities = 54/221 (24%), Positives = 86/221 (38%), Gaps = 48/221 (21%)
Query: 374 DLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAE 433
+LC+ + L+ +K L
Sbjct: 1 ELCNPQDKQALLQIKK--------------------------------------DLGNPT 22
Query: 434 LQSNYLSGSLPENG-------NSSSNPDRLGQLNLSNNLLSG--PLPFSLSNFSSLQILL 484
S++L + N ++ + R+ L+LS L P+P SL+N L L
Sbjct: 23 TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82
Query: 485 LSGN-QFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIP 543
+ G GPIPP+I +L Q+ L ++ ++SG IP + L LD S N LSG++P
Sbjct: 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142
Query: 544 PEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFN 584
P IS++ L + N ++ IP S GS L +
Sbjct: 143 PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (270), Expect = 6e-26
Identities = 55/311 (17%), Positives = 105/311 (33%), Gaps = 28/311 (9%)
Query: 691 GNVIGRGGAGIVYHGK-MPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLL 749
+G G V+ K M N +A+K + G + EI+ L + + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 750 AFCSNKETNLLVYEYMRNGSLG--------------EALHGKKGAFLGWNLRYKIAIEAA 795
+ +N LL + + + + + + +I+ +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 796 KGLCYLHHDCSPLIVHRDVKSNNILLNSA-FEAHVADFGLAKFLIDGGASECMSAIAGSY 854
GL Y+H C I+H D+K N+L+ ++ +A E + +
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 855 GYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914
Y +PE +D++S ++ EL+TG F + E
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL---FEPDEGHSYTKDDDHIAQIIEL 250
Query: 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDFNQSSSS 974
L L L K +L +I + + + +L+E + S D + S
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLL----RNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 975 SLKN-LEKDPK 984
L L+ DP+
Sbjct: 307 FLSPMLQLDPR 317
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 103 bits (257), Expect = 4e-24
Identities = 82/376 (21%), Positives = 134/376 (35%), Gaps = 35/376 (9%)
Query: 161 LEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYY 220
L+++ L K + L L ++ + N LT P L NLT L +I +
Sbjct: 43 LDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 98
Query: 221 NVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLG 280
+ + + L L + L+ LS + +
Sbjct: 99 QIADITPL----------ANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDIS 148
Query: 281 NLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQ 340
L+ L +L + NL L+ ++ N++ LA L NLE+L
Sbjct: 149 ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATN 206
Query: 341 NNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLG 400
N + + P + N L L L+ N+L L S L L L N + P L
Sbjct: 207 NQISDITPLGILTN--LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LS 260
Query: 401 ACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLN 460
LT ++LG N ++ P L L + L+ + E+ + SN L L
Sbjct: 261 GLTKLTELKLGANQISNISPLA-------GLTALTNLELNENQLEDISPISNLKNLTYLT 313
Query: 461 LSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPP 520
L N +S P S+ + LQ L + N+ S S+ L + L N +S P
Sbjct: 314 LYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP- 368
Query: 521 AIGYCNHLTYLDMSQN 536
+ +T L ++
Sbjct: 369 -LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.4 bits (241), Expect = 4e-22
Identities = 79/413 (19%), Positives = 133/413 (32%), Gaps = 63/413 (15%)
Query: 161 LEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYY 220
L + LG + + +L + L + I G + L NL +I
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINF-SN 75
Query: 221 NVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPK--- 277
N P + L LV + +++ ++ P T+F + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 278 ---------QLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNR-LHGSIPDYL 327
+ +++ L L G L L S L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 328 ADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILL 387
A L NLE+L N + + P + N L L L+ N+L L S L L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILTN--LDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 388 KNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENG 447
N + P L LT ++LG N ++ P L L + L+ + E+
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLA-------GLTALTNLELNENQLEDI 300
Query: 448 NSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKL 507
+ SN L L L N +S P S + + LQ L + N+ S
Sbjct: 301 SPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSDV-------------- 344
Query: 508 DLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRN 560
++ ++ +L N +S P ++N+ + L L+
Sbjct: 345 ------------SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.1 bits (235), Expect = 2e-21
Identities = 76/353 (21%), Positives = 130/353 (36%), Gaps = 42/353 (11%)
Query: 91 LDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLD-WNYSSLVNLEV------- 142
LD++T L + L++L +N SNNQ + N + LV++ +
Sbjct: 43 LDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIAD 102
Query: 143 --FDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTG 200
A N T L + +L N+ ++ L L+ G
Sbjct: 103 ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG 162
Query: 201 KIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKL 260
+L L NL + + + + KL NL L ++ ++ P I
Sbjct: 163 NQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TN 220
Query: 261 LDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLH 320
LD + L+ N L L +LTNL +LDL+NN ++ P L +L L N++
Sbjct: 221 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 276
Query: 321 GSIP--------------------DYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVL 360
P +++L NL L L+ NN + + P + KLQ L
Sbjct: 277 NISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 334
Query: 361 DLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQN 413
++NK++ + L + + L N + P L +T++ L
Sbjct: 335 FFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 94.3 bits (233), Expect = 5e-21
Identities = 82/422 (19%), Positives = 139/422 (32%), Gaps = 59/422 (13%)
Query: 91 LDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNF 150
L + L N T ++ +L + L +D L NL + NN
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQL 78
Query: 151 TALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLT 210
T + P+ L KL + + N P + ++ ++
Sbjct: 79 TDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGLT----------LFNNQITDID 126
Query: 211 NLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINL 270
L+ + ++ L L L S + NL L+ + + N
Sbjct: 127 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN- 185
Query: 271 LSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADL 330
S L LTNL +L +NN ++ P + L +L N+L LA L
Sbjct: 186 -KVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASL 240
Query: 331 PNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNF 390
NL L L N + + P L KL L L +N+++ P ++ N
Sbjct: 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE----LNE 294
Query: 391 LFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSS 450
+ +LT + L N ++ P +L +LQ
Sbjct: 295 NQLEDISPISNLKNLTYLTLYFNNISDISPVS-------SLTKLQR-------------- 333
Query: 451 SNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLS 510
L +NN +S SL+N +++ L NQ S P + L ++ +L L+
Sbjct: 334 --------LFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 381
Query: 511 RN 512
Sbjct: 382 DQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.2 bits (225), Expect = 5e-20
Identities = 65/378 (17%), Positives = 120/378 (31%), Gaps = 42/378 (11%)
Query: 234 LVNLVHLDLSSCELDGQIPH-EIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSN 292
L + L + + ++ + L L I + G + L NL ++ SN
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 293 NALTGEIPYSFINLRQLKL------FNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGV 346
N LT P NL +L + L L N + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 347 IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLT 406
+ + + + S + + L+ L L I + S+
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 407 RVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLL 466
L + P L L L+G+ ++ + ++ L L+L+NN +
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQI 253
Query: 467 SGPLPFSLSNFSSLQILLLSGNQFSGPIP--------------------PSIGELRQVLK 506
S P S + L L L NQ S P I L+ +
Sbjct: 254 SNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTY 311
Query: 507 LDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNI 566
L L N++S P + L L + N +S ++N+ +N+L+ N ++
Sbjct: 312 LTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 567 PKSIGSMKSLTIADFSFN 584
P + ++ +T +
Sbjct: 368 P--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.9 bits (206), Expect = 1e-17
Identities = 49/237 (20%), Positives = 82/237 (34%), Gaps = 39/237 (16%)
Query: 58 CSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQ 117
S + + SL T+ + P IL L LSL GN + +L++L
Sbjct: 187 VSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKDIGTLASLTNLT 244
Query: 118 FLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGK 177
L+++NNQ S S L L N + + P+ L N +
Sbjct: 245 DLDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLE----LNENQLE 298
Query: 178 IPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNL 237
+ L+ L YL+L N+++ P + +LT L+ ++ N + L N+
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA-NNKVSD--VSSLANLTNI 353
Query: 238 VHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNA 294
L ++ P L NLT + L L++ A
Sbjct: 354 NWLSAGHNQISDLTP--------------------------LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.1 bits (139), Expect = 2e-09
Identities = 55/332 (16%), Positives = 100/332 (30%), Gaps = 56/332 (16%)
Query: 305 NLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSS 364
L + L + ++ DL + TL + + + + L ++ S+
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 365 NKLTGTIP-------TDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNG 417
N+LT P D+ +N I L L L
Sbjct: 76 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 418 SIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLS-GPLPFSLSN 476
+ + ++ ++ S L L + + L+
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 477 FSSLQILLLSGNQFSGPIP--------------------PSIGELRQVLKLDLSRNSLSG 516
++L+ L+ + NQ S P ++ L + LDL+ N +S
Sbjct: 196 LTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISN 255
Query: 517 EIPPAIGYCNHLTYLDMSQNNLSGSIP--------------------PEISNVRILNYLN 556
P + LT L + N +S P ISN++ L YL
Sbjct: 256 LAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLT 313
Query: 557 LSRNHLNQNIPKSIGSMKSLTIADFSFNDFSG 588
L N+++ P + S+ L F+ N S
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 2e-07
Identities = 22/137 (16%), Positives = 42/137 (30%), Gaps = 5/137 (3%)
Query: 12 SLLNIPNLSSAASLVNDFHVLVALKQGFENPEPALISWNSSNPSSVCSWAGICCSRDRVA 71
+ N+ LS L + N + + +
Sbjct: 252 QISNLAPLSGLTKLTE-LKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLT 310
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLD 131
L L N+ P + L KL L A N + + NL+++ +L+ +NQ S
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLTP 368
Query: 132 WNYSSLVNLEVFDAYNN 148
++L + +
Sbjct: 369 L--ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 8e-06
Identities = 18/90 (20%), Positives = 37/90 (41%), Gaps = 6/90 (6%)
Query: 472 FSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYL 531
F+ + + +L + + + +L QV L R + + Y N+LT +
Sbjct: 16 FTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQI 71
Query: 532 DMSQNNLSGSIPPEISNVRILNYLNLSRNH 561
+ S N L+ P + N+ L + ++ N
Sbjct: 72 NFSNNQLTDITP--LKNLTKLVDILMNNNQ 99
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.0 bits (240), Expect = 2e-22
Identities = 58/278 (20%), Positives = 104/278 (37%), Gaps = 17/278 (6%)
Query: 227 IPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLV 286
+P+++ + LDL + ++ + NLK L T+ L N +S P L L
Sbjct: 25 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 287 NLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGV 346
L LS N L L++L++ + ++ S+ + L + +E LG +G+
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGI 141
Query: 347 IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLT 406
KL + ++ +T TIP L S L L L N + L +L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS--LTELHLDGNKITKVDAASLKGLNNLA 198
Query: 407 RVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLL 466
++ L N ++ P L + + + L + ++ + + L NN +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLR----ELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI 254
Query: 467 SG------PLPFSLSNFSSLQILLLSGNQFS-GPIPPS 497
S P + +S + L N I PS
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.5 bits (236), Expect = 6e-22
Identities = 56/296 (18%), Positives = 105/296 (35%), Gaps = 40/296 (13%)
Query: 274 SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNL 333
+PK L + LDL NN +T F NL+ L L N++ P A L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 334 ETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFG 393
E L L +N + + +L+V + K+ ++ L + +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL---------- 131
Query: 394 PIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNP 453
+G F + L+ + ++ ++P+ P
Sbjct: 132 ---------------GTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ-----GLP 170
Query: 454 DRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNS 513
L +L+L N ++ SL ++L L LS N S S+ + +L L+ N
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 514 LSGEIPPAIGYCNHLTYLDMSQNNLSG------SIPPEISNVRILNYLNLSRNHLN 563
L ++P + ++ + + NN+S P + + ++L N +
Sbjct: 231 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.0 bits (227), Expect = 9e-21
Identities = 54/251 (21%), Positives = 85/251 (33%), Gaps = 6/251 (2%)
Query: 139 NLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDL 198
+ + D NN T + L+ L L L N P ++ L LE L L+ N L
Sbjct: 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 199 TGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNL 258
L LR V + + +V L + + G +
Sbjct: 92 KELPEKMPKTLQELRVHENEITKVRKSVFNGL--NQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 259 KLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNR 318
K L + + ++ +IP+ G +L L L N +T S L L L N
Sbjct: 150 KKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 319 LHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSS 378
+ LA+ P+L L L N +P L + +QV+ L +N ++ D C
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
Query: 379 NQLRILILLKN 389
Sbjct: 266 GYNTKKASYSG 276
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.7 bits (195), Expect = 1e-16
Identities = 59/295 (20%), Positives = 99/295 (33%), Gaps = 27/295 (9%)
Query: 58 CSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE--IGNLSS 115
C + CS L L VP + L L N T + NL +
Sbjct: 10 CHLRVVQCS-----DLGLE------KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKN 56
Query: 116 LQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFF 175
L L + NN+ S ++ LV LE N L L++L+ +
Sbjct: 57 LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVR 116
Query: 176 GKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLV 235
+ N ++ + L +G G + L I + N+ IP+ G
Sbjct: 117 KSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT--IPQ--GLPP 171
Query: 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNAL 295
+L L L ++ + L L + L N +S L N +L L L+NN L
Sbjct: 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231
Query: 296 TGEIPYSFINLRQLKLFNLFMNRLHG------SIPDYLADLPNLETLGLWQNNFT 344
++P + + +++ L N + P Y + + L+ N
Sbjct: 232 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.5 bits (171), Expect = 1e-13
Identities = 42/264 (15%), Positives = 87/264 (32%), Gaps = 37/264 (14%)
Query: 347 IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLT 406
+P++L + +LDL +NK+T D + L LIL+ N + P L
Sbjct: 25 VPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 407 RVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLL 466
R+ L +N L +P+ +L + N +
Sbjct: 83 RLYLSKNQLK-ELPEKMPKTLQ-----------------------------ELRVHENEI 112
Query: 467 SGPLPFSLSNFSSLQILLLSG--NQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGY 524
+ + + + ++ L + SG + ++++ + ++ +++ IP G
Sbjct: 113 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GL 169
Query: 525 CNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFN 584
LT L + N ++ + + L L LS N ++ S+ + L + N
Sbjct: 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229
Query: 585 DFSGKLPESGQFTVFNASSFAGNP 608
N
Sbjct: 230 KLVKVPGGLADHKYIQVVYLHNNN 253
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (231), Expect = 2e-21
Identities = 57/268 (21%), Positives = 92/268 (34%), Gaps = 10/268 (3%)
Query: 274 SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNL 333
++P + + L N ++ SF R L + L N L L L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 334 ETLGLWQNNFTGVI-PENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLF 392
E L L N + P G+L L L L P L+ L L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 393 GPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSN 452
+ +LT + L N ++ F L L+ L N ++ P ++ +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP---HAFRD 199
Query: 453 PDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRN 512
RL L L N LS +L+ +LQ L L+ N + + + K S +
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSS 258
Query: 513 SLSGEIPPAIGYCNHLTYLDMSQNNLSG 540
+ +P + ++ N+L G
Sbjct: 259 EVPCSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (217), Expect = 1e-19
Identities = 59/254 (23%), Positives = 87/254 (34%), Gaps = 4/254 (1%)
Query: 188 LEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCEL 247
+ + L GN ++ NL ++L + G + + +L
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 248 DGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLR 307
P L L T+ L L P L L L L +NAL +F +L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 308 QLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKL 367
L L NR+ L +L+ L L QN V P G+L L L +N L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 368 TGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLP 427
+ L L+ L L N R + L + R + + S+P L
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW-LQKFRGSSSEVPCSLPQ---RLA 269
Query: 428 GLNLAELQSNYLSG 441
G +L L +N L G
Sbjct: 270 GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (207), Expect = 2e-18
Identities = 55/268 (20%), Positives = 90/268 (33%), Gaps = 10/268 (3%)
Query: 322 SIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQL 381
++P + + + L N + V + L +L L SN L L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 382 RILILLKNFLFGPI-PERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLS 440
L L N + P L + L + L P F L L LQ N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 441 GSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGE 500
++ + L L L N +S + SL LLL N+ + P + +
Sbjct: 143 ALPD---DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 501 LRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRN 560
L +++ L L N+LS A+ L YL ++ N L S +
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSS 258
Query: 561 HLNQNIPKSIGSMKSLTIADFSFNDFSG 588
+ ++P+ + + + ND G
Sbjct: 259 EVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (205), Expect = 4e-18
Identities = 64/293 (21%), Positives = 100/293 (34%), Gaps = 16/293 (5%)
Query: 56 SVCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE--IGNL 113
C C + + L +VP I + L GN +
Sbjct: 4 GACV-----CYNEPKVTTSCPQQGL-QAVPVGIPAA--SQRIFLHGNRISHVPAASFRAC 55
Query: 114 SSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNF-TALLPVGILKLEKLKYLDLGGN 172
+L L + +N + ++ L LE D +N ++ P L +L L L
Sbjct: 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115
Query: 173 YFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVG 232
P + L L+YL L N L +L NL ++L + N R
Sbjct: 116 GLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL-HGNRISSVPERAFR 174
Query: 233 KLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSN 292
L +L L L + PH +L L T++L N LS + L L L L L++
Sbjct: 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234
Query: 293 NALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTG 345
N + + L+ F + + S+P LA L N+ G
Sbjct: 235 NPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQRLAGRDLKR---LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.0 bits (185), Expect = 2e-15
Identities = 54/248 (21%), Positives = 87/248 (35%), Gaps = 7/248 (2%)
Query: 347 IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLT 406
+P + Q + L N+++ + L IL L N L L
Sbjct: 26 VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 407 RVRLGQNYLNGSI-PDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNL 465
++ L N S+ P F L L+ L L P + L L L +N
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA---LQYLYLQDNA 140
Query: 466 LSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYC 525
L + + +L L L GN+ S + L + +L L +N ++ P A
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 526 NHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFND 585
L L + NNLS ++ +R L YL L+ N + + L S ++
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSE 259
Query: 586 FSGKLPES 593
LP+
Sbjct: 260 VPCSLPQR 267
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 36/178 (20%), Positives = 58/178 (32%), Gaps = 6/178 (3%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE--IGNLSSLQFLNISNNQFSGG 129
+L L L P L L L L N + +L +L L + N+ S
Sbjct: 109 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168
Query: 130 LDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLE 189
+ + L +L+ + N + P L +L L L N + L+ L+
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228
Query: 190 YLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVG--KLVNLVHLDLSSC 245
YL L N L++ + +P+ + L L DL C
Sbjct: 229 YLRLNDNPWVCDCR-ARPLWAWLQKFRG-SSSEVPCSLPQRLAGRDLKRLAANDLQGC 284
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 2e-20
Identities = 27/157 (17%), Positives = 49/157 (31%), Gaps = 18/157 (11%)
Query: 691 GNVIGRGGAGIVYHGKMPNGVEIAVKKL---------LGFGTHSHDHGFRAEIQTLGNIR 741
G ++G G V++ E VK + D F
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 742 HRNIVRLLAFCSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYL 801
R + +L K Y + N L E + K+ + ++ + +
Sbjct: 65 FRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 802 HHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFL 838
+H IVH D+ N+L+ S + DF + +
Sbjct: 120 YHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEV 152
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (152), Expect = 3e-11
Identities = 42/286 (14%), Positives = 80/286 (27%), Gaps = 23/286 (8%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI-EIGNLSSLQFLNISNNQFSG-G 129
+LDLT NL V ++L + + + E + +Q +++SN+
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 130 LDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLE 189
L S L+ + + + K L L+L G F +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT------- 115
Query: 190 YLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDG 249
++ + V L S
Sbjct: 116 -----LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTL 170
Query: 250 QIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSN-NALTGEIPYSFINLRQ 308
L+ +L ++ L L +L LS + E +
Sbjct: 171 VRRCPN----LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226
Query: 309 LKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQN 354
LK +F G++ LP+L+ + ++FT + +G
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNK 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (144), Expect = 3e-10
Identities = 40/294 (13%), Positives = 86/294 (29%), Gaps = 35/294 (11%)
Query: 239 HLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGE 298
LDL+ L + + + ++ + + + + + + ++DLSN+ +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVS 61
Query: 299 IPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQ 358
++ L+ L+ L L + I L +N L
Sbjct: 62 -----------------------TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 98
Query: 359 VLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGS 418
L+LS S+ R+ L ++ F + + + + Q L+G
Sbjct: 99 RLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158
Query: 419 IPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQ------LNLSN-NLLSGPLP 471
+ + + + Q L+LS +
Sbjct: 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL 218
Query: 472 FSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYC 525
L +L+ L + G G + L L ++ + + P IG
Sbjct: 219 LELGEIPTLKTLQVFGIVPDGTLQLLKEALP---HLQINCSHFTTIARPTIGNK 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 1e-09
Identities = 46/275 (16%), Positives = 93/275 (33%), Gaps = 15/275 (5%)
Query: 119 LNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGK- 177
L+++ + S + F + L +++++DL +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVST 62
Query: 178 IPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGY-YNVFEGGIPREVGKLVN 236
+ + L+ LSL G L+ I L +NL + L E + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 237 LVHLDL------SSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDL 290
L L+L + + + H + L+ NL + + NLV+LDL
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 291 SNNAL-TGEIPYSFINLRQLKLFNL-FMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIP 348
S++ + + F L L+ +L + L ++P L+TL ++ G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 349 ENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRI 383
L L ++ + T + + I
Sbjct: 243 LLKEA---LPHLQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 2e-09
Identities = 47/274 (17%), Positives = 91/274 (33%), Gaps = 13/274 (4%)
Query: 313 NLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTG-TI 371
+L LH + L + ++ + E+ ++Q +DLS++ + T+
Sbjct: 6 DLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTL 63
Query: 372 PTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRV--RLGQNYLNGSIPDGFIYLPGL 429
L ++L+ L L L PI L +L R+ + ++ L
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
Query: 430 NLAELQSNYLSGSLPENGNSSSNPDRLGQLNLS----NNLLSGPLPFSLSNFSSLQILLL 485
+ L + + + + QLNLS N S + + + L
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183
Query: 486 SGNQFSGPIPPSIGELRQVLKLDLSR-NSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPP 544
+L + L LSR + E +G L L + G++
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243
Query: 545 EISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTI 578
L +L ++ +H +IG+ K+ I
Sbjct: 244 LKEA---LPHLQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 18/107 (16%), Positives = 38/107 (35%), Gaps = 3/107 (2%)
Query: 481 QILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSG 540
Q L L+G + + + V+ R+ + + + ++D+S + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEV 60
Query: 541 SIPPEI-SNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDF 586
S I S L L+L L+ I ++ +L + S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG 107
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 44/302 (14%), Positives = 82/302 (27%), Gaps = 42/302 (13%)
Query: 191 LSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQ 250
L L G +L P G L + I F E + H+DLS+
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNS----- 56
Query: 251 IPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLK 310
+ ++ L + L NL L L+ I + L
Sbjct: 57 ------------------VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 98
Query: 311 LFNLF--MNRLHGSIPDYLADLPNLETLGLWQNNFTG------VIPENLGQNGKLQVLDL 362
NL ++ L+ L+ L L + +L +
Sbjct: 99 RLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158
Query: 363 SSNKLTGTIPTDLCSSNQLRILILLKNFLFGP-IPERLGACYSLTRVRL-GQNYLNGSIP 420
N + T + L L L + + + L + L +
Sbjct: 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL 218
Query: 421 DGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSL 480
+P L ++ G+L + L L ++ + + ++ N +
Sbjct: 219 LELGEIPTLKTLQVFGIVPDGTLQLLKEA------LPHLQINCSHFTTIARPTIGNKKNQ 272
Query: 481 QI 482
+I
Sbjct: 273 EI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 37/233 (15%), Positives = 75/233 (32%), Gaps = 10/233 (4%)
Query: 358 QVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNG 417
Q LDL+ L + L S + ++F+ P+ E + + + + L + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 418 -SIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLP----- 471
++ L L+ LS + +SN RL S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 472 FSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYL 531
L + + + + Q+ +N ++ + C +L +L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 532 DMSQN-NLSGSIPPEISNVRILNYLNLSR-NHLNQNIPKSIGSMKSLTIADFS 582
D+S + L E + L +L+LSR + +G + +L
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.8 bits (151), Expect = 3e-11
Identities = 38/180 (21%), Positives = 56/180 (31%), Gaps = 5/180 (2%)
Query: 188 LEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCEL 247
L L+ N L L T L ++ L + + + + L L L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL 92
Query: 248 DGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLR 307
+ + N L+ L L L L L N L P
Sbjct: 93 PLLGQTLPAL----TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148
Query: 308 QLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKL 367
+L+ +L N L L L NL+TL L +N+ IP+ + L L N
Sbjct: 149 KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 2e-08
Identities = 41/279 (14%), Positives = 71/279 (25%), Gaps = 26/279 (9%)
Query: 109 EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLD 168
E+ ++S +N + L + + + N ++ +L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 169 LGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIP 228
L + L L L T L +P
Sbjct: 62 LDRAELTKLQVDGT-----LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 229 REVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLH-INLLSGSIPKQLGNLTNLVN 287
+ + + +P + N L+ L L NL
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 288 LDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLW-QNNFTGV 346
L L N+L IP F L L N + + W Q+N V
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN--------CEILYFRRWLQDNAENV 227
Query: 347 IPENLGQNGKLQVLDLSS------NKLTG-TIPTDLCSS 378
G + K +++S +K P C +
Sbjct: 228 YVWKQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPT 266
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 52/211 (24%), Positives = 74/211 (35%), Gaps = 10/211 (4%)
Query: 254 EIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFN 313
E+ + V L+ ++P L + L LS N L + + +L N
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 314 LFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPT 373
L +R + LP L TL L N + L VLD+S N+LT
Sbjct: 62 L--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLG 118
Query: 374 DLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAE 433
L +L+ L L N L P L L ++ L N L L L+
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 434 LQSNYLSGSLPENGNSSSNPDRLGQLNLSNN 464
LQ N L ++P+ S L L N
Sbjct: 179 LQENSLY-TIPKGFFGSHL---LPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 37/215 (17%), Positives = 58/215 (26%), Gaps = 14/215 (6%)
Query: 57 VCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE--IGNLS 114
+C ++ NL ++P + + T L L+ N + +
Sbjct: 3 ICE----VSKVASHLEVNCDKRNL-TALPPDLPKD--TTILHLSENLLYTFSLATLMPYT 55
Query: 115 SLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYF 174
L LN+ + + +L L D +N +L +G
Sbjct: 56 RLTQLNLDRAELTK--LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV--SFNR 111
Query: 175 FGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKL 234
+P G + +P L T E N + L
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171
Query: 235 VNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHIN 269
NL L L IP LL FLH N
Sbjct: 172 ENLDTLLLQENS-LYTIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 44/209 (21%), Positives = 69/209 (33%), Gaps = 27/209 (12%)
Query: 230 EVGKLVNLVHLDLSSCELDGQIPHEIG-NLKLLDTVFLHINLLSGSIPKQLGNLTNLVNL 288
EV K+ + + ++ L +P ++ + +L L NLL L T L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILH---LSENLLYTFSLATLMPYTRLTQL 60
Query: 289 DLSNNALTGEIPYSFINLRQLKLFNLFMNR---------------------LHGSIPDYL 327
+L LT + + + + L L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 328 ADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILL 387
L L+ L L N + P L KL+ L L++N LT L L L+L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 388 KNFLFGPIPERLGACYSLTRVRLGQNYLN 416
+N L+ IP+ + L L N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 1e-05
Identities = 14/65 (21%), Positives = 28/65 (43%), Gaps = 3/65 (4%)
Query: 497 SIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLN 556
+ ++ L+++ + +L+ +PP + T L +S+N L + L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 557 LSRNH 561
L R
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 32/179 (17%), Positives = 52/179 (29%), Gaps = 46/179 (25%)
Query: 453 PDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQ----------------------- 489
P L+LS NLL +L ++ L L L +
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQL 89
Query: 490 ----------------------FSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNH 527
+ ++ L ++ +L L N L P +
Sbjct: 90 QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149
Query: 528 LTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDF 586
L L ++ NNL+ ++ + L+ L L N IPK L A N +
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENS-LYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 50/182 (27%), Positives = 72/182 (39%), Gaps = 9/182 (4%)
Query: 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLD 131
L L++ L A ++ +LT L+L T G L L L++S+NQ
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPL 94
Query: 132 WNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYL 191
+ L V D N T+L + L +L+ L L GN P LE L
Sbjct: 95 LGQTL-PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153
Query: 192 SLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLS------SC 245
SLA N+LT G L L NL + L +++ IP+ L L +C
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLYT--IPKGFFGSHLLPFAFLHGNPWLCNC 211
Query: 246 EL 247
E+
Sbjct: 212 EI 213
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 33/206 (16%), Positives = 57/206 (27%), Gaps = 48/206 (23%)
Query: 451 SNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLS 510
S ++N L+ LP L IL LS N ++ ++ +L+L
Sbjct: 7 SKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 511 RNS---------------------------------------------LSGEIPPAIGYC 525
R L+ A+
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 526 NHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFND 585
L L + N L P ++ L L+L+ N+L + + +++L N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 586 FSGKLPESGQFTVFNASSFAGNPQLC 611
+ + GNP LC
Sbjct: 184 LYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 55.0 bits (131), Expect = 6e-09
Identities = 36/224 (16%), Positives = 64/224 (28%), Gaps = 17/224 (7%)
Query: 91 LDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNF 150
L ++ +N T ++ +L + L+ + ++ L NL + +N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQI 75
Query: 151 TALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLT 210
T L P+ L L I + + L L
Sbjct: 76 TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135
Query: 211 NLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINL 270
+ + + S + NL L T+ N
Sbjct: 136 LDLNQITNISPLAGLTNLQYL-----------SIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 271 LSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNL 314
+S P L +L NL+ + L NN ++ P N L + L
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 3e-08
Identities = 37/254 (14%), Positives = 68/254 (26%), Gaps = 45/254 (17%)
Query: 281 NLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQ 340
L N + + + +T + ADL + TL +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--------------------------QADLDGITTLSAFG 50
Query: 341 NNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLG 400
T + E + L L+L N++T P + L I
Sbjct: 51 TGVTTI--EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQS 108
Query: 401 ACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLN 460
+ + L + L+G S N
Sbjct: 109 IKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP 168
Query: 461 LSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPP 520
L+N S L L N+ S P + L ++++ L N +S P
Sbjct: 169 LAN-------------LSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP- 212
Query: 521 AIGYCNHLTYLDMS 534
+ ++L + ++
Sbjct: 213 -LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 2e-07
Identities = 38/216 (17%), Positives = 64/216 (29%), Gaps = 21/216 (9%)
Query: 161 LEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYY 220
L + G + + + +L G+ LS G +T I G + L NL + L
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 221 NVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLK-------------LLDTVFLH 267
+ + + + K+ L + + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 268 INLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYL 327
+ L I LS NL +L N++ P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 328 ADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLS 363
A LPNL + L N + V P L L ++ L+
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 3e-07
Identities = 34/220 (15%), Positives = 63/220 (28%), Gaps = 17/220 (7%)
Query: 73 LDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDW 132
+ N+ +V LD +T LS G T + L++L L + +NQ +
Sbjct: 24 IAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDLAPL 81
Query: 133 NYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLS 192
+ + + + + ++ L
Sbjct: 82 KNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN-- 139
Query: 193 LAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIP 252
+ L L + + + L L L ++ P
Sbjct: 140 ---------QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190
Query: 253 HEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSN 292
+ +L L V L N +S P L N +NL + L+N
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 40/257 (15%), Positives = 74/257 (28%), Gaps = 48/257 (18%)
Query: 234 LVNLVHLDLSSCELDGQIPH-EIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSN 292
L N + + + + ++ + L + + G + L NL+ L+L +
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELKD 72
Query: 293 NALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLG 352
N +T P NL + L ++ + L +
Sbjct: 73 NQITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 353 QNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQ 412
I + + L L LT ++
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 413 NYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPF 472
N ++ P LA L + L +++L NN +S P
Sbjct: 183 NKISDISP----------LASLPN-------------------LIEVHLKNNQISDVSP- 212
Query: 473 SLSNFSSLQILLLSGNQ 489
L+N S+L I+ L+ NQ
Sbjct: 213 -LANTSNLFIVTLT-NQ 227
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.0 bits (133), Expect = 1e-08
Identities = 58/332 (17%), Positives = 100/332 (30%), Gaps = 29/332 (8%)
Query: 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLS-NNA 294
L+L++ L +P +L+ L N L+ +P+ +L +L + NN
Sbjct: 39 QAHELELNNLGL-SSLPELPPHLESLV---ASCNSLT-ELPELPQ---SLKSLLVDNNNL 90
Query: 295 LTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQN 354
+ + L + + +L + + G N
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
Query: 355 GKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNY 414
++ +L + I D S +L L L + L Y
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210
Query: 415 LNGSIPDGFIYLPGLNLAELQSNYLSGSLPE----------NGNSSSNPDRLGQLNLSNN 464
+ ++ LP A + LPE + N S L N
Sbjct: 211 ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270
Query: 465 LLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGY 524
S + SL+ L +S N+ +P L +L S N L+ E+P
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPELPQ- 324
Query: 525 CNHLTYLDMSQNNLSGSIPPEISNVRILNYLN 556
+L L + N L P +V L +N
Sbjct: 325 --NLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 1e-07
Identities = 21/95 (22%), Positives = 38/95 (40%), Gaps = 9/95 (9%)
Query: 219 YYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQ 278
Y N I +L L++S+ +L ++P L+ L N L+ +P+
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPEL 322
Query: 279 LGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFN 313
NL L + N L E P ++ L++ +
Sbjct: 323 PQNLK---QLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 6e-07
Identities = 19/92 (20%), Positives = 34/92 (36%), Gaps = 9/92 (9%)
Query: 122 SNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNS 181
N S + +LE + NN L + +L+ L N+ ++P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL----PPRLERLIASFNH-LAEVPEL 322
Query: 182 YGELQGLEYLSLAGNDLTGKIPGELGNLTNLR 213
Q L+ L + N L + P ++ +LR
Sbjct: 323 ---PQNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 21/85 (24%), Positives = 32/85 (37%), Gaps = 9/85 (10%)
Query: 509 LSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPK 568
N+ S EI L L++S N L +P L L S NHL +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AEVPE 321
Query: 569 SIGSMKSLTIADFSFNDFSGKLPES 593
++K L +N + P+
Sbjct: 322 LPQNLKQL---HVEYNPLR-EFPDI 342
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 5e-05
Identities = 15/62 (24%), Positives = 27/62 (43%), Gaps = 5/62 (8%)
Query: 525 CNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFN 584
L+++ LS S+P + L L S N L + +P+ S+KSL + + +
Sbjct: 37 DRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLTE-LPELPQSLKSLLVDNNNLK 91
Query: 585 DF 586
Sbjct: 92 AL 93
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 5e-05
Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 5/67 (7%)
Query: 502 RQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRNH 561
RQ +L+L+ LS +P HL L S N+L+ +P +++ L N +
Sbjct: 38 RQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 562 LNQNIPK 568
L+ P
Sbjct: 93 LSDLPPL 99
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 8e-04
Identities = 14/108 (12%), Positives = 27/108 (25%), Gaps = 7/108 (6%)
Query: 58 CSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQ 117
I + + + L L+++ N + L+
Sbjct: 250 DVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP-ALPPRLE 307
Query: 118 FLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLK 165
L S N + + NL+ N P +E L+
Sbjct: 308 RLIASFNHLA-EVP---ELPQNLKQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 53.7 bits (127), Expect = 1e-08
Identities = 35/178 (19%), Positives = 62/178 (34%), Gaps = 7/178 (3%)
Query: 191 LSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQ 250
+ G L +IP ++ + E+ L + G+L +LV L+L +L G
Sbjct: 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 251 IPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLK 310
P+ + + L N + K L L L+L +N ++ +P SF +L L
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129
Query: 311 LFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLT 368
N + L L P + +Q+ DL ++
Sbjct: 130 SLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.1 bits (97), Expect = 9e-05
Identities = 27/153 (17%), Positives = 42/153 (27%), Gaps = 5/153 (3%)
Query: 462 SNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPA 521
L P LLL+ N+ + L + + I P
Sbjct: 17 GRGLKEIPRDI----PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72
Query: 522 IGYCNHLTYLDMSQNNLSGSIPPE-ISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIAD 580
N I + + L LNL N ++ +P S + SLT +
Sbjct: 73 AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132
Query: 581 FSFNDFSGKLPESGQFTVFNASSFAGNPQLCGT 613
+ N F+ + S G CG
Sbjct: 133 LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.0 bits (124), Expect = 1e-08
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 5/117 (4%)
Query: 97 LSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPV 156
L LA + T + L + L++S+N+ ++L LEV A +N + V
Sbjct: 3 LHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGV 61
Query: 157 GILKLEKLKYLDLGGNYFFG-KIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNL 212
L +L+ L L N L L+L GN L G L +
Sbjct: 62 ANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 2e-08
Identities = 26/97 (26%), Positives = 40/97 (41%), Gaps = 4/97 (4%)
Query: 274 SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNL 333
++ L L + +LDLS+N L P + LR L++ N L +LP L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVA--NLPRL 67
Query: 334 ETLGLWQNNFTGV-IPENLGQNGKLQVLDLSSNKLTG 369
+ L L N + L +L +L+L N L
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 7e-07
Identities = 25/112 (22%), Positives = 40/112 (35%), Gaps = 5/112 (4%)
Query: 190 YLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDG 249
L LA DLT + L L + + L +N P + L L L S
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDL-SHNRLRALPP-ALAALRCLEVLQASDNA-LE 56
Query: 250 QIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPY 301
+ +L + + + L + + L + LV L+L N+L E
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 108
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 7e-07
Identities = 27/119 (22%), Positives = 44/119 (36%), Gaps = 7/119 (5%)
Query: 459 LNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEI 518
L+L++ L+ L + L LS N+ PP++ LR + L S N+ E
Sbjct: 3 LHLAHKDLTVLC--HLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNA--LEN 57
Query: 519 PPAIGYCNHLTYLDMSQNNL-SGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSL 576
+ L L + N L + + + L LNL N L Q + +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 32/149 (21%), Positives = 46/149 (30%), Gaps = 34/149 (22%)
Query: 358 QVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNG 417
+VL L+ LT + L +T + L N L
Sbjct: 1 RVLHLAHKDLT--------------------------VLCHLEQLLLVTHLDLSHNRLRA 34
Query: 418 SIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLL-SGPLPFSLSN 476
P L L+ S + EN + +N RL +L L NN L L +
Sbjct: 35 LPPALA------ALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVS 88
Query: 477 FSSLQILLLSGNQFSGPIPPSIGELRQVL 505
L +L L GN L ++L
Sbjct: 89 CPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 54.1 bits (128), Expect = 4e-08
Identities = 42/335 (12%), Positives = 94/335 (28%), Gaps = 21/335 (6%)
Query: 184 ELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGG---IPREVGKLVNLVHL 240
E + L+ ++ D + L +++EI L + + + +L
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 241 DLSSC---ELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTG 297
+ S + +IP + L ++ + S + LS +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 298 EIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKL 357
+ L + ++ + P L ++ +N + + +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 358 QVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNG 417
L + + I + L L + + ++ L
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLE---GLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241
Query: 418 SIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSL--- 474
+ L L+ + + + + N L L L N + +L
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIG-----LQTLRLQYNEIELDAVRTLKTV 296
Query: 475 --SNFSSLQILLLSGNQFSGPIPPSIGELRQVLKL 507
L L L+GN+FS + E+R+V
Sbjct: 297 IDEKMPDLLFLELNGNRFSE-EDDVVDEIREVFST 330
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.7 bits (101), Expect = 8e-05
Identities = 41/314 (13%), Positives = 88/314 (28%), Gaps = 32/314 (10%)
Query: 274 SIPKQLGNLTNLVNLDLSNNALT-------GEIPYSFINLRQLKLFNLFMNRLHGSIPDY 326
S+ L ++ + LS N + E S +L + ++F R+ IP+
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 327 LADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILIL 386
L L + + + LS + + +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 387 LKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPEN 446
+ + ++ L + G+N L + + L + + +
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRL-ENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200
Query: 447 GNSSSNPDRL-----------GQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIP 495
Q N +L S L +L ++ +L+ L L+ S
Sbjct: 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 260
Query: 496 PSIGE------LRQVLKLDLSRNSLSGEIPPAI-----GYCNHLTYLDMSQNNLS--GSI 542
++ + + L L N + + + L +L+++ N S +
Sbjct: 261 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDV 320
Query: 543 PPEISNVRILNYLN 556
EI V
Sbjct: 321 VDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 49/306 (16%), Positives = 101/306 (33%), Gaps = 28/306 (9%)
Query: 240 LDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSG----SIPKQLGNLTNLVNLDLSNN-- 293
LD + E + + + + + L N + + + + + +L + S+
Sbjct: 12 LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71
Query: 294 -ALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLG 352
+ EIP + L Q L ++ + S + L ++ + +
Sbjct: 72 GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131
Query: 353 QNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFL----FGPIPERLGACYSLTRV 408
G ++ + ++ LR +I +N L + + L V
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191
Query: 409 RLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPD------RLGQLNLS 462
++ QN + + + EL+ L + + SS+ L +L L+
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251
Query: 463 NNLLSG------PLPFSLSNFSSLQILLLSGNQFSGPIPPSIGE-----LRQVLKLDLSR 511
+ LLS FS LQ L L N+ ++ + +L L+L+
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311
Query: 512 NSLSGE 517
N S E
Sbjct: 312 NRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 41/309 (13%), Positives = 86/309 (27%), Gaps = 29/309 (9%)
Query: 307 RQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTG----VIPENLGQNGKLQVLDL 362
+ LKL + S+ L + +++ + L N + EN+ L++ +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 363 SSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDG 422
S + L +L L + + + +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 423 FIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQI 482
+++ GL + + N L + N L +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 483 LLLSGNQFSGPIPPSIGELRQVLKL-------------DLSRNSLSGEIPPAIGYCNHLT 529
LL + I P E + L + + S + A+ +L
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 530 YLDMSQNNLSGSIPPEISNV------RILNYLNLSRNHLNQNIPKSIGS-----MKSLTI 578
L ++ LS + + L L L N + + +++ + M L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 579 ADFSFNDFS 587
+ + N FS
Sbjct: 307 LELNGNRFS 315
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 4e-07
Identities = 14/92 (15%), Positives = 27/92 (29%), Gaps = 5/92 (5%)
Query: 479 SLQILLLSGNQFS-GPIPPSIGELRQVLKLDLSRNSLSGE----IPPAIGYCNHLTYLDM 533
+Q L + + S + L+Q + L L+ I A+ L L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 534 SQNNLSGSIPPEISNVRILNYLNLSRNHLNQN 565
N L + + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 4e-07
Identities = 20/92 (21%), Positives = 32/92 (34%), Gaps = 10/92 (10%)
Query: 284 NLVNLDLSNNALTGE-IPYSFINLRQLKLFNLFMNRLHG----SIPDYLADLPNLETLGL 338
++ +LD+ L+ L+Q ++ L L I L P L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 339 WQNNFTGVIPENLGQ-----NGKLQVLDLSSN 365
N V + Q + K+Q L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 5e-07
Identities = 18/92 (19%), Positives = 31/92 (33%), Gaps = 5/92 (5%)
Query: 235 VNLVHLDLSSCEL-DGQIPHEIGNLKLLDTVFLHINLLSG----SIPKQLGNLTNLVNLD 289
+++ LD+ EL D + + L+ V L L+ I L L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 290 LSNNALTGEIPYSFINLRQLKLFNLFMNRLHG 321
L +N L + + Q + L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 14/85 (16%), Positives = 33/85 (38%), Gaps = 13/85 (15%)
Query: 507 LDLSRNSLSGE----IPPAIGYCNHLTYLDMSQNNLSGSIPPEIS-----NVRILNYLNL 557
L L+ +S + + + L LD+S N L + ++ +L L L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433
Query: 558 SRNHLNQNIPKSIGSMK----SLTI 578
+ ++ + + +++ SL +
Sbjct: 434 YDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 8e-06
Identities = 20/80 (25%), Positives = 29/80 (36%), Gaps = 9/80 (11%)
Query: 331 PNLETLGLWQNNFTGV----IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSS-----NQL 381
L L L + + + L N L+ LDLS+N L L S L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 382 RILILLKNFLFGPIPERLGA 401
L+L + + +RL A
Sbjct: 429 EQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 8e-06
Identities = 15/95 (15%), Positives = 26/95 (27%), Gaps = 13/95 (13%)
Query: 303 FINLRQLKLFNLFMNRLHG----SIPDYLADLPNLETLGLWQNNFTGVIPENLGQ----- 353
L++ L + S+ L +L L L N L +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 354 NGKLQVLDLSSNKLTGTIPTDLC----SSNQLRIL 384
L+ L L + + L LR++
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 7e-05
Identities = 20/92 (21%), Positives = 32/92 (34%), Gaps = 9/92 (9%)
Query: 440 SGSLPENGNSSSNPDRLGQLNLSNNLLSG----PLPFSLSNFSSLQILLLSGNQFSGPIP 495
+G L L L++ +S L +L SL+ L LS N
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414
Query: 496 PSIGE-LRQ----VLKLDLSRNSLSGEIPPAI 522
+ E +RQ + +L L S E+ +
Sbjct: 415 LQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 7e-05
Identities = 12/73 (16%), Positives = 19/73 (26%), Gaps = 5/73 (6%)
Query: 506 KLDLSRNSLSGE-IPPAIGYCNHLTYLDMSQNNLSG----SIPPEISNVRILNYLNLSRN 560
LD+ LS + + + L+ I + L LNL N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 561 HLNQNIPKSIGSM 573
L +
Sbjct: 66 ELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 2e-04
Identities = 10/71 (14%), Positives = 24/71 (33%), Gaps = 5/71 (7%)
Query: 528 LTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHLN----QNIPKSIGSMKSLTIADFS 582
+ LD+ LS + E+ ++ + L L ++I ++ +L +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 583 FNDFSGKLPES 593
N+
Sbjct: 64 SNELGDVGVHC 74
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 17/111 (15%), Positives = 32/111 (28%), Gaps = 21/111 (18%)
Query: 332 NLETLGLWQNNFTGV-IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNF 390
++++L + + E L + QV+ L LT D+ S+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------ 50
Query: 391 LFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSG 441
L +L + L N L + ++Q L
Sbjct: 51 --------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 20/110 (18%), Positives = 31/110 (28%), Gaps = 29/110 (26%)
Query: 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNAL 295
L L L+ C++ + L +L LDLSNN L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAAT--------------------LLANHSLRELDLSNNCL 409
Query: 296 TGEIPYSFI-----NLRQLKLFNLFMNRLHGSIPDYLADL----PNLETL 336
+ L+ L+ + D L L P+L +
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 11/94 (11%), Positives = 30/94 (31%), Gaps = 10/94 (10%)
Query: 138 VNLEVFDAYNNNFTALLPVGILK-LEKLKYLDLGGNYF----FGKIPNSYGELQGLEYLS 192
++++ D + +L L++ + + L I ++ L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 193 LAGNDLTGKIPGELG-----NLTNLREIYLGYYN 221
L N+L + ++++ L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 6e-04
Identities = 12/91 (13%), Positives = 23/91 (25%), Gaps = 5/91 (5%)
Query: 115 SLQFLNISNNQFS-GGLDWNYSSLVNLEVFDAYNNNFT----ALLPVGILKLEKLKYLDL 169
+Q L+I + S L +V + T + + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 170 GGNYFFGKIPNSYGELQGLEYLSLAGNDLTG 200
N + + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 17/88 (19%), Positives = 31/88 (35%), Gaps = 5/88 (5%)
Query: 188 LEYLSLAGNDLTGKIPGEL-GNLTNLREIYLGYYNVFEGG---IPREVGKLVNLVHLDLS 243
++ L + +L+ EL L + + L + E I + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 244 SCELDGQIPHEIGN-LKLLDTVFLHINL 270
S EL H + L+ ++L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 17/106 (16%), Positives = 31/106 (29%), Gaps = 10/106 (9%)
Query: 429 LNLAEL--QSNYLSGS-LPENGNSSSNPDRLGQLNLSNNLLSG----PLPFSLSNFSSLQ 481
L++ L Q LS + E + L + L+ + +L +L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQ---CQVVRLDDCGLTEARCKDISSALRVNPALA 58
Query: 482 ILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNH 527
L L N+ + + Q + + SL G
Sbjct: 59 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL 104
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 16/84 (19%), Positives = 29/84 (34%), Gaps = 15/84 (17%)
Query: 72 SLDLTDLNLCGSVPAQIL-RLDKLTNLSLAGNNFTGSI------EIGNLSSLQFLNISNN 124
SLD+ L + A++L L + + L T + + +L LN+ +N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 125 QFSG--------GLDWNYSSLVNL 140
+ GL + L
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKL 89
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.1 bits (115), Expect = 8e-07
Identities = 36/283 (12%), Positives = 67/283 (23%), Gaps = 44/283 (15%)
Query: 54 PSSVCSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE--IG 111
+C CS + + +P+ + R L +
Sbjct: 2 HHRICH-----CSNRVF---LCQESKV-TEIPSDLPR--NAIELRFVLTKLRVIQKGAFS 50
Query: 112 NLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGG 171
L+ + IS N ++ + S +
Sbjct: 51 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN--------------------- 89
Query: 172 NYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREV 231
N + L ++ +L + N+ V
Sbjct: 90 NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 149
Query: 232 GKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLS 291
G V L L+ + +L + N L + V LD+S
Sbjct: 150 GLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 209
Query: 292 NNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLE 334
+ Y NL++L+ + + L LP LE
Sbjct: 210 RTRIHSLPSYGLENLKKLRARSTY----------NLKKLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 1e-05
Identities = 36/231 (15%), Positives = 59/231 (25%), Gaps = 8/231 (3%)
Query: 262 DTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHG 321
+ ++ IP L N + L L +F L+ + N +
Sbjct: 11 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 322 SI--PDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSN 379
I + E NN + PE LQ L +S+ + S
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 380 QLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQ-SNY 438
Q +L + N I S V L N + N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 439 LSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQ 489
LP + L++S + + L N L+ +
Sbjct: 188 NLEELPN--DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (101), Expect = 5e-05
Identities = 36/238 (15%), Positives = 71/238 (29%), Gaps = 9/238 (3%)
Query: 139 NLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDL 198
+ VF + T + P + + L ++ LE + ++ ND+
Sbjct: 9 SNRVFLCQESKVTEI-PSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 199 TGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHE---I 255
I ++ + I E + + + L S +P
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 256 GNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLF 315
K+L + +IN+ + +G V L L+ N + +F + +L
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 316 MNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPT 373
N L D L + + + L KL+ + K +PT
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 4e-04
Identities = 33/214 (15%), Positives = 66/214 (30%), Gaps = 5/214 (2%)
Query: 347 IPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLT 406
IP +L +N L KL L + + +N + I + +
Sbjct: 23 IPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 407 RVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLL 466
+ N + + NL L + + + + ++ N +
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 467 SGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPP-AIGYC 525
S S ++L I Q+ +L+LS N+ E+P
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 526 NHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLS 558
+ LD+S+ + S+P N++ L +
Sbjct: 201 SGPVILDISRTRIH-SLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 30/224 (13%), Positives = 58/224 (25%), Gaps = 6/224 (2%)
Query: 322 SIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQL 381
IP L N L + G L+ +++S N + I D+ S+
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 382 RILILLKNFLFGPIPERLGACYSLTRVRLGQNYLN-GSIPDGFIYLPGLNLAELQSNYLS 440
I ++ L + +PD + + ++
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 441 GSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGE 500
E + L L+ N + + + ++ L N
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 501 LRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPP 544
+ LD+SR + + L NL +P
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT 240
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 37/216 (17%), Positives = 72/216 (33%), Gaps = 21/216 (9%)
Query: 83 SVPAQI------LRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSS 136
+VP I + +L + T ++ L+S+ + +N+
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKS--VQGIQY 66
Query: 137 LVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGN 196
L N+ N T + P+ LK +LD + +
Sbjct: 67 LPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS---------L 117
Query: 197 DLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIG 256
L ++ L +L ++ Y + + +L L L L ++ +P +
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LA 175
Query: 257 NLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSN 292
L L ++L N +S + L L NL L+L +
Sbjct: 176 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 36/207 (17%), Positives = 64/207 (30%), Gaps = 19/207 (9%)
Query: 281 NLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQ 340
+ +L ++T + + L + + + + LPN+ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 341 NNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLG 400
N T + P L L SS + + + I + G
Sbjct: 78 NKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129
Query: 401 ACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLN 460
+ L + L L+ L+ N +S +P G + L L
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTK-----LQNLY 184
Query: 461 LSNNLLSGPLPFSLSNFSSLQILLLSG 487
LS N +S L +L+ +L +L L
Sbjct: 185 LSKNHISD-LR-ALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 39/226 (17%), Positives = 78/226 (34%), Gaps = 23/226 (10%)
Query: 289 DLSNNALTGEIPYSFI----NLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFT 344
L + +T P I + NL + ++ +L +++ + ++
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 59
Query: 345 GVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYS 404
V + + L L+ NKLT P + + +
Sbjct: 60 SVQ--GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWL------FLDENKVKDLSSLKDL 111
Query: 405 LTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNN 464
L + S +G ++LP L L +N ++ + +L L+L +N
Sbjct: 112 KKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLS-----RLTKLDTLSLEDN 166
Query: 465 LLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLS 510
+S +P + + LQ L LS N S ++ L+ + L+L
Sbjct: 167 QISDIVPLA--GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (109), Expect = 2e-06
Identities = 23/148 (15%), Positives = 48/148 (32%), Gaps = 7/148 (4%)
Query: 439 LSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSI 498
L+ L E +N R +L+L + + + + S N+
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGF 59
Query: 499 GELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPE----ISNVRILNY 554
LR++ L ++ N + LT L ++ N+L + + ++ L
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 119
Query: 555 LNLSRNHLNQNIPKSIGSMKSLTIADFS 582
L + I + + + DF
Sbjct: 120 LRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (105), Expect = 7e-06
Identities = 28/142 (19%), Positives = 43/142 (30%), Gaps = 8/142 (5%)
Query: 278 QLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLG 337
Q N LDL + I L Q + N + D L L+TL
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLL 69
Query: 338 LWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPE 397
+ N + L L L++N L D +S + + +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 398 -RLGACYSLTRVRLGQNYLNGS 418
RL Y + +VR L+
Sbjct: 130 YRLYVIYKVPQVR----VLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (95), Expect = 1e-04
Identities = 23/135 (17%), Positives = 46/135 (34%), Gaps = 8/135 (5%)
Query: 161 LEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYY 220
+ + LDL G I N L + + + N++ K+ G L L+ + +
Sbjct: 17 AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KLDGF-PLLRRLKTLLV-NN 72
Query: 221 NVFEGGIPREVGKLVNLVHLDLSSCEL-DGQIPHEIGNLKLLDTVFLH---INLLSGSIP 276
N L +L L L++ L + + +LK L + + +
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 277 KQLGNLTNLVNLDLS 291
+ + + LD
Sbjct: 133 YVIYKVPQVRVLDFQ 147
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (106), Expect = 6e-06
Identities = 27/134 (20%), Positives = 47/134 (35%), Gaps = 6/134 (4%)
Query: 241 DLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIP 300
+L +++ Q+ + L + L L V L+ ++ +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLR 58
Query: 301 YSFINLRQLKLFNLFMNRL--HGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQ 358
N+ +L NL NRL + + PNL+ L L N + + KL+
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 359 VLDLSSNKLTGTIP 372
L L N L+ T
Sbjct: 119 ELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 3e-04
Identities = 24/135 (17%), Positives = 48/135 (35%), Gaps = 3/135 (2%)
Query: 83 SVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEV 142
+ + + + +L ++ + LN ++ + L ++ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLS 69
Query: 143 FDAYNNNFTAL--LPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTG 200
+ NN L + + K LK L+L GN + + LE L L GN L+
Sbjct: 70 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
Query: 201 KIPGELGNLTNLREI 215
+ ++ +RE
Sbjct: 130 TFRDQSTYISAIRER 144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.002
Identities = 26/145 (17%), Positives = 46/145 (31%), Gaps = 13/145 (8%)
Query: 201 KIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKL 260
++ + + + L + ++ V L+ S + + N+
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL---RSDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPE 66
Query: 261 LDTVFLHINLLSG--SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNR 318
L ++ L N L + + NL L+LS N L E I +L+ L N
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 319 LHGSIPDY-------LADLPNLETL 336
L + D P L L
Sbjct: 127 LSDTFRDQSTYISAIRERFPKLLRL 151
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.003
Identities = 25/141 (17%), Positives = 48/141 (34%), Gaps = 13/141 (9%)
Query: 431 LAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQIL--LLSGN 488
L EL+ + L + + + L+L S + + I L +
Sbjct: 1 LNELKPEQVE-QLKLIMSKRYDGSQQ-ALDLKGL-------RSDPDLVAQNIDVVLNRRS 51
Query: 489 QFSGPIPPSIGELRQVLKLDLSRNSLSG--EIPPAIGYCNHLTYLDMSQNNLSGSIPPEI 546
+ + + ++L L+LS N L ++ + +L L++S N L +
Sbjct: 52 SMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK 111
Query: 547 SNVRILNYLNLSRNHLNQNIP 567
L L L N L+
Sbjct: 112 IKGLKLEELWLDGNSLSDTFR 132
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 3e-05
Identities = 19/110 (17%), Positives = 36/110 (32%), Gaps = 2/110 (1%)
Query: 507 LDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEI-SNVRILNYLNLSRNHLNQN 565
L +R+ + + +LT L + + + L L + ++ L
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 566 IPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLL 615
P + L+ + SFN ++ Q +GNP C L
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (98), Expect = 4e-05
Identities = 23/152 (15%), Positives = 41/152 (26%), Gaps = 6/152 (3%)
Query: 65 CSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIE---IGNLSSLQFLNI 121
C + L T + + LT L + +E + L L+ L I
Sbjct: 5 CCPHGSSGLRCTRDGA-LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63
Query: 122 SNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFF-GKIPN 180
+ + L + N + L ++ L+ L L GN
Sbjct: 64 VKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCSCALR 122
Query: 181 SYGELQGLEYLSLAGNDLTGKIPGELGNLTNL 212
+ + L G L ++ N
Sbjct: 123 WLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.001
Identities = 32/132 (24%), Positives = 43/132 (32%), Gaps = 10/132 (7%)
Query: 274 SIPKQLGNLTNLVNLDLSNNALTGEIP-YSFINLRQLKLFNLFMNRLHGSIPDYLADLPN 332
L NL L + N + L +L+ + + L PD P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 333 LETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLF 392
L L L N + Q LQ L LS N L CS LR L +
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL-------HCSCA-LRWLQRWEEEGL 132
Query: 393 GPIPERLGACYS 404
G +PE+ C+
Sbjct: 133 GGVPEQKLQCHG 144
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 7e-04
Identities = 35/220 (15%), Positives = 62/220 (28%), Gaps = 38/220 (17%)
Query: 91 LDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNF 150
L + L N T ++ +L + L +++
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-----------SID--------- 56
Query: 151 TALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLT 210
G+ L L ++ N P + ++ L
Sbjct: 57 ------GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDIL-------MNNNQIADITPLA 103
Query: 211 NLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINL 270
NL + + + L NL L+LSS + + N
Sbjct: 104 NLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSL--QQLNFSSNQ 161
Query: 271 LSGSIPKQLGNLTNLVNLDLSNNALTG-EIPYSFINLRQL 309
++ P L NLT L LD+S+N ++ + NL L
Sbjct: 162 VTDLKP--LANLTTLERLDISSNKVSDISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 7e-04
Identities = 25/204 (12%), Positives = 61/204 (29%), Gaps = 21/204 (10%)
Query: 281 NLTNLVNLDLSNNALTGEIPYS-FINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLW 339
L + L +T + + + L+ L + + G + L NL +
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 70
Query: 340 QNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERL 399
N T + P +++ + + + + + L
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 400 GACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQL 459
+ + L+G + + +L+ +N L +L
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP-------------LANLTTLERL 177
Query: 460 NLSNNLLSGPLPFSLSNFSSLQIL 483
++S+N +S L+ ++L+ L
Sbjct: 178 DISSNKVSDISV--LAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 995 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.53 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.53 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.39 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.28 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.25 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.22 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.21 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.41 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.38 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.25 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.41 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.39 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.37 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.64 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.48 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.46 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.23 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.56 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=425.27 Aligned_cols=263 Identities=30% Similarity=0.448 Sum_probs=208.7
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++|+..+.||+|+||+||+|++. ..||||++.... .....+.|.+|++++++++|||||++++++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 56888999999999999999874 369999985432 34456789999999999999999999998754 568999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
|++|+|.+++.. .+..+++..+..++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+........
T Consensus 85 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 85 CEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 999999999974 3456899999999999999999999877 999999999999999999999999999876544444
Q ss_pred ccccccccCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 845 ECMSAIAGSYGYIAPEYAYT---LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
.......||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+............. + ...+.
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~---~-------~~~p~ 230 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR---G-------YLSPD 230 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH---T-------SCCCC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc---C-------CCCCc
Confidence 44456789999999999864 35889999999999999999999999765443333222221 1 11122
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
....+.+++..+.+++.+||+.||++|||++||++.|+.+.+..
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 22334456678999999999999999999999999999877643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=420.09 Aligned_cols=254 Identities=22% Similarity=0.254 Sum_probs=206.9
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.++|+..+.||+|+||+||+|++ .+|+.||||++.........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 35688899999999999999987 46899999998654444445668999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
||++|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 84 y~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999995 3457999999999999999999999887 99999999999999999999999999998755444
Q ss_pred CccccccccCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
.......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....+........ .... ..
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~---~~~~----------~~ 225 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---KEKK----------TY 225 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH---HTTC----------TT
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH---hcCC----------CC
Confidence 444456789999999999988876 578999999999999999999997644332222111 1110 00
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.......+..+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112234567889999999999999999999965
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=415.77 Aligned_cols=255 Identities=23% Similarity=0.408 Sum_probs=201.7
Q ss_pred hccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEecc
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMR 766 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 766 (995)
+|+..+.||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||++++++.+++..++||||++
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 56778899999999999999988999999998543 3346779999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCcc
Q 001922 767 NGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASEC 846 (995)
Q Consensus 767 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 846 (995)
+|+|.+++.. ....+++..+.+++.|||.||.|+|+++ |+||||||+||++++++.+||+|||+++.+...... .
T Consensus 84 ~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-S 158 (263)
T ss_dssp TCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-e
Confidence 9999999874 3466889999999999999999999887 999999999999999999999999999876443222 2
Q ss_pred ccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMVP 926 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 926 (995)
.....||+.|+|||++.+..++.++|||||||++|||+|+..|+...... .+....+..+. ....|
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~~~~-----------~~~~p 224 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGF-----------RLYKP 224 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHHHTC-----------CCCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHHhcC-----------CCCCc
Confidence 23457899999999999999999999999999999999955554332222 22222222211 11223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 927 KEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 927 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
..++..+.+++.+||+.||++|||++||+++|+++.
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 445678899999999999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-48 Score=423.10 Aligned_cols=260 Identities=28% Similarity=0.414 Sum_probs=203.6
Q ss_pred hhccCCCeeeccCceEEEEEEeCC-C---cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN-G---VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
++|+..++||+|+||+||+|+++. + ..||||++.........++|.+|++++++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 467778999999999999998743 3 358889886555555567799999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
||||++|+|.+++.. ....+++..+.+++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+.+.
T Consensus 106 ~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 999999999998874 3456899999999999999999999877 999999999999999999999999999876543
Q ss_pred CCCcc---ccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 842 GASEC---MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 842 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
..... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+... .+....+..+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----~~~~~~i~~~-------- 249 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN----QDVINAIEQD-------- 249 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTT--------
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH----HHHHHHHHcC--------
Confidence 22211 123457899999999999999999999999999999998 8999965432 1222222221
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.....+.+++..+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 250 ---~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 ---YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11123445667899999999999999999999999999987653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-48 Score=418.68 Aligned_cols=259 Identities=23% Similarity=0.297 Sum_probs=216.9
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++|+..+.||+|+||+||+|++. +++.||||++... ....++|.+|++++++++|||||++++++.+++..++||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT--CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc--cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 46788899999999999999875 5889999998543 33467799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
|++|+|.+++.......+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...... .
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-Y 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-S
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC-c
Confidence 99999999998766778999999999999999999999887 9999999999999999999999999998764432 2
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
.......|++.|+|||++.+..++.++|||||||++|||++|..||....+...+. ..+..+. ...
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~---~~i~~~~-----------~~~ 236 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELLEKDY-----------RME 236 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHHTTC-----------CCC
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH---HHHhcCC-----------CCC
Confidence 23344568999999999999999999999999999999999888775433322222 2222111 112
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.+..++..+.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 3344567899999999999999999999999999988654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=415.65 Aligned_cols=256 Identities=28% Similarity=0.397 Sum_probs=211.8
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
++|+..+.||+|+||+||+|++++++.||||++... ....+.|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC--cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 568888999999999999999988899999998543 3346779999999999999999999998864 5679999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++|+|.+++....+..+++..+.+++.||++||.|||+++ |+||||||+|||+++++.+||+|||+|+.+.+... .
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T 165 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-c
Confidence 9999999887655556899999999999999999999877 99999999999999999999999999997654322 2
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
......||+.|+|||++.+..++.++|||||||++|||+||..|+......... ...+..+ .....
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~---~~~i~~~-----------~~~~~ 231 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNLERG-----------YRMVR 231 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTT-----------CCCCC
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH---HHHHHhc-----------CCCCC
Confidence 234567899999999999999999999999999999999976665443332222 2222221 11123
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
+..++..+.+++.+||+.||++|||++||++.|+++.
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 3455667999999999999999999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=407.36 Aligned_cols=254 Identities=22% Similarity=0.380 Sum_probs=214.4
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
++|+..++||+|+||+||+|++++++.||||++... ....+.|.+|++++++++||||+++++++.+++..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 357888999999999999999988889999998643 334677999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++|++.+++.. ....+++..+++++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+......
T Consensus 82 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 82 ANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 99999999764 3456889999999999999999999877 999999999999999999999999999876544332
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSM 924 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 924 (995)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .+....+..+ ....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----~~~~~~i~~~-----------~~~~ 221 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAEHIAQG-----------LRLY 221 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHHHHHHHTT-----------CCCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH----HHHHHHHHhC-----------CCCC
Confidence 2344679999999999999999999999999999999998 8999965432 2222222222 1122
Q ss_pred CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 925 VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 925 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.|..++..+.+++.+||+.||++|||++|+++.|.++
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 3445667899999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=412.45 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=208.5
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
.++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 45799999999999999999976 569999999985433 3345679999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
||++|+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 98 y~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp CCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred ecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 9999999998864 35899999999999999999999887 9999999999999999999999999998764432
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||............ ..... +. .
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~~~~---------~~-~ 236 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGT---------PE-L 236 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHHCS---------CC-C
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH---HhCCC---------CC-C
Confidence 2234568999999999999999999999999999999999999999653221111111 11110 01 1
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
..+...+..+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1234456778999999999999999999999763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=407.75 Aligned_cols=246 Identities=27% Similarity=0.394 Sum_probs=206.6
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
++|+..+.||+|+||+||+|+.+ +++.||+|++.+. ......+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999874 6889999998432 12234567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
|||++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 99999999999963 356899999999999999999999887 999999999999999999999999999865332
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..+....+....
T Consensus 160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~------------ 220 (263)
T d2j4za1 160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN----TYQETYKRISRVE------------ 220 (263)
T ss_dssp ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTTC------------
T ss_pred ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC----CHHHHHHHHHcCC------------
Confidence 234568999999999999999999999999999999999999999642 2222222222211
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
...|...+..+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1123345667899999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=420.76 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=211.4
Q ss_pred hhccCCCeeeccCceEEEEEEeCC------CcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 758 (995)
++|+.+++||+|+||+||+|++.. ...||||++...........+.+|+.+++++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578889999999999999997632 2368999986655555667799999999998 899999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 001922 759 LLVYEYMRNGSLGEALHGKKG---------------------AFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSN 817 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~ 817 (995)
|+|||||++|+|.++++.... ..+++..++.++.||+.||+|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999975432 35889999999999999999999877 999999999
Q ss_pred CEEECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 001922 818 NILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDG 896 (995)
Q Consensus 818 Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~ 896 (995)
||+++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987765544444456678999999999999999999999999999999998 89999765544
Q ss_pred chHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHc
Q 001922 897 VDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLS 959 (995)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 959 (995)
..+...+. .+ .....|..++..+.++|.+||+.||++|||++||+++|.
T Consensus 274 ~~~~~~~~---~~-----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYKLIQ---NG-----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHH---TT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHh---cC-----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 33333222 11 011234455678999999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=411.67 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=196.3
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEec--CCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN--KETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 761 (995)
+.|+..+.||+|+||+||+|+. .+|+.||||++.... .....+.+.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5688899999999999999976 468999999985433 23345668899999999999999999999854 4568999
Q ss_pred EEeccCCChhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 762 YEYMRNGSLGEALHG--KKGAFLGWNLRYKIAIEAAKGLCYLHHDC--SPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
||||++|+|.+++.. ..+..+++..++.++.||+.||.|||+++ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999863 23467999999999999999999999764 23599999999999999999999999999997
Q ss_pred cccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
+.... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.... ..+....+...
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~----~~~~~~~i~~~-------- 229 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----QKELAGKIREG-------- 229 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHT--------
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC----HHHHHHHHHcC--------
Confidence 64432 22345689999999999999999999999999999999999999996432 22222222221
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
.....+...+..+.+++.+||+.||++|||++|+++
T Consensus 230 ---~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 230 ---KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 122234455678999999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=410.15 Aligned_cols=259 Identities=29% Similarity=0.396 Sum_probs=209.4
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
++|+.++.||+|+||+||+|+++++++||||++... ....+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 578999999999999999999988889999998543 3346779999999999999999999999864 5679999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++|+|..++.......+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.+... .
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 9999999987655567999999999999999999999887 99999999999999999999999999987644322 2
Q ss_pred cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 846 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
......||+.|+|||++..+.++.++|||||||++|||++|..|+............ +..+ .....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~---i~~~-----------~~~~~ 235 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERG-----------YRMPC 235 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HHTT-----------CCCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---HHhc-----------CCCCC
Confidence 334567999999999999999999999999999999999977776543333222222 2211 11123
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCC
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHS 965 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 965 (995)
+..++..+.+++.+||+.||++||++++|+++|+++....
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 4456678999999999999999999999999999977543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=410.21 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=209.2
Q ss_pred hccCCC-eeeccCceEEEEEEeC---CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 687 CVKDGN-VIGRGGAGIVYHGKMP---NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 687 ~~~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
.|...+ .||+|+||+||+|.++ ++..||||++.........++|.+|++++++++|||||++++++.+ +..|+||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 445555 4999999999999763 3557999999765555556789999999999999999999999975 5689999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
|||++|+|.+++.. .+..+++..+.+++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 88 E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 88 EMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp ECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 99999999999853 3457899999999999999999999877 9999999999999999999999999998765433
Q ss_pred CC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 843 AS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 843 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... + ....+..+
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~---~~~~i~~~----------- 228 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-E---VMAFIEQG----------- 228 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-H---HHHHHHTT-----------
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-H---HHHHHHcC-----------
Confidence 22 22234568999999999999999999999999999999998 99999764332 2 22222222
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.....|+.++..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 229 ~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 229 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11223455667899999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=410.12 Aligned_cols=261 Identities=29% Similarity=0.398 Sum_probs=206.6
Q ss_pred hhccCCCeeeccCceEEEEEEeCCC-----cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNG-----VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
++|+..++||+|+||+||+|.++.+ ..||||++...........|.+|++++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3577889999999999999976432 46999999655555555678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
||||+.+|++.+++.. ....+++..+.+++.||+.|++|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 9999999999998863 3457899999999999999999999877 99999999999999999999999999987654
Q ss_pred CCCC-ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 841 GGAS-ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 841 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..|+........ ....+..+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~---~~~~i~~~---------- 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAINDG---------- 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTT----------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH---HHHHHhcc----------
Confidence 3221 222345689999999999999999999999999999999997777654332222 22222221
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
.....+.+++..+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 230 -~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 -FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11223445667899999999999999999999999999988764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=411.19 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=206.1
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
+.|+..+.||+|+||+||+|++ .+++.||||++... .....+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 4688889999999999999986 46889999998543 344567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
|++|+|.+++.. .+..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 91 ~~~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 164 (288)
T ss_dssp CTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred CCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence 999999999763 2456899999999999999999999887 999999999999999999999999999765321 1
Q ss_pred ccccccccCcccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 845 ECMSAIAGSYGYIAPEYAY-----TLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.......||+.|+|||++. ...|+.++||||+||++|||++|+.||........... +....
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~----i~~~~--------- 231 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK----IAKSE--------- 231 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH----HHHSC---------
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH----HHcCC---------
Confidence 2234568999999999874 45689999999999999999999999975433222221 11110
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
+.....+...+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111223445678899999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=411.62 Aligned_cols=250 Identities=21% Similarity=0.252 Sum_probs=204.5
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
++|+..+.||+|+||+||+|+. .+|+.||||++... ......+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688999999999999999987 46899999998432 12334567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+++|+|.+++.. .+.+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999999863 356899999999999999999999887 9999999999999999999999999999775443
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||... +.......+.... .
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~~~~~~~i~~~~-----------~ 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----NEYLIFQKIIKLE-----------Y 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHTTC-----------C
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc----CHHHHHHHHHcCC-----------C
Confidence 334445668999999999999999999999999999999999999999642 2222222222211 1
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..+...+..+.+++.+||+.||++|||++|+.+
T Consensus 228 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 123345567899999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=418.48 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=206.9
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++|+..+.||+|+||+||+|++ .+|+.||+|++..........++.+|+.++++++|||||+++++|.++++.|+||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5688899999999999999986 468999999996655555567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|++|+|.+++.+ ...+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||+|+.+.+.
T Consensus 86 ~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 86 MDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp CTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999963 3468999999999999999999996 47 999999999999999999999999999976432
Q ss_pred CccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh------------
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK------------ 911 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~------------ 911 (995)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.....................
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 223568999999999999999999999999999999999999999764332211111110000000
Q ss_pred ---------------hhhhhhcCCcCCC-CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 ---------------EEFLSILDPRLSM-VPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 ---------------~~~~~~~d~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...........+. .....+..+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000000000 111234678899999999999999999999873
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-47 Score=411.41 Aligned_cols=255 Identities=23% Similarity=0.284 Sum_probs=193.4
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
++.+.|+..+.||+|+||+||+|+.+ +++.||||++...........+.+|+.++++++|||||++++++.+++..|+|
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45677999999999999999999874 68999999986544444456688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC---CCCCeEEeeecccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN---SAFEAHVADFGLAKFL 838 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~---~~~~vkl~DfGla~~~ 838 (995)
||||+||+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||++. +++.+||+|||+|+..
T Consensus 86 mE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp ECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999999964 457999999999999999999999887 99999999999995 5789999999999875
Q ss_pred ccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 839 IDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 839 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.. ..+....+...... .
T Consensus 161 ~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~i~~~~~~-----~ 228 (307)
T d1a06a_ 161 DPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----DAKLFEQILKAEYE-----F 228 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHTTCCC-----C
T ss_pred cCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC----HHHHHHHHhccCCC-----C
Confidence 432 22345689999999999999999999999999999999999999996532 12222222221110 0
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. ...+...+..+.+++.+||+.||++|||++|++++
T Consensus 229 ~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 D---SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp C---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C---CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 11223455678999999999999999999999984
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=403.42 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=200.6
Q ss_pred CeeeccCceEEEEEEeC---CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEeccC
Q 001922 692 NVIGRGGAGIVYHGKMP---NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYMRN 767 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 767 (995)
++||+|+||+||+|.+. .++.||||++.... .....+++.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999753 35689999985432 23345679999999999999999999999965 467899999999
Q ss_pred CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC-cc
Q 001922 768 GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS-EC 846 (995)
Q Consensus 768 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~-~~ 846 (995)
|+|.+++.. ...+++..+.+++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+...... ..
T Consensus 92 g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999964 456899999999999999999999877 999999999999999999999999999876543322 22
Q ss_pred ccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCCCC
Q 001922 847 MSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLSMV 925 (995)
Q Consensus 847 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 925 (995)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+... .+....+..+ .....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----~~~~~~i~~~-----------~~~~~ 231 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKG-----------ERMGC 231 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTT-----------CCCCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----HHHHHHHHcC-----------CCCCC
Confidence 234578999999999999999999999999999999998 8999975332 2222222222 11223
Q ss_pred CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 926 PKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 926 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
|..++..+.+++.+||+.||++|||+++|++.|+.+
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 445667899999999999999999999999888754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=399.22 Aligned_cols=248 Identities=30% Similarity=0.431 Sum_probs=197.0
Q ss_pred ccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEec----CCcceEE
Q 001922 688 VKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN----KETNLLV 761 (995)
Q Consensus 688 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv 761 (995)
|+..+.||+|+||+||+|++. +++.||+|++.... .....+.+.+|++++++++|||||++++++.+ ....|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 345568999999999999764 68899999985433 33345678999999999999999999999864 3457999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC-CCCCeEEeeecccccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN-SAFEAHVADFGLAKFLID 840 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~-~~~~vkl~DfGla~~~~~ 840 (995)
|||+++|+|.+++.. ...+++..++.++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 91 mE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999963 356899999999999999999999652 3499999999999996 578999999999986422
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
......+||+.|+|||++.+ .++.++||||+||++|||++|+.||....+.. ...+.+..+....
T Consensus 168 ----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~---~~~~~i~~~~~~~------- 232 (270)
T d1t4ha_ 168 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA---QIYRRVTSGVKPA------- 232 (270)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---HHHHHHTTTCCCG-------
T ss_pred ----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH---HHHHHHHcCCCCc-------
Confidence 22345689999999998865 59999999999999999999999996543322 2222222221110
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
..+...+..+.+++.+||+.||++|||++|+++
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111223456889999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.5e-46 Score=412.42 Aligned_cols=255 Identities=23% Similarity=0.305 Sum_probs=209.4
Q ss_pred HHHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
++.++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3567899999999999999999986 46899999998543 233456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC--CCCeEEeeeccccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS--AFEAHVADFGLAKFLI 839 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~--~~~vkl~DfGla~~~~ 839 (995)
||||+||+|.+++.. ....+++..++.++.||+.||.|||+++ ||||||||+|||++. ++.+||+|||+|+.+.
T Consensus 102 mE~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 102 YEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp ECCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999999999863 3456999999999999999999999887 999999999999964 6789999999998764
Q ss_pred cCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+....+....... .
T Consensus 178 ~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~~~~~i~~~~~~~-----~ 245 (350)
T d1koaa2 178 PK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDETLRNVKSCDWNM-----D 245 (350)
T ss_dssp TT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHTCCCS-----C
T ss_pred cc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCC-----C
Confidence 32 23345789999999999999999999999999999999999999996432 222222222111000 0
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.......+..+.+++.+||+.||++|||++|++++
T Consensus 246 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 ---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112345678899999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.8e-46 Score=411.01 Aligned_cols=254 Identities=19% Similarity=0.224 Sum_probs=208.9
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.+.|+..+.||+|+||+||+|+. .+|+.||||++... .......+.+|++++++++|||||+++++|.+++..|+||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc-chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 456799999999999999999976 57999999998543 2234567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC--CCCCeEEeeecccccccc
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN--SAFEAHVADFGLAKFLID 840 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~--~~~~vkl~DfGla~~~~~ 840 (995)
|||+||+|.+++.. .+..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+.+..
T Consensus 106 E~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 106 EFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp ECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999999998753 3456999999999999999999999887 99999999999998 578999999999998644
Q ss_pred CCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
. .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+... .+....+......
T Consensus 182 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~-------- 246 (352)
T d1koba_ 182 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWE-------- 246 (352)
T ss_dssp T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHHCCCC--------
T ss_pred C---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCC--------
Confidence 3 233556899999999999999999999999999999999999999964322 1222222111100
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.........+..+.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011223345678899999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-46 Score=405.50 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=213.2
Q ss_pred HhhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 758 (995)
.++|+..+.||+|+||+||+|+++ +++.||||++.........++|.+|++++++++||||+++++++.+.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 457888999999999999999763 45789999986544444566799999999999999999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 001922 759 LLVYEYMRNGSLGEALHGKK----------------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKS 816 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp 816 (995)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+++ ||||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999986321 234789999999999999999999877 99999999
Q ss_pred CCEEECCCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCC
Q 001922 817 NNILLNSAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGR-RPVGDFGD 895 (995)
Q Consensus 817 ~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~Pf~~~~~ 895 (995)
+||+++.++.+||+|||+|+.+.+...........||+.|+|||.+.+..++.++|||||||++|||++|. .||....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~- 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA- 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC-
Confidence 99999999999999999998765544444445677899999999999999999999999999999999986 5664422
Q ss_pred CchHHHHHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 896 GVDIVQWSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
. .+....+..+ .....+..++..+.+++.+||+.||++||||.||+++|+++.
T Consensus 248 ~---~e~~~~v~~~-----------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 H---EEVIYYVRDG-----------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp H---HHHHHHHHTT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred H---HHHHHHHHcC-----------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2 2222222222 222234455678999999999999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-46 Score=403.84 Aligned_cols=248 Identities=24% Similarity=0.319 Sum_probs=202.5
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC--ChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceE
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLL 760 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 760 (995)
..+.|+..+.||+|+||+||+|+. .+++.||||++...... ...+.+.+|++++++++|||||++++++.+++..|+
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 345688899999999999999976 56889999998543322 223568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccccccc
Q 001922 761 VYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLID 840 (995)
Q Consensus 761 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~ 840 (995)
|||||++|++..++.. +..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 93 v~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999999877643 356899999999999999999999887 99999999999999999999999999986532
Q ss_pred CCCCccccccccCccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYT---LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
.....||+.|+|||++.+ ..|+.++||||+||++|||++|+.||..... . +....+.....
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~-~~~~~i~~~~~------ 231 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---M-SALYHIAQNES------ 231 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---H-HHHHHHHHSCC------
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---H-HHHHHHHhCCC------
Confidence 234579999999999864 4689999999999999999999999964322 1 11111111110
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
+ ...+...+..+.+++.+||+.||++|||++|+++
T Consensus 232 --~--~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 --P--ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --C--CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --C--CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 1112234567999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=400.98 Aligned_cols=254 Identities=22% Similarity=0.249 Sum_probs=207.6
Q ss_pred HHhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC-----CChhHHHHHHHHHHhccCCCCceeEeEEEecCCc
Q 001922 684 ILECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT-----HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKET 757 (995)
Q Consensus 684 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 757 (995)
+.++|+..+.||+|+||+||+|+. .+|+.||||++.+... ....+.+.+|++++++++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 456799999999999999999987 5789999999853221 2235679999999999999999999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC----CeEEeeec
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF----EAHVADFG 833 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~----~vkl~DfG 833 (995)
.|+|||||++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+|++|||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999999964 346999999999999999999999887 99999999999998876 49999999
Q ss_pred cccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
+|+....+ .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+....+.......
T Consensus 163 ~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 163 LAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANVSAVNYEF 235 (293)
T ss_dssp TCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHTTCCCC
T ss_pred hhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC----HHHHHHHHHhcCCCC
Confidence 99876433 22345689999999999999999999999999999999999999996432 222222222211100
Q ss_pred hhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 914 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. ...+...+..+.+++.+||+.||++|||++|++++
T Consensus 236 ~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 236 E--------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp C--------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C--------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00111245578899999999999999999999873
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=397.69 Aligned_cols=256 Identities=26% Similarity=0.360 Sum_probs=200.2
Q ss_pred hhccCCCeeeccCceEEEEEEeCC----CcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN----GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
++|+.++.||+|+||+||+|++.. +..||||++.........+.+.+|++++++++|||||++++++. .+..|+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 578899999999999999997643 45688998865444445667999999999999999999999996 4678999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|++.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||+|+.+...
T Consensus 86 ~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 86 MELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCC
Confidence 999999999998764 3456899999999999999999999877 999999999999999999999999999876433
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
.. .......||+.|+|||++.+..++.++|||||||++|||++ |..||....... +. ..+..+
T Consensus 162 ~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-~~---~~i~~~----------- 225 (273)
T d1mp8a_ 162 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VI---GRIENG----------- 225 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HH---HHHHTT-----------
T ss_pred cc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-HH---HHHHcC-----------
Confidence 22 22345678999999999999999999999999999999998 899986543322 11 112211
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
.....+..++..+.++|.+||+.||++|||++||++.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112234456678999999999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=394.97 Aligned_cols=250 Identities=29% Similarity=0.413 Sum_probs=199.9
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec-CCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN-KETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~ 764 (995)
++|+..+.||+|+||.||+|++ .|++||||+++. ....+.+.+|++++++++||||+++++++.+ .+..++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCC---CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECc---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 4577889999999999999998 578999999853 3345779999999999999999999999854 5668999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+++|+|.+++.......+++..+++++.||+.||.|||+.+ |+||||||+||+++.++.+|++|||+++....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~---- 155 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---- 155 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC----
Confidence 99999999997544456899999999999999999999777 99999999999999999999999999986532
Q ss_pred ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 845 ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......+|+.|+|||++.+..++.++|||||||++|||+| |+.||... +..++.. .+..+ ...
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~---~i~~~-----------~~~ 219 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVP---RVEKG-----------YKM 219 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHH---HHTTT-----------CCC
T ss_pred -CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHHH---HHHcC-----------CCC
Confidence 2234568899999999999999999999999999999998 67777543 2222222 22221 112
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
..+...+..+.+++.+||+.||++|||++|++++|+.++
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 234455678999999999999999999999999998875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=404.88 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=204.9
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCc----EEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGV----EIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
.|+..++||+|+||+||+|++. +|+ +||+|++.........+++.+|++++++++|||||++++++.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 4788899999999999999764 343 68999886555555677899999999999999999999999864 56788
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+.+|+|.+++.. ....+++..+++++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+|+.+...
T Consensus 89 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 89 TQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 999999999998874 3567899999999999999999999877 999999999999999999999999999987654
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCC
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDP 920 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 920 (995)
..........||+.|+|||++.++.++.++|||||||++|||+| |..||...... .+...+. .+
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~~~~~i~---~~----------- 229 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILE---KG----------- 229 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-GHHHHHH---HT-----------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-HHHHHHH---cC-----------
Confidence 44444445678999999999999999999999999999999999 78888654322 2222211 11
Q ss_pred cCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 921 RLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 921 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.....+..++..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 230 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1112344566789999999999999999999999999887654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=400.87 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=202.8
Q ss_pred hhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEec-CCc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSN-KET 757 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~ 757 (995)
++|+..+.||+|+||+||+|++. +++.||||++.........+.+.+|..++.++ +|+|||.+++++.+ +..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 57889999999999999999753 34689999986554444556688888888777 68999999998765 456
Q ss_pred ceEEEEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC
Q 001922 758 NLLVYEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS 823 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~ 823 (995)
.++|||||++|+|.++++... ...+++..+..++.||++||+|||+++ |+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECC
Confidence 899999999999999996432 345889999999999999999999877 999999999999999
Q ss_pred CCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCCchHHHH
Q 001922 824 AFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTG-RRPVGDFGDGVDIVQW 902 (995)
Q Consensus 824 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~Pf~~~~~~~~~~~~ 902 (995)
++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+|| ..||............
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999876554444444567899999999999999999999999999999999996 4577654433333222
Q ss_pred HHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 903 SKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 903 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
... + .....+...+..+.+++.+||+.||++|||++|++++|+++.+
T Consensus 250 ~~~---~-----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 250 LKE---G-----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHH---T-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hhc---C-----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 221 1 0112333456678999999999999999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=399.57 Aligned_cols=249 Identities=22% Similarity=0.231 Sum_probs=207.8
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.|+..+.||+|+||+||+|+. .+|+.||||++.+.. .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4688899999999999999986 579999999985321 2334567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
|||+||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 85 EYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence 99999999999964 456899999999999999999999887 999999999999999999999999999875432
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
.......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ..+....+....
T Consensus 159 -~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~----~~~~~~~i~~~~------------ 221 (337)
T d1o6la_ 159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERLFELILMEE------------ 221 (337)
T ss_dssp -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCC------------
T ss_pred -CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC----HHHHHHHHhcCC------------
Confidence 223356789999999999999999999999999999999999999996532 222222222211
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERPR-----MREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 957 (995)
...|...+..+.++|.+||+.||++||+ ++|++++
T Consensus 222 ~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1123445667899999999999999994 8888764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-44 Score=395.26 Aligned_cols=246 Identities=24% Similarity=0.285 Sum_probs=205.6
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.|+..+.||+|+||+||+|+. .+|+.||||++... ......+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999986 46899999998432 12234567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
|||+||++..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp CCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 99999999999863 456788899999999999999999777 99999999999999999999999999987633
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||... +..+....+....
T Consensus 157 ---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~~i~~~~------------ 217 (316)
T d1fota_ 157 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----NTMKTYEKILNAE------------ 217 (316)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHCC------------
T ss_pred ---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc----CHHHHHHHHHcCC------------
Confidence 224568999999999999999999999999999999999999999643 2222222222211
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQM 957 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 957 (995)
...+...+..+.+++.+|++.||++|| +++|++++
T Consensus 218 ~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 112334456788999999999999996 89999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=397.36 Aligned_cols=261 Identities=23% Similarity=0.369 Sum_probs=215.4
Q ss_pred hhccCCCeeeccCceEEEEEEe------CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM------PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETN 758 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 758 (995)
++|+.+++||+|+||.||+|++ .+++.||||++...........+.+|+.+++++ +|||||++++++.+++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5788899999999999999975 346789999997655555666789999999999 699999999999999999
Q ss_pred eEEEEeccCCChhhhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC
Q 001922 759 LLVYEYMRNGSLGEALHGKK----------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN 822 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~ 822 (995)
++|||||++|+|.++++... ...+++..+.+++.||+.||+|||+++ |+||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 99999999999999986432 236889999999999999999999887 99999999999999
Q ss_pred CCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCCCCchHHH
Q 001922 823 SAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTG-RRPVGDFGDGVDIVQ 901 (995)
Q Consensus 823 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~Pf~~~~~~~~~~~ 901 (995)
.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+|+ .+||........+.+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999987655444455567899999999999999999999999999999999995 555544333323322
Q ss_pred HHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 902 WSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 902 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
.+..-. ....+...+..+.++|.+||+.||++|||++||+++|+++..
T Consensus 260 ~i~~~~--------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 260 MIKEGF--------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHTC--------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCC--------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 222110 112233456779999999999999999999999999987643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=395.37 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=210.4
Q ss_pred hhccCCCeeeccCceEEEEEEeCC--------CcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCC
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN--------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKE 756 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 756 (995)
++|+.++.||+|+||.||+|+... +..||||++...........+.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578889999999999999997532 3479999996655555567788899999888 7999999999999999
Q ss_pred cceEEEEeccCCChhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC
Q 001922 757 TNLLVYEYMRNGSLGEALHGKK--------------GAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLN 822 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~ 822 (995)
..++||||+++|+|.+++.... ...+++..+.+++.||+.||+|||+.+ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 9999999999999999997543 245899999999999999999999887 99999999999999
Q ss_pred CCCCeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHH
Q 001922 823 SAFEAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQ 901 (995)
Q Consensus 823 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 901 (995)
.++.+||+|||+++...............+|+.|+|||.+.++.|+.++|||||||++|||++ |..||.+... .+
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----~~ 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----EE 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH----HH
Confidence 999999999999998766555555566789999999999999999999999999999999998 6888754321 12
Q ss_pred HHHHHhcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 902 WSKRATNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 902 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
....+..+ .....+...+..+.+++.+||+.||++|||++||++.|+++.
T Consensus 246 ~~~~i~~~-----------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 LFKLLKEG-----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHTT-----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcC-----------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 22222211 111233445667999999999999999999999999998763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=394.80 Aligned_cols=260 Identities=24% Similarity=0.323 Sum_probs=216.1
Q ss_pred hhccCCCeeeccCceEEEEEEeC------CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP------NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
++|+..+.||+|+||+||+|.+. +++.||||++...........|.+|++++++++|||||++++++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 57888899999999999999753 357899999965544445567899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEee
Q 001922 760 LVYEYMRNGSLGEALHG--------KKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVAD 831 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~--------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~D 831 (995)
+||||+++|+|.+++.. .....+++..+.+++.|+++||.|||+++ |+||||||+|||+++++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 99999999999999863 12245789999999999999999999877 99999999999999999999999
Q ss_pred eccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCCCCchHHHHHHHHhcCC
Q 001922 832 FGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGR-RPVGDFGDGVDIVQWSKRATNGR 910 (995)
Q Consensus 832 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~ 910 (995)
||+|+.+.............||+.|+|||.+.+..++.++||||||+++|||+||. .||... ...++...+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~----~~~~~~~~i~--- 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----SNEQVLRFVM--- 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CHHHHHHHHH---
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC----CHHHHHHHHH---
Confidence 99998775544444445567999999999999999999999999999999999985 666432 2222222222
Q ss_pred hhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 911 KEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 911 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
+......+..++..+.+++.+||+.+|++|||++||+++|++..+
T Consensus 250 --------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 --------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --------hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222233445566789999999999999999999999999998765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=397.64 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=208.6
Q ss_pred hhccCCCeeeccCceEEEEEEeCC-Cc--EEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPN-GV--EIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 761 (995)
++|+..++||+|+||+||+|++++ |. .||||++.........+.+.+|+++++++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 577888999999999999997743 43 47888875554555567799999999999 799999999999999999999
Q ss_pred EEeccCCChhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCe
Q 001922 762 YEYMRNGSLGEALHGK--------------KGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEA 827 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~v 827 (995)
|||+++|+|.++++.. ....+++..+..++.||+.||.|+|+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 3467999999999999999999999877 9999999999999999999
Q ss_pred EEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCC-CCCCCCCCchHHHHHHHH
Q 001922 828 HVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRR-PVGDFGDGVDIVQWSKRA 906 (995)
Q Consensus 828 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~-Pf~~~~~~~~~~~~~~~~ 906 (995)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||... +..+....+
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~----~~~~~~~~i 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TCAELYEKL 239 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHG
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC----CHHHHHHHH
Confidence 999999998653221 2234568999999999999999999999999999999999765 56432 222222222
Q ss_pred hcCChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCCCccc
Q 001922 907 TNGRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRHSSDF 968 (995)
Q Consensus 907 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 968 (995)
..+ .....+...+..+.++|.+||+.||++||||+||++.|+++.+..+..
T Consensus 240 ~~~-----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~ 290 (309)
T d1fvra_ 240 PQG-----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 290 (309)
T ss_dssp GGT-----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred Hhc-----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCC
Confidence 222 112234456678999999999999999999999999999987654433
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=396.58 Aligned_cols=254 Identities=21% Similarity=0.218 Sum_probs=206.5
Q ss_pred HHHhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEE
Q 001922 683 DILECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 683 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 761 (995)
++.++|++.+.||+|+||+||+|.++ +++.||||++... ......+.+|++++++++|||||++++++.+++..|+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 35678999999999999999999774 6889999998542 23345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC--CCeEEeeeccccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA--FEAHVADFGLAKFLI 839 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~--~~vkl~DfGla~~~~ 839 (995)
||||+||+|.+++.. .+..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||+++...
T Consensus 80 mE~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 80 FEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp ECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999999999964 3446899999999999999999999887 9999999999999854 479999999998763
Q ss_pred cCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD 919 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 919 (995)
.. .......+|+.|+|||...+..++.++||||+||++|+|++|+.||..... .+....+.........
T Consensus 156 ~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~---- 224 (321)
T d1tkia_ 156 PG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDE---- 224 (321)
T ss_dssp TT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTCCCCCH----
T ss_pred cC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCh----
Confidence 32 233456799999999999999999999999999999999999999965321 2222222221100000
Q ss_pred CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
......+..+.+++.+|++.||++|||++|++++
T Consensus 225 ----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 225 ----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001235568899999999999999999999873
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=391.58 Aligned_cols=256 Identities=29% Similarity=0.407 Sum_probs=206.4
Q ss_pred CCeeeccCceEEEEEEeCCC----cEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec-CCcceEEEEec
Q 001922 691 GNVIGRGGAGIVYHGKMPNG----VEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN-KETNLLVYEYM 765 (995)
Q Consensus 691 ~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~ 765 (995)
.++||+|+||+||+|++.++ ..||||++.........++|.+|++++++++|||||++++++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999987432 35899998655555556789999999999999999999999765 55789999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
++|+|.+++.. .....++..+.+++.|++.||.|+|+.+ |+||||||+|||+++++.+||+|||+++.+.......
T Consensus 112 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999874 4456778889999999999999999777 9999999999999999999999999998765433222
Q ss_pred --cccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcCC
Q 001922 846 --CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRLS 923 (995)
Q Consensus 846 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 923 (995)
......||+.|+|||++.+..++.++||||||+++|||+||+.||.......+... .+..+ ...
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~---~i~~g-----------~~~ 253 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQG-----------RRL 253 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH---HHHTT-----------CCC
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH---HHHcC-----------CCC
Confidence 22345689999999999999999999999999999999998888865433333222 22222 111
Q ss_pred CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCCC
Q 001922 924 MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPRH 964 (995)
Q Consensus 924 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 964 (995)
..|..++..+.++|.+||+.||++||+++||+++|+++...
T Consensus 254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 23344566799999999999999999999999999988653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-45 Score=387.91 Aligned_cols=257 Identities=24% Similarity=0.331 Sum_probs=197.6
Q ss_pred hhccCCCeeeccCceEEEEEEeC--C--CcEEEEEEecCCC--CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP--N--GVEIAVKKLLGFG--THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~--~--~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
++|+..+.||+|+||+||+|++. + ...||||++.... .....++|.+|+.++++++|||||++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 46888899999999999999753 2 2478999885432 22334679999999999999999999999976 4678
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+||||+++|++.+++.. ....+++..+.+++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 87 lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999998864 3456899999999999999999999877 9999999999999999999999999999875
Q ss_pred cCCCCc-cccccccCcccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCCCCchHHHHHHHHhcCChhhhhhh
Q 001922 840 DGGASE-CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLT-GRRPVGDFGDGVDIVQWSKRATNGRKEEFLSI 917 (995)
Q Consensus 840 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (995)
...... ......||..|+|||++.+..++.++|||||||++|||+| |+.||..... .+....+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~----~~~~~~i~~~~------- 231 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----SQILHKIDKEG------- 231 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTSC-------
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH----HHHHHHHHhCC-------
Confidence 443322 2234567889999999999999999999999999999998 8999965322 22222222210
Q ss_pred cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccC
Q 001922 918 LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEF 961 (995)
Q Consensus 918 ~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 961 (995)
.....+...+..+.+++.+||+.||++||||+||++.|++.
T Consensus 232 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ---ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122344556799999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-44 Score=384.60 Aligned_cols=253 Identities=25% Similarity=0.297 Sum_probs=205.1
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCC--------hhHHHHHHHHHHhccC-CCCceeEeEEEec
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHS--------HDHGFRAEIQTLGNIR-HRNIVRLLAFCSN 754 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 754 (995)
.++|+..+.||+|+||+||+|+. .+|+.||||++....... ..+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36788999999999999999986 578999999985433221 1235788999999997 9999999999999
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 755 KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 755 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
+++.|+|||||++|+|.+++.. .+.+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999964 457899999999999999999999888 99999999999999999999999999
Q ss_pred ccccccCCCCccccccccCccccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhc
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYT------LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATN 908 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~ 908 (995)
++.+.+.. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ....+.+..
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----~~~~~~i~~ 229 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----MLMLRMIMS 229 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHH
T ss_pred eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----HHHHHHHHh
Confidence 98764432 2245679999999998763 3468899999999999999999999965321 111122221
Q ss_pred CChhhhhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 909 GRKEEFLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 909 ~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+... . ........++.+.+++.+||+.||++||+++|++++
T Consensus 230 ~~~~-------~-~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 230 GNYQ-------F-GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TCCC-------C-CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCC-------C-CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1110 0 011223456679999999999999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-44 Score=389.85 Aligned_cols=261 Identities=27% Similarity=0.349 Sum_probs=201.4
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC--ChhHHHHHHHHHHhccCCCCceeEeEEEecCC----c
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH--SHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE----T 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~ 757 (995)
.++|++.+.||+|+||+||+|++ .+|+.||||++...... ....++.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46789999999999999999976 57999999999653332 23456899999999999999999999986644 3
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 7899999999999998853 356899999999999999999999887 99999999999999999999999999876
Q ss_pred cccCC-CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 838 LIDGG-ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 838 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
..... ........+||+.|+|||++.+..++.++||||+||++|||+||+.||..... .+............
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----VSVAYQHVREDPIP--- 233 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHCCCCC---
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH----HHHHHHHHhcCCCC---
Confidence 53322 22233456799999999999999999999999999999999999999964321 11111111110000
Q ss_pred hcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCC-CHHHHHHHHccCC
Q 001922 917 ILDPRLSMVPKEEAMHLLFVAMLCIQENSIERP-RMREVVQMLSEFP 962 (995)
Q Consensus 917 ~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~ 962 (995)
+ .......+..+.+++.+||+.||++|| +++++.+.|.++.
T Consensus 234 ---~--~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 ---P--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---G--GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---C--chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0 011223456788999999999999999 8999999887764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=395.78 Aligned_cols=253 Identities=23% Similarity=0.247 Sum_probs=201.1
Q ss_pred HHhhccCC-CeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhcc-CCCCceeEeEEEec----CC
Q 001922 684 ILECVKDG-NVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNI-RHRNIVRLLAFCSN----KE 756 (995)
Q Consensus 684 ~~~~~~~~-~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~----~~ 756 (995)
+.+.|++. +.||+|+||+||+|++ .+++.||||++.. ...+.+|+.++.++ +|||||+++++|++ ..
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 35678765 5699999999999976 5789999999842 35578899987655 89999999999865 46
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCCeEEeeec
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS---AFEAHVADFG 833 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~---~~~vkl~DfG 833 (995)
..|+|||||+||+|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+||+++. .+.+||+|||
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 7899999999999999998655567999999999999999999999887 999999999999986 5679999999
Q ss_pred cccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 834 LAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 834 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
+|+...... ......||+.|+|||++.+..|+.++||||+||++|+|+||+.||...............+....
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~--- 233 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--- 233 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS---
T ss_pred eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC---
Confidence 998764432 23456899999999999999999999999999999999999999965433222111111111100
Q ss_pred hhhhcCCcCC-CCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 914 FLSILDPRLS-MVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 914 ~~~~~d~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...+ ......+..+.+++.+||+.||++|||++|++++
T Consensus 234 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0011 1112456789999999999999999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-44 Score=394.78 Aligned_cols=245 Identities=20% Similarity=0.209 Sum_probs=205.7
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC--CCCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF--GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 762 (995)
++|+..+.||+|+||+||+|++ .+|+.||||++... ......+.+.+|++++++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5788999999999999999976 47999999998432 12234567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCC
Q 001922 763 EYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGG 842 (995)
Q Consensus 763 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~ 842 (995)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 99999999999964 346899999999999999999999887 999999999999999999999999999876322
Q ss_pred CCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCcC
Q 001922 843 ASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPRL 922 (995)
Q Consensus 843 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 922 (995)
.....||+.|||||++.+..++.++||||+||++|||+||+.||... +.......+....
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~~i~~~~------------ 254 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----QPIQIYEKIVSGK------------ 254 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCC------------
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc----CHHHHHHHHhcCC------------
Confidence 23568999999999999999999999999999999999999999642 2222222222211
Q ss_pred CCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 001922 923 SMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQ 956 (995)
Q Consensus 923 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 956 (995)
...+...+..+.+++.+||+.||.+|+ +++|+++
T Consensus 255 ~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 112334556789999999999999994 8999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.7e-44 Score=396.16 Aligned_cols=250 Identities=23% Similarity=0.237 Sum_probs=199.6
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHH---HHHHHhccCCCCceeEeEEEecCCcce
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRA---EIQTLGNIRHRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~---E~~~l~~l~hpniv~~~~~~~~~~~~~ 759 (995)
+.|++.+.||+|+||+||+|+.. +|+.||||++.+.. .......+.+ |+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 46888999999999999999864 68999999984211 1111223333 466777888999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
+|||||++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 84 ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999964 456889999999999999999999887 9999999999999999999999999998764
Q ss_pred cCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc
Q 001922 840 DGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL 918 (995)
Q Consensus 840 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (995)
.. .....+||+.|+|||++.. ..|+.++||||+||++|||+||+.||...... +.....+.....
T Consensus 159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~~~~~~~--------- 224 (364)
T d1omwa3 159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEIDRMTLTM--------- 224 (364)
T ss_dssp SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-CHHHHHHHSSSC---------
T ss_pred CC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccC---------
Confidence 32 2245689999999999864 56899999999999999999999999754322 222221111111
Q ss_pred CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCC-----HHHHHHH
Q 001922 919 DPRLSMVPKEEAMHLLFVAMLCIQENSIERPR-----MREVVQM 957 (995)
Q Consensus 919 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 957 (995)
....+...+..+.++|.+||+.||++||| ++|++++
T Consensus 225 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 ---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11223345667899999999999999999 6888754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=391.32 Aligned_cols=248 Identities=24% Similarity=0.307 Sum_probs=202.5
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCC--CCChhHHHHHHHHHHh-ccCCCCceeEeEEEecCCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFG--THSHDHGFRAEIQTLG-NIRHRNIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv 761 (995)
++|+..+.||+|+||+||+|+.+ +++.||||++.+.. .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46888999999999999999774 68999999985321 2233455666766654 68999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccC
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDG 841 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~ 841 (995)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999963 456889999999999999999999887 999999999999999999999999999865432
Q ss_pred CCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcCCc
Q 001922 842 GASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILDPR 921 (995)
Q Consensus 842 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 921 (995)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+....+... .+
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~----~~~~~~~i~~~---------~~- 220 (320)
T d1xjda_ 157 --DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHSIRMD---------NP- 220 (320)
T ss_dssp --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC---------CC-
T ss_pred --cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC----HHHHHHHHHcC---------CC-
Confidence 223345689999999999999999999999999999999999999996432 22222222211 11
Q ss_pred CCCCCHHHHHHHHHHHhcccCCCCCCCCCHH-HHHH
Q 001922 922 LSMVPKEEAMHLLFVAMLCIQENSIERPRMR-EVVQ 956 (995)
Q Consensus 922 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 956 (995)
..|...+..+.+++.+||+.||++||++. |+++
T Consensus 221 --~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 12334566789999999999999999985 6754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=385.57 Aligned_cols=259 Identities=22% Similarity=0.248 Sum_probs=197.3
Q ss_pred CCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCC----hhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEec
Q 001922 691 GNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHS----HDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEYM 765 (995)
Q Consensus 691 ~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 765 (995)
.++||+|+||+||+|++ .+|+.||||++....... ....+.+|++++++++|||||++++++.++++.|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 36799999999999986 468999999985432221 1346889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCCc
Q 001922 766 RNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGASE 845 (995)
Q Consensus 766 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 845 (995)
.++++..+.. .+..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...... .
T Consensus 83 ~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--R 155 (299)
T ss_dssp SEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--C
T ss_pred cchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--c
Confidence 9887776663 4566888899999999999999999887 9999999999999999999999999998764432 2
Q ss_pred cccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhcC-----
Q 001922 846 CMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSILD----- 919 (995)
Q Consensus 846 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d----- 919 (995)
.....+||+.|+|||++... .++.++||||+||++|||++|+.||....+...+....+.........+.....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 23456799999999998654 579999999999999999999999965433322222222221111111110000
Q ss_pred --CcCCCCC-----HHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 920 --PRLSMVP-----KEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 920 --~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
......+ ...+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0011111 123567899999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=382.95 Aligned_cols=266 Identities=20% Similarity=0.257 Sum_probs=203.2
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
++|+..+.||+|+||+||+|++ .+|+.||||++..... ....+++.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4688899999999999999986 5789999999854322 2235678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
|+.+ ++.+++.......+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-- 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-- 155 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC--
Confidence 9976 5555554455677999999999999999999999887 999999999999999999999999999876432
Q ss_pred CccccccccCcccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc---C
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLR-VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL---D 919 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---d 919 (995)
........||+.|+|||+..... ++.++||||+||++|+|++|+.||............................ +
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 22334568999999999877665 4789999999999999999999997543222222222221111111111000 0
Q ss_pred --Cc---CCCC-----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 920 --PR---LSMV-----PKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 920 --~~---~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.. .... ....+..+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 0000 11234678899999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=387.29 Aligned_cols=264 Identities=27% Similarity=0.333 Sum_probs=199.9
Q ss_pred HhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHH--HHHHHHhccCCCCceeEeEEEecCC----cc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFR--AEIQTLGNIRHRNIVRLLAFCSNKE----TN 758 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~--~E~~~l~~l~hpniv~~~~~~~~~~----~~ 758 (995)
.+.|...+.||+|+||+||+|++ +|+.||||++.. .....+. .|+..+.+++|||||++++++.+.+ ..
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~----~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECc----cchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 35677788999999999999987 688999999843 2233333 4555566789999999999986543 57
Q ss_pred eEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEECCCCCeEEeeec
Q 001922 759 LLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC-----SPLIVHRDVKSNNILLNSAFEAHVADFG 833 (995)
Q Consensus 759 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----~~~iiHrDlkp~Nill~~~~~vkl~DfG 833 (995)
|+|||||++|+|.+++++. .+++..+++++.|+|.||+|+|..+ +++|+||||||+|||++.++.+||+|||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 8999999999999999753 5899999999999999999999631 2459999999999999999999999999
Q ss_pred cccccccCCCC--ccccccccCcccccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCCCCc--------
Q 001922 834 LAKFLIDGGAS--ECMSAIAGSYGYIAPEYAYTL------RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGV-------- 897 (995)
Q Consensus 834 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~-------- 897 (995)
+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||+||..||.......
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 99876543322 123456799999999998754 36779999999999999999998875422111
Q ss_pred ---hHHHHHHHHhcCChhhhhhhcCCcCCC--CCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCCC
Q 001922 898 ---DIVQWSKRATNGRKEEFLSILDPRLSM--VPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFPR 963 (995)
Q Consensus 898 ---~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 963 (995)
........... ....+..+. .+.+....+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 234 ~~~~~~~~~~~~~~-------~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 234 SDPSVEEMRKVVCE-------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SSCCHHHHHHHHTT-------SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhc-------cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11111111111 111122211 123566779999999999999999999999999998764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.6e-43 Score=378.64 Aligned_cols=264 Identities=20% Similarity=0.247 Sum_probs=203.4
Q ss_pred hhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEEe
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYEY 764 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 764 (995)
++|+..++||+|+||+||+|++++|+.||||++.... ......++.+|+.++++++|||||++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999999999999985432 223356799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCCC
Q 001922 765 MRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGAS 844 (995)
Q Consensus 765 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 844 (995)
+.++.+..+.. ....+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 98877766663 4567999999999999999999999887 9999999999999999999999999998764332
Q ss_pred ccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhhhc-----
Q 001922 845 ECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLSIL----- 918 (995)
Q Consensus 845 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 918 (995)
.......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+........+............+....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 223445689999999998754 56899999999999999999999997643322222222222211111111000
Q ss_pred CCcC--------CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 919 DPRL--------SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 919 d~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
+... .......+..+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0112234567889999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-43 Score=380.93 Aligned_cols=270 Identities=19% Similarity=0.234 Sum_probs=203.4
Q ss_pred hhccCCCeeeccCceEEEEEEe-CC-CcEEEEEEecCCC-CCChhHHHHHHHHHHhcc---CCCCceeEeEEEec-----
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PN-GVEIAVKKLLGFG-THSHDHGFRAEIQTLGNI---RHRNIVRLLAFCSN----- 754 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~-~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~----- 754 (995)
++|++.+.||+|+||+||+|++ ++ ++.||||++.... .......+.+|+.+++.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6799999999999999999986 34 5678999984322 222334566788887766 79999999999843
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 755 KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 755 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
....+++|||++++.+..... .....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhh
Confidence 346799999998876655443 45567899999999999999999999887 99999999999999999999999999
Q ss_pred ccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 835 AKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 835 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
++.... ........||+.|+|||++.+..|+.++||||+||++|||++|+.||....+...+..............+
T Consensus 163 ~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 163 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 886432 23345678999999999999999999999999999999999999999754333333332222221111111
Q ss_pred hhh-----------cCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCC
Q 001922 915 LSI-----------LDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFP 962 (995)
Q Consensus 915 ~~~-----------~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 962 (995)
... ............+..+.+++.+||+.||++|||++|++++ ++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 100 0000111223345678899999999999999999999874 54443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=377.39 Aligned_cols=241 Identities=21% Similarity=0.353 Sum_probs=195.8
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCC-----ChhHHHHHHHHHHhccC--CCCceeEeEEEecCCc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTH-----SHDHGFRAEIQTLGNIR--HRNIVRLLAFCSNKET 757 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~ 757 (995)
++|++++.||+|+||+||+|+. .+|+.||||++...... ....++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5789999999999999999976 57899999998532211 11234678999999996 8999999999999999
Q ss_pred ceEEEEeccC-CChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CCeEEeeeccc
Q 001922 758 NLLVYEYMRN-GSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSA-FEAHVADFGLA 835 (995)
Q Consensus 758 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~-~~vkl~DfGla 835 (995)
.|+||||+.+ +++.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.+ +.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 577788753 456899999999999999999999887 9999999999999854 78999999999
Q ss_pred cccccCCCCccccccccCcccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhh
Q 001922 836 KFLIDGGASECMSAIAGSYGYIAPEYAYTLRV-DEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEF 914 (995)
Q Consensus 836 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 914 (995)
+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||... + + +...
T Consensus 159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~--~----i~~~----- 219 (273)
T d1xwsa_ 159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E--E----IIRG----- 219 (273)
T ss_dssp EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H--H----HHHC-----
T ss_pred eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----h--H----Hhhc-----
Confidence 865332 2345689999999999987776 57799999999999999999999541 0 0 1111
Q ss_pred hhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 915 LSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 915 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. ...+...+..+.+++.+||+.||++|||++|++++
T Consensus 220 ------~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 ------Q-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------C-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------c-cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 01122345678999999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-41 Score=367.15 Aligned_cols=267 Identities=19% Similarity=0.235 Sum_probs=199.3
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCC-CCCChhHHHHHHHHHHhccCCCCceeEeEEEec--------
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGF-GTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN-------- 754 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------- 754 (995)
.++|++.+.||+|+||+||+|++ .+|+.||||++... .......++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999986 57999999998433 233445678899999999999999999998854
Q ss_pred CCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecc
Q 001922 755 KETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGL 834 (995)
Q Consensus 755 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGl 834 (995)
.+..|+||||+.++.+.... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 34679999999887766554 34567889999999999999999999887 99999999999999999999999999
Q ss_pred ccccccCCC--CccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh
Q 001922 835 AKFLIDGGA--SECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK 911 (995)
Q Consensus 835 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 911 (995)
++.+..... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||....+........+ ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~-~~~~~~ 242 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ-LCGSIT 242 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH-hcCCCC
Confidence 987643221 1223346799999999998765 689999999999999999999999965432222222222 221111
Q ss_pred hhhhhhcCC----------cC-CCCCH------HHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 EEFLSILDP----------RL-SMVPK------EEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 ~~~~~~~d~----------~~-~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
.......+. .. ..... .....+.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 111110000 00 00001 123456789999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-41 Score=372.47 Aligned_cols=265 Identities=26% Similarity=0.302 Sum_probs=198.3
Q ss_pred hccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEec------CCcce
Q 001922 687 CVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN------KETNL 759 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~~ 759 (995)
.|+..++||+|+||+||+|++. +|+.||||++...... ..+|++++++++||||++++++|.. ..+.+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 4777889999999999999874 6899999998543222 3469999999999999999999843 23568
Q ss_pred EEEEeccCCChhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-CeEEeeeccccc
Q 001922 760 LVYEYMRNGSLGEALH-GKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLAKF 837 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~-~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-~vkl~DfGla~~ 837 (995)
+|||||+++.+..+.. ......+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 9999998754443332 134557899999999999999999999777 99999999999999875 899999999987
Q ss_pred cccCCCCccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
+.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........+....+.........+..
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 64432 2345689999999998765 5689999999999999999999999975443333333332222221111111
Q ss_pred hcCC----cC---------CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCC
Q 001922 917 ILDP----RL---------SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFP 962 (995)
Q Consensus 917 ~~d~----~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 962 (995)
.... .. .......+..+.+++.+||+.||++|||++|++++ ++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 1110 00 01122345678899999999999999999999964 55554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=375.55 Aligned_cols=267 Identities=21% Similarity=0.264 Sum_probs=198.6
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCceeEeEEEecCC----cce
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE----TNL 759 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~ 759 (995)
..+|+..+.||+|+||+||+|+. .+|+.||||++.........+++.+|+.++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35788999999999999999975 5799999999965444444567899999999999999999999996543 235
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccc
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLI 839 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~ 839 (995)
++++|+.+|+|.+++... .+++..++.++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 566677799999999643 5899999999999999999999887 9999999999999999999999999998754
Q ss_pred cCCC-CccccccccCccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh-
Q 001922 840 DGGA-SECMSAIAGSYGYIAPEYAYT-LRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS- 916 (995)
Q Consensus 840 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 916 (995)
.... .......+||+.|+|||++.. ..++.++||||+||++|||++|+.||..........................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 3322 122345679999999999854 4578999999999999999999999965432211111111111110000000
Q ss_pred --------h-cCCcCCCCC-----HHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 917 --------I-LDPRLSMVP-----KEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 917 --------~-~d~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
. ..+.....+ ...+..+.+++.+|++.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000001111 1223468899999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-40 Score=360.75 Aligned_cols=261 Identities=19% Similarity=0.224 Sum_probs=206.2
Q ss_pred hhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCCCChhHHHHHHHHHHhccCC-CCceeEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH-RNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 763 (995)
++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+|+++++.++| +|++.+++++.++...++|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc---CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 57889999999999999999864 68899999874332 23447789999999965 899999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-----CCCeEEeeecccccc
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS-----AFEAHVADFGLAKFL 838 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~-----~~~vkl~DfGla~~~ 838 (995)
|+ +++|.+++.. .+..+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+|+.+
T Consensus 82 ~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 6899999864 3456899999999999999999999777 999999999999975 578999999999876
Q ss_pred ccCCCC-----ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh
Q 001922 839 IDGGAS-----ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE 913 (995)
Q Consensus 839 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 913 (995)
.+.... .......||+.|||||++.+..++.++||||+||++|||++|+.||.............+ +.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~-i~~~~~~~ 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEKKQST 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-HHHHHHHS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH-HHhccCCC
Confidence 543221 123356799999999999999999999999999999999999999976544433322211 11100000
Q ss_pred hhhhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 914 FLSILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 914 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
... ......+.++.+++..|++.+|++||+++.+.+.|+++.
T Consensus 236 ~~~-------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 236 PLR-------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp CHH-------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ChH-------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 000 011123456889999999999999999999998887754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-40 Score=362.47 Aligned_cols=261 Identities=18% Similarity=0.223 Sum_probs=198.5
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCce-eEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNIV-RLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e 763 (995)
++|+..+.||+|+||+||+|++ .+|+.||||++..... ..++..|++++++++|++++ .+.+++.+++..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 4688999999999999999976 5689999998754322 23478899999999876655 55566678888999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCCeEEeeecccccccc
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNS---AFEAHVADFGLAKFLID 840 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~---~~~vkl~DfGla~~~~~ 840 (995)
|+ ++++.+.+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+|++|||+|+.+.+
T Consensus 84 ~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 84 LL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred Ec-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99 5577776653 3457899999999999999999999887 999999999999864 45799999999998754
Q ss_pred CCCC-----ccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 841 GGAS-----ECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 841 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-
Confidence 3322 1234567999999999999999999999999999999999999999765443322222111110000000
Q ss_pred hhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHHHccCC
Q 001922 916 SILDPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQMLSEFP 962 (995)
Q Consensus 916 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 962 (995)
+.....++.++.+++.+||+.+|++||+++++.+.|+.+.
T Consensus 238 -------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 238 -------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred -------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0011234567899999999999999999999988888753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=358.84 Aligned_cols=265 Identities=23% Similarity=0.246 Sum_probs=208.8
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCC-CCChhHHHHHHHHHHhccCCCCceeEeEEEecCCcceEEEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFG-THSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKETNLLVYE 763 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 763 (995)
++|+..+.||+|+||+||+|++ .+++.||||++.... ......++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4788999999999999999986 578899999985433 23346778999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccccccCCC
Q 001922 764 YMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKFLIDGGA 843 (995)
Q Consensus 764 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 843 (995)
++.++++..++. ..+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999988875 3467889999999999999999999887 99999999999999999999999999987644322
Q ss_pred CccccccccCcccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhh----hhhhc
Q 001922 844 SECMSAIAGSYGYIAPEYAYTLR-VDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEE----FLSIL 918 (995)
Q Consensus 844 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 918 (995)
......+++.|+|||.+.... ++.++||||+||++|||++|+.||....+..+............... .....
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 223456788999999887665 68999999999999999999999865544443333322222211110 00000
Q ss_pred C----------CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 919 D----------PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 919 d----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
+ ..........+..+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 01112233455678899999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=369.85 Aligned_cols=265 Identities=23% Similarity=0.315 Sum_probs=198.5
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecCC------
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNKE------ 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 756 (995)
.++|+..+.||+|+||+||+|++ .+|+.||||++..... ....+.+.+|++++++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46789999999999999999976 4699999999954322 223456889999999999999999999997654
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
+.|+||||+ +.+|..+.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 569999999 5688887753 45999999999999999999999887 9999999999999999999999999998
Q ss_pred ccccCCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||........+.......... ...+.
T Consensus 170 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~ 243 (346)
T d1cm8a_ 170 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP-PAEFV 243 (346)
T ss_dssp ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC-CHHHH
T ss_pred ccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCC-cHHHH
Confidence 7532 23456799999999998764 56899999999999999999999996543222222222211111 01000
Q ss_pred hh------------c----CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCC
Q 001922 916 SI------------L----DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFP 962 (995)
Q Consensus 916 ~~------------~----d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 962 (995)
.. . ...+.......+..+.+++.+||+.||++|||++|++++ ++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00 0 001111222345667899999999999999999999985 65554
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.2e-40 Score=365.94 Aligned_cols=291 Identities=33% Similarity=0.536 Sum_probs=227.4
Q ss_pred cccchHHHHHHHHHhCCCCCCCCCCCCCCCCCCCc--eeeeEEeCC----CceeeeecCCCCccc--cCCccccCCCCCC
Q 001922 24 SLVNDFHVLVALKQGFENPEPALISWNSSNPSSVC--SWAGICCSR----DRVASLDLTDLNLCG--SVPAQILRLDKLT 95 (995)
Q Consensus 24 ~~~~~~~~Ll~~k~~~~~~~~~l~~W~~~~~~~~C--~w~gv~C~~----~~v~~l~l~~~~l~~--~~~~~~~~l~~L~ 95 (995)
|.++|++||++||++++||. .+++|..+ +||| .|.||+|+. .||++|||++++++| .+|+.|++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~--~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTT--SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCCC--CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 67889999999999999985 69999865 5799 599999975 379999999999988 5889999999999
Q ss_pred eEeccC-CcccCcc--ccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCc
Q 001922 96 NLSLAG-NNFTGSI--EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGN 172 (995)
Q Consensus 96 ~L~L~~-n~l~~~~--~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N 172 (995)
+|+|++ |+++|.+ .+++|++|++|+|++|+|.+..+..+..+.+|+++++++|.+.+.+|..+.++++|+++++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 999986 7888754 5888888888888888888888888888888888888888888888888888888888888888
Q ss_pred cccccCCccccCCCCC-ceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCcc
Q 001922 173 YFFGKIPNSYGELQGL-EYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQI 251 (995)
Q Consensus 173 ~l~~~~p~~l~~l~~L-~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 251 (995)
.+++.+|..+..+.++ +.+++++|++++..|..++++. +..++++++...+.+
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~--------------------------~~~l~l~~~~~~~~~ 213 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN--------------------------LAFVDLSRNMLEGDA 213 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC--------------------------CSEEECCSSEEEECC
T ss_pred ccccccccccccccccccccccccccccccccccccccc--------------------------ccccccccccccccc
Confidence 8888888888777775 7788888888877666554432 234666666666666
Q ss_pred CccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCC
Q 001922 252 PHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLP 331 (995)
Q Consensus 252 ~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 331 (995)
|..+..+++|+.+++++|.+.+.+| .+..+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|. +++++
T Consensus 214 ~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~ 291 (313)
T d1ogqa_ 214 SVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQ 291 (313)
T ss_dssp GGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGG
T ss_pred ccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCC
Confidence 6666667777777777777765544 466677777777777777777777777777777777777777777774 46677
Q ss_pred CcceEEeccCc-ccc
Q 001922 332 NLETLGLWQNN-FTG 345 (995)
Q Consensus 332 ~L~~L~L~~N~-l~~ 345 (995)
+|+.+++++|+ +.|
T Consensus 292 ~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 292 RFDVSAYANNKCLCG 306 (313)
T ss_dssp GSCGGGTCSSSEEES
T ss_pred CCCHHHhCCCccccC
Confidence 77777787776 444
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-41 Score=367.07 Aligned_cols=253 Identities=25% Similarity=0.271 Sum_probs=204.8
Q ss_pred hhccCCCeeeccCceEEEEEEe----CCCcEEEEEEecCCC---CCChhHHHHHHHHHHhccCC-CCceeEeEEEecCCc
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM----PNGVEIAVKKLLGFG---THSHDHGFRAEIQTLGNIRH-RNIVRLLAFCSNKET 757 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~ 757 (995)
++|+..+.||+|+||+||+|+. .+|+.||||++.... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999975 247899999985321 12234567889999999976 899999999999999
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.++||||+.+|+|.+++.. ....++..+..++.||+.|+.|+|+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999963 345778889999999999999999887 99999999999999999999999999987
Q ss_pred cccCCCCccccccccCcccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTL--RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFL 915 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (995)
+..... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||....................
T Consensus 179 ~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~----- 252 (322)
T d1vzoa_ 179 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----- 252 (322)
T ss_dssp CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-----
T ss_pred hccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC-----
Confidence 643322 223456799999999998754 467899999999999999999999987655444443333222111
Q ss_pred hhcCCcCCCCCHHHHHHHHHHHhcccCCCCCCCC-----CHHHHHH
Q 001922 916 SILDPRLSMVPKEEAMHLLFVAMLCIQENSIERP-----RMREVVQ 956 (995)
Q Consensus 916 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 956 (995)
...+...+..+.+++.+||++||++|| |++|+++
T Consensus 253 -------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 113345677899999999999999999 4788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-39 Score=359.90 Aligned_cols=256 Identities=23% Similarity=0.253 Sum_probs=199.3
Q ss_pred hhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEec--CCcceEE
Q 001922 686 ECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSN--KETNLLV 761 (995)
Q Consensus 686 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv 761 (995)
++|++.++||+|+||+||+|+. .+|+.||||++.. ...+++.+|++++++++ ||||++++++|.. ....++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 5799999999999999999987 5689999999843 33567899999999995 9999999999974 3568999
Q ss_pred EEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-CeEEeeecccccccc
Q 001922 762 YEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAF-EAHVADFGLAKFLID 840 (995)
Q Consensus 762 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~-~vkl~DfGla~~~~~ 840 (995)
|||+.+++|.+.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+...+
T Consensus 111 ~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 111 FEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999998765 24889999999999999999999888 99999999999998765 589999999987644
Q ss_pred CCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHh------------
Q 001922 841 GGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRAT------------ 907 (995)
Q Consensus 841 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~------------ 907 (995)
.. ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....+..+.........
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 32 23456799999999998765 479999999999999999999999976544332221111111
Q ss_pred -cCChhhhhhhcCCcC---------CCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHH
Q 001922 908 -NGRKEEFLSILDPRL---------SMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQ 956 (995)
Q Consensus 908 -~~~~~~~~~~~d~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 956 (995)
......+........ .......+.++.+++.+|++.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111111111000 0111234567889999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-40 Score=364.80 Aligned_cols=262 Identities=21% Similarity=0.204 Sum_probs=192.4
Q ss_pred HhhccCCCeeeccCceEEEEEEeC-CCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEec------CC
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKMP-NGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSN------KE 756 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 756 (995)
.++|++.++||+|+||+||+|++. +|+.||||++..... .....++.+|+.++++++|||||+++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 467999999999999999999864 699999999954332 2334568899999999999999999999953 36
Q ss_pred cceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 757 TNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 757 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
+.|+||||+.++.+ +.+. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eeEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 78999999976544 4443 34789999999999999999999888 9999999999999999999999999988
Q ss_pred ccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCCh-----
Q 001922 837 FLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRK----- 911 (995)
Q Consensus 837 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~----- 911 (995)
..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||....+................
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 65332 2334567999999999999999999999999999999999999999654322222222211111100
Q ss_pred --hhhhhh---------------c----CCcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q 001922 912 --EEFLSI---------------L----DPRLSMVPKEEAMHLLFVAMLCIQENSIERPRMREVVQM 957 (995)
Q Consensus 912 --~~~~~~---------------~----d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 957 (995)
...... . .+.........+..+.+++.+|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 0 011111123467789999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-39 Score=359.57 Aligned_cols=266 Identities=21% Similarity=0.265 Sum_probs=198.5
Q ss_pred HhhccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCC-CChhHHHHHHHHHHhccCCCCceeEeEEEecC-----Cc
Q 001922 685 LECVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGT-HSHDHGFRAEIQTLGNIRHRNIVRLLAFCSNK-----ET 757 (995)
Q Consensus 685 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 757 (995)
.++|+..+.||+|+||+||+|++ .+|+.||||++..... ....+++.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 35799999999999999999976 5799999999854332 22345688999999999999999999998643 34
Q ss_pred ceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 758 NLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 758 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.+++|+|+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+|++|||.+..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 4677888889999999953 35999999999999999999999887 99999999999999999999999999975
Q ss_pred cccCCCCccccccccCcccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCCCCchHHHHHHHHhcCChhhhhh
Q 001922 838 LIDGGASECMSAIAGSYGYIAPEYAYTL-RVDEKSDVYSFGVVLLELLTGRRPVGDFGDGVDIVQWSKRATNGRKEEFLS 916 (995)
Q Consensus 838 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (995)
.. .......||+.|+|||...+. .++.++||||+||++|+|++|+.||................... ......
T Consensus 171 ~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~-~~~~~~ 244 (348)
T d2gfsa1 171 TD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP-GAELLK 244 (348)
T ss_dssp CT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CHHHHT
T ss_pred cC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC-ChHHhh
Confidence 42 233456799999999987665 46899999999999999999999996543222222221111111 111000
Q ss_pred ---------hcC--CcCCCC-----CHHHHHHHHHHHhcccCCCCCCCCCHHHHHHH--HccCC
Q 001922 917 ---------ILD--PRLSMV-----PKEEAMHLLFVAMLCIQENSIERPRMREVVQM--LSEFP 962 (995)
Q Consensus 917 ---------~~d--~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 962 (995)
... ...... ....+..+.+++.+|++.||++|||++|++++ ++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000 000111 11234568899999999999999999999973 55443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-34 Score=319.02 Aligned_cols=261 Identities=19% Similarity=0.174 Sum_probs=191.5
Q ss_pred hccCCCeeeccCceEEEEEEe-CCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-----------CCCceeEeEEEec
Q 001922 687 CVKDGNVIGRGGAGIVYHGKM-PNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-----------HRNIVRLLAFCSN 754 (995)
Q Consensus 687 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~~~~ 754 (995)
+|++.++||+|+||+||+|+. .+|+.||||++... ....+.+.+|+++++++. |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 588999999999999999986 57999999998532 223456788999888775 5789999988754
Q ss_pred --CCcceEEEEeccCCCh-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCCC-----
Q 001922 755 --KETNLLVYEYMRNGSL-GEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH-DCSPLIVHRDVKSNNILLNSAF----- 825 (995)
Q Consensus 755 --~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~iiHrDlkp~Nill~~~~----- 825 (995)
....+++|+++..+.. ............++..+..++.||+.|++|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3455677777655433 333334556778899999999999999999997 66 99999999999998765
Q ss_pred -CeEEeeeccccccccCCCCccccccccCcccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCCCCC---ch---
Q 001922 826 -EAHVADFGLAKFLIDGGASECMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELLTGRRPVGDFGDG---VD--- 898 (995)
Q Consensus 826 -~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~---~~--- 898 (995)
.++++|||.+..... ......||+.|+|||++....++.++||||+||++++|++|+.||...... ..
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 389999999986432 224567999999999999999999999999999999999999999653221 11
Q ss_pred HHHHHHHHhcCChhhh------hhhcC--------------------CcCCCCCHHHHHHHHHHHhcccCCCCCCCCCHH
Q 001922 899 IVQWSKRATNGRKEEF------LSILD--------------------PRLSMVPKEEAMHLLFVAMLCIQENSIERPRMR 952 (995)
Q Consensus 899 ~~~~~~~~~~~~~~~~------~~~~d--------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 952 (995)
+............... ....+ ..........+..+.+++.+|+..||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111111111000000 00000 001123467788999999999999999999999
Q ss_pred HHHHH
Q 001922 953 EVVQM 957 (995)
Q Consensus 953 evl~~ 957 (995)
|++++
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99874
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.7e-33 Score=308.52 Aligned_cols=259 Identities=29% Similarity=0.494 Sum_probs=185.3
Q ss_pred CCCEEEccCCcCCC--CCCccccCCCCcceEEecc-CcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCcccee
Q 001922 308 QLKLFNLFMNRLHG--SIPDYLADLPNLETLGLWQ-NNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRIL 384 (995)
Q Consensus 308 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 384 (995)
+++.|+|++|.++| .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+..|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 46667777776666 3566666667777777765 66666666666666666666666666666666555555555555
Q ss_pred eccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCC
Q 001922 385 ILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNN 464 (995)
Q Consensus 385 ~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N 464 (995)
+++.|.+.+.+|..+.+++.++.+++++ |
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~---------------------------------------------------n 159 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDG---------------------------------------------------N 159 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCS---------------------------------------------------S
T ss_pred ccccccccccCchhhccCcccceeeccc---------------------------------------------------c
Confidence 5555555555555554444444444444 4
Q ss_pred cccccCCccccCCCCC-cEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCc
Q 001922 465 LLSGPLPFSLSNFSSL-QILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIP 543 (995)
Q Consensus 465 ~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip 543 (995)
.+++.+|..+..+..+ +.+++++|++++..|..++.+..+ .+++++|.+.|.+|..++.+++|+.|++++|.+++.+|
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~ 238 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence 4444455555555443 666777777776666666665444 57778888888888888888888888888888886554
Q ss_pred cccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCCCCCCCcccccccCCCCccCCCCCCCCCCC
Q 001922 544 PEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCGTLLNNPCN 620 (995)
Q Consensus 544 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~c~ 620 (995)
+++.+++|+.|+|++|+|+|.+|..++++++|+.|||++|+|+|.||+.+.++.+...++.||+.+||.|+| +|.
T Consensus 239 -~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c~ 313 (313)
T d1ogqa_ 239 -KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-ACT 313 (313)
T ss_dssp -GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CCC
T ss_pred -ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CCC
Confidence 678888888888888888888888888899999999999999999998888888999999999999999998 884
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=5.7e-29 Score=280.69 Aligned_cols=97 Identities=22% Similarity=0.209 Sum_probs=57.9
Q ss_pred eccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCcccccc
Q 001922 98 SLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGK 177 (995)
Q Consensus 98 ~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~ 177 (995)
.++.+.+++.+....+.+|++|++++|.|+.+ ..+..+++|++|++++|+|+++. .++++++|++|++++|++.+.
T Consensus 28 ~l~~~~~~~~~~~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i 103 (384)
T d2omza2 28 VLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADI 103 (384)
T ss_dssp HTTCSSTTSEECHHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC
T ss_pred HhCCCCCCCccCHHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccccc
Confidence 44555555555555566666666666666543 23555666666666666666542 266666666666666666532
Q ss_pred CCccccCCCCCceeeccCCcccc
Q 001922 178 IPNSYGELQGLEYLSLAGNDLTG 200 (995)
Q Consensus 178 ~p~~l~~l~~L~~L~Ls~N~l~~ 200 (995)
+ .++.+++|+.|++++|.+++
T Consensus 104 -~-~l~~l~~L~~L~~~~~~~~~ 124 (384)
T d2omza2 104 -T-PLANLTNLTGLTLFNNQITD 124 (384)
T ss_dssp -G-GGTTCTTCCEEECCSSCCCC
T ss_pred -c-cccccccccccccccccccc
Confidence 2 26666666666666666664
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.1e-28 Score=278.39 Aligned_cols=357 Identities=25% Similarity=0.251 Sum_probs=204.1
Q ss_pred eecCCCCccccCCccccCCCCCCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccc
Q 001922 73 LDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTA 152 (995)
Q Consensus 73 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~ 152 (995)
.++...++++.++. ..+.+|++|++++++|+....+..|++|++|+|++|+|+++.+ ++++++|++|++++|+|++
T Consensus 27 ~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~~l~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~ 102 (384)
T d2omza2 27 TVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 102 (384)
T ss_dssp HHTTCSSTTSEECH--HHHTTCCEEECCSSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred HHhCCCCCCCccCH--HHhCCCCEEECCCCCCCCccccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccc
Confidence 34444555555432 4567889999999988866568889999999999999988754 8899999999999999988
Q ss_pred cCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccC
Q 001922 153 LLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVG 232 (995)
Q Consensus 153 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~ 232 (995)
+. .++.+++|+.|++++|.+++..+ ......+..+....|.+....+............... ......+.
T Consensus 103 i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 172 (384)
T d2omza2 103 IT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQ------VTDLKPLA 172 (384)
T ss_dssp CG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEES------CCCCGGGT
T ss_pred cc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc------cchhhhhc
Confidence 53 38899999999999999975443 3455678888888888764333222111111110000 00111222
Q ss_pred CCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEE
Q 001922 233 KLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLF 312 (995)
Q Consensus 233 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 312 (995)
............|... ....+..+++++.+++++|.+++..| +...++|+.|
T Consensus 173 ~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L 224 (384)
T d2omza2 173 NLTTLERLDISSNKVS--------------------------DISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL 224 (384)
T ss_dssp TCTTCCEEECCSSCCC--------------------------CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred cccccccccccccccc--------------------------cccccccccccceeeccCCccCCCCc--ccccCCCCEE
Confidence 2333333333333322 12234444555555555555554332 2334555555
Q ss_pred EccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccC
Q 001922 313 NLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLF 392 (995)
Q Consensus 313 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 392 (995)
++++|++++ + +.+..+++|+.|++++|++++..+ +..+++|++|++++|++++.. .+..+..++.+++..|.+.
T Consensus 225 ~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~ 298 (384)
T d2omza2 225 SLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLE 298 (384)
T ss_dssp ECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCS
T ss_pred ECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccccccccc
Confidence 555555553 1 234555555555555555554322 455555666666665555322 2445555566666666554
Q ss_pred CCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCc
Q 001922 393 GPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPF 472 (995)
Q Consensus 393 ~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~ 472 (995)
+. ..+..+.+++.|++++|++++. .
T Consensus 299 ~~--~~~~~~~~l~~L~ls~n~l~~l---------------------------------------------------~-- 323 (384)
T d2omza2 299 DI--SPISNLKNLTYLTLYFNNISDI---------------------------------------------------S-- 323 (384)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCSCC---------------------------------------------------G--
T ss_pred cc--cccchhcccCeEECCCCCCCCC---------------------------------------------------c--
Confidence 42 2344555555555555544421 1
Q ss_pred cccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCC
Q 001922 473 SLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQN 536 (995)
Q Consensus 473 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 536 (995)
.+..+++|+.|++++|+|++ ++ .++.+++|++|+|++|+|++..| +..+++|++|+|++|
T Consensus 324 ~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 324 PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 13445555666666665552 22 45556666666666666664332 566666666666665
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.1e-26 Score=252.91 Aligned_cols=269 Identities=23% Similarity=0.279 Sum_probs=158.7
Q ss_pred ceeeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCccccCcccccceeccccccccCCCccccccc
Q 001922 58 CSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSL 137 (995)
Q Consensus 58 C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l 137 (995)
|.|++|.|+..+ ++ ++|+.+. +.+++|+|++|+|+. +.+.+|.++
T Consensus 10 c~~~~~~C~~~~----------L~-~lP~~l~--~~l~~L~Ls~N~i~~----------------------l~~~~f~~l 54 (305)
T d1xkua_ 10 CHLRVVQCSDLG----------LE-KVPKDLP--PDTALLDLQNNKITE----------------------IKDGDFKNL 54 (305)
T ss_dssp EETTEEECTTSC----------CC-SCCCSCC--TTCCEEECCSSCCCC----------------------BCTTTTTTC
T ss_pred ecCCEEEecCCC----------CC-ccCCCCC--CCCCEEECcCCcCCC----------------------cChhHhhcc
Confidence 899999998543 33 4565442 356666666665554 333344444
Q ss_pred ccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhc
Q 001922 138 VNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYL 217 (995)
Q Consensus 138 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 217 (995)
++|++|++++|.+..+.|..|.++++|++|++++|+++ .+|..+ ...++.|++++|.+.+..+..+.....++.++.
T Consensus 55 ~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~ 131 (305)
T d1xkua_ 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVEL 131 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEEC
T ss_pred ccccccccccccccccchhhhhCCCccCEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhcccccccccc
Confidence 44444444444444444445555555555555555554 233322 234555555555555444434444444444443
Q ss_pred cccccc-cCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCc
Q 001922 218 GYYNVF-EGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALT 296 (995)
Q Consensus 218 ~~n~~~-~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 296 (995)
..+... ....+..+..+++|+++++++|.++. +|..+ .++|+.|++++|.+++..+..+.+++.+++|++++|.++
T Consensus 132 ~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~ 208 (305)
T d1xkua_ 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208 (305)
T ss_dssp CSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC
T ss_pred ccccccccCCCccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccc
Confidence 332211 11233455666777788888877763 33332 456777777777777777777777777777777777777
Q ss_pred CcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcc------cCCCCCCeEEecCceec
Q 001922 297 GEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENL------GQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 297 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~------~~l~~L~~L~L~~N~l~ 368 (995)
+..+..|.++++|+.|+|++|+|+ .+|.+|..+++|++|+|++|+|+.+....| ..+.+|+.|+|++|+++
T Consensus 209 ~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 209 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp EECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 777777777777777777777777 456677777777777777777775433333 33456677777777664
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.5e-25 Score=243.82 Aligned_cols=222 Identities=27% Similarity=0.316 Sum_probs=113.2
Q ss_pred CCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEec
Q 001922 284 NLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLS 363 (995)
Q Consensus 284 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 363 (995)
++++|+|++|+|+...+.+|.++++|+.|++++|.+....|..|..+++|+.|++++|+++. +|..+ ...++.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~ 108 (305)
T d1xkua_ 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVH 108 (305)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECC
T ss_pred CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhcc
Confidence 45555555555554444455555555555555555554445555555555555555555552 33222 2345555555
Q ss_pred CceecccCCCcCcCCCccceeecccccc--CCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccC
Q 001922 364 SNKLTGTIPTDLCSSNQLRILILLKNFL--FGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSG 441 (995)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l--~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~ 441 (995)
+|.+.+..+..+.....+..++...|.. ....+..+..+++|+.+++++|.+.. +|.
T Consensus 109 ~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~-------------------- 167 (305)
T d1xkua_ 109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQ-------------------- 167 (305)
T ss_dssp SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCS--------------------
T ss_pred ccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc-cCc--------------------
Confidence 5555533333333333333333333321 11222333444444444444444331 111
Q ss_pred CCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCc
Q 001922 442 SLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPA 521 (995)
Q Consensus 442 ~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 521 (995)
...++|+.|++++|.+++..+..+.+++.++.|++++|++++..+..+..+++|++|+|++|.|+ .+|.+
T Consensus 168 ---------~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~ 237 (305)
T d1xkua_ 168 ---------GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 237 (305)
T ss_dssp ---------SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred ---------ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccc
Confidence 01235566666666666666666666666666666666666555555666666666666666665 45555
Q ss_pred cCcccccceeeccCCccc
Q 001922 522 IGYCNHLTYLDMSQNNLS 539 (995)
Q Consensus 522 ~~~l~~L~~L~Ls~N~l~ 539 (995)
|..+++|++|+|++|+|+
T Consensus 238 l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 238 LADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp TTTCSSCCEEECCSSCCC
T ss_pred cccccCCCEEECCCCccC
Confidence 666666666666666665
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.6e-25 Score=240.63 Aligned_cols=207 Identities=26% Similarity=0.253 Sum_probs=149.0
Q ss_pred CCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEEC
Q 001922 163 KLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDL 242 (995)
Q Consensus 163 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~L 242 (995)
.+++|+|++|+|++..+..|.++++|++|++++|++....+..+.+++.++.+....++......+..+.++++|++|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 45555555555554444455555556666666555555555555555555555544444444444566777777888888
Q ss_pred cCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCC
Q 001922 243 SSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGS 322 (995)
Q Consensus 243 s~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 322 (995)
++|.+....+..+...++|+.+++++|+++++.+..|..+++|+.|++++|.|++..+..|.++++|+.+++++|++++.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 88887766666777777888888888888776677788888888888888888877778888888888888888888877
Q ss_pred CCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceecc
Q 001922 323 IPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLTG 369 (995)
Q Consensus 323 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 369 (995)
.|..|..+++|++|++++|++++..+..|+.+++|++|+|++|++.+
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 78888888888888888888887777778888888888888888774
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=9.5e-25 Score=234.60 Aligned_cols=115 Identities=23% Similarity=0.243 Sum_probs=62.4
Q ss_pred CCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeecc
Q 001922 455 RLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMS 534 (995)
Q Consensus 455 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 534 (995)
+|+.|++++|++++..+..|.++++|+.+++++|++++..|..|..+++|+.||+++|.+++..|..|+.+++|++|+|+
T Consensus 154 ~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~ 233 (284)
T d1ozna_ 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233 (284)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECC
T ss_pred chhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEec
Confidence 34455555555554445555556666666666666665555666666666666666666665555556666666666666
Q ss_pred CCcccCCCccccccccccCeEeccccccccccCccc
Q 001922 535 QNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSI 570 (995)
Q Consensus 535 ~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~ 570 (995)
+|.+.+.-+ ...-...++.+....+++....|..+
T Consensus 234 ~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 234 DNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRL 268 (284)
T ss_dssp SSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGG
T ss_pred CCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHH
Confidence 666654322 11112234445555555555555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.7e-22 Score=212.73 Aligned_cols=198 Identities=26% Similarity=0.231 Sum_probs=129.9
Q ss_pred cccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhcc
Q 001922 139 NLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLG 218 (995)
Q Consensus 139 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 218 (995)
.+..+|.++++++. +|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+.
T Consensus 11 ~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~------------------ 69 (266)
T d1p9ag_ 11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK------------------ 69 (266)
T ss_dssp TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE------------------
T ss_pred CCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc------------------
Confidence 33444555555554 343332 345555555555554444445555555555555555541
Q ss_pred ccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCc
Q 001922 219 YYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGE 298 (995)
Q Consensus 219 ~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 298 (995)
+| .++.+++|++|+|++|+++ ..+..+..+++|+.|++++|.+....+..+..+.++++|++++|.++..
T Consensus 70 --------l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l 139 (266)
T d1p9ag_ 70 --------LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139 (266)
T ss_dssp --------EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCC
T ss_pred --------cc-ccccccccccccccccccc-ccccccccccccccccccccccceeecccccccccccccccccccccee
Confidence 11 2345667778888888777 3455667777777777777777766666777777777777777777766
Q ss_pred CCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceec
Q 001922 299 IPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 299 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 368 (995)
.+..+..+++|+.+++++|+|++..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|++.
T Consensus 140 ~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 6777777777777777777777766777777777777777777777 56666777777777777777765
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=4.3e-22 Score=211.22 Aligned_cols=128 Identities=27% Similarity=0.287 Sum_probs=67.8
Q ss_pred CCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeecc
Q 001922 455 RLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMS 534 (995)
Q Consensus 455 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 534 (995)
+|++|+|++|+++ ..+..+.++++|+.|++++|++.+..+..+..+.+++.|++++|.+++..+..+..+++|+.|+++
T Consensus 78 ~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~ 156 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (266)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred ccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccc
Confidence 3444444444444 234444555555555555555554445555555555555555555554444445555555555555
Q ss_pred CCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCC
Q 001922 535 QNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFN 584 (995)
Q Consensus 535 ~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N 584 (995)
+|++++..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|
T Consensus 157 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~N 205 (266)
T d1p9ag_ 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205 (266)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSC
T ss_pred cccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCC
Confidence 55555444445555555555555555554 35555555555555554443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=5e-22 Score=199.16 Aligned_cols=164 Identities=17% Similarity=0.155 Sum_probs=119.5
Q ss_pred cCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCC-----------------ChhHHHHHHHHHHhccCCCCceeEeEE
Q 001922 689 KDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTH-----------------SHDHGFRAEIQTLGNIRHRNIVRLLAF 751 (995)
Q Consensus 689 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~hpniv~~~~~ 751 (995)
..+++||+|+||+||+|+..+|++||||+++..... .....+..|+..+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 357899999999999999889999999987421110 001234568889999999999988876
Q ss_pred EecCCcceEEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCCeEEee
Q 001922 752 CSNKETNLLVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLNSAFEAHVAD 831 (995)
Q Consensus 752 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iiHrDlkp~Nill~~~~~vkl~D 831 (995)
. ..+++|||+++..+.+. +......++.|++.+++|||+++ |+||||||+|||++++ .++|+|
T Consensus 83 ~----~~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred c----CCEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 4 23799999988665442 22334678999999999999888 9999999999999965 589999
Q ss_pred eccccccccCCCCccccccccCcccccc------cccccCCCCcccchhhHHHHH
Q 001922 832 FGLAKFLIDGGASECMSAIAGSYGYIAP------EYAYTLRVDEKSDVYSFGVVL 880 (995)
Q Consensus 832 fGla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwSlGvil 880 (995)
||.|....++... .|... |. ....|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9999765322111 12111 11 235678899999975433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=7.7e-19 Score=194.12 Aligned_cols=119 Identities=24% Similarity=0.233 Sum_probs=56.5
Q ss_pred cccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEcc
Q 001922 236 NLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLF 315 (995)
Q Consensus 236 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 315 (995)
.|++|++++|.+. .+|. ++.+++|+.|++++|.+... +. ....+..+.+.++... ....+..++.++.++++
T Consensus 99 ~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~ 170 (353)
T d1jl5a_ 99 LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYAD 170 (353)
T ss_dssp TCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECC
T ss_pred ccccccccccccc-cccc-hhhhccceeecccccccccc-cc---ccccccchhhcccccc--ccccccccccceecccc
Confidence 4677777777766 3332 45566666666666655532 21 1234455555544433 22334455555555555
Q ss_pred CCcCCCCCCccccCCCCcceEEeccCcccccCCCcccCCCCCCeEEecCceec
Q 001922 316 MNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 316 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 368 (995)
+|.+.. .+.. ....+.+...++.+. .++ .+..++.|+.+++++|...
T Consensus 171 ~n~~~~-~~~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~ 217 (353)
T d1jl5a_ 171 NNSLKK-LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK 217 (353)
T ss_dssp SSCCSS-CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS
T ss_pred cccccc-cccc---ccccccccccccccc-ccc-ccccccccccccccccccc
Confidence 555542 1111 122334444444433 222 2344455555555555443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=7e-19 Score=194.47 Aligned_cols=315 Identities=27% Similarity=0.268 Sum_probs=173.2
Q ss_pred cccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeec
Q 001922 114 SSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSL 193 (995)
Q Consensus 114 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 193 (995)
.+|++|||++|.++.++ . ..++|++|+|++|+|+. +|.. +.+|+.|++++|+++ .++. + .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~~lp-~---~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLP-E---LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCSCCC-S---CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEEC
T ss_pred cCCCEEEeCCCCCCCCC-C---CCCCCCEEECCCCCCcc-cccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccc
Confidence 46888888888887543 2 24567777777777775 4543 346777777777775 3332 1 134777777
Q ss_pred cCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccccC
Q 001922 194 AGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSG 273 (995)
Q Consensus 194 s~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 273 (995)
++|.++ .+|. +++ +++|++|++++|.+... +... ..+..+.+..+...
T Consensus 106 ~~n~l~-~lp~-~~~-------------------------l~~L~~L~l~~~~~~~~-~~~~---~~l~~l~~~~~~~~- 153 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQN-------------------------SSFLKIIDVDNNSLKKL-PDLP---PSLEFIAAGNNQLE- 153 (353)
T ss_dssp CSSCCS-SCCC-CTT-------------------------CTTCCEEECCSSCCSCC-CCCC---TTCCEEECCSSCCS-
T ss_pred cccccc-cccc-hhh-------------------------hccceeecccccccccc-cccc---ccccchhhcccccc-
Confidence 777776 2332 334 44555555555555422 2222 23333334333332
Q ss_pred CCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcccC
Q 001922 274 SIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQ 353 (995)
Q Consensus 274 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 353 (995)
....+..++.++.|++++|.+... +.. ....+.+....+.+. .++ .+..++.|+.+++++|.... .+. .
T Consensus 154 -~~~~l~~l~~l~~L~l~~n~~~~~-~~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~ 222 (353)
T d1jl5a_ 154 -ELPELQNLPFLTAIYADNNSLKKL-PDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---L 222 (353)
T ss_dssp -SCCCCTTCTTCCEEECCSSCCSSC-CCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---C
T ss_pred -ccccccccccceeccccccccccc-ccc---ccccccccccccccc-ccc-cccccccccccccccccccc-ccc---c
Confidence 223456667777777777776632 221 123455666665554 333 35667788888888887663 333 2
Q ss_pred CCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCcccccCCCCcEEEecCCccCCCCCCCcccCCCCceee
Q 001922 354 NGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGACYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAE 433 (995)
Q Consensus 354 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 433 (995)
..++..+.+.+|.+.. .+... .. +...++..+.+.+.. .+
T Consensus 223 ~~~l~~~~~~~~~~~~-~~~~~---~~------------------------l~~~~~~~~~~~~l~-----~l------- 262 (353)
T d1jl5a_ 223 PPSLEALNVRDNYLTD-LPELP---QS------------------------LTFLDVSENIFSGLS-----EL------- 262 (353)
T ss_dssp CTTCCEEECCSSCCSC-CCCCC---TT------------------------CCEEECCSSCCSEES-----CC-------
T ss_pred cccccccccccccccc-ccccc---cc------------------------ccccccccccccccc-----cc-------
Confidence 3456777777777652 22211 12 222222222222100 00
Q ss_pred ccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccc
Q 001922 434 LQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNS 513 (995)
Q Consensus 434 l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 513 (995)
.......+++.|.+.+ ++ ..+++|++|+|++|+|+ .+|.. +++|+.|+|++|+
T Consensus 263 -------------------~~~~~~~~~~~~~~~~-~~---~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~ 315 (353)
T d1jl5a_ 263 -------------------PPNLYYLNASSNEIRS-LC---DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNH 315 (353)
T ss_dssp -------------------CTTCCEEECCSSCCSE-EC---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSC
T ss_pred -------------------cchhcccccccCcccc-cc---ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCc
Confidence 0122344455554442 11 22456777777777776 45543 3567777777777
Q ss_pred cCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEecc
Q 001922 514 LSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLS 558 (995)
Q Consensus 514 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~ 558 (995)
|+ .+|.. +++|++|+|++|+|+ .+|... ..|+.|.+.
T Consensus 316 L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~~ 352 (353)
T d1jl5a_ 316 LA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDLRMN 352 (353)
T ss_dssp CS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEEECC
T ss_pred CC-ccccc---cCCCCEEECcCCcCC-CCCccc---cccCeeECc
Confidence 77 56653 456778888888887 566533 345555543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=3.7e-19 Score=183.54 Aligned_cols=100 Identities=22% Similarity=0.304 Sum_probs=50.9
Q ss_pred CCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCcc
Q 001922 94 LTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY 173 (995)
Q Consensus 94 L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~ 173 (995)
+..++++.+++++...+..+++|+.|++++|.|+.. ..+..+++|++|++++|+|+++.| +..+++|+++++++|.
T Consensus 21 ~~~~~l~~~~~~d~~~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (227)
T ss_dssp HHHHHTTCSSTTSEECHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHHHhCCCCcCCcCCHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccc
Confidence 334455555665555555666666666666666543 124455555555555555544322 4455555555555555
Q ss_pred ccccCCccccCCCCCceeeccCCccc
Q 001922 174 FFGKIPNSYGELQGLEYLSLAGNDLT 199 (995)
Q Consensus 174 l~~~~p~~l~~l~~L~~L~Ls~N~l~ 199 (995)
++ .++ .+..+++|++|++++|...
T Consensus 97 ~~-~i~-~l~~l~~L~~l~l~~~~~~ 120 (227)
T d1h6ua2 97 LK-NVS-AIAGLQSIKTLDLTSTQIT 120 (227)
T ss_dssp CS-CCG-GGTTCTTCCEEECTTSCCC
T ss_pred cc-ccc-ccccccccccccccccccc
Confidence 43 222 2444555555555544443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=1.1e-18 Score=180.07 Aligned_cols=209 Identities=24% Similarity=0.375 Sum_probs=113.3
Q ss_pred cccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCcee
Q 001922 112 NLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYL 191 (995)
Q Consensus 112 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 191 (995)
.+.++..++++.+++++.. .++.+.+|++|++++|+|+.+ ..+..+++|++|++++|.+++..| +..+++|++|
T Consensus 17 ~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l 90 (227)
T d1h6ua2 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (227)
T ss_dssp HHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence 3455556667777766543 445667777777777777664 246677777777777777764332 6667777777
Q ss_pred eccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccCccccCccccccccc
Q 001922 192 SLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLL 271 (995)
Q Consensus 192 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l 271 (995)
++++|.++. ++ . +.++++|+.+++++|...+. ..+...+.+..+.++.+.+
T Consensus 91 ~~~~n~~~~-i~-~-------------------------l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~ 141 (227)
T d1h6ua2 91 ELSGNPLKN-VS-A-------------------------IAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQI 141 (227)
T ss_dssp ECCSCCCSC-CG-G-------------------------GTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred ccccccccc-cc-c-------------------------cccccccccccccccccccc--chhccccchhhhhchhhhh
Confidence 777776652 11 2 23344555555555554422 1233344444444444444
Q ss_pred cCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEeccCcccccCCCcc
Q 001922 272 SGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPENL 351 (995)
Q Consensus 272 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 351 (995)
... ..+.+.++|+.|++++|.+++.. .+.++++|+.|++++|++++. + .+..+++|++|+|++|++++..| +
T Consensus 142 ~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l 213 (227)
T d1h6ua2 142 TNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--L 213 (227)
T ss_dssp CCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--G
T ss_pred chh--hhhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--c
Confidence 422 12444555555555555554322 245555555555555555532 2 24555555555555555553321 5
Q ss_pred cCCCCCCeEEec
Q 001922 352 GQNGKLQVLDLS 363 (995)
Q Consensus 352 ~~l~~L~~L~L~ 363 (995)
.++++|++|+++
T Consensus 214 ~~l~~L~~L~ls 225 (227)
T d1h6ua2 214 ANTSNLFIVTLT 225 (227)
T ss_dssp TTCTTCCEEEEE
T ss_pred ccCCCCCEEEee
Confidence 555555555554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=8.8e-19 Score=175.35 Aligned_cols=149 Identities=23% Similarity=0.245 Sum_probs=123.2
Q ss_pred ceeeeEEeCCCceeeeecCCCCccccCCccccCCCCCCeEeccCCcccCcc---ccCcccccceeccccccccCCCcccc
Q 001922 58 CSWAGICCSRDRVASLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI---EIGNLSSLQFLNISNNQFSGGLDWNY 134 (995)
Q Consensus 58 C~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~---~~~~l~~L~~L~Ls~N~i~~~~~~~~ 134 (995)
|+|..|.|+.. +|+ .||+.+. +++++|+|++|+|++.+ .|.++++|++|+|++|.+...++..|
T Consensus 8 C~~~~v~Cs~~----------~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~ 74 (192)
T d1w8aa_ 8 CEGTTVDCTGR----------GLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF 74 (192)
T ss_dssp EETTEEECTTS----------CCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTT
T ss_pred EcCCEEEEeCC----------CcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccc
Confidence 77877777643 444 5677664 68999999999998633 57899999999999999999999999
Q ss_pred cccccccccccccccccccCCccccCCCCCceeeccCccccccCCccccCCCCCceeeccCCcccccCcccccchhhhhh
Q 001922 135 SSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLRE 214 (995)
Q Consensus 135 ~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 214 (995)
..+++|++|+|++|+|+.+.|.+|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+..... ...-...++.
T Consensus 75 ~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~ 153 (192)
T d1w8aa_ 75 EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRK 153 (192)
T ss_dssp TTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHH
T ss_pred ccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhh
Confidence 999999999999999999999999999999999999999998888999999999999999999984332 2222234555
Q ss_pred hhcccc
Q 001922 215 IYLGYY 220 (995)
Q Consensus 215 L~L~~n 220 (995)
+.+..+
T Consensus 154 ~~l~~~ 159 (192)
T d1w8aa_ 154 KSLNGG 159 (192)
T ss_dssp HCCSGG
T ss_pred hcccCC
Confidence 555443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.5e-18 Score=180.94 Aligned_cols=85 Identities=16% Similarity=0.202 Sum_probs=41.4
Q ss_pred ccceeccccccccCCCccccccccccccccccccccccc-CCccccCCCCCceeeccC-ccccccCCccccCCCCCceee
Q 001922 115 SLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTAL-LPVGILKLEKLKYLDLGG-NYFFGKIPNSYGELQGLEYLS 192 (995)
Q Consensus 115 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~p~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~ 192 (995)
++++|+|++|+|+.+.+.+|.++++|++|++++|.+... .+.+|.+++++++|++.. |.+....+..|.++++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 455555555555544444555555555555555544432 233444555555554432 344444444445555555555
Q ss_pred ccCCccc
Q 001922 193 LAGNDLT 199 (995)
Q Consensus 193 Ls~N~l~ 199 (995)
+++|+++
T Consensus 110 l~~~~l~ 116 (242)
T d1xwdc1 110 ISNTGIK 116 (242)
T ss_dssp EESCCCC
T ss_pred cchhhhc
Confidence 5555444
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1.9e-18 Score=180.25 Aligned_cols=75 Identities=8% Similarity=0.113 Sum_probs=37.1
Q ss_pred ceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCccccccC-CccccCCCCCceeecc
Q 001922 117 QFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNYFFGKI-PNSYGELQGLEYLSLA 194 (995)
Q Consensus 117 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls 194 (995)
+.++.+++.++.+++ .+. +++++||+++|+|+.+.+.+|.++++|++|+|++|.+...+ +..|..++++++|.+.
T Consensus 11 ~~i~c~~~~l~~iP~-~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVTEIPS-DLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCSSCCS-CSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCCCcCC-CCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 455566655553332 221 24555555555555544445555555555555555554332 2344555555555543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=7.7e-18 Score=170.94 Aligned_cols=57 Identities=32% Similarity=0.475 Sum_probs=29.4
Q ss_pred ccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEec
Q 001922 279 LGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGLW 339 (995)
Q Consensus 279 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 339 (995)
+..+++|+.+++++|++++.. .+.++++|+.|+|++|+|++ +| .+.++++|++|+|+
T Consensus 152 ~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 152 LSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp GGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred ccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 334455555555555555322 24555555555555555552 33 35555666666654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.6e-21 Score=224.25 Aligned_cols=389 Identities=19% Similarity=0.116 Sum_probs=186.8
Q ss_pred ccceeccccccccCCC-cccccccccccccccccccccc----cCCccccCCCCCceeeccCcccccc----CCcccc-C
Q 001922 115 SLQFLNISNNQFSGGL-DWNYSSLVNLEVFDAYNNNFTA----LLPVGILKLEKLKYLDLGGNYFFGK----IPNSYG-E 184 (995)
Q Consensus 115 ~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~L~Ls~n~i~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~-~ 184 (995)
+|+.||+++|+|++.. ...+..++++++|+|++|.|+. .+...+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6788888888887542 2345667778888888887764 2344566777788888888877532 222222 2
Q ss_pred CCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCccccC-----cc
Q 001922 185 LQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPHEIGN-----LK 259 (995)
Q Consensus 185 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-----l~ 259 (995)
..+|++|+|++|++++..-.. ++..+..+++|++|++++|.++......+.. ..
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~---------------------l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~ 141 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGV---------------------LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC 141 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHH---------------------HHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred CCCCCEEECCCCCcccccccc---------------------ccchhhccccccccccccccchhhhhhhhhhccccccc
Confidence 246778888877776431111 1223344556666666666665322111110 00
Q ss_pred ccCccccccccccCC----CCccccCcCCCCeEeccCCcCcCcCCc----cc-cccCCCCEEEccCCcCCCCC----Ccc
Q 001922 260 LLDTVFLHINLLSGS----IPKQLGNLTNLVNLDLSNNALTGEIPY----SF-INLRQLKLFNLFMNRLHGSI----PDY 326 (995)
Q Consensus 260 ~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~----~~-~~l~~L~~L~L~~N~l~~~~----p~~ 326 (995)
...........+... ....+.....++.++++++.+....-. .+ ........+++..+.+.... ...
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 221 (460)
T d1z7xw1 142 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 221 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred ccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccccc
Confidence 111111111111100 011233345666777776655421110 11 11224455666666554221 122
Q ss_pred ccCCCCcceEEeccCcccc-----cCCCcccCCCCCCeEEecCceecccCCCcCcCCCccceeeccccccCCCCCccccc
Q 001922 327 LADLPNLETLGLWQNNFTG-----VIPENLGQNGKLQVLDLSSNKLTGTIPTDLCSSNQLRILILLKNFLFGPIPERLGA 401 (995)
Q Consensus 327 ~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~ 401 (995)
+...+.++.+++++|++.. ..+........++.|++++|.+...... .....+..
T Consensus 222 l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~--------------------~~~~~l~~ 281 (460)
T d1z7xw1 222 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG--------------------DLCRVLRA 281 (460)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH--------------------HHHHHHHH
T ss_pred ccccccccccchhhccccccccchhhcccccccccccccccccccccccccc--------------------cccccccc
Confidence 3345666666666666532 1122233345666666666665421110 11122334
Q ss_pred CCCCcEEEecCCccCCCCCCCcccCCCCceeeccCccccCCCCCCCCCCCCCCCCcEEEcCCCcccccCCc----cccCC
Q 001922 402 CYSLTRVRLGQNYLNGSIPDGFIYLPGLNLAELQSNYLSGSLPENGNSSSNPDRLGQLNLSNNLLSGPLPF----SLSNF 477 (995)
Q Consensus 402 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~n~l~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~----~~~~l 477 (995)
...++.+++++|.+.......+.. .+ ......|+.+++++|.++..... .+...
T Consensus 282 ~~~l~~l~l~~n~i~~~~~~~l~~----------------~l------~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~ 339 (460)
T d1z7xw1 282 KESLKELSLAGNELGDEGARLLCE----------------TL------LEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 339 (460)
T ss_dssp CTTCCEEECTTCCCHHHHHHHHHH----------------HH------TSTTCCCCEEECTTSCCBGGGHHHHHHHHHHC
T ss_pred cccccccccccccccccccchhhc----------------cc------cccccccccccccccchhhhhhhhcccccccc
Confidence 555666666666654211100000 00 00113466666666666543222 22334
Q ss_pred CCCcEEEcCCCcccCC----CCCCcc-chhhhccccccccccCCC----CCCccCcccccceeeccCCcccCCCccccc-
Q 001922 478 SSLQILLLSGNQFSGP----IPPSIG-ELRQVLKLDLSRNSLSGE----IPPAIGYCNHLTYLDMSQNNLSGSIPPEIS- 547 (995)
Q Consensus 478 ~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~- 547 (995)
++|++|+|++|+|++. +++.+. ..+.|++|+|++|.|+.. ++..+..+++|++|||++|+|+......|.
T Consensus 340 ~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~ 419 (460)
T d1z7xw1 340 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419 (460)
T ss_dssp SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHH
T ss_pred cchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHH
Confidence 5677777777776521 111121 233455666666665421 233344456666666666666533222221
Q ss_pred ----cccccCeEecccccccccc
Q 001922 548 ----NVRILNYLNLSRNHLNQNI 566 (995)
Q Consensus 548 ----~l~~L~~L~L~~N~l~~~~ 566 (995)
+...|+.|++++|.+....
T Consensus 420 ~l~~~~~~L~~l~l~~~~~~~~~ 442 (460)
T d1z7xw1 420 SVRQPGCLLEQLVLYDIYWSEEM 442 (460)
T ss_dssp HHTSTTCCCCEEECTTCCCCHHH
T ss_pred HHHhCCCccCEEECCCCCCCHHH
Confidence 2234666666666655433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=5.4e-18 Score=169.51 Aligned_cols=163 Identities=18% Similarity=0.177 Sum_probs=109.1
Q ss_pred CCCcEEEcCCCcccccC-CccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceee
Q 001922 454 DRLGQLNLSNNLLSGPL-PFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLD 532 (995)
Q Consensus 454 ~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 532 (995)
..+++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..+..+++|++|+|++|+|++..|..|..+++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 35677777777776533 45567778888888888888777777777788888888888888766666777788888888
Q ss_pred ccCCcccCCCccccccccccCeEeccccccccccCcccccCCcccEEeccCCCCCCCCCCCCCCcccccccCCCCccCCC
Q 001922 533 MSQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIPKSIGSMKSLTIADFSFNDFSGKLPESGQFTVFNASSFAGNPQLCG 612 (995)
Q Consensus 533 Ls~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~ 612 (995)
|++|+|++..|.+|..+++|++|+|++|++....+..+ -...++.+.+..|.+....|.. +......++..|..-|.
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p~~--l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCC
T ss_pred cCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCCChh--hcCCEeeecCHhhCcCC
Confidence 88888876666677778888888888887765332211 1233555666777776665542 44444555666666676
Q ss_pred CCCCCCC
Q 001922 613 TLLNNPC 619 (995)
Q Consensus 613 ~~~~~~c 619 (995)
.+-...|
T Consensus 186 ~~~~~g~ 192 (192)
T d1w8aa_ 186 SENSEGC 192 (192)
T ss_dssp CC---CC
T ss_pred CCCCCCC
Confidence 5544333
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=9.3e-18 Score=170.33 Aligned_cols=183 Identities=26% Similarity=0.316 Sum_probs=119.2
Q ss_pred CCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCcc
Q 001922 94 LTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY 173 (995)
Q Consensus 94 L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~ 173 (995)
+...+++.+.+++.+....+.+|++|++++|.++... .+..+++|++|++++|+|+++. .++.+++|++|++++|+
T Consensus 26 ~i~~~l~~~~~~~~~~~~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 26 TIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENK 101 (210)
T ss_dssp HHHHHTTCSCTTSEECHHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred HHHHHhCcCccCCccCHHHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccc
Confidence 3344566666666555556777777888888777653 3667788888888888887743 36778888888888888
Q ss_pred ccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCc
Q 001922 174 FFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPH 253 (995)
Q Consensus 174 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~ 253 (995)
+++ +| .+..+++|+.|++++|.+.. + ..+.+ +++++.+++++|.+++ +.
T Consensus 102 i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~-------------------------l~~l~~l~~~~n~l~~--~~ 150 (210)
T d1h6ta2 102 VKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVH-------------------------LPQLESLYLGNNKITD--IT 150 (210)
T ss_dssp CCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGG-------------------------CTTCCEEECCSSCCCC--CG
T ss_pred ccc-cc-cccccccccccccccccccc-c-ccccc-------------------------cccccccccccccccc--cc
Confidence 873 44 47888888888888887762 1 12333 3445555555555543 22
Q ss_pred cccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEEcc
Q 001922 254 EIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFNLF 315 (995)
Q Consensus 254 ~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 315 (995)
.+..+++|+.+++++|++++. + .+.++++|++|+|++|+|++ ++ .|.++++|++|+|+
T Consensus 151 ~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 151 VLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp GGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred ccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 344556666666666666542 2 26667777777777777763 33 46777777777765
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=2.6e-17 Score=165.44 Aligned_cols=40 Identities=18% Similarity=0.291 Sum_probs=21.2
Q ss_pred ccCCCCCceeeccCccccccCCccccCCCCCceeeccCCccc
Q 001922 158 ILKLEKLKYLDLGGNYFFGKIPNSYGELQGLEYLSLAGNDLT 199 (995)
Q Consensus 158 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 199 (995)
+..+++|++|+|++|++++..| ++++++|++|++++|.+.
T Consensus 58 l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~ 97 (199)
T d2omxa2 58 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 97 (199)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred cccCCCcCcCccccccccCccc--ccCCcccccccccccccc
Confidence 4455555555555555543222 555555555555555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1.2e-20 Score=216.74 Aligned_cols=378 Identities=19% Similarity=0.139 Sum_probs=195.5
Q ss_pred hhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCC----ccCccccCccccCccccccccccCC----CCcccc-C
Q 001922 211 NLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDG----QIPHEIGNLKLLDTVFLHINLLSGS----IPKQLG-N 281 (995)
Q Consensus 211 ~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~l~-~ 281 (995)
+|++|+++++++....+...+..+++++.|+|++|.++. .++..+..+++|++|+|++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 466677776666554444455566677777777777663 2233445666777777777766421 112222 1
Q ss_pred cCCCCeEeccCCcCcCc----CCccccccCCCCEEEccCCcCCCCCCccc-----cCCCCcceEEeccCcccccC----C
Q 001922 282 LTNLVNLDLSNNALTGE----IPYSFINLRQLKLFNLFMNRLHGSIPDYL-----ADLPNLETLGLWQNNFTGVI----P 348 (995)
Q Consensus 282 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~----p 348 (995)
..+|++|+|++|.+++. ++..+..+++|++|++++|+++......+ ........+......+.... -
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 23577777777776643 23445566667777777776653211111 11122223333333222110 0
Q ss_pred CcccCCCCCCeEEecCceecccCCCc----C-cCCCccceeeccccccCCC----CCcccccCCCCcEEEecCCccCC--
Q 001922 349 ENLGQNGKLQVLDLSSNKLTGTIPTD----L-CSSNQLRILILLKNFLFGP----IPERLGACYSLTRVRLGQNYLNG-- 417 (995)
Q Consensus 349 ~~~~~l~~L~~L~L~~N~l~~~~p~~----~-~~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~-- 417 (995)
..+.....++.++++++.+....-.. + ........+++..+.+... ....+.....++.+++++|.+..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 11233456677777766554210000 0 1112334455555543221 11234455677778877776532
Q ss_pred ---CCCCCcccCCCCceeeccCccccCCCCCC-CCCCCCCCCCcEEEcCCCcccccCCcc----c-cCCCCCcEEEcCCC
Q 001922 418 ---SIPDGFIYLPGLNLAELQSNYLSGSLPEN-GNSSSNPDRLGQLNLSNNLLSGPLPFS----L-SNFSSLQILLLSGN 488 (995)
Q Consensus 418 ---~~p~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~~~~~~~L~~L~Ls~N~l~~~~p~~----~-~~l~~L~~L~Ls~N 488 (995)
..+..+.....+..+++.+|.+....... .......+.++.+++++|.++...... + .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 12223334556677777777664321000 000112345777777777775322221 1 12356777788877
Q ss_pred cccCCCCCCc----cchhhhccccccccccCCC----CCCccC-cccccceeeccCCcccC----CCccccccccccCeE
Q 001922 489 QFSGPIPPSI----GELRQVLKLDLSRNSLSGE----IPPAIG-YCNHLTYLDMSQNNLSG----SIPPEISNVRILNYL 555 (995)
Q Consensus 489 ~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~----~ip~~l~~l~~L~~L 555 (995)
.++......+ ....+|++|+|++|+++.. ++..+. ..+.|++|+|++|+|+. .++..+..+++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 7764322222 2334677778877777532 223332 34567778888777763 244556666777788
Q ss_pred eccccccccccCccc----c-cCCcccEEeccCCCCCC
Q 001922 556 NLSRNHLNQNIPKSI----G-SMKSLTIADFSFNDFSG 588 (995)
Q Consensus 556 ~L~~N~l~~~~p~~~----~-~l~~L~~l~ls~N~l~g 588 (995)
+|++|+|+......+ . +...|+.|++++|.+..
T Consensus 403 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred ECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 888777765333222 2 23357777777777653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=3.5e-17 Score=164.49 Aligned_cols=180 Identities=26% Similarity=0.298 Sum_probs=120.4
Q ss_pred CCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCCCCceeeccCcc
Q 001922 94 LTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLEKLKYLDLGGNY 173 (995)
Q Consensus 94 L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L~~N~ 173 (995)
+..+.++.+.+++......+.+|++|++++|.|+.+ ..++.+++|++|++++|+|++..| +.++++|++|++++|.
T Consensus 20 ~i~~~l~~~~~~~~~~~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 20 KMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHHHTTCSSTTSEECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHHHhCCCCCCCccCHHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence 344556666676666566677777777777777654 236677888888888888877533 7888888888888888
Q ss_pred ccccCCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCCCCcccEEECcCCCCCCccCc
Q 001922 174 FFGKIPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGKLVNLVHLDLSSCELDGQIPH 253 (995)
Q Consensus 174 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~ 253 (995)
+. .++ .++++++|++|++++|.+.... .+ ..+++|+.|++++|++.. + .
T Consensus 96 ~~-~~~-~l~~l~~L~~L~l~~~~~~~~~--~~-------------------------~~l~~L~~L~l~~n~l~~-~-~ 144 (199)
T d2omxa2 96 IA-DIT-PLANLTNLTGLTLFNNQITDID--PL-------------------------KNLTNLNRLELSSNTISD-I-S 144 (199)
T ss_dssp CC-CCG-GGTTCTTCSEEECCSSCCCCCG--GG-------------------------TTCTTCSEEECCSSCCCC-C-G
T ss_pred cc-ccc-cccccccccccccccccccccc--cc-------------------------chhhhhHHhhhhhhhhcc-c-c
Confidence 86 333 3778888888888888776321 12 234456666666666652 2 2
Q ss_pred cccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEE
Q 001922 254 EIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLF 312 (995)
Q Consensus 254 ~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 312 (995)
.+..+++|+.|++++|++++. + .++++++|++|++++|++++. + .++++++|+.|
T Consensus 145 ~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 145 ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence 355666666666666666643 2 367777888888888877743 2 46777777765
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=5.1e-16 Score=165.17 Aligned_cols=94 Identities=22% Similarity=0.270 Sum_probs=53.3
Q ss_pred cCcCCCCeEeccCC-cCcCcCCccccccCCCCEEEccCC-cCCCCCCccccCCCCcceEEeccCcccccCCCcccCC-CC
Q 001922 280 GNLTNLVNLDLSNN-ALTGEIPYSFINLRQLKLFNLFMN-RLHGSIPDYLADLPNLETLGLWQNNFTGVIPENLGQN-GK 356 (995)
Q Consensus 280 ~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~ 356 (995)
.++++|++|++++| .+++.....+.++++|++|++++| .+++.....++++++|+.|+++++ ++. ..+..+ ..
T Consensus 172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d---~~l~~l~~~ 247 (284)
T d2astb2 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEA 247 (284)
T ss_dssp HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHH
T ss_pred cccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCH---HHHHHHHHh
Confidence 44566777777664 356555666666677777777763 565555555666777777777766 221 111111 12
Q ss_pred CCeEEecCceecccCCCcCcC
Q 001922 357 LQVLDLSSNKLTGTIPTDLCS 377 (995)
Q Consensus 357 L~~L~L~~N~l~~~~p~~~~~ 377 (995)
+..|.+..+++++..++.++.
T Consensus 248 lp~L~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 248 LPHLQINCSHFTTIARPTIGN 268 (284)
T ss_dssp STTSEESCCCSCCTTCSSCSS
T ss_pred CccccccCccCCCCCCCccCc
Confidence 333445666666555555543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=3.8e-16 Score=166.16 Aligned_cols=254 Identities=20% Similarity=0.206 Sum_probs=130.5
Q ss_pred eeecCCCCccccCCccccCCCCCCeEeccCCcccCcc-ccCcccccceeccccccccCC-Cccccccccccccccccccc
Q 001922 72 SLDLTDLNLCGSVPAQILRLDKLTNLSLAGNNFTGSI-EIGNLSSLQFLNISNNQFSGG-LDWNYSSLVNLEVFDAYNNN 149 (995)
Q Consensus 72 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~l~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~Ls~n~ 149 (995)
.+||++.++...+...+.. ..+..+.++...+..+. ......+|++|||++|.++.. +...+..+++|++|++++|.
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccC
Confidence 4566655554322222211 12334444444333222 233344556666665555432 12223444555555555555
Q ss_pred ccccCCccccCCCCCceeeccCc-ccccc-CCccccCCCCCceeeccCC-cccccCcccccchhhhhhhhccccccccCC
Q 001922 150 FTALLPVGILKLEKLKYLDLGGN-YFFGK-IPNSYGELQGLEYLSLAGN-DLTGKIPGELGNLTNLREIYLGYYNVFEGG 226 (995)
Q Consensus 150 i~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~ 226 (995)
+++..+..++.+++|++|+|+++ .++.. +...+..+++|++|+++++ .++ ...
T Consensus 83 l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~------------------------~~~ 138 (284)
T d2astb2 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT------------------------EKH 138 (284)
T ss_dssp CCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCC------------------------HHH
T ss_pred CCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccc------------------------ccc
Confidence 44444444444555555555542 33211 1111233444555555443 222 111
Q ss_pred CCcccCC-CCcccEEECcCC--CCCCc-cCccccCccccCccccccc-cccCCCCccccCcCCCCeEeccCC-cCcCcCC
Q 001922 227 IPREVGK-LVNLVHLDLSSC--ELDGQ-IPHEIGNLKLLDTVFLHIN-LLSGSIPKQLGNLTNLVNLDLSNN-ALTGEIP 300 (995)
Q Consensus 227 ~p~~~~~-l~~L~~L~Ls~n--~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~p 300 (995)
+...+.. .++|+.|+++++ .++.. +.....++++|++|++++| .+++.....+.++++|++|+|+++ .+++...
T Consensus 139 ~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l 218 (284)
T d2astb2 139 VQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL 218 (284)
T ss_dssp HHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGG
T ss_pred chhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHH
Confidence 1111212 246777777764 23322 2222345677888888775 466666667788888888888884 6776666
Q ss_pred ccccccCCCCEEEccCCcCCCC-CCccccCCCCcceEEeccCcccccCCCcccCC
Q 001922 301 YSFINLRQLKLFNLFMNRLHGS-IPDYLADLPNLETLGLWQNNFTGVIPENLGQN 354 (995)
Q Consensus 301 ~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 354 (995)
..++++++|+.|+++++ ++.. ++.....+|+ |.+..++++...+..++..
T Consensus 219 ~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~---L~i~~~~ls~~~~~~~~~~ 269 (284)
T d2astb2 219 LELGEIPTLKTLQVFGI-VPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNK 269 (284)
T ss_dssp GGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTT---SEESCCCSCCTTCSSCSST
T ss_pred HHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCcc---ccccCccCCCCCCCccCcc
Confidence 77888888999988877 3322 2222233444 4567778887766666553
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=2.1e-14 Score=131.15 Aligned_cols=101 Identities=28% Similarity=0.326 Sum_probs=55.8
Q ss_pred EEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCc
Q 001922 458 QLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNN 537 (995)
Q Consensus 458 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 537 (995)
.|+|++|+++ .++ .+.++++|++|++++|+|+ .+|+.++.+++|+.|++++|.|++ +| .++.+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4566666665 333 2555566666666666665 445555556666666666666652 33 35556666666666666
Q ss_pred ccCCC-ccccccccccCeEeccccccc
Q 001922 538 LSGSI-PPEISNVRILNYLNLSRNHLN 563 (995)
Q Consensus 538 l~~~i-p~~l~~l~~L~~L~L~~N~l~ 563 (995)
++... +..+..+++|+.|+|++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 65321 134555555666666666554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=3.2e-14 Score=129.91 Aligned_cols=104 Identities=27% Similarity=0.381 Sum_probs=92.8
Q ss_pred cEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeeccCCcccCCCccccccccccCeEecccc
Q 001922 481 QILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDMSQNNLSGSIPPEISNVRILNYLNLSRN 560 (995)
Q Consensus 481 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~l~~l~~L~~L~L~~N 560 (995)
+.|+|++|+|+ .++ .++.+.+|++||+++|+|+ .+|+.++.+++|++|++++|+|+ .+| .+.++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 57999999998 555 4899999999999999998 68889999999999999999998 566 5999999999999999
Q ss_pred cccccc-CcccccCCcccEEeccCCCCCCC
Q 001922 561 HLNQNI-PKSIGSMKSLTIADFSFNDFSGK 589 (995)
Q Consensus 561 ~l~~~~-p~~~~~l~~L~~l~ls~N~l~g~ 589 (995)
++++.. +..+..+++|+.+++++|++++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 998643 25789999999999999999864
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.6e-14 Score=138.85 Aligned_cols=125 Identities=18% Similarity=0.216 Sum_probs=97.7
Q ss_pred CCCCCcEEEcCCCcccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCccccccee
Q 001922 452 NPDRLGQLNLSNNLLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYL 531 (995)
Q Consensus 452 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 531 (995)
++.++++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .+..+++|++|+|++|+++...+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 3456888999999988 45666677889999999999988 443 57888899999999999985444456678899999
Q ss_pred eccCCcccCCCc--cccccccccCeEeccccccccccCc----ccccCCcccEEec
Q 001922 532 DMSQNNLSGSIP--PEISNVRILNYLNLSRNHLNQNIPK----SIGSMKSLTIADF 581 (995)
Q Consensus 532 ~Ls~N~l~~~ip--~~l~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~l~l 581 (995)
+|++|+++ .++ ..+..+++|++|++++|+++. .|. .+..+++|++||-
T Consensus 93 ~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 93 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETT
T ss_pred eecccccc-ccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeCC
Confidence 99999987 444 367888899999999998865 443 5777888888873
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=1.4e-15 Score=166.97 Aligned_cols=259 Identities=21% Similarity=0.190 Sum_probs=153.4
Q ss_pred CCccccCCCCCCeEeccCCcccCc--c----ccCcccccceeccccccccCCCcccccccccccccccccccccccCCcc
Q 001922 84 VPAQILRLDKLTNLSLAGNNFTGS--I----EIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVG 157 (995)
Q Consensus 84 ~~~~~~~l~~L~~L~L~~n~l~~~--~----~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~ 157 (995)
+...+.+...|++|+|++|.|... . .+...++|+.|+++++.+.......... + ..+...
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~-------------~-~~l~~~ 88 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA-------------L-RLLLQA 88 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHH-------------H-HHHHHH
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchH-------------H-HHHHHH
Confidence 444566677888888888877531 1 3566777888887776554221110000 0 012234
Q ss_pred ccCCCCCceeeccCcccccc----CCccccCCCCCceeeccCCcccccCcccccchhhhhhhhccccccccCCCCcccCC
Q 001922 158 ILKLEKLKYLDLGGNYFFGK----IPNSYGELQGLEYLSLAGNDLTGKIPGELGNLTNLREIYLGYYNVFEGGIPREVGK 233 (995)
Q Consensus 158 ~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~~~~~~~p~~~~~ 233 (995)
+..+++|++|+|++|.++.. +...+...++|++|++++|.++......++ ..|..+.... ....
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~--~~l~~~~~~~----------~~~~ 156 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--RALQELAVNK----------KAKN 156 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHH--HHHHHHHHHH----------HHHT
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccccccc--cccccccccc----------cccc
Confidence 56678899999999988654 344455678899999999988632222221 1233333221 1123
Q ss_pred CCcccEEECcCCCCCCcc----CccccCccccCccccccccccCC-----CCccccCcCCCCeEeccCCcCcCc----CC
Q 001922 234 LVNLVHLDLSSCELDGQI----PHEIGNLKLLDTVFLHINLLSGS-----IPKQLGNLTNLVNLDLSNNALTGE----IP 300 (995)
Q Consensus 234 l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~-----~p~~l~~l~~L~~L~Ls~N~l~~~----~p 300 (995)
.+.|+.+++++|.++... ...+...+.|+.|++++|+++.. +...+..+++|+.|+|++|.++.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 457888899888886432 22334556777777777776531 233456677788888888777533 23
Q ss_pred ccccccCCCCEEEccCCcCCCCCCcc----ccC--CCCcceEEeccCcccccC----CCccc-CCCCCCeEEecCceec
Q 001922 301 YSFINLRQLKLFNLFMNRLHGSIPDY----LAD--LPNLETLGLWQNNFTGVI----PENLG-QNGKLQVLDLSSNKLT 368 (995)
Q Consensus 301 ~~~~~l~~L~~L~L~~N~l~~~~p~~----~~~--l~~L~~L~L~~N~l~~~~----p~~~~-~l~~L~~L~L~~N~l~ 368 (995)
..+..+++|+.|+|++|.|++..... +.. .+.|++|++++|+++... ...+. +.++|++|+|++|++.
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred ccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 44566677777777777776432222 222 356777777777765422 22221 3566777777777765
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=5.1e-14 Score=135.30 Aligned_cols=127 Identities=23% Similarity=0.129 Sum_probs=92.3
Q ss_pred cCCCCcccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCC
Q 001922 231 VGKLVNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLK 310 (995)
Q Consensus 231 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 310 (995)
+.+..+|++|+|++|+|+. ++..+..+++|+.|++++|+|+. ++ .|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 4456678888888888884 46666777888888888888874 33 477788888888888888866666667788888
Q ss_pred EEEccCCcCCCCCC-ccccCCCCcceEEeccCcccccCCC----cccCCCCCCeEE
Q 001922 311 LFNLFMNRLHGSIP-DYLADLPNLETLGLWQNNFTGVIPE----NLGQNGKLQVLD 361 (995)
Q Consensus 311 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~ 361 (995)
.|++++|+|+.... ..+..+++|++|++++|.++. .|. .+..+++|++||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 88888888874321 456777888888888887763 332 356677777766
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.39 E-value=1.2e-14 Score=159.39 Aligned_cols=135 Identities=20% Similarity=0.170 Sum_probs=71.1
Q ss_pred cCCCCeEeccCCcCcCcC----CccccccCCCCEEEccCCcCCCC-----CCccccCCCCcceEEeccCccccc----CC
Q 001922 282 LTNLVNLDLSNNALTGEI----PYSFINLRQLKLFNLFMNRLHGS-----IPDYLADLPNLETLGLWQNNFTGV----IP 348 (995)
Q Consensus 282 l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~p 348 (995)
.+.|+.|++++|.++... ...+...+.|+.|++++|+|+.. +...+..+++|+.|+|++|.++.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 445666666666665322 22234456666667766666531 223355566677777777766532 22
Q ss_pred CcccCCCCCCeEEecCceecccCCCcCc------CCCccceeeccccccCCC----CCcccc-cCCCCcEEEecCCccC
Q 001922 349 ENLGQNGKLQVLDLSSNKLTGTIPTDLC------SSNQLRILILLKNFLFGP----IPERLG-ACYSLTRVRLGQNYLN 416 (995)
Q Consensus 349 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~------~l~~L~~L~l~~N~l~~~----~p~~l~-~l~~L~~L~l~~N~l~ 416 (995)
..+..+++|++|+|++|.|++.-...++ ....|+.|++++|.+... +...+. ++++|+.|++++|++.
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred ccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 3445566677777777766533222221 123455555555554321 122221 3456666677666664
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.28 E-value=3.1e-14 Score=141.93 Aligned_cols=117 Identities=25% Similarity=0.252 Sum_probs=98.0
Q ss_pred cCCccccCCCCCCeEeccCCcccCccccCcccccceeccccccccCCCcccccccccccccccccccccccCCccccCCC
Q 001922 83 SVPAQILRLDKLTNLSLAGNNFTGSIEIGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALLPVGILKLE 162 (995)
Q Consensus 83 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~~~~l~ 162 (995)
.++..+..+++|++|+|++|+|+....+.++++|++|+|++|.|+.+ +..+..+++|++|++++|+|+.+ ..+..++
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~i~~l~~l~~L~~L~Ls~N~i~~i-~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIKKI-ENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESCCCCHHHHTTCCEEECCEEEECSC-SSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hhhhHHhcccccceeECcccCCCCcccccCCccccChhhcccccccc-ccccccccccccccccccccccc--ccccccc
Confidence 35567888999999999999999766788999999999999999864 44556677899999999999985 4588899
Q ss_pred CCceeeccCccccccCC-ccccCCCCCceeeccCCcccccC
Q 001922 163 KLKYLDLGGNYFFGKIP-NSYGELQGLEYLSLAGNDLTGKI 202 (995)
Q Consensus 163 ~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~ 202 (995)
+|++|+|++|+|+.... ..|..+++|++|+|++|.++...
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 156 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccccCc
Confidence 99999999999974322 46889999999999999988443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.25 E-value=1.4e-13 Score=137.02 Aligned_cols=131 Identities=21% Similarity=0.238 Sum_probs=96.5
Q ss_pred CcEEEcCCC--cccccCCccccCCCCCcEEEcCCCcccCCCCCCccchhhhccccccccccCCCCCCccCcccccceeec
Q 001922 456 LGQLNLSNN--LLSGPLPFSLSNFSSLQILLLSGNQFSGPIPPSIGELRQVLKLDLSRNSLSGEIPPAIGYCNHLTYLDM 533 (995)
Q Consensus 456 L~~L~Ls~N--~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 533 (995)
++.++++++ .+. .+|..++.+++|+.|+|++|+|+ .++ .+..+++|+.|+|++|+|+ .+|..+..+++|++|++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 344455443 233 45667888888888888888888 444 5888888888888888887 57766666778888888
Q ss_pred cCCcccCCCccccccccccCeEeccccccccccC-cccccCCcccEEeccCCCCCCCCCC
Q 001922 534 SQNNLSGSIPPEISNVRILNYLNLSRNHLNQNIP-KSIGSMKSLTIADFSFNDFSGKLPE 592 (995)
Q Consensus 534 s~N~l~~~ip~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~g~~p~ 592 (995)
++|+++ .++ .+..+++|+.|+|++|+++.... ..+..+++|+.|++++|+++...+.
T Consensus 101 ~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 101 SYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEECC-CHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred cccccc-ccc-cccccccccccccccchhccccccccccCCCccceeecCCCccccCccc
Confidence 888887 344 57888888888888888865322 4678888888888888887655443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=1.1e-11 Score=117.88 Aligned_cols=107 Identities=21% Similarity=0.127 Sum_probs=75.9
Q ss_pred ccCccccccccccCCCCccccCcCCCCeEeccCC-cCcCcCCccccccCCCCEEEccCCcCCCCCCccccCCCCcceEEe
Q 001922 260 LLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNN-ALTGEIPYSFINLRQLKLFNLFMNRLHGSIPDYLADLPNLETLGL 338 (995)
Q Consensus 260 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 338 (995)
..+.++++++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3455677777766 45666777778888888655 477666677777888888888888887766777777788888888
Q ss_pred ccCcccccCCCcccCCCCCCeEEecCceec
Q 001922 339 WQNNFTGVIPENLGQNGKLQVLDLSSNKLT 368 (995)
Q Consensus 339 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 368 (995)
++|+|+...+..|. ..+|+.|+|++|++.
T Consensus 88 s~N~l~~l~~~~~~-~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 88 SFNALESLSWKTVQ-GLSLQELVLSGNPLH 116 (156)
T ss_dssp CSSCCSCCCSTTTC-SCCCCEEECCSSCCC
T ss_pred cCCCCcccChhhhc-cccccccccCCCccc
Confidence 88887744444443 346777777777764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.21 E-value=1.3e-11 Score=117.24 Aligned_cols=108 Identities=19% Similarity=0.132 Sum_probs=74.5
Q ss_pred CcccEEECcCCCCCCccCccccCccccCccccccc-cccCCCCccccCcCCCCeEeccCCcCcCcCCccccccCCCCEEE
Q 001922 235 VNLVHLDLSSCELDGQIPHEIGNLKLLDTVFLHIN-LLSGSIPKQLGNLTNLVNLDLSNNALTGEIPYSFINLRQLKLFN 313 (995)
Q Consensus 235 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 313 (995)
...+.++++++.+. ..|..+..+++|+.|++++| .++.+.+.+|.++++|+.|+|++|+|+.+.+.+|.++++|+.|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34456777777776 45666777777777777655 46655566677777777777777777777677777777777777
Q ss_pred ccCCcCCCCCCccccCCCCcceEEeccCccc
Q 001922 314 LFMNRLHGSIPDYLADLPNLETLGLWQNNFT 344 (995)
Q Consensus 314 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 344 (995)
|++|+|+...+..|.. .+|+.|+|++|.+.
T Consensus 87 Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhcc-ccccccccCCCccc
Confidence 7777777544444543 35777777777764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=1.5e-08 Score=96.45 Aligned_cols=124 Identities=23% Similarity=0.160 Sum_probs=77.0
Q ss_pred ccEEECcCCCCCCccCccccCccccCccccccccccCCCCccccCcCCCCeEeccCCcCcCcC--CccccccCCCCEEEc
Q 001922 237 LVHLDLSSCELDGQIPHEIGNLKLLDTVFLHINLLSGSIPKQLGNLTNLVNLDLSNNALTGEI--PYSFINLRQLKLFNL 314 (995)
Q Consensus 237 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L 314 (995)
.+.|+++++... ..+..+..+..+....+... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 455666655432 12344444455555544443 34445567788899999999888643 345677888888888
Q ss_pred cCCcCCCCCCccccCCCCcceEEeccCcccccCCCc-------ccCCCCCCeEEecCcee
Q 001922 315 FMNRLHGSIPDYLADLPNLETLGLWQNNFTGVIPEN-------LGQNGKLQVLDLSSNKL 367 (995)
Q Consensus 315 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-------~~~l~~L~~L~L~~N~l 367 (995)
++|+|+...+-.+....+|+.|++++|.++...... +..+++|+.|| ++.+
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 888888544433444557888888888887544322 44567777665 4443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=1.3e-08 Score=96.86 Aligned_cols=91 Identities=23% Similarity=0.130 Sum_probs=52.5
Q ss_pred cCcccccceeccccccccCCCcccccccccccccccccccccccC--CccccCCCCCceeeccCccccccCCccccCCCC
Q 001922 110 IGNLSSLQFLNISNNQFSGGLDWNYSSLVNLEVFDAYNNNFTALL--PVGILKLEKLKYLDLGGNYFFGKIPNSYGELQG 187 (995)
Q Consensus 110 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 187 (995)
+..+..+..|++.++.+. .++..+..+++|++|+|++|+|+.+. +..+..+++|++|+|++|.|+...+-.+....+
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 334444445555544433 22334455667777777777776642 344566777777777777776433323333446
Q ss_pred CceeeccCCccccc
Q 001922 188 LEYLSLAGNDLTGK 201 (995)
Q Consensus 188 L~~L~Ls~N~l~~~ 201 (995)
|+.|++++|.++..
T Consensus 117 L~~L~L~~Npl~~~ 130 (162)
T d1koha1 117 LEELWLDGNSLSDT 130 (162)
T ss_dssp CSSCCCTTSTTSSS
T ss_pred cceeecCCCCcCcC
Confidence 77777777777644
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.25 E-value=1e-06 Score=90.90 Aligned_cols=148 Identities=13% Similarity=0.042 Sum_probs=99.2
Q ss_pred HHHHHhhccCCCeeeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcce
Q 001922 681 VSDILECVKDGNVIGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNL 759 (995)
Q Consensus 681 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 759 (995)
+....+.|+..+..+.++.+.||+... +++.+++|+...... .....+.+|..+++.+. +--+.+++.+..+++..+
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 344555666555544455578999865 566788888743222 22344678888887774 333567778888888889
Q ss_pred EEEEeccCCChhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 001922 760 LVYEYMRNGSLGEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHHDC---------------------------------- 805 (995)
Q Consensus 760 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------------------------------- 805 (995)
+||++++|.++.+..... .. ...++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 999999998886654211 11 2334566666666676421
Q ss_pred ----------------------CCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 806 ----------------------SPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 806 ----------------------~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11278999999999999876667999998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=1.4e-05 Score=81.65 Aligned_cols=129 Identities=16% Similarity=0.082 Sum_probs=86.1
Q ss_pred eeccCc-eEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCC--CCceeEeEEEecCCcceEEEEeccCCCh
Q 001922 694 IGRGGA-GIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH--RNIVRLLAFCSNKETNLLVYEYMRNGSL 770 (995)
Q Consensus 694 lG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~gsL 770 (995)
+..|.. +.||+....++..+++|..... ....+..|...++.+.. --+.+++.+..+++..++||+|++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCcc----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444554 6899998878888888986332 23346778888877742 2356678888888889999999998766
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 001922 771 GEALHGKKGAFLGWNLRYKIAIEAAKGLCYLHH----------------------------------------------- 803 (995)
Q Consensus 771 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~----------------------------------------------- 803 (995)
.+.. ... ...+.++++.++.||.
T Consensus 94 ~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 4421 111 1122333344444442
Q ss_pred ----c----CCCCeEecCCCCCCEEECCCCCeEEeeecccc
Q 001922 804 ----D----CSPLIVHRDVKSNNILLNSAFEAHVADFGLAK 836 (995)
Q Consensus 804 ----~----~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~ 836 (995)
. ....++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 01227999999999999987667899999875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.41 E-value=1.9e-05 Score=74.61 Aligned_cols=109 Identities=11% Similarity=0.030 Sum_probs=67.6
Q ss_pred CCCCCCeEeccCC-cccCcc------ccCcccccceeccccccccCCC----ccccccccccccccccccccccc----C
Q 001922 90 RLDKLTNLSLAGN-NFTGSI------EIGNLSSLQFLNISNNQFSGGL----DWNYSSLVNLEVFDAYNNNFTAL----L 154 (995)
Q Consensus 90 ~l~~L~~L~L~~n-~l~~~~------~~~~l~~L~~L~Ls~N~i~~~~----~~~~~~l~~L~~L~Ls~n~i~~~----~ 154 (995)
+.+.|++|+|+++ .++... .+...++|++|+|++|.+.... ...+...+.|++|+|++|.|+.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4567888888873 465311 3566777888888888876322 22334456677777777777653 1
Q ss_pred CccccCCCCCceeeccCcccccc-------CCccccCCCCCceeeccCCcc
Q 001922 155 PVGILKLEKLKYLDLGGNYFFGK-------IPNSYGELQGLEYLSLAGNDL 198 (995)
Q Consensus 155 p~~~~~l~~L~~L~L~~N~l~~~-------~p~~l~~l~~L~~L~Ls~N~l 198 (995)
-.++...+.|++|+|++|.+... +...+...++|+.|+++.+..
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 23455566788888877754321 334455567777777766544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.39 E-value=1.2e-05 Score=76.05 Aligned_cols=38 Identities=21% Similarity=0.222 Sum_probs=23.4
Q ss_pred CCCcEEEcCCC-ccccc----CCccccCCCCCcEEEcCCCccc
Q 001922 454 DRLGQLNLSNN-LLSGP----LPFSLSNFSSLQILLLSGNQFS 491 (995)
Q Consensus 454 ~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 491 (995)
++|++|+|+++ .++.. +...+...+.|+.|+|++|.+.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence 56777777764 35422 2334555667777777777765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.37 E-value=0.00022 Score=77.36 Aligned_cols=77 Identities=18% Similarity=0.179 Sum_probs=49.3
Q ss_pred CeeeccCceEEEEEEeCC-CcEEEEEEecCC------CCCChhHHHHHHHHHHhccC-C-C-CceeEeEEEecCCcceEE
Q 001922 692 NVIGRGGAGIVYHGKMPN-GVEIAVKKLLGF------GTHSHDHGFRAEIQTLGNIR-H-R-NIVRLLAFCSNKETNLLV 761 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~-h-p-niv~~~~~~~~~~~~~lv 761 (995)
+.||.|....||+++..+ ++.|+||.-... ..+...++...|.+.++.+. + | .+++++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 358999999999997654 678999975321 11223455667888887763 2 3 34455544 34567899
Q ss_pred EEeccCCCh
Q 001922 762 YEYMRNGSL 770 (995)
Q Consensus 762 ~e~~~~gsL 770 (995)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.64 E-value=0.00014 Score=68.51 Aligned_cols=111 Identities=11% Similarity=0.011 Sum_probs=66.6
Q ss_pred cCCCCCCeEeccC-CcccCcc------ccCcccccceeccccccccCCCc----cccccccccccccccccccccc----
Q 001922 89 LRLDKLTNLSLAG-NNFTGSI------EIGNLSSLQFLNISNNQFSGGLD----WNYSSLVNLEVFDAYNNNFTAL---- 153 (995)
Q Consensus 89 ~~l~~L~~L~L~~-n~l~~~~------~~~~l~~L~~L~Ls~N~i~~~~~----~~~~~l~~L~~L~Ls~n~i~~~---- 153 (995)
.+.+.|++|+|++ +.++... .+...++|++|+|++|.++.... ..+...+.++.+++++|.+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3557788888887 5565311 35667788888888887764322 2334556677777777666542
Q ss_pred CCccccCCCCCceeec--cCccccc----cCCccccCCCCCceeeccCCccc
Q 001922 154 LPVGILKLEKLKYLDL--GGNYFFG----KIPNSYGELQGLEYLSLAGNDLT 199 (995)
Q Consensus 154 ~p~~~~~l~~L~~L~L--~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 199 (995)
+-..+...++|+.++| ++|.+.. .+...+...++|+.|+++.+...
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 2234555666765433 4556643 23444556677777777666543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.48 E-value=0.00012 Score=68.93 Aligned_cols=43 Identities=9% Similarity=-0.004 Sum_probs=25.6
Q ss_pred ccCCCCCceeeccC-cccccc----CCccccCCCCCceeeccCCcccc
Q 001922 158 ILKLEKLKYLDLGG-NYFFGK----IPNSYGELQGLEYLSLAGNDLTG 200 (995)
Q Consensus 158 ~~~l~~L~~L~L~~-N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~ 200 (995)
..+.++|++|+|++ +.++.. +...+...++|++|+|++|.++.
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~ 60 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSND 60 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccH
Confidence 34556677777776 345322 33344566777777777777663
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.46 E-value=0.0034 Score=65.70 Aligned_cols=135 Identities=14% Similarity=0.134 Sum_probs=77.2
Q ss_pred ceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCCCCc-----eeEe--EEEecCCcceEEEEeccCCChh
Q 001922 699 AGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRHRNI-----VRLL--AFCSNKETNLLVYEYMRNGSLG 771 (995)
Q Consensus 699 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~--~~~~~~~~~~lv~e~~~~gsL~ 771 (995)
--.||+++..+|+.|++|...+.. ...+++..|...+..+....+ +..- ..+...+..+.+++|+.|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 358999999899999999975432 235668889888887742221 1111 1223456678899999764432
Q ss_pred h----hh----------c----CC---CCCCCCH-------------------HHHHHHHHHHHHHHHHHHhc----CCC
Q 001922 772 E----AL----------H----GK---KGAFLGW-------------------NLRYKIAIEAAKGLCYLHHD----CSP 807 (995)
Q Consensus 772 ~----~l----------~----~~---~~~~~~~-------------------~~~~~i~~qi~~~l~~LH~~----~~~ 807 (995)
. .+ + .. .....+. .....+...+...++.+... ...
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 00 0 00 0011111 11111222222333333221 134
Q ss_pred CeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 808 LIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 808 ~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
.+||+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 58999999999999743 56899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.23 E-value=0.0064 Score=65.44 Aligned_cols=73 Identities=12% Similarity=0.160 Sum_probs=49.7
Q ss_pred CeeeccCceEEEEEEeCC--------CcEEEEEEecCCCCCChhHHHHHHHHHHhccC-CCCceeEeEEEecCCcceEEE
Q 001922 692 NVIGRGGAGIVYHGKMPN--------GVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIR-HRNIVRLLAFCSNKETNLLVY 762 (995)
Q Consensus 692 ~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 762 (995)
+.|+.|-.-.+|+++.++ .+.|++++.- . . .......+|..+++.+. +.-..++++++.+ .+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 468889999999998653 3456666653 2 2 22345668999998885 4444577777753 6899
Q ss_pred EeccCCChh
Q 001922 763 EYMRNGSLG 771 (995)
Q Consensus 763 e~~~~gsL~ 771 (995)
||++|.++.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999875553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.56 E-value=0.012 Score=61.13 Aligned_cols=153 Identities=10% Similarity=0.021 Sum_probs=78.5
Q ss_pred HHHHHhhccCCCe-----eeccCceEEEEEEeCCCcEEEEEEecCCCCCChhHHHHHHHHHHhccCC-----CCceeEeE
Q 001922 681 VSDILECVKDGNV-----IGRGGAGIVYHGKMPNGVEIAVKKLLGFGTHSHDHGFRAEIQTLGNIRH-----RNIVRLLA 750 (995)
Q Consensus 681 ~~~~~~~~~~~~~-----lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-----pniv~~~~ 750 (995)
+..+...|..++. |..|.--+.|+.+..+| ++++|++.... ..+.+..|++++..+.. |..+...+
T Consensus 8 l~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~---~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~ 83 (316)
T d2ppqa1 8 LRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKD 83 (316)
T ss_dssp HHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred HHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC---CHHHHHHHHHHHHhhhhccccccccceecC
Confidence 4556677777654 44566678899988665 58999874322 23445567777776642 22221110
Q ss_pred ---EEecCCcceEEEEeccCCChhhhh--------------c----CCC---CCCCCHH------------------HHH
Q 001922 751 ---FCSNKETNLLVYEYMRNGSLGEAL--------------H----GKK---GAFLGWN------------------LRY 788 (995)
Q Consensus 751 ---~~~~~~~~~lv~e~~~~gsL~~~l--------------~----~~~---~~~~~~~------------------~~~ 788 (995)
+.........++.+..+......- + ... ....... ...
T Consensus 84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (316)
T d2ppqa1 84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 163 (316)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence 112233445666666654332110 0 000 0000000 011
Q ss_pred HHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEECCCCCeEEeeeccccc
Q 001922 789 KIAIEAAKGLCYLHHD-CSPLIVHRDVKSNNILLNSAFEAHVADFGLAKF 837 (995)
Q Consensus 789 ~i~~qi~~~l~~LH~~-~~~~iiHrDlkp~Nill~~~~~vkl~DfGla~~ 837 (995)
..+..+...+...+.. -..++||+|+.+.||+++.+...-|.||+.+..
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1122222222222211 134599999999999999887778999998763
|